PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhou, Y; Liu, L; Huang, WF; Yuan, M; Zhou, F; Li, XH; Lin, YJ				Zhou, Yong; Liu, Li; Huang, Weifeng; Yuan, Meng; Zhou, Fei; Li, Xianghua; Lin, Yongjun			Overexpression of OsSWEET5 in Rice Causes Growth Retardation and Precocious Senescence	PLOS ONE			English	Article							AUXIN-INDUCED GROWTH; MONOSACCHARIDE TRANSPORTER; ARABIDOPSIS-THALIANA; DISEASE RESISTANCE; SUGAR TRANSPORTERS; POLLEN DEVELOPMENT; MOLECULAR-CLONING; GALACTOSE; GENE; PLANTS	As a novel sugar transporter family, SWEETs play important roles in plant growth and development. Here, we characterized a SWEET gene named OsSWEET5 through its overexpression in rice. Heterologous expression assay indicated that OsSWEET5 encoded a galactose transporter in yeast. OsSWEET5-overexpressing plants displayed the phenotypes of growth retardation and precocious senescence at seedling stage. GC-MS analysis showed that the sugar levels were largely altered in the leaves of the OsSWEET5-overexpressing plants. Molecular analysis revealed that these phenotypes might be due to the transcriptional changes of the genes involved in sugar metabolism and transport. In addition, the transgenic plants showed a lower level of auxin with altered transcription of genes involved in auxin signaling and translocation pathways. However, no obvious phenotype was observed between the amiRNA-OsSWEET5 transgenic lines and WT plants, which could be a result of the functional redundancy of the galactose transporters in rice. Taken together, our findings suggest that OsSWEET5 plays a crucial role in regulating the crosstalk between sugar and auxin in rice.	[Zhou, Yong; Huang, Weifeng; Yuan, Meng; Zhou, Fei; Li, Xianghua; Lin, Yongjun] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Zhou, Yong; Huang, Weifeng; Yuan, Meng; Zhou, Fei; Li, Xianghua; Lin, Yongjun] Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan, Peoples R China; [Liu, Li] Univ Calif Davis, Davis, CA 95616 USA	Huazhong Agricultural University; Huazhong Agricultural University; University of California System; University of California Davis	Lin, YJ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	yongjunlin@mail.hzau.edu.cn	Yuan, Meng/E-4949-2013	Yuan, Meng/0000-0003-1381-9202	National High Technology Research and Development Program of China (863 Program); National Natural Science Foundation of China; National Program of Transgenic Variety Development of China	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program of Transgenic Variety Development of China	This research was funded by the National High Technology Research and Development Program of China (863 Program), the National Natural Science Foundation of China and the National Program of Transgenic Variety Development of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKER L, 1974, ACTA BOT NEERL, V23, P705, DOI 10.1111/j.1438-8677.1974.tb00980.x; Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Baker RF, 2012, MOL PLANT, V5, P766, DOI 10.1093/mp/sss054; Braun DM, 2012, SCIENCE, V335, P173, DOI 10.1126/science.1216828; Buttner M, 2000, BBA-BIOMEMBRANES, V1465, P263, DOI 10.1016/S0005-2736(00)00143-7; Chardon F, 2013, CURR BIOL, V23, P697, DOI 10.1016/j.cub.2013.03.021; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; CHEUNG SP, 1991, PLANT CELL PHYSIOL, V32, P1015, DOI 10.1093/oxfordjournals.pcp.a078164; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Du H, 2012, J EXP BOT, V63, P6467, DOI 10.1093/jxb/ers300; Du H, 2011, PLANT MOL BIOL, V77, P547, DOI 10.1007/s11103-011-9830-9; Eom JS, 2011, PLANT PHYSIOL, V157, P109, DOI 10.1104/pp.111.176982; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; Gamas P, 1996, MOL PLANT MICROBE IN, V9, P233, DOI 10.1094/MPMI-9-0233; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Jiang HW, 2007, PLANT J, V52, P197, DOI 10.1111/j.1365-313X.2007.03221.x; Kant S, 2009, PLANT SIGNAL BEHAV, V4, P1174, DOI 10.4161/psb.4.12.10043; Kant S, 2009, PLANT PHYSIOL, V151, P691, DOI 10.1104/pp.109.143875; KENYON WH, 1985, PLANT PHYSIOL, V77, P183, DOI 10.1104/pp.77.1.183; Klemens PAW, 2013, PLANT PHYSIOL, V163, P1338, DOI 10.1104/pp.113.224972; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KRUL WR, 1977, PHYSIOL PLANTARUM, V41, P249, DOI 10.1111/j.1399-3054.1977.tb04878.x; Lalonde S, 1999, PLANT CELL, V11, P707, DOI 10.1105/tpc.11.4.707; LeClere S, 2010, PLANT PHYSIOL, V153, P306, DOI 10.1104/pp.110.155226; Lee EJ, 2007, PLANT CELL PHYSIOL, V48, P405, DOI 10.1093/pcp/pcm009; LELOIR LF, 1951, ARCH BIOCHEM BIOPHYS, V33, P186, DOI 10.1016/0003-9861(51)90096-3; Leon P, 2003, TRENDS PLANT SCI, V8, P110, DOI 10.1016/S1360-1385(03)00011-6; Li CL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002196; Liu L, 2010, PLANT PHYSIOL, V153, P1239, DOI 10.1104/pp.110.157123; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu LX, 2012, PLANT CELL REP, V31, P1173, DOI 10.1007/s00299-012-1239-7; Mao DH, 2011, THEOR APPL GENET, V122, P373, DOI 10.1007/s00122-010-1453-z; Mishra BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004502; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; O'Donoghue EM, 2009, PLANTA, V229, P709, DOI 10.1007/s00425-008-0862-6; Ohto MA, 2006, PLANT CELL PHYSIOL, V47, P1603, DOI 10.1093/pcp/pcl027; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Paul MJ, 2001, J EXP BOT, V52, P1383, DOI 10.1093/jexbot/52.360.1383; Poschet G, 2010, PLANT CELL PHYSIOL, V51, P1571, DOI 10.1093/pcp/pcq100; ROBERTS RM, 1971, PLANT PHYSIOL, V48, P36, DOI 10.1104/pp.48.1.36; Rojas-Escudero E, 2004, J CHROMATOGR A, V1027, P117, DOI 10.1016/j.chroma.2003.10.131; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Ruan YL, 2012, MOL PLANT, V5, P763, DOI 10.1093/mp/sss046; Sagar M, 2013, PLANT PHYSIOL, V161, P1362, DOI 10.1104/pp.113.213843; Sairanen I, 2012, PLANT CELL, V24, P4907, DOI 10.1105/tpc.112.104794; SAUER N, 1990, EMBO J, V9, P3045, DOI 10.1002/j.1460-2075.1990.tb07500.x; Sauer N, 2007, FEBS LETT, V581, P2309, DOI 10.1016/j.febslet.2007.03.048; Schneidereit A, 2005, PLANTA, V221, P48, DOI 10.1007/s00425-004-1420-5; Sherson SM, 2000, PLANT J, V24, P849, DOI 10.1046/j.1365-313x.2000.00935.x; Slewinski TL, 2011, MOL PLANT, V4, P641, DOI 10.1093/mp/ssr051; Slewinski TL, 2010, PLANT SIGNAL BEHAV, V5, P687, DOI 10.4161/psb.5.6.11575; Slewinski TL, 2009, J EXP BOT, V60, P881, DOI 10.1093/jxb/ern335; STADLER R, 1995, PLANT PHYSIOL, V107, P33, DOI 10.1104/pp.107.1.33; Stadler R, 2003, PLANT PHYSIOL, V133, P528, DOI 10.1104/pp.103.024240; Tang N, 2012, PLANT PHYSIOL, V158, P1755, DOI 10.1104/pp.111.190389; Truernit E, 1999, PLANT J, V17, P191, DOI 10.1046/j.1365-313X.1999.00372.x; Wang YQ, 2007, PLANT MOL BIOL, V65, P439, DOI 10.1007/s11103-007-9228-x; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Williams LE, 2000, TRENDS PLANT SCI, V5, P283, DOI 10.1016/S1360-1385(00)01681-2; YAMAMOTO R, 1988, PLANT PHYSIOL, V86, P1223, DOI 10.1104/pp.86.4.1223; YAMAMOTO R, 1981, PHYSIOL PLANTARUM, V53, P543, DOI 10.1111/j.1399-3054.1981.tb02748.x; Ye RJ, 2012, PLANT CELL REP, V31, P1159, DOI 10.1007/s00299-012-1238-8; Yuan M, 2013, MOL PLANT, V6, P665, DOI 10.1093/mp/sst035; Zhang H, 2010, PLANT CELL, V22, P672, DOI 10.1105/tpc.109.073668	67	57	79	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94210	10.1371/journal.pone.0094210	http://dx.doi.org/10.1371/journal.pone.0094210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709840	gold, Green Submitted, Green Published			2022-12-27	WOS:000334159800120
J	Kihira, Y; Miyake, M; Hirata, M; Hoshina, Y; Kato, K; Shirakawa, H; Sakaue, H; Yamano, N; Izawa-Ishizawa, Y; Ishizawa, K; Ikeda, Y; Tsuchiya, K; Tamaki, T; Tomita, S				Kihira, Yoshitaka; Miyake, Mariko; Hirata, Manami; Hoshina, Yoji; Kato, Kana; Shirakawa, Hitoshi; Sakaue, Hiroshi; Yamano, Noriko; Izawa-Ishizawa, Yuki; Ishizawa, Keisuke; Ikeda, Yasumasa; Tsuchiya, Koichiro; Tamaki, Toshiaki; Tomita, Shuhei			Deletion of Hypoxia-Inducible Factor-1 alpha in Adipocytes Enhances Glucagon-Like Peptide-1 Secretion and Reduces Adipose Tissue Inflammation	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INSULIN-RESISTANCE; MACROPHAGE INFILTRATION; 3T3-L1 ADIPOCYTES; MICE DEFICIENT; TNF-ALPHA; KINASE-A; OBESITY; EXPRESSION; ADIPONECTIN	It is known that obese adipose tissues are hypoxic and express hypoxia-inducible factor (HIF)-1 alpha. Although some studies have shown that the expression of HIF-1 alpha in adipocytes induces glucose intolerance, the mechanisms are still not clear. In this study, we examined its effects on the development of type 2 diabetes by using adipocyte-specific HIF-1 alpha knockout (ahKO) mice. ahKO mice showed improved glucose tolerance compared with wild type (WT) mice. Macrophage infiltration and mRNA levels of monocyte chemotactic protein-1 (MCP-1) and tumor necrosis factor alpha (TNF alpha) were decreased in the epididymal adipose tissues of high fat diet induced obese ahKO mice. The results indicated that the obesity-induced adipose tissue inflammation was suppressed in ahKO mice. In addition, in the ahKO mice, serum insulin levels were increased under the free-feeding but not the fasting condition, indicating that postprandial insulin secretion was enhanced. Serum glucagon-like peptide-1 (GLP-1) levels were also increased in the ahKO mice. Interestingly, adiponectin, whose serum levels were increased in the obese ahKO mice compared with the obese WT mice, stimulated GLP-1 secretion from cultured intestinal L cells. Therefore, insulin secretion may have been enhanced through the adiponectin-GLP-1 pathway in the ahKO mice. Our results suggest that the deletion of HIF-1 alpha in adipocytes improves glucose tolerance by enhancing insulin secretion through the GLP-1 pathway and by reducing macrophage infiltration and inflammation in adipose tissue.	[Kihira, Yoshitaka; Hirata, Manami; Hoshina, Yoji; Yamano, Noriko; Izawa-Ishizawa, Yuki; Ikeda, Yasumasa; Tamaki, Toshiaki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pharmacol, Tokushima 770, Japan; [Miyake, Mariko; Ishizawa, Keisuke; Tsuchiya, Koichiro] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Med Pharmacol, Tokushima 770, Japan; [Hirata, Manami; Hoshina, Yoji] Univ Tokushima, Fac Med, Student Lab, Tokushima 770, Japan; [Kato, Kana; Shirakawa, Hitoshi] Tohoku Univ, Grad Sch Agr Sci, Lab Nutr, Sendai, Miyagi 980, Japan; [Sakaue, Hiroshi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Nutr & Metab, Tokushima 770, Japan; [Tomita, Shuhei] Tottori Univ, Fac Med, Div Mol Pharmacol, Tottori 680, Japan	Tokushima University; Tokushima University; Tokushima University; Tohoku University; Tokushima University; Tottori University	Tomita, S (corresponding author), Tottori Univ, Fac Med, Div Mol Pharmacol, Tottori 680, Japan.	tomita@med.tottori-u.ac.jp	Yamano-Adachi, Noriko/AAH-8605-2019; Sakaue, Hiroshi/ABE-2337-2021; Shirakawa, Hitoshi/D-1406-2009	Yamano-Adachi, Noriko/0000-0002-2167-5379; Sakaue, Hiroshi/0000-0002-2468-2363; Ikeda, Yasumasa/0000-0003-4318-7349; SHIRAKAWA, HITOSHI/0000-0002-4828-5274; Hoshina, Yoji/0000-0003-0228-664X	Kato Memorial Bioscience Foundation; KAKENHI [23790089]; Grants for the Regional Innovation Cluster Program; SENSHIN Medical Research Foundation; The Naito Foundation; Grants-in-Aid for Scientific Research [25860063, 24590381, 23790089] Funding Source: KAKEN	Kato Memorial Bioscience Foundation; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants for the Regional Innovation Cluster Program; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); The Naito Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by the Kato Memorial Bioscience Foundation, by KAKENHI (23790089), by Grants for the Regional Innovation Cluster Program, by SENSHIN Medical Research Foundation and by The Naito Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouzakri K, 2007, J BIOL CHEM, V282, P7783, DOI 10.1074/jbc.M608602200; Chai WD, 2012, DIABETES, V61, P888, DOI 10.2337/db11-1073; Chen XH, 2010, MOL CELL ENDOCRINOL, V328, P63, DOI 10.1016/j.mce.2010.07.005; Chung LTK, 2009, BIOCHEM BIOPH RES CO, V390, P613, DOI 10.1016/j.bbrc.2009.10.015; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Curat CA, 2004, DIABETES, V53, P1285, DOI 10.2337/diabetes.53.5.1285; DRUCKER DJ, 1994, MOL ENDOCRINOL, V8, P1646, DOI 10.1210/me.8.12.1646; Gao H, 2007, ENDOCRINE, V32, P90, DOI 10.1007/s12020-007-9011-4; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; HAFFNER SM, 1995, DIABETES, V44, P1386, DOI 10.2337/diabetes.44.12.1386; Halberg N, 2008, ENDOCRIN METAB CLIN, V37, P753, DOI 10.1016/j.ecl.2008.07.002; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Jiang CT, 2013, J BIOL CHEM, V288, P3844, DOI 10.1074/jbc.M112.426338; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Langin D, 2006, TRENDS ENDOCRIN MET, V17, P314, DOI 10.1016/j.tem.2006.08.003; Lee YS, 2012, DIABETOLOGIA, V55, P2456, DOI 10.1007/s00125-012-2592-3; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Marchetti P, 2013, ADV EXP MED BIOL, V771, P288; Mojsilovic-Petrovic J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-12; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Stolarczyk E, 2013, CELL METAB, V17, P520, DOI 10.1016/j.cmet.2013.02.019; Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3717, DOI 10.1210/jc.86.8.3717; Tomita S, 2003, MOL CELL BIOL, V23, P6739, DOI 10.1128/MCB.23.19.6739-6749.2003; Vilsboll T, 2003, J CLIN ENDOCR METAB, V88, P2706, DOI 10.1210/jc.2002-021873; Wang B, 2007, PFLUG ARCH EUR J PHY, V455, P479, DOI 10.1007/s00424-007-0301-8; Wang P, 2008, J CELL PHYSIOL, V216, P3, DOI 10.1002/jcp.21386; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yu JN, 2011, EUR J CELL BIOL, V90, P1000, DOI 10.1016/j.ejcb.2011.06.004; Zhang XM, 2010, J BIOL CHEM, V285, P32869, DOI 10.1074/jbc.M110.135509	42	45	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93856	10.1371/journal.pone.0093856	http://dx.doi.org/10.1371/journal.pone.0093856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705496	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500078
J	Ul-Haq, Z; Mackay, DF; Pell, JP				Ul-Haq, Zia; Mackay, Daniel F.; Pell, Jill P.			Association between Self-Reported General and Mental Health and Adverse Outcomes: A Retrospective Cohort Study of 19 625 Scottish Adults	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; QUALITY-OF-LIFE; RATED HEALTH; PSYCHOLOGICAL DISTRESS; FOLLOW-UP; WHITEHALL-II; MORTALITY; PARTICIPANTS; RISK; METAANALYSIS	Objective: Self-reported general health and mental health are independent predictors of all-cause mortality. This study examines whether they are also independent predictors of incident cancer, coronary heart disease and psychiatric hospitalisation. Methods: We conducted a retrospective, population cohort study by linking the 19 625 Scottish adults who participated in the Scottish Health Surveys 1995-2003, to hospital admissions, cancer registration and death certificate records. We conducted Cox proportional hazard models adjusting for potential confounders including age, sex, socioeconomic status, alcohol, smoking status, body mass index, hypertension and diabetes. Results: Poor general health was reported by 1215 (6.2%) participants and was associated with cancer registrations (adjusted Hazard Ratio [HR] 1.30, 95% Cl 1.10, 1.55), coronary heart disease events (adjusted HR 2.30, 95% Cl 1.86, 2.84) and psychiatric hospitalisations (adjusted HR 2.42, 95% Cl 1.65, 3.56). There was evidence of dose relationships and the associations remained significant after adjustment for mental health. 3172 (16%) participants had poor mental health (GHQ >= 4). After adjustment for general health, the associations between poor mental health and coronary heart disease events (adjusted HR 1.36, 95% Cl 1.13, 1.63) and all-cause death (adjusted HR 1.38, 95% Cl 1.23, 1.55) became non-significant, but mental health remained associated with psychiatric hospitalisations (fully adjusted HR 2.02, 95% Cl 1.48, 2.75). Conclusion: Self-reported general health is a significant predictor of a range of clinical outcomes independent of mental health. The association between mental health and non-psychiatric outcomes is mediated by general health but it is an independent predictor of psychiatric outcome. Individuals with poor general health or mental health warrant close attention.	[Ul-Haq, Zia; Mackay, Daniel F.; Pell, Jill P.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Ul-Haq, Zia] Khyber Med Univ, KPK, Inst Publ Hlth & Social Sci, Peshawar, Pakistan	University of Glasgow; Khyber Medical University	Pell, JP (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	jill.pell@glasgow.ac.uk	Ul Haq, Zia/GZM-0053-2022	Pell, Jill/0000-0002-8898-7035; ul haq, zia/0000-0001-5124-2171				Badawi G, 2013, J AFFECT DISORDERS, V145, P100, DOI 10.1016/j.jad.2012.07.018; Bath PA, 2003, GERONTOLOGIST, V43, P387, DOI 10.1093/geront/43.3.387; Benjamins MR, 2004, SOC SCI MED, V59, P1297, DOI 10.1016/j.socscimed.2003.01.001; Benyamini Y, 2000, J GERONTOL B-PSYCHOL, V55, pP107, DOI 10.1093/geronb/55.2.P107; Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Gao W, 2010, EUR J CANCER, V46, P2036, DOI 10.1016/j.ejca.2010.03.033; General Register Office, 1966, CLASS OCC; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Gray L, 2010, INT J EPIDEMIOL, V39, P345, DOI 10.1093/ije/dyp155; Hamer M, 2009, J PSYCHOSOM RES, V66, P255, DOI 10.1016/j.jpsychores.2008.11.002; Hirve S, 2012, INT J EPIDEMIOL, V41, P1719, DOI 10.1093/ije/dys163; Idler EL, 2000, AM J EPIDEMIOL, V152, P874, DOI 10.1093/aje/152.9.874; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Kivimaki M, 2003, BRIT MED J, V327, P364, DOI 10.1136/bmj.327.7411.364; Kosloski K, 2005, J GERONTOL B-PSYCHOL, V60, pP296, DOI 10.1093/geronb/60.6.P296; Latham K, 2013, J GERONTOL B-PSYCHOL, V68, P107, DOI 10.1093/geronb/gbs104; Lazzarino AI, 2013, PSYCHOSOM MED, V75, P311, DOI 10.1097/PSY.0b013e3182898e6d; Lekander M, 2004, PSYCHOSOM MED, V66, P559, DOI 10.1097/01.psy.0000130491.95823.94; Martikainen P, 1999, SOC SCI MED, V48, P1117, DOI 10.1016/S0277-9536(98)00416-X; Mavaddat N, 2011, J EPIDEMIOL COMMUN H, V65, P800, DOI 10.1136/jech.2009.090845; Montlahuc C, 2011, NEUROLOGY, V77, P1457, DOI 10.1212/WNL.0b013e31823303e1; Guimaraes JMN, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-676; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Nielsen ABS, 2008, SCAND J PUBLIC HEALT, V36, P3, DOI 10.1177/1403494807085242; Oguz S, 2013, MEASURING NATL WELL; Robinson KL, 2004, ANN EPIDEMIOL, V14, P467, DOI 10.1016/j.annepidem.2003.11.007; Russ TC, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4933; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Scotland NHS, 2010, HOSP REC DAT MON; Sen A, 2002, BRIT MED J, V324, P860, DOI 10.1136/bmj.324.7342.860; Smith KW, 1999, QUAL LIFE RES, V8, P447, DOI 10.1023/A:1008928518577; St John P, 2013, J GERIATR PSYCH NEUR, V26, P41, DOI 10.1177/0891988713476369; Stansfeld SA, 2002, INT J EPIDEMIOL, V31, P248, DOI 10.1093/ije/31.1.248; Tiainen K, 2013, AGE AGEING, V42, P468, DOI 10.1093/ageing/aft030; Ul-Haq Z, 2013, PSYCHOL MED, V1-10; Ul-Haq Z, 2014, J EPIDEMIOL COMMUN H, V68, P340, DOI 10.1136/jech-2013-203077; Ul-Haq Z, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-143; van der Linde RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065290; World Health Organization, 1996, HLTH INT SURV INT HA	40	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93857	10.1371/journal.pone.0093857	http://dx.doi.org/10.1371/journal.pone.0093857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6MJ	24705574	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000334107500079
J	Wu, J; Bakerink, KJ; Evangelista, ME; Thomas, GH				Wu, Juan; Bakerink, Katelyn J.; Evangelista, Meagan E.; Thomas, Graham H.			Cytoplasmic Capes Are Nuclear Envelope Intrusions That Are Enriched in Endosomal Proteins and Depend upon beta(H)-Spectrin and Annexin B9	PLOS ONE			English	Article							ANKYRIN-G; MEMBRANE; SPECTRIN; BETA(HEAVY)-SPECTRIN; TRANSPORT; ACTIVATION; CRUMBS; CELLS; BINDS; STAR	It is increasingly recognized that non-erythroid spectrins have roles remote from the plasma membrane, notably in endomembrane trafficking. The large spectrin isoform, beta(H), partners with Annexin B9 to modulate endosomal processing of internalized proteins. This modulation is focused on the early endosome through multivesicular body steps of endocytic processing and loss of either protein appears to cause a traffic jam before removal of ubiquitin at the multivesicular body. We previously reported that beta(H)/Annexin B9 influenced EGF receptor signaling. While investigating this effect we noticed that mSptiz, the membrane bound precursor of the secreted EGF receptor ligand sSpitz, is located in striking intrusions of the nuclear membrane. Here we characterize these structures and identify them as `cytoplasmic capes', which were previously identified in old ultrastructural studies and probably coincide with recently recognized sites of non-nuclear-pore RNA export. We show that cytoplasmic capes contain multiple endosomal markers and that their existence is dependent upon bH and Annexin B9. Diminution of these structures does not lead to a change in mSpitz processing. These results extend the endosomal influence of bH and its partner Annexin B9 to this unusual compartment at the nuclear envelope.	[Wu, Juan; Bakerink, Katelyn J.; Evangelista, Meagan E.; Thomas, Graham H.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Wu, Juan; Bakerink, Katelyn J.; Evangelista, Meagan E.; Thomas, Graham H.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Wu, Juan] Harvard Univ, Sch Med, Sch Publ Hlth, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health	Thomas, GH (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	gxt5@psu.edu			National Science Foundation [MCB-1122013]; Direct For Biological Sciences [1122013] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by grant # MCB-1122013 from the National Science Foundation (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DERKSEN J, 1974, CELL DIFFER DEV, V3, P157, DOI 10.1016/0045-6039(74)90027-X; Eden ER, 2009, BIOCHEM SOC T, V37, P173, DOI 10.1042/BST0370173; Friedman JR, 2013, MOL BIOL CELL, V24, P1030, DOI 10.1091/mbc.E12-10-0733; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; GAY H, 1956, COLD SPRING HARB SYM, V21, P257, DOI 10.1101/SQB.1956.021.01.021; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lee S-K, 2010, MECH DEV; Lorenzo DN, 2010, J CELL BIOL, V189, P143, DOI 10.1083/jcb.200905158; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Natalizio BJ, 2013, TRENDS CELL BIOL, V23, P365, DOI 10.1016/j.tcb.2013.03.006; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Phillips MD, 2006, J CELL SCI, V119, P1361, DOI 10.1242/jcs.02839; Pilecka I, 2007, EUR J CELL BIOL, V86, P533, DOI 10.1016/j.ejcb.2007.04.004; Pyrzynska B, 2009, MOL ONCOL, V3, P321, DOI 10.1016/j.molonc.2009.06.001; Rose A, 2012, TRENDS CELL BIOL, V22, P509, DOI 10.1016/j.tcb.2012.07.003; Rousso T, 2010, DEVELOPMENT, V137, P3427, DOI 10.1242/dev.049858; Schlesinger A, 2004, DEV CELL, V7, P535, DOI 10.1016/j.devcel.2004.09.001; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; Sridharan D, 2003, J CELL SCI, V116, P823, DOI 10.1242/jcs.00294; THOMAS GH, 1994, DEVELOPMENT, V120, P2039; THOMOPOULOS GN, 1983, CELL TISSUE RES, V228, P497; Tjota M, 2011, J CELL SCI, V124, P2914, DOI 10.1242/jcs.078667; Tsruya R, 2002, GENE DEV, V16, P222, DOI 10.1101/gad.214202; Tsruya R, 2007, EMBO J, V26, P1211, DOI 10.1038/sj.emboj.7601581; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Williams JA, 2004, J CELL SCI, V117, P771, DOI 10.1242/jcs.00922; Yogev S, 2008, EMBO J, V27, P1219, DOI 10.1038/emboj.2008.58; Yogev S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000505	34	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93680	10.1371/journal.pone.0093680	http://dx.doi.org/10.1371/journal.pone.0093680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705398	Green Submitted, Green Published, gold			2022-12-27	WOS:000334107500055
J	Zhang, YQ; Zheng, L; Huang, J; Gao, F; Lin, XS; He, L; Li, D; Li, ZJ; Ding, Y; Chen, LH				Zhang, Yuqin; Zheng, Lin; Huang, Jing; Gao, Fei; Lin, Xiaoshan; He, Lian; Li, Dan; Li, Zhijun; Ding, Yi; Chen, Longhua			MiR-124 Radiosensitizes Human Colorectal Cancer Cells by Targeting PRRX1	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELL; EXPRESSION PROFILES; IONIZING-RADIATION; TUMOR-CELLS; RADIORESISTANCE; RESISTANCE; EMT; MICRORNAS; GROWTH	One of the challenges in the treatment of colorectal cancer patients is that these tumors show resistance to radiation. MicroRNAs ( miRNAs) are involved in essential biological activities, including chemoresistance and radioresistance. Several research studies have indicated that miRNA played an important role in sensitizing cellular response to ionizing radiation (IR). In this study, we found that miR-124 was significantly down-regulated both in CRC-derived cell lines and clinical CRC samples compared with adjacent non-tumor colorectal tissues, MiR-124 could sensitize human colorectal cancer cells to IR in vitro and in vivo. We identified PRRX1, a new EMT inducer and stemness regulator as a novel direct target of miR-124 by using target prediction algorithms and luciferase assay. PRRX1 knockdown could sensitize CRC cells to IR similar to the effects caused by miR-124. Overexpression of PRRX1 in stably overexpressed-miR-124 cell lines could rescue the effects of radiosensitivity enhancement brought by miR-124. Taking these observations into consideration, we illustrated that miR-124 could increase the radiosensitivity of CRC cells by blocking the expression of PRRX1, which indicated miR-124 could act as a great therapeutic target for CRC patients.	[Zhang, Yuqin; Lin, Xiaoshan; He, Lian; Li, Dan; Li, Zhijun; Ding, Yi; Chen, Longhua] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China; [Zheng, Lin] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Huang, Jing] Guangdong Med Coll, Affiliated Hosp, Dept Canc Ctr, Zhanjiang, Guangdong, Peoples R China; [Gao, Fei] Jinan Univ, Affiliated Hosp 1, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Guangdong Medical University; Jinan University	Ding, Y (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China.	dingyi197980@126.com; chenlhsmu@126.com	Ding, Yi/CAG-6304-2022	Ding, Yi/0000-0001-5035-9255	National Natural Scientific Foundation of China [81272507]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Scientific Foundation of China (Grant No. 81272507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Ansieau S, 2013, CANCER LETT, V338, P63, DOI 10.1016/j.canlet.2012.05.014; Beskow C, 2009, BRIT J CANCER, V101, P816, DOI 10.1038/sj.bjc.6605201; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Chaachouay H, 2011, RADIOTHER ONCOL, V99, P287, DOI 10.1016/j.radonc.2011.06.002; Deng XB, 2013, J NEURO-ONCOL, V114, P263, DOI 10.1007/s11060-013-1179-2; Dumont FJ, 2012, CURR CANCER DRUG TAR, V12, P899; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Fukuda K, 2004, BRIT J CANCER, V91, P1543, DOI 10.1038/sj.bjc.6602187; Guo P, 2013, EXP CELL RES; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Inoue A, 2002, CANCER CELL, V2, P279, DOI 10.1016/S1535-6108(02)00155-1; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jung IL, 2010, INT J MOL MED, V25, P517, DOI 10.3892/ijmm_00000372; KASID U, 1987, SCIENCE, V237, P1039, DOI 10.1126/science.3616625; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kitahara O, 2002, NEOPLASIA, V4, P295, DOI 10.1038/sj.neo.7900251; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Liang YJ, 2013, CARCINOGENESIS, V34, P713, DOI 10.1093/carcin/bgs383; Liu KJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/867537; Liu YF, 2013, STAT INTERFACE, V6, P1; Lv ZH, 2013, MOL MED REP, V8, P345, DOI 10.3892/mmr.2013.1561; Magnon C, 2007, J CLIN INVEST, V117, P1844, DOI 10.1172/JCI30269; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marie-Egyptienne DT, 2013, CANCER LETT, V341, P63, DOI 10.1016/j.canlet.2012.11.019; Metheetrairut C, 2013, CURR OPIN GENET DEV, V23, P12, DOI 10.1016/j.gde.2013.01.002; Moncharmont C, 2012, CANCER LETT, V322, P139, DOI 10.1016/j.canlet.2012.03.024; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Niemoeller OM, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-29; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Reichert M, 2013, GENE DEV, V27, P288, DOI 10.1101/gad.204453.112; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shi LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078344; Shimozaki K, 2013, J NEUROSCI, V33, P4066, DOI 10.1523/JNEUROSCI.4586-12.2013; Silber J, 2013, NEURO-ONCOLOGY, V15, P83, DOI 10.1093/neuonc/nos281; Takahashi Y, 2013, BRIT J CANCER, V109, P307, DOI 10.1038/bjc.2013.339; Theys J, 2011, RADIOTHER ONCOL, V99, P392, DOI 10.1016/j.radonc.2011.05.044; Wang P, 2013, ONCOGENE; Wang P, 2013, GASTROENTEROLOGY, V145, P1133, DOI 10.1053/j.gastro.2013.07.048; Wei J, 2013, CANCER RES, V73, P3913, DOI 10.1158/0008-5472.CAN-12-4318; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Xia HP, 2012, J BIOL CHEM, V287, P9962, DOI 10.1074/jbc.M111.332627; Xu DP, 2011, CARCINOGENESIS, V32, P488, DOI 10.1093/carcin/bgr007; Xu XL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-276; Yaromina A, 2007, RADIOTHER ONCOL, V83, P304, DOI 10.1016/j.radonc.2007.04.020; Zafar F, 2010, RADIAT RES, V173, P27, DOI 10.1667/RR1910.1; Zhang HW, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-84; Zhang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070300; Zhuang WZ, 2011, INT J CANCER, V129, P2720, DOI 10.1002/ijc.25975	54	61	72	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93917	10.1371/journal.pone.0093917	http://dx.doi.org/10.1371/journal.pone.0093917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705396	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500094
J	Anderson, SC; Monnahan, CC; Johnson, KF; Ono, K; Valero, JL				Anderson, Sean C.; Monnahan, Cole C.; Johnson, Kelli F.; Ono, Kotaro; Valero, Juan L.			ss3sim: An R Package for Fisheries Stock Assessment Simulation with Stock Synthesis	PLOS ONE			English	Article							AD MODEL BUILDER; NATURAL MORTALITY; AGE; PERFORMANCE; FRAMEWORK; DYNAMICS; BIAS; FLR	Simulation testing is an important approach to evaluating fishery stock assessment methods. In the last decade, the fisheries stock assessment modeling framework Stock Synthesis (SS3) has become widely used around the world. However, there lacks a generalized and scriptable framework for SS3 simulation testing. Here, we introduce ss3sim, an R package that facilitates reproducible, flexible, and rapid end-to-end simulation testing with SS3. ss3sim requires an existing SS3 model configuration along with plain-text control files describing alternative population dynamics, fishery properties, sampling scenarios, and assessment approaches. ss3sim then generates an underlying `truth' from a specified operating model, samples from that truth, modifies and runs an estimation model, and synthesizes the results. The simulations can be run in parallel, reducing runtime, and the source code is free to be modified under an open-source MIT license. ss3sim is designed to explore structural differences between the underlying truth and assumptions of an estimation model, or between multiple estimation model configurations. For example, ss3sim can be used to answer questions about model misspecification, retrospective patterns, and the relative importance of different types of fisheries data. We demonstrate the software with an example, discuss how ss3sim complements other simulation software, and outline specific research questions that ss3sim could address.	[Anderson, Sean C.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Monnahan, Cole C.] Univ Washington, Seattle, WA 98195 USA; [Johnson, Kelli F.; Ono, Kotaro] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Valero, Juan L.] Ctr Adv Populat Assessment Methodol, La Jolla, CA USA	Simon Fraser University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Anderson, SC (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada.	sean@seananderson.ca	Anderson, Sean C./AFN-3267-2022	Anderson, Sean C./0000-0001-9563-1937; ono, kotaro/0000-0003-4236-5916	Fulbright Canada; NSERC; Garfield Weston Foundation/B.C. Packers Ltd.; Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under NOAA [NA10OAR4320148, 2218]	Fulbright Canada; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Garfield Weston Foundation/B.C. Packers Ltd.; Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under NOAA	SCA was supported by Fulbright Canada (hosted by Trevor A. Branch), NSERC, and a Garfield Weston Foundation/B.C. Packers Ltd. Graduate Fellowship in Marine Sciences. This publication was partially funded by the Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under NOAA Cooperative Agreement NA10OAR4320148, Contribution No. 2218. This research addresses the methods component of the good practices guide to stock assessment program of the Center for the Advancement of Population Assessment Methodology (CAPAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beamish R. J., 1995, CAN SPEC PUBL FISH A, V121; Bolker BM, 2013, METHODS ECOL EVOL, V4, P501, DOI 10.1111/2041-210X.12044; Cope JM, 2013, FISH RES, V142, P3, DOI 10.1016/j.fishres.2012.03.006; Crone PR, EVALUATION IN PRESS; Crone PR, 2013, WORKSHOP SERIES REPO, V1; Deroba JJ, 2015, ICES J MAR SCI, V72, P19, DOI 10.1093/icesjms/fst237; Deroba JJ, 2013, FISH RES, V146, P27, DOI 10.1016/j.fishres.2013.03.015; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Fu CH, 2001, CAN J FISH AQUAT SCI, V58, P1613, DOI 10.1139/f01-095; Gulland JA, 1983, FISH STOCK ASSESSMEN; Haltuch MA, 2013, TECHNICAL REPORT; Helu SL, 2000, CAN J FISH AQUAT SCI, V57, P1784, DOI 10.1139/cjfas-57-9-1784; HILBORN R, 1987, CAN J FISH AQUAT SCI, V44, P1366, DOI 10.1139/f87-163; HILBORN R, 1992; Hill KT, 2012, TECHNICAL REPORT; Hillary R, 2009, AQUAT LIVING RESOUR, V22, P225, DOI 10.1051/alr/2009023; Hurtado-Ferro F, 2014, FISH RES, V158, P102, DOI 10.1016/j.fishres.2013.10.001; Jiao Y, 2012, ICES J MAR SCI, V69, P105, DOI 10.1093/icesjms/fsr184; Johnson KF, 2015, ICES J MAR SCI, V72, P137, DOI 10.1093/icesjms/fsu055; Kell LT, 2007, ICES J MAR SCI, V64, P640, DOI 10.1093/icesjms/fsm012; Lee HH, 2012, FISH RES, V125, P254, DOI 10.1016/j.fishres.2012.03.001; Lee HH, 2011, FISH RES, V109, P89, DOI 10.1016/j.fishres.2011.01.021; Legault CM, 2008, 0901 NOAA NMFS; Magnusson A, 2007, FISH FISH, V8, P337, DOI 10.1111/j.1467-2979.2007.00258.x; Maunder MN, 2013, FISH RES, V142, P61, DOI 10.1016/j.fishres.2012.07.025; Methot RD, 2013, FISH RES, V142, P86, DOI 10.1016/j.fishres.2012.10.012; Methot RD, 2011, CAN J FISH AQUAT SCI, V68, P1744, DOI 10.1139/F2011-092; Mohn R, 1999, ICES J MAR SCI, V56, P473, DOI 10.1006/jmsc.1999.0481; Ono K, 2015, ICES J MAR SCI, V72, P31, DOI 10.1093/icesjms/fsu007; Peterman RM, 2004, ICES J MAR SCI, V61, P1331, DOI 10.1016/j.icesjms.2004.08.017; Piner KR, 2011, MAR COAST FISH, V3, P336, DOI 10.1080/19425120.2011.611005; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; R Core Team, 2021, R LANGUAGE ENV STAT; ROSENBERG AA, 1994, CAN J FISH AQUAT SCI, V51, P2715, DOI 10.1139/f94-271; Royama T., 1992, ANAL POPULATION ECOL; Schirripa MJ, 2009, ICES J MAR SCI, V66, P1605, DOI 10.1093/icesjms/fsp043; Taylor I, 2013, R4SS R CODE STOCK SY; Vert-pre KA, 2013, P NATL ACAD SCI USA, V110, P1779, DOI 10.1073/pnas.1214879110; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wetzel CR, 2011, MAR FRESHWATER RES, V62, P927, DOI 10.1071/MF11006; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilberg MJ, 2006, CAN J FISH AQUAT SCI, V63, P2275, DOI 10.1139/F06-111; Wilson G, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001745; Yin YS, 2004, N AM J FISH MANAGE, V24, P865, DOI 10.1577/M03-107.1	44	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92725	10.1371/journal.pone.0092725	http://dx.doi.org/10.1371/journal.pone.0092725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699270	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000033
J	Brar, MS; Shi, M; Hui, RKH; Leung, FCC				Brar, Manreetpal Singh; Shi, Mang; Hui, Raymond Kin-Hi; Leung, Frederick Chi-Ching			Genomic Evolution of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Isolates Revealed by Deep Sequencing	PLOS ONE			English	Article							MYSTERY SWINE DISEASE; NORTH-AMERICAN; STRUCTURAL PROTEINS; MOSAIC STRUCTURE; RECOMBINATION; STRAINS; NSP2; DISSECTION; EMERGENCE; ABORTION	Most studies on PRRSV evolution have been limited to a particular region of the viral genome. A thorough genome-wide understanding of the impact of different mechanisms on shaping PRRSV genetic diversity is still lacking. To this end, deep sequencing was used to obtain genomic sequences of a diverse set of 16 isolates from a region of Hong Kong with a complex PRRSV epidemiological record. Genome assemblies and phylogenetic typing indicated the co-circulation of strains of both genotypes (type 1and type 2) with varying Nsp2 deletion patterns and distinct evolutionary lineages ("High Fever''-like and local endemic type). Recombination analyses revealed genomic breakpoints in structural and non-structural regions of genomes of both genotypes with evidence of many recombination events originating from common ancestors. Additionally, the high fold of coverage per nucleotide allowed the characterization of minor variants arising from the quasispecies of each strain. Overall, 0.56-2.83% of sites were found to be polymorphic with respect to cognate consensus genomes. The distribution of minor variants across each genome was not uniform indicating the influence of selective forces. Proportion of variants capable of causing an amino acid change in their respective codons ranged between 25-67% with many predicted to be non-deleterious. Low frequency deletion variants were also detected providing one possible mechanism for their sudden emergence as cited in previous reports.	[Brar, Manreetpal Singh; Hui, Raymond Kin-Hi; Leung, Frederick Chi-Ching] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Shi, Mang] Univ Sydney, Sch Biol Sci, Sydney Emerging Infect & Biosecur Inst, Darlington, Australia; [Shi, Mang] Univ Sydney, Sydney Med Sch, Darlington, Australia	University of Hong Kong; University of Sydney; University of Sydney	Leung, FCC (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	fcleung@hkucc.hku.hk		Shi, Mang/0000-0002-6154-4437	Research Grant Council of the Hong Kong Government [GRF770612]; HKU Strategic Research Theme of Infection and Immunology; Nanjing Agricultural University Bioinformatics Center	Research Grant Council of the Hong Kong Government; HKU Strategic Research Theme of Infection and Immunology; Nanjing Agricultural University Bioinformatics Center	This work was supported by grants from the Research Grant Council of the Hong Kong Government [GRF770612], HKU Strategic Research Theme of Infection and Immunology and Nanjing Agricultural University Bioinformatics Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Damrongwatanapokin S., 1996, Journal of the Thai Veterinary Medical Association, V47, P19; Dea S, 2000, ARCH VIROL, V145, P659, DOI 10.1007/s007050050662; Duan X, 1997, ARCH VIROL, V142, P2483, DOI 10.1007/s007050050256; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards S, 1992, AM ASS SWINE PRACTIT, V4, P32; Fang Y, 2004, VIRUS RES, V100, P229, DOI 10.1016/j.virusres.2003.12.026; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Guo B., 1996, CHINESE J PREVENTIVE, V2, P1; Halbur PG, 1997, SWINE HEALTH PROD, V5, P73; Han J, 2006, VIRUS RES, V122, P175, DOI 10.1016/j.virusres.2006.06.003; Hill H., 1990, PROC MYSTERY SWINE D, P29; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Kim WI, 2008, VIRUS GENES, V37, P380, DOI 10.1007/s11262-008-0278-1; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kweon C. H., 1994, Korean Journal of Veterinary Research, V34, P77; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; MAGAR R, 1995, CAN J VET RES, V59, P232; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Murtaugh MP, 2002, J SWINE HEALTH PROD, V10, P15; MURTAUGH MP, 1995, ARCH VIROL, V140, P1451, DOI 10.1007/BF01322671; Nelsen CJ, 1999, J VIROL, V73, P270, DOI 10.1128/JVI.73.1.270-280.1999; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Nielsen HS, 2001, J GEN VIROL, V82, P1263, DOI 10.1099/0022-1317-82-6-1263; Nodelijk G., 2002, Veterinary Quarterly, V24, P96; Opriessnig T, 2002, J VIROL, V76, P11837, DOI 10.1128/JVI.76.23.11837-11844.2002; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Paton D. J., 1995, Reviews in Medical Microbiology, V6, P119; PLANA J, 1992, VET MICROBIOL, V33, P203, DOI 10.1016/0378-1135(92)90048-X; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Roongtham K, 2010, VIROLOGY J, V7; Shi M, 2010, VIRUS RES; Shi M, 2010, J VIROL, V84, P8700, DOI 10.1128/JVI.02551-09; SHIMIZU M, 1994, J VET MED SCI, V56, P389, DOI 10.1292/jvms.56.389; SMITH JM, 1992, J MOL EVOL, V34, P126; Storgaard T, 1999, ARCH VIROL, V144, P2389, DOI 10.1007/s007050050652; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Team R. D. C., 2008, R LANG ENV STAT COMP; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; van Vugt JJFA, 2001, J GEN VIROL, V82, P2615, DOI 10.1099/0022-1317-82-11-2615; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Yoshii M, 2008, ARCH VIROL, V153, P1323, DOI 10.1007/s00705-008-0098-6; Yuan SS, 1999, VIRUS RES, V61, P87, DOI 10.1016/S0168-1702(99)00029-5; Zhou L, 2009, J VIROL, V83, P5156, DOI 10.1128/JVI.02678-08; Zhou Z, 2011, VET MICROBIOL, V150, P257, DOI 10.1016/j.vetmic.2011.02.013	49	38	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e88807	10.1371/journal.pone.0088807	http://dx.doi.org/10.1371/journal.pone.0088807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24698958	Green Submitted, gold, Green Published			2022-12-27	WOS:000334105000003
J	Chen, FY; Jiang, LR; Zheng, JS; Huang, RY; Wang, HC; Hong, ZL; Huang, YM				Chen, Fangyu; Jiang, Liangrong; Zheng, Jingsheng; Huang, Rongyu; Wang, Houcong; Hong, Zonglie; Huang, Yumin			Identification of Differentially Expressed Proteins and Phosphorylated Proteins in Rice Seedlings in Response to Strigolactone Treatment	PLOS ONE			English	Article							MITOCHONDRIAL PHOSPHATE; SIGNAL-TRANSDUCTION; KINASE-ACTIVITY; BUD OUTGROWTH; ABSCISIC-ACID; DWARF MUTANT; ARABIDOPSIS; GENES; GROWTH; ELECTROPHORESIS	Strigolactones (SLs) are recently identified plant hormones that inhibit shoot branching and control various aspects of plant growth, development and interaction with parasites. Previous studies have shown that plant D10 protein is a carotenoid cleavage dioxygenase that functions in SL biosynthesis. In this work, we used an allelic SL-deficient d10 mutant XJC of rice (Oryza sativa L. spp. indica) to investigate proteins that were responsive to SL treatment. When grown in darkness, d10 mutant seedlings exhibited elongated mesocotyl that could be rescued by exogenous application of SLs. Soluble protein extracts were prepared from d10 mutant seedlings grown in darkness in the presence of GR24, a synthetic SL analog. Soluble proteins were separated on two-dimensional gels and subjected to proteomic analysis. Proteins that were expressed differentially and phosphoproteins whose phosphorylation status changed in response to GR24 treatment were identified. Eight proteins were found to be induced or down-regulated by GR24, and a different set of 8 phosphoproteins were shown to change their phosphorylation intensities in the dark-grown d10 seedlings in response to GR24 treatment. Analysis of these proteins revealed that they are important enzymes of the carbohydrate and amino acid metabolic pathways and key components of the cellular energy generation machinery. These proteins may represent potential targets of the SL signaling pathway. This study provides new insight into the complex and negative regulatory mechanism by which SLs control shoot branching and plant development.	[Chen, Fangyu; Jiang, Liangrong; Zheng, Jingsheng; Huang, Rongyu; Wang, Houcong; Hong, Zonglie; Huang, Yumin] Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China; [Huang, Rongyu; Hong, Zonglie] Univ Idaho, Dept Plant Soil & Entomol Sci, Moscow, ID 83843 USA; [Huang, Rongyu; Hong, Zonglie] Univ Idaho, Program Microbiol Mol Biol & Biochem, Moscow, ID 83843 USA	Xiamen University; Idaho; University of Idaho; Idaho; University of Idaho	Hong, ZL (corresponding author), Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China.	zhong@uidaho.edu; hym@xmu.edu.cn	Hong, Zonglie/F-5679-2010	Hong, Zonglie/0000-0001-9057-4128; Jiang, Liangrong/0000-0001-7294-0518; Chen, Fangyu/0000-0003-1476-5306	Natural Science Foundation of China [31100866]; Fundamental Research Funds for the Central Universities [2010121088]; Fujian Province Science and Technology Project [2011N5013]; Natural Science Foundation of Fujian Province [2011J01249]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fujian Province Science and Technology Project; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work was supported by the Natural Science Foundation of China (31100866), Fundamental Research Funds for the Central Universities (2010121088), Fujian Province Science and Technology Project (2011N5013) and Natural Science Foundation of Fujian Province (2011J01249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Arite T, 2007, PLANT J, V51, P1019, DOI 10.1111/j.1365-313X.2007.03210.x; Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; Beveridge CA, 1996, PLANT PHYSIOL, V110, P859, DOI 10.1104/pp.110.3.859; BEVERIDGE CA, 1994, PLANT PHYSIOL, V104, P953, DOI 10.1104/pp.104.3.953; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Bouwmeester HJ, 2003, CURR OPIN PLANT BIOL, V6, P358, DOI 10.1016/S1369-5266(03)00065-7; CAPOBIANCO L, 1991, BIOCHEMISTRY-US, V30, P4963, DOI 10.1021/bi00234a018; Cardoso C, 2011, PLANT SCI, V180, P414, DOI 10.1016/j.plantsci.2010.11.007; Chen FY, 2013, PLANT OMICS, V6, P36; Chitteti BR, 2007, J PROTEOME RES, V6, P1718, DOI 10.1021/pr060678z; Choi DS, 2003, PLANT CELL, V15, P1386, DOI 10.1105/tpc.011965; DAMERVAL C, 1986, ELECTROPHORESIS, V7, P52, DOI 10.1002/elps.1150070108; Delaux PM, 2012, NEW PHYTOL, V195, P857, DOI 10.1111/j.1469-8137.2012.04209.x; Deng ZP, 2007, MOL CELL PROTEOMICS, V6, P2058, DOI 10.1074/mcp.M700123-MCP200; Engelsberger WR, 2012, PLANT J, V69, P978, DOI 10.1111/j.1365-313X.2011.04848.x; Gao JJ, 2009, NUCLEIC ACIDS RES, V37, pD960, DOI 10.1093/nar/gkn733; Gao ZY, 2009, PLANT MOL BIOL, V71, P265, DOI 10.1007/s11103-009-9522-x; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Gomi K, 2003, CURR OPIN PLANT BIOL, V6, P489, DOI 10.1016/S1369-5266(03)00079-7; Grimsrud PA, 2010, PLANT PHYSIOL, V152, P19, DOI 10.1104/pp.109.149625; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; He HQ, 2008, BIOCHEM BIOPH RES CO, V371, P883, DOI 10.1016/j.bbrc.2008.05.001; Hoeberichts FA, 2008, J BIOL CHEM, V283, P5708, DOI 10.1074/jbc.M704991200; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; Hsu YT, 2005, PHYSIOL PLANTARUM, V124, P71, DOI 10.1111/j.1399-3054.2005.00490.x; Hu ZY, 2010, PLANT CELL PHYSIOL, V51, P1136, DOI 10.1093/pcp/pcq075; Ishikawa S, 2005, PLANT CELL PHYSIOL, V46, P79, DOI 10.1093/pcp/pci022; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; JONES AM, 1991, PLANT PHYSIOL, V97, P352, DOI 10.1104/pp.97.1.352; Kagiyama M, 2013, GENES CELLS, V18, P147, DOI 10.1111/gtc.12025; Kaufmann H, 2001, PROTEOMICS, V1, P194, DOI 10.1002/1615-9861(200102)1:2<194::AID-PROT194>3.3.CO;2-B; Ke YQ, 2009, BIOCHEM BIOPH RES CO, V379, P133, DOI 10.1016/j.bbrc.2008.12.067; Khan MMK, 2005, PLANT MOL BIOL, V58, P27, DOI 10.1007/s11103-005-4013-1; Komatsu S, 1999, ELECTROPHORESIS, V20, P630, DOI 10.1002/(SICI)1522-2683(19990301)20:3&lt;630::AID-ELPS630&gt;3.0.CO;2-Z; KOMATSU S, 1993, PLANT SCI, V94, P127, DOI 10.1016/0168-9452(93)90014-Q; Lewis TS, 2000, MOL CELL, V6, P1343, DOI 10.1016/S1097-2765(00)00132-5; Lin H, 2009, PLANT CELL, V21, P1512, DOI 10.1105/tpc.109.065987; Liu WZ, 2009, PLANTA, V230, P649, DOI 10.1007/s00425-009-0975-6; Mashiguchi K, 2009, BIOSCI BIOTECH BIOCH, V73, P2460, DOI 10.1271/bbb.90443; Mayank P, 2012, PLANT J, V72, P89, DOI 10.1111/j.1365-313X.2012.05061.x; Mayzlish-Gati E, 2012, PLANT PHYSIOL, V160, P1329, DOI 10.1104/pp.112.202358; Melo-Braga MN, 2012, MOL CELL PROTEOMICS, V11, P945, DOI 10.1074/mcp.M112.020214; Moffatt BA, 2002, PLANT PHYSIOL, V128, P812, DOI 10.1104/pp.010880; Mori M, 2002, PLANT PHYSIOL, V130, P1152, DOI 10.1104/pp.007179; Morris SE, 2001, PLANT PHYSIOL, V126, P1205, DOI 10.1104/pp.126.3.1205; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Napoli C, 1996, PLANT PHYSIOL, V111, P27, DOI 10.1104/pp.111.1.27; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PALMIERI F, 1993, J BIOENERG BIOMEMBR, V25, P493, DOI 10.1007/BF01108406; Qian WQ, 2007, PLANT J, V49, P399, DOI 10.1111/j.1365-313X.2006.02967.x; Rasmussen A, 2012, PLANT PHYSIOL, V158, P1976, DOI 10.1104/pp.111.187104; Rate DN, 2001, PLANT J, V27, P203, DOI 10.1046/j.0960-7412.2001.1075umedoc.x; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Rose CM, 2012, MOL CELL PROTEOMICS, V11, P724, DOI 10.1074/mcp.M112.019208; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Ruyter-Spira C, 2013, TRENDS PLANT SCI, V18, P72, DOI 10.1016/j.tplants.2012.10.003; Sawers RJH, 2002, PLANT PHYSIOL, V130, P155, DOI 10.1104/pp.006411; Scaffidi A, 2013, PLANT J, V76, P1, DOI 10.1111/tpj.12265; Shinohara N, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001474; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Simons JL, 2007, PLANT PHYSIOL, V143, P697, DOI 10.1104/pp.106.087957; Snowden KC, 2005, PLANT CELL, V17, P746, DOI 10.1105/tpc.104.027714; Somers DE, 2009, TRENDS PLANT SCI, V14, P206, DOI 10.1016/j.tplants.2009.01.003; Song JT, 2004, PLANT CELL, V16, P353, DOI 10.1105/tpc.019372; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; STAPPEN R, 1994, J BIOL CHEM, V269, P11240; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Sun TP, 2011, CURR BIOL, V21, pR338, DOI 10.1016/j.cub.2011.02.036; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Tang WQ, 2008, MOL CELL PROTEOMICS, V7, P728, DOI 10.1074/mcp.M700358-MCP200; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Umehara M, 2010, PLANT CELL PHYSIOL, V51, P1118, DOI 10.1093/pcp/pcq084; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Waters MT, 2011, PLANT SIGNAL BEHAV, V6, P1418, DOI 10.4161/psb.6.9.17303; Yamaguchi S, 2010, PLANT CELL PHYSIOL, V51, P1091, DOI 10.1093/pcp/pcq088; Yan H, 2007, GENES GENET SYST, V82, P361, DOI 10.1266/ggs.82.361; Zegzouti H, 1997, PLANT MOL BIOL, V35, P847, DOI 10.1023/A:1005860302313; Zhao LH, 2013, CELL RES, V23, P436, DOI 10.1038/cr.2013.19; Zhou F, 2013, NATURE, V504, P406, DOI 10.1038/nature12878; Zou JH, 2005, PLANTA, V222, P604, DOI 10.1007/s00425-005-0007-0; Zou JH, 2006, PLANT J, V48, P687, DOI 10.1111/j.1365-313X.2006.02916.x	87	9	9	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93947	10.1371/journal.pone.0093947	http://dx.doi.org/10.1371/journal.pone.0093947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699514	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000124
J	Chou, YE; Hsieh, MJ; Hsin, CH; Chiang, WL; Lai, YC; Lee, YH; Huang, SC; Yang, SF; Lin, CW				Chou, Ying-Erh; Hsieh, Ming-Ju; Hsin, Chung-Han; Chiang, Whei-Ling; Lai, Yi-Cheng; Lee, Yu-Hsien; Huang, Shu-Ching; Yang, Shun-Fa; Lin, Chiao-Wen			CD44 Gene Polymorphisms and Environmental Factors on Oral Cancer Susceptibility in Taiwan	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; STEM-LIKE CELLS; CHANGHUA COUNTY; HEAD; EXPRESSION; ADHESION; MIGRATION; VARIANTS; IDENTIFICATION; CONSUMPTION	Background: Oral squamous cell carcinoma (OSCC) is the fourth leading cause of male cancer death in Taiwan. Exposure to environmental carcinogens is the primary risk factor for developing OSCC. CD44, a well-known tumor marker, plays a crucial role in tumor cell differentiation, invasion, and metastasis. This study investigated CD44 single-nucleotide polymorphisms (SNPs) with environmental risk factors to determine OSCC susceptibility and clinicopathological characteristics. Methodology/Principal Findings: Real-time polymerase chain reaction (PCR) was used to analyze 6 SNPs of CD44 in 599 patients with oral cancer and 561 cancer-free controls. We determined that the CD44 rs187115 polymorphism carriers with the genotype AG, GG, or AG+GG were associated with oral cancer susceptibility. Among 731 smokers, CD44 polymorphisms carriers with the betel-nut chewing habit had a 10.30-37.63-fold greater risk of having oral cancer compared to CD44 wild-type (WT) carriers without the betel-nut chewing habit. Among 552 betel-nut chewers, CD44 polymorphisms carriers who smoked had a 4.23-16.11-fold greater risk of having oral cancer compared to those who carried the WT but did not smoke. Finally, we also observed that the stage III and IV oral cancer patients had higher frequencies of CD44 rs187115 polymorphisms with the variant genotype (AG+GG) compared with the wild-type (WT) carriers. Conclusion: Our results suggest that gene-environment interactions between the CD44 polymorphisms and betel quid chewing and tobacco smoking increase the susceptibility to oral cancer development. Patients with CD44 rs187115 variant genotypes (AG+GG) were correlated with a higher risk of oral cancer development, and these patients may possess greater chemoresistance to advanced-to late-stage oral cancer than WT carriers do. The CD44 rs187115 polymorphism has potential predictive significance in oral carcinogenesis and also may be applied as factors to predict the clinical stage in OSCC patients.	[Chou, Ying-Erh; Hsieh, Ming-Ju; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hsieh, Ming-Ju] Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan; [Hsin, Chung-Han] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Hsin, Chung-Han] Chung Shan Med Univ Hosp, Dept Otolaryngol, Taichung, Taiwan; [Chiang, Whei-Ling] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan; [Lai, Yi-Cheng; Lee, Yu-Hsien; Huang, Shu-Ching] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan; [Lee, Yu-Hsien; Huang, Shu-Ching; Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan	Chung Shan Medical University; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University	Lin, CW (corresponding author), Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan.	cwlin@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020; Lai, Yi-Cheng/GRS-1513-2022; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Hsieh, Ming-Ju/0000-0001-9726-3234	National Science Council, Taiwan [NSC-100-2632-B-040-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by grants from National Science Council, Taiwan (NSC-100-2632-B-040-001-MY3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Chen YW, 2010, MOL CANCER THER, V9, P2879, DOI 10.1158/1535-7163.MCT-10-0504; Chien MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060283; Costea DE, 2006, ORAL DIS, V12, P443, DOI 10.1111/j.1601-0825.2006.01264.x; de Jong MC, 2010, CLIN CANCER RES, V16, P5329, DOI 10.1158/1078-0432.CCR-10-0799; Facompre N, 2012, ADV PHARMACOL, V65, P235, DOI 10.1016/B978-0-12-397927-8.00008-7; Gerger A, 2011, CLIN CANCER RES, V17, P6934, DOI 10.1158/1078-0432.CCR-11-1180; Gonzalez-Moles MA, 2007, ONCOL REP, V18, P389; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hill A, 2006, CANCER LETT, V237, P1, DOI 10.1016/j.canlet.2005.05.006; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; HOFMANN M, 1993, CANCER RES, V53, P1516; Huang SM, 2011, J CELL BIOCHEM, V112, P643, DOI 10.1002/jcb.22966; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3225; Joshua B, 2012, HEAD NECK-J SCI SPEC, V34, P42, DOI 10.1002/hed.21699; Judd NP, 2012, CANCER RES, V72, P365, DOI 10.1158/0008-5472.CAN-11-1831; KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x; Kokko LL, 2011, ORAL ONCOL, V47, P510, DOI 10.1016/j.oraloncology.2011.03.026; Kuo MYP, 1998, J ORAL PATHOL MED, V27, P428; LU CT, 1993, COMMUNITY DENT ORAL, V21, P370, DOI 10.1111/j.1600-0528.1993.tb01101.x; Lu CT, 1996, J ORAL PATHOL MED, V25, P245, DOI 10.1111/j.1600-0714.1996.tb01379.x; Lu DY, 2012, NEURO-ONCOLOGY, V14, P1367, DOI 10.1093/neuonc/nos262; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Margaritescu C, 2011, ROM J MORPHOL EMBRYO, V52, P985; Marhaba R, 2004, J MOL HISTOL, V35, P211; Marhaba R, 2008, CURR MOL MED, V8, P784, DOI 10.2174/156652408786733667; Maula SM, 2003, CANCER RES, V63, P1920; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Okamoto A, 2009, ORAL ONCOL, V45, P633, DOI 10.1016/j.oraloncology.2008.10.003; Okamoto I, 2002, AM J PATHOL, V160, P441, DOI 10.1016/S0002-9440(10)64863-8; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Reisman DN, 2002, ONCOGENE, V21, P1196, DOI 10.1038/sj.onc.1205188; Rogers SN, 2009, ORAL ONCOL, V45, P201, DOI 10.1016/j.oraloncology.2008.05.008; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Shastry BS, 2009, METHODS MOL BIOL, V578, P3, DOI 10.1007/978-1-60327-411-1_1; Situ DR, 2010, J CANCER RES CLIN, V136, P1213, DOI 10.1007/s00432-010-0771-5; Stoll C, 1999, ORAL ONCOL, V35, P484, DOI 10.1016/S1368-8375(99)00021-4; Strobeck MW, 2001, J BIOL CHEM, V276, P9273, DOI 10.1074/jbc.M009747200; Tsai CF, 2012, INT J MOL SCI, V13, P9877, DOI 10.3390/ijms13089877; Vazquez A, 2010, CANCER RES, V70, P172, DOI 10.1158/0008-5472.CAN-09-2218; Wang SJ, 2011, AM J PATHOL, V178, P956, DOI 10.1016/j.ajpath.2010.11.077; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; Winder T, 2011, INT J CANCER, V129, P1096, DOI 10.1002/ijc.25787; Yang YH, 2005, J ORAL PATHOL MED, V34, P596, DOI 10.1111/j.1600-0714.2005.00266.x; Yen TT, 2008, EUR ARCH OTO-RHINO-L, V265, P1403, DOI 10.1007/s00405-008-0659-z; Zhang ZC, 2012, ORAL ONCOL, V48, P1, DOI 10.1016/j.oraloncology.2011.10.004; Zhou JH, 2010, ANTICANCER RES, V30, P1263	50	30	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93692	10.1371/journal.pone.0093692	http://dx.doi.org/10.1371/journal.pone.0093692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699672	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000090
J	McAllister, DA; Ahmed, FS; Austin, JHM; Henschke, CI; Keller, BM; Lemeshow, A; Reeves, AP; Mesia-Vela, S; Pearson, GDN; Shiau, MC; Schwartz, JE; Yankelevitz, DF; Barr, RG				McAllister, David A.; Ahmed, Firas S.; Austin, John H. M.; Henschke, Claudia I.; Keller, Brad M.; Lemeshow, Adina; Reeves, Anthony P.; Mesia-Vela, Sonia; Pearson, G. D. N.; Shiau, Maria C.; Schwartz, Joseph E.; Yankelevitz, David F.; Barr, R. Graham			Emphysema Predicts Hospitalisation and Incident Airflow Obstruction among Older Smokers: A Prospective Cohort Study	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; LUNG-CANCER; PULMONARY-EMPHYSEMA; COPD; CT; PREVALENCE; TRIAL; DIAGNOSIS; MORTALITY; DISEASE	Background: Emphysema on CT is common in older smokers. We hypothesised that emphysema on CT predicts acute episodes of care for chronic lower respiratory disease among older smokers. Materials and Methods: Participants in a lung cancer screening study age >= 60 years were recruited into a prospective cohort study in 2001-02. Two radiologists independently visually assessed the severity of emphysema as absent, mild, moderate or severe. Percent emphysema was defined as the proportion of voxels <= -910 Hounsfield Units. Participants completed a median of 5 visits over a median of 6 years of follow-up. The primary outcome was hospitalization, emergency room or urgent office visit for chronic lower respiratory disease. Spirometry was performed following ATS/ERS guidelines. Airflow obstruction was defined as FEV1/FVC ratio <0.70 and FEV <80% predicted. Results: Of 521 participants, 4% had moderate or severe emphysema, which was associated with acute episodes of care (rate ratio 1.89; 95% CI: 1.01- 3.52) adjusting for age, sex and race/ ethnicity, as was percent emphysema, with similar associations for hospitalisation. Emphysema on visual assessment also predicted incident airflow obstruction ( HR 5.14; 95% CI 2.19- 21.1). Conclusion: Visually assessed emphysema and percent emphysema on CT predicted acute episodes of care for chronic lower respiratory disease, with the former predicting incident airflow obstruction among older smokers.	[McAllister, David A.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [McAllister, David A.; Ahmed, Firas S.; Lemeshow, Adina; Mesia-Vela, Sonia; Schwartz, Joseph E.; Barr, R. Graham] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10027 USA; [Austin, John H. M.; Pearson, G. D. N.] Columbia Univ Coll Phys & Surg, Dept Radiol, New York, NY 10032 USA; [Henschke, Claudia I.; Yankelevitz, David F.] Mt Sinai Med Ctr, Dept Radiol, New York, NY 10029 USA; [Keller, Brad M.] Univ Penn, Dept Biomed Engn, Philadelphia, PA 19104 USA; [Reeves, Anthony P.] Cornell Univ, Coll Engn, Sch Elect & Comp Engn, Ithaca, NY USA; [Shiau, Maria C.] NYU, Langone Med Ctr, Dept Radiol, New York, NY USA; [Barr, R. Graham] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	University of Edinburgh; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Cornell University; New York University; NYU Langone Medical Center; Columbia University	Barr, RG (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10027 USA.	rgb9@columbia.edu	Shiau, Maria/GQH-8481-2022	Schwartz, Joseph/0000-0002-8944-3566; McAllister, David/0000-0003-3550-1764	National Institutes of Health [R01-HL075476, R01-HL077612, R01-HL093081, RR024156, ES09089]; City of New York Department of Health and Mental Hygiene; Starr Foundation; Empire Blue Cross and Blue Shield; New York Community Trust; New York State Office of Science, Technology, and Academic Research; Rogers Family Fund; Weill Medical College of Cornell University; Cornell University; AMDeC Foundation; Chest Heart and Stroke Scotland [ResFell07/A109] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077612, R01HL075476, R01HL093081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH013043] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); City of New York Department of Health and Mental Hygiene; Starr Foundation; Empire Blue Cross and Blue Shield; New York Community Trust; New York State Office of Science, Technology, and Academic Research; Rogers Family Fund; Weill Medical College of Cornell University(General Electric); Cornell University; AMDeC Foundation; Chest Heart and Stroke Scotland; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Collection of spirometric and percent emphysema measures, longitudinal components from the third visit onwards, and analysis and interpretation of the data were supported via grants R01-HL075476, R01-HL077612, R01-HL093081, RR024156, and ES09089 from the National Institutes of Health. The baseline and second visits were funded by the City of New York Department of Health and Mental Hygiene; the Starr Foundation; Empire Blue Cross and Blue Shield; the New York Community Trust; New York State Office of Science, Technology, and Academic Research; the Rogers Family Fund; Weill Medical College of Cornell University; Cornell University; and AMDeC Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2008, STAT CONS COPD EX TR; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 2010, NATL VITAL STAT REPO; Barr RG, 2008, RESP CARE, V53, P433; BERGIN C, 1986, AM REV RESPIR DIS, V133, P541; Burge S, 2003, EUR RESPIR J, V21, p46S, DOI 10.1183/09031936.03.00078002; Camiciottoli G, 2009, EUR RADIOL, V19, P58, DOI 10.1007/s00330-008-1131-6; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; COXSON HO, 1995, J APPL PHYSIOL, V79, P1525, DOI 10.1152/jappl.1995.79.5.1525; de Torres JP, 2007, CHEST, V132, P1932, DOI 10.1378/chest.07-1490; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Gelb AF, 1996, CHEST, V109, P353, DOI 10.1378/chest.109.2.353; Gevenois PA, 1996, RADIOLOGY, V199, P825, DOI 10.1148/radiology.199.3.8638012; Gietema HA, 2011, ACAD RADIOL, V18, P661, DOI 10.1016/j.acra.2011.01.011; Hall WB, 2009, ARCH INTERN MED, V169, P1961, DOI 10.1001/archinternmed.2009.360; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; Henschke CI, 2006, RADIOLOGY, V239, P586, DOI 10.1148/radiol.2392050261; Hoesein FAAM, 2011, THORAX, V66, P782, DOI 10.1136/thx.2010.145995; HRUBAN RH, 1987, AM REV RESPIR DIS, V136, P935, DOI 10.1164/ajrccm/136.4.935; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jithoo A, 2013, EUR RESPIR J, V41, P548, DOI 10.1183/09031936.00132011; Johannessen A, 2013, AM J RESP CRIT CARE, V187, P602, DOI 10.1164/rccm.201209-1722OC; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Omori H, 2006, RESPIROLOGY, V11, P205, DOI 10.1111/j.1440-1843.2006.00827.x; Onuma Y, 2006, J AM COLL CARDIOL, V48, P402, DOI 10.1016/j.jacc.2006.04.071; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Wise Robert A, 2008, Proc Am Thorac Soc, V5, P385, DOI 10.1513/pats.200709-153ET; World Health Organisation, 2008, WHO BURD CHRON OBSTR; Zulueta JJ, 2011, CHEST	34	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93221	10.1371/journal.pone.0093221	http://dx.doi.org/10.1371/journal.pone.0093221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699215	Green Published, Green Accepted, gold			2022-12-27	WOS:000334105000047
J	Razzolini, NL; Vila, B; Castanera, D; Falkingham, PL; Barco, JL; Canudo, JI; Manning, PL; Galobart, A				Razzolini, Novella L.; Vila, Bernat; Castanera, Diego; Falkingham, Peter L.; Luis Barco, Jose; Ignacio Canudo, Jose; Manning, Phillip L.; Galobart, Angel			Intra-Trackway Morphological Variations Due to Substrate Consistency: The El Frontal Dinosaur Tracksite (Lower Cretaceous, Spain)	PLOS ONE			English	Article							FOSSIL VERTEBRATE TRACKS; EASTERN CAMEROS BASIN; MAMMALIAN TRACKS; FOOTPRINTS; PRESERVATION; SYSTEM; IMPACT; LIDAR	An ichnological and sedimentological study of the El Frontal dinosaur tracksite (Early Cretaceous, Cameros basin, Soria, Spain) highlights the pronounced intra-trackway variation found in track morphologies of four theropod trackways. Photogrammetric 3D digital models revealed various and distinct intra-trackway morphotypes, which reflect changes in footprint parameters such as the pace length, the track length, depth, and height of displacement rims. Sedimentological analyses suggest that the original substrate was non-homogenous due to lateral changes in adjoining microfacies. Multidata analyses indicate that morphological differences in these deep and shallow tracks represent a part of a continuum of track morphologies and geometries produced by a gradient of substrate consistencies across the site. This implies that the large range of track morphologies at this site resulted from similar trackmakers crossing variable facies. The trackways at the El Frontal site present an exemplary case of how track morphology, and consequently potential ichnotaxa, can vary, even when produced by a single trackmaker.	[Razzolini, Novella L.; Vila, Bernat; Galobart, Angel] Inst Catala Paleontol Miquel Crusafont, Barcelona, Catalonia, Spain; [Vila, Bernat; Castanera, Diego; Ignacio Canudo, Jose] Univ Zaragoza, Fac Ciencias, Dept Paleontol, Grupo Aragosaurus IUCA, E-50009 Zaragoza, Spain; [Falkingham, Peter L.] Univ London Royal Vet Coll, Struct & Mot Lab, Dept Comparat Biomed Sci, London, England; [Falkingham, Peter L.] Brown Univ, Div Biol & Med, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Luis Barco, Jose] Paleoymas SL Pol Empresarium, Zaragoza, Spain; [Manning, Phillip L.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Manning, Phillip L.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England	Institut Catala de Paleontologia Miquel Crusafont (ICP); University of Zaragoza; University of London; University of London Royal Veterinary College; Brown University; University of Pennsylvania; University of Manchester	Razzolini, NL (corresponding author), Inst Catala Paleontol Miquel Crusafont, Carrer Escola Ind 23, Barcelona, Catalonia, Spain.	novella.razzolini@icp.cat	VILA, BERNAT/AAA-7367-2021; Falkingham, Peter/C-7656-2014; Manning, Phillip/F-9966-2011; CASTANERA, DIEGO/AAH-5598-2019; Galobart, Àngel À/H-5024-2011	VILA, BERNAT/0000-0002-5935-1732; Falkingham, Peter/0000-0003-1856-8377; Manning, Phillip/0000-0002-7161-6246; CASTANERA, DIEGO/0000-0003-3950-1630; Galobart, Àngel À/0000-0003-1508-4561; Canudo Sanagustin, Jose Ignacio/0000-0003-1732-9155	Ministerio de Economia y Competitividad of Spain [CGL2011-30069-C02-01, CGL2010-16447]; Institut Catala de Paleontologia "Miquel Crusafont"; Ministerio de Economia y Competitividad [BES- 2012-051847]; Subprograma Juan de la Cierva [MICINN-JDC-2011]; Ministry of Education [AP2008-01340]; Marie Curie International Outgoing Fellowship within the 7th European Framework Programme	Ministerio de Economia y Competitividad of Spain(Spanish Government); Institut Catala de Paleontologia "Miquel Crusafont"; Ministerio de Economia y Competitividad(Spanish Government); Subprograma Juan de la Cierva; Ministry of Education; Marie Curie International Outgoing Fellowship within the 7th European Framework Programme	This paper is a contribution to the projects CGL2011-30069-C02-01 and CGL2010-16447, subsidized by the Ministerio de Economia y Competitividad of Spain. LiDAR data adquisition was funded by the Institut Catala de Paleontologia "Miquel Crusafont". N. L. Razzolini acknowledges support from BES- 2012-051847 subsized by the Ministerio de Economia y Competitividad. B. Vila acknowledges support from Subprograma Juan de la Cierva (MICINN-JDC-2011). D. Castanera is the beneficiary of a grant from the Ministry of Education (AP2008-01340). P. L. Falkingham was supported by a Marie Curie International Outgoing Fellowship within the 7th European Framework Programme.	Aguirrezabala L.M., 1980, Munibe, V32, P257; Allen J.R.L.., 1982, DEV SEDIMENTOL, V30, P593; Allen JRL, 1997, PHILOS T ROY SOC B, V352, P481, DOI 10.1098/rstb.1997.0035; ALLEN JRL, 1989, J GEOL SOC LONDON, V146, P600, DOI 10.1144/gsjgs.146.4.0600; Baird D., 1957, Bulletin of the Museum of Comparative Zoology, V117, P449; Barco JL, 2005, CUADERNOS PALEONTOLO, V4, P60; Barco JL, 2004, 1 INT C ICHN, P18; Barco JL, 2005, 21 JORN SOC ESP PAL, P169; Barnes H.A, 2000, HDB ELEMENTARY RHEOL; Bates KT, 2010, INT ARCH PHOTOGRAMM, V38, P68; Bates KT, 2008, PALAEONTOLOGY, V51, P999, DOI 10.1111/j.1475-4983.2008.00789.x; Bates KT, 2008, J GEOL SOC LONDON, V165, P115, DOI 10.1144/0016-76492007-033; Bellian JA, 2005, J SEDIMENT RES, V75, P166, DOI 10.2110/jsr.2005.013; Breithaupt Brent H., 2001, P113; Gomez-Fernandez JC, 1994, J PALEOLIMNOL, V11, P91, DOI 10.1007/BF00683272; Casamiquela RM, 1987, GLOSSARY MANUAL TETR, P22; Castanera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081830; Castanera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054177; Craig R.F., 2004, CRAIGS SOIL MECH, VSeventh; CURRIE PJ, 1979, PALAEOGEOGR PALAEOCL, V28, P103, DOI 10.1016/0031-0182(79)90114-7; Ellis RG, 2013, PALAEONTOL ELECTRON, V16; Falkingham PL, 2014, J ZOOL, V292, P222, DOI 10.1111/jzo.12110; Falkingham PL, 2011, J R SOC INTERFACE, V8, P1142, DOI 10.1098/rsif.2010.0634; Falkingham PL, 2010, PALAIOS, V25, P356, DOI 10.2110/palo.2009.p09-164r; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; Falkingham PL, 2009, PALAEOGEOGR PALAEOCL, V271, P69, DOI 10.1016/j.palaeo.2008.09.011; FUENTES VIDARTE C., 1998, ESTUD GEOL-MADRID, V54, P147, DOI DOI 10.3989/EGEOL.98543-4213; Fuentes Vidarte C., 1996, ZUBIA, V14, P57; Gatesy SM, 2005, PALAEONTOL ELECTRON, V8; Gatesy SM, 1999, NATURE, V399, P141, DOI 10.1038/20167; Gatesy Stephen M., 2003, Ichnos, V10, P91, DOI 10.1080/10420940390255484; Hernandez Medrano N, 2008, AREVACON, V28, P18; Jackson SJ, 2010, ICHNOS, V17, P197, DOI 10.1080/10420940.2010.510026; Kuban G.J., 1989, P57; Lockley MG, 2009, GEOL Q, V53, P415; Lucas SG, 2001, LETHAIA, V34, P30, DOI 10.1080/002411601300068198; Manning Phillip L., 2008, P204; Manning PL, 2004, GEOL SOC SPEC PUBL, V228, P93, DOI 10.1144/GSL.SP.2004.228.01.06; Manning PL, 1999, THESIS U SHEFFIELD; MARTIN-CLOSAS C., 1998, REV SOC GEOLOGICA ES, V11, P253; Marty D, 2009, ICHNOS, V16, P127, DOI 10.1080/10420940802471027; Mas R., 2004, GEOLOG A ESPA A, P503; Milan J, 2006, PALAEOGEOGR PALAEOCL, V231, P253, DOI 10.1016/j.palaeo.2004.12.022; Milan J., 2003, THESIS U COPENHAGEN; Milan J, 2008, ICHNOS, V15, P19, DOI 10.1080/10420940600864712; Minter NJ, 2007, LETHAIA, V40, P365, DOI 10.1111/j.1502-3931.2007.00035.x; MORATALLA GARCIA J.J., 1993, THESIS U COMPLUTENSE; Moratalla JJ, 2010, PALAEOGEOGR PALAEOCL, V295, P116, DOI 10.1016/j.palaeo.2010.05.027; Morse SA, 2013, AM J PHYS ANTHROPOL, V151, P265, DOI 10.1002/ajpa.22276; PADIAN K, 1984, J PALEONTOL, V58, P178; Padian K, 1999, NATURE, V399, P103, DOI 10.1038/20069; Pascual-Arribas Carlos, 2011, Studia Geologica Salmanticensia, V47, P77; Pereda-Suberbiola X, 2009, ACT 4 JORN INT PAL D, P207; Quijada I, 2010, GEOGACETA, V49, P15; Quijada IE, 2013, J IBER GEOL, V39, P313, DOI 10.5209/rev_JIGE.2013.v39.n2.42503; Razzolini NL, 2012, 10 ANN M EUR ASS VER, V20, p[1, 207]; Salas R, 2001, MEM MUS NAT HIST NAT, V186, P145; Sanz J.L., 1997, HUELLAS DINOSAURIOS; Schanz T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077606; Schudack U, 2009, J IBER GEOL, V35, P141; Scott JJ, 2010, J SEDIMENT RES, V80, P639, DOI 10.2110/jsr.2010.057; SCRIVNER PJ, 1986, PALAEOGEOGR PALAEOCL, V57, P285, DOI 10.1016/0031-0182(86)90017-9; Wu C, 2013, LINEAR TIME INCREMEN	63	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93708	10.1371/journal.pone.0093708	http://dx.doi.org/10.1371/journal.pone.0093708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699696	Green Published, gold			2022-12-27	WOS:000334105000093
J	Wu, PH; Lin, YT; Kuo, CN; Chang, WC; Chang, WP				Wu, Ping-Hsun; Lin, Yi-Ting; Kuo, Chun-Nan; Chang, Wei-Chiao; Chang, Wei-Pin			No Increased Risk of Herpes Zoster Found in Cirrhotic Patients: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; LIVER-TRANSPLANTATION; RHEUMATOID-ARTHRITIS; UNITED-KINGDOM; MATCHED-COHORT; LONG-TERM; INFECTION; VIRUS; CYTOMEGALOVIRUS; COMPLICATIONS	Background: The association between liver cirrhosis (LC) and herpes zoster has rarely been studied. We investigated the hypothesis that LC, known as an immunodeficiency disease, may increase the risk of herpes zoster using a national health insurance database in Taiwan. Materials and Methods: The study cohort included cirrhotic patients between 1998 and 2005 (n = 4667), and a ratio of 1:5 randomly sampled age- and gender-matched control patients (n = 23,335). All subjects were followed up for 5 years from the date of cohort entry to identify whether or not they had developed herpes zoster. Cox proportional-hazard regressions were performed to evaluate 5-year herpes zoster-free survival rates. Results: Of all patients, 523 patients developed herpes zoster during the 5-year follow-up period, among whom 82 were LC patients and 441 were in the comparison cohort. The adjusted hazard ratio (AHR) of herpes zoster in patients with LC was not higher (AHR: 0.77, 95% confidence interval: 0.59-1.01, p = 0.06) than that of the controls during the 5-year follow-up. No increased risk of herpes zoster was found in LC patients after stratification by age, gender, urbanization level, income, geographic region, and all comorbidities. Conclusions: This large nationwide population-based cohort study suggests that there is no increased risk for herpes zoster among people who have LC compared to a matching population.	[Wu, Ping-Hsun] Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan; [Lin, Yi-Ting] Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Wu, Ping-Hsun] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Kuo, Chun-Nan; Chang, Wei-Chiao] Taipei Med Univ, Dept Pharm, Wanfang Hosp, Taipei, Taiwan; [Kuo, Chun-Nan; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Chang, Wei-Pin] Yuanpei Univ, Dept Healthcare Management, Hsinchu, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Chang, WC (corresponding author), Taipei Med Univ, Dept Pharm, Wanfang Hosp, Taipei, Taiwan.	weichiao.chang@gmail.com; wpchang@mail.ypu.edu.tw	Wu, Ping-Hsun/S-8746-2017; LIN, YI-TING/S-8855-2017	Wu, Ping-Hsun/0000-0003-1021-8161; Chang, Wei-Chiao/0000-0002-8573-5924; LIN, YI-TING/0000-0002-5833-0040	Taipei Medical University [TMU101-AE1-B14]	Taipei Medical University	This study was supported by grant TMU101-AE1-B14 from the Taipei Medical University (associate professor Wei-Chiao Chang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliegro MB, 1996, CLIN INFECT DIS, V23, P990, DOI 10.1093/clinids/23.5.990; Bahr MJ, 2001, Z GASTROENTEROL, V39, P601, DOI 10.1055/s-2001-16696; Bajaj JS, 2012, HEPATOLOGY, V56, P2328, DOI 10.1002/hep.25947; Bonnel AR, 2011, CLIN GASTROENTEROL H, V9, P727, DOI 10.1016/j.cgh.2011.02.031; Brisson M, 2001, EPIDEMIOL INFECT, V127, P305, DOI 10.1017/S0950268801005921; Chen HH, 2011, CLINICS, V66, P1177, DOI 10.1590/S1807-59322011000700009; Chiu HF, 2013, J EPIDEMIOL, V23, P205, DOI 10.2188/jea.JE20120155; Christou L, 2007, AM J GASTROENTEROL, V102, P1510, DOI 10.1111/j.1572-0241.2007.01286.x; DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605; FELIU E, 1977, EUR J CLIN INVEST, V7, P571, DOI 10.1111/j.1365-2362.1977.tb01653.x; Ghassemi S, 2007, BEST PRACT RES CL GA, V21, P77, DOI 10.1016/j.bpg.2006.07.004; Gilden DH, 2000, NEW ENGL J MED, V342, P635, DOI 10.1056/NEJM200003023420906; Gourishankar S, 2004, AM J TRANSPLANT, V4, P108, DOI 10.1046/j.1600-6143.2003.00287.x; Herrero JI, 2004, LIVER TRANSPLANT, V10, P1140, DOI 10.1002/lt.20219; Heymann AD, 2008, INFECTION, V36, P226, DOI 10.1007/s15010-007-6347-x; Ho JD, 2011, OPHTHALMOLOGY, V118, P1076, DOI 10.1016/j.ophtha.2010.10.008; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Jih JS, 2009, ACTA DERM-VENEREOL, V89, P612, DOI 10.2340/00015555-0729; Kang JH, 2009, STROKE, V40, P3443, DOI 10.1161/STROKEAHA.109.562017; Kuo CC, 2012, AM J KIDNEY DIS, V59, P428, DOI 10.1053/j.ajkd.2011.10.049; Kusaba N, 1998, INTERNAL MED, V37, P11; Levin MJ, 2003, J INFECT DIS, V188, P1336, DOI 10.1086/379048; Levitsky J, 2005, LIVER TRANSPLANT, V11, P320, DOI 10.1002/lt.20356; Liesegang Thomas J, 2004, Curr Opin Ophthalmol, V15, P531, DOI 10.1097/01.icu.0000143686.68103.46; Lin HC, 2010, NEUROLOGY, V74, P792, DOI 10.1212/WNL.0b013e3181d31e5c; Lin YH, 2010, VACCINE, V28, P1217, DOI 10.1016/j.vaccine.2009.11.029; McDonald JR, 2009, CLIN INFECT DIS, V48, P1364, DOI 10.1086/598331; Morgan D, 2001, AIDS, V15, P223, DOI 10.1097/00002030-200101260-00012; NAGASAWA K, 1990, ANN RHEUM DIS, V49, P630, DOI 10.1136/ard.49.8.630; Schmader K, 1998, J INFECT DIS, V178, pS67, DOI 10.1086/514254; Smitten AL, 2007, ARTHRIT RHEUM-ARTHR, V57, P1431, DOI 10.1002/art.23112; TANAKA S, 1992, HEPATOLOGY, V16, P1409, DOI 10.1002/hep.1840160617; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Varani S, 2000, J MED VIROL, V62, P25, DOI 10.1002/1096-9071(200009)62:1&lt;25::AID-JMV4&gt;3.0.CO;2-E; Wareham DW, 2007, BMJ-BRIT MED J, V334, P1211, DOI 10.1136/bmj.39206.571042.AE; Wolfe F, 2006, RHEUMATOLOGY, V45, P1370, DOI 10.1093/rheumatology/kel328; Wu MY, 2012, AM J KIDNEY DIS, V60, P548, DOI 10.1053/j.ajkd.2012.03.018; Wung Peter K, 2005, Am J Med, V118, P1416, DOI 10.1016/j.amjmed.2005.06.012; Yang YW, 2011, CAN MED ASSOC J, V183, pE275, DOI 10.1503/cmaj.101137; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341	40	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93443	10.1371/journal.pone.0093443	http://dx.doi.org/10.1371/journal.pone.0093443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699628	gold, Green Published, Green Submitted			2022-12-27	WOS:000334105000061
J	Brooke, ZM; Bielby, J; Nambiar, K; Carbone, C				Brooke, Zoe M.; Bielby, Jon; Nambiar, Kate; Carbone, Chris			Correlates of Research Effort in Carnivores: Body Size, Range Size and Diet Matter	PLOS ONE			English	Article							EXTINCTION RISK; CONSERVATION RESEARCH; TAXONOMIC CHAUVINISM; SETTING PRIORITIES; ZOO ANIMALS; GAP; IMPLEMENTATION; PRACTITIONERS; RELEVANT; PRIMATES	Given the budgetary restrictions on scientific research and the increasing need to better inform conservation actions, it is important to identify the patterns and causes of biases in research effort. We combine bibliometric information from a literature review of almost 16,500 peer-reviewed publications on a well-known group of 286 species, the Order Carnivora, with global datasets on species' life history and ecological traits to explore patterns in research effort. Our study explores how species' characteristics influenced the degree to which they were studied ( measured as the number of publications). We identified a wide variation in intensity of research effort at both Family and Species levels, with some of the least studied being those which may need protection in future. Our findings hint at the complex role of human perspectives in setting research agendas. We found that better-studied species tended to be large-bodied and have a large geographic range whilst omnivory had a negative relationship with research effort. IUCN threat status did not exhibit a strong relationship with research effort which suggests that the conservation needs of individual species are not major drivers of research interest. This work is the first to use a combination of bibliometric analysis and biological data to quantify and interpret gaps in research knowledge across an entire Order. Our results could be combined with other resources, such as Biodiversity Action Plans, to prioritise and co-ordinate future research effort, whilst our methods can be applied across many scientific disciplines to describe knowledge gaps.	[Brooke, Zoe M.; Bielby, Jon; Carbone, Chris] Zool Soc London, Inst Zool, London NW1 4RY, England; [Nambiar, Kate] Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England	Zoological Society of London; University of Brighton; University of Sussex	Carbone, C (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	chris.carbone@ioz.ac.uk		Bielby, Jon/0000-0003-4586-0429; Nambiar, Kate/0000-0001-8591-0203				Amori G, 2000, BIODIVERS CONSERV, V9, P785, DOI 10.1023/A:1008971823774; [Anonymous], 2005, EC HUM WELLB CURR ST; Arlettaz R, 2010, BIOSCIENCE, V60, P835, DOI 10.1525/bio.2010.60.10.10; Bajomi B, 2010, ORYX, V44, P358, DOI 10.1017/S0030605310000281; Balme GA, 2013, CONSERV LETT, V00, P1; Balmford A, 1996, CONSERV BIOL, V10, P719, DOI 10.1046/j.1523-1739.1996.10030719.x; BITGOOD S, 1988, ENVIRON BEHAV, V20, P474, DOI 10.1177/0013916588204006; Bonnet X, 2002, TRENDS ECOL EVOL, V17, P1, DOI 10.1016/S0169-5347(01)02381-3; Braunisch V, 2012, BIOL CONSERV, V153, P201, DOI 10.1016/j.biocon.2012.05.007; Brodie JF, 2009, BIODIVERS CONSERV, V18, P2927, DOI 10.1007/s10531-009-9617-3; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Clark JA, 2002, SCIENCE, V297, P191; Collen B, 2004, GLOBAL ECOL BIOGEOGR, V13, P459, DOI 10.1111/j.1466-822X.2004.00121.x; Collen B, 2011, PHILOS T R SOC B, V366, P2577, DOI 10.1098/rstb.2011.0015; Fazey I, 2005, BIOL CONSERV, V124, P63, DOI 10.1016/j.biocon.2005.01.013; Fisher R, 2011, CONSERV LETT, V4, P64, DOI 10.1111/j.1755-263X.2010.00146.x; Frynta D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063110; Garfield E, 2007, CHEM HER FDN PHIL US; Ghosal S, 2013, BIODIVERS CONSERV, V22, P2665, DOI 10.1007/s10531-013-0549-6; Griffiths RA, 2012, BIOL CONSERV, V153, P153, DOI 10.1016/j.biocon.2012.05.011; Hopkins ME, 2007, DIVERS DISTRIB, V13, P561, DOI 10.1111/j.1472-4642.2007.00364.x; Howe D, 2008, NATURE, V455, P47, DOI 10.1038/455047a; IUCN, 2011, IUCN 2011 IUCN RED L; Johnson PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012866; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kaschner K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044075; Knight AT, 2008, CONSERV BIOL, V22, P610, DOI 10.1111/j.1523-1739.2008.00914.x; Kot CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012990; Laurance WF, 2012, BIOL CONSERV, V153, P164, DOI 10.1016/j.biocon.2012.05.012; Lawler JJ, 2006, FRONT ECOL ENVIRON, V4, P473, DOI 10.1890/1540-9295(2006)4[473:CSAYRC]2.0.CO;2; Loe J, 2004, AMBIO, V33, P283, DOI 10.1639/0044-7447(2004)033[0283:LCAHSA]2.0.CO;2; Mabe M, 2001, SCIENTOMETRICS, V51, P147, DOI 10.1023/A:1010520913124; MASTER LL, 1991, CONSERV BIOL, V5, P559, DOI 10.1111/j.1523-1739.1991.tb00370.x; Moss A, 2010, ZOO BIOL, V29, P715, DOI 10.1002/zoo.20316; NEWEY WK, 1987, ECONOMETRICA, V55, P703, DOI 10.2307/1913610; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Pawar S, 2003, BIOSCIENCE, V53, P861, DOI 10.1641/0006-3568(2003)053[0861:TCATMC]2.0.CO;2; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Safi K, 2010, GLOBAL ECOL BIOGEOGR, V19, P352, DOI 10.1111/j.1466-8238.2010.00523.x; Thomas DF, 2012, QUANTPSYC QUANTIATIV; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Trimble MJ, 2010, CONSERV BIOL, V24, P886, DOI 10.1111/j.1523-1739.2010.01453.x; Tyler EHM, 2012, GLOBAL ECOL BIOGEOGR, V21, P922, DOI 10.1111/j.1466-8238.2011.00726.x; United Nations, 2012, DEM YB 2011; Venables WN., 2002, MODERN APPL STAT S 4; Ward PI, 1998, CONSERV BIOL, V12, P1408, DOI 10.1046/j.1523-1739.1998.97402.x; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; *WORLD BANK, 2011, POP GROWTH ANN; Zeileis A., 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i10, DOI 10.18637/JSS.V011.I10]; ZEILEIS A., 2006, J STAT SOFTW, V16, P1, DOI DOI 10.18637/JSS.V016.I09; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	57	75	76	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93195	10.1371/journal.pone.0093195	http://dx.doi.org/10.1371/journal.pone.0093195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695422	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000047
J	Guo, S; Lopez-Marquez, H; Fan, KC; Choy, E; Cote, G; Harmon, D; Nielsen, GP; Yang, C; Zhang, CQ; Mankin, H; Hornicek, FJ; Borger, DR; Duan, ZF				Guo, Shang; Lopez-Marquez, Hector; Fan, Kenneth C.; Choy, Edwin; Cote, Gregory; Harmon, David; Nielsen, G. Petur; Yang, Cao; Zhang, Changqing; Mankin, Henry; Hornicek, Francis J.; Borger, Darrell R.; Duan, Zhenfeng			Synergistic Effects of Targeted PI3K Signaling Inhibition and Chemotherapy in Liposarcoma	PLOS ONE			English	Article							DEDIFFERENTIATED LIPOSARCOMA; EXPRESSION; DIAGNOSIS; PATHWAY; MDM2; CDK4; ACTIVATION; MANAGEMENT	While liposarcoma is the second most common soft tissue malignant tumor, the molecular pathogenesis in this malignancy is poorly understood. Our goal was therefore to expand the understanding of molecular mechanisms that drive liposarcoma and identify therapeutically-susceptible genetic alterations. We studied a cohort of high-grade liposarcomas and benign lipomas across multiple disease sites, as well as two liposarcoma cell lines, using multiplexed mutational analysis. Nucleic acids extracted from diagnostic patient tissue were simultaneously interrogated for 150 common mutations across 15 essential cancer genes using a clinically-validated platform for cancer genotyping. Western blot analysis was implemented to detect activation of downstream pathways. Liposarcoma cell lines were used to determine the effects of PI3K targeted drug treatment with or without chemotherapy. We identified mutations in the PIK3CA gene in 4 of 18 human liposarcoma patients (22%). No PIK3CA mutations were identified in benign lipomas. Western blot analysis confirmed downstream activation of AKT in both PIK3CA mutant and non-mutant liposarcoma samples. PI-103, a dual PI3K/mTOR inhibitor, effectively inhibited the activation of the PI3K/AKT in liposarcoma cell lines and induced apoptosis. Importantly, combination with PI-103 treatment strongly synergized the growth-inhibitory effects of the chemotherapy drugs doxorubicin and cisplatin in liposarcoma cells. Taken together, these findings suggest that activation of the PI3K/AKT pathway is an important cancer mechanism in liposarcoma. Targeting the PI3K/AKT/pathway with small molecule inhibitors in combination with chemotherapy could be exploited as a novel strategy in the treatment of liposarcoma.	[Guo, Shang; Choy, Edwin; Cote, Gregory; Harmon, David; Mankin, Henry; Hornicek, Francis J.; Duan, Zhenfeng] Massachusetts Gen Hosp, Ctr Sarcoma & Connect Tissue Oncol, Boston, MA 02114 USA; [Guo, Shang; Zhang, Changqing] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China; [Lopez-Marquez, Hector; Fan, Kenneth C.; Borger, Darrell R.] Massachusetts Gen Hosp, Translat Res Lab, Boston, MA 02114 USA; [Nielsen, G. Petur] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Yang, Cao] Huazhong Univ Sci & Technol, Union Hosp, Dept Orthopaed, Wuhan 430074, Peoples R China	Harvard University; Massachusetts General Hospital; Shanghai Jiao Tong University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Huazhong University of Science & Technology	Duan, ZF (corresponding author), Massachusetts Gen Hosp, Ctr Sarcoma & Connect Tissue Oncol, Boston, MA 02114 USA.	zduan@mgh.harvard.edu		zhang, changqing/0000-0002-7408-4126; Cote, Gregory/0000-0003-0181-886X	Jeff Guyer Fund; Gattegno fund; Wechsler fund; Kenneth Stanton Fund; Sarcoma Foundation of America (SFA); National Cancer Institute (NCI)/National Institutes of Health (NIH) [CA 151452-01]; Academic Enrichment Fund of MGH Orthopaedics; NATIONAL CANCER INSTITUTE [U01CA151452] Funding Source: NIH RePORTER	Jeff Guyer Fund; Gattegno fund; Wechsler fund; Kenneth Stanton Fund; Sarcoma Foundation of America (SFA); National Cancer Institute (NCI)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Academic Enrichment Fund of MGH Orthopaedics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported, in part, by grants from the Jeff Guyer Fund. Support has also been provided by the Gattegno and Wechsler funds, the Kenneth Stanton Fund. ZD is supported, in part, through a grant from Sarcoma Foundation of America (SFA), a grant from National Cancer Institute (NCI)/National Institutes of Health (NIH), UO1, CA 151452-01, and a grant from an Academic Enrichment Fund of MGH Orthopaedics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agell L, 2011, MODERN PATHOL, V24, P443, DOI 10.1038/modpathol.2010.208; Bagci-Onder T, 2011, CANCER RES, V71, P154, DOI 10.1158/0008-5472.CAN-10-1601; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Conyers Rachel, 2011, Sarcoma, V2011, P483154, DOI 10.1155/2011/483154; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Crago AM, 2011, CURR OPIN ONCOL, V23, P373, DOI 10.1097/CCO.0b013e32834796e6; Dalal KM, 2008, J SURG ONCOL, V97, P298, DOI 10.1002/jso.20975; de Vreeze RSA, 2010, ANN SURG ONCOL, V17, P686, DOI 10.1245/s10434-009-0806-9; Demicco EG, 2012, MODERN PATHOL, V25, P212, DOI 10.1038/modpathol.2011.148; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Duan Z, 2007, MOL PHARMACOL, V72, P1137, DOI 10.1124/mol.107.038117; Duan ZF, 2012, CLIN CANCER RES, V18, P4580, DOI 10.1158/1078-0432.CCR-12-1157; Duan ZF, 2010, CANCER LETT, V293, P220, DOI 10.1016/j.canlet.2010.01.014; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; Fan JX, 2013, AM J HEALTH PROMOT, V28, P41, DOI 10.4278/ajhp.120606-QUAL-286; Gutierrez A, 2011, P NATL ACAD SCI USA, V108, P16386, DOI 10.1073/pnas.1106127108; Hoffman A, 2011, DRUG RESIST UPDATE, V14, P52, DOI 10.1016/j.drup.2010.11.001; Italiano A, 2008, INT J CANCER, V122, P2233, DOI 10.1002/ijc.23380; Mankin Henry J, 2005, Cancer Control, V12, P5; Nardi V, 2012, CLIN CANCER RES, V18, P1227, DOI 10.1158/1078-0432.CCR-11-2308; Opel D, 2011, CLIN CANCER RES, V17, P3233, DOI 10.1158/1078-0432.CCR-10-2530; Pedeutour F, 1999, GENE CHROMOSOME CANC, V24, P30, DOI 10.1002/(SICI)1098-2264(199901)24:1<30::AID-GCC5>3.0.CO;2-P; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Sachdeva MP, 2009, AM J DERMATOPATH, V31, P423, DOI 10.1097/DAD.0b013e3181a129b7; Sakamoto A, 2001, AM J CLIN PATHOL, V115, P235; Schneider-Stock R, 1998, VIRCHOWS ARCH, V433, P315, DOI 10.1007/s004280050255; Schwab J, 2009, ANTICANCER RES, V29, P1867; Segura-Sanchez J, 2006, ANTICANCER RES, V26, P4937; Smith KB, 2013, AM J PATHOL, V182, P1400, DOI 10.1016/j.ajpath.2013.01.002; Smith WA, 2013, BMC EVOL BIOL, V13, P109, DOI DOI 10.1186/1471-2148-13-109; Tanas MR, 2009, ADV ANAT PATHOL, V16, P383, DOI 10.1097/PAP.0b013e3181bb6b86; Tos APD, 2000, J PATHOL, V190, P531; Warner EL, 2014, J CANCER EPIDEMIOL, V2014, DOI 10.1155/2014/531958; Westhoff MA, 2009, ONCOGENE, V28, P3586, DOI 10.1038/onc.2009.215; Willems L, 2012, CURR ONCOL REP, V14, P129, DOI 10.1007/s11912-012-0227-y	35	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93996	10.1371/journal.pone.0093996	http://dx.doi.org/10.1371/journal.pone.0093996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695632	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000133
J	Pedrelli, M; Davoodpour, P; Degirolamo, C; Gomaraschi, M; Graham, M; Ossoli, A; Larsson, L; Calabresi, L; Gustafsson, JA; Steffensen, KR; Eriksson, M; Parini, P				Pedrelli, Matteo; Davoodpour, Padideh; Degirolamo, Chiara; Gomaraschi, Monica; Graham, Mark; Ossoli, Alice; Larsson, Lilian; Calabresi, Laura; Gustafsson, Jan-Ake; Steffensen, Knut R.; Eriksson, Mats; Parini, Paolo			Hepatic ACAT2 Knock Down Increases ABCA1 and Modifies HDL Metabolism in Mice	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; REVERSE CHOLESTEROL TRANSPORT; TISSUE-CULTURE CELLS; APOLIPOPROTEIN-E; DIETARY-CHOLESTEROL; ESTER METABOLISM; ACYL-COENZYME; LXR AGONIST; PLASMA; EFFLUX	Objectives: ACAT2 is the exclusive cholesterol esterifying enzyme in hepatocytes and enterocytes. Hepatic ABCA1 transfers unesterified cholesterol (UC) to apoAI, thus generating HDL. By changing the hepatic UC pool available for ABCA1, ACAT2 may affect HDL metabolism. The aim of this study was to reveal whether hepatic ACAT2 influences HDL metabolism. Design: WT and LXR alpha/beta double knockout (DOKO) mice were fed a western-type diet for 8 weeks. Animals were i.p. injected with an antisense oligonucleotide targeted to hepatic ACAT2 (ASO6), or with an ASO control. Injections started 4 weeks after, or concomitantly with, the beginning of the diet. Results: ASO6 reduced liver cholesteryl esters, while not inducing UC accumulation. ASO6 increased hepatic ABCA1 protein independently of the diet conditions. ASO6 affected HDL lipids (increased UC) only in DOKO, while it increased apoE-containing HDL in both genotypes. In WT mice ASO6 led to the appearance of large HDL enriched in apoAI and apoE. Conclusions: The use of ASO6 revealed a new pathway by which the liver may contribute to HDL metabolism in mice. ACAT2 seems to be a hepatic player affecting the cholesterol fluxes fated to VLDL or to HDL, the latter via up-regulation of ABCA1.	[Pedrelli, Matteo; Davoodpour, Padideh; Larsson, Lilian; Parini, Paolo] Karolinska Inst, Dept Lab Med, Div Clin Chem, Stockholm, Sweden; [Pedrelli, Matteo; Gustafsson, Jan-Ake; Steffensen, Knut R.; Eriksson, Mats; Parini, Paolo] Karolinska Inst, Dept Biosci & Nutr, Mol Nutr Unit, Stockholm, Sweden; [Degirolamo, Chiara] Wake Forest Univ, Sch Med, Dept Pathol, Div Lipid Sci, Winston Salem, NC 27109 USA; [Gomaraschi, Monica; Ossoli, Alice; Calabresi, Laura] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Graham, Mark] Isis Pharmaceut Inc, Dept Antisense Drug Discovery, Cardiovasc Grp, Carlsbad, CA USA; [Gustafsson, Jan-Ake] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA; [Eriksson, Mats] Karolinska Inst, Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Wake Forest University; University of Milan; Isis Pharmaceuticals Inc; University of Houston System; University of Houston; Karolinska Institutet	Parini, P (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Chem, Stockholm, Sweden.	paolo.parini@ki.se	Gomaraschi, Monica/A-3601-2014; Ossoli, Alice/K-5917-2016	Gomaraschi, Monica/0000-0003-3082-2120; Ossoli, Alice/0000-0002-9902-252X; Steffensen, Knut/0000-0001-6093-2801; Pedrelli, Matteo/0000-0003-0771-0569; Eriksson, Mats/0000-0001-6481-5549; Calabresi, Laura/0000-0001-5042-9532	Swedish Heart-Lung Foundation; Swedish Research Council; Karolinska Institutet; Swedish Medical Association; Stockholm County Council; Novo Nordisk Research Foundation	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Swedish Medical Association; Stockholm County Council(Stockholm County Council); Novo Nordisk Research Foundation(Novo Nordisk Foundation)	The studies described in this paper were supported by the Swedish Heart-Lung Foundation, the Swedish Research Council, the Karolinska Institutet, the Swedish Medical Association, the Stockholm County Council, and Novo Nordisk Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Alger HM, 2010, J BIOL CHEM, V285, P14267, DOI 10.1074/jbc.M110.118422; Bell TA, 2007, ARTERIOSCL THROM VAS, V27, P1396, DOI 10.1161/ATVBAHA.107.142802; Bell TA, 2006, ARTERIOSCL THROM VAS, V26, P1814, DOI 10.1161/01.ATV.0000225289.30767.06; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; Camont L, 2013, ARTERIOSCL THROM VAS, V33, P2715, DOI 10.1161/ATVBAHA.113.301468; Camont L, 2011, TRENDS MOL MED, V17, P594, DOI 10.1016/j.molmed.2011.05.013; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; CARR TP, 1992, ARTERIOSCLER THROMB, V12, P1274, DOI 10.1161/01.ATV.12.11.1274; Chen SN, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-111; de la Llera-Moya M, 1999, J LIPID RES, V40, P575; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; Favari E, 2004, J BIOL CHEM, V279, P9930, DOI 10.1074/jbc.M312476200; Favari E, 2009, BIOCHEMISTRY-US, V48, P11067, DOI 10.1021/bi901564g; Fazio S, 2006, NEW ENGL J MED, V354, P1307, DOI 10.1056/NEJMe068012; Feingold KR, 2011, J LIPID RES, V52, P1, DOI 10.1194/jlr.E012138; Jiang ZY, 2009, BIOCHEM BIOPH RES CO, V379, P49, DOI 10.1016/j.bbrc.2008.11.131; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Krimbou L, 2004, J LIPID RES, V45, P839, DOI 10.1194/jlr.M300418-JLR200; Lada AT, 2004, J LIPID RES, V45, P378, DOI 10.1194/jlr.D300037-JLR200; Lee RG, 2005, J LIPID RES, V46, P1205, DOI 10.1194/jlr.M500018-JLR200; Lee RG, 2004, CIRC RES, V95, P998, DOI 10.1161/01.RES.0000147558.15554.67; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Linder MD, 2009, ARTERIOSCL THROM VAS, V29, P883, DOI 10.1161/ATVBAHA.108.179481; Lovgren-Sandblom A, 2007, J CHROMATOGR B, V856, P15, DOI 10.1016/j.jchromb.2007.05.019; Ma J, 1997, AM J CLIN NUTR, V65, P551, DOI 10.1093/ajcn/65.2.551; Miller CD, 2012, ACAD EMERG MED, V19, P673, DOI 10.1111/j.1553-2712.2012.01378.x; Oram JF, 2003, ARTERIOSCL THROM VAS, V23, P720, DOI 10.1161/01.ATV.0000054662.44688.9A; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Parini P, 2009, ATHEROSCLEROSIS, V207, P266, DOI 10.1016/j.atherosclerosis.2009.04.010; Pedrelli M, 2010, ARTERIOSCLER THROMB, V30, pE183; Pramfalk C, 2012, EUR J LIPID SCI TECH, V114, P624, DOI 10.1002/ejlt.201100294; Qiu Shenfeng, 2012, Frontiers in Genetics, V3, P124, DOI 10.3389/fgene.2012.00124; ROTHBLAT GH, 1976, LIPIDS, V11, P97, DOI 10.1007/BF02532658; ROTHBLAT GH, 1974, LIPIDS, V9, P526, DOI 10.1007/BF02532500; Rudel LL, 2005, ARTERIOSCL THROM VAS, V25, P1112, DOI 10.1161/01.ATV.0000166548.65753.1e; SHENG J, 1990, METABOLISM, V39, P155, DOI 10.1016/0026-0495(90)90069-O; Singaraja RR, 2009, CIRC RES, V105, P138, DOI 10.1161/CIRCRESAHA.108.193011; Slatis K, 2010, J LIPID RES, V51, P3289, DOI 10.1194/jlr.M009308; Tang WQ, 2008, ARTERIOSCL THROM VAS, V28, P448, DOI 10.1161/ATVBAHA.107.160465; Temel RE, 2005, J LIPID RES, V46, P2423, DOI 10.1194/jlr.M500232-JLR200; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Vaisman BL, 2001, J CLIN INVEST, V108, P303; Wang MD, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700326200; Warensjo E, 2008, AM J CLIN NUTR, V88, P203, DOI 10.1093/ajcn/88.1.203; Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD; Yancey PG, 2000, J BIOL CHEM, V275, P36596, DOI 10.1074/jbc.M006924200; Zanotti I, 2008, J LIPID RES, V49, P954, DOI 10.1194/jlr.M700254-JLR200; Zanotti I, 2011, ARTERIOSCL THROM VAS, V31, P74, DOI 10.1161/ATVBAHA.110.213892; Zhang J, 2012, J LIPID RES, V53, P1144, DOI 10.1194/jlr.M024356	55	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93552	10.1371/journal.pone.0093552	http://dx.doi.org/10.1371/journal.pone.0093552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695360	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000089
J	Rahim, BEEA; Mahfouz, MS; Yagoub, U; Solan, YMH; Alsanosy, RM				Rahim, Bahaa-Eldin E. Abdel; Mahfouz, Mohamed Salih; Yagoub, Umar; Solan, Yahya M. H.; Alsanosy, Rashad Mohammed			Practice and Attitude of Cigarette Smoking: A Community-Based Study	PLOS ONE			English	Article							SAUDI-ARABIA; SOCIOECONOMIC-STATUS; DRUG-USE; PREVALENCE; DETERMINANTS; POPULATION; ADOLESCENTS; TANZANIA; STUDENTS; ALCOHOL	Background: In Saudi Arabia many studies have addressed cigarette smoking from various perspectives. Most of these studies, however, were conducted among males and confined to Riyadh, the capital city. Such limitations have enhanced the need for community-based epidemiological studies that include both genders and various age groups and socio-demographic features, as well as different regions. Objective: This cross-sectional study aims to assess the prevalence of cigarette smoking and to discuss the association between cigarette smoking habits and socio-demographic factors among community members of the Jazan area in southwest Saudi Arabia. Methods: A pre-coded questionnaire was designed and tested for data consistency. A well-trained health team was assigned to gather the data from the 30 primary healthcare centers distributed across eight provinces. The response rate was 92.8% (4,326 respondents >= 13 years old). The associations among the subjects' socio-demographic characteristics were examined by the chi-square test. A multiple logistic regression and odds ratios were calculated as well. Results: A total of 1,017 ( 23.5%), 1,042 ( 24.1%), and 3,284 ( 75.9%) respondents were, respectively, current smokers ( TCS), ever-smokers ( TES), and non-smokers ( TNS). Though current smokers seem to be more prevalent in urban populations ( 13.8%) than in rural populations ( 9.7%), the association of urbanization with a current smoking habit is insignificant. Conclusion: Having fun, relieving stress, and the influence of parents, particularly of mothers, were the main motives that encouraged participants' cigarette-smoking habits. This situation was worsened by the fact that accessing cigarettes was either very easy or easy for over 90% of the respondents.	[Rahim, Bahaa-Eldin E. Abdel; Yagoub, Umar] Jazan Univ, Med Res Ctr, Unit Populat Hlth, Jazan, Saudi Arabia; [Mahfouz, Mohamed Salih] Jazan Univ, Fac Med, Dept Community Med, Jazan, Saudi Arabia; [Solan, Yahya M. H.] Minist Hlth, Dept Primary Healthcare Jazan, Jazan, Saudi Arabia; [Alsanosy, Rashad Mohammed] Jazan Univ, SARC, Jazan, Saudi Arabia	Jazan University; Jazan University; Ministry of Health - Saudi Arabia; Jazan University	Rahim, BEEA (corresponding author), Jazan Univ, Med Res Ctr, Unit Populat Hlth, Jazan, Saudi Arabia.	babdelrahimelwali@jazanu.edu.sa	Mahfouz, Mohamed/A-7388-2012; YAGOUB, UMAR/W-8037-2018; Mohammed, Umar/AHE-4079-2022	Mahfouz, Mohamed/0000-0002-3155-6381; Mohammed, Umar/0000-0001-8662-9229; Alsanosy, Rashad/0000-0002-0719-9708	Substance Abuse Research Center, Jazan University, Jazan City, Saudi Arabia [SARC007/1433]	Substance Abuse Research Center, Jazan University, Jazan City, Saudi Arabia	This study was funded by the Substance Abuse Research Center, Jazan University, Jazan City, Saudi Arabia, SARC007/1433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott-Chapman J, 2008, YOUTH SOC, V40, P131, DOI 10.1177/0044118X07309206; Al-Bassiony MM, 2009, SAUDI MED J, V30, P876; Al-Dawood KM, 2000, SAUDI MED J, V21, P735; Al-Doghether MH, 2004, ASIA PACIFIC FAMILY, V3, P19; Al-Munif MA, 2009, REPORT ON TOBACCO CO; Al-Turki K. A., 2010, Eastern Mediterranean Health Journal, V16, P671; Al-Turki YA, 2006, SAUDI MED J, V27, P700; [Anonymous], 2004, YOUNG PEOPLES HLTH C; Baska T, 2009, INT J PUBLIC HEALTH, V54, P439, DOI 10.1007/s00038-009-0051-9; Bovet P, 2002, INT J EPIDEMIOL, V31, P240, DOI 10.1093/ije/31.1.240; Chiatti C, 2010, ITALIAN J PUBLIC HLT, V7, P243; Cigarette Prices, 2014, INT CIG PRIC; Cronk CE, 1997, AM J PUBLIC HEALTH, V87, P760, DOI 10.2105/AJPH.87.5.760; Geckova A, 2002, SOZ PRAVENTIV MED, V47, P233, DOI 10.1007/BF01326404; Gupta R, 1997, J CLIN EPIDEMIOL, V50, P203, DOI 10.1016/S0895-4356(96)00281-8; Idris AM, 1998, PREV MED, V27, P597, DOI 10.1006/pmed.1998.0331; Idris BI, 2007, HEALTH PLACE, V13, P702, DOI 10.1016/j.healthplace.2006.11.001; Ilhan IO, 2009, INT J PUBLIC HEALTH, V54, P40, DOI 10.1007/s00038-009-7049-1; Jagoe K, 2002, TOB CONTROL, V11, P210, DOI 10.1136/tc.11.3.210; Jarallah JS, 1999, TOB CONTROL, V8, P53, DOI 10.1136/tc.8.1.53; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; JOHNSON SF, 1987, AM J EPIDEMIOL, V126, P695, DOI 10.1093/oxfordjournals.aje.a114709; McDermott L, 2009, ADDICTION, V104, P478, DOI 10.1111/j.1360-0443.2008.02452.x; Metintas S, 1998, PUBLIC HEALTH, V112, P261, DOI 10.1038/sj.ph.1900470; Onadl CT, 2005, SMOKING STATUS TOBAC, V9, P478; Piko BF, 2007, EUR J PUBLIC HEALTH, V17, P353, DOI 10.1093/eurpub/ckl257; Pitel L, 2010, PUBLIC HEALTH, V124, P512, DOI 10.1016/j.puhe.2010.05.005; Pitel L, 2011, INT J PUBLIC HEALTH, V56, P645, DOI 10.1007/s00038-010-0219-3; Royal College of Physicians, 2007, HARM RED NIC ADD HEL; Salonna F, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-57; Sardu C, 2009, J Prev Med Hyg, V50, P191; Semyonov L, 2012, SCI WORLD J, DOI 10.1100/2012/286472; Siahpush M, 2003, TOB CONTROL, V12, P60, DOI 10.1136/tc.12.1.60; Siddiqui S, 2001, FAM MED, V33, P367	34	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92939	10.1371/journal.pone.0092939	http://dx.doi.org/10.1371/journal.pone.0092939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695369	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000031
J	Saunders, DR; Bex, PJ; Rose, DJ; Woods, RL				Saunders, Daniel R.; Bex, Peter J.; Rose, Dylan J.; Woods, Russell L.			Measuring Information Acquisition from Sensory Input Using Automated Scoring of Natural-Language Descriptions	PLOS ONE			English	Article							IMAGE QUALITY; READING-COMPREHENSION; VIDEO QUALITY; ENHANCEMENT; TEXT	Information acquisition, the gathering and interpretation of sensory information, is a basic function of mobile organisms. We describe a new method for measuring this ability in humans, using free-recall responses to sensory stimuli which are scored objectively using a "wisdom of crowds'' approach. As an example, we demonstrate this metric using perception of video stimuli. Immediately after viewing a 30 s video clip, subjects responded to a prompt to give a short description of the clip in natural language. These responses were scored automatically by comparison to a dataset of responses to the same clip by normally-sighted viewers (the crowd). In this case, the normative dataset consisted of responses to 200 clips by 60 subjects who were stratified by age (range 22 to 85y) and viewed the clips in the lab, for 2,400 responses, and by 99 crowdsourced participants (age range 20 to 66y) who viewed clips in their Web browser, for 4,000 responses. We compared different algorithms for computing these similarities and found that a simple count of the words in common had the best performance. It correctly matched 75% of the lab-sourced and 95% of crowdsourced responses to their corresponding clips. We validated the measure by showing that when the amount of information in the clip was degraded using defocus lenses, the shared word score decreased across the five predetermined visual-acuity levels, demonstrating a dose- response effect (N = 15). This approach, of scoring open-ended immediate free recall of the stimulus, is applicable not only to video, but also to other situations where a measure of the information that is successfully acquired is desirable. Information acquired will be affected by stimulus quality, sensory ability, and cognitive processes, so our metric can be used to assess each of these components when the others are controlled.	[Saunders, Daniel R.; Bex, Peter J.; Rose, Dylan J.; Woods, Russell L.] Schepens Eye Res Inst, Boston, MA 02114 USA	Harvard University; Schepens Eye Research Institute	Saunders, DR (corresponding author), Schepens Eye Res Inst, Boston, MA 02114 USA.	daniel_saunders@meei.harvard.edu	Woods, Russell L/O-2600-2015	Woods, Russell L/0000-0002-7193-1211	National Eye Institute [R01EY019100]; NATIONAL EYE INSTITUTE [R01EY019100] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by grant number R01EY019100 from the National Eye Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson J. C, 2000, ASSESSING READING; Allwood CM, 2005, PSYCHOL CRIME LAW, V11, P183, DOI 10.1080/10683160512331329943; [Anonymous], 1992, HDB NEUROPSYCHOLOGIC; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Baroni M, 2010, COMPUT LINGUIST, V36, P673, DOI 10.1162/coli_a_00016; Baroni M, 2009, LANG RESOUR EVAL, V43, P209, DOI 10.1007/s10579-009-9081-4; BARTEN PGJ, 1990, J OPT SOC AM A, V7, P2024, DOI 10.1364/JOSAA.7.002024; Bernhardt E.B., 1983, UNTERRICHTSPRAXIS, V16, P27, DOI DOI 10.2307/3530598; Bernhardt E. B., 1991, READING DEV 2 LANGUA; DICKINSON CM, 1991, CLIN VISION SCI, V6, P301; Eskicioglu AM, 1995, IEEE T COMMUN, V43, P2959, DOI 10.1109/26.477498; Ferraresi A., 2008, P 4 WEB CORPUS WORKS, P47; Fine E, 1996, VIS 96 P INT C LOW V, P85; Foltz PW, 1999, BEHAV RES METH INS C, V31, P208, DOI 10.3758/BF03207712; Fullerton M, 2007, J OPT SOC AM A, V24, pB174, DOI 10.1364/JOSAA.24.00B174; HAMBERG R, 1995, J OPT SOC AM A, V12, P2573, DOI 10.1364/JOSAA.12.002573; Heinz P. J, 2004, READING FOREIGN LANG, V16, P97; Janssen DP, 2012, BEHAV RES METHODS, V44, P232, DOI 10.3758/s13428-011-0145-1; Jepsen ML, 2008, J ACOUST SOC AM, V124, P422, DOI 10.1121/1.2924135; Kies JK, 1997, COMPUT EDUC, V28, P79, DOI 10.1016/S0360-1315(97)00004-3; Kim J, 2004, OPT ENG, V43, P1318, DOI 10.1117/1.1723493; Kintsch W., 1974, REPRESENTATION MEANI; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Lee C, 2006, OPT ENG, V45, DOI 10.1117/1.2160515; Lubin J., 1995, VISION MODELS TARGET, P245; Martin Allwood C, 2008, PSYCHOL CRIME LAW, V14, P529, DOI 10.1080/10683160801961231; MEYER BJF, 1980, READ RES QUART, V16, P72, DOI 10.2307/747349; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Papineni K, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P311, DOI 10.3115/1073083.1073135; Peli E, 2005, OPHTHAL PHYSL OPT, V25, P543, DOI 10.1111/j.1475-1313.2005.00340.x; Peli E, 1996, J VISUAL IMPAIR BLIN, V90, P378; Peli E., 1999, OSA TECHNICAL DIGEST, P46; Peli E, 2009, INT J ARTIF INTELL T, V18, P415, DOI 10.1142/S0218213009000214; Pinson M, 2003, PROC SPIE, V5150, P573, DOI 10.1117/12.509908; PYRCZAK F, 1975, J READING, V18, P308; Satgunam P, 2010, SOC INF DISPL INT S, P94; Saunders DR, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2620; SEKULER R, 1977, AM J OPTOM PHYS OPT, V54, P573; STOCKHAM TG, 1972, PR INST ELECTR ELECT, V60, P828, DOI 10.1109/PROC.1972.8782; Surowiecki J., 2004, WISDOM CROWDS WHY MA, VXXI, P295; Turney PD, 2010, J ARTIF INTELL RES, V37, P141, DOI 10.1613/jair.2934; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Zeimpekis D., 2005, P WORKSH CLUST HIGH, P38	43	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93251	10.1371/journal.pone.0093251	http://dx.doi.org/10.1371/journal.pone.0093251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695546	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000053
J	Wang, N; Zhang, HY; Zhang, BQ; Liu, W; Zhang, ZL; Qiao, M; Zhang, HM; Deng, F; Wu, NN; Chen, X; Wen, S; Zhang, JH; Liao, Z; Zhang, Q; Yan, ZJ; Yin, LJ; Ye, JX; Deng, YL; Luu, HH; Haydon, RC; Liang, HJ; He, TC				Wang, Ning; Zhang, Hongyu; Zhang, Bing-Qiang; Liu, Wei; Zhang, Zhonglin; Qiao, Min; Zhang, Hongmei; Deng, Fang; Wu, Ningning; Chen, Xian; Wen, Sheng; Zhang, Junhui; Liao, Zhan; Zhang, Qian; Yan, Zhengjian; Yin, Liangjun; Ye, Jixing; Deng, Youlin; Luu, Hue H.; Haydon, Rex C.; Liang, Houjie; He, Tong-Chuan			Adenovirus-Mediated Efficient Gene Transfer into Cultured Three-Dimensional Organoids	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; IN-VITRO; RECOMBINANT ADENOVIRUSES; SELF-RENEWAL; DIFFERENTIATION; SYSTEM; INTESTINE; THERAPY; CRYPT; LGR5	Three-dimensional organoids have been recently established from various tissue-specific progenitors (such as intestinal stem cells), induced pluripotent stem cells, or embryonic stem cells. These cultured self-sustaining stem cell-based organoids may become valuable systems to study the roles of tissue-specific stem cells in tissue genesis and disease development. It is thus conceivable that effective genetic manipulations in such organoids may allow us to reconstruct disease processes and/or develop novel therapeutics. Recombinant adenoviruses are one of the most commonly used viral vectors for in vitro and in vivo gene deliveries. In this study, we investigate if adenoviruses can be used to effectively deliver transgenes into the cultured "mini-gut'' organoids derived from intestinal stem cells. Using adenoviral vectors that express fluorescent proteins, we demonstrate that adenoviruses can effectively deliver transgenes into the cultured 3-D "mini-gut'' organoids. The transgene expression can last at least 10 days in the cultured organoids. As a proof-of-principle experiment, we demonstrate that adenovirus-mediated noggin expression effectively support the survival and self-renewal of mini-gut organoids, while adenovirus-mediated expression of BMP4 inhibits the self-sustainability and proliferation of the organoids. Thus, our results strongly suggest that adenovirus vectors can be explored as effective gene delivery vehicles to introduce genetic manipulations in 3-D organoids.	[Wang, Ning; Liang, Houjie] Third Mil Med Univ, Affiliated Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; [Wang, Ning; Liang, Houjie] Third Mil Med Univ, Affiliated Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China; [Wang, Ning; Zhang, Hongyu; Zhang, Bing-Qiang; Liu, Wei; Zhang, Zhonglin; Qiao, Min; Zhang, Hongmei; Deng, Fang; Wu, Ningning; Chen, Xian; Wen, Sheng; Zhang, Junhui; Liao, Zhan; Zhang, Qian; Yan, Zhengjian; Yin, Liangjun; Ye, Jixing; Deng, Youlin; Luu, Hue H.; Haydon, Rex C.; He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA; [Zhang, Hongyu; Zhang, Bing-Qiang; Liu, Wei; Qiao, Min; Zhang, Hongmei; Wu, Ningning; Chen, Xian; Wen, Sheng; Zhang, Junhui; Zhang, Qian; Yan, Zhengjian; Yin, Liangjun; Deng, Youlin; He, Tong-Chuan] Chongqing Med Univ, Key Lab Clin Diagnost Med, Minist Educ, Chongqing, Peoples R China; [Zhang, Hongyu; Zhang, Bing-Qiang; Liu, Wei; Qiao, Min; Zhang, Hongmei; Wu, Ningning; Chen, Xian; Wen, Sheng; Zhang, Junhui; Zhang, Qian; Yan, Zhengjian; Yin, Liangjun; Deng, Youlin; He, Tong-Chuan] Chongqing Med Univ, Affiliated Hosp, Chongqing, Peoples R China; [Zhang, Zhonglin] Wuhan Univ, Affiliated Zhongnan Hosp, Dept Surg, Wuhan 430072, Peoples R China; [Liao, Zhan] Cent S Univ, Xiang Ya Hosp, Dept Orthopaed Surg, Changsha, Hunan, Peoples R China; [Ye, Jixing] Chongqing Univ, Sch Bioengn, Chongqing 630044, Peoples R China	Army Medical University; Army Medical University; University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Chongqing Medical University; Wuhan University; Central South University; Chongqing University	Liang, HJ (corresponding author), Third Mil Med Univ, Affiliated Southwest Hosp, Dept Oncol, Chongqing, Peoples R China.	lianghoujie@sina.com; tche@uchicago.edu		Deng, Fang/0000-0002-7927-5394; Yin, Liang-jun/0000-0002-9244-4965	National Institutes of Health [AT004418, AR50142, AR054381]; Ministry of Science and Technology (MOST) of China [2011CB707906]; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health [UL1 TR000430]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR050142, K08AR054381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology (MOST) of China(Ministry of Science and Technology, China); National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by research grants from the National Institutes of Health (AT004418, AR50142, and AR054381 to TCH, RCH and HHL) and the Ministry of Science and Technology (MOST) of China (#2011CB707906 to TCH). This project was also supported by a core facility subsidies grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health through Grant Number UL1 TR000430. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Breyer Benjamin, 2001, Current Gene Therapy, V1, P149, DOI 10.2174/1566523013348689; Cao L, 2011, DIFFERENTIATION, V81, P1, DOI 10.1016/j.diff.2010.09.182; Chen X, 2013, CELL PHYSIOL BIOCHEM, V32, P1083, DOI 10.1159/000354508; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082436; Gasiunas G, 2013, TRENDS MICROBIOL, V21, P562, DOI 10.1016/j.tim.2013.09.001; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He BC, 2011, MOL PHARMACOL, V79, P211, DOI 10.1124/mol.110.068668; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Kong YH, 2013, CELL PHYSIOL BIOCHEM, V32, P1187, DOI 10.1159/000354518; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lou JR, 1999, J ORTHOPAED RES, V17, P43, DOI 10.1002/jor.1100170108; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; St George JA, 2003, GENE THER, V10, P1135, DOI 10.1038/sj.gt.3302071; Subramanian K, 2014, STEM CELLS DEV, V23, P124, DOI 10.1089/scd.2013.0097; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Wang Y, 2013, J ORTHOP RES; Yu B, 2013, CELL STEM CELL, V13, P328, DOI 10.1016/j.stem.2013.06.017; Zhang WW, 2013, INT J MED SCI, V10, P1888, DOI 10.7150/ijms.6019	43	56	56	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93608	10.1371/journal.pone.0093608	http://dx.doi.org/10.1371/journal.pone.0093608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695466	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000092
J	Maumus, F; Quesneville, H				Maumus, Florian; Quesneville, Hadi			Deep Investigation of Arabidopsis thaliana Junk DNA Reveals a Continuum between Repetitive Elements and Genomic Dark Matter	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; IDENTIFICATION; METHYLATION; ANNOTATION; SEQUENCES; FAMILIES	Eukaryotic genomes contain highly variable amounts of DNA with no apparent function. This so- called junk DNA is composed of two components: repeated and repeat- derived sequences ( together referred to as the repeatome), and nonannotated sequences also known as genomic dark matter. Because of their high duplication rates as compared to other genomic features, transposable elements are predominant contributors to the repeatome and the products of their decay is thought to be a major source of genomic dark matter. Determining the origin and composition of junk DNA is thus important to help understanding genome evolution as well as host biology. In this study, we have used a combination of tools enabling to show that the repeatome from the small and reducing A. thaliana genome is significantly larger than previously thought. Furthermore, we present the concepts and results from a series of innovative approaches suggesting that a significant amount of the A. thaliana dark matter is of repetitive origin. As a tentative standard for the community, we propose a deep compendium annotation of the A. thaliana repeatome that may help addressing farther genome evolution as well as transcriptional and epigenetic regulation in this model plant.	[Maumus, Florian; Quesneville, Hadi] INRA, Res Unit Genom Info, URGI, UR1 164, F-78026 Versailles, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Maumus, F (corresponding author), INRA, Res Unit Genom Info, URGI, UR1 164, F-78026 Versailles, France.	florian.maumus@versailles.inra.fr; hadi.quesneville@versailles.inra.fr	Quesneville, Hadi/AAG-1048-2020; Maumus, Florian/O-5426-2016	Quesneville, Hadi/0000-0003-3001-4908; Maumus, Florian/0000-0001-7325-0527	French national research agency [ANR-08-KBBE-012, ANR-2011-BSV6-00801]	French national research agency(French National Research Agency (ANR))	FM was supported by two grants from the French national research agency (ANR-08-KBBE-012, ANR-2011-BSV6-00801) attributed to Hadi Quesneville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieu O, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-94; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bergman CM, 2007, BRIEF BIOINFORM, V8, P382, DOI 10.1093/bib/bbm048; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; Brosius J, 1999, GENETICA, V107, P209, DOI 10.1023/A:1004018519722; Buisine N, 2008, GENOMICS, V91, P467, DOI 10.1016/j.ygeno.2008.01.005; Clauss MJ, 2006, TRENDS PLANT SCI, V11, P449, DOI 10.1016/j.tplants.2006.07.005; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cowley M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003234; Dassanayake M, 2011, NAT GENET, V43, P913, DOI 10.1038/ng.889; Dawkins Richard, 1976, SELFISH GENE; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Fedoroff NV, 2012, SCIENCE, V338, P758, DOI 10.1126/science.338.6108.758; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; Gu WJ, 2008, ANAL BIOCHEM, V380, P77, DOI 10.1016/j.ab.2008.05.015; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; KARLIN S, 1995, TRENDS GENET, V11, P283; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LANGLEY CH, 1988, GENET RES, V52, P223, DOI 10.1017/S0016672300027695; Lerat E, 2010, HEREDITY, V104, P520, DOI 10.1038/hdy.2009.165; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lysak MA, 2009, MOL BIOL EVOL, V26, P85, DOI 10.1093/molbev/msn223; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; OHNO S, 1972, BROOKHAVEN SYM BIOL, P366; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Oyama RK, 2008, PLANT SYST EVOL, V273, P257, DOI 10.1007/s00606-008-0017-z; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; Quesneville H, 2003, J MOL EVOL, V57, pS50, DOI 10.1007/s00239-003-0007-2; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Slotte T, 2013, NAT GENET, V45, P831, DOI 10.1038/ng.2669; Smit A, 1996, REPEATMASKER OPEN 30; Smit AFA, 2008, REPEATMODELER OP 1 0; THOMAS CA, 1971, ANNU REV GENET, V5, P237, DOI 10.1146/annurev.ge.05.120171.001321; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wu HJ, 2012, P NATL ACAD SCI USA, V109, P12219, DOI 10.1073/pnas.1209954109; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zytnicki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025988	48	39	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94101	10.1371/journal.pone.0094101	http://dx.doi.org/10.1371/journal.pone.0094101			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709859	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800101
J	Feng, F; Jiang, YB; Yuan, M; Shen, J; Yin, HB; Geng, DY; Xu, JR; Hua, YQ; Shi, JY; Shi, YX; Zhang, ZY				Feng, Feng; Jiang, Yebin; Yuan, Min; Shen, Jie; Yin, Huabin; Geng, Daoying; Xu, Jianrong; Hua, Yanqing; Shi, Jingyun; Shi, Yuxin; Zhang, Zhiyong			Association of Radiologic Findings with Mortality in Patients with Avian Influenza H7N9 Pneumonia	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; VIRUS; INFECTION	Background: The novel H7N9 virus causes severe illness, including pneumonia and acute respiratory distress syndrome, with high rates of mortality. We investigated the association of initial radiologic characteristics obtained at admission with clinical outcomes in patients with avian influenza H7N9 pneumonia. Methods: Demographics, comorbidities, clinical findings, radiologic appearance and scores of the affected lung parenchyma were compared between survivor group (n = 15) and mortality group (n = 7). Two radiologic scores were calculated, one using chest radiography and one using CT. Follow-up CT scans at discharge were analyzed in 12 patients of the survival group. Results: All the patients in mortality group developed acute respiratory distress syndrome and required mechanical ventilation, while in the survival group 33% (5/15) developed acute respiratory distress syndrome (P < 0.05) and 27% (4/15) required mechanical ventilation (P < 0.05). The mean radiographic and CT scores of the mortality group were 50% higher compared to the survival group ( P < 0.05). ROC analysis revealed an area under curve of 0.738 for the radiographic score with an optimal cutoff value of a score of 19 for prediction of mortality, with a sensitivity of 71% and a specificity of 67%, and an area under curve of 0.833 for the CT score with an optimal cutoff value of a CT score of 21 for prediction of mortality, with a sensitivity of 86% and a specificity of 73%. The mean CT score of the affected lung parenchyma at discharge was 30% lower than the initial CT examination ( P < 0.05). Conclusion: High initial radiologic score is associated with mortality in patients with avian influenza H7N9 pneumonia.	[Feng, Feng; Jiang, Yebin; Yuan, Min; Shen, Jie; Shi, Yuxin; Zhang, Zhiyong] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Radiol, Shanghai 200433, Peoples R China; [Yin, Huabin] Fudan Univ, Peoples Hosp Shanghai 5, Dept Radiol, Shanghai 200433, Peoples R China; [Geng, Daoying] Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Xu, Jianrong] Shanghai Jiao Tong Univ, Renji Hosp, Dept Radiol, Shanghai, Peoples R China; [Hua, Yanqing] Fudan Univ, Huadong Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Shi, Jingyun] Tongji Univ, Shanghai Pulm Hosp, Dept Radiol, Shanghai 200092, Peoples R China; [Jiang, Yebin] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA; [Feng, Feng] Nantong Univ, Nantong Tumor Hosp, Dept Radiol, Nantong, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Fudan University; Tongji University; University of Michigan System; University of Michigan; Nantong University	Shi, YX (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Radiol, Shanghai 200433, Peoples R China.	shiyx828288@163.com; zhangzy@shaphc.org	Cao, Xin/AAX-8367-2021; Shi, Jing/HHS-6413-2022					Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Bay A, 2007, EUR J RADIOL, V61, P245, DOI 10.1016/j.ejrad.2006.10.006; Chang YC, 2005, RADIOLOGY, V236, P1067, DOI 10.1148/radiol.2363040958; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Franquet T, 2011, RADIOLOGY, V260, P18, DOI 10.1148/radiol.11092149; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Grieser C, 2012, EUR J RADIOL, V81, P389, DOI 10.1016/j.ejrad.2010.12.085; Grinblat L, 2003, RADIOLOGY, V228, P802, DOI 10.1148/radiol.2283030671; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Kim EA, 2002, RADIOGRAPHICS, V22, pS137, DOI 10.1148/radiographics.22.suppl_1.g02oc15s137; Ko SF, 2004, RADIOLOGY, V233, P173, DOI 10.1148/radiol.2323031547; Li P, 2011, EUR J RADIOL, V80, pE146, DOI 10.1016/j.ejrad.2010.05.029; Lu SH, 2013, BIOSCI TRENDS, V7, P109, DOI 10.5582/bst.2013.v7.2.109; Marchiori E, 2011, AM J ROENTGENOL, V196, pW723, DOI 10.2214/AJR.10.5109; Marchiori E, 2011, EUR J RADIOL, V77, P80, DOI 10.1016/j.ejrad.2009.06.017; Marchiori E, 2010, EUR J RADIOL, V74, P93, DOI 10.1016/j.ejrad.2009.11.005; Parry J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2222; Qureshi NR, 2006, J THORAC IMAG, V21, P259, DOI 10.1097/01.rti.0000213573.94032.53; So LKY, 2003, LANCET, V361, P1615, DOI 10.1016/S0140-6736(03)13265-5; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Wang QL, 2013, RADIOLOGY, V268, P882, DOI 10.1148/radiol.13130988; World Health Organization, 2013, NUMB CONF HUM CAS AV	23	28	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93885	10.1371/journal.pone.0093885	http://dx.doi.org/10.1371/journal.pone.0093885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705783	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500084
J	Le Texier, L; Durand, J; Lavault, A; Hulin, P; Collin, O; Le Bras, Y; Cuturi, MC; Chiffoleau, E				Le Texier, Laetitia; Durand, Justine; Lavault, Amelie; Hulin, Philippe; Collin, Olivier; Le Bras, Yvan; Cuturi, Maria-Cristina; Chiffoleau, Elise			LIMLE, a New Molecule Over-Expressed following Activation, Is Involved in the Stimulatory Properties of Dendritic Cells	PLOS ONE			English	Article							PANCREATIC SPASMOLYTIC POLYPEPTIDE; REGULATORY T-CELLS; ALLOGRAFT TOLERANCE; PROTEIN-STRUCTURE; SUBCELLULAR-LOCALIZATION; ENDOTHELIAL-CELLS; SYNAPSE FORMATION; NUCLEAR EXPORT; ACTIN; INDUCTION	Dendritic cells are sentinels of the immune system distributed throughout the body, that following danger signals will migrate to secondary lymphoid organs to induce effector T cell responses. We have identified, in a rodent model of graft rejection, a new molecule expressed by dendritic cells that we have named LIMLE (RGD1310371). To characterize this new molecule, we analyzed its regulation of expression and its function. We observed that LIMLE mRNAs were rapidly and strongly up regulated in dendritic cells following inflammatory stimulation. We demonstrated that LIMLE inhibition does not alter dendritic cell maturation or cytokine production following Toll-like-receptor stimulation. However, it reduces their ability to stimulate effector T cells in a mixed leukocyte reaction or T cell receptor transgenic system. Interestingly, we observed that LIMLE protein localized with actin at some areas under the plasma membrane. Moreover, LIMLE is highly expressed in testis, trachea, lung and ciliated cells and it has been shown that cilia formation bears similarities to formation of the immunological synapse which is required for the T cell activation by dendritic cells. Taken together, these data suggest a role for LIMLE in specialized structures of the cytoskeleton that are important for dynamic cellular events such as immune synapse formation. In the future, LIMLE may represent a new target to reduce the capacity of dendritic cells to stimulate T cells and to regulate an immune response.	[Le Texier, Laetitia; Durand, Justine; Lavault, Amelie; Cuturi, Maria-Cristina; Chiffoleau, Elise] INSERM, U1064, Nantes, France; [Le Texier, Laetitia; Durand, Justine; Lavault, Amelie; Cuturi, Maria-Cristina; Chiffoleau, Elise] CHU Nantes, ITUN, Inst Transplantat & Rech Transplantat, F-44035 Nantes 01, France; [Le Texier, Laetitia; Durand, Justine; Lavault, Amelie; Cuturi, Maria-Cristina; Chiffoleau, Elise] Univ Nantes, Fac Med, Nantes, France; [Hulin, Philippe] SFR Sante, Plateforme MicroPICell, Nantes, France; [Collin, Olivier; Le Bras, Yvan] IRISA INRIA, Plateforme GenOuest, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; UDICE-French Research Universities; Universite Paris Saclay	Chiffoleau, E (corresponding author), INSERM, U1064, Nantes, France.	elise.chiffoleau@univ-nantes.fr	Le Bras, Yvan/B-4017-2010; Chiffoleau, Elise/N-2982-2018	Le Bras, Yvan/0000-0002-8504-068X; Chiffoleau, Elise/0000-0001-6167-682X; Collin, Olivier/0000-0002-8959-8402	Ministere de l'Enseignement Superieur et de la Recherche; Fondation Progreffe; Fondation Centaure	Ministere de l'Enseignement Superieur et de la Recherche; Fondation Progreffe; Fondation Centaure	This work was supported by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche and by Fondation Progreffe and Fondation Centaure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Alwan MM, 2003, J IMMUNOL, V171, P4479, DOI 10.4049/jimmunol.171.9.4479; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAKER ME, 1988, BIOCHEM J, V253, P307, DOI 10.1042/bj2530307; Bannert N, 2003, J BIOL CHEM, V278, P42190, DOI 10.1074/jbc.M306669200; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bouma G, 2011, BLOOD, V118, P2492, DOI 10.1182/blood-2011-03-340265; Celli S, 2011, NAT MED, V17, P744, DOI 10.1038/nm.2376; CHARREAU B, 1994, TRANSPLANTATION, V58, P1222, DOI 10.1097/00007890-199412150-00015; Cheng SL, 2007, J BIOMED SCI, V14, P87, DOI 10.1007/s11373-006-9130-6; Chiffoleau E, 2002, J IMMUNOL, V168, P5058, DOI 10.4049/jimmunol.168.10.5058; Chiffoleau E, 2002, AM J TRANSPLANT, V2, P745, DOI 10.1034/j.1600-6143.2002.20808.x; Condamine T, 2010, J LEUKOCYTE BIOL, V88, P507, DOI 10.1189/jlb.1109738; David A, 1997, CYTOKINE, V9, P818, DOI 10.1006/cyto.1997.0234; Eisenhaber F, 2003, NUCLEIC ACIDS RES, V31, P3631, DOI 10.1093/nar/gkg537; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Gingras AR, 2010, J BIOL CHEM, V285, P29577, DOI 10.1074/jbc.M109.095455; Griffiths GM, 2010, J CELL BIOL, V189, P397, DOI 10.1083/jcb.201002027; Grummt I, 2006, CURR OPIN GENET DEV, V16, P191, DOI 10.1016/j.gde.2006.02.001; HELMKE RJ, 1987, IN VITRO CELL DEV B, V23, P567; Heslan JM, 2006, TRANSPLANTATION, V82, P1185, DOI 10.1097/01.tp.0000236573.01428.f3; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Hu P, 2004, GENE DEV, V18, P3010, DOI 10.1101/gad.1250804; Kelley LA, 2009, PROTEIN ENG DES SEL, V22, P561, DOI 10.1093/protein/gzp035; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klatt AR, 2007, BIOLOGICALS, V35, P321, DOI 10.1016/j.biologicals.2006.12.003; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; Le Texier L, 2011, AM J TRANSPLANT, V11, P429, DOI 10.1111/j.1600-6143.2010.03336.x; Lee HJ, 2012, INFLAMM RES, V61, P817, DOI 10.1007/s00011-012-0474-2; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louvet C, 2004, TRANSPLANTATION, V78, P1259, DOI 10.1097/01.TP.0000140482.20336.77; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Martinez-Borra J, 2012, ADV EXP MED BIOL, V738, P277, DOI 10.1007/978-1-4614-1680-7_16; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nobile C, 2008, BLOOD, V111, P3579, DOI 10.1182/blood-2007-08-107755; ONO K, 1969, J THORAC CARDIOV SUR, V57, P225, DOI 10.1016/S0022-5223(19)42744-X; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Peche H, 2005, AM J TRANSPLANT, V5, P255, DOI 10.1111/j.1600-6143.2004.00683.x; Peche H, 2003, TRANSPLANTATION, V76, P1503, DOI 10.1097/01.TP.0000092494.75313.38; Ponting CP, 2000, J MOL BIOL, V302, P1041, DOI 10.1006/jmbi.2000.4087; Qi TY, 2011, J BIOL CHEM, V286, P15171, DOI 10.1074/jbc.M110.184374; Reichardt P, 2007, BLOOD, V110, P1519, DOI 10.1182/blood-2006-10-053793; Roncarolo MG, 2001, J EXP MED, V193, pF5, DOI 10.1084/jem.193.2.F5; Roy A, 2011, JOVE-J VIS EXP, DOI 10.3791/3259; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Spisek R, 2001, CANCER IMMUNOL IMMUN, V50, P417, DOI 10.1007/s002620100215; Tatarano S, 2012, INT J ONCOL, V40, P951, DOI 10.3892/ijo.2011.1294; Thebault P, 2007, AM J TRANSPLANT, V7, P2472, DOI 10.1111/j.1600-6143.2007.01960.x; Thebault P, 2009, J IMMUNOL, V183, P3099, DOI 10.4049/jimmunol.0803767; THIM L, 1988, BIOCHEM J, V253, P309; THIM L, 1989, FEBS LETT, V250, P85, DOI 10.1016/0014-5793(89)80690-8; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Tubb B, 2002, EXP CELL RES, V275, P92, DOI 10.1006/excr.2002.5486; van Helden SFG, 2006, J IMMUNOL, V177, P1567, DOI 10.4049/jimmunol.177.3.1567; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Wada A, 1998, EMBO J, V17, P1635, DOI 10.1093/emboj/17.6.1635; Watts C, 2007, CURR OPIN IMMUNOL, V19, P73, DOI 10.1016/j.coi.2006.11.014; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Yamashiro S, 2012, CRIT REV IMMUNOL, V32, P11, DOI 10.1615/CritRevImmunol.v32.i1.20; Yeats C, 2006, NUCLEIC ACIDS RES, V34, pD281, DOI 10.1093/nar/gkj057; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Zanin-Zhorov A, 2011, TRENDS IMMUNOL, V32, P358, DOI 10.1016/j.it.2011.04.007; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	67	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93894	10.1371/journal.pone.0093894	http://dx.doi.org/10.1371/journal.pone.0093894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705920	Green Submitted, Green Published, gold			2022-12-27	WOS:000334107500088
J	Li, XX; Sun, GP; Meng, J; Li, X; Tang, YX; Li, Z; Wang, MF; Liang, GF; Lu, XB				Li, Xiao-Xia; Sun, Gong-Ping; Meng, Jin; Li, Xin; Tang, Yuan-Xin; Li, Zhen; Wang, Mo-Fei; Liang, Gao-Feng; Lu, Xiao-Bo			Role of Toll-Like Receptor 4 in Colorectal Carcinogenesis: A Meta-Analysis	PLOS ONE			English	Article							INNATE IMMUNITY; CANCER; EXPRESSION; POLYMORPHISMS; ASSOCIATION; THR399ILE; RISK	Objective: This meta-analysis was performed to evaluate the role of toll-like receptor 4 (TLR-4) in colorectal carcinogenesis. Methods: The PubMed, CISCOM, CINAHL, Web of Science, Google Scholar, EBSCO, Cochrane Library, and CBM databases were searched from inception through November 1st, 2013 without language restrictions. Odds ratios (ORs) or standardized mean differences (SMD) with their 95% confidence intervals (Cl) were calculated. Results: Fourteen case-control studies met the inclusion criteria for this meta-analysis. A total of 1,209 colorectal cancer (CRC) cases and 1,218 healthy controls were involved in this meta-analysis. Two common polymorphisms (299 A > G and 399 C > T) in the TLR-4 gene, TLR-4 mRNA and protein expression were assessed. Our meta-analysis results revealed that the TLR4 399 C > T polymorphism might increase the risk of CRC (allele model: OR = 1.77, 95% Cl = 1.32 similar to 2.36, P < 0.001; dominant model: OR = 1.83, 95% Cl = 1.32 similar to 2.52, P < 0.001; respectively). However, we found no correlation between the TLR-4 299 A. G polymorphism and CRC risk (all P > 0.05). A subgroup analysis by ethnicity suggested that TLR-4 genetic polymorphisms were associated with an increased risk of CRC among Asians (allele model: OR = 1.50, 95% Cl = 1.19 similar to 1.88, P = 0.001; dominant model: OR = 1.49, 95% Cl = 1.16 similar to 1.92, P = 0.002; respectively), but not among Caucasians and Africans ( all P. 0.05). Furthermore, our results showed that TLR-4 mRNA and protein levels in CRC patients were higher than those in healthy controls ( TLR-4 mRNA: SMD = 2.51, 95% Cl = 0.98,4.05, P = 0.001; TLR-4 protein: OR = 4.75, 95% Cl = 1.16,19.36, P = 0.030; respectively). Conclusion: Our findings provide empirical evidence that TLR-4 may play an important role in colorectal carcinogenesis. Thus, TLR-4 is a promising potential biomarker for the early diagnosis of CRC.	[Li, Xiao-Xia; Sun, Gong-Ping; Meng, Jin; Li, Xin; Tang, Yuan-Xin; Li, Zhen; Wang, Mo-Fei; Liang, Gao-Feng] China Med Univ, Affiliated Hosp 4, Dept Gastrointestinal Surg, Shenyang, Peoples R China; [Lu, Xiao-Bo] China Med Univ, Sch Publ Hlth, Dept Toxicol, Shenyang, Peoples R China	China Medical University; China Medical University	Li, XX (corresponding author), China Med Univ, Affiliated Hosp 4, Dept Gastrointestinal Surg, Shenyang, Peoples R China.	cmu4h_lxx@126.com			Foundation of Education Department of Liaoning Province [2008781]; Natural Science Foundation of Liaoning Province [201102281, 20062053]	Foundation of Education Department of Liaoning Province; Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by the Foundation of Education Department of Liaoning Province (No. 2008781) and the Natural Science Foundation of Liaoning Province (Nos. 201102281 and 20062053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Cheng ZL, 2012, J SHANDONG U HLTH SC, V50, P92; Cheng ZL, 2012, J SHANDONG U HLTH SC, V50, P98; [戴穹 Dai Qiong], 2012, [中国病理生理杂志, Chinese Journal of Pathophysiology], V28, P1976; Davoodi H, 2011, IRAN J ALLERGY ASTHM, V10, P91, DOI 010.02/ijaai.9199; Eissmann P, 2010, J IMMUNOL, V184, P6901, DOI 10.4049/jimmunol.0903985; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; [郭云蔚 GUO Yunwei], 2007, [广东医学, Guangdong Medical Journal], V28, P1435; Hormannsperger G, 2010, INT J MED MICROBIOL, V300, P63, DOI 10.1016/j.ijmm.2009.08.006; Horie Y, 2009, RHEUMATOLOGY, V48, P638, DOI 10.1093/rheumatology/kep077; Hu KF, 2013, J BASIC CLIN ONCOL, V26, P198; [黄宏耀 Huang Hongyao], 2010, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V33, P953; Hunt R, 2009, METHODS MOL BIOL, V578, P23, DOI 10.1007/978-1-60327-411-1_2; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Jelavic TB, 2006, CLIN GENET, V70, P156, DOI 10.1111/j.1399-0004.2006.00651.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin HM, 2009, MODERN PRACTIC MED, V21, P682; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kutikhin AG, 2011, HUM IMMUNOL, V72, P193, DOI 10.1016/j.humimm.2010.11.003; Lagos D, 2008, CELL HOST MICROBE, V4, P470, DOI 10.1016/j.chom.2008.09.012; Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200; Mlecnik B, 2010, GASTROENTEROLOGY, V138, P1429, DOI 10.1053/j.gastro.2009.10.057; Moossavi S, 2013, INT IMMUNOPHARMACOL, V16, P199, DOI 10.1016/j.intimp.2013.03.017; Nihon-Yanagi Y, 2012, CANCER IMMUNOL IMMUN, V61, P71, DOI 10.1007/s00262-011-1085-4; Omrane I, 2014, TUMOR BIOL, V35, P545, DOI 10.1007/s13277-013-1075-6; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Pimentel-Nunes P, 2013, DIGEST LIVER DIS, V45, P63, DOI 10.1016/j.dld.2012.08.006; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Slattery ML, 2012, INT J CANCER, V130, P2974, DOI 10.1002/ijc.26314; Soares JB, 2010, HEPATOL INT, V4, P659, DOI 10.1007/s12072-010-9219-x; Spiller RC, 2010, AM J GASTROENTEROL, V105, P775, DOI 10.1038/ajg.2010.69; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stein KB, 2010, DIGEST DIS SCI, V55, P1839, DOI 10.1007/s10620-009-0944-8; Thomas KH, 2006, AM J PHYSIOL-LUNG C, V291, pL386, DOI 10.1152/ajplung.00193.2005; Tian F, 2008, CHIN J CURRENT ADV G, V11, P248; Tian F, 2008, CHIN J CURRENT ADV G, V11, P254; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang EL, 2010, BRIT J CANCER, V102, P908, DOI 10.1038/sj.bjc.6605558; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062870; Yang G, 2011, CHIN J GASTROINTEST, V14, P814; Yu L, 2010, CANCER IMMUNOL IMMUN, V59, P1021, DOI 10.1007/s00262-010-0825-1; Yu YH, 2011, HAINAN MED J, V22, P9; Zintzaras E, 2005, BIOINFORMATICS, V21, P3672, DOI 10.1093/bioinformatics/bti536	48	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93904	10.1371/journal.pone.0093904	http://dx.doi.org/10.1371/journal.pone.0093904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705379	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500092
J	Pan, Y; Tao, QS; Wang, HP; Xiong, SD; Zhang, R; Chen, TP; Tao, LL; Zhai, ZM				Pan, Ying; Tao, Qianshan; Wang, Huiping; Xiong, Shudao; Zhang, Rui; Chen, Tianping; Tao, Lili; Zhai, Zhimin			Dendritic Cells Decreased the Concomitant Expanded Tregs and Tregs Related IL-35 in Cytokine-Induced Killer Cells and Increased Their Cytotoxicity against Leukemia Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; ADOPTIVE IMMUNOTHERAPY; CIK CELLS; SUPPRESSION; EXPANSION; CANCER	Regulatory T cells (Tregs) are potent immunosuppressive cells and essential for inducing immune tolerance. Recent studies have reported that Tregs and Tregs related cytokines can inhibit the antitumor activity of cytokine-induced killer (CIK) cells, but dendritic cells co-cultured CIK (DC-CIK) cells can be used for induction of a specific immune response by blocking of Tregs and TGF-beta, IL-10. As a novel identified cytokine, IL-35 is specially produced by Tregs and plays an essential role in immune regulation. However, it remains unknown whether IL-35 roles in tumor immunotherapy mediated by CIK and DC-CIK cells. In this study, we cultured CIK and DC-CIK cells from the same healthy adult samples, and investigated their phenotype, proliferation, cytotoxic activity against leukemia cell lines K562 and NB4 by FCM and CCK-8, measured IL-35, TGF-beta and IL-10 protein by ELISA, detected Foxp3, IL-35 and IL-35 receptor mRNA by Real-time PCR, respectively. We found Tregs and IL-35 concomitantly expanded by a time-dependent way during the generation of CIK cells, but DC significantly down-regulated the expression of them and simultaneously up-regulated the proliferation ability as well as cytotoxic activity of CIK cells against leukemia cell lines. Therefore, our data suggested that DC decreased concomitant expanded Tregs and Tregs related IL-35 in CIK cells and might contribute to improve their cytotoxicity against leukemia cells in vitro.	[Zhai, Zhimin] Anhui Med Univ, Hosp 2, Dept Hematol, Hefei, Anhui, Peoples R China; Hematol Res Ctr, Hefei, Anhui, Peoples R China	Anhui Medical University	Zhai, ZM (corresponding author), Anhui Med Univ, Hosp 2, Dept Hematol, Hefei, Anhui, Peoples R China.	zzm889@126.com	TAO, Li/HIR-4254-2022; wang, hui/GRS-4730-2022		National Natural Science Foundation of China [81272259]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (item No. 81272259). The funders had no role in study design, data collection and analysis.	Antony PA, 2005, J IMMUNOTHER, V28, P120, DOI 10.1097/01.cji.0000155049.26787.45; Bardel E, 2008, J IMMUNOL, V181, P6898, DOI 10.4049/jimmunol.181.10.6898; Chaturvedi V, 2011, J IMMUNOL, V186, P6661, DOI 10.4049/jimmunol.1100315; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Hontscha C, 2011, J CANCER RES CLIN, V137, P305, DOI 10.1007/s00432-010-0887-7; Jiang JT, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-83; Li H, 2007, J CLIN IMMUNOL, V27, P317, DOI 10.1007/s10875-007-9076-0; Li Hui, 2005, Zhonghua Yi Xue Za Zhi, V85, P3134; Lin GH, 2012, J IMMUNOTHER, V35, P337, DOI 10.1097/CJI.0b013e318255ada3; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Marten A, 2001, J IMMUNOTHER, V24, P502, DOI 10.1097/00002371-200111000-00007; Mesiano G, 2012, EXPERT OPIN BIOL TH, V12, P673, DOI 10.1517/14712598.2012.675323; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Olioso P, 2009, HEMATOL ONCOL, V27, P130, DOI 10.1002/hon.886; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Schmidt J, 2004, CANCER IMMUNOL IMMUN, V53, P1018, DOI 10.1007/s00262-004-0554-4; SCHMIDTWOLF IGH, 1993, EXP HEMATOL, V21, P1673; SCHMIDTWOLF IGH, 1991, J EXP MED, V174, P139, DOI 10.1084/jem.174.1.139; Schmitt EG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00152; Shevach EM, 2012, TRENDS IMMUNOL, V33, P626, DOI 10.1016/j.it.2012.07.007; Thanendrarajan S, 2012, EXPERT OPIN BIOL TH, V12, P565, DOI 10.1517/14712598.2012.668879; Wang ZH, 2013, J IMMUNOL, V190, P2415, DOI 10.4049/jimmunol.1202535; Whiteside TL, 2012, EXPERT OPIN BIOL TH, V12, P1383, DOI 10.1517/14712598.2012.707184; Whiteside TL, 2012, SEMIN CANCER BIOL, V22, P327, DOI 10.1016/j.semcancer.2012.03.004; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018	28	23	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93591	10.1371/journal.pone.0093591	http://dx.doi.org/10.1371/journal.pone.0093591			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705499	gold, Green Submitted, Green Published			2022-12-27	WOS:000334107500045
J	Astola, L; Stigter, H; van Dijk, ADJ; van Daelen, R; Molenaar, J				Astola, Laura; Stigter, Hans; van Dijk, Aalt D. J.; van Daelen, Raymond; Molenaar, Jaap			Inferring the Gene Network Underlying the Branching of Tomato Inflorescence	PLOS ONE			English	Article							REPRODUCTIVE STRUCTURE; REGULATORY NETWORKS; ABSCISSION ZONE; FLOWERING TIME; INFERENCE; FALSIFLORA; TRANSITION; JOINTLESS	The architecture of tomato inflorescence strongly affects flower production and subsequent crop yield. To understand the genetic activities involved, insight into the underlying network of genes that initiate and control the sympodial growth in the tomato is essential. In this paper, we show how the structure of this network can be derived from available data of the expressions of the involved genes. Our approach starts from employing biological expert knowledge to select the most probable gene candidates behind branching behavior. To find how these genes interact, we develop a stepwise procedure for computational inference of the network structure. Our data consists of expression levels from primary shoot meristems, measured at different developmental stages on three different genotypes of tomato. With the network inferred by our algorithm, we can explain the dynamics corresponding to all three genotypes simultaneously, despite their apparent dissimilarities. We also correctly predict the chronological order of expression peaks for the main hubs in the network. Based on the inferred network, using optimal experimental design criteria, we are able to suggest an informative set of experiments for further investigation of the mechanisms underlying branching behavior.	[Astola, Laura; Stigter, Hans; van Dijk, Aalt D. J.; Molenaar, Jaap] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Astola, Laura; van Dijk, Aalt D. J.; van Daelen, Raymond; Molenaar, Jaap] Netherlands Consortium Syst Biol, Amsterdam, Netherlands; [van Daelen, Raymond] Keygene NV, Wageningen, Netherlands	Wageningen University & Research; Keygene N.V.	Astola, L (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	l.j.astola@gmail.com		Stigter, Johannes Daniel/0000-0001-5210-5929; van Dijk, Aalt-Jan/0000-0002-8872-5123	Netherlands Genomics Initiative of the Netherlands Consortium for Systems Biology [050-060-620]	Netherlands Genomics Initiative of the Netherlands Consortium for Systems Biology	This work was funded by the Netherlands Genomics Initiative (grant 050-060-620) of the Netherlands Consortium for Systems Biology (http://www.ncsb.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1969, ANN I STAT MATH, V21, P243, DOI 10.1007/BF02532251; Akutsu T, 2000, BIOINFORMATICS, V16, P727, DOI 10.1093/bioinformatics/16.8.727; Allen KD, 1996, PLANTA, V200, P254, DOI 10.1007/BF00208316; Astola L, 2013, TICSP SERIES, V63, P42; Bansal M, 2006, BIOINFORMATICS, V22, P815, DOI 10.1093/bioinformatics/btl003; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Busch B, 2009, THESIS U KOLN GERMAN; Busch BL, 2011, PLANT CELL, V23, P3595, DOI 10.1105/tpc.111.087981; D'haeseleer P, 1999, Pac Symp Biocomput, P41; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Dielen V, 1998, PLANT GROWTH REGUL, V25, P149, DOI 10.1023/A:1006094318083; Efroni I, 2008, PLANT CELL, V20, P2293, DOI 10.1105/tpc.107.057521; Gupta R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-52; Lee WP, 2009, BRIEF BIOINFORM, V10, P408, DOI 10.1093/bib/bbp028; Lippman Z, 2008, PLOS BIOL, V6, P6398; Ljung L., 1999, SYSTEM IDENTIFICATIO; Lozano R, 2009, INT J DEV BIOL, V53, P1635, DOI 10.1387/ijdb.072440rl; MacAlister CA, 2012, NAT GENET, V44, P1393, DOI 10.1038/ng.2465; Mao L, 2000, NATURE, V406, P910, DOI 10.1038/35022611; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Molinero-Rosales N, 1999, PLANT J, V20, P685, DOI 10.1046/j.1365-313X.1999.00641.x; Nakano T, 2012, PLANT PHYSIOL, V158, P439, DOI 10.1104/pp.111.183731; Park SJ, 2012, P NATL ACAD SCI USA, V109, P639, DOI 10.1073/pnas.1114963109; Quinet M, 2006, NEW PHYTOL, V170, P701, DOI 10.1111/j.1469-8137.2006.01717.x; Quinet M., 2007, INT J PLANT DEV BIOL, V1, P64, DOI DOI 10.1093/JXB/ERJ117; Samach A, 2007, PLANT BIOTECHNOL-NAR, V24, P71, DOI 10.5511/plantbiotechnology.24.71; Schmidt H, 2005, FEBS J, V272, P2141, DOI 10.1111/j.1742-4658.2005.04605.x; Schmitz G, 2002, P NATL ACAD SCI USA, V99, P1064, DOI 10.1073/pnas.022516199; Stigter Johannes D, 2012, BMC Res Notes, V5, P518, DOI 10.1186/1756-0500-5-518; Stumpf M, 2011, HANDBOOK OF STATISTICAL SYSTEMS BIOLOGY, pXVII; Szymkowiak EJ, 2006, PLANTA, V223, P646, DOI 10.1007/s00425-005-0115-x; Szymkowiak EJ, 1999, PLANT CELL, V11, P159, DOI 10.1105/tpc.11.2.159; Thouet J, 2008, PLANT PHYSIOL, V148, P61, DOI 10.1104/pp.108.124164; Toni T, 2009, INTERFACE, V6; Voit Eberhard O., 2005, In Silico Biology, V5, P83; Weber M, 2013, BMC SYSTEMS BIOL, V7, P39; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448	38	4	4	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e89689	10.1371/journal.pone.0089689	http://dx.doi.org/10.1371/journal.pone.0089689			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699171	gold, Green Published, Green Submitted			2022-12-27	WOS:000334105000006
J	Farzan, SF; Karagas, MR; Christensen, BC; Li, ZZ; Kuriger, JK; Nelson, HH				Farzan, Shohreh F.; Karagas, Margaret R.; Christensen, Brock C.; Li, Zhongze; Kuriger, Jacquelyn K.; Nelson, Heather H.		New Hampshire Skin Canc Study	RNASEL and MIR146A SNP-SNP Interaction as a Susceptibility Factor for Non-Melanoma Skin Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PROSTATE-CANCER; BASAL-CELL; CHINESE POPULATION; ARTHRITIS SUSCEPTIBILITY; FUNCTIONAL POLYMORPHISM; HUMAN PAPILLOMAVIRUSES; ORGAN-TRANSPLANTATION; SIGNALING PROTEINS; COLORECTAL-CANCER	Immunity and inflammatory pathways are important in the genesis of non-melanoma skin cancers (NMSC). Functional genetic variation in immune modulators has the potential to affect disease etiology. We investigated associations between common variants in two key regulators, MIR146A and RNASEL, and their relation to NMSCs. Using a large population-based case-control study of basal cell (BCC) and squamous cell carcinoma (SCC), we investigated the impact of MIR146A SNP rs2910164 on cancer risk, and interaction with a SNP in one of its putative targets (RNASEL, rs486907). To examine associations between genotype and BCC and SCC, occurrence odds ratios (OR) and 95% confidence intervals (95%CI) were calculated using unconditional logistic regression, accounting for multiple confounding factors. We did not observe an overall change in the odds ratios for SCC or BCC among individuals carrying either of the RNASEL or MIR146A variants compared with those who were wild type at these loci. However, there was a sex-specific association between BCC and MIR146A in women (ORGC=0.73, [95%CI=0.52-1.03]; ORCC=0.29, [95% CI=0.14-0.61], p-trend < 0.001), and a reduction in risk, albeit not statistically significant, associated with RNASEL and SCC in men (ORAG=0.88, [95%CI=0.65-1.19]; ORAA=0.68, [95%CI=0.43-1.08], p-trend=0.10). Most striking was the strong interaction between the two genes. Among individuals carrying variant alleles of both rs2910164 and rs486907, we observed inverse relationships with SCC (ORSCC=0.56, [95%CI=0.38-0.81], p-interaction=0.012) and BCC (ORBCC=0.57, [95%CI=0.40-0.80], p-interaction=0.005). Our results suggest that genetic variation in immune and inflammatory regulators may influence susceptibility to NMSC, and novel SNP-SNP interaction for a microRNA and its target. These data suggest that RNASEL, an enzyme involved in RNA turnover, is controlled by miR-146a and may be important in NMSC etiology.	[Farzan, Shohreh F.; Karagas, Margaret R.; Christensen, Brock C.; Li, Zhongze] Geisel Sch Med Dartmouth, Dept Community & Family Med, Sect Biostat & Epidemiol, Lebanon, NH USA; [Farzan, Shohreh F.; Karagas, Margaret R.; Christensen, Brock C.; Li, Zhongze] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH USA; [Christensen, Brock C.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA; [Kuriger, Jacquelyn K.; Nelson, Heather H.] Univ Minnesota, Mason Canc Ctr, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; University of Minnesota System; University of Minnesota Twin Cities	Nelson, HH (corresponding author), Univ Minnesota, Mason Canc Ctr, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	hhnelson@umn.edu		Nelson, Heather/0000-0003-1901-9513	NIH [R01 CA82354, R01 CA057494, R25 CA134286]; NCI [R21 CA175553]; NATIONAL CANCER INSTITUTE [R21CA175553, R25CA134286, R01CA057494, P30CA023108, R01CA082354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022772] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH R01 CA82354, NIH R01 CA057494, NIH R25 CA134286, and NCI R21 CA175553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 2007, ONCOGENE, V26, P3081, DOI 10.1038/sj.onc.1210111; Andersson K, 2012, AM J EPIDEMIOL, V175, P685, DOI 10.1093/aje/kwr373; Bartsch DK, 2005, INT J CANCER, V117, P718, DOI 10.1002/ijc.21254; Bavinck JNB, 2010, CANCER RES, V70, P9777, DOI 10.1158/0008-5472.CAN-10-0352; Bisbal C, 2007, BIOCHIMIE, V89, P789, DOI 10.1016/j.biochi.2007.02.006; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Casey G, 2002, NAT GENET, V32, P582, DOI 10.1038/ng1021; Castelli JC, 1997, J EXP MED, V186, P967, DOI 10.1084/jem.186.6.967; Chatzikyriakidou A, 2010, SCAND J IMMUNOL, V71, P382, DOI 10.1111/j.1365-3083.2010.02381.x; Chatzikyriakidou A, 2010, JOINT BONE SPINE, V77, P411, DOI 10.1016/j.jbspin.2010.05.013; Chen AC, 2013, PATHOLOGY, V45, P331, DOI 10.1097/PAT.0b013e32835f515c; Cheng HS, 2013, EMBO MOL MED, V5, P1017, DOI 10.1002/emmm.201202318; Cybulski C, 2007, UROL INT, V79, P44, DOI 10.1159/000102913; Daugherty SE, 2007, PROSTATE, V67, P849, DOI 10.1002/pros.20537; Etzrodt M, 2012, CELL REPORTS, V1, P317, DOI 10.1016/j.celrep.2012.02.009; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Ezelle Heather J, 2012, Front Biosci (Schol Ed), V4, P767; Farzan SF, 2013, INT J CANC; Fesinmeyer MD, 2011, PROSTATE; Gazouli M, 2013, DIG DIS SCI; HASSEL BA, 1993, EMBO J, V12, P3297, DOI 10.1002/j.1460-2075.1993.tb05999.x; Iannacone MR, 2012, CANCER EPIDEM BIOMAR, V21, P1303, DOI 10.1158/1055-9965.EPI-12-0032; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Karagas M, 2006, CANC EPIDEMIOLOGY PR; Karagas MR, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c2986; Karagas MR, 2006, J NATL CANCER I, V98, P389, DOI 10.1093/jnci/djj092; Karagas MR, 1996, J NATL CANCER I, V88, P1848, DOI 10.1093/jnci/88.24.1848; Karagas MR, 2001, BRIT J CANCER, V85, P683, DOI 10.1054/bjoc.2001.1931; Karagas MR, 1999, INT J CANCER, V81, P555, DOI 10.1002/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO;2-R; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Kim RH, 2012, DERMATOL CLIN, V30, P125, DOI 10.1016/j.det.2011.08.008; KRICKER A, 1994, CANCER CAUSE CONTROL, V5, P367, DOI 10.1007/BF01804988; KRICKER A, 1991, INT J CANCER, V48, P650, DOI 10.1002/ijc.2910480504; Krueger S, 2007, CANCER LETT, V252, P55, DOI 10.1016/j.canlet.2006.12.006; Kruger S, 2005, LANCET ONCOL, V6, P566, DOI 10.1016/S1470-2045(05)70253-9; Lee TY, 2013, J INTERF CYTOK RES, V33, P34, DOI 10.1089/jir.2012.0062; Leonardi-Bee J, 2012, ARCH DERMATOL, V148, P939, DOI 10.1001/archdermatol.2012.1374; Li XL, 2007, J BIOL CHEM, V282, P7950, DOI 10.1074/jbc.M607939200; Lian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031615; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Ma L, 2013, ARCH TOXICOL, V87, P825, DOI 10.1007/s00204-012-1004-2; Madan V, 2010, LANCET, V375, P673, DOI 10.1016/S0140-6736(09)61196-X; Madsen BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002492; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; Moloney FJ, 2006, BRIT J DERMATOL, V154, P790, DOI 10.1111/j.1365-2133.2006.07156.x; Nguyen LH, 2001, BIOCHEMISTRY-US, V40, P7174, DOI 10.1021/bi010141t; Orsos Z, 2013, ANTICANCER RES, V33, P341; Pentecost BT, 1998, J STEROID BIOCHEM, V64, P25, DOI 10.1016/S0960-0760(97)00140-4; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; Rennert H, 2005, CANCER EPIDEM BIOMAR, V14, P949, DOI 10.1158/1055-9965.EPI-04-0637; So AYL, 2013, IMMUNOL REV, V253, P129, DOI 10.1111/imr.12043; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Thornton MJ, 2002, EXP DERMATOL, V11, P487, DOI 10.1034/j.1600-0625.2002.110601.x; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Urosevic M, 2004, AM J CLIN DERMATOL, V5, P453, DOI 10.2165/00128071-200405060-00010; Wang AX, 2012, GENET MOL RES, V11, P3051, DOI 10.4238/2012.August.31.2; Wei WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056638; Welsh MM, 2008, CARCINOGENESIS, V29, P1950, DOI 10.1093/carcin/bgn160; Welsh MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020019; Whitehead Institute for Biomedical Research, TARGETSCANHUMAN PRED; Wu D, 2013, ASIAN PAC J CANCER P, V14, P399, DOI 10.7314/APJCP.2013.14.1.399; Xiang Y, 2003, CANCER RES, V63, P6795; Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080; Yin ZH, 2013, MOL BIOL REP, V40, P3003, DOI 10.1007/s11033-012-2372-7; Yue C, 2011, GYNECOL ONCOL, V122, P33, DOI 10.1016/j.ygyno.2011.03.032; Zhang LF, 2011, MOL BIOL REP, V38, P5099, DOI 10.1007/s11033-010-0657-2; Zhou FY, 2012, DNA CELL BIOL, V31, P1290, DOI 10.1089/dna.2011.1596	69	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93602	10.1371/journal.pone.0093602	http://dx.doi.org/10.1371/journal.pone.0093602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699816	gold, Green Published, Green Submitted			2022-12-27	WOS:000334105000078
J	Levri, EP; Krist, AC; Bilka, R; Dybdahl, MF				Levri, Edward P.; Krist, Amy C.; Bilka, Rachel; Dybdahl, Mark F.			Phenotypic Plasticity of the Introduced New Zealand Mud Snail, Potamopyrgus antipodarum, Compared to Sympatric Native Snails	PLOS ONE			English	Article							FRESH-WATER SNAIL; FORAGING BEHAVIOR; PARASITISM; GASTROPODA; DENSITY; SIZE	Phenotypic plasticity is likely to be important in determining the invasive potential of a species, especially if invasive species show greater plasticity or tolerance compared to sympatric native species. Here in two separate experiments we compare reaction norms in response to two environmental variables of two clones of the New Zealand mud snail, Potamopyrgus antipodarum, isolated from the United States, (one invasive and one not yet invasive) with those of two species of native snails that are sympatric with the invader, Fossaria bulimoides group and Physella gyrina group. We placed juvenile snails in environments with high and low conductivity (300 and 800 mS) in one experiment, and raised them at two different temperatures ( 16(circle)C and 22(circle)C) in a second experiment. Growth rate and mortality were measured over the course of 8 weeks. Mortality rates were higher in the native snails compared to P. antipodarum across all treatments, and variation in conductivity influenced mortality. In both experiments, reaction norms did not vary significantly between species. There was little evidence that the success of the introduced species is a result of greater phenotypic plasticity to these variables compared to the sympatric native species.	[Levri, Edward P.; Bilka, Rachel] Div Math & Sci, Altoona, PA 16601 USA; [Krist, Amy C.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Krist, Amy C.] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; [Dybdahl, Mark F.] Washington State Univ, Dept Biol Sci, Pullman, WA 99164 USA	University of Wyoming; University of Wyoming; Washington State University	Levri, EP (corresponding author), Div Math & Sci, Altoona, PA 16601 USA.	epl1@psu.edu	Levri, Edward P/B-3235-2012		Penn State Altoona	Penn State Altoona	This work was financially supported through grants from Penn State Altoona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2012, AQUAT SCI, V74, P375, DOI 10.1007/s00027-012-0254-7; Baker H. G., 1965, The genetics of colonizing species., P147; Brown K. M., 2001, ECOLOGY CLASSIFICATI; Christensen NS, 2004, CLIMATIC CHANGE, V62, P337, DOI 10.1023/B:CLIM.0000013684.13621.1f; CROWL TA, 1990, OIKOS, V59, P359, DOI 10.2307/3545147; Dalton BM, 2006, THESIS WASHINGTON ST; Dillon R. T., 2000, ECOLOGY FRESHWATER M, DOI 10.1017/CBO9780511542008; Drown DM, 2011, EVOL APPL, V4, P132, DOI 10.1111/j.1752-4571.2010.00149.x; Dybdahl MF, 2011, BIOL INVASIONS, V13, P1663, DOI 10.1007/s10530-010-9923-4; Dybdahl MF, 2005, ECOLOGY, V86, P1592, DOI 10.1890/04-0898; Hall RO, 2006, ECOL APPL, V16, P1121, DOI 10.1890/1051-0761(2006)016[1121:EHSPOI]2.0.CO;2; HAYNES A, 1984, ARCH HYDROBIOL, V100, P479; Herbst DB, 2008, WEST N AM NATURALIST, V68, P324, DOI 10.3398/1527-0904(2008)68[324:LSCLGA]2.0.CO;2; Horsak M, 2007, J MOLLUS STUD, V73, P53, DOI 10.1093/mollus/eyl024; James MR, 2000, HYDROBIOLOGIA, V441, P93, DOI 10.1023/A:1017504820168; Kerans BL, 2005, J N AM BENTHOL SOC, V24, P123, DOI 10.1899/0887-3593(2005)024<0123:PADDAE>2.0.CO;2; Kistner EJ, 2013, ECOL EVOL, V3, P424, DOI 10.1002/ece3.471; Levri EP, 2012, CAN J ZOOL, V90, P616, DOI 10.1139/Z2012-027; Levri E, 2008, AQUAT ECOSYST HEALTH, V11, P412, DOI 10.1080/14634980802523140; Levri EP, 1996, ANIM BEHAV, V51, P891, DOI 10.1006/anbe.1996.0093; Levri EP, 1998, CAN J ZOOL, V76, P1878, DOI 10.1139/cjz-76-10-1878; Neiman M, 2013, EVOLUTION, V67, P1511, DOI 10.1111/evo.12026; Neter J, 1990, APPL LINEAR STAT MOD; Proctor T, 2007, NATL MANAGEMENT CONT; QUINN JM, 1994, NEW ZEAL J MAR FRESH, V28, P391, DOI 10.1080/00288330.1994.9516629; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Riley LA, 2008, J N AM BENTHOL SOC, V27, P509, DOI 10.1899/07-119.1; Schreiber ESG, 1998, MAR FRESHWATER RES, V49, P73, DOI 10.1071/MF97113; TALBOT JM, 1987, NEW ZEAL J MAR FRESH, V21, P199, DOI 10.1080/00288330.1987.9516216; Taylor DW, 1987, 1000 ISLANDS P UNPUB; Zaranko DT, 1997, CAN J FISH AQUAT SCI, V54, P809, DOI 10.1139/cjfas-54-4-809	31	12	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93985	10.1371/journal.pone.0093985	http://dx.doi.org/10.1371/journal.pone.0093985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699685	Green Submitted, gold, Green Published			2022-12-27	WOS:000334105000131
J	Pak, T; Yoo, S; Miranda-Angulo, AM; Wang, H; Blackshaw, S				Pak, Thomas; Yoo, Sooyeon; Miranda-Angulo, Ana M.; Wang, Hong; Blackshaw, Seth			Rax-CreER(T2) Knock-In Mice: A Tool for Selective and Conditional Gene Deletion in Progenitor Cells and Radial Glia of the Retina and Hypothalamus	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; HOMEOBOX GENE; MOUSE; EXPRESSION; TANYCYTES; RAX; DIFFERENTIATION; CHX10; PROLIFERATION; SPECIFICATION	To study gene function in neural progenitors and radial glia of the retina and hypothalamus, we developed a Rax-CreER(T2) mouse line in which a tamoxifen-inducible Cre recombinase is inserted into the endogenous Rax locus. By crossing Rax-CreER(T2) with the Cre-dependent Ai9 reporter line, we demonstrate that tamoxifen-induced Cre activity recapitulates the endogenous Rax mRNA expression pattern. During embryonic development, Cre recombinase activity in Rax-CreER(T2) is confined to retinal and hypothalamic progenitor cells, as well as progenitor cells of the posterior pituitary. At postnatal time points, selective Cre recombinase activity is seen in radial glial-like cell types in these organs - specifically Muller glia and tanycytes - as well as pituicytes. We anticipate that this line will prove useful for cell lineage analysis and investigation of gene function in the developing and mature retina, hypothalamus and pituitary.	[Pak, Thomas; Yoo, Sooyeon; Miranda-Angulo, Ana M.; Wang, Hong; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Ctr High Throughput Biol, Baltimore, MD USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA; [Miranda-Angulo, Ana M.] Univ Antioquia, Sch Med, Inst Med Res, Medellin, Colombia	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Universidad de Antioquia	Blackshaw, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	sblack@jhmi.edu		Pak, Thomas/0000-0003-2716-1210; Miranda-Angulo, Ana L./0000-0003-4938-3033	NIH [R21NS067393]; Diabetes Research and Training Center Pilot and Feasibility Award; NATIONAL EYE INSTITUTE [R01EY020560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067393, P30NS050274] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research and Training Center Pilot and Feasibility Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported by NIH R21NS067393 and a Diabetes Research and Training Center Pilot and Feasibility Award. SB was a WM Keck Distinguished Young Scholar in Medical Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Bolborea M, 2013, TRENDS NEUROSCI, V36, P91, DOI 10.1016/j.tins.2012.12.008; Brauksiepe B, 2013, CELL TISSUE RES; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Chen J, 2009, GENESIS, V47, P122, DOI 10.1002/dvg.20465; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Engelhard C, 2013, ELIFE, V2, DOI 10.7554/eLife.01160; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Gordon PJ, 2013, J NEUROSCI, V33, P12197, DOI 10.1523/JNEUROSCI.1494-13.2013; Haan N, 2013, J NEUROSCI, V33, P6170, DOI 10.1523/JNEUROSCI.2437-12.2013; Hafler BP, 2012, P NATL ACAD SCI USA, V109, P7882, DOI 10.1073/pnas.1203138109; HUXLIN KR, 1992, J NEUROCYTOL, V21, P530, DOI 10.1007/BF01186955; Karl MO, 2010, TRENDS MOL MED, V16, P193, DOI 10.1016/j.molmed.2010.02.003; Klimova L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063029; Lee DA, 2012, INT J DEV NEUROSCI, V30, P615, DOI 10.1016/j.ijdevneu.2012.07.003; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu F, 2013, DEVELOPMENT, V140, P1111, DOI 10.1242/dev.080226; Livne-Bar I, 2006, P NATL ACAD SCI USA, V103, P4988, DOI 10.1073/pnas.0600083103; Lu FQ, 2013, J NEUROSCI, V33, P259, DOI 10.1523/JNEUROSCI.0913-12.2013; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Marsili A, 2011, J ENDOCRINOL, V211, P73, DOI 10.1530/JOE-11-0248; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Matsuoka RL, 2011, NEURON, V71, P460, DOI 10.1016/j.neuron.2011.06.009; Miranda-Angulo AL, 2013, J COMP NEUROL; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Muranishi Y, 2012, DEV GROWTH DIFFER, V54, P341, DOI 10.1111/j.1440-169X.2012.01337.x; Nelson BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022817; Pearson CA, 2011, DEVELOPMENT, V138, P2613, DOI 10.1242/dev.062794; Peng CY, 2012, J NEUROSCI, V32, P17211, DOI 10.1523/JNEUROSCI.2484-12.2012; Plageman TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050426; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Robins SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3049; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Rohde K, 2011, J NEUROCHEM, V118, P999, DOI 10.1111/j.1471-4159.2011.07385.x; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Roy A, 2013, J NEUROSCI, V33, P6877, DOI 10.1523/JNEUROSCI.4216-12.2013; Sato S, 2007, GENESIS, V45, P502, DOI 10.1002/dvg.20318; Shaham O, 2012, PROG RETIN EYE RES, V31, P351, DOI 10.1016/j.preteyeres.2012.04.002; Shimogori T, 2010, NAT NEUROSCI, V13, P767, DOI 10.1038/nn.2545; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Trimarchi JM, 2009, DEV DYNAM, V238, P2327, DOI 10.1002/dvdy.21973; Wei XY, 2009, NEUROSCI LETT, V465, P27, DOI 10.1016/j.neulet.2009.06.059; Wichterle H, 2013, SCIENCE, V341, P726, DOI 10.1126/science.1235884; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	50	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e90381	10.1371/journal.pone.0090381	http://dx.doi.org/10.1371/journal.pone.0090381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699247	gold, Green Submitted, Green Published			2022-12-27	WOS:000334105000009
J	Stephens, D; Diesing, M				Stephens, David; Diesing, Markus			A Comparison of Supervised Classification Methods for the Prediction of Substrate Type Using Multibeam Acoustic and Legacy Grain-Size Data	PLOS ONE			English	Article							BENTHIC HABITAT; BACKSCATTER; EXAMPLE; AGREEMENT; COVERAGE; BIGHT	Detailed seabed substrate maps are increasingly in demand for effective planning and management of marine ecosystems and resources. It has become common to use remotely sensed multibeam echosounder data in the form of bathymetry and acoustic backscatter in conjunction with ground-truth sampling data to inform the mapping of seabed substrates. Whilst, until recently, such data sets have typically been classified by expert interpretation, it is now obvious that more objective, faster and repeatable methods of seabed classification are required. This study compares the performances of a range of supervised classification techniques for predicting substrate type from multibeam echosounder data. The study area is located in the North Sea, off the north-east coast of England. A total of 258 ground-truth samples were classified into four substrate classes. Multibeam bathymetry and backscatter data, and a range of secondary features derived from these datasets were used in this study. Six supervised classification techniques were tested: Classification Trees, Support Vector Machines, k-Nearest Neighbour, Neural Networks, Random Forest and Naive Bayes. Each classifier was trained multiple times using different input features, including i)the two primary features of bathymetry and backscatter, ii) a subset of the features chosen by a feature selection process and iii) all of the input features. The predictive performances of the models were validated using a separate test set of ground-truth samples. The statistical significance of model performances relative to a simple baseline model (Nearest Neighbour predictions on bathymetry and backscatter) were tested to assess the benefits of using more sophisticated approaches. The best performing models were tree based methods and Naive Bayes which achieved accuracies of around 0.8 and kappa coefficients of up to 0.5 on the test set. The models that used all input features didn't generally perform well, highlighting the need for some means of feature selection.	[Stephens, David; Diesing, Markus] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England	Centre for Environment Fisheries & Aquaculture Science	Stephens, D (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England.	david.stephens@cefas.co.uk	Diesing, Markus/D-6868-2011	Diesing, Markus/0000-0003-4331-7553	Cefas Research and Development [DP312]	Cefas Research and Development	The work was supported by Cefas Research and Development funding (research project DP312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpaydin E., 2010, INTRO MACHINE LEARNI; Anderson JT, 2008, ICES J MAR SCI, V65, P1004, DOI 10.1093/icesjms/fsn061; Blondel P, 2009, APPL ACOUST, V70, P1288, DOI 10.1016/j.apacoust.2008.07.015; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown CJ, 2008, ESTUAR COAST SHELF S, V78, P203, DOI 10.1016/j.ecss.2007.11.026; Brown CJ, 2012, J SEA RES, V72, P1, DOI 10.1016/j.seares.2012.04.009; Brown CJ, 2011, ESTUAR COAST SHELF S, V92, P502, DOI 10.1016/j.ecss.2011.02.007; Buhl-Mortensen P, 2009, ICES J MAR SCI, V66, P2026, DOI 10.1093/icesjms/fsp200; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Collier JS, 2005, MAR GEOL, V214, P431, DOI 10.1016/j.margeo.2004.11.011; Dartnell P, 2004, PHOTOGRAMM ENG REM S, V70, P1081, DOI 10.14358/PERS.70.9.1081; Diesing M, 2006, CONT SHELF RES, V26, P902, DOI 10.1016/j.csr.2006.02.009; FOLK RL, 1954, J GEOL, V62, P344, DOI 10.1086/626171; Fonseca L, 2009, APPL ACOUST, V70, P1298, DOI 10.1016/j.apacoust.2008.09.008; Foody GM, 2007, INT J REMOTE SENS, V28, P1733, DOI 10.1080/01431160600962566; Foody GM, 2004, PHOTOGRAMM ENG REM S, V70, P627, DOI 10.14358/PERS.70.5.627; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Harrison R, 2012, INT J NEURAL SYST, V22, DOI 10.1142/S0129065712500268; Hasan RC, 2012, REMOTE SENS-BASEL, V4, P3427, DOI 10.3390/rs4113427; Hasan RC, 2012, ESTUAR COAST SHELF S, V97, P1, DOI 10.1016/j.ecss.2011.10.004; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Holmes KW, 2008, CONT SHELF RES, V28, P1800, DOI 10.1016/j.csr.2008.04.016; Ierodiaconou D, 2011, CONT SHELF RES, V31, pS28, DOI 10.1016/j.csr.2010.01.012; Isaaks E.H, 1989, INTRO APPL GEOSTATIS; John GHG, 1995, P 11 C UNC ART INT, P338, DOI [DOI 10.1109/TGRS.2004.834800, 10.1.1.8. 3257.]; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Kohavi R, 1995, SUBSET SELECTION USI, P192; Kubicki A, 2006, CONT SHELF RES, V26, P1858, DOI 10.1016/j.csr.2006.06.003; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; LAST D, 1992, J NAVIGATION, V45, P36, DOI 10.1017/S0373463300010456; Lathrop RG, 2006, ESTUAR COAST SHELF S, V68, P221, DOI 10.1016/j.ecss.2006.01.019; Li J, 2011, CONT SHELF RES, V31, P1365, DOI 10.1016/j.csr.2011.05.015; Lucieer V, 2013, ESTUAR COAST SHELF S, V117, P94, DOI 10.1016/j.ecss.2012.11.001; Ludtke A, 2012, COMPUT GEOSCI-UK, V39, P120, DOI 10.1016/j.cageo.2011.06.020; Lundblad E., 2006, GEOD, V29, P89, DOI [10.1080/01490410600738021, DOI 10.1080/01490410600738021]; Luts J, 2010, ANAL CHIM ACTA, V665, P129, DOI 10.1016/j.aca.2010.03.030; Marsh I, 2009, APPL ACOUST, V70, P1269, DOI 10.1016/j.apacoust.2008.07.012; McGonigle C, 2009, ESTUAR COAST SHELF S, V81, P423, DOI 10.1016/j.ecss.2008.11.017; McKenzie DP, 1996, J PSYCHIAT RES, V30, P483, DOI 10.1016/S0022-3956(96)00033-7; Meyer D, 2012, SUPPORT VECTOR MACHI; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Ojeda GY, 2004, ESTUAR COAST SHELF S, V59, P399, DOI 10.1016/j.ecss.2003.09.012; PINGREE RD, 1979, J MAR BIOL ASSOC UK, V59, P497, DOI 10.1017/S0025315400042806; R Core Team, 2021, R LANGUAGE ENV STAT; Rattray A, 2009, ESTUAR COAST SHELF S, V84, P237, DOI 10.1016/j.ecss.2009.06.023; Rooper CN, 2007, CONT SHELF RES, V27, P947, DOI 10.1016/j.csr.2006.12.006; Simons DG, 2009, APPL ACOUST, V70, P1258, DOI 10.1016/j.apacoust.2008.07.013; Therneau T. M., 1997, INTRO RECURSIVE PART; Venables W., 2013, MODERN APPL STAT S P, DOI DOI 10.1007/978-0-387-21706-2; Wilson MFJ, 2007, MAR GEOD, V30, P3, DOI 10.1080/01490410701295962; Wynn R., 2012, INVESTIGATING FEASIB	52	95	97	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93950	10.1371/journal.pone.0093950	http://dx.doi.org/10.1371/journal.pone.0093950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699553	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000126
J	Tsodikov, OV; Green, KD; Garneau-Tsodikova, S				Tsodikov, Oleg V.; Green, Keith D.; Garneau-Tsodikova, Sylvie			A Random Sequential Mechanism of Aminoglycoside Acetylation by Mycobacterium tuberculosis Eis Protein	PLOS ONE			English	Article							GENTAMICIN ACETYLTRANSFERASE-I; KINETIC MECHANISM; BISUBSTRATE; ENZYME; RESISTANCE; INHIBITOR; OVEREXPRESSION; PROBES	An important cause of bacterial resistance to aminoglycoside antibiotics is the enzymatic acetylation of their amino groups by acetyltransferases, which abolishes their binding to and inhibition of the bacterial ribosome. Enhanced intracellular survival (Eis) protein from Mycobacterium tuberculosis (Mt) is one of such acetyltransferases, whose upregulation was recently established as a cause of resistance to aminoglycosides in clinical cases of drug-resistant tuberculosis. The mechanism of aminoglycoside acetylation by MtEis is not completely understood. A systematic analysis of steady-state kinetics of acetylation of kanamycin A and neomycin B by Eis as a function of concentrations of these aminoglycosides and the acetyl donor, acetyl coenzyme A, reveals that MtEis employs a random-sequential bisubstrate mechanism of acetylation and yields the values of the kinetic parameters of this mechanism. The implications of these mechanistic properties for the design of inhibitors of Eis and other aminoglycoside acetyltransferases are discussed.	[Tsodikov, Oleg V.; Green, Keith D.; Garneau-Tsodikova, Sylvie] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40506 USA	University of Kentucky	Tsodikov, OV (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, BioPharm Complex, Lexington, KY 40506 USA.	oleg.tsodikov@uky.edu; sylviegtsodikova@uky.edu	Garneau-Tsodikova, Sylvie/ABH-5882-2020	Garneau-Tsodikova, Sylvie/0000-0002-7961-5555	National Institutes of Health (NIH) [AI090048]; University of Kentucky College of Pharmacy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090048] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kentucky College of Pharmacy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health (NIH) Grant AI090048 (to S.G.-T.) and startup funds from the University of Kentucky College of Pharmacy (to O.V.T. and S.G.-T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Chen WJ, 2012, BIOCHEMISTRY-US, V51, P4959, DOI 10.1021/bi3004473; Chen WJ, 2011, P NATL ACAD SCI USA, V108, P9804, DOI 10.1073/pnas.1105379108; Draker KA, 2003, BIOCHEMISTRY-US, V42, P6565, DOI 10.1021/bi034148h; Gao F, 2005, ANGEW CHEM INT EDIT, V44, P6859, DOI 10.1002/anie.200501399; Gao F, 2008, BIOORG MED CHEM LETT, V18, P5518, DOI 10.1016/j.bmcl.2008.09.004; Gao F, 2009, CHEM-EUR J, V15, P2064, DOI 10.1002/chem.200802172; Hegde SS, 2001, J BIOL CHEM, V276, P45876, DOI 10.1074/jbc.M108810200; Houghton JL, 2013, CHEMBIOCHEM, V14, P2127, DOI 10.1002/cbic.201300359; Houghton JL, 2013, J ANTIMICROB CHEMOTH, V68, P800, DOI 10.1093/jac/dks497; Khalil EM, 1998, J AM CHEM SOC, V120, P6195, DOI 10.1021/ja981365a; Kim C, 2007, BIOCHEMISTRY-US, V46, P5270, DOI 10.1021/bi700111z; Kim C, 2006, BIOCHEMISTRY-US, V45, P8368, DOI 10.1021/bi060723g; Magalhaes MLB, 2005, BIOCHEMISTRY-US, V44, P16275, DOI 10.1021/bi051777d; Magnet S, 2001, BIOCHEMISTRY-US, V40, P3700, DOI 10.1021/bi002736e; MARTEL A, 1983, EUR J BIOCHEM, V133, P515, DOI 10.1111/j.1432-1033.1983.tb07494.x; Poux AN, 2002, P NATL ACAD SCI USA, V99, P14065, DOI 10.1073/pnas.222373899; Pricer RE, 2012, MOL BIOSYST, V8, P3305, DOI 10.1039/c2mb25341k; WILLIAMS JW, 1979, J ANTIBIOT, V32, P1147, DOI 10.7164/antibiotics.32.1147; WILLIAMS JW, 1978, J BIOL CHEM, V253, P5902; Yu M, 2006, BIOCHEMISTRY-US, V45, P14788, DOI 10.1021/bi061621t; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106	22	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92370	10.1371/journal.pone.0092370	http://dx.doi.org/10.1371/journal.pone.0092370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699000	Green Published, gold			2022-12-27	WOS:000334105000023
J	Wei, F; Liu, JY; Liu, F; Hu, HD; Ren, H; Hu, P				Wei, Fang; Liu, Junying; Liu, Fen; Hu, Huaidong; Ren, Hong; Hu, Peng			Interferon-Based Anti-Viral Therapy for Hepatitis C Virus Infection after Renal Transplantation: An Updated Meta-Analysis	PLOS ONE			English	Article							CHRONIC VIRAL-HEPATITIS; FIBROSING CHOLESTATIC HEPATITIS; IFN-ALPHA TREATMENT; KIDNEY-TRANSPLANT; PEGYLATED INTERFERON; ACUTE REJECTION; PLUS RIBAVIRIN; COMBINED LIVER; CHRONIC HCV; RECIPIENTS	Background: Hepatitis C virus (HCV) infection is highly prevalent in renal transplant (RT) recipients. Currently, interferon-based (IFN-based) antiviral therapies are the standard approach to control HCV infection. In a post-transplantation setting, however, IFN-based therapies appear to have limited efficacy and their use remains controversial. The present study aimed to evaluate the efficacy and safety of IFN-based therapies for HCV infection post RT. Methods: We searched Pubmed, Embase, Web of Knowledge, and The Cochrane Library (1997-2013) for clinical trials in which transplant patients were given Interferon (IFN), pegylated interferon (PEG), interferon plus ribavirin (IFN-RIB), or pegylated interferon plus ribavirin (PEG-RIB). The Sustained Virological Response (SVR) and/or drop-out rates were the primary outcomes. Summary estimates were calculated using the random-effects model of DerSimonian and Laird, with heterogeneity and sensitivity analysis. Results: We identified 12 clinical trials (140 patients in total). The summary estimate for SVR rate, drop-out rate and graft rejection rate was 26.6% (95%CI, 15.0-38.1%), 21.1% (95% CI, 10.9-31.2%) and 4% (95%CI: 0.8%-7.1%), respectively. The overall SVR rate in PEG-based and standard IFN-based therapy was 40.6% (24/59) and 20.9% (17/81), respectively. The most frequent side-effect requiring discontinuation of treatment was graft dysfunction (14 cases, 45.1%). Meta-regression analysis showed the covariates included contribute to the heterogeneity in the SVR logit rate, but not in the drop-out logit rate. The sensitivity analyses by the random model yielded very similar results to the fixed-effects model. Conclusions: IFN-based therapy for HCV infection post RT has poor efficacy and limited safety. PEG-based therapy is a more effective approach for treating HCV infection post-RT than standard IFN-based therapy. Future research is required to develop novel strategies to improve therapeutic efficacy and tolerability, and reduce the liver-related morbidity and mortality in this important patient population.	[Wei, Fang; Liu, Fen; Hu, Huaidong; Ren, Hong; Hu, Peng] Chongqing Med Univ, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis, Dept Infect Dis,Inst Viral Hepatitis, Chongqing, Peoples R China; [Liu, Junying] Cent Hosp Zhoukou, Dept Gastroenterol, Zhoukou, Henan Province, Peoples R China	Chongqing Medical University	Hu, P (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis, Dept Infect Dis,Inst Viral Hepatitis, Chongqing, Peoples R China.	hp_cq@163.com			National Natural Science Foundation of China [81171560, 30930082, 81171561, 30972584]; National Science and Technology Major Project of China [2008ZX10002-006, 2012ZX1002007001, 2011ZX09302005, 2012ZX09303001-001, 2012ZX10002003]; National High Technology Research and Development Program of China [2011AA020111]; Key Project of Chongqing Science and Technology Commission [cstc2012gg-yyjsB10007]; Chongqing Natural Science Foundation [cstc2011jjA10025]; Medical Research Fund by Chongqing Municipal Health Bureau [2009-1-71]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Key Project of Chongqing Science and Technology Commission; Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing); Medical Research Fund by Chongqing Municipal Health Bureau	This research was supported by the National Natural Science Foundation of China (81171560, 30930082, 81171561, 30972584), The National Science and Technology Major Project of China (2008ZX10002-006, 2012ZX1002007001, 2011ZX09302005, 2012ZX09303001-001, 2012ZX10002003), The National High Technology Research and Development Program of China (2011AA020111), the Key Project of Chongqing Science and Technology Commission (cstc2012gg-yyjsB10007), the Chongqing Natural Science Foundation (cstc2011jjA10025), and the Medical Research Fund by Chongqing Municipal Health Bureau (2009-1-71). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Z, 2012, HEPATOLOGY, V6, P150; Alfurayh O, 2002, NEPHROL DIAL TRANSPL, P110; Aljumah AA, 2012, WORLD J GASTROENTERO, V18, P55, DOI 10.3748/wjg.v18.i1.55; [Anonymous], 2004, AM J TRANSPLANT, V4, P72; Baid S, 2000, TRANSPLANTATION, V70, P255, DOI 10.1097/00007890-200007270-00001; Baid S, 2003, AM J TRANSPLANT, V3, P74, DOI 10.1034/j.1600-6143.2003.30113.x; Caeiro F, 2011, TRANSPL P, V43, P259, DOI 10.1016/j.transproceed.2011.01.001; Carbognin SJ, 2006, AM J TRANSPLANT, V6, P1746, DOI 10.1111/j.1600-6143.2006.01374.x; Chang Ming-Ling, 2011, J Med Case Rep, V5, P246, DOI 10.1186/1752-1947-5-246; Cimsit B, 2011, TRANSPL P, V43, P901, DOI 10.1016/j.transproceed.2011.02.033; Covic A, 2009, NEPHROL DIAL TRANSPL, V24, P719, DOI 10.1093/ndt/gfn608; Cruzado JM, 2001, AM J TRANSPLANT, V1, P171, DOI 10.1034/j.1600-6143.2001.10212.x; Dale CH, 2009, CAN J GASTROENTEROL, V23, P265, DOI 10.1155/2009/912848; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fabriz F, 2006, CURR OPIN ORGAN TRAN, V11, P583, DOI 10.1097/MOT.0b013e3280105c5c; Fabrizi F, 2006, ALIMENT PHARM THER, V24, P1413, DOI 10.1111/j.1365-2036.2006.03151.x; Fabrizi F, 2001, AM J KIDNEY DIS, V38, P919, DOI 10.1053/ajkd.2001.28576; Fraile P, 2009, NEFROLOGIA, V29, P366, DOI 10.3265/Nefrologia.2009.29.4.5258.en.full; Fujiwara K, 2012, HEPATOLOGY S1, V56, p1047A; Fujiwara K, 2011, HEPATOLOGY S1, V54, p839A; Hanafusa T, 1998, TRANSPLANT P, V30, P122, DOI 10.1016/S0041-1345(97)01207-4; Hassan Q, 2012, TRANSPL INT, V25, P941, DOI 10.1111/j.1432-2277.2012.01520.x; Heintges T, 1997, HEPATOLOGY, V26, P521, DOI 10.1002/hep.510260338; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ichikawa Y, 1998, TRANSPLANTATION, V65, P134, DOI 10.1097/00007890-199801150-00026; Izopet J, 1997, AM J NEPHROL, V17, P417, DOI 10.1159/000169133; Kamar N, 2003, J AM SOC NEPHROL, V14, P2092, DOI 10.1097/01.ASN.0000079613.81511.3C; Kamar N, 2004, J CLIN VIROL, V30, P110, DOI 10.1016/j.jcv.2003.10.001; Kim E, 2011, ANN HEPATOL, V10, P5, DOI 10.1016/S1665-2681(19)31580-7; Kim Hyung Wook, 2001, Journal of the American Society of Nephrology, V12, p901A; Kim YK, 2008, AM J TRANSPLANT, V8, P567; Konishi I, 2004, INTERNAL MED, V43, P931, DOI 10.2169/internalmedicine.43.931; Kotanko Peter, 2001, Journal of the American Society of Nephrology, V12, p936A; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Luciani G, 2003, J NEPHROL, V16, P417; Martin P, 2008, J HEPATOL, V49, P613, DOI 10.1016/j.jhep.2008.06.003; Meyers CM, 2003, AM J KIDNEY DIS, V42, P631, DOI 10.1016/S0272-6386(03)00828-X; Mitwalli AH, 2006, NEPHRON CLIN PRACT, V102, P72, DOI 10.1159/000089090; Molina E, 2010, HEPATOLOGY, V52, p872A; Montalbano M, 2007, J CLIN GASTROENTEROL, V41, P216, DOI 10.1097/01.mcg.0000225569.04773.8b; Morales JM, 2004, NEPHROL DIAL TRANSPL, V19, P72, DOI 10.1093/ndt/gfh1020; Morales JM, 2002, SEMIN NEPHROL, V22, P365, DOI 10.1053/snep.2002.33677; Mukherjee S, 2007, TRANSPLANTATION, V84, P1374, DOI 10.1097/01.tp.0000289996.37615.7d; Ozdemir BH, 2006, TRANSPL P, V38, P492, DOI 10.1016/j.transproceed.2005.12.109; OZMINKOWSKI RJ, 1988, STAT MED, V7, P1207, DOI 10.1002/sim.4780071202; Pageaux GP, 2006, HEPATOLOGY, V44, p331A; Pageaux GP, 2009, TRANSPL INT, V22, P562, DOI 10.1111/j.1432-2277.2008.00831.x; Pereira BJG, 1997, KIDNEY INT, V51, P981, DOI 10.1038/ki.1997.139; PERIERA BJG, 1995, TRANSPLANTATION, V60, P799, DOI 10.1097/00007890-199510270-00007; Petitti DB, 2001, STAT MED, V20, P3625, DOI 10.1002/sim.1091; Ridruejo E, 2010, ANN HEPATOL, V9, P271, DOI 10.1016/S1665-2681(19)31636-9; Rostaing L, 1999, TRANSPLANTATION, V67, P556, DOI 10.1097/00007890-199902270-00012; Rostaing L, 2000, NEPHROL DIAL TRANSPL, V15, P74, DOI 10.1093/ndt/15.suppl_8.74; Rostaing L, 2012, CONTRIB NEPHROL, V176, P87, DOI 10.1159/000333775; Samuel D, 2004, LIVER TRANSPLANT, V10, P868, DOI 10.1002/lt.20194; Sanai FM, 2013, J HEPATOLOGY; Sanai FM, 2010, HEPATOLOGY S1, V52, p789A; Sanchez W, 2005, AM J TRANSPLANT, V5, P301; Schmitz V, 2007, ANN TRANSPL, V12, P22; Scott DR, 2010, TRANSPLANTATION, V90, P1165, DOI 10.1097/TP.0b013e3181f92548; Scott DR, 2008, HEPATOLOGY, V48, p1130A; Seron D, 2003, TRANSPLANTATION, V76, P1588, DOI 10.1097/01.TP.0000092495.07385.3C; Sharma RK, 2006, CLIN TRANSPLANT, V20, P677, DOI 10.1111/j.1399-0012.2006.00534.x; Shepherd J, 2004, HEALTH TECHNOL ASSES, V8, P1; Shepherd J, 2000, Health Technol Assess, V4, P1; Shu KH, 2004, AM J TRANSPLANT, V4, P205; Siddiqui AR, 2012, TRANSPL P, V44, P721, DOI 10.1016/j.transproceed.2011.12.019; Sperl J, 2008, J HEPATOL, V49, P461, DOI 10.1016/j.jhep.2008.06.002; Tang S, 2003, J HEPATOL, V39, P875, DOI 10.1016/S0168-8278(03)00358-1; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tokumoto T, 1998, TRANSPLANT P, V30, P3270, DOI 10.1016/S0041-1345(98)01024-0; Tokumoto T, 1999, TRANSPLANTATION, V67, pS99, DOI 10.1097/00007890-199904150-00400; Toth CM, 1998, TRANSPLANTATION, V66, P1254, DOI 10.1097/00007890-199811150-00023; Van Wagner LB, 2009, J HEPATOL, V51, P874, DOI 10.1016/j.jhep.2009.05.025; Voiculescu Mihai, 2003, Rom J Gastroenterol, V12, P41; Weclawiak H, 2007, NEPHROL DIAL TRANSPL, V22, P203; Wells Jennifer T, 2006, Clin Liver Dis, V10, P901, DOI 10.1016/j.cld.2006.08.025; WHO, 2020, HEP C; Yasumura T, 1997, TRANSPL P, V29, P784, DOI 10.1016/S0041-1345(96)00101-7	80	14	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e90611	10.1371/journal.pone.0090611	http://dx.doi.org/10.1371/journal.pone.0090611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699257	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000011
J	Wu, C; Rosenfeld, R; Clermont, G				Wu, Chuang; Rosenfeld, Roni; Clermont, Gilles			Using Data-Driven Rules to Predict Mortality in Severe Community Acquired Pneumonia	PLOS ONE			English	Article							HIV DRUG-RESISTANCE; APACHE IV; SAPS 3; HOSPITAL MORTALITY; ACUTE PHYSIOLOGY; CLINICAL-TRIALS; SEVERE SEPSIS; MODELS; RISK; PERFORMANCE	Prediction of patient-centered outcomes in hospitals is useful for performance benchmarking, resource allocation, and guidance regarding active treatment and withdrawal of care. Yet, their use by clinicians is limited by the complexity of available tools and amount of data required. We propose to use Disjunctive Normal Forms as a novel approach to predict hospital and 90-day mortality from instance-based patient data, comprising demographic, genetic, and physiologic information in a large cohort of patients admitted with severe community acquired pneumonia. We develop two algorithms to efficiently learn Disjunctive Normal Forms, which yield easy-to-interpret rules that explicitly map data to the outcome of interest. Disjunctive Normal Forms achieve higher prediction performance quality compared to a set of state-of-the-art machine learning models, and unveils insights unavailable with standard methods. Disjunctive Normal Forms constitute an intuitive set of prediction rules that could be easily implemented to predict outcomes and guide criteria-based clinical decision making and clinical trial execution, and thus of greater practical usefulness than currently available prediction tools. The Java implementation of the tool JavaDNF will be publicly available.	[Wu, Chuang; Rosenfeld, Roni] Carnegie Mellon Univ, Sch Comp Sci, Pittsburgh, PA 15213 USA; [Clermont, Gilles] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Clermont, Gilles] Univ Pittsburgh, Dept Ind Engn, Pittsburgh, PA USA; [Clermont, Gilles] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Clermont, G (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA.	clermontg@ccm.upmc.edu		Rosenfeld, Ronald/0000-0002-3274-5862	 [NIH-GM61992]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061992] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The GenIMS observational study was sponsored by NIH-GM61992. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2004, CRIT CARE MED, V32, P2199, DOI 10.1097/01.CCM.0000145228.62451.F6; Beerenwinkel N, 2002, P NATL ACAD SCI USA, V99, P8271, DOI 10.1073/pnas.112177799; Beerenwinkel N, 2001, IEEE INTELL SYST, V16, P35, DOI 10.1109/5254.972080; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Brayton RK, 1985, LOGIC MINIMIZATION A; Clark P., 1991, P 5 EUR WORK SESS LE, P151, DOI [DOI 10.1007/BFB0017011, 10.1007/bfb0017011]; Clermont G, 2001, CRIT CARE MED, V29, P291, DOI 10.1097/00003246-200102000-00012; Clermont G, 2004, CRIT CARE MED, V32, P2061, DOI 10.1097/01.CCM.0000142394.28791.C3; Clermont G., 1998, Annals Academy of Medicine Singapore, V27, P397; Silva VTCE, 2011, NEPHROL DIAL TRANSPL, V26, P3894, DOI 10.1093/ndt/gfr201; DALEY J, 1988, JAMA-J AM MED ASSOC, V260, P3617, DOI 10.1001/jama.260.24.3617; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; DiRienzo AG, 2003, STAT MED, V22, P2785, DOI 10.1002/sim.1516; Draghici S, 2003, BIOINFORMATICS, V19, P98, DOI 10.1093/bioinformatics/19.1.98; Feldmann M, 1999, ANN RHEUM DIS, V58, P27; FINE MJ, 1990, AM J MED, V89, P713, DOI 10.1016/0002-9343(90)90211-U; FINE MJ, 1990, AM J MED, V88, pN1; FINE MJ, 1995, J GEN INTERN MED, V10, P359, DOI 10.1007/BF02599830; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Gimpel JF, 1965, IEEE T COMPUTERS; Kamath, 2005, MATH PROGRAM, V57, P215; Kaplan V, 2003, ARCH INTERN MED, V163, P317, DOI 10.1001/archinte.163.3.317; Kaplan V, 2001, AM J RESP CRIT CARE, pA253; Kasal J, 2004, CRIT CARE MED, V32, P700, DOI 10.1097/01.CCM.0000114819.37569.4B; Keegan MT, 2012, CHEST, V142, P851, DOI 10.1378/chest.11-2164; KEELER EB, 1990, JAMA-J AM MED ASSOC, V264, P1962, DOI 10.1001/jama.264.15.1962; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kooperberg C, 2005, GENET EPIDEMIOL, V28, P157, DOI 10.1002/gepi.20042; Kooperberg C, 2001, GENET EPIDEMIOL, V21, pS626, DOI 10.1002/gepi.2001.21.s1.s626; KURASHI NY, 1992, THORAX, V47, P115, DOI 10.1136/thx.47.2.115; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Leteurtre S, 2001, CRIT CARE MED, V29, P1239, DOI 10.1097/00003246-200106000-00033; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; MARRIE TJ, 1989, REV INFECT DIS, V11, P586; ORTQVIST A, 1990, EUR RESPIR J, V3, P1105; Panacek EA, 2004, CRIT CARE MED, V32, P2173, DOI 10.1097/01.CCM.0000145229.59014.6c; Poynter Sue E, 2002, Pediatr Crit Care Med, V3, P382, DOI 10.1097/00130478-200210000-00013; Quinlan JR, 1990, READINGS MACHINE LEA, V1, P81; Read RC, 1998, J ANTIMICROB CHEMOTH, V41, P65, DOI 10.1093/jac/41.suppl_1.65; Rhee SY, 2006, PNAS, V10, P53; Ruckert U, 2002, LECT NOTES ARTIF INT, V2430, P405; Ruckert U., 2003, MACH LEARN P 20 INT, P648; Sakr Y, 2008, BRIT J ANAESTH, V101, P798, DOI 10.1093/bja/aen291; Sanchez SN, 2002, COMPUT OPER RES, V29, P1677, DOI 10.1016/S0305-0548(01)00050-8; Sevin AD, 2000, J INFECT DIS, V182, P59, DOI 10.1086/315673; Stuber F, 2001, J AM SOC NEPHROL, V12, pS60; Triantaphyllou E, 1999, COMPUTERS OPERATIONS, V23, P783; Vasilevskis EE, 2009, CHEST, V136, P89, DOI 10.1378/chest.08-2591; Vincent JL, 2007, CONTRIB NEPHROL, V156, P64; Wang DC, 2003, J INFECT DIS, V188, P653, DOI 10.1086/377453; Wang K, 2004, ANTIVIR THER, V9, P343; Wunderink RG, 2002, CHEST, V121, p87S, DOI 10.1016/S0012-3692(15)35491-X; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	55	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e89053	10.1371/journal.pone.0089053	http://dx.doi.org/10.1371/journal.pone.0089053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699007	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000334105000004
J	Falkingham, PL; Bates, KT; Farlow, JO				Falkingham, Peter L.; Bates, Karl T.; Farlow, James O.			Historical Photogrammetry: Bird's Paluxy River Dinosaur Chase Sequence Digitally Reconstructed as It Was prior to Excavation 70 Years Ago	PLOS ONE			English	Article								It is inevitable that some important specimens will become lost or damaged over time, conservation is therefore of vital importance. The Paluxy River dinosaur tracksite is among the most famous in the world. In 1940, Roland T. Bird described and excavated a portion of the site containing associated theropod and sauropod trackways. This excavated trackway was split up and housed in different institutions, and during the process a portion was lost or destroyed. We applied photogrammetric techniques to photographs taken by Bird over 70 years ago, before the trackway was removed, to digitally reconstruct the site as it was prior to excavation. The 3D digital model offers the opportunity to corroborate maps drawn by R.T. Bird when the tracksite was first described. More broadly, this work demonstrates the exciting potential for digitally recreating palaeontological, geological, or archaeological specimens that have been lost to science, but for which photographic documentation exists.	[Falkingham, Peter L.] Royal Vet Coll, Dept Comparat Biomed Sci, Struct & Motion Lab, London, England; [Falkingham, Peter L.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Bates, Karl T.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol 2, Liverpool L69 3BX, Merseyside, England; [Farlow, James O.] Indiana Purdue Univ, Dept Geosci, Indiana, PA USA	University of London; University of London Royal Veterinary College; Brown University; University of Liverpool	Falkingham, PL (corresponding author), Royal Vet Coll, Dept Comparat Biomed Sci, Struct & Motion Lab, London, England.	pfalkingham@rvc.ac.uk	Falkingham, Peter/C-7656-2014	Falkingham, Peter/0000-0003-1856-8377	Marie Curie International Outgoing Fellowship within the 7th European Framework Programme; National Geographic grant; Jurassic foundation grant; Palaeontological Association grant	Marie Curie International Outgoing Fellowship within the 7th European Framework Programme; National Geographic grant(National Geographic Society); Jurassic foundation grant; Palaeontological Association grant	This work was supported by a Marie Curie International Outgoing Fellowship within the 7th European Framework Programme awarded to PLF, and a National Geographic grant awarded to JOF. The Laser scans of the AMNH and TMM sections were collected during previous work funded by Jurassic foundation and Palaeontological Association grants awarded to KTB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, SIFTGPU GPU IMPLEMEN; [Anonymous], 2010, CLUSTERING VIEWS MUL; Bates Karl T., 2009, Geology Today, V25, P134; Bennett MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060755; Bird R.T., 1985, BONES BARNUM BROWN A; Bird Roland T., 1944, NAT HIST [NEW YORK], V53, P60; Changchang Wu, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P3057, DOI 10.1109/CVPR.2011.5995552; Falkingham PL, 2011, BIOL LETTERS, V7, P142, DOI 10.1098/rsbl.2010.0403; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; Farlow J.O., 1989, P371; Farlow J.O., 2012, P 5 INT S DIN PAL TH, P41; Furukawa Y, 2010, INTERNET SCALE MULTI; Furukawa Y, 2010, IEEE T PATTERN ANAL, V32, P1362, DOI 10.1109/TPAMI.2009.161; Kazhdan M, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2487228.2487237; Shuler E. W., 1937, Field & Laboratory Dallas, V5, P33; Shuler E.W., 1935, FIELD LAB, V4, P9; Shuler EW, 1917, AM J SCI, V44, P294; Thomas DA, 1997, SCI AM, V277, P74, DOI 10.1038/scientificamerican1297-74; [No title captured]	20	40	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93247	10.1371/journal.pone.0093247	http://dx.doi.org/10.1371/journal.pone.0093247			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695537	gold, Green Published, Green Accepted			2022-12-27	WOS:000334103000052
J	Suquet, M; Labbe, C; Puyo, S; Mingant, C; Quittet, B; Boulais, M; Queau, I; Ratiskol, D; Diss, B; Haffray, P				Suquet, Marc; Labbe, Catherine; Puyo, Sophie; Mingant, Christian; Quittet, Benjamin; Boulais, Myrina; Queau, Isabelle; Ratiskol, Dominique; Diss, Blandine; Haffray, Pierrick			Survival, Growth and Reproduction of Cryopreserved Larvae from a Marine Invertebrate, the Pacific Oyster (Crassostrea gigas)	PLOS ONE			English	Article							OOCYTES; EMBRYOS; SPERM; SYSTEM; DAMAGE; FISH	This study is the first demonstration of successful post-thawing development to reproduction stage of diploid cryopreserved larvae in an aquatic invertebrate. Survival, growth and reproductive performances were studied in juvenile and adult Pacific oysters grown from cryopreserved embryos. Cryopreservation was performed at three early stages: trochophore (13 +/- 2 hours post fertilization: hpf), early D-larvae (24 +/- 2 hpf) and late D-larvae (43 +/- 2 hpf). From the beginning (88 days) at the end of the ongrowing phase (195 days), no mortality was recorded and mean body weights did not differ between the thawed oysters and the control. At the end of the growing-out phase (982 days), survival of the oysters cryopreserved at 13 +/- 2 hpf and at 43 +/- 2 hpf was significantly higher (P<0.001) than those of the control (non cryopreserved larvae). Only the batches cryopreserved at 24 +/- 2 hpf showed lower survival than the control. Reproductive integrity of the mature oysters, formely cryopreserved at 13 +/- 2 hpf and 24 +/- 2 hpf, was estimated by the sperm movement and the larval development of their offspring in 13 crosses gamete pools (five males and five females in each pool). In all but two crosses out of 13 tested (P<0.001), development rates of the offspring were not significantly different between frozen and unfrozen parents. In all, the growth and reproductive performances of oysters formerly cryopreserved at larval stages are close to those of controls. Furthermore, these performances did not differ between the three initial larval stages of cryopreservation. The utility of larvae cryopreservation is discussed and compared with the cryopreservation of gametes as a technique for selection programs and shellfish cryobanking.	[Suquet, Marc; Mingant, Christian; Boulais, Myrina; Queau, Isabelle; Ratiskol, Dominique] IFREMER, PFOM Dept, Stn Expt Argenton, UMR 6539, Argenton, France; [Labbe, Catherine] INRA, LPGP, UR 1037, Rennes, France; [Puyo, Sophie; Quittet, Benjamin; Haffray, Pierrick] SYSAAF, LPGP, Rennes, France; [Diss, Blandine] Satmar, Barfleur, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); INRAE	Suquet, M (corresponding author), IFREMER, PFOM Dept, Stn Expt Argenton, UMR 6539, Argenton, France.	marc.suquet@ifremer.fr		Haffray, Pierrick/0000-0001-8604-4562; Boulais, Myrina/0000-0002-9309-9278	national project CRECHE [Ofimer 136/08/C]; CRYOAQUA (GIS IBISA); European Union [FEP 30906-2009]	national project CRECHE; CRYOAQUA (GIS IBISA); European Union(European Commission)	The present research was supported by the national project CRECHE (Ofimer 136/08/C) and CRYOAQUA (GIS IBISA) and by the European Union (FEP 30906-2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudry P, 2008, SUMMER MORTALITY PAC, P153; Cabrita E, 2005, CRYOBIOLOGY, V50, P144, DOI 10.1016/j.cryobiol.2004.12.003; Cabrita E, 2010, J APPL ICHTHYOL, V26, P623, DOI 10.1111/j.1439-0426.2010.01556.x; Gwo JC, 2003, CRYOLETTERS, V24, P171; Hiemstra S. J., 2006, The role of biotechnology in exploring and protecting agricultural genetic resources, P45; Honkoop PJC, 2002, AQUACULTURE, V213, P171, DOI 10.1016/S0044-8486(02)00030-3; Leopold Roger A., 2010, P325, DOI 10.1017/CBO9780511675997.014; Paniagua-Chavez C. O., 2000, CRYOPRESERVATION AQU, P230; Paredes E, 2012, CRYOBIOLOGY, V65, P256, DOI 10.1016/j.cryobiol.2012.07.078; Piferrer F, 2009, AQUACULTURE, V293, P125, DOI 10.1016/j.aquaculture.2009.04.036; RENARD P, 1991, AQUACULTURE, V92, P43, DOI 10.1016/0044-8486(91)90007-T; Rico-Villa B, 2008, AQUACULTURE, V282, P54, DOI 10.1016/j.aquaculture.2008.06.016; Smith GD, 2004, REPROD BIOMED ONLINE, V9, P171, DOI 10.1016/S1472-6483(10)62126-8; Song YP, 2009, AQUACULTURE, V287, P311, DOI 10.1016/j.aquaculture.2008.10.018; Suquet M, 2012, THERIOGENOLOGY, V78, P462, DOI 10.1016/j.theriogenology.2012.02.014; Tervit HR, 2005, CRYOBIOLOGY, V51, P142, DOI 10.1016/j.cryobiol.2005.06.001; TOLEDO JD, 1990, AQUACULTURE, V91, P385, DOI 10.1016/0044-8486(90)90202-X; Usuki H, 2002, FISHERIES SCI, V68, P757, DOI 10.1046/j.1444-2906.2002.00490.x; Wang HR, 2011, AQUAC RES, V42, P1816, DOI 10.1111/j.1365-2109.2010.02782.x; Wang WB, 2000, INVERTEBR BIOL, V119, P309; Wilson-Leedy JG, 2007, THERIOGENOLOGY, V67, P661, DOI 10.1016/j.theriogenology.2006.10.003	21	24	25	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93486	10.1371/journal.pone.0093486	http://dx.doi.org/10.1371/journal.pone.0093486			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695576	Green Published, gold			2022-12-27	WOS:000334103000079
J	Zhang, CX; Cui, W; Zhang, M; Zhang, J; Wang, TY; Zhu, J; Jiao, GZ; Tan, JH				Zhang, Chuan-Xin; Cui, Wei; Zhang, Min; Zhang, Jie; Wang, Tian-Yang; Zhu, Jiang; Jiao, Guang-Zhong; Tan, Jing-He			Role of Na+/Ca2+ Exchanger (NCX) in Modulating Postovulatory Aging of Mouse and Rat Oocytes	PLOS ONE			English	Article							NA-CA EXCHANGE; MAMMALIAN EGG ACTIVATION; CELL NUCLEAR TRANSFER; IN-VITRO; OXIDATIVE STRESS; CHROMOSOME CONDENSATION; CALCIUM OSCILLATIONS; PARTHENOGENETIC ACTIVATION; INTRACELLULAR CALCIUM; BLASTOCYST STAGE	We studied the role of the Na+/Ca2+ exchanger (NCX) in modulating oocyte postovulatory aging by observing changes in NCX contents and activities in aging mouse and rat oocytes. Whereas the NCX activity was measured by observing oocyte activation following culture with NCX inhibitor or activator, the NCX contents were determined by immunohistochemical quantification. Although NCX was active in freshly-ovulated rat oocytes recovered 13 h post hCG injection and in aged oocytes recovered 19 h post hCG in both species, it was not active in freshly-ovulated mouse oocytes. However, NCX became active when the freshly-ovulated mouse oocytes were activated with ethanol before culture. Measurement of cytoplasmic Ca2+ revealed Ca2+ increases always before NCX activation. Whereas levels of the reactive oxygen species (ROS) and the activation susceptibility increased, the density of NCX member 1 (NCX1) decreased significantly with oocyte aging in both species. While culture with H2O2 decreased the density of NCX1 significantly, culture with NaCl supplementation sustained the NCX1 density in mouse oocytes. It was concluded that (a) the NCX activity was involved in the modulation of oocyte aging and spontaneous activation; (b) ROS and Na+ regulated the NCX activity in aging oocytes by altering its density as well as functioning; and (c) cytoplasmic Ca2+ elevation was essential for NCX activation in the oocyte.	[Zhang, Chuan-Xin; Cui, Wei; Zhang, Min; Zhang, Jie; Wang, Tian-Yang; Zhu, Jiang; Jiao, Guang-Zhong; Tan, Jing-He] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Tan, JH (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China.	tanjh@sdau.edu.cn	Cui, Wei/F-2192-2016	Cui, Wei/0000-0001-7281-3471	National Basic Research Program of China [2012CB944403, 2014CB138503]; China National Natural Science Foundation [31272444, 30972096]	National Basic Research Program of China(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of China (Nos. 2012CB944403 and 2014CB138503) and the China National Natural Science Foundation (Nos. 31272444 and 30972096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajduk A, 2008, REPROD BIOLOGY, V8, P3, DOI 10.1016/S1642-431X(12)60001-1; BAKER PF, 1969, J PHYSIOL-LONDON, V200, P431, DOI 10.1113/jphysiol.1969.sp008702; BOERJAN ML, 1990, MOL REPROD DEV, V25, P155, DOI 10.1002/mrd.1080250208; BOSMIKICH A, 1995, MOL REPROD DEV, V41, P84, DOI 10.1002/mrd.1080410113; Carroll J, 2000, J REPROD FERTIL, V118, P337, DOI 10.1530/reprod/118.2.337; Cervera RP, 2003, ZYGOTE, V11, P151, DOI 10.1017/S0967199403002181; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Chebotareva T, 2011, MOL REPROD DEV, V78, P795, DOI 10.1002/mrd.21385; COLONNA R, 1989, GAMETE RES, V24, P171, DOI 10.1002/mrd.1120240205; CRESPO LM, 1990, NATURE, V345, P618, DOI 10.1038/345618a0; Cui W, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108266; Cui W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032044; Despa S, 2007, AM J PHYSIOL-CELL PH, V293, pC321, DOI 10.1152/ajpcell.00597.2006; DIPOLO R, 1979, NATURE, V278, P271, DOI 10.1038/278271a0; DiPolo R, 1989, SODIUM CALCIUM EXCHA, P526; DiPolo R, 2011, AM J PHYSIOL-CELL PH, V301, pC687, DOI 10.1152/ajpcell.00521.2010; Egger M, 1999, J MEMBRANE BIOL, V168, P107, DOI 10.1007/s002329900502; EISNER DA, 1985, AM J PHYSIOL, V248, pC189, DOI 10.1152/ajpcell.1985.248.3.C189; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Galan C, 2010, MOLECULES, V15, P7167, DOI 10.3390/molecules15107167; GEORGIOU P, 1988, J PHYSIOL-LONDON, V402, P121, DOI 10.1113/jphysiol.1988.sp017196; Grupen CG, 2002, J REPROD DEVELOP, V48, P313, DOI 10.1262/jrd.48.313; Hayes E, 2001, PHYSIOL GENOMICS, V5, P193, DOI 10.1152/physiolgenomics.2001.5.4.193; Hirabayashi M, 2003, CLONING STEM CELLS, V5, P35, DOI 10.1089/153623003321512148; Iannaccone P, 2001, ZYGOTE, V9, P135, DOI 10.1017/S0967199401001149; IGUSA Y, 1983, J PHYSIOL-LONDON, V340, P611, DOI 10.1113/jphysiol.1983.sp014783; Ito J, 2005, REPRODUCTION, V129, P171, DOI 10.1530/rep.1.00431; Iwamoto M, 2005, ZYGOTE, V13, P335, DOI 10.1017/S0967199405003370; Jellerette T, 2000, DEV BIOL, V223, P238, DOI 10.1006/dbio.2000.9675; JUETTEN J, 1983, GAMETE RES, V8, P219, DOI 10.1002/mrd.1120080303; KEEFER CL, 1982, J EXP ZOOL, V224, P371, DOI 10.1002/jez.1402240310; KLINE D, 1992, DEV BIOL, V149, P80, DOI 10.1016/0012-1606(92)90265-I; Lacham-Kaplan O, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-58; Liu N, 2009, REPRODUCTION, V138, P223, DOI 10.1530/REP-09-0122; LONGO FJ, 1980, GAMETE RES, V3, P379, DOI 10.1002/mrd.1120030409; Lord T, 2013, REPRODUCTION, V146, pR217, DOI 10.1530/REP-13-0111; Machaty Z, 2002, BIOL REPROD, V67, P1133, DOI 10.1095/biolreprod67.4.1133; Malcuit C, 2006, J CELL PHYSIOL, V206, P565, DOI 10.1002/jcp.20471; Miao YL, 2005, BIOL REPROD, V73, P1025, DOI 10.1095/biolreprod.105.043703; NASRESFAHANI MH, 1990, DEVELOPMENT, V109, P501; Oh SH, 1998, BIOL REPROD, V59, P884, DOI 10.1095/biolreprod59.4.884; Pepperell JR, 1999, BIOL REPROD, V60, P1137, DOI 10.1095/biolreprod60.5.1137; REUTER H, 1968, J PHYSIOL-LONDON, V195, P451, DOI 10.1113/jphysiol.1968.sp008467; Salido GM, 2009, CELL SIGNAL, V21, P457, DOI 10.1016/j.cellsig.2008.11.005; Shiraga M, 1998, BLOOD, V92, P3710, DOI 10.1182/blood.V92.10.3710.422k13_3710_3720; Squier TC, 2000, FRONT BIOSCI-LANDMRK, V5, pD504, DOI 10.2741/Squier; Sterthaus O, 2009, CLONING STEM CELLS, V11, P463, DOI 10.1089/clo.2009.0014; Swift F, 2008, CARDIOVASC RES, V78, P71, DOI 10.1093/cvr/cvn013; Swift F, 2010, CELL CALCIUM, V48, P54, DOI 10.1016/j.ceca.2010.06.006; Takahashi T, 2003, MOL REPROD DEV, V66, P143, DOI 10.1002/mrd.10341; Tarin JJ, 1998, HUM REPROD, V13, P381, DOI 10.1093/humrep/13.2.381; Tarin JJ, 1999, BIOL REPROD, V61, P1347, DOI 10.1095/biolreprod61.5.1347; Tarin JJ, 2002, BIOL REPROD, V66, P495, DOI 10.1095/biolreprod66.2.495; TESARIK J, 1993, HUM REPROD, V8, P1245, DOI 10.1093/oxfordjournals.humrep.a138235; Tomioka I, 2007, J REPROD DEVELOP, V53, P835, DOI 10.1262/jrd.18144; Vines CA, 2002, P NATL ACAD SCI USA, V99, P2026, DOI 10.1073/pnas.042700899; WEBB M, 1986, J EMBRYOL EXP MORPH, V95, P131; WHITTINGHAM DG, 1978, EXP CELL RES, V113, P311, DOI 10.1016/0014-4827(78)90371-3; WINSTON NJ, 1993, HUM REPROD, V8, P503, DOI 10.1093/oxfordjournals.humrep.a138084; Wu YG, 2007, CLONING STEM CELLS, V9, P417, DOI 10.1089/clo.2006.0023; YANAGIMACHI R, 1961, J EXP ZOOL, V148, P185, DOI 10.1002/jez.1401480303	61	10	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93446	10.1371/journal.pone.0093446	http://dx.doi.org/10.1371/journal.pone.0093446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695407	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000073
J	Hare, JM; Ferrell, JC; Witkowski, TA; Grice, AN				Hare, Janelle M.; Ferrell, Joshua C.; Witkowski, Travis A.; Grice, Alison N.			Prophage Induction and Differential RecA and UmuDAb Transcriptome Regulation in the DNA Damage Responses of Acinetobacter baumannii and Acinetobacter baylyi	PLOS ONE			English	Article							COLI LEXA PROTEIN; ESCHERICHIA-COLI; INDUCED MUTAGENESIS; GENOME SEQUENCE; GENE-EXPRESSION; CELL-DIVISION; VERSATILE; SYSTEM; SIPHOVIRIDAE; PATHOGENESIS	The SOS response to DNA damage that induces up to 10% of the prokaryotic genome requires RecA action to relieve LexA transcriptional repression. In Acinetobacter species, which lack LexA, the error-prone polymerase accessory UmuDAb is instead required for ddrR induction after DNA damage, suggesting it might be a LexA analog. RNA-Seq experiments defined the DNA damage transcriptome (mitomycin C-induced) of wild type, recA and umuDAb mutant strains of both A. baylyi ADP1 and A. baumannii ATCC 17978. Of the typical SOS response genes, few were differentially regulated in these species; many were repressed or absent. A striking 38.4% of all ADP1 genes, and 11.4% of all 17978 genes, were repressed under these conditions. In A. baylyi ADP1, 66 genes (2.0% of the genome), including a CRISPR/Cas system, were DNA damage-induced, and belonged to four regulons defined by differential use of recA and umuDAb. In A. baumannii ATCC 17978, however, induction of 99% of the 152 mitomycin C-induced genes depended on recA, and only 28 of these genes required umuDAb for their induction. 90% of the induced A. baumannii genes were clustered in three prophage regions, and bacteriophage particles were observed after mitomycin C treatment. These prophages encoded esvI, esvK1, and esvK2, ethanol-stimulated virulence genes previously identified in a Caenorhabditis elegans model, as well as error-prone polymerase alleles. The induction of all 17978 error-prone polymerase alleles, whether prophage-encoded or not, was recA dependent, but only these DNA polymerase V-related genes were de-repressed in the umuDAb mutant in the absence of DNA damage. These results suggest that both species possess a robust and complex DNA damage response involving both recA-dependent and recA-independent regulons, and further demonstrates that although umuDAb has a specialized role in repressing error-prone polymerases, additional regulators likely participate in these species' transcriptional response to DNA damage.	[Hare, Janelle M.; Ferrell, Joshua C.; Witkowski, Travis A.; Grice, Alison N.] Morehead State Univ, Dept Biol & Chem, Morehead, KY 40351 USA	Morehead State University	Hare, JM (corresponding author), Morehead State Univ, Dept Biol & Chem, Morehead, KY 40351 USA.	jm.hare@morehead-st.edu	Hare, Janelle/AAG-1144-2019	Hare, Janelle/0000-0001-5482-8143; Ferrell, Joshua/0000-0003-4570-8240	KBRIN NIH grant [P20GM103436]; NIH [R15GM085722-02]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM085722, P20GM103436] Funding Source: NIH RePORTER	KBRIN NIH grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a KBRIN NIH grant (P20GM103436) and NIH grant R15GM085722-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella M, 2007, J BACTERIOL, V189, P8855, DOI 10.1128/JB.01213-07; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; Aranda J, 2013, J BACTERIOL, V195, P5577, DOI 10.1128/JB.00853-13; Aranda J, 2011, J BACTERIOL, V193, P3740, DOI 10.1128/JB.00389-11; Aranda J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-279; Aravind L, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-20; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barbe V, 2004, NUCLEIC ACIDS RES, V32, P5766, DOI 10.1093/nar/gkh910; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; BRENT R, 1981, P NATL ACAD SCI-BIOL, V78, P4204, DOI 10.1073/pnas.78.7.4204; Brussow H, 2001, MOL MICROBIOL, V39, P213, DOI 10.1046/j.1365-2958.2001.02228.x; Cirz RT, 2006, J BACTERIOL, V188, P7101, DOI 10.1128/JB.00807-06; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Deghorain M, 2012, VIRUSES-BASEL, V4, P3316, DOI 10.3390/v4123316; Di Nocera PP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-224; ERASO JM, 1994, J BACTERIOL, V176, P32, DOI 10.1128/JB.176.1.32-43.1994; Erill I, 2003, BIOINFORMATICS, V19, P2225, DOI 10.1093/bioinformatics/btg303; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Gohl O, 2006, APPL ENVIRON MICROB, V72, P1394, DOI 10.1128/AEM.72.2.1394-1401.2006; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hare JM, 2006, APPL ENVIRON MICROB, V72, P4036, DOI 10.1128/AEM.02774-05; Hare JM, 2012, FEMS MICROBIOL LETT, V334, P57, DOI 10.1111/j.1574-6968.2012.02618.x; Hare JM, 2012, MICROBIOL-SGM, V158, P601, DOI 10.1099/mic.0.054668-0; Hauck Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044597; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HORII T, 1981, CELL, V27, P515, DOI 10.1016/0092-8674(81)90393-7; HUISMAN O, 1981, NATURE, V290, P797, DOI 10.1038/290797a0; Jara M, 2003, J BACTERIOL, V185, P2493, DOI 10.1128/JB.185.8.2493-2502.2003; Jeon J, 2012, J VIROL, V86, P12437, DOI 10.1128/JVI.02132-12; Khil PP, 2002, MOL MICROBIOL, V44, P89, DOI 10.1046/j.1365-2958.2002.02878.x; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Klaiman D, 2014, NUCLEIC ACIDS RES, V42, P328, DOI 10.1093/nar/gkt851; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longkumer T, 2014, MICROBIOL-SGM, V160, P102, DOI 10.1099/mic.0.070664-0; Mortensen BL, 2012, CELL MICROBIOL, V14, P1336, DOI 10.1111/j.1462-5822.2012.01817.x; Norton MD, 2013, J BACTERIOL, V195, P1335, DOI 10.1128/JB.02176-12; Petrovski S, 2012, J VIROL, V86, P358, DOI 10.1128/JVI.05460-11; Rauch PJG, 1996, MICROBIOL-UK, V142, P1025, DOI 10.1099/00221287-142-4-1025; ROBERTS JW, 1975, P NATL ACAD SCI USA, V72, P147, DOI 10.1073/pnas.72.1.147; Rutala WA, 2010, INFECT CONT HOSP EP, V31, P1025, DOI 10.1086/656244; SCHOEMAKER JM, 1984, J BACTERIOL, V158, P551, DOI 10.1128/JB.158.2.551-561.1984; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; WALKER GC, 1996, SOS RESPONSE ESCHERI; Young DM, 2005, ANNU REV MICROBIOL, V59, P519, DOI 10.1146/annurev.micro.59.051905.105823; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	49	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93861	10.1371/journal.pone.0093861	http://dx.doi.org/10.1371/journal.pone.0093861			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709747	Green Submitted, gold, Green Published			2022-12-27	WOS:000334159800059
J	Iyer, S; Reyes, J; Killingback, T				Iyer, Swami; Reyes, Joshua; Killingback, Timothy			An Application of Evolutionary Game Theory to Social Dilemmas: The Traveler ' s Dilemma and the Minimum Effort Coordination Game	PLOS ONE			English	Article							COOPERATION; DYNAMICS; TRAGEDY; POPULATIONS; BEHAVIOR; RESOLVE; ORIGIN; SIZE	The Traveler's Dilemma game and the Minimum Effort Coordination game are two social dilemmas that have attracted considerable attention due to the fact that the predictions of classical game theory are at odds with the results found when the games are studied experimentally. Moreover, a direct application of deterministic evolutionary game theory, as embodied in the replicator dynamics, to these games does not explain the observed behavior. In this work, we formulate natural variants of these two games as smoothed continuous-strategy games. We study the evolutionary dynamics of these continuous-strategy games, both analytically and through agent-based simulations, and show that the behavior predicted theoretically is in accord with that observed experimentally. Thus, these variants of the Traveler's Dilemma and the Minimum Effort Coordination games provide a simple resolution of the paradoxical behavior associated with the original games.	[Iyer, Swami] Univ Massachusetts, Dept Comp Sci, Boston, MA 02125 USA; [Reyes, Joshua] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Killingback, Timothy] Univ Massachusetts, Dept Math, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Boston	Killingback, T (corresponding author), Univ Massachusetts, Dept Math, Harbor Campus, Boston, MA 02125 USA.	timothy.killingback@umb.edu						Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Anderson SP, 2001, GAME ECON BEHAV, V34, P177, DOI 10.1006/game.2000.0800; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BASU K, 1994, AM ECON REV, V84, P391; Basu K, 2007, SCI AM, V296, P90, DOI 10.1038/scientificamerican0607-90; Basu K, 2011, SOC CHOICE WELFARE, V37, P575, DOI 10.1007/s00355-011-0577-7; Becker T., 2005, EXPERTS PLAYING TRAV; BRYANT J, 1983, Q J ECON, V98, P525, DOI 10.2307/1886025; Camerer CF, 2004, Q J ECON, V119, P861, DOI 10.1162/0033553041502225; Capra CM, 1999, AM ECON REV, V89, P678, DOI 10.1257/aer.89.3.678; Capraro V, 2013, LECT NOTES COMPUT SC, V8146, P146, DOI 10.1007/978-3-642-41392-6_13; Capraro V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072427; Costa-Gomes M, 2001, ECONOMETRICA, V69, P1193, DOI 10.1111/1468-0262.00239; Doebeli M, 2004, SCIENCE, V306, P859, DOI 10.1126/science.1101456; Dufwenberg M, 2000, INT J IND ORGAN, V18, P7, DOI 10.1016/S0167-7187(99)00031-4; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; FLOOD MM, 1958, MANAGE SCI, V5, P5, DOI 10.1287/mnsc.5.1.5; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Goeree JK, 2001, AM ECON REV, V91, P1402, DOI 10.1257/aer.91.5.1402; Goeree JK, 1999, P NATL ACAD SCI USA, V96, P10564, DOI 10.1073/pnas.96.19.10564; Halpern JY, 2012, GAME ECON BEHAV, V74, P184, DOI 10.1016/j.geb.2011.05.012; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Holt CA, 2004, P NATL ACAD SCI USA, V101, P3999, DOI 10.1073/pnas.0308738101; Ifti M, 2004, J THEOR BIOL, V231, P97, DOI 10.1016/j.jtbi.2004.06.003; ISAAC RM, 1988, Q J ECON, V103, P179, DOI 10.2307/1882648; Killingback T, 1996, P ROY SOC B-BIOL SCI, V263, P1135, DOI 10.1098/rspb.1996.0166; Killingback T, 1999, P ROY SOC B-BIOL SCI, V266, P1723, DOI 10.1098/rspb.1999.0838; Killingback T, 2006, P ROY SOC B-BIOL SCI, V273, P1477, DOI 10.1098/rspb.2006.3476; Killingback Timothy, 2010, Biology Theory, V5, P3, DOI 10.1162/BIOT_a_00019; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Li RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058597; Manapat ML, 2012, J THEOR BIOL, V303, P119, DOI 10.1016/j.jtbi.2012.03.014; Maynard Smith J., 1982, pi; MCKELVEY RD, 1995, GAME ECON BEHAV, V10, P6, DOI 10.1006/game.1995.1023; Metz J, 1996, STOCHAST SPATIAL STR, P183; Nakamaru M, 1997, J THEOR BIOL, V184, P65, DOI 10.1006/jtbi.1996.0243; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Riehl C, 2011, P ROY SOC B-BIOL SCI, V278, P1728, DOI 10.1098/rspb.2010.1752; Riehl C, 2009, WILSON J ORNITHOL, V121, P679, DOI 10.1676/09-017.1; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Skyrms B, 2003, STAG HUNT EVOLUTION; STAHL DO, 1994, J ECON BEHAV ORGAN, V25, P309, DOI 10.1016/0167-2681(94)90103-1; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Tirole J., 1988, THEORY IND ORG; van Baalen M, 1998, J THEOR BIOL, V193, P631, DOI 10.1006/jtbi.1998.0730; VANHUYCK JB, 1990, AM ECON REV, V80, P234; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wright JR, 2010, AAAI CONF ARTIF INTE, P901	55	12	12	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93988	10.1371/journal.pone.0093988	http://dx.doi.org/10.1371/journal.pone.0093988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7EP	24709851	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800081
J	Ndumbi, P; Falutz, J; Pai, NP; Tsoukas, CM				Ndumbi, Patricia; Falutz, Julian; Pai, Nitika Pant; Tsoukas, Christos M.			Delay in cART Initiation Results in Persistent Immune Dysregulation and Poor Recovery of T-Cell Phenotype Despite a Decade of Successful HIV Suppression	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; C-REACTIVE PROTEIN; ANTIRETROVIRAL THERAPY; LYMPHOCYTE SUBSETS; INFECTED PATIENTS; CONTROLLED-TRIAL; CYTOMEGALOVIRUS; HOMEOSTASIS; COUNT; AIDS	Background: Successful combination antiretroviral therapy (cART) increases levels of CD4+ T-cells, however this increase may not accurately reflect long-term immune recovery since T-cell dysregulation and loss of T-cell homeostasis often persist. We therefore assessed the impact of a decade of effective cART on immune regulation, T-cell homeostasis, and overall T-cell phenotype. Methods: We conducted a retrospective study of 288 HIV+ cART-naive patients initiating therapy. We identified 86 individuals who received cART for at least a decade, of which 44 consistently maintained undetectable plasma HIV-RNA levels throughout therapy. At baseline, participants were classified into three groups according to pre-treatment CD4+ T-cell counts: Group I (CD4 < 200 cells/mm(3)); Group II (CD4: 200-350 cells/mm(3)); Group III (CD4 > 350 cells/mm(3)). Outcomes of interest were: (1) CD4+ T-cell count restoration (CD4 > 532 cells/mm(3)); (2) normalization of CD4: CD8 T-cell ratio (1.2-3.3); (3) maintenance of CD3+ T-cell homeostasis (CD3: 65%-85% of peripheral lymphocytes); (4) normalization of the complete T Cell phenotype (TCP). Results: Despite a decade of sustained successful cART, complete T-cell phenotype normalization only occurred in 16% of patients, most of whom had initiated therapy at high CD4+ T-cell counts (> 350 cells/mm(3)). The TCP parameter that was the least restored among patients was the CD4: CD8 T-cell ratio. Conclusions: Failure to normalize the complete T-cell phenotype was most apparent in patients who initiated cART with a CD4+ T-cell count < 200 cells/mm(3). The impact of this impaired T-cell phenotype on life-long immune function and potential comorbidities remains to be elucidated.	[Ndumbi, Patricia; Falutz, Julian; Tsoukas, Christos M.] McGill Univ, Ctr Hlth, Immune Deficiency Treatment Ctr, Montreal, PQ, Canada; [Pai, Nitika Pant] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ, Canada	McGill University; McGill University	Ndumbi, P (corresponding author), McGill Univ, Ctr Hlth, Immune Deficiency Treatment Ctr, Montreal, PQ, Canada.	patricia.ndumbi@mail.mcgill.ca; chris.tsoukas@muhc.mcgill.ca		Pant Pai, Nitika/0000-0002-4672-0500	Canadian Institutes of Health Research (CIHR) [200303HHP-118726-HSR-CFAC-26137]; McGill University Health Center (MUHC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); McGill University Health Center (MUHC)	This work was supported by research funding from the Canadian Institutes of Health Research (CIHR) grant 200303HHP-118726-HSR-CFAC-26137. Paticia Ndumbi was also supported by the McGill University Health Center (MUHC) graduate fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLEMAN LM, 1993, J ACQ IMMUN DEF SYND, V6, P144; Althoff KN, 2010, AIDS, V24, P2467, DOI 10.1097/QAD.0b013e32833e6d14; Baker JV, 2008, JAIDS-J ACQ IMM DEF, V48, P541, DOI 10.1097/QAI.0b013e31817bebb3; Bower JE, 2003, JNCI-J NATL CANCER I, V95, P1165, DOI 10.1093/jnci/djg0019; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Carmichael K F, 2006, Afr J Med Med Sci, V35, P53; Chattopadhyay PK, 2006, AIDS RES HUM RETROV, V22, P501, DOI 10.1089/aid.2006.22.501; EDELMAN AS, 1989, FASEB J, V3, P22, DOI 10.1096/fasebj.3.1.2562947; FAHEY JL, 1984, AM J MED, V76, P95, DOI 10.1016/0002-9343(84)90756-3; FERGUSON FG, 1995, J GERONTOL A-BIOL, V50, pB378, DOI 10.1093/gerona/50A.6.B378; Gange SJ, 1998, P NATL ACAD SCI USA, V95, P10848, DOI 10.1073/pnas.95.18.10848; Goodrum F, 2012, CELL MICROBIOL, V14, P644, DOI 10.1111/j.1462-5822.2012.01774.x; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Hirsch M, 1999, J INFECT DIS, V180, P659, DOI 10.1086/314948; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Jain V, 2013, J INFECT DIS, V208, P1202, DOI 10.1093/infdis/jit311; Keller M, 2009, AIDS, V23, P731, DOI 10.1097/QAD.0b013e328326f77f; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Khoruts A, 2005, IMMUNOL LETT, V98, P23, DOI 10.1016/j.imlet.2004.10.022; LABALETTE M, 1994, CLIN EXP IMMUNOL, V95, P465; Leung V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077665; Lo J, 2010, AIDS, V24, P243, DOI 10.1097/QAD.0b013e328333ea9e; MALONE JL, 1990, J ACQ IMMUN DEF SYND, V3, P144; Malphettes M, 2009, CLIN INFECT DIS, V49, P1329, DOI 10.1086/606059; Margolick J B, 1997, Semin Immunol, V9, P381, DOI 10.1006/smim.1997.0096; MARGOLICK JB, 1995, NAT MED, V1, P674, DOI 10.1038/nm0795-674; Margolick JB, 1993, JAIDS J ACQUIRED IMM, V6; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Muhlestein JB, 2000, CIRCULATION, V102, P1917, DOI 10.1161/01.CIR.102.16.1917; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Ndumbi P, 2013, AIDS; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; Shete A, 2010, INDIAN J MED RES, V132, P667; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Stockinger B, 2004, CURR OPIN IMMUNOL, V16, P775, DOI 10.1016/j.coi.2004.09.003; Strindhall J, 2012, AGE DORDR; Torti C, 2012, CLIN MICROBIOL INFEC, V18, P449, DOI 10.1111/j.1469-0691.2011.03650.x; Vila LM, 2006, ARTHRIT RHEUM-ARTHR, V55, P799, DOI 10.1002/art.22224; Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6; Wikby A, 2008, BIOGERONTOLOGY, V9, P299, DOI 10.1007/s10522-008-9138-6; Zhu JH, 1999, J AM COLL CARDIOL, V34, P1738, DOI 10.1016/S0735-1097(99)00410-6; ZOLLAPAZNER S, 1987, P NATL ACAD SCI USA, V84, P5404, DOI 10.1073/pnas.84.15.5404	42	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94018	10.1371/journal.pone.0094018	http://dx.doi.org/10.1371/journal.pone.0094018			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710051	Green Submitted, gold, Green Published			2022-12-27	WOS:000334159800087
J	Fitch-Rogalsky, C; Steber, W; Mahler, M; Lupton, T; Martin, L; Barr, SG; Mosher, DP; Wick, J; Fritzler, MJ				Fitch-Rogalsky, Christie; Steber, Whitney; Mahler, Michael; Lupton, Terri; Martin, Liam; Barr, Susan G.; Mosher, Dianne P.; Wick, James; Fritzler, Marvin J.			Clinical and Serological Features of Patients Referred through a Rheumatology Triage System because of Positive Antinuclear Antibodies	PLOS ONE			English	Article							PRIMARY-CARE PHYSICIANS; LUPUS-ERYTHEMATOSUS; CLASSIFICATION CRITERIA; DIAGNOSTIC ALGORITHM; HEALTHY-INDIVIDUALS; AUTOIMMUNE-DISEASES; AMERICAN-COLLEGE; PREDICTIVE-VALUE; ANTI-DFS70 ANTIBODIES; IMMUNOLOGICAL TESTS	Background: The referral of patients with positive anti-nuclear antibody ( ANA) tests has been criticized as an inappropriate use of medical resources. The utility of a positive ANA test in a central triage (CT) system was studied by determining the autoantibody profiles and clinical diagnoses of patients referred to rheumatologists through a CT system because of a positive ANA test. Methods: Patients that met three criteria were included: (1) referred to Rheumatology CT over a three year interval; (2) reason for referral was a ``positive ANA''; (3) were evaluated by a certified rheumatologist. The CT clinical database was used to obtain demographic and clinical information and a serological database was used to retrieve specific ANA and/or extractable nuclear antigen (ENA) test results. Clinical information was extracted from the consulting rheumatologist's report. Results: 15,357 patients were referred through the CT system; 643 (4.1%) of these because of a positive ANA and of these 263 (40.9%) were evaluated by a certified rheumatologist. In 63/263 (24%) of ANA positive patients, the specialist provided a diagnosis of an ANA associated rheumatic disease (AARD) while 69 (26.2%) had no evidence of any disease; 102 (38.8%) had other rheumatologic diagnoses and 29 (11%) had conditions that did not meet AARD classification criteria. Of ANA positive archived sera, 15.1% were anti-DFS70 positive and 91.2% of these did not have an AARD. Conclusions: This is the first study to evaluate the serological and clinical features of patients referred through a CT system because of a positive ANA. The spectrum of autoantibody specificities was wide with anti-Ro52/TRIM21 being the most common autoantibody detected. Approximately 15% of referrals had only antibodies to DFS70, the vast majority of which did not have clinical evidence for an AARD. These findings provide insight into the utility of autoantibody testing in a CT system.	[Fitch-Rogalsky, Christie; Steber, Whitney; Lupton, Terri; Martin, Liam; Barr, Susan G.; Mosher, Dianne P.; Wick, James; Fritzler, Marvin J.] Univ Calgary, Fac Med, Calgary, AB, Canada; [Mahler, Michael] INOVA Diagnost Inc, San Diego, CA USA	University of Calgary; Inova Diagnostics, Inc.	Fritzler, MJ (corresponding author), Univ Calgary, Fac Med, Calgary, AB, Canada.	fritzler@ucalgary.ca		Wick, James/0000-0002-1210-5294; Addison, Christie/0000-0001-8346-3884	Mitogen Advanced Diagnostics Laboratory; University of Calgary, Division of Rheumatology, at the University of Calgary	Mitogen Advanced Diagnostics Laboratory; University of Calgary, Division of Rheumatology, at the University of Calgary	This project was funded and supported by resources from Mitogen Advanced Diagnostics Laboratory and as well as funds allocated to the Arthritis Society Research Chair by the University of Calgary, Division of Rheumatology, at the University of Calgary. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles AM, 2013, AM J MED, V126, P342, DOI 10.1016/j.amjmed.2012.09.014; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Bellando-Randone S, 2012, POL ARCH MED WEWN, V122, P18, DOI 10.20452/pamw.1487; Bonaguri C, 2011, AUTOIMMUN REV, V11, P1, DOI 10.1016/j.autrev.2011.06.006; Bonaguri C, 2009, ANN NY ACAD SCI, V1173, P124, DOI 10.1111/j.1749-6632.2009.04635.x; Bossuyt X, 2008, ANN RHEUM DIS, V67, P1061, DOI 10.1136/ard.2007.084228; CONRAD K, 2007, ETIOPATHOGENESIS PRE, P16; Emery P, 2002, ANN RHEUM DIS, V61, P290, DOI 10.1136/ard.61.4.290; Esdaile JM, 1996, J RHEUMATOL, V23, P1891; Fritzler M.J., 2011, PREDICTION PREVENTIO, P584; Fritzler MJ, 2012, AUTOIMMUN HIGHLIGHTS, V3, P51, DOI 10.1007/s13317-012-0030-7; Fritzler MJ, 2011, ARTHRITIS RHEUM-US, V63, P19, DOI 10.1002/art.30078; Funovits J, 2010, ANN RHEUM DIS, V69, P1589, DOI 10.1136/ard.2010.130310; Gamez-Nava JI, 1998, BRIT J RHEUMATOL, V37, P1215; Gormley GJ, 2003, RHEUMATOLOGY, V42, P763, DOI 10.1093/rheumatology/keg213; Gran JT, 2000, CLIN RHEUMATOL, V19, P450, DOI 10.1007/s100670070004; Heinlen LD, 2007, ARTHRITIS RHEUM, V56, P2344, DOI 10.1002/art.22665; Johnson SR, 2012, ARTHRIT CARE RES, V64, P358, DOI 10.1002/acr.20684; JUBY A, 1991, J RHEUMATOL, V18, P354; Kavanaugh AF, 2002, ARTHRIT RHEUM-ARTHR, V47, P546, DOI 10.1002/art.10558; Lard LR, 2001, AM J MED, V111, P446, DOI 10.1016/S0002-9343(01)00872-5; Lateef A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3919; Lyons PA, 2012, NEW ENGL J MED, V367, P214, DOI 10.1056/NEJMoa1108735; Lyons R, 2005, ANN NY ACAD SCI, V1050, P217, DOI 10.1196/annals.1313.023; Mahler M, 2012, J RHEUMATOL, V39, P2104, DOI 10.3899/jrheum.120598; Mahler M, 2012, AUTOIMMUN REV, V11, P642, DOI 10.1016/j.autrev.2011.11.005; Mahler M, 2010, ANN NY ACAD SCI, V1183, P267, DOI 10.1111/j.1749-6632.2009.05127.x; Man A, 2013, CLIN RHEUMATOL, V32, P601, DOI 10.1007/s10067-012-2141-y; Mariz HA, 2011, ARTHRITIS RHEUM-US, V63, P191, DOI 10.1002/art.30084; Meacock R, 2013, PHARMACOECONOMICS, V31, P49, DOI 10.1007/s40273-012-0007-4; Miyara M, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/703759; Muro Y, 2008, LUPUS, V17, P171, DOI 10.1177/0961203307086311; Narain S, 2004, ARCH INTERN MED, V164, P2435, DOI 10.1001/archinte.164.22.2435; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Qian JY, 2010, RHEUMATOL INT, V30, P705, DOI 10.1007/s00296-009-1297-5; SHIEL WC, 1989, J RHEUMATOL, V16, P782; Shoenfeld Y, 2007, ANN NY ACAD SCI, V1109, P138, DOI 10.1196/annals.1398.016; Shojania K, 2000, CAN MED ASSOC J, V162, P1157; Solomon DH, 2002, ARTHRIT RHEUM-ARTHR, V47, P434, DOI 10.1002/art.10561; Stinton LM, 2007, LUPUS, V16, P394, DOI 10.1177/0961203307078391; Stinton LM, 2007, AUTOIMMUN REV, V7, P77, DOI 10.1016/j.autrev.2007.08.003; Suarez-Almazor ME, 1998, J RHEUMATOL, V25, P1980; Tampoia M, 2003, CLIN CHIM ACTA, V333, P181, DOI 10.1016/S0009-8981(03)00183-9; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; Trouw LA, 2012, AUTOIMMUN REV, V12, P318, DOI 10.1016/j.autrev.2012.05.007; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; Vlachoyiannopoulos PG, 1998, J RHEUMATOL, V25, P886; VONMUHLEN CA, 1995, SEMIN ARTHRITIS RHEU, V24, P323, DOI 10.1016/S0049-0172(95)80004-2; Watanabe A, 2004, ARTHRITIS RHEUM-US, V50, P892, DOI 10.1002/art.20096; Wiik AS, 2012, AUTOIMMUN HIGHLIGHTS, V3, P35, DOI 10.1007/s13317-012-0029-0; Wiik AS, 2005, SCAND J RHEUMATOL, V34, P260, DOI 10.1080/03009740500202664; Wiik AS, 2004, ARTHRIT RHEUM-ARTHR, V51, P291, DOI 10.1002/art.20229; Wiles NJ, 2001, ARTHRITIS RHEUM-US, V44, P1033, DOI 10.1002/1529-0131(200105)44:5<1033::AID-ANR182>3.3.CO;2-7; Yang P, 2012, CURR OPIN OPHTHALMOL, V23, P528, DOI 10.1097/ICU.0b013e328358b937; Yazdany J, 2013, ARTHRIT CARE RES, V65, P329, DOI 10.1002/acr.21930	55	54	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93812	10.1371/journal.pone.0093812	http://dx.doi.org/10.1371/journal.pone.0093812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705829	Green Submitted, Green Published, gold			2022-12-27	WOS:000334107500068
J	Li, L; Liu, H; Cheng, HJ; Han, YZ; Wang, CL; Chen, Y; Song, JL; Liu, DX				Li, Liang; Liu, Hong; Cheng, Huijuan; Han, Yanzhao; Wang, Chunling; Chen, Yu; Song, Jinlin; Liu, Dongxu			CBCT Evaluation of the Upper Airway Morphological Changes in Growing Patients of Class II Division 1 Malocclusion with Mandibular Retrusion Using Twin Block Appliance: A Comparative Research	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; HYOID BONE POSITION; CEPHALOMETRIC EVALUATION; SUPERIMPOSITION; ADVANCEMENT; GROWTH	Objective: The purpose of this study was to evaluate the morphological changes of upper airway after Twin Block (TB) treatment in growing patients with Class II division 1 malocclusion and mandibular retrusion compared with untreated Class II patients by cone beam computed tomography (CBCT). Materials and Methods: Thirty growing patients who have completed TB treatment were recruited into TB group. The control group (n = 30) was selected from the patients with the same diagnosis and without TB treatment. CBCT scans of the pre-treatment (T1) and post-treatment (T2) data of TB group and control data were collected. After three-dimensional (3D) reconstruction and registration of T1 and T2 data, the morphological changes of upper airway during TB treatment were measured. The statistical differences between T1 and T2 data of TB group as well as T2 and control data were accessed by t-test. Results: During the TB treatment, the mandible moved advanced by 3.52 +/- 2.14 mm in the horizontal direction and 3.77 +/- 2.10 mm in the vertical direction. The hyoid bone was in a more forward and inferior place. The upper airway showed a significant enlargement in nasopharynx, oropharynx and hypopharynx. In addition, the nasopharynx turned more circular, and the oropharynx became more elliptic in transverse shape. However, the transverse shape of the hypopharynx showed no significant difference. After comparison between T2 and control data, only the horizontal movement of the hyoid bone, the volumetric expansion of the oropharynx and hypopharynx, and changes of the oropharyngeal transverse shape showed significant difference. Conclusion: Compared to the untreated Class II patients, the upper airway of growing patients with Class II division 1 malocclusion and mandibular retrusion showed a significant enlargement in the oropharynx and hypopharynx as well as a more elliptic transverse shape in the oropharynx, and the hyoid bone moved to an anterior position after TB treatment.	[Li, Liang; Cheng, Huijuan; Han, Yanzhao; Wang, Chunling; Chen, Yu; Liu, Dongxu] Shandong Univ, Sch Dent, Shandong Prov Key Lab Oral Biomed, Dept Orthodont, Jinan 250100, Peoples R China; [Liu, Hong] Shandong Univ, Sch Dent, Dept Orthodont, Jinan 250100, Peoples R China; [Song, Jinlin] Chongqing Med Univ, Affiliated Hosp Stomatol, Dept Orthodont, Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China	Shandong University; Shandong University; Chongqing Medical University	Song, JL (corresponding author), Chongqing Med Univ, Affiliated Hosp Stomatol, Dept Orthodont, Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China.	soongjl@163.com; liudongxu@sdu.edu.cn			National Creative Project Contract Research [201310422049]; Shandong Science and Technology Planning Project Contract Research [2010G0020232, 2010HM053, 2050205]; Shandong University Dental School Project Research of China [P2009008, P2009010]	National Creative Project Contract Research; Shandong Science and Technology Planning Project Contract Research; Shandong University Dental School Project Research of China	The study was supported by grants from National Creative Project Contract Research (201310422049), Shandong Science and Technology Planning Project Contract Research (2010G0020232 and 2010HM053, 2050205) and Shandong University Dental School Project Research (P2009008, P2009010) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkarim A., 2012, JWFO, V1, P55; Baccetti T, 1997, AM J ORTHOD DENTOFAC, V111, P502, DOI 10.1016/S0889-5406(97)70287-7; BIBBY RE, 1981, AM J ORTHOD DENTOFAC, V80, P92, DOI 10.1016/0002-9416(81)90199-8; Cevidanes LHC, 2009, AM J ORTHOD DENTOFAC, V136, P94, DOI 10.1016/j.ajodo.2009.01.018; Chen Y, 2012, ANGLE ORTHOD, V82, P964, DOI 10.2319/110211-675.1; Deng Jin-rong, 2010, Beijing Da Xue Xue Bao Yi Xue Ban, V42, P697; Eggensperger N, 2005, ORAL SURG ORAL MED O, V99, P404, DOI 10.1016/j.tripleo.2004.07.019; El H, 2011, AM J ORTHOD DENTOFAC, V139, pE511, DOI 10.1016/j.ajodo.2011.02.015; Fogel RB, 2003, SLEEP, V26, P150, DOI 10.1093/sleep/26.2.150; Gao Xue-Mei, 2005, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V40, P137; GHAFARI J, 1987, AM J ORTHOD DENTOFAC, V91, P403, DOI 10.1016/0889-5406(87)90393-3; Haskell JA., 2009, SEMIN ORTHOD, V15, P132; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Jena AK, 2006, AM J ORTHOD DENTOFAC, V130, P594, DOI 10.1016/j.ajodo.2005.02.025; Johal A, 2004, ANGLE ORTHOD, V74, P648; Johnston CD, 1999, EUR J ORTHODONT, V21, P357, DOI 10.1093/ejo/21.4.357; Lenza MG, 2010, ORTHOD CRANIOFAC RES, V13, P96, DOI 10.1111/j.1601-6343.2010.01482.x; Li CT, 2006, J MED, V41, P25; Liu H, 2011, AM J ORTHOD DENTOFAC, V139, DOI 10.1016/j.ajodo.2010.07.018; Liu H, 2010, AM J ORTHOD DENTOFAC, V137, P728, DOI 10.1016/j.ajodo.2010.02.002; LOWE AA, 1986, AM J ORTHOD DENTOFAC, V90, P484, DOI 10.1016/0889-5406(86)90108-3; Major MP, 2006, AM J ORTHOD DENTOFAC, V130, P700, DOI 10.1016/j.ajodo.2005.05.050; Melsen B, 1974, ACTA ODONTOL SCA S62, V32, P86; Muto T, 2008, INT J ORAL MAX SURG, V37, P228, DOI 10.1016/j.ijom.2007.06.020; Nelogi S, 2011, J PROSTHODONT RES, V55, P179, DOI 10.1016/j.jpor.2010.09.008; Ogutcen-Toller M, 2004, J PROSTHET DENT, V92, P184, DOI 10.1016/j.prosdent.2004.05.003; SCHEERER WD, 1980, ARCH OTO-RHINO-LARYN, V229, P221, DOI 10.1007/BF02565525; Sheng CM, 2009, ANGLE ORTHOD, V79, P484, DOI 10.2319/062308-328.1; Trenouth MJ, 2000, AM J ORTHOD DENTOFAC, V117, P54, DOI 10.1016/S0889-5406(00)70248-4; Tsai Hung-Huey, 2002, J Clin Pediatr Dent, V27, P29; Tsai HH, 2007, ANGLE ORTHOD, V77, P1054, DOI 10.2319/112106-477.1; Vieira BB, 2011, INT J PEDIATR OTORHI, V75, P383, DOI 10.1016/j.ijporl.2010.12.010	32	30	36	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94378	10.1371/journal.pone.0094378	http://dx.doi.org/10.1371/journal.pone.0094378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705466	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500139
J	Ogata-Kawata, H; Izumiya, M; Kurioka, D; Honma, Y; Yamada, Y; Furuta, K; Gunji, T; Ohta, H; Okamoto, H; Sonoda, H; Watanabe, M; Nakagama, H; Yokota, J; Kohno, T; Tsuchiya, N				Ogata-Kawata, Hiroko; Izumiya, Masashi; Kurioka, Daisuke; Honma, Yoshitaka; Yamada, Yasuhide; Furuta, Koh; Gunji, Toshiaki; Ohta, Hideki; Okamoto, Hiroyuki; Sonoda, Hikaru; Watanabe, Masatoshi; Nakagama, Hitoshi; Yokota, Jun; Kohno, Takashi; Tsuchiya, Naoto			Circulating Exosomal microRNAs as Biomarkers of Colon Cancer	PLOS ONE			English	Article							PROGNOSTIC BIOMARKER; COLORECTAL-CANCER; PLASMA; DYSREGULATION; SIGNATURES; MARKERS; MIR-221; MIRNAS; GROWTH	Purpose: Exosomal microRNAs (miRNAs) have been attracting major interest as potential diagnostic biomarkers of cancer. The aim of this study was to characterize the miRNA profiles of serum exosomes and to identify those that are altered in colorectal cancer (CRC). To evaluate their use as diagnostic biomarkers, the relationship between specific exosomal miRNA levels and pathological changes of patients, including disease stage and tumor resection, was examined. Experimental Design: Microarray analyses of miRNAs in exosome-enriched fractions of serum samples from 88 primary CRC patients and 11 healthy controls were performed. The expression levels of miRNAs in the culture medium of five colon cancer cell lines were also compared with those in the culture medium of a normal colon-derived cell line. The expression profiles of miRNAs that were differentially expressed between CRC and control sample sets were verified using 29 paired samples from post-tumor resection patients. The sensitivities of selected miRNAs as biomarkers of CRC were evaluated and compared with those of known tumor markers (CA19-9 and CEA) using a receiver operating characteristic analysis. The expression levels of selected miRNAs were also validated by quantitative real-time RT-PCR analyses of an independent set of 13 CRC patients. Results: The serum exosomal levels of seven miRNAs (let-7a, miR-1229, miR-1246, miR-150, miR-21, miR-223, and miR-23a) were significantly higher in primary CRC patients, even those with early stage disease, than in healthy controls, and were significantly down-regulated after surgical resection of tumors. These miRNAs were also secreted at significantly higher levels by colon cancer cell lines than by a normal colon-derived cell line. The high sensitivities of the seven selected exosomal miRNAs were confirmed by a receiver operating characteristic analysis. Conclusion: Exosomal miRNA signatures appear to mirror pathological changes of CRC patients and several miRNAs are promising biomarkers for non-invasive diagnosis of the disease.	[Ogata-Kawata, Hiroko; Kurioka, Daisuke; Yokota, Jun; Kohno, Takashi; Tsuchiya, Naoto] Natl Canc Ctr, Res Inst, Div Genome Biol, Tokyo 104, Japan; [Nakagama, Hitoshi] Natl Canc Ctr, Res Inst, Div Canc Dev Syst, Tokyo 104, Japan; [Izumiya, Masashi] Tokyo Univ Hosp, Dept Gastroenterol, Tokyo 113, Japan; [Kurioka, Daisuke; Watanabe, Masatoshi] Yokohama Natl Univ, Grad Sch Engn, Div Mat & Chem Engn, Med Engn Lab, Yokohama, Kanagawa, Japan; [Honma, Yoshitaka; Yamada, Yasuhide] Natl Canc Ctr, Gastrointestinal Oncol Div, Tokyo, Japan; [Furuta, Koh] Natl Canc Ctr, Div Clin Labs, Tokyo, Japan; [Gunji, Toshiaki] NTT Med Ctr Tokyo, Tokyo, Japan; [Ohta, Hideki; Okamoto, Hiroyuki; Sonoda, Hikaru] Shionogi & Co Ltd, Osaka, Japan; [Yokota, Jun] Inst Predict & Personalized Med Canc IMPPC, Barcelona, Spain	National Cancer Center - Japan; National Cancer Center - Japan; University of Tokyo; Yokohama National University; National Cancer Center - Japan; National Cancer Center - Japan; Kanto Medical Center NTT EC; Shionogi & Company Limited	Tsuchiya, N (corresponding author), Natl Canc Ctr, Res Inst, Div Genome Biol, Tokyo 104, Japan.	ntsuchiy@ncc.go.jp	Yamada, Yasuhide/AAH-9124-2020; Izumiya, Masashi/AAL-3763-2020	Watanabe, Masatoshi/0000-0002-9423-0901	Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) [08-02]; Ministry of Health, Labor and Welfare [13802015]; Ministry of Education, Culture, Sports & Technology of Japan [13314780]; National Cancer Center Research and Development Fund [23-B-08]; National Cancer Center Research and Development Fund; Grants-in-Aid for Scientific Research [23300359] Funding Source: KAKEN	Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports & Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding provided by The Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO)(08-02), http://www.nibio.go.jp; Grant-in-Aids from the Ministry of Health, Labor and Welfare (13802015), http://www.mhlw.go.jp/; Grant-in-Aids from the Ministry of Education, Culture, Sports & Technology of Japan (13314780), http://www.jsps.go.jp/; National Cancer Center Research and Development Fund (23-B-08), http://www.ncc.go.jp. National Cancer Center Biobank is supported by National Cancer Center Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 2013, J CELL BIOCHEM, V114, P2160, DOI 10.1002/jcb.24565; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; BOYD D, 1988, CANCER RES, V48, P3112; Bretthauer M, 2010, BEST PRACT RES CL GA, V24, P417, DOI 10.1016/j.bpg.2010.06.005; CHEN TR, 1987, CANCER GENET CYTOGEN, V27, P125, DOI 10.1016/0165-4608(87)90267-6; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Hu Guoku, 2012, Frontiers in Genetics, V3, P56, DOI 10.3389/fgene.2012.00056; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Izumiya M, 2010, CARCINOGENESIS, V31, P1354, DOI 10.1093/carcin/bgq112; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kawaguchi T, 2013, BRIT J CANCER, V108, P361, DOI 10.1038/bjc.2012.546; Koberle V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075184; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo XY, 2011, CANCER EPIDEM BIOMAR, V20, P1272, DOI 10.1158/1055-9965.EPI-11-0035; Madhavan D, 2012, CLIN CANCER RES, V18, P5972, DOI 10.1158/1078-0432.CCR-12-1407; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Ogawa Y, 2008, BIOL PHARM BULL, V31, P1059, DOI 10.1248/bpb.31.1059; Pu XX, 2010, J GASTROEN HEPATOL, V25, P1674, DOI 10.1111/j.1440-1746.2010.06417.x; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Scheffer AR, 2012, WORLD J UROL; Si HY, 2013, J CANCER RES CLIN, V139, P223, DOI 10.1007/s00432-012-1315-y; SIDDIQUI KM, 1984, IN VITRO CELL DEV B, V20, P859; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Takeshita N, 2013, BRIT J CANCER, V108, P644, DOI 10.1038/bjc.2013.8; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang XF, 2012, J CANCER RES CLIN, V138, P573, DOI 10.1007/s00432-011-1114-x	37	589	615	8	166	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92921	10.1371/journal.pone.0092921	http://dx.doi.org/10.1371/journal.pone.0092921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705249	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500022
J	Schwarzenberg, R; Freisleben, B; Nimsky, C; Egger, J				Schwarzenberg, Robert; Freisleben, Bernd; Nimsky, Christopher; Egger, Jan			Cube-Cut: Vertebral Body Segmentation in MRI-Data through Cubic-Shaped Divergences	PLOS ONE			English	Article							IMAGES; SYSTEM	In this article, we present a graph-based method using a cubic template for volumetric segmentation of vertebrae in magnetic resonance imaging (MRI) acquisitions. The user can define the degree of deviation from a regular cube via a smoothness value D. The Cube-Cut algorithm generates a directed graph with two terminal nodes (s-t-network), where the nodes of the graph correspond to a cubic-shaped subset of the image's voxels. The weightings of the graph's terminal edges, which connect every node with a virtual source s or a virtual sink t, represent the affinity of a voxel to the vertebra (source) and to the background (sink). Furthermore, a set of infinite weighted and non-terminal edges implements the smoothness term. After graph construction, a minimal s-t-cut is calculated within polynomial computation time, which splits the nodes into two disjoint units. Subsequently, the segmentation result is determined out of the source-set. A quantitative evaluation of a C++ implementation of the algorithm resulted in an average Dice Similarity Coefficient (DSC) of 81.33% and a running time of less than a minute.	[Schwarzenberg, Robert; Freisleben, Bernd; Egger, Jan] Univ Marburg, Dept Math & Comp Sci, Marburg, Germany; [Nimsky, Christopher; Egger, Jan] Univ Hosp Marburg, Dept Neurosurg, Marburg, Germany	Philipps University Marburg; University Hospital of Giessen & Marburg	Egger, J (corresponding author), Univ Marburg, Dept Math & Comp Sci, Marburg, Germany.	egger@med.uni-marburg.de	Nimsky, Christopher/E-3702-2014	Nimsky, Christopher/0000-0002-8216-9410; Schwarzenberg, Robert/0000-0002-8819-1635; Freisleben, Bernd/0000-0002-7205-8389				Aslan M. S., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3951, DOI 10.1109/ICPR.2010.961; Bauer M. H. A., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P4016, DOI 10.1109/ICPR.2010.1155; Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; Carballido-Gamio J, 2004, IEEE T MED IMAGING, V23, P36, DOI 10.1109/TMI.2003.819929; Chen M., 2010, BASIC RADIOLOGY; Drake R., 2009, GRAYS ANATOMY STUDEN; Egger J., 2008, 4th European Conference of the International Federation for Medical and Biological Engineering - ECIFMBE 2008, P584; Egger J, 2014, COMPUT MED IMAGING G; Egger J, 2012, 5 NCIGT NIH IM GUID, P43; Egger J., 2010, LNCS, V6376, P383; Egger J., 2009, 12 INT C MED IM COMP; Egger J, 2012, SCI REPORTS, V2, P1; Egger J, 2013, JAHR SEKT WIRB DTSCH; Egger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076645; Egger J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01364; Egger J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051788; Egger J, 2012, J MED SYST, V36, P2829, DOI 10.1007/s10916-011-9761-7; Egger J, 2012, J MED SYST, V36, P2097, DOI 10.1007/s10916-011-9673-6; Egger J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031064; Ghebreab S, 2004, IEEE T BIO-MED ENG, V51, P1821, DOI 10.1109/TBME.2004.831540; GREIG DM, 1989, J ROY STAT SOC B MET, V51, P271, DOI 10.1111/j.2517-6161.1989.tb01764.x; Hoad CL, 2002, PHYS MED BIOL, V47, P3503, DOI 10.1088/0031-9155/47/19/305; Huang SH, 2009, IEEE T MED IMAGING, V28, P1595, DOI 10.1109/TMI.2009.2023362; Joaquim AF, 2009, ARQ NEURO-PSIQUIAT, V67, P553, DOI 10.1590/S0004-282X2009000300039; Kelm BM, 2011, LECT NOTES COMPUT SC, V6533, P96, DOI 10.1007/978-3-642-18421-5_10; Klinder T, 2008, LECT NOTES COMPUT SC, V5241, P227, DOI 10.1007/978-3-540-85988-8_28; Li K, 2006, IEEE T PATTERN ANAL, V28, P119, DOI 10.1109/TPAMI.2006.19; Miao J, 2013, EUR SPINE J, V22, P425, DOI 10.1007/s00586-012-2428-3; Michopoulou SK, 2009, IEEE T BIO-MED ENG, V56, P2225, DOI 10.1109/TBME.2009.2019765; Peng ZG, 2005, P ANN INT IEEE EMBS, P2527; Sampat M. P., 2006, IEEE INT C IM PROC; Schwarzenberg R., 2013, P BILDV MED BVM, P69; Schwarzenberg R, 2012, 5 NCIGT NIH IM GUID, P44; Shi RQ, 2007, 2007 IEEE/ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING, VOLS 1-4, P713, DOI 10.1109/ICCME.2007.4381830; Stern D, 2011, P SPIE MED IMAGING, V7963; Veksler O, 2008, STAR SHAPE PRIOR GRA; Vezhnevets V., 2005, P GRAPH, V1, P150, DOI DOI 10.1016/J.AJ0D0.2004.07.036; Weese J., 2001, Information Processing in Medical Imaging. 17th International Conference, IPMI 2001. Proceedings (Lecture Notes in Computer Science Vol.2082), P380; Weinstein JN, 2007, NEW ENGL J MED, V356, P2257, DOI 10.1056/NEJMoa070302; Yao JH, 2006, I S BIOMED IMAGING, P390; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8; Zukic D, 2014, COMPUTER GRAPHICS FO; Zukic D, 2012, VISION MODELING VISU, P135, DOI DOI 10.2312/PE/VMV/VMV12/135-142	43	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93389	10.1371/journal.pone.0093389	http://dx.doi.org/10.1371/journal.pone.0093389			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705281	Green Submitted, gold, Green Published			2022-12-27	WOS:000334107500035
J	Yang, K; Xu, JF; Zhang, JF; Li, W; He, J; Liang, S; Bergquist, R				Yang, Kun; Xu, Jun-Fang; Zhang, Jian-Feng; Li, Wei; He, Jian; Liang, Song; Bergquist, Robert			Establishing and Applying a Schistosomiasis Early Warning Index (SEWI) in the Lower Yangtze River Region of Jiangsu Province, China	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; ONCOMELANIA-HUPENSIS; JAPONICA; TRANSMISSION; SURVEILLANCE; ELIMINATION; SYSTEM; HEALTH; DETERMINANTS; CHALLENGES	Background: China has made remarkable progress in schistosomiasis control over the past decades. Transmission control has replaced morbidity control as the country moves towards the goal of elimination and the current challenge is to find a sensitive measure capable of gauging transmission risk in low-prevalence areas. The study aims to develop a Schistosomiasis Early Warning Index (SEWI) and demonstrate its use in Jiangsu Province along the lower Yangtze River. Methodology/Principal Findings: The Delphi approach, a structured communication technique, was used to develop the SEWI. Two rounds of interviews with 30 public health experts specialized in schistosomiasis control were conducted using 40 indicators that reflected different aspects of schistosomiasis transmission and control. The necessity, feasibility, and sensitivity of each indicator were assessed and the weight value of each indicator determined based on these experts' judgment. The system included 3 first-order indicators, 7 second-order indicators, and 30 third-order indicators. The 3 first-order indicators were endemic status, control measures, social and environmental factors, with the weight values 0.366, 0.343 and 0.291, respectively. For the 7 second-order indicators, the highest weight value was for control measures for snails (0.175) and the lowest for transmission route (0.110). We estimated and mapped the SEWI for endemic areas at the county scale in Jiangsu Province finding that the majority of the endemic areas were characterized as medium transmission risk (SEWI risk values between 0.3 and 0.6), while areas where transmission interruption had been officially declared showed SEWI values <0.30. A few isolated areas (e. g. endemic islands in the Yangtze River) produced SEWI values >0.60. These estimates are largely in agreement with the endemicity levels based on recent epidemiological surveys. Conclusions/Significance: The SEWI should be useful for estimation of schistosomiasis transmission surveillance, particularly with reference to the elimination of the disease in China.	[Yang, Kun; Zhang, Jian-Feng; Li, Wei; He, Jian] Jiangsu Inst Parasit Dis, Key Lab Parasit Dis Control & Prevent, Minist Health, Jiangsu Prov Key Lab Parasite Mol Biol, Wuxi, Jiangsu, Peoples R China; [Xu, Jun-Fang] Hubei Univ Nationalities, Sch Med, Enshi, Hubei Province, Peoples R China; [Liang, Song] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Liang, Song] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	Hubei Minzu University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Yang, K (corresponding author), Jiangsu Inst Parasit Dis, Key Lab Parasit Dis Control & Prevent, Minist Health, Jiangsu Prov Key Lab Parasite Mol Biol, Wuxi, Jiangsu, Peoples R China.	jipdyk76@hotmail.com		yang, kun/0000-0001-8198-132X	National Natural Science Foundation of China [81101275, 81101280]; Natural Science Foundation of Jiangsu Province [BS2010153]; Project of Public Health Department of Jiangsu Province [RC2011094]; Chinese Important Scientific Research Project on Infectious Diseases [2012ZX10004-220]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Project of Public Health Department of Jiangsu Province; Chinese Important Scientific Research Project on Infectious Diseases	This work received financial support from the National Natural Science Foundation of China (No. 81101275; 81101280), Natural Science Foundation of Jiangsu Province (BS2010153), Project of Public Health Department of Jiangsu Province (No. RC2011094), and the Chinese Important Scientific Research Project on Infectious Diseases (No. 2012ZX10004-220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Coates V, 2001, TECHNOL FORECAST SOC, V67, P1, DOI 10.1016/S0040-1625(00)00122-0; Collins C, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-8; Drake JM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000020; Gavaza P, 2012, RURAL REMOTE HEALTH, V12; Gray DJ, 2010, LANCET INFECT DIS, V10, P733, DOI 10.1016/S1473-3099(10)70099-2; Green K., 2007, FORESIGHT INT J APPL, V8, P17; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hong QB, 2011, ACTA TROP, V120, pS151, DOI 10.1016/j.actatropica.2010.11.006; HUANG YX, 1992, ACTA TROP, V51, P175, DOI 10.1016/0001-706X(92)90037-X; Huang YX, 2005, ACTA TROP, V96, P223, DOI 10.1016/j.actatropica.2005.07.015; King CH, 2009, NEW ENGL J MED, V360, P106, DOI 10.1056/NEJMp0808041; Landeta J, 2006, TECHNOL FORECAST SOC, V73, P467, DOI 10.1016/j.techfore.2005.09.002; Liang S, 2006, B WORLD HEALTH ORGAN, V84, P139, DOI 10.2471/BLT.05.025031; Liang You-Sheng, 2012, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V24, P119; Luo TianPeng, 2009, Chinese Journal of Schistosomiasis Control, V21, P27; Morse SS, 2012, BIOSECUR BIOTERROR, V10, P6, DOI 10.1089/bsp.2011.0088; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Rudge JW, 2013, P NATL ACAD SCI USA, V110, P11457, DOI 10.1073/pnas.1221509110; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Sun LP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-243; Sun LP, 2008, CHIN J SCHISTO CONTR, V20, P13; Sun LP, 2012, CHIN J SCHISTO CONTR, P32; Uphoff EPMM, 2012, CANCER NURS, V35, P29, DOI 10.1097/NCC.0b013e318210e3a2; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; Wang L, 2008, LANCET; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; Wang TP, 2005, ACTA TROP, V96, P198, DOI 10.1016/j.actatropica.2005.07.017; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; Wu XH, 2007, GEOSPATIAL HEALTH, V2, P75, DOI 10.4081/gh.2007.256; Xu Jing, 2013, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V25, P5; Yang J, 2009, INT J INFECT DIS; Yang K, 2008, INT J PARASITOL, V38, P1007, DOI 10.1016/j.ijpara.2007.12.007; Yang K, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-138; Yang K, 2012, GEOSPATIAL HEALTH, V6, P195, DOI 10.4081/gh.2012.137; Yang K, 2009, AM J TROP MED HYG, V81, P416, DOI 10.4269/ajtmh.2009.81.416; Yi YA, 2005, ACTA TROP, V96, P191, DOI 10.1016/j.actatropica.2005.07.014; Yu Hao, 1996, Chinese Journal of Schistosomiasis Control, V8, P263; Yu LeiBin, 2006, Chinese Journal of Schistosomiasis Control, V18, P146; YUAN HC, 1993, CHINESE MED J-PEKING, V106, P563; Zhao GM, 2005, ACTA TROP, V96, P288, DOI 10.1016/j.actatropica.2005.07.023; Zheng Q, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-15; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhou XN, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-1; Zhou XN, 2010, ADV PARASIT, V72, P145, DOI 10.1016/S0065-308X(10)72006-6; Zhou XN, 2005, ACTA TROP, V96, P255, DOI 10.1016/j.actatropica.2005.07.026	47	7	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94012	10.1371/journal.pone.0094012	http://dx.doi.org/10.1371/journal.pone.0094012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705352	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500111
J	Chavez-Alvarez, R; Chavoya, A; Mendez-Vazquez, A				Chavez-Alvarez, Rocio; Chavoya, Arturo; Mendez-Vazquez, Andres			Discovery of Possible Gene Relationships through the Application of Self-Organizing Maps to DNA Microarray Databases	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; REGULATORY NETWORKS; EXPRESSION; TRANSCRIPTION; IDENTIFICATION; MODELS; PHASE	DNA microarrays and cell cycle synchronization experiments have made possible the study of the mechanisms of cell cycle regulation of Saccharomyces cerevisiae by simultaneously monitoring the expression levels of thousands of genes at specific time points. On the other hand, pattern recognition techniques can contribute to the analysis of such massive measurements, providing a model of gene expression level evolution through the cell cycle process. In this paper, we propose the use of one of such techniques -an unsupervised artificial neural network called a Self-Organizing Map (SOM)-which has been successfully applied to processes involving very noisy signals, classifying and organizing them, and assisting in the discovery of behavior patterns without requiring prior knowledge about the process under analysis. As a test bed for the use of SOMs in finding possible relationships among genes and their possible contribution in some biological processes, we selected 282 S. cerevisiae genes that have been shown through biological experiments to have an activity during the cell cycle. The expression level of these genes was analyzed in five of the most cited time series DNA microarray databases used in the study of the cell cycle of this organism. With the use of SOM, it was possible to find clusters of genes with similar behavior in the five databases along two cell cycles. This result suggested that some of these genes might be biologically related or might have a regulatory relationship, as was corroborated by comparing some of the clusters obtained with SOMs against a previously reported regulatory network that was generated using biological knowledge, such as protein-protein interactions, gene expression levels, metabolism dynamics, promoter binding, and modification, regulation and transport of proteins. The methodology described in this paper could be applied to the study of gene relationships of other biological processes in different organisms.	[Chavez-Alvarez, Rocio; Chavoya, Arturo] Univ Guadalajara, Dept Informat Syst CUCEA, Zapopan, Jalisco, Mexico; [Mendez-Vazquez, Andres] CINVESTAV, Dept Elect Engn & Comp Sci, Zapopan, Jalisco, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Chavoya, A (corresponding author), Univ Guadalajara, Dept Informat Syst CUCEA, Zapopan, Jalisco, Mexico.	achavoya@cucea.udg.mx		Chavez, Rocio/0000-0003-2012-0248	CONACYT	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was funded by a CONACYT Scholarship for PhD Student Rocio Chavez-Alvarez. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Abbas O, 2008, INT ARAB J INF TECHN, V5, P320; Alberghina L, 2012, BIOTECHNOL ADV, V30, P52, DOI 10.1016/j.biotechadv.2011.07.010; Alberghina L, 2009, BIOTECHNOL ADV, V27, P960, DOI 10.1016/j.biotechadv.2009.05.021; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Cho KH, 2007, IET SYST BIOL, V1, P149, DOI 10.1049/iet-syb:20060075; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; D'haeseleer P, 1999, Pac Symp Biocomput, P41; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gaisne M, 1999, CURR GENET, V36, P195, DOI 10.1007/s002940050490; Hamalainen TD, 2002, STUD FUZZ SOFT COMP, V78, P245; Hancioglu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030810; He F, 2009, J BIOTECHNOL, V144, P190, DOI 10.1016/j.jbiotec.2009.07.013; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Huang JH, 2003, J BIOSCI BIOENG, V96, P421, DOI 10.1263/jbb.96.421; Khan SQ, 2013, 5 INT C COMP SCI INF, DOI [10.1109/CSIT.2013.6588785, DOI 10.1109/CSIT.2013.6588785]; Kim H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-37; Kimura S, 2005, BIOINFORMATICS, V21, P1154, DOI 10.1093/bioinformatics/bti071; Kohonen T, 1998, NEUROCOMPUTING, V21, P1, DOI 10.1016/S0925-2312(98)00030-7; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Pozlbauer G., 2004, P 5 WORKSH DAT AN WD, P67; Pramila T, 2002, GENE DEV, V16, P3034, DOI 10.1101/gad.1034302; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Repsilber D, 2002, BIOSYSTEMS, V66, P31, DOI 10.1016/S0303-2647(02)00019-9; Singh R, 2012, APPLIED WELDING ENGINEERING: PROCESSES, CODES AND STANDARDS, P7; Sokhansanj BA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-108; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Vesanto J., 1999, P MATL DSP C, V99, P16; Zou M, 2005, BIOINFORMATICS, V21, P71, DOI 10.1093/bioinformatics/bth463	33	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93233	10.1371/journal.pone.0093233	http://dx.doi.org/10.1371/journal.pone.0093233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699245	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000048
J	Fuchs, L; Novack, V; McLennan, S; Celi, LA; Baumfeld, Y; Park, S; Howell, MD; Talmor, DS				Fuchs, Lior; Novack, Victor; McLennan, Stuart; Celi, Leo Anthony; Baumfeld, Yael; Park, Shinhyuk; Howell, Michael D.; Talmor, Daniel S.			Trends in Severity of Illness on ICU Admission and Mortality among the Elderly	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ADMINISTRATIVE DATA; NEW-ZEALAND; MULTICENTER; SURVIVAL; SEPSIS; STATES; EPIDEMIOLOGY; AUSTRALIA	Background: There is an increase in admission rate for elderly patients to the ICU. Mortality rates are lower when more liberal ICU admission threshold are compared to more restrictive threshold. We sought to describe the temporal trends in elderly admissions and outcomes in a tertiary hospital before and after the addition of an 8-bed medical ICU. Methods: We conducted a retrospective analysis of a comprehensive longitudinal ICU database, from a large tertiary medical center, examining trends in patients' characteristics, severity of illness, intensity of care and mortality rates over the years 2001-2008. The study population consisted of elderly patients and the primary endpoints were 28 day and one year mortality from ICU admission. Results: Between the years 2001 and 2008, 7,265 elderly patients had 8,916 admissions to ICU. The rate of admission to the ICU increased by 5.6% per year. After an eight bed MICU was added, the severity of disease on ICU admission dropped significantly and crude mortality rates decreased thereafter. Adjusting for severity of disease on presentation, there was a decreased mortality at 28- days but no improvement in one- year survival rates for elderly patient admitted to the ICU over the years of observation. Hospital mortality rates have been unchanged from 2001 through 2008. Conclusion: In a high capacity ICU bed hospital, there was a temporal decrease in severity of disease on ICU admission, more so after the addition of additional medical ICU beds. While crude mortality rates decreased over the study period, adjusted one-year survival in ICU survivors did not change with the addition of ICU beds. These findings suggest that outcome in critically ill elderly patients may not be influenced by ICU admission. Adding additional ICU beds to deal with the increasing age of the population may therefore not be effective.	[Fuchs, Lior; Novack, Victor; Celi, Leo Anthony; Howell, Michael D.; Talmor, Daniel S.] Beth Israel Deaconess Med Ctr, Intens Care Unit, Boston, MA 02215 USA; [Fuchs, Lior; Novack, Victor; Celi, Leo Anthony; Howell, Michael D.; Talmor, Daniel S.] Harvard Univ, Sch Med, Boston, MA USA; [Fuchs, Lior; Novack, Victor; Baumfeld, Yael] Soroka Univ, Med Ctr, Clin Res Ctr, Beer Sheva, Israel; [Fuchs, Lior; Novack, Victor; Baumfeld, Yael] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [McLennan, Stuart] Univ Basel, Inst Biomed Eth, Basel, Switzerland; [Celi, Leo Anthony; Park, Shinhyuk] Harvard MIT Div Hlth Sci & Technol, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Ben Gurion University; Soroka Medical Center; Ben Gurion University; University of Basel; Harvard University	Fuchs, L (corresponding author), Beth Israel Deaconess Med Ctr, Intens Care Unit, Boston, MA 02215 USA.	liorfuchs@gmail.com	Howell, Michael/B-8065-2009; McLennan, Stuart/C-1048-2015	Howell, Michael/0000-0001-7003-6971; McLennan, Stuart/0000-0002-2019-6253				Arts DGT, 2005, CRIT CARE MED, V33, P1988, DOI 10.1097/01.CCM.0000178178.02574.AB; Bagshaw SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7768; CLEVELAND WS, 1979, SCIENCE, V204, P1273, DOI 10.1126/science.204.4399.1273; Dreiher J, 2012, CRIT CARE MED, V40, P855, DOI 10.1097/CCM.0b013e318236f7b8; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fowler RA, 2008, CRIT CARE, V12, DOI 10.1186/cc6984; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Hudson LD, 1999, CHEST, V116, p74S, DOI 10.1378/chest.116.suppl_1.74S-a; LEGALL JR, 1984, CRIT CARE MED, V12, P975; Lerolle N, 2010, CRIT CARE MED, V38, P59, DOI 10.1097/CCM.0b013e3181b088ec; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Saeed M, 2002, COMPUT CARDIOL, V29, P641, DOI 10.1109/CIC.2002.1166854; Saeed M, 2011, CRIT CARE MED, V39, P952, DOI 10.1097/CCM.0b013e31820a92c6; Simchen E, 2004, CRIT CARE MED, V32, P1654, DOI 10.1097/01.CCM.0000133021.22188.35; Simchen E, 2007, CRIT CARE MED, V35, P449, DOI 10.1097/01.CCM.0000253407.89594.15; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; Sprung CL, 2012, CRIT CARE MED, V40, P132, DOI 10.1097/CCM.0b013e318232d6b0; Story DA, 2010, ANAESTHESIA, V65, P1022, DOI 10.1111/j.1365-2044.2010.06478.x; Wunsch H, 2012, CHEST, V141, P1393, DOI 10.1378/chest.11-2819; Nguyen YL, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-29	22	33	36	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93234	10.1371/journal.pone.0093234	http://dx.doi.org/10.1371/journal.pone.0093234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699251	gold, Green Published, Green Submitted			2022-12-27	WOS:000334105000049
J	Jamison, J; Wang, JHC; Wells, A				Jamison, Joshua; Wang, James H-C.; Wells, Alan			PKC delta Regulates Force Signaling during VEGF/CXCL4 Induced Dissociation of Endothelial Tubes	PLOS ONE			English	Article							PROTEIN-KINASE-C; BARRIER FUNCTION; CELL-MOVEMENT; WOUND REPAIR; ACTIVATION; MIGRATION; MOTILITY; PERMEABILITY; MECHANISMS; MEMBRANE	Wound healing requires the vasculature to re-establish itself from the severed ends; endothelial cells within capillaries must detach from neighboring cells before they can migrate into the nascent wound bed to initiate angiogenesis. The dissociation of these endothelial capillaries is driven partially by platelets' release of growth factors and cytokines, particularly the chemokine CXCL4/platelet factor-4 ( PF4) that increases cell-cell de-adherence. As this retraction is partly mediated by increased transcellular contractility, the protein kinase c-delta/myosin light chain-2 ( PKCd/MLC-2) signaling axis becomes a candidate mechanism to drive endothelial dissociation. We hypothesize that PKC delta activation induces contractility through MLC-2 to promote dissociation of endothelial cords after exposure to platelet-released CXCL4 and VEGF. To investigate this mechanism of contractility, endothelial cells were allowed to form cords following CXCL4 addition to perpetuate cord dissociation. In this study, CXCL4- induced dissociation was reduced by a VEGFR inhibitor ( sunitinib malate) and/or PKCd inhibition. During combined CXCL4+ VEGF treatment, increased contractility mediated by MLC-2 that is dependent on PKCd regulation. As cellular force is transmitted to focal adhesions, zyxin, a focal adhesion protein that is mechano-responsive, was upregulated after PKCd inhibition. This study suggests that growth factor regulation of PKCd may be involved in CXCL4- mediated dissociation of endothelial cords.	[Jamison, Joshua; Wells, Alan] Univ Pittsburgh, Dept Pathol, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA; [Wang, James H-C.] Univ Pittsburgh, Dept Orthoped Surg, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wells, A (corresponding author), Univ Pittsburgh, Dept Pathol, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.	wellsa@upmc.edu		Wells, Alan/0000-0002-1637-8150	National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069668, R01GM063569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This has been funded the by National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; ANDUJAR MB, 1992, J SUBMICR CYTOL PATH, V24, P145; Bodnar RJ, 2006, CIRC RES, V98, P617, DOI 10.1161/01.RES.0000209968.66606.10; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; CHEN P, 1994, J CELL BIOL, V124, P547, DOI 10.1083/jcb.124.4.547; Fordjour AK, 2009, BBA-GEN SUBJECTS, V1790, P1179, DOI 10.1016/j.bbagen.2009.07.012; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Grinnell KL, 2012, MICROVASC RES, V83, P12, DOI 10.1016/j.mvr.2011.04.005; Harrington EO, 2005, EXP CELL RES, V308, P407, DOI 10.1016/j.yexcr.2005.05.005; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Jamison J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077434; JOYCE NC, 1992, INVEST OPHTH VIS SCI, V33, P1958; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Lee S, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194115; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; Li Q, 1999, J BIOL CHEM, V274, P3764, DOI 10.1074/jbc.274.6.3764; Lum H, 1996, CAN J PHYSIOL PHARM, V74, P787, DOI 10.1139/cjpp-74-7-787; LUM H, 1994, AM J PHYSIOL, V267, pL223, DOI 10.1152/ajplung.1994.267.3.L223; LYNCH JJ, 1990, J CLIN INVEST, V85, P1991, DOI 10.1172/JCI114663; Murphy Diane D., 1994, Microcirculation (New York), V1, P121, DOI 10.3109/10739689409148267; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Seki T, 2005, GENES CELLS, V10, P225, DOI 10.1111/j.1365-2443.2005.00830.x; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; Shizukuda Y, 1999, CIRC RES, V85, P247, DOI 10.1161/01.RES.85.3.247; Shizukuda Y, 1999, CIRCULATION, V100, P1909, DOI 10.1161/01.CIR.100.18.1909; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; STOKES CL, 1991, J CELL SCI, V99, P419; Tinsley JH, 2004, AM J PHYSIOL-CELL PH, V286, pC105, DOI 10.1152/ajpcell.00340.2003; Wells A, 1999, CELL MOTIL CYTOSKEL, V44, P227, DOI 10.1002/(SICI)1097-0169(199912)44:4<227::AID-CM1>3.0.CO;2-B; Woo CH, 2005, AM J PHYSIOL-LUNG C, V288, pL307, DOI 10.1152/ajplung.00105.2004; Yamamura S, 1996, J SURG RES, V63, P349, DOI 10.1006/jsre.1996.0274	32	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93968	10.1371/journal.pone.0093968	http://dx.doi.org/10.1371/journal.pone.0093968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699667	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000334105000128
J	Tanomsing, N; Mayxay, M; Newton, PN; Nosten, F; Dolecek, C; Hien, TT; White, NJ; Day, NPJ; Dondorp, AM; Imwong, M				Tanomsing, Naowarat; Mayxay, Mayfong; Newton, Paul N.; Nosten, Francois; Dolecek, Christiane; Tran Tinh Hien; White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.; Imwong, Mallika			Genetic Variability of Plasmodium malariae dihydropteroate synthase (dhps) in Four Asian Countries	PLOS ONE			English	Article							DIHYDROFOLATE-REDUCTASE GENE; POINT MUTATIONS; DRUG PRESSURE; PYRIMETHAMINE; RESISTANCE; FALCIPARUM; VIVAX	The dihydropteroate synthase (dhps) genes of 44 P. malariae strains from four Asian countries were isolated. Only a limited number of polymorphisms were observed. Comparison with homologous mutations in other Plasmodium species showed that these polymorphisms are unlikely to be associated with sulfadoxine resistance.	[Tanomsing, Naowarat; Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Mayxay, Mayfong; Newton, Paul N.] Lao Oxford Mahosot Hosp Wellcome Trust Res Unit, Microbiol Lab, Mahosot Hosp, Viangchan, Laos; [Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos; [Mayxay, Mayfong; Newton, Paul N.; Nosten, Francois; Dolecek, Christiane; Tran Tinh Hien; White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.] Univ Oxford, Churchill Hosp, Nuffield Dept Med, Ctr Trop Med, Oxford, England; [Nosten, Francois] Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Bangkok, Thailand; [Dolecek, Christiane; Tran Tinh Hien] Univ Oxford, Hosp Trop Dis, Ho Chi Minh City, Clin Res Unit, Ho Chi Minh City, Vietnam; [Tran Tinh Hien] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam; [White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand	Mahidol University; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Imwong, M (corresponding author), Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand.	noi@tropmedres.ac	White, Nick/AAC-6527-2019; Nosten, Francois/AAC-5509-2019; Imwong, Mallika/ABE-6493-2020	White, Nick/0000-0002-1897-1978; Nosten, Francois/0000-0002-7951-0745; Newton, Paul/0000-0002-4608-6431	Thailand Research Fund (TRF) [MRG5480066]; Mahidol University; Wellcome Trust of Great Britain	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Mahidol University; Wellcome Trust of Great Britain(Wellcome Trust)	This study was supported by Thailand Research Fund (TRF) grant code MRG5480066, Mahidol University and was part of the Wellcome Trust Mahidol University-Oxford Tropical Medicine Research Programme supported by the Wellcome Trust of Great Britain. NT is the TRF research grantee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Imwong M, 2003, ANTIMICROB AGENTS CH, V47, P1514, DOI 10.1128/AAC.47.5.1514-1521.2003; Imwong M, 2001, ANTIMICROB AGENTS CH, V45, P3122, DOI 10.1128/AAC.45.11.3122-3127.2001; Khim N, 2012, ANTIMICROB AGENTS CH, V56, P863, DOI 10.1128/AAC.05284-11; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Tanomsing N, 2007, ANTIMICROB AGENTS CH, V51, P3523, DOI 10.1128/AAC.00234-07; ZOLG JW, 1989, MOL BIOCHEM PARASIT, V36, P253, DOI 10.1016/0166-6851(89)90173-4	6	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93942	10.1371/journal.pone.0093942	http://dx.doi.org/10.1371/journal.pone.0093942			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699454	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000123
J	Long, HC; O'Connor, BP; Zemans, RL; Zhou, XF; Yang, IV; Schwartz, DA				Long, Huaicong; O'Connor, Brian P.; Zemans, Rachel L.; Zhou, Xiaofang; Yang, Ivana V.; Schwartz, David A.			The Toll-Like Receptor 4 Polymorphism Asp299Gly but Not Thr399Ile Influences TLR4 Signaling and Function	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE BINDING-PROTEIN; RESPIRATORY SYNCYTIAL VIRUS; RESPONSES; LPS; TRANSDUCTION; MACROPHAGES; POPULATION; HYALURONAN; EXPRESSION; MUTATIONS	The common, co-segregating Toll-like receptor 4 (TLR4) non-synonymous single nucleotide polymorphisms (SNPs), Asp299Gly and Thr399Ile, are associated with hyporesponsiveness to inhaled lipopolysaccharide (LPS) and increased susceptibility to Gram negative pathogens in humans. The purpose of this study was to identify the relative contributions of the Asp299Gly and the Thr399Ile variants in inhibiting the function of TLR4. 293/hMD2-CD14 cell line was transfected with lentiviral constructs containing human wild type (WT) TLR4-EGFP or TLR4-EGFP with Asp299Gly, Thr399Ile or Asp299Gly/Thr399Ile complementary DNA (cDNA). Multiple stable cell lines were established for each construct: three for WT TLR4, Asp299Gly, and Thr399Ile, and only two for Asp299Gly/Thr399Ile mutants and EGFP control. We did not observe a significant effect of polymorphisms on cell surface and intracellular TLR4 expression nor were there any significant differences in TLR4 and EGFP protein levels assessed by Western blotting and confocal microscopy among the multiple cell lines of each of the constructs. All cell lines had a dose-dependent responsiveness to LPS stimulation. However, compared to the WT TLR4, cells expressing TLR4 with Asp299Gly but not Thr399Ile polymorphism produced significantly less (P<0.05) IL-8 following LPS stimulation. Similarly, cells expressing TLR4 Asp299Gly but not Thr399Ile allele had significantly lower percentage of phosphorylated and total NF-kappa B P65 following LPS stimulation. While we could not do statistics on the Asp299Gly/Thr399Ile group, we observed a reduced responsiveness to LPS compared to WT TLR4. Taken together, we observed that the TLR4 Asp299Gly variant, but not the Thr399Ile variant, is responsible for impaired responsiveness of TLR4 to LPS and corresponding activation of NF-kappa B.	[Long, Huaicong; O'Connor, Brian P.; Zemans, Rachel L.; Yang, Ivana V.; Schwartz, David A.] Ctr Genes Environm & Hlth Natl Jewish Hlth, Denver, CO USA; [Long, Huaicong; Zhou, Xiaofang] Sichuan Acad Med Sci, Dept Geriatr, Chengdu, Sichuan, Peoples R China; [Long, Huaicong; Zhou, Xiaofang] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [O'Connor, Brian P.; Schwartz, David A.] Univ Colorado & Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA; [Zemans, Rachel L.; Yang, Ivana V.; Schwartz, David A.] Univ Colorado Denver, Dept Med, Aurora, CO USA	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Schwartz, DA (corresponding author), Ctr Genes Environm & Hlth Natl Jewish Hlth, Denver, CO USA.	david.schwartz@ucdenver.edu	Yang, Ivana V/P-3059-2018	Yang, Ivana V/0000-0002-1018-489X	National Institutes of Health; China Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL103772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research reported in this manuscript has been funded through the National Institutes of Health and China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Balistreri CR, 2011, MECH AGEING DEV, V132, P86, DOI 10.1016/j.mad.2010.12.005; Bhuvanendran S, 2011, MICROBES INFECT, V13, P844, DOI 10.1016/j.micinf.2011.04.007; Bottcher MF, 2004, J ALLERGY CLIN IMMUN, V114, P561, DOI 10.1016/j.jaci.2004.04.050; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; Candore G, 2006, ANN NY ACAD SCI, V1067, P282, DOI 10.1196/annals.1354.037; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Figueroa L, 2012, J IMMUNOL, V188, P4506, DOI 10.4049/jimmunol.1200202; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Guillot L, 2002, J IMMUNOL, V168, P5989, DOI 10.4049/jimmunol.168.12.5989; Guo JS, 2009, HEPATOLOGY, V49, P960, DOI 10.1002/hep.22697; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kuhns DB, 2001, J IMMUNOL, V167, P2869, DOI 10.4049/jimmunol.167.5.2869; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Liadaki K, 2011, CLIN VACCINE IMMUNOL, V18, P217, DOI 10.1128/CVI.00460-10; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Lorenz E, 2001, BIOTECHNIQUES, V31, P22, DOI 10.2144/01311bm01; Lundberg A, 2008, CLIN VACCINE IMMUNOL, V15, P1878, DOI 10.1128/CVI.00241-08; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Montes AH, 2006, CLIN EXP IMMUNOL, V143, P404, DOI 10.1111/j.1365-2249.2005.03002.x; Norata GD, 2005, J INTERN MED, V258, P21, DOI 10.1111/j.1365-2796.2005.01509.x; OHTO U, 2012, J BIOL CHEM; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Prohinar P, 2010, J IMMUNOL, V184, P4362, DOI 10.4049/jimmunol.0903142; Rallabhandi P, 2008, J IMMUNOL, V180, P1139, DOI 10.4049/jimmunol.180.2.1139; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Senthilselvan A, 2009, J ALLERGY CLIN IMMUN, V123, P1034, DOI 10.1016/j.jaci.2009.02.019; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; TOBIAS PS, 1988, J BIOL CHEM, V263, P13479; TOBIAS PS, 1989, J BIOL CHEM, V264, P10867; Tsan MF, 2004, AM J PHYSIOL-CELL PH, V286, pC739, DOI 10.1152/ajpcell.00364.2003; Tulic MK, 2007, J IMMUNOL, V179, P132, DOI 10.4049/jimmunol.179.1.132; Vogel SN, 2003, BIOCHEM SOC T, V31, P664, DOI 10.1042/bst0310664; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	40	30	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93550	10.1371/journal.pone.0093550	http://dx.doi.org/10.1371/journal.pone.0093550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695807	Green Submitted, gold, Green Published			2022-12-27	WOS:000334103000088
J	M'Zali, F; Bounizra, C; Leroy, S; Mekki, Y; Quentin-Noury, C; Kann, M				M'Zali, Fatima; Bounizra, Carole; Leroy, Sandrine; Mekki, Yahia; Quentin-Noury, Claudine; Kann, Michael			Persistence of Microbial Contamination on Transvaginal Ultrasound Probes despite Low-Level Disinfection Procedure	PLOS ONE			English	Article							ULTRAVIOLET C; OUTBREAK; INFECTIONS; GEL	Aim of the Study: In many countries, Low Level Disinfection (LLD) of covered transvaginal ultrasound probes is recommended between patients' examinations. The aim of this study was to evaluate the antimicrobial efficacy of LLD under routine conditions on a range of microorganisms. Materials and Methods: Samples were taken over a six month period in a private French Radiology Center. 300 specimens derived from endovaginal ultrasound probes were analyzed after disinfection of the probe with wipes impregnated with a quaternary ammonium compound and chlorhexidine. Human papillomavirus (HPV) was sought in the first set of s100 samples, Chlamydia trachomatis and mycoplasmas were searched in the second set of 100 samples, bacteria and fungi in the third 100 set samples. HPV, C. trachomatis and mycoplasmas were detected by PCR amplification. PCR positive samples were subjected to a nuclease treatment before an additional PCR assay to assess the likely viable microorganisms. Bacteria and fungi were investigated by conventional methods. Results: A substantial persistence of microorganisms was observed on the disinfected probes: HPV DNA was found on 13% of the samples and 7% in nuclease-resistant form. C. trachomatis DNA was detected on 20% of the probes by primary PCR but only 2% after nuclease treatment, while mycoplasma DNA was amplified in 8% and 4%, respectively. Commensal and/or environmental bacterial flora was present on 86% of the probes, occasionally in mixed culture, and at various levels (10->3000 CFU/probe); Staphylococcus aureus was cultured from 4% of the probes (10-560 CFU/probe). No fungi were isolated. Conclusion: Our findings raise concerns about the efficacy of impregnated towels as a sole mean for disinfection of ultrasound probes. Although the ultrasound probes are used with disposable covers, our results highlight the potential risk of cross contamination between patients during ultrasound examination and emphasize the need for reviewing the disinfection procedure.	[M'Zali, Fatima; Bounizra, Carole; Quentin-Noury, Claudine; Kann, Michael] Univ Bordeaux Segalen, Microbiol Fondamentale & Pathogen, Unite Mixte Rech 5234, Bordeaux, France; [Leroy, Sandrine] Ctr Hospitalier Univ Nimes, Serv Biostat, Nimes, France; [Mekki, Yahia] Hosp Civils Lyon, Ctr Biol & Pathol Est, Virol Lab, Lyon, France	UDICE-French Research Universities; Universite de Bordeaux; CHU Lyon	M'Zali, F (corresponding author), Univ Bordeaux Segalen, Microbiol Fondamentale & Pathogen, Unite Mixte Rech 5234, Bordeaux, France.	fatima.mzali@u-bordeaux2.fr	Leroy, Sandrine/I-9136-2014	Leroy, Sandrine/0000-0002-2964-2002	Germitec	Germitec	The laboratory received a grant from Germitec (www.germitec.com). The fact that the authors received this external funding does not alter their adherence to PLOS ONE policy. The funders had no role in the study design, data collection and analysis or preparation of the manuscript.	Abreu ALP, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-262; American Institute of Ultrasound in Medicine, 2003, ULTRASOUND OBST GYN, V7, P94; Amis S, 2000, J CLIN ULTRASOUND, V28, P295, DOI 10.1002/1097-0096(200007/08)28:6<295::AID-JCU5>3.0.CO;2-G; [Anonymous], 2007, GAIN PROT US UN DISP; Backhouse S., 2003, BMUS B, V11, P37; BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Bloc S, 2011, J ULTRAS MED, V30, P785, DOI 10.7863/jum.2011.30.6.785; Gaillot O, 1998, J CLIN MICROBIOL, V36, P1357, DOI 10.1128/JCM.36.5.1357-1360.1998; Gillespie JL, 2007, UROLOGY, V69, P912, DOI 10.1016/j.urology.2007.01.047; Gray RA, 2012, CLIN RADIOL, V67, P1069, DOI 10.1016/j.crad.2012.02.015; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Hutchinson J, 2004, INFECT CONT HOSP EP, V25, P291, DOI 10.1086/502394; Institut de veille sanitaire, 2008, AN RISQ INF LIE ECH; Judlin F, 2003, GYNECOL OBSTET FERTI, V31, P054; Kac G, 2007, J HOSP INFECT, V65, P163, DOI 10.1016/j.jhin.2006.10.008; Kac G, 2010, INFECT CONT HOSP EP, V31, P165, DOI 10.1086/649794; Koibuchi H, 2013, MED ULTRASON, V15, P41, DOI 10.11152/mu.2013.2066.151.hk1upp2; Leroy S, 2013, J HOSP INFECT, V83, P99, DOI 10.1016/j.jhin.2012.07.014; Lesourd F, 2000, HUM REPROD, V15, P1083, DOI 10.1093/humrep/15.5.1083; Ma STC, 2012, EMERG MED J; McGowin CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001324; Ohara T, 1998, J HOSP INFECT, V40, P73, DOI 10.1016/S0195-6701(98)90028-7; Olshtain-Pops K, 2011, J UROLOGY, V185, P144, DOI 10.1016/j.juro.2010.08.093; Organ Michael, 2010, Can Urol Assoc J, V4, pE58; Paz A, 2001, J HOSP INFECT, V49, P148, DOI 10.1053/jhin.2001.1056; Rutala W.A., 2019, GUIDELINE DISINFECTI; Santos Cristina, 2003, Braz J Infect Dis, V7, P91, DOI 10.1590/S1413-86702003000200001; Sykes A, 2006, BR J INFECT CONTROL, V7, P16; VANKUPPEVELD FJM, 1992, APPL ENVIRON MICROB, V58, P2606, DOI 10.1128/AEM.58.8.2606-2615.1992; Williamson DA, 2013, CLIN INFECT IN PRESS	30	41	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93368	10.1371/journal.pone.0093368	http://dx.doi.org/10.1371/journal.pone.0093368			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695371	gold, Green Submitted, Green Published			2022-12-27	WOS:000334103000061
J	Cook, LC; Hillhouse, AE; Myles, MH; Lubahn, DB; Bryda, EC; Davis, JW; Franklin, CL				Cook, Lydia C.; Hillhouse, Andrew E.; Myles, Matthew H.; Lubahn, Dennis B.; Bryda, Elizabeth C.; Davis, J. Wade; Franklin, Craig L.			The Role of Estrogen Signaling in a Mouse Model of Inflammatory Bowel Disease: A Helicobacter Hepaticus Model	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENE-EXPRESSION; RECEPTOR-BETA; MICROSCOPIC COLITIS; INFECTION; MICE; IMMUNITY; GENDER; RISK; DIFFERENTIATION	The pathogenesis of inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis, is due in part to interactions between the immune system, genetics, the environment, and endogenous microbiota. Gonadal sex hormones (GSH), such as estrogen, are thought to be involved in the development of IBD as variations in disease severity occur during pregnancy, menopause, or oral contraceptives use. In certain strains of mice, infection with Helicobacter hepaticus triggers IBD-like mucosal inflammation that is more severe in female mice than in males, suggesting a role for GSH in this model. To determine the role of estrogen signaling in microbiota-induced intestinal inflammation, estrogen receptor (ER) a and b knock-out (KO) mice, ER agonists, and adoptive transfers were utilized. We demonstrate that, when signaling is limited to ERb on a non-CD4(+) cell subset, disease is less severe and this correlates with decreased expression of pro-inflammatory mediators.	[Cook, Lydia C.; Hillhouse, Andrew E.; Myles, Matthew H.; Bryda, Elizabeth C.; Franklin, Craig L.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Hillhouse, Andrew E.] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO USA; [Myles, Matthew H.] IDEXX Labs, Columbia, MO USA; [Lubahn, Dennis B.] Univ Missouri, Dept Biochem, Columbia, MO USA; [Davis, J. Wade] Univ Missouri, Dept Hlth Management & Informat, Columbia, MO USA; [Davis, J. Wade] Univ Missouri, Dept Stat, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Franklin, CL (corresponding author), Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.	franklinc@missouri.edu		Myles, Matthew/0000-0002-8685-516X	National Institutes of Health [K26 RR018811]; JE Wagner Endowment (University of Missouri); NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR018811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JE Wagner Endowment (University of Missouri); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by funding from the National Institutes of Health (grant K26 RR018811) and the JE Wagner Endowment (University of Missouri). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5; Bebo BF, 2001, J IMMUNOL, V166, P2080, DOI 10.4049/jimmunol.166.3.2080; Bousvaros A, 2006, INFLAMM BOWEL DIS, V12, P885, DOI 10.1097/01.mib.0000228358.25364.8b; Brant SR, 2008, INFLAMM BOWEL DIS, V14, pS2, DOI 10.1002/ibd.20540; Cahill RJ, 1997, INFECT IMMUN, V65, P3126, DOI 10.1128/IAI.65.8.3126-3131.1997; Campbell-Thompson M, 2001, CANCER RES, V61, P632; Chadwick CC, 2005, P NATL ACAD SCI USA, V102, P2543, DOI 10.1073/pnas.0405841102; Cornish JA, 2008, AM J GASTROENTEROL, V103, P2394, DOI 10.1111/j.1572-0241.2008.02064.x; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Ferguson CB, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.39566.681458.BE; Gleicher N, 2007, J AUTOIMMUN, V28, P1, DOI 10.1016/j.jaut.2006.12.004; GODET PG, 1995, GUT, V37, P668, DOI 10.1136/gut.37.5.668; Gunel O, 2003, INFLAMMATION, V27, P351; Harnish DC, 2004, AM J PHYSIOL-GASTR L, V286, pG118, DOI 10.1152/ajpgi.00024.2003; Harris HA, 2003, ENDOCRINOLOGY, V144, P4241, DOI 10.1210/en.2003-0550; Jansson L, 1998, INFLAMM RES, V47, P290, DOI 10.1007/s000110050332; Kane SV, 2008, AM J GASTROENTEROL, V103, P1193, DOI 10.1111/j.1572-0241.2007.01700.x; Kao KT, 2009, WORLD J GASTROENTERO, V15, P3122, DOI 10.3748/wjg.15.3122; Khalili H, 2012, GUT; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Liu HY, 2002, J NEUROSCI RES, V70, P238, DOI 10.1002/jnr.10409; Livingston RS, 2004, COMPARATIVE MED, V54, P301; Looijer-van Langen M, 2011, AM J PHYSIOL-GASTR L, V300, pG621, DOI 10.1152/ajpgi.00274.2010; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Maggio-Price L, 2006, CANCER RES, V66, P828, DOI 10.1158/0008-5472.CAN-05-2448; Maggio-Price L, 2005, AM J PATHOL, V166, P1793, DOI 10.1016/S0002-9440(10)62489-3; Maggio-Price L, 2002, AM J PATHOL, V160, P739, DOI 10.1016/S0002-9440(10)64894-8; Mao A, 2005, J IMMUNOL, V175, P5146, DOI 10.4049/jimmunol.175.8.5146; McCarthy M, 2000, LANCET, V356, P1088, DOI 10.1016/S0140-6736(05)74535-9; Mewshaw RE, 2005, J MED CHEM, V48, P3953, DOI 10.1021/jm058173s; Mohammadi M, 1996, INFECT IMMUN, V64, P238, DOI 10.1128/IAI.64.1.238-245.1996; Myles MH, 2007, INFLAMM BOWEL DIS, V13, P822, DOI 10.1002/ibd.20138; Myles MH, 2003, INFECT IMMUN, V71, P3885, DOI 10.1128/IAI.71.7.3885-3893.2003; Nalbandian G, 2005, IMMUNOL RES, V31, P91, DOI 10.1385/IR:31:2:091; Phiel KL, 2005, IMMUNOL LETT, V97, P107, DOI 10.1016/j.imlet.2004.10.007; Riis L, 2006, AM J GASTROENTEROL, V101, P1539, DOI 10.1111/j.1572-0241.2006.00602.x; Riley LK, 1996, J CLIN MICROBIOL, V34, P942, DOI 10.1128/JCM.34.4.942-946.1996; Saleiro D, 2012, INT J CANCER, V131, P2553, DOI 10.1002/ijc.27578; Siracusa MC, 2008, J IMMUNOL, V180, P1423, DOI 10.4049/jimmunol.180.3.1423; Subramanian S, 2005, CLIN IMMUNOL, V115, P162, DOI 10.1016/j.clim.2005.01.006; Subramanian S, 2003, J IMMUNOL, V170, P1548, DOI 10.4049/jimmunol.170.3.1548; Verdu EF, 2002, AM J PHYSIOL-GASTR L, V283, pG27, DOI 10.1152/ajpgi.00460.2001; Cives MV, 2009, AM J GASTROENTEROL, V104, P534, DOI 10.1038/ajg.2008.70; Wada-Hiraike O, 2006, BIOCHEM SOC T, V34, P1114, DOI 10.1042/BST0341114; Wada-Hiraike O, 2006, P NATL ACAD SCI USA, V103, P2959, DOI 10.1073/pnas.0511271103; Whary MT, 1998, INFECT IMMUN, V66, P3142, DOI 10.1128/IAI.66.7.3142-3148.1998; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Williams JJ, 2008, CLIN GASTROENTEROL H, V6, P35, DOI 10.1016/j.cgh.2007.10.031; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	50	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94209	10.1371/journal.pone.0094209	http://dx.doi.org/10.1371/journal.pone.0094209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709804	Green Submitted, Green Published, gold			2022-12-27	WOS:000334159800119
J	Liou, JW; Chang, FT; Chung, Y; Chen, WY; Fischer, WB; Hsu, HJ				Liou, Je-Wen; Chang, Fang-Tzu; Chung, Yi; Chen, Wen-Yi; Fischer, Wolfgang B.; Hsu, Hao-Jen			In Silico Analysis Reveals Sequential Interactions and Protein Conformational Changes during the Binding of Chemokine CXCL-8 to Its Receptor CXCR1	PLOS ONE			English	Article							N-TERMINAL DOMAIN; MOLECULAR-DYNAMICS; INTERLEUKIN-8; ACTIVATION; AFFINITY; IDENTIFICATION; RECOGNITION; MUTAGENESIS; NMR	Chemokine CXCL-8 plays a central role in human immune response by binding to and activate its cognate receptor CXCR1, a member of the G-protein coupled receptor (GPCR) family. The full-length structure of CXCR1 is modeled by combining the structures of previous NMR experiments with those from homology modeling. Molecular docking is performed to search favorable binding sites of monomeric and dimeric CXCL-8 with CXCR1 and a mutated form of it. The receptor-ligand complex is embedded into a lipid bilayer and used in multi ns molecular dynamics (MD) simulations. A multi-steps binding mode is proposed: (i) the N-loop of CXCL-8 initially binds to the N-terminal domain of receptor CXCR1 driven predominantly by electrostatic interactions; (ii) hydrophobic interactions allow the N-terminal Glu-Leu-Arg (ELR) motif of CXCL-8 to move closer to the extracellular loops of CXCR1; (iii) electrostatic interactions finally dominate the interaction between the N-terminal ELR motif of CXCL-8 and the EC-loops of CXCR1. Mutation of CXCR1 abrogates this mode of binding. The detailed binding process may help to facilitate the discovery of agonists and antagonists for rational drug design.	[Liou, Je-Wen; Chen, Wen-Yi] Tzu Chi Univ, Sch Med, Dept Biochem, Hualien, Taiwan; [Chang, Fang-Tzu; Chung, Yi; Hsu, Hao-Jen] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Liou, Je-Wen] Natl Dong Hwa Univ, Nanotechnol Res Ctr, Hualien, Taiwan; [Fischer, Wolfgang B.] Natl Yang Ming Univ, Sch Biomed Sci & Engn, Inst Biophoton, Taipei 112, Taiwan; [Fischer, Wolfgang B.] Natl Yang Ming Univ, BMIRC, Taipei 112, Taiwan	Tzu Chi University; Tzu Chi University; National Dong Hwa University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Hsu, HJ (corresponding author), Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan.	hjhsu32@mail.tcu.edu.tw	Liou, Je-Wen/ABB-2157-2020; Hsu, Hao-Jen/ABE-3718-2020	Liou, Je-Wen/0000-0002-6181-7263; Hsu, Hao-Jen/0000-0001-6096-7481; Fischer, Wolfgang/0000-0001-7753-1828	Tzu Chi University [TCIRP101005]; National Science Council Taiwan [NSC100-2218-E-320-001-MY3]	Tzu Chi University; National Science Council Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Tzu Chi University (TCIRP101005), and the National Science Council Taiwan (NSC100-2218-E-320-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN ET, 1991, P NATL ACAD SCI USA, V88, P502, DOI 10.1073/pnas.88.2.502; Barter EF, 2012, BIOCHEMISTRY-US, V51, P1322, DOI 10.1021/bi201615y; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; David R, 2008, J AM CHEM SOC, V130, P15311, DOI 10.1021/ja802453x; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003; HEBERT CA, 1991, J BIOL CHEM, V266, P18989; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Hsu HJ, 2012, J MOL MODEL, V18, P501, DOI 10.1007/s00894-011-1092-6; Huynh N, 2008, BIOPOLYMERS, V89, P52, DOI 10.1002/bip.20851; Joseph PRB, 2010, J BIOL CHEM, V285, P29262, DOI 10.1074/jbc.M110.146555; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kuschert GSV, 1998, BIOCHEMISTRY-US, V37, P11193, DOI 10.1021/bi972867o; Lebard DN, 2012, PLOS COMPUTATIONAL B, V8, P1; LEONG SR, 1994, J BIOL CHEM, V269, P19343; Li L, 2003, PROTEINS, V53, P693, DOI 10.1002/prot.10460; Love M, 2012, BIOCHEMISTRY-US, V51, P733, DOI 10.1021/bi201601k; Lowman HB, 1996, J BIOL CHEM, V271, P14344, DOI 10.1074/jbc.271.24.14344; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Nicholls DJ, 2008, MOL PHARMACOL, V74, P1193, DOI 10.1124/mol.107.044610; Park SH, 2012, NATURE, V491, P779, DOI 10.1038/nature11580; Park SH, 2011, J MOL BIOL, V414, P194, DOI 10.1016/j.jmb.2011.08.025; Prado GN, 2007, BIOCHEMISTRY-US, V46, P8961, DOI 10.1021/bi7004043; Rajagopalan L, 2004, J BIOL CHEM, V279, P30000, DOI 10.1074/jbc.M313883200; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Rajarathnam K, 1999, BIOCHEMISTRY-US, V38, P7653, DOI 10.1021/bi990033v; Rajarathnam K, 2006, BIOCHEMISTRY-US, V45, P7882, DOI 10.1021/bi0605944; Ravindran A, 2009, BIOCHEMISTRY-US, V48, P8795, DOI 10.1021/bi901194p; Sharma B, 2010, EXPERT OPIN THER TAR, V14, P435, DOI 10.1517/14728221003652471; Skelton NJ, 1999, STRUCTURE, V7, P157, DOI 10.1016/S0969-2126(99)80022-7; Sramala I, 2003, BIOPHYS J, V84, P3276, DOI 10.1016/S0006-3495(03)70052-6; Suetomi K, 1999, J BIOL CHEM, V274, P11768, DOI 10.1074/jbc.274.17.11768; Szpakowska M, 2012, BIOCHEM PHARMACOL, V84, P1366, DOI 10.1016/j.bcp.2012.08.008; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; Yuan SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047114; Zhou J, 2004, J PHYS CHEM B, V108, P17418, DOI 10.1021/jp038048x	41	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94178	10.1371/journal.pone.0094178	http://dx.doi.org/10.1371/journal.pone.0094178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705928	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500130
J	Miyazaki, T; Chiuve, S; Sacks, FM; Ridker, PM; Libby, P; Aikawa, M				Miyazaki, Tetsuro; Chiuve, Stephanie; Sacks, Frank M.; Ridker, Paul M.; Libby, Peter; Aikawa, Masanori			Plasma Pentraxin 3 Levels Do Not Predict Coronary Events but Reflect Metabolic Disorders in Patients with Coronary Artery Disease in the CARE Trial	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LONG PENTRAXIN; INNATE IMMUNITY; CARDIOVASCULAR-DISEASE; VASCULAR INFLAMMATION; MYOCARDIAL-INFARCTION; ADIPOSE-TISSUE; HEART-FAILURE; KEY COMPONENT; PTX3	Chronic inflammation closely associates with obesity, metabolic syndrome, diabetes mellitus, and atherosclerosis. Evidence indicates that the immunomodulator pentraxin 3 (PTX3) may serve as a biomarker of these cardiometabolic disorders, but whether PTX3 predicts cardiovascular complications is unknown. We examined the association of plasma PTX3 levels with recurrent coronary events via a prospective, nested, case-control design in the CARE trial. Among 4159 patients who had a prior myocardial infarction 3 to 20 months before enrollment and also had total cholesterol levels <240 mg/dL and LDL cholesterol levels between 115 and 175 mg/dL, we measured plasma PTX3 levels at baseline by high-sensitivity ELISA in 413 cases with recurrent myocardial infarction or coronary death during a 5-year follow-up period, and in 366 sex-and age-matched controls. Cases with recurrent coronary events and controls had similar PTX3 levels, and PTX3 did not predict recurrent coronary events - a finding that contrasts with that of C-reactive protein (CRP) and serum amyloid A (SAA) in this cohort. We then associated PTX3 levels with metabolic disorders. Low plasma PTX3 levels correlated with high body-mass index, waist circumference, and triglycerides; and with low HDL cholesterol. Overall, PTX3 levels correlated inversely with the number of metabolic syndrome components. PTX3 levels also correlated inversely with apoCIII and tissue plasminogen activator, but did not associate with CRP. Although the study further links low PTX3 levels with various features associated with metabolic syndrome, the results do not indicate that PTX3 can predict recurrent coronary events among MI survivors.	[Miyazaki, Tetsuro; Sacks, Frank M.; Ridker, Paul M.; Libby, Peter; Aikawa, Masanori] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Chiuve, Stephanie; Sacks, Frank M.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ridker, Paul M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Miyazaki, T (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA.	tetsuro@juntendo.ac.jp	Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X; Aikawa, Masanori/0000-0002-9275-2079; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Institutes of Health [R01HL66086, R01HL107550]; Perseus Proteomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107550, R01HL066086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perseus Proteomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by grants from the National Institutes of Health (R01HL66086 and R01HL107550, to M. A.) and from Perseus Proteomics (to M. A.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahim-Ferkoune A, 2003, J LIPID RES, V44, P994, DOI 10.1194/jlr.M200382-JLR200; Alberti L, 2009, ATHEROSCLEROSIS, V202, P455, DOI 10.1016/j.atherosclerosis.2008.05.015; ALLES VV, 1994, BLOOD, V84, P3483; Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; Camozzi M, 2005, ARTERIOSCL THROM VAS, V25, P1837, DOI 10.1161/01.ATV.0000177807.54959.7d; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Doni A, 2006, J LEUKOCYTE BIOL, V79, P797, DOI 10.1189/jlb.0905493; Dubin R, 2012, AM HEART J, V163, P274, DOI 10.1016/j.ahj.2011.11.007; Fung E, 2007, CIRCULATION, V115, P2948, DOI 10.1161/CIRCULATIONAHA.106.675462; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Inoue K, 2007, ARTERIOSCL THROM VAS, V27, P161, DOI 10.1161/01.ATV.0000252126.48375.d5; Inoue K, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/657025; Jenny NS, 2009, ARTERIOSCL THROM VAS, V29, P594, DOI 10.1161/ATVBAHA.108.178947; Klouche M, 2004, ATHEROSCLEROSIS, V175, P221, DOI 10.1016/j.atherosclerosis.2004.03.020; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; Maekawa Yuichiro, 2011, Inflammation & Allergy Drug Targets, V10, P229; Matsubara J, 2011, J AM COLL CARDIOL, V57, P861, DOI 10.1016/j.jacc.2010.10.018; Matter CM, 2007, CIRCULATION, V115, P946, DOI 10.1161/CIRCULATIONAHA.106.685230; Miyamoto T, 2011, CLIN J AM SOC NEPHRO, V6, P2785, DOI 10.2215/CJN.02320311; Norata GD, 2008, ARTERIOSCL THROM VAS, V28, P925, DOI 10.1161/ATVBAHA.107.160606; Norata GD, 2009, CIRCULATION, V120, P699, DOI 10.1161/CIRCULATIONAHA.108.806547; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; PFEFFER MA, 1995, AM J CARDIOL, V76, pC98, DOI 10.1016/S0002-9149(99)80478-0; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rolph MS, 2002, ARTERIOSCL THROM VAS, V22, pE10, DOI 10.1161/01.ATV.0000015595.95497.2F; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Savchenko AS, 2008, J PATHOL, V215, P48, DOI 10.1002/path.2314; Shah PK, 2007, CIRC RES, V100, P1531, DOI 10.1161/CIRCRESAHA.107.101104; Souza DG, 2002, AM J PATHOL, V160, P1755, DOI 10.1016/S0002-9440(10)61122-4; Suliman ME, 2008, CLIN J AM SOC NEPHRO, V3, P976, DOI 10.2215/CJN.03960907; Suzuki S, 2008, AM HEART J, V155, P75, DOI 10.1016/j.ahj.2007.08.013; Suzuki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053133; Yamasaki K, 2009, CLIN CHEM LAB MED, V47, P471, DOI 10.1515/CCLM.2009.110; Zheng CY, 2007, J LIPID RES, V48, P1190, DOI 10.1194/jlr.P600011-JLR200; Zheng CY, 2013, EUR HEART J, V34, P615, DOI 10.1093/eurheartj/ehs271	42	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94073	10.1371/journal.pone.0094073	http://dx.doi.org/10.1371/journal.pone.0094073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705587	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500120
J	Cheng, FY; Yang, YR; Wang, CJ; Wu, YR; Cheng, SJ; Wang, HC; Wang, RY				Cheng, Fang-Yu; Yang, Yea-Ru; Wang, Chung-Jen; Wu, Yih-Ru; Cheng, Shih-Jung; Wang, Han-Cheng; Wang, Ray-Yau			Factors Influencing Turning and Its Relationship with Falls in Individuals with Parkinson's Disease	PLOS ONE			English	Article							GAIT; WALKING; PEOPLE; PREDICTORS; MOVEMENT; MOBILITY	Background: Falls are a major problem for people with Parkinson's disease (PD). Many studies indicate that more than 50% of people with PD have difficulty in turning that may lead to falls during daily activities. The aims of this study were to identify the relationship between turning performance and falls, and to determine the factors that influence turning performance. Methods: This study examined 45 patients with idiopathic PD (Hoehn and Yahr stage 1-3) using a battery of tests, including 180 degrees turn time, balance, and muscle strength. The levels of disease severity and freezing of gait were also measured. The number of falls in the past 6 months was recorded. Results: Sixteen out of forty-five participants experienced falls in the past 6 months. A receiver operating characteristic curve showed that turn time was highly related to falls [more affected side: sensitivity = 0.81, specificity = 0.79, area under the curve (AUC) = 0.83; less affected side: sensitivity = 0.88, specificity = 0.76, AUC = 0.83]. The most important factor influencing turn time was balance ability (both sides: p = 0.000) according to the regression model. Correlations between turn time and dynamic balance were further established with reaction time, movement velocity, endpoint excursion, and maximal excursion of the LOS (limits of stability) test. Conclusion: The time needed to complete a 180 degrees turn during the SQT (step/quick turn) test is a good index to differentiate fallers from non-fallers in persons with PD. Turn time is most influenced by balance. Furthermore, balance control, especially in an anterior or sideways direction, is important for turning performance.	[Cheng, Fang-Yu; Yang, Yea-Ru; Wang, Ray-Yau] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan; [Wang, Chung-Jen] Cheng Hsin Gen Hosp, Dept Neurol, Taipei, Taiwan; [Wu, Yih-Ru] Chang Guan Mem Hosp, Dept Neuromuscular Disorder, Linkou, Taiwan; [Cheng, Shih-Jung] Mackay Mem Hosp, Dept Neurol, Taipei, Taiwan; [Wang, Han-Cheng] Shin Kong Wu Ho Mem Hosp, Dept Neurol, Taipei, Taiwan	National Yang Ming Chiao Tung University; Cheng Hsin General Hospital; Chang Gung Memorial Hospital; Mackay Memorial Hospital; Shin Kong Wu Ho Su Memorial Hospital	Wang, RY (corresponding author), Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan.	rywang@ym.edu.tw			Cheng Hsin Rehabilitation Medical Center [101F195CY23]; National Science Council [NSC100-2314-B-010-022-MY2]	Cheng Hsin Rehabilitation Medical Center; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Cheng Hsin Rehabilitation Medical Center (Grant No. 101F195CY23) and National Science Council (NSC100-2314-B-010-022-MY2). In addition, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOHANNON RW, 1986, PHYS THER, V66, P206, DOI 10.1093/ptj/66.2.206; CUMMING RG, 1994, J AM GERIATR SOC, V42, P774, DOI 10.1111/j.1532-5415.1994.tb06540.x; Faria CDCM, 2009, BRAZ J PHYS THER, V13, P451, DOI 10.1590/S1413-35552009005000052; Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0; Huxham F, 2008, MOVEMENT DISORD, V23, P817, DOI 10.1002/mds.21932; Jessop RT, 2006, NEUROREHAB NEURAL RE, V20, P459, DOI 10.1177/1545968306287107; JORDAN N, 1992, J NEUROL NEUROSUR PS, V55, P658, DOI 10.1136/jnnp.55.8.658; Kerr GK, 2010, NEUROLOGY, V75, P116, DOI 10.1212/WNL.0b013e3181e7b688; Laessoe U, 2008, GAIT POSTURE, V28, P62, DOI 10.1016/j.gaitpost.2007.10.001; Louie S, 2009, MOVEMENT DISORD, V24, P1991, DOI 10.1002/mds.22741; Mak MKY, 2008, EXP BRAIN RES, V190, P43, DOI 10.1007/s00221-008-1446-1; Mak MKY, 2009, J NEUROL, V256, P742, DOI 10.1007/s00415-009-5007-8; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Mancini M, 2008, CLIN BIOMECH BRISTOL; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; Morris ME, 2001, CLIN BIOMECH, V16, P459, DOI 10.1016/S0268-0033(01)00035-3; NeuroCom International, 2001, BAL MAN SYST CLIN OP; Patla AE, 1999, EXP BRAIN RES, V129, P629, DOI 10.1007/s002210050932; Stack EL, 2006, PARKINSONISM RELAT D, V12, P87, DOI 10.1016/j.parkreldis.2005.08.008; Tan D, 2012, PARKINSONISM RELAT D, V18, P117, DOI 10.1016/j.parkreldis.2011.07.014; Thigpen MT, 2000, PHYS THER, V80, P1174, DOI 10.1093/ptj/80.12.1174; Thomas AA, 2010, J NEUROL, V257, P1124, DOI 10.1007/s00415-010-5475-x; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Vaishali P., 2012, INT J BIOL MED RES, V3, P1392; Visser JE, 2007, CLIN NEUROPHYSIOL, V118, P1602, DOI 10.1016/j.clinph.2007.03.010; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	26	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93572	10.1371/journal.pone.0093572	http://dx.doi.org/10.1371/journal.pone.0093572			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699675	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000071
J	Nunez, DJ; Bush, MA; Collins, DA; McMullen, SL; Gillmor, D; Apseloff, G; Atiee, G; Corsino, L; Morrow, L; Feldman, PL				Nunez, Derek J.; Bush, Mark A.; Collins, David A.; McMullen, Susan L.; Gillmor, Dawn; Apseloff, Glen; Atiee, George; Corsino, Leonor; Morrow, Linda; Feldman, Paul L.			Gut Hormone Pharmacology of a Novel GPR119 Agonist (GSK1292263), Metformin, and Sitagliptin in Type 2 Diabetes Mellitus: Results from Two Randomized Studies	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; RECEPTOR AGONIST; ORAL METFORMIN; OBESE-PATIENTS; WEIGHT-LOSS; IV ACTIVITY; GLUCOSE; INHIBITION; SECRETION; DEGRADATION	GPR119 receptor agonists improve glucose metabolism and alter gut hormone profiles in animal models and healthy subjects. We therefore investigated the pharmacology of GSK1292263 (GSK263), a selective GPR119 agonist, in two randomized, placebo-controlled studies that enrolled subjects with type 2 diabetes. Study 1 had drug-naive subjects or subjects who had stopped their diabetic medications, and Study 2 had subjects taking metformin. GSK263 was administered as single (25-800 mg; n = 45) or multiple doses (100-600 mg/day for 14 days; n = 96). Placebo and sitagliptin 100 mg/day were administered as comparators. In Study 1, sitagliptin was co-administered with GSK263 or placebo on Day 14 of dosing. Oral glucose and meal challenges were used to assess the effects on plasma glucose, insulin, C-peptide, glucagon, peptide tyrosine-tyrosine (PYY), glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP). After 13 days of dosing, GSK263 significantly increased plasma total PYY levels by, five-fold compared with placebo, reaching peak concentrations of similar to 50 pM after each of the three standardized meals with the 300 mg BID dose. Co-dosing of GSK263 and metformin augmented peak concentrations to,100 pM at lunchtime. GSK263 had no effect on active or total GLP-1 or GIP, but co-dosing with metformin increased post-prandial total GLP-1, with little effect on active GLP-1. Sitagliptin increased active GLP-1, but caused a profound suppression of total PYY, GLP-1, and GIP when dosed alone or with GSK263. This suppression of peptides was reduced when sitagliptin was co-dosed with metformin. GSK263 had no significant effect on circulating glucose, insulin, C-peptide or glucagon levels. We conclude that GSK263 did not improve glucose control in type 2 diabetics, but it had profound effects on circulating PYY. The gut hormone effects of this GPR119 agonist were modulated when co-dosed with metformin and sitagliptin. Metformin may modulate negative feedback loops controlling the secretion of enteroendocrine peptides.	[Nunez, Derek J.; Bush, Mark A.; Collins, David A.; McMullen, Susan L.; Gillmor, Dawn; Feldman, Paul L.] GlaxoSmithKline Res & Dev Ltd, Res Triangle Pk, NC 27709 USA; [Apseloff, Glen] Ohio State Univ, Clin Pharmacol Unit, Columbus, OH 43210 USA; [Atiee, George] Worldwide Clin Trials, San Antonio, TX USA; [Corsino, Leonor] Duke Univ, Med Ctr, Durham, NC USA; [Morrow, Linda] Profil Inst Clin Res, Chula Vista, CA USA	GlaxoSmithKline; University System of Ohio; Ohio State University; Duke University	Nunez, DJ (corresponding author), GlaxoSmithKline Res & Dev Ltd, Res Triangle Pk, NC 27709 USA.	derek.j.nunez@gsk.com			GlaxoSmithKline Research and Development; GlaxoSmithKline	GlaxoSmithKline Research and Development(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline)	The studies were funded by GlaxoSmithKline Research and Development. Funding for editorial assistance was provided by GlaxoSmithKline. Employees of GlaxoSmithKline R&D were involved in the design of the two studies, data collection and analysis, decision to publish, and preparation of the manuscript.	Aaboe K, 2010, DIABETES OBES METAB, V12, P323, DOI 10.1111/j.1463-1326.2009.01167.x; Babilon S, 2013, BIOL CHEM, V394, P921, DOI 10.1515/hsz-2013-0123; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; Beckman LM, 2010, J AM DIET ASSOC, V110, P571, DOI 10.1016/j.jada.2009.12.023; Chronaiou A, 2012, OBES SURG, V22, P1761, DOI 10.1007/s11695-012-0738-5; Correia S, 2008, MINI-REV MED CHEM, V8, P1343, DOI 10.2174/138955708786369546; Cuthbertson J, 2009, DIABETIC MED, V26, P649, DOI 10.1111/j.1464-5491.2009.02748.x; Dalla Man C, 2005, DIABETES, V54, P3265, DOI 10.2337/diabetes.54.11.3265; Deacon CF, 2007, EXPERT OPIN INV DRUG, V16, P533, DOI 10.1517/13543784.16.4.533; Deacon CF, 2004, HORM METAB RES, V36, P761, DOI 10.1055/s-2004-826160; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; El-Ouaghlidi A, 2007, J CLIN ENDOCR METAB, V92, P4165, DOI 10.1210/jc.2006-1932; Engelstoft MS, 2013, CURR OPIN PHARMACOL, V13, P912, DOI 10.1016/j.coph.2013.09.018; Engelstoft MS, 2008, CELL METAB, V8, P447, DOI 10.1016/j.cmet.2008.11.004; FANG J, 2008, Patent No. 2007086434; Goodman ML, 2011, DIABETES, V60, pA84; Green BD, 2006, EUR J PHARMACOL, V547, P192, DOI 10.1016/j.ejphar.2006.07.043; Herman GA, 2006, J CLIN ENDOCR METAB, V91, P4612, DOI 10.1210/jc.2006-1009; Hinke SA, 2002, BIOCHEM BIOPH RES CO, V291, P1302, DOI 10.1006/bbrc.2002.6607; International Conference on Harmonization, 1996, INT C HARM TECHN REQ; Karra E, 2009, J PHYSIOL-LONDON, V587, P19, DOI 10.1113/jphysiol.2008.164269; Katz LB, 2012, DIABETES OBES METAB, V14, P709, DOI 10.1111/j.1463-1326.2012.01587.x; Katz LB, 2011, CLIN PHARMACOL THER, V90, P685, DOI 10.1038/clpt.2011.169; Lan H, 2009, J ENDOCRINOL, V201, P219, DOI 10.1677/JOE-08-0453; le Roux CW, 2007, ANN SURG, V246, P780, DOI 10.1097/SLA.0b013e3180caa3e3; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; Lindsay JR, 2005, DIABETIC MED, V22, P654, DOI 10.1111/j.1464-5491.2005.01461.x; Mannucci E, 2004, DIABETES NUTR METAB, V17, P336; Migoya EM, 2010, CLIN PHARMACOL THER, V88, P801, DOI 10.1038/clpt.2010.184; Mulherin AJ, 2011, ENDOCRINOLOGY, V152, P4610, DOI 10.1210/en.2011-1485; Naslund E, 1999, AM J PHYSIOL-REG I, V277, pR910, DOI 10.1152/ajpregu.1999.277.3.R910; Natali A, 2006, DIABETOLOGIA, V49, P434, DOI 10.1007/s00125-006-0141-7; Nauck MA, 2009, AM J MED, V122, P3, DOI 10.1016/j.amjmed.2009.03.012; Odori S, 2013, METABOLISM, V62, P70, DOI 10.1016/j.metabol.2012.06.010; Ohishi T, 2012, EXPERT OPIN INV DRUG, V21, P321, DOI 10.1517/13543784.2012.657797; Polli JW, 2013, XENOBIOTICA, V43, P498, DOI 10.3109/00498254.2012.739719; Roberts B, 2010, DIABETES, V59, pA164; Roberts B, 2009, DIABETES, V58, pA43; Sangle GV, 2012, ENDOCRINOLOGY, V153, P564, DOI 10.1210/en.2011-1732; Shah U, 2010, VITAM HORM, V84, P415, DOI [10.1016/S0083-6729(10)84001-4, 10.1016/B978-0-12-381517-0.00016-3]; Sze L, 2011, J CLIN ENDOCR METAB, V96, pE1314, DOI 10.1210/jc.2011-0038; Tharakan G, 2011, TRENDS PHARMACOL SCI, V32, P8, DOI 10.1016/j.tips.2010.10.003; Thondam SK, 2012, DIABETIC MED, V29, pE205, DOI 10.1111/j.1464-5491.2012.03675.x; [Anonymous], 2000, JAMA, V284, P3043, DOI 10.1001/jama.2013.281053; Yasuda N, 2002, BIOCHEM BIOPH RES CO, V298, P779, DOI 10.1016/S0006-291X(02)02565-2	46	51	55	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92494	10.1371/journal.pone.0092494	http://dx.doi.org/10.1371/journal.pone.0092494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699248	Green Published, gold			2022-12-27	WOS:000334105000029
J	Sundararaj, S; Saxena, AK; Sharma, R; Vashisht, K; Sharma, S; Anvikar, A; Dixit, R; Rosenthal, PJ; Pandey, KC				Sundararaj, Srinivasan; Saxena, Ajay K.; Sharma, Ruby; Vashisht, Kapil; Sharma, Supriya; Anvikar, Anup; Dixit, Rajnikant; Rosenthal, Philip J.; Pandey, Kailash C.			Cross-Talk between Malarial Cysteine Proteases and Falstatin: The BC Loop as a Hot-Spot Target	PLOS ONE			English	Article							STRUCTURAL BASIS; FALCIPAIN-2; HEMOGLOBIN; INHIBITOR; CHAGASIN; BINDING; IDENTIFICATION; VIVAPAINS	Cysteine proteases play a crucial role in the development of the human malaria parasites Plasmodium falciparum and Plasmodium vivax. Our earlier studies demonstrated that these enzymes are equipped with specific domains for defined functions and further suggested the mechanism of activation of cysteine proteases. The activities of these proteases are regulated by a new class of endogenous inhibitors of cysteine proteases (ICPs). Structural studies of the ICPs of Trypanosoma cruzi (chagasin) and Plasmodium berghei (PbICP) indicated that three loops (termed BC, DE, and FG) are crucial for binding to target proteases. Falstatin, an ICP of P. falciparum, appears to play a crucial role in invasion of erythrocytes and hepatocytes. However, the mechanism of inhibition of cysteine proteases by falstatin has not been established. Our study suggests that falstatin is the first known ICP to function as a multimeric protein. Using site-directed mutagenesis, hemoglobin hydrolysis assays and peptide inhibition studies, we demonstrate that the BC loop, but not the DE or FG loops, inhibits cysteine proteases of P. falciparum and P. vivax via hydrogen bonds. These results suggest that the BC loop of falstatin acts as a hot-spot target for inhibiting malarial cysteine proteases. This finding suggests new strategies for the development of anti-malarial agents based on protease-inhibitor interactions.	[Sundararaj, Srinivasan; Vashisht, Kapil; Sharma, Supriya; Anvikar, Anup; Dixit, Rajnikant; Pandey, Kailash C.] Indian Council Med Res, Natl Inst Malaria Res, Host Parasite Interact Biol Grp, New Delhi, India; [Saxena, Ajay K.; Sharma, Ruby] Jawaharlal Nehru Univ, Sch Life Sci, Struct Biol Lab, New Delhi 110067, India; [Rosenthal, Philip J.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Jawaharlal Nehru University, New Delhi; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Pandey, KC (corresponding author), Indian Council Med Res, Natl Inst Malaria Res, Host Parasite Interact Biol Grp, New Delhi, India.	kailashcp@mrcindia.org	vashisht, kapil/ABB-3966-2020; Sundararaj, Srinivasan/AAF-6809-2019; Pandey, Kailash/H-5048-2011; Sharma, Supriya/M-3849-2017; Dixit, Rajnikant/D-2566-2009	Dixit, Rajnikant/0000-0002-3536-8329; SHARMA, RUBY/0000-0002-8441-0415; sundararaj, Srinivasan/0000-0002-9112-2454	Department of Biotechnology, Government of India [BT/HRD/35/02/2006]; Ramalingaswami Fellowship; NIMR	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Ramalingaswami Fellowship; NIMR	Work in the laboratory is supported by Department of Biotechnology, Government of India (BT/HRD/35/02/2006, dated 05.02.2010). KCP is a recipient of a Ramalingaswami Fellowship. The authors thank NIMR for extramural funds for setting a new laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farias SL, 2005, MOL BIOCH; Hansen G, 2011, STRUCTURE, V19, P919, DOI 10.1016/j.str.2011.03.025; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jo H, 2012, J AM CHEM SOC, V134, P17704, DOI 10.1021/ja307599z; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kang JM, 2012, PARASITOLOGY, V139, P1029, DOI 10.1017/S0031182012000297; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kerr ID, 2009, J BIOL CHEM, V284, P25697, DOI 10.1074/jbc.M109.014340; Kerr LD, 2009, J MED CHEM, V52, P852, DOI 10.1021/jm8013663; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Liu S, 2004, PROTEINS, V56, P93, DOI 10.1002/prot.20019; Monteiro ACS, 2001, J CELL SCI, V114, P3933; Moon SU, 2011, EXP PARASITOL, V128, P127, DOI 10.1016/j.exppara.2011.02.015; Na BK, 2004, BIOCHEM J, V378, P529, DOI 10.1042/BJ20031487; Pandey KC, 2006, PLOS PATHOG, V2, P1031, DOI 10.1371/journal.ppat.0020117; Pandey KC, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/345195; Pandey Kailash C, 2011, J Parasit Dis, V35, P94; Pandey KC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005694; Pandey KC, 2005, P NATL ACAD SCI USA, V102, P9138, DOI 10.1073/pnas.0502368102; Rennenberg A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000825; Shahian T, 2009, NAT CHEM BIOL, V5, P640, DOI 10.1038/nchembio.192; Sijwali PS, 2002, J BIOL CHEM, V277, P14910, DOI 10.1074/jbc.M109680200; Smith BO, 2005, J BIOL CHEM, V510, P868; Subramanian S, 2007, J BIOL CHEM, V282, P24961, DOI 10.1074/jbc.M703316200; Sundararaj S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047227; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Men TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-272; Wang SX, 2007, STRUCTURE, V15, P535, DOI 10.1016/j.str.2007.03.012; Wang SX, 2006, P NATL ACAD SCI USA, V103, P11503, DOI 10.1073/pnas.0600489103; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; WHO, 2010, WORLD MALARIA REPORT 2010, P1	36	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93008	10.1371/journal.pone.0093008	http://dx.doi.org/10.1371/journal.pone.0093008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699522	gold, Green Submitted, Green Published			2022-12-27	WOS:000334105000039
J	Liu, DG; Wang, LJ; Liu, CL; Song, XJ; He, SZ; Zhai, H; Liu, QC				Liu, Degao; Wang, Lianjun; Liu, Chenglong; Song, Xuejin; He, Shaozhen; Zhai, Hong; Liu, Qingchang			An Ipomoea batatas Iron-Sulfur Cluster Scaffold Protein Gene, IbNFU1, Is Involved in Salt Tolerance	PLOS ONE			English	Article							EMBRYOGENIC SUSPENSION-CULTURES; PROLINE ACCUMULATION; STRESS TOLERANCE; SWEET-POTATO; TRANSCRIPT EXPRESSION; PLANT-REGENERATION; FERREDOXIN; MECHANISMS; REDUCTASE; SALINITY	Iron-sulfur cluster biosynthesis involving the nitrogen fixation (Nif) proteins has been proposed as a general mechanism acting in various organisms. NifU-like protein may play an important role in protecting plants against abiotic and biotic stresses. An iron-sulfur cluster scaffold protein gene, IbNFU1, was isolated from a salt-tolerant sweetpotato (Ipomoea batatas (L.) Lam.) line LM79 in our previous study, but its role in sweetpotato stress tolerance was not investigated. In the present study, the IbNFU1 gene was introduced into a salt-sensitive sweetpotato cv. Lizixiang to characterize its function in salt tolerance. The IbNFU1-overexpressing sweetpotato plants exhibited significantly higher salt tolerance compared with the wild-type. Proline and reduced ascorbate content were significantly increased, whereas malonaldehyde (MDA) content was significantly decreased in the transgenic plants. The activities of superoxide dismutase (SOD) and photosynthesis were significantly enhanced in the transgenic plants. H2O2 was also found to be significantly less accumulated in the transgenic plants than in the wild-type. Overexpression of IbNFU1 up-regulated pyrroline-5-carboxylate synthase (P5CS) and pyrroline-5- carboxylate reductase (P5CR) genes under salt stress. The systemic up-regulation of reactive oxygen species (ROS) scavenging genes was found in the transgenic plants under salt stress. These findings suggest that IbNFU1gene is involved in sweetpotato salt tolerance and enhances salt tolerance of the transgenic sweetpotato plants by regulating osmotic balance, protecting membrane integrity and photosynthesis and activating ROS scavenging system.	[Liu, Degao; Wang, Lianjun; Liu, Chenglong; Song, Xuejin; He, Shaozhen; Zhai, Hong; Liu, Qingchang] China Agr Univ, Minist Educ, Lab Crop Heterosis & Utilizat, Beijing Key Lab Crop Genet Improvement, Beijing 100094, Peoples R China; [Wang, Lianjun] Hubei Acad Agr Sci, Inst Food Crops, Wuhan, Peoples R China	China Agricultural University; Hubei Academy of Agricultural Sciences	Liu, QC (corresponding author), China Agr Univ, Minist Educ, Lab Crop Heterosis & Utilizat, Beijing Key Lab Crop Genet Improvement, Beijing 100094, Peoples R China.	liuqc@cau.edu.cn	Liu, Degao/L-3682-2016	Liu, Degao/0000-0002-0090-9455	China Agriculture Research System [CARS-11]; National Natural Science Foundation of China [31371680]; Hubei Innovation Center of Agricultural Science and Technology [2007-620-001-03]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Innovation Center of Agricultural Science and Technology	This work was supported by China Agriculture Research System (CARS-11, Sweetpotato), the National Natural Science Foundation of China (31371680) and Hubei Innovation Center of Agricultural Science and Technology (2007-620-001-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar JN, 2000, J BIOL INORG CHEM, V5, P167, DOI 10.1007/s007750050361; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Asano T, 2012, PLANT J, V69, P26, DOI 10.1111/j.1365-313X.2011.04766.x; Balasubramanian R, 2006, J BACTERIOL, V188, P3182, DOI 10.1128/JB.188.9.3182-3191.2006; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Balk J, 2011, TRENDS PLANT SCI, V16, P218, DOI 10.1016/j.tplants.2010.12.006; Bao AK, 2009, PLANT SCI, V176, P232, DOI 10.1016/j.plantsci.2008.10.009; Chen HC, 2010, INTEGR SER INFORM SY, V21, P167, DOI 10.1007/978-1-4419-1278-7_12; de Ronde JA, 2000, PLANT GROWTH REGUL, V32, P13, DOI 10.1023/A:1006338911617; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Deng XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069881; Dhir SK, 1998, PLANT CELL REP, V17, P665, DOI 10.1007/s002990050462; Dietz KJ, 2006, J EXP BOT, V57, P1697, DOI 10.1093/jxb/erj160; Eltayeb AE, 2006, PHYSIOL PLANTARUM, V127, P57, DOI 10.1111/j.1399-3054.2006.00624.x; Fan WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037344; Fernandez-Falcon M, 2006, SCI HORTIC-AMSTERDAM, V107, P373, DOI 10.1016/j.scienta.2005.08.009; Fricke W, 2004, J EXP BOT, V55, P1115, DOI 10.1093/jxb/erh117; Gallie DR, 2013, J EXP BOT, V64, P433, DOI 10.1093/jxb/ers330; Gao S, 2011, PLANT CELL TISS ORG, V107, P205, DOI 10.1007/s11240-011-9971-1; Giacomelli L, 2007, PLANT MOL BIOL, V65, P627, DOI 10.1007/s11103-007-9227-y; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Hase Toshiharu, 2006, V24, P477; He SZ, 2009, PLANT CELL TISS ORG, V96, P69, DOI 10.1007/s11240-008-9461-2; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; HU CAA, 1992, P NATL ACAD SCI USA, V89, P9354, DOI 10.1073/pnas.89.19.9354; JEFFERSON RA, 1987, EMBO J, V6, P3901; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Koca H, 2006, BIOL PLANTARUM, V50, P745, DOI 10.1007/s10535-006-0121-2; Kumar V, 2010, PLANT BIOTECHNOL REP, V4, P37, DOI 10.1007/s11816-009-0118-3; Kumeta H, 2007, J BIOMOL NMR, V38, P161, DOI 10.1007/s10858-007-9155-9; Leon S, 2003, BIOCHEM J, V371, P823, DOI 10.1042/BJ20021946; Lin YH, 2013, INT J MOL SCI, V14, P20913, DOI 10.3390/ijms141020913; Lintala M, 2009, PLANT J, V57, P1103, DOI 10.1111/j.1365-313X.2008.03753.x; Liu DG, 2014, PLANT CELL TISS ORG, V117, P1, DOI 10.1007/s11240-013-0415-y; Liu QC, 2001, IN VITRO CELL DEV-PL, V37, P564; Mano J, 2001, BBA-BIOENERGETICS, V1504, P275, DOI 10.1016/S0005-2728(00)00256-5; Mishra MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063064; MIYAKE C, 1994, PLANT CELL PHYSIOL, V35, P539, DOI 10.1093/oxfordjournals.pcp.a078628; Mohammadi M, 2008, GENOME, V51, P357, DOI 10.1139/G08-020; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; SAVOURE A, 1995, FEBS LETT, V372, P13, DOI 10.1016/0014-5793(95)00935-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Shim KS, 2004, PLANT CELL REP, V22, P599, DOI 10.1007/s00299-003-0742-2; Sun YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059924; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; SZOKE A, 1992, PLANT PHYSIOL, V99, P1642, DOI 10.1104/pp.99.4.1642; Tognetti VB, 2006, PLANT CELL, V18, P2035, DOI 10.1105/tpc.106.042424; Touraine B, 2004, PLANT J, V40, P101, DOI 10.1111/j.1365-313X.2004.02189.x; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; VERBRUGGEN N, 1993, PLANT PHYSIOL, V103, P771, DOI 10.1104/pp.103.3.771; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Wang LJ, 2013, J INTEGR AGR, V12, P27, DOI 10.1016/S2095-3119(13)60202-6; Wang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058952; WATAD AEA, 1983, PLANT PHYSIOL, V73, P624, DOI 10.1104/pp.73.3.624; WYNJONES RG, 1978, AUST J PLANT PHYSIOL, V5, P817, DOI 10.1071/PP9780817; Xu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069810, 10.1371/journal.pone.0079289]; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Yale J, 2001, J BIOL CHEM, V276, P15996, DOI 10.1074/jbc.M008209200; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Yu B, 2007, PLANT CELL TISS ORG, V90, P265, DOI 10.1007/s11240-007-9265-9; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599; Zang N, 2009, SCI HORTIC-AMSTERDAM, V122, P649, DOI 10.1016/j.scienta.2009.06.023; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhang H, 2012, PLANT CELL TISS ORG, V110, DOI 10.1007/s11240-012-0142-9; Zhao Q, 2013, J PROTEOMICS, V82, P230, DOI 10.1016/j.jprot.2013.01.024; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, J BIOL CHEM, V269, P18723	73	18	22	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93935	10.1371/journal.pone.0093935	http://dx.doi.org/10.1371/journal.pone.0093935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695556	Green Submitted, Green Published, gold			2022-12-27	WOS:000334103000131
J	de Souza, JES; Fonseca, AF; Valieris, R; Carraro, DM; Wang, JYJ; Kolodner, RD; de Souza, SJ				de Souza, Jorge E. S.; Fonseca, Andre F.; Valieris, Renan; Carraro, Dirce M.; Wang, Jean Y. J.; Kolodner, Richard D.; de Souza, Sandro J.			S-Score: A Scoring System for the Identification and Prioritization of Predicted Cancer Genes	PLOS ONE			English	Article							HUMAN BREAST; MUTATIONS; CARCINOMA; PATHWAY; GENOMES; NOTCH1; LMO7	A new method, which allows for the identification and prioritization of predicted cancer genes for future analysis, is presented. This method generates a gene-specific score called the "S-Score'' by incorporating data from different types of analysis including mutation screening, methylation status, copy-number variation and expression profiling. The method was applied to the data from The Cancer Genome Atlas and allowed the identification of known and potentially new oncogenes and tumor suppressors associated with different clinical features including shortest term of survival in ovarian cancer patients and hormonal subtypes in breast cancer patients. Furthermore, for the first time a genome-wide search for genes that behave as oncogenes and tumor suppressors in different tumor types was performed. We envisage that the S-score can be used as a standard method for the identification and prioritization of cancer genes for follow-up studies.	[de Souza, Jorge E. S.; Fonseca, Andre F.; Valieris, Renan] Inst Bioinformat & Biotechnol, Sao Paulo, Brazil; [de Souza, Jorge E. S.] Univ Sao Paulo, Fac Med, Ctr Cell Therapy, BR-14049 Ribeirao Preto, Brazil; [de Souza, Jorge E. S.] Univ Sao Paulo, Fac Med, Reg Blood Ctr, Dept Clin Med, BR-14049 Ribeirao Preto, Brazil; [Fonseca, Andre F.; de Souza, Sandro J.] Univ Fed Rio Grande do Norte, Inst Brain, Natal, RN, Brazil; [de Souza, Jorge E. S.; Valieris, Renan; Carraro, Dirce M.] Int Res Ctr, CIPE AC Camargo Canc Ctr, Sao Paulo, Brazil; [Wang, Jean Y. J.; Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Moores UCSD Canc Ctr, San Diego, CA 92103 USA; [Wang, Jean Y. J.; Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA; [Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Moores UCSD Canc Ctr,San Diego Branch, Dept Med & Cellular & Mol Med,Ludwig Inst Canc Re, San Diego, CA 92103 USA; [Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Inst Genom Med, San Diego, CA 92103 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Rio Grande do Norte; A.C.Camargo Cancer Center; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	de Souza, SJ (corresponding author), Univ Fed Rio Grande do Norte, Inst Brain, Natal, RN, Brazil.	sandro@neuro.ufrn.br	carraro, dirce/C-9179-2009; de Souza, Sandro Jose/AAG-6270-2020	carraro, dirce/0000-0001-5667-1418; 	CNPq [483775/2012-6]; National Institutes of Health [GM26017]; NATIONAL CANCER INSTITUTE [R01CA043054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026017, R37GM026017] Funding Source: NIH RePORTER	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by CNPq grant 483775/2012-6 to SJS and by National Institutes of Health grant GM26017 to RDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Burska UL, 2013, J BIOL CHEM; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collier LS, 2006, CURR OPIN GENET DEV, V16, P23, DOI 10.1016/j.gde.2005.11.001; Dai JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021120; Eifert C, 2012, NAT REV CANCER, V12, P572, DOI 10.1038/nrc3299; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gangula NR, 2013, J BIOL CHEM; Gnad F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S7; Hu QD, 2011, MOL CELL BIOL, V31, P3223, DOI 10.1128/MCB.01365-10; Huang L, 2011, CANCER-AM CANCER SOC, V117, P3363, DOI 10.1002/cncr.25870; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakamura H, 2005, CANCER LETT, V220, P95, DOI 10.1016/j.canlet.2004.07.023; Nakamura H, 2011, EXP THER MED, V2, P1053, DOI 10.3892/etm.2011.329; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Patel VN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003237; Pope WB, 2008, RADIOLOGY, V249, P268, DOI 10.1148/radiol.2491072000; Tanaka-Okamoto M, 2009, CANCER SCI, V100, P608, DOI 10.1111/j.1349-7006.2009.01091.x; Viatour P, 2011, J EXP MED, V208, P1963, DOI 10.1084/jem.20110198; Volgestein B, 2013, SCIENCE, V339, P1546; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zins K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074924	29	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94147	10.1371/journal.pone.0094147	http://dx.doi.org/10.1371/journal.pone.0094147			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710071	gold, Green Published			2022-12-27	WOS:000334159800107
J	Hosseini-Mazinani, M; Mariotti, R; Torkzaban, B; Sheikh-Hassani, M; Ataei, S; Cultrera, NGM; Pandolfi, S; Baldoni, L				Hosseini-Mazinani, Mehdi; Mariotti, Roberto; Torkzaban, Bahareh; Sheikh-Hassani, Massoma; Ataei, Saeedeh; Cultrera, Nicolo G. M.; Pandolfi, Saverio; Baldoni, Luciana			High Genetic Diversity Detected in Olives beyond the Boundaries of the Mediterranean Sea	PLOS ONE			English	Article							OLEA-EUROPAEA L.; CULTIVATED OLIVES; WILD OLIVES; DOMESTICATION; CUSPIDATA; SOFTWARE; DIFFERENTIATION; IDENTIFICATION; PROVINCE; HISTORY	Background: Olive trees (Olea europaea subsp. europaea var. europaea) naturally grow in areas spanning the Mediterranean basin and towards the East, including the Middle East. In the Iranian plateau, the presence of olives has been documented since very ancient times, though the early history of the crop in this area is shrouded in uncertainty. Methods: The varieties presently cultivated in Iran and trees of an unknown cultivation status, surviving under extreme climate and soil conditions, were sampled from different provinces and compared with a set of Mediterranean cultivars. All samples were analyzed using SSR and chloroplast markers to establish the relationships between Iranian olives and Mediterranean varieties, to shed light on the origins of Iranian olives and to verify their contribution to the development of the current global olive variation. Results: Iranian cultivars and ecotypes, when analyzed using SSR markers, clustered separately from Mediterranean cultivars and showed a high number of private alleles, on the contrary, they shared the same single chlorotype with the most widespread varieties cultivated in the Mediterranean. Conclusion: We hypothesized that Iranian and Mediterranean olive trees may have had a common origin from a unique center in the Near East region, possibly including the western Iranian area. The present pattern of variation may have derived from different environmental conditions, distinct levels and selection criteria, and divergent breeding opportunities found by Mediterranean and Iranian olives. These unexpected findings emphasize the importance of studying the Iranian olive germplasm as a promising but endangered source of variation.	[Hosseini-Mazinani, Mehdi; Torkzaban, Bahareh; Sheikh-Hassani, Massoma; Ataei, Saeedeh] Natl Inst Genet Engn & Biotechnol, Tehran, Iran; [Mariotti, Roberto; Cultrera, Nicolo G. M.; Pandolfi, Saverio; Baldoni, Luciana] CNR, Inst Biosci & Bioresources, Perugia, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR)	Baldoni, L (corresponding author), Natl Inst Genet Engn & Biotechnol, Tehran, Iran.	hosseini@nigeb.ac.ir; luciana.baldoni@ibbr.cnr.it	Cultrera, Nicolò G/P-7376-2018; Baldoni, Luciana/A-4411-2016; mariotti, roberto/AAG-7294-2021	Cultrera, Nicolò G/0000-0003-1361-7539; Baldoni, Luciana/0000-0002-3221-333X; mariotti, roberto/0000-0002-9111-5123; BALDONI, LUCIANA/0000-0002-6636-0055				Al-Ameri TK, 2011, ARAB J GEOSCI, V4, P945, DOI 10.1007/s12517-010-0159-5; Baali-Cherif D, 2005, ANN BOT-LONDON, V96, P823, DOI 10.1093/aob/mci232; Baldoni L, 2006, ANN BOT-LONDON, V98, P935, DOI 10.1093/aob/mcl178; Baldoni L, 2009, MOL BREEDING, V24, P213, DOI 10.1007/s11032-009-9285-8; Belaj A, 2012, TREE GENET GENOMES, V8, P365, DOI 10.1007/s11295-011-0447-6; Besnard G, 2007, J BIOGEOGR, V34, P736, DOI 10.1111/j.1365-2699.2006.01653.x; Besnard G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2833; Besnard G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-80; Besnard G, 2009, ANN BOT-LONDON, V104, P143, DOI 10.1093/aob/mcp105; Blondel J, 2006, HUM ECOL, V34, P713, DOI 10.1007/s10745-006-9030-4; Breton C, 2006, J BIOGEOGR, V33, P1916, DOI 10.1111/j.1365-2699.2006.01544.x; Breton C, 2009, CR BIOL, V332, P1059, DOI 10.1016/j.crvi.2009.08.001; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Colledge S, 2004, CURR ANTHROPOL, V45, pS35, DOI 10.1086/422086; Cornuet JM, 1996, GENETICS, V144, P2001; Djamali M, 2009, VEG HIST ARCHAEOBOT, V18, P123, DOI 10.1007/s00334-008-0178-2; Floor Willem, 2005, ENCY IRANICA; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hannachi H, 2009, GENET RESOUR CROP EV, V56, P393, DOI 10.1007/s10722-008-9374-2; Hemmat MA, 2012, ARCH SCI, V65; Hosseini-Mazinani S, 2002, ACTA HORTIC, V634, P145; Jacquemoud-Collet, 2006, DARWIN SOFTWARE VERS; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kaniewski D, 2012, BIOL REV, V87, P885, DOI 10.1111/j.1469-185X.2012.00229.x; Lovell JL, 2010, RADIOCARBON, V52, P364, DOI 10.1017/S0033822200045410; Mariotti R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-211; Mousavi S, 2014, GENET RESOUR CROP EV, V61, P775, DOI 10.1007/s10722-013-0071-4; Noormohammadi Z, 2012, GENET MOL RES, V11, P707, DOI 10.4238/2012.March.19.4; Noormohammadi Z, 2007, HORTSCIENCE, V42, P1545, DOI 10.21273/HORTSCI.42.7.1545; Noormohammadi Zahra, 2009, Acta Biologica Szegediensis, V53, P27; Omrani-Sabbaghi A, 2007, SCI HORTIC-AMSTERDAM, V112, P439, DOI 10.1016/j.scienta.2006.12.051; Park SDE, 2001, MICROSATELLITE TOOLK; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pickersgill B, 2007, ANN BOT-LONDON, V100, P925, DOI 10.1093/aob/mcm193; Pritchard JK., 2010, DOCUMENTATION STRUCT; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sadeghi H, 1992, CULTIVATION PRESERVA; Sanei S. J., 2012, Annual Review & Research in Biology, V2, P27; Sheidai M, 2010, SCIENCEASIA, V36, P187, DOI 10.2306/scienceasia1513-1874.2010.36.187; Sheidai M, 2009, CYTOLOGIA, V74, P369, DOI 10.1508/cytologia.74.369; Terral JF, 2004, J BIOGEOGR, V31, P63, DOI 10.1046/j.0305-0270.2003.01019.x; Trujillo I, 2012, ACTA HORTIC, V949, P47; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VAVILOV N. I., 1949, Chronica botanica, V13; Zohary D., 2000, Domestication of plants in the Old World: the origin and spread of cultivated plants in West Asia, Europe and the Nile Valley; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	48	28	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93146	10.1371/journal.pone.0093146	http://dx.doi.org/10.1371/journal.pone.0093146			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709858	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800022
J	Akkad, H; Corpeno, R; Larsson, L				Akkad, Hazem; Corpeno, Rebeca; Larsson, Lars			Masseter Muscle Myofibrillar Protein Synthesis and Degradation in an Experimental Critical Illness Myopathy Model	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ACUTE QUADRIPLEGIC MYOPATHY; ALPHA-B-CRYSTALLIN; RESPIRATORY-DISTRESS-SYNDROME; HEAT-SHOCK PROTEINS; SKELETAL-MUSCLE; GENE-EXPRESSION; DISUSE ATROPHY; SOLEUS MUSCLE; NEUROMUSCULAR-TRANSMISSION	Critical illness myopathy (CIM) is a debilitating common consequence of modern intensive care, characterized by severe muscle wasting, weakness and a decreased myosin/actin (M/A) ratio. Limb/trunk muscles are primarily affected by this myopathy while cranial nerve innervated muscles are spared or less affected, but the mechanisms underlying these muscle-specific differences remain unknown. In this time-resolved study, the cranial nerve innervated masseter muscle was studied in a unique experimental rat intensive care unit (ICU) model, where animals were exposed to sedation, neuromuscular blockade (NMB), mechanical ventilation, and immobilization for durations varying between 6 h and 14d. Gel electrophoresis, immunoblotting, RT-PCR and morphological staining techniques were used to analyze M/A ratios, myofiber size, synthesis and degradation of myofibrillar proteins, and levels of heat shock proteins (HSPs). Results obtained in the masseter muscle were compared with previous observations in experimental and clinical studies of limb muscles. Significant muscle-specific differences were observed, i.e., in the masseter, the decline in M/A ratio and muscle fiber size was small and delayed. Furthermore, transcriptional regulation of myosin and actin synthesis was maintained, and Akt phosphorylation was only briefly reduced. In studied degradation pathways, only mRNA, but not protein levels of MuRF1, atrogin-1 and the autophagy marker LC3b were activated by the ICU condition. The matrix metalloproteinase MMP-2 was inhibited and protective HSPs were up-regulated early. These results confirm that the cranial nerve innervated masticatory muscles is less affected by the ICU-stress response than limb muscles, in accordance with clinical observation in ICU patients with CIM, supporting the model' credibility as a valid CIM model.	[Akkad, Hazem; Corpeno, Rebeca; Larsson, Lars] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Larsson, Lars] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA	Uppsala University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Larsson, L (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	lars.larsson@neurofys.uu.se	Larsson, Lars/AAY-1347-2021	Larsson, Lars/0000-0003-3722-035X	Swedish Research Council [8651]; STINT; European Commission (MyoAge) [EC Fp7 CT-223756, COST CM1001]	Swedish Research Council(Swedish Research CouncilEuropean Commission); STINT; European Commission (MyoAge)(European CommissionEuropean Commission Joint Research Centre)	This study was supported by grants from the Swedish Research Council (8651), STINT, and the European Commission (MyoAge, EC Fp7 CT-223756 and COST CM1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aare S, 2013, PHYSIOL GENOMICS, V45, P312, DOI 10.1152/physiolgenomics.00123.2012; Aare S, 2012, PHYSIOL GENOMICS, V44, P865, DOI 10.1152/physiolgenomics.00031.2012; Aare S, 2011, PHYSIOL GENOMICS, V43, P1334, DOI 10.1152/physiolgenomics.00116.2011; Ahlbeck K, 2009, ACTA ANAESTH SCAND, V53, P717, DOI 10.1111/j.1399-6576.2009.01952.x; Ali MAM, 2010, CIRCULATION, V122, P2039, DOI 10.1161/CIRCULATIONAHA.109.930222; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Baehr LM, 2011, J PHYSIOL-LONDON, V589, P4759, DOI 10.1113/jphysiol.2011.212845; Banduseela VC, 2013, PHYSIOL GENOMICS, V45, P477, DOI 10.1152/physiolgenomics.00141.2012; Banduseela VC, 2009, PHYSIOL GENOMICS, V39, P141, DOI 10.1152/physiolgenomics.00026.2009; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Carmeli E., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P96; Carmeli E, 2004, MUSCLE NERVE, V29, P191, DOI 10.1002/mus.10529; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Choi YC, 2000, NEUROLOGY, V54, P65, DOI 10.1212/WNL.54.1.65; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Cros N, 2001, J CELL BIOCHEM, V83, P508, DOI 10.1002/jcb.1248; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; DALMAN FC, 1991, J BIOL CHEM, V266, P3482; Dupont E, 2011, AM J PHYSIOL-REG I, V300, pR408, DOI 10.1152/ajpregu.00793.2009; DWORKIN BR, 1990, BEHAV NEUROSCI, V104, P298, DOI 10.1037/0735-7044.104.2.298; Dworkin BR, 2000, AM J PHYSIOL-REG I, V279, pR1910, DOI 10.1152/ajpregu.2000.279.5.R1910; Ferrer-Martinez A, 2006, GENE, V384, P145, DOI 10.1016/j.gene.2006.07.042; Franch HA, 2005, CURR OPIN CLIN NUTR, V8, P271, DOI 10.1097/01.mco.0000165005.01331.45; Friedrich O, 2005, J NUTR, V135, p1813S, DOI 10.1093/jn/135.7.1813S; FURUNO K, 1990, J BIOL CHEM, V265, P8550; Giannelli G, 2005, HISTOL HISTOPATHOL, V20, P99, DOI 10.14670/HH-20.99; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; Han B, 2007, APPL PHYSIOL NUTR ME, V32, P1115, DOI 10.1139/H07-102; Hermans G, 2009, COCHRANE DB SYST REV, V1; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; LARSSON L, 1979, J APPL PHYSIOL, V46, P451, DOI 10.1152/jappl.1979.46.3.451; Larsson L, 2000, CRIT CARE MED, V28, P34, DOI 10.1097/00003246-200001000-00006; Larsson L, 2008, ADV EXP MED BIOL, V642, P92; Latronico N, 2012, CURR OPIN RHEUMATOL, V24, P616, DOI 10.1097/BOR.0b013e3283588d2f; Latronico N, 2011, LANCET NEUROL, V10, P931, DOI 10.1016/S1474-4422(11)70178-8; Liu YF, 2001, FRONT BIOSCI-LANDMRK, V6, pD12, DOI 10.2741/Liu; Llano-Diez M, 2012, CRIT CARE, V16, DOI 10.1186/cc11841; Llano-Diez M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-602; Marimuthu K, 2011, J APPL PHYSIOL, V110, P555, DOI 10.1152/japplphysiol.00962.2010; MARTIN AF, 1981, J BIOL CHEM, V256, P964; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Matsumoto N, 2000, MUSCLE NERVE, V23, P1270, DOI 10.1002/1097-4598(200008)23:8<1270::AID-MUS18>3.0.CO;2-E; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Nordquist J, 2007, MOL MED, V13, P461, DOI 10.2119/2006-00066.Nordquist; Norman H, 2006, PFLUG ARCH EUR J PHY, V453, P53, DOI 10.1007/s00424-006-0110-5; Norman H, 2009, J NEUROL SCI, V285, P28, DOI 10.1016/j.jns.2009.04.041; Ochala J, 2011, J PHYSIOL-LONDON, V589, P2007, DOI 10.1113/jphysiol.2010.202044; Parcellier A, 2005, ANTIOXID REDOX SIGN, V7, P404, DOI 10.1089/ars.2005.7.404; Renaud G, 2013, J PHYSIOL-LONDON, V591, P1385, DOI 10.1113/jphysiol.2012.248724; Rudis MI, 1996, CRIT CARE MED, V24, P1749, DOI 10.1097/00003246-199610000-00024; Sakurai T, 2005, FASEB J, V19, P1199, DOI 10.1096/fj.04-3060fje; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2010, AM J PHYSIOL-CELL PH, V298, pC1291, DOI 10.1152/ajpcell.00531.2009; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Seneff MG, 2000, CRIT CARE MED, V28, P342, DOI 10.1097/00003246-200002000-00009; Seo Y, 2006, J BIOCHEM, V139, P71, DOI 10.1093/jb/mvj007; Skittone LK, 2008, J ORTHOP RES, V26, P357, DOI 10.1002/jor.20513; Stephanou A, 1998, BIOCHEM J, V330, P189, DOI 10.1042/bj3300189; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Wilcox ME, 2010, SEMIN RESP CRIT CARE, V31, P55, DOI 10.1055/s-0029-1246285; Yogev O, 2010, AUTOPHAGY, V6, P566, DOI 10.4161/auto.6.4.11950	66	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92622	10.1371/journal.pone.0092622	http://dx.doi.org/10.1371/journal.pone.0092622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705179	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500021
J	Collier, CJ; Villacorta-Rath, C; van Dijk, KJ; Takahashi, M; Waycott, M				Collier, Catherine J.; Villacorta-Rath, Cecilia; van Dijk, Kor-jent; Takahashi, Miwa; Waycott, Michelle			Seagrass Proliferation Precedes Mortality during Hypo-Salinity Events: A Stress-Induced Morphometric Response	PLOS ONE			English	Article							ANTARCTICA LABILL SONDER; POSIDONIA-OCEANICA; HALOPHILA-JOHNSONII; CYMODOCEA-NODOSA; MORPHOGENIC RESPONSES; MARINE ANGIOSPERMS; WESTERN-AUSTRALIA; SHARK BAY; GROWTH; SURVIVAL	Halophytes, such as seagrasses, predominantly form habitats in coastal and estuarine areas. These habitats can be seasonally exposed to hypo-salinity events during watershed runoff exposing them to dramatic salinity shifts and osmotic shock. The manifestation of this osmotic shock on seagrass morphology and phenology was tested in three Indo-Pacific seagrass species, Halophila ovalis, Halodule uninervis and Zostera muelleri, to hypo-salinity ranging from 3 to 36 PSU at 3 PSU increments for 10 weeks. All three species had broad salinity tolerance but demonstrated a moderate hypo-salinity stress response - analogous to a stress induced morphometric response (SIMR). Shoot proliferation occurred at salinities <30 PSU, with the largest increases, up to 400% increase in shoot density, occurring at the sub-lethal salinities <15 PSU, with the specific salinity associated with peak shoot density being variable among species. Resources were not diverted away from leaf growth or shoot development to support the new shoot production. However, at sub-lethal salinities where shoots proliferated, flowering was severely reduced for H. ovalis, the only species to flower during this experiment, demonstrating a diversion of resources away from sexual reproduction to support the investment in new shoots. This SIMR response preceded mortality, which occurred at 3 PSU for H. ovalis and 6 PSU for H. uninervis, while complete mortality was not reached for Z. muelleri. This is the first study to identify a SIMR in seagrasses, being detectable due to the fine resolution of salinity treatments tested. The detection of SIMR demonstrates the need for caution in interpreting in-situ changes in shoot density as shoot proliferation could be interpreted as a healthy or positive plant response to environmental conditions, when in fact it could signal pre-mortality stress.	[Collier, Catherine J.; Villacorta-Rath, Cecilia; van Dijk, Kor-jent; Takahashi, Miwa] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [van Dijk, Kor-jent; Waycott, Michelle] Univ Adelaide, Australian Ctr Evolutionary Biol & Biodivers, Sch Earth & Environm Sci, Adelaide, SA, Australia	James Cook University; University of Adelaide	Collier, CJ (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	Catherine.collier@jcu.edu.au	Collier, Catherine/M-6308-2014; Villacorta-Rath, Cecilia/G-8819-2013; Takahashi, Miwa/Y-8655-2019; Waycott, Michelle/AAR-8809-2021	Collier, Catherine/0000-0001-9494-6582; Villacorta-Rath, Cecilia/0000-0002-1060-5447; Waycott, Michelle/0000-0002-0822-0564; Takahashi, Miwa/0000-0001-8952-051X	Australian Government's National Environmental Research Program (NEEP) Tropical Ecosystem Hub	Australian Government's National Environmental Research Program (NEEP) Tropical Ecosystem Hub(Australian Government)	This work was funded by the Australian Government's National Environmental Research Program (NEEP) Tropical Ecosystem Hub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JB, 1994, J EXP MAR BIOL ECOL, V183, P53, DOI 10.1016/0022-0981(94)90156-2; Campbell SJ, 2004, ESTUAR COAST SHELF S, V60, P477, DOI 10.1016/j.ecss.2004.02.007; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Coles R, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P1, DOI 10.1016/B978-044450891-1/50001-3; Collier CJ, 2012, MAR POLLUT BULL, V65, P342, DOI 10.1016/j.marpolbul.2011.06.017; Fernandez-Torquemada Y, 2005, J EXP MAR BIOL ECOL, V320, P57, DOI 10.1016/j.jembe.2004.12.019; Fernandez-Torquemada Y, 2011, HYDROBIOLOGIA, V669, P21, DOI 10.1007/s10750-011-0644-1; Furnas M., 2003, CATCHMENT CORALS TER; Gacia E, 2007, ESTUAR COAST SHELF S, V72, P579, DOI 10.1016/j.ecss.2006.11.021; Griffin NE, 2012, MAR BIOL, V159, P1439, DOI 10.1007/s00227-012-1923-8; HILLMAN K, 1995, AQUAT BOT, V51, P1, DOI 10.1016/0304-3770(95)00466-D; Howarth JF, 2013, BOT MAR, V56, P261, DOI 10.1515/bot-2012-0226; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; Jiang ZJ, 2013, J EXP MAR BIOL ECOL, V443, P114, DOI 10.1016/j.jembe.2013.02.034; Kahn AE, 2006, J EXP MAR BIOL ECOL, V335, P1, DOI 10.1016/j.jembe.2006.02.011; Kahn AE, 2008, J EXP MAR BIOL ECOL, V367, P230, DOI 10.1016/j.jembe.2008.10.006; KIRKMAN H, 1990, AQUAT BOT, V37, P367, DOI 10.1016/0304-3770(90)90022-D; Koch MS, 2007, AQUAT BOT, V86, P14, DOI 10.1016/j.aquabot.2006.08.003; Koch MS, 2007, AQUAT BOT, V87, P104, DOI 10.1016/j.aquabot.2007.03.004; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; Lirman D, 2003, ESTUARIES, V26, P131, DOI 10.1007/BF02691700; Marin-Guirao L, 2013, AQUAT BOT, V109, P14, DOI 10.1016/j.aquabot.2013.03.006; Marin-Guirao L, 2013, MAR ENVIRON RES, V84, P60, DOI 10.1016/j.marenvres.2012.12.001; Marin-Guirao L, 2011, ESTUAR COAST SHELF S, V92, P286, DOI 10.1016/j.ecss.2011.01.003; McMahon K.M., 2005, RECOVERY SUBTROPICAL; Sandoval-Gil JM, 2012, MAR BIOL, V159, P1129, DOI 10.1007/s00227-012-1892-y; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Pages JF, 2010, J EXP MAR BIOL ECOL, V386, P34, DOI 10.1016/j.jembe.2010.02.017; Potters G, 2009, PLANT CELL ENVIRON, V32, P158, DOI 10.1111/j.1365-3040.2008.01908.x; Potters G, 2007, TRENDS PLANT SCI, V12, P98, DOI 10.1016/j.tplants.2007.01.004; PREEN AR, 1995, AQUAT BOT, V52, P3, DOI 10.1016/0304-3770(95)00491-H; Ralph PJ, 1998, J EXP MAR BIOL ECOL, V227, P203, DOI 10.1016/S0022-0981(97)00269-4; Ruiz JM, 2009, BOT MAR, V52, P459, DOI 10.1515/BOT.2009.051; Sandoval-Gil JM, 2012, ESTUAR COAST SHELF S, V115, P260, DOI 10.1016/j.ecss.2012.09.008; Strazisar T, 2013, J EXP MAR BIOL ECOL, V445, P129, DOI 10.1016/j.jembe.2013.02.045; Torquemada YF, 2005, MAR BIOL, V148, P251, DOI 10.1007/s00227-005-0075-5; Touchette BW, 2007, J EXP MAR BIOL ECOL, V350, P194, DOI 10.1016/j.jembe.2007.05.037; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; WALKER DI, 1985, AQUAT BOT, V23, P13, DOI 10.1016/0304-3770(85)90017-8; WALKER DI, 1990, AQUAT BOT, V36, P359, DOI 10.1016/0304-3770(90)90052-M; WALKER DI, 1988, AQUAT BOT, V30, P305, DOI 10.1016/0304-3770(88)90063-0; WAYCOTT M, 2004, GUIDE TROPICAL SEAGR; Zolla G, 2010, J EXP BOT, V61, P211, DOI 10.1093/jxb/erp290	43	35	35	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94014	10.1371/journal.pone.0094014	http://dx.doi.org/10.1371/journal.pone.0094014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705377	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000334107500112
J	Sasaki, H; Takeuchi, I; Okada, M; Sawada, R; Kanie, K; Kiyota, Y; Honda, H; Kato, R				Sasaki, Hiroto; Takeuchi, Ichiro; Okada, Mai; Sawada, Rumi; Kanie, Kei; Kiyota, Yasujiro; Honda, Hiroyuki; Kato, Ryuji			Label-Free Morphology-Based Prediction of Multiple Differentiation Potentials of Human Mesenchymal Stem Cells for Early Evaluation of Intact Cells	PLOS ONE			English	Article							SENESCENCE; GENE; EXPRESSION; SHAPE; APOPTOSIS; CULTURE; TENSION; TARGET; P53	Precise quantification of cellular potential of stem cells, such as human bone marrow-derived mesenchymal stem cells (hBMSCs), is important for achieving stable and effective outcomes in clinical stem cell therapy. Here, we report a method for image-based prediction of the multiple differentiation potentials of hBMSCs. This method has four major advantages: ( 1) the cells used for potential prediction are fully intact, and therefore directly usable for clinical applications; ( 2) predictions of potentials are generated before differentiation cultures are initiated; ( 3) prediction of multiple potentials can be provided simultaneously for each sample; and ( 4) predictions of potentials yield quantitative values that correlate strongly with the experimental data. Our results show that the collapse of hBMSC differentiation potentials, triggered by in vitro expansion, can be quantitatively predicted far in advance by predicting multiple potentials, multi-lineage differentiation potentials ( osteogenic, adipogenic, and chondrogenic) and population doubling potential using morphological features apparent during the first 4 days of expansion culture. In order to understand how such morphological features can be effective for advance predictions, we measured gene-expression profiles of the same early undifferentiated cells. Both senescence-related genes ( p16 and p21) and cytoskeleton-related genes (PTK2, CD146, and CD49) already correlated to the decrease of potentials at this stage. To objectively compare the performance of morphology and gene expression for such early prediction, we tested a range of models using various combinations of features. Such comparison of predictive performances revealed that morphological features performed better overall than gene-expression profiles, balancing the predictive accuracy with the effort required for model construction. This benchmark list of various prediction models not only identifies the best morphological feature conversion method for objective potential prediction, but should also allow clinicians to choose the most practical morphology-based prediction method for their own purposes.	[Sasaki, Hiroto; Kanie, Kei; Honda, Hiroyuki; Kato, Ryuji] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Nagoya, Aichi 4648601, Japan; [Takeuchi, Ichiro] Nagoya Inst Technol, Grad Sch Engn, Dept Comp Sci Sci & Engn Simulat, Nagoya, Aichi, Japan; [Okada, Mai; Kanie, Kei; Kato, Ryuji] Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Nagoya, Aichi 4648601, Japan; [Sawada, Rumi] Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, Tokyo 1588501, Japan; [Kiyota, Yasujiro] Nikon Inc, Chiyoda Ku, Tokyo, Japan	Nagoya University; Nagoya Institute of Technology; Nagoya University; National Institute of Health Sciences - Japan; Nikon Corporation	Kato, R (corresponding author), Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Nagoya, Aichi 4648601, Japan.	kato-r@ps.nagoya-u.ac.jp	Kanie, Kei/AAO-1186-2021; Kato, Ryuji/I-6952-2014	Kanie, Kei/0000-0002-0833-6997; 	New Energy and Industrial Technology Development Organization (NEDO) [09C46036a]; Japan Society for the Promotion of Science (JSPS) [25.8678]; Hori Sciences and Arts Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hori Sciences and Arts Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors are grateful for financial support from the New Energy and Industrial Technology Development Organization (NEDO), which provided the Grant for Industrial Technology Research (Financial Support to Young Researchers, 09C46036a); the Japan Society for the Promotion of Science (JSPS) no. 25.8678; the Hori Sciences and Arts Foundation; and the Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur A, 2009, J CELL PHYSIOL, V218, P237, DOI 10.1002/jcp.21592; Ben Azouna N, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt97; Bin Noh H, 2010, GENES GENOM, V32, P87, DOI 10.1007/s13258-010-0868-x; Braude P, 2005, BMJ-BRIT MED J, V330, P1159, DOI 10.1136/bmj.330.7501.1159; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Comer KA, 1998, ONCOGENE, V16, P1299, DOI 10.1038/sj.onc.1201645; Docheva D, 2008, J CELL MOL MED, V12, P537, DOI 10.1111/j.1582-4934.2007.00138.x; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Futamura Y, 2012, CHEM BIOL, V19, P1620, DOI 10.1016/j.chembiol.2012.10.014; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Ito T, 2008, CYTOTECHNOLOGY, V56, P1, DOI 10.1007/s10616-007-9092-1; Ito T, 2007, BIOCHEM BIOPH RES CO, V359, P108, DOI 10.1016/j.bbrc.2007.05.067; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Kim JJ, 2013, METHODS MOL BIOL, V1052, P41, DOI 10.1007/7651_2013_29; Kinkel AD, 2004, CYTOTECHNOLOGY, V46, P49, DOI 10.1007/s10616-004-3903-4; KONSTANTINOV KB, 1994, CYTOTECHNOLOGY, V14, P233, DOI 10.1007/BF00749619; Massague J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023; Matsuoka F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055082; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Misselwitz B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-30; Motaln H, 2010, CANCER-AM CANCER SOC, V116, P2519, DOI 10.1002/cncr.25056; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Seiler C, 2012, J TISSUE ENG REGEN M; Settleman J, 2004, MOL CELL, V14, P148, DOI 10.1016/S1097-2765(04)00207-2; Shibata KR, 2007, STEM CELLS, V25, P2371, DOI 10.1634/stemcells.2007-0225; STEEDMAN HF, 1950, Q J MICROSC SCI, V91, P477; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107; Vega SL, 2012, J BIOMOL SCREEN, V17, P1151, DOI 10.1177/1087057112453853; Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200; Wang YW, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/652034; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584	43	35	36	45	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93952	10.1371/journal.pone.0093952	http://dx.doi.org/10.1371/journal.pone.0093952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705458	Green Submitted, Green Published, gold			2022-12-27	WOS:000334107500097
J	Yamanishi, R; Yoshigai, E; Okuyama, T; Mori, M; Murase, H; Machida, T; Okumura, T; Nishizawa, M				Yamanishi, Ryota; Yoshigai, Emi; Okuyama, Tetsuya; Mori, Masatoshi; Murase, Hiromitsu; Machida, Toru; Okumura, Tadayoshi; Nishizawa, Mikio			The Anti-Inflammatory Effects of Flavanol-Rich Lychee Fruit Extract in Rat Hepatocytes	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; HEXOSE CORRELATED COMPOUND; MESSENGER-RNA; GENE-EXPRESSION; INDUCTION; POLYPHENOL; BINDING; INOS; DNA	Flavanol (flavan-3-ol)- rich lychee fruit extract (FRLFE) is a mixture of oligomerized polyphenols primarily derived from lychee fruit and is rich in flavanol monomers, dimers, and trimers. Supplementation with this functional food has been shown to suppress inflammation and tissue damage caused by high-intensity exercise training. However, it is unclear whether FRLFE has in vitro anti-inflammatory effects, such as suppressing the production of the proinflammatory cytokine tumor necrosis factor a (TNF-alpha) and the proinflammatory mediator nitric oxide (NO), which is synthesized by inducible nitric oxide synthase (iNOS). Here, we analyzed the effects of FRLFE and its constituents on the expression of inflammatory genes in interleukin 1 beta (IL- 1 beta)- treated rat hepatocytes. FRLFE decreased the mRNA and protein expression of the iNOS gene, leading to the suppression of IL- 1 beta- induced NO production. FRLFE also decreased the levels of the iNOS antisense transcript, which stabilizes iNOS mRNA. By contrast, unprocessed lychee fruit extract, which is rich in flavanol polymers, and flavanol monomers had little effect on NO production. When a construct harboring the iNOS promoter fused to the firefly luciferase gene was used, FRLFE decreased the luciferase activity in the presence of IL- 1 beta, suggesting that FRLFE suppresses the promoter activity of the iNOS gene at the transcriptional level. Electrophoretic mobility shift assays indicated that FRLFE reduced the nuclear transport of a key regulator, nuclear factor kappa B (NF-kappa B). Furthermore, FRLFE inhibited the phosphorylation of NF-kappa B inhibitor alpha(I kappa B-alpha). FRLFE also reduced the mRNA levels of NF-kappa B target genes encoding cytokines and chemokines, such as TNF-alpha. Therefore, FRLFE inhibited NF-kappa B activation and nuclear translocation to suppress the expression of these inflammatory genes. Our results suggest that flavanols may be responsible for the anti-inflammatory and hepatoprotective effects of FRLFE and may be used to treat inflammatory diseases.	[Yamanishi, Ryota; Yoshigai, Emi; Mori, Masatoshi; Murase, Hiromitsu; Machida, Toru; Nishizawa, Mikio] Ritsumeikan Univ, Coll Life Sci, Dept Biomed Sci, Kusatsu, Shiga, Japan; [Okuyama, Tetsuya] Ritsumeikan Univ, Grad Sch Sci & Engn, Kusatsu, Shiga, Japan; [Okumura, Tadayoshi] Ritsumeikan Univ, Res Org Sci & Technol, Kusatsu, Shiga, Japan; [Okumura, Tadayoshi] Kansai Med Univ, Dept Surg, Hirakata, Osaka, Japan	Ritsumeikan University; Ritsumeikan University; Ritsumeikan University; Kansai Medical University	Nishizawa, M (corresponding author), Ritsumeikan Univ, Coll Life Sci, Dept Biomed Sci, Kusatsu, Shiga, Japan.	nishizaw@sk.ritsumei.ac.jp	Nishizawa, Mikio/M-4544-2014	Nishizawa, Mikio/0000-0002-1117-2807	Amino Up Chemical Co., Ltd. (Sapporo, Japan); Amino Up Chemical Co., Ltd.; Ritsumeikan Global Innovation Research Organization (R-GIRO) of Ritsumeikan University	Amino Up Chemical Co., Ltd. (Sapporo, Japan); Amino Up Chemical Co., Ltd.; Ritsumeikan Global Innovation Research Organization (R-GIRO) of Ritsumeikan University	1) T. Okumura and M. Nishizawa received research grants from Amino Up Chemical Co., Ltd. (Sapporo, Japan). 2) E. Yoshigai, T. Okuyama, T. Okumura, and M. Nishizawa received travel grants from Amino Up Chemical Co., Ltd. 3) E. Yoshigai, T. Okumura, and M. Nishizawa received research funding from the Ritsumeikan Global Innovation Research Organization (R-GIRO) of Ritsumeikan University. 4) R. Yamanishi, M. Mori, H. Murase, and T. Machida performed this study as graduate students of the Graduate School of Science and Engineering, Ritsumeikan University and did not receive the above-mentioned research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ANAL BIOCH, V126, P131; Aruoma OI, 2006, BIOFACTORS, V27, P245, DOI 10.1002/biof.5520270121; Brat P, 2006, J NUTR, V136, P2368, DOI 10.1093/jn/136.9.2368; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Colasanti M, 2000, TRENDS PHARMACOL SCI, V21, P249, DOI 10.1016/S0165-6147(00)01499-1; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fujii H, 2007, FOOD CHEM TOXICOL, V45, P378, DOI 10.1016/j.fct.2006.08.026; Fujji H, 2006, BIOSCI BIOTECH BIOCH, V70, P2104, DOI 10.1271/bbb.60053; Gurib-Fakim Ameenah, 2006, Molecular Aspects of Medicine, V27, P1, DOI 10.1016/j.mam.2005.07.008; Hackman Robert M., 2008, Phytochemistry Reviews, V7, P195, DOI 10.1007/s11101-007-9070-4; Kalgaonkar S, 2010, PHYTOTHER RES, V24, P1223, DOI 10.1002/ptr.3137; KANEMAKI T, 1993, PROSTAGLANDINS, V45, P459, DOI 10.1016/0090-6980(93)90122-N; Kimura T, 2013, CELL MOL LIFE SCI, V70, P1451, DOI 10.1007/s00018-012-1216-x; Kitadate K, 2014, REGUL TOXICOL PHARM, V68, P140, DOI 10.1016/j.yrtph.2013.12.001; Kitade H, 1996, HEPATOLOGY, V23, P797, DOI 10.1002/hep.510230421; Kuzuhara T, 2006, J BIOL CHEM, V281, P17446, DOI 10.1074/jbc.M601196200; Lawrence T, 2010, INT J BIOCHEM CELL B, V42, P519, DOI 10.1016/j.biocel.2009.12.016; Lin YL, 1999, EUR J PHARMACOL, V367, P379, DOI 10.1016/S0014-2999(98)00953-4; Mackenzie GG, 2004, FASEB J, V18, P167, DOI 10.1096/fj.03-0402fje; Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028; Mao T, 2000, J NUTR, V130, p2093S, DOI 10.1093/jn/130.8.2093S; Matsui K, 2011, EUR SURG RES, V47, P274, DOI 10.1159/000333833; Matsui K, 2008, HEPATOLOGY, V47, P686, DOI 10.1002/hep.22036; Matsui K, 2007, JPEN-PARENTER ENTER, V31, P373, DOI 10.1177/0148607107031005373; Matsuura T, 2012, HEPATOL RES, V42, P76, DOI 10.1111/j.1872-034X.2011.00891.x; Miura T, 2010, BIOTECHNOLOGY IN FUNCTIONAL FOODS AND NUTRACEUTICALS, P91, DOI 10.1201/9781420087123-c6; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Nafisi S, 2009, J PHOTOCH PHOTOBIO B, V94, P1, DOI 10.1016/j.jphotobiol.2008.08.001; Nakanishi H, 2004, J HEPATOL, V41, P730, DOI 10.1016/j.jhep.2004.07.007; Nishizawa M, 2000, GENES CELLS, V5, P111, DOI 10.1046/j.1365-2443.2000.00310.x; Nishizawa M, 2012, FRONT BIOSCI-LANDMRK, V17, P938, DOI 10.2741/3965; Nishizawa M, 2011, PHYTOTHER RES, V25, P1486, DOI 10.1002/ptr.3430; Nonaka G., 2004, International Patent Application, Patent No. [WO2004103988(A1), 2004103988, WO/2004/103988 A1]; Ogasawara J, 2009, PHYTOTHER RES, V23, P1626, DOI 10.1002/ptr.2846; Sakitani K, 1997, HEPATOLOGY, V25, P416; Serra A, 2013, EUR J NUTR, V52, P1029, DOI 10.1007/s00394-012-0409-2; Shimizu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085520; Shoji T, 2006, J AGR FOOD CHEM, V54, P884, DOI 10.1021/jf052260b; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Suganuma M, 1998, CARCINOGENESIS, V19, P1771, DOI 10.1093/carcin/19.10.1771; Takimoto Y, 2013, NITRIC OXIDE-BIOL CH, V28, P47, DOI 10.1016/j.niox.2012.10.003; Tanaka T., 2007, JPN J FOOD CHEM, V14, P134; Uehata T, 2013, BBA-GENE REGUL MECH, V1829, P708, DOI 10.1016/j.bbagrm.2013.03.001; Ververidis Filippos, 2007, Biotechnology Journal, V2, P1214, DOI 10.1002/biot.200700084; Werner A, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-31; Yamada M, 2007, NITRIC OXIDE-BIOL CH, V17, P98, DOI 10.1016/j.niox.2007.06.003; Yamashita Y, 2013, BIOSCI BIOTECH BIOCH, V77, P888, DOI 10.1271/bbb.130095; Yoshigai E., 2012, HOAJ BIOL, V1, P10, DOI 10.7243/2050-0874-1-10.; Yoshigai E., 2012, HOAJ BIOL, V1, P10, DOI DOI 10.7243/2050-0874-1-10; Yoshigai E, 2014, HEPATOL RES, V44, P571, DOI 10.1111/hepr.12157; Yoshigai E, 2013, BIOCHEM BIOPH RES CO, V439, P54, DOI 10.1016/j.bbrc.2013.08.029; Yoshigai E, 2013, NITRIC OXIDE-BIOL CH, V30, P9, DOI 10.1016/j.niox.2013.01.001	52	32	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93818	10.1371/journal.pone.0093818	http://dx.doi.org/10.1371/journal.pone.0093818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705335	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500071
J	Klein, EY; Serohijos, AWR; Choi, JM; Shakhnovich, EI; Pekosz, A				Klein, Eili Y.; Serohijos, Adrian W. R.; Choi, Jeong-Mo; Shakhnovich, Eugene I.; Pekosz, Andrew			Influenza A H1N1 Pandemic Strain Evolution - Divergence and the Potential for Antigenic Drift Variants	PLOS ONE			English	Article							VIRUS HEMAGGLUTININ; VACCINE EFFICACY; UNITED-STATES; HUMANS; SUBTYPE; DESIGN; MAFFT	The emergence of a novel A(H1N1) strain in 2009 was the first influenza pandemic of the genomic age, and unprecedented surveillance of the virus provides the opportunity to better understand the evolution of influenza. We examined changes in the nucleotide coding regions and the amino acid sequences of the hemagglutinin (HA), neuraminidase (NA), and nucleoprotein (NP) segments of the A(H1N1)pdm09 strain using publicly available data. We calculated the nucleotide and amino acid hamming distance from the vaccine strain A/California/07/2009 for each sequence. We also estimated P-epitope-a measure of antigenic diversity based on changes in the epitope regions-for each isolate. Finally, we compared our results to A(H3N2) strains collected over the same period. Our analysis found that the mean hamming distance for the HA protein of the A(H1N1)pdm09 strain increased from 3.6 (standard deviation [SD]: 1.3) in 2009 to 11.7 (SD: 1.0) in 2013, while the mean hamming distance in the coding region increased from 7.4 (SD: 2.2) in 2009 to 28.3 (SD: 2.1) in 2013. These trends are broadly similar to the rate of mutation in H3N2 over the same time period. However, in contrast to H3N2 strains, the rate of mutation accumulation has slowed in recent years. Our results are notable because, over the course of the study, mutation rates in H3N2 similar to that seen with A(H1N1)pdm09 led to the emergence of two antigenic drift variants. However, while there has been an H1N1 epidemic in North America this season, evidence to date indicates the vaccine is still effective, suggesting the epidemic is not due to the emergence of an antigenic drift variant. Our results suggest that more research is needed to understand how viral mutations are related to vaccine effectiveness so that future vaccine choices and development can be more predictive.	[Klein, Eili Y.] Johns Hopkins Sch Med, Dept Emergency Med, Ctr Adv Modeling Social Behav & Hlth Sci, Baltimore, MD 21205 USA; [Klein, Eili Y.] Ctr Dis Dynam Econ & Policy, Washington, DC USA; [Serohijos, Adrian W. R.; Choi, Jeong-Mo; Shakhnovich, Eugene I.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA USA; [Pekosz, Andrew] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Klein, EY (corresponding author), Johns Hopkins Sch Med, Dept Emergency Med, Ctr Adv Modeling Social Behav & Hlth Sci, Baltimore, MD 21205 USA.	eklein@jhu.edu		Serohijos, Adrian/0000-0001-8369-982X; Klein, Eili/0000-0002-1304-5289; Pekosz, Andrew/0000-0003-3248-1761; Choi, Jeong-Mo/0000-0003-2656-4851	Defense Advanced Research Projects Agency [HR0011-11-C-0093]; Models of Infectious Disease Agent Study (MIDAS) from the National Institutes of General Medical Sciences [U01GM070708]; National Institutes of Health [DP1OD003874]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070708] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003874] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Models of Infectious Disease Agent Study (MIDAS) from the National Institutes of General Medical Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the Defense Advanced Research Projects Agency through grant HR0011-11-C-0093 and by the Models of Infectious Disease Agent Study (MIDAS), under Award Number U01GM070708 from the National Institutes of General Medical Sciences, as well as a National Institutes of Health Pioneer Award (DP1OD003874). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Office of Naval Research or the official policy or position of the Department of Defense or the U.S. government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Catania J, 2014, AM J RESP CRITICAL C; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Centers for Disease Control and Prevention, 2013, NOT CLIN EARL REP PH; Centers for Disease Control and Prevention, 2011, FIN EST 2009 10 SEAS; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de la Rosa-Zamboni D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050116; Deem MW, 2009, PROTEIN ENG DES SEL, V22, P543, DOI 10.1093/protein/gzp027; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Guarnaccia T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003354; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; Huang JW, 2012, VACCINE, V30, P6327, DOI 10.1016/j.vaccine.2012.07.079; Jegaskanda S, 2013, J INFECT DIS, V208, P1051, DOI 10.1093/infdis/jit294; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khandaker I, 2013, VIRUS GENES, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Makkoch J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051275; Munoz ET, 2005, VACCINE, V23, P1144, DOI 10.1016/j.vaccine.2004.08.028; Ndifon W, 2009, P NATL ACAD SCI USA, V106, P8701, DOI 10.1073/pnas.0903427106; Park AW, 2009, SCIENCE, V326, P726, DOI 10.1126/science.1175980; Pascalis H, 2012, PLOS ONE, V7; Plotkin JB, 2002, P NATL ACAD SCI USA, V99, P6263, DOI 10.1073/pnas.082110799; R Core Team, 2018, R LANG ENV STAT COMP; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Skowronski DM, 2014, EUROSURVEILLANCE, V19, P4, DOI 10.2807/1560-7917.ES2014.19.5.20690; Smith CB, 2002, J INFECT DIS, V185, P980, DOI 10.1086/339416; Strengell M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025848; WHO, 2013, REC COMP INFL VIR VA; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wolf YI, 2010, PLOS CURRENTS, V2; Wu AP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000882	34	29	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93632	10.1371/journal.pone.0093632	http://dx.doi.org/10.1371/journal.pone.0093632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699432	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000084
J	Mourao, M; Satin, L; Schnell, S				Mourao, Marcio; Satin, Leslie; Schnell, Santiago			Optimal Experimental Design to Estimate Statistically Significant Periods of Oscillations in Time Course Data	PLOS ONE			English	Article							CHI-SQUARE PERIODOGRAM; CIRCADIAN-RHYTHMS; SPECTRAL-ANALYSIS; SERIES; IDENTIFICATION; SEARCH	We investigated commonly used methods (Autocorrelation, Enright, and Discrete Fourier Transform) to estimate the periodicity of oscillatory data and determine which method most accurately estimated periods while being least vulnerable to the presence of noise. Both simulated and experimental data were used in the analysis performed. We determined the significance of calculated periods by applying these methods to several random permutations of the data and then calculating the probability of obtaining the period's peak in the corresponding periodograms. Our analysis suggests that the Enright method is the most accurate for estimating the period of oscillatory data. We further show that to accurately estimate the period of oscillatory data, it is necessary that at least five cycles of data are sampled, using at least four data points per cycle. These results suggest that the Enright method should be more widely applied in order to improve the analysis of oscillatory data.	[Mourao, Marcio; Schnell, Santiago] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Satin, Leslie] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Schnell, Santiago] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI USA; [Schnell, Santiago] Univ Michigan, Sch Med, Brehm Ctr Diabet Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Schnell, S (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	schnells@umich.edu	Schnell, Santiago/B-8682-2008	Schnell, Santiago/0000-0002-9477-3914	James S. McDonnell Foundation under the 21st Century Science Initiative, Studying Complex Systems Program [220020223]; National Institutes of Health [RO1 DK46409]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046409, P30DK020572] Funding Source: NIH RePORTER	James S. McDonnell Foundation under the 21st Century Science Initiative, Studying Complex Systems Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been funded by a grant of the James S. McDonnell Foundation under the 21st Century Science Initiative, Studying Complex Systems Program (Grant No. 220020223). Work in the Satin Lab was supported by research grant RO1 DK46409 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Jaoude W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017075; Bloomfield P., 2000, FOURIER ANAL TIME SE, P261; DOWSE HB, 1991, J THEOR BIOL, V148, P139, DOI 10.1016/S0022-5193(05)80468-0; DOWSE HB, 1989, J THEOR BIOL, V139, P487, DOI 10.1016/S0022-5193(89)80067-0; DUTILLEUL P, 1995, BIOL RHYTHM RES, V26, P173, DOI 10.1080/09291019509360334; ENRIGHT JT, 1965, J THEOR BIOL, V8, P426, DOI 10.1016/0022-5193(65)90021-4; Frescura FAM, 2008, MON NOT R ASTRON SOC, V388, P1693, DOI 10.1111/j.1365-2966.2008.13499.x; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Geva-Zatorsky N, 2010, P NATL ACAD SCI USA, V107, P13550, DOI 10.1073/pnas.1001107107; GIRLING AJ, 1995, BIOL RHYTHM RES, V26, P149, DOI 10.1080/09291019509360333; Gottman JM, 1981, COMPREHENSIVE INTRO; He L, 2010, NAT CELL BIOL, V12, P1133, DOI 10.1038/ncb2124; Herrgen L, 2010, CURR BIOL, V20, P1244, DOI 10.1016/j.cub.2010.06.034; KLEMFUSS H, 1993, J INTERDISCIPL CYCLE, V24, P1, DOI 10.1080/09291019309360191; KUSHLER RH, 1991, STAT MED, V10, P329, DOI 10.1002/sim.4780100305; Merrins MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034036; MINORS DS, 1989, BIOL RHYTHMS CLIN PR, P272; MORGAN E, 1995, BIOL RHYTHM RES, V26, P124, DOI 10.1080/09291019509360332; REFINETTI R, 1993, PHYSIOL BEHAV, V54, P869, DOI 10.1016/0031-9384(93)90294-P; REFINETTI R, 1992, BEHAV RES METH INS C, V24, P28, DOI 10.3758/BF03203466; REFINETTI R, 1991, INT J BIOMED COMPUT, V27, P125, DOI 10.1016/0020-7101(91)90091-R; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Ristow M, 1999, DIABETES, V48, P1557, DOI 10.2337/diabetes.48.8.1557; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Schuster A, 1898, TERRESTRIAL MAGNETIS, V3, P179; Schwarzenberg-Czerny A, 1998, MON NOT R ASTRON SOC, V301, P831, DOI 10.1046/j.1365-8711.1998.02086.x; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; VANCAUTER E, 1988, AM J PHYSIOL, V254, pE786, DOI 10.1152/ajpendo.1988.254.6.E786; VELDHUIS JD, 1986, AM J PHYSIOL, V250, pE486, DOI 10.1152/ajpendo.1986.250.4.E486	29	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93826	10.1371/journal.pone.0093826	http://dx.doi.org/10.1371/journal.pone.0093826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699692	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000113
J	Ng, CF; Possingham, HP; McAlpine, CA; de Villiers, DL; Preece, HJ; Rhodes, JR				Ng, Chooi Fei; Possingham, Hugh P.; McAlpine, Clive A.; de Villiers, Deidre L.; Preece, Harriet J.; Rhodes, Jonathan R.			Impediments to the Success of Management Actions for Species Recovery	PLOS ONE			English	Article							WILLINGNESS-TO-SELL; CONSERVATION OPPORTUNITY; MAXIMIZING RETURN; LAND MANAGERS; THREATS; COSTS; RESTORATION; INVESTMENT; ROADS	Finding cost-effective management strategies to recover species declining due to multiple threats is challenging, especially when there are limited resources. Recent studies offer insights into how costs and threats can influence the best choice of management actions. However, when implementing management actions in the real-world, a range of impediments to management success often exist that can be driven by social, technological and land-use factors. These impediments may limit the extent to which we can achieve recovery objectives and influence the optimal choice of management actions. Nonetheless, the implications of these impediments are not well understood, especially for recovery planning involving multiple actions. We used decision theory to assess the impact of these types of impediments for allocating resources among recovery actions to mitigate multiple threats. We applied this to a declining koala (Phascolarctos cinereus) population threatened by habitat loss, vehicle collisions, dog attacks and disease. We found that the unwillingness of dog owners to restrain their dogs at night (a social impediment), the effectiveness of wildlife crossings to reduce vehicle collisions (a technological impediment) and the unavailability of areas for restoration (a land-use impediment) significantly reduced the effectiveness of our actions. In the presence of these impediments, achieving successful recovery may be unlikely. Further, these impediments influenced the optimal choice of recovery actions, but the extent to which this was true depended on the target koala population growth rate. Given that species recovery is an important strategy for preserving biodiversity, it is critical that we consider how impediments to the success of recovery actions modify our choice of actions. In some cases, it may also be worth considering whether investing in reducing or removing impediments may be a cost-effective course of action.	[Ng, Chooi Fei; Possingham, Hugh P.] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia; [Ng, Chooi Fei; Possingham, Hugh P.; Rhodes, Jonathan R.] Univ Queensland, Ctr Excellence Environm Decis, Australian Res Council, Brisbane, Qld, Australia; [Ng, Chooi Fei; Possingham, Hugh P.; McAlpine, Clive A.; Rhodes, Jonathan R.] Univ Queensland, Natl Environm Res Program, Environm Decis Hub, Brisbane, Qld, Australia; [Possingham, Hugh P.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Possingham, Hugh P.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England; [McAlpine, Clive A.; Rhodes, Jonathan R.] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia; [de Villiers, Deidre L.; Preece, Harriet J.] Dept Environm & Heritage Protect, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland; Imperial College London; University of Queensland	Ng, CF (corresponding author), Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia.	fei.ng@uqconnect.edu.au	Possingham, Hugh/B-1337-2008; POSSINGHAM, HUGH/R-8310-2019; Rhodes, Jonathan/C-4841-2008	Possingham, Hugh/0000-0001-7755-996X; POSSINGHAM, HUGH/0000-0001-7755-996X; McAlpine, Clive/0000-0003-0457-8144; Rhodes, Jonathan/0000-0001-6746-7412; Preece, Harriet/0000-0002-4404-8837	Queensland Department of Environment and Heritage Protection; Redland City Council; Queensland Department of Main Roads; Australian Research Council Centre of Excellence for Environmental Decisions; National Environmental Research Program Environmental Decisions Hub	Queensland Department of Environment and Heritage Protection; Redland City Council; Queensland Department of Main Roads; Australian Research Council Centre of Excellence for Environmental Decisions(Australian Research Council); National Environmental Research Program Environmental Decisions Hub	This research was conducted with the support of funding from Queensland Department of Environment and Heritage Protection (http://www.ehp.qld.gov.au/), Redland City Council (http://www.redland.qld.gov.au/Pages/home.aspx), the Queensland Department of Main Roads (http://www.tmr.qld.gov.au/), the Australian Research Council Centre of Excellence for Environmental Decisions (http://www.ceed.edu.au/) and the National Environmental Research Program Environmental Decisions Hub http://www.nerpdecisions.edu.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage DR, 2009, FRONT ECOL ENVIRON, V7, P95, DOI 10.1890/070089; Balmford A, 2006, CONSERV BIOL, V20, P692, DOI 10.1111/j.1523-1739.2006.00434.x; Baxter PWJ, 2006, CONSERV BIOL, V20, P893, DOI 10.1111/j.1523-1739.2006.00378.x; BenHaim Y, 2006, INFO GAP DECISION TH, DOI DOI 10.1016/B978-0-12-373552-2.X5000-0; Bode M, 2009, BIOL CONSERV, V142, P1333, DOI 10.1016/j.biocon.2009.01.029; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Burgman MA, 2007, BIOL CONSERV, V134, P73, DOI 10.1016/j.biocon.2006.08.005; Carey AJ, 2010, AM J REPROD IMMUNOL, V63, P161, DOI 10.1111/j.1600-0897.2009.00776.x; Caswell, 2000, MATRIX POPULATION MO; Chomitz KM, 2005, ENVIRON DEV ECON, V10, P293, DOI 10.1017/S1355770X05002081; Clark M, 2006, STUDY ATTITUDES KOAL, P1; Crain CM, 2009, ANN NY ACAD SCI, V1162, P39, DOI 10.1111/j.1749-6632.2009.04496.x; Curran P, 2012, RESTOR ECOL, V20, P56, DOI 10.1111/j.1526-100X.2010.00746.x; Department of Environment and Resource Management (DERM), 2009, DECL KOAL COAST KOAL; DERM, 2006, NAT CONS KOAL CONS P, P140; Dique DS, 2003, WILDLIFE RES, V30, P419, DOI 10.1071/WR02029; Evans MEK, 2010, ECOL MONOGR, V80, P627, DOI 10.1890/09-1758.1; Evans MC, 2011, BIOSCIENCE, V61, P281, DOI 10.1525/bio.2011.61.4.8; Glista DJ, 2009, LANDSCAPE URBAN PLAN, V91, P1, DOI 10.1016/j.landurbplan.2008.11.001; Guerrero AM, 2010, CONSERV LETT, V3, P332, DOI 10.1111/j.1755-263X.2010.00116.x; Handasyde K.A., 1990, P203; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; King SL, 1999, RESTOR ECOL, V7, P348, DOI 10.1046/j.1526-100X.1999.72029.x; Knight AT, 2007, CONSERV BIOL, V21, P1124, DOI 10.1111/j.1523-1739.2007.00690.x; Knight AT, 2011, DIVERS DISTRIB, V17, P1234, DOI 10.1111/j.1472-4642.2011.00789.x; Knight AT, 2011, BIOL CONSERV, V144, P2623, DOI 10.1016/j.biocon.2011.07.013; Knight AT, 2006, CONSERV BIOL, V20, P408, DOI 10.1111/j.1523-1739.2006.00305.x; Lawler JJ, 2002, ECOL APPL, V12, P663, DOI 10.2307/3060975; Lesbarreres D, 2012, TRENDS ECOL EVOL, V27, P374, DOI 10.1016/j.tree.2012.01.015; McCarthy MA, 2007, ENVIRON MANAGE, V39, P553, DOI 10.1007/s00267-006-0022-3; McCollister MF, 2010, J WILDLIFE MANAGE, V74, P1722, DOI 10.2193/2009-535; Melzer A, 2000, CONSERV BIOL, V14, P619, DOI 10.1046/j.1523-1739.2000.99383.x; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Polasky S, 2008, P NATL ACAD SCI USA, V105, P6505, DOI 10.1073/pnas.0802815105; Possingham HP, 2001, CONSERVATION BIOLOGY: RESEARCH PRIORITIES FOR THE NEXT DECADE, P225; Prugh LR, 2010, CONSERV LETT, V3, P267, DOI 10.1111/j.1755-263X.2010.00111.x; Regan HM, 2005, ECOL APPL, V15, P1471, DOI 10.1890/03-5419; Rhodes JR, 2011, BIOL CONSERV, V144, P1081, DOI 10.1016/j.biocon.2010.12.027; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Runge MC, 2011, BIOL CONSERV, V144, P1214, DOI 10.1016/j.biocon.2010.12.020; Schneider RR, 2010, BIOL CONSERV, V143, P1603, DOI 10.1016/j.biocon.2010.04.002; Semeniuk M, 2011, NSW ROADS TRAFFIC AU, P1; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thompson J., 2006, THESIS U QUEENSLAND; Thomson JR, 2009, ECOL APPL, V19, P817, DOI 10.1890/08-0915.1; Tockner K, 2010, FRESHWATER BIOL, V55, P135, DOI 10.1111/j.1365-2427.2009.02371.x; Underwood EC, 2009, CONSERV LETT, V2, P130, DOI 10.1111/j.1755-263X.2008.00018.x; van der Ree R, 2008, REV MITIGATION MEASU; Venter O, 2006, BIOSCIENCE, V56, P903, DOI 10.1641/0006-3568(2006)56[903:TTESIC]2.0.CO;2; Vesk PA, 2008, BIOL CONSERV, V141, P174, DOI 10.1016/j.biocon.2007.09.010; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Withey JC, 2012, ECOL LETT, V15, P1249, DOI 10.1111/j.1461-0248.2012.01847.x	54	11	11	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92430	10.1371/journal.pone.0092430	http://dx.doi.org/10.1371/journal.pone.0092430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699170	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000026
J	Palacios, L; Rosado, H; Micol, V; Rosato, AE; Bernal, P; Arroyo, R; Grounds, H; Anderson, JC; Stabler, RA; Taylor, PW				Palacios, Lucia; Rosado, Helena; Micol, Vicente; Rosato, Adriana E.; Bernal, Patricia; Arroyo, Raquel; Grounds, Helen; Anderson, James C.; Stabler, Richard A.; Taylor, Peter W.			Staphylococcal Phenotypes Induced by Naturally Occurring and Synthetic Membrane-Interactive Polyphenolic beta-Lactam Resistance Modifiers	PLOS ONE			English	Article							WALL STRESS STIMULON; CELL-WALL; TEA CATECHINS; GREEN TEA; ANTIBACTERIAL PROPERTIES; CYTOPLASMIC MEMBRANE; ANTIOXIDANT CAPACITY; EPICATECHIN GALLATE; TEICHOIC-ACID; AUREUS	Galloyl catechins, in particular (-)-epicatechin gallate (ECg), have the capacity to abrogate beta-lactam resistance in methicillin-resistant strains of Staphylococcus aureus (MRSA); they also prevent biofilm formation, reduce the secretion of a large proportion of the exoproteome and induce profound changes to cell morphology. Current evidence suggests that these reversible phenotypic traits result from their intercalation into the bacterial cytoplasmic membrane. We have endeavoured to potentiate the capacity of ECg to modify the MRSA phenotype by stepwise removal of hydroxyl groups from the B-ring pharmacophore and the A:C fused ring system of the naturally occurring molecule. ECg binds rapidly to the membrane, inducing up-regulation of genes responsible for protection against cell wall stress and maintenance of membrane integrity and function. Studies with artificial membranes modelled on the lipid composition of the staphylococcal bilayer indicated that ECg adopts a position deep within the lipid palisade, eliciting major alterations in the thermotropic behaviour of the bilayer. The non-galloylated homolog (-)-epicatechin enhanced ECg-mediated effects by facilitating entry of ECg molecules into the membrane. ECg analogs with unnatural B-ring hydroxylation patterns induced higher levels of gene expression and more profound changes to MRSA membrane fluidity than ECg but adopted a more superficial location within the bilayer. ECg possessed a high affinity for the positively charged staphylococcal membrane and induced changes to the biophysical properties of the bilayer that are likely to account for its capacity to disperse the cell wall biosynthetic machinery responsible for beta-lactam resistance. The ability to enhance these properties by chemical modification of ECg raises the possibility that more potent analogs could be developed for clinical evaluation.	[Palacios, Lucia; Rosado, Helena; Bernal, Patricia; Arroyo, Raquel; Taylor, Peter W.] UCL, Sch Pharm, London, England; [Micol, Vicente] Univ Miguel Hernandez, Alicante, Spain; [Rosato, Adriana E.] Methodist Hosp, Res Inst, Houston, TX 77030 USA; [Grounds, Helen; Anderson, James C.] UCL, Dept Chem, London, England; [Stabler, Richard A.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; University College London; University of London School of Pharmacy; Universidad Miguel Hernandez de Elche; The Methodist Hospital System; The Methodist Hospital - Houston; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Taylor, PW (corresponding author), UCL, Sch Pharm, London, England.	peter.taylor@ucl.ac.uk	Bernal, Patricia/K-6399-2014; Arroyo, Raquel/H-2952-2015; Arroyo, Raquel/AAZ-1323-2020; Micol, Vicente/K-6841-2014	Bernal, Patricia/0000-0002-6228-0496; Arroyo, Raquel/0000-0003-0612-3928; Arroyo, Raquel/0000-0003-0612-3928; Rosato, Adriana E./0000-0001-6115-6955; Micol, Vicente/0000-0001-8089-0696; Stabler, Richard/0000-0002-2402-6630	Medical Research Council [G060004, G0801757]; National Institute for Health Research University College London Hospitals Biomedical Research Centre; Spanish Ministry of Science and Innovation [AGL2011-29857-C03-03]; Generalitat Valenciana [PROMETEO/2012/007, ACOMP/2013/093]; CIBER from Fisiopatologia de la Obesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos III [CB12/03/30038]; NIH [5R01AI080688-04]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080688] Funding Source: NIH RePORTER; Medical Research Council [G0600004] Funding Source: researchfish; MRC [G0600004, G0801757] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); CIBER from Fisiopatologia de la Obesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos III; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by research grants G060004 and G0801757 from the Medical Research Council (http://www.mrc.ac.uk/index.htm) and was supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre. Work undertaken in VM's laboratory was supported by grants AGL2011-29857-C03-03 from the Spanish Ministry of Science and Innovation, PROMETEO/2012/007 and ACOMP/2013/093 from Generalitat Valenciana and CIBER CB12/03/30038 from Fisiopatologia de la Obesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos III. Activities in AER's laboratory were supported by NIH grant 5R01AI080688-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Anderson DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008305; Anderson JC, 2011, BIOORG MED CHEM LETT, V21, P6996, DOI 10.1016/j.bmcl.2011.09.116; Anderson JC, 2005, TETRAHEDRON, V61, P7703, DOI 10.1016/j.tet.2005.05.086; Andra J, 2011, J BIOL CHEM, V286, P18692, DOI 10.1074/jbc.M111.226886; Bernal P, 2007, ENVIRON MICROBIOL, V9, P1135, DOI 10.1111/j.1462-2920.2006.01236.x; Bernal P, 2010, J BIOL CHEM, V285, P24055, DOI 10.1074/jbc.M110.114793; Bernal P, 2009, J ANTIMICROB CHEMOTH, V63, P1156, DOI 10.1093/jac/dkp094; Bertsche U, 2011, ANTIMICROB AGENTS CH, V55, P3922, DOI 10.1128/AAC.01226-10; Boyle-Vavra S, 2013, ANTIMICROB AGENTS CH, V57, P83, DOI 10.1128/AAC.01651-12; Caturla N, 2003, FREE RADICAL BIO MED, V34, P648, DOI 10.1016/S0891-5849(02)01366-7; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Cushnie TPT, 2011, INT J ANTIMICROB AG, V38, P99, DOI 10.1016/j.ijantimicag.2011.02.014; Datta R, 2008, CLIN INFECT DIS, V47, P176, DOI 10.1086/589241; DAVENPORT L, 1985, BIOCHEMISTRY-US, V24, P4097, DOI 10.1021/bi00336a044; Dengler V, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-16; Doyle M, 2009, J ANTIMICROB CHEMOTH, V64, P949, DOI 10.1093/jac/dkp325; Edgeworth JD, 2011, J ANTIMICROB CHEMOTH, V66, pII41, DOI 10.1093/jac/dkq325; EFTINK MR, 1976, J PHYS CHEM-US, V80, P486, DOI 10.1021/j100546a014; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Falord M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021323; Funes L, 2010, CHEM PHYS LIPIDS, V163, P190, DOI 10.1016/j.chemphyslip.2009.11.004; Geddes AM, 2007, INT J ANTIMICROB AG, V30, pS109, DOI 10.1016/j.ijantimicag.2007.07.015; Hubscher J, 2009, FEMS MICROBIOL LETT, V295, P251, DOI 10.1111/j.1574-6968.2009.01603.x; Ichihashi N, 2003, J BIOL CHEM, V278, P28778, DOI 10.1074/jbc.M212202200; Inoue R, 2001, MOL GENET GENOMICS, V266, P564, DOI 10.1007/s004380100564; Jousselin A, 2012, ANTIMICROB AGENTS CH, V56, P3629, DOI 10.1128/AAC.06264-11; Kaiser RD, 1998, BIOCHEMISTRY-US, V37, P8180, DOI 10.1021/bi980064a; Kajiya K, 2002, BIOSCI BIOTECH BIOCH, V66, P2330, DOI 10.1271/bbb.66.2330; Kajiya K, 2001, BIOSCI BIOTECH BIOCH, V65, P2638, DOI 10.1271/bbb.65.2638; Kajiya K, 2008, MAGN RESON CHEM, V46, P174, DOI 10.1002/mrc.2157; Laporta O, 2007, FOOD CHEM, V101, P1425, DOI 10.1016/j.foodchem.2006.03.051; Lazarevic V, 2011, FUTURE MICROBIOL, V6, P513, DOI [10.2217/FMB.11.38, 10.2217/fmb.11.38]; Lee BY, 2011, INFECT CONT HOSP EP, V32, P562, DOI 10.1086/660014; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; Martinez JL, 2007, NAT REV MICROBIOL, V5, P958, DOI 10.1038/nrmicro1796; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; Mehta S, 2012, ANTIMICROB AGENTS CH, V56, P6192, DOI 10.1128/AAC.01525-12; Mehta S, 2012, ANTIMICROB AGENTS CH, V56, P92, DOI 10.1128/AAC.00432-10; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Mukhopadhyay K, 2007, MICROBIOL-SGM, V153, P1187, DOI 10.1099/mic.0.2006/003111-0; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Perez-Fons L, 2010, J AGR FOOD CHEM, V58, P161, DOI 10.1021/jf9026487; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Peterson LR, 2007, JT COMM J QUAL PATIE, V33, P732, DOI 10.1016/S1553-7250(07)33088-2; Pinho MG, 2005, MOL MICROBIOL, V55, P799, DOI 10.1111/j.1365-2958.2004.04420.x; Pinho MG, 2003, MOL MICROBIOL, V50, P871, DOI 10.1046/j.1365-2958.2003.03719.x; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Rosado H, 2012, INT J ASTROBIOL, V11, P71, DOI 10.1017/S1473550411000346; Sass P, 2009, INT J MED MICROBIOL, V299, P313, DOI 10.1016/j.ijmm.2008.10.005; Shah S, 2008, LETT APPL MICROBIOL, V46, P181, DOI 10.1111/j.1472-765X.2007.02296.x; SHORT SA, 1971, J BACTERIOL, V108, P219, DOI 10.1128/JB.108.1.219-226.1971; Sirk TW, 2008, J AGR FOOD CHEM, V56, P7750, DOI 10.1021/jf8013298; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stapleton MR, 2007, J BACTERIOL, V189, P7316, DOI 10.1128/JB.00734-07; Stapleton PD, 2007, MICROBIOL-SGM, V153, P2093, DOI 10.1099/mic.0.2007/007807-0; Stapleton PD, 2006, INT J FOOD MICROBIOL, V111, P276, DOI 10.1016/j.ijfoodmicro.2006.06.005; Stapleton PD, 2006, ANTIMICROB AGENTS CH, V50, P752, DOI 10.1128/AAC.50.2.752-755.2006; Stapleton PD, 2004, INT J ANTIMICROB AG, V23, P462, DOI 10.1016/j.ijantimicag.2003.09.027; Taylor Peter W, 2005, Food Sci Technol Bull, V2, P71, DOI 10.1616/1476-2137.14184; Taylor PW, 2013, INT J ANTIMICROB AG, V42, P195, DOI 10.1016/j.ijantimicag.2013.05.004; Taylor PW, 2009, PHARM RES SAF TEST, P43; Trevors JT, 2003, J BIOCHEM BIOPH METH, V57, P87, DOI 10.1016/S0165-022X(03)00076-9; TROTTER PJ, 1989, BIOCHIM BIOPHYS ACTA, V982, P131, DOI 10.1016/0005-2736(89)90183-1; Tsuchiya H, 2001, CHEM-BIOL INTERACT, V134, P41, DOI 10.1016/S0009-2797(00)00308-2; Turner RD, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1025; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; WARDLAW JR, 1987, FEBS LETT, V223, P20, DOI 10.1016/0014-5793(87)80502-1; Wilkinson Brian J., 2005, Current Medicinal Chemistry - Anti-Infective Agents, V4, P259, DOI 10.2174/1568012054368119; Witney AA, 2005, APPL ENVIRON MICROB, V71, P7504, DOI 10.1128/AEM.71.11.7504-7514.2005	71	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93830	10.1371/journal.pone.0093830	http://dx.doi.org/10.1371/journal.pone.0093830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699700	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000334105000114
J	Stathopoulos, S; Bishop, JM; O'Ryan, C				Stathopoulos, Sofia; Bishop, Jacqueline M.; O'Ryan, Colleen			Genetic Signatures for Enhanced Olfaction in the African Mole-Rats	PLOS ONE			English	Article							FALSE DISCOVERY RATE; AMINO-ACID SITES; RECEPTOR GENES; MOLECULAR PHYLOGENY; EVOLUTIONARY DYNAMICS; COMPARATIVE GENOMICS; MAXIMUM-LIKELIHOOD; CLUSTAL-W; ODORANT; CRYPTOMYS	The Olfactory Receptor (OR) superfamily, the largest in the vertebrate genome, is responsible for vertebrate olfaction and is traditionally subdivided into 17 OR families. Recent studies characterising whole-OR subgenomes revealed a 'birth and death' model of evolution for a range of species, however little is known about fine-scale evolutionary dynamics within single-OR families. This study reports the first assessment of fine-scale OR evolution and variation in African mole-rats (Bathyergidae), a family of subterranean rodents endemic to sub-Saharan Africa. Because of the selective pressures of life underground, enhanced olfaction is proposed to be fundamental to the evolutionary success of the Bathyergidae, resulting in a highly diversified OR gene-repertoire. Using a PCR-sequencing approach, we analysed variation in the OR7 family across 14 extant bathyergid species, which revealed enhanced levels of functional polymorphisms concentrated across the receptors' ligand-binding region. We propose that mole-rats are able to recognise a broad range of odorants and that this diversity is reflected throughout their OR7 gene repertoire. Using both classic tests and tree-based methods to test for signals of selection, we investigate evolutionary forces across the mole-rat OR7 gene tree. Four well-supported clades emerged in the OR phylogeny, with varying signals of selection; from neutrality to positive and purifying selection. Bathyergid life-history traits and environmental niche-specialisation are explored as possible drivers of adaptive OR evolution, emerging as non-exclusive contributors to the positive selection observed at OR7 genes. Our results reveal unexpected complexity of evolutionary mechanisms acting within a single OR family, providing insightful perspectives into OR evolutionary dynamics.	[Stathopoulos, Sofia; O'Ryan, Colleen] Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, Western Cape, South Africa; [Bishop, Jacqueline M.] Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, Western Cape, South Africa	University of Cape Town; University of Cape Town	Stathopoulos, S (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, Western Cape, South Africa.	sofiastathopoulos@hotmail.com		O'Ryan, Colleen/0000-0003-3719-4657	University of Cape Town Research Committee; South African National Research Foundation	University of Cape Town Research Committee; South African National Research Foundation(National Research Foundation - South Africa)	This study was supported by the University of Cape Town Research Committee and the South African National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Adkins RM, 2001, MOL BIOL EVOL, V18, P777, DOI 10.1093/oxfordjournals.molbev.a003860; Alioto TS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-173; Bardeleben C, 2005, MOL PHYLOGENET EVOL, V37, P815, DOI 10.1016/j.ympev.2005.07.019; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett N.C., 2000, AFRICAN MOLE RATS EC; Bhatnagar KP, 2010, CURRENT NEUROBIOLOGY, V1, P1; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blanga-Kanfi S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-71; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BURDA H, 1995, EXPERIENTIA, V51, P411, DOI 10.1007/BF01928906; Crish SD, 2003, BRAIN BEHAV EVOLUT, V62, P141, DOI 10.1159/000072723; Deuve JL, 2008, CHROMOSOMA, V117, P211, DOI 10.1007/s00412-007-0140-6; Deuve JL, 2008, CHROMOSOME RES, V16, P57, DOI 10.1007/s10577-007-1200-8; Deuve JL, 2006, CHROMOSOME RES, V14, P681, DOI 10.1007/s10577-006-1080-3; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; ELOFF G., 1958, S AFRICAN JOUR SCI, V54, P293; Emes RD, 2004, GENOME RES, V14, P591, DOI 10.1101/gr.1940604; Faulkes CG, 1990, THESIS U LONDON UK; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Freitag J, 1998, J COMP PHYSIOL A, V183, P635, DOI 10.1007/s003590050287; Freitag J, 1995, NEURON, V15, P1383, DOI 10.1016/0896-6273(95)90016-0; Gaillard I, 2002, EUR J NEUROSCI, V15, P409, DOI 10.1046/j.0953-816x.2001.01871.x; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Gilad Y, 2003, AM J HUM GENET, V73, P489, DOI 10.1086/378132; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hayden S, 2010, GENOME RES, V20, P1, DOI 10.1101/gr.099416.109; Heth G, 2004, FOLIA ZOOL, V53, P269; Heth G, 2002, BEHAV ECOL SOCIOBIOL, V52, P53, DOI 10.1007/s00265-002-0476-0; Heth G, 2002, J MAMMAL, V83, P569, DOI 10.1644/1545-1542(2002)083<0569:IOSWCA>2.0.CO;2; HOLMES WG, 1983, AM SCI, V71, P46; Ingram CM, 2004, MOL PHYLOGENET EVOL, V31, P997, DOI 10.1016/j.ympev.2003.11.004; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Jacob S, 2001, PHYSIOL BEHAV, V74, P15, DOI 10.1016/S0031-9384(01)00537-6; Jacob S, 2001, NEUROREPORT, V12, P2391, DOI 10.1097/00001756-200108080-00021; Jarvis J.U.M., 1991, P384; Jarvis Jennifer U.M., 2002, Mammalian Species, V706, P1, DOI 10.1644/1545-1410(2002)706<0001:HG>2.0.CO;2; Judd TM, 1996, ANIM BEHAV, V52, P957, DOI 10.1006/anbe.1996.0244; Kambere MB, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-S3-S2; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Keller A, 2008, CURR OPIN NEUROBIOL, V18, P364, DOI 10.1016/j.conb.2008.09.020; KIMURA M, 1969, GENETICS, V61, P763; Kishida T, 2010, J EVOLUTION BIOL, V23, P302, DOI 10.1111/j.1420-9101.2009.01899.x; Kishida T, 2007, BIOLOGY LETT, V3, P428, DOI 10.1098/rsbl.2007.0191; Kishida T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002385; Klein J, 1998, ANNU REV ECOL SYST, V29, P1, DOI 10.1146/annurev.ecolsys.29.1.1; Kondo R, 2002, GENE, V282, P113, DOI 10.1016/S0378-1119(01)00843-5; Kott O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011810; Lacey EA, 2000, LIFE UNDERGROUND BIO; Lange S, 2005, FOLIA ZOOL, V54, P263; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LI WH, 1981, NATURE, V292, P237, DOI 10.1038/292237a0; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Man O, 2004, PROTEIN SCI, V13, P240, DOI 10.1110/ps.03296404; Matsui A, 2010, MOL BIOL EVOL, V27, P1192, DOI 10.1093/molbev/msq003; Menashe I, 2007, PLOS BIOL, V5, P2462, DOI 10.1371/journal.pbio.0050284; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; NEDBAL MA, 1994, MOL PHYLOGENET EVOL, V3, P206, DOI 10.1006/mpev.1994.1023; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Nemec P, 2008, BRAIN RES BULL, V75, P356, DOI 10.1016/j.brainresbull.2007.10.055; Nielsen R, 1998, GENETICS, V148, P929; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; Niimura Y, 2005, GENE, V346, P13, DOI 10.1016/j.gene.2004.09.025; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Niimura Y, 2009, GENOME BIOL EVOL, V1, P34, DOI 10.1093/gbe/evp003; ORiain MJ, 1997, ANIM BEHAV, V53, P487, DOI 10.1006/anbe.1996.0299; Parsegian V. A., 2006, VANDERWAALS FORCES H; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramm SA, 2008, MOL BIOL EVOL, V25, P207, DOI 10.1093/molbev/msm242; Reeve H., 1991, BIOL NAKED MOLE RAT, P337; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Rozas J, 2001, GENETICS, V158, P1147; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Sanders KL, 2008, J EVOLUTION BIOL, V21, P682, DOI 10.1111/j.1420-9101.2008.01525.x; Smith TD, 2007, BRAIN RES, V1132, P78, DOI 10.1016/j.brainres.2006.11.021; Spinks AC, 1998, BEHAV ECOL, V69, P224; Steiger SS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-117; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Thewissen JGM, 2011, MAR MAMMAL SCI, V27, P282, DOI 10.1111/j.1748-7692.2010.00406.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wyart C, 2007, J NEUROSCI, V27, P1261, DOI 10.1523/JNEUROSCI.4430-06.2007; Yang Z, 2009, PAML MANUAL VERSION; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zarzo M, 2007, BIOL REV, V82, P455, DOI 10.1111/j.1469-185X.2007.00019.x; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhang XH, 2007, GENOMICS, V89, P441, DOI 10.1016/j.ygeno.2007.01.002; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhao HY, 2009, J FRANKLIN I, V346, P945, DOI 10.1016/j.jfranklin.2009.05.007	114	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93336	10.1371/journal.pone.0093336	http://dx.doi.org/10.1371/journal.pone.0093336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699281	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000054
J	Totaro, A; Astro, V; Tonoli, D; de Curtis, I				Totaro, Antonio; Astro, Veronica; Tonoli, Diletta; de Curtis, Ivan			Identification of Two Tyrosine Residues Required for the Intramolecular Mechanism Implicated in GIT1 Activation	PLOS ONE			English	Article							REGULATES PROTRUSIVE ACTIVITY; EPIDERMAL-GROWTH-FACTOR; PAXILLIN KINASE LINKER; SYNAPSE FORMATION; ANGIOTENSIN-II; LD4 MOTIF; BETA-PIX; PROTEINS; FAMILY; COMPLEX	GIT1 is an ArfGAP and scaffolding protein regulating cell adhesion and migration. The multidomain structure of GIT1 allows the interaction with several partners. Binding of GIT1 to some of its partners requires activation of the GIT1 polypeptide. Our previous studies indicated that binding of paxillin to GIT1 is enhanced by release of an intramolecular interaction between the amino-terminal and carboxy-terminal portions that keeps the protein in a binding-incompetent state. Here we have addressed the mechanism mediating this intramolecular inhibitory mechanism by testing the effects of the mutation of several formerly identified GIT1 phosphorylation sites on the binding to paxillin. We have identified two tyrosines at positions 246 and 293 of the human GIT1 polypeptide that are needed to keep the protein in the inactive conformation. Interestingly, mutation of these residues to phenylalanine did not affect binding to paxillin, while mutation to either alanine or glutamic acid enhanced binding to paxillin, without affecting the constitutive binding to the Rac/Cdc42 exchange factor beta PIX. The involvement of the two tyrosine residues in the intramolecular interaction was supported by reconstitution experiments showing that these residues are important for the binding between the amino-terminal fragment and carboxyterminal portions of GIT1. Either GIT1 or GIT1-N tyrosine phosphorylation by Src and pervanadate treatment to inhibit protein tyrosine phosphatases did not affect the intramolecular binding between the amino-and carboxy-terminal fragments, nor the binding of GIT1 to paxillin. Mutations increasing the binding of GIT1 to paxillin positively affected cell motility, measured both by transwell migration and wound healing assays. Altogether these results show that tyrosines 246 and 293 of GIT1 are required for the intramolecular inhibitory mechanism that prevents the binding of GIT1 to paxillin. The data also suggest that tyrosine phosphorylation may not be sufficient to release the intramolecular interaction that keeps GIT1 in the inactive conformation.	[Totaro, Antonio; Astro, Veronica; Tonoli, Diletta; de Curtis, Ivan] Ist Sci San Raffaele, Div Neurosci, Cell Adhes Unit, I-20132 Milan, Italy; [de Curtis, Ivan] Univ Vita Salute San Raffaele, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	de Curtis, I (corresponding author), Ist Sci San Raffaele, Div Neurosci, Cell Adhes Unit, I-20132 Milan, Italy.	decurtis.ivan@hsr.it		DE CURTIS, Ivanmatteo/0000-0002-7651-1515; Astro, Veronica/0000-0001-7852-7046	Telethon-Italy [GGP12126]; AIRC [10321]; FIRC	Telethon-Italy(Fondazione Telethon); AIRC(Fondazione AIRC per la ricerca sul cancro); FIRC(Fondazione AIRC per la ricerca sul cancro)	The following sources of funding to Ivan de Curtis have supported this work: Telethon-Italy, grant GGP12126 (http://www.telethon.it/). AIRC, grant 10321 (http://www.airc.it/). Moreover, a fellowship to Veronica Astro was supported by FIRC (http://www.fondazionefirc.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen GPV, 2004, CIRC RES, V94, P1041, DOI 10.1161/01.RES.0000125627.77235.0C; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Botrugno OA, 2006, EUR J CELL BIOL, V85, P35, DOI 10.1016/j.ejcb.2005.09.018; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Fujikawa A, 2011, J BIOL CHEM, V286, P37137, DOI 10.1074/jbc.M111.270140; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Haendeler J, 2003, J BIOL CHEM, V278, P49936, DOI 10.1074/jbc.M307317200; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Kim S, 2001, J BIOL CHEM, V276, P10581, DOI 10.1074/jbc.C000806200; Lamorte L, 2003, MOL BIOL CELL, V14, P2818, DOI 10.1091/mbc.E02-08-0497; Manabe R, 2002, J CELL SCI, V115, P1497; Matafora V, 2001, J CELL SCI, V114, P4509; Paris S, 2003, BIOCHEM J, V372, P391, DOI 10.1042/BJ20030047; Premont RT, 2000, J BIOL CHEM, V275, P22373, DOI 10.1074/jbc.275.29.22373; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Sabe H, 2006, CURR OPIN CELL BIOL, V18, P558, DOI 10.1016/j.ceb.2006.08.002; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Shih JL, 2005, MOL BIOL CELL, V16, P4595, DOI 10.1091/mbc.E05-02-0108; Shikata Y, 2003, J APPL PHYSIOL, V94, P1193, DOI 10.1152/japplphysiol.00690.2002; Totaro A, 2007, MOL BIOL CELL, V18, P5124, DOI 10.1091/mbc.E07-06-0550; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Webb DJ, 2006, BIOCHEM BIOPH RES CO, V346, P1284, DOI 10.1016/j.bbrc.2006.06.036; Webb DJ, 2006, J CELL SCI, V119, P2847, DOI 10.1242/jcs03044; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Yin GY, 2004, MOL CELL BIOL, V24, P875, DOI 10.1128/MCB.24.2.875-885.2004; Za L, 2006, J CELL SCI, V119, P2654, DOI 10.1242/jcs.02996; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	36	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93199	10.1371/journal.pone.0093199	http://dx.doi.org/10.1371/journal.pone.0093199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699139	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000045
J	Berto, GE; Iobbi, C; Camera, P; Scarpa, E; Iampietro, C; Bianchi, F; Gai, M; Sgro, F; Cristofani, F; Gartner, A; Dotti, CG; Di Cunto, F				Berto, Gaia Elena; Iobbi, Cristina; Camera, Paola; Scarpa, Elena; Iampietro, Corinne; Bianchi, Federico; Gai, Marta; Sgro, Francesco; Cristofani, Flavio; Gaertner, Annette; Dotti, Carlos G.; Di Cunto, Ferdinando			The DCR Protein TTC3 Affects Differentiation and Golgi Compactness in Neurons through Specific Actin-Regulating Pathways	PLOS ONE			English	Article							SYNDROME CRITICAL REGION; CULTURED HIPPOCAMPAL-NEURONS; CITRON KINASE CONTROLS; DOWN-SYNDROME; LIM-KINASE; SYNAPTIC PLASTICITY; MOUSE MODEL; COFILIN PHOSPHORYLATION; CYTOSKELETAL DYNAMICS; AXON FORMATION	In neuronal cells, actin remodeling plays a well known role in neurite extension but is also deeply involved in the organization of intracellular structures, such as the Golgi apparatus. However, it is still not very clear which mechanisms may regulate actin dynamics at the different sites. In this report we show that high levels of the TTC3 protein, encoded by one of the genes of the Down Syndrome Critical Region (DCR), prevent neurite extension and disrupt Golgi compactness in differentiating primary neurons. These effects largely depend on the capability of TTC3 to promote actin polymerization through signaling pathways involving RhoA, ROCK, CIT-N and PIIa. However, the functional relationships between these molecules differ significantly if considering the TTC3 activity on neurite extension or on Golgi organization. Finally, our results reveal an unexpected stage-dependent requirement for F-actin in Golgi organization at different stages of neuronal differentiation.	[Berto, Gaia Elena; Camera, Paola; Scarpa, Elena; Iampietro, Corinne; Bianchi, Federico; Gai, Marta; Sgro, Francesco; Cristofani, Flavio; Di Cunto, Ferdinando] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Gaertner, Annette; Dotti, Carlos G.] VIB, VIB Ctr Biol Dis, Louvain, Belgium; [Dotti, Carlos G.] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain	University of Turin; Flanders Institute for Biotechnology (VIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Di Cunto, F (corresponding author), Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy.	gaia.berto@unito.it; ferdinando.dicunto@unito.it	Dotti, Carlos G/I-5533-2015; Di Cunto, Ferdinando/K-5575-2016; Gaertner, Annette/B-5393-2013	Dotti, Carlos G/0000-0003-4052-1719; Scarpa, Elena/0000-0002-0849-1276; di cunto, ferdinando/0000-0001-9367-6357; Bianchi, Federico Tommaso/0000-0002-8385-3310; Iampietro, Corinne/0000-0003-3153-9271	Jerome Lejeune foundation; Telethon Foundation	Jerome Lejeune foundation; Telethon Foundation(Fondazione Telethon)	This work was supported by the generous contribution of the Jerome Lejeune foundation to FDC. Moreover, the financial support of the Telethon Foundation, to the laboratory of FDC, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Bard F, 2003, J BIOL CHEM, V278, P46601, DOI 10.1074/jbc.M302221200; Bassi ZI, 2013, P NATL ACAD SCI USA, V110, P9782, DOI 10.1073/pnas.1301328110; Bassi ZI, 2011, J CELL BIOL, V195, P595, DOI 10.1083/jcb.201105136; BECKER L, 1991, PROG CLIN BIOL RES, V373, P133; BECKER LE, 1986, ANN NEUROL, V20, P520, DOI 10.1002/ana.410200413; Belichenko NP, 2009, J NEUROSCI, V29, P5938, DOI 10.1523/JNEUROSCI.1547-09.2009; Berto G, 2007, J CELL SCI, V120, P1859, DOI 10.1242/jcs.000703; Bisel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080446; Bradke F, 2000, MICROSC RES TECHNIQ, V48, P3, DOI 10.1002/(SICI)1097-0029(20000101)48:1<3::AID-JEMT2>3.0.CO;2-O; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Burkhardt JK, 1998, BBA-MOL CELL RES, V1404, P113, DOI 10.1016/S0167-4889(98)00052-4; Camera P, 2003, NAT CELL BIOL, V5, P1071, DOI 10.1038/ncb1064; Camera P, 2008, EMBO REP, V9, P384, DOI 10.1038/embor.2008.21; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8; Di Cunto F, 2003, BRAIN RES BULL, V60, P319, DOI 10.1016/S0361-9230(03)00058-3; Di Cunto F, 1998, J BIOL CHEM, V273, P29706, DOI 10.1074/jbc.273.45.29706; Dierssen M, 2006, THESCIENTIFICWORLDJO, V6, P1911, DOI 10.1100/tsw.2006.319; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Eki T, 1997, DNA SEQUENCE, V7, P153, DOI 10.3109/10425179709034031; Farg MA, 2013, HUM MOL GENET, V22, P717, DOI 10.1093/hmg/dds479; Flynn KC, 2012, NEURON, V76, P1091, DOI 10.1016/j.neuron.2012.09.038; Furuyashiki T, 1999, J NEUROSCI, V19, P109, DOI 10.1523/JNEUROSCI.19-01-00109.1999; Gai M, 2011, MOL BIOL CELL, V22, P3768, DOI 10.1091/mbc.E10-12-0952; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Gonatas NK, 2006, J NEUROL SCI, V246, P21, DOI 10.1016/j.jns.2006.01.019; Holcomb PS, 2013, J PHYSIOL-LONDON, V591, P3145, DOI 10.1113/jphysiol.2012.248542; Hoogenraad CC, 2009, TRENDS CELL BIOL, V19, P669, DOI 10.1016/j.tcb.2009.08.006; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kleschevnikov AM, 2012, J NEUROSCI, V32, P9217, DOI 10.1523/JNEUROSCI.1673-12.2012; Lazaro-Dieguez F, 2006, CELL MOTIL CYTOSKEL, V63, P778, DOI 10.1002/cm.20161; Madaule P, 1995, FEBS LETT, V377, P243, DOI 10.1016/0014-5793(95)01351-2; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; de Lagran MM, 2012, CEREB CORTEX, V22, P2867, DOI 10.1093/cercor/bhr362; Matas OB, 2004, TRAFFIC, V5, P838, DOI 10.1111/j.1600-0854.2004.00225.x; Neukirchen D, 2011, SEMIN CELL DEV BIOL, V22, P825, DOI 10.1016/j.semcdb.2011.08.007; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Rendon WO, 2013, HISTOCHEM CELL BIOL, V139, P671, DOI 10.1007/s00418-012-1059-4; Repetto D, 2014, J NEUROSCI, V34, P1542, DOI 10.1523/JNEUROSCI.2341-13.2014; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siarey RJ, 2005, NEUROPHARMACOLOGY, V49, P122, DOI 10.1016/j.neuropharm.2005.02.012; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Suizu F, 2009, DEV CELL, V17, P800, DOI 10.1016/j.devcel.2009.09.007; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Takata M, 2013, BR J PHARM; Tsukahara F, 1996, J BIOCHEM-TOKYO, V120, P820; Vilardell M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-229; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Yadav S., 2011, COLD SPRING HARB PER, V3, P3; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yin DM, 2008, J NEUROSCI, V28, P8832, DOI 10.1523/JNEUROSCI.1291-08.2008	62	5	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93721	10.1371/journal.pone.0093721	http://dx.doi.org/10.1371/journal.pone.0093721			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695496	gold, Green Published			2022-12-27	WOS:000334103000110
J	Jiang, YD; Zhang, QH; Steinle, JJ				Jiang, Youde; Zhang, Qiuhua; Steinle, Jena J.			Intravitreal Injection of IGFBP-3 Restores Normal Insulin Signaling in Diabetic Rat Retina	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; NECROSIS-FACTOR-ALPHA; TNF-ALPHA; MULLER CELLS; RECEPTOR; SOCS-3; PHOSPHORYLATION; RESISTANCE; PATHWAYS; PROTEINS	Diabetes-induced changes in growth factor binding protein 3 (IGFBP-3) and tumor necrosis factor alpha (TNF alpha) have been linked to decreased insulin receptor signaling in diabetic retinopathy. Our previous studies in retinas of diabetic rats have shown that Compound 49b, a novel beta-adrenergic receptor agonist, prevented diabetic changes by increasing IGFBP-3 and decreasing TNF alpha, thus restoring insulin signaling and protection against diabetic retinopathy. The current study was designed to determine whether boosted expression of IGFBP-3 NB (a non-IGF-1 binding form of IGFBP-3) alone is sufficient to mimic the full actions of Compound 49b in protecting against diabetic retinopathy, as well as testing whether IGFBP-3 NB is linked to a restoration of normal insulin signal transduction. Two months after initiation of streptozotocin-induced diabetes, rats received a single intravitreal injection of IGFBP-3 NB plasmid in the right eye. Four days after injection, electroretinogram (ERG) analyses were performed prior to sacrifice. Whole retinal lysates from control, diabetic, diabetic + control plasmid, and diabetic+IGFBP-3 NB were analyzed for IGFBP-3, TNF alpha, suppressor of cytokine signaling 3 (SOCS3), and insulin receptor signaling partners using Western blotting or ELISA. Data show that a single intraocular injection of IGFBP-3 NB in diabetic animals significantly reduced TNF alpha levels, concomitant with reductions in IRS-1(Ser307), SOCS3, and proapoptotic markers, while restoring insulin receptor phosphorylation and increasing anti-apoptotic marker levels. These cellular changes were linked to restoration of retinal function. Our findings establish IGFBP-3 as a pivotal regulator of the insulin receptor/TNF alpha pathway and a potential therapeutic target for diabetic retinopathy.	[Jiang, Youde; Zhang, Qiuhua; Steinle, Jena J.] Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA; [Steinle, Jena J.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Steinle, Jena J.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Steinle, JJ (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA.	jsteinl1@uthsc.edu	zhang, qiu/GXG-5600-2022	Steinle, Jena/0000-0002-7539-2892	NEI [R01-EY022045]; JDRF [2-2011-597]; Oxnard Foundation; HEI Research to Prevent Blindness Award; NEI Vision Core Grant [PHS 3P30 EY013080]; NATIONAL EYE INSTITUTE [R01EY022045, P30EY021721, P30EY013080] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); JDRF(Juvenile Diabetes Research Foundation); Oxnard Foundation; HEI Research to Prevent Blindness Award; NEI Vision Core Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NEI R01-EY022045 (JJS), JDRF (2-2011-597 to JJS), Oxnard Foundation (JJS), HEI Research to Prevent Blindness Award (PI: James C. Fleming), and NEI Vision Core Grant: PHS 3P30 EY013080 (PI: Dianna Johnson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Fasshauer M, 2004, J ENDOCRINOL, V181, P129, DOI 10.1677/joe.0.1810129; Ferry RJ, 1999, HORM RES, V51, P53; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Jiang Y, 2013, PLOS ONE, V8; Jiang Y, 2013, MOL VIS, V19, P804; Jiang YD, 2012, CELL SIGNAL, V24, P1086, DOI 10.1016/j.cellsig.2012.01.003; Jiang YD, 2010, EXP EYE RES, V91, P171, DOI 10.1016/j.exer.2010.04.014; Krebs DL, 2000, J CELL SCI, V113, P2813; Panjala SR, 2011, MOL VIS, V17, P1822; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Steinle JJ, 2009, EXP EYE RES, V88, P1014, DOI 10.1016/j.exer.2008.12.015; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Walker RJ, 2011, INVEST OPHTHALMOL VI; Walker RJ, 2012, MOL VIS, V18, P271; Wiley LA, 2005, INVEST OPHTH VIS SCI, V46, P744, DOI 10.1167/iovs.04-1023; Zhang Q, 2013, INVEST OPHTHALMOL VI; Zhang QH, 2013, INVEST OPHTH VIS SCI, V54, P5376, DOI 10.1167/iovs.13-12497; Zhang QH, 2013, APOPTOSIS, V18, P361, DOI 10.1007/s10495-012-0793-3; Zhang QH, 2012, INVEST OPHTH VIS SCI, V53, P3004, DOI 10.1167/iovs.11-8779	23	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93788	10.1371/journal.pone.0093788	http://dx.doi.org/10.1371/journal.pone.0093788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695399	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000123
J	Wang, XW; Yuan, BB; Dong, WP; Yang, B; Yang, YC; Lin, X; Gong, G				Wang, Xiaowu; Yuan, Binbin; Dong, Wenpeng; Yang, Bo; Yang, Yongchao; Lin, Xi; Gong, Gu			Induction of Heat-Shock Protein 70 Expression by Geranylgeranylacetone Shows Cytoprotective Effects in Cardiomyocytes of Mice under Humid Heat Stress	PLOS ONE			English	Article							SHOCK-PROTEIN INDUCTION; CULTURED RAT HEPATOCYTES; NF-KAPPA-B; INDUCED APOPTOSIS; ISCHEMIA-REPERFUSION; HYDROGEN-PEROXIDE; INDUCED INJURY; LIVER-INJURY; HSP70; ACTIVATION	Background: Increasing evidence has revealed that humid heat stress (HHS) causes considerable damage to human health. The cardiovascular system has been suggested to be the primary target of heat stress, which results in serious cardiovascular diseases. However, there is still a lack of effective approaches for the prevention and treatment of cardiovascular diseases induced by HHS. Objective: Heat-shock proteins (Hsps), especially Hsp70, are reported to provide effective cytoprotection under various stress stimuli. In the present study, we evaluated the cytoprotective effect of geranylgeranylacetone (GGA), which was previously been reported to induce Hsp70 expression in cardiomyocytes under HHS. Methods and Principal Findings: Using a mouse model of HHS, we showed that the pretreatment of GGA enhanced Hsp70 expression under HHS, as examined by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot. We then examined the effect of GGA pretreatment on the cardiomyocyte apoptosis induced by HHS using terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) staining, and found that GGA pretreatment inhibited mitochondria-mediated apoptosis. GGA pretreatment could reverse the effect of HHS on cell apoptosis by increasing expression of Bcl-2, decreasing cytochrome c in cytosol, and increasing cytochrome c in mitochondria. However, GGA pretreatment had no effect on the oxidative stress induced by HHS as determined by levels of superoxide dismutase (SOD), malondialdehyde (MDA), and glutathione (GSH). Conclusion: We have demonstrated that GGA pretreatment suppressed HHS-induced apoptosis of cardiomyocytes through the induction of Hsp70 overexpression.	[Wang, Xiaowu; Yuan, Binbin; Dong, Wenpeng; Yang, Bo; Yang, Yongchao; Lin, Xi] Guangzhou Gen Hosp Guangzhou Mil Command, Ctr Cardiovasc Surg, Guangzhou, Guangdong, Peoples R China; [Gong, Gu] Gen Hosp Chengdu Mil Command, Dept Anesthesiol, Chengdu, Peoples R China	Southern Theater Command General Hospital	Gong, G (corresponding author), Gen Hosp Chengdu Mil Command, Dept Anesthesiol, Chengdu, Peoples R China.	gugongcd@163.com		Wang, Xiaowu/0000-0003-1371-7791				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; BOLLI R, 1995, J CLIN INVEST, V96, P1066, DOI 10.1172/JCI118093; BROWN CR, 1993, J CELL BIOL, V120, P1101, DOI 10.1083/jcb.120.5.1101; Buzzard KA, 1998, J BIOL CHEM, V273, P17147, DOI 10.1074/jbc.273.27.17147; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Carreira RS, 2011, CURR PHARM DESIGN, V17, P2017; Chen HQ, 2006, FEBS LETT, V580, P3145, DOI 10.1016/j.febslet.2006.04.066; Chien KR, 2000, NATURE, V407, P227, DOI 10.1038/35025196; Cvoro A, 2004, MOL CELL BIOCHEM, V265, P27, DOI 10.1023/B:MCBI.0000044312.59958.c8; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Fujimori S, 1997, DIGEST DIS SCI, V42, P1987, DOI 10.1023/A:1018892000606; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; Guzhova IV, 1997, CELL STRESS CHAPERON, V2, P132, DOI 10.1379/1466-1268(1997)002<0132:MSPHIW>2.3.CO;2; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hasegawa M, 2012, NAGOYA J MED SCI, V74, P123; Hirakawa T, 1996, GASTROENTEROLOGY, V111, P345, DOI 10.1053/gast.1996.v111.pm8690199; Hoshino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076306; Ikeyama S, 2001, J HEPATOL, V35, P53, DOI 10.1016/S0168-8278(01)00053-8; Ishii H, 2005, LIFE SCI, V77, P858, DOI 10.1016/j.lfs.2004.11.038; IWAKI K, 1993, CIRCULATION, V87, P2023, DOI 10.1161/01.CIR.87.6.2023; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Kamal Manal M, 2013, Pathophysiology, V20, P139, DOI 10.1016/j.pathophys.2013.03.003; Kayama M, 2011, AM J PATHOL, V178, P1080, DOI 10.1016/j.ajpath.2010.11.072; Kume M, 1996, J LAB CLIN MED, V128, P251, DOI 10.1016/S0022-2143(96)90026-8; Lau SS, 2000, AM J PHYSIOL-HEART C, V278, pH1439, DOI 10.1152/ajpheart.2000.278.5.H1439; Lennikov A, 2013, INT J MOL SCI, V14, P2175, DOI 10.3390/ijms14012175; Liu J, 2002, J BIOL CHEM, V277, P20927, DOI 10.1074/jbc.M110712200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo FC, 2013, MOL MED REP, V7, P694, DOI 10.3892/mmr.2012.1217; Luo FC, 2012, FREE RADICAL BIO MED, V52, P1218, DOI 10.1016/j.freeradbiomed.2012.01.004; Lv T, 2013, PHARMACOLOGY, V92, P131, DOI 10.1159/000353213; Mancuso DJ, 2003, J BIOL CHEM, V278, P22231, DOI 10.1074/jbc.C300033200; MELLO AC, 1984, BIOCHEM J, V218, P273, DOI 10.1042/bj2180273; MINOWADA G, 1995, J CLIN INVEST, V95, P3, DOI 10.1172/JCI117655; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Ooie T, 2001, CIRCULATION, V104, P1837, DOI 10.1161/hc3901.095771; Pei YL, 2012, CELL STRESS CHAPERON, V17, P81, DOI 10.1007/s12192-011-0287-1; Polla BS, 1996, P NATL ACAD SCI USA, V93, P6458, DOI 10.1073/pnas.93.13.6458; Powers MV, 2010, CELL CYCLE, V9, P1542, DOI 10.4161/cc.9.8.11204; Prodius P A, 1997, Biull Eksp Biol Med, V123, P629; Qian LJ, 2004, CELL STRESS CHAPERON, V9, P281, DOI 10.1379/CSC-20R.1; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; SAAD S, 1995, SURGERY, V118, P510, DOI 10.1016/S0039-6060(05)80367-8; Salminen WF, 1997, TOXICOL APPL PHARM, V147, P247, DOI 10.1006/taap.1997.8290; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; Steenland K, 1996, AM J IND MED, V30, P495, DOI 10.1002/(SICI)1097-0274(199610)30:4<495::AID-AJIM16>3.3.CO;2-I; Takano M, 1998, CELL STRESS CHAPERON, V3, P109, DOI 10.1379/1466-1268(1998)003<0109:DCAMPM>2.3.CO;2; Tanito M, 2005, J NEUROSCI, V25, P2396, DOI 10.1523/JNEUROSCI.4866-04.2005; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Wu YJ, 2011, CELL TISSUE RES, V344, P355, DOI 10.1007/s00441-011-1151-4; Yamagami K, 1998, J SURG RES, V79, P47, DOI 10.1006/jsre.1998.5403; Yeh ETH, 1997, CIRCULATION, V95, P782; Yoda M, 2011, J ORTHOP SCI, V16, P791, DOI 10.1007/s00776-011-0138-z; Yun T, 2009, GUANGXI J TRADIT CHI, V32, P54; Zamzami N, 1997, J BIOENERG BIOMEMBR, V29, P185, DOI 10.1023/A:1022694131572; Zhao Y, 2007, CELL STRESS CHAPERON, V12, P83, DOI 10.1379/CSC-231R.1	61	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93536	10.1371/journal.pone.0093536	http://dx.doi.org/10.1371/journal.pone.0093536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695789	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000085
J	Wang, Y; Wang, ZL; Feng, XP; Guo, CC; Chen, Q				Wang, Yidong; Wang, Zhong-Liang; Feng, Xiaoping; Guo, Changcheng; Chen, Qing			Long-Term Effect of Agricultural Reclamation on Soil Chemical Properties of a Coastal Saline Marsh in Bohai Rim, Northern China	PLOS ONE			English	Article							PINE PLANTATION; ORGANIC-MATTER; LITTER LAYER; RATIO; STRATIFICATION; DYNAMICS; WETLANDS; CARBON; N2O	Over the past six decades, coastal wetlands in China have experienced rapid and extensive agricultural reclamation. In the context of saline conditions, long-term effect of cultivation after reclamation on soil chemical properties has not been well understood. We studied this issue using a case of approximately 60-years cultivation of a coastal saline marsh in Bohai Rim, northern China. The results showed that long-term reclamation significantly decreased soil organic carbon (SOC) (-42.2%) and total nitrogen (TN) (-25.8%) at surface layer (0-30 cm) as well as their stratification ratios (SRs) (0-5 cm: 50-70 cm and 5-10 cm: 50-70 cm). However, there was no significant change in total phosphorus (TP) as well as its SRs under cultivation. Cultivation markedly reduced ratios of SOC to TN, SOC to TP and TN to TP at surface layer (0-30 cm) and their SRs (0-5 cm: 50-70 cm). After cultivation, electrical conductivity and salinity significantly decreased by 60.1% and 55.3% at 0-100 cm layer, respectively, suggesting a great desalinization. In contrast, soil pH at 20-70 cm horizons notably increased as an effect of reclamation. Cultivation also changed compositions of cations at 0-10 cm layer and anions at 5-100 cm layer, mainly decreasing the proportion of Na+, Cl- and SO42-. Furthermore, cultivation significantly reduced the sodium adsorption ratio and exchangeable sodium percentage in plow-layer (0-20 cm) but not residual sodium carbonate, suggesting a reduction in sodium harm.	[Wang, Yidong; Wang, Zhong-Liang; Feng, Xiaoping; Guo, Changcheng; Chen, Qing] Tianjin Normal Univ, Tianjin Key Lab Water Resources & Environm, Tianjin, Peoples R China; [Wang, Zhong-Liang] Chinese Acad Sci, Inst Geochem, State Key Lab Environm Geochem, Guiyang, Peoples R China; [Feng, Xiaoping] Tianjin Normal Univ, Coll Urban & Environm Sci, Tianjin, Peoples R China	Tianjin Normal University; Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS; Tianjin Normal University	Wang, ZL (corresponding author), Tianjin Normal Univ, Tianjin Key Lab Water Resources & Environm, Tianjin, Peoples R China.	wangzhongliang@vip.skleg.cn	Wang, Yidong/I-4027-2014	Wang, Yidong/0000-0002-5399-2803; Chen, Qing/0000-0002-4589-0161	National Science & Technology Pillar Program [2012BAC07B02]; Program for New Century Excellent Talents in University [NCET-10-0954]; National Natural Science Foundation of China [31300381]; Opening Fund of Tianjin Key Laboratory of Water Resources and Environment [YF11700102]	National Science & Technology Pillar Program; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Fund of Tianjin Key Laboratory of Water Resources and Environment	This research was supported by the National Science & Technology Pillar Program (2012BAC07B02), the Program for New Century Excellent Talents in University (NCET-10-0954), the National Natural Science Foundation of China (31300381), and the Opening Fund of Tianjin Key Laboratory of Water Resources and Environment (YF11700102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SQ, 2007, AMBIO, V36, P335, DOI 10.1579/0044-7447(2007)36[335:CNWPPC]2.0.CO;2; An SQ, 2013, AQUAT SCI, V75, P63, DOI 10.1007/s00027-012-0281-4; Bridgham SD, 1998, ECOLOGY, V79, P1545, DOI 10.1890/0012-9658(1998)079[1545:CNAPMI]2.0.CO;2; CASHIN GE, 1992, WETLANDS, V12, P63, DOI 10.1007/BF03160587; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cui J, 2012, SOIL TILL RES, V123, P50, DOI 10.1016/j.still.2012.03.009; Du ZL, 2010, SOIL SCI SOC AM J, V74, P196, DOI 10.2136/sssaj2009.0048; Ellis S, 2003, CATENA, V52, P129, DOI 10.1016/S0341-8162(02)00179-0; Fernandez S, 2010, GEOMORPHOLOGY, V114, P497, DOI 10.1016/j.geomorph.2009.08.014; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P95, DOI 10.1016/S0167-1987(02)00018-1; Han G, 2013, AGR ECOSYST ENV; Huang LB, 2012, ECOL INFORM, V10, P49, DOI 10.1016/j.ecoinf.2011.11.001; Huo Li-li, 2013, Huanjing Kexue, V34, P283; Iost S, 2007, GEODERMA, V142, P245, DOI 10.1016/j.geoderma.2007.08.001; Jin XB, 2012, BIOL FERT SOILS, V48, P363, DOI 10.1007/s00374-011-0631-8; Johnson D.W., 1980, ENVIRON INT, V3, P79; Liu H, 1999, SCI TECHNOL TIANJIN, V2, P43; Lou YL, 2012, CATENA, V95, P124, DOI 10.1016/j.catena.2012.02.009; Lou YL, 2011, CATENA, V87, P386, DOI 10.1016/j.catena.2011.07.006; Macreadie PI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069244; Munshower FF., 1994, PRACTICAL HDB DISTUR; OSTER JD, 1980, SOIL SCI SOC AM J, V44, P258, DOI 10.2136/sssaj1980.03615995004400020011x; Portnoy JW, 1999, ENVIRON MANAGE, V24, P111, DOI 10.1007/s002679900219; ROBBINS CW, 1984, IRRIGATION SCI, V5, P173, DOI 10.1007/BF00264606; Sahrawat KL, 2004, ADV AGRON, V81, P169, DOI 10.1016/S0065.2113(03)81004-0; Santin C, 2009, ORG GEOCHEM, V40, P931, DOI 10.1016/j.orggeochem.2009.06.005; Shen JB, 2011, PLANT PHYSIOL, V156, P997, DOI 10.1104/pp.111.175232; Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374; Shi Y.C., 1983, WATER SALT MOVEMENT; Wan H, 1983, SOILS, V23, P319; Wang Li-li, 2009, China Environmental Science, V29, P656; Wang YD, 2014, ATMOS ENVIRON, V82, P106, DOI 10.1016/j.atmosenv.2013.10.028; Wang YD, 2013, SOIL BIOL BIOCHEM, V66, P45, DOI 10.1016/j.soilbio.2013.06.018; Wang YD, 2012, CAN J FOREST RES, V42, P657, DOI [10.1139/x2012-017, 10.1139/X2012-017]; Weston NB, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000071; Wong VNL, 2010, SOIL USE MANAGE, V26, P2, DOI 10.1111/j.1475-2743.2009.00251.x; [吴明 WU Ming], 2008, [土壤, Soils], V40, P760; Zhu M, 2011, THESIS CHINESE ACA A	38	21	24	7	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93727	10.1371/journal.pone.0093727	http://dx.doi.org/10.1371/journal.pone.0093727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695526	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000111
J	Weng, SC; Tarng, DC; Chen, CM; Cheng, CH; Wu, MJ; Chen, CH; Yu, TM; Shu, KH				Weng, Shuo-Chun; Tarng, Der-Cherng; Chen, Chyong-Mei; Cheng, Chi-Hung; Wu, Ming-Ju; Chen, Cheng-Hsu; Yu, Tung-Min; Shu, Kuo-Hsiung		CKDBHPDH Investigators	Estimated Glomerular Filtration Rate Decline Is a Better Risk Factor for Outcomes of Systemic Disease-Related Nephropathy than for Outcomes of Primary Renal Diseases	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; DIABETIC-NEPHROPATHY; ESTIMATED GFR; MORTALITY; TAIWAN; ALBUMINURIA; EDUCATION; MICROINFLAMMATION; HYPERTENSION; ASSOCIATIONS	Background: Currently, the contribution of kidney function decline in renal and patient outcomes is unclear. There are few data on the associations of different etiologies of estimated glomerular filtration rate (eGFR) decline with outcomes in multidisciplinary care. The purpose of this investigation was to establish whether eGFR decline in patients with disease is an important risk factor for developing end-stage renal disease ( ESRD) and death. Methods: From December 1, 2001 to December 31, 2011, 5097 adults with chronic kidney disease (CKD) received biochemical tests, physical examinations, a pathological examination, and a comprehensive questionnaire. We used linear regression models and multivariate Cox proportional hazards model to examine the outcome of eGFR decline in renal diseases with different etiologies. Results: Mean age was 68.1+/-16.1 ( standard deviation, SD) years, and 63.3% patients were male. In the studied cohort, 58.2% of the patients had systemic disease-related nephropathy (SDRN), 29.4% had primary renal diseases (PRDs), and 12.4% had other etiologies. The eGFR decline in SDRN had a significant association with dialysis in the Cox proportional hazards model [ crude hazard ratio (HR) = 1.07, 95% confidence interval (CI), 1.04 to 1.10; adjusted HR 1.05, 95% CI, 1.02 to 1.08]. Diabetic nephropathy ( DN) had the most severe eGFR decline in CKD stages 3, 4, and 5, and all contributed to the initiation of dialysis and death regardless of whether DN with or without eGFR decline was considered to be the cause. Although hypertensive nephropathy ( HN) was related to significant acceleration of eGFR decline, it did not lead to poor outcome. There were still discrepancies between eGFR decline and outcomes in PRDs, hypertensive nephropathy, and lupus nephritis. Conclusions: eGFR decline and CKD staging provide an informative guide for physicians to make proper clinical judgments in the treatment of CKD, especially SDRN. Poor control of the underlying systemic disease will thus lead to more rapid progression of SDRN.	[Weng, Shuo-Chun] Taichung Vet Gen Hosp, Ctr Geriatr & Gerontol, Taichung, Taiwan; [Weng, Shuo-Chun; Cheng, Chi-Hung; Wu, Ming-Ju; Chen, Cheng-Hsu; Yu, Tung-Min; Shu, Kuo-Hsiung] Taichung Vet Gen Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan; [Weng, Shuo-Chun; Tarng, Der-Cherng; Wu, Ming-Ju] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Tarng, Der-Cherng] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei 112, Taiwan; [Tarng, Der-Cherng] Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Tarng, Der-Cherng] Taipei Vet Gen Hosp, Immunol Res Ctr, Taipei, Taiwan; [Chen, Chyong-Mei] Providence Univ, Dept Stat & Informat Sci, Taichung, Taiwan; [Cheng, Chi-Hung] HungKuang Univ, Dept Biotechnol, Taichung, Taiwan; [Wu, Ming-Ju; Shu, Kuo-Hsiung] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wu, Ming-Ju; Chen, Cheng-Hsu] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Providence University - Taiwan; Hungkuang University; Chung Shan Medical University; China Medical University Taiwan	Shu, KH (corresponding author), Taichung Vet Gen Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan.	khshu@vghtc.gov.tw			TCVGH, Taiwan, R.O.C. [TCVGH-1003606A, TCVGH-1013602A, TCVGH-1023601A, CGG-TCVGH1020101-4.4]; Taipei Veterans General Hospital [V97S5-004, V98S5-002, V99S5-002, V100E4-003, V101E4-001]; Ministry of Education, Taiwan, Aim for the Top University Plan	TCVGH, Taiwan, R.O.C.; Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Education, Taiwan, Aim for the Top University Plan	The authors are very grateful for the study grants provided by TCVGH, Taiwan, R.O.C. (TCVGH-1003606A, TCVGH-1013602A, TCVGH-1023601A, CGG-TCVGH1020101-4.4), and Taipei Veterans General Hospital (V97S5-004, V98S5-002, V99S5-002, V100E4-003, V101E4-001), and the Ministry of Education, Taiwan, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aly Z, 2013, KIDNEY INT, V83, P189, DOI 10.1038/ki.2012.418; Al-Aly Z, 2012, KIDNEY INT, V82, P1208, DOI 10.1038/ki.2012.276; Andreoli SP, 1998, SEMIN NEPHROL, V18, P270; Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A; Chang TI, 2013, AM J KIDNEY DIS, V61, pS4, DOI 10.1053/j.ajkd.2012.12.016; Chen YR, 2013, NEPHROL DIAL TRANSPL, V28, P671, DOI 10.1093/ndt/gfs469; Cheng HT, 2012, J CLIN ENDOCR METAB, V97, P1268, DOI 10.1210/jc.2011-2658; Chiu YL, 2008, NEPHRON CLIN PRACT, V109, pC109, DOI 10.1159/000145453; Chou YH, 2012, CLIN J AM SOC NEPHRO, V7, P1401, DOI 10.2215/CJN.04500511; Crook ED, 2002, AM J MED SCI, V324, P138, DOI 10.1097/00000441-200209000-00004; Derose SF, 2013, AM J KIDNEY DIS, V62, P236, DOI 10.1053/j.ajkd.2013.01.019; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Glymour MM, 2005, AM J EPIDEMIOL, V162, P267, DOI 10.1093/aje/kwi187; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Hansen HP, 2002, KIDNEY INT, V61, P163, DOI 10.1046/j.1523-1755.2002.00092.x; HINCHLIFFE SA, 1992, BRIT J OBSTET GYNAEC, V99, P296, DOI 10.1111/j.1471-0528.1992.tb13726.x; Hsu TW, 2014, JAMA INTERN MED, V174, P347, DOI 10.1001/jamainternmed.2013.12700; Jocelyn W., 2009, CHANGES KIDNEY FUNCT, V6th, P1009; Kajitani N, 2010, DIABETES RES CLIN PR, V88, P171, DOI 10.1016/j.diabres.2010.01.012; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Li LS, 2004, KIDNEY INT, V66, P920, DOI 10.1111/j.1523-1755.2004.00837.x; Mahajan A, 2010, KIDNEY INT, V78, P303, DOI 10.1038/ki.2010.129; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Moriya T, 2012, KIDNEY INT, V81, P486, DOI 10.1038/ki.2011.404; Mulec H, 1998, NEPHROL DIAL TRANSPL, V13, P651, DOI 10.1093/ndt/13.3.651; *NAT KIDN FDN INC, EST GFR KDOQI CLIN P; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; Peralta CA, 2013, AM J KIDNEY DIS, V62, P261, DOI 10.1053/j.ajkd.2013.01.012; Perkins RM, 2012, KIDNEY INT, V82, P1332, DOI 10.1038/ki.2012.281; Reich HN, 2011, KIDNEY INT, V79, P914, DOI 10.1038/ki.2010.525; Shikata K, 2013, J DIABETES INVEST, V4, P142, DOI 10.1111/jdi.12050; SOWERS JR, 1995, HYPERTENSION, V26, P869, DOI 10.1161/01.HYP.26.6.869; Van Biesen W, 2009, NEPHROL DIAL TRANSPL, V24, P3277, DOI 10.1093/ndt/gfp448; Wen CP, 2010, AM J KIDNEY DIS, V56, P273, DOI 10.1053/j.ajkd.2010.01.024; Wu IW, 2009, NEPHROL DIAL TRANSPL, V24, P3426, DOI 10.1093/ndt/gfp259; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406	36	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92881	10.1371/journal.pone.0092881	http://dx.doi.org/10.1371/journal.pone.0092881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695125	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000029
J	Katheria, A; Blank, D; Rich, W; Finer, N				Katheria, Anup; Blank, Doug; Rich, Wade; Finer, Neil			Umbilical Cord Milking Improves Transition in Premature Infants at Birth	PLOS ONE			English	Article							PULSE OXIMETRY VALUES; HEART-RATE; DELIVERY	Background: Umbilical cord milking (UCM) improves blood pressure and urine output, and decreases the need for transfusions in comparison to immediate cord clamping (ICC). The immediate effect of UCM in the first few minutes of life and the impact on neonatal resuscitation has not been described. Methods: Women admitted to a tertiary care center and delivering before 32 weeks gestation were randomized to receive UCM or ICC. A blinded analysis of physiologic data collected on the newborns in the delivery room was performed using a data acquisition system. Heart rate (HR), SpO(2), mean airway pressure (MAP), and FiO(2) in the delivery room were compared between infants receiving UCM and infants with ICC. Results: 41 of 60 neonates who were enrolled and randomized had data from analog tracings at birth. 20 of these infants received UCM and 21 had ICC. Infants receiving UCM had higher heart rates and higher SpO(2) over the first 5 minutes of life, were exposed to less FiO2 over the first 10 minutes of life than infants with ICC. Conclusions: UCM when compared to ICC had decreased need for support immediately following delivery, and in situations where resuscitation interventions were needed immediately, UCM has the advantage of being completed in a very short time to improve stability following delivery. Trial Registration: ClinicalTrials.gov NCT01434732	[Katheria, Anup; Blank, Doug; Rich, Wade; Finer, Neil] Univ Calif San Diego, Med Ctr, Div Neonatol, San Diego, CA 92103 USA	University of California System; University of California San Diego	Katheria, A (corresponding author), Univ Calif San Diego, Med Ctr, Div Neonatol, 225 Dickinson St, San Diego, CA 92103 USA.	anup.katheria@sharp.com	Katheria, Anup/AAA-6834-2022; Katheria, Anup/K-2355-2013	Katheria, Anup/0000-0001-9352-0934; Blank, Douglas/0000-0002-6711-5799	University of California, San Diego	University of California, San Diego(University of California System)	This study was funded by the University of California, San Diego with no external funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt S, 2013, J PHYSIOL-LONDON, V591, P2113, DOI 10.1113/jphysiol.2012.250084; BRADY JP, 1962, AM J OBSTET GYNECOL, V84, P1; Committee on Obstetric Practice American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V120, P1522, DOI 10.1097/01.AOG.0000423817.47165.48; Dawson JA, 2010, ARCH DIS CHILD-FETAL, V95, pF177, DOI 10.1136/adc.2009.169102; Dawson JA, 2010, PEDIATRICS, V125, pE1340, DOI 10.1542/peds.2009-1510; Gandhi B, 2013, J PEDIATR-US, V163, P412, DOI 10.1016/j.jpeds.2013.01.010; Gandhi B, 2013, RESUSCITATION, V84, P970, DOI 10.1016/j.resuscitation.2012.12.007; Hosono S, 2008, ARCH DIS CHILD-FETAL, V93, pF14, DOI 10.1136/adc.2006.108902; Kaempf JW, 2012, OBSTET GYNECOL, V120, P325, DOI 10.1097/AOG.0b013e31825f269f; Katheria AC, J PEDIAT; Katheria A, 2012, PEDIATRICS, V130, pE1177, DOI 10.1542/peds.2012-0784; Kattwinkel J, 2010, PEDIATRICS, V126, pE1400, DOI 10.1542/peds.2010-2972E; March MI, 2013, J PERINATOL; Rabe H, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003248.pub4, 10.1002/14651858.CD003248.pub3]; Rich WD, 2010, PEDIATRICS, V126, pE215, DOI 10.1542/peds.2009-3353	15	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94085	10.1371/journal.pone.0094085	http://dx.doi.org/10.1371/journal.pone.0094085			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709780	Green Submitted, Green Published, gold			2022-12-27	WOS:000334159800099
J	Ulrich, D; Edwards, SL; Su, K; White, JF; Ramshaw, JAM; Jenkin, G; Deprest, J; Rosamilia, A; Werkmeister, JA; Gargett, CE				Ulrich, Daniela; Edwards, Sharon L.; Su, Kai; White, Jacinta F.; Ramshaw, John A. M.; Jenkin, Graham; Deprest, Jan; Rosamilia, Anna; Werkmeister, Jerome A.; Gargett, Caroline E.			Influence of Reproductive Status on Tissue Composition and Biomechanical Properties of Ovine Vagina	PLOS ONE			English	Article							PELVIC ORGAN PROLAPSE; RAT VAGINA; COLLAGENS; PROTEOGLYCANS; TERMINOLOGY; PREGNANCY; DELIVERY	Objective: To undertake a comprehensive analysis of the biochemical tissue composition and passive biomechanical properties of ovine vagina and relate this to the histo-architecture at different reproductive stages as part of the establishment of a large preclinical animal model for evaluating regenerative medicine approaches for surgical treatment of pelvic organ prolapse. Methods: Vaginal tissue was collected from virgin (n = 3), parous (n = 6) and pregnant sheep (n = 6; mean gestation; 132 d; term = 145 d). Tissue histology was analyzed using H+E and Masson's Trichrome staining. Biochemical analysis of the extracellular matrix proteins used a hydroxyproline assay to quantify total collagen, SDS PAGE to measure collagen III/I+III ratios, dimethylmethylene blue to quantify glycosaminoglycans and amino acid analysis to quantify elastin. Uniaxial tensiometry was used to determine the Young's modulus, maximum stress and strain, and permanent strain following cyclic loading. Results: Vaginal tissue of virgin sheep had the lowest total collagen content and permanent strain. Parous tissue had the highest total collagen and lowest elastin content with concomitant high maximum stress. In contrast, pregnant sheep had the highest elastin and lowest collagen contents, and thickest smooth muscle layer, which was associated with low maximum stress and poor dimensional recovery following repetitive loading. Conclusion: Pregnant ovine vagina was the most extensible, but the weakest tissue, whereas parous and virgin tissues were strong and elastic. Pregnancy had the greatest impact on tissue composition and biomechanical properties, compatible with significant tissue remodeling as demonstrated in other species. Biochemical changes in tissue protein composition coincide with these altered biomechanical properties.	[Ulrich, Daniela; Jenkin, Graham; Gargett, Caroline E.] MIMR, Ritchie Ctr, PHI Inst Med Res, Melbourne, Vic, Australia; [Ulrich, Daniela; Rosamilia, Anna; Gargett, Caroline E.] Monash Univ, Dept Obstet & Gynecol, Melbourne, Vic 3004, Australia; [Edwards, Sharon L.; Su, Kai; White, Jacinta F.; Ramshaw, John A. M.; Werkmeister, Jerome A.] CSIRO, Mat Sci Engn, Melbourne, Vic, Australia; [Deprest, Jan] Univ Hosp Leuven, Dept Obstet & Gynecol, Louvain, Belgium	Prince Henry's Institute of Medical Research; Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); KU Leuven; University Hospital Leuven	Werkmeister, JA (corresponding author), CSIRO, Mat Sci Engn, Melbourne, Vic, Australia.	Jerome.Werkmeister@csiro.au	Gargett, Caroline Eve/I-4895-2019; Gargett, Caroline E/Q-7911-2019; White, Jacinta F/D-6961-2013; Gold, Daniela/ABE-4818-2020	Gargett, Caroline E/0000-0002-3590-2077; White, Jacinta F/0000-0002-4855-0170; Gold, Daniela/0000-0002-7196-454X; Ramshaw, John A.M./0000-0002-2131-3685; Deprest, Jan/0000-0002-4920-945X	Australian National Health and Medical Research Council [1021126, 1042298]; CASS Foundation; South East Melbourne Alliance for Regenerative Therapies (SMART) grant; Victorian Government's Operational Infrastructure Support Program; Monash University; SMART; Australian Stem Cell Centre; Australian Government as part of the National Collaborative Research Infrastructure Strategy	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); CASS Foundation; South East Melbourne Alliance for Regenerative Therapies (SMART) grant; Victorian Government's Operational Infrastructure Support Program; Monash University(Monash University); SMART; Australian Stem Cell Centre; Australian Government as part of the National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science)	The authors acknowledge support from the Australian National Health and Medical Research Council grants (1021126) (to CEG JAW AR) and Senior Research Fellowship 1042298 (to CEG), the CASS Foundation (to CEG), South East Melbourne Alliance for Regenerative Therapies (SMART) grant (to CEG JAW AR SE) and the Victorian Government's Operational Infrastructure Support Program. DU received scholarships from Monash University, SMART and the Australian Stem Cell Centre. JD is a fundamental clinical researcher from the Fonds Wetenschappelijk Onderzoek Vlaanderen (1801207N). This research has been facilitated by access to Australian Proteome Analysis Facility which is funded by an initiative of the Australian Government as part of the National Collaborative Research Infrastructure Strategy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitch SD, 2009, EUR J OBSTET GYN R B, V144, pS146, DOI 10.1016/j.ejogrb.2009.02.022; Alperin M, 2010, INT UROGYNECOL J, V21, P1169, DOI 10.1007/s00192-010-1149-6; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; CHAN D, 1984, ANAL BIOCHEM, V139, P322, DOI 10.1016/0003-2697(84)90012-5; CHANDRASEKHAR S, 1987, ANAL BIOCHEM, V161, P103, DOI 10.1016/0003-2697(87)90658-0; Couchman JR, 2012, J HISTOCHEM CYTOCHEM, V60, P885, DOI 10.1369/0022155412464638; Couri Bruna M, 2012, Expert Rev Obstet Gynecol, V7, P249; De Landsheere L, 2013, INT UROGYNECOL J, V24, P2011, DOI 10.1007/s00192-013-2111-1; DELANCEY JOL, 1992, AM J OBSTET GYNECOL, V166, P1717, DOI 10.1016/0002-9378(92)91562-O; Deprest J, 2013, BJOG-INT J OBSTET GY, V120, P141, DOI 10.1111/1471-0528.12088; Diani J, 2009, EUR POLYM J, V45, P601, DOI 10.1016/j.eurpolymj.2008.11.017; Edwards SL, 2013, J MECH BEHAV BIOMED, V23, P53, DOI 10.1016/j.jmbbm.2013.04.002; Ennen S, 2011, THERIOGENOLOGY, V75, P212, DOI 10.1016/j.theriogenology.2010.08.007; Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798; Hulmes DJS, 2002, J STRUCT BIOL, V137, P2, DOI 10.1006/jsbi.2002.4450; Jean-Charles C, 2010, INT UROGYNECOL J, V21, P1535, DOI 10.1007/s00192-010-1208-z; Lowder JL, 2007, OBSTET GYNECOL, V109, P136, DOI 10.1097/01.AOG.0000250472.96672.6c; Lukacz ES, 2006, OBSTET GYNECOL, V107, P1253, DOI 10.1097/01.AOG.0000218096.54169.34; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Ozog Y, 2011, INT UROGYNECOL J, V22, P1099, DOI 10.1007/s00192-011-1440-1; Rahn DD, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.02.022; Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4; Rubod C, 2012, J UROLOGY, V79; Rubod C, 2008, INT UROGYNECOL J, V19, P811, DOI 10.1007/s00192-007-0533-3; Rubod C, 2007, J UROLOGY, V178, P320, DOI 10.1016/j.juro.2007.03.040; SHEPHERD PR, 1992, VET REC, V130, P564, DOI 10.1136/vr.130.25.564; SYKES B, 1976, BIOCHEM BIOPH RES CO, V72, P1472, DOI 10.1016/S0006-291X(76)80180-5; Ulrich D, 2014, TISSUE ENG PT A, V20, P785, DOI 10.1089/ten.TEA.2013.0170; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0	29	30	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93172	10.1371/journal.pone.0093172	http://dx.doi.org/10.1371/journal.pone.0093172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709913	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800024
J	Chen, D; Yang, Z; Xia, H; Huang, JF; Zhang, Y; Jiang, TN; Wang, GY; Chuai, ZR; Fu, WL; Huang, Q				Chen, Dong; Yang, Zhao; Xia, Han; Huang, Jun-Fu; Zhang, Yang; Jiang, Tian-Nun; Wang, Gui-Yu; Chuai, Zheng-Ran; Fu, Wei-Ling; Huang, Qing			Enhanced Specificity of TPMT*2 Genotyping Using Unidirectional Wild-Type and Mutant Allele-Specific Scorpion Primers in a Single Tube	PLOS ONE			English	Article							THIOPURINE METHYLTRANSFERASE GENOTYPE; IMPLEMENTATION CONSORTIUM GUIDELINES; POLYMERASE-CHAIN-REACTION; TAGUCHI OPTIMIZATION; MINIMUM INFORMATION; SENSITIVE DETECTION; DNA AMPLIFICATION; PCR EXPERIMENTS; TIME; PHARMACOGENETICS	Genotyping of thiopurine S-methyltransferase (TPMT) is recommended for predicting the adverse drug response of thiopurines. In the current study, a novel version of allele-specific PCR (AS-PCR), termed competitive real-time fluorescent AS-PCR (CRAS-PCR) was developed to analyze the TPMT*2 genotype in ethnic Chinese. This technique simultaneously uses wild-type and mutant allele-specific scorpion primers in a single reaction. To determine the optimal conditions for both traditional AS-PCR and CRAS-PCR, we used the Taguchi method, an engineering optimization process that balances the concentrations of all components using an orthogonal array rather than a factorial array. Instead of running up to 264 experiments with the conventional factorial method, the Taguchi method achieved the same optimization using only 16 experiments. The optimized CRAS-PCR system completely avoided non-specific amplification occurring in traditional AS-PCR and could be performed at much more relaxed reaction conditions at 1% sensitivity, similar to traditional AS-PCR. TPMT*2 genotyping of 240 clinical samples was consistent with published data. In conclusion, CRAS-PCR is a novel and robust genotyping method, and the Taguchi method is an effective tool for the optimization of molecular analysis techniques.	[Chen, Dong; Yang, Zhao; Xia, Han; Huang, Jun-Fu; Zhang, Yang; Wang, Gui-Yu; Chuai, Zheng-Ran; Fu, Wei-Ling; Huang, Qing] Third Mil Med Univ, Southwest Hosp, Dept Lab Med, Chongqing, Peoples R China; [Jiang, Tian-Nun] Third Mil Med Univ, Southwest Hosp, Dept Blood Transfus, Chongqing, Peoples R China	Army Medical University; Army Medical University	Fu, WL (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Lab Med, Chongqing, Peoples R China.	weilingfu@yahoo.com; Dr.Q.Huang@gmail.com	Huang, Qing/E-1872-2017; Zhang, Yang/AAQ-5411-2021; fu, weiling/AAX-3286-2021	Huang, Qing/0000-0002-0140-8978; fu, weiling/0000-0002-5768-6563; zhang, yang/0000-0002-4061-4408	Transformation Foundation on Scientific and Technological Achievements of The Third Military Medical University [2012XZH03]; Nature Scientific Foundation of China [31370853]; National High Technology Research and Development Program of China [2011AA02A121, 2013AA020204]; Preferential Foundations of Science; Technology Activities for Students Study Abroad of Chongqing [YuLiuZhu201201]	Transformation Foundation on Scientific and Technological Achievements of The Third Military Medical University; Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Preferential Foundations of Science; Technology Activities for Students Study Abroad of Chongqing	This work was supported in part by the Transformation Foundation on Scientific and Technological Achievements of The Third Military Medical University [2012XZH03]; The Nature Scientific Foundation of China [31370853]; The National High Technology Research and Development Program of China [2011AA02A121 and 2013AA020204]; Preferential Foundations of Science; and Technology Activities for Students Study Abroad of Chongqing [YuLiuZhu201201]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameyaw MM, 1999, HUM MOL GENET, V8, P367, DOI 10.1093/hmg/8.2.367; Anderson SM, 2011, EXPERT REV MOL DIAGN, V11, P635, DOI [10.1586/erm.11.42, 10.1586/ERM.11.42]; Appell ML, 2013, PHARMACOGENET GENOM, V23, P242, DOI 10.1097/FPC.0b013e32835f1cc0; Ballantyne KN, 2008, FORENS SCI INT-GEN S, V1, P7, DOI 10.1016/j.fsigss.2007.10.050; Bayrak OU, 2010, INT J CIVIL STRUCTUR, V3, P518; Bui M, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-1; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caetano-Anolles G, 1998, BIOTECHNIQUES, V25, P472, DOI 10.2144/98253rr03; Carter MJ, 2004, GUT, V53, DOI 10.1136/gut.2004.043372; Celani DSH, 2011, MOL CELL PROBE, V25, P231; COBB BD, 1994, NUCLEIC ACIDS RES, V22, P3801, DOI 10.1093/nar/22.18.3801; Collie-Duguid ESR, 1999, PHARMACOGENETICS, V9, P37, DOI 10.1097/00008571-199902000-00006; Dobay O, 2009, ACTA MICROBIOL IMM H, V56, P327, DOI 10.1556/AMicr.56.2009.4.3; Duley JA, 2012, PHARMACOGENOMICS, V13, P1549, DOI [10.2217/pgs.12.140, 10.2217/PGS.12.140]; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Ford LT, 2010, J CLIN PATHOL, V63, P288, DOI 10.1136/jcp.2009.069252; Ford L, 2009, ANN CLIN BIOCHEM, V46, P152, DOI 10.1258/acb.2008.008167; Gibson NJ, 2006, CLIN CHIM ACTA, V363, P32, DOI 10.1016/j.cccn.2005.06.022; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Huang Q, 2010, CLIN LAB, V56, P149; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Jarry A, 2004, MOL CELL PROBE, V18, P349, DOI 10.1016/j.mcp.2004.05.004; Kaladhar M, 2011, J ENG SCI TECHNOLOGY, V1, P55; Kamaruddin S., 2004, J MEKANIKAL, P98; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Kubota T, 2001, BRIT J CLIN PHARMACO, V51, P475, DOI 10.1046/j.1365-2125.2001.01371.x; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lyon E, 2009, J MOL DIAGN, V11, P93, DOI 10.2353/jmoldx.2009.080094; Mackay John, 2007, Methods Mol Biol, V353, P237; Morgan E., 2005, CHEMOMETRICS EXPT DE; Nguyen CM, 2011, PLOS CURR, V3, pN1236; Niens M, 2005, BIOTECHNOL APPL BIOC, V42, P157, DOI 10.1042/BA20040192; Oliver DH, 2000, J MOL DIAGN, V2, P202, DOI 10.1016/S1525-1578(10)60638-1; Rama RS, 2012, IJERA, V3, P192; Ramakrishna US, 2013, FEMS MICROBIOL LETT, V340, P93, DOI 10.1111/1574-6968.12070; Rao Ravella Sreenivas, 2008, Biotechnology Journal, V3, P510, DOI 10.1002/biot.200700201; Relling MV, 2013, CLIN PHARMACOL THER, V93, P324, DOI 10.1038/clpt.2013.4; Relling MV, 2011, CLIN PHARMACOL THER, V89, P387, DOI 10.1038/clpt.2010.320; Ross P. J., 1988, TAGUCHI TECHNIQUES Q; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Schutz E, 2000, CLIN CHEM, V46, P1728; Shi CJ, 2004, NAT METHODS, V1, P141, DOI 10.1038/NMETH713; Swen JJ, 2011, CLIN PHARMACOL THER, V89, P662, DOI 10.1038/clpt.2011.34; Taguchi G., 1986, INTRO QUALITY ENG DE; Thanakiatkrai P, 2012, INT J LEGAL MED, V126, P161, DOI 10.1007/s00414-011-0558-5; Wangkumhang P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-275; Yates CR, 1997, ANN INTERN MED, V126, P608, DOI 10.7326/0003-4819-126-8-199704150-00003; Yuryev A., 2007, PCR PRIMER DESIGN	48	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e91824	10.1371/journal.pone.0091824	http://dx.doi.org/10.1371/journal.pone.0091824			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705376	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500008
J	Orozco-Nunnelly, DA; Muhammad, DS; Lee, BS; Jayathilaka, L; Kaufman, LS; Warpeha, KM				Orozco-Nunnelly, Danielle A.; Muhammad, DurreShahwar; Lee, Bao-Shiang; Jayathilaka, Lasanthi; Kaufman, Lon S.; Warpeha, Katherine M.			Pirin1 (PRN1) Is a Multifunctional Protein that Regulates Quercetin, and Impacts Specific Light and UV Responses in the Seed-to-Seedling Transition of Arabidopsis thaliana	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; ALPHA-SUBUNIT GPA1; AUXIN TRANSPORT; GUARD-CELLS; BLUE-LIGHT; IN-VIVO; ACID; MODULATION; EXPRESSION; RECEPTOR	Pirins are cupin-fold proteins, implicated in apoptosis and cellular stress in eukaryotic organisms. Pirin1 (PRN1) plays a role in seed germination and transcription of a light-and ABA-regulated gene under specific conditions in the model plant system Arabidopsis thaliana. Herein, we describe that PRN1 possesses previously unreported functions that can profoundly affect early growth, development, and stress responses. In vitro-translated PRN1 possesses quercetinase activity. When PRN1 was incubated with G-protein-alpha subunit (GPA1) in the inactive conformation (GDP-bound), quercetinase activity was observed. Quercetinase activity was not observed when PRN1 was incubated with GPA1 in the active form (GTP-bound). Dark-grown prn1 mutant seedlings produced more quercetin after UV (317 nm) induction, compared to levels observed in wild type (WT) seedlings. prn1 mutant seedlings survived a dose of high-energy UV (254 nm) radiation that killed WT seedlings. prn1 mutant seedlings grown for 3 days in continuous white light display disoriented hypocotyl growth compared to WT, but hypocotyls of dark-grown prn1 seedlings appeared like WT. prn1 mutant seedlings transformed with GFP constructs containing the native PRN1 promoter and full ORF (PRN1::PRN1-GFP) were restored to WT responses, in that they did not survive UV (254 nm), and there was no significant hypocotyl disorientation in response to white light. prn1 mutants transformed with PRN1::PRN1-GFP were observed by confocal microscopy, where expression in the cotyledon epidermis was largely localized to the nucleus, adjacent to the nucleus, and diffuse and punctate expression occurred within some cells. WT seedlings transformed with the 35S::PRN1-GFP construct exhibited widespread expression in the epidermis of the cotyledon, also with localization in the nucleus. PRN1 may play a critical role in cellular quercetin levels and influence light- or hormonal-directed early development.	[Orozco-Nunnelly, Danielle A.; Muhammad, DurreShahwar; Lee, Bao-Shiang; Kaufman, Lon S.; Warpeha, Katherine M.] Univ Illinois, Dept Biol Sci, Dept Biol Sci, Mol Cell & Dev Grp, Chicago, IL 60612 USA; [Lee, Bao-Shiang; Jayathilaka, Lasanthi] Univ Illinois, Prot Res Lab, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Warpeha, KM (corresponding author), Univ Illinois, Dept Biol Sci, Dept Biol Sci, Mol Cell & Dev Grp, Chicago, IL 60612 USA.	kwarpeha@uic.edu		Warpeha, Katherine/0000-0001-6866-3028; Orozco-Nunnelly, Danielle/0000-0003-3381-0504	National Science Foundation [MCB-0848113]	National Science Foundation(National Science Foundation (NSF))	This work has been supported by National Science Foundation grant MCB-0848113 (NSF: http://www.nsf.gov/div/index.jsp?div=MCB) to Katherine M. Warpeha and Lon S. Kaufman. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2005, J BIOL CHEM, V280, P28675, DOI 10.1074/jbc.M501034200; Adams MA, 2007, PROTEOMICS, V7, P2920, DOI 10.1002/pmic.200700099; Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Alvarez S, 2011, J PROTEOME RES, V10, P3107, DOI 10.1021/pr2001786; Bandaranayake PCG, 2012, PLANT PHYSIOL, V158, P1046, DOI 10.1104/pp.111.186858; Bergman AC, 1999, CELL MOL LIFE SCI, V55, P467, DOI 10.1007/s000180050303; Boege F, 1996, J BIOL CHEM, V271, P2262, DOI 10.1074/jbc.271.4.2262; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Brzoska K, 2011, REDOX REP, V16, P129, DOI 10.1179/1351000211Y.0000000002; Catala R, 2007, PLANT CELL, V19, P2952, DOI 10.1105/tpc.106.049981; Ciolino HP, 1999, BIOCHEM J, V340, P715, DOI 10.1042/0264-6021:3400715; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Gelbman BD, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-10; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Jensen PJ, 1998, PLANT PHYSIOL, V116, P455, DOI 10.1104/pp.116.2.455; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Kim JY, 2002, P NATL ACAD SCI USA, V99, P4103, DOI 10.1073/pnas.052484099; Klopffleisch K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.66; Komatsu S, 2004, PLANT CELL ENVIRON, V27, P947, DOI 10.1111/j.1365-3040.2004.01202.x; Korkina LG, 2007, CELL MOL BIOL, V53, P15, DOI 10.1170/T772; KUBASEK WL, 1992, PLANT CELL, V4, P1229, DOI 10.1105/tpc.4.10.1229; Kuhn BM, 2011, PLANT PHYSIOL, V156, P585, DOI 10.1104/pp.111.175976; Lapik YR, 2003, PLANT CELL, V15, P1578, DOI 10.1105/tpc.011890; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Lewis DR, 2011, PLANT PHYSIOL, V156, P144, DOI 10.1104/pp.111.172502; Licciulli S, 2010, LEUKEMIA, V24, P429, DOI 10.1038/leu.2009.247; Licciulli S, 2011, AM J PATHOL, V178, P2397, DOI 10.1016/j.ajpath.2011.01.019; Liu X, 2011, PLANT PHYSIOL, V157, P891, DOI 10.1104/pp.111.181388; Murphy A, 2000, PLANTA, V211, P315, DOI 10.1007/s004250000300; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Nilson SE, 2010, PLANT PHYSIOL, V152, P2067, DOI 10.1104/pp.109.148262; OKA T, 1971, BIOCHEM BIOPH RES CO, V43, P1, DOI 10.1016/S0006-291X(71)80076-1; Orzaez D, 2001, PLANT MOL BIOL, V46, P459, DOI 10.1023/A:1010618515051; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Peer WA, 2001, PLANT PHYSIOL, V126, P536, DOI 10.1104/pp.126.2.536; Peer WA, 2011, MOL PLANT, V4, P487, DOI 10.1093/mp/ssr034; Pereira L, 2005, ENVIRON CHEM LETT, V3, P66, DOI 10.1007/s10311-005-0004-3; Perfus-Barbeoch L, 2004, CURR OPIN PLANT BIOL, V7, P719, DOI 10.1016/j.pbi.2004.09.013; Poppe C, 1996, PLANTA, V199, P511, DOI 10.1007/BF00195180; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Rashotte AM, 2003, PLANT PHYSIOL, V133, P761, DOI 10.1104/pp.103.022582; Routaboul JM, 2006, PLANTA, V224, P96, DOI 10.1007/s00425-005-0197-5; Rozema J, 2002, J PHOTOCH PHOTOBIO B, V66, P2, DOI 10.1016/S1011-1344(01)00269-X; Ruiz PA, 2007, J NUTR, V137, P1208, DOI 10.1093/jn/137.5.1208; Saslowsky DE, 2005, J BIOL CHEM, V280, P23735, DOI 10.1074/jbc.M413506200; Soo PC, 2007, J BACTERIOL, V189, P109, DOI 10.1128/JB.00710-06; Spencer JPE, 2003, J BIOL CHEM, V278, P34783, DOI 10.1074/jbc.M305063200; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Usadel B, 2008, PLANT PHYSIOL, V146, P1834, DOI 10.1104/pp.107.115592; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Warpeha KM, 2008, PLANT CELL ENVIRON, V31, P1756, DOI 10.1111/j.1365-3040.2008.01878.x; Warpeha KM, 2006, PLANT PHYSIOL, V140, P844, DOI 10.1104/pp.105.071282; WARPEHA KM, 2013, APPL ENV MICROBIOLOG; Weiss CA, 1997, FEBS LETT, V407, P361, DOI 10.1016/S0014-5793(97)00378-5; Wendler WMF, 1997, J BIOL CHEM, V272, P8482, DOI 10.1074/jbc.272.13.8482; Winkel-Shirley B, 2001, PLANT PHYSIOL, V127, P1399, DOI 10.1104/pp.127.4.1399; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wiseman RL, 2010, MOL CELL, V38, P291, DOI 10.1016/j.molcel.2010.04.001; Xing NZ, 2001, CARCINOGENESIS, V22, P409, DOI 10.1093/carcin/22.3.409; Young JJ, 2006, P NATL ACAD SCI USA, V103, P7506, DOI 10.1073/pnas.0602225103; Zhang W, 2011, J EXP BOT, V62, P2371, DOI 10.1093/jxb/erq424; Zhao ZX, 2010, J PROTEOME RES, V9, P1637, DOI 10.1021/pr901011h	71	16	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93371	10.1371/journal.pone.0093371	http://dx.doi.org/10.1371/journal.pone.0093371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705271	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500034
J	Sapre, N; Hong, MKH; Macintyre, G; Lewis, H; Kowalczyk, A; Costello, AJ; Corcoran, NM; Hovens, CM				Sapre, Nikhil; Hong, Matthew K. H.; Macintyre, Geoff; Lewis, Heather; Kowalczyk, Adam; Costello, Anthony J.; Corcoran, Niall M.; Hovens, Christopher M.			Curated MicroRNAs in Urine and Blood Fail to Validate as Predictive Biomarkers for High-Risk Prostate Cancer	PLOS ONE			English	Article							CIRCULATING MICRORNAS; ANTIGEN; EXPRESSION; GENE; DIAGNOSIS; IDENTIFICATION; PROGRESSION; SERUM; FLUID; PCR	Purpose: The purpose of this study was to determine if microRNA profiling of urine and plasma at radical prostatectomy can distinguish potentially lethal from indolent prostate cancer. Materials and Methods: A panel of microRNAs was profiled in the plasma of 70 patients and the urine of 33 patients collected prior to radical prostatectomy. Expression of microRNAs was correlated to the clinical endpoints at a follow-up time of 3.9 years to identify microRNAs that may predict clinical response after radical prostatectomy. A machine learning approach was applied to test the predictive ability of all microRNAs profiled in urine, plasma, and a combination of both, and global performance assessed using the area under the receiver operator characteristic curve (AUC). Validation of urinary expression of miRNAs was performed on a further independent cohort of 36 patients. Results: The best predictor in plasma using eight miRs yielded only moderate predictive performance (AUC = 0.62). The best predictor of high-risk disease was achieved using miR-16, miR-21 and miR-222 measured in urine (AUC = 0.75). This combination of three microRNAs in urine was a better predictor of high-risk disease than any individual microRNA. Using a different methodology we found that this set of miRNAs was unable to predict high-volume, high-grade disease. Conclusions: Our initial findings suggested that plasma and urinary profiling of microRNAs at radical prostatectomy may allow prognostication of prostate cancer behaviour. However we found that the microRNA expression signature failed to validate in an independent cohort of patients using a different platform for PCR. This highlights the need for independent validation patient cohorts and suggests that urinary microRNA signatures at radical prostatectomy may not be a robust way to predict the course of clinical disease after definitive treatment for prostate cancer.	[Sapre, Nikhil; Hong, Matthew K. H.; Costello, Anthony J.; Corcoran, Niall M.; Hovens, Christopher M.] Royal Melbourne Hosp, Dept Surg, Div Urol, Parkville, Vic 3050, Australia; [Sapre, Nikhil; Hong, Matthew K. H.; Costello, Anthony J.; Corcoran, Niall M.; Hovens, Christopher M.] Univ Melbourne, Parkville, Vic 3052, Australia; [Sapre, Nikhil; Hong, Matthew K. H.; Lewis, Heather; Costello, Anthony J.; Corcoran, Niall M.; Hovens, Christopher M.] Australian Prostate Canc Res Epworth, Richmond, Australia; [Macintyre, Geoff; Kowalczyk, Adam] Univ Melbourne, Dept Elect & Elect Engn, NICTA Victoria Res Lab, Parkville, Vic 3052, Australia; [Macintyre, Geoff] Univ Melbourne, Dept Comp & Informat Syst, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; University of Melbourne; University of Melbourne; University of Melbourne	Sapre, N (corresponding author), Royal Melbourne Hosp, Dept Surg, Div Urol, Parkville, Vic 3050, Australia.	sapni973@gmail.com		Macintyre, Geoff/0000-0003-3906-467X; Hovens, Christopher/0000-0002-0610-1289	Cancer Council Victoria; Cybec Foundation; Royal Australasian College of Surgeons; Australian Government; NICTA; Australian Government as represented by the Department of Broadband,; Communications and the Digital Economy; Australian Research Council through the ICT Centre of Excellence program	Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cybec Foundation; Royal Australasian College of Surgeons; Australian Government(Australian GovernmentCGIAR); NICTA(NICTA); Australian Government as represented by the Department of Broadband,(Australian Government); Communications and the Digital Economy; Australian Research Council through the ICT Centre of Excellence program(Australian Research Council)	NS is supported by postgraduate scholarships from the Cancer Council Victoria, Cybec Foundation and Royal Australasian College of Surgeons. This study was supported by funding from the Australian Government to the Australian Prostate Cancer Research Epworth. AK and GM are supported by NICTA. NICTA is funded by the Australian Government as represented by the Department of Broadband, Communications and the Digital Economy and the Australian Research Council through the ICT Centre of Excellence program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaoglu FY, 2011, TUMOR BIOL, V32, P583, DOI 10.1007/s13277-011-0154-9; Albertsen PC, 1998, JAMA-J AM MED ASSOC, V280, P975, DOI 10.1001/jama.280.11.975; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Antonarakis ES, 2010, BJU INT; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benes V, 2010, METHODS, V50, P244, DOI 10.1016/j.ymeth.2010.01.026; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Bussemakers MJG, 1999, CANCER RES, V59, P5975; Catalona WJ, 2011, J UROLOGY, V185, P1650, DOI 10.1016/j.juro.2010.12.032; CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Chen ZH, 2012, PROSTATE, V72, P1443, DOI 10.1002/pros.22495; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Daskivich TJ, 2006, J UROLOGY, V176, P1927, DOI 10.1016/j.juro.2006.07.002; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; EPSTEIN JI, 1994, JAMA-J AM MED ASSOC, V271, P368, DOI 10.1001/jama.271.5.368; Hessels D, 2003, EUR UROL, V44, P8, DOI 10.1016/S0302-2838(03)00201-X; JACOBSEN SJ, 1995, JAMA-J AM MED ASSOC, V274, P1445, DOI 10.1001/jama.274.18.1445; Jeronimo C, 2011, EUR UROL, V60, P753, DOI 10.1016/j.eururo.2011.06.035; Lu Q, 2009, PROSTATE, V69, P411, DOI 10.1002/pros.20902; Mahn R, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2011.01.020; Mees ST, 2011, J SURG RES, V169, P241, DOI 10.1016/j.jss.2009.10.005; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Molina-Pinelo S, 2012, DIS MARKERS, V32, P221, DOI [10.1155/2012/873749, 10.3233/DMA-2011-0882]; Moltzahn F, 2011, CANCER RES, V71, P550, DOI 10.1158/0008-5472.CAN-10-1229; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; OESTERLING JE, 1991, J UROLOGY, V145, P907, DOI 10.1016/S0022-5347(17)38491-4; Payne SR, 2009, PROSTATE, V69, P1257, DOI 10.1002/pros.20967; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; POTOSKY AL, 1995, JAMA-J AM MED ASSOC, V273, P548, DOI 10.1001/jama.273.7.548; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Roupret M, 2007, CLIN CANCER RES, V13, P1720, DOI 10.1158/1078-0432.CCR-06-2467; Sapre N, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/539680; Shen J, 2012, PROSTATE, V72, P1469, DOI 10.1002/pros.22499; Sherwin JC, 2010, J UROLOGY, V183, P1808, DOI 10.1016/j.juro.2010.01.017; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; van Poppel H, 2012, BJU INT, V109, P360, DOI 10.1111/j.1464-410X.2011.10377.x; Velonas VM, 2013, INT J MOL SCI, V14, P11034, DOI 10.3390/ijms140611034; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405	42	42	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e91729	10.1371/journal.pone.0091729	http://dx.doi.org/10.1371/journal.pone.0091729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705338	Green Published, gold			2022-12-27	WOS:000334107500007
J	Wallace, DJ; Angus, DC; Seymour, CW; Yealy, DM; Carr, BG; Kurland, K; Boujoukos, A; Kahn, JM				Wallace, David J.; Angus, Derek C.; Seymour, Christopher W.; Yealy, Donald M.; Carr, Brendan G.; Kurland, Kristen; Boujoukos, Arthur; Kahn, Jeremy M.			Geographic Access to High Capability Severe Acute Respiratory Failure Centers in the United States	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; DISTRESS-SYNDROME; CARE; TRANSPORT; OUTCOMES; QUALITY; IMPACT	Objective: Optimal care of adults with severe acute respiratory failure requires specific resources and expertise. We sought to measure geographic access to these centers in the United States. Design: Cross-sectional analysis of geographic access to high capability severe acute respiratory failure centers in the United States. We defined high capability centers using two criteria: (1) provision of adult extracorporeal membrane oxygenation (ECMO), based on either 2008-2013 Extracorporeal Life Support Organization reporting or provision of ECMO to 2010 Medicare beneficiaries; or (2) high annual hospital mechanical ventilation volume, based 2010 Medicare claims. Setting: Nonfederal acute care hospitals in the United States. Measurements and Main Results: We defined geographic access as the percentage of the state, region and national population with either direct or hospital-transferred access within one or two hours by air or ground transport. Of 4,822 acute care hospitals, 148 hospitals met our ECMO criteria and 447 hospitals met our mechanical ventilation criteria. Geographic access varied substantially across states and regions in the United States, depending on center criteria. Without interhospital transfer, an estimated 58.5% of the national adult population had geographic access to hospitals performing ECMO and 79.0% had geographic access to hospitals performing a high annual volume of mechanical ventilation. With interhospital transfer and under ideal circumstances, an estimated 96.4% of the national adult population had geographic access to hospitals performing ECMO and 98.6% had geographic access to hospitals performing a high annual volume of mechanical ventilation. However, this degree of geographic access required substantial interhospital transfer of patients, including up to two hours by air. Conclusions: Geographic access to high capability severe acute respiratory failure centers varies widely across states and regions in the United States. Adequate referral center access in the case of disasters and pandemics will depend highly on local and regional care coordination across political boundaries.	[Wallace, David J.; Angus, Derek C.; Seymour, Christopher W.; Boujoukos, Arthur; Kahn, Jeremy M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA 15260 USA; [Wallace, David J.; Seymour, Christopher W.; Yealy, Donald M.] Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA USA; [Carr, Brendan G.] Univ Penn, Perelman Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA; [Kurland, Kristen] Carnegie Mellon Univ, Sch Publ Policy & Management, Heinz Coll, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Pennsylvania Medicine; Carnegie Mellon University	Wallace, DJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA 15260 USA.	wallacedj@upmc.edu	Angus, Derek C/E-9671-2012	Kahn, Jeremy/0000-0001-9688-5576	National Institutes of Health [K12-HL109068, K23-GM104022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL109068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM104022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Grant support was received from the National Institutes of Health: K12-HL109068 (Wallace), K23-GM104022 (Seymour). The NIH had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Adalja AA, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.09.016; [Anonymous], 2013, MMWR-MORBID MORTAL W, V62, P557; [Anonymous], 2010, AM HOSP ASS ANN SURV; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carr BG, 2009, ANN EMERG MED, V54, P261, DOI 10.1016/j.annemergmed.2008.11.016; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Dowdy DW, 2006, INTENS CARE MED, V32, P1115, DOI 10.1007/s00134-006-0217-3; Finlayson SRG, 1999, MED CARE, V37, P204, DOI 10.1097/00005650-199902000-00010; Gastner MT, 2004, P NATL ACAD SCI USA, V101, P7499, DOI 10.1073/pnas.0400280101; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; HAGEN H, 1989, Tidsskrift for den Norske Laegeforening, V109, P607; Halpern SD, 2011, CURR OPIN CRIT CARE, V17, P648, DOI 10.1097/MCC.0b013e32834c7a53; Henneman PL, 2011, J EMERG MED, V40, P333, DOI 10.1016/j.jemermed.2009.08.058; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Horwitz JR, 2013, CIRCULATION, V128, P803, DOI 10.1161/CIRCULATIONAHA.112.000836; Jernigan D, 2013, MMWR-MORBID MORTAL W, V62, P366; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Kahn JM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-239; Klein MB, 2009, JAMA-J AM MED ASSOC, V302, P1774, DOI 10.1001/jama.2009.1548; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Lerner EB, 1999, ACAD EMERG MED, V6, P1127, DOI 10.1111/j.1553-2712.1999.tb00115.x; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Minnesota Population Center, 2011, NAT HIST GOGR INF SY; Nathens AB, 2004, J TRAUMA, V56, P173, DOI 10.1097/01.TA.0000056159.65396.7C; Noah MA, 2011, JAMA-J AM MED ASSOC, V306, P1659, DOI 10.1001/jama.2011.1471; Office of Assistant Secretary for Preparedness and Response, HSOP HEALTHC COAL TR; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Quan H, 2004, MED CARE, V42, P801, DOI 10.1097/01.mlr.0000132391.59713.0d; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubinson L, 2013, MED CARE, V51, P259, DOI 10.1097/MLR.0b013e31827da8ea; Seymour CW, 2008, CRIT CARE, V12, DOI 10.1186/cc6909; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Uusaro A, 2002, INTENS CARE MED, V28, P1122, DOI 10.1007/s00134-002-1348-9; Valta P, 1999, CRIT CARE MED, V27, P2367, DOI 10.1097/00003246-199911000-00008; Wallace DJ, 2014, ACAD EMERG MED, V21, P9, DOI 10.1111/acem.12289; Wunsch H, 2010, CRIT CARE MED, V38, P1947, DOI 10.1097/CCM.0b013e3181ef4460	40	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94057	10.1371/journal.pone.0094057	http://dx.doi.org/10.1371/journal.pone.0094057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705417	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500115
J	Xue, YF; Yue, SC; Zhang, W; Liu, DY; Cui, ZL; Chen, XP; Ye, YL; Zou, CQ				Xue, Yanfang; Yue, Shanchao; Zhang, Wei; Liu, Dunyi; Cui, Zhenling; Chen, Xinping; Ye, Youliang; Zou, Chunqin			Zinc, Iron, Manganese and Copper Uptake Requirement in Response to Nitrogen Supply and the Increased Grain Yield of Summer Maize	PLOS ONE			English	Article							DRY-MATTER ACCUMULATION; NUTRIENT ACCUMULATION; USE EFFICIENCY; PLANT-DENSITY; MANAGEMENT; FOOD; CROP; NUTRITION; SYSTEM; GROWTH	The relationships between grain yields and whole-plant accumulation of micronutrients such as zinc (Zn), iron (Fe), manganese (Mn) and copper (Cu) in maize (Zea mays L.) were investigated by studying their reciprocal internal efficiencies (RIEs, g of micronutrient requirement in plant dry matter per Mg of grain). Field experiments were conducted from 2008 to 2011 in North China to evaluate RIEs and shoot micronutrient accumulation dynamics during different growth stages under different yield and nitrogen (N) levels. Fe, Mn and Cu RIEs (average 64.4, 18.1and 5.3 g, respectively) were less affected by the yield and N levels. ZnRIE increased by 15% with an increased N supply but decreased from 36.3 to 18.0 g with increasing yield. The effect of cultivars on ZnRIE was similar to that of yield ranges. The substantial decrease in ZnRIE may be attributed to an increased Zn harvest index (from 41% to 60%) and decreased Zn concentrations in straw (a 56% decrease) and grain (decreased from 16.9 to 12.2 mg kg(-1)) rather than greater shoot Zn accumulation. Shoot Fe, Mn and Cu accumulation at maturity tended to increase but the proportions of pre-silking shoot Fe, Cu and Zn accumulation consistently decreased (from 95% to 59%, 90% to 71% and 91% to 66%, respectively). The decrease indicated the high reproductive-stage demands for Fe, Zn and Cu with the increasing yields. Optimized N supply achieved the highest yield and tended to increase grain concentrations of micronutrients compared to no or lower N supply. Excessive N supply did not result in any increases in yield or micronutrient nutrition for shoot or grain. These results indicate that optimized N management may be an economical method of improving micronutrient concentrations in maize grain with higher grain yield.	[Xue, Yanfang; Yue, Shanchao; Zhang, Wei; Liu, Dunyi; Cui, Zhenling; Chen, Xinping; Zou, Chunqin] China Agr Univ, Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China; [Ye, Youliang] Henan Agr Univ, Coll Resources & Environm Sci, Zhengzhou, Peoples R China	China Agricultural University; Henan Agricultural University	Zou, CQ (corresponding author), China Agr Univ, Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China.	zcq0206@cau.edu.cn	Yue, Shanchao/D-1846-2009	Yue, Shanchao/0000-0001-8724-2974	National Natural Science Foundation of China [31272252]; China Agriculture Research System [CARS-02]; 973 project [2009CB18606]; NSFC [31121062]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; 973 project(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (31272252), China Agriculture Research System (CARS-02), the 973 project (No. 2009CB18606) and the Innovative Group Grant of NSFC (31121062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FAO FAOSTAT AGR DAT; Banziger Marianne, 2000, Food and Nutrition Bulletin, V21, P397; Behera SK, 2011, 3 INT ZINC S IMPR CR; Bender RR, 2013, AGRON J, V105, P161, DOI 10.2134/agronj2012.0352; Cakmak I, 2002, PLANT SOIL, V247, P3, DOI 10.1023/A:1021194511492; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Ciampitti IA, 2013, AGRON J, V105, P1645, DOI 10.2134/agronj2013.0126; Ciampitti IA, 2013, AGRON J, V105, P783, DOI 10.2134/agronj2012.0467; Ciampitti IA, 2012, FIELD CROP RES, V133, P48, DOI 10.1016/j.fcr.2012.03.008; Cui ZL, 2008, FIELD CROP RES, V105, P48, DOI 10.1016/j.fcr.2007.07.008; Fageria NK, 2008, COMMUN SOIL SCI PLAN, V39, P2258, DOI 10.1080/00103620802289141; Feil B, 2005, CROP SCI, V45, P516, DOI 10.2135/cropsci2005.0516; Grzebisz W, 2008, J ELEMENTOL, V13, P17; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; Hou P, 2012, FIELD CROP RES, V129, P1, DOI 10.1016/j.fcr.2012.01.006; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; KARLEN DL, 1988, AGRON J, V80, P232, DOI 10.2134/agronj1988.00021962008000020018x; KARLEN DL, 1987, J PLANT NUTR, V10, P1409, DOI 10.1080/01904168709363673; Le C, 2010, ENVIRON MANAGE, V45, P662, DOI 10.1007/s00267-010-9440-3; Losak T, 2011, ACTA AGR SCAND B-S P, V61, P543, DOI 10.1080/09064710.2010.520729; Marschner, 2011, MINERAL NUTR HIGHER; Meng QF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068783; MORTVEDT JJ, 1994, FERT RES, V38, P213, DOI 10.1007/BF00749694; Nuss ET, 2010, COMPR REV FOOD SCI F, V9, P417, DOI 10.1111/j.1541-4337.2010.00117.x; Oktem A, 2010, COMMUN SOIL SCI PLAN, V41, P832, DOI 10.1080/00103621003592358; Potarzycki J., 2010, FERTILIZERS FERTILIZ, V39, P78, DOI DOI 10.1155/2009/251915; Rengel Z, 1995, J PLANT PHYSIOL, V147, P251, DOI 10.1016/S0176-1617(11)81513-0; Sadras VO, 2006, FIELD CROP RES, V95, P13, DOI 10.1016/j.fcr.2005.01.020; Setiyono TD, 2010, FIELD CROP RES, V118, P158, DOI 10.1016/j.fcr.2010.05.006; Shiferaw B, 2011, FOOD SECUR, V3, P475, DOI 10.1007/s12571-011-0153-0; Shivay YS, 2008, NUTR CYCL AGROECOSYS, V81, P229, DOI 10.1007/s10705-007-9159-6; Shivay YS, 2008, NUTR CYCL AGROECOSYS, V80, P181, DOI 10.1007/s10705-007-9131-5; Wang TY, 2011, CROP SCI, V51, P512, DOI 10.2135/cropsci2010.06.0383; Xue YF, 2012, PLANT SOIL, V361, P153, DOI 10.1007/s11104-012-1510-2; Yang XE, 2007, ENVIRON GEOCHEM HLTH, V29, P413, DOI 10.1007/s10653-007-9086-0; Yu WT, 2011, NUTR CYCL AGROECOSYS, V90, P75, DOI 10.1007/s10705-010-9413-1; Yue SC, 2012, AGRON J, V104, P1687, DOI 10.2134/agronj2012.0232; Zhang SS, 2013, FIELD CROP RES, V154, P153, DOI 10.1016/j.fcr.2013.08.003; Zhang Y, 2012, AGRON J, V104, P1436, DOI 10.2134/agronj2012.0125; Zheng X., 2004, GLOBAL BIOGEOCHEMICA, V18	41	32	34	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93895	10.1371/journal.pone.0093895	http://dx.doi.org/10.1371/journal.pone.0093895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705926	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500089
J	Yan, HD; Zhang, F; Kolkin, J; Wang, CY; Xia, Z; Fan, CY				Yan, Hede; Zhang, Feng; Kolkin, Jon; Wang, Chunyang; Xia, Zhen; Fan, Cunyi			Mechanisms of Nerve Capping Technique in Prevention of Painful Neuroma Formation	PLOS ONE			English	Article							ALIGNED ELECTROSPUN NANOFIBERS; STUMP TRANSPLANTATION; TRAUMATIC NEUROMA; NEUROPATHIC PAIN; POTENTIAL ROLE; SCHWANN-CELLS; REGENERATION; GROWTH; AUTOTOMY; VEIN	Nerve capping techniques have been introduced as a promising treatment modality for the treatment of painful neuroma with varied outcomes; however, its exact mechanism is still unknown. RhoA is one of the members of the RAS superfamily of GTPases that operate as molecular switches and plays an important role in peripheral nerve regeneration. Our aim was to investigate the structural and morphologic mechanisms by which the nerve capping technique prevents the formation of painful neuromas after neuroectomy. We also hoped to provide a theoretical basis for this treatment approach. An aligned nanofiber conduit was used for the capping procedure and the sciatic nerve of Sprague-Dawley rats was selected as the animal model. Behavioral analysis, extent of neuroma formation, histological assessment, expressions of pain markers of substance P and c-fos, molecular biological changes as well as ultrastructural features were investigated and compared with the findings in a no-capping control group. The formation of traumatic neuromas was significantly inhibited in the capping group with relatively "normal'' structural and morphological features and no occurrence of autotomy and significantly lower expression of pain markers compared to the no-capping group. The gene expression of RhoA was consistently in a higher level in the capping group within 8 weeks after surgery. This study shows that capping technique will alter the regeneration state of transected nerves and reduce painful neuroma formation, indicating a promising approach for the treatment of painful neuroma. The initiation of the "regenerative brake'' induced by structural as well as morphological improvements in the severed nerve is theorized to be most likely a key mechanism for the capping technique in the prevention of painful neuroma formation.	[Yan, Hede; Wang, Chunyang; Xia, Zhen; Fan, Cunyi] Shanghai Jiao Tong Univ, Dept Orthoped, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Yan, Hede] Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthopaed, Div Plast & Hand Surg, Wenzhou, Peoples R China; [Zhang, Feng] Univ Mississippi, Med Ctr, Div Plast Surg, Jackson, MS 39216 USA; [Kolkin, Jon] Duke Raleigh Hosp, Dept Plast & Hand Surg, Raleigh, NC USA	Shanghai Jiao Tong University; Wenzhou Medical University; University of Mississippi; University of Mississippi Medical Center	Fan, CY (corresponding author), Shanghai Jiao Tong Univ, Dept Orthoped, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China.	fancunyi888@gmail.com	fan, cunyi/ABI-7199-2020	fan, cunyi/0000-0002-7854-5233	National Natural Science Foundation of China [81171477]; Key Project of Health Bureau of Shanghai [2012412]; Health Department of Zhejiang province [201338025]; Department of Education of Zhejiang Province [20051185]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Health Bureau of Shanghai; Health Department of Zhejiang province; Department of Education of Zhejiang Province	This study was supported by funding from the National Natural Science Foundation of China (81171477), Key Project of Health Bureau of Shanghai (2012412), Health Department of Zhejiang province (201338025), and the Department of Education of Zhejiang Province (20051185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton DD, 2006, J HAND SURG-BRIT EUR, V31B, P652, DOI 10.1016/j.jhsb.2006.06.009; Beilke MC, 2013, ANAL CHIM ACTA, V761, P201, DOI 10.1016/j.aca.2012.11.028; CAMPBELL J B, 1963, J Trauma, V3, P303; CARLTON SM, 1991, NEUROSCI LETT, V131, P88, DOI 10.1016/0304-3940(91)90343-R; Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cheng C, 2008, EXP NEUROL, V212, P358, DOI 10.1016/j.expneurol.2008.04.023; Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025; CODERRE TJ, 1986, PAIN, V26, P61, DOI 10.1016/0304-3959(86)90174-0; COLLINS WF, 1960, ARCH NEUROL-CHICAGO, V3, P381, DOI 10.1001/archneur.1960.00450040031003; Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285; CRAVIOTO H, 1981, NEUROSURGERY, V8, P181, DOI 10.1227/00006123-198102000-00007; FARLEY H H, 1965, Minn Med, V48, P347; FREEMAN BS, 1969, PLAST RECONSTR SURG, V43, P174, DOI 10.1097/00006534-196902000-00011; Giniger E, 2002, DIFFERENTIATION, V70, P385, DOI 10.1046/j.1432-0436.2002.700801.x; Gould JS, 2013, FOOT ANKLE INT; Herbert TJ, 1998, J HAND SURG-BRIT EUR, V23B, P220, DOI 10.1016/S0266-7681(98)80178-2; HERNDON JH, 1976, J BONE JOINT SURG AM, V58, P369, DOI 10.2106/00004623-197658030-00013; Hirose K, 2010, EUR SPINE J, V19, P1746, DOI 10.1007/s00586-010-1428-4; Jimenez-Andrade JM, 2011, PAIN, V152, P2564, DOI 10.1016/j.pain.2011.07.020; Koch H, 2003, ANN PLAS SURG, V51, P45, DOI 10.1097/01.SAP.0000054187.72439.57; Koch H, 2004, FOOT ANKLE INT, V25, P476, DOI 10.1177/107110070402500706; Koch H, 2003, ANN PLAS SURG, V50, P354, DOI 10.1097/01.SAP.0000041486.24160.8C; Kreutzberg GW, 1996, ACT NEUR S, V66, P103; Lewin-Kowalik J, 2006, NEUROL MED-CHIR, V46, P62, DOI 10.2176/nmc.46.62; Lindqvist A, 2000, MUSCLE NERVE, V23, P1214, DOI 10.1002/1097-4598(200008)23:8<1214::AID-MUS9>3.0.CO;2-A; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; MASS DP, 1984, PLAST RECONSTR SURG, V74, P182, DOI 10.1097/00006534-198408000-00002; Mirsky R, 2002, J PHYSIOL-PARIS, V96, P17, DOI 10.1016/S0928-4257(01)00076-6; Mirsky R, 1999, BRAIN PATHOL, V9, P293; MUEHLEMAN C, 1990, Journal of Foot Surgery, V29, P260; Ogata T, 2006, MOL NEUROBIOL, V33, P51, DOI 10.1385/MN:33:1:051; Okuda T, 2006, J ORTHOP RES, V24, P1427, DOI 10.1002/jor.20196; Prabhakaran MP, 2013, BIOTECHNOL BIOENG; Rajput K, 2012, CLIN J PAIN, V28, P639, DOI 10.1097/AJP.0b013e31823d30a2; ROGISTER B, 1993, J NEUROSCI RES, V34, P32, DOI 10.1002/jnr.490340105; Sakai Y, 2005, J BIOMED MATER RES B, V73B, P355, DOI 10.1002/jbm.b.30219; Siddall PJ, 1999, BRAIN RES, V851, P281, DOI 10.1016/S0006-8993(99)02173-3; Stoll G, 1999, BRAIN PATHOL, V9, P313; Tay SC, 2005, ANN ACAD MED SINGAP, V34, P362; Thomsen L, 2010, CHIR MAIN, V29, P255, DOI 10.1016/j.main.2010.07.004; Touchette D, 2011, OTOLARYNG HEAD NECK, V145, P699, DOI 10.1177/0194599811405292; WALL PD, 1979, PAIN, V7, P103, DOI 10.1016/0304-3959(79)90002-2; WALL PD, 1974, EXP NEUROL, V43, P580, DOI 10.1016/0014-4886(74)90197-6; Wang CY, 2012, J BIOMAT SCI-POLYM E, V23, P167, DOI 10.1163/092050610X545805; Wang CY, 2011, ACTA BIOMATER, V7, P634, DOI 10.1016/j.actbio.2010.09.011; Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001; WILLIAMS HB, 1984, CLIN PLAST SURG, V11, P79; Wu J, 1999, ANN PLAS SURG, V43, P661, DOI 10.1097/00000637-199912000-00016; Xu Y, 2013, TISSUE ENG C; Yan HD, 2012, J NEUROTRAUM, V29, P2791, DOI 10.1089/neu.2012.2502; Yin Q, 1998, J HAND SURG-BRIT EUR, V23B, P433, DOI 10.1016/S0266-7681(98)80117-4; Zeltser R, 2000, PAIN, V89, P19, DOI 10.1016/S0304-3959(00)00342-0; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6; Zochodne DW, 2001, BRAIN RES, V902, P40, DOI 10.1016/S0006-8993(01)02310-1	55	32	32	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93973	10.1371/journal.pone.0093973	http://dx.doi.org/10.1371/journal.pone.0093973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705579	Green Submitted, Green Published, gold			2022-12-27	WOS:000334107500100
J	Bodenmann, P; Favrat, B; Wolff, H; Guessous, I; Panese, F; Herzig, L; Bischoff, T; Casillas, A; Golano, T; Vaucher, P				Bodenmann, Patrick; Favrat, Bernard; Wolff, Hans; Guessous, Idris; Panese, Francesco; Herzig, Lilli; Bischoff, Thomas; Casillas, Alejandra; Golano, Thomas; Vaucher, Paul			Screening Primary-Care Patients Forgoing Health Care for Economic Reasons	PLOS ONE			English	Article							PHYSICIAN COMMUNICATION; DETERMINANTS; COST; ASSOCIATION; BARRIERS; EQUITY; ACCESS	social inequities have made it important for general practitioners to verify if patients can afford treatment and procedures. Incorporating social conditions into clinical decision-making allows general practitioners to address mismatches between patients' health-care needs and financial resources. Objectives: Identify a screening question to, indirectly, rule out patients' social risk of forgoing health care for economic reasons, and estimate prevalence of forgoing health care and the influence of physicians' attitudes toward deprivation. Design: Multicenter cross-sectional survey. Participants: Forty-seven general practitioners working in the French-speaking part of Switzerland enrolled a random sample of patients attending their private practices. Main Measures: Patients who had forgone health care were defined as those reporting a household member ( including themselves) having forgone treatment for economic reasons during the previous 12 months, through a self-administered questionnaire. Patients were also asked about education and income levels, self-perceived social position, and deprivation levels. Key Results: Overall, 2,026 patients were included in the analysis; 10.7% (CI95% 9.4-12.1) reported a member of their household to have forgone health care during the 12 previous months. The question ``Did you have difficulties paying your household bills during the last 12 months'' performed better in identifying patients at risk of forgoing health care than a combination of four objective measures of socio-economic status ( gender, age, education level, and income) (R 2 =0.184 vs. 0.083). This question effectively ruled out that patients had forgone health care, with a negative predictive value of 96%. Furthermore, for physicians who felt powerless in the face of deprivation, we observed an increase in the odds of patients forgoing health care of 1.5 times. Conclusion: General practitioners should systematically evaluate the socio-economic status of their patients. Asking patients whether they experience any difficulties in paying their bills is an effective means of identifying patients who might forgo health care.	[Bodenmann, Patrick; Casillas, Alejandra] Univ Lausanne, Dept Ambulatory Care & Community Med, Vulnerable Populat Unit, Lausanne, Switzerland; [Favrat, Bernard] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Wolff, Hans; Guessous, Idris] Univ Hosp Geneva, Dept Community Med Primary Care & Emergency Med, Geneva, Switzerland; [Wolff, Hans; Guessous, Idris] Univ Geneva, Fac Med, Geneva, Switzerland; [Guessous, Idris] Univ Lausanne, Univ Hosp Ctr, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Guessous, Idris] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland; [Panese, Francesco] Univ Lausanne, Dept Ambulatory Care & Community Med, Inst Hist Med, Lausanne, Switzerland; [Herzig, Lilli; Bischoff, Thomas; Golano, Thomas] Univ Lausanne, Inst Gen Med, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Vaucher, Paul] Univ Geneva, Sch Med, Inst Legal Med, CH-1211 Geneva, Switzerland	University of Lausanne; University of Lausanne; University of Geneva; University of Geneva; University of Lausanne; University of Lausanne; University of Geneva	Bodenmann, P (corresponding author), Univ Lausanne, Dept Ambulatory Care & Community Med, Vulnerable Populat Unit, Lausanne, Switzerland.	patrick.bodenmann@hospvd.ch	Wolff, Hans/F-2122-2015; Vaucher, Paul/A-6259-2009	Wolff, Hans/0000-0002-4978-2176; Vaucher, Paul/0000-0002-0652-0985; Favrat, Bernard/0000-0001-6920-099X; Bodenmann, Patrick/0000-0002-1058-1035; Casillas, Alejandra/0000-0003-4229-7466	Department of Ambulatory Care and Community Medicine, University of Lausanne, Switzerland; Swiss Academy of Medical Science; Department of Social Action and Health of the Canton of Vaud; Faculty of Biology and Medicine of the University of Lausanne; Swiss National Science Founding grant [SNF 32 00 3B_13 57 62]; Swiss National Science Foundation [SNF 33CM30-124087/1]	Department of Ambulatory Care and Community Medicine, University of Lausanne, Switzerland; Swiss Academy of Medical Science; Department of Social Action and Health of the Canton of Vaud; Faculty of Biology and Medicine of the University of Lausanne; Swiss National Science Founding grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was sponsored by the Department of Ambulatory Care and Community Medicine, University of Lausanne, Switzerland. The authors received grants from the following institutions: the Swiss Academy of Medical Science, the Department of Social Action and Health of the Canton of Vaud, and the Faculty of Biology and Medicine of the University of Lausanne. PB is supported by a Swiss National Science Founding grant (SNF 32 00 3B_13 57 62). IG is supported by a Swiss National Science Foundation grant (SNF 33CM30-124087/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GC, 2004, J GEN INTERN MED, V19, P856, DOI 10.1111/j.1525-1497.2004.30249.x; Alexander GC, 2003, JAMA-J AM MED ASSOC, V290, P953, DOI 10.1001/jama.290.7.953; Anyaegbu G., 2010, EC LABOUR MARKET REV, V4, P49, DOI DOI 10.1057/elmr.2010.9; Betancourt JR, 2011, IMPROVING QUALITY AC; Bihan H, 2005, DIABETES CARE, V28, P2680, DOI 10.2337/diacare.28.11.2680; Bloch G, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-62; Brcic Vanessa, 2011, Int J Family Med, V2011, P812182, DOI 10.1155/2011/812182; Carter-Pokras O, 2002, PUBLIC HEALTH REP, V117, P426, DOI 10.1093/phr/117.5.426; Chandola T, 2005, J EPIDEMIOL COMMUN H, V59, P170, DOI 10.1136/jech.2003.019539; Chen J, 2011, AM J MED QUAL, V26, P261, DOI 10.1177/1062860610390352; Franks P, 2008, J GEN INTERN MED, V23, P672, DOI 10.1007/s11606-008-0509-0; Gruen RL, 2006, JAMA-J AM MED ASSOC, V296, P2467, DOI 10.1001/jama.296.20.2467; Guessous I, 2012, PREV MED, V55, P521, DOI 10.1016/j.ypmed.2012.08.005; Hardee JT, 2005, J GEN INTERN MED, V20, P666, DOI 10.1111/j.1525-1497.2005.0125.x; Hausman A, 2001, Health Mark Q, V19, P49, DOI 10.1300/J026v19n02_05; Heisler M, 2004, MED CARE, V42, P626, DOI 10.1097/01.mlr.0000129352.36733.cc; Heisler M, 2004, AM J MED, V116, P753, DOI 10.1016/j.amjmed.2004.01.013; Kemp A, 2010, J HEALTH SERV RES PO, V15, P106, DOI 10.1258/jhsrp.2009.009059; Krieger N, 2001, INT J EPIDEMIOL, V30, P668, DOI 10.1093/ije/30.4.668; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; Ostlin P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001115; Paniz VMV, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-146; Piette JD, 2005, ARCH INTERN MED, V165, P1749, DOI 10.1001/archinte.165.15.1749; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Schoen C, 2010, HEALTH AFFAIR, V29, P2323, DOI 10.1377/hlthaff.2010.0862; Singh-Manoux A, 2003, SOC SCI MED, V56, P1321, DOI 10.1016/S0277-9536(02)00131-4; Srivastava R, 2011, NEW ENGL J MED, V365, P587, DOI 10.1056/NEJMp1106985; Taylor S, 2009, BRIT MED BULL, V91, P29, DOI 10.1093/bmb/ldp024; Vaucher P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000692; Wisk LE, 2012, PEDIATRICS, V130, P1027, DOI 10.1542/peds.2012-0668; Wolff H, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13165	32	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e94006	10.1371/journal.pone.0094006	http://dx.doi.org/10.1371/journal.pone.0094006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LR	24699726	Green Submitted, Green Published, gold			2022-12-27	WOS:000334105000134
J	Rosenberg, JN; Kobayashi, N; Barnes, A; Noel, EA; Betenbaugh, MJ; Oyler, GA				Rosenberg, Julian N.; Kobayashi, Naoko; Barnes, Austin; Noel, Eric A.; Betenbaugh, Michael J.; Oyler, George A.			Comparative Analyses of Three Chlorella Species in Response to Light and Sugar Reveal Distinctive Lipid Accumulation Patterns in the Microalga C. sorokiniana	PLOS ONE			English	Article							HETEROTROPHIC CHLORELLA; GREEN-ALGAE; BIODIESEL PRODUCTION; WASTE-WATER; VULGARIS; GROWTH; BIOMASS; CULTIVATION; ZOFINGIENSIS; STRAINS	While photosynthetic microalgae, such as Chlorella, serve as feedstocks for nutritional oils and biofuels, heterotrophic cultivation can augment growth rates, support high cell densities, and increase triacylglycerol (TAG) lipid content. However, these species differ significantly in their photoautotrophic and heterotrophic characteristics. In this study, the phylogeny of thirty Chlorella strains was determined in order to inform bioprospecting efforts and detailed physiological assessment of three species. The growth kinetics and lipid biochemistry of C. protothecoides UTEX 411, C. vulgaris UTEX 265, and C. sorokiniana UTEX 1230 were quantified during photoautotrophy in Bold's basal medium (BBM) and heterotrophy in BBM supplemented with glucose (10 g L-1). Heterotrophic growth rates of UTEX 411, 265, and 1230 were found to be 1.5-, 3.7-, and 5-fold higher than their respective autotrophic rates. With a rapid nine-hour heterotrophic doubling time, Chlorella sorokiniana UTEX 1230 maximally accumulated 39% total lipids by dry weight during heterotrophy compared to 18% autotrophically. Furthermore, the discrete fatty acid composition of each strain was examined in order to elucidate lipid accumulation patterns under the two trophic conditions. In both modes of growth, UTEX 411 and 265 produced 18: 1 as the principal fatty acid while UTEX 1230 exhibited a 2.5-fold enrichment in 18:2 relative to 18:1. Although the total lipid content was highest in UTEX 411 during heterotrophy, UTEX 1230 demonstrated a two-fold increase in its heterotrophic TAG fraction at a rate of 28.9 mg L-1 d(-1) to reach 22% of the biomass, corresponding to as much as 90% of its total lipids. Interestingly, UTEX 1230 growth was restricted during mixotrophy and its TAG production rate was suppressed to 18.2 mg L-1 d(-1). This constraint on carbon flow raises intriguing questions about the impact of sugar and light on the metabolic regulation of microalgal lipid biosynthesis.	[Rosenberg, Julian N.; Betenbaugh, Michael J.; Oyler, George A.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Rosenberg, Julian N.; Oyler, George A.] Synapt Res LLC, Baltimore, MD USA; [Kobayashi, Naoko; Barnes, Austin; Noel, Eric A.; Oyler, George A.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA	Johns Hopkins University; University of Nebraska System; University of Nebraska Lincoln	Oyler, GA (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	george@synapticresearch.com	Rosenberg, Julian/C-1396-2008	Noel, Eric/0000-0003-0839-5476	U.S. Department of Energy [DE-SC0004521, DE-EE0003373]; National Science Foundation [NSF-EFRI-1302862]; Johns Hopkins Environment, Energy, Sustainability & Health Institute (E2SHI); Johns Hopkins University Libraries; Emerging Frontiers & Multidisciplinary Activities [1332344] Funding Source: National Science Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Johns Hopkins Environment, Energy, Sustainability & Health Institute (E2SHI); Johns Hopkins University Libraries(Johns Hopkins University); Emerging Frontiers & Multidisciplinary Activities(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by funds from the U.S. Department of Energy (http://www.doe.gov/) under grant numbers DE-SC0004521 and DE-EE0003373 to GAO. Partial support was also provided by grant number NSF-EFRI-1302862 to MJB from the National Science Foundation (http://www.nsf.gov/) and a fellowship to JNR from the Johns Hopkins Environment, Energy, Sustainability & Health Institute (E<SUP>2</SUP>SHI, http://e2shi.jhu.edu/). Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SS, 1999, PLANT BIOLOGY, V1, P418, DOI 10.1111/j.1438-8677.1999.tb00724.x; Banskota AH, 2013, NAT PROD RES, V27, P1028, DOI 10.1080/14786419.2012.696255; Blanc G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r39; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bock C, 2011, FOTTEA, V11, P293, DOI 10.5507/fot.2011.028; BRAND JJ, 1989, BIOTECHNOL BIOENG, V33, P1482, DOI 10.1002/bit.260331116; Bumbak F, 2011, APPL MICROBIOL BIOT, V91, P31, DOI 10.1007/s00253-011-3311-6; Burlew JS, 1953, ALGAL CULTURE LAB PI; Campenni' L, 2013, APPL MICROBIOL BIOT, V97, P1383, DOI 10.1007/s00253-012-4570-6; Converti A, 2009, CHEM ENG PROCESS, V48, P1146, DOI 10.1016/j.cep.2009.03.006; COOKSEY KE, 1987, J MICROBIOL METH, V6, P333, DOI 10.1016/0167-7012(87)90019-4; Davis  R., 2012, ANLESD124; DILLON HF, 2009, Patent No. 8476059; DILLON HF, 2009, Patent No. 1219489; Dunigan DD, 2012, J VIROL, V86, P8821, DOI 10.1128/JVI.00907-12; FAHEY RC, 1987, J MOL EVOL, V25, P81, DOI 10.1007/BF02100044; Fan JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050414; Fan JH, 2012, BIORESOURCE TECHNOL, V112, P206, DOI 10.1016/j.biortech.2012.02.046; Feng PZ, 2012, J BIOSCI BIOENG, V114, P405, DOI 10.1016/j.jbiosc.2012.05.007; Gouveia L., 2008, FOOD CHEM RES DEV; Guarnieri MT, 2013, J PROTEOMICS, V93, P245, DOI 10.1016/j.jprot.2013.05.025; Guarnieri MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025851; GUCKERT JB, 1990, J PHYCOL, V26, P72, DOI 10.1111/j.0022-3646.1990.00072.x; HAASS D, 1974, PLANT PHYSIOL, V53, P14, DOI 10.1104/pp.53.1.14; HAEHNEL W, 1982, BIOCHIM BIOPHYS ACTA, V680, P161, DOI 10.1016/0005-2728(82)90007-X; Harwood JL, 2009, BIOCHIMIE, V91, P679, DOI 10.1016/j.biochi.2008.11.004; He PJ, 2013, BIORESOURCE TECHNOL, V129, P177, DOI 10.1016/j.biortech.2012.10.162; Heredia-Arroyo T, 2010, APPL BIOCHEM BIOTECH, V162, P1978, DOI 10.1007/s12010-010-8974-4; Hoshina R, 2010, PHYCOL RES, V58, P188, DOI 10.1111/j.1440-1835.2010.00579.x; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Huss VAR, 1999, J PHYCOL, V35, P587, DOI 10.1046/j.1529-8817.1999.3530587.x; Ip PF, 2005, PROCESS BIOCHEM, V40, P733, DOI 10.1016/j.procbio.2004.01.039; Jeong ML, 2003, B KOR CHEM SOC, V24, P1763; *JGI, 2011, COCC SUB C 169 V2 0; KAMIYA A, 1987, PLANT CELL PHYSIOL, V28, P611; KESSLER E, 1976, PLANT SYST EVOL, V125, P129, DOI 10.1007/BF00986146; Kim DG, 2013, ALGAE, V28, P101, DOI 10.4490/algae.2013.28.1.101; Kiron V, 2012, AQUACULT NUTR, V18, P521, DOI 10.1111/j.1365-2095.2011.00923.x; Kobayashi N, 2013, BIORESOURCE TECHNOL, V150, P377, DOI 10.1016/j.biortech.2013.10.032; Kobayashi N, 2013, LIPIDS, V48, P1035, DOI 10.1007/s11745-013-3828-9; Kodner RB, 2009, ORG GEOCHEM, V40, P854, DOI 10.1016/j.orggeochem.2009.05.003; KOMOR E, 1974, J GEN PHYSIOL, V64, P568, DOI 10.1085/jgp.64.5.568; KOMOR E, 1988, BOT ACTA, V101, P321, DOI 10.1111/j.1438-8677.1988.tb00051.x; Laurens LML, 2012, ANAL CHEM, V84, P1879, DOI 10.1021/ac202668c; Lee YK, 1996, J APPL PHYCOL, V8, P163, DOI 10.1007/BF02186320; LEE YK, 2006, HDB MICROALGAL CULTU, P116; Li XF, 2007, BIOTECHNOL BIOENG, V98, P764, DOI 10.1002/bit.21489; Li YC, 2011, BIORESOURCE TECHNOL, V102, P10861, DOI 10.1016/j.biortech.2011.09.064; Liu J, 2012, PLANTA, V236, P1665, DOI 10.1007/s00425-012-1718-7; Liu ZY, 2008, BIORESOURCE TECHNOL, V99, P4717, DOI 10.1016/j.biortech.2007.09.073; Lu SH, 2012, BIOTECHNOL BIOENG, V109, P1651, DOI 10.1002/bit.24447; Luo W, 2006, PROTIST, V157, P315, DOI 10.1016/j.protis.2006.05.006; Luthria D, 2004, OIL EXTRACTION AND ANALYSIS: CRITICAL ISSUES AND COMPARATIVE STUDIES, P25; Matsukawa R, 2000, J APPL PHYCOL, V12, P263, DOI 10.1023/A:1008141414115; MCAULEY PJ, 1986, PLANTA, V168, P523, DOI 10.1007/BF00392272; Meyer JR, 2006, P NATL ACAD SCI USA, V103, P10690, DOI 10.1073/pnas.0600434103; Miao XL, 2006, BIORESOURCE TECHNOL, V97, P841, DOI 10.1016/j.biortech.2005.04.008; Mitra D, 2012, ALGAL RES, V1, P40, DOI 10.1016/j.algal.2012.03.002; Msanne J, 2012, PHYTOCHEMISTRY, V75, P50, DOI 10.1016/j.phytochem.2011.12.007; Mulbry W, 2009, J AM OIL CHEM SOC, V86, P909, DOI 10.1007/s11746-009-1432-1; MUSCATIN.L, 1967, COMP BIOCHEM PHYSIOL, V20, P1; *NAT RES COUNC, 2012, SUSTAINABLE DEV ALGA; Ngangkham M, 2013, BIOCATAL AGRIC BIOTE, V2, P240, DOI 10.1016/j.bcab.2013.04.007; NGUYEN HM, 2013, PLANT PHYSIOL, V113; NICHOLS HW, 1965, J PHYCOL, V1, P34, DOI 10.1111/j.1529-8817.1965.tb04552.x; Niederholtmeyer H, 2010, APPL ENVIRON MICROB, V76, P3462, DOI 10.1128/AEM.00202-10; Noutoshi Y, 1998, NUCLEIC ACIDS RES, V26, P3900, DOI 10.1093/nar/26.17.3900; Patnaik S, 2006, AQUACULT NUTR, V12, P395, DOI 10.1111/j.1365-2095.2006.00440.x; Perez-Garcia O, 2011, WATER RES, V45, P11, DOI 10.1016/j.watres.2010.08.037; Poerschmann J, 2004, MICROB ECOL, V48, P78, DOI 10.1007/s00248-003-0144-6; Polakovicova G, 2012, CHEM ENGINEER TRANS, V29, P1129, DOI 10.3303/CET1229189; Prescott GW, 1954, KNOW FRESH WATER ALG; Reddy HK, 2013, ENVIRON PROG SUSTAIN, V32, P910, DOI 10.1002/ep.11862; ROGERS JN, 2014, ALGAL RES IN PRESS; ROSEN BH, 1985, PLANT SCI, V41, P23, DOI 10.1016/0168-9452(85)90061-5; Rosenberg JN, 2008, CURR OPIN BIOTECH, V19, P430, DOI 10.1016/j.copbio.2008.07.008; RUNNING JA, 1994, J APPL PHYCOL, V6, P99, DOI 10.1007/BF02186063; SAKAI N, 1995, ENERG CONVERS MANAGE, V36, P693, DOI 10.1016/0196-8904(95)00100-R; SAMEJIMA H, 1958, J GEN MICROBIOL, V18, P107, DOI 10.1099/00221287-18-1-107; Santos CA, 2011, J IND MICROBIOL BIOT, V38, P909, DOI 10.1007/s10295-010-0860-0; Schenk PM, 2008, BIOENERG RES, V1, P20, DOI 10.1007/s12155-008-9008-8; Senanayake S. P. J. N., 2010, Handbook of seafood quality, safety and health applications, P455; SHEEHAN J, 1998, TP58024190 US DEP EN; Shen Y, 2010, APPL BIOCHEM BIOTECH, V160, P1674, DOI 10.1007/s12010-009-8659-z; Shi XM, 2006, MOL NUTR FOOD RES, V50, P763, DOI 10.1002/mnfr.200600037; Shi XM, 2000, ENZYME MICROB TECH, V27, P312, DOI 10.1016/S0141-0229(00)00208-8; SOROKIN C, 1953, SCIENCE, V117, P330, DOI 10.1126/science.117.3039.330; SPOEHR HA, 1949, PLANT PHYSIOL, V24, P120, DOI 10.1104/pp.24.1.120; Stephens E, 2010, NAT BIOTECHNOL, V28, P126, DOI 10.1038/nbt0210-126; Stephenson AL, 2010, BIOFUELS-UK, V1, P47, DOI 10.4155/BFS.09.1; Sun N, 2008, PROCESS BIOCHEM, V43, P1288, DOI 10.1016/j.procbio.2008.07.014; TAKEDA H, 1988, PHYTOCHEMISTRY, V27, P3823, DOI 10.1016/0031-9422(88)83025-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TANAKA K, 1990, IMMUNOPHARM IMMUNOT, V12, P277, DOI 10.3109/08923979009019673; Tirichine L, 2011, PLANT J, V66, P45, DOI 10.1111/j.1365-313X.2011.04540.x; Tredici MR, 2009, BASICS, P610, DOI 10.1533/9781845696474.3.610; Van Etten JL, 2003, ANNU REV GENET, V37, P153, DOI 10.1146/annurev.genet.37.110801.143915; Vasudevan V, 2012, ENVIRON SCI TECHNOL, V46, P2451, DOI 10.1021/es2026399; Vigeolas H, 2012, J BIOTECHNOL, V162, P3, DOI 10.1016/j.jbiotec.2012.03.017; Wakasugi T, 1997, P NATL ACAD SCI USA, V94, P5967, DOI 10.1073/pnas.94.11.5967; Wan MX, 2012, BIOTECHNOL BIOENG, V109, P1958, DOI 10.1002/bit.24477; Wan MX, 2013, J MICROBIOL METH, V92, P122, DOI 10.1016/j.mimet.2012.10.010; Wan MX, 2011, APPL MICROBIOL BIOT, V91, P835, DOI 10.1007/s00253-011-3399-8; Wan MX, 2011, BIOTECHNOL LETT, V33, P1615, DOI 10.1007/s10529-011-0596-6; Warburg O, 1920, BIOCHEM Z, V110, P66; WASE N, 2014, J PROTEOME IN PRESS; Wu QY, 1992, PROG NAT SCI, V3, P435; Xiong W, 2010, PLANT PHYSIOL, V154, P1001, DOI 10.1104/pp.110.158956; Yamada T, 2006, ADV VIRUS RES, V66, P293, DOI 10.1016/S0065-3527(06)66006-5; YONGHA P, 1997, KOREAN I SCI TECHNOL; ZELIBOR JL, 1988, APPL ENVIRON MICROB, V54, P1051, DOI 10.1128/AEM.54.4.1051-1060.1988; Zheng YB, 2012, BIORESOURCE TECHNOL, V103, P484, DOI 10.1016/j.biortech.2011.09.122; Zhu XG, 2008, CURR OPIN BIOTECH, V19, P153, DOI 10.1016/j.copbio.2008.02.004; ZIESENISZ E, 1981, PLANTA, V153, P481, DOI 10.1007/BF00394991; [No title captured]	117	94	97	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92460	10.1371/journal.pone.0092460	http://dx.doi.org/10.1371/journal.pone.0092460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699196	Green Published, gold			2022-12-27	WOS:000334105000027
J	Yatkin, E; Polari, L; Laajala, TD; Smeds, A; Eckerman, C; Holmbom, B; Saarinen, NM; Aittokallio, T; Makela, SI				Yatkin, Emrah; Polari, Lauri; Laajala, Teemu D.; Smeds, Annika; Eckerman, Christer; Holmbom, Bjarne; Saarinen, Niina M.; Aittokallio, Tero; Makela, Sari I.			Novel Lignan and Stilbenoid Mixture Shows Anticarcinogenic Efficacy in Preclinical PC-3M-luc2 Prostate Cancer Model	PLOS ONE			English	Article							CELLS IN-VITRO; RESVERATROL; APOPTOSIS; GROWTH; TRAIL; CHEMOPREVENTION; MECHANISMS; PLANT; ADENOCARCINOMA; PROLIFERATION	Prostate cancer is the most common cancer of men in the Western world, and novel approaches for prostate cancer risk reduction are needed. Plant-derived phenolic compounds attenuate prostate cancer growth in preclinical models by several mechanisms, which is in line with epidemiological findings suggesting that consumption of plant-based diets is associated with low risk of prostate cancer. The objective of this study was to assess the effects of a novel lignan-stilbenoid mixture in PC-3M-luc2 human prostate cancer cells in vitro and in orthotopic xenografts. Lignan and stilbenoid -rich extract was obtained from Scots pine (Pinus sylvestris) knots. Pine knot extract as well as stilbenoids (methyl pinosylvin and pinosylvin), and lignans (matairesinol and nortrachelogenin) present in pine knot extract showed antiproliferative and proapoptotic efficacy at >= 40 mu M concentration in vitro. Furthermore, pine knot extract derived stilbenoids enhanced tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induced apoptosis already at >= 10 mu M concentrations. In orthotopic PC-3M-luc2 xenograft bearing immunocompromized mice, three-week peroral exposure to pine knot extract (52 mg of lignans and stilbenoids per kg of body weight) was well tolerated and showed anti-tumorigenic efficacy, demonstrated by multivariate analysis combining essential markers of tumor growth (i.e. tumor volume, vascularization, and cell proliferation). Methyl pinosylvin, pinosylvin, matairesinol, nortrachelogenin, as well as resveratrol, a metabolite of pinosylvin, were detected in serum at total concentration of 7-73 mu M, confirming the bioavailability of pine knot extract derived lignans and stilbenoids. In summary, our data indicates that pine knot extract is a novel and cost-effective source of resveratrol, methyl pinosylvin and other bioactive lignans and stilbenoids. Pine knot extract shows anticarcinogenic efficacy in preclinical prostate cancer model, and our in vitro data suggests that compounds derived from the extract may have potential as novel chemosensitizers to TRAIL. These findings promote further research on health-related applications of wood biochemicals.	[Yatkin, Emrah; Polari, Lauri; Saarinen, Niina M.; Makela, Sari I.] Univ Turku, Turku, Finland; [Yatkin, Emrah; Polari, Lauri; Saarinen, Niina M.; Makela, Sari I.] Univ Turku, Inst Biomed, TCDM, Turku, Finland; [Laajala, Teemu D.; Aittokallio, Tero] Univ Turku, Dept Math & Stat, Turku, Finland; [Smeds, Annika; Eckerman, Christer; Holmbom, Bjarne] Abo Akad Univ, Proc Chem Ctr, Lab Wood & Paper Chem, Turku, Finland; [Aittokallio, Tero] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland	University of Turku; University of Turku; University of Turku; Abo Akademi University; University of Helsinki	Makela, SI (corresponding author), Univ Turku, Turku, Finland.	sarmak@utu.fi	Aittokallio, Tero/B-6583-2009	Aittokallio, Tero/0000-0002-0886-9769; Laajala, Teemu Daniel/0000-0002-7016-7354; Saarinen, Niina/0000-0003-3531-378X; Makela, Sari/0000-0002-8698-4076; Polari, Lauri/0000-0002-0052-6489; Yatkin, Emrah/0000-0002-2597-6638	FIBIC Finnish Bioeconomy Cluster; BioRefine program of Finnish Funding Agency for Technology and Innovation; Academy of Finland	FIBIC Finnish Bioeconomy Cluster; BioRefine program of Finnish Funding Agency for Technology and Innovation; Academy of Finland(Academy of Finland)	This project was supported by the FIBIC Finnish Bioeconomy Cluster, the BioRefine program of Finnish Funding Agency for Technology and Innovation, and Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlercreutz H, 2007, CRIT REV CL LAB SCI, V44, P483, DOI 10.1080/10408360701612942; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bylund A, 2005, EXP BIOL MED, V230, P217; Bylund A, 2000, PROSTATE, V42, P304, DOI 10.1002/(SICI)1097-0045(20000301)42:4<304::AID-PROS8>3.0.CO;2-Z; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Deeb DD, 2005, J EXP THER ONCOL, V5, P81; Fulda S, 2004, CANCER RES, V64, P337, DOI 10.1158/0008-5472.CAN-03-1656; Ganapathy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015627; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Harper CE, 2007, CARCINOGENESIS, V28, P1946, DOI 10.1093/carcin/bgm144; Holmbom Bjarne, 2003, Phytochemistry Reviews, V2, P331, DOI 10.1023/B:PHYT.0000045493.95074.a8; Horvath Z, 2007, ANTICANCER RES, V27, P3459; Hutz JE, 2013, J BIOMOL SCREEN, V18, P367, DOI 10.1177/1087057112469257; Karna P, 2011, CARCINOGENESIS, V32, P1872, DOI 10.1093/carcin/bgr215; Kwon GT, 2012, J NUTR BIOCHEM, V23, P228, DOI 10.1016/j.jnutbio.2010.11.019; Laajala TD, 2012, CLIN CANCER RES, V18, P4385, DOI 10.1158/1078-0432.CCR-11-3215; Landstrom M, 1998, PROSTATE, V36, P151, DOI 10.1002/(SICI)1097-0045(19980801)36:3&lt;151::AID-PROS2&gt;3.0.CO;2-K; Li GL, 2012, SCI WORLD J, DOI 10.1100/2012/874053; Lieberman R, 2001, UROLOGY, V58, P835, DOI 10.1016/S0090-4295(01)01416-9; Lin X, 2001, ANTICANCER RES, V21, P3995; Lin X, 2002, UROLOGY, V60, P919, DOI 10.1016/S0090-4295(02)01863-0; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; McCann MJ, 2008, MOL NUTR FOOD RES, V52, P567, DOI 10.1002/mnfr.200700052; Park EJ, 2013, FOOD CHEM TOXICOL, V55, P424, DOI 10.1016/j.fct.2013.01.007; Peuhu E, 2010, ONCOGENE, V29, P898, DOI 10.1038/onc.2009.386; Peuhu E, 2013, BIOCHEM PHARMACOL, V86, P571, DOI 10.1016/j.bcp.2013.05.026; Roupe K, 2005, J PHARMACEUT BIOMED, V38, P148, DOI 10.1016/j.jpba.2004.12.015; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; Scott E, 2012, MOL NUTR FOOD RES, V56, P7, DOI 10.1002/mnfr.201100400; Shankar S, 2007, MOL CELL BIOCHEM, V304, P273, DOI 10.1007/s11010-007-9510-x; Smeds AI, 2005, J CHROMATOGR B, V816, P87, DOI 10.1016/j.jchromb.2004.11.017; Smeds AI, 2004, J CHROMATOGR B, V813, P303, DOI 10.1016/j.jchromb.2004.10.033; Smeds AI, 2007, J AGR FOOD CHEM, V55, P1337, DOI 10.1021/jf0629134; Smeds AI, 2006, J PHARMACEUT BIOMED, V41, P898, DOI 10.1016/j.jpba.2005.12.036; Smeds AI, 2012, HOLZFORSCHUNG, V66, P283, DOI [10.1515/HF.2011.151, 10.1515/hf.2011.151]; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Szliszka E, 2011, INT J ONCOL, V39, P771, DOI 10.3892/ijo.2011.1116; Trottier G, 2010, NAT REV UROL, V7, P21, DOI 10.1038/nrurol.2009.234; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; Venkateswaran V, 2010, NAT REV UROL, V7, P442, DOI 10.1038/nrurol.2010.102; Wang TTY, 2008, CARCINOGENESIS, V29, P2001, DOI 10.1093/carcin/bgn131; Wang TTY, 2010, MOL NUTR FOOD RES, V54, P335, DOI 10.1002/mnfr.200900143; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Willfor S, 2003, HOLZFORSCHUNG, V57, P359, DOI 10.1515/HF.2003.054; Xu Q, 2012, NUTR RES, V32, P648, DOI 10.1016/j.nutres.2012.07.002	45	22	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93764	10.1371/journal.pone.0093764	http://dx.doi.org/10.1371/journal.pone.0093764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699425	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000103
J	Mercurio, AD; Hernandez, SM; Maerz, JC; Yabsley, MJ; Ellis, AE; Coleman, AL; Shelnutt, LM; Fischer, JR; Wilde, SB				Mercurio, Albert D.; Hernandez, Sonia M.; Maerz, John C.; Yabsley, Michael J.; Ellis, Angela E.; Coleman, Amanda L.; Shelnutt, Leslie M.; Fischer, John R.; Wilde, Susan B.			Experimental Feeding of Hydrilla verticillata Colonized by Stigonematales Cyanobacteria Induces Vacuolar Myelinopathy in Painted Turtles (Chrysemys picta)	PLOS ONE			English	Article							AMERICAN COOTS; RESERVOIRS; WATERBIRDS; MALLARDS	Vacuolar myelinopathy (VM) is a neurologic disease primarily found in birds that occurs when wildlife ingest submerged aquatic vegetation colonized by an uncharacterized toxin-producing cyanobacterium (hereafter "UCB'' for "uncharacterized cyanobacterium''). Turtles are among the closest extant relatives of birds and many species directly and/or indirectly consume aquatic vegetation. However, it is unknown whether turtles can develop VM. We conducted a feeding trial to determine whether painted turtles (Chrysemys picta) would develop VM after feeding on Hydrilla (Hydrilla verticillata), colonized by the UCB (Hydrilla is the most common "host'' of UCB). We hypothesized turtles fed Hydrilla colonized by the UCB would exhibit neurologic impairment and vacuolation of nervous tissues, whereas turtles fed Hydrilla free of the UCB would not. The ability of Hydrilla colonized by the UCB to cause VM (hereafter, "toxicity'') was verified by feeding it to domestic chickens (Gallus gallus domesticus) or necropsy of field collected American coots (Fulica americana) captured at the site of Hydrilla collections. We randomly assigned ten wild-caught turtles into toxic or non-toxic Hydrilla feeding groups and delivered the diets for up to 97 days. Between days 82 and 89, all turtles fed toxic Hydrilla displayed physical and/or neurologic impairment. Histologic examination of the brain and spinal cord revealed vacuolations in all treatment turtles. None of the control turtles exhibited neurologic impairment or had detectable brain or spinal cord vacuolations. This is the first evidence that freshwater turtles can become neurologically impaired and develop vacuolations after consuming toxic Hydrilla colonized with the UCB. The southeastern United States, where outbreaks of VM occur regularly and where vegetation colonized by the UCB is common, is also a global hotspot of freshwater turtle diversity. Our results suggest that further investigations into the effect of the putative UCB toxin on wild turtles in situ are warranted.	[Mercurio, Albert D.; Hernandez, Sonia M.; Maerz, John C.; Yabsley, Michael J.; Coleman, Amanda L.; Wilde, Susan B.] Univ Georgia, DB Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Mercurio, Albert D.; Hernandez, Sonia M.; Yabsley, Michael J.; Fischer, John R.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, SCWDS, Athens, GA USA; [Ellis, Angela E.] Univ Georgia, Coll Vet Med, Athens Vet Diagnost Lab, Athens, GA USA; [Shelnutt, Leslie M.] Univ Georgia, Coll Vet Med, Athens, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Mercurio, AD (corresponding author), Univ Georgia, DB Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	mercurad@uga.edu		Maerz, John/0000-0002-1592-5431; Wilde, Susan/0000-0002-5388-9582; Yabsley, Michael/0000-0003-2452-5015	University of Georgia Graduate School; D. B. Warnell school of Forestry and Natural Resources; National Institutes of Health (NIH R15) [1R15AI089565-01]; United States Army Corps of Engineers [W912HZ-12-2-0013]; United States Fish and Wildlife Service [F11AC00889]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI089565] Funding Source: NIH RePORTER	University of Georgia Graduate School; D. B. Warnell school of Forestry and Natural Resources; National Institutes of Health (NIH R15); United States Army Corps of Engineers(United States Department of DefenseUnited States Army); United States Fish and Wildlife Service(US Fish & Wildlife Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by The University of Georgia Graduate School, The D. B. Warnell school of Forestry and Natural Resources, The National Institutes of Health (NIH R15 # 1R15AI089565-01), The United States Army Corps of Engineers (W912HZ-12-2-0013), and The United States Fish and Wildlife Service (F11AC00889). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augspurger T, 2003, J WILDLIFE DIS, V39, P412, DOI 10.7589/0090-3558-39.2.412; Birrenkott AH, 2004, J WILDLIFE DIS, V40, P485, DOI 10.7589/0090-3558-40.3.485; Bjorndal Karen A., 1997, Chelonian Conservation and Biology, V2, P430; Buhlmann KA, 2009, CHELONIAN CONSERV BI, V8, P116, DOI 10.2744/CCB-0774.1; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Clippinger Tracy L, 2007, Vet Clin North Am Exot Anim Pract, V10, P803, DOI 10.1016/j.cvex.2007.04.006; Davis KM, 2007, BEHAV PROCESS, V75, P225, DOI 10.1016/j.beproc.2007.02.021; Ernst CH, 2009, TURTLES US CANADA; Fields JR, 2003, J HERPETOL, V37, P726, DOI 10.1670/193-02N; Fischer JR, 2006, J WILDLIFE DIS, V42, P501, DOI 10.7589/0090-3558-42.3.501; Fischer JR, 2003, J WILDLIFE DIS, V39, P400, DOI 10.7589/0090-3558-39.2.400; Haynie RS, 2013, J AQUAT ANIM HEALTH, V25, P252, DOI 10.1080/08997659.2013.833556; Johnson JH, 2004, SEMIN AVIAN EXOT PET, V13, P223, DOI 10.1053/j.saep.2004.04.008; Kozlowsky-Suzuki B, 2012, HARMFUL ALGAE, V18, P47, DOI 10.1016/j.hal.2012.04.002; Larsen RS, 2002, J AM VET MED ASSOC, V221, P80, DOI 10.2460/javma.2002.221.80; Lewis-Weis LA, 2004, J WILDLIFE DIS, V40, P476, DOI 10.7589/0090-3558-40.3.476; Lightfoot TL, 2006, CLIN AVIAN MED; Mader D.R, 2006, REPTILE MED SURG; Mariani Christopher L, 2007, Vet Clin North Am Exot Anim Pract, V10, P855, DOI 10.1016/j.cvex.2007.04.004; Quinn GP, 2003, EXPT DESIGN DATA ANA; Robertson SM, 2012, THESIS U GEORGIA; Rocke TE, 2005, J WILDLIFE DIS, V41, P163, DOI 10.7589/0090-3558-41.1.163; Rocke TE, 2002, J WILDLIFE DIS, V38, P678, DOI 10.7589/0090-3558-38.4.678; Thomas NJ, 1998, VET PATHOL, V35, P479, DOI 10.1177/030098589803500602; Wilde SB, 2005, ENVIRON TOXICOL, V20, P348, DOI 10.1002/tox.20111; Wiley FE, 2009, ENVIRON TOXICOL, V24, P362, DOI 10.1002/tox.20424; Williams BJ, 2009, J FRESHWATER ECOL, V24, P309, DOI 10.1080/02705060.2009.9664297; Williams SK, 2007, HARMFUL ALGAE, V6, P343, DOI 10.1016/j.hal.2006.07.005	28	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93295	10.1371/journal.pone.0093295	http://dx.doi.org/10.1371/journal.pone.0093295			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695109	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000056
J	Mollot, G; Duyck, PF; Lefeuvre, P; Lescourret, F; Martin, JF; Piry, S; Canard, E; Tixier, P				Mollot, Gregory; Duyck, Pierre-Francois; Lefeuvre, Pierre; Lescourret, Francoise; Martin, Jean-Francois; Piry, Sylvain; Canard, Elsa; Tixier, Philippe			Cover Cropping Alters the Diet of Arthropods in a Banana Plantation: A Metabarcoding Approach	PLOS ONE			English	Article							FOOD-WEB STRUCTURE; STABLE-ISOTOPES; SPECIES ABUNDANCE; TROPHIC POSITION; NATURAL ENEMIES; BODY-SIZE; DNA; PREDATORS; PREY; BIODIVERSITY	Plant diversification using cover crops may promote natural regulation of agricultural pests by supporting alternative prey that enable the increase of arthropod predator densities. However, the changes in the specific composition of predator diet induced by cover cropping are poorly understood. Here, we hypothesized that the cover crop can significantly alter the diet of predators in agroecosystems. The cover crop Brachiaria decumbens is increasingly used in banana plantations to control weeds and improve physical soil properties. In this paper, we used a DNA metabarcoding approach for the molecular analysis of the gut contents of predators (based on mini-COI) to identify 1) the DNA sequences of their prey, 2) the predators of Cosmopolites sordidus (a major pest of banana crops), and 3) the difference in the specific composition of predator diets between a bare soil plot (BSP) and a cover cropped plot (CCP) in a banana plantation. The earwig Euborellia caraibea, the carpenter ant Camponotus sexguttatus, and the fire ant Solenopsis geminata were found to contain C. sordidus DNA at frequencies ranging from 1 to 7%. While the frequencies of predators positive for C. sordidus DNA did not significantly differ between BSP and CCP, the frequency at which E. caraibea was positive for Diptera was 26% in BSP and 80% in CCP; the frequency at which C. sexguttatus was positive for Jalysus spinosus was 14% in BSP and 0% in CCP; and the frequency at which S. geminata was positive for Polytus mellerborgi was 21% in BSP and 3% in CCP. E. caraibea, C. sexguttatus and S. geminata were identified as possible biological agents for the regulation of C. sordidus. The detection of the diet changes of these predators when a cover crop is planted indicates the possible negative effects on pest regulation if predators switch to forage on alternative prey.	[Mollot, Gregory; Duyck, Pierre-Francois; Canard, Elsa; Tixier, Philippe] PRAM, CIRAD, UR Syst Culture Base Bananiers Plantains & Ananas, Le Lamentin, Martinique, France; [Mollot, Gregory; Lescourret, Francoise] INRA, UR Plantes & Syst Culture Hort 1115, Avignon, France; [Duyck, Pierre-Francois; Lefeuvre, Pierre] Univ Reunion, CIRAD, UMR PVBMT, St Pierre, Reunion, France; [Martin, Jean-Francois] Montpellier SupAgro, UMR CBGP, Montferrier Sur Lez, France; [Piry, Sylvain] INRA, CBGP, UMR1062, Montferrier Sur Lez, France; [Canard, Elsa] MIVEGEC, CNRS, IRD, UMR 2724, Montpellier, France; [Tixier, Philippe] CIRAD, CATIE, Dept Agr & Agroforesteria, Turrialba, Costa Rica	CIRAD; INRAE; CIRAD; University of La Reunion; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); INRAE; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CATIE - Centro Agronomico Tropical de Investigacion y Ensenanza; CIRAD	Duyck, PF (corresponding author), PRAM, CIRAD, UR Syst Culture Base Bananiers Plantains & Ananas, Le Lamentin, Martinique, France.	duyck@cirad.fr	Tixier, Philippe/C-2119-2008; Martin, Jean-Francois/M-9426-2017; Piry, Sylvain/Q-6206-2019; Martin, Jean-Francois/AAD-3883-2019; Duyck, Pierre-François/C-2416-2008	Tixier, Philippe/0000-0001-5147-9777; Martin, Jean-Francois/0000-0001-9176-4476; Piry, Sylvain/0000-0002-7717-7555; Martin, Jean-Francois/0000-0001-9176-4476; Duyck, Pierre-François/0000-0001-5484-1970; Lefeuvre, Pierre/0000-0003-2645-8098; Lescourret, Francoise/0000-0002-6576-8067	CIRAD; E.U. FEFER [30411]	CIRAD; E.U. FEFER	This research is a part of a PhD funded by the CIRAD and funded by the project "sustainable cropping systems design'' from E.U. FEFER (grant PRESAGE no 30411). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abera-Kalibata AM, 2008, BIOL CONTROL, V46, P147, DOI 10.1016/j.biocontrol.2008.04.017; Abera-Kalibata AM, 2006, BIOL CONTROL, V37, P16, DOI 10.1016/j.biocontrol.2005.11.009; Barberi P, 2010, WEED RES, V50, P388, DOI 10.1111/j.1365-3180.2010.00798.x; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; Blanchard JL, 2009, J ANIM ECOL, V78, P270, DOI 10.1111/j.1365-2656.2008.01466.x; BUGG RL, 1994, AGR ECOSYST ENVIRON, V50, P11, DOI 10.1016/0167-8809(94)90121-X; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; Carreon-Martinez L, 2010, MOL ECOL, V19, P25, DOI 10.1111/j.1365-294X.2009.04412.x; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Dornhaus A, 2008, BEHAV ECOL SOCIOBIOL, V63, P43, DOI 10.1007/s00265-008-0634-0; Duyck PF, 2011, BASIC APPL ECOL, V12, P47, DOI 10.1016/j.baae.2010.11.009; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; Gold Clifford S., 2002, Integrated Pest Management Reviews, V6, P79, DOI 10.1023/A:1023330900707; Harper GL, 2005, MOL ECOL, V14, P819, DOI [10.1111/j.1365-294X.2005.02442.x, 10.1111/j.1365-294x.2005.02442.x]; Harris DJ, 2003, TRENDS ECOL EVOL, V18, P317, DOI 10.1016/S0169-5347(03)00150-2; Harwood JD, 2007, BIOL CONTROL, V41, P397, DOI 10.1016/j.biocontrol.2007.02.008; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Jennings S, 2003, ECOL LETT, V6, P971, DOI 10.1046/j.1461-0248.2003.00529.x; Jonsson T, 2005, ADV ECOL RES, V36, P1, DOI 10.1016/S0065-2504(05)36001-6; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; KOPPENHOFER AM, 1993, J APPL ENTOMOL, V116, P352, DOI 10.1111/j.1439-0418.1993.tb01207.x; Leray M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058076; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; Meglecz E, 2011, BIOINFORMATICS, V27, P277, DOI 10.1093/bioinformatics/btq641; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Mollot G, 2012, AGR FOREST ENTOMOLOG; NICKERSON JC, 1977, FLA ENTOMOL, V60, P193, DOI 10.2307/3493905; Perfecto Ivette, 1998, P269, DOI 10.1016/B978-012078147-8/50061-X; PETERSON BJ, 1985, SCIENCE, V227, P1361, DOI 10.1126/science.227.4692.1361; Piry S, 2012, MOL ECOL RESOUR, V12, P1151, DOI 10.1111/j.1755-0998.2012.03171.x; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Ponsard S, 2000, ECOLOGY, V81, P852, DOI 10.1890/0012-9658(2000)081[0852:WCSINA]2.0.CO;2; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Core Team, 2021, R LANGUAGE ENV STAT; RISCH S, 1981, J ECON ENTOMOL, V74, P88, DOI 10.1093/jee/74.1.88; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Simon S, 2010, AGRON SUSTAIN DEV, V30, P139, DOI 10.1051/agro/2009013; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; TOPHAM M, 1975, P HAWAII ENTOMOL SOC, V22, P145; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Van Veen FJF, 2008, J ANIM ECOL, V77, P191, DOI 10.1111/j.1365-2656.2007.01325.x; VANDENBERG H, 1995, INT J PEST MANAGE, V41, P134, DOI 10.1080/09670879509371938; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Wise DH, 2006, ECOL APPL, V16, P865, DOI 10.1890/1051-0761(2006)016[0865:USITRS]2.0.CO;2; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x	50	53	57	1	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93740	10.1371/journal.pone.0093740	http://dx.doi.org/10.1371/journal.pone.0093740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695585	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000116
J	Marriott, AC; Dove, BK; Whittaker, CJ; Bruce, C; Ryan, KA; Bean, TJ; Rayner, E; Pearson, G; Taylor, I; Dowall, S; Plank, J; Newman, E; Barclay, WS; Dimmock, NJ; Easton, AJ; Hallis, B; Silman, NJ; Carroll, MW				Marriott, Anthony C.; Dove, Brian K.; Whittaker, Catherine J.; Bruce, Christine; Ryan, Kathryn A.; Bean, Thomas J.; Rayner, Emma; Pearson, Geoff; Taylor, Irene; Dowall, Stuart; Plank, Jenna; Newman, Edmund; Barclay, Wendy S.; Dimmock, Nigel J.; Easton, Andrew J.; Hallis, Bassam; Silman, Nigel J.; Carroll, Miles W.			Low Dose Influenza Virus Challenge in the Ferret Leads to Increased Virus Shedding and Greater Sensitivity to Oseltamivir	PLOS ONE			English	Article							A H1N1 VIRUS; APRIL 2009; MORTALITY; INFECTION; MODEL; TRANSMISSION; INHIBITOR; PROTECTS; PATHOGENESIS; EFFICACY	Ferrets are widely used to study human influenza virus infection. Their airway physiology and cell receptor distribution makes them ideal for the analysis of pathogenesis and virus transmission, and for testing the efficacy of anti-influenza interventions and vaccines. The 2009 pandemic influenza virus (H1N1pdm09) induces mild to moderate respiratory disease in infected ferrets, following inoculation with 10(6) plaque-forming units (pfu) of virus. We have demonstrated that reducing the challenge dose to 10(2) pfu delays the onset of clinical signs by 1 day, and results in a modest reduction in clinical signs, and a less rapid nasal cavity innate immune response. There was also a delay in virus production in the upper respiratory tract, this was up to 9-fold greater and virus shedding was prolonged. Progression of infection to the lower respiratory tract was not noticeably delayed by the reduction in virus challenge. A dose of 10(4) pfu gave an infection that was intermediate between those of the 10(6) pfu and 10(2) pfu doses. To address the hypothesis that using a more authentic low challenge dose would facilitate a more sensitive model for antiviral efficacy, we used the well-known neuraminidase inhibitor, oseltamivir. Oseltamivir-treated and untreated ferrets were challenged with high (10(6) pfu) and low (10(2) pfu) doses of influenza H1N1pdm09 virus. The low dose treated ferrets showed significant delays in innate immune response and virus shedding, delayed onset of pathological changes in the nasal cavity, and reduced pathological changes and viral RNA load in the lung, relative to untreated ferrets. Importantly, these observations were not seen in treated animals when the high dose challenge was used. In summary, low dose challenge gives a disease that more closely parallels the disease parameters of human influenza infection, and provides an improved pre-clinical model for the assessment of influenza therapeutics, and potentially, influenza vaccines.	[Marriott, Anthony C.; Dove, Brian K.; Whittaker, Catherine J.; Bruce, Christine; Ryan, Kathryn A.; Bean, Thomas J.; Rayner, Emma; Pearson, Geoff; Taylor, Irene; Dowall, Stuart; Plank, Jenna; Newman, Edmund; Hallis, Bassam; Silman, Nigel J.; Carroll, Miles W.] Publ Hlth England, Salisbury, Wilts, England; [Barclay, Wendy S.] Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, London, England; [Dimmock, Nigel J.; Easton, Andrew J.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	Public Health England; Imperial College London; University of Warwick	Marriott, AC (corresponding author), Publ Hlth England, Salisbury, Wilts, England.	Anthony.marriott@phe.gov.uk		Marriott, Anthony/0000-0002-8862-9852; Barclay, Wendy/0000-0002-3948-0895; Ryan, Kathryn Ann/0000-0001-8608-1144	National Institute for Health Research, Centre for Health Protection Research [104663]; MRC [G0600504] Funding Source: UKRI; Medical Research Council [G0600504] Funding Source: researchfish	National Institute for Health Research, Centre for Health Protection Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by National Institute for Health Research, Centre for Health Protection Research, project number 104663. http://www.nihr.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800, DOI 10.3181/00379727-122-31255; Bodewes R, 2010, EXPERT REV VACCINES, V9, P59, DOI [10.1586/erv.09.148, 10.1586/ERV.09.148]; Boltz DA, 2008, J INFECT DIS, V197, P1315, DOI 10.1086/586711; CHEN KS, 1995, INT J EXP PATHOL, V76, P55; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dimmock NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049394; Dimmock NJ, 2012, ANTIVIR RES, V96, P376, DOI 10.1016/j.antiviral.2012.09.017; Dimmock NJ, 2006, J GEN VIROL, V87, P1259, DOI 10.1099/vir.0.81678-0; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Govorkova EA, 2011, ANTIVIR RES, V91, P81, DOI 10.1016/j.antiviral.2011.05.008; Gustin KM, 2011, P NATL ACAD SCI USA, V108, P8432, DOI 10.1073/pnas.1100768108; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Killingley B, 2011, LANCET INFECT DIS, V11, P879, DOI 10.1016/S1473-3099(11)70142-6; Kirkeby S, 2009, VIRUS RES, V144, P225, DOI 10.1016/j.virusres.2009.05.004; Lednicky JA, 2010, COMPARATIVE MED, V60, P364; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Matsuoka Yumiko, 2009, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g03s13, 10.1002/9780471729259.mc15g02s13]; Mendel DB, 1998, ANTIMICROB AGENTS CH, V42, P640, DOI 10.1128/AAC.42.3.640; Mishin VR, 2005, VACCINE, V23, P2922, DOI 10.1016/j.vaccine.2004.11.058; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Pebody RG, 2010, EUROSURVEILLANCE, V15; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; RYAN DM, 1995, ANTIMICROB AGENTS CH, V39, P2583, DOI 10.1128/AAC.39.11.2583; Slomka MJ, 2010, INFLUENZA OTHER RESP, V4, P277, DOI 10.1111/j.1750-2659.2010.00149.x; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Smith JEH, 2011, NEW SYNTH HIST LIB, V67, P1, DOI 10.1007/978-94-007-0041-3_1; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Suguitan AL, 2014, INFLUENZA OTHER RESP, V8, P169, DOI 10.1111/irv.12220; Sweet C, 2002, ANTIMICROB AGENTS CH, V46, P996, DOI 10.1128/AAC.46.4.996-1004.2002; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018	34	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94090	10.1371/journal.pone.0094090	http://dx.doi.org/10.1371/journal.pone.0094090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709834	gold, Green Submitted, Green Published			2022-12-27	WOS:000334159800100
J	Reece, JC; Martyushev, A; Petravic, J; Grimm, A; Gooneratne, S; Amaresena, T; De Rose, R; Loh, L; Davenport, MP; Kent, SJ				Reece, Jeanette C.; Martyushev, Alexey; Petravic, Janka; Grimm, Andrew; Gooneratne, Shayarana; Amaresena, Thakshila; De Rose, Robert; Loh, Liyen; Davenport, Miles P.; Kent, Stephen J.			Measuring Turnover of SIV DNA in Resting CD4+T Cells Using Pyrosequencing: Implications for the Timing of HIV Eradication Therapies	PLOS ONE			English	Article							CD4(+) T-CELLS; IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; HISTONE DEACETYLASE INHIBITORS; LATENT RESERVOIR; VALPROIC ACID; LIFELONG PERSISTENCE; INTRINSIC STABILITY; ANTIVIRAL THERAPY; LYMPHOCYTE ESCAPE	Resting CD4+ T cells are a reservoir of latent HIV-1. Understanding the turnover of HIV DNA in these cells has implications for the development of eradication strategies. Most studies of viral latency focus on viral persistence under antiretroviral therapy (ART). We studied the turnover of SIV DNA resting CD4+ T cells during active infection in a cohort of 20 SIV-infected pigtail macaques. We compared SIV sequences at two Mane-A1*084:01-restricted CTL epitopes using serial plasma RNA and resting CD4+ T cell DNA samples by pyrosequencing, and used a mathematical modeling approach to estimate SIV DNA turnover. We found SIV DNA turnover in resting CD4+ T cells was slow in animals with low chronic viral loads, consistent with the long persistence of latency seen under ART. However, in animals with high levels of chronic viral replication, turnover was high. SIV DNA half-life within resting CD4 cells correleated with viral load (p=0.0052) at the Gag KP9 CTL epitope. At a second CTL epitope in Tat (KVA10) there was a trend towards an association of SIV DNA half-life in resting CD4 cells and viral load (p=0.0971). Further, we found that the turnover of resting CD4+ T cell SIV DNA was higher for escape during early infection than for escape later in infection (p=0.0084). Our results suggest viral DNA within resting CD4 T cells is more labile and may be more susceptible to reactivation/eradication treatments when there are higher levels of virus replication and during early/acute infection.	[Reece, Jeanette C.; Gooneratne, Shayarana; Amaresena, Thakshila; De Rose, Robert; Loh, Liyen; Kent, Stephen J.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Martyushev, Alexey; Petravic, Janka; Grimm, Andrew; Davenport, Miles P.] Univ New S Wales, Ctr Vasc Res, Kensington, NSW 2033, Australia	University of Melbourne; University of New South Wales Sydney	Kent, SJ (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia.	skent@unimelb.edu.au	Petravic, Janka/AAD-9192-2020; Kent, Stephen/AAL-5101-2020	Petravic, Janka/0000-0002-2263-2776; Kent, Stephen/0000-0002-8539-4891; Loh, Liyen/0000-0002-1676-0579; Reece, Jeanette/0000-0003-2897-0271; De Rose, Robert/0000-0003-4316-3910; Gooneratne, Shayarana/0000-0001-6839-4729; Davenport, Miles/0000-0002-4751-1831	Australian National Health and Medical Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007762] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2013, CROI C RETR OPP INF; Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2012, P NATL ACAD SCI USA, V109, P9523, DOI 10.1073/pnas.1120248109; Archin NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009390; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Blankenberg D, 2011, BIOINFORMATICS, V27, P2426, DOI 10.1093/bioinformatics/btr398; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Blankson JN, 2000, J INFECT DIS, V182, P1636, DOI 10.1086/317615; Blazkova J, 2012, J INFECT DIS, V206, P765, DOI 10.1093/infdis/jis412; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; De Rose R, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000055; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; Kent SJ, 2013, LANCET INFECT DIS; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koelsch KK, 2011, AIDS, V25, P2069, DOI 10.1097/QAD.0b013e32834b9658; Kumar R, 2002, J VIROL METHODS, V105, P233, DOI 10.1016/S0166-0934(02)00105-2; Lewden C, 2012, INT J EPIDEMIOL, V41, P433, DOI 10.1093/ije/dyr164; Loh L, 2008, AIDS RES HUM RETROV, V24, P1067, DOI 10.1089/aid.2007.0309; Mason RD, 2009, VIROLOGY, V388, P315, DOI 10.1016/j.virol.2009.03.020; Matalon S, 2011, MOL MED, V17, P466, DOI 10.2119/molmed.2011.00076; Mexas AM, 2012, AIDS, V26, P2295, DOI 10.1097/QAD.0b013e32835a5c2f; Monie D, 2005, J VIROL, V79, P5185, DOI 10.1128/JVI.79.8.5185-5202.2005; O'Connor SL, 2012, J VIROL, V86, P605, DOI 10.1128/JVI.05511-11; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; Pierson TC, 2002, J VIROL, V76, P4138, DOI 10.1128/JVI.76.8.4138-4144.2002; Reece J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002615; Reece JC, 2013, J VIROL, V87, P4146, DOI 10.1128/JVI.02645-12; Routy JP, 2012, HIV MED, V13, P291, DOI 10.1111/j.1468-1293.2011.00975.x; Ruff CT, 2002, J VIROL, V76, P9481, DOI 10.1128/JVI.76.18.9481-9492.2002; Sankatsing SUC, 2003, ANTIVIR THER, V8, P137; Sexton A, 2009, J VIROL, V83, P7619, DOI 10.1128/JVI.00470-09; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Smith MZ, 2005, J VIROL, V79, P684, DOI 10.1128/JVI.79.2.684-695.2005; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Tran TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003305; Wind-Rotolo M, 2009, J INFECT DIS, V199, P1301, DOI 10.1086/597759; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xing SF, 2012, J ANTIMICROB CHEMOTH, V67, P398, DOI 10.1093/jac/dkr496; Xing SF, 2011, J VIROL, V85, P6060, DOI 10.1128/JVI.02033-10; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005	55	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93330	10.1371/journal.pone.0093330	http://dx.doi.org/10.1371/journal.pone.0093330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710023	gold, Green Published			2022-12-27	WOS:000334159800028
J	Desarzens, S; Liao, WH; Mammi, C; Caprio, M; Faresse, N				Desarzens, Sebastien; Liao, Wan-Hui; Mammi, Caterina; Caprio, Massimiliano; Faresse, Nourdine			Hsp90 Blockers Inhibit Adipocyte Differentiation and Fat Mass Accumulation	PLOS ONE			English	Article							PHASE-II TRIAL; GLUCOCORTICOID-RECEPTOR FUNCTION; SHOCK-PROTEIN 90; MINERALOCORTICOID RECEPTOR; TISSUE DISTRIBUTION; CARBOXYL-TERMINUS; ANDROGEN RECEPTOR; OBESITY; MICE; 17-(ALLYLAMINO)-17-DEMETHOXYGELDANAMYCIN	Geldanamycin derivatives are benzoquinone ansamycin antibiotics that bind to Hsp90 and alter its function. The alteration of Hsp90 activity limits some cellular hormonal responses by inhibiting nuclear receptors activation. The nuclear receptors activity, such as PPAR gamma, the mineralocorticoid and glucocorticoid receptors (MR and GR) play a critical role in the conversion of preadipocytes to mature adipocytes. Given the importance of these nuclear receptors for adipogenesis, we investigated the effects of geldanamycin analogues (GA) on adipocyte differentiation and function. We found that early exposure of preadipocyte cells to GA inhibited their conversion into mature adipocytes by inhibiting the adipogenic transcriptional program and lipid droplets accumulation. Furthermore, GA altered the adipokines secretion profile of mature adipocyte. The anti-adipogenic effect of GA was also confirmed in mice fed a high fat diet. Biochemical analysis revealed that anti-adipogenic effects of geldanamycin analogues may result from the simultaneous inhibition of MR, GR and PPAR gamma activity. Taken together, our observations lead us to propose Hsp90 as a potent target for drug development in the control of obesity and its related metabolic complications.	[Desarzens, Sebastien; Liao, Wan-Hui; Faresse, Nourdine] Univ Zurich, Zurich, Switzerland; [Mammi, Caterina; Caprio, Massimiliano] IRCCS San Raffaele, Rome, Italy	University of Zurich; IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Faresse, N (corresponding author), Univ Zurich, Zurich, Switzerland.	nourdine.faresse@uzh.ch	Mammi, Caterina/O-1047-2013; Caprio, Massimiliano/J-3020-2012	Caprio, Massimiliano/0000-0003-0722-7163; mammi, caterina/0000-0002-2687-4422	Swiss National Science Foundation [PZ00P3_142594]; National Centre of Competence in Research (NCCR) Kidney	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centre of Competence in Research (NCCR) Kidney	The study was supported by funding form the Swiss National Science Foundation (Ambizone grant PZ00P3_142594) and the National Centre of Competence in Research (NCCR) Kidney. CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamberger CM, 1997, MOL CELL ENDOCRINOL, V131, P233, DOI 10.1016/S0303-7207(97)00115-9; Briones AM, 2012, HYPERTENSION, V59, P1069, DOI 10.1161/HYPERTENSIONAHA.111.190223; Caprio M, 2007, FASEB J, V21, P2185, DOI 10.1096/fj.06-7970com; Caprio M, 2011, ENDOCRINOLOGY, V152, P113, DOI 10.1210/en.2010-0674; Egorin MJ, 2002, CANCER CHEMOTH PHARM, V49, P7, DOI 10.1007/s00280-001-0380-8; Egorin MJ, 2001, CANCER CHEMOTH PHARM, V47, P291, DOI 10.1007/s002800000242; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Faresse N, 2012, FASEB J, V26, P4373, DOI 10.1096/fj.12-209924; Faresse N, 2010, AM J PHYSIOL-RENAL, V299, pF1462, DOI 10.1152/ajprenal.00285.2010; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Goetz MP, 2005, J CLIN ONCOL, V23, P1078, DOI 10.1200/JCO.2005.09.119; GREEN H, 1979, J CELL PHYSIOL, V101, P169, DOI 10.1002/jcp.1041010119; Grem JL, 2005, J CLIN ONCOL, V23, P1885, DOI 10.1200/JCO.2005.12.085; Guo C, 2008, CIRCULATION, V117, P2253, DOI 10.1161/CIRCULATIONAHA.107.748640; He YH, 2013, BIOCHEM BIOPH RES CO, V436, P169, DOI 10.1016/j.bbrc.2013.05.068; Heath EI, 2008, CLIN CANCER RES, V14, P7940, DOI 10.1158/1078-0432.CCR-08-0221; Hirata A, 2009, CARDIOVASC RES, V84, P164, DOI 10.1093/cvr/cvp191; Hoppmann J, 2010, J ENDOCRINOL, V204, P153, DOI 10.1677/JOE-09-0292; Leal VD, 2013, CLIN CHIM ACTA, V419, P87, DOI 10.1016/j.cca.2013.02.003; Lee MJ, 2013, BIOCH BIOPHYS ACTA; Marzolla V, 2011, MOL CELLULAR ENDOCRI; McInnes KJ, 2012, DIABETES, V61, P1072, DOI 10.2337/db11-1136; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Morales JL, 2007, BIOCHEMISTRY-US, V46, P610, DOI 10.1021/bi062165b; Nguyen MT, 2013, CELL DEATH DIFFER, V20, P1654, DOI 10.1038/cdd.2013.129; Prins JB, 1997, CLIN SCI, V92, P3, DOI 10.1042/cs0920003; Ronnen EA, 2006, INVEST NEW DRUG, V24, P543, DOI 10.1007/s10637-006-9208-z; Sahin-Efe A, 2012, METABOLISM, V61, P1659, DOI 10.1016/j.metabol.2012.09.001; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Shemin D, 2011, CRIT CARE CLIN, V27, P379, DOI 10.1016/j.ccc.2010.12.003; Singh R, 2006, ENDOCRINOLOGY, V147, P141, DOI 10.1210/en.2004-1649; Solit DB, 2008, CLIN CANCER RES, V14, P8302, DOI 10.1158/1078-0432.CCR-08-1002; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; Zennaro MC, 2009, TRENDS ENDOCRIN MET, V20, P444, DOI 10.1016/j.tem.2009.05.006; Zhang HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032746	38	27	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94127	10.1371/journal.pone.0094127	http://dx.doi.org/10.1371/journal.pone.0094127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705830	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000334107500126
J	Nkum, BC; Micah, FB; Ankrah, TC; Nyan, O				Nkum, Bernard Cudjoe; Micah, Frank Botsi; Ankrah, Theophilus C.; Nyan, Ousman			Left Ventricular Hypertrophy and Insulin Resistance in Adults from an Urban Community in the Gambia: Cross-Sectional Study	PLOS ONE			English	Article							GROWTH-FACTOR-I; HYPERTENSIVE PATIENTS; METABOLIC SYNDROME; CARDIAC STRUCTURE; MASS INDEX; SENSITIVITY; ASSOCIATION; RAT; HYPERINSULINEMIA; TRIGLYCERIDE	Objective: To determine the association between left ventricular hypertrophy and insulin resistance in Gambians. Design: Cross-sectional study. Setting: Outpatient clinics of Royal Victoria Teaching Hospital and Medical Research Council Laboratories in Banjul. Participants: Three hundred and sixteen consecutive patients were enrolled from outpatient clinics. The data of 275 participants (89 males) were included in the analysis with a mean (+/- standard deviation) age of 53.7 (+/- 11.9) years. Interventions: A questionnaire was filled and anthropometric measurements were taken. 2-D guided M-mode echocardiography, standard 12-1ead electrocardiogram, fasting insulin and the oral glucose tolerance test were performed. Main Outcome Measures: The Penn formula was used to determine the left ventricular mass index, 125 g/m(2) in males and 110 g/m2 in females as the cut-off for left ventricular hypertrophy. Using the fasting insulin and fasting glucose levels, the insulin resistance was estimated by the homeostatic model assessment formula. Logistic regression analysis was used to determine the association between left ventricular hypertrophy and insulin resistance. Results: The mean Penn left ventricular mass index was 119.5 (+/- 54.3) and the prevalence of Penn left ventricular mass index left ventricular hypertrophy was 41%. The mean fasting glucose was 5.6 (+/- 2.5) mmol/l, fasting insulin was 6.39 (+/- 5.49) mu U/ml and insulin resistance was 1.58 (+/- 1.45). There was no association between Penn left ventricular mass index left ventricular hypertrophy and log of insulin resistance in univariate (OR = 0.98, 95% CI = 0.80 - 1.19, p = 0.819) and multivariate logistic regression (OR = 0.93, 95% CI = 0.76-1.15, p = 0.516) analysis. Conclusion: No association was found in this study between left ventricular hypertrophy and insulin resistance in Gambians and this does not support the suggestion that insulin is an independent determinant of left ventricular hypertrophy in hypertensives.	[Nkum, Bernard Cudjoe; Micah, Frank Botsi; Ankrah, Theophilus C.] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Med, Kumasi, Ghana; [Nyan, Ousman] Royal Victoria Teaching Hosp, Dept Med, Banjul, Gambia	Kwame Nkrumah University Science & Technology	Nkum, BC (corresponding author), Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Med, Kumasi, Ghana.	bcnkum@yahoo.co.uk			Medical Research Council (MRC), UK	Medical Research Council (MRC), UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Medical Research Council (MRC), UK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agabiti-Rosei E, 2006, J AM SOC NEPHROL, V17, pS104, DOI 10.1681/ASN.2005121336; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; ATTAH EB, 1977, AM HEART J, V94, P189, DOI 10.1016/S0002-8703(77)80279-2; Barud Wojciech, 2004, Ann Univ Mariae Curie Sklodowska Med, V59, P232; COSTA CHRM, 1995, HYPERTENSION, V26, P1085, DOI 10.1161/01.HYP.26.6.1085; DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450; Ebinc H, 2006, ACTA CARDIOL, V61, P398, DOI 10.2143/AC.61.4.2017299; *EXP COMM ART HYP, 1962, WHO TECHN REP SER, V231, P28; FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180; Galvan AQ, 2000, CIRCULATION, V102, P2233; Grundy SM, 1998, AM J CARDIOL, V81, p18B, DOI 10.1016/S0002-9149(98)00033-2; HAMMOND IW, 1986, J AM COLL CARDIOL, V7, P639, DOI 10.1016/S0735-1097(86)80476-4; Homcy CJ, 1998, CIRCULATION, V97, P1890, DOI 10.1161/01.CIR.97.19.1890; Hsueh WA, 1999, AM J CARDIOL, V84, p21J; Ilercil A, 2002, DIABETES, V51, P1543, DOI 10.2337/diabetes.51.5.1543; ITO H, 1993, CIRCULATION, V87, P1715, DOI 10.1161/01.CIR.87.5.1715; Kahan T, 1998, J HYPERTENS, V16, pS23; LIND L, 1995, J HYPERTENS, V13, P433; Malmqvist K, 2001, J HYPERTENS, V19, P311, DOI 10.1097/00004872-200102000-00019; MAYET J, 1994, BMJ-BRIT MED J, V308, P1011, DOI 10.1136/bmj.308.6935.1011; Nickenig G, 1998, CIRCULATION, V98, P2453, DOI 10.1161/01.CIR.98.22.2453; NKUM BC, 2009, J SCI TECHNOL, V29, P130; Okada K, 2004, HYPERTENS RES, V27, P293, DOI 10.1291/hypres.27.293; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; Rheeder P, 1999, AM J CARDIOL, V84, P233, DOI 10.1016/S0002-9149(99)00243-X; ROCCHINI AP, 1989, HYPERTENSION, V14, P367, DOI 10.1161/01.HYP.14.4.367; Ruilope LM, 2008, AM J HYPERTENS, V21, P500, DOI 10.1038/ajh.2008.16; Rutter MK, 2003, CIRCULATION, V107, P448, DOI 10.1161/01.CIR.0000045671.62860.98; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; SASSON Z, 1993, CIRCULATION, V88, P1431, DOI 10.1161/01.CIR.88.4.1431; Scherrer U, 1997, CIRCULATION, V96, P4104; SHARP SD, 1992, CARDIOLOGY, V81, P207, DOI 10.1159/000175806; Sherif K, 2000, AM J MED SCI, V320, P13, DOI 10.1097/00000441-200007000-00003; Top C, 2007, J INT MED RES, V35, P909, DOI 10.1177/147323000703500621; Urbina EM, 1999, AM HEART J, V138, P122, DOI 10.1016/S0002-8703(99)70256-5; Verdecchia P, 1999, CIRCULATION, V100, P1802, DOI 10.1161/01.CIR.100.17.1802; Whaley-Connell A, 2007, AM J PHYSIOL-ENDOC M, V293, pE355, DOI 10.1152/ajpendo.00632.2006	37	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93606	10.1371/journal.pone.0093606	http://dx.doi.org/10.1371/journal.pone.0093606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705608	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500048
J	Xu, CL; Zhang, ZS; Wang, HF; Song, QX; Wei, RC; Yu, YW; Li, J; Sun, YH				Xu, Chuanliang; Zhang, Zhensheng; Wang, Haifeng; Song, Qixiang; Wei, Rongchao; Yu, Yongwei; Li, Jian; Sun, Yinghao			A New Tool for Distinguishing Muscle Invasive and Non-Muscle Invasive Bladder Cancer: The Initial Application of Flexible Ultrasound Bronchoscope in Bladder Tumor Staging	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; ENDOLUMINAL ULTRASONOGRAPHY; TRANSURETHRAL RESECTION; RECURRENCE; TUR	Objectives: To validate the flexible ultrasound bronchoscope (FUB) as a tool in distinguishing muscle invasive and nonmuscle invasive bladder tumors. Materials and Methods: From June 2010 to April 2012, 62 patients (11 female and 51 male) with 92 bladder urothelial carcinoma were treated in our study. The mean (+/- SD) patient age was 64.0 +/- 12.5 years old (ranged from 22 to 87). Clinical T stage was assessed by FUB at first in operating room, then immediately initial diagnostic transurethral resection (TUR) was performed. A second TUR would be done 2-4 weeks after initial TUR when the latter was incomplete (in large and multiple tumours, no muscle in the specimen) or when an exophytic high-grade and/or T1 tumour was detected. And radical cystectomy would be performed for the patients who were diagnosed with muscle-invasive tumors. FUB staging and initial TUR staging, final pathological results were compared. Results: In ultrasonic images, the normal muscle layer of bladder wall could be clearly distinguished into three layers, which were hyperechogenic mucosa, hypoechogenic muscle and hyperechogenic serosal. For non-muscle invasive tumors, the muscle layers were continuous. And distorted or discontinuous muscle layers could be seen in muscle-invasive case. The overall accuracy (95.7%) and the specificity of muscle invasion detection of FUB (98.8%) were comparable to TUR (overall accuracy 90.2% and specificity 100%), but sensitivity of muscle invasion detection of FUB was significantly higher than initial TUR (72.7%VS18.2%). Moreover, the tumor's diameter could not affect the FUB's accuracy of muscle invasion detection. For tumors near the bladder neck, FUB also showed the similar validity as those far from bladder neck. Conclusions: To conclude, the flexible ultrasound bronchoscope is an effective tool for muscle invasion detection of bladder tumor with ideal ultrasonic images. It is an alternative option for bladder tumor staging besides TUR. It might have the potentiality to change the bladder diagnostic strategy.	[Xu, Chuanliang; Zhang, Zhensheng; Wang, Haifeng; Song, Qixiang; Wei, Rongchao; Sun, Yinghao] Second Mil Univ, Changhai Hosp, Dept Urol, Shanghai, Peoples R China; [Song, Qixiang] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Yu, Yongwei] Second Mil Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China; [Li, Jian] Second Mil Univ, Changhai Hosp, Dept Ultrasound, Shanghai, Peoples R China	Naval Medical University; Cleveland Clinic Foundation; Naval Medical University; Naval Medical University	Sun, YH (corresponding author), Second Mil Univ, Changhai Hosp, Dept Urol, Shanghai, Peoples R China.	zzsfimmu1981@gmail.com						BABJUK M, 2011, EUR UROL, V59, P584; BARENTSZ JO, 1993, AM J ROENTGENOL, V160, P937, DOI 10.2214/ajr.160.5.8470608; Brausi M, 2002, EUR UROL, V41, P523, DOI 10.1016/S0302-2838(02)00068-4; Dalbagni G, 2010, NAT REV UROL, V7, P649, DOI 10.1038/nrurol.2010.189; DIMAGNO EP, 1980, LANCET, V1, P629; Dutta SC, 2001, J UROLOGY, V166, P490, DOI 10.1016/S0022-5347(05)65969-1; GAMMELGAARD J, 1980, J UROLOGY, V124, P863, DOI 10.1016/S0022-5347(17)55704-3; Herr HW, 2007, J UROLOGY, V177, P75, DOI 10.1016/j.juro.2006.08.070; Horiuchi K, 2000, UROLOGY, V56, P404, DOI 10.1016/S0090-4295(00)00646-4; Hwang SW, 2010, J GASTROEN HEPATOL, V25, P512, DOI 10.1111/j.1440-1746.2009.06106.x; Hwangbo B, 2009, CHEST, V135, P1280, DOI 10.1378/chest.08-2019; KORAITIM M, 1995, J UROLOGY, V154, P375, DOI 10.1016/S0022-5347(01)67051-4; Miladi M, 2003, EUR UROL, V43, P241, DOI 10.1016/S0302-2838(03)00040-X; Rajesh A, 2011, CLIN RADIOL, V66, P1140, DOI 10.1016/j.crad.2011.05.019; Rosenkrantz AB, 2012, ACTA RADIOL, V53, P695, DOI 10.1258/ar.2012.120069; Saga Y, 2004, INT J UROL, V11, P597, DOI 10.1111/j.1442-2042.2004.00865.x; Scattoni V, 1996, J UROLOGY, V155, P1594, DOI 10.1016/S0022-5347(01)66139-1; Wagner B, 2005, ULTRASOUND MED BIOL, V31, P301, DOI 10.1016/j.ultrasmedbio.2004.12.017	18	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92385	10.1371/journal.pone.0092385	http://dx.doi.org/10.1371/journal.pone.0092385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24704988	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500015
J	Zallocchi, M; Binley, K; Lad, Y; Ellis, S; Widdowson, P; Iqball, S; Scripps, V; Kelleher, M; Loader, J; Miskin, J; Peng, YW; Wang, WM; Cheung, LD; Delimont, D; Mitrophanous, KA; Cosgrove, D				Zallocchi, Marisa; Binley, Katie; Lad, Yatish; Ellis, Scott; Widdowson, Peter; Iqball, Sharifah; Scripps, Vicky; Kelleher, Michelle; Loader, Julie; Miskin, James; Peng, You-Wei; Wang, Wei-Min; Cheung, Linda; Delimont, Duane; Mitrophanous, Kyriacos A.; Cosgrove, Dominic			EIAV-Based Retinal Gene Therapy in the shaker1 Mouse Model for Usher Syndrome Type 1B: Development of UshStat	PLOS ONE			English	Article							LIGHT-DRIVEN TRANSLOCATION; MYOSIN-VIIA; TRANSDUCIN TRANSLOCATION; INDUCED DEGENERATION; ROD PHOTORECEPTORS; LENTIVIRAL VECTORS; STARGARDT DISEASE; PROTEIN; MUTATIONS; MICE	Usher syndrome type 1B is a combined deaf-blindness condition caused by mutations in the MYO7A gene. Loss of functional myosin VIIa in the retinal pigment epithelia (RPE) and/or photoreceptors leads to blindness. We evaluated the impact of subretinally delivered UshStat, a recombinant EIAV-based lentiviral vector expressing human MYO7A, on photoreceptor function in the shaker1 mouse model for Usher type 1B that lacks a functional Myo7A gene. Subretinal injections of EIAV-CMV-GFP, EIAV-RK-GFP (photoreceptor specific), EIAV-CMV-MYO7A (UshStat) or EIAV-CMV-Null (control) vectors were performed in shaker1 mice. GFP and myosin VIIa expression was evaluated histologically. Photoreceptor function in EIAV-CMV-MYO7A treated eyes was determined by evaluating a-transducin translocation in photoreceptors in response to low light intensity levels, and protection from light induced photoreceptor degeneration was measured. The safety and tolerability of subretinally delivered UshStat was evaluated in macaques. Expression of GFP and myosin VIIa was confirmed in the RPE and photoreceptors in shaker1 mice following subretinal delivery of the EIAV-CMV-GFP/MYO7A vectors. The EIAV-CMV-MYO7A vector protected the shaker1 mouse photoreceptors from acute and chronic intensity light damage, indicated by a significant reduction in photoreceptor cell loss, and restoration of the a-transducin translocation threshold in the photoreceptors. Safety studies in the macaques demonstrated that subretinal delivery of UshStat is safe and well-tolerated. Subretinal delivery of EIAV-CMV-MYO7A (UshStat) rescues photoreceptor phenotypes in the shaker1 mouse. In addition, subretinally delivered UshStat is safe and well-tolerated in macaque safety studies These data support the clinical development of UshStat to treat Usher type 1B syndrome.	[Zallocchi, Marisa; Peng, You-Wei; Wang, Wei-Min; Cheung, Linda; Delimont, Duane; Cosgrove, Dominic] Boys Town Natl Res Hosp, Omaha, NE 68131 USA; [Binley, Katie; Lad, Yatish; Ellis, Scott; Widdowson, Peter; Iqball, Sharifah; Scripps, Vicky; Kelleher, Michelle; Loader, Julie; Miskin, James; Mitrophanous, Kyriacos A.] Oxford BioMed UK Ltd, Oxford, England; [Cosgrove, Dominic] Univ Nebraska Med Ctr, Omaha, NE USA	Boys Town National Research Hospital; Oxford Biomedica (UK) Ltd; University of Nebraska System; University of Nebraska Medical Center	Cosgrove, D (corresponding author), Boys Town Natl Res Hosp, Omaha, NE 68131 USA.	Dominic.cosgrove@boystown.org	Zallocchi, Marisa/HHS-7445-2022		Foundation Fighting Blindness (NNRI) [NNPC-GT-0710-0054-BTNRH-FR]; National Institutes of Health [R01 DC004844, 5 P20 RR018788-08]; NCRR, NIH [5P20RR016469]; NIGMS, NIH [8P20GM103427]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018788, P20RR016469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004844] Funding Source: NIH RePORTER	Foundation Fighting Blindness (NNRI); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the Foundation Fighting Blindness (NNRI Grant No.: NNPC-GT-0710-0054-BTNRH-FR) and the National Institutes of Health (R01 DC004844 and 5 P20 RR018788-08). Confocal microscopy was conducted at the Integrative Biological Imaging Facility, Creighton University, Omaha, NE (5P20RR016469, NCRR, NIH and 8P20GM103427, NIGMS, NIH). Oxford BioMedica (UK) Ltd provided support in the form of salaries for authors KB, YL, SE, PW, SI, VS, MK, JL, JM and KAM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adato A, 2002, EUR J HUM GENET, V10, P339, DOI 10.1038/sj.ejhg.5200831; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Balaggan KS, 2006, J GENE MED, V8, P275, DOI 10.1002/jgm.845; Binley K, 2013, INVEST OPHTH VIS SCI, V54, P4061, DOI 10.1167/iovs.13-11871; Binley K, 2012, HUM GENE THER, V23, P980, DOI 10.1089/hum.2012.008; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; Colella P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072027; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Fields RR, 2002, AM J HUM GENET, V71, P607, DOI 10.1086/342098; Gibbs D, 2004, J CELL SCI, V117, P6473, DOI 10.1242/jcs.01580; Gibbs D, 2009, INVEST OPHTH VIS SCI, V50, P4386, DOI 10.1167/iovs.09-3471; Gruter O, 2005, GENE THER, V12, P942, DOI 10.1038/sj.gt.3302485; Hashimoto T, 2007, GENE THER, V14, P584, DOI 10.1038/sj.gt.3302897; Hasson T, 1997, CELL MOTIL CYTOSKEL, V37, P127, DOI 10.1002/(SICI)1097-0169(1997)37:2<127::AID-CM5>3.0.CO;2-5; Kerov V, 2005, J BIOL CHEM, V280, P41069, DOI 10.1074/jbc.M508849200; Kong J, 2008, GENE THER, V15, P1311, DOI 10.1038/gt.2008.78; Kong L, 2006, NEUROBIOL DIS, V21, P468, DOI 10.1016/j.nbd.2005.08.017; Kostic C, 2003, GENE THER, V10, P818, DOI 10.1038/sj.gt.3301948; Libby RT, 2001, INVEST OPHTH VIS SCI, V42, P770; Lillo C, 2003, ADV EXP MED BIOL, V533, P143; Liu XR, 1999, J NEUROSCI, V19, P6267; Lopes VS, 2013, GENE THER, V20, P824, DOI 10.1038/gt.2013.3; Lopes VS, 2011, HUM MOL GENET, V20, P2560, DOI 10.1093/hmg/ddr155; Peng YW, 2008, INVEST OPHTH VIS SCI, V49, P4647, DOI 10.1167/iovs.08-2011; Peng YW, 2011, INVEST OPHTH VIS SCI, V52, P6421, DOI 10.1167/iovs.10-6557; Redmond TM, 2007, MOL VIS, V13, P1813; Reiners J, 2005, MOL VIS, V11, P347; Riazuddin S, 2012, NAT GENETICS ONLINE, P1; Schwander M, 2009, J NEUROSCI, V29, P15810, DOI 10.1523/JNEUROSCI.4876-09.2009; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Soni LE, 2005, CELL MOTIL CYTOSKEL, V62, P13, DOI 10.1002/cm.20080; Stewart HJ, 2009, GENE THER, V16, P805, DOI 10.1038/gt.2009.20; Tian M, 2014, EXP EYE RES, V118, P145, DOI 10.1016/j.exer.2013.10.021; Trapani I, 2013, EMBO MOL MED, P1; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Williams DS, 2012, ADV EXP MED BIOL, V723, P235, DOI 10.1007/978-1-4614-0631-0_31; Williams DS, 2011, BIOCHEM SOC T, V39, P1207, DOI 10.1042/BST0391207	43	68	73	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94272	10.1371/journal.pone.0094272	http://dx.doi.org/10.1371/journal.pone.0094272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705452	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500138
J	Hsu, CL; Voss, MW; Handy, TC; Davis, JC; Nagamatsu, LS; Chan, A; Bolandzadeh, N; Liu-Ambrose, T				Hsu, Chun Liang; Voss, Michelle W.; Handy, Todd C.; Davis, Jennifer C.; Nagamatsu, Lindsay S.; Chan, Alison; Bolandzadeh, Niousha; Liu-Ambrose, Teresa			Disruptions in Brain Networks of Older Fallers Are Associated with Subsequent Cognitive Decline: A 12-Month Prospective Exploratory Study	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; SELF-EFFICACY BELIEFS; RESTING-STATE; FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; DEFAULT NETWORK; MOTOR CONTROL; AGE-DIFFERENCES; GAIT; RISK	Cognitive impairment and impaired mobility are major public health concerns. There is growing recognition that impaired mobility is an early biomarker of cognitive impairment and dementia. The neural basis for this association is currently unclear. We propose disrupted functional connectivity as a potential mechanism. In this 12-month prospective exploratory study, we compared functional connectivity of four brain networks-the default mode network (DMN), fronto-executive network (FEN), fronto-parietal network (FPN), and the primary motor sensory network (SMN) - between community-dwelling older adults with >= two falls in the last 12 months and their non-falling counterparts (<= one fall in the last 12 months). Functional connectivity was examined both at rest and during a simple motor tapping task. Compared with non-fallers, fallers showed more connectivity between the DMN and FPN during right finger tapping (p=0.04), and significantly less functional connectivity between the SMN and FPN during rest (p <= 0.05). Less connectivity between the SMN and FPN during rest was significantly associated with greater decline in both cognitive function and mobility over the12-month period (r =-0.32 and 0.33 respectively; p <= 0.04). Thus, a recent history of multiple falls among older adults without a diagnosis of dementia may indicate sub-clinical changes in brain function and increased risk for subsequent decline.	[Hsu, Chun Liang; Nagamatsu, Lindsay S.; Chan, Alison; Bolandzadeh, Niousha; Liu-Ambrose, Teresa] Univ British Columbia, Aging Mobil & Cognit Neurosci Lab, Vancouver, BC V5Z 1M9, Canada; [Hsu, Chun Liang; Davis, Jennifer C.; Chan, Alison; Bolandzadeh, Niousha; Liu-Ambrose, Teresa] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Hsu, Chun Liang; Davis, Jennifer C.; Nagamatsu, Lindsay S.; Chan, Alison; Bolandzadeh, Niousha; Liu-Ambrose, Teresa] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Hsu, Chun Liang; Nagamatsu, Lindsay S.; Chan, Alison; Bolandzadeh, Niousha; Liu-Ambrose, Teresa] Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Voss, Michelle W.] Univ Iowa, Hlth Brain & Cognit Lab, Iowa City, IA USA; [Voss, Michelle W.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Handy, Todd C.; Davis, Jennifer C.] Univ British Columbia, Ctr Clin Epidemiol & Evaluat, Vancouver, BC V5Z 1M9, Canada; [Handy, Todd C.; Davis, Jennifer C.] VCHRI, Vancouver, BC, Canada; [Handy, Todd C.; Nagamatsu, Lindsay S.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of Iowa; University of Iowa; University of British Columbia; University of British Columbia	Liu-Ambrose, T (corresponding author), Univ British Columbia, Aging Mobil & Cognit Neurosci Lab, Vancouver, BC V5Z 1M9, Canada.	tlambrose@exchange.ubc.ca	Hsu, Chun Liang/AAN-4254-2021; Liu-Ambrose, Teresa/W-2332-2019	Hsu, Chun Liang/0000-0003-2090-1001; Liu-Ambrose, Teresa/0000-0002-8297-5308	Canadian Institutes of Health Research [MOB-93373]; Canadian Institutes of Health Research Emerging Team Grant: Mobility in Aging	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Emerging Team Grant: Mobility in Aging(Canadian Institutes of Health Research (CIHR))	The Canadian Institutes of Health Research (MOB-93373) to TLA and a Canadian Institutes of Health Research Emerging Team Grant: Mobility in Aging to Karim Miran-Khan provided funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Aramaki Y, 2010, EXP BRAIN RES, V203, P407, DOI 10.1007/s00221-010-2244-0; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Atkinson HH, 2007, J GERONTOL A-BIOL, V62, P844, DOI 10.1093/gerona/62.8.844; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Berchicci M, 2012, NEUROIMAGE, V62, P1750, DOI 10.1016/j.neuroimage.2012.06.031; Brier MR, 2012, J NEUROSCI, V32, P8890, DOI 10.1523/JNEUROSCI.5698-11.2012; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; Colcombe SJ, 2005, PSYCHOL AGING, V20, P363, DOI 10.1037/0882-7974.20.3.363; CUMMINGS SR, 1988, J AM GERIATR SOC, V36, P613, DOI 10.1111/j.1532-5415.1988.tb06155.x; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; DAVIS JC, 2012, AGE AGEING; Davis JC, 2012, AGE AGEING, V41, P495, DOI 10.1093/ageing/afs029; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; de Laat KF, 2011, BRAIN, V134, P73, DOI 10.1093/brain/awq343; Delbaere K, 2010, J AM GERIATR SOC, V58, P1679, DOI 10.1111/j.1532-5415.2010.03017.x; Delbaere K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4165; Della Nave R, 2007, AM J NEURORADIOL, V28, P1313, DOI 10.3174/ajnr.A0555; Divani AA, 2011, STROKE, V42, P1821, DOI 10.1161/STROKEAHA.110.607630; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Esposito F, 2008, MAGN RESON IMAGING, V26, P905, DOI 10.1016/j.mri.2008.01.045; Fleisher AS, 2009, NEUROIMAGE, V47, P1678, DOI 10.1016/j.neuroimage.2009.06.021; Fogassi L, 2005, CURR OPIN NEUROBIOL, V15, P626, DOI 10.1016/j.conb.2005.10.015; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Geerligs L, 2012, HUM BRAIN MAPP; Grabowska A, 2012, ACTA NEUROBIOL EXP, V72, P439; GRAF P, 1995, J CLIN EXP NEUROPSYC, V17, P390, DOI 10.1080/01688639508405132; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Groll DL, 2005, J CLIN EPIDEMIOL, V58, P595, DOI 10.1016/j.jclinepi.2004.10.018; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hauer K, 2006, AGE AGEING, V35, P5, DOI 10.1093/ageing/afi218; Inman CS, 2012, NEUROIMAGE, V59, P227, DOI 10.1016/j.neuroimage.2011.07.083; Inzitari M, 2007, NEUROEPIDEMIOLOGY, V29, P156, DOI 10.1159/000111577; KAFRI M, 2012, J NEUROIMAGING; Kahneman D., 1973, ATTENTION EFFORT; Kam JWY, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00329; Kantarci K, 2011, NEUROLOGY, V77, P26, DOI 10.1212/WNL.0b013e31822313dc; Kokmen E, 1996, NEUROLOGY, V46, P154, DOI 10.1212/WNL.46.1.154; KONISHI S, 1981, BIOMETRIKA, V68, P647, DOI 10.1093/biomet/68.3.647; Kuo HK, 2004, J GERONTOL A-BIOL, V59, P818; Liu-Ambrose T, 2006, J GERONTOL A-BIOL, V61, P832, DOI 10.1093/gerona/61.8.832; Liu-Ambrose T, 2009, J GERONTOL A-BIOL, V64, P975, DOI 10.1093/gerona/glp063; LORD SR, 1994, J AM GERIATR SOC, V42, P1110, DOI 10.1111/j.1532-5415.1994.tb06218.x; LORD SR, 1991, J AM GERIATR SOC, V39, P1194, DOI 10.1111/j.1532-5415.1991.tb03574.x; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; Madden DJ, 2009, J COGNITIVE NEUROSCI, V21, P289, DOI 10.1162/jocn.2009.21047; Mennes M, 2013, CEREB CORTEX, V23, P223, DOI 10.1093/cercor/bhs010; Nagamatsu LS, 2013, PSYCHOL AGING, V28, P685, DOI 10.1037/a0034197; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; ONODA K, 2012, AGING EFFECTS FUNCTI, P119; Pammi VSC, 2012, NEUROIMAGE, V59, P1180, DOI 10.1016/j.neuroimage.2011.08.006; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Persson J, 2008, NEUROPSYCHOLOGIA, V46, P1679, DOI 10.1016/j.neuropsychologia.2008.01.026; Persson J, 2007, J COGNITIVE NEUROSCI, V19, P1021, DOI 10.1162/jocn.2007.19.6.1021; Persson J, 2006, CEREB CORTEX, V16, P907, DOI 10.1093/cercor/bhj036; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Reuter-Lorenz PA, 2005, CURR OPIN NEUROBIOL, V15, P245, DOI 10.1016/j.conb.2005.03.016; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rosano C, 2005, J AM GERIATR SOC, V53, P649, DOI 10.1111/j.1532-5415.2005.53214.x; Rosano C, 2008, J AM GERIATR SOC, V56, P1618, DOI 10.1111/j.1532-5415.2008.01856.x; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeman T, 1996, PSYCHOL AGING, V11, P538, DOI 10.1037/0882-7974.11.3.538; Seeman TE, 1999, J GERONTOL B-PSYCHOL, V54, pP214, DOI 10.1093/geronb/54B.4.P214; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spreen O., 1998, COMPENDIUM NEUROLOGI, V2nd ed.; Spreng RN, 2012, CEREB CORTEX, V22, P2610, DOI 10.1093/cercor/bhr339; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stark S, 2011, ALZHEIMERS DEMENT, V7, pS176; Starr JM, 2003, J NEUROL NEUROSUR PS, V74, P94, DOI 10.1136/jnnp.74.1.94; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Impe A, 2012, NEUROBIOL AGING, V33, P1900, DOI 10.1016/j.neurobiolaging.2011.06.013; VANMARWIJK HWJ, 1995, BRIT J GEN PRACT, V45, P195; Verghese J, 2002, NEW ENGL J MED, V347, P1761, DOI 10.1056/NEJMoa020441; Verwey WB, 2001, ACTA PSYCHOL, V106, P69, DOI 10.1016/S0001-6918(00)00027-5; Verwey WB, 2010, ACTA PSYCHOL, V134, P206, DOI 10.1016/j.actpsy.2010.02.001; Vidoni ED, 2012, J NEUROL PHYS THER, V36, P8, DOI 10.1097/NPT.0b013e3182462ea6; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Washburn RA, 1999, J CLIN EPIDEMIOL, V52, P643, DOI 10.1016/S0895-4356(99)00049-9; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Weerdesteyn V, 2008, J REHABIL RES DEV, V45, P1195, DOI 10.1682/JRRD.2007.09.0145; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Wymbs NF, 2012, NEURON, V74, P936, DOI 10.1016/j.neuron.2012.03.038; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	97	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93673	10.1371/journal.pone.0093673	http://dx.doi.org/10.1371/journal.pone.0093673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699668	Green Published, gold			2022-12-27	WOS:000334105000089
J	Nah, GSS; Lim, ZW; Tay, BH; Osato, M; Venkatesh, B				Nah, Giselle Sek Suan; Lim, Zhi Wei; Tay, Boon-Hui; Osato, Motomi; Venkatesh, Byrappa			Runx Family Genes in a Cartilaginous Fish, the Elephant Shark (Callorhinchus milii)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR PEBP2; DNA-BINDING ACTIVITY; BONE-FORMATION; FUGU GENOME; CBF-BETA; EXPRESSION; EVOLUTION; PROTEINS; LEUKEMIA; DOMAIN	The Runx family genes encode transcription factors that play key roles in hematopoiesis, skeletogenesis and neurogenesis and are often implicated in diseases. We describe here the cloning and characterization of Runx1, Runx2, Runx3 and Runxb genes in the elephant shark (Callorhinchus milii), a member of Chondrichthyes, the oldest living group of jawed vertebrates. Through the use of alternative promoters and/or alternative splicing, each of the elephant shark Runx genes expresses multiple isoforms similar to their orthologs in human and other bony vertebrates. The expression profiles of elephant shark Runx genes are similar to those of mammalian Runx genes. The syntenic blocks of genes at the elephant shark Runx gene loci are highly conserved in human, but represented by shorter conserved blocks in zebrafish indicating a higher degree of rearrangements in this teleost fish. Analysis of promoter regions revealed conservation of binding sites for transcription factors, including two tandem binding sites for Runx that are totally conserved in the distal promoter regions of elephant shark Runx1-3. Several conserved noncoding elements (CNEs), which are putative cis-regulatory elements, and miRNA binding sites were identified in the elephant shark and human Runx gene loci. Some of these CNEs and miRNA binding sites are absent in teleost fishes such as zebrafish and fugu. In summary, our analysis reveals that the genomic organization and expression profiles of Runx genes were already complex in the common ancestor of jawed vertebrates.	[Nah, Giselle Sek Suan; Lim, Zhi Wei; Tay, Boon-Hui; Osato, Motomi; Venkatesh, Byrappa] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore; [Nah, Giselle Sek Suan] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Osato, Motomi] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Osato, Motomi] Agcy Sci Technol & Res, Inst Bioengn & Nanotechnol, Singapore, Singapore; [Venkatesh, Byrappa] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); National University of Singapore	Osato, M (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore.	csimo@nus.edu.sg; mcbbv@imcb.a-star.edu.sg	Lim, Zhiwei/Q-7858-2016; Osato, Motomi/N-5056-2014	Lim, Zhiwei/0000-0003-4620-1986; Osato, Motomi/0000-0003-3982-9054; Venkatesh, Byrappa/0000-0003-3620-0277	Biomedical Research Council of A*STAR, Singapore	Biomedical Research Council of A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	Funding provided by Biomedical Research Council of A*STAR, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adya N, 2000, SEMIN CELL DEV BIOL, V11, P361, DOI 10.1006/scdb.2000.0189; Akamatsu Y, 1997, J BIOL CHEM, V272, P14497, DOI 10.1074/jbc.272.23.14497; Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Bee T, 2010, BLOOD, V115, P3042, DOI 10.1182/blood-2009-08-238626; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Boehm T, 2012, ANNU REV GENOM HUM G, V13, P127, DOI 10.1146/annurev-genom-090711-163747; Braun T, 2009, BLOOD CELL MOL DIS, V43, P43, DOI 10.1016/j.bcmd.2009.05.001; Brenner O, 2004, P NATL ACAD SCI USA, V101, P16016, DOI 10.1073/pnas.0407180101; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Davies WIL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051276; Dooley H, 2006, DEV COMP IMMUNOL, V30, P43, DOI 10.1016/j.dci.2005.06.022; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Drissi H, 2002, EXP CELL RES, V274, P323, DOI 10.1006/excr.2002.5474; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Fan HY, 2011, MOL ENDOCRINOL, V25, P253, DOI 10.1210/me.2010-0318; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Glusman G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-43; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; Hecht J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000025; Hovhannisyan H, 2013, J CELL PHYSIOL, V228, P313, DOI 10.1002/jcp.22109; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Inoue KI, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-20; Jacob B, 2010, BLOOD, V115, P1610, DOI 10.1182/blood-2009-07-232249; Javed A, 2000, J CELL SCI, V113, P2221; Jeong JH, 2008, J CELL PHYSIOL, V217, P511, DOI 10.1002/jcp.21524; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; Kagoshima H, 1996, J BIOL CHEM, V271, P33074, DOI 10.1074/jbc.271.51.33074; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kudo Y, 2011, J CELL BIOCHEM, V112, P387, DOI 10.1002/jcb.22967; Lee AP, 2011, MOL BIOL EVOL, V28, P1205, DOI 10.1093/molbev/msq304; Lee CWL, 2011, GYNECOL ONCOL, V122, P410, DOI 10.1016/j.ygyno.2011.04.044; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Liu JC, 2011, J BIOL CHEM, V286, P30057, DOI 10.1074/jbc.M111.241505; Morrison NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042617; Ng CEL, 2007, GENE, V399, P162, DOI 10.1016/j.gene.2007.05.014; Ng CEL, 2010, STEM CELLS, V28, P1869, DOI 10.1002/stem.507; OGAWA E, 1993, VIROLOGY, V194, P314, DOI 10.1006/viro.1993.1262; Ohno SI, 2008, INT IMMUNOL, V20, P71, DOI 10.1093/intimm/dxm120; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osato M, 2005, CRIT REV EUKAR GENE, V15, P217, DOI 10.1615/CritRevEukarGeneExpr.v15.i3.40; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Osorio KM, 2008, DEVELOPMENT, V135, P1059, DOI 10.1242/dev.012799; Otto F, 2002, HUM MUTAT, V19, P209, DOI 10.1002/humu.10043; Park ES, 2012, MOL CELL ENDOCRINOL, V362, P165, DOI 10.1016/j.mce.2012.06.005; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Qiao M, 2006, J BIOL CHEM, V281, P7118, DOI 10.1074/jbc.M508162200; Rossetti S, 2013, INT J MOL SCI, V14, P1566, DOI 10.3390/ijms14011566; Sears KE, 2007, EVOL DEV, V9, P555, DOI 10.1111/j.1525-142X.2007.00196.x; Soung DY, 2007, J BONE MINER RES, V22, P1260, DOI 10.1359/JBMR.070502; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Spender LC, 2005, ONCOGENE, V24, P1873, DOI 10.1038/sj.onc.1208404; Sullivan JC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-228; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Tan YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047174; Tanaka T, 1996, MOL CELL BIOL, V16, P3967; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Terry A, 2004, GENE, V336, P115, DOI 10.1016/j.gene.2004.04.015; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; van der Meulen T, 2005, BBA-GENE STRUCT EXPR, V1729, P105, DOI 10.1016/j.bbaexp.2005.03.008; Venkatesh B, 2005, CURR BIOL, V15, pR82, DOI 10.1016/j.cub.2005.01.021; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Venkatesh B, 2006, SCIENCE, V314, P1892, DOI 10.1126/science.1130708; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Watanabe K, 2010, J IMMUNOL, V184, P2785, DOI 10.4049/jimmunol.0901823; Xu Y, 2013, FEBS LETT, V587, P3166, DOI 10.1016/j.febslet.2013.05.069; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zhang YH, 2004, J BIOL CHEM, V279, P53116, DOI 10.1074/jbc.M405502200	72	4	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93816	10.1371/journal.pone.0093816	http://dx.doi.org/10.1371/journal.pone.0093816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699678	Green Submitted, gold, Green Published			2022-12-27	WOS:000334105000111
J	Sandoval-Castro, E; Dodd, RS; Riosmena-Rodriguez, R; Enriquez-Paredes, LM; Tovilla-Hernandez, C; Lopez-Vivas, JM; Aguilar-May, B; Muniz-Salazar, R				Sandoval-Castro, Eduardo; Dodd, Richard S.; Riosmena-Rodriguez, Rafael; Manuel Enriquez-Paredes, Luis; Tovilla-Hernandez, Cristian; Lopez-Vivas, Juan Manuel; Aguilar-May, Bily; Muniz-Salazar, Raquel			Post-Glacial Expansion and Population Genetic Divergence of Mangrove Species Avicennia germinans (L.) Stearn and Rhizophora mangle L. along the Mexican Coast	PLOS ONE			English	Article							MIGRATION RATES; F-STATISTICS; DISPERSAL; DIVERSITY; INFERENCE; RECOLONIZATION; EXTINCTION; DISTANCES; SOFTWARE; ECOLOGY	Mangrove forests in the Gulf of California, Mexico represent the northernmost populations along the Pacific coast and thus they are likely to be source populations for colonization at higher latitudes as climate becomes more favorable. Today, these populations are relatively small and fragmented and prior research has indicated that they are poor in genetic diversity. Here we set out to investigate whether the low diversity in this region was a result of recent colonization, or fragmentation and genetic drift of once more extensive mangroves due to climatic changes in the recent past. By sampling the two major mangrove species, Rhizophora mangle and Avicennia germinans, along the Pacific and Atlantic coasts of Mexico, we set out to test whether concordant genetic signals could elucidate recent evolution of the ecosystem. Genetic diversity of both mangrove species showed a decreasing trend toward northern latitudes along the Pacific coast. The lowest levels of genetic diversity were found at the range limits around the Gulf of California and the outer Baja California peninsula. Lack of a strong spatial genetic structure in this area and recent northern gene flow in A. germinans suggest recent colonization by this species. On the other hand, lack of a signal of recent northern dispersal in R. mangle, despite the higher dispersal capability of this species, indicates a longer presence of populations, at least in the southern Gulf of California. We suggest that the longer history, together with higher genetic diversity of R. mangle at the range limits, likely provides a gene pool better able to colonize northwards under climate change than A. germinans.	[Sandoval-Castro, Eduardo; Muniz-Salazar, Raquel] Univ Autonoma Baja California, Escuela Ciencias Salud, Ensenada, Baja California, Mexico; [Sandoval-Castro, Eduardo; Manuel Enriquez-Paredes, Luis] Univ Autonoma Baja California, Fac Ciencias Marinas, Ensenada, Baja California, Mexico; [Dodd, Richard S.; Lopez-Vivas, Juan Manuel] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Riosmena-Rodriguez, Rafael] Univ Autonoma Baja California Sur, Dept Acad Biol Marina, La Paz, Baja California, Mexico; [Tovilla-Hernandez, Cristian] Colegio Frontera Sur, Tapachula, Chiapas, Mexico; [Aguilar-May, Bily] Inst Tecnol Super Villa La Venta, Huamanguillo, Tabasco, Mexico	Universidad Autonoma de Baja California; University of California System; University of California Berkeley; El Colegio de la Frontera Sur (ECOSUR)	Muniz-Salazar, R (corresponding author), Univ Autonoma Baja California, Escuela Ciencias Salud, Ensenada, Baja California, Mexico.	ramusal@uabc.edu.mx	Lopez-Vivas, Juan M/B-8015-2018; Sandoval-Castro, Eduardo/J-2164-2017; Sandoval-Castro, Eduardo/AAT-4171-2021; MUNIZ-SALAZAR, RAQUEL/F-5309-2019	Lopez-Vivas, Juan M/0000-0002-3417-1153; Sandoval-Castro, Eduardo/0000-0001-8875-0225; MUNIZ-SALAZAR, RAQUEL/0000-0001-5528-7772; Enriquez-Paredes, Luis Manuel/0000-0002-9835-1225; Tovilla, Cristian/0000-0003-0469-9771	International Community Foundation [20030900]; UABC [0843]; CONACYT-SEMARNAT-INE [107696]	International Community Foundation; UABC; CONACYT-SEMARNAT-INE	International Community Foundation Grant No.: 20030900; 14th Internal Call for Support to Investigation Projects of the UABC, Grant No. 0843; CONACYT-SEMARNAT-INE 2009, Grant No. 107696. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Aburto-Oropeza O, 2008, P NATL ACAD SCI USA, V105, P10456, DOI 10.1073/pnas.0804601105; Acosta-Velazquez J, 2009, 33 INT S REM SENS EN, P1; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Bialozyt R, 2006, J EVOLUTION BIOL, V19, P12, DOI 10.1111/j.1420-9101.2005.00995.x; Castillo-Cardenas MF, 2005, BIOTROPICA, V37, P266, DOI 10.1111/j.1744-7429.2005.00036.x; Ceron-Souza I, 2006, MOL ECOL NOTES, V6, P692, DOI 10.1111/j.1471-8286.2006.01312.x; Ceron-Souza I, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-205; Dodd RS, 2002, MOL ECOL, V11, P1327, DOI 10.1046/j.1365-294X.2002.01525.x; Dodd RS, 2000, NEW PHYTOL, V145, P115, DOI 10.1046/j.1469-8137.2000.00551.x; Duke NC, 1998, GLOBAL ECOL BIOGEOGR, V7, P27, DOI 10.2307/2997695; Dutech C, 2003, EVOLUTION, V57, P2753, DOI 10.1111/j.0014-3820.2003.tb01517.x; Salas-Leiva DE, 2009, AQUAT BOT, V91, P187, DOI 10.1016/j.aquabot.2009.06.001; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Falush D, 2003, GENETICS, V164, P1567; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Graham A, 2006, ANN MO BOT GARD, V93, P325, DOI 10.3417/0026-6493(2006)93[325:PEAMDI]2.0.CO;2; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, HEREDITY, V92, P1, DOI 10.1038/sj.hdy.6800365; Jacobs DK, 2004, ANNU REV EARTH PL SC, V32, P601, DOI 10.1146/annurev.earth.32.092203.122436; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Ledesma-Vazquez J., 1997, PLIOCENE CARBONATES, VVolume 318, P73; Lewis PO, 2001, GENETIC DATA ANAL GD; MCCAULEY DE, 1991, TRENDS ECOL EVOL, V6, P5, DOI 10.1016/0169-5347(91)90139-O; Michalakis Y, 1996, GENETICS, V142, P1061; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; Nettel A, 2005, MOL ECOL NOTES, V5, P103, DOI 10.1111/j.1471-8286.2004.00851.x; Nettel A, 2008, MOL ECOL, V17, P2680, DOI 10.1111/j.1365-294X.2008.03766.x; Nettel A, 2007, EVOLUTION, V61, P958, DOI 10.1111/j.1558-5646.2007.00070.x; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; ONG JE, 1993, CHEMOSPHERE, V27, P1097; Pacheco-Ruiz I, 2006, CIENCIA MAR, V28, P19; Perry CL, 2009, WETLANDS, V29, P396, DOI 10.1672/08-100.1; Peterman WE, 2013, BIOL CONSERV, V158, P351, DOI 10.1016/j.biocon.2012.07.028; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pil MW, 2011, AM J BOT, V98, P1031, DOI 10.3732/ajb.1000392; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosero-Galindo C, 2002, MOL ECOL NOTES, V2, P281, DOI 10.1046/j.1471-8286.2002.00232.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rull V., 1998, INTERCIENCIA, V23, P255; Sandoval-Castro E, 2012, AQUAT BOT, V99, P20, DOI 10.1016/j.aquabot.2012.01.002; SHERROD CL, 1985, CONTRIB MAR SCI, V28, P129; SLATKIN M, 1995, GENETICS, V139, P457; Sousa WP, 2007, ECOL MONOGR, V77, P53, DOI 10.1890/05-1935; Takayama K, 2013, AM J BOT, V100, P1191, DOI 10.3732/ajb.1200567; Thampanya U, 2006, ESTUAR COAST SHELF S, V68, P75, DOI 10.1016/j.ecss.2006.01.011; Tomlinson PB, 1994, BOT MANGROVES; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177; WOODROFFE CD, 1991, J BIOGEOGR, V18, P479, DOI 10.2307/2845685; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474	60	40	40	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93358	10.1371/journal.pone.0093358	http://dx.doi.org/10.1371/journal.pone.0093358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699389	Green Submitted, Green Published, gold			2022-12-27	WOS:000334105000056
J	Inzaule, S; Otieno, J; Kalyango, J; Nafisa, L; Kabugo, C; Nalusiba, J; Kwaro, D; Zeh, C; Karamagi, C				Inzaule, Seth; Otieno, Juliana; Kalyango, Joan; Nafisa, Lillian; Kabugo, Charles; Nalusiba, Josephine; Kwaro, Daniel; Zeh, Clement; Karamagi, Charles			Incidence and Predictors of First Line Antiretroviral Regimen Modification in Western Kenya	PLOS ONE			English	Article							HIV-INFECTION; THERAPY; STAVUDINE; PREVALENCE; TOXICITY; ADULTS; DISCONTINUATION; DURABILITY; REASONS; WOMEN	Background: Limited antiretroviral treatment regimens in resource-limited settings require long-term sustainability of patients on the few available options. We evaluated the incidence and predictors of combined antiretroviral treatment (cART) modifications, in an outpatient cohort of 955 patients who initiated cART between January 2009 and January 2011 in western Kenya. Methods: cART modification was defined as either first time single drug substitution or switch. Incidence rates were determined by Poisson regression and risk factor analysis assessed using multivariate Cox regression modeling. Results: Over a median follow-up period of 10.7 months, 178 (18.7%) patients modified regimens (incidence rate (IR); 18.6 per 100 person years [95% CI: 16.2-21.8]). Toxicity was the most common cited reason (66.3%). In adjusted multivariate Cox piecewise regression model, WHO disease stage III/IV (aHR; 1.82, 95% CI: 1.25-2.66), stavudine (d4T) use (aHR; 2.21 95% CI: 1.49-3.30) and increase in age (aHR; 1.02, 95% CI: 1.0-1.04) were associated with increased risk of treatment modification within the first year post-cART. Zidovudine (AZT) and tenofovir (TDF) use had a reduced risk for modification (aHR; 0.60 95% CI: 0.38-0.96 and aHR; 0.51 95% CI: 0.29-0.91 respectively). Beyond one year of treatment, d4T use (aHR; 2.75, 95% CI: 1.25-6.05), baseline CD4 counts <= 350 cells/mm(3) (aHR; 2.45, 95% CI: 1.14-5.26), increase in age (aHR; 1.05 95% CI: 1.02-1.07) and high baseline weight >60kg aHR; 2.69 95% CI: 1.58-4.59) were associated with risk of cART modification. Conclusions: Early treatment initiation at higher CD4 counts and avoiding d4T use may reduce treatment modification and subsequently improve sustainability of patients on the available limited options.	[Inzaule, Seth; Nafisa, Lillian; Kwaro, Daniel] Kenya Govt Med Res Ctr, Kisumu, Kenya; [Otieno, Juliana] Jaramogi Oginga Odinga Teaching & Referral Hosp, Kisumu, Kenya; [Inzaule, Seth; Kalyango, Joan; Kabugo, Charles; Nalusiba, Josephine; Karamagi, Charles] Makerere Univ, Sch Med, Clin Epidemiol Unit, Kampala, Uganda; [Kwaro, Daniel; Zeh, Clement] US Ctr Dis Control & Prevent, HIV Res Branch, Kisumu, Kenya; [Zeh, Clement] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA	Kenya Medical Research Institute; Makerere University; Centers for Disease Control & Prevention - USA	Inzaule, S (corresponding author), Kenya Govt Med Res Ctr, Kisumu, Kenya.	maserya@gmail.com		Kwaro, Daniel/0000-0002-0929-8072	European and Developing Countries Clinical Trial Partnership (EDCTP); Training Health Researchers into Vocational Excellence in East Africa, (THRIVE) initiative; Wellcome Trust [087540]	European and Developing Countries Clinical Trial Partnership (EDCTP); Training Health Researchers into Vocational Excellence in East Africa, (THRIVE) initiative; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by European and Developing Countries Clinical Trial Partnership (EDCTP, http://www.edctp.org/), and Training Health Researchers into Vocational Excellence in East Africa, (THRIVE) initiative(grant number 087540 funded by the Wellcome Trust (http://thrive.or.ug/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abimanyi-Ochom J, 2011, AIDS CARE, V23, P1545, DOI 10.1080/09540121.2011.582477; Anand A, 2009, AIDS, V23, P1565, DOI 10.1097/QAD.0b013e32832cb10c; [Anonymous], 2014, WORLD AIDS DAY 2014; Australian HIV Observational Database, 2002, HIV Med, V3, P28; Bolhaar MG, 2007, CLIN INFECT DIS, V45, P254, DOI 10.1086/518976; Boulle A, 2007, ANTIVIR THER, V12, P753; Braitstein P, 2010, JAIDS-J ACQ IMM DEF, V53, P254, DOI 10.1097/QAI.0b013e3181b8f26e; Breen RAM, 2000, AIDS, V14, P615, DOI 10.1097/00002030-200003310-00017; Calmy A, 2007, CLIN INFECT DIS, V44, P128, DOI 10.1086/510073; Cesar C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010490; Cicconi P, 2010, HIV MED, V11, P104, DOI 10.1111/j.1468-1293.2009.00750.x; Davidson I, 2010, ANTIVIR RES, V86, P227, DOI 10.1016/j.antiviral.2010.03.001; Dieleman JP, 2002, AIDS, V16, P737, DOI 10.1097/00002030-200203290-00009; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Elzi L, 2010, ARCH INTERN MED, V170, P57, DOI 10.1001/archinternmed.2009.432; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hawkins C, 2007, JAIDS-J ACQ IMM DEF, V45, P304; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Johansson KA, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-3; Kalyesubula R, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/562790; Kantor R, 2009, CLIN INFECT DIS, V49, P454, DOI 10.1086/600396; Kebba A, 2003, J ANTIMICROB CHEMOTH, V52, P747, DOI 10.1093/jac/dkg453; Kiguba R, 2007, JAIDS-J ACQ IMM DEF, V45, P218, DOI 10.1097/QAI.0b013e31805d8ae3; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kumarasamy N, 2006, JAIDS-J ACQ IMM DEF, V41, P53, DOI 10.1097/01.qai.0000188123.15493.43; Maskew M, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-13; McComsey GA, 2008, CLIN INFECT DIS, V46, P1290, DOI 10.1086/529384; Messou E, 2010, AIDS, V24, P93, DOI 10.1097/QAD.0b013e32832ec1c3; Mocroft A, 2001, AIDS, V15, P185, DOI 10.1097/00002030-200101260-00007; Mutimura E, 2007, JAIDS-J ACQ IMM DEF, V46, P451, DOI 10.1097/QAI.0b013e318158c0a6; NASCOP, 2008, GUID ANT THER KEN; Oluoch Tom, 2011, Open AIDS J, V5, P125, DOI 10.2174/1874613601105010125; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Rosen S, 2008, JAIDS-J ACQ IMM DEF, V48, P334, DOI 10.1097/QAI.0b013e31817ae5ef; Rubin DB, 2004, MULTIPLE IMPUTATION; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Subbaraman R, 2007, CLIN INFECT DIS, V45, P1093, DOI 10.1086/521150; Takuva S., 2012, J ANTIVIRALS ANTIRET, V4, P14, DOI DOI 10.4172/jaa.1000040; UNAIDS, 2011, WORLD REF DAY 2019 H; UNAIDS, 2009, GLOB REP FACT SHEET; van Griensven J, 2007, T ROY SOC TROP MED H, V101, P793, DOI 10.1016/j.trstmh.2007.02.020; van Griensven J, 2010, T ROY SOC TROP MED H, V104, P148, DOI 10.1016/j.trstmh.2009.07.009; Vo TTN, 2008, J INFECT DIS, V197, P1685, DOI 10.1086/588141; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2008, UN ACC SCAL PRIOR HI	45	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93106	10.1371/journal.pone.0093106	http://dx.doi.org/10.1371/journal.pone.0093106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695108	Green Submitted, Green Published, gold			2022-12-27	WOS:000334103000041
J	Naghii, MR; Babaei, M; Hedayati, M				Naghii, Mohammad Reza; Babaei, Mnasour; Hedayati, Mehdi			Androgens Involvement in the Pathogenesis of Renal Stones Formation	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; SEX-HORMONES; IDIOPATHIC NEPHROLITHIASIS; UROLITHIASIS; TESTOSTERONE; OXALATE; MEN; OLDER; RATS; AGE	Objective: The potential role for the gonadal steroids in the pathogenesis of urolithiasis, higher mean of plasma oxalate concentration and kidney calcium oxalate deposition influenced by androgens in men has been proposed. In this study, the serum levels of steroid hormones as a pathogenesis of this condition in male patients with active renal stone disease compared with controls was investigated. Methods: Forty patients diagnosed with renal stones and hospitalized for further clinical treatments or referred to our office after ultrasonographic evaluations participated in the study. Forty six healthy subjects served as controls. Steroid sex hormones in the plasma samples including testosterone, free testosterone, dihydrotestosterone, estradiol, and sex hormone binding globulin were analyzed. Results: A significant difference was observed between patients and the control subjects regarding serum testosterone, free testosterone, dihydrotestosterone, estradiol, and sex hormone binding globulin. Conclusions: Based on the results, a higher androgens level was diagnosed in renal stone patients, indicating a possibility of a substantial pathogenic role of testosterone, free testosterone, and dihydrotestosterone involvement in the pathogenesis of renal stones formation. Therefore, data presentation and further investigation on the relation between male steroids and urolithiasis is of importance and should be considered in evaluation of the etiology of the disease.	[Naghii, Mohammad Reza] Univ Med Sci, Baqiyatallah As, Hlth Sch, Sport Physiol Res Ctr, Tehran, Iran; [Naghii, Mohammad Reza] Univ Med Sci, Baqiyatallah As, Hlth Sch, Dept Nutr, Tehran, Iran; [Babaei, Mnasour] Univ Med Sci, Baqiyatallah As, Med Sci Res Management, Tehran, Iran; [Hedayati, Mehdi] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Cellular & Mol Endocrine Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences	Naghii, MR (corresponding author), Univ Med Sci, Baqiyatallah As, Hlth Sch, Sport Physiol Res Ctr, Tehran, Iran.	naghiimr@yahoo.com	babaei, mansuor/ABB-8590-2020; Hedayati, Mehdi/AAG-3006-2019	babaei, mansuor/0000-0001-7385-9885; Hedayati, Mehdi/0000-0001-5816-775X				Curhan GC, 2007, UROL CLIN N AM, V34, P287, DOI 10.1016/j.ucl.2007.04.003; Curhan GC, 1999, J ENDOUROL, V13, P629, DOI 10.1089/end.1999.13.629; Fan J, 1998, UROL RES, V26, P71, DOI 10.1007/s002400050026; Fan J, 1999, J AM SOC NEPHROL, V10, pS376; Finlayson B, 1974, Urol Clin North Am, V1, P181; Griffin DG, 2004, J CLIN PATHOL, V57, P793, DOI 10.1136/jcp.2003.014886; Hammond GL, 2012, CURR OPIN ENDOCRINOL, V19, P183, DOI 10.1097/MED.0b013e328353732f; Kato Y, 2005, UROL RES, V33, P476, DOI 10.1007/s00240-005-0511-5; Kaygusuz I, 2013, UROLITHIASIS, V41, P361, DOI 10.1007/s00240-013-0564-9; Li JY, 2010, J UROLOGY, V184, P2360, DOI 10.1016/j.juro.2010.08.009; Litman HJ, 2006, J CLIN ENDOCR METAB, V91, P4326, DOI 10.1210/jc.2006-0037; Liu PY, 2007, J CLIN ENDOCR METAB, V92, P3599, DOI 10.1210/jc.2007-0862; Naghii M R, 2010, Endocr Regul, V44, P143, DOI 10.4149/endo_2010_04_143; Naghii MR, 2013, UROLITHIASIS    1108; Nath SJ, 2013, UROTODAY INT J, V6; Shakhssalim N, 2011, UROL RES, V39, P1, DOI 10.1007/s00240-010-0276-3; Soundararajan P., 2006, Indian Journal of Experimental Biology, V44, P981; Travison TG, 2009, CURR OPIN ENDOCRINOL, V16, P211, DOI 10.1097/MED.0b013e32832b6348; Yagisawa T, 2001, J UROLOGY, V166, P1078, DOI 10.1016/S0022-5347(05)65925-3; Yeap BB, 2007, EUR J ENDOCRINOL, V156, P585, DOI 10.1530/EJE-06-0714; Yoshioka I, 2010, UROLOGY, V75, P907, DOI 10.1016/j.urology.2009.09.094; Zhao ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075513	22	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93790	10.1371/journal.pone.0093790	http://dx.doi.org/10.1371/journal.pone.0093790			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695421	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000124
J	Perjes, A; Skoumal, R; Tenhunen, O; Konyi, A; Simon, M; Horvath, IG; Kerkela, R; Ruskoaho, H; Szokodi, I				Perjes, Abel; Skoumal, Reka; Tenhunen, Olli; Konyi, Attila; Simon, Mihaly; Horvath, Ivan G.; Kerkela, Risto; Ruskoaho, Heikki; Szokodi, Istvan			Apelin Increases Cardiac Contractility via Protein Kinase C epsilon- and Extracellular Signal-Regulated Kinase-Dependent Mechanisms	PLOS ONE			English	Article							LIGHT-CHAIN PHOSPHORYLATION; ENDOGENOUS PEPTIDE LIGAND; ORPHAN RECEPTOR APJ; DIFFERENTIAL ACTIVATION; VENTRICULAR MYOCYTES; POSITIVE INOTROPY; TROPONIN-I; ENDOTHELIN-1; MYOCARDIUM; MODULATION	Background: Apelin, the endogenous ligand for the G protein-coupled apelin receptor, is an important regulator of the cardiovascular homoeostasis. We previously demonstrated that apelin is one of the most potent endogenous stimulators of cardiac contractility; however, its underlying signaling mechanisms remain largely elusive. In this study we characterized the contribution of protein kinase C (PKC), extracellular signal-regulated kinase 1/2 (ERK1/2) and myosin light chain kinase (MLCK) to the positive inotropic effect of apelin. Methods and Results: In isolated perfused rat hearts, apelin increased contractility in association with activation of prosurvival kinases PKC and ERK1/2. Apelin induced a transient increase in the translocation of PKC epsilon, but not PKC alpha, from the cytosol to the particulate fraction, and a sustained increase in the phosphorylation of ERK1/2 in the left ventricle. Suppression of ERK1/2 activation diminished the apelin-induced increase in contractility. Although pharmacological inhibition of PKC attenuated the inotropic response to apelin, it had no effect on ERK1/2 phosphorylation. Moreover, the apelin-induced positive inotropic effect was significantly decreased by inhibition of MLCK, a kinase that increases myofilament Ca2+ sensitivity. Conclusions: Apelin increases cardiac contractility through parallel and independent activation of PKCe and ERK1/2 signaling in the adult rat heart. Additionally MLCK activation represents a downstream mechanism in apelin signaling. Our data suggest that, in addition to their role in cytoprotection, modest activation of PKC epsilon and ERK1/2 signaling improve contractile function, therefore these pathways represent attractive possible targets in the treatment of heart failure.	[Perjes, Abel; Tenhunen, Olli; Kerkela, Risto; Ruskoaho, Heikki] Univ Oulu, Inst Biomed, Dept Pharmacol & Toxicol, Oulu, Finland; [Perjes, Abel; Skoumal, Reka; Konyi, Attila; Simon, Mihaly; Horvath, Ivan G.; Szokodi, Istvan] Univ Pecs, Sch Med, Inst Heart, Pecs, Hungary; [Perjes, Abel; Skoumal, Reka; Konyi, Attila; Simon, Mihaly; Horvath, Ivan G.; Szokodi, Istvan] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary; [Ruskoaho, Heikki] Univ Helsinki, Fac Pharm, Helsinki, Finland; [Kerkela, Risto] Med Res Ctr Oulu, Oulu, Finland	University of Oulu; University of Pecs; University of Pecs; University of Helsinki	Szokodi, I (corresponding author), Univ Oulu, Inst Biomed, Dept Pharmacol & Toxicol, Oulu, Finland.	istvan.szokodi@pte.hu	Szokodi, Istvan/X-3704-2019	Szokodi, Istvan/0000-0002-2162-6155	Academy of Finland Center of Excellence; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; Biocenter Finland; Foundation for the Development of Interventional Cardiology (Hungary); Social Renewal Operational Programme of New Hungary Development Plan [TAMOP-4.2.4.A/2-11-1-2012-0001, TAMOP 4.2.2./B-10/1-2010-0029]; European Union; European Social Fund	Academy of Finland Center of Excellence(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Biocenter Finland; Foundation for the Development of Interventional Cardiology (Hungary); Social Renewal Operational Programme of New Hungary Development Plan; European Union(European Commission); European Social Fund(European Social Fund (ESF))	This work was supported by the Academy of Finland Center of Excellence, the Sigrid Juselius Foundation, the Finnish Foundation for Cardiovascular Research, the Biocenter Finland (to A.P.), and the Foundation for the Development of Interventional Cardiology (Hungary). In addition, the study was supported by the Social Renewal Operational Programme of New Hungary Development Plan (TAMOP-4.2.4.A/2-11-1-2012-0001, Zoltan Magyary Postdoctoral Fellowship in the frames of the "National Excellence Program" to R.S.; and TAMOP 4.2.2./B-10/1-2010-0029 Supporting Scientific Training of Talented Youth at the University of Pecs to M.S., subsidized by the European Union and co-financed by the European Social Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes GD, 2013, CIRC-HEART FAIL, V6, P482, DOI 10.1161/CIRCHEARTFAILURE.111.000077; Bellahcene M, 2006, J AM COLL CARDIOL, V48, P545, DOI 10.1016/j.jacc.2006.02.072; Berry MF, 2004, CIRCULATION, V110, pII187, DOI 10.1161/01.CIR.0000138382.57325.5c; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Chamberland C, 2010, J MOL CELL CARDIOL, V48, P694, DOI 10.1016/j.yjmcc.2009.12.011; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Chen MM, 2003, CIRCULATION, V108, P1432, DOI 10.1161/01.CIR.0000091235.94914.75; Cheng X, 2003, EUR J PHARMACOL, V470, P171, DOI 10.1016/S0014-2999(03)01821-1; Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871; Churchill E, 2008, ANNU REV PHARMACOL, V48, P569, DOI 10.1146/annurev.pharmtox.48.121806.154902; CLERK A, 1994, J BIOL CHEM, V269, P32848; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; D'Aniello C, 2009, CIRC RES, V105, P231, DOI 10.1161/CIRCRESAHA.109.201186; Dai TY, 2006, EUR J PHARMACOL, V553, P222, DOI 10.1016/j.ejphar.2006.09.034; Ding PG, 2010, J BIOL CHEM, V285, P40819, DOI 10.1074/jbc.M110.160499; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Falcao-Pires I, 2009, AM J PHYSIOL-HEART C, V296, pH2007, DOI 10.1152/ajpheart.00089.2009; Farkasfalvi K, 2007, BIOCHEM BIOPH RES CO, V357, P889, DOI 10.1016/j.bbrc.2007.04.017; Foldes G, 2003, BIOCHEM BIOPH RES CO, V308, P480, DOI 10.1016/S0006-291X(03)01424-4; Grimm M, 2006, BRIT J PHARMACOL, V148, P991, DOI 10.1038/sj.bjp.0706803; Gu XH, 2010, CARDIOVASC RES, V88, P334, DOI 10.1093/cvr/cvq223; Hashimoto T, 2006, ARTERIOSCL THROM VAS, V26, P1267, DOI 10.1161/01.ATV.0000218841.39828.91; Heidkamp MC, 2001, CIRC RES, V89, P882, DOI 10.1161/hh2201.099434; Hidalgo C, 2006, ARCH BIOCHEM BIOPHYS, V456, P216, DOI 10.1016/j.abb.2006.06.026; Hunter J. Craig, 2005, Journal of Pharmacological and Toxicological Methods, V51, P129, DOI 10.1016/j.vascn.2004.10.003; Japp AG, 2010, CIRCULATION, V121, P1818, DOI 10.1161/CIRCULATIONAHA.109.911339; Kaikkonen L, 2014, J MOL CELL CARDIOL, V67, P86, DOI 10.1016/j.yjmcc.2013.12.005; Kamm KE, 2011, J BIOL CHEM, V286, P9941, DOI 10.1074/jbc.R110.198697; Kanaya N, 2003, ANESTHESIOLOGY, V98, P1363, DOI 10.1097/00000542-200306000-00010; Kang M, 2006, EXP BIOL MED, V231, P865; Kang MS, 2005, J MOL CELL CARDIOL, V38, P753, DOI 10.1016/j.yjmcc.2005.02.017; Kehat I, 2011, CIRC RES, V108, P176, DOI 10.1161/CIRCRESAHA.110.231514; KRAMER BK, 1991, CIRC RES, V68, P269, DOI 10.1161/01.RES.68.1.269; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Liao P, 2002, CIRC RES, V90, P190, DOI 10.1161/hh0202.104220; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Maguire JJ, 2009, HYPERTENSION, V54, P598, DOI 10.1161/HYPERTENSIONAHA.109.134619; Malo ME, 2007, J BIOL CHEM, V282, P6292, DOI 10.1074/jbc.M611073200; Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje; MOCHLYROSEN D, 1990, CELL REGUL, V1, P693, DOI 10.1091/mbc.1.9.693; O-Uchi J, 2008, CIRC RES, V102, P1378, DOI 10.1161/CIRCRESAHA.107.167734; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Pi YQ, 2003, J PHYSIOL-LONDON, V552, P845, DOI 10.1113/jphysiol.2003.045260; Pitkin SL, 2010, PHARMACOL REV, V62, P331, DOI 10.1124/pr.110.002949; Rajashree R, 2005, AM J PHYSIOL-HEART C, V289, pH1736, DOI 10.1152/ajpheart.00318.2004; Riise J, 2008, CARDIOVASC RES, V80, P407, DOI 10.1093/cvr/cvn216; Robia SL, 2001, BIOPHYS J, V80, P2140, DOI 10.1016/S0006-3495(01)76187-5; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Russell FD, 2004, CARDIOVASC RES, V63, P673, DOI 10.1016/j.cardiores.2004.05.009; Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263; Simpkin JC, 2007, BASIC RES CARDIOL, V102, P518, DOI 10.1007/s00395-007-0671-2; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Szokodi I, 2008, CIRCULATION, V118, P1651, DOI 10.1161/CIRCULATIONAHA.107.758623; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; VENEMA RC, 1993, BIOCHEM J, V294, P401, DOI 10.1042/bj2940401; Wang C, 2008, AM J PHYSIOL-HEART C, V294, pH2540, DOI 10.1152/ajpheart.00046.2008; Wang W, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000249; Wu GY, 2000, J BIOL CHEM, V275, P29927, DOI 10.1074/jbc.C000380200; Zheng M, 2000, J BIOL CHEM, V275, P40635, DOI 10.1074/jbc.M006325200	59	64	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93473	10.1371/journal.pone.0093473	http://dx.doi.org/10.1371/journal.pone.0093473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695532	Green Submitted, gold, Green Published			2022-12-27	WOS:000334103000077
J	Scott, FM; Speck, SH				Scott, Francine M.; Speck, Samuel H.			A Tissue Culture Model of Murine Gammaherpesvirus Replication Reveals Roles for the Viral Cyclin in Both Virus Replication and Egress from Infected Cells	PLOS ONE			English	Article							68 V-CYCLIN; EPITHELIAL-CELL; HERPESVIRUS-INFECTION; CDK INHIBITORS; DEFICIENT MICE; PROTEIN; PATHOGENESIS; REACTIVATION; PROGRESSION; LYMPHOMA	Passage through the eukaryotic cell cycle is regulated by the activity of cyclins and their cyclin-dependent kinase partners. Rhadinoviruses, such as Kaposi's sarcoma-associated herpesvirus (KSHV) and murine gammaherpesvirus 68 (MHV68), encode a viral homologue of mammalian D-type cyclins. In MHV68, the interaction of the viral cyclin with its CDK partners is important for acute replication in the lungs following low dose inoculation. Attempts to further study this requirement in vitro have been limited by the lack of available tissue culture models that mimic the growth defect observed in vivo. It is hypothesized that analysis of virus replication in a cell line that displays properties of primary airway epithelium, such as the ability to polarize, might provide a suitable environment to characterize the role of the v-cyclin in virus replication. We report here MHV68 replication in the rat lung cell line RL-65, a non-transformed polarizable epithelial cell line. These analyses reveal a role for the v-cyclin in both virus replication, as well as virus egress from infected cells. As observed for acute replication in vivo, efficient replication in RL-65 cells requires CDK binding. However, we show that the KSHV v-cyclin (K-cyclin), which utilizes different CDK partners (CDK4 and CDK6) than the MHV68 v-cyclin (CDK2 and CDC2), can partially rescue the replication defect observed with a v-cyclin null mutant - both in vitro and in vivo. Finally, we show that MHV68 is shed from both the apical and basolateral surfaces of polarized RL-65 cells. In summary, the RL-65 cell line provides an attractive in vitro model that mimics critical aspects of MHV68 replication in the lungs.	[Scott, Francine M.; Speck, Samuel H.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Scott, Francine M.; Speck, Samuel H.] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA	Emory University; Emory University	Speck, SH (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	sspeck@emory.edu	Speck, Samuel/L-5893-2019		NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; Besson A, 2004, NAT REV CANCER, V4, P948, DOI 10.1038/nrc1501; Blagosklonny MV, 2006, J CELL PHYSIOL, V209, P592, DOI 10.1002/jcp.20750; Caldon CE, 2010, CELL CYCLE, V9, P1918, DOI 10.4161/cc.9.10.11474; Chang PC, 2008, J VIROL, V82, P278, DOI 10.1128/JVI.01552-07; Coleman HM, 2003, J VIROL, V77, P2410, DOI 10.1128/JVI.77.4.2410-2417.2003; Collins CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033230; Dal Conto AJ, 2000, J VIROL, V74, P11304, DOI 10.1128/JVI.74.23.11304-11310.2000; Ebrahimi B, 2001, AM J PATHOL, V158, P2117, DOI 10.1016/S0002-9440(10)64683-4; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; GoddenKent D, 1997, J VIROL, V71, P4193, DOI 10.1128/JVI.71.6.4193-4198.1997; Hamirally S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000275; Johnson DC, 2002, J VIROL, V76, P1, DOI 10.1128/JVI.76.1.1-8.2002; Kazmierczak BI, 2001, ANNU REV MICROBIOL, V55, P407, DOI 10.1146/annurev.micro.55.1.407; Lee KS, 2009, J VIROL, V83, P11397, DOI 10.1128/JVI.00989-09; Li MT, 1997, J VIROL, V71, P1984, DOI 10.1128/JVI.71.3.1984-1991.1997; Mora AL, 2007, AM J RESP CRIT CARE, V175, P1139, DOI 10.1164/rccm.200610-1426OC; Nelson WJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000513; Platt GM, 2000, VIROLOGY, V272, P257, DOI 10.1006/viro.2000.0343; RAJCANI J, 1985, ACTA VIROL, V29, P51; ROBERTS PE, 1990, AM J PHYSIOL, V259, pL415, DOI 10.1152/ajplung.1990.259.6.L415; Ryeom SW, 2000, MOL BIOL CELL, V11, P1687, DOI 10.1091/mbc.11.5.1687; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P2347, DOI 10.1099/0022-1317-73-9-2347; Swanton C, 2001, INT J EXP PATHOL, V82, P3, DOI 10.1046/j.1365-2613.2001.00165.x; Tarakanova VL, 2005, J VIROL, V79, P14668, DOI 10.1128/JVI.79.23.14668-14679.2005; Terry LA, 2000, J GEN VIROL, V81, P2635, DOI 10.1099/0022-1317-81-11-2635; Upton JW, 2006, J VIROL, V80, P11946, DOI 10.1128/JVI.01722-06; Upton JW, 2005, VIROLOGY, V341, P271, DOI 10.1016/j.virol.2005.07.014; van Dyk LF, 2000, J VIROL, V74, P7451, DOI 10.1128/JVI.74.16.7451-7461.2000; Van Dyk LF, 1999, J VIROL, V73, P5110, DOI 10.1128/JVI.73.6.5110-5122.1999; Verschuren EW, 2004, J GEN VIROL, V85, P1347, DOI 10.1099/vir.0.79812-0; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Wang XQ, 2009, MOL BIOL CELL, V20, P791, DOI 10.1091/mbc.E08-07-0732; Xie ZG, 2006, CEREB CORTEX, V16, pI64, DOI 10.1093/cercor/bhj170	35	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93871	10.1371/journal.pone.0093871	http://dx.doi.org/10.1371/journal.pone.0093871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695529	gold, Green Published, Green Submitted			2022-12-27	WOS:000334103000128
J	Liu, YW; Cao, L; Chang, J; Lin, J; He, B; Rao, J; Zhang, Z; Zhang, XM				Liu, Yingwen; Cao, Lei; Chang, Jiang; Lin, Jia; He, Bing; Rao, Juan; Zhang, Zhi; Zhang, Xuemei			XPF-673C > T Polymorphism Effect on the Susceptibility to Esophageal Cancer in Chinese Population	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; NUCLEOTIDE EXCISION-REPAIR; DNA-REPAIR; GENETIC VARIANT; BREAST-CANCER; RISK; EXPRESSION; DAMAGE; ERCC1; XPF	Purpose: Xeroderma pigmentsum group F (XPF) plays a pivotal role in DNA nucleotide excision repair and has been linked to the development of various cancers. This study aims to assess the association of XPF genetic variants with the susceptibility to esophageal squamous cell carcinoma (ESCC) in Chinese population. Methods: This two-stage case-control study was conducted in a total of 1524 patients with ESCC and 1524 controls. Genotype of XPF -673C>T and 11985A>G variants were determined by polymerase chain reaction-based restriction fragment length polymorphism (PCR- RFLP). Logistic regression analysis was performed to estimate odd ratios (ORs) and 95% confidence intervals (95% CI). Results: Our case-control study showed that XPF -673TT genotype was associated with a decreased risk of ESCC compared with CC genotype in both case-control sets (Tangshan set: OR = 0.58; 95%CI = 0.34-0.99, P = 0.040; Beijing set: OR = 0.66; 95% CI = 0.46- 0.95, P = 0.027). Stratified analyses revealed that a multiplicative interaction between - 673C>T variant and age, sex or smoking status was evident (Gene-age: P-interaction = 0.002; Gene- sex: P-interaction = 0.002; Gene- smoking: P-interaction = 0.002). For XPF 11985A>G polymorphism, there was no significant difference of genotype distribution between ESCC cases and controls. Conclusion: These findings indicated that genetic variants in XPF might contribute to the susceptibility to ESCC.	[Liu, Yingwen; Cao, Lei; Lin, Jia; He, Bing; Rao, Juan; Zhang, Xuemei] Hebei United Univ, Coll Life Sci, Dept Mol Genet, Tangshan, Peoples R China; [Liu, Yingwen] Hebei United Univ, Coll Life Sci, Dept Epidemiol, Tangshan, Peoples R China; [Chang, Jiang] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100730, Peoples R China; [Zhang, Zhi] Hebei United Univ, Affiliated Tangshan Gongren Hosp, Tangshan, Peoples R China	North China University of Science & Technology; North China University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; North China University of Science & Technology	Zhang, XM (corresponding author), Hebei United Univ, Coll Life Sci, Dept Mol Genet, Tangshan, Peoples R China.	jyxuemei@gmail.com	LIU, YING/GZL-7252-2022		National Natural Science Foundation of China [81272613]; Science Fund for Distinguished Young Scholars of Hebei Scientific Committee [H2012401022]; Leader Talent Cultivation Plan of Innovation Team in Hebei province [LJRC001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Distinguished Young Scholars of Hebei Scientific Committee; Leader Talent Cultivation Plan of Innovation Team in Hebei province	This study was supported by the National Natural Science Foundation of China (81272613 to X. Zhang), Science Fund for Distinguished Young Scholars of Hebei Scientific Committee (H2012401022 to X. Zhang) and Leader Talent Cultivation Plan of Innovation Team in Hebei province (LJRC001 to X. Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstralh DT, 2008, TRENDS GENET, V24, P70, DOI 10.1016/j.tig.2007.11.003; Berwick M, 2000, JNCI-J NATL CANCER I, V92, P874, DOI 10.1093/jnci/92.11.874; Bowles M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks284; Chen W, 2013, BREAST CANCER RES TR, V142, P637, DOI 10.1007/s10549-013-2775-8; Das D, 2012, STRUCTURE, V20, P667, DOI 10.1016/j.str.2012.02.009; FAN XJ, 2013, SICHUAN DA XUE XUE B, V44; Fareed KR, 2010, BRIT J CANCER, V102, P1600, DOI 10.1038/sj.bjc.6605686; Gaillard PHL, 2001, NUCLEIC ACIDS RES, V29, P872, DOI 10.1093/nar/29.4.872; Han JL, 2009, BREAST CANCER RES TR, V115, P613, DOI 10.1007/s10549-008-0089-z; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; Ji GX, 2013, TOXICOL LETT, V218, P144, DOI 10.1016/j.toxlet.2013.01.017; Lee JM, 2001, INT J CANCER, V95, P240, DOI 10.1002/1097-0215(20010720)95:4<240::AID-IJC1041>3.0.CO;2-1; Lieberman L, 2013, AM J PUBLIC HEALTH, V103, P1942, DOI 10.2105/AJPH.2013.301284; Liu Y, 2011, DNA REPAIR, V10, P684, DOI 10.1016/j.dnarep.2011.04.020; McNeil EM, 2012, NUCLEIC ACIDS RES, V40, P9990, DOI 10.1093/nar/gks818; Nathrath M, 2002, KLIN PADIATR, V214, P230, DOI 10.1055/s-2002-33189; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shaoa MH, 2008, LUNG CANCER, V60, P332, DOI 10.1016/j.lungcan.2007.10.023; Shi TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038606; Thrift AP, 2012, INT J CANCER, V131, pE759, DOI 10.1002/ijc.27420; Vaezi A, 2011, CLIN CANCER RES, V17, P5513, DOI 10.1158/1078-0432.CCR-11-0086; WANG M, 2010, ONCOGENE, V29; Wang YF, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-11; Ye B, 2013, GENET TEST MOL BIOMA; Yu D-K, 2010, FRONT MED-PRC, V4, P82, DOI [10.1007/s11684-010-0014-9, DOI 10.1007/S11684-010-0014-9]; Zhang JS, 2013, ASIAN PAC J CANCER P, V14, P1847, DOI 10.7314/APJCP.2013.14.3.1847; Zhang XJ, 2013, CARCINOGENESIS, V34, P2309, DOI 10.1093/carcin/bgt213; Zhong R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04147; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395; 2013, APPL BIOCH BIOTECHNO	30	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94136	10.1371/journal.pone.0094136	http://dx.doi.org/10.1371/journal.pone.0094136			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709955	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800104
J	Nagata, M; Nakamura, T; Sotozono, C; Inatomi, T; Yokoi, N; Kinoshita, S				Nagata, Maho; Nakamura, Takahiro; Sotozono, Chie; Inatomi, Tsutomu; Yokoi, Norihiko; Kinoshita, Shigeru			LRIG1 as a Potential Novel Marker for Neoplastic Transformation in Ocular Surface Squamous Neoplasia	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CONJUNCTIVAL INTRAEPITHELIAL NEOPLASIA; NEGATIVE REGULATOR LRIG1; CANCER STEM-CELLS; HUMAN-PAPILLOMAVIRUS; IMMUNOHISTOCHEMICAL ANALYSIS; TUMOR-SUPPRESSOR; CARCINOMA; EXPRESSION; HOMEOSTASIS	The leucine rich repeats and immunoglobulin-like protein 1 (LRIG1) is a newly discovered negative regulator of epidermal growth factor receptor (EGFR) and a proposed tumor suppressor. It is not universally downregulated in human cancers, and its role in neoplastic transformation and tumorigenesis is not well-documented. In this study, we show the expression of LRIG1 as a novel potential marker for neoplastic transformation in ocular-surface squamous neoplasia (OSSN). The following two groups were included in this study: 1) benign group (3 cases; 1 with papilloma and 2 with dysplasia) and 2) malignant group (3 cases with squamous cell carcinoma (SCC)). In both groups, immunofluorescence analysis was firstly performed for keratins 4, 12, 13, and 15 to characterize the state of differentiation, and for Ki67 to evaluate the proliferation activity. Subsequently, LRIG1 and EGFR expression was analyzed. Either keratin 4 and/or 13, both non-keratinized epithelial cell markers, were generally expressed in both groups, except for 1 severe SCC case. Keratin 15, an undifferentiated basal cell marker, was more strongly expressed in the malignant cases than in the benign cases. The Ki67 index was significantly higher (P<0.002) in the malignant group (33.2%) than in the benign group (10.9%). LRIG1 expression was limited to basal epithelial cells in normal corneal epithelial tissue. Interestingly, LRIG1 was expressed throughout the epithelium in all the benign cases. In contrast, its expression was limited or totally disappeared in the malignant cases. Inversely, EGFR staining was faintly expressed in the benign cases, yet strongly expressed in the malignant cases. Malignant tissue with proliferative potential presented EGFR overexpression and inverse downregulation of LRIG1, consistent with LRIG1 being a suppressor of neoplastic transformation by counteracting the tumor growth property of EGFR. Our findings indicate that downregulation of LRIG1 is possibly a novel potential marker of transformation and tumorigenesis in OSSN cases.	[Nagata, Maho; Nakamura, Takahiro; Sotozono, Chie; Inatomi, Tsutomu; Yokoi, Norihiko; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Nakamura, Takahiro] Doshisha Univ, Res Ctr Inflammat & Regenerat Med, Kyoto 602, Japan	Kyoto Prefectural University of Medicine; Doshisha University	Nakamura, T (corresponding author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan.	tnakamur@koto.kpu-m.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [23592621]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in-Aid for scientific research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (23592621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves LFD, 2012, CORNEA, V31, P817, DOI 10.1097/ICO.0b013e31823f7857; Ateenyi-Agaba C, 2004, MUTAGENESIS, V19, P399, DOI 10.1093/mutage/geh048; Ateenyi-Agaba C, 2004, BRIT J CANCER, V90, P1777, DOI 10.1038/sj.bjc.6601743; De Vries A, 1998, EXP EYE RES, V67, P53, DOI 10.1006/exer.1998.0485; Di Girolamo N, 2013, OCUL SURF, V11, P193, DOI 10.1016/j.jtos.2013.01.006; Eng HL, 2002, AM J CLIN PATHOL, V117, P429, DOI 10.1309/RVUP-QMU3-5X6W-3CQ1; ERIE JC, 1986, OPHTHALMOLOGY, V93, P176; Goldoni S, 2007, ONCOGENE, V26, P368, DOI 10.1038/sj.onc.1209803; Gridelli C, 2011, LUNG CANCER, V72, P3, DOI 10.1016/j.lungcan.2010.12.009; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Guthoff R, 2009, CURR EYE RES, V34, P666, DOI 10.1080/02713680903007162; Hedman H, 2002, ACTA ONCOL, V41, P352, DOI 10.1080/028418602760169398; ILIFF WJ, 1975, ARCH OPHTHALMOL-CHIC, V93, P119; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Kelly JG, 2010, ANALYST, V135, P3120, DOI 10.1039/c0an00507j; KESTELYN P, 1990, LANCET, V336, P51, DOI 10.1016/0140-6736(90)91562-O; Kiire CA, 2006, BRIT J OPHTHALMOL, V90, P109, DOI 10.1136/bjo.2005.077305; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Lee GA, 1997, AUST NZ J OPHTHALMOL, V25, P269, DOI 10.1111/j.1442-9071.1997.tb01514.x; LEE GA, 1995, SURV OPHTHALMOL, V39, P429, DOI 10.1016/S0039-6257(05)80054-2; LEE GA, 1992, ARCH OPHTHALMOL-CHIC, V110, P525, DOI 10.1001/archopht.1992.01080160103042; Lu L, 2013, J PATHOL, V229, P608, DOI 10.1002/path.4148; Mao F, 2013, INT J ONCOL, V42, P1081, DOI 10.3892/ijo.2013.1776; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; Nakamura T, 2014, J CLIN INVEST, V124, P385, DOI 10.1172/JCI71488; Newton R, 1996, LANCET, V347, P1450, DOI 10.1016/S0140-6736(96)91685-2; Nilsson J, 2001, BIOCHEM BIOPH RES CO, V284, P1155, DOI 10.1006/bbrc.2001.5092; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; Ohara M, 2004, JPN J OPHTHALMOL, V48, P524, DOI 10.1007/s10384-004-0129-0; Park KS, 2006, INVEST OPHTH VIS SCI, V47, P892, DOI 10.1167/iovs.05-1006; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Saegusa M, 1995, J CLIN PATHOL, V48, P1106, DOI 10.1136/jcp.48.12.1106; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Scott IU, 2002, OPHTHALMOLOGY, V109, P542, DOI 10.1016/S0161-6420(01)00991-5; Shepler TR, 2006, OPHTHAL PLAST RECONS, V22, P113, DOI 10.1097/01.iop.0000202609.92772.c3; Sheu JJ, 2013, ONCOGENE; Shields CL, 2004, OPHTHALMOLOGY, V111, P1747, DOI 10.1016/j.ophtha.2004.02.013; Shimizu T, 2001, DERMATOLOGY, V202, P203, DOI 10.1159/000051637; Sjo NC, 2007, BRIT J OPHTHALMOL, V91, P1014, DOI 10.1136/bjo.2006.108811; Stutz MA, 2008, ONCOGENE, V27, P5741, DOI 10.1038/onc.2008.185; Suzuki Y, 2002, BRAIN DEV-JPN, V24, P1; TABBARA KF, 1988, OPHTHALMOLOGY, V95, P318; Tanemura A, 2005, DERMATOL SURG, V31, P423, DOI 10.1097/00042728-200504000-00008; TEMPLETON AC, 1967, CANCER-AM CANCER SOC, V20, P1689, DOI 10.1002/1097-0142(196710)20:10<1689::AID-CNCR2820201019>3.0.CO;2-F; Thomasson M, 2003, BRIT J CANCER, V89, P1285, DOI 10.1038/sj.bjc.6601208; Tulvatana W, 2003, BRIT J OPHTHALMOL, V87, P396, DOI 10.1136/bjo.87.4.396; Tunc M, 1999, BRIT J OPHTHALMOL, V83, P98, DOI 10.1136/bjo.83.1.98; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Vermeulen L, 2008, CELL DEATH DIFFER, V15, P947, DOI 10.1038/cdd.2008.20; Vermorken JB, 2010, ANN ONCOL, V21, P252, DOI 10.1093/annonc/mdq453; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Xie RF, 2013, ONCOL REP, V29, P177, DOI 10.3892/or.2012.2102; Ye F, 2009, J NEURO-ONCOL, V94, P183, DOI 10.1007/s11060-009-9836-1; Yi W, 2011, EXP CELL RES, V317, P504, DOI 10.1016/j.yexcr.2010.11.005	56	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93164	10.1371/journal.pone.0093164	http://dx.doi.org/10.1371/journal.pone.0093164			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709893	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800023
J	Ranucci, M; Ballotta, A; La Rovere, MT; Castelvecchio, S				Ranucci, Marco; Ballotta, Andrea; La Rovere, Maria Teresa; Castelvecchio, Serenella		Surgical & Clinical Outcome Res SC	Postoperative Hypoxia and Length of Intensive Care Unit Stay after Cardiac Surgery: The Underweight Paradox?	PLOS ONE			English	Article							HEPARIN-COATED CIRCUITS; CARDIOPULMONARY BYPASS; RESPIRATORY SYSTEM; LUNG DYSFUNCTION; OBESE-PATIENTS; RISK PATIENTS; TRANSFUSION; COMPONENTS; MECHANICS; INJURY	Objective: Cardiac operations with cardiopulmonary bypass can be associated with postoperative lung dysfunction. The present study investigates the incidence of postoperative hypoxia after cardiac surgery, its relationship with the length of intensive care unit stay, and the role of body mass index in determining postoperative hypoxia and intensive care unit length of stay. Design: Single-center, retrospective study. Setting: University Hospital. Patients. Adult patients ( N = 5,023) who underwent cardiac surgery with CPB. Interventions: None. Measurements and main results: According to the body mass index, patients were attributed to six classes, and obesity was defined as a body mass index > 30. POH was defined as a PaO2/FiO2 ratio < 200 at the arrival in the intensive care unit. Postoperative hypoxia was detected in 1,536 patients ( 30.6%). Obesity was an independent risk factor for postoperative hypoxia ( odds ratio 2.4, 95% confidence interval 2.05-2.78, P = 0.001) and postoperative hypoxia was a determinant of intensive care unit length of stay. There is a significant inverse correlation between body mass index and PaO2/FiO2 ratio, with the risk of postoperative hypoxia increasing by 1.7 folds per each incremental body mass index class. The relationship between body mass index and intensive care unit length of stay is U-shaped, with longer intensive care unit stay in underweight patients and moderate-morbid obese patients. Conclusions: Obese patients are at higher risk for postoperative hypoxia, but this leads to a prolonged intensive care unit stay only for moderate-morbid obese patients. Obese patients are partially protected against the deleterious effects of hemodilution and transfusions. Underweight patients present the "paradox" of a better lung gas exchange but a longer intensive care unit stay. This is probably due to a higher severity of their cardiac disease.	[Ranucci, Marco; Ballotta, Andrea; Castelvecchio, Serenella] Fdn Salvatore Maugeri, IRCCS, Ist Sci Montescano, Dept Cardiothorac Vasc Anesthesia & Intens Care, Montescano, Italy; [La Rovere, Maria Teresa] Fdn Salvatore Maugeri, IRCCS, Ist Sci Montescano, Dept Cardiol, Montescano, Italy	Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS	Ranucci, M (corresponding author), Fdn Salvatore Maugeri, IRCCS, Ist Sci Montescano, Dept Cardiothorac Vasc Anesthesia & Intens Care, Montescano, Italy.	cardioanestesia@virgilio.it	Ranucci, Marco/K-1040-2016; La Rovere, Maria Teresa/D-6796-2019; , CASTELVECCHIO/J-9091-2016	Ranucci, Marco/0000-0002-4915-3572; La Rovere, Maria Teresa/0000-0002-1884-5058; , CASTELVECCHIO/0000-0001-5365-7063	IRCCS Policlinico San Donato	IRCCS Policlinico San Donato	This work was supported by local research funds at the IRCCS Policlinico San Donato. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, WHO TECH REP SER, V894, P1; Apostolakis E, 2010, J CARDIAC SURG, V25, P47, DOI 10.1111/j.1540-8191.2009.00823.x; Apostolakis EE, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-1; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Koch CG, 2006, CRIT CARE MED, V34, P1608, DOI 10.1097/01.CCM.0000217920.48559.D8; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Kress JP, 1999, AM J RESP CRIT CARE, V160, P883, DOI 10.1164/ajrccm.160.3.9902058; Leal-Noval SM, 2001, CHEST, V119, P1461, DOI 10.1378/chest.119.5.1461; Lin CK, 2012, RESPIROLOGY, V17, P402, DOI 10.1111/j.1440-1843.2011.02124.x; Lomivorotov VV, 2013, INTERACT CARDIOV TH, V16, P612, DOI 10.1093/icvts/ivs549; NAIMARK A, 1960, J APPL PHYSIOL, V15, P377, DOI 10.1152/jappl.1960.15.3.377; Ng CSH, 2002, CHEST, V121, P1269, DOI 10.1378/chest.121.4.1269; Pelosi P, 1996, CHEST, V109, P144, DOI 10.1378/chest.109.1.144; Ranucci M, 1996, ANN THORAC SURG, V61, P76, DOI 10.1016/0003-4975(95)00820-9; Ranucci M, 1999, J CARDIOTHOR VASC AN, V13, P280, DOI 10.1016/S1053-0770(99)90264-1; Ranucci M, 1999, ANN THORAC SURG, V67, P994, DOI 10.1016/S0003-4975(99)00062-4; Ranucci M, 1997, PERFUSION-UK, V12, P309, DOI 10.1177/026765919701200506; Ranucci M, 2009, ANN THORAC SURG, V87, P1311, DOI 10.1016/j.athoracsur.2008.09.076; RAY CS, 1983, AM REV RESPIR DIS, V128, P501, DOI 10.1164/arrd.1983.128.3.501; SAMPSON MG, 1983, AM J MED, V75, P81, DOI 10.1016/0002-9343(83)91171-3; Stephens RS, 2013, ANN THORAC SURG, V95, P1122, DOI 10.1016/j.athoracsur.2012.10.024; Szeles Tais Felix, 2008, Rev. Bras. Anestesiol., V58, P124, DOI 10.1590/S0034-70942008000200005; Tuinman PR, 2011, CRIT CARE, V15, DOI 10.1186/cc10032; Valentijn TM, 2013, SURG-J R COLL SURG E, V11, P169, DOI 10.1016/j.surge.2013.02.003; Weiss YG, 2000, J CARDIOTHOR VASC AN, V14, P506, DOI 10.1053/jcan.2000.9488; YAP JCH, 1995, J APPL PHYSIOL, V79, P1199, DOI 10.1152/jappl.1995.79.4.1199	27	44	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93992	10.1371/journal.pone.0093992	http://dx.doi.org/10.1371/journal.pone.0093992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709952	Green Submitted, gold, Green Published			2022-12-27	WOS:000334159800083
J	Basit, A; Ahmad, N; Khan, AH; Javaid, A; Sulaiman, SAS; Afridi, AK; Adnan, AS; ul Haq, I; Shah, SS; Ahadi, A; Ahmad, I				Basit, Anila; Ahmad, Nafees; Khan, Amer Hayat; Javaid, Arshad; Sulaiman, Syed Azhar Syed; Afridi, Afsar Khan; Adnan, Azreen Syazril; ul Haq, Israr; Shah, Syed Saleem; Ahadi, Ahmed; Ahmad, Izaz			Predictors of Two Months Culture Conversion in Multidrug-Resistant Tuberculosis: Findings from a Retrospective Cohort Study	PLOS ONE			English	Article							POSITIVE PULMONARY TUBERCULOSIS; SPUTUM SMEAR; MYCOBACTERIUM-TUBERCULOSIS; TREATMENT OUTCOMES; TIME; TRANSMISSION; PAKISTAN	Background: Various studies have reported culture conversion at two months as a predictor of successful treatment outcome in multidrug-resistant tuberculosis (MDR-TB). Objectives: The present study was conducted with the aim to evaluate the rate and predictors of culture conversion at two months in MDR-TB patients. Methods: All confirmed pulmonary MDR-TB patients enrolled for treatment at Lady Reading Hospital Peshawar, Pakistan from 1 January to 31 December 2012 and met the inclusion criteria were reviewed retrospectively. Rate and predictors of culture conversion at two months were evaluated. Results: Eighty seven (53.4%) out of 163 patients achieved culture conversion at two months. In a multivariate analysis lung cavitation at baseline chest X-ray (P = 0.006, OR = 0.349), resistance to ofloxacin (P = 0.041, OR = 0.193) and streptomycin (P = 0.017, OR = 0.295) had statistically significant (P<0.05) negative association with culture conversion at two months. Conclusion: A reasonable proportion of patients achieved culture conversion at two months. Factors negatively associated with culture conversion at two months can be easily identified either before diagnosis or early in the course of MDR-TB treatment. This may help in better care of individual patients by identifying them early and treating them vigorously.	[Basit, Anila] Post Grad Med Inst, Peshawar, Pakistan; [Ahmad, Nafees; Khan, Amer Hayat; Sulaiman, Syed Azhar Syed] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia; [Javaid, Arshad] Lady Reading Hosp, Dept Pulmonol, Peshawar, Pakistan; [Afridi, Afsar Khan] Lady Reading Hosp, Programmat Management Unit Drug Resistant TB, Peshawar, Pakistan; [Adnan, Azreen Syazril] Univ Sains Malaysia, Sch Med Sci, CKD Resource Ctr, Kota Baharu, Kelantan, Malaysia; [ul Haq, Israr] Saidu Med Coll, Dept Pediat, Saidu Sharif Swat, Pakistan; [Shah, Syed Saleem] Khyber Med Univ, Peshawar, Pakistan; [Ahadi, Ahmed] Univ Balochistan, Dept Pharm, Quetta, Pakistan; [Ahmad, Izaz] Quaid i Azam Univ, Dept Microbiol, Islamabad, Pakistan	Universiti Sains Malaysia; Universiti Sains Malaysia; Khyber Medical University; University of Balochistan; Quaid I Azam University	Ahmad, N (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia.	nafeesuob@gmail.com	Khan, Amer Hayat/O-5310-2018	Khan, Amer Hayat/0000-0003-4802-6181; Syed Sulaiman, Syed Azhar/0000-0002-0775-859X; Basit, Anila/0000-0003-1166-1632				Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Brust JCM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073975; Chan ED, 2004, AM J RESP CRIT CARE, V169, P1103, DOI 10.1164/rccm.200308-1159OC; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Guler M, 2007, INT J CLIN PRACT, V61, P231, DOI 10.1111/j.1742-1241.2006.01131.x; Hernandez-Garduno E, 2004, THORAX, V59, P286, DOI 10.1136/thx.2003.011759; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Hwang SS, 2009, EUR RESPIR J, V33, P581, DOI 10.1183/09031936.00099608; Jabeen K, 2011, EMERG INFECT DIS, V17, P564, DOI 10.3201/eid1703.100957; Joseph P, 2011, INDIAN J MED RES, V133, P529; Kim DH, 2010, AM J RESP CRIT CARE, V182, P113, DOI 10.1164/rccm.200911-1656OC; Kurbatova EV, 2012, INT J TUBERC LUNG D, V16, P1335, DOI 10.5588/ijtld.11.0811; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Qazi F, 2011, INT J TUBERC LUNG D, V15, P1556, DOI 10.5588/ijtld.10.0679; Rieder HL, 1996, TUBERCLE LUNG DIS, V77, P124, DOI 10.1016/S0962-8479(96)90026-X; Rodriguez M, 2013, INT J TUBERC LUNG D, V17, P520, DOI 10.5588/ijtld.12.0481; Salaniponi FML, 1999, INT J TUBERC LUNG D, V3, P1047; Singla R, 2003, INT J TUBERC LUNG D, V7, P58; Singla R, 2009, INT J TUBERC LUNG D, V13, P976; Telzak EE, 1997, CLIN INFECT DIS, V25, P666, DOI 10.1086/513772; Wells WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018964; Yew WW, 2000, CHEST, V117, P744, DOI 10.1378/chest.118.3.744	23	37	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93206	10.1371/journal.pone.0093206	http://dx.doi.org/10.1371/journal.pone.0093206			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705411	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500029
J	Cox, MC; Di Napoli, A; Scarpino, S; Salerno, G; Tatarelli, C; Talerico, C; Lombardi, M; Monarca, B; Amadori, S; Ruco, L				Cox, M. Christina; Di Napoli, Arianna; Scarpino, Stefania; Salerno, Gerardo; Tatarelli, Caterina; Talerico, Caterina; Lombardi, Mariangela; Monarca, Bruno; Amadori, Sergio; Ruco, Luigi			Clinicopathologic Characterization of Diffuse-Large-B-Cell Lymphoma with an Associated Serum Monoclonal IgM Component	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RITUXIMAB PLUS CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN CLASS SWITCH; CHOP CHEMOTHERAPY; STRONG PREDICTOR; POOR-PROGNOSIS; EXPRESSION; MYC; BCL2; DOXORUBICIN	Recently, diffuse-large-B-cell lymphoma (DLBCL) associated with serum IgM monoclonal component (MC) has been shown to be a very poor prognostic subset although, detailed pathological and molecular data are still lacking. In the present study, the clinicopathological features and survival of IgM-secreting DLBCL were analyzed and compared to non-secreting cases in a series of 151 conventional DLBCL treated with R-CHOP. IgM MC was detected in 19 (12.5%) out of 151 patients at disease onset. In 17 of these cases secretion was likely due to the neoplastic clone, as suggested by the expression of heavy chain IgM protein in the cytoplasm of tumor cells. In IgM-secreting cases immunoblastic features (p <.0001), non-GCB-type (p = .002) stage III- IV(p = .003), >= 2 extra nodal sites (p <.0001), bone-marrow (p = .002), central-nervous- system (CNS) involvement at disease onset or relapse (p <.0001), IPI-score 3-5 (p = .009) and failure to achieve complete remission (p = .005), were significantly more frequent. FISH analyses for BCL2, BCL6 and MYC gene rearrangements detected only two cases harboring BCL2 gene translocation and in one case a concomitant BCL6 gene translocation was also observed. None of the IgM-secreting DLBCL was found to have L265P mutation of MYD88 gene. Thirty-six month event-free (11.8% vs 66.4% p <.0001), progression-free (23.5% vs 75.7%, p <.0001) and overall (47.1% vs 74.8%, p <.0001) survivals were significantly worse in the IgM-secreting group. In multivariate analysis IgM-secreting (p = .005, expB = 0.339, Cl = 0.160-0.716) and IPI-score 3-5 (p = .010, expB = 0.274, Cl = 0.102-0.737) were the only significant factors for progression-free-survival. Notably, four relapsed patients, who were treated with salvage immmunochemotherapy combined with bortezomib or lenalidomide, achieved lasting remission. Our data suggests that IgM-secreting cases are a distinct subset of DLBCL, originating from activated-B-cells with terminally differentiated features, prevalent extra nodal dissemination and at high risk of CNS involvement.	[Cox, M. Christina; Tatarelli, Caterina; Monarca, Bruno] Univ Roma La Sapienza, Dept Clin & Mol Med, Hematol Unit, St Andreas Hosp, I-00185 Rome, Italy; [Di Napoli, Arianna; Scarpino, Stefania; Talerico, Caterina; Lombardi, Mariangela; Ruco, Luigi] Univ Roma La Sapienza, Dept Clin & Mol Med, Pathol Unit, St Andreas Hosp, I-00185 Rome, Italy; [Salerno, Gerardo] Univ Roma La Sapienza, Dept Clin & Mol Med, Clin Pathol Unit, St Andreas Hosp, I-00185 Rome, Italy; [Amadori, Sergio] Univ Roma Tor Vergata, Dept Hematol, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; University of Rome Tor Vergata	Cox, MC (corresponding author), Univ Roma La Sapienza, Dept Clin & Mol Med, Hematol Unit, St Andreas Hosp, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	chrisscox@gmail.com	Cox, M Christina/AAB-3514-2022; Di Napoli, Arianna/AAB-3210-2022; cox, maria christina/K-7503-2016	Di Napoli, Arianna/0000-0002-3159-5380; cox, maria christina/0000-0002-8597-8459; Amadori, Sergio/0000-0002-2356-8681; Salerno, Gerardo/0000-0002-6597-1452	Fondi di ricerca di Ateneo	Fondi di ricerca di Ateneo	Fondi di ricerca di Ateneo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani RH, 2010, BRIT J HAEMATOL, V151, P143, DOI 10.1111/j.1365-2141.2010.08331.x; Ahn JS, 2013, AM J HEMATOL, V88, P774, DOI 10.1002/ajh.23507; Akyurek N, 2012, CANCER-AM CANCER SOC, V118, P4173, DOI 10.1002/cncr.27396; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Barrans S, 2010, J CLIN ONCOL, V28, P3360, DOI 10.1200/JCO.2009.26.3947; Barrans SL, 2003, CLIN CANCER RES, V9, P2133; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Choi JW, 2013, HUM PATHOL, V44, P1375, DOI 10.1016/j.humpath.2012.10.026; Copie-Bergman C, 2009, J CLIN ONCOL, V27, P5573, DOI 10.1200/JCO.2009.22.7058; COX DR, 1972, J R STAT SOC B, V34, P187; Cox MC, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.2659.2659; Cox MC, 2008, LEUKEMIA LYMPHOMA, V49, P1745, DOI 10.1080/10428190802226425; Eskazan Ahmet Emre, 2011, Case Rep Gastroenterol, V5, P262, DOI 10.1159/000328445; Fu K, 2008, J CLIN ONCOL, V26, P4587, DOI 10.1200/JCO.2007.15.9277; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Hans CP, 2004, BLOOD; Hoeller S, 2010, HUM PATHOL, V41, P352, DOI 10.1016/j.humpath.2009.07.024; Horn H, 2013, BLOOD, V121, P2253, DOI 10.1182/blood-2012-06-435842; Jardin F, 2013, LEUKEMIA LYMPHOMA, V54, P1898, DOI 10.3109/10428194.2013.767456; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Koens L, 2010, AM J SURG PATHOL, V34, P1043, DOI 10.1097/PAS.0b013e3181e5060a; Kohyama S, 2001, SURG NEUROL, V56, P325, DOI 10.1016/S0090-3019(01)00573-0; Kraan W, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.28; Kramer MHH, 1998, BLOOD, V92, P3152, DOI 10.1182/blood.V92.9.3152.421a07_3152_3162; Lennert K, 1992, HISTOPATHOLOGY NONHO; Lenz G, 2007, J EXP MED, V204, P633, DOI 10.1084/jem.20062041; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Martelli M, 2013, CRIT REV ONCOL HEMAT, V87, P146, DOI 10.1016/j.critrevonc.2012.12.009; Marzano A, 2007, DIGEST LIVER DIS, V39, P397, DOI 10.1016/j.dld.2006.12.017; Maurer MJ, 2011, J CLIN ONCOL, V29, P1620, DOI 10.1200/JCO.2010.29.4413; Montes-Moreno S, 2010, HAEMATOL-HEMATOL J, V95, P1342, DOI 10.3324/haematol.2009.016113; Montesinos-Rongen M, 2005, AM J PATHOL, V166, P1773, DOI 10.1016/S0002-9440(10)62487-X; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Noguchi M, 2003, BRIT J HAEMATOL, V123, P600, DOI 10.1046/j.1365-2141.2003.04651.x; Ott G, 2010, BLOOD, V116, P4916, DOI 10.1182/blood-2010-03-276766; Pedersen MO, 2014, EUR J HAEMATOL, V92, P42, DOI 10.1111/ejh.12212; Pei L, 2005, AM J CLIN PATHOL, V123, P200, DOI 10.1309/2A0FL1HM5PN2510P; Pfreundschuh M, 2004, BLOOD, V104, P626, DOI 10.1182/blood-2003-06-2094; Randen U, 2014, HAEMATOLOGICA, V99, P497, DOI 10.3324/haematol.2013.091702; Ria R, 2009, EUR J CLIN INVEST, V39, P627, DOI 10.1111/j.1365-2362.2009.02147.x; Rigacci L, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.3694.3694; Ruminy P, 2011, LEUKEMIA, V25, P681, DOI 10.1038/leu.2010.302; Schroers R, 2010, EUR J HAEMATOL, V85, P236, DOI 10.1111/j.1600-0609.2010.01475.x; Sehn LH, 2005, J CLIN ONCOL, V23, P5027, DOI 10.1200/JCO.2005.09.137; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Swerdlow SH, 2008, WHO CLASSIFICATION T; Ventura RA, 2006, J MOL DIAGN, V8, P141, DOI 10.2353/jmoldx.2006.050083; Visco C, 2012, LEUKEMIA, V26, P2103, DOI 10.1038/leu.2012.83; Vitolo U, 2009, HAEMATOL-HEMATOL J, V94, P1250, DOI 10.3324/haematol.2009.007005; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Xu L, 2013, BLOOD, V121, P2051, DOI 10.1182/blood-2012-09-454355; Zinzani PL PC, 2012, HEMATOLOGIC IN PRESS	54	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93903	10.1371/journal.pone.0093903	http://dx.doi.org/10.1371/journal.pone.0093903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705344	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500091
J	McGillivray, A; Golden, NA; Gautam, US; Mehra, S; Kaushal, D				McGillivray, Amanda; Golden, Nadia Abrahams; Gautam, Uma Shankar; Mehra, Smriti; Kaushal, Deepak			The Mycobacterium tuberculosis Rv2745c Plays an Important Role in Responding to Redox Stress	PLOS ONE			English	Article							SIGMA-FACTOR; GENE-EXPRESSION; REGULATES EXPRESSION; 2-COMPONENT SYSTEM; IMMUNOPATHOLOGY; PATHOGENESIS; MACROPHAGES; CHAPERONE; PATHWAY; MPRAB	Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is the leading cause of death from an infectious disease worldwide. Over the course of its life cycle in vivo, Mtb is exposed to a plethora of environmental stress conditions. Temporal regulation of genes involved in sensing and responding to such conditions is therefore crucial for Mtb to establish an infection. The Rv2745c (clgR) gene encodes a Clp protease gene regulator that is induced in response to a variety of stress conditions and potentially plays a role in Mtb pathogenesis. Our isogenic mutant, Mtb:Delta Rv2745c, is significantly more sensitive to in vitro redox stress generated by diamide, relative to wild-type Mtb as well as to a complemented strain. Together with the fact that the expression of Rv2745c is strongly induced in response to redox stress, these results strongly implicate a role for ClgR in the management of intraphagosomal redox stress. Additionally, we observed that redox stress led to the dysregulation of the expression of the sigma(H)/sigma(E) regulon in the isogenic mutant, Mtb:Delta Rv2745c. Furthermore, induction of clgR in Mtb and Mtb:Delta Rv2745c (comp) did not lead to Clp protease induction, indicating that clgR has additional functions that need to be elucidated. Our data, when taken together with that obtained by other groups, indicates that ClgR plays diverse roles in multiple regulatory networks in response to different stress conditions. In addition to redox stress, the expression of Rv2745c correlates with the expression of genes involved in sulfate assimilation as well as in response to hypoxia and reaeration. Clearly, the Mtb Rv2745c-encoded ClgR performs different functions during stress response and is important for the pathogenicity of Mtb in-vivo, regardless of its induction of the Clp proteolytic pathway.	[McGillivray, Amanda; Golden, Nadia Abrahams; Gautam, Uma Shankar; Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Bacteriol, Covington, LA 70433 USA; [McGillivray, Amanda; Golden, Nadia Abrahams; Gautam, Uma Shankar; Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Parasitol, Covington, LA USA; [McGillivray, Amanda; Kaushal, Deepak] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Mehra, Smriti] Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA	Tulane University; Tulane University; Tulane University; Tulane University	Kaushal, D (corresponding author), Tulane Natl Primate Res Ctr, Div Bacteriol, Covington, LA 70433 USA.	dkaushal@tulane.edu	GAUTAM, UMA/AAI-1531-2021; Uma S Gautam, MSc/H-3474-2019	Uma S Gautam, MSc/0000-0003-0326-6325	NIH [AI089323, HL106790, AI091457, RR026006, RR020159, RR000164/OD011104, C06AI058609]; Louisiana Board of Regents [LEQSF (2007-12)-ENHPKSFI-PRS]; Tulane Research Enhancement Fund; Tulane Center for Infectious Diseases; Tulane National Primate Research Center Office; Tulane Office of the Vice-President for Research; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR026006, P20RR020159] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI091457, R01AI089323] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents; Tulane Research Enhancement Fund; Tulane Center for Infectious Diseases; Tulane National Primate Research Center Office; Tulane Office of the Vice-President for Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the NIH grants AI089323, with additional support from NIH grants HL106790, AI091457, RR026006, RR020159, RR000164/ OD011104 and C06AI058609. Additionally, the authors also acknowledge the support from the Louisiana Board of Regents (LEQSF (2007-12)-ENHPKSFI-PRS), the Tulane Research Enhancement Fund, the Tulane Center for Infectious Diseases, the Tulane National Primate Research Center Office of the Director and a Bridge Award from the Tulane Office of the Vice-President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren D, 2008, J BIOL CHEM, V283, P31567, DOI 10.1074/jbc.M804877200; Arko-Mensah J, 2007, SCAND J IMMUNOL, V65, P148, DOI 10.1111/j.1365-3083.2006.01888.x; Ascenzi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069762; Barik S, 2010, MOL MICROBIOL, V75, P592, DOI 10.1111/j.1365-2958.2009.07008.x; Bellier A, 2004, J BACTERIOL, V186, P3238, DOI 10.1128/JB.186.10.3238-3248.2004; Bhat SA, 2012, FREE RADICAL BIO MED, V53, P1625, DOI 10.1016/j.freeradbiomed.2012.08.008; Dutta NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028958; Dutta NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010069; Dye C, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0365; Estorninho M, 2010, MICROBIOL-SGM, V156, P3445, DOI 10.1099/mic.0.042275-0; Fontan PA, 2009, J BACTERIOL, V191, P5628, DOI 10.1128/JB.00510-09; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Hatzios SK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002036; He HJ, 2006, J BACTERIOL, V188, P2134, DOI 10.1128/JB.188.6.2134-2143.2006; Hernandez-Abanto SM, 2006, ARCH MICROBIOL, V186, P459, DOI 10.1007/s00203-006-0160-2; Jeena PM, 2001, B WORLD HEALTH ORGAN, V79, P337; Jurgenson CT, 2008, BIOCHEMISTRY-US, V47, P10354, DOI 10.1021/bi800915j; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Kumar A, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002079; Larsen Michelle H, 2007, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/9780471729259.mc10a02s6; Manganelli R, 2004, INFECT IMMUN, V72, P3038, DOI 10.1128/IAI.72.5.3038-3041.2004; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Mehra S, 2012, J INFECT DIS, V205, P1203, DOI 10.1093/infdis/jis102; Mehra S, 2010, J INFECT DIS, V202, P943, DOI 10.1086/654820; Mehra S, 2009, J BACTERIOL, V191, P3965, DOI 10.1128/JB.00064-09; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Pang XH, 2007, J BACTERIOL, V189, P6213, DOI 10.1128/JB.00492-07; Personne Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060228; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rohde KH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002769; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Sachdeva P, 2010, FEBS J, V277, P605, DOI 10.1111/j.1742-4658.2009.07479.x; Sherrid AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011622; Stewart GR, 2005, MOL MICROBIOL, V55, P1127, DOI 10.1111/j.1365-2958.2004.04450.x; Vandal OH, 2009, J BACTERIOL, V191, P4714, DOI 10.1128/JB.00305-09; Wang Y, 2011, J BIOL CHEM, V286, P31159, DOI 10.1074/jbc.M111.241802; World Health Organization, 2012, GLOB TUB REP 2012 IR, Vviii	38	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93604	10.1371/journal.pone.0093604	http://dx.doi.org/10.1371/journal.pone.0093604			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705585	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500047
J	Park, R; El-Guindy, A; Heston, L; Lin, SF; Yu, KP; Nagy, M; Borah, S; Delecluse, HJ; Steitz, J; Miller, G				Park, Richard; El-Guindy, Ayman; Heston, Lee; Lin, Su-Fang; Yu, Kuan-Ping; Nagy, Mate; Borah, Sumit; Delecluse, Henri-Jacques; Steitz, Joan; Miller, George			Nuclear Translocation and Regulation of Intranuclear Distribution of Cytoplasmic Poly(A)-Binding Protein Are Distinct Processes Mediated by Two Epstein Barr Virus Proteins	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; POLY(A) BINDING-PROTEIN; MESSENGER-RNA; GENE-EXPRESSION; ZEBRA PROTEIN; HOST SHUTOFF; IN-VIVO; REPLICATION COMPARTMENTS; BURKITTS-LYMPHOMA; DNA-REPLICATION	Many viruses target cytoplasmic polyA binding protein (PABPC) to effect widespread inhibition of host gene expression, a process termed viral host-shutoff (vhs). During lytic replication of Epstein Barr Virus (EBV) we observed that PABPC was efficiently translocated from the cytoplasm to the nucleus. Translocated PABPC was diffusely distributed but was excluded from viral replication compartments. Vhs during EBV infection is regulated by the viral alkaline nuclease, BGLF5. Transfection of BGLF5 alone into BGLF5-KO cells or uninfected 293 cells promoted translocation of PAPBC that was distributed in clumps in the nucleus. ZEBRA, a viral bZIP protein, performs essential functions in the lytic program of EBV, including activation or repression of downstream viral genes. ZEBRA is also an essential replication protein that binds to viral oriLyt and interacts with other viral replication proteins. We report that ZEBRA also functions as a regulator of vhs. ZEBRA translocated PABPC to the nucleus, controlled the intranuclear distribution of PABPC, and caused global shutoff of host gene expression. Transfection of ZEBRA alone into 293 cells caused nuclear translocation of PABPC in the majority of cells in which ZEBRA was expressed. Co-transfection of ZEBRA with BGLF5 into BGLF5-KO cells or uninfected 293 cells rescued the diffuse intranuclear pattern of PABPC seen during lytic replication. ZEBRA mutants defective for DNA-binding were capable of regulating the intranuclear distribution of PABPC, and caused PABPC to co-localize with ZEBRA. One ZEBRA mutant, Z(S186E), was deficient in translocation yet was capable of altering the intranuclear distribution of PABPC. Therefore ZEBRA-mediated nuclear translocation of PABPC and regulation of intranuclear PABPC distribution are distinct events. Using a click chemistry-based assay for new protein synthesis, we show that ZEBRA and BGLF5 each function as viral host shutoff factors.	[Park, Richard; Steitz, Joan; Miller, George] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [El-Guindy, Ayman; Heston, Lee; Yu, Kuan-Ping; Miller, George] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Lin, Su-Fang] Natl Hlth Res Inst, Inst Canc Res, Zhunan Town, Taiwan; [Nagy, Mate] Yale Univ, Sch Med, Program Computat Biol & Bioinformat, New Haven, CT USA; [Borah, Sumit] Univ Colorado, Biofrontiers Inst, Howard Hughes Med Inst, Dept Biochem, Boulder, CO 80309 USA; [Delecluse, Henri-Jacques] German Canc Res Ctr, Dept Tumor Virol, Heidelberg, Germany; [Miller, George] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA	Yale University; Yale University; National Health Research Institutes - Taiwan; Yale University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Helmholtz Association; German Cancer Research Center (DKFZ); Yale University	Miller, G (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA.	George.Miller@yale.edu	Lin, Su-Fang/B-2666-2010	BORAH, SUMIT/0000-0002-1842-7024; Lin, Su-Fang/0000-0001-8706-2439; Delecluse, Henri-Jacques/0000-0002-1744-6274	National Institutes of Health [CA16038, CA12055]; NATIONAL CANCER INSTITUTE [R37CA012055, R01CA012055, P01CA016038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health grants CA16038 and CA12055. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 2006, BIOCHEM J, V396, P219, DOI 10.1042/BJ20060108; Aranda M, 1998, VIROLOGY, V243, P261, DOI 10.1006/viro.1998.9032; Bhende PM, 2005, J VIROL, V79, P7338, DOI 10.1128/JVI.79.12.7338-7348.2005; Bryant HE, 2001, J VIROL, V75, P4376, DOI 10.1128/JVI.75.9.4376-4385.2001; Covarrubias S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002339; Covarrubias S, 2009, J VIROL, V83, P9554, DOI 10.1128/JVI.01051-09; Daikoku T, 2005, J VIROL, V79, P3409, DOI 10.1128/JVI.79.6.3409-3418.2005; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; DETHE G, 1978, NATURE, V274, P756, DOI 10.1038/274756a0; Dobrikova E, 2010, J VIROL, V84, P270, DOI 10.1128/JVI.01740-09; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; Feederle R, 2009, J VIROL, V83, P4952, DOI 10.1128/JVI.00170-09; Francis A, 1999, J VIROL, V73, P4543, DOI 10.1128/JVI.73.6.4543-4551.1999; Francis AL, 1997, J VIROL, V71, P3054, DOI 10.1128/JVI.71.4.3054-3061.1997; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Gaglia MM, 2012, J VIROL; Glaunsinger B, 2004, MOL CELL, V13, P713, DOI 10.1016/S1097-2765(04)00091-7; Gruffat H, 2002, J VIROL, V76, P9635, DOI 10.1128/JVI.76.19.9635-9644.2002; Harb M, 2008, J VIROL, V82, P11283, DOI 10.1128/JVI.00872-08; Heston L, 2006, J VIROL, V80, P9115, DOI 10.1128/JVI.00909-06; Horst D, 2012, J VIROL, V86, P9175, DOI 10.1128/JVI.00309-12; Joachims M, 1999, J VIROL, V73, P718, DOI 10.1128/JVI.73.1.718-727.1999; Keryer-Bibens C, 2009, BIOCHEM BIOPH RES CO, V390, P302, DOI 10.1016/j.bbrc.2009.09.115; Kumar GR, 2010, MOL CELL BIOL, V30, P4996, DOI 10.1128/MCB.00600-10; Kuyumcu-Martinez NM, 2004, MOL CELL BIOL, V24, P1779, DOI 10.1128/MCB.24.4.1779-1790.2004; Kuyumcu-Martinez NM, 2002, J VIROL, V76, P2062, DOI 10.1128/JVI.76.5.2062-2074.2002; KWONG AD, 1987, P NATL ACAD SCI USA, V84, P1926, DOI 10.1073/pnas.84.7.1926; LIN SF, 1994, VIROLOGY, V199, P223, DOI 10.1006/viro.1994.1115; Mears WE, 1996, J VIROL, V70, P7445, DOI 10.1128/JVI.70.11.7445-7453.1996; OLD LJ, 1966, P NATL ACAD SCI USA, V56, P1699, DOI 10.1073/pnas.56.6.1699; OROSKAR AA, 1989, J VIROL, V63, P1897, DOI 10.1128/JVI.63.5.1897-1906.1989; Park R, 2008, VIROLOGY, V382, P145, DOI 10.1016/j.virol.2008.09.009; Park R, 2011, J BIOL CHEM, V286, P9748, DOI 10.1074/jbc.M110.198325; PEARSON GR, 1983, J VIROL, V47, P193, DOI 10.1128/JVI.47.1.193-201.1983; PHELAN A, 1993, P NATL ACAD SCI USA, V90, P9056, DOI 10.1073/pnas.90.19.9056; Piron M, 1999, J VIROL, V73, P5411, DOI 10.1128/JVI.73.7.5411-5421.1999; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; ROONEY C, 1988, P NATL ACAD SCI USA, V85, P9801, DOI 10.1073/pnas.85.24.9801; Rowe M, 2007, P NATL ACAD SCI USA, V104, P3366, DOI 10.1073/pnas.0611128104; Ruvolo V, 2001, J VIROL, V75, P6033, DOI 10.1128/JVI.75.13.6033-6041.2001; Salaun C, 2010, J VIROL, V84, P8539, DOI 10.1128/JVI.00668-10; Sandri-Goldin RM, 1998, GENE DEV, V12, P868, DOI 10.1101/gad.12.6.868; SANDRIGOLDIN RM, 1995, J VIROL, V69, P6063, DOI 10.1128/JVI.69.10.6063-6076.1995; SCHEPERS A, 1993, EMBO J, V12, P3921, DOI 10.1002/j.1460-2075.1993.tb06070.x; Sciabica KS, 2003, EMBO J, V22, P1608, DOI 10.1093/emboj/cdg166; Sokolowski M, 2003, J BIOL CHEM, V278, P33540, DOI 10.1074/jbc.M302063200; Sugimoto A, 2013, J VIROL, V87, P6693, DOI 10.1128/JVI.00219-13; VANDEREB AJ, 1977, GENE, V2, P115, DOI 10.1016/0378-1119(77)90012-9; Vende P, 2000, J VIROL, V74, P7064, DOI 10.1128/JVI.74.15.7064-7071.2000; Vitour D, 2004, J VIROL, V78, P3851, DOI 10.1128/JVI.78.8.3851-3862.2004; Walsh D, 2008, MOL CELL BIOL, V28, P2648, DOI 10.1128/MCB.01631-07; ZENG Y, 1985, INT J CANCER, V36, P545, DOI 10.1002/ijc.2910360505; Zhu H, 1998, P NATL ACAD SCI USA, V95, P14470, DOI 10.1073/pnas.95.24.14470	53	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92593	10.1371/journal.pone.0092593	http://dx.doi.org/10.1371/journal.pone.0092593			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705134	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500020
J	Salazar-Echegarai, FJ; Tobar, HE; Nieto, PA; Riedel, CA; Bueno, SM				Salazar-Echegarai, Francisco J.; Tobar, Hugo E.; Nieto, Pamela A.; Riedel, Claudia A.; Bueno, Susan M.			Conjugal Transfer of the Pathogenicity Island ROD21 in Salmonella enterica serovar Enteritidis Depends on Environmental Conditions	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; ESCHERICHIA-COLI; COMPARATIVE GENOMICS; IN-VIVO; TYPHIMURIUM; TRANSFORMATION; RECOMBINATION; TEMPERATURE; PROTEINS; BARRIERS	Unstable pathogenicity islands are chromosomal elements that can be transferred from one bacterium to another. Salmonella enterica serovar Enteritidis (S. Enteritidis) is a pathogenic bacterium containing such unstable pathogenicity islands. One of them, denominated ROD21, is 26.5 kb in size and capable of excising from the chromosome in certain culture conditions, as well as during bacterial infection of phagocytic cells. In this study we have evaluated whether ROD21 can be effectively transferred from one bacterium to another. We generated a donor and several recipient strains of S. Enteritidis to carry out transfer assays in liquid LB medium. These assays showed that ROD21 is effectively transferred from donor to recipient strains of S. Enteritidis and S. Typhimurium. When Escherichia coli was used as the recipient strain, ROD21 transfer failed to be observed. Subsequently, we showed that a conjugative process was required for the transfer of the island and that changes in temperature and pH increased the transfer frequency between Salmonella strains. Our data indicate that ROD21 is an unstable pathogenicity island that can be transferred by conjugation in a species-specific manner between Salmonellae. Further, ROD21 transfer frequency increases in response to environmental changes, such as pH and temperature.	[Salazar-Echegarai, Francisco J.; Tobar, Hugo E.; Nieto, Pamela A.; Bueno, Susan M.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Mol Genet & Microbiol, Millennium Inst Immunol & Immunotherapy, Santiago, Chile; [Riedel, Claudia A.] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Millennium Inst Immunol & Immunotherapy, Santiago, Chile; [Riedel, Claudia A.] Univ Andres Bello, Fac Med, Santiago, Chile; [Bueno, Susan M.] INSERM, UMR 1064, Nantes, France	Pontificia Universidad Catolica de Chile; Universidad Andres Bello; Universidad Andres Bello; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bueno, SM (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Mol Genet & Microbiol, Millennium Inst Immunol & Immunotherapy, Alameda 340, Santiago, Chile.	sbueno@bio.puc.cl		Riedel, Claudia/0000-0001-6168-8601; Salazar-Echegarai, Francisco/0000-0001-6709-699X; Bueno, Susan M./0000-0002-7551-8088	Millennium Institute on Immunology and Immunotherapy [P09-016-F]; FONDECYT [11075060, 1110604, 1100971, 1110397, 1100926]	Millennium Institute on Immunology and Immunotherapy; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The authors are supported by the following grants: FONDECYT N. 11075060, FONDECYT N. 1110604, FONDECYT N. 1100971, FONDECYT N. 1110397, FONDECYT N. 1100926 and Millennium Institute on Immunology and Immunotherapy (P09-016-F). PAN is a CONICYT fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betancor L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-237; Broudy TB, 2003, INFECT IMMUN, V71, P3782, DOI 10.1128/IAI.71.7.3782-3786.2003; Bustamante P, 2012, J MOL MICROB BIOTECH, V22, P399, DOI 10.1159/000346669; Coburn PS, 2007, MOL MICROBIOL, V63, P530, DOI 10.1111/j.1365-2958.2006.05520.x; Corvaglia AR, 2010, P NATL ACAD SCI USA, V107, P11954, DOI 10.1073/pnas.1000489107; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421; Doublet B, 2005, MOL MICROBIOL, V55, P1911, DOI 10.1111/j.1365-2958.2005.04520.x; Edwards RA, 2002, TRENDS MICROBIOL, V10, P94, DOI 10.1016/S0966-842X(01)02293-4; Forns N, 2005, J BACTERIOL, V187, P3950, DOI 10.1128/JB.187.12.3950-3959.2005; Garcia-Quintanilla M, 2011, PLASMID, V65, P169, DOI 10.1016/j.plasmid.2010.12.001; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Giloh M, 2012, POULTRY SCI, V91, P175, DOI 10.3382/ps.2011-01497; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Maniatis T., 1982, MOL CLONING LAB MANU; Matic I, 2000, J BACTERIOL, V182, P5922, DOI 10.1128/JB.182.20.5922-5924.2000; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Porwollik S, 2003, MICROBES INFECT, V5, P977, DOI 10.1016/S1286-4579(03)00186-2; Quiroz TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026031; Ramsay JP, 2009, MOL MICROBIOL, V73, P1141, DOI 10.1111/j.1365-2958.2009.06843.x; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; RAYSSIGUIER C, 1991, BIOCHIMIE, V73, P371, DOI 10.1016/0300-9084(91)90103-8; Rotger R, 1999, Int Microbiol, V2, P177; Schubert S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000257; Sentchilo V, 2009, MOL MICROBIOL, V72, P1293, DOI 10.1111/j.1365-2958.2009.06726.x; Silva CA, 2012, INFECT IMMUN, V80, P839, DOI 10.1128/IAI.05497-11; Switt AIM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041247; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; TINGE SA, 1990, INFECT IMMUN, V58, P3084, DOI 10.1128/IAI.58.9.3084-3092.1990; Tobar HE, 2013, CURR GENE THER, V13, P240; Turner SA, 2004, ANTIMICROB AGENTS CH, V48, P1028, DOI 10.1128/AAC.48.3.1028-1031.2004; Williams HG, 1996, APPL ENVIRON MICROB, V62, P2994, DOI 10.1128/AEM.62.8.2994-2998.1996; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Yasmin A, 2010, J BACTERIOL, V192, P1122, DOI 10.1128/JB.01293-09	40	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e90626	10.1371/journal.pone.0090626	http://dx.doi.org/10.1371/journal.pone.0090626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705125	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500001
J	Varendi, K; Airavaara, M; Anttila, J; Vose, S; Planken, A; Saarma, M; Mitchell, JR; Andressoo, JO				Varendi, Kart; Airavaara, Mikko; Anttila, Jenni; Vose, Sarah; Planken, Anu; Saarma, Mart; Mitchell, James R.; Andressoo, Jaan-Olle			Short-term Preoperative Dietary Restriction Is Neuroprotective in a Rat Focal Stroke Model	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; ISCHEMIA-REPERFUSION INJURY; TUMOR-NECROSIS-FACTOR; NEUROTROPHIC FACTOR; CARDIAC-SURGERY; TNF-ALPHA; CALORIE RESTRICTION; BRAIN ISCHEMIA; MICE; EXPRESSION	Stroke is a major complication of cardiovascular surgery, resulting in over 100,000 deaths and over a million postoperative encephalopathies annually in the US and Europe. While mitigating damage from stroke after it occurs has proven elusive, opportunities to reduce the incidence and/or severity of stroke prior to surgery in at-risk individuals remain largely unexplored. We tested the potential of short-term preoperative dietary restriction to provide neuroprotection in rat models of focal stroke. Rats were preconditioned with either three days of water-only fasting or six days of a protein free diet prior to induction of transient middle cerebral artery occlusion using two different methods, resulting in either a severe focal stroke to forebrain and midbrain, or a mild focal stroke localized to cortex only. Infarct volume, functional recovery and molecular markers of damage and protection were assessed up to two weeks after reperfusion. Preoperative fasting for 3 days reduced infarct volume after severe focal stroke. Neuroprotection was associated with modulation of innate immunity, including elevation of circulating neutrophil chemoattractant C-X-C motif ligand 1 prior to ischemia and suppression of striatal pro-inflammatory markers including tumor necrosis factor a, its receptor and downstream effector intercellular adhesion molecule-1 after reperfusion. Similarly, preoperative dietary protein restriction for 6 days reduced ischemic injury and improved functional recovery in a milder cortical infarction model. Our results suggest that short-term dietary restriction regimens may provide simple and translatable approaches to reduce perioperative stroke severity in high-risk elective vascular surgery.	[Varendi, Kart; Airavaara, Mikko; Anttila, Jenni; Planken, Anu; Saarma, Mart; Andressoo, Jaan-Olle] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Vose, Sarah; Mitchell, James R.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	University of Helsinki; Harvard University; Harvard T.H. Chan School of Public Health	Mitchell, JR (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	jmitchel@hsph.harvard.edu; Jaan-Olle.Andressoo@helsinki.fi	Andressoo, Jaan-Olle/AAA-1216-2021; Planken, Anu/N-6359-2019; Andressoo, Jaan-Olle/AFU-7846-2022	Planken, Anu/0000-0003-4553-1852; Andressoo, Jaan-Olle/0000-0002-0271-3157; Matlik, Kart/0000-0003-1777-5614; Anttila, Jenni E./0000-0001-6565-2323; Airavaara, Mikko/0000-0002-2026-1609	Sigrid Juselius Foundation; Academy of Finland [250275, 256398, 136591, 140983, 263700, 1126735]; Doctoral Program Brain Mind; National Institutes of Health [AG036712, DK090629]; Radiation Biology [T32CA009078]; NATIONAL CANCER INSTITUTE [T32CA009078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036712] Funding Source: NIH RePORTER	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Doctoral Program Brain Mind; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Radiation Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the Sigrid Juselius Foundation; the Academy of Finland [grant number 250275, 256398 to MA; 136591, 140983 and 263700 to JOA; 1126735 to MS]; the Doctoral Program Brain & Mind to KV; JRM was supported by the National Institutes of Health [AG036712 and DK090629]; and SV by Radiation Biology T32CA009078.	Ahmet I, 2005, CIRCULATION, V112, P3115, DOI 10.1161/CIRCULATIONAHA.105.563817; Airavaara M, 2009, J COMP NEUROL, V515, P116, DOI 10.1002/cne.22039; Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Arumugam TV, 2010, ANN NEUROL, V67, P41, DOI 10.1002/ana.21798; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bowen KK, 2006, NEUROCHEM INT, V49, P127, DOI 10.1016/j.neuint.2006.02.011; Bruggemans EF, 2013, NETH HEART J, V21, P70, DOI 10.1007/s12471-012-0347-x; Chandrasekar B, 2001, AM J PHYSIOL-HEART C, V280, pH2094, DOI 10.1152/ajpheart.2001.280.5.H2094; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; COMBS DJ, 1987, STROKE, V18, P503, DOI 10.1161/01.STR.18.2.503; Damm J, 2012, NEUROSCIENCE, V201, P166, DOI 10.1016/j.neuroscience.2011.11.013; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Duan WZ, 2001, J MOL NEUROSCI, V16, P1, DOI 10.1385/JMN:16:1:1; Duan WZ, 2001, J NEUROCHEM, V76, P619, DOI 10.1046/j.1471-4159.2001.00071.x; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P229; Fond G, 2013, PSYCHIAT RES, V209, P253, DOI 10.1016/j.psychres.2012.12.018; Gandhi GY, 2005, MAYO CLIN PROC, V80, P862, DOI 10.4065/80.7.862; GO KG, 1988, METAB BRAIN DIS, V3, P257, DOI 10.1007/BF00999535; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Green AR, 2008, BRIT J PHARMACOL, V153, pS325, DOI 10.1038/sj.bjp.0707594; Gregersen R, 2000, J CEREBR BLOOD F MET, V20, P53, DOI 10.1097/00004647-200001000-00009; Hall MJ, 2010, NATL HLTH STAT REPOR, V26, p[1, 24]; Harvey BK, 2005, PHARMACOL THERAPEUT, V105, P113, DOI 10.1016/j.pharmthera.2004.09.003; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Kagansky N, 2001, ARCH NEUROL-CHICAGO, V58, P1209, DOI 10.1001/archneur.58.8.1209; Kellermann K, 2010, SEMIN CARDIOTHORAC V, V14, P95, DOI 10.1177/1089253210370902; KIRSCH JR, 1979, STROKE, V10, P288, DOI 10.1161/01.STR.10.3.288; Koizumi J., 1986, JPN J STROKE, V8, P1, DOI DOI 10.3995/JSTROKE.8.1; Kollmar R, 2007, STROKE, V38, P1585, DOI 10.1161/STROKEAHA.106.475897; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Lee ST, 2012, ANN NEUROL, V72, P269, DOI 10.1002/ana.23588; Lin T. N., 2009, P141, DOI 10.1007/978-1-60327-185-1_12; MARIE C, 1990, METAB BRAIN DIS, V5, P65, DOI 10.1007/BF01001047; Michalsen A, 2013, FORSCH KOMPLEMENTMED, V20, P444, DOI 10.1159/000357765; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Mitchell JR, 2013, SURGERY, V153, P594, DOI 10.1016/j.surg.2012.09.007; Mitchell JR, 2010, AGING CELL, V9, P40, DOI 10.1111/j.1474-9726.2009.00532.x; Miura P, 2012, J NEUROCHEM, V120, P230, DOI 10.1111/j.1471-4159.2011.07583.x; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Newman MF, 2006, LANCET, V368, P694, DOI 10.1016/S0140-6736(06)69254-4; Pandya JD, 2011, BRAIN RES, V1384, P151, DOI 10.1016/j.brainres.2011.01.102; Peng Wei, 2012, Sci Transl Med, V4, p118ra11, DOI 10.1126/scitranslmed.3002629; PERDRIZET G A, 1989, Current Surgery, V46, P23; Poldermans D, 2009, EUR HEART J, V30, P2769, DOI 10.1093/eurheartj/ehp337; Reglodi D, 2000, EXP NEUROL, V163, P399, DOI 10.1006/exnr.2000.7367; REHNCRONA S, 1985, EXP NEUROL, V87, P458, DOI 10.1016/0014-4886(85)90176-1; Robertson LT, 2013, EXP GERONTOL, V48, P1043, DOI 10.1016/j.exger.2013.01.009; Rosenzweig HL, 2007, J CEREBR BLOOD F MET, V27, P1663, DOI 10.1038/sj.jcbfm.9600464; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Selim M, 2007, NEW ENGL J MED, V356, P706, DOI 10.1056/NEJMra062668; Sharp Frank R, 2004, NeuroRx, V1, P26, DOI 10.1602/neurorx.1.1.26; SIMONET WS, 1994, J CLIN INVEST, V94, P1310, DOI 10.1172/JCI117450; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Thored P, 2009, GLIA, V57, P835, DOI 10.1002/glia.20810; van Ginhoven TM, 2010, J SURG RES; Varon J, 2008, CHEST, V133, P1267, DOI 10.1378/chest.07-2190; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2; Zeynalov E, 2009, NEUROBIOL DIS, V35, P264, DOI 10.1016/j.nbd.2009.05.010	63	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93911	10.1371/journal.pone.0093911	http://dx.doi.org/10.1371/journal.pone.0093911			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705386	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500093
J	Hannan, NJ; Bambang, K; Kaitu'u-Lino, TJ; Konje, JC; Tong, S				Hannan, Natalie J.; Bambang, Katerina; Kaitu'u-Lino, Tu'uhevaha J.; Konje, Justin C.; Tong, Stephen			A Bioplex Analysis of Cytokines and Chemokines in First Trimester Maternal Plasma to Screen for Predictors of Miscarriage	PLOS ONE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; HUMAN ENDOMETRIUM; LEUKOCYTE RECRUITMENT; EMBRYO IMPLANTATION; EXPRESSION; PREGNANCY; RECEPTOR; WOMEN; SERUM; ROLES	Background: We have previously shown in two independent cohorts that circulating first trimester Macrophage Inhibitory Cytokine-1 (MIC-1) levels are lower in women in early pregnancy who are destined to miscarriage. While promising, the diagnostic performance of measuring MIC-1 alone was not sufficient for it to be a useful predictive test for miscarriage. Besides MIC-1, there are other cytokines, as well as chemokines, involved in facilitating early pregnancy. We reasoned that screening these factors in maternal plasma could uncover other predictive markers of miscarriage. Methods: This was a nested case control study, of 78 women from a prospective study of 462 attending the Early Pregnancy Assessment Unit in the first trimester (EPAU) with a threatened miscarriage; 34 of these subsequently miscarried (cases) and 44 went on to have a normal delivery (controls) Cytokines IL-1 beta, IL-6 and IL-10, and the chemokines, CXCL8, CCL2, CCL5, CCL7 and CX3CL1 were measured in plasma from our cohort. Results: The cytokines IL-1 beta, IL-6, IL-10 and the chemokine CXCL8 were not detectable in first trimester plasma. The chemokines CCL2, CCL5, CCL7 and CX3CL1 were detectable in all samples but levels did not vary across 5-12 weeks of gestation among controls. Plasma levels of these chemokines were no different in the miscarriage cohort compared to controls. Conclusion: The chemokines CCL2, CCL5, CCL7 and CX3CL1 were detectable in plasma during the first trimester while IL-1 beta, IL-6, IL-10 and CXCL8 were not. However, none of the cytokines and chemokines screened were different in maternal plasma in cases or controls. These therefore do not appear to have potential for application as predictive biomarkers of miscarriage.	[Hannan, Natalie J.; Kaitu'u-Lino, Tu'uhevaha J.; Tong, Stephen] Univ Melbourne, Dept Obstet & Gynaecol, Mercy Hosp Women, Translat Obstet Grp, Heidelberg, Vic, Australia; [Bambang, Katerina; Konje, Justin C.] Univ Leicester, Endocannabinoid Res Grp, Reprod Sci Sect, Dept Canc Studies & Mol Med, Leicester, Leics, England	University of Melbourne; University of Leicester	Hannan, NJ (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Mercy Hosp Women, Translat Obstet Grp, Heidelberg, Vic, Australia.	nhannan@unimelb.edu.au	Proost, Paul/V-3052-2017	Proost, Paul/0000-0002-0133-5545; Hannan, Natalie/0000-0001-8446-2250; Kaitu'u-Lino, Tu'uhevaha/0000-0001-6233-9737; Tong, Stephen/0000-0002-2319-0586	Medical Research Council of the United Kingdom [G0801523]; National Health and Medical Research Council of Australia [628927, 1050765, 1062418]; MRC [G0801523] Funding Source: UKRI; Medical Research Council [G0801523] Funding Source: researchfish; National Institute for Health Research [PB-PG-0909-19305] Funding Source: researchfish	Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The following funding bodies are acknowledged: The Medical Research Council of the United Kingdom for funding this work (#G0801523 to JCK) and The National Health and Medical Research Council of Australia who provided salary support (#628927 to NJH; #1050765 to ST; #1062418 to TJKL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan Emine, 2004, Archives of Gynecology and Obstetrics, V270, P227, DOI 10.1007/s00404-003-0547-0; Bates MD, 2002, HUM REPROD, V17, P2439, DOI 10.1093/humrep/17.9.2439; Calleja-Agius J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/175041; Chaouat G, 2004, INT ARCH ALLERGY IMM, V134, P93, DOI 10.1159/000074300; Coomarasamy Arri, 2011, BMJ, V342, pd1914, DOI 10.1136/bmj.d1914; Dimitriadis E, 2006, J REPROD IMMUNOL, V69, P53, DOI 10.1016/j.jri.2005.07.004; Galazios G, 2011, J MATERN-FETAL NEO M, V24, P1283, DOI 10.3109/14767058.2011.575482; Hampton AL, 2001, J REPROD IMMUNOL, V49, P115, DOI 10.1016/S0165-0378(00)00082-6; Hanna J, 2003, BLOOD, V102, P1569, DOI 10.1182/blood-2003-02-0517; Hannan NJ, 2008, BIOL REPROD, V79, P58, DOI 10.1095/biolreprod.107.066480; Hannan NJ, 2007, CURR OPIN OBSTET GYN, V19, P266, DOI 10.1097/GCO.0b013e328133885f; Hannan NJ, 2011, EXPERT REV CLIN IMMU, V7, P789, DOI [10.1586/ECI.11.65, 10.1586/eci.11.65]; Hannan NJ, 2006, BIOL REPROD, V74, P896, DOI 10.1095/biolreprod.105.045518; Hannan NJ, 2004, J CLIN ENDOCR METAB, V89, P6119, DOI 10.1210/jc.2003-031379; Hefler LA, 2001, FERTIL STERIL, V76, P377, DOI 10.1016/S0015-0282(01)01914-8; Jasper MJ, 2007, J REPROD IMMUNOL, V73, P74, DOI 10.1016/j.jri.2006.06.003; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Johns J, 2007, REPROD BIOMED ONLINE, V15, P413, DOI 10.1016/S1472-6483(10)60367-7; Jones RL, 2004, J CLIN ENDOCR METAB, V89, P6155, DOI 10.1210/jc.2004-0507; Kaitu'u-Lino TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072437; Kaitu'u-Lino TJ, 2012, J REPROD IMMUNOL, V95, P46, DOI 10.1016/j.jri.2012.06.003; KAUMA S, 1990, AM J OBSTET GYNECOL, V163, P1430, DOI 10.1016/0002-9378(90)90601-3; Koumantaki Y, 2001, EUR J OBSTET GYN R B, V98, P66, DOI 10.1016/S0301-2115(01)00289-5; Laird S, 2006, REPROD BIOMED ONLINE, V13, P13, DOI 10.1016/S1472-6483(10)62011-1; Lim KJH, 2000, FERTIL STERIL, V73, P136, DOI 10.1016/S0015-0282(99)00457-4; Marjono AB, 2003, PLACENTA, V24, P100, DOI 10.1053/plac.2002.0881; Muttukrishna S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018041; Red-Horse K, 2001, AM J PATHOL, V159, P2199, DOI 10.1016/S0002-9440(10)63071-4; Rumbold A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004073.pub3; Salamonsen LA, 2007, SEMIN REPROD MED, V25, P437, DOI 10.1055/s-2007-991041; Sato Y, 2003, DEVELOPMENT, V130, P5519, DOI 10.1242/dev.00729; Segerer SE, 2012, HUM REPROD, V27, P200, DOI 10.1093/humrep/der358; TABIBZADEH S, 1992, HUM REPROD, V7, P1214, DOI 10.1093/oxfordjournals.humrep.a137829; Tong S, 2004, LANCET, V363, P129, DOI 10.1016/S0140-6736(03)15265-8; Tong S, 2012, OBSTET GYNECOL, V119, P1000, DOI 10.1097/AOG.0b013e3182518fd3; von Wolff M, 2002, GYNECOL ENDOCRINOL, V16, P121, DOI 10.1080/713603031; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Zenclussen AC, 2002, AM J REPROD IMMUNOL, V48, P245, DOI 10.1034/j.1600-0897.2002.01136.x; Zhang J, 2000, BIOL REPROD, V62, P404, DOI 10.1095/biolreprod62.2.404	39	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93320	10.1371/journal.pone.0093320	http://dx.doi.org/10.1371/journal.pone.0093320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699265	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000051
J	Laitera, T; Sarajarvi, T; Haapasalo, A; Puli, L; Kauppinen, T; Makinen, P; Rauramaa, T; Tanila, H; Jaaskelainen, JE; Alafuzoff, I; Soininen, H; Leinonen, V; Hiltunen, M				Laitera, Tiina; Sarajarvi, Timo; Haapasalo, Annakaisa; Puli, Lakshman; Kauppinen, Tarja; Makinen, Petra; Rauramaa, Tuomas; Tanila, Heikki; Jaaskelainen, Juha E.; Alafuzoff, Irina; Soininen, Hilkka; Leinonen, Ville; Hiltunen, Mikko			Increased gamma-Secretase Activity in Idiopathic Normal Pressure Hydrocephalus Patients with beta-Amyloid Pathology	PLOS ONE			English	Article							CORTICAL BRAIN BIOPSY; ALZHEIMERS-DISEASE; EXPRESSION; PROTEIN; BACE1; ISCHEMIA; PATHWAY; APH-1; GENE; CSF	The potential similarity between the brain pathology of idiopathic normal pressure hydrocephalus (iNPH) and Alzheimer disease (AD) is intriguing and thus further studies focusing on the underlying molecular mechanisms may offer valuable information for differential diagnostics and the development of treatments for iNPH. Here, we investigated beta- and gamma-secretase activities in relation to amyloid-beta (A beta) pathology in the brain tissue samples collected from iNPH and AD patients. beta- and gamma-secretase activities were measured from the frontal cortical biopsies of 26 patients with suspected iNPH as well as post-mortem tissue samples from the inferior temporal cortex of 74 AD patients and eight subjects without neurofibrillary pathology. In iNPH samples with detectable A beta plaques, gamma-secretase activity was significantly increased (similar to 1.6-fold) when compared to iNPH samples without A beta plaques (p=0.009). In the AD samples, statistically significant differences in the gamma-secretase activity were not observed with respect to disease severity (mild, moderate and severe AD according to neurofibrillary pathology). Conversely, beta-secretase activity was unaltered in iNPH samples with or without A beta plaques, while it was significantly increased in relation to disease severity in the AD patients. These results show for the first time increased gamma-secretase but not b-secretase activity in the biopsy samples from the frontal cortex of iNPH patients with AD-like A beta pathology. Conversely, the opposite was observed in these secretase activities in AD patients with respect to neurofibrillary pathology. Despite the resemblances in the A beta pathology, iNPH and AD patients appear to have marked differences in the cellular mechanisms responsible for the production of A beta.	[Laitera, Tiina; Jaaskelainen, Juha E.; Leinonen, Ville] Univ Eastern Finland, Inst Clin Med Neurosurg, Kuopio, Finland; [Laitera, Tiina; Jaaskelainen, Juha E.; Leinonen, Ville] Kuopio Univ Hosp, Neurosurg NeuroCtr, SF-70210 Kuopio, Finland; [Sarajarvi, Timo; Haapasalo, Annakaisa; Kauppinen, Tarja; Makinen, Petra; Soininen, Hilkka; Hiltunen, Mikko] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Puli, Lakshman; Tanila, Heikki] Univ Eastern Finland, AI Virtanen Inst, Kuopio, Finland; [Rauramaa, Tuomas] Univ Eastern Finland, Inst Clin Med Pathol, Kuopio, Finland; [Rauramaa, Tuomas] Kuopio Univ Hosp, Dept Pathol, SF-70210 Kuopio, Finland; [Alafuzoff, Irina] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Soininen, Hilkka] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Uppsala University; Kuopio University Hospital; University of Eastern Finland	Hiltunen, M (corresponding author), Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland.	mikko.hiltunen@uef.fi	Sarajärvi, Timo/AAN-3855-2021	Sarajärvi, Timo/0000-0001-8710-1282; PULI, LAKSHMAN/0000-0001-9140-2360; Haapasalo, Annakaisa/0000-0003-0959-2957	Academy of Finland; Kuopio University Hospital [5772708]; Sigrid Juselius Foundation; University of Eastern Finland (UEF-Brain)	Academy of Finland(Academy of Finland); Kuopio University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Eastern Finland (UEF-Brain)	This study was funded by the Academy of Finland, EVO grant 5772708 of Kuopio University Hospital, Sigrid Juselius Foundation, and the Strategic Funding of the University of Eastern Finland (UEF-Brain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RR, 2010, J NEUROCHEM, V112, P1045, DOI 10.1111/j.1471-4159.2009.06528.x; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; De Gasperi R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-38; de la Torre JC, 2008, J ALZHEIMERS DIS, V14, P353; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; DELEON MJ, 1983, AM J NEURORADIOL, V4, P568; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hakim S, 1965, J Neurol Sci, V2, P307, DOI 10.1016/0022-510X(65)90016-X; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Kakuda N, 2012, EMBO MOL MED, V4, P344, DOI 10.1002/emmm.201200214; Leinonen V, 2012, NEUROPATH APPL NEURO, V38, P72, DOI 10.1111/j.1365-2990.2011.01195.x; Leinonen V, 2010, ANN NEUROL, V68, P446, DOI 10.1002/ana.22100; Li L, 2009, NEUROBIOL AGING, V30, P1091, DOI 10.1016/j.neurobiolaging.2007.10.011; Liu F, 2013, EUR J NEUROSCI, V37, P1714, DOI 10.1111/ejn.12159; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Natunen T, 2013, J ALZHEIMERS DIS, V37, P217, DOI 10.3233/JAD-130104; Pluta R, 2007, CURR NEUROVASC RES, V4, P121, DOI 10.2174/156720207780637207; Relkin N, 2005, NEUROSURGERY, V57, P4, DOI 10.1227/01.NEU.0000168185.29659.C5; Seppala TT, 2012, NEUROLOGY, V78, P1568, DOI 10.1212/WNL.0b013e3182563bd0; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Tabaton M, 2007, CELL MOL LIFE SCI, V64, P2211, DOI 10.1007/s00018-007-7219-3; Tanimukai H, 1998, MOL BRAIN RES, V54, P212, DOI 10.1016/S0169-328X(97)00337-9; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Wen Y, 2004, BRAIN RES, V1009, P1, DOI 10.1016/j.brainres.2003.09.086; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200	31	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93717	10.1371/journal.pone.0093717	http://dx.doi.org/10.1371/journal.pone.0093717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699723	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000094
J	Molina-Ortiz, D; Camacho-Carranza, R; Gonzalez-Zamora, JF; Shalkow-Kalincovstein, J; Cardenas-Cardos, R; Nosti-Palacios, R; Vences-Mejia, A				Molina-Ortiz, Dora; Camacho-Carranza, Rafael; Francisco Gonzalez-Zamora, Jose; Shalkow-Kalincovstein, Jaime; Cardenas-Cardos, Rocio; Nosti-Palacios, Rosario; Vences-Mejia, Araceli			Differential Expression of Cytochrome P450 Enzymes in Normal and Tumor Tissues from Childhood Rhabdomyosarcoma	PLOS ONE			English	Article							CANCER; METABOLISM; CYP3A4/5; CHILDREN; CYP2W1	Intratumoral expression of genes encoding Cytochrome P450 enzymes (CYP) might play a critical role not only in cancer development but also in the metabolism of anticancer drugs. The purpose of this study was to compare the mRNA expression patterns of seven representative CYPs in paired tumor and normal tissue of child patients with rabdomyosarcoma (RMS). Using real time quantitative RT-PCR, the gene expression pattern of CYP1A1, CYP1A2, CYP1B1, CYP2E1, CYP2W1, CYP3A4, and CYP3A5 were analyzed in tumor and adjacent non-tumor tissues from 13 child RMS patients. Protein concentration of CYPs was determined using Western blot. The expression levels were tested for correlation with the clinical and pathological data of the patients. Our data showed that the expression levels of CYP1A1 and CYP1A2 were negligible. Elevated expression of CYP1B1 mRNA and protein was detected in most RMS tumors and adjacent normal tissues. Most cancerous samples exhibit higher levels of both CYP3A4 and CYP3A5 compared with normal tissue samples. Expression of CYP2E1 mRNA was found to be significantly higher in tumor tissue, however no relation was found with protein levels. CYP2W1 mRNA and/or protein are mainly expressed in tumors. In conclusion, we defined the CYP gene expression profile in tumor and paired normal tissue of child patients with RMS. The overexpression of CYP2W1, CYP3A4 and CYP3A5 in tumor tissues suggests that they may be involved in RMS chemoresistance; furthermore, they may be exploited for the localized activation of anticancer prodrugs.	[Molina-Ortiz, Dora; Francisco Gonzalez-Zamora, Jose; Cardenas-Cardos, Rocio; Nosti-Palacios, Rosario; Vences-Mejia, Araceli] Inst Nacl Pediat, Mexico City, DF, Mexico; [Camacho-Carranza, Rafael] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Shalkow-Kalincovstein, Jaime] Ctr Nacl Prevenc & El Tratamiento Canc Infancia &, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Vences-Mejia, A (corresponding author), Inst Nacl Pediat, Mexico City, DF, Mexico.	aritaven@yahoo.com.mx	Carranza, Rafael Camacho/AFM-7246-2022; Carranza, Rafael Camacho/AAT-9540-2021; Shalkow, Jaime/AAT-7676-2021	Carranza, Rafael Camacho/0000-0003-0693-8449; Carranza, Rafael Camacho/0000-0003-0693-8449; Shalkow, Jaime/0000-0003-0056-3455; Gonzalez-Zamora, Jose Francisco/0000-0001-5444-270X	Consejo Nacional de Ciencia y Tecnologia, Mexico [86395]; Instituto Nacional de Pediatria	Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto Nacional de Pediatria	This study was supported in part by the Consejo Nacional de Ciencia y Tecnologia, Mexico, Grant 86395, and Instituto Nacional de Pediatria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androutsopoulos VP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-187; Bergheim I, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-34; CHANG TKH, 1993, CANCER RES, V53, P5629; Cocker HA, 2001, CLIN CANCER RES, V7, P3193; Dhaini HR, 2003, J CLIN ONCOL, V21, P2481, DOI 10.1200/JCO.2003.06.015; Ding XX, 2003, ANNU REV PHARMACOL, V43, P149, DOI 10.1146/annurev.pharmtox.43.100901.140251; Gomez A, 2007, PHARMACOGENOMICS, V8, P1315, DOI 10.2217/14622416.8.10.1315; GRUFFERMAN S, 1982, JNCI-J NATL CANCER I, V68, P107; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; HARTLEY AL, 1988, BRIT J CANCER, V58, P838, DOI 10.1038/bjc.1988.321; Karlgren M, 2007, EXPERT OPIN THER TAR, V11, P61, DOI 10.1517/14728222.11.1.61; Karlgren Maria, 2005, Toxicol Appl Pharmacol, V207, P57, DOI 10.1016/j.taap.2004.12.022; Kocarek TA, 2000, ARCH BIOCHEM BIOPHYS, V376, P180, DOI 10.1006/abbi.2000.1704; Martinez C, 2002, BRIT J CANCER, V87, P681, DOI 10.1038/sj.bjc.6600494; McFadyen MCE, 2004, MOL CANCER THER, V3, P363; Melguizo C, 2011, ONCOL REP, V26, P755, DOI 10.3892/or.2011.1347; Mir O, 2007, LANCET ONCOL, V8, P667, DOI 10.1016/S1470-2045(07)70215-2; Molina-Ortiz D., 2013, PHARM PHARMACOL-RUSS, V4, P231; Murray GI, 1997, CANCER RES, V57, P3026; Murray GI, 2001, ANNU REV PHARMACOL, V41, P297, DOI 10.1146/annurev.pharmtox.41.1.297; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Oyama T, 2004, FRONT BIOSCI-LANDMRK, V9, P1967, DOI 10.2741/1378; PAPPO AS, 1995, J CLIN ONCOL, V13, P2123, DOI 10.1200/JCO.1995.13.8.2123; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Potter GA, 2002, BRIT J CANCER, V86, P774, DOI 10.1038/sj.bjc.6600197; Rochat B, 2001, J PHARMACOL EXP THER, V296, P537; Rodriguez-Antona C, 2006, ONCOGENE, V25, P1679, DOI 10.1038/sj.onc.1209377; Saab R, 2011, CURR TOP DEV BIOL, V94, P197, DOI 10.1016/B978-0-12-380916-2.00007-3; Tanaka E, 2000, J CLIN PHARM THER, V25, P165; Tredan O, 2009, CANCER RES, V69, P940, DOI 10.1158/0008-5472.CAN-08-0676; Wang C, 2012, J DENT RES, V91, P341, DOI 10.1177/0022034511421490; Weiss AR, 2013, J CLIN ONCOL, V31, P3226, DOI 10.1200/JCO.2012.44.6476	32	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93261	10.1371/journal.pone.0093261	http://dx.doi.org/10.1371/journal.pone.0093261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699256	gold, Green Published, Green Submitted			2022-12-27	WOS:000334105000050
J	Nguitragool, W; Rayavara, K; Desai, SA				Nguitragool, Wang; Rayavara, Kempaiah; Desai, Sanjay A.			Proteolysis at a Specific Extracellular Residue Implicates Integral Membrane CLAG3 in Malaria Parasite Nutrient Channels	PLOS ONE			English	Article							SURFACE ANION CHANNEL; PLASMODIUM-FALCIPARUM; MULTIGENE FAMILY; RHOPTRY PROTEIN; PLASMA-MEMBRANE; ERYTHROCYTES; RESISTANCE; INVASION; PERMEABILITY; CHYMOTRYPSIN	The plasmodial surface anion channel mediates uptake of nutrients and other solutes into erythrocytes infected with malaria parasites. The clag3 genes of P. falciparum determine this channel's activity in human malaria, but how the encoded proteins contribute to transport is unknown. Here, we used proteases to examine the channel's composition and function. While proteases with distinct specificities all cleaved within an extracellular domain of CLAG3, they produced differing degrees of transport inhibition. Chymotrypsin-induced inhibition depended on parasite genotype, with channels induced by the HB3 parasite affected to a greater extent than those of the Dd2 clone. Inheritance of functional proteolysis in the HB3xDd2 genetic cross, DNA transfection, and gene silencing experiments all pointed to the clag3 genes, providing independent evidence for a role of these genes. Protease protection assays with a Dd2-specific inhibitor and site-directed mutagenesis revealed that a variant L1115F residue on a CLAG3 extracellular loop contributes to inhibitor binding and accounts for differences in functional proteolysis. These findings indicate that surface-exposed CLAG3 is the relevant pool of this protein for channel function. They also suggest structural models for how exposed CLAG3 domains contribute to pore formation and parasite nutrient uptake.	[Nguitragool, Wang; Rayavara, Kempaiah; Desai, Sanjay A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nguitragool, W (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	wang.ngu@mahidol.ac.th; sdesai@niaid.nih.gov		Nguitragool, Wang/0000-0002-5484-7130	National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000882] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexadre Jean Seme Fits, 2012, Tropical Medicine and Health, V40, P71, DOI 10.2149/tmh.2012-13; Alkhalil A, 2004, BLOOD, V104, P4279, DOI 10.1182/blood-2004-05-2047; Alkhalil A, 2007, CELL MICROBIOL, V9, P851, DOI 10.1111/j.1462-5822.2006.00834.x; Alkhalil A, 2009, MOL MICROBIOL, V72, P459, DOI 10.1111/j.1365-2958.2009.06661.x; ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; Asahi H, 1996, PARASITOLOGY, V113, P19, DOI 10.1017/S0031182000066233; Baumeister S, 2006, MOL MICROBIOL, V60, P493, DOI 10.1111/j.1365-2958.2006.05112.x; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Bouyer G, 2011, BLOOD, V118, P2305, DOI 10.1182/blood-2011-01-329300; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Bullen HE, 2012, CURR OPIN MICROBIOL, V15, P699, DOI 10.1016/j.mib.2012.09.008; Cohn JV, 2003, MOL BIOCHEM PARASIT, V132, P27, DOI 10.1016/j.molbiopara.2003.08.001; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; Cortes A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002943; Counihan NA, 2013, TRENDS PARASITOL, V29, P228, DOI 10.1016/j.pt.2013.03.003; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crowley VM, 2011, MOL MICROBIOL, V80, P391, DOI 10.1111/j.1365-2958.2011.07574.x; Desai SA, 2005, J BIOL CHEM, V280, P16861, DOI 10.1074/jbc.M414629200; Desai SA, 2005, NANOMED-NANOTECHNOL, V1, P58, DOI 10.1016/j.nano.2004.11.001; Desai SA, 2012, CELL MICROBIOL, V14, P1003, DOI 10.1111/j.1462-5822.2012.01790.x; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; FIEDLER F, 1987, EUR J BIOCHEM, V163, P303, DOI 10.1111/j.1432-1033.1987.tb10801.x; GINSBURG H, 1986, BIOCHIM BIOPHYS ACTA, V861, P194, DOI 10.1016/0005-2736(86)90418-9; Haerteis S, 2012, J GEN PHYSIOL, V140, P375, DOI 10.1085/jgp.201110763; HOMEWOOD CA, 1974, NATURE, V252, P718, DOI 10.1038/252718a0; Hviid L, 2010, HUM VACCINES, V6, P84, DOI 10.4161/hv.6.1.9602; Iriko H, 2008, MOL BIOCHEM PARASIT, V158, P11, DOI 10.1016/j.molbiopara.2007.11.004; Istvan ES, 2011, P NATL ACAD SCI USA, V108, P1627, DOI 10.1073/pnas.1011560108; Kaneko O, 2005, MOL BIOCHEM PARASIT, V143, P20, DOI 10.1016/j.molbiopara.2005.05.003; Kaneko O, 2001, MOL BIOCHEM PARASIT, V118, P223, DOI 10.1016/S0166-6851(01)00391-7; Kaneko O, 2007, PARASITOL INT, V56, P255, DOI 10.1016/j.parint.2007.05.003; Kang MS, 2005, MOL PHARMACOL, V68, P34, DOI 10.1124/mol.104.010553; Kerr LD, 2009, J MED CHEM, V52, P852, DOI 10.1021/jm8013663; King LS, 2000, MOL MED TODAY, V6, P60, DOI 10.1016/S1357-4310(99)01636-6; KUTNER S, 1985, J CELL PHYSIOL, V125, P521, DOI 10.1002/jcp.1041250323; KUTNER S, 1987, BIOCHEM PHARMACOL, V36, P123, DOI 10.1016/0006-2952(87)90389-3; Li J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-337; Lisk G, 2005, EUKARYOT CELL, V4, P2153, DOI 10.1128/EC.4.12.2153-2159.2005; Lisk G, 2008, ANTIMICROB AGENTS CH, V52, P2346, DOI 10.1128/AAC.00057-08; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Lyko B, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-124; MCCONN J, 1971, J BIOL CHEM, V246, P2918; Mira-Martinez S, 2013, CELL MICROBIOL, V15, P1913, DOI 10.1111/cmi.12162; NARAHASH.Y, 1968, J BIOCHEM-TOKYO, V64, P427, DOI 10.1093/oxfordjournals.jbchem.a128914; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Ocampo M, 2005, PROTEIN SCI, V14, P504, DOI 10.1110/ps.04883905; Pillai AD, 2012, MOL PHARMACOL, V82, P1104, DOI 10.1124/mol.112.081224; Pillai AD, 2010, MOL PHARMACOL, V77, P724, DOI 10.1124/mol.109.062711; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Sharma P, 2013, J BIOL CHEM, V288, P19429, DOI 10.1074/jbc.M113.468371; Staines HM, 2007, INT J PARASITOL, V37, P475, DOI 10.1016/j.ijpara.2006.12.013; Trenholme KR, 2000, P NATL ACAD SCI USA, V97, P4029, DOI 10.1073/pnas.040561197; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084; Vincensini L, 2008, MOL BIOCHEM PARASIT, V160, P81, DOI 10.1016/j.molbiopara.2008.04.002; Wagner MA, 2003, BIOPHYS J, V84, P116, DOI 10.1016/S0006-3495(03)74836-X	56	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93759	10.1371/journal.pone.0093759	http://dx.doi.org/10.1371/journal.pone.0093759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699906	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000101
J	Weng, LM; Ziliak, D; LaCroix, B; Geeleher, P; Huang, RS				Weng, Liming; Ziliak, Dana; LaCroix, Bonnie; Geeleher, Paul; Huang, R. Stephanie			Integrative "Omic" Analysis for Tamoxifen Sensitivity through Cell Based Models	PLOS ONE			English	Article							BREAST-CANCER; TRANSCRIPTION; RECEPTOR; DISCOVERY; PATHWAY	It has long been observed that tamoxifen sensitivity varies among breast cancer patients. Further, ethnic differences of tamoxifen therapy between Caucasian and African American have also been reported. Since most studies have been focused on Caucasian people, we sought to comprehensively evaluate genetic variants related to tamoxifen therapy in African-derived samples. An integrative "omic" approach developed by our group was used to investigate relationships among endoxifen (an active metabolite of tamoxifen) sensitivity, SNP genotype, mRNA and microRNA expressions in 58 HapMap YRI lymphoblastoid cell lines. We identified 50 SNPs that associate with cellular sensitivity to endoxifen through their effects on 34 genes and 30 microRNA expression. Some of these findings are shared in both Caucasian and African samples, while others are unique in the African samples. Among gene/microRNA that were identified in both ethnic groups, the expression of TRAF1 is also correlated with tamoxifen sensitivity in a collection of 44 breast cancer cell lines. Further, knock-down TRAF1 and over-expression of hsa-let-7i confirmed the roles of hsa-let-7i and TRAF1 in increasing tamoxifen sensitivity in the ZR-75-1 breast cancer cell line. Our integrative omic analysis facilitated the discovery of pharmacogenomic biomarkers that potentially affect tamoxifen sensitivity.	[Weng, Liming; Ziliak, Dana; LaCroix, Bonnie; Geeleher, Paul; Huang, R. Stephanie] Univ Chicago, Dept Med, Sect Hematol & Oncol, Chicago, IL 60637 USA	University of Chicago	Huang, RS (corresponding author), Univ Chicago, Dept Med, Sect Hematol & Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	rhuang@medicine.bsd.uchicago.edu	Weng, Liming/E-7791-2015; Geeleher, Paul/C-7040-2019	LaCroix, Bonnie/0000-0002-6833-5267; Huang, R. Stephanie/0000-0002-9862-0368	University of Chicago Cancer Center Support Grant [P30 CA14599]; National Institutes of Health/National Institute of General Medical Science [U01GM61393]; National Institute of General Medical Science [K08 (GM089941)]; National Cancer Institute [R21 (CA139278)]; University of Chicago Breast Cancer SPORE Career Development Award [CA125183]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1RR024999]; NATIONAL CANCER INSTITUTE [P30CA014599, P50CA125183, R21CA139278] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM089941, U01GM061393] Funding Source: NIH RePORTER	University of Chicago Cancer Center Support Grant; National Institutes of Health/National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Chicago Breast Cancer SPORE Career Development Award; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by the University of Chicago Cancer Center Support Grant (#P30 CA14599) and the National Institutes of Health/National Institute of General Medical Science (Pharmacogenomics of Anticancer Agents grant U01GM61393). RSH also received support from the National Institute of General Medical Science K08 (GM089941), the National Cancer Institute R21 (CA139278), the University of Chicago Breast Cancer SPORE Career Development Award (CA125183), and the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1RR024999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nasiry S, 2007, HUM REPROD, V22, P1304, DOI 10.1093/humrep/dem011; Bernassola F, 2010, CELL DEATH DIFFER, V17, P1, DOI 10.1038/cdd.2009.189; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Cao J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00026; Clarke R, 2001, PHARMACOL REV, V53, P25; Escarcega RO, 2007, CLIN ONCOL-UK, V19, P154, DOI 10.1016/j.clon.2006.11.013; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Gamazon Eric R., 2013, Frontiers in Genetics, V3, P202, DOI 10.3389/fgene.2012.00202; Gamazon ER, 2012, AM J HUM GENET, V90, P1046, DOI 10.1016/j.ajhg.2012.04.023; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Huang RS, 2011, CLIN CANCER RES, V17, P5490, DOI 10.1158/1078-0432.CCR-11-0724; Inoue A, 2004, J MOL ENDOCRINOL, V32, P649, DOI 10.1677/jme.0.0320649; Jemal A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1672; Lee JC, 2003, IMMUNOL REV, V193, P39, DOI 10.1034/j.1600-065X.2003.00043.x; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259; Mueller MD, 2000, P NATL ACAD SCI USA, V97, P10972, DOI 10.1073/pnas.200377097; Newman LA, 2005, ONCOLOGIST, V10, P1, DOI 10.1634/theoncologist.10-1-1; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Weng L, 2013, ANN ONCOL, P1; Yang G, 2013, PHARMACOL THERAPEUT, V139, P392, DOI 10.1016/j.pharmthera.2013.05.005; Zapata JM, 2001, J BIOL CHEM, V276, P24242, DOI 10.1074/jbc.M100354200; Zhao YC, 2011, MOL MED, V17, P1233, DOI 10.2119/molmed.2010.00225; Ziliak D, 2011, TRANSL RES, V157, P265, DOI 10.1016/j.trsl.2011.01.005	27	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93420	10.1371/journal.pone.0093420	http://dx.doi.org/10.1371/journal.pone.0093420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699530	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000060
J	Bello, NT; Yeh, CY; Verpeut, JL; Walters, AL				Bello, Nicholas T.; Yeh, Chung-Yang; Verpeut, Jessica L.; Walters, Amy L.			Binge-Like Eating Attenuates Nisoxetine Feeding Suppression, Stress Activation, and Brain Norepinephrine Activity	PLOS ONE			English	Article							LIMITED ACCESS; BULIMIA-NERVOSA; RECEPTOR EXPRESSION; INTERMITTENT ACCESS; GENDER DIFFERENCES; PREFRONTAL CORTEX; LOCUS-COERULEUS; REBOXETINE; ANTIDEPRESSANT; RESPONSES	Stress is often associated with binge eating. A critical component of the control of stress is the central norepinephrine system. We investigated how dietary-induced binge eating alters central norepinephrine and related behaviors. Young male Sprague Dawley rats received calorie deprivation (24 h) and /or intermittent sweetened fat (vegetable shortening with sucrose; 30 min) twice a week for 10 weeks. The groups were Restrict Binge (calorie deprivation/sweetened fat), Binge (sweetened fat), Restrict (calorie deprivation), and Naive (no calorie deprivation/no sweetened fat). Dietary-induced binge eating was demonstrated by Restrict Binge and Binge, which showed an escalation in 30-min intake over time. Feeding suppression following nisoxetine (3 mg/kg; IP), a selective norepinephrine reuptake inhibitor, was not evident in Restrict Binge (Restrict Binge: 107 +/- 13, Binge: 52 +/- 9, Restrict: 80 +/- 8, Naive: 59 +/- 13% of saline injection at 1 h). In subsequent experiments with Restrict Binge and Naive, Restrict Binge had reduced corticosterone (Restrict Binge: 266625; Naive: 494 +/- 36 ng/ml) and less feeding suppression (Restrict Binge: 81 +/- 12, Naive: 50 +/- 11% of non-restraint intake at 30 min) following restraint stress (1 h). Dietary-induced binge eating in Restrict Binge was not altered by a dorsal noradrenergic bundle lesion caused by N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4), but frontal cortex norepinephrine was positively correlated with the average 30-min intake post- lesion (0.69; p<0.01). In a separate set of animals, single-unit in vivo electrophysiological recording of locus coeruleus-norepinephrine neural activity demonstrated reduced sensory-evoked response as a consequence of the Restrict Binge schedule (Restrict Binge: 8.1 +/- 0.67, Naive: 11.9 +/- 1.09 Hz). These results, which suggest that a consequence of dietary-induced binge eating is to attenuate the responsiveness of the brain norepinephrine system, will further our understanding of how highly palatable foods dampen the stress neuraxis.	[Bello, Nicholas T.; Yeh, Chung-Yang; Verpeut, Jessica L.; Walters, Amy L.] Rutgers State Univ, Dept Anim Sci, New Brunswick, NJ 08903 USA; [Bello, Nicholas T.; Verpeut, Jessica L.] Rutgers State Univ, Grad Program Endocrinol & Anim Biosci, New Brunswick, NJ 08903 USA; [Bello, Nicholas T.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Bello, NT (corresponding author), Rutgers State Univ, Dept Anim Sci, New Brunswick, NJ 08903 USA.	ntbello@aesop.rutgers.edu		Verpeut, Jessica/0000-0003-2941-7697; Yeh, Chung-Yang/0000-0002-0970-1300; Bello, Nicholas/0000-0001-5300-5604	USDA-NIFA [NJ06156]; Busch Biomedical Grant Program	USDA-NIFA(United States Department of Agriculture (USDA)); Busch Biomedical Grant Program	Support was provided by NJ06156 (USDA-NIFA) and the Busch Biomedical Grant Program (http://ored.rutgers.edu/internal-funding-programs/busch-biomedical-grant-program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, Vxxvii; Aston-Jones G, 2000, PROG BRAIN RES, V126, P165; Babbs RK, 2012, APPETITE, V59, P478, DOI 10.1016/j.appet.2012.05.022; Bambico FR, 2010, NEUROBIOL DIS, V37, P641, DOI 10.1016/j.nbd.2009.11.020; Barry DT, 2002, INT J EAT DISORDER, V31, P63, DOI 10.1002/eat.1112; Bello NT, 2013, J OBES, V2013, DOI 10.1155/2013/457047; Bello NT, 2012, PHYSIOL BEHAV, V105, P720, DOI 10.1016/j.physbeh.2011.09.021; Bello NT, 2011, PHYSIOL BEHAV, V104, P98, DOI 10.1016/j.physbeh.2011.04.032; Bello NT, 2009, AM J PHYSIOL-REG I, V297, pR622, DOI 10.1152/ajpregu.00087.2009; Berner LA, 2008, OBESITY, V16, P1998, DOI 10.1038/oby.2008.328; Bingham B, 2011, NEUROPSYCHOPHARMACOL, V36, P896, DOI 10.1038/npp.2010.229; Boggiano M.M., 2006, CURR PROTOC NEUROSCI, V23A; Burton E, 2007, INT J EAT DISORDER, V40, P27, DOI 10.1002/eat.20292; Cheetham SC, 1996, NEUROPHARMACOLOGY, V35, P63, DOI 10.1016/0028-3908(95)00134-4; Cohen-Yavin I, 2009, CLIN NEUROPHARMACOL, V32, P179, DOI 10.1097/WNF.0b013e318183796d; Colantuoni C, 2002, OBES RES, V10, P478, DOI 10.1038/oby.2002.66; Corwin RL, 2011, PHYSIOL BEHAV, V104, P87, DOI 10.1016/j.physbeh.2011.04.041; Corwin RL, 1998, PHYSIOL BEHAV, V65, P545, DOI 10.1016/S0031-9384(98)00201-7; Corwin RL, 2004, APPETITE, V42, P139, DOI 10.1016/j.appet.2003.08.010; Cottone P, 2008, AM J PHYSIOL-REG I, V295, pR1066, DOI 10.1152/ajpregu.90309.2008; Cryan JF, 2002, EUR J PHARMACOL, V436, P197, DOI 10.1016/S0014-2999(01)01628-4; Cullinan WE, 2008, BRAIN STRUCT FUNCT, V213, P63, DOI 10.1007/s00429-008-0192-2; Dallman MF, 2010, TRENDS ENDOCRIN MET, V21, P159, DOI 10.1016/j.tem.2009.10.004; Davis JF, 2007, PHYSIOL BEHAV, V92, P924, DOI 10.1016/j.physbeh.2007.06.024; El-Giamal N, 2000, INT CLIN PSYCHOPHARM, V15, P351, DOI 10.1097/00004850-200015060-00006; ELMORE DK, 1991, PHYSIOL BEHAV, V49, P99, DOI 10.1016/0031-9384(91)90238-J; Fassino S, 2004, J PSYCHOPHARMACOL, V18, P423, DOI 10.1177/026988110401800314; Field AE, 2013, JAMA PEDIAT; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; Foster MT, 2009, ENDOCRINOLOGY, V150, P2325, DOI 10.1210/en.2008-1426; Gardner EL, 2011, ADV PSYCHOSOM MED, V30, P22, DOI 10.1159/000324065; GEORGE DT, 1990, PSYCHIAT RES, V33, P1, DOI 10.1016/0165-1781(90)90143-S; Gibson EL, 2006, PHYSIOL BEHAV, V89, P53, DOI 10.1016/j.physbeh.2006.01.024; Ginty AT, 2012, PSYCHONEUROENDOCRINO, V37, P715, DOI 10.1016/j.psyneuen.2011.09.004; GREENO CG, 1994, PSYCHOL BULL, V115, P444, DOI 10.1037/0033-2909.115.3.444; Greeno CG, 2000, J CONSULT CLIN PSYCH, V68, P95, DOI 10.1037/0022-006X.68.1.95; Itoi K, 2010, J NEUROENDOCRINOL, V22, P355, DOI 10.1111/j.1365-2826.2010.01988.x; JONSSON G, 1981, EUR J PHARMACOL, V72, P173, DOI 10.1016/0014-2999(81)90272-7; Karteris E, 2005, AM J PHYSIOL-ENDOC M, V288, pE1089, DOI 10.1152/ajpendo.00351.2004; KAYE WH, 1990, AM J PSYCHIAT, V147, P225; Kinzig KP, 2008, PHYSIOL BEHAV, V95, P108, DOI 10.1016/j.physbeh.2008.04.026; Koo-Loeb JH, 1998, PSYCHIAT RES, V80, P13, DOI 10.1016/S0165-1781(98)00057-2; la Fleur SE, 2005, ENDOCRINOLOGY, V146, P2193, DOI 10.1210/en.2004-1603; Lardeux S, 2013, PHYSIOL BEHAV, V114, P21, DOI 10.1016/j.physbeh.2013.03.005; Laugero KD, 2001, ENDOCRINOLOGY, V142, P2796, DOI 10.1210/en.142.7.2796; LEIBOWITZ SF, 1988, NEUROSCI BIOBEHAV R, V12, P101, DOI 10.1016/S0149-7634(88)80002-2; LEMBERGER L, 1976, BRIT J CLIN PHARMACO, V3, P215, DOI 10.1111/j.1365-2125.1976.tb00595.x; Levin BE, 1996, AM J PHYSIOL-REG I, V270, pR456, DOI 10.1152/ajpregu.1996.270.2.R456; Lewinsohn PM, 2002, INT J EAT DISORDER, V32, P426, DOI 10.1002/eat.10103; McElroy SL, 2007, J CLIN PSYCHIAT, V68, P390, DOI 10.4088/JCP.v68n0306; McGee HM, 2010, BRAIN RES, V1350, P103, DOI 10.1016/j.brainres.2010.01.033; Merali Z, 2003, BIOL PSYCHIAT, V54, P552, DOI 10.1016/S0006-3223(02)01827-9; Millan MJ, 2007, INT J NEUROPSYCHOPH, V10, P579, DOI 10.1017/S1461145706007309; Miner LH, 2003, J COMP NEUROL, V466, P478, DOI 10.1002/cne.10898; Moron JA, 2002, J NEUROSCI, V22, P389, DOI 10.1523/JNEUROSCI.22-02-00389.2002; Mussell MP, 1997, INT J EAT DISORDER, V21, P353, DOI 10.1002/(SICI)1098-108X(1997)21:4&lt;353::AID-EAT8&gt;3.0.CO;2-N; Ottersen O P, 1986, Adv Exp Med Biol, V203, P263; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pecoraro N, 2004, ENDOCRINOLOGY, V145, P3754, DOI 10.1210/en.2004-0305; Radley JJ, 2008, J NEUROSCI, V28, P5806, DOI 10.1523/JNEUROSCI.0552-08.2008; Radley JJ, 2009, J NEUROSCI, V29, P7330, DOI 10.1523/JNEUROSCI.5924-08.2009; Rinaman L, 2011, AM J PHYSIOL-REG I, V300, pR222, DOI 10.1152/ajpregu.00556.2010; Rosenberg N, 2012, PSYCHIAT RES; Rowley HL, 2000, N-S ARCH PHARMACOL, V361, P187, DOI 10.1007/s002109900170; Telch CF, 1996, INT J EAT DISORDER, V20, P271, DOI 10.1002/(SICI)1098-108X(199611)20:3&lt;271::AID-EAT6&gt;3.0.CO;2-L; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; Vanderlinden J, 2004, Eat Weight Disord, V9, P300; Waters A, 2001, INT J EAT DISORDER, V29, P17, DOI 10.1002/1098-108X(200101)29:1<17::AID-EAT3>3.0.CO;2-R; Wojnicki FHE, 2008, PHYSIOL BEHAV, V95, P649, DOI 10.1016/j.physbeh.2008.09.017; WOLFMAN C, 1994, NEUROCHEM INT, V25, P395, DOI 10.1016/0197-0186(94)90147-3	71	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93610	10.1371/journal.pone.0093610	http://dx.doi.org/10.1371/journal.pone.0093610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695494	Green Submitted, gold, Green Published			2022-12-27	WOS:000334103000093
J	Zhou, J; Zhan, SH; Zhu, Q; Gong, HJ; Wang, YD; Fan, DS; Gong, ZG; Huang, YW				Zhou, Jun; Zhan, Songhua; Zhu, Qiong; Gong, Hangjun; Wang, Yidong; Fan, Desheng; Gong, Zhigang; Huang, Yanwen			Prediction of Nodal Involvement in Primary Rectal Carcinoma without Invasion to Pelvic Structures: Accuracy of Preoperative CT, MR, and DWIBS Assessments Relative to Histopathologic Findings	PLOS ONE			English	Article							MULTIDETECTOR ROW CT; LATERAL LYMPH-NODE; THIN-SECTION MR; COLORECTAL-CANCER; CORONAL REFORMATIONS; ISOTROPIC VOXELS; METASTASIS; ONCOLOGY; USPIO	Objective: To investigate the accuracy of preoperative computed tomography (CT), magnetic resonance (MR) imaging and diffusion-weighted imaging with background body signal suppression (DWIBS) in the prediction of nodal involvement in primary rectal carcinoma patients in the absence of tumor invasion into pelvic structures. Methods and Materials: Fifty-two subjects with primary rectal cancer were preoperatively assessed by CT and MRI at 1.5 T with a phased-array coil. Preoperative lymph node staging with imaging modalities ( CT, MRI, and DWIBS) were compared with the final histological findings. Results: The accuracy of CT, MRI, and DWIBS were 57.7%, 63.5%, and 40.4%. The accuracy of DWIBS with higher sensitivity and negative predictive value for evaluating primary rectal cancer patients was lower than that of CT and MRI. Nodal staging agreement between imaging and pathology was fairly strong for CT and MRI ( Kappa value = 0.331 and 0.348, P<0.01) but was relatively weaker for DWIBS (Kappa value = 0.174, P<0.05). The accuracy was 57.7% and 59.6%, respectively, for CT and MRI when the lymph node border information was used as the criteria, and was 57.7% and 61.5%, respectively, for enhanced CT and MRI when the lymph node enhancement pattern was used as the criteria. Conclusion: MRI is more accurate than CT in predicting nodal involvement in primary rectal carcinoma patients in the absence of tumor invasion into pelvic structures. DWIBS has a great diagnostic value in differentiating small malignant from benign lymph nodes.	[Zhou, Jun; Zhan, Songhua; Zhu, Qiong; Gong, Zhigang; Huang, Yanwen] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Radiol, Shanghai, Peoples R China; [Gong, Hangjun; Wang, Yidong] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Gen Surg, Shanghai, Peoples R China; [Wang, Yidong] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Pathol, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Zhan, SH (corresponding author), Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Radiol, Shanghai, Peoples R China.	zhansonghuapre@163.com			Science and Technology Commission Foundation of Shanghai Municipality in China [10411952300]	Science and Technology Commission Foundation of Shanghai Municipality in China	This study was supported by a grant from the Science and Technology Commission Foundation of Shanghai Municipality (NO, 10411952300) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akay S, 2013, J MED IMAGING RAD ON; Arii K, 2006, LANGENBECK ARCH SURG, V391, P449, DOI 10.1007/s00423-006-0066-0; Beets-Tan RGH, 2004, RADIOLOGY, V232, P335, DOI 10.1148/radiol.2322021326; Bipat S, 2004, RADIOLOGY, V232, P773, DOI 10.1148/radiol.2323031368; Brown G, 2003, RADIOLOGY, V227, P371, DOI 10.1148/radiol.2272011747; Brown G, 1999, RADIOLOGY, V211, P215, DOI 10.1148/radiology.211.1.r99ap35215; Cui CY, 2011, EUR RADIOL, V21, P2318, DOI 10.1007/s00330-011-2182-7; Filippone A, 2004, RADIOLOGY, V231, P83, DOI 10.1148/radiol.2311021152; Fowler JM, 2007, RADIOLOGY, V243, P132, DOI 10.1148/radiol.2431051825; Hosonuma Tomonori, 2006, Magn Reson Med Sci, V5, P173, DOI 10.2463/mrms.5.173; Iafrate F, 2006, RADIOGRAPHICS, V26, P701, DOI 10.1148/rg.263055086; Ishida H, 2012, JPN J CLIN ONCOL, V42, P485, DOI 10.1093/jjco/hys041; Jaffe TA, 2006, RADIOLOGY, V238, P135, DOI 10.1148/radiol.2381050489; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Kaur H, 2012, RADIOGRAPHICS, V32, P389, DOI 10.1148/rg.322115122; Kim H, 2010, RADIOLOGY, V254, P485, DOI 10.1148/radiol.09090587; Koh DM, 2004, RADIOLOGY, V231, P91, DOI 10.1148/radiol.2311030142; Kwee TC, 2008, EUR RADIOL, V18, P1937, DOI 10.1007/s00330-008-0968-z; Lahaye MJ, 2008, RADIOLOGY, V246, P804, DOI 10.1148/radiol.2463070221; Mizukami Y, 2011, WORLD J SURG, V35, P895, DOI 10.1007/s00268-011-0986-x; Mulkens TH, 2005, RADIOLOGY, V237, P213, DOI 10.1148/radiol.2363041220; Nasu K, 2004, JPN J CLIN ONCOL, V34, P620, DOI 10.1093/jjco/hyh108; Paulson EK, 2005, RADIOLOGY, V235, P879, DOI 10.1148/radiol.2353041231; PHILLIPS RKS, 1984, BRIT J SURG, V71, P12, DOI 10.1002/bjs.1800710104; Rao SX, 2007, WORLD J GASTROENTERO, V13, P4141, DOI 10.3748/wjg.v13.i30.4141; Samee A, 2011, WORLD J GASTROENTERO, V17, P828, DOI 10.3748/wjg.v17.i7.828; Scaranelo AM, 2012, RADIOLOGY, V262, P425, DOI 10.1148/radiol.11110639; Takahara T., 2004, MATRIX, V160, P160; Turkbey B, 2012, DIAGN INTERV RADIOL, V18, P46, DOI 10.4261/1305-3825.DIR.4708-11.2; Viera AJ, 2005, FAM MED, V37, P360; Wallengren NO, 2000, RADIOLOGY, V215, P108, DOI 10.1148/radiology.215.1.r00mr14108; Yasui O, 2009, TOHOKU J EXP MED, V218, P177, DOI 10.1620/tjem.218.177; Zerhouni EA, 1996, RADIOLOGY, V200, P443, DOI 10.1148/radiology.200.2.8685340	33	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92779	10.1371/journal.pone.0092779	http://dx.doi.org/10.1371/journal.pone.0092779			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695111	gold, Green Published, Green Submitted			2022-12-27	WOS:000334103000027
J	Hawkes, LA; Butler, PJ; Frappell, PB; Meir, JU; Milsom, WK; Scott, GR; Bishop, CM				Hawkes, Lucy A.; Butler, Patrick J.; Frappell, Peter B.; Meir, Jessica U.; Milsom, William K.; Scott, Graham R.; Bishop, Charles M.			Maximum Running Speed of Captive Bar-Headed Geese Is Unaffected by Severe Hypoxia	PLOS ONE			English	Article							HIGH-ALTITUDE; HEART-RATE; OXYGEN-CONSUMPTION; BRANTA-LEUCOPSIS; EXERCISE PERFORMANCE; SEA-LEVEL; BLOOD; FLIGHT; BIRDS; MIGRATION	While bar-headed geese are renowned for migration at high altitude over the Himalayas, previous work on captive birds suggested that these geese are unable to maintain rates of oxygen consumption while running in severely hypoxic conditions. To investigate this paradox, we re-examined the running performance and heart rates of bar-headed geese and barnacle geese (a low altitude species) during exercise in hypoxia. Bar-headed geese (n = 7) were able to run at maximum speeds (determined in normoxia) for 15 minutes in severe hypoxia (7% O-2; simulating the hypoxia at 8500 m) with mean heart rates of 466 +/- 8 beats min(-1). Barnacle geese (n = 10), on the other hand, were unable to complete similar trials in severe hypoxia and their mean heart rate (316 beats.min(-1)) was significantly lower than bar-headed geese. In bar-headed geese, partial pressures of oxygen and carbon dioxide in both arterial and mixed venous blood were significantly lower during hypoxia than normoxia, both at rest and while running. However, measurements of blood lactate in bar-headed geese suggested that anaerobic metabolism was not a major energy source during running in hypoxia. We combined these data with values taken from the literature to estimate (i) oxygen supply, using the Fick equation and (ii) oxygen demand using aerodynamic theory for bar-headed geese flying aerobically, and under their own power, at altitude. This analysis predicts that the maximum altitude at which geese can transport enough oxygen to fly without environmental assistance ranges from 6,800 m to 8,900 m altitude, depending on the parameters used in the model but that such flights should be rare.	[Hawkes, Lucy A.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Butler, Patrick J.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Frappell, Peter B.] Univ Tasmania, Hobart, Tas, Australia; [Meir, Jessica U.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA; [Milsom, William K.] Univ British Columbia, Dept Zool, Vancouver, BC V5Z 1M9, Canada; [Scott, Graham R.] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Hawkes, Lucy A.; Bishop, Charles M.] Univ Exeter, Coll Life & Environm Sci, Penryn, Cornwall, England	Bangor University; University of Birmingham; University of Tasmania; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of British Columbia; McMaster University; University of Exeter	Hawkes, LA (corresponding author), Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales.	l.hawkes@exeter.ac.uk	Hawkes, Lucy/L-7407-2014	Hawkes, Lucy/0000-0002-6696-1862	Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom [BB/F015615/1]; Biotechnology and Biological Sciences Research Council [BB/F015615/1] Funding Source: researchfish; BBSRC [BB/F015615/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The project was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom [Grant number BB/F015615/1] to CMB and PJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beneke R, 2003, EUR J APPL PHYSIOL, V88, P361, DOI 10.1007/s00421-002-0713-2; Bishop CM, 2013, J THEOR BIOL, V323, P11, DOI 10.1016/j.jtbi.2013.01.002; BISHOP CM, 1995, J EXP BIOL, V198, P2153; Bishop CM, 2002, COMP BIOCHEM PHYS A, V133, P225, DOI 10.1016/S1095-6433(02)00157-5; Bishop CM, 1999, P ROY SOC B-BIOL SCI, V266, P2275, DOI 10.1098/rspb.1999.0919; Bishop Mary A., 1997, Wildfowl, V48, P118; BLACK CP, 1980, RESP PHYSIOL, V39, P217, DOI 10.1016/0034-5687(80)90046-8; Blum Arlene, 1998, ANNAPURNA WOMANS PLA; BOND CF, 1958, AM J PHYSIOL, V194, P519, DOI 10.1152/ajplegacy.1958.194.3.519; Brown WEL, 1923, P R SOC LOND B-CONTA, V94, P297, DOI 10.1098/rspb.1923.0006; Butler PJ, 2010, COMP BIOCHEM PHYS A, V156, P325, DOI 10.1016/j.cbpa.2010.01.016; BUTLER PJ, 1993, J EXP BIOL, V179, P159; Butler PJ, 1998, J AVIAN BIOL, V29, P536, DOI 10.2307/3677173; BUTLER PJ, 1991, J EXP BIOL, V160, P233; DAVIES CTM, 1979, EUR J APPL PHYSIOL O, V41, P233, DOI 10.1007/BF00429740; di Prampero PE, 1999, RESP PHYSIOL, V118, P103, DOI 10.1016/S0034-5687(99)00083-3; Eichhorn G, 2009, J ANIM ECOL, V78, P63, DOI 10.1111/j.1365-2656.2008.01485.x; FARACI FM, 1985, RESP PHYSIOL, V61, P21, DOI 10.1016/0034-5687(85)90025-8; FARACI FM, 1986, AM J PHYSIOL, V250, pR499, DOI 10.1152/ajpregu.1986.250.3.R499; FARACI FM, 1984, AM J PHYSIOL, V247, pR402, DOI 10.1152/ajpregu.1984.247.2.R402; FARACI FM, 1991, ANNU REV PHYSIOL, V53, P59, DOI 10.1146/annurev.ph.53.030191.000423; FARACI FM, 1984, AM J PHYSIOL, V247, pR69, DOI 10.1152/ajpregu.1984.247.1.R69; FEDAK MA, 1981, J APPL PHYSIOL, V51, P772, DOI 10.1152/jappl.1981.51.3.772; FEDDE MR, 1989, RESP PHYSIOL, V77, P239, DOI 10.1016/0034-5687(89)90010-8; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Hartman F. A., 1961, Condor, V66, P403; Hawkes LA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2114; Hawkes LA, 2011, P NATL ACAD SCI USA, V108, P9516, DOI 10.1073/pnas.1017295108; Lee SY, 2008, COMP BIOCHEM PHYS C, V148, P324, DOI 10.1016/j.cbpc.2008.05.009; Liechti F, 2002, J EXP BIOL, V205, P2461; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Lundby C, 2001, HIGH ALT MED BIOL, V2, P369, DOI 10.1089/15270290152608543; MARGARIA R, 1963, J APPL PHYSIOL, V18, P371, DOI 10.1152/jappl.1963.18.2.371; Meir JU, 2013, J EXP BIOL, V216, P2172, DOI 10.1242/jeb.085282; Noakes TD, 2007, J PHYSIOL-LONDON, V585, P919, DOI 10.1113/jphysiol.2007.145110; NOLET BA, 1992, PHYSIOL ZOOL, V65, P1188, DOI 10.1086/physzool.65.6.30158275; Nudds RL, 2010, COMP BIOCHEM PHYS A, V156, P318, DOI 10.1016/j.cbpa.2010.01.023; Pennycuick CJ, 2008, THEOR ECOL SER, P1; PETSCHOW D, 1977, J APPL PHYSIOL, V42, P139, DOI 10.1152/jappl.1977.42.2.139; Piersma T, 1996, CONDOR, V98, P363, DOI 10.2307/1369154; Portugal SJ, 2012, BIOL LETTERS, V8, P469, DOI 10.1098/rsbl.2011.0975; Portugal SJ, 2009, J EXP BIOL, V212, P2941, DOI 10.1242/jeb.034546; Prop J, 2003, OIKOS, V103, P403, DOI 10.1034/j.1600-0706.2003.12042.x; RAYNER JMV, 1991, PHILOS T ROY SOC B, V334, P119, DOI 10.1098/rstb.1991.0101; RAYNER JMV, 1994, J ZOOL, V234, P537; RODKEY FL, 1979, AM J VET RES, V40, P887; RUIZ G, 1995, INT J BIOMETEOROL, V39, P103, DOI 10.1007/BF01212588; Schippers MP, 2012, CURR BIOL, V22, P2350, DOI 10.1016/j.cub.2012.10.043; Scott GR, 2007, AM J PHYSIOL-REG I, V293, pR379, DOI 10.1152/ajpregu.00161.2007; Scott GR, 2011, J EXP BIOL, V214, P2455, DOI 10.1242/jeb.052548; Scott GR, 2006, RESP PHYSIOL NEUROBI, V154, P284, DOI 10.1016/j.resp.2006.02.012; Scott GR, 2009, P R SOC B, V276, P3645, DOI 10.1098/rspb.2009.0947; Scott GR, 2009, AM J PHYSIOL-REG I, V297, pR1066, DOI 10.1152/ajpregu.00241.2009; SEEHERMAN HJ, 1981, RESP PHYSIOL, V44, P11, DOI 10.1016/0034-5687(81)90074-8; SNYDER GK, 1984, RESP PHYSIOL, V58, P151; STEPHENSON R, 1986, J EXP BIOL, V126, P341; Swan L. W., 1970, Nat. Hist., N.Y., V79, P68; SWAN LW, 1961, SCI AM, V205, P68, DOI 10.1038/scientificamerican1061-68; Tickle PG, 2010, COMP BIOCHEM PHYS A, V156, P309, DOI 10.1016/j.cbpa.2010.01.022; Verhulst S, 2002, AVIAN SCI, V2, P1; VOGEL JA, 1974, J APPL PHYSIOL, V36, P173, DOI 10.1152/jappl.1974.36.2.173; Vogel JA, 1974, J APPL PHYSL, V36; Ward S, 2002, J EXP BIOL, V205, P3347; WEST JB, 1983, J APPL PHYSIOL, V55, P688, DOI 10.1152/jappl.1983.55.3.688; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120; WOAKES AJ, 1986, J EXP BIOL, V120, P215	66	24	24	0	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94015	10.1371/journal.pone.0094015	http://dx.doi.org/10.1371/journal.pone.0094015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710001	gold, Green Published			2022-12-27	WOS:000334159800086
J	Pankova, H; Raabova, J; Munzbergova, Z				Pankova, Hana; Raabova, Jana; Muenzbergova, Zuzana			Mycorrhizal Symbiosis and Local Adaptation in Aster amellus: A Field Transplant Experiment	PLOS ONE			English	Article							COEVOLUTION; FUNGI	Many plant populations have adapted to local soil conditions. However, the role of arbuscular mycorrhizal fungi is often overlooked in this context. Only a few studies have used reciprocal transplant experiments to study the relationships between soil conditions, mycorrhizal colonisation and plant growth. Furthermore, most of the studies were conducted under controlled greenhouse conditions. However, long-term field experiments can provide more realistic insights into this issue. We conducted a five-year field reciprocal transplant experiment to study the relationships between soil conditions, arbuscular mycorrhizal fungi and plant growth in the obligate mycotrophic herb Aster amellus. We conducted this study in two regions in the Czech Republic that differ significantly in their soil nutrient content, namely Czech Karst (region K) and Ceske Stredohori (region S). Plants that originated from region S had significantly higher mycorrhizal colonisation than plants from region K, indicating that the percentage of mycorrhizal colonisation has a genetic basis. We found no evidence of local adaptation in Aster amellus. Instead, plants from region S outperformed the plants from region K in both target regions. Similarly, plants from region S showed more mycorrhizal colonisation in all cases, which was likely driven by the lower nutrient content in the soil from that region. Thus, plant aboveground biomass and mycorrhizal colonisation exhibited corresponding differences between the two target regions and regions of origin. Higher mycorrhizal colonisation in the plants from region with lower soil nutrient content (region S) in both target regions indicates that mycorrhizal colonisation is an adaptive trait. However, lower aboveground biomass in the plants with lower mycorrhizal colonisation suggests that the plants from region K are in fact maladapted by their low inherent mycorrhizal colonization. We conclude that including mycorrhizal symbiosis in local adaptation studies may increase our understanding of the mechanisms by which plants adapt to their environment.	[Pankova, Hana; Muenzbergova, Zuzana] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Raabova, Jana] Natl Museum, Dept Bot, Prague, Czech Republic; [Muenzbergova, Zuzana] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; National Museum; Charles University Prague	Munzbergova, Z (corresponding author), Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic.	zuzmun@natur.cuni.cz	Münzbergová, Zuzana/F-6321-2013; Pánková, Hana/H-1617-2014	Münzbergová, Zuzana/0000-0002-4026-6220; Pánková, Hana/0000-0001-6012-541X	Grant Agency of the Czech Republic [P504/10/1486, P505/11/P482]; Academy of Sciences of the Czech Republic [RVO 67985939]; Ministry of Culture of the Czech Republic [DKRVO 2014/08, 00023272]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Ministry of Culture of the Czech Republic	The study was supported by Grant Agency of the Czech Republic (grants no P504/10/1486, P505/11/P482) and also partly by long-term research projects of the Academy of Sciences of the Czech Republic (RVO 67985939) and the Ministry of Culture of the Czech Republic (DKRVO 2014/08, National Museum, 00023272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker U, 2006, OECOLOGIA, V150, P506, DOI 10.1007/s00442-006-0534-9; Chylova T, 2008, PRESLIA, V80, P183; Cogni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029220; Doubkova P, 2012, SOIL BIOL BIOCHEM, V44, P56, DOI 10.1016/j.soilbio.2011.09.011; Ehrenberger F., 1973, METHODEN ORGANISCHEN; Ellenberg H, 1996, VEGETATION MITTELEUR; Garrido JL, 2012, PLANT ECOL, V213, P1555, DOI 10.1007/s11258-012-0111-8; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Hoeksema JD, 2010, NEW PHYTOL, V187, P286, DOI 10.1111/j.1469-8137.2010.03305.x; Hufford KM, 2008, RESTOR ECOL, V16, P59, DOI 10.1111/j.1526-100X.2007.00262.x; Ji BM, 2010, ECOLOGY, V91, P3037, DOI 10.1890/09-1451.1; Johnson NC, 2010, NEW PHYTOL, V185, P631, DOI 10.1111/j.1469-8137.2009.03110.x; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Koorem K, 2012, BASIC APPL ECOL, V13, P663, DOI 10.1016/j.baae.2012.09.008; KOSKE RE, 1989, MYCOL RES, V92, P486, DOI 10.1016/S0953-7562(89)80195-9; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lenssen JPM, 2004, J ECOL, V92, P696, DOI 10.1111/j.0022-0477.2004.00895.x; Macel M, 2007, ECOLOGY, V88, P424, DOI 10.1890/0012-9658(2007)88[424:CVSFIL]2.0.CO;2; Mandakova T, 2006, ANN BOT-LONDON, V98, P845, DOI 10.1093/aob/mcl165; Moore P.D., 1986, METHODS PLANT ECOLOG, VSecond edition; Munzbergova Z, 2011, PERSPECT PLANT ECOL, V13, P151, DOI 10.1016/j.ppees.2011.03.002; Nuismer SL, 2008, AM NAT, V171, P658, DOI 10.1086/587077; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Pankova H, 2008, OECOLOGIA, V157, P211, DOI 10.1007/s00442-008-1064-4; Pankova H, 2011, AM J BOT, V98, P850, DOI 10.3732/ajb.0900350; Raabova J, 2008, OECOLOGIA, V158, P463, DOI 10.1007/s00442-008-1156-1; Raabova J, 2007, BIOL CONSERV, V139, P348, DOI 10.1016/j.biocon.2007.07.007; Raabova J, 2011, BASIC APPL ECOL, V12, P152, DOI 10.1016/j.baae.2011.01.001; Schultz PA, 2001, AM J BOT, V88, P1650, DOI 10.2307/3558410; Thrall PH, 2007, TRENDS ECOL EVOL, V22, P120, DOI 10.1016/j.tree.2006.11.007; van Aarle IM, 2003, SOIL BIOL BIOCHEM, V35, P1557, DOI 10.1016/S0038-0717(03)00248-7; Wagner V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017580	35	9	9	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93967	10.1371/journal.pone.0093967	http://dx.doi.org/10.1371/journal.pone.0093967			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709748	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800079
J	Chueca, B; Pagan, R; Garcia-Gonzalo, D				Chueca, Beatriz; Pagan, Rafael; Garcia-Gonzalo, Diego			Differential Mechanism of Escherichia coli Inactivation by (+)-Limonene as a Function of Cell Physiological State and Drug's Concentration	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; ESSENTIAL OILS; BACTERICIDAL ANTIBIOTICS; SULFHYDRYL COMPOUND; OXIDATIVE STRESS; DNA-DAMAGE; LIMONENE; CONSTITUENTS; OXYGEN; DEATH	(+)-limonene is a lipophilic antimicrobial compound, extracted from citrus fruits' essential oils, that is used as a flavouring agent and organic solvent by the food industry. A recent study has proposed a common and controversial mechanism of cell death for bactericidal antibiotics, in which hydroxyl radicals ultimately inactivated cells. Our objective was to determine whether the mechanism of Escherichia coli MG1655 inactivation by (+)-limonene follows that of bactericidal antibiotics. A treatment with 2,000 mu L/L (+)-limonene inactivated 4 log(10) cycles of exponentially growing E. coli cells in 3 hours. On one hand, an increase of cell survival in the Delta acnB mutant (deficient in a TCA cycle enzyme), or in the presence of 2,2'-dipyridyl (inhibitor of Fenton reaction by iron chelation), thiourea, or cysteamine (hydroxyl radical scavengers) was observed. Moreover, the Delta recA mutant (deficient in an enzyme involved in SOS response to DNA damage) was more sensitive to (+)-limonene. Thus, this indirect evidence indicates that the mechanism of exponentially growing E. coli cells inactivation by 2,000 mu L/L (+)-limonene is due to the TCA cycle and Fenton-mediated hydroxyl radical formation that caused oxidative DNA damage, as observed for bactericidal drugs. However, several differences have been observed between the proposed mechanism for bactericidal drugs and for (+)-limonene. In this regard, our results demonstrated that E. coli inactivation was influenced by its physiological state and the drug's concentration: experiments with stationary-phase cells or 4,000 mu L/L (+)-limonene uncovered a different mechanism of cell death, likely unrelated to hydroxyl radicals. Our research has also shown that drug's concentration is an important factor influencing the mechanism of bacterial inactivation by antibiotics, such as kanamycin. These results might help in improving and spreading the use of (+)-limonene as an antimicrobial compound, and in clarifying the controversy about the mechanism of inactivation by bactericidal antibiotics.	[Chueca, Beatriz; Pagan, Rafael; Garcia-Gonzalo, Diego] Univ Zaragoza, Fac Vet, Dept Prod Anim & Ciencia Alimentos, Zaragoza, Spain	University of Zaragoza	Garcia-Gonzalo, D (corresponding author), Univ Zaragoza, Fac Vet, Dept Prod Anim & Ciencia Alimentos, Zaragoza, Spain.	Diego.Garcia@unizar.es	Gonzalo, Diego Garcia/AAE-8947-2021; Pagan, Rafael/H-4401-2011; Gonzalo, Diego Garcia/A-2766-2012	Gonzalo, Diego Garcia/0000-0002-7629-8101; Pagan, Rafael/0000-0002-0238-6328; Gonzalo, Diego Garcia/0000-0002-7629-8101	CICYT [AGL2012-32165]; European Social Fund; Aragonese Departamento de Ciencia, Tecnologia y Universidad; Spanish Ministerio de Educacion, Cultura y Deporte	CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); European Social Fund(European Social Fund (ESF)); Aragonese Departamento de Ciencia, Tecnologia y Universidad; Spanish Ministerio de Educacion, Cultura y Deporte(Spanish Government)	This study was financially supported by the CICYT (Project AGL2012-32165), European Social Fund and Aragonese Departamento de Ciencia, Tecnologia y Universidad; and Spanish Ministerio de Educacion, Cultura y Deporte that provided B. Chueca with a grant to carry out this investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Ouazzou A, 2011, INNOV FOOD SCI EMERG, V12, P320, DOI 10.1016/j.ifset.2011.04.004; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Braun JEF, 1996, MUTAT RES-DNA REPAIR, V364, P171, DOI 10.1016/S0921-8777(96)00030-4; Chee Hee Youn, 2009, Mycobiology, V37, P243, DOI 10.4489/MYCO.2009.37.3.243; Condon S, 1996, LETT APPL MICROBIOL, V22, P149, DOI 10.1111/j.1472-765X.1996.tb01130.x; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Crowell PL, 1999, J NUTR, V129, p775S, DOI 10.1093/jn/129.3.775S; Dambolena JS, 2008, TOXICON, V51, P37, DOI 10.1016/j.toxicon.2007.07.005; Dorman HJD, 2000, J APPL MICROBIOL, V88, P308, DOI 10.1046/j.1365-2672.2000.00969.x; Espina L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056769; Espina L, 2013, INT J FOOD MICROBIOL, V161, P23, DOI 10.1016/j.ijfoodmicro.2012.11.015; Espina L, 2011, FOOD CONTROL, V22, P896, DOI 10.1016/j.foodcont.2010.11.021; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Fisher K, 2008, TRENDS FOOD SCI TECH, V19, P156, DOI 10.1016/j.tifs.2007.11.006; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Friedman M, 2002, J FOOD PROTECT, V65, P1545, DOI 10.4315/0362-028X-65.10.1545; Guyton Kathryn Z, 2002, Curr Oncol Rep, V4, P464, DOI 10.1007/s11912-002-0057-4; HARTMAN PS, 1978, J BACTERIOL, V133, P769, DOI 10.1128/JB.133.2.769-774.1978; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; IMLAY JA, 1986, J BACTERIOL, V166, P519, DOI 10.1128/jb.166.2.519-527.1986; Jaroenkit P., 2011, International Journal of Medicinal and Aromatic Plants, V1, P234; Jones SFA, 1996, EUR J GASTROEN HEPAT, V8, P1227, DOI 10.1097/00042737-199612000-00018; KELNER MJ, 1990, J BIOL CHEM, V265, P1306; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Letain TE, 1997, MOL MICROBIOL, V24, P271, DOI 10.1046/j.1365-2958.1997.3331703.x; Liu JD, 2013, APPL MICROBIOL BIOT, V97, P6467, DOI 10.1007/s00253-013-4931-9; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Moeck GS, 1998, MOL MICROBIOL, V28, P675, DOI 10.1046/j.1365-2958.1998.00817.x; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; NOVOGRODSKY A, 1982, P NATL ACAD SCI-BIOL, V79, P1171, DOI 10.1073/pnas.79.4.1171; Raso J, 1998, APPL ENVIRON MICROB, V64, P465; REPINE JE, 1981, J BIOL CHEM, V256, P7094; Rolseth V, 2002, TOXICOLOGY, V170, P75, DOI 10.1016/S0300-483X(01)00537-6; Salih FM, 2002, J APPL MICROBIOL, V92, P920, DOI 10.1046/j.1365-2672.2002.01601.x; SIKKEMA J, 1994, J BIOL CHEM, V269, P8022; Somolinos M, 2010, J APPL MICROBIOL, V108, P1928, DOI 10.1111/j.1365-2672.2009.04597.x; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Van Vuuren SF, 2007, FLAVOUR FRAG J, V22, P540, DOI 10.1002/ffj.1843; WALSH K, 1984, J BIOL CHEM, V259, P9646; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; ZUKERMAN I, 1951, NATURE, V168, P517, DOI 10.1038/168517a0	43	30	31	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94072	10.1371/journal.pone.0094072	http://dx.doi.org/10.1371/journal.pone.0094072			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705541	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500119
J	Lefevre, CE; Wilson, VAD; Morton, FB; Brosnan, SF; Paukner, A; Bates, TC				Lefevre, Carmen Emilia; Wilson, Vanessa A. D.; Morton, F. Blake; Brosnan, Sarah F.; Paukner, Annika; Bates, Timothy C.			Facial Width-To-Height Ratio Relates to Alpha Status and Assertive Personality in Capuchin Monkeys	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; BODY-WEIGHT; COMPETITION; FACES; CUES; TESTOSTERONE; COOPERATION; AGGRESSION; STRATEGIES; COALITIONS	Social dominance hierarchies play a pivotal role in shaping the behaviour of many species, and sex differences within these hierarchies often exist. To date, however, few physical markers of dominance have been identified. Such markers would be valuable in terms of understanding the etiology of dominant behaviour and changes in social hierarchies over time. Animals may also use such traits to evaluate the potential dominance of others relative to themselves (i.e. a physical "cue"). Facial width-to-height ratio (fWHR), for example, has been suggested as a cue to dominance in humans, with links to both dominant behaviour and the perception of dominance in other individuals. Whether this association is present in nonhuman animals is currently not known. Therefore, here we examine within-species links between fWHR and dominant behaviour in 64 brown capuchin monkeys (Sapajus spp.) aged between 2 and 40 years. fWHR was positively associated with alpha status and with a dimensional rating of assertive personality in both males and females. Moreover, fWHR showed significant sexual dimorphism in adults but not juveniles, suggesting a developmental change may occur during puberty. In a sub-sample, sex differences were mediated by weight, suggesting fWHR dimorphism does not exceed what would be expected by differences in body weight. This is the first report of an association between face shape and behaviour in a nonhuman species. Results are discussed in terms of the role that face-behaviour associations might play within capuchin societies, and the possible selective forces that might have led to the evolution of fWHR-dominance associations in humans.	[Lefevre, Carmen Emilia] Univ Leeds, Sch Business, Ctr Decis Res, Leeds, W Yorkshire, England; [Wilson, Vanessa A. D.; Bates, Timothy C.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Wilson, Vanessa A. D.; Morton, F. Blake] Scottish Primate Res Grp, Edinburgh, Midlothian, Scotland; [Morton, F. Blake] Univ Stirling, Sch Nat Sci, Behav & Evolut Res Grp, Stirling FK9 4LA, Scotland; [Brosnan, Sarah F.] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [Brosnan, Sarah F.] Georgia State Univ, Language Res Ctr, Atlanta, GA 30303 USA; [Paukner, Annika] NIH, Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Comparat Ethol Lab, Dept Hlth & Human Serv, Poolesville, MD USA	University of Leeds; University of Edinburgh; University of Stirling; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lefevre, CE (corresponding author), Univ Leeds, Sch Business, Ctr Decis Res, Leeds, W Yorkshire, England.	carmenlefevre@me.com; tim.bates@ed.ac.uk	Paukner, Annika/ABA-3275-2020; Bates, Timothy C/C-9637-2010	Paukner, Annika/0000-0002-3421-1864; Bates, Timothy C/0000-0002-1153-9007; Wilson, Vanessa/0000-0001-7253-6013	Intramural NIH HHS [Z99 HD999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alfaro JWL, 2012, AM J PRIMATOL, V74, P273, DOI 10.1002/ajp.22007; [Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Archer J, 2009, BEHAV BRAIN SCI, V32, P249, DOI 10.1017/S0140525X09990951; BERCU BB, 1983, J CLIN ENDOCR METAB, V56, P1214, DOI 10.1210/jcem-56-6-1214; Boinski S, 1996, ADAPTIVE RADIATIONS OF NEOTROPICAL PRIMATES, P251; Buikstra J, 1994, ARKANSAS AGR SURVEY, V44; Carre JM, 2010, PERCEPTION, V39, P356, DOI 10.1068/p6543; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Clutton-Brock T.H., 1983, P457; Coetzee V, 2010, PERCEPTION, V39, P51, DOI 10.1068/p6560; Deaner RO, 2012, J RES PERS, V46, P235, DOI 10.1016/j.jrp.2012.01.005; DEWAAL FBM, 1984, ETHOL SOCIOBIOL, V5, P239, DOI 10.1016/0162-3095(84)90004-9; DiBitetti MS, 1997, ANIM BEHAV, V54, P199, DOI 10.1006/anbe.1996.0416; Fashing PJ, 2001, BEHAV ECOL SOCIOBIOL, V50, P219, DOI 10.1007/s002650100358; Fragaszy D. M., 2004, COMPLETE CAPUCHIN; Gammell MP, 2003, ANIM BEHAV, V66, P601, DOI 10.1006/anbe.2003.2226; Haselhuhn MP, 2012, P ROY SOC B-BIOL SCI, V279, P571, DOI 10.1098/rspb.2011.1193; IZAWA K, 1980, Primates, V21, P443, DOI 10.1007/BF02373834; JANSON C, 1985, BEHAV ECOL SOCIOBIOL, V18, P125, DOI 10.1007/BF00299041; Kapila Rishabh, 2011, J Dent Res Dent Clin Dent Prospects, V5, P51; Kramer RSS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042705; Lefevre CE, 2013, EVOL HUM BEHAV, V34, P273, DOI 10.1016/j.evolhumbehav.2013.03.005; Lefevre CE, 2012, EVOL HUM BEHAV, V33, P623, DOI 10.1016/j.evolhumbehav.2012.03.002; Leonardi R, 2010, AM J PRIMATOL, V72, P33, DOI 10.1002/ajp.20748; Lewis GJ, 2012, PERS INDIV DIFFER, V52, P855, DOI 10.1016/j.paid.2011.12.030; Macdonald C., 2011, International Zoo Yearbook, V45, P7, DOI 10.1111/j.1748-1090.2010.00120.x; Masterson TJ, 1997, AM J PHYS ANTHROPOL, V104, P487, DOI 10.1002/(SICI)1096-8644(199712)104:4<487::AID-AJPA5>3.3.CO;2-J; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Michael PH, 1994, ANIM BEHAV, V48, P6; Morton FB, 2013, J COMP PSYCHOL, V127, P282, DOI 10.1037/a0031723; National Centre for the Replacement Refinement and Reduction of Animals in Research, 2006, NC3RS GUID PRIM ACC; Ozener B, 2012, EVOL HUM BEHAV, V33, P169, DOI 10.1016/j.evolhumbehav.2011.08.001; Plavcan JM, 2012, HUM NATURE-INT BIOS, V23, P45, DOI 10.1007/s12110-012-9130-3; Plavcan JM, 1997, AM J PHYS ANTHROPOL, V103, P37, DOI 10.1002/(SICI)1096-8644(199705)103:1<37::AID-AJPA4>3.0.CO;2-A; PLAVCAN JM, 1995, J HUM EVOL, V28, P245, DOI 10.1006/jhev.1995.1019; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; R Core Team, 2012, R LANG ENV STAT COMP; REY R, 1995, BIOL REPROD, V52, P997, DOI 10.1095/biolreprod52.5.997; Steiper ME, 2006, MOL PHYLOGENET EVOL, V41, P384, DOI 10.1016/j.ympev.2006.05.021; Stirrat M, 2012, PSYCHOL SCI, V23, P718, DOI 10.1177/0956797611435133; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Weiss A, 2009, AM J PRIMATOL, V71, P283, DOI 10.1002/ajp.20649; Weston EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000710; Weston EM, 2004, P ROY SOC B-BIOL SCI, V271, pS416, DOI 10.1098/rsbl.2004.0203; Wheeler BC, 2013, BEHAV ECOL, V24, P1369, DOI 10.1093/beheco/art076	48	41	41	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93369	10.1371/journal.pone.0093369	http://dx.doi.org/10.1371/journal.pone.0093369			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705247	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000334107500033
J	Oren, M; Brikner, I; Appelbaum, L; Levy, O				Oren, Matan; Brikner, Itzchak; Appelbaum, Lior; Levy, Oren			Fast Neurotransmission Related Genes Are Expressed in Non Nervous Endoderm in the Sea Anemone Nematostella vectensis	PLOS ONE			English	Article							ANTHO-RFAMIDE; EVOLUTIONARY ORIGIN; SYSTEM; IMMUNOREACTIVITY; NEUROPEPTIDE; JELLYFISH; NEURONS; HYDRA; GABA	Cnidarian nervous systems utilize chemical transmission to transfer signals through synapses and neurons. To date, ample evidence has been accumulated for the participation of neuropeptides, primarily RFamides, in neurotransmission. Yet, it is still not clear if this is the case for the classical fast neurotransmitters such as GABA, Glutamate, Acetylcholine and Monoamines. A large repertoire of cnidarian Fast Neurotransmitter related Genes (FNGs) has been recently identified in the genome of the sea anemone, Nematostella vectensis. In order to test whether FNGs are localized in cnidarian neurons, we characterized the expression patterns of eight Nematostella genes that are closely or distantly related to human central and peripheral nervous systems genes, in adult Nematostella and compared them to the RFamide localization. Our results show common expression patterns for all tested genes, in a single endodermal cell layer. These expressions did not correspond with the RFamide expressing nerve cell network. Following these results we suggest that the tested Nematostella genes may not be directly involved in vertebrate-like fast neurotransmission.	[Oren, Matan; Levy, Oren] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Appelbaum, Lior] Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, Ramat Gan, Israel; [Brikner, Itzchak] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel	Bar Ilan University; Bar Ilan University; Tel Aviv University	Oren, M (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	matanok@gmail.com	oren, matan/AAX-8770-2021	oren, matan/0000-0002-6162-324X	United States -Israel Binational Science Foundation [2011187]; Ministry of Science, Israel [3-8874]	United States -Israel Binational Science Foundation(US-Israel Binational Science Foundation); Ministry of Science, Israel(Israel Science Foundation)	This work was supported by the United States -Israel Binational Science Foundation (award 2011187 to A. M. T. and O.L). The Ministry of Science, Israel (http://most.gov.il/Pages/HomePage.aspx) Grant no. 3-8874: The New Emerging Marine Model Organism Nematostella vectensis: Evolutionary, Genomic and Ecological studies with a potential for Industrial applications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anctil M, 2009, COMP BIOCHEM PHYS D, V4, P268, DOI 10.1016/j.cbd.2009.07.001; Anderson PAV, 2004, BIOL BULL-US, V207, P141, DOI 10.2307/1543588; BATHAM EJ, 1960, Q J MICROSC SCI, V101, P487; Brown DA, 2010, J MOL NEUROSCI, V41, P340, DOI 10.1007/s12031-010-9377-2; Conaco C, 2012, P NATL ACAD SCI USA, V109, P10612, DOI 10.1073/pnas.1201890109; Darling JA, 2005, BIOESSAYS, V27, P211, DOI 10.1002/bies.20181; Delgado LM, 2010, J MORPHOL, V271, P845, DOI 10.1002/jmor.10838; Edmondson DE, 2004, CURR MED CHEM, V11, P1983, DOI 10.2174/0929867043364784; FRANK P, 1976, J NAT HIST, V10, P441, DOI 10.1080/00222937600770331; Fritzenwanker JH, 2002, DEV GENES EVOL, V212, P99, DOI 10.1007/s00427-002-0214-7; Galliot B, 2009, DEV BIOL, V332, P2, DOI 10.1016/j.ydbio.2009.05.563; Garm A, 2006, CELL TISSUE RES, V325, P333, DOI 10.1007/s00441-005-0134-8; Geigerseder C, 2003, NEUROENDOCRINOLOGY, V77, P314, DOI 10.1159/000070897; Girosi L, 2007, CELL TISSUE RES, V329, P187, DOI 10.1007/s00441-007-0408-4; GRIMMELIKHUIJZEN CJP, 1986, P NATL ACAD SCI USA, V83, P9817, DOI 10.1073/pnas.83.24.9817; Kass-Simon G, 2007, COMP BIOCHEM PHYS A, V146, P9, DOI 10.1016/j.cbpa.2006.09.008; Koizumi O, 2004, HYDROBIOLOGIA, V530, P41, DOI 10.1007/s10750-004-2636-x; Koizumi O, 2007, BRAIN BEHAV EVOLUT, V69, P151, DOI 10.1159/000095204; Liguz-Lecznar M, 2007, ACTA NEUROBIOL EXP, V67, P207; Mackie GO, 2004, NEUROSIGNALS, V13, P5, DOI 10.1159/000076155; Marlow HQ, 2009, DEV NEUROBIOL, V69, P235, DOI 10.1002/dneu.20698; MCFARLANE ID, 1987, J EXP BIOL, V133, P157; Nakanishi N, 2012, DEVELOPMENT, V139, P347, DOI 10.1242/dev.071902; PANTIN CFA, 1952, PROC R SOC SER B-BIO, V140, P147, DOI 10.1098/rspb.1952.0052; Pennisi E, 2013, SCIENCE, V339, P25; Pernet V, 2004, J COMP NEUROL, V472, P208, DOI 10.1002/cne.20108; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Richards GS, 2008, CURR BIOL, V18, P1156, DOI 10.1016/j.cub.2008.06.074; Roopin M, 2012, J PINEAL RES, V53, P259, DOI 10.1111/j.1600-079X.2012.00994.x; Ryan TJ, 2009, NAT REV NEUROSCI, V10, P701, DOI 10.1038/nrn2717; Sakarya O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000506; Satterlie RA, 2011, J EXP BIOL, V214, P1215, DOI 10.1242/jeb.043687; Stephenson TA, 1935, BRIT SEA ANEMONES, VII; Tripathi A, 2008, ANN NEUROSCI, V15; UMBRIACO D, 1990, J COMP NEUROL, V291, P167, DOI 10.1002/cne.902910202; Watanabe H, 2009, DEV GROWTH DIFFER, V51, P167, DOI 10.1111/j.1440-169X.2009.01103.x; Westfall JA, 1995, BIOL BULL, V189, P280, DOI 10.2307/1542145; WESTFALL JA, 1993, BIOL BULL, V185, P109, DOI 10.2307/1542134	38	8	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93832	10.1371/journal.pone.0093832	http://dx.doi.org/10.1371/journal.pone.0093832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705400	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500073
J	Singh, RK; Patel, KD; Lee, JH; Lee, EJ; Kim, JH; Kim, TH; Kim, HW				Singh, Rajendra K.; Patel, Kapil D.; Lee, Jae Ho; Lee, Eun-Jung; Kim, Joong-Hyun; Kim, Tae-Hyun; Kim, Hae-Won			Potential of Magnetic Nanofiber Scaffolds with Mechanical and Biological Properties Applicable for Bone Regeneration	PLOS ONE			English	Article							CELL-PROLIFERATION; HYPERTHERMIA; NANOPARTICLES; COMPOSITE	Magnetic nanofibrous scaffolds of poly(caprolactone) (PCL) incorporating magnetic nanoparticles (MNP) were produced, and their effects on physico-chemical, mechanical and biological properties were extensively addressed to find efficacy for bone regeneration purpose. MNPs 12 nm in diameter were citrated and evenly distributed in PCL solutions up to 20% and then were electrospun into nonwoven nanofibrous webs. Incorporation of MNPs greatly improved the hydrophilicity of the nanofibers. Tensile mechanical properties of the nanofibers (tensile strength, yield strength, elastic modulus and elongation) were significantly enhanced with the addition of MNPs up to 15%. In particular, the tensile strength increase was as high as similar to 25 MPa at 15% MNPs vs. similar to 10 MPa in pure PCL. PCL-MNP nanofibers exhibited magnetic behaviors, with a high saturation point and hysteresis loop area, which increased gradually with MNP content. The incorporation of MNPs substantially increased the degradation of the nanofibers, with a weight loss of similar to 20% in pure PCL, similar to 45% in 10% MNPs and similar to 60% in 20% MNPs. Apatite forming ability of the nanofibers tested in vitro in simulated body fluid confirmed the substantial improvement gained by the addition of MNPs. Osteoblastic cells favored the MNPs-incorporated nanofibers with significantly improved initial cell adhesion and subsequent penetration through the nanofibers, compared to pure PCL. Alkaline phosphatase activity and expression of genes associated with bone (collagen I, osteopontin and bone sialoprotein) were significantly up-regulated in cells cultured on PCL-MNP nanofibers than those on pure PCL. PCL-MNP nanofibers subcutaneously implanted in rats exhibited minimal adverse tissue reactions, while inducing substantial neoblood vessel formation, which however, greatly limited in pure PCL. In vivo study in radial segmental defects also signified the bone regeneration ability of the PCL-MNP nanofibrous scaffolds. The magnetic, bone-bioactive, mechanical, cellular and tissue attributes of MNP-incorporated PCL nanofibers make them promising candidate scaffolds for bone regeneration.	[Singh, Rajendra K.; Patel, Kapil D.; Lee, Jae Ho; Lee, Eun-Jung; Kim, Joong-Hyun; Kim, Tae-Hyun; Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan, South Korea; [Singh, Rajendra K.; Patel, Kapil D.; Lee, Jae Ho; Lee, Eun-Jung; Kim, Joong-Hyun; Kim, Tae-Hyun; Kim, Hae-Won] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea; [Singh, Rajendra K.; Patel, Kapil D.; Lee, Jae Ho; Lee, Eun-Jung; Kim, Joong-Hyun; Kim, Tae-Hyun; Kim, Hae-Won] Dankook Univ, Plus NBM Global Res Ctr Regenerat Med BK21, Cheonan, South Korea; [Kim, Hae-Won] Dankook Univ, Coll Dent, Dept Biomat Sci, Cheonan, South Korea	Dankook University; Dankook University; Dankook University; Dankook University	Kim, HW (corresponding author), Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan, South Korea.	kimhw@dku.edu	Knowles, Jonathan Campbell/B-9019-2008; Singh, Rajendra K/O-9797-2016; Singh, Rajendra K/AAQ-1217-2020; Patel, Kapil/F-3874-2012	Knowles, Jonathan Campbell/0000-0003-3917-3446; Singh, Rajendra K/0000-0003-3127-3346; Singh, Rajendra K/0000-0003-3127-3346; Patel, Kapil/0000-0002-0393-9166	Priority Research Centers Program through the NSF [2009-0093829]; MEST, Republic of Korea	Priority Research Centers Program through the NSF; MEST, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Priority Research Centers Program (No. 2009-0093829) through the NSF, funded by the MEST, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock N, 2010, ACTA BIOMATER, V6, P786, DOI 10.1016/j.actbio.2009.09.017; Campbell RB, 2007, NANOMEDICINE-UK, V2, P649, DOI 10.2217/17435889.2.5.649; Chung HJ, 2007, ADV DRUG DELIVER REV, V59, P249, DOI 10.1016/j.addr.2007.03.015; de la Presa P, 2012, J PHYS CHEM C, V116, P25602, DOI 10.1021/jp310771p; De Santis R, 2011, J APPL POLYM SCI, V122, P3599, DOI 10.1002/app.34771; Gu ZW, 2010, BIOMED MATER, V5; Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1; Hacliipanayis CG, 2008, SMALL, V4, P1925, DOI 10.1002/smll.200800261; Hammond C., 1997, BASICS CRYSTALLOGRAP; Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009; Hou RX, 2013, COLLOID SURFACE B, V103, P318, DOI 10.1016/j.colsurfb.2012.10.067; Hu H, 2013, RSC ADV, V3, P879, DOI 10.1039/c2ra22726f; Huang DM, 2009, BIOMATERIALS, V30, P3645, DOI 10.1016/j.biomaterials.2009.03.032; Hughes S, 2005, MED ENG PHYS, V27, P754, DOI 10.1016/j.medengphy.2005.04.006; Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036; Cabaco MI, 2011, J PHYS CHEM B, V115, P3538, DOI 10.1021/jp111453a; Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008; Kannarkat JT, 2010, J APPL PHYS, V107, DOI 10.1063/1.3357340; Kim HW, 2005, ADV FUNCT MATER, V15, P1988, DOI 10.1002/adfm.200500116; Kim HJ, 2012, TISSUE ENG REGEN MED, V9, P63, DOI 10.1007/s13770-012-0022-8; Kumar CSSR, 2011, ADV DRUG DELIVER REV, V63, P789, DOI 10.1016/j.addr.2011.03.008; Lai KL, 2012, RSC ADV, V2, P13007, DOI 10.1039/c2ra22376g; Lang S. B., 1996, NATURE, V212, P704; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lee EJ, 2010, ACTA BIOMATER, V6, P3557, DOI 10.1016/j.actbio.2010.03.022; Lee JJ, 2009, J MATER SCI-MATER M, V20, P1927, DOI 10.1007/s10856-009-3743-z; Lim SH, 2009, ADV DRUG DELIVER REV, V61, P1084, DOI 10.1016/j.addr.2009.07.011; Lin TC, 2012, ACTA BIOMATER, V8, P2704, DOI 10.1016/j.actbio.2012.03.045; Lopez MB, 2011, J APPL PHYS, V109; Lv G, 2008, LANGMUIR, V24, P2151, DOI 10.1021/la702845s; Mavis B, 2009, ACTA BIOMATER, V5, P3098, DOI 10.1016/j.actbio.2009.04.037; Meenach SA, 2010, ACTA BIOMATER, V6, P1039, DOI 10.1016/j.actbio.2009.10.017; Meng J, 2010, NANOSCALE, V2, P2565, DOI 10.1039/c0nr00178c; Nomura S, 2000, MATRIX BIOL, V19, P91, DOI 10.1016/S0945-053X(00)00050-0; Oh SA, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/475260; Panseri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038710; Patel KH, 2013, J TISSUE ENG, V4, DOI 10.1177/2041731413516782; Revi D, 2013, J TISSUE ENG, V4, DOI 10.1177/2041731413518060; Shin SH, 2012, J TISSUE ENG, V3, DOI 10.1177/2041731412443530; Singh A, 2010, J MATER CHEM, V20, P8832, DOI 10.1039/c0jm01613f; Singh RK, 2012, J BIOMED MATER RES A, V100A, P1734, DOI 10.1002/jbm.a.34140; Singh RK, 2012, MATER LETT, V75, P130, DOI 10.1016/j.matlet.2012.01.129; Tampieri A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/1/015104; Tanahashi M, 1997, J BIOMED MATER RES, V34, P305; Wei Y, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055008; Wu CT, 2011, ACTA BIOMATER, V7, P3563, DOI 10.1016/j.actbio.2011.06.028; Yu HS, 2009, J BIOMED MATER RES A, V88A, P747, DOI 10.1002/jbm.a.31709; Zeng XB, 2012, INT J NANOMED, V7, P3365, DOI 10.2147/IJN.S32264; Zhang F, 2008, J PHYS CHEM C, V112, P15151, DOI 10.1021/jp804452r	49	107	108	6	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e91584	10.1371/journal.pone.0091584	http://dx.doi.org/10.1371/journal.pone.0091584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705279	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500005
J	Yang, HC; Liu, TB; Rong, H; Bi, JQ; Ji, EN; Peng, HJ; Wang, XP; Fang, YR; Yuan, CM; Si, TM; Lu, Z; Hu, J; Chen, ZY; Huang, Y; Sun, J; Li, HC; Hu, C; Zhang, JB; Li, LJ				Yang, Hai-Chen; Liu, Tie-Bang; Rong, Han; Bi, Jian-Qiang; Ji, Er-Ni; Peng, Hong-Jun; Wang, Xiao-Ping; Fang, Yi-Ru; Yuan, Cheng-Mei; Si, Tian-Mei; Lu, Zheng; Hu, Jian; Chen, Zhi-Yu; Huang, Yi; Sun, Jing; Li, Hui-Chun; Hu, Chen; Zhang, Jin-Bei; Li, Ling-Jiang			Evaluation of Mood Disorder Questionnaire (MDQ) in Patients with Mood Disorders: A Multicenter Trial across China	PLOS ONE			English	Article							HYPOMANIA CHECKLIST HCL-32; BIPOLAR SPECTRUM DISORDER; MAJOR DEPRESSION; II-DISORDER; VALIDATION; VALIDITY; VERSION; PREVALENCE; INSTRUMENT; DIAGNOSIS	Background: The aim of this study was to test the ability of the Chinese version of the Mood Disorder Questionnaire (MDQ) to identify Bipolar Disorders (BD) in patients diagnosed with Major Depressive Disorder (MDD) or Unipolar Disorder (UD) in the clinical setting. Methods: 1,487 being treated for MDD or UD at 12 mental health centers across China, completed the MDQ and subsequently examined by the Mini International Neuropsychiatric Interview (MINI). Receiver Operating Characteristic(ROC) curves were used to determine the ability of the MDQ to differentiate between BD (BD, BD-I and BD-II) and MDD or UD and patients with BD-I from patients with BD-II. Results: Of the 1,487 patients, 309 (20.8%) satisfied the DSM-IV criteria for BD: 118 (7.9%) for BD-I and 191 (12.8%) for BD-II. When only part one of the MDQ was used, the best cutoff was 7 between BD and UD (sensitivity 0.66, specificity 0.88, positive predictive value 0.59, negative predictive value 0.91), 6 between BD-II and UD, and 10 between BD-I and BD-II. If all three parts of the MDQ were used, the MDQ could not distinguish between BD and UD at a cutoff of 7 (or 6), and the sensitivity was only 0.22 (or 0.24). Conclusion: The Chinese version of the MDQ had good psychometric features in screening bipolar disorders from depressive patients with mood disorders when part two and part three of the MDQ were ignored.	[Yang, Hai-Chen; Liu, Tie-Bang; Rong, Han; Bi, Jian-Qiang; Ji, Er-Ni] Shenzhen Mental Hlth Ctr, Div Mood Disorders, Shenzhen Key Lab Psychol Healthcare, Shenzhen, Guangdong, Peoples R China; [Peng, Hong-Jun; Wang, Xiao-Ping; Li, Ling-Jiang] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Fang, Yi-Ru; Yuan, Cheng-Mei] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Div Mood Disorders, Shanghai 200030, Peoples R China; [Si, Tian-Mei] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Lu, Zheng] Tongji Univ, Sch Med, Shanghai Tongji Hosp, Shanghai 200092, Peoples R China; [Hu, Jian] Harbin Med Univ, Hosp 1, Harbin, Heilongjiang, Peoples R China; [Chen, Zhi-Yu] Hangzhou Seventh Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Huang, Yi] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China; [Sun, Jing] Nanjing Med Univ, Affiliated Brain Hosp, Nanjing, Jiangsu, Peoples R China; [Li, Hui-Chun] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China; [Hu, Chen] Capital Med Univ, Beijing Anding Hosp, Mood Disorders Ctr, Beijing, Peoples R China; [Zhang, Jin-Bei] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China	Central South University; Shanghai Jiao Tong University; Peking University; Tongji University; Harbin Medical University; Sichuan University; Nanjing Medical University; Zhejiang University; Capital Medical University; Sun Yat Sen University	Liu, TB (corresponding author), Shenzhen Mental Hlth Ctr, Div Mood Disorders, Shenzhen Key Lab Psychol Healthcare, Shenzhen, Guangdong, Peoples R China.	liutbsz@gmail.com; llj2920@163.com	wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341	scientific and technological bureau of Shenzhen in China [200602032]; AstraZeneca China	scientific and technological bureau of Shenzhen in China; AstraZeneca China(AstraZeneca)	This study was funded by the grant (200602032) from the scientific and technological bureau of Shenzhen in China. The study was initiated by the Chinese Society of Psychiatry (CSP) with support from AstraZeneca China. AstraZeneca China had no role in the study design or in the generation and interpretation of the results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiskal HS, 2005, J CLIN PSYCHIAT, V66, P914, DOI 10.4088/JCP.v66n0715; Angst J, 2005, J AFFECT DISORDERS, V88, P217, DOI 10.1016/j.jad.2005.05.011; Angst J, 1999, J CLIN PSYCHIAT, V60, P5; Dell'Osso L, 2002, BIPOLAR DISORD, V4, P315, DOI 10.1034/j.1399-5618.2002.01192.x; Hantouche EG, 1998, J AFFECT DISORDERS, V50, P163, DOI 10.1016/S0165-0327(98)00112-8; Hardoy Maria Carolina, 2005, Clin Pract Epidemiol Ment Health, V1, P8, DOI 10.1186/1745-0179-1-8; Hirschfeld RMA, 2000, AM J PSYCHIAT, V157, P1873, DOI 10.1176/appi.ajp.157.11.1873; Hirschfeld RMA, 2003, AM J PSYCHIAT, V160, P178, DOI 10.1176/appi.ajp.160.1.178; Hirschfeld RMA, 2003, J CLIN PSYCHIAT, V64, P161, DOI 10.4088/JCP.v64n0209; Isometsa E, 2003, BMC PSYCHIATRY, V3, DOI 10.1186/1471-244X-3-8; Kemp DE, 2008, J PSYCHIATR RES, V42, P778, DOI 10.1016/j.jpsychires.2007.08.001; Kim B, 2008, COMPR PSYCHIAT, V49, P469, DOI 10.1016/j.comppsych.2008.01.002; Konuk N, 2007, TURK PSIKIYATR DERG, V18, P147; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Manning JS, 1997, COMPR PSYCHIAT, V38, P102; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543; Miller CJ, 2004, J AFFECT DISORDERS, V81, P167, DOI 10.1016/S0165-0327(03)00156-3; Rouget BW, 2005, J AFFECT DISORDERS, V88, P103, DOI 10.1016/j.jad.2005.06.005; Sheehan D. V., 1998, J CLIN PSYCHIAT, V59, P34; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; [司天梅 SI Tian-Mei], 2009, [中国心理卫生杂志, Chinese Mental Health Journal], V23, P493; Solomon DA, 2006, J CLIN PSYCHIAT, V67, P434, DOI 10.4088/JCP.v67n0315; Wu YS, 2008, J AFFECT DISORDERS, V106, P133, DOI 10.1016/j.jad.2007.06.004; Yang HC, 2011, PSYCHIAT RES, V189, P446, DOI 10.1016/j.psychres.2011.02.007; Yang HC, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-84; Zimmerman M, 2009, BIPOLAR DISORD, V11, P759, DOI 10.1111/j.1399-5618.2009.00755.x	26	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e91895	10.1371/journal.pone.0091895	http://dx.doi.org/10.1371/journal.pone.0091895			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6MJ	24705393	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500009
J	Chiang, CY; Lee, JJ; Chien, ST; Enarson, DA; Chang, YC; Chen, YT; Hu, TY; Lin, CB; Suk, CW; Tao, JM; Bai, KJ				Chiang, Chen-Yuan; Lee, Jen-Jyh; Chien, Shun-Tien; Enarson, Donald A.; Chang, You-Cheng; Chen, Yi-Ting; Hu, Ting-Yu; Lin, Chih-Bin; Suk, Chi-Won; Tao, Jui-Ming; Bai, Kuan-Jen			Glycemic Control and Radiographic Manifestations of Tuberculosis in Diabetic Patients	PLOS ONE			English	Article							LOWER LUNG FIELD; PULMONARY TUBERCULOSIS; MELLITUS; AGE; IMAGES; IMPACT	Background: Radiographic manifestations of pulmonary tuberculosis (TB) in patients with diabetes mellitus (DM) have previously been reported, with inconsistent results. We conducted a study to investigate whether glycemic control has an impact on radiographic manifestations of pulmonary TB. Methods: Consecutive patients with culture-positive pulmonary TB who had DM in three tertiary care hospitals from 2005-2010 were selected for review and compared with a similar number without DM. Glycemic control was assessed by glycated haemoglobin A1C (HbA1C). A pre-treatment chest radiograph was read independently by two qualified pulmonologists blinded to patients' diabetic status. Films with any discordant reading were read by a third reader. Results: 1209 culture positive pulmonary TB patients (581 with DM and 628 without DM) were enrolled. Compared with those without DM, TB patients with DM were significantly more likely to have opacity over lower lung fields, extensive parenchymal lesions, any cavity, multiple cavities and large cavities (>= 3 cm). The relative risk of lower lung field opacities was 0.80 (95% CI 0.46-1.42) for those with DM with A1C<7%, 2.32 (95% CI 1.36 - 3.98) for A1C 7%-9%, and 1.62 (95% CI 1.12-2.36) for A1C>9%; and that of any cavity over no cavity was 0.87 (95% CI 0.46-1.62) for patients with DM with A1C<7%, 1.84 (95% CI 1.20-2.84) for A1C 7%-9%, and 3.71 (95% CI 2.64-5.22) for A1C>9%, relative to patients without DM. Conclusions: Glycemic control significantly influenced radiographic manifestations of pulmonary TB in patients with DM.	[Chiang, Chen-Yuan; Hu, Ting-Yu; Suk, Chi-Won; Bai, Kuan-Jen] Wan Fang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Chiang, Chen-Yuan] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Lee, Jen-Jyh; Chen, Yi-Ting; Lin, Chih-Bin] Tzu Chi Gen Hosp, Dept Internal Med, Hualien, Taiwan; [Lee, Jen-Jyh; Chen, Yi-Ting; Lin, Chih-Bin] Tzu Chi Univ, Hualien, Taiwan; [Chien, Shun-Tien; Chang, You-Cheng; Tao, Jui-Ming] Chest Hosp, Dept Hlth & Welf, Tainan, Taiwan; [Bai, Kuan-Jen] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan	Taipei Municipal WanFang Hospital; Taipei Medical University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Taipei Medical University	Bai, KJ (corresponding author), Wan Fang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan.	kjbai@wanfang.gov.tw	Hu, Ting-Yu/AAJ-3797-2021; Chen, Yi/HIR-2608-2022	Hu, Ting-Yu/0000-0002-8251-3808; 	Taiwan Centers for Disease Control [DOH101-DC-1103]	Taiwan Centers for Disease Control	This study was funded by a research grant DOH101-DC-1103 of Taiwan Centers for Disease Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL AK, 1988, LUNG INDIA, V6, P177; Aktogu S, 1996, EUR RESPIR J, V9, P2031, DOI 10.1183/09031936.96.09102031; Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; AlWabel AH, 1996, TROP DOCT, V26, P183, DOI 10.1177/004947559602600417; AlWabel AH, 1997, E AFR MED J, V74, P62; CHAN CHS, 1995, TUBERCLE LUNG DIS, V76, P290, DOI 10.1016/S0962-8479(05)80026-7; Chang JT, 2011, J FORMOS MED ASSOC, V110, P372, DOI 10.1016/S0929-6646(11)60055-7; CHANG SC, 1987, CHEST, V91, P230, DOI 10.1378/chest.91.2.230; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; HENDY M, 1983, BRIT J DIS CHEST, V77, P87, DOI 10.1016/0007-0971(83)90010-4; *INTL DIAB FED, IDF DIABETES ATLAS; Jain NK, 1985, LUNG INDIA, V3, P11; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; MARAIS RM, 1980, S AFR MED J, V57, P483; MORRIS JT, 1992, CHEST, V102, P539, DOI 10.1378/chest.102.2.539; Park SW, 2012, EUR J CLIN MICROBIOL, V31, P1305, DOI 10.1007/s10096-011-1443-3; Perez-Guzman C, 2000, AM J RESP CRIT CARE, V162, P1738, DOI 10.1164/ajrccm.162.5.2001040; Perez-Guzman C, 2001, INT J TUBERC LUNG D, V5, P455; Perez-Guzman Carlos, 1999, Chest, V116, P961, DOI 10.1378/chest.116.4.961; Podell BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046824; Shaikh MA, 2003, SAUDI MED J, V24, P278; Tsukaguchi Katsuhiko, 2002, Kekkaku, V77, P409; UMUT S, 1994, CHEST, V106, P326; Wang CS, 2009, EPIDEMIOL INFECT, V137, P203, DOI 10.1017/S0950268808000782; Wang JY, 2006, INT J TUBERC LUNG D, V10, P578; WEAVER RA, 1974, AM REV RESPIR DIS, V109, P162; Yamashiro S, 2005, CLIN EXP IMMUNOL, V139, P57, DOI 10.1111/j.1365-2249.2005.02677.x	28	40	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93397	10.1371/journal.pone.0093397	http://dx.doi.org/10.1371/journal.pone.0093397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699457	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000058
J	Drummond, A; Sauer, JD				Drummond, Aaron; Sauer, James D.			Video-Games Do Not Negatively Impact Adolescent Academic Performance in Science, Mathematics or Reading	PLOS ONE			English	Article							LEISURE ACTIVITIES; AGGRESSION; TELEVISION; PREVALENCE; EXPOSURE; CHILDREN	Video-gaming is a common pastime among adolescents, particularly adolescent males in industrialized nations. Despite widespread suggestions that video-gaming negatively affects academic achievement, the evidence is inconclusive. We reanalyzed data from over 192,000 students in 22 countries involved in the 2009 Programme for International Student Assessment (PISA) to estimate the true effect size of frequency of videogame use on adolescent academic achievement in science, mathematics and reading. Contrary to claims that increased video-gaming can impair academic performance, differences in academic performance were negligible across the relative frequencies of videogame use. Videogame use had little impact on adolescent academic achievement.	[Drummond, Aaron] Flinders Univ S Australia, Sch Educ, Adelaide, SA 5001, Australia; [Sauer, James D.] Univ Portsmouth, Sch Psychol, Portsmouth, Hants, England	Flinders University South Australia; University of Portsmouth	Drummond, A (corresponding author), Flinders Univ S Australia, Sch Educ, Adelaide, SA 5001, Australia.	Aaron.Drummond@flinders.edu.au		Drummond, Aaron/0000-0002-2386-072X; Sauer, James/0000-0002-0872-3647	Sidney Myer Fund; Myer Foundation	Sidney Myer Fund; Myer Foundation	Research was supported by The Sidney Myer Fund and The Myer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C.A., 2007, VIOLENT VIDEO GAME E, DOI DOI 10.1111/j.1469-8986.2009.00925.x; Anderson CA, 2000, J PERS SOC PSYCHOL, V78, P772, DOI 10.1037//0022-3514.78.4.772; Barlett CP, 2009, SIMULAT GAMING, V40, P377, DOI 10.1177/1046878108327539; CREASEY GL, 1986, MERRILL PALMER QUART, V32, P251; Desai RA, 2010, PEDIATRICS, V126, pE1414, DOI 10.1542/peds.2009-2706; Dewar G, 2013, EFFECTS VIDEO GAMES; Ferguson CJ, 2013, J YOUTH ADOLESCENCE, V42, P109, DOI 10.1007/s10964-012-9803-6; Ferguson CJ, 2011, J PSYCHIATR RES, V45, P1573, DOI 10.1016/j.jpsychires.2011.09.005; Ferguson CJ, 2011, J PSYCHIATR RES, V45, P808, DOI 10.1016/j.jpsychires.2010.11.010; Gentile DA, 2004, J ADOLESCENCE, V27, P5, DOI 10.1016/j.adolescence.2003.10.002; Gentile DA, EFFECTS VIDEO GAMES; Gentile D, 2009, PSYCHOL SCI, V20, P594, DOI 10.1111/j.1467-9280.2009.02340.x; Gentile DA, 2011, PEDIATRICS, V127, pE319, DOI 10.1542/peds.2010-1353; GOLDSTEIN H, 1986, BIOMETRIKA, V73, P43; Hsu SH, 2009, COMPUT EDUC, V53, P990, DOI 10.1016/j.compedu.2009.05.016; IMF, 2013, WOR ECON OUTLOOK, P1; Isanski B, 2010, GAME VIDEO GAME OWNE; King DL, 2013, PRINCIPLES OF ADDICTION: COMPREHENSIVE ADDICTIVE BEHAVIORS AND DISORDERS, VOL 1, P819, DOI 10.1016/B978-0-12-398336-7.00082-6; King DL, 2013, J SLEEP RES, V22, P137, DOI 10.1111/j.1365-2869.2012.01060.x; OECD, 2009, TAK TEST SAMPL QUEST; OECD, 2009, PISA DAT AN MAN SPSS, V2nd, DOI DOI 10.1787/9789264056275-EN; Pelham B. W., 2003, CONDUCTING RES PSYCH; PISA, 2009, PROGR INT STUD ASS 2; Rasbash J., 2012, USERS GUIDE MLWIN; Robertson G, 2006, WIDE RANGE ACHIEVEME; Rosenthal R., 1968, PYGMALION CLASSROOM; Sabella RA, 2010, NEGATIVE POTENTIAL V; Sharif I, 2006, PEDIATRICS, V118, pE1061, DOI 10.1542/peds.2005-2854; Skoric MM, 2009, CYBERPSYCHOL BEHAV, V12, P567, DOI 10.1089/cpb.2009.0079; Smyth JM, 2007, CYBERPSYCHOL BEHAV, V10, P717, DOI 10.1089/cpb.2007.9963; Swing EL, 2010, PEDIATRICS, V126, P214, DOI 10.1542/peds.2009-1508; VanSchie EGM, 1997, J APPL SOC PSYCHOL, V27, P1175; Weis R, 2010, PSYCHOL SCI, V21, P463, DOI 10.1177/0956797610362670; Willoughby T, 2008, DEV PSYCHOL, V44, P195, DOI 10.1037/0012-1649.44.1.195	34	46	47	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e87943	10.1371/journal.pone.0087943	http://dx.doi.org/10.1371/journal.pone.0087943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LR	24699536	gold, Green Published, Green Submitted			2022-12-27	WOS:000334105000002
J	Penton, CR; Gupta, VVSR; Tiedje, JM; Neate, SM; Ophel-Keller, K; Gillings, M; Harvey, P; Pham, A; Roget, DK				Penton, C. Ryan; Gupta, V. V. S. R.; Tiedje, James M.; Neate, Stephen M.; Ophel-Keller, Kathy; Gillings, Michael; Harvey, Paul; Pham, Amanda; Roget, David K.			Fungal Community Structure in Disease Suppressive Soils Assessed by 28S LSU Gene Sequencing	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; RHIZOSPHERE MICROBIOME; ENDOPHYTIC FUNGUS; ORGANIC-MATTER; PLANT; DIVERSITY; MANAGEMENT; WHEAT; GRADIENT; HEALTH	Natural biological suppression of soil-borne diseases is a function of the activity and composition of soil microbial communities. Soil microbe and phytopathogen interactions can occur prior to crop sowing and/or in the rhizosphere, subsequently influencing both plant growth and productivity. Research on suppressive microbial communities has concentrated on bacteria although fungi can also influence soil-borne disease. Fungi were analyzed in co-located soils 'suppressive' or 'non-suppressive' for disease caused by Rhizoctonia solani AG 8 at two sites in South Australia using 454 pyrosequencing targeting the fungal 28S LSU rRNA gene. DNA was extracted from a minimum of 125 g of soil per replicate to reduce the micro-scale community variability, and from soil samples taken at sowing and from the rhizosphere at 7 weeks to cover the peak Rhizoctonia infection period. A total of similar to 994,000 reads were classified into 917 genera covering 54% of the RDP Fungal Classifier database, a high diversity for an alkaline, low organic matter soil. Statistical analyses and community ordinations revealed significant differences in fungal community composition between suppressive and non-suppressive soil and between soil type/location. The majority of differences associated with suppressive soils were attributed to less than 40 genera including a number of endophytic species with plant pathogen suppression potentials and mycoparasites such as Xylaria spp. Non-suppressive soils were dominated by Alternaria, Gibberella and Penicillum. Pyrosequencing generated a detailed description of fungal community structure and identified candidate taxa that may influence pathogen-plant interactions in stable disease suppression.	[Penton, C. Ryan; Tiedje, James M.; Pham, Amanda] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; [Gupta, V. V. S. R.; Harvey, Paul; Roget, David K.] CSIRO Ecosyst Sci, Glen Osmond, SA, Australia; [Neate, Stephen M.] Leslie Res Ctr, Dept Agr Fisheries & Forestry, Towoomba, Qld, Australia; [Ophel-Keller, Kathy] SARDI, Glen Osmond, SA, Australia; [Gillings, Michael] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Michigan State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Queensland Department of Agriculture & Fisheries; Macquarie University	Penton, CR (corresponding author), Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA.	dobber4uf@gmail.com	Gillings, Michael/AAF-5772-2020; Penton, C. Ryan/H-5274-2019; Neate, Stephen M/T-8753-2017; Harvey, Paul/C-7013-2008; vvsr, Gupta/C-1722-2009; Gillings, Michael R/C-6553-2008	Gillings, Michael/0000-0002-4043-4351; Penton, C. Ryan/0000-0001-9166-7852; Neate, Stephen M/0000-0003-0766-198X; vvsr, Gupta/0000-0001-9774-6471; Gillings, Michael R/0000-0002-4043-4351	Commonwealth Scientific and Industrial Research Organisation; Grains Research Development Corporation	Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Grains Research Development Corporation(Grains R&D Corp)	Financial support was provided by the Commonwealth Scientific and Industrial Research Organisation and Grains Research Development Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BAKER K F, 1974, P433; Barnett SJ, 2006, AUST J SOIL RES, V44, P331, DOI 10.1071/SR05113; Benitez MS, 2009, APPL ENVIRON MICROB, V75, P915, DOI 10.1128/AEM.01296-08; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bonanomi G, 2010, SOIL BIOL BIOCHEM, V42, P136, DOI 10.1016/j.soilbio.2009.10.012; Bowen GD, 1999, ADV AGRON, V66, P1, DOI 10.1016/S0065-2113(08)60425-3; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Campbell CD, 2003, APPL ENVIRON MICROB, V69, P3593, DOI 10.1128/AEM.69.6.3593-3599.2003; Clarke K. R., 2001, CHANGES MARINE COMMU; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Conn VM, 2008, MOL PLANT MICROBE IN, V21, P208, DOI 10.1094/MPMI-21-2-0208; Cook A, 2008, P 14 ASA C; de Boer W, 2003, APPL ENVIRON MICROB, V69, P835, DOI 10.1128/AEM.69.2.835-844.2003; Duveiller E, 2007, EUPHYTICA, V157, P417, DOI 10.1007/s10681-007-9380-z; FAO, 2006, 103 UN FAO; Fernandez MR., 2011, PRAIRIE SOILS CROPS, V4, P151; Fukui R, 2003, MICROBES ENVIRON, V18, P1; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Garnica S, 2013, FEMS MICROBIOL ECOL, V83, P265, DOI 10.1111/j.1574-6941.2012.01473.x; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Gupta V.V., 2011, RAINFED FARMING SYST, P149, DOI DOI 10.1007/978-1-4020-9132-2_6; Gupta VVSR, 1999, P 1 AUSTR SOILB DIS, P3; Hopple JS, 1999, MOL PHYLOGENET EVOL, V13, P1, DOI 10.1006/mpev.1999.0634; HORNBY D, 1983, ANNU REV PHYTOPATHOL, V21, P65, DOI 10.1146/annurev.py.21.090183.000433; Hyde KD, 2007, BIODIVERS CONSERV, V16, P7, DOI 10.1007/s10531-006-9119-5; Jang YW, 2007, J ANTIBIOT, V60, P696, DOI 10.1038/ja.2007.89; Janvier C, 2007, SOIL BIOL BIOCHEM, V39, P1, DOI 10.1016/j.soilbio.2006.07.001; Jeger MJ, 1996, POTATO RES, V39, P437, DOI 10.1007/BF02357949; Kim HY, 2007, LETT APPL MICROBIOL, V44, P332, DOI 10.1111/j.1472-765X.2006.02093.x; Kinkel LL, 2011, ANNU REV PHYTOPATHOL, V49, P47, DOI 10.1146/annurev-phyto-072910-095232; Klich MA, 1998, MYCOPATHOLOGIA, V142, P97, DOI 10.1023/A:1006989712282; Larran S, 2002, WORLD J MICROB BIOT, V18, P683, DOI 10.1023/A:1016857917950; Larran S, 2007, WORLD J MICROB BIOT, V23, P565, DOI 10.1007/s11274-006-9266-6; Liu KL, 2012, APPL ENVIRON MICROB, V78, P1523, DOI 10.1128/AEM.06826-11; Loss A, 2012, SOIL RES, V50, P685, DOI 10.1071/SR12196; Macia-Vicente JG, 2008, CAN J MICROBIOL, V54, P600, DOI [10.1139/W08-047, 10.1139/w08-047]; Mazzola M, 2004, ANNU REV PHYTOPATHOL, V42, P35, DOI 10.1146/annurev.phyto.42.040803.140408; McGuire KL, 2012, MICROB ECOL, V63, P804, DOI 10.1007/s00248-011-9973-x; McKay A, 2012, 7 AUSTR SOILB DIS S; McKay A, 2008, ROOT DIS RISK MAANGE; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; MOLLER WJ, 1978, PLANT DIS REP, V62, P254; Neate SM., 1994, SOIL BIOTA MANAGEMEN, P96; Nelson E. B., 2004, ENCY PLANT CROP SCI, P137; Northcote KH, 1975, DESCRIPTION AUSTR; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Ophel-Keller K, 2008, AUSTRALAS PLANT PATH, V37, P243, DOI 10.1071/AP08029; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; Pan JJ, 2008, NEW PHYTOL, V178, P147, DOI 10.1111/j.1469-8137.2007.02350.x; Park JH, 2005, J MICROBIOL BIOTECHN, V15, P112; PAULITZ TC, 1987, CAN J MICROBIOL, V33, P349, DOI 10.1139/m87-061; Paulitz TC, 2006, EUR J PLANT PATHOL, V115, P271, DOI 10.1007/s10658-006-9023-6; Penton CR, 2013, APPL ENVIRON MICROB, V79, P7063, DOI 10.1128/AEM.01702-13; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Porter TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035749; Postma J, 2003, EUR J SOIL BIOL, V39, P157, DOI 10.1016/S1164-5563(03)00031-1; Reddy, 2010, P 6 AUSTR SOILB DIS; Roget D.K., 1999, P 1 AUSTRALASIAN SOI, P129; Roget DK, 1995, AUST J EXP AGR, V35, P1009, DOI 10.1071/EA9951009; Roget DK, 2009, 5 AUSTR SOILB DIS S, P85; ROPER MM, 1995, AUST J SOIL RES, V33, P321, DOI 10.1071/SR9950321; Rosenzweig N, 2012, PLANT DIS, V96, P718, DOI 10.1094/PDIS-07-11-0571; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; ROVIRA A, 1990, Australasian Plant Pathology, V19, P101, DOI 10.1071/APP9900101; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Schnare MN, 1996, J MOL BIOL, V256, P701, DOI 10.1006/jmbi.1996.0119; Schroers HJ, 2001, STUD MYCOL, P1; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Shiono Y, 2012, NAT PROD COMMUN, V7, P1065; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Suryanarayanan TS, 2002, CAN J BOT, V80, P818, DOI [10.1139/B02-069, 10.1139/b02-069]; Vainio EJ, 2000, MYCOL RES, V104, P927, DOI 10.1017/S0953756200002471; van Elsas JD, 2008, TRENDS BIOTECHNOL, V26, P591, DOI 10.1016/j.tibtech.2008.07.004; Vilich V, 1998, Z PFLANZENK PFLANZEN, V105, P130; Vinale F, 2008, SOIL BIOL BIOCHEM, V40, P1, DOI 10.1016/j.soilbio.2007.07.002; WARWICK RM, 1990, J EXP MAR BIOL ECOL, V138, P119, DOI 10.1016/0022-0981(90)90180-K; Weber CF, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00078; Wellacher M, 1991, THESIS; Weller DM, 2007, PLANT BIOLOGY, V9, P4, DOI 10.1055/s-2006-924473; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wiseman BM, 1996, SOIL BIOL BIOCHEM, V28, P727, DOI 10.1016/0038-0717(95)00178-6; Woo Sheridan L., 2007, P107, DOI 10.1007/978-1-4020-5799-1_6; Xu LH, 2012, FEMS MICROBIOL ECOL, V82, P736, DOI 10.1111/j.1574-6941.2012.01445.x; Xu LH, 2012, SOIL BIOL BIOCHEM, V46, P26, DOI 10.1016/j.soilbio.2011.11.010	90	84	87	2	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93893	10.1371/journal.pone.0093893	http://dx.doi.org/10.1371/journal.pone.0093893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699870	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000119
J	Pozeg, P; Rognini, G; Salomon, R; Blanke, O				Pozeg, Polona; Rognini, Giulio; Salomon, Roy; Blanke, Olaf			Crossing the Hands Increases Illusory Self-Touch	PLOS ONE			English	Article							RUBBER HAND; REFERENCE FRAMES; SOMATOSENSORY HOMUNCULUS; SPATIAL INFORMATION; SENSORY INFORMATION; BODY REPRESENTATION; TACTILE PERCEPTION; TEMPORAL-ORDER; VISUAL CAPTURE; ILLUSION	Manipulation of hand posture, such as crossing the hands, has been frequently used to study how the body and its immediately surrounding space are represented in the brain. Abundant data show that crossed arms posture impairs remapping of tactile stimuli from somatotopic to external space reference frame and deteriorates performance on several tactile processing tasks. Here we investigated how impaired tactile remapping affects the illusory self-touch, induced by the non-visual variant of the rubber hand illusion (RHI) paradigm. In this paradigm blindfolded participants (Experiment 1) had their hands either uncrossed or crossed over the body midline. The strength of illusory self-touch was measured with questionnaire ratings and proprioceptive drift. Our results showed that, during synchronous tactile stimulation, the strength of illusory self-touch increased when hands were crossed compared to the uncrossed posture. Follow-up experiments showed that the increase in illusion strength was not related to unfamiliar hand position (Experiment 2) and that it was equally strengthened regardless of where in the peripersonal space the hands were crossed (Experiment 3). However, while the boosting effect of crossing the hands was evident from subjective ratings, the proprioceptive drift was not modulated by crossed posture. Finally, in contrast to the illusion increase in the non-visual RHI, the crossed hand postures did not alter illusory ownership or proprioceptive drift in the classical, visuo-tactile version of RHI (Experiment 4). We argue that the increase in illusory self-touch is related to misalignment of somatotopic and external reference frames and consequently inadequate tactile-proprioceptive integration, leading to re-weighting of the tactile and proprioceptive signals. The present study not only shows that illusory self-touch can be induced by crossing the hands, but importantly, that this posture is associated with a stronger illusion.	[Pozeg, Polona; Rognini, Giulio; Salomon, Roy; Blanke, Olaf] Ecole Polytech Fed Lausanne, Sch Life Sci, Ctr Neuroprosthet, Lausanne, Switzerland; [Pozeg, Polona; Rognini, Giulio; Salomon, Roy] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Cognit Neurosci, Lausanne, Switzerland; [Rognini, Giulio; Blanke, Olaf] Ecole Polytech Fed Lausanne, Sch Engn, Inst Microengn, Robot Syst Lab 1, Lausanne, Switzerland; [Blanke, Olaf] Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Blanke, O (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Ctr Neuroprosthet, Lausanne, Switzerland.	olaf.blanke@epfl.ch	Salomon, Roy/N-8249-2015	Salomon, Roy/0000-0002-6688-617X	Swiss National Science Foundation [CRSII1_125135/1]; Bertarelli Foundation; Swiss National Science Foundation (NCCR) [SYNAPSY 51AU40_125759]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bertarelli Foundation; Swiss National Science Foundation (NCCR)(Swiss National Science Foundation (SNSF))	This work has been supported by the grants from Swiss National Science Foundation (CRSII1_125135/1) and the Bertarelli Foundation. RS was suported by the Swiss National Science Foundation (NCCR, SYNAPSY 51AU40_125759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti S, 1999, J COGNITIVE NEUROSCI, V11, P67, DOI 10.1162/089892999563256; Aristotle, 2007, METAPHYSICS; Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Azanon E, 2008, CURR BIOL, V18, P1044, DOI 10.1016/j.cub.2008.06.045; BENEDETTI F, 1985, J EXP PSYCHOL HUMAN, V11, P517, DOI 10.1037/0096-1523.11.4.517; Berlucchi G, 1997, TRENDS NEUROSCI, V20, P560, DOI 10.1016/S0166-2236(97)01136-3; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Block HJ, 2011, J NEUROPHYSIOL, V106, P59, DOI 10.1152/jn.00641.2010; Bolognini N, 2007, CURR BIOL, V17, P1890, DOI 10.1016/j.cub.2007.09.057; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bremner AJ, 2008, J EXP PSYCHOL GEN, V137, P149, DOI 10.1037/0096-3445.137.1.149; Cadieux ML, 2011, NEUROSCI LETT, V504, P191, DOI 10.1016/j.neulet.2011.09.010; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Damasio A.R., 2000, FEELING WHAT HAPPENS; Davies AMA, 2013, CONSCIOUS COGN, V22, P613, DOI 10.1016/j.concog.2013.03.006; Davies AMA, 2010, PERCEPTION, V39, P830, DOI 10.1068/p6610; de Haan AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045408; de Vignemont F, 2005, CURR BIOL, V15, P1286, DOI 10.1016/j.cub.2005.06.067; Dieguez S, 2009, CURR BIOL, V19, pR1108, DOI 10.1016/j.cub.2009.10.055; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Eimer M, 2003, PSYCHOPHYSIOLOGY, V40, P924, DOI 10.1111/1469-8986.00110; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Farne A, 2000, BRAIN, V123, P2350, DOI 10.1093/brain/123.11.2350; Gallagher S., 2005, BODY SHAPES MIND; Graziano MSA, 1998, CURR OPIN NEUROBIOL, V8, P195, DOI 10.1016/S0959-4388(98)80140-2; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Gruasser O.-J., 1983, SPATIALLY ORIENTED B, P327, DOI 10.1007/978-1-4612-5488-1_18; Haans A, 2008, BODY IMAGE, V5, P389, DOI 10.1016/j.bodyim.2008.04.003; Haggard P, 2003, CURR BIOL, V13, pR170, DOI 10.1016/S0960-9822(03)00115-5; Hagura N, 2007, J NEUROSCI, V27, P7047, DOI 10.1523/JNEUROSCI.0970-07.2007; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Holmes NP, 2006, BRAIN RES, V1077, P108, DOI 10.1016/j.brainres.2005.11.010; Jeannerod M, 2007, J PHYSIOL-PARIS, V101, P161, DOI 10.1016/j.jphysparis.2007.11.005; Kammers MPM, 2010, CURR BIOL, V20, P1819, DOI 10.1016/j.cub.2010.08.038; Kobor I, 2006, NEUROSCI LETT, V400, P163, DOI 10.1016/j.neulet.2006.02.037; Kurth R, 2000, NEUROREPORT, V11, P1487, DOI 10.1097/00001756-200005150-00025; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; Longo MR, 2010, NEUROPSYCHOLOGIA, V48, P655, DOI 10.1016/j.neuropsychologia.2009.08.022; Lopez C, 2010, CONSCIOUS COGN, V19, P33, DOI 10.1016/j.concog.2009.12.003; Macaluso E, 2010, NEUROPSYCHOLOGIA, V48, P782, DOI 10.1016/j.neuropsychologia.2009.10.010; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Matsumoto E, 2004, EXP BRAIN RES, V158, P9, DOI 10.1007/s00221-004-1872-7; Medina J, 2010, NEUROPSYCHOLOGIA, V48, P645, DOI 10.1016/j.neuropsychologia.2009.08.017; Merleau-Ponty Maurice, 2005, PHENOMENOLOGY PERCEP; Metzinger T, 2008, PROG BRAIN RES, V168, P215, DOI 10.1016/S0079-6123(07)68018-2; MOSCOVITCH M, 1994, J COGNITIVE NEUROSCI, V6, P151, DOI 10.1162/jocn.1994.6.2.151; Nakamura A, 1998, NEUROIMAGE, V7, P377, DOI 10.1006/nimg.1998.0332; NARICI L, 1991, NEUROSCI LETT, V121, P51, DOI 10.1016/0304-3940(91)90647-C; OLDFIELD SR, 1983, PERCEPTION, V12, P615, DOI 10.1068/p120615; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Peru A, 2006, EXP BRAIN RES, V169, P145, DOI 10.1007/s00221-005-0132-9; Petkova VI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035912; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; RIVERS WHR, 1894, MIND, V3, P583; Roder B, 2004, CURR BIOL, V14, P121, DOI 10.1016/j.cub.2003.12.054; Salomon R, 2013, EXP BRAIN RES, V228, P173, DOI 10.1007/s00221-013-3549-6; Schutz-Bosbach S, 2009, CONSCIOUS COGN, V18, P2, DOI 10.1016/j.concog.2008.08.003; Sekine T, 2009, NEUROREPORT, V20, P467, DOI 10.1097/WNR.0b013e3283277087; Serino A, 2010, NEUROSCI BIOBEHAV R, V34, P224, DOI 10.1016/j.neubiorev.2009.04.004; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; Sigmundsson H, 2007, SEX ROLES, V57, P181, DOI 10.1007/s11199-007-9228-y; Spence C, 2004, COGN AFFECT BEHAV NE, V4, P148, DOI 10.3758/CABN.4.2.148; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; van Stralen HE, 2011, PHILOS T R SOC B, V366, P3142, DOI 10.1098/rstb.2011.0163; VONHOFSTEN C, 1988, NEUROPSYCHOLOGIA, V26, P805, DOI 10.1016/0028-3932(88)90051-6; Wada M, 2004, NEUROPSYCHOLOGIA, V42, P1887, DOI 10.1016/j.neuropsychologia.2004.05.009; White RC, 2011, CONSCIOUS COGN, V20, P956, DOI 10.1016/j.concog.2011.03.021; White RC, 2010, CONSCIOUS COGN, V19, P505, DOI 10.1016/j.concog.2009.08.003; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	74	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e94008	10.1371/journal.pone.0094008	http://dx.doi.org/10.1371/journal.pone.0094008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LR	24699795	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000135
J	Subramaniam, G; Campsteijn, C; Thompson, EM				Subramaniam, Gunasekaran; Campsteijn, Coen; Thompson, Eric M.			Lifespan Extension in a Semelparous Chordate Occurs via Developmental Growth Arrest Just Prior to Meiotic Entry	PLOS ONE			English	Article							GERMLINE STEM-CELLS; ELEGANS L1 ARREST; OIKOPLEURA-DIOICA; CAENORHABDITIS-ELEGANS; C-ELEGANS; STRESS RESPONSES; DROSOPHILA OVARY; TOR PATHWAY; P38 MAPK; RAPAMYCIN	It is proposed that the ageing process is linked to signaling from the germline such that the rate of ageing can be adjusted to the state of the reproductive system, allowing these two processes to co-evolve. Mechanistic insight into this link has been primarily derived from iteroparous reproductive models, the nematode C. elegans, and the arthropod Drosophila. Here, we examined to what extent these mechanisms are evolutionarily conserved in a semelparous chordate, Oikopleura dioica, where we identify a developmental growth arrest (GA) in response to crowded, diet-restricted conditions, which can extend its lifespan at least three-fold. Under nutritional stress, the iteroparative models sacrifice germ cells that have entered meiosis, while maintaining a reduced pool of active germline stem cells (GSCs). In contrast, O. dioica only entered GA prior to meiotic entry. Stress conditions encountered after this point led to maturation in a normal time frame but with reduced reproductive output. During GA, TOR signaling was inhibited, whereas MAPK, ERK1/2 and p38 pathways were activated, and under such conditions, activation of these pathways was shown to be critical for survival. Direct inhibition of TOR signaling alone was sufficient to prevent meiotic entry and germline differentiation. This inhibition activated the p38 pathway, but did not activate the ERK1/2 pathway. Thus, the link between reproductive status and lifespan extension in response to nutrient-limited conditions is interpreted in a significantly different manner in these iteroparative versus semelparous models. In the latter case, meiotic entry is a definitive signal that lifespan extension can no longer occur, whereas in the former, meiotic entry is not a unique chronological event, and can be largely erased during lifespan extension in response to nutrient stress, and reactivated from a pool of maintained GSCs when conditions improve.	[Subramaniam, Gunasekaran; Campsteijn, Coen; Thompson, Eric M.] Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen, Norway; [Thompson, Eric M.] Univ Bergen, Dept Biol, Bergen, Norway	University of Bergen; University of Bergen	Thompson, EM (corresponding author), Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen, Norway.	Eric.Thompson@sars.uib.no			Norwegian Research Council [183690/S10 NFR-FUGE, 133335/V40]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by grants 183690/S10 NFR-FUGE and 133335/V40 from the Norwegian Research Council (http://www.forskningsradet.no/en/Home_page/1177315753906) to EMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Baugh LR, 2013, GENETICS, V194, P539, DOI 10.1534/genetics.113.150847; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Blain SW, 2008, CELL CYCLE, V7, P892, DOI 10.4161/cc.7.7.5637; Bouquet JM, 2009, J PLANKTON RES, V31, P359, DOI 10.1093/plankt/fbn132; Britton JS, 1998, DEVELOPMENT, V125, P2149; Campsteijn C, 2012, MOL BIOL EVOL, V29, P487, DOI 10.1093/molbev/msr136; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Cloninger C, 2011, MOL CANCER THER, V10, P2244, DOI 10.1158/1535-7163.MCT-11-0478; Craig CR, 2004, EMBO REP, V5, P1058, DOI 10.1038/sj.embor.7400282; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; Delsuc F, 2008, GENESIS, V46, P592, DOI 10.1002/dvg.20450; Densham RM, 2008, CELL SIGNAL, V20, P1986, DOI 10.1016/j.cellsig.2008.07.005; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fox PM, 2011, DEVELOPMENT, V138, P2223, DOI 10.1242/dev.059535; FRIEDMAN DB, 1988, GENETICS, V118, P75; Fukuyama M, 2012, BIOL OPEN, V1, P929, DOI 10.1242/bio.2012836; Gaben AM, 2004, INT J CANCER, V108, P200, DOI 10.1002/ijc.11521; Ganot P, 2002, DEV BIOL, V252, P59, DOI 10.1006/dbio.2002.0834; Ganot P, 2007, DEV BIOL, V302, P577, DOI 10.1016/j.ydbio.2006.10.022; Ganot P, 2007, DEV BIOL, V302, P591, DOI 10.1016/j.ydbio.2006.10.021; Ganot P, 2006, BIOL CELL, V98, P389, DOI 10.1042/BC20060005; Ganot P, 2008, DEV BIOL, V324, P266, DOI 10.1016/j.ydbio.2008.09.016; HARPER JW, 1993, CELL, V75, P805; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Hosp J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040172; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Ikeyama S, 2002, FASEB J, V16, pA1163, DOI 10.1096/fj.01-0409fje; Inoue H, 2001, EMBO J, V20, P5421, DOI 10.1093/emboj/20.19.5421; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kimble J, 1988, NEMATODE CAENORHABDI, P191; Koga M, 2000, EMBO J, V19, P5148, DOI 10.1093/emboj/19.19.5148; LaFever L, 2010, DEVELOPMENT, V137, P2117, DOI 10.1242/dev.050351; Leung-Pineda V, 2004, BIOCHEM J, V379, P79, DOI 10.1042/BJ20031383; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu GM, 2002, J BIOL CHEM, V277, P8810, DOI 10.1074/jbc.M110477200; Lobon CM, 2013, LIMNOL OCEANOGR, V58, P215, DOI 10.4319/lo.2013.58.1.0215; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Luo Y, 1996, MOL CELL BIOL, V16, P6744; Martinet W, 2012, ARTERIOSCL THROM VAS, V32, P1228, DOI 10.1161/ATVBAHA.112.245381; Mattock H, 2001, EXP CELL RES, V265, P234, DOI 10.1006/excr.2001.5160; Mifsud KR, 2011, BRAIN BEHAV IMMUN, V25, P1305, DOI 10.1016/j.bbi.2011.06.005; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Okuyama T, 2010, J BIOL CHEM, V285, P30274, DOI 10.1074/jbc.M110.146274; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Sato R, 2001, J PLANKTON RES, V23, P415, DOI 10.1093/plankt/23.4.415; Schulmeister A, 2007, CHROMOSOME RES, V15, P189, DOI 10.1007/s10577-006-1112-z; Seidel HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028074; SHAN B, 1992, MOL CELL BIOL, V12, P5620, DOI 10.1128/MCB.12.12.5620; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shibutani ST, 2008, DEV CELL, V15, P890, DOI 10.1016/j.devcel.2008.10.003; Spada F, 2005, J CELL BIOCHEM, V95, P885, DOI 10.1002/jcb.20416; Staver JM, 2002, BIOL BULL, V203, P58, DOI 10.2307/1543458; Sun P, 2010, DEVELOPMENT, V137, P2461, DOI 10.1242/dev.051466; Troedsson C, 2002, MAR ECOL PROG SER, V243, P83, DOI 10.3354/meps243083; Troedsson C, 2009, J PLANKTON RES, V31, P1453, DOI 10.1093/plankt/fbp085; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; van der Heide LP, 2011, J BIOL CHEM, V286, P5003, DOI 10.1074/jbc.M110.167379; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666; Zheng XF, 1997, P NATL ACAD SCI USA, V94, P3070, DOI 10.1073/pnas.94.7.3070; Zielke N, 2011, NATURE, V480, P123, DOI 10.1038/nature10579	76	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93787	10.1371/journal.pone.0093787	http://dx.doi.org/10.1371/journal.pone.0093787			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695788	Green Submitted, Green Published, gold			2022-12-27	WOS:000334103000122
J	Zhang, LJ; Dong, LJ; Liu, X; Jiang, YF; Zhang, LJ; Zhang, XM; Li, XR; Zhang, Y				Zhang, Lijuan; Dong, Lijie; Liu, Xun; Jiang, Yuanfeng; Zhang, Lingjun; Zhang, Xiaomin; Li, Xiaorong; Zhang, Yan			alpha-Melanocyte-Stimulating Hormone Protects Retinal Vascular Endothelial Cells from Oxidative Stress and Apoptosis in a Rat Model of Diabetes	PLOS ONE			English	Article							MELANOCORTIN SYSTEM; NEURAL APOPTOSIS; GLYCEMIC CONTROL; MAP KINASE; RETINOPATHY; EXPRESSION; INSULIN; TYPE-1; MECHANISMS; RECEPTORS	Aims: Oxidative stress and apoptosis are among the earliest lesions of diabetic retinopathy. This study sought to examine the anti-oxidative and anti-apoptotic effects of alpha-melanocyte-stimulating hormone (alpha-MSH) in early diabetic retinas and to explore the underlying mechanisms in retinal vascular endothelial cells. Methods: Sprague-Dawley rats were injected intravenously with streptozocin to induce diabetes. The diabetic rats were injected intravitreally with alpha-MSH or saline. At week 5 after diabetes, the retinas were analyzed for reactive oxygen species (ROS) and gene expression. One week later, the retinas were processed for terminal deoxynucleotidyl transferase dUTP nick-end labeling staining and transmission electron microscopy. Retinal vascular endothelial cells were stimulated by high glucose (HG) with or without alpha-MSH. The expression of Forkhead box O genes (Foxos) was examined through real-time PCR. The Foxo4 gene was overexpressed in endothelial cells by transient transfection prior to alpha-MSH or HG treatment, and oxidative stress and apoptosis were analyzed through CM-H2DCFDA and annexin-V assays, respectively. Results: In diabetic retinas, the levels of H2O2 and ROS and the total anti-oxidant capacity were normalized, the apoptotic cell number was reduced, and the ultrastructural injuries were ameliorated by alpha-MSH. Treatment with alpha-MSH also corrected the aberrant changes in eNOS, iNOS, ICAM-1, and TNF-alpha expression levels in diabetic retinas. Furthermore, alpha-MSH inhibited Foxo4 up-regulation in diabetic retinas and in endothelial cells exposed to HG, whereas Foxo4 overexpression abrogated the anti-oxidative and anti-apoptotic effects of alpha-MSH in HG-stimulated retinal vascular endothelial cells. Conclusions: alpha-MSH normalized oxidative stress, reduced apoptosis and ultrastructural injuries, and corrected gene expression levels in early diabetic retinas. The protective effects of alpha-MSH in retinal vascular endothelial cells may be mediated through the inhibition of Foxo4 up-regulation induced by HG. This study suggests an alpha-MSH-mediated potential intervention approach to early diabetic retinopathy and a novel regulatory mechanism involving Foxo4.	[Zhang, Lijuan; Dong, Lijie; Liu, Xun; Jiang, Yuanfeng; Zhang, Lingjun; Zhang, Xiaomin; Li, Xiaorong; Zhang, Yan] Tianjin Med Univ, Hosp Eye, Inst Eye, Tianjin, Peoples R China	Tianjin Medical University	Li, XR (corresponding author), Tianjin Med Univ, Hosp Eye, Inst Eye, Tianjin, Peoples R China.	xiaorli@163.com; yanzhang9927@163.com	Jiang, Yuanfeng/ABC-4039-2020	Zhang, Xiaomin/0000-0003-4898-4152	Ph.D. Programs Foundation of Ministry of Education of China [20121202120005, 20111202110008]; 45th Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; start-up fund for introduction of talents to Tianjin Medical University Eye Hospital [TJEC20101110]; National Natural Science Foundation of China [31100991]	Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); 45th Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); start-up fund for introduction of talents to Tianjin Medical University Eye Hospital; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research work was supported by Ph.D. Programs Foundation of Ministry of Education of China (# 20121202120005 to Y.Z., URL: http://www.cutech.edu.cn/cn/zxgz/2012/12/1354173228992896.htm); The 45th Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry to Y.Z., URL: http://www.cscse.edu.cn/publish/portal0/tab182/; The start-up fund for introduction of talents to Tianjin Medical University Eye Hospital (# TJEC20101110 to Y.Z., URL: http://www.tmuec.com/tmuec/ykzx/ykindex.jsp); Ph.D. Programs Foundation of Ministry of Education of China (# 20111202110008 to X. L., URL: http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/2012/02/1326778644477072.htm); The National Natural Science Foundation of China (# 31100991 to L. D., URL: http://npd.nsfc.gov. cnfundingProjectSearchAction!search.action). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Aleksandrushkina NI, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1436, DOI 10.1134/S0006297912130032; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Asa FA, 2007, J MOL NEUROSCI, V33, P239, DOI 10.1007/s12031-007-0019-2; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; BAUMGARTI HJ, 1991, DIABETES RES CLIN EX, V16, P145; Behl Y, 2009, DIABETES, V58, P917, DOI 10.2337/db08-0537; Bressler NM, 2011, NEW ENGL J MED, V365, P1520, DOI 10.1056/NEJMct0908432; Ceriello A, 2009, J CLIN ENDOCR METAB, V94, P2751, DOI 10.1210/jc.2009-0762; Chai BX, 2007, REGUL PEPTIDES, V139, P115, DOI 10.1016/j.regpep.2006.11.003; Chen Y, 2013, DIABETES, V62, P261, DOI 10.2337/db11-0413; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Chuang PY, 2007, KIDNEY INT, V72, P965, DOI 10.1038/sj.ki.5002456; Chuang PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023566; da Silva AA, 2008, HYPERTENSION, V51, P884, DOI 10.1161/HYPERTENSIONAHA.107.100636; Dietrich Nadine, 2012, Methods Mol Biol, V933, P291, DOI 10.1007/978-1-62703-068-7_19; Edling AE, 2011, J NEUROIMMUNOL, V236, P1, DOI 10.1016/j.jneuroim.2011.04.015; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Fujita K, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/324256; HAMMES HP, 1995, MOL MED, V1, P527, DOI 10.1007/BF03401589; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542; Hazra S, 2012, DIABETES, V61, P3270, DOI 10.2337/db11-1596; Henri P, 2012, J CELL PHYSIOL, V227, P2578, DOI 10.1002/jcp.22996; Hu BJ, 2014, INT J MOL SCI, V15, P1606, DOI 10.3390/ijms15011606; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Jung DS, 2008, AM J PHYSIOL-RENAL, V295, pF595, DOI 10.1152/ajprenal.00624.2007; Kadekaro AL, 2012, MOL CANCER RES, V10, P778, DOI 10.1158/1541-7786.MCR-11-0436; Kay JG, 2013, ADV EXP MED BIOL, V991, P177, DOI 10.1007/978-94-007-6331-9_10; Kokot A, 2009, ENDOCRINOLOGY, V150, P3197, DOI 10.1210/en.2008-1315; Kowluru RA, 2003, DIABETES, V52, P818, DOI 10.2337/diabetes.52.3.818; Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/43603; Lee DJ, 2009, INT IMMUNOPHARMACOL, V9, P1079, DOI 10.1016/j.intimp.2009.05.001; Li QH, 2010, INVEST OPHTH VIS SCI, V51, P5240, DOI 10.1167/iovs.09-5147; [刘冕 Liu Mian], 2013, [中华实验眼科杂志, Chinese Journal of Experimental Ophthalmology], V31, P440; Mason JO, 2006, CURR OPIN OPHTHALMOL, V17, P281, DOI 10.1097/01.icu.0000193098.28798.18; Naveh N, 2003, GRAEF ARCH CLIN EXP, V241, P1044, DOI 10.1007/s00417-003-0781-y; Nohara K, 2011, ENDOCRINOLOGY, V152, P1661, DOI 10.1210/en.2010-1288; Ponugoti B, 2012, EXP DIABETES RES, DOI 10.1155/2012/939751; Rahmouni K, 2003, J NEUROSCI, V23, P5998, DOI 10.1523/JNEUROSCI.23-14-05998.2003; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; Rodrigues AR, 2009, MOL CELL ENDOCRINOL, V303, P74, DOI 10.1016/j.mce.2009.01.014; RUDMAN D, 1983, AM J PHYSIOL, V245, pE47, DOI 10.1152/ajpendo.1983.245.1.E47; Schaible EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071056; Shiratori K, 2004, INVEST OPHTH VIS SCI, V45, P159, DOI 10.1167/iovs.03-0492; Spaccapelo L, 2011, EUR J PHARMACOL, V670, P479, DOI 10.1016/j.ejphar.2011.09.015; Stitt AW, 2013, CLIN SCI, V125, P1, DOI 10.1042/CS20120588; Stitt AW, 1997, AM J PATHOL, V150, P523; Taylor AW, 2010, ADV EXP MED BIOL, V681, P143, DOI 10.1007/978-1-4419-6354-3_12; Tsuchiya K, 2012, CELL METAB, V15, P372, DOI 10.1016/j.cmet.2012.01.018; Ugwu SO, 1997, BIOPHARM DRUG DISPOS, V18, P259, DOI 10.1002/(SICI)1099-081X(199704)18:3<259::AID-BDD20>3.0.CO;2-X; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Voisey J, 2003, CURR DRUG TARGETS, V4, P586; Vongs A, 2004, REGUL PEPTIDES, V120, P113, DOI 10.1016/j.regpep.2004.02.018; Wardlaw SL, 2011, EUR J PHARMACOL, V660, P213, DOI 10.1016/j.ejphar.2010.10.107; WILSON JF, 1980, J ENDOCRINOL, V86, P61, DOI 10.1677/joe.0.0860061; Xu L, 2013, PEPTIDES, V48, P137, DOI 10.1016/j.peptides.2013.08.010; Yang YK, 2011, EUR J PHARMACOL, V660, P125, DOI 10.1016/j.ejphar.2010.12.020; Zhang B, 2009, INVEST OPHTH VIS SCI, V50, P3943, DOI 10.1167/iovs.08-2954; Zhang LW, 2012, DIABETES RES CLIN PR, V96, P286, DOI 10.1016/j.diabres.2011.12.006; Zhang Y, 2009, J NEUROCHEM, V110, P390, DOI 10.1111/j.1471-4159.2009.06144.x	64	44	49	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93433	10.1371/journal.pone.0093433	http://dx.doi.org/10.1371/journal.pone.0093433			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695675	Green Published, gold			2022-12-27	WOS:000334103000071
J	Chadha, S; Sharma, M				Chadha, Sonia; Sharma, Mradul			Transposable Elements as Stress Adaptive Capacitors Induce Genomic Instability in Fungal Pathogen Magnaporthe oryzae	PLOS ONE			English	Article							RICE-BLAST-FUNGUS; PWWP DOMAIN; GENETIC DIVERSITY; DNA-DAMAGE; PLANT; RETROTRANSPOSON; EVOLUTION; GRISEA; MUTATION; PROTEIN	A fundamental problem in fungal pathogenesis is to elucidate the evolutionary forces responsible for genomic rearrangements leading to races with fitter genotypes. Understanding the adaptive evolutionary mechanisms requires identification of genomic components and environmental factors reshaping the genome of fungal pathogens to adapt. Herein, Magnaporthe oryzae, a model fungal plant pathogen is used to demonstrate the impact of environmental cues on transposable elements (TE) based genome dynamics. For heat shock and copper stress exposed samples, eight TEs belonging to class I and II family were employed to obtain DNA profiles. Stress induced mutant bands showed a positive correlation with dose/duration of stress and provided evidences of TEs role in stress adaptiveness. Further, we demonstrate that genome dynamics differ for the type/family of TEs upon stress exposition and previous reports of stress induced MAGGY transposition has underestimated the role of TEs in M. oryzae. Here, we identified Pyret, MAGGY, Pot3, MINE, MgSINE, Grasshopper and MGLR3 as contributors of high genomic instability in M. oryzae in respective order. Sequencing of mutated bands led to the identification of LTR-retrotransposon sequences within regulatory regions of psuedogenes. DNA transposon Pot3 was identified in the coding regions of chromatin remodelling protein containing tyrosinase copperbinding and PWWP domains. LTR-retrotransposons Pyret and MAGGY are identified as key components responsible for the high genomic instability and perhaps these TEs are utilized by M. oryzae for its acclimatization to adverse environmental conditions. Our results demonstrate how common field stresses change genome dynamics of pathogen and provide perspective to explore the role of TEs in genome adaptability, signalling network and its impact on the virulence of fungal pathogens.	[Chadha, Sonia] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Mumbai 400085, Maharashtra, India; [Sharma, Mradul] Bhabha Atom Res Ctr, Astrophys Sci Div, Mumbai 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC); Bhabha Atomic Research Center (BARC)	Chadha, S (corresponding author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Mumbai 400085, Maharashtra, India.	schadha@barc.gov.in	Chadha, Sonia/AAJ-2483-2020	CHADHA, SONIA/0000-0003-2831-6907	Department of Atomic Energy, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	Funding was provided by Department of Atomic Energy, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qurainy F, 2011, PAK J BOT, V43, P2183; Atienzar FA, 2004, MUTAT RES-FUND MOL M, V552, P125, DOI 10.1016/j.mrfmmm.2004.06.009; Badyaev AV, 2005, P ROY SOC B-BIOL SCI, V272, P877, DOI 10.1098/rspb.2004.3045; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Behe MJ, 2010, Q REV BIOL, V85, P419, DOI 10.1086/656902; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; BRADSHAW AD, 1989, BIOL J LINN SOC, V37, P137, DOI 10.1111/j.1095-8312.1989.tb02099.x; Chadha S, 2005, GENOME, V48, P943, DOI 10.1139/g05-045; Chadha S, 2005, CURR SCI INDIA, V88, P1466; Chadha S, 2007, CURR SCI INDIA, V93, P688; Dasilva C, 2002, P NATL ACAD SCI USA, V99, P13636, DOI 10.1073/pnas.202284199; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; DOBINSON KF, 1993, MOL PLANT MICROBE IN, V6, P114, DOI 10.1094/MPMI-6-114; Eto Y, 2001, MOL GEN GENET, V264, P565, DOI 10.1007/s004380000343; Ewing AD, 2011, GENOME RES, V21, P985, DOI 10.1101/gr.114777.110; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Fedoroff NV, 2012, SCIENCE, V338, P758, DOI 10.1126/science.338.6108.758; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fudal I, 2005, FUNGAL GENET BIOL, V42, P761, DOI 10.1016/j.fgb.2005.05.001; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hua-Van A, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-19; Huen MSY, 2010, MOL CELL, V37, P854, DOI 10.1016/j.molcel.2009.12.040; Ikeda K, 2002, MOL MICROBIOL, V45, P1355, DOI 10.1046/j.1365-2958.2002.03101.x; Ikeda K, 2001, MOL GENET GENOMICS, V266, P318, DOI 10.1007/s004380100560; Ishii T, 2001, NUCLEIC ACIDS RES, V29, P278, DOI 10.1093/nar/29.1.278; Jeon J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065416; KACHROO P, 1995, P NATL ACAD SCI USA, V92, P11125, DOI 10.1073/pnas.92.24.11125; Kang S, 2001, MOL PLANT MICROBE IN, V14, P671, DOI 10.1094/MPMI.2001.14.5.671; KANG S, 2000, PLANT PATHOLOGY J, V16, P1; Kumar A, 2004, BIOCHEM BIOPH RES CO, V318, P1025, DOI 10.1016/j.bbrc.2004.04.129; LEE WC, 1991, J CELL BIOL, V113, P1, DOI 10.1083/jcb.113.1.1; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Liu W, 2007, CHEMOSPHERE, V67, P1155, DOI 10.1016/j.chemosphere.2006.11.011; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Maeda T, 1999, CANCER LETT, V138, P183, DOI 10.1016/S0304-3835(99)00004-X; Mathioni SM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-49; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Nishimura M, 2000, MOL PLANT MICROBE IN, V13, P892, DOI 10.1094/MPMI.2000.13.8.892; Ou S H, 1987, RICE DIS; Shan EL, 2009, J CREATION, V23, P110; Shull V, 1996, CURR GENET, V30, P263, DOI 10.1007/s002940050131; Sinha H, 2008, GENETICS, V180, P1661, DOI 10.1534/genetics.108.092932; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; STEPHAN W, 1994, GENETICS, V136, P333, DOI 10.1093/genetics/136.1.333; Theodorakis CW, 2001, ENVIRON TOXICOL CHEM, V20, P317, DOI 10.1002/etc.5620200212; Thon MR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r16; Tosa Yukio, 1995, Annals of the Phytopathological Society of Japan, V61, P549, DOI 10.3186/jjphytopath.61.549; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Viaud MC, 2002, PLANT CELL, V14, P917, DOI 10.1105/tpc.010389; Wessler SR, 1996, CURR BIOL, V6, P959, DOI 10.1016/S0960-9822(02)00638-3; Xue MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002869; Zeh DW, 2009, BIOESSAYS, V31, P715, DOI 10.1002/bies.200900026; Zhou EX, 2007, FUNGAL GENET BIOL, V44, P1024, DOI 10.1016/j.fgb.2007.02.003	58	30	32	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94415	10.1371/journal.pone.0094415	http://dx.doi.org/10.1371/journal.pone.0094415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709911	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800142
J	Sharabi, O; Shirian, J; Grossman, M; Lebendiker, M; Sagi, I; Shifman, J				Sharabi, Oz; Shirian, Jason; Grossman, Moran; Lebendiker, Mario; Sagi, Irit; Shifman, Julia			Affinity- and Specificity-Enhancing Mutations Are Frequent in Multispecific Interactions between TIMP2 and MMPs	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERFACES; TISSUE INHIBITOR; MATRIX-METALLOPROTEINASES; CRYSTAL-STRUCTURE; 1-MATRIX METALLOPROTEINASE; COMPLEX; BINDING; DOMAIN; OPTIMIZATION; FLEXIBILITY	Multispecific proteins play a major role in controlling various functions such as signaling, regulation of transcription/translation, and immune response. Hence, a thorough understanding of the atomic-level principles governing multispecific interactions is important not only for the advancement of basic science but also for applied research such as drug design. Here, we study evolution of an exemplary multispecific protein, a Tissue Inhibitor of Matrix Metalloproteinases 2 (TIMP2) that binds with comparable affinities to more than twenty-six members of the Matrix Metalloproteinase (MMP) and the related ADAMs families. We postulate that due to its multispecific nature, TIMP2 is not optimized to bind to any individual MMP type, but rather embodies a compromise required for interactions with all MMPs. To explore this hypothesis, we perform computational saturation mutagenesis of the TIMP2 binding interface and predict changes in free energy of binding to eight MMP targets. Computational results reveal the non-optimality of the TIMP2 binding interface for all studied proteins, identifying many affinity-enhancing mutations at multiple positions. Several TIMP2 point mutants predicted to enhance binding affinity and/or binding specificity towards MMP14 were selected for experimental verification. Experimental results show high abundance of affinity-enhancing mutations in TIMP2, with some point mutations producing more than ten-fold improvement in affinity to MMP14. Our computational and experimental results collaboratively demonstrate that the TIMP2 sequence lies far from the fitness maximum when interacting with its target enzymes. This non-optimality of the binding interface and high potential for improvement might characterize all proteins evolved for binding to multiple targets.	[Sharabi, Oz; Shirian, Jason; Shifman, Julia] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Grossman, Moran; Sagi, Irit] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Lebendiker, Mario] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Wolfson Ctr Struct Biol, Jerusalem, Israel	Hebrew University of Jerusalem; Weizmann Institute of Science; Hebrew University of Jerusalem	Shifman, J (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	jshifman@cc.huji.ac.il			Israel Science Foundation [1372/10]; Abisch-Frenkel Foundation	Israel Science Foundation(Israel Science Foundation); Abisch-Frenkel Foundation	This work was supported in part by the Israel Science Foundation (1372/10) and by the Abisch-Frenkel Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizner Y, 2014, STRUCTURE, V22, P636, DOI 10.1016/j.str.2014.01.012; Bahudhanapati H, 2011, J BIOL CHEM, V286, P31761, DOI 10.1074/jbc.M111.253328; Batra J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075836; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Butler GS, 1999, J BIOL CHEM, V274, P20391, DOI 10.1074/jbc.274.29.20391; Cho KI, 2006, PROTEINS, V65, P593, DOI 10.1002/prot.21056; DESMET J, 1992, NATURE, V356, P539, DOI 10.1038/356539a0; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Erijman A, 2011, J STRUCT BIOL, V175, P171, DOI 10.1016/j.jsb.2011.04.005; Erijman A, 2011, BIOCHEMISTRY-US, V50, P602, DOI 10.1021/bi101563v; Ernst A, 2013, SCIENCE, V339, P590, DOI 10.1126/science.1230161; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Fromer M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000627; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Gordon DB, 2003, J COMPUT CHEM, V24, P232, DOI 10.1002/jcc.10121; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Grossman M, 2011, CURR OPIN STRUC BIOL, V21, P678, DOI 10.1016/j.sbi.2011.07.008; Grossman M, 2010, BIOCHEMISTRY-US, V49, P6184, DOI 10.1021/bi902141x; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; Huang W, 1996, FEBS LETT, V384, P155, DOI 10.1016/0014-5793(96)00304-3; Humphris EL, 2007, PLOS COMPUT BIOL, V3, P1591, DOI 10.1371/journal.pcbi.0030164; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Lee MH, 2003, J BIOL CHEM, V278, P40224, DOI 10.1074/jbc.M305678200; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; Litwin S, 1992, THEORETICAL EXPT INS, P289; Maskos K, 2007, J MOL BIOL, V366, P1222, DOI 10.1016/j.jmb.2006.11.072; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Nishida Y, 2008, CANCER RES, V68, P9096, DOI 10.1158/0008-5472.CAN-08-2522; Sammond DW, 2007, J MOL BIOL, V371, P1392, DOI 10.1016/j.jmb.2007.05.096; Sharabi O, 2013, BIOCHEM SOC T, V41, P1166, DOI 10.1042/BST20130121; Sharabi O, 2013, METHOD ENZYMOL, V523, P41, DOI 10.1016/B978-0-12-394292-0.00003-5; Sharabi O, 2011, PROTEINS, V79, P1487, DOI 10.1002/prot.22977; Wei S, 2005, J BIOL CHEM, V280, P32877, DOI 10.1074/jbc.C500220200; Wei S, 2003, J BIOL CHEM, V278, P9831, DOI 10.1074/jbc.M211793200; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999	39	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93712	10.1371/journal.pone.0093712	http://dx.doi.org/10.1371/journal.pone.0093712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710006	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800046
J	Goodman, CD; McFadden, GI				Goodman, Christopher D.; McFadden, Geoffrey I.			Ycf93 (Orf105), a Small Apicoplast-Encoded Membrane Protein in the Relict Plastid of the Malaria Parasite Plasmodium falciparum That Is Conserved in Apicomplexa	PLOS ONE			English	Article							GREEN ALGAL ORIGIN; PEPTIDE DEFORMYLASE; GENOME SEQUENCE; ERYTHROCYTE INVASION; BABESIA-BOVIS; LIFE-CYCLE; TARGET; IDENTIFICATION; LOCALIZATION; PLAYS	Malaria parasites retain a relict plastid (apicoplast) from a photosynthetic ancestor shared with dinoflagellate algae. The apicoplast is a useful drug target; blocking housekeeping pathways such as genome replication and translation in the organelle kills parasites and protects against malaria. The apicoplast of Plasmodium falciparum encodes 30 proteins and a suite of rRNAs and tRNAs that facilitate their expression. orf105 is a hypothetical apicoplast gene that would encode a small protein (PfOrf105) with a predicted C-terminal transmembrane domain. We produced antisera to a predicted peptide within PfOrf105. Western blot analysis confirmed expression of orf105 and immunofluorescence localised the gene product to the apicoplast. Pforf105 encodes a membrane protein that has an apparent mass of 17.5 kDa and undergoes substantial turnover during the 48-hour asexual life cycle of the parasite in blood stages. The effect of actinonin, an antimalarial with a putative impact on post-translational modification of apicoplast proteins like PfOrf105, was examined. Unlike other drugs perturbing apicoplast housekeeping that induce delayed death, actinonin kills parasites immediately and has an identical drug exposure phenotype to the isopentenyl diphosphate synthesis blocker fosmidomycin. Open reading frames of similar size to PfOrf105, which also have predicted C-terminal trans membrane domains, occur in syntenic positions in all sequenced apicoplast genomes from Phylum Apicomplexa. We therefore propose to name these genes ycf93 (hypothetical chloroplast reading frame 93) according to plastid gene nomenclature convention for conserved proteins of unknown function.	[Goodman, Christopher D.; McFadden, Geoffrey I.] Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia	University of Melbourne	McFadden, GI (corresponding author), Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia.	gim@unimelb.edu.au	McFadden, Geoffrey McFadden I/F-7667-2014	McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Goodman, Christopher/0000-0002-8923-7594	Australian National Medical Health and Research Council; Federation Fellowship; Discovery Project	Australian National Medical Health and Research Council; Federation Fellowship; Discovery Project(Australian Research Council)	A Program Grant from the Australian National Medical Health and Research Council and a Federation Fellowship to GIM and a Discovery Project to GIM are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisue N, 2012, MOL BIOL EVOL, V29, P2095, DOI 10.1093/molbev/mss082; Biswal U.C., 2013, ADV PHOTOSYNTHESIS R, V36, P453, DOI 10.1007/978-94-007-5724-0_20; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; Bracchi-Ricard V, 2001, ARCH BIOCHEM BIOPHYS, V396, P162, DOI 10.1006/abbi.2001.2631; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Cai XM, 2003, GENE, V321, P39, DOI 10.1016/j.gene.2003.08.008; Clements JM, 2001, ANTIMICROB AGENTS CH, V45, P563, DOI 10.1128/AAC.45.2.563-570.2001; Dahl EL, 2008, TRENDS PARASITOL, V24, P279, DOI 10.1016/j.pt.2008.03.007; Dahl EL, 2007, ANTIMICROB AGENTS CH, V51, P3485, DOI 10.1128/AAC.00527-07; Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06; Drew DR, 2005, INFECT IMMUN, V73, P3912, DOI 10.1128/IAI.73.7.3912-3922.2005; El Bakkouri M, 2010, J MOL BIOL, V404, P456, DOI 10.1016/j.jmb.2010.09.051; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Giglione C, 2003, EMBO J, V22, P13, DOI 10.1093/emboj/cdg007; Giglione C, 2001, TRENDS PLANT SCI, V6, P566, DOI 10.1016/S1360-1385(01)02151-3; Giglione C, 2000, MOL MICROBIOL, V36, P1197, DOI 10.1046/j.1365-2958.2000.01908.x; Giglione Carmela, 2002, Expert Opin Ther Targets, V6, P691, DOI 10.1517/14728222.6.6.691; Goodman CD, 2007, MOL BIOCHEM PARASIT, V152, P181, DOI 10.1016/j.molbiopara.2007.01.005; HALLICK RB, 1994, PLANT MOL BIOL REP, V12, pS29, DOI DOI 10.1007/BF02671562; Imura T, 2014, PARASITOL RES, V113, P823, DOI 10.1007/s00436-013-3712-9; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kalanon M, 2009, EUKARYOT CELL, V8, P1146, DOI 10.1128/EC.00061-09; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Krishna S, 2012, TREATMENT PREVENTION, P141; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau AOT, 2009, EXP PARASITOL, V123, P236, DOI 10.1016/j.exppara.2009.07.007; Lin WJ, 2009, PARASITOL RES, V105, P1715, DOI 10.1007/s00436-009-1612-9; Madison V, 2002, BIOPHYS CHEM, V101, P239, DOI 10.1016/S0301-4622(02)00179-5; McFadden GI, 1997, BIOESSAYS, V19, P1033, DOI 10.1002/bies.950191114; Molteni V, 2004, BIOORG MED CHEM LETT, V14, P1477, DOI 10.1016/j.bmcl.2004.01.014; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Mullin KA, 2006, P NATL ACAD SCI USA, V103, P9572, DOI 10.1073/pnas.0602293103; Nair SC, 2011, J EXP MED, V208, P1547, DOI 10.1084/jem.20110039; Obornik M, 2012, PROTIST, V163, P306, DOI 10.1016/j.protis.2011.09.001; Okamoto N, 2008, FUTURE MICROBIOL, V3, P391, DOI 10.2217/17460913.3.4.391; Ponpuak M, 2007, MOL MICROBIOL, V63, P314, DOI 10.1111/j.1365-2958.2006.05443.x; PREISER P, 1995, NUCLEIC ACIDS RES, V23, P4329, DOI 10.1093/nar/23.21.4329; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Rathore S, 2010, MOL MICROBIOL, V77, P873, DOI 10.1111/j.1365-2958.2010.07251.x; Sato S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061778; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Tan KR, 2011, AM J TROP MED HYG, V84, P517, DOI 10.4269/ajtmh.2011.10-0285; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; van Dooren GG, 2002, J BIOL CHEM, V277, P23612, DOI 10.1074/jbc.M201748200; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; WELLNER D, 1990, P NATL ACAD SCI USA, V87, P1947, DOI 10.1073/pnas.87.5.1947; Wiesner J, 2001, TRENDS PARASITOL, V17, P7, DOI 10.1016/S1471-4922(00)01735-9; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138; Zhang YJ, 2009, BMC EVOL BIOL, V9, DOI [10.1186/1471-2148-9-290, 10.1186/1471-2148-9-137]	59	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e91178	10.1371/journal.pone.0091178	http://dx.doi.org/10.1371/journal.pone.0091178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705170	Green Published, gold			2022-12-27	WOS:000334107500002
J	Olivetta, E; Tirelli, V; Chiozzini, C; Scazzocchio, B; Romano, I; Arenaccio, C; Sanchez, M				Olivetta, Eleonora; Tirelli, Valentina; Chiozzini, Chiara; Scazzocchio, Beatrice; Romano, Ignazio; Arenaccio, Claudia; Sanchez, Massimo			HIV-1 Nef Impairs Key Functional Activities in Human Macrophages through CD36 Downregulation	PLOS ONE			English	Article							B SCAVENGER RECEPTOR; HUMAN MONOCYTE/MACROPHAGES; IN-VITRO; ANTIRETROVIRAL THERAPY; PLASMODIUM-FALCIPARUM; BACTERIAL RECOGNITION; ALVEOLAR MACROPHAGES; PNEUMOCYSTIS-CARINII; INFECTED PATIENTS; INNATE IMMUNITY	Monocytes and macrophages utilize the class A and B scavenger receptors to recognize and perform phagocytosis of invading microbes before a pathogen-specific immune response is generated. HIV-1 Nef protein affects the innate immune system impairing oxidative burst response and phagocytic capacity of macrophages. Our data show that exogenous recombinant myristoylated Nef protein induces a marked CD36 downregulation in monocytes from Peripheral Blood Mononuclear Cells, in Monocyte-Derived Macrophages (MDMs) differentiated by cytokines and in MDMs contained in a mixed culture obtained expanding PBMCs under Human Erythroid Massive Amplification condition. Under the latter culture condition we identify three main populations after 6 days of expansion: lymphocytes (37.8+/-14.7%), erythroblasts (46.7+/-6.1%) and MDMs (15.7+/-7.5%). The Nef addition to the cell culture significantly downregulates CD36 expression in MDMs, but not in erythroid cells. Furthermore, CD36 inhibition is highly specific since it does not modify the expression levels of other MDM markers such as CD14, CD11c, CD86, CD68, CD206, Toll-like Receptor 2 and Toll-like Receptor 4. Similar results were obtained in MDMs infected with VSV-G pseudotyped HIV-1-expressing Nef. The reduced CD36 membrane expression is associated with decrease of correspondent CD36 mRNA transcript. Furthermore, Nef-induced CD36 downregulation is linked to both impaired scavenger activity with reduced capability to take up oxidized lipoproteins and to significant decreased phagocytosis of fluorescent beads and GFP-expressing Salmonella tiphymurium. In addition we observed that Nef induces TNF-alpha release in MDMs. Although these data suggest a possible involvement of TNF-alpha in mediating Nef activity, our results exclude a possible relationship between Nef-induced TNF-alpha release and Nef-mediated CD36 downregulation. The present work shows that HIV-1 Nef protein may have a role in the strategies elaborated by HIV-1 to alter pathogen disease outcomes, by modulating CD36 expression in macrophages, favoring the onset of opportunistic infections in HIV-1 infected people.	[Olivetta, Eleonora; Chiozzini, Chiara; Arenaccio, Claudia] Ist Super Sanita, Natl AIDS Ctr, I-00161 Rome, Italy; [Tirelli, Valentina; Romano, Ignazio; Sanchez, Massimo] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Scazzocchio, Beatrice] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Arenaccio, Claudia] Univ Roma TRE, Dept Sci, Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Italfarmaco; Roma Tre University	Sanchez, M (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	massimo.sanchez@iss.it	chiozzini, chiara/M-8906-2017; scazzocchio, beatrice/B-4110-2015; Tirelli, Valentina/AAB-2422-2019; Chiozzini, Chiara/AAH-1790-2021; Sanchez, Massimo/AAD-1746-2021; Scazzocchio, Beatrice/AAH-1395-2021; Arenaccio, Claudia/J-9914-2016; Olivetta, Eleonora/N-5736-2017	Tirelli, Valentina/0000-0001-6021-0833; Chiozzini, Chiara/0000-0002-4153-0927; Sanchez, Massimo/0000-0003-3696-7582; Scazzocchio, Beatrice/0000-0002-5123-3897; Arenaccio, Claudia/0000-0003-3297-2608; Olivetta, Eleonora/0000-0003-3296-5328	Istituto Superiore di Sanita, Rome, Italy	Istituto Superiore di Sanita, Rome, Italy	This work was supported by institutional funds from Istituto Superiore di Sanita, Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Asztalos BF, 2010, J INFECT DIS, V202, P614, DOI 10.1086/654817; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Baranova IN, 2012, J IMMUNOL, V188, P1371, DOI 10.4049/jimmunol.1100350; Biggs TE, 1999, J MOL BIOL, V290, P21, DOI 10.1006/jmbi.1999.2849; Boccara F, 2008, AIDS, V22, pS19, DOI 10.1097/01.aids.0000327512.76126.6e; Boyer JF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2133; Briggs SD, 2001, J BIOL CHEM, V276, P25605, DOI 10.1074/jbc.M103244200; Buechler C, 1999, BIOCHEM BIOPH RES CO, V262, P251, DOI 10.1006/bbrc.1999.1193; Capparelli R, 2010, J INFECT DIS, V201, P52, DOI 10.1086/648478; Collot-Teixeira S, 2007, CARDIOVASC RES, V75, P468, DOI 10.1016/j.cardiores.2007.03.010; Dennis CA, 2005, PROTEINS, V60, P658, DOI 10.1002/prot.20544; Dressman J, 2003, J CLIN INVEST, V111, P389, DOI 10.1172/JCI200316261; DUFF GW, 1982, J IMMUNOL METHODS, V52, P333, DOI 10.1016/0022-1759(82)90005-9; Duong M, 2006, HIV CLIN TRIALS, V7, P41, DOI 10.1310/7381-M1YD-RTV5-4RYT; Erdman LK, 2009, J IMMUNOL, V183, P6452, DOI 10.4049/jimmunol.0901374; ESPEVIK T, 1986, J IMMUNOL METHODS, V95, P99, DOI 10.1016/0022-1759(86)90322-4; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Federico M, 2001, BLOOD, V98, P2752, DOI 10.1182/blood.V98.9.2752; Feeney ER, 2013, J INFECT DIS, V207, P628, DOI 10.1093/infdis/jis723; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; Ghiglione Y, 2011, CURR HIV RES, V9, P505, DOI 10.2174/157016211798842080; Han JH, 2000, J BIOL CHEM, V275, P1241, DOI 10.1074/jbc.275.2.1241; Han S, 2002, IMMUNOLOGY, V106, P53, DOI 10.1046/j.1365-2567.2002.01404.x; Hirano K, 2003, TRENDS CARDIOVAS MED, V13, P136, DOI 10.1016/S1050-1738(03)00026-4; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; Kedzierska K, 2003, J CLIN VIROL, V26, P247, DOI 10.1016/S1386-6532(02)00123-3; Kedzierska K, 2002, J IMMUNOL, V168, P2895, DOI 10.4049/jimmunol.168.6.2895; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Koziel H, 2000, AM J RESP CELL MOL, V23, P452, DOI 10.1165/ajrcmb.23.4.4084; Koziel H, 1998, AM J RESP CELL MOL, V18, P834, DOI 10.1165/ajrcmb.18.6.3059; Laguette N, 2010, MOL ASPECTS MED, V31, P418, DOI 10.1016/j.mam.2010.05.003; Lamers SL, 2012, INT REV IMMUNOL, V31, P432, DOI 10.3109/08830185.2012.737073; Masella R, 2004, J NUTR, V134, P785, DOI 10.1093/jn/134.4.785; Mazzolini J, 2010, BLOOD, V115, P4226, DOI 10.1182/blood-2009-12-259473; Meroni L, 2005, JAIDS-J ACQ IMM DEF, V38, P310; Migliaccio G, 2002, BLOOD CELL MOL DIS, V28, P169, DOI 10.1006/bcmd.2002.0502; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munteanu A, 2005, FREE RADICAL BIO MED, V38, P1047, DOI 10.1016/j.freeradbiomed.2004.12.030; Olivetta E, 2005, BIOCHEM J, V390, P591, DOI 10.1042/BJ20042139; Olivetta E, 2003, J IMMUNOL, V170, P1716, DOI 10.4049/jimmunol.170.4.1716; Olivetta E, 2009, J CELL BIOCHEM, V106, P812, DOI 10.1002/jcb.22041; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; Percario Z, 2003, J LEUKOCYTE BIOL, V74, P821, DOI 10.1189/jlb.0403161; Petit JM, 2002, EUR J CLIN INVEST, V32, P354, DOI 10.1046/j.1365-2362.2002.00989.x; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Pitrak DL, 1998, J LAB CLIN MED, V132, P284, DOI 10.1016/S0022-2143(98)90041-5; Pou J, 2008, EXP BIOL MED, V233, P1572, DOI 10.3181/0805-RM-144; Renga B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-274; Renga B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035924; Rios FJO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036632; Serghides L, 2002, AIDS, V16, P353, DOI 10.1097/00002030-200202150-00006; Shen LJ, 2001, J LIPID RES, V42, P813; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Smith TG, 2003, INFECT IMMUN, V71, P393, DOI 10.1128/IAI.71.1.393-400.2003; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Tirelli V, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/602483; Torre D, 2002, CLIN DIAGN LAB IMMUN, V9, P983, DOI 10.1128/CDLI.9.5.983-986.2002; YAGI K, 1987, CHEM PHYS LIPIDS, V45, P337, DOI 10.1016/0009-3084(87)90071-5; Zamora C, 2012, CYTOKINE, V60, P257, DOI 10.1016/j.cyto.2012.06.020	64	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93699	10.1371/journal.pone.0093699	http://dx.doi.org/10.1371/journal.pone.0093699			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705461	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500059
J	Shrestha, S; Bell, JS; Marais, D				Shrestha, Sanu; Bell, Jacqueline S.; Marais, Debbi			An Analysis of Factors Linked to the Decline in Maternal Mortality in Nepal	PLOS ONE			English	Article							HEALTH-SERVICES; WOMENS STATUS; COUNTRIES; TRENDS; BIRTH	Nepal experienced a steep decline in maternal mortality between 1996 and 2006, which had again dropped by 2010. The aim of this study was to investigate any trends in factors that may be responsible for this decline. The study was based on a secondary data analysis of maternity care services and socio-demographic variables extracted from the Nepal Demographic Health Surveys (1996, 2001, 2006 and 2011). Complex sample analysis was performed to determine the trends in these variables across the four surveys. Univariate logistic regression was performed for selected maternity care service variables to calculate the average change in odds ratio for each survey. Multivariate logistic regression was performed to determine the trends in the health service uptake adjusting for socio-demographic variables. There were major demographic and socio-economic changes observed between 1996 and 2011: notably fewer women delivering at 'high risk' ages, decreased fertility, higher education levels and migration to urban areas. Significant trends were observed for improved uptake of all maternity care services. The largest increase was observed in health facility delivery (odds ratio = 2.21; 95% confidence interval = 1.92, 2.34) and women making four or more antenatal visits (odds ratio = 2.24; 95% confidence interval = 2.03, 2.47). After adjusting for all socio-demographic factors, the trends were still significant but disparities become more pronounced at the extremes of the socio-economic spectrum. The odds ratios for each maternity care service examined decreased slightly after adjusting for education, indicating that improved levels of education could partly explain these trends. The improved utilisation of maternity care services seems essential to the decline in maternal mortality in Nepal. These findings have implications for policy planning in terms of government resources for maternity care services and the education sector.	[Shrestha, Sanu; Bell, Jacqueline S.; Marais, Debbi] Univ Aberdeen, Div Appl Hlth Sci, Aberdeen AB9 1FX, Scotland	University of Aberdeen	Bell, JS (corresponding author), Univ Aberdeen, Div Appl Hlth Sci, Aberdeen AB9 1FX, Scotland.	j.bell@abdn.ac.uk		Marais, Debbi/0000-0002-9073-0706; Bell, Jacqueline/0000-0003-1784-0180				Abou-Zahr CL, 2003, ANTENATAL CARE DEV C; Ajwad MI, 2007, ATTAINING HLTH ED MI; Althabe F, 2006, BIRTH-ISS PERINAT C, V33, P270, DOI 10.1111/j.1523-536X.2006.00118.x; [Anonymous], 2010, HUMAN DEV REPORT 201; Asamoah BO, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-159; Bell J, 2003, BIRTH-ISS PERINAT C, V30, P227, DOI 10.1046/j.1523-536X.2003.00252.x; Bertrand JT, 2002, COMPENDIUM INDICATOR, V1; Bhattarai B, 2008, MARRIAGE FAM REV, V44, P318, DOI 10.1080/01494920802255943; Fauveau V, 2006, INT J GYNECOL OBSTET, V93, P308, DOI 10.1016/j.ijgo.2006.01.031; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hossain AHMK, 2010, ASIA-PAC J PUBLIC HE, V22, P395, DOI 10.1177/1010539510366177; Hussein J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019898; JHPIEGO, 2004, BEH CHANG INT SAF MO; Karki YB, 2008, EFFECTS COMMUNICATIO; Karlsen S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-606; Alvarez JL, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-462; Maine D, 1997, GUIDELINES MONITORIN, V1997; Ministry of Health and Population (MOHP), 2012, NEP DEM HLTH SURV 20; National Planning Commission, 2011, MILL DEV GOALS NEEDS; Nuraini E, 2005, Asia Pac J Public Health, V17, P3, DOI 10.1177/101053950501700102; Ochako R, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-1; Pant PD, 2008, IMPROVEMENTS MATERNA; Powell-Jackson T, 2008, EVALUATION SAFE DELI; Pradhan A, 2005, Kathmandu Univ Med J (KUMJ), V3, P266; Pradhan A, 2007, TRENDS DEMOGRAPHIC R; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Shah QH, 2007, REPROD HEALTH MATTER, V15, P17, DOI 10.1016/S0968-8080(07)30339-X; Sharma SK, 2007, J BIOSOC SCI, V39, P671, DOI 10.1017/S0021932007001952; Shen C, 1999, SOC SCI MED, V49, P197, DOI 10.1016/S0277-9536(99)00112-4; Stanton CK, 2006, STUD FAMILY PLANN, V37, P41, DOI 10.1111/j.1728-4465.2006.00082.x; Suvedi B. K., 2009, NEPAL MATERNAL MORTA; United Nations, 2010, MILL DEV GOALS REP 2; Urassa DP, 2002, INT J QUAL HEALTH C, V14, P441, DOI 10.1093/intqhc/14.6.441; USAID, 2011, FOC ANT CAR INT IND; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; WHO UNICEF and The World Bank, 2012, TRENDS MAT MORT 1990; WHO UNICEF UNFPA & Bank T. W, 2010, TRENDS MAT MORT 1990; Witter S, 2011, HEALTH POLICY PLANN, V26, pII84, DOI 10.1093/heapol/czr066	39	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93029	10.1371/journal.pone.0093029	http://dx.doi.org/10.1371/journal.pone.0093029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6MJ	24705366	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500026
J	Wang, HS; Wang, ZW; Yin, ZT				Wang, Hui-Shan; Wang, Zeng-Wei; Yin, Zong-Tao			Carvedilol for Prevention of Atrial Fibrillation after Cardiac Surgery: A Meta-Analysis	PLOS ONE			English	Article							POSTOPERATIVE TREATMENT; BYPASS-SURGERY; METOPROLOL; INFLAMMATION; DECREASES; EFFICACY; BLOCKER	Background: Postoperative atrial fibrillation (POAF) remains the most common complication after cardiac surgery. Current guidelines recommend beta-blockers to prevent POAF. Carvedilol is a non-selective beta-adrenergic blocker with anti-inflammatory, antioxidant, and multiple cationic channel blocking properties. These unique properties of carvedilol have generated interest in its use as a prophylaxis for POAF. Objective: To investigate the efficacy of carvedilol in preventing POAF. Methods: PubMed from the inception to September 2013 was searched for studies assessing the effect of carvedilol on POAF occurrence. Pooled relative risk (RR) with 95% confidence interval (CI) was calculated using random-or fixed-effect models when appropriate. Six comparative trials (three randomized controlled trials and three nonrandomized controlled trials) including 765 participants met the inclusion criteria. Results: Carvedilol was associated with a significant reduction in POAF (relative risk [RR] 0.49, 95% confidence interval [CI] 0.37 to 0.64, p<0.001). Subgroup analyses yielded similar results. In a subgroup analysis, carvedilol appeared to be superior to metoprolol for the prevention of POAF (RR 0.51, 95% CI 0.37 to 0.70, p<0.001). No evidence of heterogeneity was observed. Conclusions: In conclusion, carvedilol may effectively reduce the incidence of POAF in patients undergoing cardiac surgery. It appeared to be superior to metoprolol. A large-scale, well-designed randomized controlled trial is needed to conclusively answer the question regarding the utility of carvedilol in the prevention of POAF.	[Wang, Hui-Shan; Wang, Zeng-Wei; Yin, Zong-Tao] Shenyang Northern Hosp, Dept Cardiovasc Surg, Shenyang, Liaoning Provin, Peoples R China		Wang, HS (corresponding author), Shenyang Northern Hosp, Dept Cardiovasc Surg, Shenyang, Liaoning Provin, Peoples R China.	wanghuishanCA@126.com	Wang, Huishan/V-5258-2017	Wang, Huishan/0000-0001-6523-7488				Acikel S, 2008, INT J CARDIOL, V126, P108, DOI 10.1016/j.ijcard.2007.03.123; Aranki SF, 1996, CIRCULATION, V94, P390, DOI 10.1161/01.CIR.94.3.390; Armitage P, 2002, STAT METHODS MED RES, P83, DOI DOI 10.1136/BMJ.315.7109.629; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Burgess DC, 2006, EUR HEART J, V27, P2846, DOI 10.1093/eurheartj/ehl272; Carnes CA, 2001, CIRC RES, V89, pE32, DOI 10.1161/hh1801.097644; Daoud EG, 1997, NEW ENGL J MED, V337, P1785, DOI 10.1056/NEJM199712183372501; Eagle KA, CIRCULATION, V110, pe340; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Gaudino M, 2003, CIRCULATION, V108, P195, DOI 10.1161/01.cir.0000087441.48566.0d; Haghjoo M, 2007, HEART RHYTHM, V4, P1170, DOI 10.1016/j.hrthm.2007.04.022; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang CX, 2009, MED HYPOTHESES, V72, P466, DOI 10.1016/j.mehy.2008.08.031; Kalman JM, 1995, ANN THORAC SURG, V60, P1709, DOI 10.1016/0003-4975(95)00718-0; Kamei M, 2006, CARDIOVASC DRUG THER, V20, P219, DOI 10.1007/s10557-006-8375-7; Khan MF, 2013, ANN NONINVAS ELECTRO, V18, P58, DOI 10.1111/anec.12004; Kumagai K, 2004, CARDIOVASC RES, V62, P105, DOI 10.1016/j.cardiores.2004.01.018; Marazzi G, 2011, AM J CARDIOL, V107, P215, DOI 10.1016/j.amjcard.2010.08.062; Mathew JP, 2004, JAMA-J AM MED ASSOC, V291, P1720, DOI 10.1001/jama.291.14.1720; McBride BF, 2005, J CLIN PHARMACOL, V45, P6, DOI 10.1177/0091270004269841; Merritt JC, 2003, AM J CARDIOL, V92, P735, DOI 10.1016/S0002-9149(03)00842-7; Mihm MJ, 2001, CIRCULATION, V104, P174, DOI 10.1161/01.CIR.104.2.174; Miranda Sandra Marina Ribeiro de, 2010, Arq Bras Cardiol, V94, P308; Ommen SR, 1997, NEW ENGL J MED, V336, P1429, DOI 10.1056/NEJM199705153362006; Ozaydin M, 2007, CARDIOLOGY, V107, P117, DOI 10.1159/000094589; Ozaydin M, 2013, EUR HEART J, V34, P597, DOI 10.1093/eurheartj/ehs423; de Miranda SMR, 2010, ARQ BRAS CARDIOL, V94, P328, DOI 10.1590/S0066-782X2010000300008; Song, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4100; Stroe Alice F, 2004, Rev Cardiovasc Med, V5 Suppl 1, pS18; Tsuboi J, 2008, CIRC J, V72, P588; Yoshioka I, 2009, THORAC CARDIOV SURG, V57, P464, DOI 10.1055/s-0029-1186069	31	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94005	10.1371/journal.pone.0094005	http://dx.doi.org/10.1371/journal.pone.0094005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705913	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500109
J	Ali, SE; Thoen, E; Evensen, O; Skaar, I				Ali, Shimaa E.; Thoen, Even; Evensen, Oystein; Skaar, Ida			Boric Acid Inhibits Germination and Colonization of Saprolegnia Spores In Vitro and In Vivo	PLOS ONE			English	Article							RAINBOW-TROUT; ATLANTIC SALMON; MALACHITE GREEN; BORON; MECHANISMS; GROWTH; EGGS; FISH; SPP.	Saprolegnia infections cause severe economic losses among freshwater fish and their eggs. The banning of malachite green increased the demand for finding effective alternative treatments to control the disease. In the present study, we investigated the ability of boric acid to control saprolegniosis in salmon eggs and yolk sac fry. Under in vitro conditions, boric acid was able to decrease Saprolegnia spore activity and mycelial growth in all tested concentrations above 0.2 g/L, while complete inhibition of germination and growth was observed at a concentration of 0.8 g/L. In in vivo experiments using Atlantic salmon eyed eggs, saprolegniosis was controlled by boric acid at concentrations ranging from 0.2-1.4 g/L during continuous exposure, and at 1.0-4.0 g/L during intermittent exposure. The same effect was observed on salmon yolk sac fry exposed continuously to 0.5 g/L boric acid during the natural outbreak of saprolegniosis. During the experiments no negative impact with regard to hatchability and viability was observed in either eggs or fry, which indicate safety of use at all tested concentrations. The high hatchability and survival rates recorded following the in vivo testing suggest that boric acid is a candidate for prophylaxis and control of saprolegniosis.	[Ali, Shimaa E.; Thoen, Even; Skaar, Ida] Norwegian Vet Inst, Oslo, Norway; [Thoen, Even; Evensen, Oystein] Norwegian Sch Vet Sci, Oslo, Norway	Norwegian Veterinary Institute; Norwegian University of Life Sciences	Skaar, I (corresponding author), Norwegian Vet Inst, Oslo, Norway.	ida.skaar@vetinst.no	Ali, Shimaa E/HHD-0713-2022; Evensen, Øystein/O-3011-2015	Evensen, Øystein/0000-0002-4856-3043; Ali, Shimaa E/0000-0002-0227-8124	European Commission through the EU Marie Curie ITN project SAPRO [238550]	European Commission through the EU Marie Curie ITN project SAPRO	The work has been funded by the European Commission through the EU Marie Curie ITN project SAPRO (238550) (http://www.abdn.ac.uk/oomycetes/SAPRO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SE, 2013, VET MICROBIOL, V163, P133, DOI 10.1016/j.vetmic.2012.12.012; Bailey TA, 1989, FISH WILDLIFE SERVIC, V99, P1; BEAKES GW, 1980, J GEN MICROBIOL, V119, P361; Branson E, 2002, VET REC, V151, P539, DOI 10.1136/vr.151.18.539; Bruno DW, 2011, FISH DISEASES AND DISORDERS, VOL 3: VIRAL, BACTERIAL AND FUNGAL INFECTIONS, 2ND EDITION, P669, DOI 10.1079/9781845935542.0669; Cao BH, 2012, POSTHARVEST BIOL TEC, V68, P16, DOI 10.1016/j.postharvbio.2012.01.008; De Seta F, 2009, J ANTIMICROB CHEMOTH, V63, P325, DOI 10.1093/jac/dkn486; Decision RE, 1993, 738R93017 EPA; DieguezUribeondo J, 1996, AQUACULTURE, V140, P247; Eckhert CD, 1998, J NUTR, V128, P2488, DOI 10.1093/jn/128.12.2488; Fregeneda-Grandes JM, 2007, J FISH BIOL, V71, P510, DOI 10.1111/j.1095-8649.2007.01510.x; Magaraggia M, 2006, J ENVIRON MONITOR, V8, P923, DOI 10.1039/b606975d; MARKING LL, 1994, PROG FISH CULT, V56, P225, DOI 10.1577/1548-8640(1994)056&lt;0225:AFSEOA&gt;2.3.CO;2; MEYER FP, 1983, T AM FISH SOC, V112, P818, DOI 10.1577/1548-8659(1983)112&lt;818:TAOEOM&gt;2.0.CO;2; NEISH GA, 1980, DIS FISHES, P159; Pottinger TG, 1999, DIS AQUAT ORGAN, V36, P129, DOI 10.3354/dao036129; Qin GZ, 2010, INT J FOOD MICROBIOL, V138, P145, DOI 10.1016/j.ijfoodmicro.2009.12.018; Quarles W., 2001, IPM Practitioner, V23, P1; Rowe RI, 1999, J EXP BIOL, V202, P1649; Shi XQ, 2011, PLANT DIS, V95, P63, DOI 10.1094/PDIS-06-10-0437; Srivastava R. C., 1987, FISH MYCOPATHOLOGY; Srivastava S, 2004, AQUAT TOXICOL, V66, P319, DOI 10.1016/j.aquatox.2003.09.008; Stueland S, 2005, J FISH DIS, V28, P445, DOI 10.1111/j.1365-2761.2005.00635.x; Thoen E, 2011, J FISH DIS, V34, P601, DOI 10.1111/j.1365-2761.2011.01273.x; WILLOUGHBY LG, 1994, FUNGI FISH DIS	25	26	27	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e91878	10.1371/journal.pone.0091878	http://dx.doi.org/10.1371/journal.pone.0091878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699283	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000334105000017
J	Barden, P; Grimaldi, D				Barden, Phillip; Grimaldi, David			A Diverse Ant Fauna from the Mid-Cretaceous of Myanmar (Hymenoptera: Formicidae)	PLOS ONE			English	Article							AMBER HYMENOPTERA; GENUS	A new collection of 24 wingless ant specimens from mid-Cretaceous Burmese amber (Albian-Cenomanian, 99 Ma) comprises nine new species belonging to the genus Sphecomyrmodes Engel and Grimaldi. Described taxa vary considerably with regard to total size, head and body proportion, cuticular sculpturing, and petiole structure while all species are unified by a distinct shared character. The assemblage represents the largest known diversification of closely related Cretaceous ants with respect to species number. These stem-group ants exhibit some characteristics previously known only from their extant counterparts along with presumed plesiomorphic morphology. Consequently, their morphology may inform hypotheses relating to basal relationships and general patterns of ant evolution. These and other uncovered Cretaceous species indicate that stem-group ants are not simply wasp-like, transitional formicids, but rather a group of considerable adaptive diversity, exhibiting innovations analogous to what crown-group ants would echo 100 million years later.	[Barden, Phillip; Grimaldi, David] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Barden, Phillip] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA	American Museum of Natural History (AMNH); American Museum of Natural History (AMNH)	Barden, P (corresponding author), Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA.	pbarden@amnh.org	Barden, Phillip/GLS-1283-2022	Barden, Phillip/0000-0001-6277-320X	Richard Gilder Graduate School at the American Museum of Natural History; National Science Foundation Graduate Research Fellowship Program	Richard Gilder Graduate School at the American Museum of Natural History; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	Financial support was provided by the Richard Gilder Graduate School at the American Museum of Natural History and National Science Foundation Graduate Research Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barden P, 2013, ZOOTAXA, V3681, P405, DOI 10.11646/zootaxa.3681.4.5; Barden P, 2012, AM MUS NOVIT, P1; Bolton Barry, 2003, Memoirs of the American Entomological Institute (Gainesville), V71, P1; Cruickshank RD, 2003, J ASIAN EARTH SCI, V21, P441, DOI 10.1016/S1367-9120(02)00044-5; Dlussky G. M., 1996, PALEONTOL J, V1996, p[83, 449]; Engel MS, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)485[0001:PNAICA]2.0.CO;2; Grimaldi DA, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)361<0001:FCAFMB>2.0.CO;2; Grimaldi David, 1997, American Museum Novitates, V3208, P1; Grimaldi David A., 2010, P167; LaPolla JS, 2013, ANNU REV ENTOMOL, V58, P609, DOI 10.1146/annurev-ento-120710-100600; McKellar RC, 2013, CAN ENTOMOL, V145, P454, DOI 10.4039/tce.2013.23; Nascimbene Paul, 2000, P93; Nel A., 2004, Geologica Acta, V2, P23; Noetling F., 1893, RECORDS GEOLOGICAL S, V26, P31; Perrichot V, 2008, NATURWISSENSCHAFTEN, V95, P91, DOI 10.1007/s00114-007-0302-7; Rabeling C, 2008, P NATL ACAD SCI USA, V105, P14913, DOI 10.1073/pnas.0806187105; Ross Andrew, 2010, P208; Shi GH, 2012, CRETACEOUS RES, V37, P155, DOI 10.1016/j.cretres.2012.03.014; WARD PS, 1994, SYST ENTOMOL, V19, P159, DOI 10.1111/j.1365-3113.1994.tb00585.x; WILSON EDWARD O., 1967, PSYCHE J ENTOMOL, V74, P1, DOI 10.1155/1967/89604; Xu X.D, 2011, CHINESE ANCIENT AMBE; Yoshimura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033325	22	30	31	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93627	10.1371/journal.pone.0093627	http://dx.doi.org/10.1371/journal.pone.0093627			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699881	Green Submitted, Green Published, gold			2022-12-27	WOS:000334105000082
J	Dauvilliers, Y; Bayard, S; Lopez, R; Comte, F; Zanca, M; Peigneux, P				Dauvilliers, Yves; Bayard, Sophie; Lopez, Regis; Comte, Frederic; Zanca, Michel; Peigneux, Philippe			Widespread Hypermetabolism in Symptomatic and Asymptomatic Episodes in Kleine-Levin Syndrome	PLOS ONE			English	Article							HYPERSOMNIA; SPECT; PET	Background: No reliable biomarkers are identified in KLS. However, few functional neuroimaging studies suggested hypoactivity in thalamic and hypothalamic regions during symptomatic episodes. Here, we investigated relative changes in regional brain metabolism in Kleine-Levin syndrome (KLS) during symptomatic episodes and asymptomatic periods, as compared to healthy controls. Methods: Four drug-free male patients with typical KLS and 15 healthy controls were included. (18)-F-fluorodeoxy glucose positron emission tomography (PET) was obtained in baseline condition in all participants, and during symptomatic episodes in KLS patients. All participants were asked to remain fully awake during the whole PET procedure. Results: Between state-comparisons in KLS disclosed higher metabolism in paracentral, precentral, and postcentral areas, supplementary motor area, medial frontal gyrus, thalamus and putamen during symptomatic episodes, and decreased metabolism in occipital and temporal gyri. As compared to healthy control subjects, KLS patients in the asymptomatic phase consistently exhibited significant hypermetabolism in a wide cortical network including frontal and temporal cortices, posterior cingulate and precuneus, with no detected hypometabolism. In symptomatic KLS episodes, hypermetabolism was additionally found in orbital frontal and supplementary motor areas, insula and inferior parietal areas, and right caudate nucleus, and hypometabolism in the middle occipital gyrus and inferior parietal areas. Conclusion: Our results demonstrated significant hypermetabolism and few hypometabolism in specific but widespread brain regions in drug-free KLS patients at baseline and during symptomatic episodes, highlighting the behavioral state-dependent nature of changes in regional brain activity in KLS.	[Dauvilliers, Yves; Bayard, Sophie; Lopez, Regis] CHU Montpellier, Hop Gui de Chauliac, Serv Neurol, Montpellier, France; [Dauvilliers, Yves; Bayard, Sophie; Lopez, Regis] Ctr Reference Natl Malad Rare Narcolepsie & Hyper, Montpellier, France; [Dauvilliers, Yves; Bayard, Sophie; Lopez, Regis] Inserm U1061, Montpellier, France; [Comte, Frederic; Zanca, Michel] CHU Montpellier, Hop Gui de Chauliac, Nucl Med Serv, Montpellier, France; [Peigneux, Philippe] Univ Libre Bruxelles, Neuropsychol & Funct Neuroimaging Res Unit, UR2NF, Brussels, Belgium	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite Libre de Bruxelles	Dauvilliers, Y (corresponding author), CHU Montpellier, Hop Gui de Chauliac, Serv Neurol, Montpellier, France.	ydauvilliers@yahoo.fr	Lopez, Regis/X-4694-2019	Bayard, Sophie/0000-0003-0767-4924; Peigneux, Philippe/0000-0003-4745-1434; Dauvilliers, yves/0000-0003-0683-6506; Lopez, Regis/0000-0001-8591-0553				Arias M, 2002, REV NEUROLOGIA, V35, P531, DOI 10.33588/rn.3506.2002264; Arnulf I, 2005, BRAIN, V128, P2763, DOI 10.1093/brain/awh620; Arnulf I, 2008, ANN NEUROL, V63, P482, DOI 10.1002/ana.21333; Arnulf I, 2012, LANCET NEUROL, V11, P918, DOI 10.1016/S1474-4422(12)70187-4; Billiard M, 2011, SLEEP MED REV, V15, P247, DOI 10.1016/j.smrv.2010.08.001; Dauvilliers Y, 2002, NEUROLOGY, V59, P1739, DOI 10.1212/01.WNL.0000036605.89977.D0; Dauvilliers Y, 2010, J NEUROL NEUROSUR PS, V81, P344, DOI 10.1136/jnnp.2009.175786; Drummond SPA, 2001, J SLEEP RES, V10, P85, DOI 10.1046/j.1365-2869.2001.00245.x; Haba-Rubio J, 2012, NEUROLOGY, V79, P1927, DOI 10.1212/WNL.0b013e318271f85a; Hong SB, 2006, SLEEP, V29, P1091, DOI 10.1093/sleep/29.8.1091; Huang YS, 2005, SLEEP, V28, P955, DOI 10.1093/sleep/28.8.955; Huang YS, 2012, SLEEP, V35, P123, DOI 10.5665/sleep.1600; Landtblom AM, 2002, ACTA NEUROL SCAND, V105, P318, DOI 10.1034/j.1600-0404.2002.1c162.x; Lo YC, 2012, SLEEP MED, V13, P771, DOI 10.1016/j.sleep.2012.01.009; The International Classification of Sleep Disorders, 2005, INT CLASS SLEEP DIS; Vigren P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056279	16	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93813	10.1371/journal.pone.0093813	http://dx.doi.org/10.1371/journal.pone.0093813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699677	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000110
J	Li, QG; Cai, GX; Li, DW; Wang, YW; Zhuo, CH; Cai, SJ				Li, Qingguo; Cai, Guoxiang; Li, Dawei; Wang, Yuwei; Zhuo, Changhua; Cai, Sanjun			Better Long-Term Survival in Young Patients with Non-Metastatic Colorectal Cancer after Surgery, an Analysis of 69,835 Patients in SEER Database	PLOS ONE			English	Article							COLON-CANCER; OLDER PATIENTS; CARCINOMA; ADENOCARCINOMA; PROGNOSIS; ADULTS; RATES; AGE	Objective: To compare the long-term survival of colorectal cancer (CRC) in young patients with elderly ones. Methods: Using Surveillance, Epidemiology, and End Results (SEER) population-based data, we identified 69,835 patients with non-metastatic colorectal cancer diagnosed between January 1, 1988 and December 31, 2003 treated with surgery. Patients were divided into young (40 years and under) and elderly groups (over 40 years of age). Five-year cancer specific survival data were obtained. Kaplan-Meier methods were adopted and multivariable Cox regression models were built for the analysis of long-term survival outcomes and risk factors. Results: Young patients showed significantly higher pathological grading (p < 0.001), more cases of mucinous and signet-ring histological type (p < 0.001), later AJCC stage (p<0.001), more lymph nodes (>= 12 nodes) dissected (p < 0.001) and higher metastatic lymph node ratio (p < 0.001). The 5-year colorectal cancer specific survival rates were 78.6% in young group and 75.3% in elderly group, which had significant difference in both univariate and multivariate analysis (P < 0.001). Further analysis showed this significant difference only existed in stage II and III patients. Conclusions: Compared with elderly patients, young patients with colorectal cancer treated with surgery appear to have unique characteristics and a higher cancer specific survival rate although they presented with higher proportions of unfavorable biological behavior as well as advanced stage disease.	Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai 200433, Peoples R China; [Li, Qingguo; Cai, Guoxiang; Li, Dawei; Wang, Yuwei; Zhuo, Changhua; Cai, Sanjun] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Cai, SJ (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai 200433, Peoples R China.	caisanjun_sh@163.com	ZHUO, CHANGHUA/H-7592-2012	ZHUO, CHANGHUA/0000-0002-5900-9048	National Natural Science Foundation of China [81001055]; Shanghai Pujiang Program [13PJD008]; National High Technology Research and Development Program (863 Program) [2012AA02A506]; Shanghai Shenkang Program [SHDC12012120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); Shanghai Shenkang Program	This study was supported by grants from the National Natural Science Foundation of China (No.81001055), Shanghai Pujiang Program (No.13PJD008), National High Technology Research and Development Program (863 Program, No.2012AA02A506) and Shanghai Shenkang Program (No. SHDC12012120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINS RB, 1987, AM SURGEON, V53, P141; ATKIN WS, 1993, LANCET, V341, P736, DOI 10.1016/0140-6736(93)90499-7; Ben-Ishay O, 2013, ISR MED ASSOC J, V15, P284; Benmoussa A, 2012, TURK J GASTROENTEROL, V23, P686, DOI 10.4318/tjg.2012.0474; Byeon JS, 2007, GASTROINTEST ENDOSC, V65, P1015, DOI 10.1016/j.gie.2006.12.065; Chan KK, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-82; Chang GJ, 2007, J NATL CANCER I, V99, P433, DOI 10.1093/jnci/djk092; Chew MH, 2009, INT J COLORECTAL DIS, V24, P1075, DOI 10.1007/s00384-009-0701-7; Cusack JC, 1996, J AM COLL SURGEONS, V183, P105; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Goodwin Rachel A, 2009, Clin Colon Rectal Surg, V22, P251, DOI 10.1055/s-0029-1242465; HEIMANN TM, 1989, DIS COLON RECTUM, V32, P473, DOI 10.1007/BF02554500; Kam M H, 2004, Colorectal Dis, V6, P191, DOI 10.1111/j.1463-1318.2004.00596.x; Karsten B, 2008, AM SURGEON, V74, P973; Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; Li M, 2011, J SURG RES, V167, P231, DOI 10.1016/j.jss.2010.10.040; MARBLE K, 1992, J SURG ONCOL, V51, P179, DOI 10.1002/jso.2930510311; Mitry E, 2001, DIS COLON RECTUM, V44, P380, DOI 10.1007/BF02234737; Nakamura T, 1999, SURG TODAY, V29, P226, DOI 10.1007/BF02483011; Neufeld D, 2009, TECH COLOPROCTOL, V13, P201, DOI 10.1007/s10151-009-0501-7; O'Connell JB, 2004, AM J SURG, V187, P343, DOI 10.1016/j.amjsurg.2003.12.020; O'Connell JB, 2003, AM SURGEON, V69, P866; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Schellerer VS, 2012, INT J COLORECTAL DIS, V27, P71, DOI 10.1007/s00384-011-1291-8; Serra-Rexach JA, 2012, ONCOLOGIST, V17, P1277, DOI 10.1634/theoncologist.2012-0060; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel RL, 2009, CANCER EPIDEM BIOMAR, V18, P1695, DOI 10.1158/1055-9965.EPI-09-0186; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; TAYLOR MC, 1988, CAN J SURG, V31, P150; Varma J R, 1990, J Am Board Fam Pract, V3, P54; You YN, 2012, ARCH INTERN MED, V172, P287, DOI 10.1001/archinternmed.2011.602; Zhang JZ, 2013, J CANCER RES CLIN, V139, P1947, DOI 10.1007/s00432-013-1525-y	32	46	47	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93756	10.1371/journal.pone.0093756	http://dx.doi.org/10.1371/journal.pone.0093756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699879	Green Submitted, gold, Green Published			2022-12-27	WOS:000334105000100
J	Mei, SY; Liu, YH; Bao, Y; Zhang, Y; Min, SP; Liu, YF; Huang, Y; Yuan, XD; Feng, Y; Shi, JD; Yang, RC				Mei, Shiyue; Liu, Yuanhang; Bao, Yue; Zhang, Yuan; Min, Siping; Liu, Yifei; Huang, Yun; Yuan, Xidi; Feng, Yue; Shi, Jiandang; Yang, Rongcun			Dendritic Cell-Associated miRNAs Are Modulated via Chromatin Remodeling in Response to Different Environments	PLOS ONE			English	Article							NF-KAPPA-B; HISTONE METHYLTRANSFERASE ACTIVITY; EMBRYONIC STEM-CELLS; RNA-POLYMERASE-II; MICRORNA GENES; LYSINE-27 METHYLATION; REPRESSOR COMPLEX; IMMUNE-RESPONSES; EXPRESSION; PHOSPHORYLATION	Introduction: Epigenetic modification plays a critical role in regulating gene expression. To understand how epigenetic modification alters miRNA expression in monocyte-derived dendritic cells (moDCs) in different environments, we analyzed the connections between H3K4me3 and H3K27me3 modification and the expression of miRNAs in LPS- and TGF-beta-conditioned moDCs. Results: In moDCs, H3K4me3 modification was strongly associated with the expression of activating miRNAs, whereas H3K27me3 was related to repressive miRNAs. The regulation of miRNA expression by H3K4me3 and H3K27me3 was further confirmed by silencing or inhibiting methyltransferases or methylation-associated factors in LPS- and TGF-beta-conditioned moDCs. siRNAs targeting H3K4me3-associated mixed lineage leukemia (MLL) and retinoblastoma binding protein 5 (RBBP5) reduced H3K4me3 enrichment and downregulated miRNA expression; conversely, silencing H3K27me3-associated enhancer of zeste homolog 2 (EZH2) and embryonic ectoderm development (EED) genes upregulated the DC-associated miRNAs. However, LPS-mediated miRNAs were often associated with H3K4me3 redistribution from the transcription start site (TSS) to the miRNA-coding region. Silencing LPS-associated NF-kappa B p65 and CBP/p300 not only inhibited H3K4m3 redistribution but also reduced miRNA expression. LPS-upregulated RBBP4 and RBBP7, which are involved in chromatin remodeling, also affected the redistribution of H3K4me3 and reduced the expression of miRNAs. Conclusion: In LPS- and TGF-beta-conditioned moDCs, miRNAs may be modulated not only by H3K4m3 and H3K27me3 modification but also by redistribution of H3K4me3 around the transcriptional start site of miRNAs. Thus, H3K4me3 and H3K27me3 epigenetic modification may play an important role in regulating DC differentiation and function in the presence of tumor or inflammatory environments.	[Mei, Shiyue; Liu, Yuanhang; Bao, Yue; Zhang, Yuan; Min, Siping; Liu, Yifei; Huang, Yun; Yuan, Xidi; Feng, Yue; Yang, Rongcun] Nankai Univ, Sch Med, Dept Immunol, Tianjin 300071, Peoples R China; [Yang, Rongcun] Minist Educ, Key Lab Bioact Mat, Tianjin, Peoples R China; [Shi, Jiandang] Nankai Univ, Coll Life Sci, Dept Biochem, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Yang, RC (corresponding author), Nankai Univ, Sch Med, Dept Immunol, Tianjin 300071, Peoples R China.	ryang@nankai.edu.cn		Liu, Yuanhang/0000-0002-0147-8394	NSFC [91029736]; Ministry of Science and Technology [2008AA02Z129]; National Theme Program of China (863 Program) [2011AA020116]; National Key Scientific Program [2011CB964902]	NSFC(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Theme Program of China (863 Program); National Key Scientific Program	This research was supported by NSFC grants 91029736, a Ministry of Science and Technology grant (863 program, 2008AA02Z129), the National Theme Program of China (863 Program, 2011AA020116) and the National Key Scientific Program (2011CB964902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Dufter C, 2001, TRANSPLANT P, V33, P190, DOI 10.1016/S0041-1345(00)01971-0; Elsharkawy AM, 2010, J HEPATOL, V53, P519, DOI 10.1016/j.jhep.2010.03.025; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Gao Y, 2011, NUCLEIC ACIDS RES, V39, P454, DOI 10.1093/nar/gkq782; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huang Y, 2012, GENES IMMUN, V13, P311, DOI 10.1038/gene.2011.87; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Hussain A, 2011, CANCER BIOTHER RADIO, V26, P519, DOI 10.1089/cbr.2010.0925; Jamaluddin M, 2007, CELL SIGNAL, V19, P1419, DOI 10.1016/j.cellsig.2007.01.020; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Song W, 2011, LEUKEMIA, V25, P161, DOI 10.1038/leu.2010.244; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tserel L, 2011, J BIOL CHEM, V286, P26487, DOI 10.1074/jbc.M110.213561; Tserel L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-642; Turner ML, 2011, J IMMUNOL, V187, P3911, DOI 10.4049/jimmunol.1101137; Ura H, 2011, EMBO J, V30, P2190, DOI 10.1038/emboj.2011.126; Varga-Weisz P, 2005, PROG MOLEC, V38, P1; Wang JQ, 2012, NUCLEUS-AUSTIN, V3, P155, DOI 10.4161/nucl.19477; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yang RC, 1999, J IMMUNOL, V163, P1037; Zhan YF, 2012, PROTEIN CELL, V3, P497, DOI 10.1007/s13238-012-0042-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	48	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e90231	10.1371/journal.pone.0090231	http://dx.doi.org/10.1371/journal.pone.0090231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699235	Green Submitted, gold, Green Published			2022-12-27	WOS:000334105000008
J	Hakonen, E; Ustinov, J; Palgi, J; Miettinen, PJ; Otonkoski, T				Hakonen, Elina; Ustinov, Jarkko; Palgi, Jaan; Miettinen, Paivi J.; Otonkoski, Timo			EGFR Signaling Promotes beta-Cell Proliferation and Survivin Expression during Pregnancy	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PANCREATIC-ISLETS; LACTOGENIC HORMONES; INSULIN-SECRETION; GENE-EXPRESSION; FACTOR RECEPTOR; MICE; LANGERHANS; MASS; APOPTOSIS	Placental lactogen (PL) induced serotonergic signaling is essential for gestational beta-cell mass expansion. We have previously shown that intact Epidermal growth factor -receptor (EGFR) function is a crucial component of this pathway. We now explored more specifically the link between EGFR and pregnancy-induced beta-cell mass compensation. Islets were isolated from wild-type and beta-cell-specific EGFR-dominant negative mice (E1-DN), stimulated with PL and analyzed for beta-cell proliferation and expression of genes involved in gestational beta-cell growth. beta-cell mass dynamics were analyzed both with traditional morphometrical methods and three dimensional optical projection tomography (OPT) of whole-mount insulin-stained pancreata. Insulin-positive volume analyzed with OPT increased 1.4-fold at gestational day 18.5 (GD18.5) when compared to non-pregnant mice. Number of islets peaked by GD13.5 (680 vs 1134 islets per pancreas, non-pregnant vs. GD13.5). PL stimulated beta cell proliferation in the wild-type islets, whereas the proliferative response was absent in the E1-DN mouse islets. Serotonin synthesizing enzymes were upregulated similarly in both the wild-type and E1-DN mice. However, while survivin (Birc5) mRNA was upregulated 5.5-fold during pregnancy in the wild-type islets, no change was seen in the E1-DN pregnant islets. PL induced survivin expression also in isolated islets and this was blocked by EGFR inhibitor gefitinib, mTOR inhibitor rapamycin and MEK inhibitor PD0325901. Our 3D-volumetric analysis of beta-cell mass expansion during murine pregnancy revealed that islet number increases during pregnancy. In addition, our results suggest that EGFR signaling is required for lactogen-induced survivin expression via MAPK and mTOR pathways.	[Hakonen, Elina; Ustinov, Jarkko; Palgi, Jaan; Miettinen, Paivi J.; Otonkoski, Timo] Univ Helsinki, Mol Neurol Biomedicum Stem Cell Ctr, Res Programs Unit, Helsinki, Finland; [Miettinen, Paivi J.; Otonkoski, Timo] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Miettinen, Paivi J.; Otonkoski, Timo] Univ Helsinki, Cent Hosp, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Hakonen, E (corresponding author), Univ Helsinki, Mol Neurol Biomedicum Stem Cell Ctr, Res Programs Unit, Helsinki, Finland.	elina.hakonen@helsinki.fi		Hakonen, Elina/0000-0002-9652-3724; Miettinen, Paivi/0000-0002-5184-9616	Diabetes Research Foundation; Helsinki University Central Hospital; Foundation for Pediatric Research; Sigrid Juselius Foundation; Helsinki Biomedical Graduate Program; Academy of Finland [257157]; Orion-Farmos Research Foundation; Biomedicum Helsinki Foundation	Diabetes Research Foundation; Helsinki University Central Hospital; Foundation for Pediatric Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki Biomedical Graduate Program; Academy of Finland(Academy of Finland); Orion-Farmos Research Foundation; Biomedicum Helsinki Foundation	These studies were funded by the Diabetes Research Foundation (www.diabetestutkimus.fi), the Helsinki University Central Hospital, the Foundation for Pediatric Research (www.lastentautientutkimussaatio.fi), the Sigrid Juselius Foundation (www.sigridjuselius.fi), the Helsinki Biomedical Graduate Program (www.hbgs.helsinki.fi), the Academy of Finland (Grant no 257157) (www.aka.fi), the Orion-Farmos Research Foundation and the Biomedicum Helsinki Foundation (www.biomedicum.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouna S, 2010, ORGANOGENESIS, V6, P125, DOI 10.4161/org.6.2.10374; Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Alanentalo T, 2010, DIABETES, V59, P1756, DOI 10.2337/db09-1400; Amaral MEC, 2003, HORM METAB RES, V35, P282; Brelje TC, 2002, J HISTOCHEM CYTOCHEM, V50, P365, DOI 10.1177/002215540205000308; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Cras-Meneur C, 2001, DIABETES, V50, P1571, DOI 10.2337/diabetes.50.7.1571; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Dohi T, 2006, EMBO REP, V7, P438, DOI 10.1038/sj.embor.7400640; Frank SJ, 2008, J MAMMARY GLAND BIOL, V13, P119, DOI 10.1007/s10911-008-9065-9; Hakonen E, 2011, DIABETOLOGIA, V54, P1735, DOI 10.1007/s00125-011-2153-1; Hakonen E, 2014, DIABETOLOGIA, V57, P970, DOI 10.1007/s00125-014-3175-2; Hanley SC, 2011, J ENDOCRINOLOGY; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Huang Y, 2006, ONCOGENE, V25, P7565, DOI 10.1038/sj.onc.1209740; Huotari MA, 2002, ENDOCRINOLOGY, V143, P4437, DOI 10.1210/en.2002-220382; Jiang Y, 2008, DIABETES, V57, P2718, DOI 10.2337/db08-0170; Kanwar JR, 2011, DRUG DISCOV TODAY, V16, P485, DOI 10.1016/j.drudis.2011.04.001; Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Means AL, 2003, GASTROENTEROLOGY, V124, P1020, DOI 10.1053/gast.2003.50150; Miettinen PJ, 2006, DIABETES, V55, P3299, DOI 10.2337/db06-0413; PARSONS JA, 1995, ENDOCRINOLOGY, V136, P2013, DOI 10.1210/en.136.5.2013; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Rescan C, 2005, LAB INVEST, V85, P65, DOI 10.1038/labinvest.3700204; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Schraenen A, 2010, DIABETOLOGIA, V53, P2579, DOI 10.1007/s00125-010-1912-8; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Tamm I, 1998, CANCER RES, V58, P5315; VinterJensen L, 1997, GASTROENTEROLOGY, V113, P1367, DOI 10.1053/gast.1997.v113.pm9322532; Wang Q, 2005, EXP MOL PATHOL, V79, P100, DOI 10.1016/j.yexmp.2005.05.002; Wu X, 2009, DIABETOLOGIA, V52, P2130, DOI 10.1007/s00125-009-1469-6; Wu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041976; Zarrouki B, 2014, DIABETES, V63, P982, DOI 10.2337/db13-0425; Zhang H, 2010, DIABETES, V59, P143, DOI 10.2337/db09-0050	40	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93651	10.1371/journal.pone.0093651	http://dx.doi.org/10.1371/journal.pone.0093651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695557	Green Submitted, Green Published, gold			2022-12-27	WOS:000334103000098
J	Kojima, H; Watanabe, T; Iwata, T; Fukui, M				Kojima, Hisaya; Watanabe, Tomohiro; Iwata, Tomoya; Fukui, Manabu			Identification of Major Planktonic Sulfur Oxidizers in Stratified Freshwater Lake	PLOS ONE			English	Article							MOLECULAR ANALYSIS; DIVERSITY; REDUCTASE; MARKER; GENE; DETOXIFICATION; PROKARYOTES; PHYLOGENY; SEDIMENT; BACTERIA	Planktonic sulfur oxidizers are important constituents of ecosystems in stratified water bodies, and contribute to sulfide detoxification. In contrast to marine environments, taxonomic identities of major planktonic sulfur oxidizers in freshwater lakes still remain largely unknown. Bacterioplankton community structure was analyzed in a stratified freshwater lake, Lake Mizugaki in Japan. In the clone libraries of 16S rRNA gene, clones very closely related to a sulfur oxidizer isolated from this lake, Sulfuritalea hydrogenivorans, were detected in deep anoxic water, and occupied up to 12.5% in each library of different water depth. Assemblages of planktonic sulfur oxidizers were specifically analyzed by constructing clone libraries of genes involved in sulfur oxidation, aprA, dsrA, soxB and sqr. In the libraries, clones related to betaproteobacteria were detected with high frequencies, including the close relatives of Sulfuritalea hydrogenivorans.	[Kojima, Hisaya; Watanabe, Tomohiro; Fukui, Manabu] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan; [Iwata, Tomoya] Univ Yamanashi, Dept Environm Sci, Kofu, Yamanashi, Japan	Hokkaido University; University of Yamanashi	Kojima, H (corresponding author), Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan.	kojimah@pop.lowtem.hokudai.ac.jp	Watanabe, Tomohiro/U-2519-2019; Kojima, Hisaya/D-9100-2012; Fukui, Manabu/E-1323-2012	Iwata, Tomoya/0000-0003-4258-0050; Watanabe, Tomohiro/0000-0002-5397-2124	Institute for Fermentation, Osaka; JSPS KAKENHI [22370005, 16710016]	Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Institute for Fermentation, Osaka, to Kojima. This study was also supported by JSPS KAKENHI Grant Number 22370005 (to Fukui) and 16710016 (to Iwata). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Biderre-Petit C, 2011, MICROB ECOL, V61, P313, DOI 10.1007/s00248-010-9769-4; Danis PA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020833; Grote J, 2012, P NATL ACAD SCI USA, V109, P506, DOI 10.1073/pnas.1111262109; Juretschko S, 2002, SYST APPL MICROBIOL, V25, P84, DOI 10.1078/0723-2020-00093; Kojima H, 2012, SYST APPL MICROBIOL, V35, P233, DOI 10.1016/j.syapm.2012.03.005; Kojima H, 2011, INT J SYST EVOL MICR, V61, P1651, DOI 10.1099/ijs.0.024968-0; Kojima H, 2009, FRESHWATER BIOL, V54, P1501, DOI 10.1111/j.1365-2427.2009.02199.x; Lavik G, 2009, NATURE, V457, P581, DOI 10.1038/nature07588; Livingstone DM, 2003, CLIMATIC CHANGE, V57, P205, DOI 10.1023/A:1022119503144; Loy A, 2009, ENVIRON MICROBIOL, V11, P289, DOI 10.1111/j.1462-2920.2008.01760.x; Luo JF, 2011, APPL MICROBIOL BIOT, V90, P769, DOI 10.1007/s00253-010-3061-x; Matzinger A, 2007, LIMNOL OCEANOGR, V52, P338, DOI 10.4319/lo.2007.52.1.0338; Meyer B, 2007, APPL ENVIRON MICROB, V73, P7664, DOI 10.1128/AEM.01272-07; Meyer B, 2007, ENVIRON MICROBIOL, V9, P2957, DOI 10.1111/j.1462-2920.2007.01407.x; Meyer B, 2007, MICROBIOL-SGM, V153, P3478, DOI 10.1099/mic.0.2007/008250-0; Pham VH, 2008, MICROBIOL-SGM, V154, P3112, DOI 10.1099/mic.0.2008/018580-0; Rotaru AE, 2010, FEMS MICROBIOL ECOL, V71, P460, DOI 10.1111/j.1574-6941.2009.00814.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsutsumi M, 2011, FRESHWATER BIOL, V56, P342, DOI 10.1111/j.1365-2427.2010.02502.x; Walsh DA, 2009, SCIENCE, V326, P578, DOI 10.1126/science.1175309; Watanabe T, 2013, SYST APPL MICROBIOL, V36, P436, DOI 10.1016/j.syapm.2013.04.009; Yagi JM, 2010, ISME J, V4, P131, DOI 10.1038/ismej.2009.101	24	25	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93877	10.1371/journal.pone.0093877	http://dx.doi.org/10.1371/journal.pone.0093877			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695535	Green Submitted, gold, Green Published			2022-12-27	WOS:000334103000129
J	Rowan, MP; Bierbower, SM; Eskander, MA; Szteyn, K; Por, ED; Gomez, R; Veldhuis, N; Bunnett, NW; Jeske, NA				Rowan, Matthew P.; Bierbower, Sonya M.; Eskander, Michael A.; Szteyn, Kalina; Por, Elaine D.; Gomez, Ruben; Veldhuis, Nicholas; Bunnett, Nigel W.; Jeske, Nathaniel A.			Activation of Mu Opioid Receptors Sensitizes Transient Receptor Potential Vanilloid Type 1 (TRPV1) via beta-Arrestin-2-Mediated Cross-Talk	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; ROOT GANGLION NEURONS; INDUCED HYPERALGESIA; BETA-ARRESTINS; ANTINOCICEPTIVE TOLERANCE; SENSORY NEURONS; CAPSAICIN RECEPTOR; PAIN; DESENSITIZATION; MECHANISMS	The transient receptor potential family V1 channel (TRPV1) is activated by multiple stimuli, including capsaicin, acid, endovanilloids, and heat (>42C). Post-translational modifications to TRPV1 result in dynamic changes to the sensitivity of receptor activation. We have previously demonstrated that beta-arrestin2 actively participates in a scaffolding mechanism to inhibit TRPV1 phosphorylation, thereby reducing TRPV1 sensitivity. In this study, we evaluated the effect of beta-arrestin2 sequestration by G-protein coupled receptors (GPCRs) on thermal and chemical activation of TRPV1. Here we report that activation of mu opioid receptor by either morphine or DAMGO results in beta-arrestin2 recruitment to mu opioid receptor in sensory neurons, while activation by herkinorin does not. Furthermore, treatment of sensory neurons with morphine or DAMGO stimulates beta-arrestin2 dissociation from TRPV1 and increased sensitivity of the receptor. Conversely, herkinorin treatment has no effect on TRPV1 sensitivity. Additional behavioral studies indicate that GPCR-driven beta-arrestin2 sequestration plays an important peripheral role in the development of thermal sensitivity. Taken together, the reported data identify a novel cross-talk mechanism between GPCRs and TRPV1 that may contribute to multiple clinical conditions.	[Rowan, Matthew P.; Szteyn, Kalina; Gomez, Ruben; Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Oral & Maxillofacial Surg, San Antonio, TX 78229 USA; [Eskander, Michael A.; Por, Elaine D.; Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Bierbower, Sonya M.; Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Veldhuis, Nicholas; Bunnett, Nigel W.] Monash Inst Pharmacol Sci, Dept Pharmacol, Parkville, Vic, Australia; [Veldhuis, Nicholas; Bunnett, Nigel W.] Monash Inst Pharmacol Sci, Dept Med, Parkville, Vic, Australia	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Jeske, NA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Oral & Maxillofacial Surg, San Antonio, TX 78229 USA.	jeske@uthscsa.edu		Veldhuis, Nicholas/0000-0002-8902-9365; Por, Elaine/0000-0001-8025-5713; Bunnett, Nigel W./0000-0003-3367-0644	NIH [NINDS R01NS061884, RO1NS082746, NINDS F32NS079148]; NHMRC [63303, 103188, 1049682]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061884, R01NS082746, F31NS083358, F32NS079148] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NINDS R01NS061884 and RO1NS082746 to NAJ, NINDS F32NS079148 to SMB and NHMRC grants 63303, 103188 and 1049682 to NWB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Belanger S, 2002, NEUROSCIENCE, V115, P441, DOI 10.1016/S0306-4522(02)00452-9; Berg KA, 2007, J PHARMACOL EXP THER, V321, P839, DOI 10.1124/jpet.106.116681; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2002, J NEUROSCI, V22, P10494; Butelman ER, 2008, J PHARMACOL EXP THER, V327, P154, DOI 10.1124/jpet.108.140079; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chia YT, 1999, CAN J ANAESTH, V46, P872, DOI 10.1007/BF03012978; Compton P, 2001, DRUG ALCOHOL DEPEN, V63, P139, DOI 10.1016/S0376-8716(00)00200-3; Cunha TM, 2010, P NATL ACAD SCI USA, V107, P4442, DOI 10.1073/pnas.0914733107; De Felice M, 2009, CEPHALALGIA, V29, P1277, DOI 10.1111/j.1468-2982.2009.01873.x; Debic HH, 2005, J NEUROSCI, V25, P7847, DOI 10.1523/JNEUROSCI.5045-04.2005; Diogenes A, 2006, J NEUROSCI, V26, P8126, DOI 10.1523/JNEUROSCI.0793-06.2006; Endres-Becker J, 2007, MOL PHARMACOL, V71, P12, DOI 10.1124/mol.106.026740; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Groer CE, 2007, MOL PHARMACOL, V71, P549, DOI 10.1124/mol.106.028258; Groer CE, 2011, J BIOL CHEM, V286, P31731, DOI 10.1074/jbc.M111.248310; Guignard B, 2000, ANESTHESIOLOGY, V93, P409, DOI 10.1097/00000542-200008000-00019; Harding WW, 2005, J MED CHEM, V48, P4765, DOI 10.1021/jm048963m; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Heinke B, 2011, J NEUROSCI, V31, P1313, DOI 10.1523/JNEUROSCI.4060-10.2011; Heinl C, 2011, J NEUROSCI, V31, P16748, DOI 10.1523/JNEUROSCI.3491-11.2011; Hernandez L, 2009, BRAIN RES, V1248, P31, DOI 10.1016/j.brainres.2008.10.065; Holzer P, 2008, BRIT J PHARMACOL, V155, P1145, DOI 10.1038/bjp.2008.351; Jeske NA, 2006, J NEUROCHEM, V97, P13, DOI 10.1111/j.1471-4159.2006.03706.x; Jeske NA, 2011, J NEUROSCI, V31, P8681, DOI 10.1523/JNEUROSCI.0020-11.2011; Johnson EE, 2005, NEUROSIGNALS, V14, P290, DOI 10.1159/000093044; Lamb K, 2012, DRUG ALCOHOL DEPEN, V121, P181, DOI 10.1016/j.drugalcdep.2011.10.026; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Li XQ, 2001, MOL BRAIN RES, V86, P56, DOI 10.1016/S0169-328X(00)00260-6; Low Y, 2012, SINGAP MED J, V53, P357; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Patierno S, 2011, GASTROENTEROLOGY, V140, P618, DOI 10.1053/j.gastro.2010.11.005; Patil MJ, 2011, J NEUROSCI RES, V89, P945, DOI 10.1002/jnr.22597; Piovezan AP, 1998, EUR J PHARMACOL, V351, P15, DOI 10.1016/S0014-2999(98)00281-7; Por ED, 2012, J BIOL CHEM, V287, P37552, DOI 10.1074/jbc.M112.391847; Por ED, 2010, BIOCHEM J, V432, P549, DOI 10.1042/BJ20100936; Raehal KM, 2011, NEUROPHARMACOLOGY, V60, P58, DOI 10.1016/j.neuropharm.2010.08.003; Ramasubbu Chitra, 2011, J Pain Palliat Care Pharmacother, V25, P219, DOI 10.3109/15360288.2011.589490; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Rowan MP, 2009, EUR J PHARMACOL, V602, P283, DOI 10.1016/j.ejphar.2008.11.028; Shukla AK, 2010, J BIOL CHEM, V285, P30115, DOI 10.1074/jbc.M110.141549; Spahn V, 2013, PAIN, V154, P598, DOI 10.1016/j.pain.2012.12.026; STEIN C, 1989, J PHARMACOL EXP THER, V248, P1269; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; Tominaga M, 2004, NOVART FDN SYMP, V261, P47; Tominaga M, 2004, NOVART FDN SYMP, V261, P12; Tominaga Makoto, 2004, Novartis Found Symp, V261, P4; Vanderah TW, 2000, J NEUROSCI, V20, P7074, DOI 10.1523/JNEUROSCI.20-18-07074.2000; Vardanyan A, 2009, J PAIN, V10, P243, DOI 10.1016/j.jpain.2008.07.004; Vetter I, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-22; Vetter I, 2008, J BIOL CHEM, V283, P19540, DOI 10.1074/jbc.M707865200; Walwyn WM, 2006, NEUROSCIENCE, V142, P493, DOI 10.1016/j.neuroscience.2006.06.021; Wang HJ, 2011, PAIN, V152, P1649, DOI 10.1016/j.pain.2011.03.010; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Wu ZZ, 2004, J PHARMACOL EXP THER, V311, P939, DOI 10.1124/jpet.104.073429; Xu H, 2007, SYNAPSE, V61, P166, DOI 10.1002/syn.20356; Zeitelhofer M, 2007, NAT PROTOC, V2, P1692, DOI 10.1038/nprot.2007.226; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	63	33	35	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93688	10.1371/journal.pone.0093688	http://dx.doi.org/10.1371/journal.pone.0093688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695785	Green Published, gold			2022-12-27	WOS:000334103000104
J	Gabay, Y; Fine, M; Barkay, Z; Benayahu, Y				Gabay, Yasmin; Fine, Maoz; Barkay, Zahava; Benayahu, Yehuda			Octocoral Tissue Provides Protection from Declining Oceanic pH	PLOS ONE			English	Article							CORAL; ACIDIFICATION; CALCIFICATION; RESPONSES	Increase in anthropogenic pCO(2) alters seawater chemistry and could lead to reduced calcification or skeleton dissolution of calcifiers and thereby weaken coral-reef structure. Studies have suggested that the complex and diverse responses in stony coral growth and calcification, as a result of elevated pCO(2), can be explained by the extent to which their soft tissues cover the underlying skeleton. This study compared the effects of decreased pH on the microstructural features of both in hospite (within the colony) and isolated sclerites (in the absence of tissue protection) of the zooxanthellate reef-dwelling octocoral Ovabunda macrospiculata. Colonies and isolated sclerites were maintained under normal (8.2) and reduced (7.6 and 7.3) pH conditions for up to 42 days. Both in hospite and isolated sclerites were then examined under SEM and ESEM microscopy in order to detect any microstructural changes. No differences were found in the microstructure of the in hospite sclerites between the control and the pH treatments. In stark contrast, the isolated sclerites revealed dissolution damage related to the acidity of the water. These findings suggest a protective role of the octocoral tissue against adverse pH conditions, thus maintaining them unharmed at high pCO(2). In light of the competition for space with the less resilient reef calcifiers, octocorals may thus have a significant advantage under greater than normal acidic conditions.	[Gabay, Yasmin; Barkay, Zahava; Benayahu, Yehuda] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Gabay, Yasmin; Fine, Maoz] Interuniv Inst Marine Sci, Elat, Israel; [Fine, Maoz] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Tel Aviv University; Bar Ilan University	Gabay, Y (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	yasminga@post.tau.ac.il	Fine, Maoz/S-5582-2019	Fine, Maoz/0000-0003-4911-4562	Israel Cohen Chair in Environmental Zoology; Israel Science Foundation	Israel Cohen Chair in Environmental Zoology; Israel Science Foundation(Israel Science Foundation)	This research was in part supported by the Israel Cohen Chair in Environmental Zoology to Y. Benayahu and an Israel Science Foundation grant to M. Fine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonovich D, 2012, MAR BIODIVERS, V42, P173, DOI 10.1007/s12526-011-0102-3; Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Bramanti L, 2013, GLOBAL CHANGE BIOL, V19, P1897, DOI 10.1111/gcb.12171; Cerrano C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01457; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; Fabricius K., 2001, SOFT CORALS SEA FANS; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Gabay Y, 2013, ECOL EVOL, V3, P465, DOI 10.1002/ece3.351; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Jeng MS, 2011, CORAL REEFS, V30, P925, DOI 10.1007/s00338-011-0765-z; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Jury CP, 2010, GLOBAL CHANGE BIOL, V16, P1632, DOI 10.1111/j.1365-2486.2009.02057.x; Krief S, 2010, GEOCHIM COSMOCHIM AC, V74, P4988, DOI 10.1016/j.gca.2010.05.023; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; Renegar DA, 2005, MAR ECOL PROG SER, V293, P69, DOI 10.3354/meps293069; Ries J, 2011, NAT CLIM CHANGE, V1, P294, DOI 10.1038/nclimate1204; Ries JB, 2011, J EXP MAR BIOL ECOL, V403, P54, DOI 10.1016/j.jembe.2011.04.006; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Rodolfo-Metalpa R, 2010, MAR ECOL-EVOL PERSP, V31, P447, DOI 10.1111/j.1439-0485.2009.00354.x; Schneider K, 2006, LIMNOL OCEANOGR, V51, P1284, DOI 10.4319/lo.2006.51.3.1284; Sheppard C, 1992, MARINE ECOLOGY ARABI, P359; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; Stemmer K, 2013, ORG DIVERS EVOL, V13, P135, DOI 10.1007/s13127-012-0119-x; Tentori E, 2006, BIOL BULL-US, V211, P193, DOI 10.2307/4134593; [No title captured]; [No title captured]; [No title captured]	29	32	32	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e91553	10.1371/journal.pone.0091553	http://dx.doi.org/10.1371/journal.pone.0091553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710022	Green Submitted, Green Published, gold			2022-12-27	WOS:000334159800008
J	Tanner, SA; Berner, AZ; Rigozzi, E; Grattepanche, F; Chassard, C; Lacroix, C				Tanner, Sabine A.; Berner, Annina Zihler; Rigozzi, Eugenia; Grattepanche, Franck; Chassard, Christophe; Lacroix, Christophe			In Vitro Continuous Fermentation Model ( PolyFermS) of the Swine Proximal Colon for Simultaneous Testing on the Same Gut Microbiota	PLOS ONE			English	Article							REAL-TIME PCR; CONTINUOUS-CULTURE; INTESTINAL MICROBIOTA; BACTERIAL COMMUNITIES; FIBER FERMENTATION; FECAL MICROBIOTA; FECES; STARCH; PIGS; FEED	In vitro gut modeling provides a useful platform for a fast and reproducible assessment of treatment- related changes. Currently, pig intestinal fermentation models are mainly batch models with important inherent limitations. In this study we developed a novel in vitro continuous fermentation model, mimicking the porcine proximal colon, which we validated during 54 days of fermentation. This model, based on our recent PolyFermS design, allows comparing different treatment effects on the same microbiota. It is composed of a first- stage inoculum reactor seeded with immobilized fecal swine microbiota and used to constantly inoculate ( 10% v/v) five second- stage reactors, with all reactors fed with fresh nutritive chyme medium and set to mimic the swine proximal colon. Reactor effluents were analyzed for metabolite concentrations and bacterial composition by HPLC and quantitative PCR, and microbial diversity was assessed by 454 pyrosequencing. The novel PolyFermS featured stable microbial composition, diversity and metabolite production, consistent with bacterial activity reported for swine proximal colon in vivo. The constant inoculation provided by the inoculum reactor generated reproducible microbial ecosystems in all second- stage reactors, allowing the simultaneous investigation and direct comparison of different treatments on the same porcine gut microbiota. Our data demonstrate the unique features of this novel PolyFermS design for the swine proximal colon. The model provides a tool for efficient, reproducible and costeffective screening of environmental factors, such as dietary additives, on pig colonic fermentation.	[Tanner, Sabine A.; Berner, Annina Zihler; Rigozzi, Eugenia; Grattepanche, Franck; Chassard, Christophe; Lacroix, Christophe] ETH, Inst Food Nutr & Hlth, Lab Food Biotechnol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Lacroix, C (corresponding author), ETH, Inst Food Nutr & Hlth, Lab Food Biotechnol, Zurich, Switzerland.	christophe.lacroix@hest.ethz.ch	Lacroix, Christophe/B-5139-2016	Lacroix, Christophe/0000-0003-4360-2020	Commission of Technology and Innovation of Switzerland (CTI) [11962.1 PFLS-LS]	Commission of Technology and Innovation of Switzerland (CTI)	This study was carried out thanks to the financial support of the Commission of Technology and Innovation of Switzerland (CTI-Project Nr. 11962.1 PFLS-LS) (URL: http://www.kti.admin.ch/?lang = en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Berner AZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077772; Bindelle J, 2007, ANIM FEED SCI TECH, V132, P111, DOI 10.1016/j.anifeedsci.2006.03.009; Bird AR, 2009, DIGEST DIS SCI, V54, P947, DOI 10.1007/s10620-008-0451-3; Buzoianu SG, 2012, APPL ENVIRON MICROB, V78, P4217, DOI 10.1128/AEM.00307-12; Chassard C, 2013, CURR OPIN CLIN NUTR, V16, P453, DOI 10.1097/MCO.0b013e3283619e63; Cinquin C, 2004, MICROB ECOL, V48, P128, DOI 10.1007/s00248-003-2022-7; Cinquin C, 2006, FEMS MICROBIOL ECOL, V57, P324, DOI 10.1111/j.1574-6941.2006.00117.x; Cleusix V, 2010, J APPL MICROBIOL, V108, P181, DOI 10.1111/j.1365-2672.2009.04408.x; Dostal A, 2013, FEMS MICROBIOL ECOL, V83, P161, DOI 10.1111/j.1574-6941.2012.01461.x; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Grieshop CM, 2000, SWINE NUTR, P107; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Hippe H, 1999, INT J SYST BACTERIOL, V49, P779, DOI 10.1099/00207713-49-2-779; Hosseini E, 2011, NUTR REV, V69, P245, DOI 10.1111/j.1753-4887.2011.00388.x; Jha R, 2011, ANIM FEED SCI TECH, V165, P191, DOI 10.1016/j.anifeedsci.2010.10.002; Jonathan MC, 2012, FOOD CHEM, V133, P889, DOI 10.1016/j.foodchem.2012.01.110; Jost T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044595; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Kim HB, 2012, P NATL ACAD SCI USA, V109, P15485, DOI 10.1073/pnas.1205147109; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Le Blay G, 2010, BRIT J NUTR, V103, P403, DOI 10.1017/S0007114509991796; Lee TT, 2011, J AGR FOOD CHEM, V59, P7353, DOI 10.1021/jf200402u; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Lin B, 2011, FOOD HYDROCOLLOID, V25, P180, DOI 10.1016/j.foodhyd.2010.02.006; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Macfarlane GT, 2007, CURR OPIN BIOTECH, V18, P156, DOI 10.1016/j.copbio.2007.01.011; Macfarlane GT, 1998, MICROB ECOL, V35, P180, DOI 10.1007/s002489900072; Messens W, 2010, VET MICROBIOL, V141, P73, DOI 10.1016/j.vetmic.2009.08.002; Michel C, 1998, ANAEROBE, V4, P257, DOI 10.1006/anae.1998.0178; Mozzetti V, 2012, BENEF MICROBES, V3, P261, DOI 10.3920/BM2012.0025; Nyannor EKD, 2007, J ANIM SCI, V85, P1946, DOI 10.2527/jas.2007-0037; Payne AN, 2012, TRENDS BIOTECHNOL, V30, P17, DOI 10.1016/j.tibtech.2011.06.011; Pinloche E, 2012, J ANIM SCI, V90, P353, DOI 10.2527/jas.53800; Pluske JR, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-1; Poroyko V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012459; Possemiers S, 2004, FEMS MICROBIOL ECOL, V49, P495, DOI 10.1016/j.femsec.2004.05.002; Rajilic-Stojanovic M, 2010, MICROBIOL-SGM, V156, P3270, DOI 10.1099/mic.0.042044-0; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Riboulet-Bisson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031113; Ricca DM, 2010, ANAEROBE, V16, P516, DOI 10.1016/j.anaerobe.2010.03.010; Russell WR, 2013, CURR OPIN MICROBIOL, V16, P246, DOI 10.1016/j.mib.2013.07.002; Sakata T, 2003, P NUTR SOC, V62, P73, DOI 10.1079/PNS2002211; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Van den Abbeele P, 2010, APPL ENVIRON MICROB, V76, P5237, DOI 10.1128/AEM.00759-10; von Heimendahl E, 2010, J ANIM SCI, V88, P972, DOI 10.2527/jas.2009-2370; Wang JP, 2011, J ANIM SCI, V89, P2768, DOI 10.2527/jas.2009-1800; Williams BA, 2005, ANIM RES, V54, P191, DOI 10.1051/animres:2005011; Zhu WY, 2003, ANAEROBE, V9, P175, DOI 10.1016/S1075-9964(03)00083-0	53	48	48	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94123	10.1371/journal.pone.0094123	http://dx.doi.org/10.1371/journal.pone.0094123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709947	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800103
J	Wu, ZH				Wu, Zhenghua			SSVEP Extraction Based on the Similarity of Background EEG	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; VISUAL-EVOKED POTENTIALS; BCI; IMPLEMENTATION; COMMUNICATION; PHASE	Steady-state Visual Evoked Potential (SSVEP) outperforms the other types of ERPs for Brain-computer Interface (BCI), and thus it is widely employed. In order to apply SSVEP-based BCI to real life situations, it is important to improve the accuracy and transfer rate of the system. Aimed at this target, many SSVEP extraction methods have been proposed. All these methods are based directly on the properties of SSVEP, such as power and phase. In this study, we first filtered out the target frequencies from the original EEG to get a new signal and then computed the similarity between the original EEG and the new signal. Based on this similarity, SSVEP in the original EEG can be identified. This method is referred to as SOB (Similarity of Background). The SOB method is used to detect SSVEP in 1s-length and 3s-length EEG segments respectively. The accuracy of detection is compared with its peers computed by the widely-used Power Spectrum (PS) method and the Canonical Coefficient (CC) method. The comparison results illustrate that the SOB method can lead to a higher accuracy than the PS method and CC method when detecting a short period SSVEP signal.	[Wu, Zhenghua] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu 610054, Sichuan, Peoples R China; [Wu, Zhenghua] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab Neuro Informat, Minist Educ, Chengdu 610054, Sichuan, Peoples R China	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China	Wu, ZH (corresponding author), Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu 610054, Sichuan, Peoples R China.	wzhzxwz@sina.com			Science and Technology Bureau of Sichuan Province [2013GZ0017]	Science and Technology Bureau of Sichuan Province	The work was supported by Science and Technology Bureau of Sichuan Province (#2013GZ0017), and the grant number is 40,000 $. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BZ, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/1/013001; Allison BZ, 2012, J NEUROSCI METH, V209, P299, DOI 10.1016/j.jneumeth.2012.06.022; ALLISON BZ, 2005, 3 INT BRAIN COMP INT; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; DAVILA CE, 1994, IEEE T BIO-MED ENG, V41, P197, DOI 10.1109/10.284933; Diez PF, 2013, IFMBE PROC, V33, P1154; Friman O, 2007, IEEE T BIO-MED ENG, V54, P742, DOI 10.1109/TBME.2006.889160; Gao XR, 2003, IEEE T NEUR SYS REH, V11, P137, DOI 10.1109/TNSRE.2003.814449; Gary G.M., 2013, INT J AUTONOMOUS ADA, V6, P1; Gary G. M., 2013, BIOL MED PHYS BIOMED, V25, P269; Hwang HJ, 2012, J NEUROSCI METH, V208, P59, DOI 10.1016/j.jneumeth.2012.04.011; Lee PL, 2010, ANN BIOMED ENG, V38, P2383, DOI 10.1007/s10439-010-9964-y; Lin ZL, 2007, IEEE T BIO-MED ENG, V54, P1172, DOI 10.1109/TBME.2006.889197; Lopez MA, 2009, NEURAL PROCESS LETT, V29, P179, DOI 10.1007/s11063-009-9102-8; Lopez-Gordo MA, 2010, NEURAL PROCESS LETT, V32, P1, DOI 10.1007/s11063-010-9139-8; Luo A, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026010; McCullagh Paul, 2013, Universal Access in Human-Computer Interaction. Design Methods, Tools, and Interaction Techniques for eInclusion. 7th International Conference, UAHCI 2013 Held as Part of HCI International 2013. Proceedings. LNCS 8009, P530, DOI 10.1007/978-3-642-39188-0_57; Ortiz-Rosario A., 2013, REV NEUROSCIENCES, V24, P455; Ortner R, 2011, IEEE T NEUR SYS REH, V19, P1, DOI 10.1109/TNSRE.2010.2076364; Volosyak I, 2011, IEEE T NEUR SYS REH, V19, P232, DOI 10.1109/TNSRE.2011.2121919; Wang YJ, 2004, P ANN INT IEEE EMBS, V26, P4507; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Wu ZH, 2008, J NEURAL ENG, V5, P36, DOI 10.1088/1741-2560/5/1/004; Yin EW, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026012; Zhu DH, 2011, LECT NOTES COMPUT SC, V6766, P645, DOI 10.1007/978-3-642-21663-3_70	26	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93884	10.1371/journal.pone.0093884	http://dx.doi.org/10.1371/journal.pone.0093884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709951	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800063
J	Ge, YZ; Wu, R; Lu, TZ; Jia, RP; Li, MH; Gao, XF; Jiang, XM; Zhu, XB; Li, LP; Tan, SJ; Song, Q; Li, WC; Zhu, JG				Ge, Yu-Zheng; Wu, Ran; Lu, Tian-Ze; Jia, Rui-Peng; Li, Ming-Hao; Gao, Xiao-Fei; Jiang, Xiao-Min; Zhu, Xian-Bo; Li, Liang-Peng; Tan, Si-Jia; Song, Qun; Li, Wen-Cheng; Zhu, Jia-Geng			Combined Effects of TGFB1+869 T/C and+915 G/C Polymorphisms on Acute Rejection Risk in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CYTOKINE GENE POLYMORPHISMS; TRANSFORMING GROWTH-FACTOR-BETA-1 GENE; GROWTH-FACTOR-BETA; GRAFT-REJECTION; MESSENGER-RNA; TGF-BETA; ALLOGRAFT-REJECTION; RENAL-TRANSPLANTS; TURKISH PATIENTS; TGF-BETA-1	Background: Transforming growth factor-beta 1(TGF-beta 1) is involved in the development of acute rejection (AR) episodes in solid organ transplant recipients; and a number of studies have been conducted to investigate the combined effects of human TGF-beta 1 gene (TGFB1) +869 T/C and +915 G/C polymorphisms on AR risk. However, the results obtained are inconclusive. Methods: Eligible studies that investigated the haplotypic association between TGFB1 +869 T/C and +915 G/C polymorphisms and AR risk were comprehensively searched in the PUBMED, EMBASE, China National Knowledge Infrastructure, and Wanfang Database. Statistical analyses were performed by using STATA 12.0 and Review Manager 5.0. Results: Fourteen eligible studies with 565 AR cases and 1219 non-AR cases were included. Overall, a significantly decreased risk was detected in patients carried with intermediate producer (IP) haplotypes (T/C G/C, T/T G/C, and C/C G/G) and/or low producer ( LP) haplotypes (C/C G/C, C/C C/C, T/T C/C, and T/C C/C) compared with high producer ( HP) haplotypes (T/T G/G and T/C G/G; IP vs. HP: OR = 0.75, 95% Cl, 0.58-0.96, P (heterogeneity) = 0.238; IP/LP vs. HP: OR = 0.77, 95% Cl, 0.61-0.98, P heterogeneity = 0.144). In addition, subgroup analysis by transplant types demonstrated a similar association in patients receiving heart transplant ( IP vs. HP: OR = 0.32, 95% Cl, 0.14-0.73, P (heterogeneity) = 0.790; IP/LP vs. HP: OR = 0.41, 95% Cl, 0.20-0.85, P (heterogeneity) = 0.320). Conclusions: The current meta-analysis and systematic review indicated that recipient TGFB1 HP haplotypes were significantly associated with an increased risk for AR in solid organ transplant recipients, particularly patients receiving cardiac allograft.	[Ge, Yu-Zheng; Wu, Ran; Lu, Tian-Ze; Jia, Rui-Peng; Li, Ming-Hao; Tan, Si-Jia; Song, Qun; Li, Wen-Cheng; Zhu, Jia-Geng] Nanjing Med Univ, Nanjing Hosp 1, Ctr Renal Transplantat, Nanjing, Jiangsu, Peoples R China; [Ge, Yu-Zheng; Wu, Ran; Lu, Tian-Ze; Jia, Rui-Peng; Li, Ming-Hao; Tan, Si-Jia; Song, Qun; Li, Wen-Cheng; Zhu, Jia-Geng] Nanjing Med Univ, Nanjing Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Gao, Xiao-Fei; Jiang, Xiao-Min] Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Zhu, Xian-Bo] Nanjing Med Univ, Nanjing Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Li, Liang-Peng] Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Jia, RP (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Ctr Renal Transplantat, Nanjing, Jiangsu, Peoples R China.	ruipeng_jia@yeah.net		Ge, Yu-Zheng/0000-0003-1615-9473	National Natural Science Foundation of China [81070597, 81370853]; Science and Education Development Program of the Jiangsu Province Health Board [LJ201107]; Six Talent Peaks of the Jiangsu Province Health Bureau [2011-WS-093]; Research and Innovation Program for Graduates of Jiangsu Province [CXZZ13_0583]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Education Development Program of the Jiangsu Province Health Board; Six Talent Peaks of the Jiangsu Province Health Bureau; Research and Innovation Program for Graduates of Jiangsu Province	This project was supported by grants from the National Natural Science Foundation of China (81070597, 81370853), Science and Education Development Program of the Jiangsu Province Health Board (LJ201107), Six Talent Peaks of the Jiangsu Province Health Bureau (2011-WS-093) and Research and Innovation Program for Graduates of Jiangsu Province (CXZZ13_0583). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad M R, 1998, Transplantation, V66, P1014; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benza RL, 2009, J HEART LUNG TRANSPL, V28, P1057, DOI 10.1016/j.healun.2009.06.001; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Canossi A, 2007, TRANSPL P, V39, P1805, DOI 10.1016/j.transproceed.2007.05.035; Dai JN, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021891, 10.1371/journal.pone.0028903]; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhaouadi T, 2013, TRANSPL P, V45, P2152, DOI 10.1016/j.transproceed.2012.12.006; Di Filippo S, 2006, TRANSPLANTATION, V81, P934, DOI 10.1097/01.tp.0000202725.55923.37; Edgley AJ, 2012, CARDIOVASC THER, V30, pe30, DOI 10.1111/j.1755-5922.2010.00228.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gagliardo R, 2013, INT J IMMUNOPATH PH, V26, P725, DOI 10.1177/039463201302600316; Ge YZ, 2014, TRANSPL IMMUNOL; Gomez-Mateo J, 2006, TRANSPL IMMUNOL, V17, P55, DOI 10.1016/j.trim.2006.09.011; Gourley IS, 2004, HUM IMMUNOL, V65, P248, DOI 10.1016/j.humimm.2004.01.008; Gu Xin-wei, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P1211; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoffmann S, 2004, KIDNEY INT, V66, P1686, DOI 10.1111/j.1523-1755.2004.00936.x; Hueso M, 2006, TRANSPLANTATION, V81, P1463, DOI 10.1097/01.tp.0000206102.67063.24; Hussein YM, 2014, GENE, V536, P393, DOI 10.1016/j.gene.2013.11.042; Hutchinson IV, 1999, TRANSPL P, V31, p9S; Karasu Z, 2004, TRANSPLANT P, V36, P2791, DOI 10.1016/j.transproceed.2004.10.034; Kocierz M, 2011, TISSUE ANTIGENS, V77, P283, DOI 10.1111/j.1399-0039.2010.01623.x; Lacha J, 2005, TRANSPLANT P, V37, P764, DOI 10.1016/j.transproceed.2004.12.224; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lv RX, 2012, TRANSPL IMMUNOL, V26, P11, DOI 10.1016/j.trim.2011.10.003; MANTEL N, 1959, J NATL CANCER I, V22, P719; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morris-Stiff G, 2005, ANN ROY COLL SURG, V87, P326, DOI 10.1308/003588405X60533; Opelz G, 2008, TRANSPLANTATION, V85, P661, DOI 10.1097/TP.0b013e3181661695; Pakosz K, 2012, ANN TRANSPL, V17, P45; Pelletier R, 2000, TRANSPLANTATION, V70, P674, DOI 10.1097/00007890-200008270-00023; Perrey C, 1998, TRANSPL IMMUNOL, V6, P193, DOI 10.1016/S0966-3274(98)80045-2; Pribylova-Hribova P, 2006, KIDNEY INT, V69, P1872, DOI 10.1038/sj.ki.5000328; Seyhun Y, 2012, TRANSPL P, V44, P1670, DOI 10.1016/j.transproceed.2012.05.046; Seyhun Y, 2012, TRANSPL P, V44, P1241, DOI 10.1016/j.transproceed.2012.01.125; Shah R, 2006, HUM GENET, V119, P61, DOI 10.1007/s00439-005-0112-y; Stehlik J, 2012, J HEART LUNG TRANSPL, V31, P1052, DOI 10.1016/j.healun.2012.08.002; Suthanthiran M, 2000, P NATL ACAD SCI USA, V97, P3479, DOI 10.1073/pnas.050420897; Tambur AR, 2001, TRANSPLANTATION, V71, P1475, DOI 10.1097/00007890-200105270-00020; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Thurairajah PH, 2013, TRANSPLANTATION, V95, P955, DOI 10.1097/TP.0b013e3182845f6c; Tian Y, 2001, Zhonghua Yi Xue Za Zhi, V81, P719; Tian Ye, 2002, Zhonghua Wai Ke Za Zhi, V40, P256; Yamada Y, 1998, J BONE MINER RES, V13, P1569, DOI 10.1359/jbmr.1998.13.10.1569	46	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93938	10.1371/journal.pone.0093938	http://dx.doi.org/10.1371/journal.pone.0093938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705444	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500096
J	Jaberi-Douraki, M; Pietropaolo, M; Khadra, A				Jaberi-Douraki, Majid; Pietropaolo, Massimo; Khadra, Anmar			Predictive Models of Type 1 Diabetes Progression: Understanding T-Cell Cycles and Their Implications on Autoantibody Release	PLOS ONE			English	Article							CLASS-II TETRAMERS; AUTOIMMUNITY; IMMUNE; COMPETITION; ACTIVATION; IMMUNOLOGY; EPITOPES; RECEPTOR; IDENTIFICATION; PROLIFERATION	Defining the role of T-cell avidity and killing efficacy in forming immunological response(s), leading to relapse-remission and autoantibody release in autoimmune type 1 diabetes (T1D), remains incompletely understood. Using competition-based population models of T-and B-cells, we provide a predictive tool to determine how these two parametric quantities, namely, avidity and killing efficacy, affect disease outcomes. We show that, in the presence of T-cell competition, successive waves along with cyclic fluctuations in the number of T-cells are exhibited by the model, with the former induced by transient bistability and the latter by transient periodic orbits. We hypothesize that these two immunological processes are responsible for making T1D a relapsing-remitting disease within prolonged but limited durations. The period and the number of peaks of these two processes differ, making them potential candidates to determine how plausible waves and cyclic fluctuations are in producing such effects. By assuming that T-cell and B-cell avidities are correlated, we demonstrate that autoantibodies associated with the higher avidity T-cell clones are first to be detected, and they reach their detectability level faster than those associated with the low avidity clones, independent of what T-cell killing efficacies are. Such outcomes are consistent with experimental observations in humans and they provide a rationale for observing rapid and slow progressors of T1D in high risk subjects. Our analysis of the models also reveals that it is possible to improve disease outcomes by unexpectedly increasing the avidity of certain subclones of T-cells. The decline in the number of beta-cells in these cases still occurs, but it terminates early, leaving sufficient number of functioning beta-cells in operation and the affected individual asymptomatic. These results indicate that the models presented here are of clinical relevance because of their potential use in developing predictive algorithms of rapid and slow progression to clinical T1D.	[Jaberi-Douraki, Majid; Khadra, Anmar] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Pietropaolo, Massimo] Univ Michigan, Immunogenet Lab, Ann Arbor, MI 48109 USA	McGill University; University of Michigan System; University of Michigan	Khadra, A (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	anmar.khadra@mcgill.ca			National Institutes of Health [R01 DK53456, R01 DK56200, R21 DK073724]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK073724, R01DK056200, R01DK053456, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (grants R01 DK53456, R01 DK56200, and R21 DK073724). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HK, 2011, B MATH BIOL, V73, P33, DOI 10.1007/s11538-010-9519-2; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Arazi A, 2010, J THEOR BIOL, V267, P426, DOI 10.1016/j.jtbi.2010.08.033; Arazi A, 2013, SEMIN IMMUNOL, V25, P193, DOI 10.1016/j.smim.2012.11.003; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; BONIFACIO E, 1995, J IMMUNOL, V155, P5419; Borg H, 1997, CLIN CHEM, V43, P2358; Borghans JAM, 1999, P NATL ACAD SCI USA, V96, P10782, DOI 10.1073/pnas.96.19.10782; Delitala M, 2013, COMPUT MATH APPL, V66, P1010, DOI 10.1016/j.camwa.2013.06.026; DeNiro M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050360; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Galea I, 2012, EUR J IMMUNOL, V42, P256, DOI 10.1002/eji.201142010; Hawa M, 1997, DIABETES, V46, P1270, DOI 10.2337/diabetes.46.8.1270; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; James EA, 2009, J VISUALIZED EXPT JO; Janeway C., 2005, IMMUNOBIOLOGY IMMUNE; Kawasaki E, 2012, ENDOCR J, V59, P531, DOI 10.1507/endocrj.EJ12-0069; Khadra A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014796; Khadra A, 2009, J THEOR BIOL, V256, P126, DOI 10.1016/j.jtbi.2008.09.019; Lejeune O, 2008, MATH COMPUT MODEL, V47, P649, DOI 10.1016/j.mcm.2007.02.026; Liu Y, 2008, ANN NY ACAD SCI, V1150, P245, DOI 10.1196/annals.1447.035; Mahaffy JM, 2007, SIAM J APPL MATH, V67, P915, DOI 10.1137/060661144; Mallone R, 2005, BLOOD, V106, P2798, DOI 10.1182/blood-2004-12-4848; Maree AFM, 2006, INT IMMUNOL, V18, P1067, DOI 10.1093/intimm/dxl040; Margulies DH, 1997, CURR OPIN IMMUNOL, V9, P390, DOI 10.1016/S0952-7915(97)80086-6; Miao DM, 2007, FRONT BIOSCI-LANDMRK, V12, P1889, DOI 10.2741/2195; Morran MP, 2008, MT SINAI J MED, V75, P314, DOI 10.1002/msj.20052; Morran MP, 2010, ENDOCRINOLOGY, V151, P2528, DOI 10.1210/en.2009-1257; Nelson P, 2009, MATH BIOSCI ENG, V6, P753, DOI 10.3934/mbe.2009.6.753; Oling V, 2005, J AUTOIMMUN, V25, P235, DOI 10.1016/j.jaut.2005.09.018; Parham P, 2009, IMMUNE SYSTEM, V3rd; Peakman M, 1999, J CLIN INVEST, V104, P1449, DOI 10.1172/JCI7936; Peakman M, 2001, DIABETES, V50, P1749, DOI 10.2337/diabetes.50.8.1749; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Pietropaolo M, 2002, DIABETOLOGIA, V45, P66, DOI 10.1007/s125-002-8246-5; Pietropaolo M, 2008, DIABETES, V57, P2872, DOI 10.2337/db07-1691; Pietropaolo M, 2007, DIABETES, V56, P1189, DOI 10.2337/db06-0880; Pietropaolo M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012831; Reijonen H, 2002, DIABETES, V51, P1375, DOI 10.2337/diabetes.51.5.1375; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Scherer A, 2006, PLOS COMPUT BIOL, V2, P948, DOI 10.1371/journal.pcbi.0020109; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Standifer NE, 2006, DIABETES, V55, P3061, DOI 10.2337/db06-0066; Trudeau JD, 2003, J CLIN INVEST, V111, P217, DOI 10.1172/JCI200316409; Uibo R, 2008, ADV IMMUNOL, V100, P39, DOI 10.1016/S0065-2776(08)00803-1; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; Vendrame F, 2010, DIABETES, V59, P947, DOI 10.2337/db09-0498; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; von Herrath M, 2007, NAT REV IMMUNOL, V7, P988, DOI 10.1038/nri2192; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Wenzlau JM, 2008, ANN NY ACAD SCI, V1150, P256, DOI 10.1196/annals.1447.029	54	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93326	10.1371/journal.pone.0093326	http://dx.doi.org/10.1371/journal.pone.0093326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705439	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500031
J	Totrov, M				Totrov, Maxim			Estimated Secondary Structure Propensities within V1/V2 Region of HIV gp120 Are an Important Global Antibody Neutralization Sensitivity Determinant	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN TRIMER; VARIABLE REGIONS; VACCINE EFFICACY; AMINO-ACIDS; FREE-ENERGY; V2 DOMAIN; PROTEIN; LOOP; CONFORMATION	Background: Neutralization sensitivity of HIV-1 virus to antibodies and anti-sera varies greatly between the isolates. Significant role of V1/V2 domain as a global neutralization sensitivity regulator has been suggested. Recent X-ray structures revealed presence of well-defined tertiary structure within this domain but also demonstrated partial disorder and conformational heterogeneity. Methods: Correlations of neutralization sensitivity with the conformational propensities for beta-strand and alpha-helix formation over the entire folded V1/V2 domain as well as within sliding 5-residue window were investigated. Analysis was based on a set of neutralization data for 106 HIV isolates for which consistent neutralization sensitivity measurements against multiple pools of human immune sera have been previously reported. Results: Significant correlation between beta-sheet formation propensity of the folded segments of V1/V2 domain and neutralization sensitivity was observed. Strongest correlation peaks localized to the beta-strands B and C. Correlation persisted when subsets of HIV isolates belonging to clades B, C and circulating recombinant form BC where analyzed individually or in combinations. Conclusions: Observed correlations suggest that stability of the beta-sheet structure and/or degree of structural disorder in the V1/V2 domain is an important determinant of the global neutralization sensitivity of HIV-1 virus. While specific mechanism is to yet to be investigated, plausible hypothesis is that less ordered V1/V2s may have stronger masking effect on various neutralizing epitopes, perhaps effectively occupying larger volume and thereby occluding antibody access.	Molsoft LLC, San Diego, CA 92121 USA		Totrov, M (corresponding author), Molsoft LLC, San Diego, CA 92121 USA.	max@molsoft.com		totrov, maxim/0000-0001-8594-274X	NIAID [5P01AI100151]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100151] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a subcontract of the NIAID grant 5P01AI100151. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Abagyan R, 2013, ICM USER MANUAL; Cao J, 1997, J VIROL, V71, P9808, DOI 10.1128/JVI.71.12.9808-9812.1997; Ching LK, 2008, J VIROL, V82, P949, DOI 10.1128/JVI.02143-07; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Cohen J., 2003, APPL MULTIPLE REGRES; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Edgington E.S., 2007, RANDOMIZATION TESTS; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Haim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002101; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; Krachmarov CP, 2006, J VIROL, V80, P7127, DOI 10.1128/JVI.02619-05; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Liu L, 2011, P NATL ACAD SCI USA, V108, P20148, DOI 10.1073/pnas.1104840108; Magnus C, 2013, J IMMUNOL METHODS; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; Mayr LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070859; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; MUNOZ V, 1995, J MOL BIOL, V245, P275, DOI 10.1006/jmbi.1994.0023; Nakamura GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039045; NEMETHY G, 1966, J PHYS CHEM-US, V70, P998, DOI 10.1021/j100876a008; O'Rourke SM, 2012, J VIROL, V86, P12105, DOI 10.1128/JVI.01352-12; O'Rourke SM, 2010, J VIROL, V84, P11200, DOI 10.1128/JVI.00790-10; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Rusert P, 2011, J EXP MED, V208, P1419, DOI 10.1084/jem.20110196; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; SMITH CK, 1994, BIOCHEMISTRY-US, V33, P5510, DOI 10.1021/bi00184a020; Stamatatos L, 1998, J VIROL, V72, P7840, DOI 10.1128/JVI.72.10.7840-7845.1998; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang J, 1996, J AM CHEM SOC, V118, P995, DOI 10.1021/ja953347o; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WILLIAMS RW, 1987, BIOCHIM BIOPHYS ACTA, V916, P200, DOI 10.1016/0167-4838(87)90109-9; WYATT R, 1993, J VIROL, V67, P4557, DOI 10.1128/JVI.67.8.4557-4565.1993; Xue B, 2012, CELL MOL LIFE SCI, V69, P1211, DOI 10.1007/s00018-011-0859-3; Xue B, 2010, PROTEIN PEPTIDE LETT, V17, P932, DOI 10.2174/092986610791498984; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	47	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94002	10.1371/journal.pone.0094002	http://dx.doi.org/10.1371/journal.pone.0094002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705879	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500108
J	Villumsen, KR; Neumann, L; Ohtani, M; Strom, HK; Raida, MK				Villumsen, Kasper Romer; Neumann, Lukas; Ohtani, Maki; Strom, Helene Kragelund; Raida, Martin Kristian			Oral and Anal Vaccination Confers Full Protection against Enteric Redmouth Disease (ERM) in Rainbow Trout	PLOS ONE			English	Article							ONCORHYNCHUS-MYKISS WALBAUM; YERSINIA-RUCKERI BACTERINS; SALMO-GAIRDNERI RICHARDSON; RED MOUTH-DISEASE; VIBRIO-ANGUILLARUM; BIOTYPE 2; GENE-EXPRESSION; IMMUNE-RESPONSE; ANTIGEN UPTAKE; TELEOST FISH	The effect of oral vaccines against bacterial fish diseases has been a topic for debate for decades. Recently both M-like cells and dendritic cells have been discovered in the intestine of rainbow trout. It is therefore likely that antigens reaching the intestine can be taken up and thereby induce immunity in orally vaccinated fish. The objective of this project was to investigate whether oral and anal vaccination of rainbow trout induces protection against an experimental waterborne infection with the pathogenic enterobacteria Yersinia ruckeri O1 biotype 1 the causative agent of enteric redmouth disease (ERM). Rainbow trout were orally vaccinated with AquaVac ERM Oral (MERCK Animal Health) or an experimental vaccine bacterin of Y. ruckeri O1. Both vaccines were tested with and without a booster vaccination four months post the primary vaccination. Furthermore, two groups of positive controls were included, one group receiving the experimental oral vaccine in a 50 times higher dose, and the other group receiving a single dose administered anally in order to bypass the stomach. Each group was bath challenged with 6.3X10(8) CFU/ml Y. ruckeri, six months post the primary vaccination. The challenge induced significant mortality in all the infected groups except for the groups vaccinated anally with a single dose or orally with the high dose of bacterin. Both of these groups had 100% survival. These results show that a low dose of Y. ruckeri bacterin induces full protection when the bacterin is administered anally. Oral vaccination also induces full protection, however, at a dose 50 times higher than if the fish were to be vaccinated anally. This indicates that much of the orally fed antigen is digested in the stomach before it reaches the second segment of the intestine where it can be taken up as immunogenic antigens and presented to lymphocytes.	[Villumsen, Kasper Romer; Neumann, Lukas; Ohtani, Maki; Strom, Helene Kragelund; Raida, Martin Kristian] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Res Grp Fish Dis & Immunol,Sect Vet Clin Microbio, Copenhagen, Denmark	University of Copenhagen	Raida, MK (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Res Grp Fish Dis & Immunol,Sect Vet Clin Microbio, Copenhagen, Denmark.	mr@sund.ku.dk	Villumsen, Kasper Rømer/L-2471-2019	Villumsen, Kasper Rømer/0000-0002-0616-4095	Danish Research Council [11-105095]	Danish Research Council(Det Frie Forskningsrad (DFF))	This work was funded by a Sapere Aude Grant 11-105095 from the Danish Research Council, entitled: "Understanding Key Mechanisms in Mucosal Immunity: Development of a New Immersion Vaccine''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEND DF, 1983, J FISH DIS, V6, P337, DOI 10.1111/j.1365-2761.1983.tb00085.x; ANDERSON DP, 1972, PROG FISH CULT, V34, P226, DOI 10.1577/1548-8659(1972)34[226:CSOHRD]2.0.CO;2; ANDERSON DP, 1974, J FISH RES BOARD CAN, V31, P214, DOI 10.1139/f74-035; ANTIPA R, 1980, J FISH DIS, V3, P161, DOI 10.1111/j.1365-2761.1980.tb00199.x; Arias CR, 2007, J AQUAT ANIM HEALTH, V19, P35, DOI 10.1577/H06-011.1; Austin DA, 2003, SYST APPL MICROBIOL, V26, P127, DOI 10.1078/072320203322337416; Bullock G.L., 1984, ENTERIC REDMOUTH DIS; BUSCH RA, 1978, MAR FISH REV, V40, P42; BUSCH RA, 1975, J FISH RES BOARD CAN, V32, P2429, DOI 10.1139/f75-279; Cagirgan H, 1998, J APPL ICHTHYOL, V14, P239, DOI 10.1111/j.1439-0426.1998.tb00649.x; Cain KD, 2000, FISH SHELLFISH IMMUN, V10, P651, DOI 10.1006/fsim.2000.0280; Chettri JK, 2012, DEV COMP IMMUNOL, V36, P463, DOI 10.1016/j.dci.2011.08.014; Chettri JK, 2013, VET IMMUNOL IMMUNOP, V154, P42, DOI 10.1016/j.vetimm.2013.04.001; DAVIDSON GA, 1993, DEV COMP IMMUNOL, V17, P373, DOI 10.1016/0145-305X(93)90008-E; Deshmukh S, 2012, VET IMMUNOL IMMUNOP, V145, P379, DOI 10.1016/j.vetimm.2011.12.014; Duff DCB, 1942, J IMMUNOL, V44, P87; Evenhuis JP, 2014, DEV COMP IMMUNOL, V44, P145, DOI 10.1016/j.dci.2013.12.004; Evenhuis JP, 2012, VET IMMUNOL IMMUNOP, V146, P8, DOI 10.1016/j.vetimm.2012.01.008; EWING WH, 1978, INT J SYST BACTERIOL, V28, P37, DOI 10.1099/00207713-28-1-37; Fouz B, 2006, J FISH DIS, V29, P339, DOI 10.1111/j.1365-2761.2006.00723.x; Fuglem B, 2010, DEV COMP IMMUNOL, V34, P768, DOI 10.1016/j.dci.2010.02.007; GEORGOPOULOU U, 1986, DEV COMP IMMUNOL, V10, P529, DOI 10.1016/0145-305X(86)90174-6; Gravningen K, 1998, J APPL ICHTHYOL, V14, P163, DOI 10.1111/j.1439-0426.1998.tb00636.x; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Horne MT, 1999, FISH DISEASES AND DISORDERS, VOL 3, P455; JOBLING M, 1981, J FISH BIOL, V19, P439, DOI 10.1111/j.1095-8649.1981.tb05847.x; JOHNSON KA, 1983, J FISH DIS, V6, P331, DOI 10.1111/j.1365-2761.1983.tb00084.x; JOHNSON KA, 1983, J FISH DIS, V6, P473, DOI 10.1111/j.1365-2761.1983.tb00101.x; Khimmakthong U, 2013, MICROB PATHOGENESIS, V59-60, P33, DOI 10.1016/j.micpath.2013.03.001; Merck-animal-health, 2014, AQUAVAC ERM OR; Newman Stephen G., 1993, Annual Review of Fish Diseases, V3, P145, DOI 10.1016/0959-8030(93)90033-8; Plant KP, 2011, DEV COMP IMMUNOL, V35, P1256, DOI 10.1016/j.dci.2011.03.007; Press CM, 1996, J FISH DIS, V19, P215, DOI 10.1111/j.1365-2761.1996.tb00128.x; Raida MK, 2008, VACCINE, V26, P1050, DOI 10.1016/j.vaccine.2007.12.029; Raida MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018832; Raida MK, 2008, FISH SHELLFISH IMMUN, V25, P533, DOI 10.1016/j.fsi.2008.07.008; ROBOHM RA, 1986, DEV COMP IMMUNOL, V10, P145; ROSS AJ, 1965, J FISH RES BOARD CAN, V22, P713, DOI 10.1139/f65-063; ROSS AJ, 1966, CAN J MICROBIOL, V12, P763, DOI 10.1139/m66-103; Ruckner R. R., 1966, Bulletin Office International des Epizooties, V65, P825; Salinas I, 2011, DEV COMP IMMUNOL, V35, P1346, DOI 10.1016/j.dci.2011.11.009; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Stevenson RMW, 1997, DEV BIOLOGICALS, V90, P117; TATNER MF, 1987, AQUACULTURE, V62, P173, DOI 10.1016/0044-8486(87)90164-5; TATNER MF, 1984, AQUACULTURE, V41, P193, DOI 10.1016/0044-8486(84)90282-5; Tebbit G. L., 1981, Developments in Biological Standardization, V49, P395; Tobar JA, 2011, VACCINE, V29, P2336, DOI 10.1016/j.vaccine.2010.12.107; Tobback E, 2007, J FISH DIS, V30, P257, DOI 10.1111/j.1365-2761.2007.00816.x; Tobback E, 2010, DIS AQUAT ORGAN, V90, P175, DOI 10.3354/dao02230; Vandenberg Grant W., 2004, Animal Health Research Reviews, V5, P301, DOI 10.1079/AHR200488; Welch TJ, 2011, APPL ENVIRON MICROB, V77, P3493, DOI 10.1128/AEM.02997-10; Wheeler RW, 2009, DIS AQUAT ORGAN, V84, P25, DOI 10.3354/dao02039; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913	53	33	33	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93845	10.1371/journal.pone.0093845	http://dx.doi.org/10.1371/journal.pone.0093845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705460	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500077
J	Wu, Z; Zhou, Q; Duan, HY; Wang, XR; Xiao, JH; Duan, HC; Li, NY; Li, CY; Wan, PX; Liu, Y; Song, YY; Zhou, CJ; Huang, ZQ; Wang, ZC				Wu, Zheng; Zhou, Qiang; Duan, Haoyun; Wang, Xiaoran; Xiao, Jianhui; Duan, Hucheng; Li, Naiyang; Li, Chaoyang; Wan, Pengxia; Liu, Ying; Song, Yiyue; Zhou, Chenjing; Huang, Zheqian; Wang, Zhichong			Reconstruction of Auto-Tissue-Engineered Lamellar Cornea by Dynamic Culture for Transplantation: A Rabbit Model	PLOS ONE			English	Article							LIMBAL EPITHELIAL-CELLS; OCULAR SURFACE; REGENERATIVE MEDICINE; STROMA; SCAFFOLD; MATRIX; COLLAGEN; SHEETS; GEL; DIFFERENTIATION	To construct an auto-tissue-engineered lamellar cornea (ATELC) for transplantation, based on acellular porcine corneal stroma and autologous corneal limbal explants, a dynamic culture process, which composed of a submersion culture, a perfusion culture and a dynamic air-liquid interface culture, was performed using appropriate parameters. The results showed that the ATELC-Dynamic possessed histological structure and DNA content that were similar to native lamellar cornea (NLC, p>0.05). Compared to NLC, the protein contents of zonula occludens-1, desmocollin-2 and integrin beta 4 in ATELC-Dynamic reached 93%, 89% and 73%, respectively. The basal cells of ATELC-Dynamic showed a better differentiation phenotype (K3(-), P63(+), ABCG2(+)) compared with that of ATELC in static air-lift culture (ATELC-Static, K3(+), P63(-), ABCG2(-)). Accordingly, the cell-cloning efficiency of ATELC-Dynamic (9.72 +/- 3.5%) was significantly higher than that of ATELC-Static (2.13 +/- 1.46%, p<0.05). The levels of trans-epithelial electrical resistance, light transmittance and areal modulus variation in ATELC-Dynamic all reached those of NLC (p>0.05). Rabbit lamellar keratoplasty showed that the barrier function of ATELC-Dynamic was intact, and there were no signs of epithelial shedding or neovascularization. Furthermore, the ATELC-Dynamic group had similar optical properties and wound healing processes compared with the NLC group. Thus, the sequential dynamic culture process that was designed according to corneal physiological characteristics could successfully reconstruct an auto-lamellar cornea with favorable morphological characteristics and satisfactory physiological function.	[Wu, Zheng; Zhou, Qiang; Duan, Haoyun; Wang, Xiaoran; Xiao, Jianhui; Duan, Hucheng; Li, Naiyang; Li, Chaoyang; Wan, Pengxia; Liu, Ying; Song, Yiyue; Zhou, Chenjing; Huang, Zheqian; Wang, Zhichong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Wang, ZC (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	wzc001@hotmail.com	Li, Chao/GSM-8117-2022; zhou, qiang/AAJ-7571-2020	Li, Chao/0000-0001-6110-6210; 	National High Technology Research and Development Program of China (863 Project) [2012AA020507]; National Natural Science Foundation of China [81270971, 31000445]; Guangdong Province & Ministry of Education Industry-University-Research Institute Collaboration Project of China [2011B090400353]; Fundamental Research Funds of State Key Laboratory of Ophthalmology [2012PI05, 2010Q02]	National High Technology Research and Development Program of China (863 Project)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province & Ministry of Education Industry-University-Research Institute Collaboration Project of China; Fundamental Research Funds of State Key Laboratory of Ophthalmology	This work was supported by grant No. 2012AA020507 (Z. Wang) from the National High Technology Research and Development Program of China (863 Project), grant No. 81270971 (Z. Wang) from the National Natural Science Foundation of China, grant No. 2011B090400353 (Z. Wang) from Guangdong Province & Ministry of Education Industry-University-Research Institute Collaboration Project of China, grant No. 31000445 (Z. Wu) from the National Natural Science Foundation of China, grant No. 2012PI05 (Z. Wang) and No. 2010Q02 (Z. Wu) from the Fundamental Research Funds of State Key Laboratory of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cattan V, 2011, EUR UROL, V60, P1291, DOI 10.1016/j.eururo.2011.05.051; Chen B, 2010, TISSUE ENG PT A, V16, P2721, DOI 10.1089/ten.tea.2009.0711; Das S, 2007, CORNEA, V26, P526, DOI 10.1097/ICO.0b013e318038d2e8; Deng C, 2010, ACTA BIOMATER, V6, P187, DOI 10.1016/j.actbio.2009.07.027; Dua HS, 2010, CLIN EXP OPHTHALMOL, V38, P104, DOI 10.1111/j.1442-9071.2010.02229.x; Fagerholm P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001022; Gonzalez-Andrades M, 2009, J TISSUE ENG REGEN M, V3, P442, DOI 10.1002/term.178; Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169; Griffith M, 2009, EYE, V23, P1985, DOI 10.1038/eye.2008.409; Han ES, 2007, GRAEF ARCH CLIN EXP, V245, P745, DOI 10.1007/s00417-006-0453-9; Hashimoto Y, 2010, BIOMATERIALS, V31, P3941, DOI 10.1016/j.biomaterials.2010.01.122; Hayashi R, 2010, TISSUE ENG PART C-ME, V16, P553, DOI [10.1089/ten.tec.2009.0277, 10.1089/ten.TEC.2009.0277]; Huang MH, 2011, BIOMATERIALS, V32, P7812, DOI 10.1016/j.biomaterials.2011.07.012; Jayasuriya AC, 2003, BIOSENS BIOELECTRON, V18, P381, DOI 10.1016/S0956-5663(02)00144-6; Ke QC, 2011, J TISSUE ENG REGEN M, V5, P138, DOI 10.1002/term.298; Lin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049571; Liu JB, 2007, EXP EYE RES, V84, P599, DOI 10.1016/j.exer.2006.11.014; Liu JB, 2012, INVEST OPHTH VIS SCI, V53, P4130, DOI 10.1167/iovs.12-9876; Liu Y, 2010, TISSUE ENG PART C-ME, V16, P793, DOI [10.1089/ten.tec.2009.0380, 10.1089/ten.TEC.2009.0380]; Liu Z, 2012, BIOMATERIALS, V33, P7336, DOI 10.1016/j.biomaterials.2012.06.080; Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015; Meek KM, 2003, EYE, V17, P927, DOI 10.1038/sj.eye.6700574; Meek KM, 2003, BIOPHYS J, V85, P2205, DOI 10.1016/S0006-3495(03)74646-3; Mi SL, 2010, TISSUE ENG PT A, V16, P2091, DOI 10.1089/ten.TEA.2009.0748; Mi SL, 2010, J BIOMED MATER RES A, V95A, P447, DOI 10.1002/jbm.a.32861; MINAMI Y, 1993, INVEST OPHTH VIS SCI, V34, P2316; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Pang KP, 2010, BIOMATERIALS, V31, P7257, DOI 10.1016/j.biomaterials.2010.05.066; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Shafiq MA, 2012, TISSUE ENG PART C-ME, V18, P340, DOI [10.1089/ten.tec.2011.0072, 10.1089/ten.TEC.2011.0072]; Sitalakshmi G, 2009, TISSUE ENG PT A, V15, P407, DOI 10.1089/ten.tea.2008.0041; Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Tseng SCG, 1996, CURR EYE RES, V15, P973, DOI 10.3109/02713689609017643; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Wu Z, 2009, BIOMATERIALS, V30, P3513, DOI 10.1016/j.biomaterials.2009.03.003; Xiao JH, 2011, BIOMATERIALS, V32, P6962, DOI 10.1016/j.biomaterials.2011.05.084; Zhang W, 2011, TISSUE ENG PART C-ME, V17, P569, DOI [10.1089/ten.TEC.2010.0529, 10.1089/ten.tec.2010.0529]; Zhu J, 2013, TISSUE ENG PT A, V19, P2412, DOI [10.1089/ten.tea.2013.0097, 10.1089/ten.TEA.2013.0097]	40	22	23	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93012	10.1371/journal.pone.0093012	http://dx.doi.org/10.1371/journal.pone.0093012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705327	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500025
J	Zhu, FR; Zheng, YJ; Ding, YQ; Liu, Y; Zhang, XH; Wu, RR; Guo, XF; Zhao, JP				Zhu, Furong; Zheng, Yingjun; Ding, Yu-qiang; Liu, Yong; Zhang, Xianghui; Wu, Renrong; Guo, Xiaofeng; Zhao, Jingping			Minocycline and Risperidone Prevent Microglia Activation and Rescue Behavioral Deficits Induced by Neonatal Intrahippocampal Injection of Lipopolysaccharide in Rats	PLOS ONE			English	Article							IN-VITRO; SCHIZOPHRENIA; MICE; NEUROINFLAMMATION; MODEL; METHAMPHETAMINE; HYPERLOCOMOTION	Background: Various signs of activation of microglia have been reported in schizophrenia, and it is hypothesized that microglia activation is closely associated with the neuropathology of schizophrenia. Methods: Neonatal intrahippocampal injection of lipopolysaccharide (LPS), an activator of microglia, was performed in rats at postnatal day 7 (P7), and they were separately given saline, risperidone (0.5 mg/kg), minocycline (40 mg/kg) or a combination of both of them at P42 for consecutive 14 days. Behavioral changes ( locomotion activity, social interaction, novel object recognition and prepulse inhibition) were examined and the number of microglia was assessed by using immunohistochemistry in adulthood. Results: The adult rats in LPS-injected group showed obvious behavioral alteration ( e. g. deficits in social interaction, novel object recognition and prepulse inhibition) and a dramatic increase of number of activated microglial cells in the hippocampus and other brain regions such as cerebral cortex and thalamus compared to those in saline-injected group. Interestingly, application of either minocycline, risperidone or both of them significantly rescued behavioral deficits and attenuated microglia activation. Conclusion: Our results suggest that inhibition of microglia activation may be one of mechanisms underlying the antipsychotic effect of minocycline and risperidone.	[Zhu, Furong; Zheng, Yingjun; Ding, Yu-qiang; Liu, Yong; Zhang, Xianghui; Wu, Renrong; Guo, Xiaofeng; Zhao, Jingping] Cent S Univ, Key Lab Psychiat & Mental Hlth Hunan Prov, Natl Technol Inst Psychiat, Xiangya Hosp 2,Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Zheng, Yingjun] Guangzhou Med Univ, Affiliated Hosp, Guangzhou Brain Hosp, Dept Gen Psychiat, Guangzhou, Guangdong, Peoples R China; [Ding, Yu-qiang] Tongji Univ, Sch Med, Dept Anat & Neurobiol, Shanghai 200092, Peoples R China	Central South University; Guangzhou Medical University; Tongji University	Zhao, JP (corresponding author), Cent S Univ, Key Lab Psychiat & Mental Hlth Hunan Prov, Natl Technol Inst Psychiat, Xiangya Hosp 2,Mental Hlth Inst, Changsha, Hunan, Peoples R China.	zhaojingpingcsu@163.com	zhao, jing/B-3868-2019	Ding, Yu-Qiang/0000-0003-1202-4635	Natural Science Foundation of China (NSFC) [81071093]; National Research and Development Program for Health Professions [201002003]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Research and Development Program for Health Professions	The present study was supported by Natural Science Foundation of China (NSFC, 81071093), National Research and Development Program for Health Professions (Project No. 201002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amann LC, 2010, BRAIN RES BULL, V83, P147, DOI 10.1016/j.brainresbull.2010.04.008; Bayer TA, 1999, NEUROSCI LETT, V271, P126, DOI 10.1016/S0304-3940(99)00545-5; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Chaves C, 2009, BRAZ J MED BIOL RES, V42, P1002, DOI 10.1590/S0100-879X2009001100002; Feleder C, 2010, BIOL PSYCHIAT, V67, P386, DOI 10.1016/j.biopsych.2009.09.028; Fujita Y, 2008, PROG NEURO-PSYCHOPH, V32, P336, DOI 10.1016/j.pnpbp.2007.08.031; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Jhamnani K, 2013, J NEUROPSYCH CLIN N, V25, pE6, DOI 10.1176/appi.neuropsych.11120376; Kato T, 2007, SCHIZOPHR RES, V92, P108, DOI 10.1016/j.schres.2007.01.019; Kato TA, 2011, SCHIZOPHR RES, V129, P172, DOI 10.1016/j.schres.2011.03.019; Lee M, 2013, CURR PROTEIN PEPT SC, V14, P21, DOI 10.2174/1389203711314010005; Lee SY, 2010, NEUROCHEM INT, V57, P600, DOI 10.1016/j.neuint.2010.07.008; Levkovitz Y, 2010, J CLIN PSYCHIAT, V71, P138, DOI 10.4088/JCP.08m04666yel; MacDowell KS, 2013, INT J NEUROPSYCHOPH, V16, P121, DOI 10.1017/S1461145711001775; Manitz MP, 2013, SCHIZOPHR RES, V143, P221, DOI 10.1016/j.schres.2012.10.028; Mizoguchi H, 2008, PSYCHOPHARMACOLOGY, V196, P233, DOI 10.1007/s00213-007-0955-0; Monji A, 2013, PROG NEURO-PSYCHOPH, V42, P115, DOI 10.1016/j.pnpbp.2011.12.002; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Radewicz K, 2000, J NEUROPATH EXP NEUR, V59, P137, DOI 10.1093/jnen/59.2.137; Ratnayake U, 2012, BRAIN BEHAV IMMUN, V26, P1288, DOI 10.1016/j.bbi.2012.08.011; Richtand NM, 2011, J PSYCHIATR RES, V45, P1194, DOI 10.1016/j.jpsychires.2011.02.007; SamsDodd F, 1997, PSYCHOPHARMACOLOGY, V132, P303, DOI 10.1007/s002130050349; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Tseng KY, 2009, BEHAV BRAIN RES, V204, P295, DOI 10.1016/j.bbr.2008.11.039; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; van Berckel BN, 2008, BIOL PSYCHIAT, V64, P820, DOI 10.1016/j.biopsych.2008.04.025; Zhang L, 2007, NEUROPSYCHOPHARMACOL, V32, P2004, DOI 10.1038/sj.npp.1301313; Zhang L, 2006, PROG NEURO-PSYCHOPH, V30, P1381, DOI 10.1016/j.pnpbp.2006.05.015	29	67	69	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93966	10.1371/journal.pone.0093966	http://dx.doi.org/10.1371/journal.pone.0093966			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705495	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500098
J	Ahn, JH; Yu, HK; Lee, HJ; Hong, SW; Kim, SJ; Kim, JS				Ahn, Jin-Hyung; Yu, Hyun-Kyung; Lee, Ho-Jeong; Hong, Soon Won; Kim, Sun Jin; Kim, Jang-Seong			Suppression of Colorectal Cancer Liver Metastasis by Apolipoprotein(a) Kringle V in a Nude Mouse Model through the Induction of Apoptosis in Tumor-Associated Endothelial Cells	PLOS ONE			English	Article							HUMAN PLASMINOGEN KRINGLE-5; HUMAN PROSTATE-CANCER; SURGICAL RESECTION; IN-VITRO; ANGIOGENESIS; THERAPY; GROWTH; CARCINOMA; MICE; ANGIOSTATIN	The formation of liver metastases in colorectal cancer patients is the primary cause of patient death. Current therapies directed at liver metastasis from colorectal cancer have had minimal impact on patient outcomes. Therefore, the development of alternative treatment strategies for liver metastasis is needed. In the present study, we demonstrated that recombinant human apolipoprotein(a) kringle V, also known as rhLK8, induced the apoptotic turnover of endothelial cells in vitro through the mitochondrial apoptosis pathway. The interaction of rhLK8 with glucose-regulated protein 78 (GRP78) may be involved in the induction of apoptosis because the inhibition of GRP78 by GRP78-specific antibodies or siRNA knockdown inhibited the rhLK8-mediated apoptosis of human umbilical vein endothelial cells in vitro. Next, to evaluate the effects of rhLK8 on angiogenesis and metastasis, an experimental model of liver metastasis was established by injecting a human colorectal cancer cell line, LS174T, into the spleens of BALB/c nude mice. The systemic administration of rhLK8 significantly suppressed liver metastasis from human colorectal cancer cells and improved host survival compared with controls. The combination of rhLK8 and 5-fluorouracil substantially increased these survival benefits compared with either therapy alone. Histological observation showed significant induction of apoptosis among tumor-associated endothelial cells in liver metastases from rhLK8-treated mice compared with control mice. Collectively, these results suggest that the combination of rhLK8 with conventional chemotherapy may be a promising approach for the treatment of patients with life-threatening colorectal cancer liver metastases.	[Ahn, Jin-Hyung; Yu, Hyun-Kyung; Lee, Ho-Jeong; Kim, Jang-Seong] Mogam Biotechnol Res Inst, Canc Biol Team, Yongin, South Korea; [Hong, Soon Won] Yonsei Univ, Gangnam Sevrance Hosp, Dept Pathol, Seoul 120749, South Korea; [Lee, Ho-Jeong; Kim, Sun Jin] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Kim, Jang-Seong] Korea Res Inst Biosci & Biotechnol, Res Ctr Integrat Cellul, Taejon, South Korea	Yonsei University; University of Texas System; UTMD Anderson Cancer Center; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, SJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	sunkim@mdanderson.org; jangskim@kribb.re.kr		Hong, SoonWon/0000-0002-0324-2414	Green Cross Corporation; Ministry for Health, Welfare and Family Affairs, Republic of Korea [A050905]; KRIBB Research Initiative Program; National Research Foundation of Korea; Ministry of Education, Science and Technology [2012R1A1A2007994]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Green Cross Corporation; Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); KRIBB Research Initiative Program; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was financially supported by the Green Cross Corporation, a grant from the Korea Health 21 R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A050905), a grant from the KRIBB Research Initiative Program, and by a Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2012R1A1A2007994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao YH, 1997, J BIOL CHEM, V272, P22924, DOI 10.1074/jbc.272.36.22924; Cao Yihai, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P667, DOI 10.2174/1568011023353705; Chambers AF, 2000, ADV CANCER RES, V79, P91, DOI 10.1016/S0065-230X(00)79003-8; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chavakis E, 2002, ARTERIOSCL THROM VAS, V22, P887, DOI 10.1161/01.ATV.0000017728.55907.A9; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; Eberhard A, 2000, CANCER RES, V60, P1388; Fan JK, 2008, BIOCHEM BIOPH RES CO, V374, P198, DOI 10.1016/j.bbrc.2008.07.005; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Gerber HP, 2005, CANCER RES, V65, P671; Gu XQ, 2011, APOPTOSIS, V16, P846, DOI 10.1007/s10495-011-0618-9; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; HOBSON B, 1984, BRIT J CANCER, V49, P405, DOI 10.1038/bjc.1984.66; Hofmeister V, 2008, CANCER IMMUNOL IMMUN, V57, P1, DOI 10.1007/s00262-007-0365-5; Huang GC, 2008, CANCER BIOTHER RADIO, V23, P661, DOI 10.1089/cbr.2008.0492; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Ji WDR, 1998, FASEB J, V12, P1731, DOI 10.1096/fasebj.12.15.1731; Jin GH, 2007, INT J CANCER, V121, P2539, DOI 10.1002/ijc.22708; Jung YD, 2000, CANCER METAST REV, V19, P147, DOI 10.1023/A:1026510130114; Kang KY, 2006, BIOSCI BIOTECH BIOCH, V70, P916, DOI 10.1271/bbb.70.916; Katsouras CS, 2001, J CARDIOVASC RISK, V8, P311, DOI 10.1097/00043798-200110000-00011; Kim JS, 2004, BIOCHEM BIOPH RES CO, V313, P534, DOI 10.1016/j.bbrc.2003.11.148; Kim JS, 2003, J BIOL CHEM, V278, P29000, DOI 10.1074/jbc.M301042200; Kim SJ, 2004, CANCER RES, V64, P4201, DOI 10.1158/0008-5472.CAN-03-3763; Lee HJ, 2012, NEOPLASIA, V14, P335, DOI 10.1593/neo.12380; Lee TH, 2006, J BIOTECHNOL, V126, P562, DOI 10.1016/j.jbiotec.2006.05.011; Li YH, 2008, CANCER BIOTHER RADIO, V23, P332, DOI 10.1089/cbr.2007.0437; Lorenz M, 2000, SEMIN ONCOL, V27, P112; Lucas R, 1998, BLOOD, V92, P4730; Ma J, 2008, MOL CANCER THER, V7, P3670, DOI 10.1158/1535-7163.MCT-08-0715; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Midgley R, 1999, LANCET, V353, P391, DOI 10.1016/S0140-6736(98)07127-X; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; Mow BMF, 2001, CURR OPIN ONCOL, V13, P453, DOI 10.1097/00001622-200111000-00007; Nguyen TMB, 2007, BLOOD, V109, P4793, DOI 10.1182/blood-2006-11-059352; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; Perri SR, 2007, MOL CANCER THER, V6, P441, DOI 10.1158/1535-7163.MCT-06-0434; Perri SR, 2005, CANCER RES, V65, P8359, DOI 10.1158/0008-5472.CAN-05-0508; Pijpers AHJM, 2001, J AM SOC NEPHROL, V12, P767, DOI 10.1681/ASN.V124767; SCHEELE J, 1990, BRIT J SURG, V77, P1241, DOI 10.1002/bjs.1800771115; Schulter V, 2001, ARTERIOSCL THROM VAS, V21, P433, DOI 10.1161/01.ATV.21.3.433; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Takeda A, 2002, ANN SURG ONCOL, V9, P610, DOI 10.1245/aso.2002.9.7.610; Trieu VN, 1999, BIOCHEM BIOPH RES CO, V257, P714, DOI 10.1006/bbrc.1999.0519; Velde ET, 2005, BRIT J CANCER, V92, P729, DOI 10.1038/sj.bjc.6602385; Yang Y, 2006, CANCER BIOL THER, V5, P399	50	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93794	10.1371/journal.pone.0093794	http://dx.doi.org/10.1371/journal.pone.0093794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699568	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000107
J	Cordova, C; Gutierrez, B; Martinez-Garcia, C; Martin, R; Gallego-Munoz, P; Hernandez, M; Nieto, ML				Cordova, Claudia; Gutierrez, Beatriz; Martinez-Garcia, Carmen; Martin, Ruben; Gallego-Munoz, Patricia; Hernandez, Marita; Nieto, Maria L.			Oleanolic Acid Controls Allergic and Inflammatory Responses in Experimental Allergic Conjunctivitis	PLOS ONE			English	Article							EPITHELIAL-CELLS; MURINE MODEL; MAST-CELLS; EXPRESSION; INTERLEUKIN-13; IL-13; HYPERSENSITIVITY; CHEMOATTRACTANT; DEGRANULATION; TRITERPENES	Pollen is the most common aeroallergen to cause seasonal conjunctivitis. The result of allergen exposure is a strong Th2-mediated response along with conjunctival mast cell degranulation and eosinophilic infiltration. Oleanolic acid (OA) is natural a triterpene that displays strong anti-inflammatory and immunomodulatory properties being an active anti-allergic molecule on hypersensitivity reaction models. However, its effect on inflammatory ocular disorders including conjunctivits, has not yet been addressed. Hence, using a Ragweed pollen (RWP)-specific allergic conjunctivitis (EAC) mouse model we study here whether OA could modify responses associated to allergic processes. We found that OA treatment restricted mast cell degranulation and infiltration of eosinophils in conjunctival tissue and decreased allergen-specific Igs levels in EAC mice. Th2-type cytokines, secreted phospholipase A(2) type-IIA (sPLA(2)-IIA), and chemokines levels were also significantly diminished in the conjunctiva and serum of OA-treated EAC mice. Moreover, OA treatment also suppressed RWP-specific T-cell proliferation. In vitro studies, on relevant cells of the allergic process, revealed that OA reduced the proliferative and migratory response, as well as the synthesis of proinflammatory mediators on EoL-1 eosinophils and RBL-2H3 mast cells exposed to allergic and/or crucial inflammatory stimuli such as RWP, sPLA(2)-IIA or eotaxin. Taken together, these findings demonstrate the beneficial activity of OA in ocular allergic processes and may provide a new intervention strategy and potential therapy for allergic diseases.	[Cordova, Claudia; Gutierrez, Beatriz; Hernandez, Marita; Nieto, Maria L.] Univ Valladolid, Consejo Super Invest Cient, Inst Biol & Genet Mol, Valladolid, Spain; [Martinez-Garcia, Carmen; Gallego-Munoz, Patricia] Univ Valladolid, Dept Biol Celular Histol & Farmacol, Valladolid, Spain; [Martin, Ruben] Hosp Clin Univ, Inst Ciencias Corazon, Valladolid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Universidad de la Laguna	Nieto, ML (corresponding author), Univ Valladolid, Consejo Super Invest Cient, Inst Biol & Genet Mol, Valladolid, Spain.	mlnieto@ibgm.uva.es	Nieto, Maria L/G-7492-2015; Martinez, Carmen/G-7166-2017; hernández, marita/H-6122-2015; Muñoz, Patricia Gallego/AAB-6111-2019	Nieto, Maria L/0000-0001-6842-799X; Martinez, Carmen/0000-0002-9533-6169; hernández, marita/0000-0002-3999-5653; Muñoz, Patricia Gallego/0000-0002-1826-8123; Cordova Marcos, Claudia/0000-0002-2108-2629	Spanish MINECO [SAF2009-08407]; FPI Program from the Government of Castilla y Leon; FSE; Sara Borrell Program from the Spanish MINECO	Spanish MINECO(Spanish Government); FPI Program from the Government of Castilla y Leon; FSE(European Social Fund (ESF)); Sara Borrell Program from the Spanish MINECO	The study was supported by grants from the Spanish MINECO (reference SAF2009-08407). Patricia Gallego-Munoz and Claudia Cordova were funded by the FPI Program from the Government of Castilla y Leon (co-funded by FSE). Ruben Martin was supported by the Sara Borrell Program from the Spanish MINECO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho VV, 2002, GRAEF ARCH CLIN EXP, V240, P521, DOI 10.1007/s00417-002-0477-8; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Bielory L, 2003, CURR OPIN ALLERGY CL, V3, P395, DOI 10.1097/01.a11.0000092612.76804.18; Bundoc VG, 2007, EXP EYE RES, V85, P575, DOI 10.1016/j.exer.2007.07.005; Chen DM, 2009, EXP EYE RES, V88, P880, DOI 10.1016/j.exer.2008.11.035; Chung SH, 2012, MOL VIS, V18, P1966; Cipriani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025637; Cota BB, 2013, RECENT PATENTS ENDOC, V7, P26, DOI 10.2174/1872214811307010026; Fukushima A, 2006, BIOCHEM BIOPH RES CO, V339, P1048, DOI 10.1016/j.bbrc.2005.11.114; Giner-Larza EM, 2001, EUR J PHARMACOL, V428, P137, DOI 10.1016/S0014-2999(01)01290-0; Gu NB, 2010, AM J PHYSIOL-LUNG C, V298, pL290, DOI 10.1152/ajplung.90612.2008; Hayat K, 2011, CURR EYE RES, V36, P591, DOI 10.3109/02713683.2011.573898; Hingorani M, 1998, J ALLERGY CLIN IMMUN, V102, P821, DOI 10.1016/S0091-6749(98)70023-5; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Kim YH, 2012, ALLERGY, V67, P183, DOI 10.1111/j.1398-9995.2011.02735.x; Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547; Lee DKC, 2003, CLIN EXP ALLERGY, V33, P882, DOI 10.1046/j.1365-2222.2003.01705.x; Leonardi A, 2012, ALLERGY, V67, P1327, DOI 10.1111/all.12009; Li KJ, 2010, MOL VIS, V16, P2084; Lim EJ, 2011, J BIOL CHEM, V286, P13193, DOI 10.1074/jbc.M110.210724; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Magone MT, 1998, CLIN IMMUNOL IMMUNOP, V87, P75, DOI 10.1006/clin.1997.4507; Mainardi T, 2009, J ALLERGY CLIN IMMUN, V123, P283, DOI 10.1016/j.jaci.2008.12.023; Mannon P, 2012, GUT, V61, P1765, DOI 10.1136/gutjnl-2012-303461; Martin R, 2012, BRIT J PHARMACOL, V166, P1708, DOI 10.1111/j.1476-5381.2012.01869.x; Martin R, 2010, BIOCHEM PHARMACOL, V79, P198, DOI 10.1016/j.bcp.2009.08.002; Matsuba-Kitamura S, 2010, INT IMMUNOL, V22, P479, DOI 10.1093/intimm/dxq035; Matsukura S, 2001, AM J RESP CELL MOL, V24, P755, DOI 10.1165/ajrcmb.24.6.4351; MAYUMI M, 1992, LEUKEMIA LYMPHOMA, V7, P243, DOI 10.3109/10428199209053629; Miyahara S, 2006, J ALLERGY CLIN IMMUN, V118, P1110, DOI 10.1016/j.jaci.2006.06.014; Mould AW, 1997, J CLIN INVEST, V99, P1064, DOI 10.1172/JCI119234; MURAKAMI M, 1993, J IMMUNOL, V151, P5675; Oh MH, 2011, J IMMUNOL, V186, P7232, DOI 10.4049/jimmunol.1100504; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; PRICE KR, 1987, CRC CR REV FOOD SCI, V26, P27, DOI 10.1080/10408398709527461; Rios JL, 2010, J ETHNOPHARMACOL, V128, P1, DOI 10.1016/j.jep.2009.12.045; Royer B, 2001, CLIN EXP ALLERGY, V31, P694, DOI 10.1046/j.1365-2222.2001.01069.x; SAITO H, 1985, BLOOD, V66, P1233; Sanchez MC, 2011, J INVEST ALLERG CLIN, V21, P1; Schempp CM, 2003, PHYTOMEDICINE, P1031; Somova LI, 2003, J ETHNOPHARMACOL, V84, P299, DOI 10.1016/S0378-8741(02)00332-X; Somova LO, 2003, PHYTOMEDICINE, V10, P115, DOI 10.1078/094471103321659807; Tominaga T, 2009, INVEST OPHTH VIS SCI, V50, P5181, DOI 10.1167/iovs.09-3637; Wei Y, 2011, INVEST OPHTH VIS SCI, V52, P4780, DOI 10.1167/iovs.10-6350; Zheng T, 2009, J INVEST DERMATOL, V129, P742, DOI 10.1038/jid.2008.295	45	32	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e91282	10.1371/journal.pone.0091282	http://dx.doi.org/10.1371/journal.pone.0091282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699261	Green Published, gold			2022-12-27	WOS:000334105000013
J	Haley, BJ; Choi, SY; Grim, CJ; Onifade, TJ; Cinar, HN; Tall, BD; Taviani, E; Hasan, NA; Abdullah, AH; Carter, L; Sahu, SN; Kothary, MH; Chen, A; Baker, R; Hutchinson, R; Blackmore, C; Cebula, TA; Huq, A; Colwell, RR				Haley, Bradd J.; Choi, Seon Young; Grim, Christopher J.; Onifade, Tiffiani J.; Cinar, Hediye N.; Tall, Ben D.; Taviani, Elisa; Hasan, Nur A.; Abdullah, AbdulShakur H.; Carter, Laurenda; Sahu, Surasri N.; Kothary, Mahendra H.; Chen, Arlene; Baker, Ron; Hutchinson, Richard; Blackmore, Carina; Cebula, Thomas A.; Huq, Anwar; Colwell, Rita R.			Genomic and Phenotypic Characterization of Vibrio cholerae Non-O1 Isolates from a US Gulf Coast Cholera Outbreak	PLOS ONE			English	Article							EL-TOR STRAINS; TOXIN-COREGULATED PILI; UNITED-STATES; CTX PROPHAGE; INFECTIONS; VIRULENCE; DIARRHEA; HEMAGGLUTININ/PROTEASE; VIBRIO-CHOLERAE-O1; EPIDEMIOLOGY	Between November 2010, and May 2011, eleven cases of cholera, unrelated to a concurrent outbreak on the island of Hispaniola, were recorded, and the causative agent, Vibrio cholerae serogroup O75, was traced to oysters harvested from Apalachicola Bay, Florida. From the 11 diagnosed cases, eight isolates of V. cholerae were isolated and their genomes were sequenced. Genomic analysis demonstrated the presence of a suite of mobile elements previously shown to be involved in the disease process of cholera (ctxAB, VPI-1 and -2, and a VSP-II like variant) and a phylogenomic analysis showed the isolates to be sister taxa to toxigenic V. cholerae V51 serogroup O141, a clinical strain isolated 23 years earlier. Toxigenic V. cholerae O75 has been repeatedly isolated from clinical cases in the southeastern United States and toxigenic V. cholerae O141 isolates have been isolated globally from clinical cases over several decades. Comparative genomics, phenotypic analyses, and a Caenorhabditis elegans model of infection for the isolates were conducted. This analysis coupled with isolation data of V. cholerae O75 and O141 suggests these strains may represent an underappreciated clade of cholera-causing strains responsible for significant disease burden globally.	[Haley, Bradd J.; Taviani, Elisa; Hasan, Nur A.; Chen, Arlene; Huq, Anwar; Colwell, Rita R.] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA; [Choi, Seon Young; Hasan, Nur A.; Abdullah, AbdulShakur H.; Cebula, Thomas A.; Colwell, Rita R.] CosmosID, College Pk, MD USA; [Grim, Christopher J.; Cinar, Hediye N.; Tall, Ben D.; Carter, Laurenda; Sahu, Surasri N.; Kothary, Mahendra H.] US FDA, CFSAN, DVA, Laurel, MD USA; [Onifade, Tiffiani J.; Hutchinson, Richard; Blackmore, Carina] Bur Environm Publ Hlth Med, Florida Dept Hlth, Tallahassee, FL USA; [Baker, Ron] Florida Dept Hlth Bur, Publ Hlth Labs, Jacksonville, FL USA; [Cebula, Thomas A.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Huq, Anwar] Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA; [Colwell, Rita R.] Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA; [Colwell, Rita R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA); Florida Department of Health; Florida Department of Health; Johns Hopkins University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Colwell, RR (corresponding author), Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA.	rcolwell@umiacs.umd.edu	Taviani, Elisa/AAB-1000-2020; Haley, Bradd/AAB-9164-2020; hasan, nur a/AAX-3881-2021	Taviani, Elisa/0000-0002-1025-0439; Haley, Bradd/0000-0001-7996-1143; hasan, nur a/0000-0003-0175-8879; Tall, Ben/0000-0003-0399-3629; Colwell, Rita R./0000-0001-5432-1502	National Science Foundation [0813066]; National Institutes of Health [2RO1A1039129-11A2]; National Institutes of Health-Fogarty International Center [1RC1TW008587-01]; National Oceanic and Atmospheric Administration [SO660009]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health-Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported by a grant the National Science Foundation (www.nsf.gov), No. 0813066, National Institutes of Health (www.nih.gov) Grant 2RO1A1039129-11A2, National Institutes of Health-Fogarty International Center (http://www.fic.nih.gov) Challenge Grant 1RC1TW008587-01 and National Oceanic and Atmospheric Administration (www.noaa.gov) Grant No. SO660009. The funders provided salary and laboratory supplies only. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BLAKE PA, 1980, NEW ENGL J MED, V302, P305, DOI 10.1056/NEJM198002073020601; Boucher Y, 2011, MBIO, V2, DOI 10.1128/mBio.00335-10; Chatterjee S, 2009, J CLIN MICROBIOL, V47, P1087, DOI 10.1128/JCM.02026-08; Choi SY, 2010, J MED MICROBIOL, V59, P302, DOI 10.1099/jmm.0.017053-0; Choi SY, 2011, ASM BIOD EM PATH RES; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; Cinar HN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011558; Crump JA, 2003, J INFECT DIS, V187, P866, DOI 10.1086/368330; Dalsgaard A, 2001, J CLIN MICROBIOL, V39, P4086, DOI 10.1128/JCM.39.11.4086-4092.2001; Dumontier S, 1998, FEMS MICROBIOL LETT, V164, P91, DOI 10.1016/S0378-1097(98)00201-8; Ghosh R, 2008, FEMS MICROBIOL LETT, V288, P196, DOI 10.1111/j.1574-6968.2008.01352.x; Haley BJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-154; HALL RH, 1990, INFECT IMMUN, V58, P3375, DOI 10.1128/IAI.58.10.3375-3379.1990; Halpern M, 2003, APPL ENVIRON MICROB, V69, P4200, DOI 10.1128/AEM.69.7.4200-4204.2003; Hasan NA, 2012, P NATL ACAD SCI USA, V109, pE2010, DOI 10.1073/pnas.1207359109; Hlady WG, 1996, J INFECT DIS, V173, P1176, DOI 10.1093/infdis/173.5.1176; Huq A, 2005, APPL ENVIRON MICROB, V71, P4645, DOI 10.1128/AEM.71.8.4645-4654.2005; Ko WC, 1998, CLIN INFECT DIS, V27, P774, DOI 10.1086/514947; Krukonis ES, 2003, CURR OPIN MICROBIOL, V6, P186, DOI 10.1016/S1369-5274(03)00032-8; Lang H, 1994, Infect Immun, V62, P4781; LIN FYC, 1986, J CLIN MICROBIOL, V23, P624, DOI 10.1128/JCM.23.3.624-626.1986; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Lukinmaa S, 2006, DIAGN MICR INFEC DIS, V54, P1, DOI 10.1016/j.diagmicrobio.2005.06.020; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Marin MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002049; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Michel-Briand Y, 2002, BIOCHIMIE, V84, P499, DOI 10.1016/S0300-9084(02)01422-0; Mohamed AA, 2012, EMERG INFECT DIS, V18, P925, DOI 10.3201/eid1806.111774; Morita M, 2013, MICROBIOL IMMUNOL, V57, P334, DOI 10.1111/1348-0421.12039; Murphy RA, 2008, J BACTERIOL, V190, P636, DOI 10.1128/JB.00562-07; Nair GB, 2006, J CLIN MICROBIOL, V44, P4211, DOI 10.1128/JCM.01304-06; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nusrin S, 2004, J CLIN MICROBIOL, V42, P5854, DOI 10.1128/JCM.42.12.5854-5856.2004; Octavia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065342; Onifade TJM, 2011, EUROSURVEILLANCE, V16, P10; Reguera G, 2005, J BACTERIOL, V187, P3551, DOI 10.1128/JB.187.10.3551-3555.2005; Safa A, 2008, EMERG INFECT DIS, V14, P987, DOI 10.3201/eid1406.080129; SAFRIN S, 1988, REV INFECT DIS, V10, P1012; Shannon JD, 2006, J CLIN MICROBIOL, V44, P3459, DOI 10.1128/JCM.02343-05; Shapiro RL, 1998, J INFECT DIS, V178, P752, DOI 10.1086/515367; Shin OS, 2011, MBIO, V2, DOI 10.1128/mBio.00106-11; Shinoda S, 2011, INFECT DIS-SER, P245, DOI 10.1007/978-1-60327-265-0_14; Silva AJ, 2006, INFECT IMMUN, V74, P2072, DOI 10.1128/IAI.74.4.2072-2079.2006; Son MS, 2011, CURR PROTOC MICROBIO, V22; Sprando RL, 2009, FOOD CHEM TOXICOL, V47, P722, DOI 10.1016/j.fct.2009.01.007; Tacket CO, 1998, INFECT IMMUN, V66, P692, DOI 10.1128/IAI.66.2.692-695.1998; Tamplin ML, 2001, HUM ECOL RISK ASSESS, V7, P1437, DOI 10.1080/20018091095113; Taviani E, 2010, FEMS MICROBIOL LETT, V308, P130, DOI 10.1111/j.1574-6968.2010.02008.x; Tobin-D'Angelo M, 2008, CLIN INFECT DIS, V47, P1035, DOI 10.1086/591973; Udden SMN, 2008, P NATL ACAD SCI USA, V105, P11951, DOI 10.1073/pnas.0805560105; Vanden Broeck D, 2007, INT J BIOCHEM CELL B, V39, P1771, DOI 10.1016/j.biocel.2007.07.005; Vora GJ, 2005, P NATL ACAD SCI USA, V102, P19109, DOI 10.1073/pnas.0505033102; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Yamasaki S, 1999, GENE, V237, P321, DOI 10.1016/S0378-1119(99)00344-3	56	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e86264	10.1371/journal.pone.0086264	http://dx.doi.org/10.1371/journal.pone.0086264			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699521	gold, Green Submitted, Green Published			2022-12-27	WOS:000334105000001
J	Yu, YP; Michalopoulos, A; Ding, Y; Tseng, G; Luo, JH				Yu, Yan P.; Michalopoulos, Amantha; Ding, Ying; Tseng, George; Luo, Jian-Hua			High Fidelity Copy Number Analysis of Formalin-Fixed and Paraffin-Embedded Tissues Using Affymetrix Cytoscan HD Chip	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR CARCINOMAS; PROSTATE-CANCER; FRESH-FROZEN; ARRAYS; GROWTH; DNA; AMPLIFICATION; SAMPLES	Detection of human genome copy number variation (CNV) is one of the most important analyses in diagnosing human malignancies. Genome CNV detection in formalin-fixed and paraffin-embedded (FFPE) tissues remains challenging due to suboptimal DNA quality and failure to use appropriate baseline controls for such tissues. Here, we report a modified method in analyzing CNV in FFPE tissues using microarray with Affymetrix Cytoscan HD chips. Gel purification was applied to select DNA with good quality and data of fresh frozen and FFPE tissues from healthy individuals were included as baseline controls in our data analysis. Our analysis showed a 91% overlap between CNV detection by microarray with FFPE tissues and chromosomal abnormality detection by karyotyping with fresh tissues on 8 cases of lymphoma samples. The CNV overlap between matched frozen and FFPE tissues reached 93.8%. When the analyses were restricted to regions containing genes, 87.1% concordance between FFPE and fresh frozen tissues was found. The analysis was further validated by Fluorescence In Situ Hybridization on these samples using probes specific for BRAF and CITED2. The results suggested that the modified method using Affymetrix Cytoscan HD chip gave rise to a significant improvement over most of the previous methods in terms of accuracy in detecting CNV in FFPE tissues. This FFPE microarray methodology may hold promise for broad application of CNV analysis on clinical samples.	[Yu, Yan P.; Michalopoulos, Amantha; Luo, Jian-Hua] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Ding, Ying; Tseng, George] Univ Pittsburgh, Sch Med, Dept Stat, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Luo, JH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	luoj@msx.upmc.edu	Luo, jian/HGE-7331-2022; Yu, Yan/GYV-4514-2022		National Cancer Institute; Amercain Cancer Society; University of Pittsburgh Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA098249] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Amercain Cancer Society; University of Pittsburgh Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded by the National Cancer Institute, Amercain Cancer Society and University of Pittsburgh Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARIGOZZI C, 1947, NATURE, V159, P505, DOI 10.1038/159505b0; Cheung KF, 2013, CANCER-AM CANCER SOC, V119, P1217, DOI 10.1002/cncr.27865; HU J, 1991, HUM PATHOL, V22, P1009, DOI 10.1016/0046-8177(91)90009-E; Krijgsman O, 2012, GENE CHROMOSOME CANC, V51, P344, DOI 10.1002/gcc.21920; Lips EH, 2005, CANCER RES, V65, P10188, DOI 10.1158/0008-5472.CAN-05-2486; Little SE, 2006, GENOMICS, V87, P298, DOI 10.1016/j.ygeno.2005.09.019; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Luo JH, 2006, HEPATOLOGY, V44, P1012, DOI 10.1002/hep.21328; Nalesnik MA, 2012, AM J PATHOL, V180, P1495, DOI 10.1016/j.ajpath.2011.12.021; Nasri S, 2010, CANCER GENET CYTOGEN, V198, P1, DOI 10.1016/j.cancergencyto.2009.12.002; Oosting J, 2007, GENOME RES, V17, P368, DOI 10.1101/gr.5686107; Ren B, 2006, ONCOGENE, V25, P1090, DOI 10.1038/sj.onc.1209134; Salawu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050415; Strassburger K, 2008, STAT MED, V27, P4914, DOI 10.1002/sim.3338; Thompson ER, 2005, HUM MUTAT, V26, P384, DOI 10.1002/humu.20220; Tuefferd M, 2008, GENE CHROMOSOME CANC, V47, P957, DOI 10.1002/gcc.20599; Wang L, 2013, J MOL DIAGN; Wang Y, 2012, CANCER GENET-NY, V205, P341, DOI 10.1016/j.cancergen.2012.06.005; Yu GY, 2006, AM J PATHOL, V168, P597, DOI 10.2353/ajpath.2006.050620; Yu YP, 2007, HISTOL HISTOPATHOL, V22, P1291, DOI 10.14670/HH-22.1291; Yu YP, 2012, AM J PATHOL, V180, P2240, DOI 10.1016/j.ajpath.2012.03.008	21	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92820	10.1371/journal.pone.0092820	http://dx.doi.org/10.1371/journal.pone.0092820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699316	Green Accepted, Green Published, gold			2022-12-27	WOS:000334105000035
J	Hu, XJ; Shang, MQ; Zhou, J; Ye, YX; Lu, XJ; Tao, CM; Ying, BW; Wang, LL				Hu, Xuejiao; Shang, Mengqiao; Zhou, Juan; Ye, Yuanxin; Lu, Xiaojun; Tao, Chuanmin; Ying, Binwu; Wang, Lanlan			Association of Genetic Variants in Wnt Signaling Pathway with Tuberculosis in Chinese Han Population	PLOS ONE			English	Article							BETA-CATENIN; CANCER; AXIN2; SUSCEPTIBILITY; MACROPHAGES; IMMUNITY; RISK; POLYMORPHISMS; ACTIVATION; SPECTRUM	Compelling studies have implicated that the Wnt signaling pathway plays an important role in the development and progression of tuberculosis, however, there is little literature addressing the role of polymorphisms in Wnt pathway on tuberculosis. We took a pathway based candidate gene approach to investigate the possible correlation between genetic variants in Wnt pathway and tuberculosis. Three single nucleotide polymorphisms (SNPs) in Wnt pathway (rs4135385 in CTNNB1 gene, rs7832767 in SFRP1 gene, and rs11079571 in AXIN2 gene) were genotyped in 422 Chinese Han tuberculosis patients and 402 frequency matched (age, gender, and ethnicity) controls using high-resolution melting analysis. The genotype and allelic frequencies of rs4135385 and rs7832767 were significantly different among patients and controls. The dominant model of rs4135385 was significantly associated with an increased risk of tuberculosis (AG/GG versus AA: OR = 1.49, 95% CI = 1.06-2.09, p = 0.019). The recessive model of rs7832767 posed a significant higher risk for tuberculosis (TT versus TC/CC, OR = 2.70, 95% CI = 1.41-5.18, p = 0.002). These SNPs were further evaluated whether they were correlated with the site of tuberculosis and the level of inflammatory markers. Rs7832767 was significantly associated with the level of CRP (p = 0.014), and the patients carrying T allele might present with elevated CRP values (OR = 1.90, 95% CI = 1.21-2.96, p = 0.005). Our study provided the first evidence that rs4135385 and rs7832767 were associated with tuberculosis risk, and genetic variants in Wnt signaling pathway might participate in genetic susceptibility to tuberculosis in Chinese Han population. Further epidemiological and functional studies in larger populations are warranted to verify our results.	[Hu, Xuejiao; Shang, Mengqiao; Zhou, Juan; Ye, Yuanxin; Lu, Xiaojun; Tao, Chuanmin; Ying, Binwu; Wang, Lanlan] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University	Ying, BW (corresponding author), Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Sichuan Provinc, Peoples R China.	docbwy@126.com; huaxiwangll@gmail.com	Ying, Binwu/AAB-5934-2022	Ying, Binwu/0000-0001-8077-3908				Akiyama T, 2000, CYTOKINE GROWTH F R, V11, P273, DOI 10.1016/S1359-6101(00)00011-3; Alanazi MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059555; Ansari A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004778; Barandon L, 2011, ARTERIOSCL THROM VAS, V31, pE80, DOI 10.1161/ATVBAHA.111.232280; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Dong X, 2001, CYTOGENET CELL GENET, V93, P26, DOI 10.1159/000056942; Feng WX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014652; Furuhashi Kazuki, 2012, Kekkaku, V87, P1; Gunes EG, 2009, MOL MED REP, V2, P1029, DOI 10.3892/mmr_00000210; Guo S, 2010, MED MICROBIOL IMMUN, V199, P129, DOI 10.1007/s00430-010-0146-1; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Ke BB, 2013, HEPATOLOGY, V57, P1203, DOI 10.1002/hep.26100; Kumar AS, 2012, MOL IMMUNOL, V49, P655, DOI 10.1016/j.molimm.2011.11.011; Lawn SD, 2013, INT J TUBERC LUNG D, V17, P636, DOI 10.5588/ijtld.12.0811; Lee JY, 2009, CARCINOGENESIS, V30, P1528, DOI 10.1093/carcin/bgp084; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Liu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084407; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Neumann J, 2010, FASEB J, V24, P4599, DOI 10.1096/fj.10-160994; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Rogler A, 2013, INT J CLIN EXP PATHO, V6, P1984; Schaale K, 2013, J IMMUNOL, V191, P5182, DOI 10.4049/jimmunol.1201819; Schaale K, 2011, EUR J CELL BIOL, V90, P553, DOI 10.1016/j.ejcb.2010.11.004; Sims AM, 2008, J BONE MINER RES, V23, P499, DOI 10.1359/JBMR.071113; Song XB, 2013, MOL BIOL REP, V40, P6027, DOI 10.1007/s11033-013-2712-2; Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591; Torres-Garcia D, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-220; Wang M, 2010, ONCOGENE, V29, P1920, DOI 10.1038/onc.2009.484; Wang SZ, 2012, MUTAGENESIS, V27, P623, DOI 10.1093/mutage/ges027; Wang XS, 2008, CANCER EPIDEM BIOMAR, V17, P2101, DOI 10.1158/1055-9965.EPI-08-0134; Zhao L, 2014, CELL BIOCHEM BIOPHYS, V68, P529, DOI 10.1007/s12013-013-9733-2	35	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93841	10.1371/journal.pone.0093841	http://dx.doi.org/10.1371/journal.pone.0093841			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695522	Green Submitted, gold, Green Published			2022-12-27	WOS:000334103000127
J	Jun, LS; Showalter, AD; Ali, N; Dai, FH; Ma, WZ; Coskun, T; Ficorilli, JV; Wheeler, MB; Michael, MD; Sloop, KW				Jun, Lucy S.; Showalter, Aaron D.; Ali, Nosher; Dai, Feihan; Ma, Wenzhen; Coskun, Tamer; Ficorilli, James V.; Wheeler, Michael B.; Michael, M. Dodson; Sloop, Kyle W.			A Novel Humanized GLP-1 Receptor Model Enables Both Affinity Purification and Cre-LoxP Deletion of the Receptor	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; EXOCRINE PANCREAS DYSPLASIA; SURFACTANT SECRETION; TISSUE DISTRIBUTION; ENDOCRINE PANCREAS; INCRETIN THERAPY; MARKED EXPANSION; EXPRESSION; MOUSE; RAT	Class B G protein-coupled receptors (GPCRs) are important regulators of endocrine physiology, and peptide-based therapeutics targeting some of these receptors have proven effective at treating disorders such as hypercalcemia, osteoporosis, and type 2 diabetes mellitus (T2DM). As next generation efforts attempt to develop novel non-peptide, orally available molecules for these GPCRs, new animal models expressing human receptor orthologs may be required because small molecule ligands make fewer receptor contacts, and thus, the impact of amino acid differences across species may be substantially greater. The objective of this report was to generate and characterize a new mouse model of the human glucagon-like peptide-1 receptor (hGLP-1R), a class B GPCR for which established peptide therapeutics exist for the treatment of T2DM. hGLP-1R knock-in mice express the receptor from the murine Glp-1r locus. Glucose tolerance tests and gastric emptying studies show hGLP-1R mice and their wild-type littermates display similar physiological responses for glucose metabolism, insulin secretion, and gastric transit, and treatment with the GLP-1R agonist, exendin-4, elicits similar responses in both groups. Further, ex vivo assays show insulin secretion from humanized islets is glucose-dependent and enhanced by GLP-1R agonists. To enable additional utility, the targeting construct of the knock-in line was engineered to contain both flanking LoxP sites and a C-terminal FLAG epitope. Anti-FLAG affinity purification shows strong expression of hGLP-1R in islets, lung, and stomach. We crossed the hGLP-1R line with Rosa26Cre mice and generated global Glp-1r(-/-) animals. Immunohistochemistry of pancreas from humanized and knock-out mice identified a human GLP-1R-specific antibody that detects the GLP-1R in human pancreas as well as in the pancreas of hGLP-1r knock-in mice. This new hGLP-1R model will allow tissue-specific deletion of the GLP-1R, purification of potential GLP-1R partner proteins, and testing of novel therapeutic agents targeting the hGLP-1R.	[Jun, Lucy S.; Showalter, Aaron D.; Ali, Nosher; Ma, Wenzhen; Coskun, Tamer; Ficorilli, James V.; Michael, M. Dodson; Sloop, Kyle W.] Eli Lilly & Co, Lilly Res Labs, Endocrine Discovery, Indianapolis, IN 46285 USA; [Dai, Feihan; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	Eli Lilly; University of Toronto	Sloop, KW (corresponding author), Eli Lilly & Co, Lilly Res Labs, Endocrine Discovery, Indianapolis, IN 46285 USA.	sloop_kyle_w@lilly.com	Coskun, Tamer/AAR-8422-2021	Michael, Mervyn/0000-0002-0224-1065; Wheeler, Michael B./0000-0002-7480-7267	Eli Lilly and Company; Lilly Research Awards Program (LRAP)	Eli Lilly and Company(Eli Lilly); Lilly Research Awards Program (LRAP)	This work was supported by Eli Lilly and Company and the Lilly Research Awards Program (LRAP). The LRAP grant enabled immunohistochemistry analyses of the mouse and human pancreas tissues. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Benito E, 1998, ENDOCRINOLOGY, V139, P2363, DOI 10.1210/en.139.5.2363; Bullock BP, 1996, ENDOCRINOLOGY, V137, P2968, DOI 10.1210/en.137.7.2968; Butler AE, 2013, DIABETES; Butler AE, 2013, DIABETES, V62, P2595, DOI 10.2337/db12-1686; CAMPOS RV, 1994, ENDOCRINOLOGY, V134, P2156, DOI 10.1210/en.134.5.2156; Chen QA, 2010, AM J PHYSIOL-ENDOC M, V299, pE62, DOI 10.1152/ajpendo.00067.2010; Chia CW, 2008, J CLIN ENDOCR METAB, V93, P3703, DOI 10.1210/jc.2007-2109; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Dunphy JL, 1998, MOL CELL ENDOCRINOL, V141, P179, DOI 10.1016/S0303-7207(98)00096-3; Estall JL, 2006, CURR PHARM DESIGN, V12, P1731, DOI 10.2174/138161206776873671; Gier B, 2012, J CLIN ENDOCR METAB, V97, P121, DOI 10.1210/jc.2011-2407; GOKE R, 1994, PEPTIDES, V15, P675, DOI 10.1016/0196-9781(94)90095-7; Halbirk M, 2010, AM J PHYSIOL-HEART C, V298, pH1096, DOI 10.1152/ajpheart.00930.2009; Hansotia T, 2005, REGUL PEPTIDES, V128, P125, DOI 10.1016/j.regpep.2004.07.019; Hansotia T, 2004, DIABETES, V53, P1326, DOI 10.2337/diabetes.53.5.1326; Heine RJ, 2013, DIABETES, V62, pE16, DOI 10.2337/db13-0690; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Imeryuz N, 1997, AM J PHYSIOL-GASTR L, V273, pG920, DOI 10.1152/ajpgi.1997.273.4.G920; Kim M, 2013, NAT MED, V19, P567, DOI 10.1038/nm.3128; Knudsen LB, 2010, ENDOCRINOLOGY, V151, P1473, DOI 10.1210/en.2009-1272; Korner M, 2007, J NUCL MED, V48, P736, DOI 10.2967/jnumed.106.038679; Kojima K, 2012, PROTEOMICS, V12, P3393, DOI 10.1002/pmic.201100663; Lamont BJ, 2012, J CLIN INVEST, V122, P388, DOI 10.1172/JCI42497; Lobbestael E, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-16; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Mendis B, 2012, BRIT J CLIN PHARMACO, V74, P437, DOI 10.1111/j.1365-2125.2012.04214.x; Monami M, 2009, EUR J ENDOCRINOL, V160, P909, DOI 10.1530/EJE-09-0101; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; Otto C, 2009, BIOL REPROD, V80, P34, DOI 10.1095/biolreprod.108.071175; Panjwani N, 2013, ENDOCRINOLOGY, V154, P127, DOI 10.1210/en.2012-1937; Persani L, 2007, NAT CLIN PRACT ENDOC, V3, P180, DOI 10.1038/ncpendmet0401; Pyke C, 2013, ENDOCRINOLOGY, V154, P4, DOI 10.1210/en.2012-2124; RICHTER G, 1993, AM J PHYSIOL, V265, pL374, DOI 10.1152/ajplung.1993.265.4.L374; Roman-Perez M, 2013, ENDOCRINOLOGY, V154, P1144, DOI 10.1210/en.2012-1786; Schlatter P, 2007, REGUL PEPTIDES, V141, P120, DOI 10.1016/j.regpep.2006.12.016; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Sloop KW, 2004, J CLIN INVEST, V113, P1571, DOI 10.1172/JCI200420911; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Suzuki H, 2013, GENESIS, V51, P50, DOI 10.1002/dvg.22347; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Tornehave D, 2008, J HISTOCHEM CYTOCHEM, V56, P841, DOI 10.1369/jhc.2008.951319; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Tushuizen ME, 2006, LIVER INT, V26, P1015, DOI 10.1111/j.1478-3231.2006.01315.x; Vara E, 2001, AM J RESP CRIT CARE, V163, P840, DOI 10.1164/ajrccm.163.4.9912132; Whitaker GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032675; Wilson-Perez HE, 2013, DIABETES, V62, P2380, DOI 10.2337/db12-1498; Zvonok N, 2007, J PROTEOME RES, V6, P2068, DOI 10.1021/pr060671h	52	24	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93746	10.1371/journal.pone.0093746	http://dx.doi.org/10.1371/journal.pone.0093746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695667	Green Submitted, Green Published, gold			2022-12-27	WOS:000334103000118
J	Onishi, A; Natsume, K				Onishi, Akinari; Natsume, Kiyohisa			Overlapped Partitioning for Ensemble Classifiers of P300-Based Brain-Computer Interfaces	PLOS ONE			English	Article							BCI-COMPETITION-III; CLASSIFICATION; WHEELCHAIR	A P300-based brain-computer interface (BCI) enables a wide range of people to control devices that improve their quality of life. Ensemble classifiers with naive partitioning were recently applied to the P300-based BCI and these classification performances were assessed. However, they were usually trained on a large amount of training data (e. g., 15300). In this study, we evaluated ensemble linear discriminant analysis (LDA) classifiers with a newly proposed overlapped partitioning method using 900 training data. In addition, the classification performances of the ensemble classifier with naive partitioning and a single LDA classifier were compared. One of three conditions for dimension reduction was applied: the stepwise method, principal component analysis (PCA), or none. The results show that an ensemble stepwise LDA (SWLDA) classifier with overlapped partitioning achieved a better performance than the commonly used single SWLDA classifier and an ensemble SWLDA classifier with naive partitioning. This result implies that the performance of the SWLDA is improved by overlapped partitioning and the ensemble classifier with overlapped partitioning requires less training data than that with naive partitioning. This study contributes towards reducing the required amount of training data and achieving better classification performance.	[Onishi, Akinari; Natsume, Kiyohisa] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 804, Japan	Kyushu Institute of Technology	Onishi, A (corresponding author), Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 804, Japan.	onishi-akinari@edu.brain.kyutech.ac.jp	Natsume, Kiyohisa/AGZ-3810-2022	Natsume, Kiyohisa/0000-0003-2529-4466	Japan Society for the Promotion of Science under KAKENHI [24650353]	Japan Society for the Promotion of Science under KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Japan Society for the Promotion of Science under KAKENHI Grant Number 24650353 (see http://kaken.nii.ac.jp/d/p/24650353/2012/1/ja.en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahangi A, 2013, NEURAL COMPUT APPL, V23, P1319, DOI 10.1007/s00521-012-1074-3; Arjona C, 2011, J PHYS CONF SER, V332, DOI 10.1088/1742-6596/332/1/012025; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P153, DOI 10.1109/TNSRE.2006.875642; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Brunner P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056013; Campbell A., 2010, NEUROPHONE P SEC OND, P3, DOI DOI 10.1145/1851322.1851326; Cho SB, 2007, APPL INTELL, V26, P243, DOI 10.1007/s10489-006-0020-4; Citi L, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056006; DONCHIN E, 1973, PERCEPT PSYCHOPHYS, V14, P319, DOI 10.3758/BF03212398; Draper N, 1981, APPL REGRESSION ANAL, P307; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Finke A, 2009, NEURAL NETWORKS, V22, P1329, DOI 10.1016/j.neunet.2009.07.003; Furdea A, 2009, PSYCHOPHYSIOLOGY, V46, P617, DOI 10.1111/j.1469-8986.2008.00783.x; Guger C, 2009, EUR S ART NEUR NETW, V1, P22; Guger C, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00060; Guo XJ, 2008, ICNC 2008: FOURTH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, VOL 4, PROCEEDINGS, P192, DOI 10.1109/ICNC.2008.871; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Iturrate I, 2009, IEEE T ROBOT, V25, P614, DOI 10.1109/TRO.2009.2020347; Johnson GD, 2009, LECT NOTES COMPUT SC, V5611, P551, DOI 10.1007/978-3-642-02577-8_60; Katayama J, 1999, CLIN NEUROPHYSIOL, V110, P463, DOI 10.1016/S1388-2457(98)00035-2; Kindermans PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033758; Koo M, 2008, J PERS SOC PSYCHOL, V94, P183, DOI 10.1037/0022-3514.94.2.183; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Kuncheva LI, 2010, MAGN RESON IMAGING, V28, P583, DOI 10.1016/j.mri.2009.12.021; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Lotte F, 2009, ASS MACH LEARN PEOPL, P7; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; McFarland DJ, 2011, CLIN NEUROPHYSIOL, V122, P731, DOI 10.1016/j.clinph.2010.10.029; Mugler E., 2008, INT J BIOELECTROMAGN, V10, P56; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pires G, 2008, IEEE ENG MED BIO, P658, DOI 10.1109/IEMBS.2008.4649238; Rakotomarnonjy A, 2008, IEEE T BIO-MED ENG, V55, P1147, DOI 10.1109/TBME.2008.915728; Salvaris M, 2012, IEEE T NEUR SYS REH, V20, P8, DOI 10.1109/TNSRE.2011.2174463; Salvaris M, 2010, IEEE ENG MED BIO, P4189, DOI 10.1109/IEMBS.2010.5627388; Salvaris M, 2009, I IEEE EMBS C NEUR E, P332; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Sellers EW, 2010, AMYOTROPH LATERAL SC, V11, P449, DOI 10.3109/17482961003777470; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	46	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93045	10.1371/journal.pone.0093045	http://dx.doi.org/10.1371/journal.pone.0093045			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695550	gold, Green Published, Green Submitted			2022-12-27	WOS:000334103000037
J	Rask-Andersen, M; Philippot, G; Moschonis, G; Dedoussis, G; Manios, Y; Marcus, C; Fredriksson, R; Schioth, HB				Rask-Andersen, Mathias; Philippot, Gaetan; Moschonis, George; Dedoussis, George; Manios, Yannis; Marcus, Claude; Fredriksson, Robert; Schioeth, Helgi B.			CDKAL1-Related Single Nucleotide Polymorphisms Are Associated with Insulin Resistance in a Cross-Sectional Cohort of Greek Children	PLOS ONE			English	Article							GRANULE MEMBRANE-PROTEIN; BODY-MASS INDEX; COMMON VARIANTS; OBESITY; GLYCOPROTEIN; OVERWEIGHT; GLUCOSE; CDKAL1; GENE; PAX6	Five novel loci recently found to be associated with body mass in two GWAS of East Asian populations were evaluated in two cohorts of Swedish and Greek children and adolescents. These loci are located within, or in the proximity of: CDKAL1, PCSK1, GP2, PAX6 and KLF9. No association with body mass has previously been reported for these loci in GWAS performed on European populations. The single nucleotide polymorphisms ( SNPs) with the strongest association at each loci in the East Asian GWAS were genotyped in two cohorts, one obesity case control cohort of Swedish children and adolescents consisting of 496 cases and 520 controls and one cross-sectional cohort of 2293 nine-to-thirteen year old Greek children and adolescents. SNPs were surveyed for association with body mass and other phenotypic traits commonly associated with obesity, including adipose tissue distribution, insulin resistance and daily caloric intake. No association with body mass was found in either cohort. However, among the Greek children, association with insulin resistance could be observed for the two CDKAL1-related SNPs: rs9356744 (beta = 0.018, p = 0.014) and rs2206734 (beta = 0.024, p = 0.001). CDKAL1-related variants have previously been associated with type 2 diabetes and insulin response. This study reports association of CDKAL1-related SNPs with insulin resistance, a clinical marker related to type 2 diabetes in a cross-sectional cohort of Greek children and adolescents of European descent.	[Rask-Andersen, Mathias; Philippot, Gaetan; Fredriksson, Robert; Schioeth, Helgi B.] Uppsala Univ, Dept Neurosci Funct Pharmacol, Uppsala, Sweden; Harokopio Univ, Dept Nutr & Dietet, Athens, Greece; [Marcus, Claude] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Pediat, Natl Childhood Obes Ctr, Stockholm, Sweden	Uppsala University; Harokopio University Athens; Karolinska Institutet	Rask-Andersen, M (corresponding author), Uppsala Univ, Dept Neurosci Funct Pharmacol, Uppsala, Sweden.	Mathias.Rask-Andersen@neuro.uu.se	Dedoussis, George/AAN-7252-2021; Moschonis, George/AAM-9616-2021; Manios, Yannis/AAM-8953-2021; Schioth, Helgi/AAQ-7239-2020; Marcus, Claude/ABE-1177-2020	Dedoussis, George/0000-0002-7798-6221; Manios, Yannis/0000-0001-6486-114X; Marcus, Claude/0000-0003-0890-2650; Moschonis, George/0000-0003-3009-6675; Fredriksson, Robert/0000-0002-2810-3226	Swedish Research Council; Brain Research Foundation; Novo Nordisk Foundation; Engkvist and the Ahlens Foundation; Novo Nordisk Fonden [NNF13OC0005723] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Brain Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Engkvist and the Ahlens Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was supported by the Swedish Research Council, the Brain Research Foundation, Novo Nordisk Foundation, Engkvist and the Ahlens Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogardus C, 2009, OBESITY, V17, P209, DOI 10.1038/oby.2008.613; Brambillasca S, 2012, J BIOL CHEM, V287, P41808, DOI 10.1074/jbc.M112.376558; Cole TJ, 2000, BRIT MED J, V321, P281; Dumas ME, 2014, GASTROENTEROLOGY, V146, P46, DOI 10.1053/j.gastro.2013.11.001; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; FUKUOKA SI, 1991, P NATL ACAD SCI USA, V88, P2898, DOI 10.1073/pnas.88.7.2898; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Gosmain Y, 2010, J BIOL CHEM, V285, P33381, DOI 10.1074/jbc.M110.147215; Hart AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054173; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Heller RS, 2004, DEV BIOL, V268, P123, DOI 10.1016/j.ydbio.2003.12.008; HOOPS TC, 1991, J BIOL CHEM, V266, P4257; Jacobsson JA, 2012, INT J OBESITY, V36, P119, DOI 10.1038/ijo.2011.11; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Lee JM, 2006, DIABETES CARE, V29, P2427, DOI 10.2337/dc06-0709; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moschonis G, 2010, PUBLIC HEALTH NUTR, V13, P1693, DOI 10.1017/S1368980010002247; Neovius M, 2006, OBES REV, V7, P1, DOI 10.1111/j.1467-789x.2006.00190.x; Nijpels G, 1998, EUR J CLIN INVEST, V28, P8; Ohara-Imaizumi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015553; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qu HQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021041; Rask-Andersen M, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-36; Roggenbuck D, 2009, GUT, V58, P1620, DOI 10.1136/gut.2008.162495; RONZIO RA, 1978, BIOCHIM BIOPHYS ACTA, V508, P65, DOI 10.1016/0005-2736(78)90189-X; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Shiwaku K, 2004, INT J OBESITY, V28, P152, DOI 10.1038/sj.ijo.0802486; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tanner JM, 1955, GROWTH ADOLESCENCE; Ten S, 2004, J CLIN ENDOCR METAB, V89, P2526, DOI 10.1210/jc.2004-0276; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yu S, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-58	43	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93193	10.1371/journal.pone.0093193	http://dx.doi.org/10.1371/journal.pone.0093193			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695378	gold, Green Published, Green Submitted			2022-12-27	WOS:000334103000046
J	Bogorodzki, P; Piatkowska-Janko, E; Szaflik, J; Szaflik, JP; Gacek, M; Grieb, P				Bogorodzki, Piotr; Piatkowska-Janko, Ewa; Szaflik, Jerzy; Szaflik, Jacek Pawel; Gacek, Mira; Grieb, Pawel			Mapping Cortical Thickness of the Patients with Unilateral End-Stage Open Angle Glaucoma on Planar Cerebral Cortex Maps	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; VOXEL-BASED MORPHOMETRY; SURFACE-BASED ANALYSIS; MAGNETIC-RESONANCE; VISUAL PATHWAY; OPTIC PATHWAY; BRAIN; MRI; SEGMENTATION; ATROPHY	Purpose: To estimate and compare cerebral cortex thickness in patients with unilateral end-stage glaucoma with that of age-matched individuals with unaffected vision. Methods: 14 patients with unilateral end-stage primary open angle glaucoma (POAG) and 12 age-matched control individuals with no problems with vision were selected for the study based on detailed ophthalmic examination. For each participant 3D high-resolution structural brain T1-weighted magnetization prepared MR images were acquired on a 3.0 T scanner. Brain cortex thickness was estimated using the FreeSurfer image analysis environment. After warping of subjects' cortical surfaces to FreeSurfer common space, differences between POAG and control groups were inferred at the group analysis level with the General Linear Model. Results: The analysis performed revealed local thinning in the visual cortex areas in the POAG group. Statistically significant differences form 600 mm(2) clusters located in the Brodmann area BA19 in the left and right hemisphere. Conclusion: Unilateral vision loss due to end-stage neuropathy from POAG is associated with significant thinning of cortical areas employed in vision.	[Bogorodzki, Piotr; Piatkowska-Janko, Ewa] Warsaw Univ Technol, Inst Radioelect, Warsaw, Poland; [Bogorodzki, Piotr; Grieb, Pawel] Polish Acad Sci, Med Res Ctr, Dept Expt Pharmacol, Warsaw, Poland; [Szaflik, Jerzy; Szaflik, Jacek Pawel; Gacek, Mira] Med Univ Warsaw, SPKSO Ophthalm Univ Hosp, Dept Ophthalmol, Warsaw, Poland	Warsaw University of Technology; Polish Academy of Sciences; Medical University of Warsaw	Bogorodzki, P (corresponding author), Warsaw Univ Technol, Inst Radioelect, Warsaw, Poland.	piotr@ire.pw.edu.pl	Grieb, Pawel/AAT-8173-2021	Piatkowska-Janko, Ewa/0000-0002-9895-4317; Grieb, Pawel/0000-0002-6983-7947; Szaflik, Jerzy/0000-0002-7601-1326; Bogorodzki, Piotr/0000-0001-6596-5274				Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bernal-Rusiel JL, 2010, NEUROIMAGE, V52, P158, DOI 10.1016/j.neuroimage.2010.03.074; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Cedrone C, 2008, PROG BRAIN RES, V173, P3, DOI 10.1016/S0079-6123(08)01101-1; CHATURVEDI N, 1993, AM J OPHTHALMOL, V116, P182, DOI 10.1016/S0002-9394(14)71283-8; Chen WW, 2013, INVEST OPHTH VIS SCI, V54, P545, DOI 10.1167/iovs.12-9893; Chen ZQ, 2013, CLIN EXP OPHTHALMOL, V41, P43, DOI 10.1111/j.1442-9071.2012.02832.x; Collignon O, 2013, BRAIN, V136, P2769, DOI 10.1093/brain/awt176; Dai H, 2011, AM J NEURORADIOL, V32, P1347, DOI 10.3174/ajnr.A2486; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Duncan RO, 2012, VISION RES, V60, P51, DOI 10.1016/j.visres.2012.03.012; European Glaucoma Society, 2020, TERM GUID GLAUC; Fiedorowicz M, 2011, MED SCI MONITOR, V17, pRA227, DOI 10.12659/MSM.881973; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, HUM BRAIN MAPP; Fischl B., 2012, NEUROIMAGE; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Gupta N, 2006, BRIT J OPHTHALMOL, V90, P674, DOI 10.1136/bjo.2005.086769; Harwerth RS, 2006, ARCH OPHTHALMOL-CHIC, V124, P853, DOI 10.1001/archopht.124.6.853; Hernowo AT, 2011, INVEST OPHTH VIS SCI, V52, P2758, DOI 10.1167/iovs.10-5682; HOFMAN MA, 1985, BRAIN BEHAV EVOLUT, V27, P28, DOI 10.1159/000118718; Jindahra P, 2009, BRAIN, V132, P628, DOI 10.1093/brain/awp001; Kanski JJ, 2011, CLIN OPHTHALMOLOGY S; Kitsos G, 2009, BRIT J RADIOL, V82, P896, DOI 10.1259/bjr/55866125; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Li CY, 2012, CURR EYE RES, V37, P794, DOI 10.3109/02713683.2012.683506; Long XJ, 2012, ACAD RADIOL, V19, P785, DOI 10.1016/j.acra.2012.03.006; MORGAN JE, 1994, BRIT J OPHTHALMOL, V78, P875, DOI 10.1136/bjo.78.11.875; Nucci C, 2013, CURR OPIN PHARMACOL, V13, P128, DOI 10.1016/j.coph.2012.08.004; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Parisi V, 1999, OPHTHALMOLOGY, V106, P1126, DOI 10.1016/S0161-6420(99)90269-5; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Rejdak Robert, 2003, Med Sci Monit, V9, pPI24; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; STROMAN GA, 1995, ARCH OPHTHALMOL-CHIC, V113, P168, DOI 10.1001/archopht.1995.01100020050027; Van Essen DC, 2007, NEURON, V56, P209, DOI 10.1016/j.neuron.2007.10.015; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Williams AL, 2013, INVEST OPHTH VIS SCI, V54, P5880, DOI 10.1167/iovs.13-11776; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Yu LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073208; Zikou AK, 2012, AM J NEURORADIOL, V33, P128, DOI 10.3174/ajnr.A2714	50	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93682	10.1371/journal.pone.0093682	http://dx.doi.org/10.1371/journal.pone.0093682			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709970	Green Submitted, gold, Green Published			2022-12-27	WOS:000334159800044
J	Jiang, HL; Deng, XX; Wang, JA; Wang, J; Peng, J; Zhou, TT				Jiang, Hailan; Deng, Xiaoxia; Wang, Jungang; Wang, Jing; Peng, Jun; Zhou, Tingting			Effects of Gibberellic Acid and N, N-Dimethyl Piperidinium Chloride on the Dose of and Physiological Responses to Prometryn in Black Nightshade (Solanum nigrum L.)	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; OXIDATIVE DAMAGE; WEED MANAGEMENT; COTTON; ANTIOXIDANT; ENZYMES; GLUTATHIONE; STRESS; METABOLISM	The use of gibberellic acid (GA(3)) and N, N-dimethyl piperidinium chloride (DPC) in combination with prometryn would likely increase the control of black nightshade in cotton fields. Experiments were designed to investigate the physiological and biochemical responses of black nightshade at the three-to four-leaf stage to prometryn applied at different rates, either alone or in combination with GA(3) or DPC, in a greenhouse environment. These studies demonstrated that prometryn applied in combination with DPC at low rates (7.2 g ai ha(-1)) led to increased fresh weight and visible injury of black nightshade compared with prometryn applied alone or in combination with GA(3); however, at rates of 36, 180, and 900 g ai ha(-1), prometryn in combination with DPC caused the least visible injury among all treatments and prometryn in combination with GA(3) caused the greatest visible injury. These results suggest that black nightshade suffered more severe damage when prometryn was applied in combination with GA(3), which is supported by the reduced soluble protein content, lower antioxidant enzyme activities, and higher malondialdehyde (MDA) content in the plants treated with prometryn plus GA(3). These results indicate that the application of GA(3) in combination with prometryn to black nightshade may have the potential to lower the levels of prometryn tolerance in these plants.	[Jiang, Hailan; Deng, Xiaoxia; Wang, Jungang; Wang, Jing; Peng, Jun; Zhou, Tingting] Shihezi Univ, Coll Agr, Shihezi, Xinjiang, Peoples R China; [Jiang, Hailan; Deng, Xiaoxia] Kuerle Agr Technol Extens Ctr, Kuerle, Xinjiang, Peoples R China	Shihezi University	Wang, JA (corresponding author), Shihezi Univ, Coll Agr, Shihezi, Xinjiang, Peoples R China.	jungangwang98@163.com			Special Fund for Agro-scientific Research in the Public Interest [201303022]; corps doctoral Fund [2013BB004]; National Natural Science Foundation Project of China [31260435]	Special Fund for Agro-scientific Research in the Public Interest; corps doctoral Fund; National Natural Science Foundation Project of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (201303022), corps doctoral Fund (2013BB004) and National Natural Science Foundation Project of China (31260435). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bailly C, 1996, PHYSIOL PLANTARUM, V97, P104, DOI 10.1111/j.1399-3054.1996.tb00485.x; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byrd Jr J., 2000, 2000 P BELTW COTT C, V2, P1455; Chance M, 1955, METHOD ENZYMOL, V2, P764, DOI DOI 10.1016/S0076-6879(55)02300-8; Davey MW, 2000, J SCI FOOD AGR, V80, P825, DOI [10.1002/(SICI)1097-0010(20000515)80:7<825::AID-JSFA598>3.0.CO;2-6, 10.1002/(SICI)1097-0010(20000515)80:7&lt;825::AID-JSFA598&gt;3.0.CO;2-6]; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Dunk P, 2002, WEED SCI, V50, P642; Economou G, 2005, PHYTOPARASITICA, V33, P406, DOI 10.1007/BF02981309; [冯国艺 Feng Guoyi], 2012, [棉花学报, Cotton Science], V24, P44; FRIDOVICH I, 1986, ARCH BIOCHEM BIOPHYS, V247, P1, DOI 10.1016/0003-9861(86)90526-6; Gausman HW, 1979, P 6 ANN M PLANT GROW, P117; GREEN JM, 1989, WEED TECHNOL, V3, P217, DOI 10.1017/S0890037X00031717; Gurinderbir SC, 2012, WEED TECHNOL, V26, P638; GUY CL, 1990, ANNU REV PLANT PHYS, V41, P187, DOI 10.1146/annurev.pp.41.060190.001155; Hake K., 1991, PHYSL TODAY, V2; HATZIOS K K, 1985, Reviews of Weed Science, V1, P1; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Holm LG., 1991, WORLDS WORST WEEDS D, P430; Jerry LC, 2002, WEED TECHNOL, V16, P712; Kaloumenos NS, 2005, WEED TECHNOL, V19, P207, DOI 10.1614/WT-04-188; Keeling JW, 2011, WEED TECHNOL, V25, P178, DOI 10.1614/WT-D-10-00110.1; KENYON WH, 1985, PLANT PHYSIOL, V79, P862, DOI 10.1104/pp.79.3.862; Ma XW, 2008, PLANT GROWTH REGUL, V56, P77, DOI 10.1007/s10725-008-9287-2; Ma YH, 2008, PLANT SCI, V175, P761, DOI 10.1016/j.plantsci.2008.07.010; Molassiotis A, 2006, ENVIRON EXP BOT, V56, P54, DOI 10.1016/j.envexpbot.2005.01.002; Nemat MM, 2008, PLANT BIOSYST, V142, P5; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Parida AK, 2004, J PLANT PHYSIOL, V161, P531, DOI 10.1078/0176-1617-01084; Porterfield D, 2002, WEED SCI, V50, P642, DOI 10.1614/0043-1745(2002)050[0642:WMWCFA]2.0.CO;2; Reddy AR, 1996, PLANT GROWTH REGUL, V20, P179, DOI 10.1007/BF00043305; Sairam RK, 2002, PLANT SCI, V162, P897, DOI 10.1016/S0168-9452(02)00037-7; Scott BC, 2007, WEED TECHNOL, V21, P45; Scott BC, 2008, WEED TECHNOL, V22, P160; Shah K, 2001, PLANT SCI, V161, P1135, DOI 10.1016/S0168-9452(01)00517-9; Shrestha A, 2005, WEED SCI, V53, P802, DOI 10.1614/WS-04-181R1.1; Thomas WE, 2006, WEED TECHNOL, V20, P6, DOI 10.1614/WT-04-257R1.1; Walter ET, 2006, WEED TECHNOL, V20, P6; Wang ZhengGui, 2010, Journal of Agro-Environment Science, V29, P1027; Wuolo A, 2002, NATTSKATTA AR PROBLE; Zhang Dingyi, 2007, Chinese Journal of Applied and Environmental Biology, V13, P294; [张明生 Zhang Mingsheng], 2004, [南京农业大学学报, Journal of Nanjing Agricultural University], V27, P123	44	3	4	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93654	10.1371/journal.pone.0093654	http://dx.doi.org/10.1371/journal.pone.0093654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709895	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800042
J	Kowno, M; Watanabe-Susaki, K; Ishimine, H; Komazaki, S; Enomoto, K; Seki, Y; Wang, YY; Ishigaki, Y; Ninomiya, N; Noguchi, TAK; Kokubu, Y; Ohnishi, K; Nakajima, Y; Kato, K; Intoh, A; Takada, H; Yamakawa, N; Wang, PC; Asashima, M; Kurisaki, A				Kowno, Megumi; Watanabe-Susaki, Kanako; Ishimine, Hisako; Komazaki, Shinji; Enomoto, Kei; Seki, Yasuhiro; Wang, Ying Ying; Ishigaki, Yohei; Ninomiya, Naoto; Noguchi, Taka-aki K.; Kokubu, Yuko; Ohnishi, Keigoh; Nakajima, Yoshiro; Kato, Kaoru; Intoh, Atsushi; Takada, Hitomi; Yamakawa, Norio; Wang, Pi-Chao; Asashima, Makoto; Kurisaki, Akira			Prohibitin 2 Regulates the Proliferation and Lineage-Specific Differentiation of Mouse Embryonic Stem Cells in Mitochondria	PLOS ONE			English	Article							DOMINANT OPTIC ATROPHY; NUCLEAR EXPORT; CRISTAE MORPHOGENESIS; OPA1; PLURIPOTENCY; REPRESSION; EFFICIENT; APOPTOSIS; ESTROGEN; PROTEIN	Background: The pluripotent state of embryonic stem (ES) cells is controlled by a network of specific transcription factors. Recent studies also suggested the significant contribution of mitochondria on the regulation of pluripotent stem cells. However, the molecules involved in these regulations are still unknown. Methodology/ Principal Findings: In this study, we found that prohibitin 2 (PHB2), a pleiotrophic factor mainly localized in mitochondria, is a crucial regulatory factor for the homeostasis and differentiation of ES cells. PHB2 was highly expressed in undifferentiated mouse ES cells, and the expression was decreased during the differentiation of ES cells. Knockdown of PHB2 induced significant apoptosis in pluripotent ES cells, whereas enhanced expression of PHB2 contributed to the proliferation of ES cells. However, enhanced expression of PHB2 strongly inhibited ES cell differentiation into neuronal and endodermal cells. Interestingly, only PHB2 with intact mitochondrial targeting signal showed these specific effects on ES cells. Moreover, overexpression of PHB2 enhanced the processing of a dynamin-like GTPase (OPA1) that regulates mitochondrial fusion and cristae remodeling, which could induce partial dysfunction of mitochondria. Conclusions/ Significance: Our results suggest that PHB2 is a crucial mitochondrial regulator for homeostasis and lineagespecific differentiation of ES cells.	[Kowno, Megumi; Ishimine, Hisako; Ishigaki, Yohei; Noguchi, Taka-aki K.; Kokubu, Yuko; Ohnishi, Keigoh; Wang, Pi-Chao; Kurisaki, Akira] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Watanabe-Susaki, Kanako; Ishimine, Hisako; Wang, Ying Ying; Nakajima, Yoshiro; Takada, Hitomi; Yamakawa, Norio; Asashima, Makoto; Kurisaki, Akira] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki, Japan; [Komazaki, Shinji] Saitama Med Sch, Dept Anat, Moroyama, Saitama 35004, Japan; [Enomoto, Kei; Ninomiya, Naoto] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Meguro Ku, Tokyo 113, Japan; [Seki, Yasuhiro; Intoh, Atsushi; Asashima, Makoto] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Biol, Meguro Ku, Tokyo, Japan; [Wang, Ying Ying] Japan Soc Promot Sci, Tsukuba, Ibaraki, Japan; [Kato, Kaoru] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Tsukuba, Ibaraki, Japan; [Asashima, Makoto] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki, Japan	University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST); Saitama Medical University; University of Tokyo; University of Tokyo; Japan Society for the Promotion of Science; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Kurisaki, A (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	akikuri@hotmail.com	Asashima, Makoto/O-8389-2018; wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022; Enomoto, Kei/GQP-7270-2022; Katoh, Kaoru/M-7526-2018	Asashima, Makoto/0000-0002-0012-026X; Enomoto, Kei/0000-0001-6210-8699; Katoh, Kaoru/0000-0001-6590-413X	 [17510165];  [20610008]	; 	This work was supported by Grant-in-Aid for Scientific Research (17510165 and 20610008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama K, 2011, BBA-PROTEINS PROTEOM, V1814, P265, DOI 10.1016/j.bbapap.2010.10.009; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Baharvand H, 2006, PROTEOMICS, V6, P3544, DOI 10.1002/pmic.200500844; Chen CT, 2012, BBA-GEN SUBJECTS, V1820, P571, DOI 10.1016/j.bbagen.2011.09.013; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Comelli M, 2011, MITOCHONDRION, V11, P315, DOI 10.1016/j.mito.2010.12.007; Czarnecka AM, 2006, CANCER BIOL THER, V5, P714, DOI 10.4161/cbt.5.7.2975; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Feng RP, 2013, BIOCHEM J, V450, P459, DOI 10.1042/BJ20120924; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Heron-Milhavet L, 2008, J CELL PHYSIOL, V214, P158, DOI 10.1002/jcp.21177; Hogan B, 1994, MANIPULATING MOUSE E; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Intoh A, 2009, BIOMED CHROMATOGR, V23, P607, DOI 10.1002/bmc.1159; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kunisada Y, 2012, STEM CELL RES, V8, P274, DOI 10.1016/j.scr.2011.10.002; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Park SE, 2005, MOL CELL BIOL, V25, P1989, DOI 10.1128/MCB.25.5.1989-1999.2005; Rastogi S, 2006, J BIOL CHEM, V281, P2951, DOI 10.1074/jbc.M508669200; Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2; Sun LG, 2011, CELL SIGNAL, V23, P1686, DOI 10.1016/j.cellsig.2011.06.005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thuaud F, 2013, CHEM BIOL, V20, P316, DOI 10.1016/j.chembiol.2013.02.006; Voccoli V, 2009, BRAIN RES, V1252, P15, DOI 10.1016/j.brainres.2008.11.026; Wang S, 1999, MOL CELL BIOL, V19, P7447; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Watanabe M, 2000, EMBO REP, V1, P176, DOI 10.1093/embo-reports/kvd029; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	44	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e81552	10.1371/journal.pone.0081552	http://dx.doi.org/10.1371/journal.pone.0081552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709813	gold, Green Submitted, Green Published			2022-12-27	WOS:000334159800001
J	Chen, X; Foy, M; Kimmel, M; Gorlova, OY				Chen, Xing; Foy, Millennia; Kimmel, Marek; Gorlova, Olga Y.			Modeling the Natural History and Detection of Lung Cancer Based on Smoking Behavior	PLOS ONE			English	Article							TUMOR DOUBLING TIME; SIZE; METASTASIS; MORTALITY	In this study, we developed a method for modeling the progression and detection of lung cancer based on the smoking behavior at an individual level. The model allows obtaining the characteristics of lung cancer in a population at the time of diagnosis. Lung cancer data from Surveillance, Epidemiology and End Results ( SEER) database collected between 2004 and 2008 were used to fit the lung cancer progression and detection model. The fitted model combined with a smoking based carcinogenesis model was used to predict the distribution of age, gender, tumor size, disease stage and smoking status at diagnosis and the results were validated against independent data from the SEER database collected from 1988 to 1999. The model accurately predicted the gender distribution and median age of LC patients of diagnosis, and reasonably predicted the joint tumor size and disease stage distribution.	[Chen, Xing] Zhejiang Univ, Minist Educ China, Key Lab Biomed Engn, Dept Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Xing; Gorlova, Olga Y.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Foy, Millennia] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Kimmel, Marek] Rice Univ, Dept Stat & Bioengn, Houston, TX USA; [Gorlova, Olga Y.] Dartmouth Coll, Geisel Sch Med, Dept Community & Family Med, Lebanon, NH 03756 USA	Ministry of Education, China; Zhejiang University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Rice University; Dartmouth College	Chen, X (corresponding author), Zhejiang Univ, Minist Educ China, Key Lab Biomed Engn, Dept Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China.	cnxingchen@gmail.com			CISNET [5 U01 CA097431]; FAMRI Young Clinical Scientist Award; Prevent Cancer Foundation; National Institutes of Health (NIH) [R01 CA149462, R03CA1338885, R03128025, CA55769]; National Natural Science Foundation of China [81201166]; Research Fund for the Doctoral Program of Ministry of Education of China [20120101120165]; Zhejiang Key Science and Technology Innovation Team [2011R50018, CA016672]; NATIONAL CANCER INSTITUTE [T32CA096520, R01CA055769, R01CA149462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104416] Funding Source: NIH RePORTER	CISNET; FAMRI Young Clinical Scientist Award; Prevent Cancer Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Ministry of Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Zhejiang Key Science and Technology Innovation Team; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the following grants: CISNET 5 U01 CA097431 to M. K. and O.G., FAMRI Young Clinical Scientist Award and Prevent Cancer Foundation grants to O.G., National Institutes of Health (NIH) grants R01 CA149462 to OYG, R03CA1338885 and R03128025 to I. G., CA55769 to M. R. S., National Natural Science Foundation of China No. 81201166 to X. C., Research Fund for the Doctoral Program of Ministry of Education of China No. 20120101120165 to X. C., Zhejiang Key Science and Technology Innovation Team 2011R50018 to X. C., and CA016672 to MD Anderson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1973, SURV EP END RES SEER; ARAI T, 1994, JPN J CLIN ONCOL, V24, P199; Bacac M, 2008, ANNU REV PATHOL-MECH, V3, P221, DOI 10.1146/annurev.pathmechdis.3.121806.151523; Barton RR, 1996, MANAGE SCI, V42, P954, DOI 10.1287/mnsc.42.7.954; Bartoszynski R, 2001, MATH BIOSCI, V171, P113, DOI 10.1016/S0025-5564(01)00058-X; Boffetta P, 2011, CANCER CAUSE CONTROL, V22, P73, DOI 10.1007/s10552-010-9676-5; Campbell M, 2007, BRIT J GEN PRACT, V57, P410; Del Monte U, 2009, CELL CYCLE, V8, P505, DOI 10.4161/cc.8.3.7608; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FLEHINGER BJ, 1987, BIOMETRICS, V43, P127, DOI 10.2307/2531955; Foy M, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-64; Foy M, 2011, CANCER-AM CANCER SOC, V117, P2703, DOI 10.1002/cncr.25847; Foy M, 2011, INT J CANCER, V129, P1907, DOI 10.1002/ijc.25834; Gasperino J, 2011, MED HYPOTHESES, V76, P328, DOI 10.1016/j.mehy.2010.10.030; Gorlova O, 2005, STAT MED, V24, P1117, DOI 10.1002/sim.1987; Hasegawa M, 2000, BRIT J RADIOL, V73, P1252, DOI 10.1259/bjr.73.876.11205667; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; KIMMEL M, 1991, BIOMETRICS, V47, P987, DOI 10.2307/2532654; KOSCIELNY S, 1984, BRIT J CANCER, V49, P709, DOI 10.1038/bjc.1984.112; Magdowski M, 2010, IEEE T ELECTROMAGN C, V52, P1060, DOI 10.1109/TEMC.2010.2052621; MOOLGAVKAR SH, 1979, MATH BIOSCI, V47, P55, DOI 10.1016/0025-5564(79)90005-1; Moolgavkar SH, 2012, JNCI-J NATL CANCER I, V104, P541, DOI 10.1093/jnci/djs136; OLSSON DM, 1975, TECHNOMETRICS, V17, P45, DOI 10.2307/1267998; Plevritis SK, 2007, STAT MED, V26, P581, DOI 10.1002/sim.2550; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; USUDA K, 1994, CANCER, V74, P2239, DOI 10.1002/1097-0142(19941015)74:8<2239::AID-CNCR2820740806>3.0.CO;2-P; Wang Xin, 2009, Zhonghua Zhongliu Zazhi, V31, P456, DOI 10.3760/cma.j.issn.0253-3766.2009.06.015; Xu JL, 1998, BIOMETRICS, V54, P859, DOI 10.2307/2533840	28	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93430	10.1371/journal.pone.0093430	http://dx.doi.org/10.1371/journal.pone.0093430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705368	Green Published, gold			2022-12-27	WOS:000334107500037
J	Creswell, J; Khowaja, S; Codlin, A; Hashmi, R; Rasheed, E; Khan, M; Durab, I; Mergenthaler, C; Hussain, O; Khan, F; Khan, AJ				Creswell, Jacob; Khowaja, Saira; Codlin, Andrew; Hashmi, Rabia; Rasheed, Erum; Khan, Mubashir; Durab, Irfan; Mergenthaler, Christina; Hussain, Owais; Khan, Faisal; Khan, Aamir J.			An Evaluation of Systematic Tuberculosis Screening at Private Facilities in Karachi, Pakistan	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; CARE; HEALTH; DELAY; COMMUNITIES; DIAGNOSIS; SYMPTOMS; DISTRICT; COUGH; MIX	Background: In Pakistan, like many Asian countries, a large proportion of healthcare is provided through the private sector. We evaluated a systematic screening strategy to identify people with tuberculosis in private facilities in Karachi and assessed the approaches' ability to diagnose patients earlier in their disease progression. Methods and Findings: Lay workers at 89 private clinics and a large hospital outpatient department screened all attendees for tuberculosis using a mobile phone-based questionnaire during one year. The number needed to screen to detect a case of tuberculosis was calculated. To evaluate early diagnosis, we tested for differences in cough duration and smear grading by screening facility. 529,447 people were screened, 1,010 smear-positive tuberculosis cases were detected and 942 (93.3%) started treatment, representing 58.7% of all smear-positive cases notified in the intervention area. The number needed to screen to detect a smear-positive case was 124 (prevalence 806/100,000) at the hospital and 763 ( prevalence 131/100,000) at the clinics; however, ten times the number of individuals were screened in clinics. People with smear-positive TB detected at the hospital were less likely to report cough lasting 2-3 weeks (RR 0.66 95% Cl [0.49-0.90]) and more likely to report cough duration > 3 weeks (RR 1.10 95% Cl [1.03-1.18]). Smear-positive cases at the clinics were less likely to have a +3 grade (RR 0.76 95% Cl [0.63-0.92]) and more likely to have +1 smear grade (RR 1.24 95% Cl [1.02-1.51]). Conclusions: Tuberculosis screening at private facilities is acceptable and can yield large numbers of previously undiagnosed cases. Screening at general practitioner clinics may find cases earlier than at hospitals although more people must be screened to identify a case of tuberculosis. Limitations include lack of culture testing, therefore underestimating true TB prevalence. Using more sensitive and specific screening and diagnostic tests such as chest x-ray and Xpert MTB/RIF may improve results.	[Creswell, Jacob; Mergenthaler, Christina] Stop TB Partnership, Geneva, Switzerland; [Khowaja, Saira; Codlin, Andrew; Hashmi, Rabia; Rasheed, Erum; Khan, Mubashir; Durab, Irfan; Hussain, Owais; Khan, Faisal; Khan, Aamir J.] Interact Res & Dev, Karachi, Pakistan		Creswell, J (corresponding author), Stop TB Partnership, Geneva, Switzerland.	creswellj@who.int		Creswell, Jacob/0000-0002-4885-940X; Hussain, Owais/0000-0002-5449-1867	Foreign Affairs, Trade and Development of Canada	Foreign Affairs, Trade and Development of Canada	TB REACH, an initiative of the Stop TB Partnership, is funded by Foreign Affairs, Trade and Development of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.acdi-cida.gc.ca/home.	ALUOCH JA, 1985, TUBERCLE, V66, P237, DOI 10.1016/0041-3879(85)90061-3; Arantes G R, 1980, Rev Saude Publica, V14, P185, DOI 10.1590/S0034-89101980000200004; Asch S, 1998, AM J RESP CRIT CARE, V157, P1244, DOI 10.1164/ajrccm.157.4.9709071; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Cambodia National Tuberculosis Control Program, 2002, NAT TUB PREV SURV; Cattamanchi A, 2010, J CLIN MICROBIOL, V48, P2433, DOI 10.1128/JCM.00208-10; Claassens MM, 2013, INT J TUBERC LUNG D, V17, P608, DOI 10.5588/ijtld.12.0506; Codlin AJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-331; Den Boon S, 2008, EPIDEMIOL INFECT, V136, P1342, DOI 10.1017/S0950268807000106; Dowdy DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077517; Eang MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-469; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; KRIVINKA R, 1974, B WORLD HEALTH ORGAN, V51, P59; Lienhardt C, 2001, INT J TUBERC LUNG D, V5, P233; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Lonnroth K, 2006, B WORLD HEALTH ORGAN, V84, P876; Lonnroth K, 2004, B WORLD HEALTH ORGAN, V82, P580; Ministry of Health Department of Health Government of Myanmar, 2011, REP NAT TB PREV SURV; Ngadaya ES, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-112; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Pantoja A, 2009, INT J TUBERC LUNG D, V13, P698; Qadeer E., 2013, PREVALENCE PULMONARY; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Rieder H, 2004, TOMANS TUBERCULOSIS; Rojpibulstit M, 2006, INT J TUBERC LUNG D, V10, P422; Salim MAH, 2006, B WORLD HEALTH ORGAN, V84, P479, DOI 10.2471/BLT.05.023929; Santha T, 2005, INT J TUBERC LUNG D, V9, P61; Shapiro AE, 2013, SYSTEMATIC REV NUMBE; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Thomas Aleyamma, 2008, Indian J Tuberc, V55, P77; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; Uplekar M, 2013, INT J TUBERC LUNG D, V17, P1248, DOI 10.5588/ijtld.13.0199; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2013, SYST SCREEN ACT TUB	35	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93858	10.1371/journal.pone.0093858	http://dx.doi.org/10.1371/journal.pone.0093858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705600	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500080
J	Downs, LM; Mellersh, CS				Downs, Louise M.; Mellersh, Cathryn S.			An Intronic SINE Insertion in FAM161A that Causes Exon-Skipping Is Associated with Progressive Retinal Atrophy in Tibetan Spaniels and Tibetan Terriers	PLOS ONE			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; LEBER CONGENITAL AMAUROSIS; CONE-ROD DYSTROPHY; GENE-THERAPY; INDIAN FAMILY; DNA-SEQUENCE; MUTATIONS; DOGS; LOCUS; PHOTORECEPTOR	Progressive retinal atrophy (PRA) in dogs is characterised by the degeneration of the photoreceptor cells of the retina, resulting in vision loss and eventually complete blindness. The condition affects more than 100 dog breeds and is known to be genetically heterogeneous between breeds. Around 19 mutations have now been identified that are associated with PRA in around 49 breeds, but for the majority of breeds the mutation(s) responsible have yet to be identified. Using genome-wide association with 22 Tibetan Spaniel PRA cases and 10 controls, we identified a novel PRA locus, PRA3, on CFA10 (p(raw) = 2.01 x 10(-5), p(genome) = 0.014), where a 3.8 Mb region was homozygous within 12 cases. Using targeted next generation sequencing, a short interspersed nuclear element insertion was identified near a splice acceptor site in an intron of a provocative gene, FAM161A. Analysis of mRNA from an affected dog revealed that the SINE causes exon skipping, resulting in a frame shift, leading to a downstream premature termination codon and possibly a truncated protein product. This mutation segregates with the disease in 22 out of 35 cases tested (63%). Of the PRA controls, none are homozygous for the mutation, 15% carry the mutation and 85% are homozygous wildtype. This mutation was also identified in Tibetan Terriers, although our results indicate that PRA is genetically heterogeneous in both Tibetan Spaniels and Tibetan Terriers.	[Downs, Louise M.; Mellersh, Cathryn S.] Anim Hlth Trust, Genet Ctr, Kennel Club, Newmarket, Suffolk, England	Animal Health Trust	Mellersh, CS (corresponding author), Anim Hlth Trust, Genet Ctr, Kennel Club, Newmarket, Suffolk, England.	cathryn.mellersh@aht.org.uk		Burmeister, Louise/0000-0002-6551-055X	Petplan Charitable Trust [10-06]; Kennel Club Charitable Trust	Petplan Charitable Trust; Kennel Club Charitable Trust	The work was supported by the the Petplan Charitable Trust (grant no 10-06; http://www.petplantrust.org/) and by private donations from dog breeders and owners. The Kennel Club Genetics Centre at the Animal Health Trust is maintained by funding from the Kennel Club Charitable Trust (http://www.thekennelclub.org.uk/our-resources/kennel-club-charitable-trust/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Andre C, 2008, PRAT MED CHIR ANIM, V43, P75; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P382, DOI 10.1016/j.ajhg.2010.07.022; Beggs AH, 2010, P NATL ACAD SCI USA, V107, P14697, DOI 10.1073/pnas.1003677107; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; BJERKAS E, 1994, VET REC, V134, P377, DOI 10.1136/vr.134.15.377; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Clark LA, 2006, P NATL ACAD SCI USA, V103, P1376, DOI 10.1073/pnas.0506940103; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; den Hollander AI, 2007, NAT GENET, V39, P889, DOI 10.1038/ng2066; Di Gioia SA, 2012, HUM MOL GENET; Downs LL, 2012, TRAV GENRE SOC, P169; Downs LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021452; Fairbanks D.J., 1999, GENETICS CONTINUITY; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Gomez-Baldo L, 2010, CELL CYCLE, V9, P1143, DOI 10.4161/cc.9.6.11018; Grall A, 2012, NAT GENET, V44, P140, DOI 10.1038/ng.1056; GRONDAHL J, 1987, CLIN GENET, V31, P255; Gu SM, 1999, J MED GENET, V36, P705; HAIM M, 1992, ACTA OPHTHALMOL, V70, P178; Howell JM, 1997, NEUROMUSCULAR DISORD, V7, P325; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kumar A, 2004, MOL VIS, V10, P399; Langmann T, 2010, AM J HUM GENET, V87, P376, DOI 10.1016/j.ajhg.2010.07.018; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mellersh CS, 2006, GENOMICS, V88, P293, DOI 10.1016/j.ygeno.2006.05.004; MINNICK MF, 1992, GENE, V110, P235, DOI 10.1016/0378-1119(92)90654-8; Miyadera K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051598; Mount JD, 2002, BLOOD, V99, P2670, DOI 10.1182/blood.V99.8.2670; PAGON RA, 1988, SURV OPHTHALMOL, V33, P137, DOI 10.1016/0039-6257(88)90085-9; PARRY HB, 1953, BRIT J OPHTHALMOL, V37, P487, DOI 10.1136/bjo.37.8.487; Petersen-Jones S, 2005, J SMALL ANIM PRACT, V46, P371, DOI 10.1111/j.1748-5827.2005.tb00333.x; Ponder KP, 2002, P NATL ACAD SCI USA, V99, P13102, DOI 10.1073/pnas.192353499; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REED R, 1988, GENE DEV, V2, P1268, DOI 10.1101/gad.2.10.1268; REED R, 1985, CELL, V41, P95, DOI 10.1016/0092-8674(85)90064-9; Roy-Engel AM, 2002, GENOME RES, V12, P1333, DOI 10.1101/gr.384802; Rozen S, 2000, Methods Mol Biol, V132, P365; Sidjanin DJ, 2002, HUM MOL GENET, V11, P1823, DOI 10.1093/hmg/11.16.1823; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorvaldsdottir H, 2012, BRIEF BIOINFORM; Veske A, 1999, GENOMICS, V57, P57, DOI 10.1006/geno.1999.5754; Zach F, 2012, HUM MOL GENET	48	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93990	10.1371/journal.pone.0093990	http://dx.doi.org/10.1371/journal.pone.0093990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705771	Green Submitted, gold, Green Published			2022-12-27	WOS:000334107500105
J	Obradovic, AL; Hwang, SM; Scarpa, J; Hong, SJ; Todorovic, SM; Jevtovic-Todorovic, V				Obradovic, Aleksandar Lj.; Hwang, Sung Mi; Scarpa, Joseph; Hong, Sung Jun; Todorovic, Slobodan M.; Jevtovic-Todorovic, Vesna			CaV3.2 T-Type Calcium Channels in Peripheral Sensory Neurons Are Important for Mibefradil-Induced Reversal of Hyperalgesia and Allodynia in Rats with Painful Diabetic Neuropathy	PLOS ONE			English	Article							PHARMACOLOGICAL-PROPERTIES; RO 40-5967; INHIBITION; BLOCKADE	We recently showed that streptozotocin (STZ) injections in rats lead to the development of painful peripheral diabetic neuropathy (PDN) accompanied by enhancement of Ca(V)3.2 T-type calcium currents (T-currents) and hyperexcitability in dorsal root ganglion (DRG) neurons. Here we used the classical peripherally acting T-channel blocker mibefradil to examine the role of Ca(V)3.2 T-channels as pharmacological targets for treatment of painful PDN. When administered intraperitoneally (i.p.), at clinically relevant doses, mibefradil effectively alleviated heat, cold and mechanical hypersensitivities in STZ-treated diabetic rats in a dose-dependent manner. We also found that Ca(V)3.2 antisense (AS)-treated diabetic rats exhibit a significant decrease in painful PDN compared with mismatch antisense (MIS)-treated diabetic rats. Co-treatment with mibefradil (9 mg/kg i.p.) resulted in reversal of heat, cold and mechanical hypersensitivity in MIS-treated but not in AS-treated diabetic rats, suggesting that mibefradil and Ca(V)3.2 AS share the same cellular target. Using patch-clamp recordings from acutely dissociated DRG neurons, we demonstrated that mibefradil similarly blocked T-currents in diabetic and healthy rats in a voltage-dependent manner by stabilizing inactive states of T-channels. We conclude that antihyperalgesic and antiallodynic effects of mibefradil in PDN are at least partly mediated by inhibition of Ca(V)3.2 channels in peripheral nociceptors. Hence, peripherally acting voltage-dependent T-channel blockers could be very useful in the treatment of painful symptoms of PDN.	[Obradovic, Aleksandar Lj.; Hwang, Sung Mi; Scarpa, Joseph; Hong, Sung Jun; Todorovic, Slobodan M.; Jevtovic-Todorovic, Vesna] Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA 22903 USA; [Obradovic, Aleksandar Lj.] Univ Belgrade, Fac Pharm, Dept Physiol, Belgrade, Serbia; [Hwang, Sung Mi] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Anesthesiol & Pain Med, Chunchon, South Korea; [Hong, Sung Jun] Hallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Todorovic, Slobodan M.; Jevtovic-Todorovic, Vesna] Univ Virginia Hlth Syst, Dept Neurosci, Charlottesville, VA USA; [Todorovic, Slobodan M.; Jevtovic-Todorovic, Vesna] Univ Virginia Hlth Syst, Neurosci Grad Program, Charlottesville, VA USA	University of Virginia; University of Belgrade; Hallym University; Hallym University; University of Virginia; University of Virginia	Jevtovic-Todorovic, V (corresponding author), Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA 22903 USA.	vj3w@virginia.edu	Obradovic, Aleksandar/AAO-9200-2020	Obradovic, Aleksandar/0000-0003-0606-4913	National Institutes of Health [DA 029342]; American Diabetes Association Basic Research Grant [7-09-BS-190]; UVA Diabetes Launch Pad Grant; Hallym University; Harold Carron Endowment; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA029342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Basic Research Grant(American Diabetes Association); UVA Diabetes Launch Pad Grant; Hallym University; Harold Carron Endowment; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by grants from National Institutes of Health DA 029342 to SMT and VJT, American Diabetes Association Basic Research Grant 7-09-BS-190 to SMT, UVA Diabetes Launch Pad Grant to VJT, funds from Hallym University to SJH and SMH, and the Harold Carron Endowment to VJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara G, 2009, J NEUROSCI, V29, P13106, DOI 10.1523/JNEUROSCI.2919-09.2009; Barriere DA, 2012, PAIN, V153, P553, DOI 10.1016/j.pain.2011.11.019; Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; Brederson JD, 2013, EUR J PHARMACOL, V716, P61, DOI 10.1016/j.ejphar.2013.03.003; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Choe W, 2011, MOL PHARMACOL, V80, P900, DOI 10.1124/mol.111.073205; CHOI Y, 1994, PAIN, V59, P369, DOI 10.1016/0304-3959(94)90023-X; Clozel JP, 1997, J HYPERTENS, V15, pS17, DOI 10.1097/00004872-199715055-00004; Dogrul A, 2003, PAIN, V105, P159, DOI 10.1016/S0304-3959(03)00177-5; Edwards JL, 2008, PHARMACOL THERAPEUT, V120, P1, DOI 10.1016/j.pharmthera.2008.05.005; Ertel SI, 1997, CARDIOVASC DRUG THER, V11, P723, DOI 10.1023/A:1007706022381; Flatters SJL, 2004, PAIN, V109, P150, DOI 10.1016/j.pain.2004.01.029; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hulse RP, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-41; Jagodic MM, 2007, J NEUROSCI, V27, P3305, DOI 10.1523/JNEUROSCI.4866-06.2007; Jimenez C, 2000, NEUROPHARMACOLOGY, V39, P1, DOI 10.1016/S0028-3908(99)00153-7; Karam H, 1999, HYPERTENSION, V34, P673, DOI 10.1161/01.HYP.34.4.673; Khomula EV, 2013, BBA-MOL BASIS DIS, V1832, P636, DOI 10.1016/j.bbadis.2013.01.017; Kraus RL, 2010, J PHARMACOL EXP THER, V335, P409, DOI 10.1124/jpet.110.171058; Latham JR, 2009, DIABETES, V58, P2656, DOI 10.2337/db08-1763; McDonough SI, 1998, MOL PHARMACOL, V54, P1080, DOI 10.1124/mol.54.6.1080; McNulty MM, 2004, MOL PHARMACOL, V66, P1652, DOI 10.1124/mol.66.6.1652; Messinger RB, 2009, PAIN, V145, P184, DOI 10.1016/j.pain.2009.06.012; Naik AK, 2008, NEUROSCIENCE, V154, P1539, DOI 10.1016/j.neuroscience.2008.04.061; Nelson MT, 2007, J NEUROSCI, V27, P8250, DOI 10.1523/JNEUROSCI.1800-07.2007; Nelson MT, 2005, J NEUROSCI, V25, P8766, DOI 10.1523/JNEUROSCI.2527-05.2005; Paquette F, 1999, CARDIOVASC DRUG THER, V13, P525, DOI 10.1023/A:1007879704878; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Sandmann S, 2001, J CARDIOVASC PHARM, V37, P64, DOI 10.1097/00005344-200101000-00008; Todorovic SM, 2011, BRIT J PHARMACOL, V163, P484, DOI 10.1111/j.1476-5381.2011.01256.x; Todorovic SM, 2002, BRAIN RES, V951, P336, DOI 10.1016/S0006-8993(02)03350-4; Todorovic SM, 1998, J NEUROPHYSIOL, V79, P240, DOI 10.1152/jn.1998.79.1.240; Uebele VN, 2009, J CLIN INVEST, V119, P1659, DOI 10.1172/JCI36954; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Viana F, 1997, CELL CALCIUM, V22, P299, DOI 10.1016/S0143-4160(97)90068-3; Wu ZZ, 2004, J PHARMACOL EXP THER, V311, P939, DOI 10.1124/jpet.104.073429	36	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e91467	10.1371/journal.pone.0091467	http://dx.doi.org/10.1371/journal.pone.0091467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705276	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500004
J	Williams, RM; Nayeem, S; Dolash, BD; Sooter, LJ				Williams, Ryan M.; Nayeem, Sara; Dolash, Bridget D.; Sooter, Letha J.			The Effect of DNA-Dispersed Single-Walled Carbon Nanotubes on the Polymerase Chain Reaction	PLOS ONE			English	Article							BAND-GAP FLUORESCENCE; RECOGNITION; SEPARATION; SPECTROSCOPY; ENRICHMENT; BIOSENSORS	The unique properties of single-wall carbon nanotubes (SWCNT) make them useful in many new technologies and applications. The interaction of DNA and SWCNT is of interest for many uses, including molecular sensors. This study determined polymerase chain reaction (PCR) efficiency in amplifying a 76 base pair DNA sequence in the presence of SWCNT, of heterogeneous "Mix'' and (6,5)-enriched chiralities, associated with three DNA sequences. The dependence of PCR efficiency on the concentration of DNA: SWCNT preparations was measured, as well as their age and level of dispersion (less than one month or between four and ten months). Additionally, the ability to directly amplify the DNA sequence associated with the SWCNT scaffold was investigated. In PCRs with DNA: SWCNT preparations less than one month old, concentrations greater than or equal to 0.1 mg/mL inhibited the PCR reaction. In PCRs with older preparations, no inhibition was seen at 0.01 or 0.1 mg/mL, with amplification at 1 mg/mL in some samples. Additionally, our studies showed that the DNA directly associated with the SWCNT can be amplified using PCR. This work provides an inhibitory concentration of DNA-dispersed SWCNT in PCR reactions for different preparations as well as a basis for future DNA: SWCNT studies that require PCR amplification. This will be useful for future studies focused on the use of SWCNT in molecular sensing technologies.	[Williams, Ryan M.; Nayeem, Sara; Dolash, Bridget D.; Sooter, Letha J.] W Virginia Univ, Morgantown, WV 26506 USA	West Virginia University	Sooter, LJ (corresponding author), W Virginia Univ, Morgantown, WV 26506 USA.	lsooter@hsc.wvu.edu			National Science Foundation Cooperative Agreements [NSF-1003907, NSF-0554328]; Department of Defense Cooperative Agreement [W911NF-09-2-0044]; West Virginia University; American Foundation for Pharmaceutical Education	National Science Foundation Cooperative Agreements(National Science Foundation (NSF)); Department of Defense Cooperative Agreement; West Virginia University; American Foundation for Pharmaceutical Education	This work was supported by National Science Foundation Cooperative Agreements (NSF-1003907 and NSF-0554328) (http://www.nsf.gov/). This work was also supported by a Department of Defense Cooperative Agreement (W911NF-09-2-0044 (http://www.defense.gov/). The work was also supported by West Virginia University (http://www.wvu.edu/). RMW was supported in part by a fellowship from the American Foundation for Pharmaceutical Education (http://www.afpenet.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g; Albertorio F, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/39/395101; Avouris P, 2008, NAT PHOTONICS, V2, P341, DOI 10.1038/nphoton.2008.94; Coleman JN, 2006, CARBON, V44, P1624, DOI 10.1016/j.carbon.2006.02.038; Cui DX, 2004, NANOTECHNOLOGY, V15, P154, DOI 10.1088/0957-4484/15/1/030; Heller DA, 2005, ADV MATER, V17, P2793, DOI 10.1002/adma.200500477; Huang HD, 2011, TRAC-TREND ANAL CHEM, V30, P1109, DOI 10.1016/j.trac.2011.03.014; Huang XY, 2005, ANAL CHEM, V77, P6225, DOI 10.1021/ac0508954; Huy GD, 2011, BIOPROC BIOSYST ENG, V34, P189, DOI 10.1007/s00449-010-0460-4; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Jeng ES, 2006, NANO LETT, V6, P371, DOI 10.1021/nl051829k; Khandurina J, 2000, ANAL CHEM, V72, P2995, DOI 10.1021/ac991471a; Kim SN, 2008, NANO LETT, V8, P4415, DOI 10.1021/nl802332v; Kim YS, 2007, BIOSENS BIOELECTRON, V22, P2525, DOI 10.1016/j.bios.2006.10.004; Lahiji RR, 2007, SMALL, V3, P1912, DOI 10.1002/smll.200700184; Langan TJ, 2012, ELECTROPHORESIS, V33, P866, DOI 10.1002/elps.201100411; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; SAITO R, 1992, APPL PHYS LETT, V60, P2204, DOI 10.1063/1.107080; So HM, 2005, J AM CHEM SOC, V127, P11906, DOI 10.1021/ja053094r; So HM, 2008, SMALL, V4, P197, DOI 10.1002/smll.200700664; Tu XM, 2011, J AM CHEM SOC, V133, P12998, DOI 10.1021/ja205407q; Tu XM, 2009, NATURE, V460, P250, DOI 10.1038/nature08116; Wang J, 2005, ELECTROANAL, V17, P7, DOI 10.1002/elan.200403113; Weisman RB, 2010, ANAL BIOANAL CHEM, V396, P1015, DOI 10.1007/s00216-009-3062-8; Yi CQ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/2/025102; Zhang YN, 2010, NANOSCALE, V2, P1919, DOI 10.1039/c0nr00222d; Zhang ZZ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/35/355706; Zhang ZZ, 2008, BIOTECHNIQUES, V44, P537, DOI 10.2144/000112692; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877	30	21	22	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94117	10.1371/journal.pone.0094117	http://dx.doi.org/10.1371/journal.pone.0094117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705714	Green Submitted, gold, Green Published			2022-12-27	WOS:000334107500124
J	Yadav, K; Kumar, C; Archana, G; Kumar, GN				Yadav, Kavita; Kumar, Chanchal; Archana, G.; Kumar, G. Naresh			Pseudomonas fluorescens ATCC 13525 Containing an Artificial Oxalate Operon and Vitreoscilla Hemoglobin Secretes Oxalic Acid and Solubilizes Rock Phosphate in Acidic Alfisols	PLOS ONE			English	Article							HETEROLOGOUS EXPRESSION; OXALOACETATE HYDROLASE; OXALOBACTER-FORMIGENES; TRICARBOXYLIC-ACID; ORGANIC-ACIDS; PLANT-GROWTH; TRANSPORTER; BACTERIA; CLONING; INVOLVEMENT	Oxalate secretion was achieved in Pseudomonas fluorescens ATCC 13525 by incorporation of genes encoding Aspergillus niger oxaloacetate acetyl hydrolase (oah), Fomitopsis plaustris oxalate transporter (FpOAR) and Vitreoscilla hemoglobin (vgb) in various combinations. Pf (pKCN2) transformant containing oah alone accumulated 19 mM oxalic acid intracellularly but secreted 1.2 mM. However, in the presence of an artificial oxalate operon containing oah and FpOAR genes in plasmid pKCN4, Pf (pKCN4) secreted 13.6 mM oxalate in the medium while 3.6 mM remained inside. This transformant solubilized 509 mM of phosphorus from rock phosphate in alfisol which is 4.5 fold higher than the Pf (pKCN2) transformant. Genomic integrants of P. fluorescens (Pf int1 and Pf int2) containing artificial oxalate operon (plac-FpOAR-oah) and artificial oxalate gene cluster (plac-FpOAR-oah, vgb, egfp) secreted 4.8 mM and 5.4 mM oxalic acid, released 329 mM and 351 mM P, respectively, in alfisol. The integrants showed enhanced root colonization, improved growth and increased P content of Vigna radiata plants. This study demonstrates oxalic acid secretion in P. fluorescens by incorporation of an artificial operon constituted of genes for oxalate synthesis and transport, which imparts mineral phosphate solubilizing ability to the organism leading to enhanced growth and P content of V. radiata in alfisol soil.	[Yadav, Kavita; Kumar, Chanchal; Kumar, G. Naresh] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Mol Microbial Biochem Lab, Vadodara, India; [Archana, G.] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Microbiol, Vadodara, India; [Archana, G.] Maharaja Sayajirao Univ Baroda, Fac Sci, Ctr Biotechnol, Vadodara, India	Maharaja Sayajirao University Baroda; Maharaja Sayajirao University Baroda; Maharaja Sayajirao University Baroda	Kumar, GN (corresponding author), Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Mol Microbial Biochem Lab, Vadodara, India.	gnaresh_k@yahoo.co.in	Kumar, Chanchal/I-8545-2016; Archana, G/AAA-8828-2019; Gattupalli, Naresh Kumar/AAF-5987-2020	Gattupalli, Nareshkumar/0000-0001-7317-7438; YADAV, KAVITA/0000-0002-2249-0675	Council for Scientific and Industrial Research, (CSIR) New Delhi, Government of India	Council for Scientific and Industrial Research, (CSIR) New Delhi, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	CK was provided with a fellowship from the Council for Scientific and Industrial Research, (CSIR) New Delhi, Government of India.	AE N, 1990, SCIENCE, V248, P477, DOI 10.1126/science.248.4954.477; Ae N, 1991, PHOSPHORUS RESPONSE; Agbenin JO, 2003, SOIL SCI SOC AM J, V67, P589, DOI 10.2136/sssaj2003.0589; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Yarzabal LA, 2010, SOIL BIOL, V21, P209, DOI 10.1007/978-3-642-05076-3_10; Appanna VD, 2003, CURR MICROBIOL, V47, P521, DOI 10.1007/s00284-003-4100-y; Archana G., 2012, MICROORGANISMS SUSTA, P35, DOI DOI 10.1007/978-94-007-2214-9_3; BOLAN NS, 1994, BIOL FERT SOILS, V18, P311, DOI 10.1007/BF00570634; Buch AD, 2010, APPL MICROBIOL BIOT, V88, P209, DOI 10.1007/s00253-010-2717-x; Chen C, 2010, J BIOL CHEM, V285, P26685, DOI 10.1074/jbc.M110.117804; Chien SH, 2011, NUTR CYCL AGROECOSYS, V89, P229, DOI 10.1007/s10705-010-9390-4; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; El-Swaify S.A., 1985, ADV SOIL SCI, V1, P1, DOI [10.1007/978-1-4612-5046-3_1, DOI 10.1007/978-1-4612-5046-3_]; Fu DX, 1998, J BIOL CHEM, V273, P17962, DOI 10.1074/jbc.273.28.17962; Gadd GM, 1999, ADV MICROB PHYSIOL, V41, P47, DOI 10.1016/S0065-2911(08)60165-4; Gyaneshwar P, 1999, FEMS MICROBIOL LETT, V171, P223, DOI 10.1111/j.1574-6968.1999.tb13436.x; Gyaneshwar P, 1998, WORLD J MICROB BIOT, V14, P669, DOI 10.1023/A:1008852718733; Gyaneshwar P, 2002, PLANT SOIL, V245, P83, DOI 10.1023/A:1020663916259; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Han Y, 2007, J BIOL CHEM, V282, P9581, DOI 10.1074/jbc.M608961200; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; JONES DL, 1994, PLANT SOIL, V166, P247, DOI 10.1007/BF00008338; Khademi Z, 2010, PLANT SOIL, V334, P151, DOI 10.1007/s11104-009-0215-7; KHAN MS, 2006, AGRON SUSTAIN DEV, V26, P1, DOI DOI 10.1051/agro:2005055; KHOSLA C, 1988, MOL GEN GENET, V214, P158, DOI 10.1007/BF00340195; KHOSLA C, 1988, NATURE, V331, P633, DOI 10.1038/331633a0; KPOMBLEKOUA K, 1994, SOIL SCI, V158, P442, DOI 10.1097/00010694-199415860-00006; KUBICEK CP, 1988, APPL ENVIRON MICROB, V54, P633, DOI 10.1128/AEM.54.3.633-637.1988; KUCEY RMN, 1989, ADV AGRON, V42, P199; LENZ H, 1976, EUR J BIOCHEM, V65, P225, DOI 10.1111/j.1432-1033.1976.tb10409.x; Liu YH, 2012, J FOOD AGRIC ENVIRON, V10, P1001; Ma JF, 1998, PLANT PHYSIOL, V117, P753, DOI 10.1104/pp.117.3.753; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Patel KJ, 2010, J MICROBIOL BIOTECHN, V20, P1491, DOI 10.4014/jmb.1006.06016; Pedersen H, 2000, MOL GEN GENET, V263, P281, DOI 10.1007/s004380051169; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; Rajan SSS, 1996, ADV AGRON, V57, P77, DOI 10.1016/S0065-2113(08)60923-2; Ramirez M, 1999, MOL PLANT MICROBE IN, V12, P1008, DOI 10.1094/MPMI.1999.12.11.1008; Reyes I, 1999, FEMS MICROBIOL ECOL, V28, P291, DOI 10.1016/S0168-6496(98)00118-4; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; Sambrook J., 2001, MOL CLONING LAB MANU; Singh R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007344; Srivastava S, 2006, DEV PLANT SOIL SCI, P117; Stark BC, 2011, BIOTECHNOL LETT, V33, P1705, DOI 10.1007/s10529-011-0621-9; Valentini M, 2011, J BACTERIOL, V193, P4307, DOI 10.1128/JB.05074-11; Vassilev N, 1996, BIORESOURCE TECHNOL, V55, P237, DOI 10.1016/0960-8524(96)00008-9; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; Watanabe T, 2010, APPL ENVIRON MICROB, V76, P7683, DOI 10.1128/AEM.00829-10; Ye LW, 2001, J BACTERIOL, V183, P2490, DOI 10.1128/JB.183.8.2490-2496.2001	51	11	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92400	10.1371/journal.pone.0092400	http://dx.doi.org/10.1371/journal.pone.0092400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705024	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500016
J	Brizuela, M; Huang, HM; Smith, C; Burgio, G; Foote, SJ; McMorran, BJ				Brizuela, Mariana; Huang, Hong Ming; Smith, Clare; Burgio, Gaetan; Foote, Simon J.; McMorran, Brendan J.			Treatment of Erythrocytes with the 2-Cys Peroxiredoxin Inhibitor, Conoidin A, Prevents the Growth of Plasmodium falciparum and Enhances Parasite Sensitivity to Chloroquine	PLOS ONE			English	Article							OXIDATIVE STRESS; MALARIA; RESISTANCE; ARTEMISININ; GLUTATHIONE; PEROXIDE; SURVIVAL; REQUIRES; DEFENSE; BERGHEI	The human erythrocyte contains an abundance of the thiol-dependant peroxidase Peroxiredoxin-2 (Prx2), which protects the cell from the pro-oxidant environment it encounters during its 120 days of life in the blood stream. In malarial infections, the Plasmodium parasite invades red cells and imports Prx2 during intraerythrocytic development, presumably to supplement in its own degradation of peroxides generated during cell metabolism, especially hemoglobin (Hb) digestion. Here we demonstrate that an irreversible Prx2 inhibitor, Conoidin A (2,3-bis(bromomethyl)-1,4-dioxide-quinoxaline; BBMQ), has potent cytocidal activity against cultured P. falciparum. Parasite growth was also inhibited in red cells that were treated with BBMQ and then washed prior to parasite infection. These cells remained susceptible to merozoite invasion, but failed to support normal intraerythrocytic development. In addition the potency of chloroquine (CQ), an antimalarial drug that prevents the detoxification of Hb-derived heme, was significantly enhanced in the presence of BBMQ. CQ IC50 values decreased an order of magnitude when parasites were either co-incubated with BBMQ, or introduced into BBMQ-pretreated cells; these effects were equivalent for both drug-resistant and drug-sensitive parasite lines. Together these results indicate that treatment of red cells with BBMQ renders them incapable of supporting parasite growth and increases parasite sensitivity to CQ. We also propose that molecules such as BBMQ that target host cell proteins may constitute a novel host-directed therapeutic approach for treating malaria.	[Brizuela, Mariana; Smith, Clare] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Huang, Hong Ming; Burgio, Gaetan; Foote, Simon J.; McMorran, Brendan J.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia	University of Tasmania; Macquarie University	McMorran, BJ (corresponding author), Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia.	Brendan.mcmorran@mq.edu.au	Burgio, Gaetan/B-6722-2015	Burgio, Gaetan/0000-0002-7434-926X; McMorran, Brendan/0000-0003-1845-8872; Foote, Simon/0000-0002-9142-2107; Smith, Clare M./0000-0003-2601-0955	Australian Research Council [DP120100061]; National Health and Medical Research Council of Australia [490037, 605524]; Australian Cancer Research Foundation; National Collaborative Research Infrastructure Strategy of Australia; Bill & Melinda Gates Foundation Grand Challenges Explorations; Howard Hughes Medical Institute	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation; National Collaborative Research Infrastructure Strategy of Australia(Australian GovernmentDepartment of Industry, Innovation and Science); Bill & Melinda Gates Foundation Grand Challenges Explorations; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The Australian Research Council (DP120100061; http://www.arc.gov.au); The National Health and Medical Research Council of Australia (490037 and 605524), http://www.nhmrc.gov.au. Australian Cancer Research Foundation, The National Collaborative Research Infrastructure Strategy of Australia, The Bill & Melinda Gates Foundation Grand Challenges Explorations and The Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; DUBOIS VL, 1995, EXP PARASITOL, V81, P117, DOI 10.1006/expr.1995.1099; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Fitch CD, 2004, LIFE SCI, V74, P1957, DOI 10.1016/j.lfs.2003.10.003; Foote SJ, 2004, PHARMACOGENOMICS J, V4, P141, DOI 10.1038/sj.tpj.6500241; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Frosch AEP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-116; Han YH, 2012, BIOCHEM BIOPH RES CO, V426, P427, DOI 10.1016/j.bbrc.2012.08.113; Haraldsen JD, 2009, ORG BIOMOL CHEM, V7, P3040, DOI 10.1039/b901735f; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; Koncarevic S, 2009, P NATL ACAD SCI USA, V106, P13323, DOI 10.1073/pnas.0905387106; Krnajski Z, 2002, J BIOL CHEM, V277, P25970, DOI 10.1074/jbc.M203539200; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Li QG, 2007, CYTOM PART A, V71A, P297, DOI 10.1002/cyto.a.20380; Low FM, 2007, BLOOD, V109, P2611, DOI 10.1182/blood-2006-09-048728; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; MOORE RB, 1991, J BIOL CHEM, V266, P18964; Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x; Nickel C, 2006, ANTIOXID REDOX SIGN, V8, P1227, DOI 10.1089/ars.2006.8.1227; Nogueira F, 2010, ACTA TROP, V114, P109, DOI 10.1016/j.actatropica.2010.01.013; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Prudencio M, 2013, CURR PHARM DESIGN, V19, P290, DOI 10.2174/138161213804070276; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Richard D, 2011, J BIOL CHEM, V286, P11746, DOI 10.1074/jbc.M110.198499; Safeukui I, 2004, BIOCHEM PHARMACOL, V68, P1903, DOI 10.1016/j.bcp.2004.05.049; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tucker MS, 2012, ANTIMICROB AGENTS CH, V56, P302, DOI 10.1128/AAC.05540-11; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wilson DW, 2013, ANTIMICROB AGENTS CH, V57, P1455, DOI 10.1128/AAC.01881-12; Witkowski B, 2010, ANTIMICROB AGENTS CH, V54, P1872, DOI 10.1128/AAC.01636-09	31	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92411	10.1371/journal.pone.0092411	http://dx.doi.org/10.1371/journal.pone.0092411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699133	gold, Green Published, Green Submitted			2022-12-27	WOS:000334105000025
J	Rod, NH; Kumari, M; Lange, T; Kivimaki, M; Shipley, M; Ferrie, J				Rod, Naja Hulvej; Kumari, Meena; Lange, Theis; Kivimaeki, Mika; Shipley, Martin; Ferrie, Jane			The Joint Effect of Sleep Duration and Disturbed Sleep on Cause-Specific Mortality: Results from the Whitehall II Cohort Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; RISK; EPIDEMIOLOGY; ASSOCIATIONS; INSOMNIA; QUALITY	Background: Both sleep duration and sleep quality are related to future health, but their combined effects on mortality are unsettled. We aimed to examine the individual and joint effects of sleep duration and sleep disturbances on cause-specific mortality in a large prospective cohort study. Methods: We included 9,098 men and women free of pre-existing disease from the Whitehall II study, UK. Sleep measures were self-reported at baseline (1985-1988). Participants were followed until 2010 in a nationwide death register for total and cause-specific (cardiovascular disease, cancer and other) mortality. Results: There were 804 deaths over a mean 22 year follow-up period. In men, short sleep (<= 6 hrs/night) and disturbed sleep were not independently associated with CVD mortality, but there was an indication of higher risk among men who experienced both (HR = 1.57; 95% CI: 0.96-2.58). In women, short sleep and disturbed sleep were independently associated with CVD mortality, and women with both short and disturbed sleep experienced a much higher risk of CVD mortality (3.19; 1.52-6.72) compared to those who slept 7-8 hours with no sleep disturbances; equivalent to approximately 90 additional deaths per 100,000 person years. Sleep was not associated with death due to cancer or other causes. Conclusion: Both short sleep and disturbed sleep are independent risk factors for CVD mortality in women and future studies on sleep may benefit from assessing disturbed sleep in addition to sleep duration in order to capture health-relevant features of inadequate sleep.	[Rod, Naja Hulvej; Lange, Theis] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Rod, Naja Hulvej] Copenhagen Stress Res Ctr, Copenhagen, Denmark; [Kumari, Meena; Kivimaeki, Mika; Shipley, Martin; Ferrie, Jane] UCL, Dept Epidemiol & Publ Hlth, London, England; [Ferrie, Jane] Univ Bristol, Sch Social & Community Med, Bristol, England	University of Copenhagen; University of London; University College London; University of Bristol	Rod, NH (corresponding author), Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark.	nahuro@sund.ku.dk	Ferrie, Jane/AAZ-2009-2020; Kivimaki, Mika/B-3607-2012; Rod, Naja/B-9411-2015	Kivimaki, Mika/0000-0002-4699-5627; Rod, Naja/0000-0002-6400-5105; Lange, Theis/0000-0001-6807-8347	UK Dunhill Medical Trust; National Heart, Lung and Blood Institute [R01HL36310]; ESRC professorship, UK; Academy of Finland; EU New OSH ERA research programme; British Heart Foundation; ESRC [ES/H029745/1, ES/K005146/1, ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI; British Heart Foundation [RG/13/2/30098] Funding Source: researchfish; Economic and Social Research Council [ES/H029745/1, ES/J023299/1, ES/K005146/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1] Funding Source: researchfish; The Dunhill Medical Trust [R247/0512] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196] Funding Source: NIH RePORTER	UK Dunhill Medical Trust; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ESRC professorship, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Academy of Finland(Academy of Finland); EU New OSH ERA research programme; British Heart Foundation(British Heart Foundation); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Dunhill Medical Trust(Dunhill Medical Trust); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The UK Medical Research Council, British Heart Foundation, and the US National Institutes of Health (R01HL36310, R01AG013196) have supported collection of data in the Whitehall II Study. Meena Kumari is supported by the UK Dunhill Medical Trust and the National Heart, Lung and Blood Institute (R01HL36310); Mika Kivimaki by an ESRC professorship, UK, the Academy of Finland, and the EU New OSH ERA research programme; and Martin J. Shipley by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cappuccio FP, 2007, HYPERTENSION, V50, P693, DOI 10.1161/HYPERTENSIONAHA.107.095471; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Chandola T, 2010, SLEEP, V33, P739, DOI 10.1093/sleep/33.6.739; Chien KL, 2010, SLEEP, V33, P177, DOI 10.1093/sleep/33.2.177; Ferrie JE, 2007, SLEEP, V30, P1659, DOI 10.1093/sleep/30.12.1659; Ferrie JE, 2011, SLEEP EPIDEMIOLOGY A; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Greenland S, 2009, EPIDEMIOLOGY, V20, P14, DOI 10.1097/EDE.0b013e318193e7b5; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Krueger PM, 2009, AM J EPIDEMIOL, V169, P1052, DOI 10.1093/aje/kwp023; Kumari M, 2009, J CLIN ENDOCR METAB, V94, P4801, DOI 10.1210/jc.2009-0555; Lockley SW, 1999, J SLEEP RES, V8, P175, DOI 10.1046/j.1365-2869.1999.00155.x; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Martinussen T., 2006, STAT BIOL HEALTH; McEwen BS, 2006, METABOLISM, V55, pS20, DOI 10.1016/j.metabol.2006.07.008; Miller MA, 2009, SLEEP, V32, P857; Patel SR, 2004, SLEEP, V27, P440, DOI 10.1093/sleep/27.3.440; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Rod NH, 2012, EPIDEMIOLOGY, V23, P733, DOI 10.1097/EDE.0b013e31825fa218; Rod NH, 2011, AM J EPIDEMIOL, V173, P300, DOI 10.1093/aje/kwq371; Signal TL, 2005, AVIAT SPACE ENVIR MD, V76, P1058; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Tasali E, 2009, PROG CARDIOVASC DIS, V51, P381, DOI 10.1016/j.pcad.2008.10.002; Vgontzas AN, 2010, SLEEP, V33, P1159, DOI 10.1093/sleep/33.9.1159; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young T, 2000, SLEEP, V23, pS122	28	70	70	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e91965	10.1371/journal.pone.0091965	http://dx.doi.org/10.1371/journal.pone.0091965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699341	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000334105000018
J	Almukhtar, A; Ju, XY; Khambay, B; McDonald, J; Ayoub, A				Almukhtar, Anas; Ju, Xiangyang; Khambay, Balvinder; McDonald, James; Ayoub, Ashraf			Comparison of the Accuracy of Voxel Based Registration and Surface Based Registration for 3D Assessment of Surgical Change following Orthognathic Surgery	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; SOFT-TISSUE CHANGES; MAXILLARY HYPOPLASIA; MUTUAL INFORMATION; SUPERIMPOSITION	Purpose: Superimposition of two dimensional preoperative and postoperative facial images, including radiographs and photographs, are used to evaluate the surgical changes after orthognathic surgery. Recently, three dimensional (3D) imaging has been introduced allowing more accurate analysis of surgical changes. Surface based registration and voxel based registration are commonly used methods for 3D superimposition. The aim of this study was to evaluate and compare the accuracy of the two methods. Materials and methods: Pre-operative and 6 months post-operative cone beam CT scan (CBCT) images of 31 patients were randomly selected from the orthognathic patient database at the Dental Hospital and School, University of Glasgow, UK. Voxel based registration was performed on the DICOM images (Digital Imaging Communication in Medicine) using Maxilim software (Medicim-Medical Image Computing, Belgium). Surface based registration was performed on the soft and hard tissue 3D models using VRMesh (VirtualGrid, Bellevue City, WA). The accuracy of the superimposition was evaluated by measuring the mean value of the absolute distance between the two 3D image surfaces. The results were statistically analysed using a paired Student t-test, ANOVA with post-hoc Duncan test, a one sample t-test and Pearson correlation coefficient test. Results: The results showed no significant statistical difference between the two superimposition methods (p < 0.05). However surface based registration showed a high variability in the mean distances between the corresponding surfaces compared to voxel based registration, especially for soft tissue. Within each method there was a significant difference between superimposition of the soft and hard tissue models. Conclusions: There were no significant statistical differences between the two registration methods and it was unlikely to have any clinical significance. Voxel based registration was associated with less variability. Registering on the soft tissue in isolation from the hard tissue may not be a true reflection of the surgical change.	[Almukhtar, Anas; McDonald, James] Univ Glasgow, Glasgow Dent Sch, Dept Orthodont, Glasgow, Lanark, Scotland; [Ju, Xiangyang] NHS Greater Glasgow & Clyde, Dept Clin Phys & Bioengn, Med Device Unit, Glasgow, Lanark, Scotland; [Ju, Xiangyang] Univ Glasgow, Glasgow Dent Sch, Glasgow, Lanark, Scotland; [Khambay, Balvinder] Univ Hong Kong, Fac Dent, Discipline Orthodont & Paediat Dent, Hong Kong, Hong Kong, Peoples R China; [Ayoub, Ashraf] Univ Glasgow, Glasgow Dent Sch, Oral & Maxillofacial Surg Dept, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Hong Kong; University of Glasgow	Khambay, B (corresponding author), Univ Hong Kong, Fac Dent, Discipline Orthodont & Paediat Dent, Hong Kong, Hong Kong, Peoples R China.	bkhambay@hku.hk	Almukhtar, Anas/G-4217-2019	Ayoub, Ashraf/0000-0002-2760-6008; Almukhtar, Anas/0000-0003-3696-6424; Ju, Xiangyang/0000-0003-3471-7256				Baik HS, 2010, AM J ORTHOD DENTOFAC, V138, P167, DOI 10.1016/j.ajodo.2010.02.022; BAUMRIND S, 1976, AM J ORTHOD DENTOFAC, V70, P617, DOI 10.1016/0002-9416(76)90224-4; Bell A, 2003, J Orthod, V30, P219, DOI 10.1093/ortho/30.3.219; CHOW J, 1995, J ORAL MAXIL SURG, V53, P1407, DOI 10.1016/0278-2391(95)90665-7; Hajeer MY, 2004, BRIT J ORAL MAX SURG, V42, P396, DOI 10.1016/j.bjoms.2004.05.006; Kim BR, 2013, J ORAL MAXIL SURG, V71, P151, DOI 10.1016/j.joms.2012.02.005; Kim YK, 2009, J CRANIO MAXILL SURG, V37, P63, DOI 10.1016/j.jcms.2008.10.011; Lee JH, 2012, OR SURG OR MED OR PA, V114, P167, DOI 10.1016/j.tripleo.2011.06.003; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Ludlow JB, 2006, DENTOMAXILLOFAC RAD, V35, P219, DOI 10.1259/dmfr/14340323; Maal TJJ, 2012, INT J ORAL MAX SURG, V41, P1137, DOI 10.1016/j.ijom.2012.04.004; MacDonald-Jankowski D., 2006, ASIAN J ORAL MAXILLO, V18, P85; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Molteni R, 2013, OR SURG OR MED OR PA, V116, P105, DOI 10.1016/j.oooo.2013.04.013; Nada RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016520; Park SB, 2012, J CRANIO MAXILL SURG, V40, pE87, DOI 10.1016/j.jcms.2011.05.008; Scarfe WC, 2006, J CAN DENT ASSOC, V72, P75; Slomka PJ, 2001, ULTRASOUND MED BIOL, V27, P945, DOI 10.1016/S0301-5629(01)00387-8; Ubaya T, 2012, INT J ORAL MAX SURG, V41, P727, DOI 10.1016/j.ijom.2012.01.019	19	92	96	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93402	10.1371/journal.pone.0093402	http://dx.doi.org/10.1371/journal.pone.0093402			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695577	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000334103000068
J	Fujita, M; Takada, YK; Izumiya, Y; Takada, Y				Fujita, Masaaki; Takada, Yoko K.; Izumiya, Yoshihiro; Takada, Yoshikazu			The Binding of Monomeric C-Reactive Protein (mCRP) to Integrins alpha v beta 3 and alpha 4 beta 1 Is Related to Its Pro-Inflammatory Action	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ACTIVATED PLATELETS; ENDOTHELIAL-CELLS; LIGAND-BINDING; RISK; EXPRESSION; SUBUNIT; MARKERS	The prototypic acute phase reactant C-reactive protein (CRP) is not only a marker but also a potential contributor to inflammatory diseases. CRP exists as the circulating native, pentameric CRP (pCRP) and the monomeric isoform (mCRP), formed as a result of a dissociation process of pCRP. mCRP is highly pro-inflammatory, but pCRP is not. The mechanism of pro-inflammatory action of mCRP is unclear. We studied the role of integrins in pro-inflammatory action of mCRP. Docking simulation of interaction between mCRP and integrin alpha v beta 3 predicted that mCRP binds to alpha v beta 3 well. We found that mCRP actually bound to integrins alpha v beta 3 and alpha 4 beta 1 well. Antagonists to alpha v beta 3 or alpha 4 beta 1 effectively suppressed the interaction, suggesting that the interaction is specific. Using an integrin beta 1 mutant (beta 1-3-1) that has a small fragment from the ligand binding site of beta 3, we showed that mCRP bound to the classical RGD-binding site in alpha v beta 3. We studied the role of integrins in CRP signaling in monocytic U937 cells. Integrins alpha v beta 3 and alpha 4 beta 1 specifically mediated binding of mCRP to U937 cells. mCRP induced AKT phosphorylation, but not ERK1/2 phosphorylation, in U937 cells. Notably, mCRP induced robust chemotaxis in U937 cells, and antagonists to integrins alpha v beta 3 and alpha 4 beta 1 and an inhibitor to phosphatidylinositide 3-kinase, but not an MEK inhibitor, effectively suppressed mCRP-induced chemotaxis in U937 cells. These results suggest that the integrin and AKT/phosphatidylinositide 3-kinase pathways play a role in pro-inflammatory action of mCRP in U937 cells. In contrast, pCRP is predicted to have a limited access to alpha v beta 3 due to steric hindrance in the simulation. Consistent with the prediction, pCRP was much less effective in integrin binding, chemotaxis, or AKT phosphorylation. These findings suggest that the ability of CRP isoforms to bind to the integrins is related to their pro-inflammatory action.	[Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Takada, Y (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu			NIH [CA13015]; TRDRP [18TX-0169]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TRDRP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH CA13015 and TRDRP (tobacco-related disease research program; grant 18TX-0169) to YT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov AS, 2004, AM J PATHOL, V165, P247, DOI 10.1016/S0002-9440(10)63293-2; AUMAILLEY M, 1991, FEBS LETT, V291, P50, DOI 10.1016/0014-5793(91)81101-D; Brennan MP, 2008, J THROMB HAEMOST, V6, P1239, DOI 10.1111/j.1538-7836.2008.02993.x; Chen LL, 1999, J BIOL CHEM, V274, P13167, DOI 10.1074/jbc.274.19.13167; Eisenhardt SU, 2009, TRENDS CARDIOVAS MED, V19, P232, DOI 10.1016/j.tcm.2010.02.002; Eisenhardt SU, 2009, CELL CYCLE, V8, P3885, DOI 10.4161/cc.8.23.10068; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; Heuertz RM, 2005, INT J BIOCHEM CELL B, V37, P320, DOI 10.1016/j.biocel.2004.07.002; HOSHIGA M, 1995, CIRC RES, V77, P1129, DOI 10.1161/01.RES.77.6.1129; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IRIE A, 1995, EMBO J, V14, P5550, DOI 10.1002/j.1460-2075.1995.tb00242.x; Ji SR, 2009, FASEB J, V23, P1806, DOI 10.1096/fj.08-116962; KAMATA T, 1995, BIOCHEM J, V305, P945, DOI 10.1042/bj3050945; Khreiss T, 2004, CIRCULATION, V109, P2016, DOI 10.1161/01.CIR.0000125527.41598.68; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Molins B, 2008, ARTERIOSCL THROM VAS, V28, P2239, DOI 10.1161/ATVBAHA.108.174359; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; POTEMPA LA, 1983, MOL IMMUNOL, V20, P1165, DOI 10.1016/0161-5890(83)90140-2; POTEMPA LA, 1987, MOL IMMUNOL, V24, P531, DOI 10.1016/0161-5890(87)90028-9; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Saegusa J, 2008, J BIOL CHEM, V283, P26107, DOI 10.1074/jbc.M804835200; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Slevin M, 2010, BRAIN PATHOL, V20, P151, DOI 10.1111/j.1750-3639.2008.00256.x; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Tsimikas S, 2006, J AM COLL CARDIOL, V47, pC19, DOI 10.1016/j.jacc.2005.10.066; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yeh ETH, 2003, CIRCULATION, V107, P370, DOI 10.1161/01.CIR.0000053731.05365.5A; Zhao J, 2010, CELL MOL BIOL LETT, V15, P485, DOI 10.2478/s11658-010-0022-4	29	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93738	10.1371/journal.pone.0093738	http://dx.doi.org/10.1371/journal.pone.0093738			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695572	gold, Green Published, Green Submitted			2022-12-27	WOS:000334103000115
J	Gaimster, H; Cama, J; Hernaandez-Ainsa, S; Keyser, UF; Summers, DK				Gaimster, Hannah; Cama, Jehangir; Hernandez-Ainsa, Silvia; Keyser, Ulrich F.; Summers, David K.			The Indole Pulse: A New Perspective on Indole Signalling in Escherichia coli	PLOS ONE			English	Article							STATIONARY-PHASE; GENES; RESISTANCE; EXPRESSION	Indole has diverse signalling roles, including modulation of biofilm formation, virulence and stress responses. Changes are induced by indole concentrations of 0.5-1.0 mM, similar to those found in the supernatant of Escherichia coli stationary phase culture. Here we describe an alternative mode of indole signalling that promotes the survival of E. coli cells during long-term stationary phase. A mutant that has lost the ability to produce indole demonstrates reduced survival under these conditions. Significantly, the addition of 1 mM indole to the culture supernatant is insufficient to restore long-term survival to the mutant. We provide evidence that the pertinent signal in this case is not 1 mM indole in the culture supernatant but a transient pulse of intra-cellular indole at the transition from exponential growth to stationary phase. During this pulse the cell-associated indole reaches a maximum of approximately 60 mM. We argue that this is sufficient to inhibit growth and division by an ionophore-based mechanism and causes the cells to enter stationary phase before resources are exhausted. The unused resources are used to repair and maintain cells during the extended period of starvation.	[Gaimster, Hannah; Summers, David K.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Cama, Jehangir; Hernandez-Ainsa, Silvia; Keyser, Ulrich F.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	University of Cambridge; University of Cambridge	Gaimster, H (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	hdg24@cam.ac.uk	Cama, Jehangir/K-3405-2019; Keyser, Ulrich/E-7696-2012; Hernandez Ainsa, silvia/J-9171-2017	Cama, Jehangir/0000-0002-5982-1941; Keyser, Ulrich/0000-0003-3188-5414; Hernandez Ainsa, silvia/0000-0003-3109-4284; Gaimster, Hannah/0000-0002-8593-0746	BBSRC DTG studentship [PCAG-EJNF]; ERC starting grant [261101 Passmembrane]; Internal Graduate Studentship from Trinity College, Cambridge; Biotechnology and Biological Sciences Research Council [BB/F002912/1] Funding Source: researchfish; BBSRC [BB/F002912/1] Funding Source: UKRI	BBSRC DTG studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC starting grant(European Research Council (ERC)); Internal Graduate Studentship from Trinity College, Cambridge; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	HG was funded by a BBSRC DTG studentship, http://www.bbsrc.ac.uk/home/home.aspx, grant number PCAG-EJNF. JC, SHA and UFK acknowledge support from an ERC starting grant, http://erc.europa.eu/, grant number 261101 Passmembrane. JC is also supported by an Internal Graduate Studentship from Trinity College, Cambridge, http://www.trin.cam.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Alberts B., 2005, MOL BIOL CELL; Balding C, 2006, PLASMID, V56, P68, DOI 10.1016/j.plasmid.2005.12.001; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Chant EL, 2007, MOL MICROBIOL, V63, P35, DOI 10.1111/j.1365-2958.2006.05481.x; Chimerel C, 2012, BIOCH BIOPHYSICA ACT, V1818; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Di Martino P, 2003, CAN J MICROBIOL, V49, P443, DOI 10.1139/W03-056; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hirakawa H, 2010, MICROB PATHOGENESIS, V49, P90, DOI 10.1016/j.micpath.2010.05.002; Kamaraju K, 2011, BIOCHEMISTRY-US, V50, P6983, DOI 10.1021/bi200684z; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Li G, 2013, MICROBIOL-SGM, V159, P402, DOI 10.1099/mic.0.064139-0; NEWTON WA, 1962, P NATL ACAD SCI USA, V48, P1431, DOI 10.1073/pnas.48.8.1431; PATIENT ME, 1993, MOL MICROBIOL, V9, P1089, DOI 10.1111/j.1365-2958.1993.tb01238.x; Pinero-Fernandez S, 2011, J BACTERIOL, V193, P1793, DOI 10.1128/JB.01477-10; REID DF, 1966, J BACTERIOL, V92, P639, DOI 10.1128/JB.92.3.639-644.1966; SUMMERS DK, 1984, CELL, V36, P1097, DOI 10.1016/0092-8674(84)90060-6; Vazquez JL, 2001, INT J PHARMACEUT, V220, P53, DOI 10.1016/S0378-5173(01)00646-9; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126	21	41	44	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93168	10.1371/journal.pone.0093168	http://dx.doi.org/10.1371/journal.pone.0093168			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695245	Green Published, gold			2022-12-27	WOS:000334103000044
J	Bari, V; Valencia, JF; Vallverdu, M; Girardengo, G; Marchi, A; Bassani, T; Caminal, P; Cerutti, S; George, AL; Brink, PA; Crotti, L; Schwartz, PJ; Porta, A				Bari, Vlasta; Valencia, Jose F.; Vallverdu, Montserrat; Girardengo, Giulia; Marchi, Andrea; Bassani, Tito; Caminal, Pere; Cerutti, Sergio; George, Alfred L., Jr.; Brink, Paul A.; Crotti, Lia; Schwartz, Peter J.; Porta, Alberto			Multiscale Complexity Analysis of the Cardiac Control Identifies Asymptomatic and Symptomatic Patients in Long QT Syndrome Type 1	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; AUTONOMIC NERVOUS-SYSTEM; POWER SPECTRUM ANALYSIS; INTERVAL VARIABILITY; REPOLARIZATION LABILITY; PERIOD VARIABILITY; NONLINEAR MEASURES; T INTERVAL; ENTROPY; STRESS	The study assesses complexity of the cardiac control directed to the sinus node and to ventricles in long QT syndrome type 1 (LQT1) patients with KCNQ1-A341V mutation. Complexity was assessed via refined multiscale entropy (RMSE) computed over the beat-to-beat variability series of heart period (HP) and QT interval. HP and QT interval were approximated respectively as the temporal distance between two consecutive R-wave peaks and between the R-wave apex and T-wave end. Both measures were automatically taken from 24-hour electrocardiographic Holter traces recorded during daily activities in non mutation carriers (NMCs, n = 14) and mutation carriers (MCs, n = 34) belonging to a South African LQT1 founder population. The MC group was divided into asymptomatic (ASYMP, n = 11) and symptomatic (SYMP, n = 23) patients according to the symptom severity. Analyses were carried out during daytime (DAY, from 2PM to 6PM) and nighttime (NIGHT, from 12PM to 4AM) off and on beta-adrenergic blockade (BBoff and BBon). We found that the complexity of the HP variability at short time scale was under vagal control, being significantly increased during NIGHT and BBon both in ASYMP and SYMP groups, while the complexity of both HP and QT variability at long time scales was under sympathetic control, being smaller during NIGHT and BBon in SYMP subjects. Complexity indexes at long time scales in ASYMP individuals were smaller than those in SYMP ones regardless of therapy (i.e. BBoff or BBon), thus suggesting that a reduced complexity of the sympathetic regulation is protective in ASYMP individuals. RMSE analysis of HP and QT interval variability derived from routine 24-hour electrocardiographic Holter recordings might provide additional insights into the physiology of the cardiac control and might be fruitfully exploited to improve risk stratification in LQT1 population.	[Bari, Vlasta] Grp Osped San Donato Fdn, Milan, Italy; [Bari, Vlasta; Marchi, Andrea; Cerutti, Sergio] Politecn Milan, Dept Elect Informat & Bioengn, I-20133 Milan, Italy; [Valencia, Jose F.] Univ San Buenaventura, Dept Elect Engn, Cali, Colombia; [Vallverdu, Montserrat; Caminal, Pere] Univ Politecn Cataluna, Biomed Engn Res Ctr, Dept Automat Control, E-08028 Barcelona, Spain; [Girardengo, Giulia; Crotti, Lia; Schwartz, Peter J.] IRCCS Ist Auxologico Italiano, Ctr Diagnost San Carlo, Ctr Cardiac Arrhythmias Genet Origin, Milan, Italy; [Marchi, Andrea] IRCCS Humanitas Clin & Res Ctr, Dept Anesthesia & Intens Care, Rozzano, Italy; [Bassani, Tito] IRCCS Humanitas Clin & Res Ctr, Rozzano, Italy; [George, Alfred L., Jr.] Vanderbilt Univ, Dept Med & Pharmacol, Nashville, TN 37235 USA; [Brink, Paul A.] Univ Stellenbosch, Dept Internal Med, ZA-7600 Stellenbosch, South Africa; [Crotti, Lia] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Porta, Alberto] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Porta, Alberto] IRCCS Galeazzi Orthoped Inst, Milan, Italy	IRCCS Policlinico San Donato; Polytechnic University of Milan; Universitat Politecnica de Catalunya; IRCCS Istituto Auxologico Italiano; IRCCS Humanitas Research Hospital; IRCCS Humanitas Research Hospital; Vanderbilt University; Stellenbosch University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Milan; IRCCS Istituto Ortopedico Galeazzi	Porta, A (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.	alberto.porta@unimi.it	Bari, Vlasta/J-8591-2016; Porta, Alberto/K-4390-2016; Crotti, Lia/AAB-3914-2019; Bassani, Tito/B-2050-2017; Schwartz, Peter J/J-4267-2016; Marchi, Andrea/J-7205-2016; Cerutti, Sergio/A-3155-2009	Bari, Vlasta/0000-0002-5346-2677; Porta, Alberto/0000-0002-6720-9824; Bassani, Tito/0000-0003-3312-1565; Schwartz, Peter J/0000-0003-0367-1048; Marchi, Andrea/0000-0001-5846-4164; Valencia, Jose Fernando/0000-0003-2997-2121; crotti, lia/0000-0001-8739-6527; Brink, Paul/0000-0001-8538-5824	Telethon [GGP09247]; National Institutes of Health [HL068880]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068880] Funding Source: NIH RePORTER	Telethon(Fondazione Telethon); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the Telethon grant GGP09247 to Peter J. Schwartz, Lia Crotti and Alberto Porta and by the National Institutes of Health grant HL068880 to Alfred L. George Jr, Peter J. Schwartz, and Lia Crotti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Bar KB, 2008, J CLIN PSYCHOPHARM, V28, P694, DOI 10.1097/JCP.0b013e31818a6d25; Baumert M, 2008, AM J PHYSIOL-HEART C, V295, pH962, DOI 10.1152/ajpheart.00301.2008; Baumert M, 2012, COMPUT BIOL MED, V42, P347, DOI 10.1016/j.compbiomed.2011.03.019; Baumert M, 2011, AM J PHYSIOL-HEART C, V300, pH1412, DOI 10.1152/ajpheart.01184.2010; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Berger RD, 1997, CIRCULATION, V96, P1557, DOI 10.1161/01.CIR.96.5.1557; Boettger MK, 2010, ANN NONINVAS ELECTRO, V15, P165, DOI 10.1111/j.1542-474X.2010.00358.x; Brink PA, 2005, CIRCULATION, V112, P2602, DOI 10.1161/CIRCULATIONAHA.105.572453; Brink PA, 2009, HEART RHYTHM, V6, pS25, DOI 10.1016/j.hrthm.2009.08.036; BROWNE KF, 1983, PACE, V6, P1050, DOI 10.1111/j.1540-8159.1983.tb04443.x; Camm AJ, 1996, CIRCULATION, V93, P1043; Cooke WH, 1999, J PHYSIOL-LONDON, V517, P617, DOI 10.1111/j.1469-7793.1999.0617t.x; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Crotti L, 2007, CIRCULATION, V116, P2366, DOI 10.1161/CIRCULATIONAHA.107.726950; Crotti L, 2012, J AM COLL CARDIOL, V60, P2515, DOI 10.1016/j.jacc.2012.08.1009; deJager T, 1996, J MED GENET, V33, P567, DOI 10.1136/jmg.33.7.567; Valencia JF, 2009, IEEE T BIO-MED ENG, V56, P2202, DOI 10.1109/TBME.2009.2021986; Furlan R, 2000, CIRCULATION, V101, P886, DOI 10.1161/01.CIR.101.8.886; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Lewis MJ, 2007, PHYSIOL MEAS, V28, P731, DOI 10.1088/0967-3334/28/6/011; Maestri R, 2007, J CARDIOVASC ELECTR, V18, P425, DOI 10.1111/j.1540-8167.2007.00728.x; Magnano AR, 2002, J AM COLL CARDIOL, V39, P1820, DOI 10.1016/S0735-1097(02)01852-1; MONTANO N, 1994, CIRCULATION, V90, P1826, DOI 10.1161/01.CIR.90.4.1826; Negoescu R, 1997, INTEGR PHYS BEH SCI, V32, P220, DOI 10.1007/BF02688620; PARLOW J, 1995, HYPERTENSION, V25, P1058, DOI 10.1161/01.HYP.25.5.1058; Piccirillo G, 2001, CLIN SCI, V101, P429, DOI 10.1042/CS20000310; Piccirillo G, 2006, TRANSL RES, V148, P72, DOI 10.1016/j.trsl.2006.02.001; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Porta A, 2007, CHAOS, V17, DOI 10.1063/1.2404630; Porta A, 1998, MED BIOL ENG COMPUT, V36, P27, DOI 10.1007/BF02522854; Porta A, 1998, MED BIOL ENG COMPUT, V36, P35, DOI 10.1007/BF02522855; Porta A, 2000, MED BIOL ENG COMPUT, V38, P180, DOI 10.1007/BF02344774; Porta A, 2007, J APPL PHYSIOL, V103, P1143, DOI 10.1152/japplphysiol.00293.2007; Porta A, 2011, J ELECTROCARDIOL, V44, P662, DOI 10.1016/j.jelectrocard.2011.08.002; Porta A, 2010, AM J PHYSIOL-HEART C, V298, pH1406, DOI 10.1152/ajpheart.01206.2009; Porta A, 2009, PHILOS T R SOC A, V367, P1215, DOI 10.1098/rsta.2008.0292; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Sauer AJ, 2007, J AM COLL CARDIOL, V49, P329, DOI 10.1016/j.jacc.2006.08.057; Schwartz PJ, 2008, J AM COLL CARDIOL, V51, P920, DOI 10.1016/j.jacc.2007.09.069; Schwartz PJ, 2011, CIRCULATION, V124, P2181, DOI 10.1161/CIRCULATIONAHA.111.062182; Schwartz PJ, 2011, HEART RHYTHM, V8, P548, DOI 10.1016/j.hrthm.2010.12.035; SCHWARTZ PJ, 1975, AM HEART J, V89, P378, DOI 10.1016/0002-8703(75)90089-7; Schwartz PJ, 2001, CIRCULATION, V103, P89; Turianikova Z, 2011, PHYSIOL MEAS, V32, DOI 10.1088/0967-3334/32/9/006; Yeragani VK, 2000, PSYCHIAT RES, V93, P225, DOI 10.1016/S0165-1781(00)00119-0; Yeragani VK, 2000, NEUROPSYCHOBIOLOGY, V41, P113, DOI 10.1159/000026642; Yeragania VK, 2003, PSYCHIAT RES, V117, P177, DOI 10.1016/S0165-1781(02)00319-0	48	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93808	10.1371/journal.pone.0093808	http://dx.doi.org/10.1371/journal.pone.0093808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705789	Green Submitted, Green Published, gold			2022-12-27	WOS:000334107500067
J	Berard, A; Sheehy, O				Berard, Anick; Sheehy, Odile			The Quebec Pregnancy Cohort - Prevalence of Medication Use during Gestation and Pregnancy Outcomes	PLOS ONE			English	Article							ADMINISTRATIVE DATABASES; MATERNAL DEPRESSION; RISK; DRUGS; WOMEN; PRESCRIPTION; POPULATION; EXPOSURE; NEURODEVELOPMENT; ANTIDEPRESSANTS	Purpose: We evaluated the potential and the validity of the Quebec Pregnancy Cohort (QPC) as a research tool in perinatal pharmacoepidemiology. Methods: The QPC was built by linking four administrative databases: RAMQ (medical and pharmaceutical data), Med-Echo (hospitalizations), ISQ (births/deaths), and MELS (Ministry of Education data). A self-administered questionnaire was sent to a random sample of women to collect lifestyle information. The QPC includes data on all pregnancies of women covered by the Quebec provincial prescription drug insurance between 1998 and 2008. Date of entry in the QPC is the first day of pregnancy, and women are followed during and after pregnancy; children are followed after birth up until 2009. The prevalence of prescribed medications before, during and after pregnancy was compared between time-window. Pregnancy outcomes were also estimated among pregnancies ending with a live born infant. Results: The QPC included 289,688 pregnancies of 186,165 women. Among them, 167,398 ended with a delivery representing 19.4% of all deliveries occurring in the Province of Quebec between 1998-2009. The total frequency of abortions was 35.9% in the QPC comparable to the 36.4% observed in the Province of Quebec. The prevalence of prescribed medication use was 74.6%, 59.0%, and 79.6% before, during and after pregnancy, respectively. Although there was a statistically significant decrease in the proportion of use once the pregnancy was diagnosed (p <. 01), post-pregnancy prescribed medication use returned above the pre- pregnancy level. The prevalence of pregnancy outcomes found in the QPC were similar to those observed in the Province of Quebec. Conclusion: The QPC is an excellent tool for the study of the risk and benefit of drug use during the perinatal period. This cohort has the advantage of including a validated date of beginning of pregnancy giving the possibility of assigning the exact gestational age at the time of maternal exposure.	[Berard, Anick] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Berard, Anick; Sheehy, Odile] CHU Ste Justine, Res Ctr, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Berard, A (corresponding author), Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada.	anick.berard@umontreal.ca			Canadian Institutes of Health Research; Fonds de la recherche du Quebec - Sante	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	The Quebec Pregnancy Cohort is funded by the Canadian Institutes of Health Research and the Fonds de la recherche du Quebec - Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKMAN DA, 1984, ANNU REV PHARMACOL, V24, P483, DOI 10.1146/annurev.pa.24.040184.002411; Berard A, 2009, IMPACT MISSING DATA, pe207; Berard A, 2007, BIRTH DEFECTS RES B, V80, P18, DOI 10.1002/bdrb.20099; Berard A, 2009, J POPUL THER CLIN PH, V16, pE360; Beyens MN, 2003, THERAPIE, V58, P505, DOI 10.2515/therapie:2003082; Blais L, 2013, PHARMACOEPIDEM DR S, V22, P881, DOI 10.1002/pds.3446; BOTTING BJ, 1987, ARCH DIS CHILD, V62, P941, DOI 10.1136/adc.62.9.941; Cassina M, 2012, ARTHRITIS RHEUM-US, V64, P2085, DOI 10.1002/art.34419; Chambers CD, 2010, ARTHRITIS RHEUM-US, V62, P1494, DOI 10.1002/art.27358; Cote SM, 2008, DEV PSYCHOL, V44, P155, DOI 10.1037/0012-1649.44.1.155; de La Rochebrochard E, 2002, HUM REPROD, V17, P1649, DOI 10.1093/humrep/17.6.1649; Egen-Lappe V, 2004, EUR J CLIN PHARMACOL, V60, P659, DOI 10.1007/s00228-004-0817-1; Einarson A, 2011, J POPUL THER CLIN PH, V18, pE390; Gervais KJ, 2013, PHARMACOEPIDEM DR S, V22, P155; Godel JC, 2007, PAED CHILD HEALT-CAN, V12, P583, DOI 10.1093/pch/12.7.583; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Health Canada, 2002, ENQ SANT COLL CAN; Health Canada, 2002, CONG AN CAN PER HLTH; Institut de la Statistique du Quebec, 2011, TEND TEMP PREV INC D; Institut de la Statistique du Quebec, 2011, NAISS SEL DUR GROSS, P2011; Institut de la Statistique du Quebec, 2013, NAISS SEL TYP, P1988; Institut de la Statistique du Quebec, 2013, INT VOL GROSS NOMBR, P1971; Jones RK, 2008, PERSPECT SEX REPRO H, V40, P6, DOI 10.1363/4000608; Keirse MJNC, 2009, PAEDIATR PERINAT EP, V23, P522, DOI 10.1111/j.1365-3016.2009.01067.x; Koren G, 1998, NEW ENGL J MED, V338, P1128, DOI 10.1056/NEJM199804163381607; Kornum Jette B, 2010, Clin Epidemiol, V2, P29; Kulaga S, 2010, J OBSTET GYNAECOL CA, V32, P549, DOI 10.1016/S1701-2163(16)34523-6; Laberge AM, 2005, CLIN GENET, V68, P287, DOI 10.1111/j.1399-0004.2005.00497.x; Lacroix I, 2000, LANCET, V356, P1735, DOI 10.1016/S0140-6736(00)03209-8; LENZ W, 1988, TERATOLOGY, V38, P203, DOI 10.1002/tera.1420380303; LEVY AR, 1995, AM J EPIDEMIOL, V142, P428, DOI 10.1093/oxfordjournals.aje.a117651; Moussally K, 2010, EUR J OBSTET GYN R B, V150, P107, DOI 10.1016/j.ejogrb.2010.02.001; Nakhai-Pour HR, 2010, CAN MED ASSOC J, V182, P1031, DOI 10.1503/cmaj.091208; Nordeng H, 2012, J CLIN PSYCHOPHARM, V32, P186, DOI 10.1097/JCP.0b013e3182490eaf; Nulman I, 2001, CLIN INVEST MED, V24, P129; Nulman I, 2012, AM J PSYCHIAT, V169, P1165, DOI 10.1176/appi.ajp.2012.11111721; Nybo, 2000, West J Med, V173, P331, DOI 10.1136/ewjm.173.5.331; Ofori B, 2007, BRIT J CLIN PHARMACO, V64, P496, DOI 10.1111/j.1365-2125.2007.02905.x; Olesen C, 1999, EUR J CLIN PHARMACOL, V55, P139, DOI 10.1007/s002280050608; Public Health Canada, 2008, CAN PER HLTH REP; Ramos E, 2008, BRIT J PSYCHIAT, V192, P344, DOI 10.1192/bjp.bp.107.042523; Reck C, 2009, J AFFECT DISORDERS, V113, P77, DOI 10.1016/j.jad.2008.05.003; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Rugie de l'assurance maladie du Quu bec, 2013, LIST MED; Santu Canada, 2008, MALADIES CHRONIQUES, V23; SOGC guideline, 2008, DIAGN EV MAN HYP DIS; TAMBLYN R, 1995, J CLIN EPIDEMIOL, V48, P999, DOI 10.1016/0895-4356(94)00234-H; Vilain A, 2008, PHARMACOEPIDEM DR S, V17, P345, DOI 10.1002/pds.1558; Wenzel A, 2005, J ANXIETY DISORD, V19, P295, DOI 10.1016/j.janxdis.2004.04.001; WHO, 2010, INT STAT CLASS DIS R; World Health Organization, 1978, INT STAT CLASS DIS R	51	68	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93870	10.1371/journal.pone.0093870	http://dx.doi.org/10.1371/journal.pone.0093870			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6MJ	24705674	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500082
J	Celik, S; Li, Y; O'Neill, C				Celik, Selcen; Li, Yan; O'Neill, Chris			The Exit of Mouse Embryonic Fibroblasts from the Cell-Cycle Changes the Nature of Solvent Exposure of the 5 '-Methylcytosine Epitope within Chromatin	PLOS ONE			English	Article							DNA METHYLATION; CONSTITUTIVE HETEROCHROMATIN; CYTOSINE METHYLATION; PATERNAL GENOME; DEMETHYLATION; INHERITANCE; QUIESCENCE; 5-HYDROXYMETHYLCYTOSINE; PROLIFERATION; EMBRYOGENESIS	The methylation of CpG dinucleotides is a pervasive epigenetic signature with critical roles governing genomic stability and lineage-specific patterns of gene expression. Reprogramming the patterns of CpG methylation accompanies key developmental transitions and the onset of some pathologies, such as cancer. In this study we show that levels of immuno-detectable 5meC decreased as mouse embryonic fibroblasts withdraw from the cell-cycle (became mitotically quiescent), but increased as they aged in culture. Two pools of 5meC epitope were found to exist, one solvent exposed after acid-induced denaturation of chromatin and another that required the additional step of tryptic digestion for detection. Proliferative cells displayed a relatively greater accumulation of detectable 5meC within the trypsin-sensitive pool than did quiescent cells. A substantial proportion of the 5meC was associated with a large number of heterochromatic foci scattered throughout nuclei, yet much of this was masked in a trypsin-sensitive manner, particularly in young proliferative cells. This study showed that the growth status of cells changed the level of solvent exposure of 5meC in fibroblasts and the long-accepted conventional methods of immunolocalization underestimate the level of 5meC in cells. This resulted in an artefactual assessment of the levels and patterns of nuclear localization of the antigen. The use of an additional tryptic digestion step improved antigen retrieval and revealed a more dynamic response of 5meC levels and distribution patterns to changes in the cell's growth state. This discovery will provide a basis for investigating the role of changes in chromatin structure that underlie this dynamism.	[Celik, Selcen; Li, Yan; O'Neill, Chris] Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Human Reprod & Dev Unit, Sydney, NSW 2006, Australia	University of Sydney; Kolling Institute of Medical Research	O'Neill, C (corresponding author), Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Human Reprod & Dev Unit, Sydney, NSW 2006, Australia.	chris.oneill@sydney.edu.au	Celik, Selcen/AAW-3014-2020	Celik, Selcen/0000-0002-9558-7048; O'Neill, Christopher/0000-0003-4003-8727	Australian National Health and Medical Research Council; Turkish Government Postgraduate Scholarship	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Turkish Government Postgraduate Scholarship	This work was supported by grants from the Australian National Health and Medical Research Council to CO and a Turkish Government Postgraduate Scholarship to SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2000, J CELL SCI, V113, P4463; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Brown SE, 2008, NEUROSCI LETT, V440, P49, DOI 10.1016/j.neulet.2008.05.028; Chan FL, 2012, NUCLEIC ACIDS RES, V40, P11178, DOI 10.1093/nar/gks921; Clouaire T, 2010, NUCLEIC ACIDS RES, V38, P4620, DOI 10.1093/nar/gkq228; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Evertts AG, 2013, MOL BIOL CELL, V24, P3025, DOI 10.1091/mbc.E12-07-0529; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grigoryev SA, 2004, J CELL SCI, V117, P6153, DOI 10.1242/cs.01537; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hajkova P, 2010, CURR OPIN CELL BIOL, V22, P342, DOI 10.1016/j.ceb.2010.04.011; Huang Y., 2010, PLOS ONE, V5; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Kang YK, 2001, FEBS LETT, V498, P1, DOI 10.1016/S0014-5793(01)02472-3; Koch CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016679; LATHAM KE, 1992, DEV BIOL, V149, P457, DOI 10.1016/0012-1606(92)90300-6; Li Y, 2012, PLOS ONE, V7; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063689; Li Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030687; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MILLER OJ, 1974, NATURE, V251, P636, DOI 10.1038/251636a0; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Probst AV, 2011, TRENDS GENET, V27, P177, DOI 10.1016/j.tig.2011.02.002; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Rountree MR, 2001, ONCOGENE, V20, P3156, DOI 10.1038/sj.onc.1204339; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; WILSON VL, 1983, SCIENCE, V220, P1054; Wongtawan T, 2011, J CELL SCI, V124, P1878, DOI 10.1242/jcs.080721; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	40	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92523	10.1371/journal.pone.0092523	http://dx.doi.org/10.1371/journal.pone.0092523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705067	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500018
J	Kagaayi, J; Gray, RH; Whalen, C; Fu, PF; Neuhauser, D; McGrath, JW; Sewankambo, NK; Serwadda, D; Kigozi, G; Nalugoda, F; Reynolds, SJ; Wawer, MJ; Singer, ME				Kagaayi, Joseph; Gray, Ronald H.; Whalen, Christopher; Fu, Pingfu; Neuhauser, Duncan; McGrath, Janet W.; Sewankambo, Nelson K.; Serwadda, David; Kigozi, Godfrey; Nalugoda, Fred; Reynolds, Steven J.; Wawer, Maria J.; Singer, Mendel E.			Indices to Measure Risk of HIV Acquisition in Rakai, Uganda	PLOS ONE			English	Article							MALE CIRCUMCISION; COST-EFFECTIVENESS; PREEXPOSURE PROPHYLAXIS; AIDS-PREVENTION; COMMUNITY TRIAL; UNITED-STATES; RURAL UGANDA; ALCOHOL-USE; INFECTION; WOMEN	Introduction: Targeting most-at-risk individuals with HIV preventive interventions is cost-effective. We developed gender-specific indices to measure risk of HIV among sexually active individuals in Rakai, Uganda. Methods: We used multivariable Cox proportional hazards models to estimate time-to-HIV infection associated with candidate predictors. Reduced models were determined using backward selection procedures with Akaike's information criterion (AIC) as the stopping rule. Model discrimination was determined using Harrell's concordance index (c index). Model calibration was determined graphically. Nomograms were used to present the final prediction models. Results: We used samples of 7,497 women and 5,783 men. 342 new infections occurred among females (incidence 1.11/100 person years,) and 225 among the males (incidence 1.00/100 person years). The final model for men included age, education, circumcision status, number of sexual partners, genital ulcer disease symptoms, alcohol use before sex, partner in high risk employment, community type, being unaware of a partner's HIV status and community HIV prevalence. The Model's optimism-corrected c index was 69.1 percent (95% CI = 0.66, 0.73). The final women's model included age, marital status, education, number of sex partners, new sex partner, alcohol consumption by self or partner before sex, concurrent sexual partners, being employed in a high-risk occupation, having genital ulcer disease symptoms, community HIV prevalence, and perceiving oneself or partner to be exposed to HIV. The models optimism-corrected c index was 0.67 (95% CI = 0.64, 0.70). Both models were well calibrated. Conclusion: These indices were discriminative and well calibrated. This provides proof-of-concept that population-based HIV risk indices can be developed. Further research to validate these indices for other populations is needed.	[Kagaayi, Joseph] Rakai Hlth Sci Program, Entebbe, Uganda; [Kagaayi, Joseph; Fu, Pingfu; Neuhauser, Duncan; Kigozi, Godfrey; Nalugoda, Fred; Singer, Mendel E.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Gray, Ronald H.; Wawer, Maria J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [McGrath, Janet W.] Case Western Reserve Univ, Dept Anthropol, Cleveland, OH 44106 USA; [Whalen, Christopher] Univ Georgia, Dept Epidemiol & Biostat, Athens, GA 30602 USA; [Sewankambo, Nelson K.; Serwadda, David] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Reynolds, Steven J.] NIAID, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Reynolds, Steven J.] Johns Hopkins Sch Med, Baltimore, MD USA	Rakai Health Sciences Program; Case Western Reserve University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Case Western Reserve University; University System of Georgia; University of Georgia; Makerere University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Medicine	Kagaayi, J (corresponding author), Rakai Hlth Sci Program, Entebbe, Uganda.	jxk597@case.edu	Fu, Pingfu/O-5415-2019; Singer, Mendel/S-8775-2019	Fu, Pingfu/0000-0002-2334-5218; Kagaayi, Joseph/0000-0003-4101-3038; Singer, Mendel/0000-0002-3331-3340; Sewankambo, Nelson/0000-0001-9362-053X; Reynolds, Steven/0000-0002-5403-2759	National Institute of Child Health and Human Development of the National Institutes of Health [RO1HD050180]; National Institutes of Health [U01AI075115]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075115, ZIAAI001040] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by National Institute of Child Health and Human Development of the National Institutes of Health; grant number RO1HD050180; and National Institutes of Health; grant number U01AI075115; and in part (SJR) by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; Arora P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044094; ATKINSON AC, 1980, BIOMETRIKA, V67, P413, DOI 10.1093/biomet/67.2.413; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bautista-Arredondo S, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327625.69974.08; Chemaitelly H, 2013, AIDS, V27, P251, DOI 10.1097/QAD.0b013e32835ad459; Commission UNA, 2009, UG HIV MOD TRANSM PR; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Fox J, 2011, AIDS, V25, P1065, DOI 10.1097/QAD.0b013e328344fe4a; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Gray R, 2011, AIDS, V25, P863, DOI 10.1097/QAD.0b013e3283448790; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrell FE Jr, REGRESSION MODELLING, V2nd; Herida M, 2006, AIDS, V20, P1753, DOI 10.1097/01.aids.0000242822.74624.5f; Hughes D, 1996, J Health Serv Res Policy, V1, P205; Juusola JL, 2012, ANN INTERN MED, V156, P541, DOI [10.7326/0003-4819-156-8-201204170-00004, 10.7326/0003-4819-156-8-201204170-00001]; Kahle EM, 2012, J ACQUIR IMMUNE DEFI; Kahn JG, 1996, AM J PUBLIC HEALTH, V86, P1709, DOI 10.2105/AJPH.86.12.1709; Kelly RJ, 2003, JAIDS-J ACQ IMM DEF, V32, P446, DOI 10.1097/00126334-200304010-00016; Koenig MA, 2004, SOC SCI MED, V58, P787, DOI 10.1016/S0277-9536(03)00244-2; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Matovu JKB, 2005, AIDS, V19, P503, DOI 10.1097/01.aids.0000162339.43310.33; Santelli JS, 2013, JAIDS-J ACQ IMM DEF, V63, P393, DOI 10.1097/QAI.0b013e3182926795; Steyerberg E., 2010, CLIN PREDICTION MODE; Steyerberg EW, 2007, J UROLOGY, V177, P107, DOI 10.1016/j.juro.2006.08.068; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; VANHOUWELINGEN JC, 1990, STAT MED, V9, P1303, DOI 10.1002/sim.4780091109; Wawer MJ, 1998, AIDS, V12, P1211, DOI 10.1097/00002030-199810000-00014; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Wojcicki JM, 2005, J BIOSOC SCI, V37, P1, DOI 10.1017/S0021932004006534; Youngkong S, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-6; Zablotska IB, 2006, AIDS, V20, P1191, DOI 10.1097/01.aids.0000226960.25589.72; Zablotska IB, 2009, AIDS BEHAV, V13, P225, DOI 10.1007/s10461-007-9333-5	40	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92015	10.1371/journal.pone.0092015	http://dx.doi.org/10.1371/journal.pone.0092015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24704778	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500012
J	Missana, M; Grigutsch, M; Grossmann, T				Missana, Manuela; Grigutsch, Maren; Grossmann, Tobias			Developmental and Individual Differences in the Neural Processing of Dynamic Expressions of Pain and Anger	PLOS ONE			English	Article							FACIAL EXPRESSIONS; BRAIN ACTIVITY; EMOTIONAL EXPRESSIONS; INFANT TEMPERAMENT; PERSPECTIVE-TAKING; AFFECTIVE STYLE; EMPATHY; RECOGNITION; ATTENTION; EEG	We examined the processing of facial expressions of pain and anger in 8-month-old infants and adults by measuring event-related brain potentials (ERPs) and frontal EEG alpha asymmetry. The ERP results revealed that while adults showed a late positive potential (LPP) to emotional expressions that was enhanced to pain expressions, reflecting increased evaluation and emotional arousal to pain expressions, infants showed a negative component (Nc) to emotional expressions that was enhanced to angry expressions, reflecting increased allocation of attention to angry faces. Moreover, infants and adults showed opposite patterns in their frontal asymmetry responses to pain and anger, suggesting developmental differences in the motivational processes engendered by these facial expressions. These findings are discussed in the light of associated individual differences in infant temperament and adult dispositional empathy.	[Missana, Manuela; Grossmann, Tobias] Max Planck Inst Human Cognit & Brain Sci, Early Social Dev Grp, Leipzig, Germany; [Grigutsch, Maren] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany	Max Planck Society; Max Planck Society	Missana, M (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Early Social Dev Grp, Leipzig, Germany.	missana@cbs.mpg.de	Grossmann, Tobias/H-6364-2019; Lowe, Lauryn/U-9710-2019	Grossmann, Tobias/0000-0002-1116-6423				Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x; [Anonymous], 2009, EXPRESS EMOT MAN; Benuzzi F, 2008, J NEUROSCI, V28, P923, DOI 10.1523/JNEUROSCI.4012-07.2008; Botvinick M, 2005, NEUROIMAGE, V25, P312, DOI 10.1016/j.neuroimage.2004.11.043; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; BURNHAM DK, 1979, J EXP CHILD PSYCHOL, V28, P191, DOI 10.1016/0022-0965(79)90083-3; Burnham DK, 1987, PERCEPTUAL DEV EARLY, P143; Buss KA, 2003, BEHAV NEUROSCI, V117, P11, DOI 10.1037/0735-7044.117.1.11; Campos JJ, 2003, ANN NY ACAD SCI, V1000, P110, DOI 10.1196/annals.1280.040; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Craig K. D., 2001, HDB PAIN ASSESSMENT, P153; Davidson R.J., 1984, EMOTIONS COGNITION B; DAVIDSON RJ, 1982, SCIENCE, V218, P1235, DOI 10.1126/science.7146906; DAVIDSON RJ, 1994, DEV PSYCHOPATHOL, V6, P741, DOI 10.1017/S0954579400004764; DAVIDSON RJ, 1988, INT J NEUROSCI, V39, P71, DOI 10.3109/00207458808985694; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; Davis M.H., 1980, JSAS CATALOG SELECTE; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Decety J, 2008, NEUROPSYCHOLOGIA, V46, P2607, DOI 10.1016/j.neuropsychologia.2008.05.026; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2012, DEV COGN NEUROS-NETH, V2, P1, DOI 10.1016/j.dcn.2011.05.003; Decety J, 2010, DEV NEUROSCI-BASEL, V32, P257, DOI 10.1159/000317771; Eisenberg N, 2000, ANNU REV PSYCHOL, V51, P665, DOI 10.1146/annurev.psych.51.1.665; EISENBERG N, 1994, J PERS SOC PSYCHOL, V66, P776, DOI 10.1037/0022-3514.66.4.776; Eisenberg N., 2004, HDB SELF REGULATION, V3rd ed., DOI DOI 10.1146/ANNUREV-PSYCH-113011-143750; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; Ekman P., 1975, UNMASKING FACE; Fan Y, 2008, NEUROPSYCHOLOGIA, V46, P160, DOI 10.1016/j.neuropsychologia.2007.07.023; FOX NA, 1991, AM PSYCHOL, V46, P863, DOI 10.1037/0003-066X.46.8.863; Frith C, 2009, PHILOS T R SOC B, V364, P3453, DOI 10.1098/rstb.2009.0142; Gartstein MA, 2003, INFANT BEHAV DEV, V26, P64, DOI 10.1016/S0163-6383(02)00169-8; Geangu E, 2010, INFANT BEHAV DEV, V33, P279, DOI 10.1016/j.infbeh.2010.03.004; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Gonzalez-Roldan AM, 2011, PAIN, V152, P853, DOI 10.1016/j.pain.2010.12.037; Goubert L, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P153; Goubert L, 2009, PAIN, V143, P5, DOI 10.1016/j.pain.2009.02.023; Grossmann T, 2007, BRAIN COGNITION, V64, P30, DOI 10.1016/j.bandc.2006.10.002; Grossmann T, 2012, DEVELOPMENTAL SCI, V15, P830, DOI 10.1111/j.1467-7687.2012.01179.x; GWIAZDA J, 1989, CAN J PSYCHOL, V43, P109, DOI 10.1037/h0084217; Harmon-Jones E, 2003, PSYCHOPHYSIOLOGY, V40, P838, DOI 10.1111/1469-8986.00121; Harmon-Jones E, 2001, J PERS SOC PSYCHOL, V80, P797, DOI 10.1037/0022-3514.80.5.797; Harmon-Jones E, 2010, BIOL PSYCHOL, V84, P451, DOI 10.1016/j.biopsycho.2009.08.010; Harwood NK, 1999, AM J MENT RETARD, V104, P270, DOI 10.1352/0895-8017(1999)104<0270:ROFEEF>2.0.CO;2; Jackson PL, 2006, PAIN, V125, P5, DOI 10.1016/j.pain.2006.09.013; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kobiella A, 2008, COGNITION EMOTION, V22, P134, DOI 10.1080/02699930701394256; Kotsoni E, 2001, PERCEPTION, V30, P1115, DOI 10.1068/p3155; LABARBERA JD, 1976, CHILD DEV, V47, P535, DOI 10.2307/1128816; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; LoBue V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022694; Martinos M, 2012, J CHILD PSYCHOL PSYC, V53, P1118, DOI 10.1111/j.1469-7610.2012.02599.x; Mohr P, 2007, PERS INDIV DIFFER, V43, P507, DOI 10.1016/j.paid.2006.12.019; Morrison I, 2007, NEUROIMAGE, V37, P642, DOI 10.1016/j.neuroimage.2007.03.079; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Nelson CA, 1996, DEV PSYCHOBIOL, V29, P577; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Paulus C., 2009, SAARBRUCKER PERSONLI; Peltola MJ, 2009, SOC COGN AFFECT NEUR, V4, P134, DOI 10.1093/scan/nsn046; Pichon S, 2008, SOC NEUROSCI-UK, V3, P199, DOI 10.1080/17470910701394368; PRKACHIN KM, 1995, J NONVERBAL BEHAV, V19, P191, DOI 10.1007/BF02173080; Reicherts P, 2012, PAIN, V153, P1959, DOI 10.1016/j.pain.2012.06.017; Richards JE, 2003, DEVELOPMENTAL SCI, V6, P312, DOI 10.1111/1467-7687.00287; Roth-Hanania R, 2011, INFANT BEHAV DEV, V34, P447, DOI 10.1016/j.infbeh.2011.04.007; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; SCHNEIRLA T, 1959, NEBRASKA S MOTIVATIO; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; SERRANO JM, 1992, DEV PSYCHOBIOL, V25, P411, DOI 10.1002/dev.420250603; Simon D, 2008, PAIN, V135, P55, DOI 10.1016/j.pain.2007.05.008; Simon D, 2006, PAIN, V126, P309, DOI 10.1016/j.pain.2006.08.033; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Stroganova TA, 1999, CLIN NEUROPHYSIOL, V110, P997, DOI 10.1016/S1388-2457(98)00009-1; Vaish A, 2004, DEVELOPMENTAL SCI, V7, P261, DOI 10.1111/j.1467-7687.2004.00344.x; Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383; Walle EA, 2012, EMOT REV, V4, P413, DOI 10.1177/1754073912445812; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080; Yamada M, 2009, PAIN, V143, P71, DOI 10.1016/j.pain.2009.01.028; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126	86	24	26	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93728	10.1371/journal.pone.0093728	http://dx.doi.org/10.1371/journal.pone.0093728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6MJ	24705497	Green Published, gold			2022-12-27	WOS:000334107500060
J	Moore, BS; Mirshahi, UL; Yost, EA; Stepanchick, AN; Bedrin, MD; Styer, AM; Jackson, KK; Still, CD; Breitwieser, GE; Gerhard, GS; Carey, DJ; Mirshahi, T				Moore, Bryn S.; Mirshahi, Uyenlinh L.; Yost, Evan A.; Stepanchick, Ann N.; Bedrin, Michael D.; Styer, Amanda M.; Jackson, Kathryn K.; Still, Christopher D.; Breitwieser, Gerda E.; Gerhard, Glenn S.; Carey, David J.; Mirshahi, Tooraj			Long-Term Weight-Loss in Gastric Bypass Patients Carrying Melanocortin 4 Receptor Variants	PLOS ONE			English	Article							PROOPIOMELANOCORTIN-DERIVED AGONISTS; PHARMACOLOGICAL CHARACTERIZATION; MUTATIONS; OBESITY; POLYMORPHISMS; GENE; ASSOCIATION; INHERITANCE; PREVALENCE; PHENOTYPE	Background: The melanocortin 4 receptor (MC4R) critically regulates feeding and satiety. Rare variants in MC4R are predominantly found in obese individuals. Though some rare variants in MC4R discovered in patients have defects in localization, ligand binding and signaling to cAMP, many have no recognized defects. Subjects/Methods: In our cohort of 1433 obese subjects that underwent Roux-en-Y Gastric Bypass (RYGB) surgery, we found fifteen variants of MC4R. We matched rare variant carriers to patients with the MC4R reference alleles for gender, age, starting BMI and T2D to determine the variant effect on weight-loss post-RYGB. In vitro, we determined expression of mutant receptors by ELISA and western blot, and cAMP production by microscopy. Results: While carrying a rare MC4R allele is associated with obesity, carriers of rare variants exhibited comparable weight-loss after RYGB to non-carriers. However, subjects carrying three of these variants, V95I, I137T or L250Q, lost less weight after surgery. In vitro, the R305Q mutation caused a defect in cell surface expression while only the I137T and C326R mutations showed impaired cAMP signaling. Despite these apparent differences, there was no correlation between in vitro signaling and pre- or post-surgery clinical phenotype. Conclusions: These data suggest that subtle differences in receptor signaling conferred by rare MC4R variants combined with additional factors predispose carriers to obesity. In the absence of complete MC4R deficiency, these differences can be overcome by the powerful weight-reducing effects of bariatric surgery. In a complex disorder such as obesity, genetic variants that cause subtle defects that have cumulative effects can be overcome after appropriate clinical intervention.	[Moore, Bryn S.; Mirshahi, Uyenlinh L.; Yost, Evan A.; Stepanchick, Ann N.; Bedrin, Michael D.; Styer, Amanda M.; Jackson, Kathryn K.; Breitwieser, Gerda E.; Gerhard, Glenn S.; Carey, David J.; Mirshahi, Tooraj] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA; [Still, Christopher D.; Mirshahi, Tooraj] Geisinger Obes Inst, Geisinger Clin, Danville, PA USA		Mirshahi, T (corresponding author), Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA.	tmirshahi@geisinger.edu		Moore, Bryn/0000-0002-8758-7611; Breitwieser, Gerda/0000-0001-9081-0362	Geisinger Clinic and National Institutes of Health [DK092775, DK072488]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK092775, P30DK072488] Funding Source: NIH RePORTER	Geisinger Clinic and National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Geisinger Clinic and National Institutes of Health DK092775 to TM, and DK072488 to GSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Aslan IR, 2011, OBES SURG, V21, P930, DOI 10.1007/s11695-010-0295-8; Biebermann H, 2003, DIABETES, V52, P2984, DOI 10.2337/diabetes.52.12.2984; Branson R, 2003, NEW ENGL J MED, V348, P1096, DOI 10.1056/NEJMoa021971; Buch TRH, 2009, J BIOL CHEM, V284, P26411, DOI 10.1074/jbc.M109.039339; Calton MA, 2009, HUM MOL GENET, V18, P1140, DOI 10.1093/hmg/ddn431; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; de Felipe P, 2004, TRAFFIC, V5, P616, DOI 10.1111/j.1398-9219.2004.00205.x; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Gu W, 1999, DIABETES, V48, P635, DOI 10.2337/diabetes.48.3.635; Hatoum IJ, 2012, J CLIN ENDOCR METAB, V97, pE1023, DOI 10.1210/jc.2011-3432; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Lubrano-Berthelier C, 2006, J CLIN ENDOCR METAB, V91, P1811, DOI 10.1210/jc.2005-1411; Lubrano-Berthelier C, 2003, HUM MOL GENET, V12, P145, DOI 10.1093/hmg/ddg016; Mirshahi UL, 2011, J CLIN ENDOCR METAB, V96, pE2088, DOI 10.1210/jc.2011-1549; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Proneth B, 2006, CHEM BIOL DRUG DES, V67, P215, DOI 10.1111/j.1747-0285.2006.00362.x; Reinehr T, 2009, OBESITY, V17, P382, DOI 10.1038/oby.2008.422; Rouskas K, 2012, OBESITY, V20, P2278, DOI 10.1038/oby.2012.77; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Scott WR, 2011, AM J PHYSIOL-REG I, V301, pR15, DOI 10.1152/ajpregu.00038.2011; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Srisai D, 2011, ENDOCRINOLOGY, V152, P890, DOI 10.1210/en.2010-0716; Still CD, 2014, OBESITY, V22, P888, DOI 10.1002/oby.20529; Stutzmann F, 2008, DIABETES, V57, P2511, DOI 10.2337/db08-0153; Stutzmann F, 2007, HUM MOL GENET, V16, P1837, DOI 10.1093/hmg/ddm132; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Tao YX, 2005, J CLIN ENDOCR METAB, V90, P5632, DOI 10.1210/jc.2005-0519; Tao YX, 2003, ENDOCRINOLOGY, V144, P4544, DOI 10.1210/en.2003-0524; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Valette M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048221; van den Berg L, 2011, OBESITY, V19, P604, DOI 10.1038/oby.2010.259; Wang ZQ, 2011, BBA-MOL BASIS DIS, V1812, P1190, DOI 10.1016/j.bbadis.2011.06.008; Wickremesekera K, 2005, OBES SURG, V15, P474, DOI 10.1381/0960892053723402; Xiang ZM, 2006, BIOCHEMISTRY-US, V45, P7277, DOI 10.1021/bi0600300; Xiang ZM, 2010, BIOCHEMISTRY-US, V49, P4583, DOI 10.1021/bi100068u; Zechner JF, 2013, GASTROENTEROLOGY, V144, P580, DOI 10.1053/j.gastro.2012.11.022	43	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93629	10.1371/journal.pone.0093629	http://dx.doi.org/10.1371/journal.pone.0093629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705671	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500050
J	Sher, YP; Wang, LJ; Chuang, LL; Tsai, MH; Kuo, TT; Huang, CC; Chuang, EY; Lai, LC				Sher, Yuh-Pyng; Wang, Li-Ju; Chuang, Li-Ling; Tsai, Mong-Hsun; Kuo, Ting-Ting; Huang, Cheng-Chung; Chuang, Eric Y.; Lai, Liang-Chuan			ADAM9 Up-Regulates N-Cadherin via miR-218 Suppression in Lung Adenocarcinoma Cells	PLOS ONE			English	Article							CANCER PROGRESSION; BETA-CATENIN; TUMOR-GROWTH; GENES; MICRORNA-218; INVASION; EXPRESSION; MIGRATION; SLIT2; IDENTIFICATION	Lung cancer is the leading cause of cancer death worldwide, and brain metastasis is a major cause of morbidity and mortality in lung cancer. CDH2 (N-cadherin, a mesenchymal marker of the epithelial-mesenchymal transition) and ADAM9 (a type I transmembrane protein) are related to lung cancer brain metastasis; however, it is unclear how they interact to mediate this metastasis. Because microRNAs regulate many biological functions and disease processes (e. g., cancer) by down-regulating their target genes, microRNA microarrays were used to identify ADAM9-regulated miRNAs that target CDH2 in aggressive lung cancer cells. Luciferase assays and western blot analysis showed that CDH2 is a target gene of miR-218. MiR-218 was generated from pri-mir-218-1, which is located in SLIT2, in non-invasive lung adenocarcinoma cells, whereas its expression was inhibited in aggressive lung adenocarcinoma. The down-regulation of ADAM9 up-regulated SLIT2 and miR-218, thus down-regulating CDH2 expression. This study revealed that ADAM9 activates CDH2 through the release of miR-218 inhibition on CDH2 in lung adenocarcinoma.	[Sher, Yuh-Pyng; Kuo, Ting-Ting; Huang, Cheng-Chung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Sher, Yuh-Pyng] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Wang, Li-Ju; Lai, Liang-Chuan] Natl Taiwan Univ, Grad Inst Physiol, Taipei 10764, Taiwan; [Chuang, Li-Ling] Chang Gung Univ, Dept Phys Therapy, Taoyuan, Taiwan; [Chuang, Li-Ling] Chang Gung Univ, Grad Inst Rehabil Sci, Taoyuan, Taiwan; [Tsai, Mong-Hsun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Chuang, Eric Y.] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Tsai, Mong-Hsun; Chuang, Eric Y.; Lai, Liang-Chuan] Natl Taiwan Univ, Ctr Genom Med, Bioinformat & Biostat Core, Taipei 10764, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Taiwan University; Chang Gung University; Chang Gung University; National Taiwan University; National Taiwan University; National Taiwan University	Lai, LC (corresponding author), Natl Taiwan Univ, Grad Inst Physiol, Taipei 10764, Taiwan.	llai@ntu.edu.tw	Lai, Liang-Chuan/B-4768-2009	Lai, Liang-Chuan/0000-0002-3913-5338; TSAI, MONG-HSUN/0000-0001-8777-5818; Chuang, Li-Ling/0000-0001-8171-4811; Sher, Yuh-Pyng/0000-0002-6062-7556	National Science Council, Taiwan [101-2325-B-039-008, 101-2320-B-002-015]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grants 101-2325-B-039-008 and 101-2320-B-002-015 from the National Science Council, Taiwan, ROC.(http://web1.nsc.gov.tw/mp.aspx?mp=7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Bonomi P, 2002, SEMIN ONCOL, V29, P78, DOI 10.1053/sonc.2002.31528; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chen WF, 2013, INT J COLORECTAL DIS, V28, P933, DOI 10.1007/s00384-013-1641-9; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Dallol A, 2002, CANCER RES, V62, P5874; Davidson MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012560; Dwyer MA, 2010, CANCER RES, V70, P9298, DOI 10.1158/0008-5472.CAN-10-0226; Felli N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056824; Fritzsche FR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-179; Fry JL, 2010, CANCER RES, V70, P8187, DOI 10.1158/0008-5472.CAN-09-4231; Gao P, 2013, ONCOGENE, V32, P491, DOI 10.1038/onc.2012.61; Goossens K, 2013, STEM CELLS DEV, V22, P1907, DOI 10.1089/scd.2012.0708; Grinberg-Rashi H, 2009, CLIN CANCER RES, V15, P1755, DOI 10.1158/1078-0432.CCR-08-2124; Guaiquil V, 2009, MOL CELL BIOL, V29, P2694, DOI 10.1128/MCB.01460-08; Guan H, 2013, J CLIN ENDOCRINOL ME; Hassan MQ, 2012, J BIOL CHEM, V287, P42084, DOI 10.1074/jbc.M112.377515; Hayama M, 2013, ANN THORAC CARDIOVAS; He H, 2013, ONCOL REP, V30, P651, DOI 10.3892/or.2013.2516; He XQ, 2012, MOL MED, V18, P1491, DOI 10.2119/molmed.2012.00304; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Josson S, 2011, PROSTATE, V71, P232, DOI 10.1002/pros.21237; Kausar H, 2013, CANCER LETT, V332, P35, DOI 10.1016/j.canlet.2013.01.008; Kinoshita T, 2012, ONCOTARGET, V3, P1386, DOI 10.18632/oncotarget.709; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JR, 2012, INT J MOL SCI, V13, P16053, DOI 10.3390/ijms131216053; Lu TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042390; Marlow R, 2008, CANCER RES, V68, P7819, DOI 10.1158/0008-5472.CAN-08-1357; Meert AP, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-5; Micocci KC, 2013, BIOCHIMIE, V95, P1371, DOI 10.1016/j.biochi.2013.03.001; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Nath D, 2000, J CELL SCI, V113, P2319; Ng YH, 2012, ENDOCRINOLOGY, V153, P925, DOI 10.1210/en.2011-1488; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; REID RA, 1990, NUCLEIC ACIDS RES, V18, P5896, DOI 10.1093/nar/18.19.5896; Sher YP, 2009, ONCOGENE, V28, P3286, DOI 10.1038/onc.2009.187; Shintani Y, 2004, CANCER RES, V64, P4190, DOI 10.1158/0008-5472.CAN-03-3235; Small EM, 2010, CIRC RES, V107, P1336, DOI 10.1161/CIRCRESAHA.110.227926; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Tseng RC, 2010, CANCER RES, V70, P543, DOI 10.1158/0008-5472.CAN-09-2084; Tu Y, 2013, CANC RES; Vincent-Chong VK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054705; Wingo PA, 1999, J NATL CANCER I, V91, P675, DOI 10.1093/jnci/91.8.675; Wu DW, 2010, CANCER RES, V70, P10392, DOI 10.1158/0008-5472.CAN-10-2341; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x	54	29	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94065	10.1371/journal.pone.0094065	http://dx.doi.org/10.1371/journal.pone.0094065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705471	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500117
J	Wei, W; Ge, JB; Zou, Y; Lin, L; Cai, Y; Liu, XB; Zhu, WQ				Wei, Wei; Ge, Jun-Bo; Zou, Yu; Lin, Li; Cai, Ying; Liu, Xue-Bo; Zhu, Wen-Qing			Anatomical Characteristics of Pulmonary Veins for the Prediction of Postoperative Recurrence after Radiofrequency Catheter Ablation of Atrial Fibrillation	PLOS ONE			English	Article							ASSOCIATION	Background: The relationship between focal pulmonary vein potential and atrial fibrillation (AF) has been confirmed. Pulmonary vein (PV) isolation and circumferential pulmonary vein ablation have been the most commonly used procedures of radiofrequency ablation. However, few studies have investigated the relationship between anatomical characteristics of PV and AF recurrences after radiofrequency ablation. Methodology: For 267 AF patients treated by radiofrequency catheter ablation, the anatomic structure characteristics of pulmonary veins were assessed by multi-slice spiral computed tomography while the values of left atrial diameter (LAD) were measured with transesophageal ultrasonic cardiogram. After radiofrequency catheter ablation, postoperative recurrence was evaluated during a 10-month term follow-up. Principal Findings: During follow-up, postoperative recurrence occurred in 44 patients. The mean diameters of LAD, left superior PV, right superior PV, all left PV, and all superior PV were significantly larger in patients with postoperative recurrence (Recurrence vs. Non-recurrence group; 43.9 +/- 6.4 mm vs. 40.7 +/- 5.6 mm; 18.4 +/- 2.1 mm vs. 17.1 +/- 3.1 mm; 18.2 +/- 2.8 mm vs. 17.2 mm +/- 3.9 mm; 16.4 +/- 1.5 mm vs. 15.6 +/- 2.5 mm; 18.3 +/- 2.1 mm vs. 17.1 +/- 3.0 mm; respectively; all P <0.05). Multivariable survival analysis showed that the type and the course of AF, LAD, and the diameters of all superior PV were the independent risk factors for the postoperative recurrence after radiofrequency catheter ablation. Conclusions: The enlargements of all superior PV and LAD, long course of diseases, and persistent AF were the independent risk factors for the postoperative recurrence after radiofrequency catheter ablation.	[Wei, Wei; Ge, Jun-Bo; Zou, Yu; Lin, Li; Cai, Ying; Liu, Xue-Bo] Tongji Univ, Sch Med, Dept Cardiovasc Med, Shanghai 200092, Peoples R China; [Wei, Wei; Ge, Jun-Bo; Zou, Yu; Zhu, Wen-Qing] Fudan Univ, Zhongshan Hosp, Dept Cardiovasc Med, Shanghai 200433, Peoples R China	Tongji University; Fudan University	Liu, XB (corresponding author), Tongji Univ, Sch Med, Dept Cardiovasc Med, Shanghai 200092, Peoples R China.	lxb1350@easthospital.cn; zhu.wenqing@zs-hospital.sh.cn						Anselmino M, 2011, J CARDIOVASC ELECTR, V22, P1, DOI 10.1111/j.1540-8167.2010.01853.x; Berruezo A, 2007, EUR HEART J, V28, P836, DOI 10.1093/eurheartj/ehm027; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Estes NAM, 2008, CIRCULATION, V117, P1101, DOI 10.1161/CIRCULATIONAHA.107.187192; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Kubala M, 2011, PACE, V34, P837, DOI 10.1111/j.1540-8159.2011.03070.x; NATHAN H, 1966, CIRCULATION, V34, P412, DOI 10.1161/01.CIR.34.3.412; Nedios S, 2011, J INTERV CARD ELECTR, V32, P87, DOI 10.1007/s10840-011-9591-z; Roten L, 2012, CURR CARDIOL REV, V8, P327, DOI 10.2174/157340312803760802; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; Zaca V, 2007, CAN J CARDIOL, V23, P869, DOI 10.1016/S0828-282X(07)70841-3; Zhuang JH, 2012, EUROPACE, V14, P638, DOI 10.1093/europace/eur364	12	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93817	10.1371/journal.pone.0093817	http://dx.doi.org/10.1371/journal.pone.0093817			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705909	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500070
J	Gao, DQ; Li, CY; Xie, XH; Zhao, P; Wei, XF; Sun, WH; Liu, HC; Alexandrou, AT; Jones, J; Zhao, RH; Li, JJ				Gao, Daiqing; Li, Changyou; Xie, Xihe; Zhao, Peng; Wei, Xiaofang; Sun, Weihong; Liu, Hsin-Chen; Alexandrou, Aris T.; Jones, Jennifer; Zhao, Ronghua; Li, Jian Jian			Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy with Cytokine-Induced Killer Cells Improves Survival in Gastric and Colorectal Cancer Patients	PLOS ONE			English	Article							SIPULEUCEL-T; ACTIVE IMMUNOTHERAPY; IMMUNE-RESPONSE; PHASE-I; VACCINATION; PEPTIDE; ANTIGEN; CHEMOTHERAPY; LYMPHOMA; ENHANCE	Gastric and colorectal cancers (GC and CRC) have poor prognosis and are resistant to chemo- and/or radiotherapy. In the present study, the prophylactic effects of dendritic cell (DC) vaccination are evaluated on disease progression and clinical benefits in a group of 54 GC and CRC patients treated with DC immunotherapy combined with cytokine-induced killer (CIK) cells after surgery with or without chemo-radiotherapy. DCs were prepared from the mononuclear cells isolated from patients using IL-2/GM-CSF and loaded with tumor antigens; CIK cells were prepared by incubating peripheral blood lymphocytes with IL-2, IFN-gamma, and CD3 antibodies. The DC/CIK therapy started 3 days after low-dose chemotherapy and was repeated 3-5 times in 2 weeks as one cycle with a total of 188.3 +/- 79.8x10(6) DCs and 58.8 +/- 22.3x10(8) CIK cells. Cytokine levels in patients' sera before and after treatments were measured and the follow-up was conducted for 98 months to determine disease-free survival (DFS) and overall survival (OS). The results demonstrate that all cytokines tested were elevated with significantly higher levels of IFN-gamma and IL-12 in both GC and CRC cohorts of DC/CIK treated patients. By Cox regression analysis, DC/CIK therapy reduced the risk of post-operative disease progression (p<0.01) with an increased OS (<0.01). These results demonstrate that in addition to chemo- and/or radiotherapy, DC/CIK immunotherapy is a potential effective approach in the control of tumor growth for post-operative GC and CRC patients.	[Gao, Daiqing; Li, Changyou; Xie, Xihe; Zhao, Peng; Wei, Xiaofang; Sun, Weihong] Qingdao Univ, Coll Med, Affiliated Hosp 2, Qingdao Ctr Hosp,Biotherapy Ctr, Qingdao 266071, Peoples R China; [Liu, Hsin-Chen; Alexandrou, Aris T.; Li, Jian Jian] Univ Calif Davis, NCI Designated Comprehens Canc Ctr, Dept Radiat Oncol, Sacramento, CA 95817 USA; [Jones, Jennifer; Zhao, Ronghua] Univ Saskatchewan, Dept Med, Saskatoon, SK S7N 0W0, Canada	Qingdao University; University of California System; University of California Davis; University of Saskatchewan	Gao, DQ (corresponding author), Qingdao Univ, Coll Med, Affiliated Hosp 2, Qingdao Ctr Hosp,Biotherapy Ctr, Qingdao 266071, Peoples R China.	gaodaiqing@126.com; jian-jian.li@ucdmc.ucdavis.edu	Zhao, Peng/AAQ-2494-2020	Li, Jian Jian/0000-0003-3694-9675				Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Beutler N, 2013, EUR J IMMUNOL, V43, P1459, DOI 10.1002/eji.201242725; Boulikas T, 2004, ONCOL REP, V11, P559; Chan JK, 2006, CLIN CANCER RES, V12, P1859, DOI 10.1158/1078-0432.CCR-05-2019; Duru N, 2012, CLIN CANCER RES, V18, P6634, DOI 10.1158/1078-0432.CCR-12-1436; Fong L, 2001, P NATL ACAD SCI USA, V98, P8809, DOI 10.1073/pnas.141226398; Frankenberger B, 2012, EUR J CELL BIOL, V91, P53, DOI 10.1016/j.ejcb.2011.01.012; Frohlich MW, 2012, SEMIN ONCOL, V39, P245, DOI 10.1053/j.seminoncol.2012.02.004; Gonzalez-Carmona MA, 2006, LIVER INT, V26, P369, DOI 10.1111/j.1478-3231.2005.01235.x; Gutgemann Stefan, 2007, Ger Med Sci, V5, pDoc07; Higano CS, 2010, NAT REV DRUG DISCOV, V9, P513, DOI 10.1038/nrd3220; Higano CS, 2009, CANCER-AM CANCER SOC, V115, P3670, DOI 10.1002/cncr.24429; Hontscha C, 2011, J CANCER RES CLIN, V137, P305, DOI 10.1007/s00432-010-0887-7; Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52; Huber ML, 2012, J NATL CANCER I, V104, P273, DOI 10.1093/jnci/djr514; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Leemhuis T, 2005, BIOL BLOOD MARROW TR, V11, P181, DOI 10.1016/j.bbmt.2004.11.019; Li CD, 2005, CELL RES, V15, P539, DOI 10.1038/sj.cr.7290323; Li H, 2009, CYTOTHERAPY, V11, P1076, DOI 10.3109/14653240903121252; Linn YC, 2003, LEUKEMIA LYMPHOMA, V44, P1457, DOI 10.1080/1042819031000083082; LU PH, 1994, J IMMUNOL, V153, P1687; Madan RA, 2012, J NATL COMPR CANC NE, V10, P1505, DOI 10.6004/jnccn.2012.0156; Margolin KA, 1997, IMMUNOL REV, V157, P231, DOI 10.1111/j.1600-065X.1997.tb00986.x; Marten A, 2001, J IMMUNOTHER, V24, P502, DOI 10.1097/00002371-200111000-00007; Marten A, 2002, CANCER IMMUNOL IMMUN, V51, P25, DOI 10.1007/s00262-001-0251-5; Marten A, 2001, CANCER GENE THER, V8, P211, DOI 10.1038/sj.cgt.7700292; Melief CJM, 2007, NATURE, V450, P803, DOI 10.1038/nature06363; Mesiano G, 2012, EXPERT OPIN BIOL TH, V12, P673, DOI 10.1517/14712598.2012.675323; Moiseyenko V, 2007, ADV EXP MED BIOL, V601, P387; Morse MA, 1999, CLIN CANCER RES, V5, P1331; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; O'Neill D, 2005, METH MOLEC MED, V109, P1; O'Neill DW, 2007, MOL BIOTECHNOL, V36, P131, DOI 10.1007/s12033-007-0020-6; OTTOMAN RE, 1963, RADIOLOGY, V81, P1014, DOI 10.1148/81.6.1014; Palesty JA, 2004, J CLIN ONCOL, V22, P2507, DOI 10.1200/jco.2004.09.168; Pan YB, 2005, J MED CHEM, V48, P875, DOI 10.1021/jm0494422; Pan Y, 2006, BIOCHEM BIOPH RES CO, V347, P551, DOI 10.1016/j.bbrc.2006.05.214; Schadendorf D, 2009, ANN ONCOL, V20, P41, DOI 10.1093/annonc/mdp253; Schlom J, 2012, CANCER BIOTHER RADIO, V27, P2, DOI 10.1089/cbr.2012.1200; Sharma A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028217; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Su XS, 2010, J CLIN IMMUNOL, V30, P766, DOI 10.1007/s10875-010-9434-1; Sun Yi, 2010, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V18, P219; Thanendrarajan S, 2011, LEUKEMIA RES, V35, P1136, DOI 10.1016/j.leukres.2011.05.005; Thurner B, 1999, J EXP MED, V190, P1669, DOI 10.1084/jem.190.11.1669; Timmerman JM, 2002, BLOOD, V99, P1517, DOI 10.1182/blood.V99.5.1517; van Broekhoven CL, 2004, CANCER RES, V64, P4357, DOI 10.1158/0008-5472.CAN-04-0138; Wongkajornsilp A, 2005, J ORTHOP RES, V23, P1460, DOI 10.1016/j.orthres.2005.03.009	49	72	89	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93886	10.1371/journal.pone.0093886	http://dx.doi.org/10.1371/journal.pone.0093886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699863	Green Submitted, Green Published, gold			2022-12-27	WOS:000334105000118
J	Lee, ZQ; Hsu, WJ; Lin, M				Lee, Zhuo Qi; Hsu, Wen-Jing; Lin, Miao			Estimating Mean First Passage Time of Biased Random Walks with Short Relaxation Time on Complex Networks	PLOS ONE			English	Article								Biased random walk has been studied extensively over the past decade especially in the transport and communication networks communities. The mean first passage time (MFPT) of a biased random walk is an important performance indicator in those domains. While the fundamental matrix approach gives precise solution to MFPT, the computation is expensive and the solution lacks interpretability. Other approaches based on the Mean Field Theory relate MFPT to the node degree alone. However, nodes with the same degree may have very different local weight distribution, which may result in vastly different MFPT. We derive an approximate bound to the MFPT of biased random walk with short relaxation time on complex network where the biases are controlled by arbitrarily assigned node weights. We show that the MFPT of a node in this general case is closely related to not only its node degree, but also its local weight distribution. The MFPTs obtained from computer simulations also agree with the new theoretical analysis. Our result enables fast estimation of MFPT, which is useful especially to differentiate between nodes that have very different local node weight distribution even though they share the same node degrees.	[Lee, Zhuo Qi; Hsu, Wen-Jing; Lin, Miao] Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Lee, ZQ (corresponding author), Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore.	zqlee1@e.ntu.edu.sg	Hsu, Wen-Jing J/A-3702-2011		Ministry of Education, Singapore, through School of Computer Engineering, Nanyang Technological University, Singapore	Ministry of Education, Singapore, through School of Computer Engineering, Nanyang Technological University, Singapore	This work was supported by the scholarship awarded by Ministry of Education, Singapore, through School of Computer Engineering, Nanyang Technological University, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, PHYSICA A, V272, P173, DOI 10.1016/S0378-4371(99)00291-5; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Benichou O, 2010, NAT CHEM, V2, P472, DOI [10.1038/nchem.622, 10.1038/NCHEM.622]; Chen SY, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/732698; Condamin S, 2007, NATURE, V450, P77, DOI 10.1038/nature06201; COPPERSMITH D, 1990, J SYMB COMPUT, V9, P251, DOI 10.1016/S0747-7171(08)80013-2; Dan Wang ZL, 2012, COMMUNICATIONS INFOR; David A, 2009, MARKOV CHAINS MIXING; De Martino D, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.015101; Erik van Doorn PP, 2011, COMMUNICATION; Even-Dar E, 2007, LECT NOTES COMPUT SC, V4858, P281; Fronczak A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016107; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098; Hwang S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.088701; Hwang S, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.056110; Kleinberg J., 2006, P INT C MATH ICM; Krioukov D, 2012, NATURE SCI REPORTS, V2; Lau HW, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/40005; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Ling X, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016113; Page L., 1999, 199966 STANF INFOLAB; Samukhin AN, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036115; Snell, 2003, INTRO PROBABILITY; Yan G, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046108	24	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93348	10.1371/journal.pone.0093348	http://dx.doi.org/10.1371/journal.pone.0093348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699325	Green Published, gold			2022-12-27	WOS:000334105000055
J	Storbeck, J; Stefanucci, JK				Storbeck, Justin; Stefanucci, Jeanine K.			Conditions under which Arousal Does and Does Not Elevate Height Estimates	PLOS ONE			English	Article							EMOTIONAL AROUSAL; PERCEPTION; BEHAVIOR; ATTENTION; MEMORY; FEAR; MISATTRIBUTION; MOTIVATION; EXCITATION; STRESS	We present a series of experiments that explore the boundary conditions for how emotional arousal influences height estimates. Four experiments are presented, which investigated the influence of context, situation-relevance, intensity, and attribution of arousal on height estimates. In Experiment 1, we manipulated the environmental context to signal either danger (viewing a height from above) or safety (viewing a height from below). High arousal only increased height estimates made from above. In Experiment 2, two arousal inductions were used that contained either 1) height-relevant arousing images or 2) height-irrelevant arousing images. Regardless of theme, arousal increased height estimates compared to a neutral group. In Experiment 3, arousal intensity was manipulated by inserting an intermediate or long delay between the induction and height estimates. A brief, but not a long, delay from the arousal induction served to increase height estimates. In Experiment 4, an attribution manipulation was included, and those participants who were made aware of the source of their arousal reduced their height estimates compared to participants who received no attribution instructions. Thus, arousal that is attributed to its true source is discounted from feelings elicited by the height, thereby reducing height estimates. Overall, we suggest that misattributed, embodied arousal is used as a cue when estimating heights from above that can lead to overestimation.	[Storbeck, Justin] CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA; [Stefanucci, Jeanine K.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA	City University of New York (CUNY) System; Queens College NY (CUNY); Utah System of Higher Education; University of Utah	Storbeck, J (corresponding author), CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA.	justin.storbeck@qc.cuny.edu			British Heart Foundation Funding Source: Medline; NHLBI NIH HHS [R01HL36310] Funding Source: Medline; NIA NIH HHS [R01AG013196] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2006, DISS ABSTR INT B; Balcetis E, 2014, CONTROL MOTIVATION I; Balcetis E, 2007, PSYCHOL SCI, V18, P917, DOI 10.1111/j.1467-9280.2007.02000.x; Bargh JA, 2006, EUR J SOC PSYCHOL, V36, P147, DOI 10.1002/ejsp.336; Bocanegra BR, 2009, PSYCHOL SCI, V20, P707, DOI 10.1111/j.1467-9280.2009.02354.x; Bradley M. M., 2007, HDB EMOTION ELICITAT, P29; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Cahill L, 2003, LEARN MEMORY, V10, P270, DOI 10.1101/lm.62403; CANTOR JR, 1975, J PERS SOC PSYCHOL, V32, P69, DOI 10.1037/h0076784; Casper K, 2001, THEORIES MOOD COGNIT, P27; CHRISTIANSON SA, 1992, HDB EMOTION MEMORY R, P307; COHEN DC, 1977, BEHAV THER, V8, P17, DOI 10.1016/S0005-7894(77)80116-0; Cole S, 2013, PSYCHOL SCI, V24, P34, DOI 10.1177/0956797612446953; DARLEY JM, 1966, J PERS SOC PSYCHOL, V4, P73, DOI 10.1037/h0023508; DUTTON DG, 1974, J PERS SOC PSYCHOL, V30, P510, DOI 10.1037/h0037031; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; EPSTEIN W, 1973, PERCEPTION, V2, P267, DOI 10.1068/p020267; Firestone C, 2013, PERSPECT PSYCHOL SCI, V8, P455, DOI 10.1177/1745691613489835; Gable PA, 2010, EMOTION, V10, P599, DOI 10.1037/a0018426; Gasper K, 1998, J PERS SOC PSYCHOL, V74, P1350, DOI 10.1037/0022-3514.74.5.1350; Gasper K, 2000, PERS SOC PSYCHOL B, V26, P698, DOI 10.1177/0146167200268005; HEUER F, 1990, MEM COGNITION, V18, P496, DOI 10.3758/BF03198482; Jackson RE, 2008, EVOL HUM BEHAV, V29, P299, DOI 10.1016/j.evolhumbehav.2008.03.001; Jackson RE, 2009, P R SOC B, V276, P1665, DOI 10.1098/rspb.2009.0004; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Lang PJ, 2008, A8 U FLORIDA; Low A, 2008, PSYCHOL SCI, V19, P865, DOI 10.1111/j.1467-9280.2008.02170.x; Mandler G., 1992, HDB EMOTION MEMORY R, P93; Mather M, 2011, PERSPECT PSYCHOL SCI, V6, P114, DOI 10.1177/1745691611400234; Payne JD, 2002, MEMORY, V10, P1, DOI 10.1080/09658210143000119; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Riener CR, 2011, COGNITION EMOTION, V25, P174, DOI 10.1080/02699931003738026; Rolls Edmund T., 1995, P1091; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schneirla TC, 1959, NEBRASKA S MOTIVATIO, P1; SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513; Stefanucci JK, 2011, SOC PERSONAL PSYCHOL, V5, P296, DOI 10.1111/j.1751-9004.2011.00352.x; Stefanucci JK, 2009, J EXP PSYCHOL HUMAN, V35, P424, DOI 10.1037/a0013894; Stefanucci JK, 2009, J EXP PSYCHOL GEN, V138, P131, DOI 10.1037/a0014797; Storbeck J, 2008, SOC PERSONAL PSYCHOL, V2, P1824, DOI 10.1111/j.1751-9004.2008.00138.x; Teachman BA, 2008, EMOTION, V8, P296, DOI 10.1037/1528-3542.8.2.296; Tsuchiya N, 2007, TRENDS COGN SCI, V11, P158, DOI 10.1016/j.tics.2007.01.005; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Wundt W.M., 1886, ETHIK EINE UNTERSUCH; ZILLMANN D, 1971, J EXP SOC PSYCHOL, V7, P419, DOI 10.1016/0022-1031(71)90075-8	48	9	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92024	10.1371/journal.pone.0092024	http://dx.doi.org/10.1371/journal.pone.0092024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LR	24699393	Green Published, gold			2022-12-27	WOS:000334105000019
J	Wang, SJ; Gong, H; Jiang, GL; Ye, Y; Wu, J; You, JY; Zhang, GP; Sun, AJ; Komuro, I; Ge, JB; Zou, YZ				Wang, Shijun; Gong, Hui; Jiang, Guoliang; Ye, Yong; Wu, Jian; You, Jieyun; Zhang, Guoping; Sun, Aijun; Komuro, Issei; Ge, Junbo; Zou, Yunzeng			Src Is Required for Mechanical Stretch-Induced Cardiomyocyte Hypertrophy through Angiotensin II Type 1 Receptor-Dependent beta-Arrestin2 Pathways	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SMOOTH-MUSCLE-CELLS; CARDIAC-HYPERTROPHY; PROTEIN-KINASE; AT1 RECEPTOR; INDEPENDENT ACTIVATION; NUCLEAR TRANSLOCATION; TYROSINE KINASES; RAT-HEART; MYOCYTES	Angiotensin II (AngII) type 1 receptor (AT1-R) can be activated by mechanical stress (MS) without the involvement of AngII during the development of cardiomyocyte hypertrophy, in which G protein-independent pathways are critically involved. Although beta-arrestin2-biased signaling has been speculated, little is known about how AT1-R/beta-arrestin2 leads to ERK1/2 activation. Here, we present a novel mechanism by which Src kinase mediates AT1-R/beta-arrestin2-dependent ERK1/2 phosphorylation in response to MS. Differing from stimulation by AngII, MS-triggered ERK1/2 phosphorylation is neither suppressed by overexpression of RGS4 (the negative regulator of the G-protein coupling signal) nor by inhibition of G proportional to q downstream protein kinase C (PKC) with GF109203X. The release of inositol 1,4,5-triphosphate (IP3) is increased by AngII but not by MS. These results collectively suggest that MS-induced ERK1/2 activation through AT1-R might be independent of G-protein coupling. Moreover, either knockdown of beta-arrestin2 or overexpression of a dominant negative mutant of beta-arrestin2 prevents MS-induced activation of ERK1/2. We further identifies a relationship between Src, a non-receptor tyrosine kinase and b-arrestin2 using analyses of co-immunoprecipitation and immunofluorescence after MS stimulation. Furthermore, MS, but not AngII-induced ERK1/2 phosphorylation is attenuated by Src inhibition, which also significantly improves pressure overload-induced cardiac hypertrophy and dysfunction in mice lacking AngII. Finally, MS-induced Src activation and hypertrophic response are abolished by candesartan but not by valsartan whereas AngII-induced responses can be abrogated by both blockers. Our results suggest that Src plays a critical role in MS-induced cardiomyocyte hypertrophy through beta-arrestin2-associated angiotensin II type 1 receptor signaling.	[Wang, Shijun; Gong, Hui; Sun, Aijun; Ge, Junbo; Zou, Yunzeng] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai 200433, Peoples R China; [Wang, Shijun; Gong, Hui; Jiang, Guoliang; Ye, Yong; Wu, Jian; You, Jieyun; Zhang, Guoping; Sun, Aijun; Ge, Junbo; Zou, Yunzeng] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan	Fudan University; Fudan University; University of Tokyo	Zou, YZ (corresponding author), Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai 200433, Peoples R China.	zou.yunzeng@zs-hospital.sh.cn		Wu, Jian/0000-0003-4259-8322	National Natural Science Fund of China [81220108003, 81000041]; China Doctoral Foundation [20110071110051]; Technology Commission of Shanghai Municipality [11JC1402400]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); China Doctoral Foundation; Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Fund of China (81220108003; 81000041); China Doctoral Foundation (20110071110051) and Technology Commission of Shanghai Municipality (11JC1402400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2009, MOL CELL ENDOCRINOL, V302, P140, DOI 10.1016/j.mce.2008.11.007; Boutahar N, 2004, J BIOL CHEM, V279, P30588, DOI 10.1074/jbc.M313244200; Chen P, 2013, INT J MOL MED, V32, P165, DOI 10.3892/ijmm.2013.1382; DOSTAL DE, 1992, AM J HYPERTENS, V5, P276; Godin CM, 2012, MINI-REV MED CHEM, V12, P812; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Kobayashi H, 2005, CELL SIGNAL, V17, P1248, DOI 10.1016/j.cellsig.2004.12.014; KOMURO I, 1988, CIRC RES, V62, P1075, DOI 10.1161/01.RES.62.6.1075; Li L, 2010, HYPERTENS RES, V33, P1289, DOI 10.1038/hr.2010.182; Lorell BH, 1999, AM J CARDIOL, V83, p48H; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Pullamsetti SS, 2012, ARTERIOSCL THROM VAS, V32, P1354, DOI 10.1161/ATVBAHA.112.248500; Purdy KE, 2001, J AM SOC NEPHROL, V12, P19, DOI 10.1681/ASN.V12119; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Rakesh K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000769; Reineke EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053395; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Seta K, 2002, J BIOL CHEM, V277, P9268, DOI 10.1074/jbc.M109221200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Tamirisa P, 1999, CIRCULATION, V99, P441, DOI 10.1161/01.CIR.99.3.441; Tokudome T, 2008, CIRCULATION, V117, P2329, DOI 10.1161/CIRCULATIONAHA.107.732990; Yan YB, 1997, J BIOL CHEM, V272, P11924, DOI 10.1074/jbc.272.18.11924; Yasuda N, 2008, N-S ARCH PHARMACOL, V377, P393, DOI 10.1007/s00210-007-0215-1; Yasuda N, 2008, EMBO REP, V9, P179, DOI 10.1038/sj.embor.7401157; Zhai PY, 2006, CIRC RES, V99, P528, DOI 10.1161/01.RES.0000240147.49390.61; Zhai PY, 2005, J CLIN INVEST, V115, P3045, DOI 10.1172/JCI25330; Zhang P, 2011, BIOMED PHARMACOTHER, V65, P590, DOI 10.1016/j.biopha.2009.12.001; Zhou N, 2010, BIOCHEM BIOPH RES CO, V397, P263, DOI 10.1016/j.bbrc.2010.05.097; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137; Zou YZ, 1996, J BIOL CHEM, V271, P33592, DOI 10.1074/jbc.271.52.33592	34	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92926	10.1371/journal.pone.0092926	http://dx.doi.org/10.1371/journal.pone.0092926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699426	Green Submitted, gold, Green Published			2022-12-27	WOS:000334105000037
J	Agassandian, K; Patel, M; Agassandian, M; Steren, KE; Rahmouni, K; Sheffield, VC; Card, JP				Agassandian, Khristofor; Patel, Milan; Agassandian, Marianna; Steren, Karina E.; Rahmouni, Kamal; Sheffield, Val C.; Card, J. Patrick			Ciliopathy Is Differentially Distributed in the Brain of a Bardet-Biedl Syndrome Mouse Model	PLOS ONE			English	Article							TYPE-3 ADENYLYL-CYCLASE; PRIMARY CILIA; SYNDROME PROTEINS; NULL MICE; NEURONS; DISEASE; COMPLEX; ROOTLET; MEMORY; ABNORMALITIES	Bardet-Biedl syndrome (BBS) is a genetically heterogeneous inherited human disorder displaying a pleotropic phenotype. Many of the symptoms characterized in the human disease have been reproduced in animal models carrying deletions or knock-in mutations of genes causal for the disorder. Thinning of the cerebral cortex, enlargement of the lateral and third ventricles, and structural changes in cilia are among the pathologies documented in these animal models. Ciliopathy is of particular interest in light of recent studies that have implicated primary neuronal cilia (PNC) in neuronal signal transduction. In the present investigation, we tested the hypothesis that areas of the brain responsible for learning and memory formation would differentially exhibit PNC abnormalities in animals carrying a deletion of the Bbs4 gene (Bbs4(-/-)). Immunohistochemical localization of adenylyl cyclase-III (ACIII), a marker restricted to PNC, revealed dramatic alterations in PNC morphology and a statistically significant reduction in number of immunopositive cilia in the hippocampus and amygdala of Bbs4(-/-) mice compared to wild type (WT) littermates. Western blot analysis confirmed the decrease of ACIII levels in the hippocampus and amygdala of Bbs4(-/-) mice, and electron microscopy demonstrated pathological alterations of PNC in the hippocampus and amygdala. Importantly, no neuronal loss was found within the subregions of amygdala and hippocampus sampled in Bbs4(-/-) mice and there were no statistically significant alterations of ACIII immunopositive cilia in other areas of the brain not known to contribute to the BBS phenotype. Considered with data documenting a role of cilia in signal transduction these findings support the conclusion that alterations in cilia structure or neurochemical phenotypes may contribute to the cognitive deficits observed in the Bbs4(-/-) mouse mode.	[Agassandian, Khristofor; Patel, Milan; Steren, Karina E.; Card, J. Patrick] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; [Agassandian, Marianna] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Rahmouni, Kamal] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; [Rahmouni, Kamal] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Sheffield, Val C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Sheffield, Val C.] Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Agassandian, K (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	khrisag@pitt.edu	Rahmouni, Kamal/Y-1788-2019	Card, John/0000-0002-6148-7364; Rahmouni, Kamal/0000-0001-5136-6748; Sheffield, Val/0000-0002-6282-0835	National Institutes of Health (NIH) [1RO1HL093134, PO1HL084207]; NIH [R01-EY-11298]; NATIONAL EYE INSTITUTE [R01EY017168, R01EY011298] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL084207, R01HL093134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083543] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research reported in this manuscript was supported by National Institutes of Health (NIH) grants 1RO1HL093134 to J.P. Card and PO1HL084207 to K. Rahmouni. V.C. Sheffield acknowledges NIH support from R01-EY-11298 and is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2004, ESSENTIAL CELL BIOL; Amador-Arjona A, 2011, J NEUROSCI, V31, P9933, DOI 10.1523/JNEUROSCI.1062-11.2011; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baker K, 2011, AM J MED GENET A, V155A, P1, DOI 10.1002/ajmg.a.33773; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Bardet G, 1920, DTSCH MED WOCHENSCHR; Barnett S, 2002, J Med Genet, V39, pe76, DOI 10.1136/jmg.39.12.e76; Beales PL, 1999, J MED GENET, V36, P437; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Biedl A., 1922, DEUT MED WOCHENSCHR, V48, P1630; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Carter CS, 2012, NAT MED, V18, P1797, DOI 10.1038/nm.2996; Chamling X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059101; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Dominguez-Bendala J, 2011, CURR OPIN ORGAN TRAN, V16, P76, DOI 10.1097/MOT.0b013e32834252b5; Eichers ER, 2006, HUM GENET, V120, P211, DOI 10.1007/s00439-006-0197-y; Fath MA, 2005, HUM MOL GENET, V14, P1109, DOI 10.1093/hmg/ddi123; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Guadiana SM, 2013, J NEUROSCI, V33, P2626, DOI 10.1523/JNEUROSCI.2906-12.2013; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Keppler-Noreuil KM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-101; Keryer G, 2011, J CLIN INVEST, V121, P4372, DOI 10.1172/JCI57552; Kumamoto N, 2012, NAT NEUROSCI, V15, P399, DOI 10.1038/nn.3042; Laurence J.Z., 1866, OPHTHALMIC REV, V2, P32; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Leroux MR, 2007, CELL, V129, P1041, DOI 10.1016/j.cell.2007.05.049; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Massinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020580; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; PARE D, 1993, NEUROSCIENCE, V57, P1077, DOI 10.1016/0306-4522(93)90050-P; Peyron C, 1998, J NEUROSCI, V18, P9996; Praetorius HA, 2005, ANNU REV PHYSIOL, V67, P515, DOI 10.1146/annurev.physiol.67.040403.101353; Rahmouni K, 2008, J CLIN INVEST, V118, P1458, DOI 10.1172/JCI32357; Rooryck C, 2007, NEUROPEDIATRICS, V38, P5, DOI 10.1055/s-2007-981466; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Scheidecker S, 2013, J MED GENETICS; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Sheffield VC, 2008, BARDET BIEDL SYNDROM; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Swiderski RE, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-22; Veland IR, 2009, NEPHRON PHYSIOL, V111, P39, DOI 10.1159/000208212; Wang ZS, 2011, J NEUROSCI, V31, P5557, DOI 10.1523/JNEUROSCI.6561-10.2011; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; Yang J, 2005, MOL CELL BIOL, V25, P4129, DOI 10.1128/MCB.25.10.4129-4137.2005; Yang J, 2002, J CELL BIOL, V159, P431, DOI 10.1083/jcb.200207153; Yang J, 2005, EXP CELL RES, V309, P379, DOI 10.1016/j.yexcr.2005.05.026; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	55	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93484	10.1371/journal.pone.0093484	http://dx.doi.org/10.1371/journal.pone.0093484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695551	Green Published, Green Accepted, gold			2022-12-27	WOS:000334103000078
J	Chisti, MJ; Graham, SM; Duke, T; Ahmed, T; Ashraf, H; Faruque, ASG; La Vincente, S; Banu, S; Raqib, R; Salam, MA				Chisti, Mohammod Jobayer; Graham, Stephen M.; Duke, Trevor; Ahmed, Tahmeed; Ashraf, Hasan; Faruque, Abu Syed Golam; La Vincente, Sophie; Banu, Sayera; Raqib, Rubhana; Salam, Mohammed Abdus			A Prospective Study of the Prevalence of Tuberculosis and Bacteraemia in Bangladeshi Children with Severe Malnutrition and Pneumonia Including an Evaluation of Xpert MTB/RIF Assay	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; MALNOURISHED CHILDREN; INDUCED SPUTUM; DIAGNOSIS; MORTALITY; DIARRHEA; INFANTS; HIV; INFECTIONS	Background: Severe malnutrition is a risk factor for pneumonia due to a wide range of pathogens but aetiological data are limited and the role of Mycobacterium tuberculosis is uncertain. Methods: We prospectively investigated severely malnourished young children (<5 years) with radiological pneumonia admitted over a 15-month period. Investigations included blood culture, sputa for microscopy and mycobacterial culture. Xpert MTB/RIF assay was introduced during the study. Study children were followed for 12 weeks following their discharge from the hospital. Results: 405 eligible children were enrolled, with a median age of 10 months. Bacterial pathogens were isolated from blood culture in 18 (4.4%) children, of which 72% were Gram negatives. Tuberculosis was confirmed microbiologically in 7% (27/396) of children that provided sputum - 10 by culture, 21 by Xpert MTB/RIF assay, and 4 by both tests. The diagnostic yield from induced sputum was 6% compared to 3.5% from gastric aspirate. Sixty (16%) additional children had tuberculosis diagnosed clinically that was not microbiologically confirmed. Most confirmed tuberculosis cases did not have a positive contact history or positive tuberculin test. The sensitivity and specificity of Xpert MTB/RIF assay compared to culture was 67% (95% CI: 24-94) and 92% (95% CI: 87-95) respectively. Overall case-fatality rate was 17% and half of the deaths occurred in home following discharge from the hospital. Conclusion and Significance: TB was common in severely malnourished Bangladeshi children with pneumonia. X-pert MTB/RIF assay provided higher case detection rate compared to sputum microscopy and culture. The high mortality among the study children underscores the need for further research aimed at improved case detection and management for better outcomes.	[Chisti, Mohammod Jobayer; Ahmed, Tahmeed; Ashraf, Hasan; Faruque, Abu Syed Golam; Banu, Sayera; Raqib, Rubhana; Salam, Mohammed Abdus] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Chisti, Mohammod Jobayer; Graham, Stephen M.; Duke, Trevor; La Vincente, Sophie] Univ Melbourne, Ctr Int Child Hlth, Dept Paediat, Melbourne, Vic, Australia; [Chisti, Mohammod Jobayer; Graham, Stephen M.; Duke, Trevor; La Vincente, Sophie] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Int Union TB & Lung Dis, Paris, France	International Centre for Diarrhoeal Disease Research (ICDDR); University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Graham, SM (corresponding author), Univ Melbourne, Ctr Int Child Hlth, Dept Paediat, Melbourne, Vic, Australia.	steve.graham@rch.org.au	Chisti, Mohammod J/A-7216-2018	Raqib, Rubhana/0000-0002-8116-4511; Banu, Sayera/0000-0002-5121-1962; Graham, Stephen/0000-0003-3525-2294	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (icddr, b) [Gr-00233]	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (icddr, b)	This research study was funded by the Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (icddr, b; grant no Gr-00233) and its donors, which provide unrestricted support to icddr, b for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency, Swedish International Development Cooperation Agency, and the Department for International Development, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; [Anonymous], 2012, NAT GUID MAN TUB CHI; [Anonymous], COTR PROPH SEV MALN; [Anonymous], 2011, TUB DIAGN AUT DNA TE; Azim T, 2008, INT J STD AIDS, V19, P327, DOI 10.1258/ijsa.2007.007269; Banu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040545; Bates M, 2012, LANCET INFECT DIS; Bates M, 2013, CURR OPIN PULM MED, V19, P229, DOI 10.1097/MCP.0b013e32835f4fe4; BERKOWITZ FE, 1992, PEDIATR INFECT DIS J, V11, P750, DOI 10.1097/00006454-199209000-00015; Carrol ED, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021042; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Chisti MJ, 2010, PEDIATR CRIT CARE ME, V11, P92, DOI 10.1097/PCC.0b013e3181b063e1; Chisti MJ, 2013, J HEALTH POPUL NUTR, V31, P308; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P174, DOI 10.1097/INF.0b013e3181b9a4d5; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Grant LR, 2012, CLIN INFECT DIS, V54, pS140, DOI [10.1093/cid/cir1069, 10.1093/cid/cir1073]; Jaganath D, 2012, J INFECT DIS, V206, P1809, DOI 10.1093/infdis/jis608; Kim BJ, 1999, J CLIN MICROBIOL, V37, P1714, DOI 10.1128/JCM.37.6.1714-1720.1999; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Nantongo JM, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-16; Nguyen TQN, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-31; Nicol MP, 2011, LANCET INFECT DIS, V11, P819, DOI 10.1016/S1473-3099(11)70167-0; Punia RS, 2012, TROP DOCT, V42, P46, DOI 10.1258/td.2011.110314; Rachow A, 2012, CLIN INFECT DIS, V54, P1388, DOI 10.1093/cid/cis190; Shata AMA, 1996, ARCH DIS CHILD, V74, P535, DOI 10.1136/adc.74.6.535; UNICEF, 2013, STAT WORLDS CHILDR 2; Waterlow JC, 1997, CLIN NUTR, V16, P3, DOI 10.1016/S0261-5614(97)80043-X; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wiersma HE, 2000, ARCH DIS CHILD, V83, P278; World Health Organisation, 2006, GUID NAT TUB PROGR M; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2	33	48	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93776	10.1371/journal.pone.0093776	http://dx.doi.org/10.1371/journal.pone.0093776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695758	gold, Green Published, Green Submitted			2022-12-27	WOS:000334103000120
J	Dietrich, S; Wiegand, S; Liesegang, H				Dietrich, Sascha; Wiegand, Sandra; Liesegang, Heiko			TraV: A Genome Context Sensitive Transcriptome Browser	PLOS ONE			English	Article							RNA-SEQ; READ ALIGNMENT; VISUALIZATION; PLATFORM; TOOL	Next-generation sequencing (NGS) technologies like Illumina and ABI Solid enable the investigation of transcriptional activities of genomes. While read mapping tools have been continually improved to enable the processing of the increasing number of reads generated by NGS technologies, analysis and visualization tools are struggling with the amount of data they are presented with. Current tools are capable of handling at most two to three datasets simultaneously before they are limited by available memory or due to processing overhead. In order to process fifteen transcriptome sequencing experiments of Bacillus licheniformis DSM13 obtained in a previous study, we developed TraV, a RNA-Seq analysis and visualization tool. The analytical methods are designed for prokaryotic RNA-seq experiments. TraV calculates single nucleotide activities from the mapping information to visualize and analyze multiple transcriptome sequencing experiments. The use of nucleotide activities instead of single read mapping information is highly memory efficient without incurring a processing overhead. TraV is available at http://appmibio.uni-goettingen.de/index.php?sec=serv.	[Dietrich, Sascha; Wiegand, Sandra; Liesegang, Heiko] Univ Gottingen, Norddeutsches Zentrum Mikrobielle Genomforsch, Inst Mikrobiol & Genet, Abt Angew & Genom Mikrobiol, D-37073 Gottingen, Germany	University of Gottingen	Liesegang, H (corresponding author), Univ Gottingen, Norddeutsches Zentrum Mikrobielle Genomforsch, Inst Mikrobiol & Genet, Abt Angew & Genom Mikrobiol, D-37073 Gottingen, Germany.	hlieseg@gwdg.de		Wiegand, Sandra/0000-0001-5403-4896; Liesegang, Heiko/0000-0003-1792-2047	Bundesministerium fur Bildung und Forschung [FKZ-0315387]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work has been funded by the Bundesministerium fur Bildung und Forschung (FKZ-0315387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; De Lay N, 2013, J BIOL CHEM, V288, P7996, DOI 10.1074/jbc.R112.441386; Filiatrault MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029335; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Milne I., 2012, BRIEF BIOINFORM; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P20130, DOI 10.1073/pnas.1112724108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Niedringhaus TP, 2011, ANAL CHEM, V83, P4327, DOI 10.1021/ac2010857; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Philipp EER, 2012, BIOINFORMATICS, V28, P777, DOI 10.1093/bioinformatics/bts056; Popendorf K, 2012, BIOINFORMATICS, V28, P1276, DOI 10.1093/bioinformatics/bts122; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Schmidtke C, 2012, NUCLEIC ACIDS RES, V40, P2020, DOI 10.1093/nar/gkr904; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-102; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wiegand S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-667; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109	27	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93677	10.1371/journal.pone.0093677	http://dx.doi.org/10.1371/journal.pone.0093677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709941	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800043
J	Echeverria, C; Montorfano, I; Hermosilla, T; Armisen, R; Velasquez, LA; Cabello-Verrugio, C; Varela, D; Simon, F				Echeverria, Cesar; Montorfano, Ignacio; Hermosilla, Tamara; Armisen, Ricardo; Velasquez, Luis A.; Cabello-Verrugio, Claudio; Varela, Diego; Simon, Felipe			Endotoxin Induces Fibrosis in Vascular Endothelial Cells through a Mechanism Dependent on Transient Receptor Protein Melastatin 7 Activity	PLOS ONE			English	Article							ANGIOTENSIN-II; CALCIUM-CHANNEL; EXTRACELLULAR-MATRIX; OXIDATIVE STRESS; MESENCHYMAL TRANSITION; MOLECULAR-MECHANISMS; LIVER FIBROSIS; TRPM7; DYSFUNCTION; EXPRESSION	The pathogenesis of systemic inflammatory diseases, including endotoxemia-derived sepsis syndrome, is characterized by endothelial dysfunction. It has been demonstrated that the endotoxin lipopolysaccharide (LPS) induces the conversion of endothelial cells (ECs) into activated fibroblasts through endothelial-to-mesenchymal transition mechanism. Fibrogenesis is highly dependent on intracellular Ca2+ concentration increases through the participation of calcium channels. However, the specific molecular identity of the calcium channel that mediates the Ca2+ influx during endotoxin-induced endothelial fibrosis is still unknown. Transient receptor potential melastatin 7 (TRPM7) is a calcium channel that is expressed in many cell types, including ECs. TRPM7 is involved in a number of crucial processes such as the conversion of fibroblasts into activated fibroblasts, or myofibroblasts, being responsible for the development of several characteristics of them. However, the role of the TRPM7 ion channel in endotoxin-induced endothelial fibrosis is unknown. Thus, our aim was to study whether the TRPM7 calcium channel participates in endotoxin- induced endothelial fibrosis. Using primary cultures of ECs, we demonstrated that TRPM7 is a crucial protein involved in endotoxin- induced endothelial fibrosis. Suppression of TRPM7 expression protected ECs from the fibrogenic process stimulated by endotoxin. Downregulation of TRPM7 prevented the endotoxin-induced endothelial markers decrease and fibrotic genes increase in ECs. In addition, TRPM7 downregulation abolished the endotoxin-induced increase in ECM proteins in ECs. Furthermore, we showed that intracellular Ca2+ levels were greatly increased upon LPS challenge in a mechanism dependent on TRPM7 expression. These results demonstrate that TRPM7 is a key protein involved in the mechanism underlying endotoxin-induced endothelial fibrosis.	[Echeverria, Cesar; Montorfano, Ignacio; Cabello-Verrugio, Claudio; Simon, Felipe] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile; [Echeverria, Cesar; Montorfano, Ignacio; Cabello-Verrugio, Claudio; Simon, Felipe] Univ Andres Bello, Fac Med, Santiago, Chile; [Simon, Felipe] Millennium Inst Immunol & Immunotherapy, Santiago, Chile; [Hermosilla, Tamara; Varela, Diego] Univ Chile, Fac Med, Ctr Estud Mol Celula, Santiago 7, Chile; [Hermosilla, Tamara; Armisen, Ricardo; Varela, Diego] Univ Chile, Fac Med, Inst Ciencias Biomed, Santiago, Chile; [Armisen, Ricardo] Univ Chile, Fac Med, Ctr Invest & Tratamiento Canc, Santiago, Chile; [Velasquez, Luis A.] Univ Andres Bello, Fac Med, CIMIS, Santiago, Chile; [Velasquez, Luis A.] Univ Santiago Chile, Ctr Para Desarrollo Nanociencia & Nanotecnol, Santiago, Chile	Universidad Andres Bello; Universidad Andres Bello; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad Andres Bello; Universidad de Santiago de Chile	Simon, F (corresponding author), Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile.	fsimon@unab.cl	Armisen, Ricardo/A-7409-2012; Cabello-Verrugio, Claudio/AAD-1454-2020; Varela, Diego/AAG-7489-2019; Echeverría, César/AAH-4994-2019	Armisen, Ricardo/0000-0003-2567-0521; Cabello-Verrugio, Claudio/0000-0001-7273-2102; Varela, Diego/0000-0002-9352-414X; Echeverría, César/0000-0001-5431-7183; Simon, Felipe/0000-0002-2653-9798; Velasquez, Luis/0000-0002-9479-1792	Fondo Nacional de Desarrollo Cientifico y Tecnologico - Fondecyt [1121078, 1120240, 1120286, 1120712, 1120380]; Millennium Institute on Immunology and Immunotherapy [P09-016-F]; Centro para el Desarrollo de la Nanociencia y Nanotecnologia (CEDENNA) [FB0807]; Association-Francaise Contre Les Myopathies [AFM 16670];  [UNAB-DI-281-13/R];  [UNAB-DI-67-12/I]	Fondo Nacional de Desarrollo Cientifico y Tecnologico - Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Institute on Immunology and Immunotherapy; Centro para el Desarrollo de la Nanociencia y Nanotecnologia (CEDENNA); Association-Francaise Contre Les Myopathies(Association Francaise contre les Myopathies); ; 	This work was supported by research grants from Fondo Nacional de Desarrollo Cientifico y Tecnologico - Fondecyt 1121078 (FS), 1120240 (DV), 1120286 (RA), 1120712 (LAV), and 1120380 (CCV). Millennium Institute on Immunology and Immunotherapy P09-016-F. Centro para el Desarrollo de la Nanociencia y Nanotecnologia (CEDENNA) FB0807 (LAV). Association-Francaise Contre Les Myopathies AFM 16670 (CCV). UNAB-DI-281-13/R (CCV). UNAB-DI-67-12/I (CE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Becerra A, 2011, CARDIOVASC RES, V91, P677, DOI 10.1093/cvr/cvr135; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Cabello-Verrugio C, 2012, J CELL MOL MED, V16, P752, DOI 10.1111/j.1582-4934.2011.01354.x; Cabello-Verrugio C, 2011, BIOCHEM BIOPH RES CO, V410, P665, DOI 10.1016/j.bbrc.2011.06.051; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Colston JT, 2002, J BIOL CHEM, V277, P23477, DOI 10.1074/jbc.M108676200; Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366; Du JY, 2010, CIRC RES, V106, P992, DOI 10.1161/CIRCRESAHA.109.206771; Echeverria C, 2013, J CELL MOL MED, V17, P800, DOI 10.1111/jcmm.12066; Morales MG, 2012, INT J BIOCHEM CELL B, V44, P1993, DOI 10.1016/j.biocel.2012.07.028; Grandel U, 2003, CRIT REV IMMUNOL, V23, P267, DOI 10.1615/CritRevImmunol.v23.i4.20; Hermosilla T, 2011, CHANNELS, V5, P280, DOI 10.4161/chan.5.3.15833; Hermosura MC, 2007, BBA-MOL BASIS DIS, V1772, P822, DOI 10.1016/j.bbadis.2007.02.008; HOOK M, 1990, CELL DIFFER DEV, V32, P433, DOI 10.1016/0922-3371(90)90060-A; Huet O, 2011, FRONT BIOSCI-LANDMRK, V16, P1986, DOI 10.2741/3835; Ivaska J, 2000, CELL MOL LIFE SCI, V57, P16, DOI 10.1007/s000180050496; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; Kim BJ, 2011, BASIC CLIN PHARMACOL, V109, P233, DOI 10.1111/j.1742-7843.2011.00706.x; Kimura C, 2001, AM J PHYSIOL-HEART C, V281, pH745, DOI 10.1152/ajpheart.2001.281.2.H745; Kozak JA, 2003, BIOPHYS J, V84, P922, DOI 10.1016/S0006-3495(03)74909-1; Kumaran C, 2002, AM J PHYSIOL-HEART C, V282, pH1855, DOI 10.1152/ajpheart.00747.2001; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Marchand A, 2012, ADV EXP MED BIOL, V740, P795, DOI 10.1007/978-94-007-2888-2_35; Matsuda H, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.07.496; Matsuda Naoyuki, 2007, Journal of Smooth Muscle Research, V43, P117, DOI 10.1540/jsmr.43.117; McNeill MS, 2007, J INVEST DERMATOL, V127, P2020, DOI 10.1038/sj.jid.5700710; Mohamad HE, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-4; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Nunez-Villena F, 2011, ANTIOXID REDOX SIGN, V15, P2425, DOI 10.1089/ars.2010.3825; Ohyama T, 2012, BRIT J PHARMACOL, V165, P1173, DOI 10.1111/j.1476-5381.2011.01599.x; Park HS, 2006, CARDIOVASC RES, V72, P447, DOI 10.1016/j.cardiores.2006.09.012; Peters K, 2003, CARDIOVASC RES, V60, P49, DOI 10.1016/S0008-6363(03)00397-3; Pinsky MR, 2004, AM J MED SCI, V328, P220, DOI 10.1097/00000441-200410000-00005; Potenta S, 2008, BRIT J CANCER, V99, P1375, DOI 10.1038/sj.bjc.6604662; Ramires FJA, 1998, J MOL CELL CARDIOL, V30, P475, DOI 10.1006/jmcc.1997.0612; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rivers EP, 2008, CRIT CARE CLIN, V24, pS1, DOI 10.1016/j.ccc.2008.04.002; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sahni J, 2010, CELL CYCLE, V9, P3565, DOI 10.4161/cc.9.17.12798; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Seccia TM, 2008, J HYPERTENS, V26, P2022, DOI 10.1097/HJH.0b013e328309f00a; Shivakumar K, 2001, J MOL CELL CARDIOL, V33, P373, DOI 10.1006/jmcc.2000.1309; Simon F, 2008, ENDOTHELIUM-J ENDOTH, V15, P175, DOI 10.1080/10623320802174480; Simon F, 2013, CELL SIGNAL, V25, P1614, DOI 10.1016/j.cellsig.2013.03.023; Simon F, 2009, J HYPERTENS, V27, P1202, DOI 10.1097/HJH.0b013e328329e31c; Singh B, 2012, FEMS MICROBIOL REV, V36, P1122, DOI 10.1111/j.1574-6976.2012.00340.x; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Targos B, 2005, ACTA BIOCHIM POL, V52, P397, DOI 10.18388/abp.2005_3452; Tran POT, 1999, EXP CELL RES, V246, P319, DOI 10.1006/excr.1998.4239; Wei CL, 2010, CAN J PHYSIOL PHARM, V88, P105, DOI 10.1139/Y09-118; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Wuensch T, 2010, DIABETES, V59, P844, DOI 10.2337/db09-1100; Wykes RCE, 2007, J IMMUNOL, V179, P4045, DOI 10.4049/jimmunol.179.6.4045; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yang KL, 2008, BIOCHEM BIOPH RES CO, V365, P484, DOI 10.1016/j.bbrc.2007.10.203; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127	63	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94146	10.1371/journal.pone.0094146	http://dx.doi.org/10.1371/journal.pone.0094146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710004	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800106
J	Somboonna, N; Wilantho, A; Jankaew, K; Assawamakin, A; Sangsrakru, D; Tangphatsornruang, S; Tongsima, S				Somboonna, Naraporn; Wilantho, Alisa; Jankaew, Kruawun; Assawamakin, Anunchai; Sangsrakru, Duangjai; Tangphatsornruang, Sithichoke; Tongsima, Sissades			Microbial Ecology of Thailand Tsunami and Non-Tsunami Affected Terrestrials	PLOS ONE			English	Article							INDIAN-OCEAN TSUNAMI; PHANG-NGA; RAST SERVER; SEQUENCE; IDENTIFICATION; EARTHQUAKE; DIVERSITY; INFECTION; COMMUNITY; SEDIMENTS	The effects of tsunamis on microbial ecologies have been ill-defined, especially in Phang Nga province, Thailand. This ecosystem was catastrophically impacted by the 2004 Indian Ocean tsunami as well as the 600 year-old tsunami in Phra Thong island, Phang Nga province. No study has been conducted to elucidate their effects on microbial ecology. This study represents the first to elucidate their effects on microbial ecology. We utilized metagenomics with 16S and 18S rDNAbarcoded pyrosequencing to obtain prokaryotic and eukaryotic profiles for this terrestrial site, tsunami affected (S1), as well as a parallel unaffected terrestrial site, non-tsunami affected (S2). S1 demonstrated unique microbial community patterns than S2. The dendrogram constructed using the prokaryotic profiles supported the unique S1 microbial communities. S1 contained more proportions of archaea and bacteria domains, specifically species belonging to Bacteroidetes became more frequent, in replacing of the other typical floras like Proteobacteria, Acidobacteria and Basidiomycota. Pathogenic microbes, including Acinetobacter haemolyticus, Flavobacterium spp. and Photobacterium spp., were also found frequently in S1. Furthermore, different metabolic potentials highlighted this microbial community change could impact the functional ecology of the site. Moreover, the habitat prediction based on percent of species indicators for marine, brackish, freshwater and terrestrial niches pointed the S1 to largely comprise marine habitat indicating-species.	[Somboonna, Naraporn] Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand; [Wilantho, Alisa; Sangsrakru, Duangjai; Tangphatsornruang, Sithichoke; Tongsima, Sissades] Natl Ctr Genet Engn & Biotechnol, Genome Inst, Pathum Thani, Thailand; [Jankaew, Kruawun] Chulalongkorn Univ, Fac Sci, Dept Geol, Bangkok, Thailand; [Assawamakin, Anunchai] Mahidol Univ, Fac Pharm, Dept Pharmacol, Bangkok 10700, Thailand	Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University; Mahidol University	Somboonna, N (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand.	Naraporn.S@chula.ac.th	Tangphatsornruang, Sithichoke/G-3633-2010; Tongsima, Sissades/F-4891-2011	Tangphatsornruang, Sithichoke/0000-0003-2673-0012; Tongsima, Sissades/0000-0002-1491-1839	Faculty of Science, Chulalongkorn University [A1B1-NS (RES-A1B1-NS-01)]; Thai Aviation Refuelling Co., Ltd.	Faculty of Science, Chulalongkorn University(Chulalongkorn University); Thai Aviation Refuelling Co., Ltd.	The research was supported by Research Funds from the Faculty of Science, Chulalongkorn University, Under the A1B1-NS (RES-A1B1-NS-01), and Thai Aviation Refuelling Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; Appeltans W, 2012, WORLD REGISTER MARIN; Auld RR, 2013, J MICROBIOL METH, V93, P108, DOI 10.1016/j.mimet.2013.01.023; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Banning EC, 2010, FEMS MICROBIOL ECOL, V73, P254, DOI 10.1111/j.1574-6941.2010.00897.x; Boszke L, 2007, J ENVIRON SCI HEAL A, V42, P847, DOI 10.1080/10934520701373018; Brunak S, 2002, SCIENCE, V298, P1333; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Chastel C, 2007, Bull Soc Pathol Exot, V100, P139; Collivignarelli C, 2008, ENVIRON MONIT ASSESS, V147, P191, DOI 10.1007/s10661-007-0111-7; Collivignarelli C, 2008, ENVIRON MONIT ASSESS, V142, P345, DOI 10.1007/s10661-007-9934-5; Grant S, 2006, APPL ENVIRON MICROB, V72, P135, DOI 10.1128/AEM.72.1.135-143.2006; Grotiuz G, 2006, J CLIN MICROBIOL, V44, P3838, DOI 10.1128/JCM.00407-06; HemphillHaley E, 1996, HOLOCENE, V6, P439, DOI 10.1177/095968369600600406; HEMPHILLHALEY E, 1995, GEOL SOC AM BULL, V107, P367, DOI 10.1130/0016-7606(1995)107<0367:DEFEIS>2.3.CO;2; HENRY EA, 1994, ARCH MICROBIOL, V161, P62, DOI 10.1007/BF00248894; Huang LN, 2002, FEMS MICROBIOL LETT, V214, P235, DOI 10.1016/S0378-1097(02)00881-9; Humblot C, 2009, APPL ENVIRON MICROB, V75, P4354, DOI 10.1128/AEM.00451-09; Huusom AJ, 2012, FORENSIC SCI MED PAT, V8, P114, DOI 10.1007/s12024-011-9283-0; Jankaew K, 2008, NATURE, V455, P1228, DOI 10.1038/nature07373; Jaszek M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/497492; Kendall MM, 2006, INT J SYST EVOL MICR, V56, P1525, DOI 10.1099/ijs.0.64216-0; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Lukaszewski Z, 2012, ECOTOX ENVIRON SAFE, V80, P184, DOI 10.1016/j.ecoenv.2012.02.026; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; Manichanh C, 2008, NUCLEIC ACIDS RES, V36, P5180, DOI 10.1093/nar/gkn496; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Osorio CR, 2000, DIS AQUAT ORGAN, V40, P177, DOI 10.3354/dao040177; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Prummongkol S, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.1101; Qadri M, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-8; Redel H, 2013, J INFECT DIS, V207, P1105, DOI 10.1093/infdis/jit005; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rosa LH, 2009, ANTON LEEUW INT J G, V95, P227, DOI 10.1007/s10482-009-9306-y; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sawai Y, 2009, MAR MICROPALEONTOL, V73, P70, DOI 10.1016/j.marmicro.2009.07.003; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Somboonna N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S29; Sri-Aroon P, 2010, SE ASIAN J TROP MED, V41, P48; Starliper CE, 2011, J ADV RES, V2, P97, DOI 10.1016/j.jare.2010.04.001; Taberlet P, 2012, MOL ECOL, V21, P1816, DOI 10.1111/j.1365-294X.2011.05317.x; Tharnpoophasiam Prapin, 2006, Southeast Asian J Trop Med Public Health, V37 Suppl 3, P216; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; Wada K, 2012, J OCCUP HEALTH, V54, P255, DOI 10.1539/joh.11-0270-FS; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530; Yoshida K, 2000, J MED MICROBIOL, V49, P1003, DOI 10.1099/0022-1317-49-11-1003; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	58	14	15	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94236	10.1371/journal.pone.0094236	http://dx.doi.org/10.1371/journal.pone.0094236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710002	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800125
J	Chiyo, PI; Grieneisen, LE; Wittemyer, G; Moss, CJ; Lee, PC; Douglas-Hamilton, I; Archie, EA				Chiyo, Patrick I.; Grieneisen, Laura E.; Wittemyer, George; Moss, Cynthia J.; Lee, Phyllis C.; Douglas-Hamilton, Iain; Archie, Elizabeth A.			The Influence of Social Structure, Habitat, and Host Traits on the Transmission of Escherichia coli in Wild Elephants	PLOS ONE			English	Article							SPRINGS-NATIONAL-RESERVES; POPULATION-STRUCTURE; AFRICAN ELEPHANTS; PHYLOGENETIC DISTRIBUTION; GENETIC-STRUCTURE; SPATIAL STRUCTURE; NETWORK ANALYSIS; ESTIMATING AGE; COLONIZATION; DYNAMICS	Social structure is proposed to influence the transmission of both directly and environmentally transmitted infectious agents. However in natural populations, many other factors also influence transmission, including variation in individual susceptibility and aspects of the environment that promote or inhibit exposure to infection. We used a population genetic approach to investigate the effects of social structure, environment, and host traits on the transmission of Escherichia coli infecting two populations of wild elephants: one in Amboseli National Park and another in Samburu National Reserve, Kenya. If E. coli transmission is strongly influenced by elephant social structure, E. coli infecting elephants from the same social group should be genetically more similar than E. coli sampled from members of different social groups. However, we found no support for this prediction. Instead, E. coli was panmictic across social groups, and transmission patterns were largely dominated by habitat and host traits. For instance, habitat overlap between elephant social groups predicted E. coli genetic similarity, but only in the relatively drier habitat of Samburu, and not in Amboseli, where the habitat contains large, permanent swamps. In terms of host traits, adult males were infected with more diverse haplotypes, and males were slightly more likely to harbor strains with higher pathogenic potential, as compared to adult females. In addition, elephants from similar birth cohorts were infected with genetically more similar E. coli than elephants more disparate in age. This age-structured transmission may be driven by temporal shifts in genetic structure of E. coli in the environment and the effects of age on bacterial colonization. Together, our results support the idea that, in elephants, social structure often will not exhibit strong effects on the transmission of generalist, fecal-oral transmitted bacteria. We discuss our results in the context of social, environmental, and host-related factors that influence transmission patterns.	[Chiyo, Patrick I.; Grieneisen, Laura E.; Archie, Elizabeth A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Wittemyer, George] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Moss, Cynthia J.; Lee, Phyllis C.] Amboseli Trust Elephants, Nairobi, Kenya; [Lee, Phyllis C.] Univ Stirling, Dept Psychol, Behav & Evolut Res Grp, Stirling FK9 4LA, Scotland; [Douglas-Hamilton, Iain] Save Elephants, Nairobi, Kenya	University of Notre Dame; Colorado State University; University of Stirling	Archie, EA (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	earchie@nd.edu	Archie, Elizabeth/AAE-7456-2022; Wittemyer, George/AFQ-1840-2022	Lee, Phyllis/0000-0002-4296-3513	Clare Boothe Luce Foundation; Amboseli Trust for Elephants	Clare Boothe Luce Foundation; Amboseli Trust for Elephants	This research was supported by funds from the Clare Boothe Luce Foundation to EAA, as well as the Amboseli Trust for Elephants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 2005, CAM S BIO EVOL ANTHR, V44, P157, DOI 10.1017/CBO9780511542343.007; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Alm EW, 2011, POPULATION GENETICS OF BACTERIA: A TRIBUTE TO THOMAS S. WHITTAM, P69; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; ANDERSON R M, 1991; Archie EA, 2006, P ROY SOC B-BIOL SCI, V273, P513, DOI 10.1098/rspb.2005.3361; Badgley BD, 2011, WATER RES, V45, P721, DOI 10.1016/j.watres.2010.08.041; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Benavides JA, 2012, APPL ENVIRON MICROB, V78, P4281, DOI 10.1128/AEM.07593-11; Bergholz PW, 2011, APPL ENVIRON MICROB, V77, P211, DOI 10.1128/AEM.01880-10; Berthe T, 2013, APPL ENVIRON MICROB, V79, P4684, DOI 10.1128/AEM.00698-13; Blyton MDJ, 2013, ENVIRON MICROBIOL, V15, P2162, DOI 10.1111/1462-2920.12088; Boudailliez B, 1997, PEDIATR NEPHROL, V11, P36, DOI 10.1007/s004670050229; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Brennan FP, 2010, APPL ENVIRON MICROB, V76, P1449, DOI 10.1128/AEM.02335-09; Bull CM, 2012, MOL ECOL, V21, P4386, DOI 10.1111/j.1365-294X.2012.05653.x; Byappanahalli MN, 2009, WATER RES, V43, P806, DOI 10.1016/j.watres.2008.11.012; Caillaud D, 2006, MICROBES INFECT, V8, P2477, DOI 10.1016/j.micinf.2006.06.003; Caillaud D, 2006, CURR BIOL, V16, pR489, DOI 10.1016/j.cub.2006.06.017; Carlos C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-161; CAUGANT DA, 1984, J HYG-CAMBRIDGE, V92, P377, DOI 10.1017/S0022172400064597; Cesaris L, 2007, FOODBORNE PATHOG DIS, V4, P473, DOI 10.1089/fpd.2007.0038; Charif RA, 2005, BEHAV ECOL SOCIOBIOL, V57, P327, DOI 10.1007/s00265-004-0867-5; Contreras CA, 2011, J MED MICROBIOL, V60, P639, DOI 10.1099/jmm.0.026666-0; Corner LAL, 2003, PREV VET MED, V59, P147, DOI 10.1016/S0167-5877(03)00075-8; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Croze H, 2011, AMBOSELI ELEPHANTS L; DEAN EA, 1989, INFECT IMMUN, V57, P82, DOI 10.1128/IAI.57.1.82-87.1989; Degnan PH, 2012, P NATL ACAD SCI USA, V109, P13034, DOI 10.1073/pnas.1110994109; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Drewe JA, 2011, PREV VET MED, V101, P113, DOI 10.1016/j.prevetmed.2011.05.006; Eames KTD, 2008, THEOR POPUL BIOL, V73, P104, DOI 10.1016/j.tpb.2007.09.007; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ezenwa VO, 2004, BEHAV ECOL, V15, P446, DOI 10.1093/beheco/arh028; Ezenwa VO, 2003, PARASITOLOGY, V126, P379, DOI 10.1017/S0031182002002913; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Ferrari N, 2004, ECOL LETT, V7, P88, DOI 10.1046/j.1461-0248.2003.00552.x; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Fowler M, 2006, BIOL MED SURG ELEPHA; Fraser C, 2005, P NATL ACAD SCI USA, V102, P1968, DOI 10.1073/pnas.0406993102; FREELAND W J, 1976, Biotropica, V8, P12, DOI 10.2307/2387816; FREELAND WJ, 1979, ECOLOGY, V60, P719, DOI 10.2307/1936609; Godfrey SS, 2009, BEHAV ECOL SOCIOBIOL, V63, P1045, DOI 10.1007/s00265-009-0730-9; Goldberg TL, 2007, BIOL CONSERV, V135, P511, DOI 10.1016/j.biocon.2006.10.048; Goldberg TL, 2006, APPL ENVIRON MICROB, V72, P6049, DOI 10.1128/AEM.00355-06; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Gordon DM, 2003, MICROBIOL-SGM, V149, P3575, DOI 10.1099/mic.0.26486-0; Gordon DM, 1997, MICROBIOL-UK, V143, P2039, DOI 10.1099/00221287-143-6-2039; Gordon DM, 2001, MICROBIOL-SGM, V147, P1079, DOI 10.1099/00221287-147-5-1079; Graham AL, 2008, P NATL ACAD SCI USA, V105, P566, DOI 10.1073/pnas.0707221105; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; Hansen DL, 2009, APPL ENVIRON MICROB, V75, P1546, DOI 10.1128/AEM.00444-08; JACHMANN H, 1988, AFR J ECOL, V26, P51, DOI 10.1111/j.1365-2028.1988.tb01127.x; Janmaat KRL, 2009, INT J PRIMATOL, V30, P443, DOI 10.1007/s10764-009-9352-3; JIMENEZ L, 1989, J APPL BACTERIOL, V67, P61, DOI 10.1111/j.1365-2672.1989.tb04955.x; Johnson JR, 2008, J INFECT DIS, V197, P218, DOI 10.1086/524844; Johnson JR, 2009, ANTIMICROB AGENTS CH, V53, P2733, DOI 10.1128/AAC.00297-09; Johnson JR, 2001, J INFECT DIS, V183, P78, DOI 10.1086/317656; Judge J, 2005, APPL ENVIRON MICROB, V71, P6033, DOI 10.1128/AEM.71.10.6033-6038.2005; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Lee P.C., 2011, AMBOSELI ELEPHANTS L; LEE PC, 1995, J ZOOL, V236, P29, DOI 10.1111/j.1469-7998.1995.tb01782.x; Lee PC, 2012, AFR J ECOL, V50, P9, DOI 10.1111/j.1365-2028.2011.01286.x; LEVINE MM, 1993, AM J EPIDEMIOL, V138, P849, DOI 10.1093/oxfordjournals.aje.a116788; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Mbise A. N., 1998, Bulletin of Animal Health and Production in Africa, V46, P95; Meric G, 2013, ENVIRON MICROBIOL, V15, P487, DOI 10.1111/j.1462-2920.2012.02852.x; Moss C.J., 2011, AMBOSELI ELEPHANTS L, DOI DOI 10.7208/CHICAGO/9780226542263.001.0001; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; Moss Cynthia J., 2011, P205; Nunn CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021677; Nunn CL, 2009, PHILOS T R SOC B, V364, P61, DOI 10.1098/rstb.2008.0148; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; POOLE JH, 1989, SYM ZOOL S, V61, P111; Rasmussen HB, 2005, AFR J ECOL, V43, P215, DOI 10.1111/j.1365-2028.2005.00571.x; ROUTMAN E, 1985, APPL ENVIRON MICROB, V50, P749, DOI 10.1128/AEM.50.4.749-754.1985; Rwego IB, 2008, CONSERV BIOL, V22, P1600, DOI 10.1111/j.1523-1739.2008.01018.x; Skorping A, 2004, TRENDS ECOL EVOL, V19, P219, DOI 10.1016/j.tree.2004.02.006; Slutsker L, 1997, ANN INTERN MED, V126, P505, DOI 10.7326/0003-4819-126-7-199704010-00002; Smith JM, 2000, BIOESSAYS, V22, P1115, DOI 10.1002/1521-1878(200012)22:12&lt;1115::AID-BIES9&gt;3.0.CO;2-R; Steens A, 2011, AM J EPIDEMIOL, V174, P1307, DOI 10.1093/aje/kwr245; SU CY, 1995, ANN INTERN MED, V123, P698, DOI 10.7326/0003-4819-123-9-199511010-00009; Tande D, 2010, J ANTIMICROB CHEMOTH, V65, P859, DOI 10.1093/jac/dkq068; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Valverde A, 2008, J CLIN MICROBIOL, V46, P2796, DOI 10.1128/JCM.01008-08; VanderWaal KL, 2014, J ANIM ECOL, V83, P406, DOI 10.1111/1365-2656.12137; Walk ST, 2007, ENVIRON MICROBIOL, V9, P2274, DOI 10.1111/j.1462-2920.2007.01341.x; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Whittam Thomas S., 1992, Current Biology, V2, P676, DOI 10.1016/0960-9822(92)90140-6; WHITTAM TS, 1989, A VAN LEEUW J MICROB, V55, P23, DOI 10.1007/BF02309616; Wilson M., 2008, BACTERIOLOGY HUMANS; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wittemyer G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1919, DOI 10.1007/s00265-007-0432-0; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018; Wittemyer G, 2005, AFR J ECOL, V43, P44, DOI 10.1111/j.1365-2028.2004.00543.x; Wittemyer G, 2001, AFR J ECOL, V39, P357, DOI 10.1046/j.1365-2028.2001.00324.x; Wittemyer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053726; Wittemyer G, 2009, P ROY SOC B-BIOL SCI, V276, P3513, DOI 10.1098/rspb.2009.0941; Young JK, 2008, J MAMMAL, V89, P1094, DOI 10.1644/07-MAMM-A-198.1	104	24	25	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93408	10.1371/journal.pone.0093408	http://dx.doi.org/10.1371/journal.pone.0093408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705319	Green Published, gold			2022-12-27	WOS:000334107500036
J	Gu, Y; Lu, KM; Yang, GH; Cen, Z; Yu, L; Lin, L; Hao, J; Yang, ZG; Peng, JB; Cui, SJ; Huang, J				Gu, Ying; Lu, Kangmo; Yang, Guanghui; Cen, Zhong; Yu, Li; Lin, Lin; Hao, Jing; Yang, Zhigang; Peng, Jiabao; Cui, Shujian; Huang, Jian			Mutation Spectrum of Six Genes in Chinese Phenylketonuria Patients Obtained through Next-Generation Sequencing	PLOS ONE			English	Article							PHENYLALANINE-HYDROXYLASE DEFICIENCY; GTP CYCLOHYDROLASE-I; DIAGNOSIS	Background: The identification of gene variants plays an important role in the diagnosis of genetic diseases. Methodology/Principal Findings: To develop a rapid method for the diagnosis of phenylketonuria (PKU) and tetrahydrobiopterin (BH4) deficiency, we designed a multiplex, PCR-based primer panel to amplify all the exons and flanking regions (50 bp average) of six PKU-associated genes (PAH, PTS, GCH1, QDPR, PCBD1 and GFRP). The Ion Torrent Personal Genome Machine (PGM) System was used to detect mutations in all the exons of these six genes. We tested 93 DNA samples from blood specimens from 35 patients and their parents (32 families) and 26 healthy adults. Using strict bioinformatic criteria, this sequencing data provided, on average, 99.14% coverage of the 39 exons at more than 70-fold mean depth of coverage. We found 23 previously documented variants in the PAH gene and six novel mutations in the PAH and PTS genes. A detailed analysis of the mutation spectrum of these patients is described in this study. Conclusions/Significance: These results were confirmed by Sanger sequencing. In conclusion, benchtop next-generation sequencing technology can be used to detect mutations in monogenic diseases and can detect both point mutations and indels with high sensitivity, fidelity and throughput at a lower cost than conventional methods in clinical applications.	[Gu, Ying] Maternal & Child Hlth Care Hosp, Prenatal Diag Ctr, Lianyungang, Jiangsu, Peoples R China; [Lu, Kangmo] Chengdu Womens & Childrens Hosp, Prenatal Diag Ctr, Chengdu, Jiangsu, Peoples R China; [Yang, Guanghui; Cen, Zhong; Lin, Lin; Hao, Jing; Yang, Zhigang; Peng, Jiabao; Cui, Shujian] Shanghai Find Biotech Co Ltd, Shanghai, Peoples R China; [Yu, Li] Life Technol Co, Shanghai, Peoples R China; [Huang, Jian] Natl Engn Ctr Biochip Shanghai, Shanghai, Peoples R China; [Huang, Jian] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai, Peoples R China	Thermo Fisher Scientific	Huang, J (corresponding author), Natl Engn Ctr Biochip Shanghai, Shanghai, Peoples R China.	huangjchgc@hotmail.com			National High Technology Research and Development Program of China (863 Program) [2012AA02A205]; Chinese National Key Program on Basic Research (973 Program) [2010CB529206, 2014CB965002]; National Natural Science Foundation of China [81272306]; Program of Shanghai Subject Chief Scientist [12XD1421400, 11JC1408800, 13431902000, 12DZ942500]; Shanghai Find Bio-Tech Co Ltd.; Life Technologies Company; National Engineering Center for Biochip at Shanghai	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Chinese National Key Program on Basic Research (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Subject Chief Scientist; Shanghai Find Bio-Tech Co Ltd.; Life Technologies Company; National Engineering Center for Biochip at Shanghai	The authors gratefully acknowledge grant support from the National High Technology Research and Development Program of China (863 Program, 2012AA02A205), the Chinese National Key Program on Basic Research (973 Program, 2010CB529206 and 2014CB965002), the National Natural Science Foundation of China (81272306) and the Program of Shanghai Subject Chief Scientist (12XD1421400, 11JC1408800, 13431902000 and 12DZ942500). Shanghai Find Bio-Tech Co Ltd., provided support in the form of salaries for authors GY, ZC, LL, JH, ZY, JP, & SC. Life Technologies Company provided support in the form of a salary for author LY. National Engineering Center for Biochip at Shanghai provided support in the form of a salary for author JH. Otherwise, these organisations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Blau N, 2004, MOL GENET METAB, V82, P101, DOI 10.1016/j.ymgme.2004.03.006; Blau N, 2011, MOL GENET METAB, V104, pS2, DOI 10.1016/j.ymgme.2011.08.017; Boland JF, 2013, HUM GENET, V132, P1153, DOI 10.1007/s00439-013-1321-4; Chen GQ, 2006, J APPL CLIN PEDIAT, V21, P483; Chiu YH, 2012, J HUM GENET, V57, P145, DOI 10.1038/jhg.2011.146; Costa JL, 2013, HUM MUTAT, V34, P629, DOI 10.1002/humu.22272; DWORNICZAK B, 1991, GENOMICS, V11, P242, DOI 10.1016/0888-7543(91)90129-3; Elliott Aaron M, 2012, J Biomol Tech, V23, P24, DOI 10.7171/jbt.12-2301-003; Gu Xue-Fan, 2004, Zhonghua Yufang Yixue Zazhi, V38, P99; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Li L, 2009, CHINESE J CHILD HLTH, V17, P464; Mitchell JJ, 2011, GENET MED, V13, P697, DOI 10.1097/GIM.0b013e3182141b48; NIEDERWIESER A, 1984, EUR J PEDIATR, V141, P208, DOI 10.1007/BF00572762; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Song F, 2005, MOL GENET METAB, V86, pS107, DOI 10.1016/j.ymgme.2005.09.001; Thony B, 2006, HUM MUTAT, V27, P870, DOI 10.1002/humu.20366; Treff NR, 2013, FERTIL STERIL, V99, P1377, DOI 10.1016/j.fertnstert.2012.12.018; Wang Q, 2006, CHINESE J BIRTH HLTH, V14, P111; Yousem SA, 2013, CHEST, V143, P1679, DOI 10.1378/chest.12-1917; Zhou YA, 2012, GENET MOL BIOL, V35, P709, DOI 10.1590/S1415-47572012005000069; Zy L., 2005, HEILONG JIANG MED J, V29, P554	22	20	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94100	10.1371/journal.pone.0094100	http://dx.doi.org/10.1371/journal.pone.0094100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705691	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500123
J	Li, N; Pasha, Z; Ashraf, M				Li, Ning; Pasha, Zeeshan; Ashraf, Muhammad			Reversal of Ischemic Cardiomyopathy with Sca-1(+) Stem Cells Modified with Multiple Growth Factors	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; DIFFERENTIATION; TRANSPLANTATION; ANGIOGENESIS; EXPRESSION; REPAIR; HEART; ENGRAFTMENT; MECHANISMS; SURVIVAL	We hypothesized that bone marrow derived Sca-1(+) stem cells (BM Sca-1(+)) transduced with multiple therapeutic cytokines with diverse effects will induce faster angiomyogenic differentiation in the infarcted myocardium. Methods and Results: BM Sca-1(+) were purified from transgenic male mice expressing GFP. Plasmids encoding for select quartet of growth factors, i. e., human IGF-1, VEGF, SDF-1 alpha and HGF were prepared and used for genetic modification of Sca1(+) cells ((GF)Sca-1(+)). Scramble transfected cells ((Sc)Sca-1(+)) were used as a control. RT-PCR and western blotting showed significantly higher expression of the growth factors in (GF)Sca-1(+). Besides the quartet of the therapeutic growth factors, PCR based growth factor array showed upregulation of multiple angiogenic and prosurvival factors such as Ang-1, Ang-2, MMP9, Cx43, BMP2, BMP5, FGF2, and NGF in (GF)Sca-1+ (p, 0.01 vs (Sc)Sca-1(+)). LDH and TUNEL assays showed enhanced survival of (GF)Sca-1(+) under lethal anoxia (p, 0.01 vs Sc Sca-1(+)). MTS assay showed significant increased cell proliferation in (GF)Sca-1(+) (p, 0.05 vs (Sc)Sca-1(+)). For in vivo study, female mice were grouped to receive the intramyocardial injection of 15 ml DMEM without cells (group-1) or containing 2.5610 5 (Sc)Sca-1(+) (group-2) or (GF)Sca-1(+) (group-3) immediately after coronary artery ligation. As indicated by Sry gene, a higher survival of (GF)Sca-1(+) in group-3 on day4 (2.3 fold higher vs group-2) was observed with massive mobilization of stem and progenitor cells (cKit+, Mdr1+, Cxcr4+ cells). Heart tissue sections immunostained for actinin and Cx43 at 4 weeks post engraftment showed extensive myofiber formation and expression of gap junctions. Immunostaining for vWF showed increased blood vessel density in both peri-infarct and infarct regions in group-3. Infarct size was attenuated and the global heart function was improved in group-3 as compared to group-2. Conclusions: Administration of BM Sca-1+ transduced with multiple genes is a novel approach to treat infarcted heart for its regeneration.	[Li, Ning] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Pasha, Zeeshan; Ashraf, Muhammad] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Ashraf, M (corresponding author), Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA.	ashrafm2@uic.edu	Ashraf, Muhammad/ABB-3463-2021		NHLBI NIH HHS [HL-087246, R01 HL087246, R01 HL095375] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087246, R01HL095375] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181; Chavakis E, 2010, CIRCULATION, V121, P325, DOI 10.1161/CIRCULATIONAHA.109.901405; Danesh SM, 2009, GENE EXPR PATTERNS, V9, P255, DOI 10.1016/j.gep.2009.04.002; Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013; Elmadbouh I, 2007, J MOL CELL CARDIOL, V42, P792, DOI 10.1016/j.yjmcc.2007.02.001; Fan BS, 2011, GENE, V485, P167, DOI 10.1016/j.gene.2011.06.027; Fedak PWM, 2008, SEMIN THORAC CARDIOV, V20, P87, DOI 10.1053/j.semtcvs.2008.04.001; Gao F, 2007, CAN J CARDIOL, V23, P891; Ghadge SK, 2011, PHARMACOL THERAPEUT, V129, P97, DOI 10.1016/j.pharmthera.2010.09.011; GHERARDI E, 1991, CANCER CELL-MON REV, V3, P227; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Hao Q, 2011, STROKE, V42, P453, DOI 10.1161/STROKEAHA.110.596452; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Jayasankar V, 2005, J CARDIAC SURG, V20, P93, DOI 10.1111/j.0886-0440.2005.200373.x; Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60; Kanemitsu N, 2006, J HEART LUNG TRANSPL, V25, P1253, DOI 10.1016/j.healun.2006.05.012; Kofidis T, 2004, STEM CELLS, V22, P1239, DOI 10.1634/stemcells.2004-0127; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Lu G, 2009, CIRCULATION, V119, P2587, DOI 10.1161/CIRCULATIONAHA.108.827691; Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220; Maulik N, 2008, J MOL CELL CARDIOL, V44, P219, DOI 10.1016/j.yjmcc.2007.11.012; Meloni M, 2010, CIRC RES, V106, P1275, DOI 10.1161/CIRCRESAHA.109.210088; Mozid AM, 2011, BRIT MED BULL, V98, P143, DOI 10.1093/bmb/ldr014; Nesselmann C, 2008, J CELL MOL MED, V12, P1795, DOI 10.1111/j.1582-4934.2008.00457.x; Ono K, 1997, CIRCULATION, V95, P2552, DOI 10.1161/01.CIR.95.11.2552; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Pasha Z, 2008, CARDIOVASC RES, V77, P134, DOI 10.1093/cvr/cvm025; Pasha Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023667; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Piepoli MF, 2010, EUR J HEART FAIL, V12, P172, DOI 10.1093/eurjhf/hfp183; Rosenblatt-Velin N, 2005, J CLIN INVEST, V115, P1724, DOI 10.1172/JCI23418; Rothhammer T, 2007, ONCOGENE, V26, P4158, DOI 10.1038/sj.onc.1210182; Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Song H, 2010, EXPERT OPIN BIOL TH, V10, P309, DOI 10.1517/14712590903455997; Song YH, 2007, BIOCHEM BIOPH RES CO, V354, P999, DOI 10.1016/j.bbrc.2007.01.095; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Virag JAI, 2007, AM J PATHOL, V171, P1431, DOI 10.2353/ajpath.2007.070003; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang YG, 2004, J MOL CELL CARDIOL, V37, P1041, DOI 10.1016/j.yjmcc.2004.09.004; Wang YG, 2006, J MOL CELL CARDIOL, V40, P736, DOI 10.1016/j.yjmcc.2006.02.004; Wen ZZ, 2011, J CELL MOL MED, V15, P1032, DOI 10.1111/j.1582-4934.2010.01255.x; Wiley DM, 2011, SEMIN CELL DEV BIOL, V22, P1012, DOI 10.1016/j.semcdb.2011.10.005; Yasuda S, 2000, J AM COLL CARDIOL, V36, P115, DOI 10.1016/S0735-1097(00)00675-6; Yu JX, 2009, J VASC SURG, V50, P608, DOI 10.1016/j.jvs.2009.05.049; Zisa D, 2009, BIOCHEM BIOPH RES CO, V390, P834, DOI 10.1016/j.bbrc.2009.10.058	50	7	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93645	10.1371/journal.pone.0093645	http://dx.doi.org/10.1371/journal.pone.0093645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705272	Green Submitted, Green Published, gold			2022-12-27	WOS:000334107500051
J	Puljic, VM; Licina, MLK; Kavic, M; Blazic, TN				Puljic, Vlatka Matkovic; Licina, Mirjana Lana Kosanovic; Kavic, Marija; Blazic, Tatjana Nemeth			Repeat HIV Testing at Voluntary Testing and Counseling Centers in Croatia: Successful HIV Prevention or Failure to Modify Risk Behaviors?	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; MEN; SEX; ZAGREB; SEROCONVERSION; INTERVENTIONS; PREDICTORS; IMPROVE	HIV testing plays a critical role in preventing the spread of the virus and identifying infected individuals in need of care. Voluntary counseling and testing centers (VCTs) not only conduct testing but they also provide counseling. Since a proportion of people who test negative for HIV on their previous visit will return for retesting, the frequency of retesting and the characteristics of those who retest may provide insights into the efficacy of testing and counseling strategies. In this cross-sectional, retrospective study of 1,482 VCT clients in Croatia in 2010, 44.3% had been tested for HIV before. The rate of repeat HIV testing is lower in Croatia than in other countries. Men who have sex with men (MSM) clients, those with three or more sexual partners in the last 12 months, consistent condom users with steady partners, and intravenous drug users were more likely to be repeat testers. This finding suggests that clients presenting for repeat HIV testing are those who self-identify as being at a higher risk of infection. Our data showed that testing positive for HIV was not associated with repeat testing. However, the effects of repeat testing on HIV epidemiology needs to be explored.	[Puljic, Vlatka Matkovic; Kavic, Marija] Univ Hosp Infect Dis, Zagreb, Croatia; [Licina, Mirjana Lana Kosanovic] Inst Publ Hlth Dr Andrija Stampar, Zagreb, Croatia; [Blazic, Tatjana Nemeth] Natl Inst Publ Hlth, Zagreb, Croatia		Puljic, VM (corresponding author), Univ Hosp Infect Dis, Zagreb, Croatia.	vlatka.m@gmail.com	Puljic, Vlatka Matkovic/V-1443-2019	Matkovic, Vlatka/0000-0001-9938-2253				[Anonymous], 2002, INCR ACC HIV TEST CO; Begovac J, 2008, AIDS BEHAV, V12, pS48, DOI 10.1007/s10461-008-9398-9; Begovac J, 2006, COLLEGIUM ANTROPOL, V30, P17; Bozicevic I, 2012, SEX TRANSM INFECT, V88, P539, DOI 10.1136/sextrans-2011-050374; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; U.S. Public Health Service, 2001, MMWR Recomm Rep, V50, P1; Chen Z, 1998, SEX TRANSM DIS, V25, P539, DOI 10.1097/00007435-199811000-00008; Croatian Institute of Public Health, 2009, HDB HIV COUNS TEST; Croatian Institute of Public Health Ministry of Health and Social Welfare Croatia, 2011, IZVJ OS LIJ ZBOG ZLO; Europaisches Zentrum fur die Pravention und die Kontrolle von Krankheiten, 2010, HIV TEST INCR UPT EF; Gjenero-Margan I, 2006, COLLEGIUM ANTROPOL, V30, P11; Glavak Tkalic R., 2012, SUBSTANCE ABUSE GEN; Gumy C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-422; Hightow LB, 2004, SEX TRANSM DIS, V31, P455, DOI 10.1097/01.olq.0000135984.27593.5f; Johnson A. Satcher, 2010, Morbidity and Mortality Weekly Report, V59, P1550; Joint United Nations Programme on HIV/ AIDS, 2000, TOOLS EV HIV VOL COU; Kalichman SC, 2008, J CLIN PSYCHOL MED S, V15, P127, DOI 10.1007/s10880-008-9116-9; Kosanovic ML, 2006, COLLEGIUM ANTROPOL, V30, P115; Kozul K, 2010, COLLEGIUM ANTROPOL, V34, P509; Leaity S, 2000, AIDS, V14, P547, DOI 10.1097/00002030-200003310-00010; Lorente N, 2012, AIDS CARE, V24, P1039, DOI 10.1080/09540121.2012.668171; Lyons MS, 2009, CURR HIV RES, V7, P580, DOI 10.2174/157016209789973646; MacKellar DA, 2002, J ACQ IMMUN DEF SYND, V29, P76, DOI 10.1097/00042560-200201010-00011; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; MCFARLAND W, 1995, AM J EPIDEMIOL, V142, P719, DOI 10.1093/oxfordjournals.aje.a117702; Nemeth Blazic T, 2008, INCREASED ACCESS VOL; Ryder K, 2005, AIDS BEHAV, V9, P459, DOI 10.1007/s10461-005-9032-z; Stulhofer A, 2008, AIDS BEHAV, V12, P505, DOI 10.1007/s10461-007-9327-3; Stulhofer A, 2007, INT FAM PLAN PERSPEC, V33, P58, DOI 10.1363/3305807; Van Loon S, 2004, 15 INT AIDS C 2004; Williams-Roberts H, 2010, VIRULENCE, V1, P68, DOI 10.4161/viru.1.2.10570; Wimonsate W, 2011, AIDS BEHAV, V15, P693, DOI 10.1007/s10461-010-9755-3	32	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93734	10.1371/journal.pone.0093734	http://dx.doi.org/10.1371/journal.pone.0093734			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6MJ	24705595	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500062
J	Salehi, MH; Kamalidehghan, B; Houshmand, M; Meng, GY; Sadeghizadeh, M; Aryani, O; Nafissi, S				Salehi, Mohammad Hossein; Kamalidehghan, Behnam; Houshmand, Massoud; Meng, Goh Yong; Sadeghizadeh, Majid; Aryani, Omid; Nafissi, Shahriar			Gene Expression Profiling of Mitochondrial Oxidative Phosphorylation (OXPHOS) Complex I in Friedreich Ataxia (FRDA) Patients	PLOS ONE			English	Article							ELECTRON-TRANSPORT CHAIN; IRON-SULFUR CLUSTERS; REPEAT EXPANSION; MAMMALIAN-CELLS; FRATAXIN; TRANSCRIPTION; BIOGENESIS; DEFICIENCY; PROTEIN; COEXPRESSION	Friedreich ataxia (FRDA) is the most frequent progressive autosomal recessive disorder associated with unstable expansion of GAA trinucleotide repeats in the first intron of the FXN gene, which encodes for the mitochondrial frataxin protein. The number of repeats correlates with disease severity, where impaired transcription of the FXN gene results in reduced expression of the frataxin protein. Gene expression studies provide insights into disease pathogenicity and identify potential biomarkers, an important goal of translational research in neurodegenerative diseases. Here, using real-time PCR (RT-PCR), the expression profiles of mitochondrial (mtDNA) and nuclear DNA (nDNA) genes that encode for the mitochondrial subunits of respiratory oxidative phosphorylation (OXPHOS) complex I in the blood panels of 21 FRDA patients and 24 healthy controls were investigated. Here, the expression pattern of mtDNA-encoded complex I subunits was distinctly different from the expression pattern of nDNA-encoded complex I subunits, where significant (p<0.05) down-regulation of the mitochondrial ND2, ND4L, and ND6 complex I genes, compared to controls, were observed. In addition, the expression pattern of one nDNA-encoded gene, NDUFA1, was significantly (p<0.05) down-regulated compared to control. These findings suggest, for the first time, that the regulation of complex I subunit expression in FRDA is complex, rather than merely being a reflection of global co-regulation, and may provide important clues toward novel therapeutic strategies for FRDA and mitochondrial complex I deficiency.	[Salehi, Mohammad Hossein; Sadeghizadeh, Majid] Tarbiat Modares Univ, Dept Mol Genet, Tehran, Iran; [Kamalidehghan, Behnam] UM, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Houshmand, Massoud] Natl Inst Genet Engn & Biotechnol, Dept Med Genet, Tehran, Iran; [Houshmand, Massoud; Aryani, Omid] Special Med Ctr, Dept Med Genet, Tehran, Iran; [Meng, Goh Yong] Univ Putra Malaysia, Fac Vet Med, Dept Preclin Sci, Serdang, Malaysia; [Meng, Goh Yong] Univ Putra Malaysia, Inst Trop Agr, Serdang, Malaysia; [Nafissi, Shahriar] Univ Tehran Med Sci, Shariati Hosp, Dept Neurol, Tehran, Iran	Tarbiat Modares University; Universiti Malaya; Universiti Putra Malaysia; Universiti Putra Malaysia; Tehran University of Medical Sciences	Houshmand, M (corresponding author), Natl Inst Genet Engn & Biotechnol, Dept Med Genet, Tehran, Iran.	massoudh@nigeb.ac.ir	Houshmand, Massoud/AEG-9909-2022; Goh, Y.M./B-2382-2010; nafissi, shahriar/A-1839-2013; Nafissi, Shahriar/AAS-1597-2020; Nafissi, Shahriar/AAX-9954-2020; Kamalidehghan, Behnam/B-5401-2013	Goh, Y.M./0000-0003-1237-2170; Nafissi, Shahriar/0000-0003-4763-4310; Kamalidehghan, Behnam/0000-0001-8530-8124; Houshmand, Massoud/0000-0002-2198-223X; , Masoud/0000-0001-7687-7464	 [187]		This work was supported by a grant(Project 187) from MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chantrel-Groussard K, 2001, HUM MOL GENET, V10, P2061, DOI 10.1093/hmg/10.19.2061; Condo I, 2007, HUM MOL GENET, V16, P1534, DOI 10.1093/hmg/ddm102; Cossee M, 1997, P NATL ACAD SCI USA, V94, P7452, DOI 10.1073/pnas.94.14.7452; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; Diaz F, 2011, SEMIN FETAL NEONAT M, V16, P197, DOI 10.1016/j.siny.2011.05.004; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Garbian Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009985; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Heidari MM, 2009, CELL MOL NEUROBIOL, V29, P225, DOI 10.1007/s10571-008-9315-9; Heidari MM, 2009, CAN J NEUROL SCI, V36, P26, DOI 10.1017/S0317167100006260; Karthikeyan G, 2003, HUM MOL GENET, V12, P3331, DOI 10.1093/hmg/ddg349; KING MP, 1993, J BIOL CHEM, V268, P10228; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mateo I, 2004, ACTA NEUROL SCAND, V109, P75, DOI 10.1034/j.1600-0404.2003.00190.x; McKenzie M, 2013, MITOCHONDRIAL DNA MU, P25; Mishmar D, 2006, GENE, V378, P11, DOI 10.1016/j.gene.2006.03.015; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Napoli E, 2006, ANTIOXID REDOX SIGN, V8, P506, DOI 10.1089/ars.2006.8.506; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Pianese L, 2004, J NEUROL NEUROSUR PS, V75, P1061, DOI 10.1136/jnnp.2003.028605; Puccio H, 2000, HUM MOL GENET, V9, P887, DOI 10.1093/hmg/9.6.887; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019; Shoichet SA, 2002, HUM MOL GENET, V11, P815, DOI 10.1093/hmg/11.7.815; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tan G, 2001, HUM MOL GENET, V10, P2099, DOI 10.1093/hmg/10.19.2099; Tucker EJ, 2011, IUBMB LIFE, V63, P669, DOI 10.1002/iub.495; van Waveren C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-18; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	44	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94069	10.1371/journal.pone.0094069	http://dx.doi.org/10.1371/journal.pone.0094069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705504	Green Submitted, gold, Green Published			2022-12-27	WOS:000334107500118
J	Wang, JK; Teng, IJ; Lo, TJ; Moore, S; Yeo, YH; Teng, YC; Kaul, M; Chen, CC; Zuo, AH; Chou, FP; Yang, XY; Tseng, IC; Johnson, MD; Lin, CY				Wang, Jehng-Kang; Teng, I-Jou; Lo, Ting-Jen; Moore, Sean; Yeo, Yee Hui; Teng, Yun-Chung; Kaul, Malvika; Chen, Chiann-Chyi; Zuo, Annie Hong; Chou, Fen-Pai; Yang, Xiaoyu; Tseng, I-Chu; Johnson, Michael D.; Lin, Chen-Yong			Matriptase Autoactivation Is Tightly Regulated by the Cellular Chemical Environments	PLOS ONE			English	Article							AUTOSOMAL RECESSIVE ICHTHYOSIS; SERINE-PROTEASE; LIVING CELLS; GOLGI PH; ACTIVATION; MITOCHONDRIAL; CONTRIBUTES; REQUIRES; MUTATION; HYPOXIA	The ability of cells to rapidly detect and react to alterations in their chemical environment, such as pH, ionic strength and redox potential, is essential for cell function and survival. We present here evidence that cells can respond to such environmental alterations by rapid induction of matriptase autoactivation. Specifically, we show that matriptase autoactivation can occur spontaneously at physiological pH, and is significantly enhanced by acidic pH, both in a cellfree system and in living cells. The acid-accelerated autoactivation can be attenuated by chloride, a property that may be part of a safety mechanism to prevent unregulated matriptase autoactivation. Additionally, the thio-redox balance of the environment also modulates matriptase autoactivation. Using the cell-free system, we show that matriptase autoactivation is suppressed by cytosolic reductive factors, with this cytosolic suppression being reverted by the addition of oxidizing agents. In living cells, we observed rapid induction of matriptase autoactivation upon exposure to toxic metal ions known to induce oxidative stress, including CoCl2 and CdCl2. The metal-induced matriptase autoactivation is suppressed by N-acetylcysteine, supporting the putative role of altered cellular redox state in metal induced matriptase autoactivation. Furthermore, matriptase knockdown rendered cells more susceptible to CdCl2-induced cell death compared to control cells. This observation implies that the metal-induced matriptase autoactivation confers cells with the ability to survive exposure to toxic metals and/or oxidative stress. Our results suggest that matriptase can act as a cellular sensor of the chemical environment of the cell that allows the cell to respond to and protect itself from changes in the chemical milieu.	[Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; [Teng, I-Jou; Lo, Ting-Jen; Yeo, Yee Hui] Natl Def Med Ctr, Dept Med, Taipei, Taiwan; [Moore, Sean] Univ Maryland, Geenebaum Canc Ctr, Baltimore, MD 21201 USA; [Teng, Yun-Chung] Natl Yang Ming Univ, Dept Biomed Engn, Taipei 112, Taiwan; [Kaul, Malvika; Chen, Chiann-Chyi] Rutgers Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ USA; [Zuo, Annie Hong; Chou, Fen-Pai; Yang, Xiaoyu; Tseng, I-Chu; Johnson, Michael D.; Lin, Chen-Yong] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA	National Defense Medical Center; National Defense Medical Center; University System of Maryland; University of Maryland Baltimore; National Yang Ming Chiao Tung University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Georgetown University	Lin, CY (corresponding author), Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	lincy@georgetown.edu	Yeo, Y/GWV-3316-2022; Feng-Pai, Chou/AGS-4250-2022	johnson, Michael/0000-0001-6260-7586	National Cancer Institute (NCI) [RO1 CA 123223]; Taiwan Department of Defense [MAB-102-8]; NATIONAL CANCER INSTITUTE [R01CA123223, P30CA051008] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000101] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Taiwan Department of Defense; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by National Cancer Institute (NCI) Grants RO1 CA 123223 (to MDJ and CYL), and Taiwan Department of Defense Grant MAB-102-8 (to JKW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen YW, 2014, J INVEST DERMATOL, V134, P405, DOI 10.1038/jid.2013.320; Chen YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062826; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Chou FP, 2013, AM J PATHOL, V183, P1306, DOI 10.1016/j.ajpath.2013.06.024; Clark EB, 2010, J BIOL CHEM, V285, P27130, DOI 10.1074/jbc.M110.153213; Desilets A, 2008, J BIOL CHEM, V283, P10535, DOI 10.1074/jbc.M707012200; Ercal N, 2002, FREE RADICAL BIO MED, V32, P906, DOI 10.1016/S0891-5849(02)00781-5; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Glitsch M, 2011, PHYSIOLOGY, V26, P252, DOI 10.1152/physiol.00005.2011; Hung RJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1159, DOI 10.1152/ajpcell.00400.2003; Inouye K, 2010, J BIOCHEM, V147, P485, DOI 10.1093/jb/mvp190; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; McQueney MS, 1997, J BIOL CHEM, V272, P13955, DOI 10.1074/jbc.272.21.13955; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Politzer P, 2007, J MOL MODEL, V13, P305, DOI 10.1007/s00894-006-0154-7; Richter C, 1998, BIOCHEM J, V335, P481, DOI 10.1042/bj3350481; SEKSEK O, 1995, J BIOL CHEM, V270, P4967, DOI 10.1074/jbc.270.10.4967; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Szabo R, 2011, ONCOGENE, V30, P2003, DOI 10.1038/onc.2010.586; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; TANNOCK IF, 1989, CANCER RES, V49, P4373; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Xu H, 2012, AM J PHYSIOL-CELL PH, V302, pC453, DOI 10.1152/ajpcell.00344.2011; Xu ZH, 2011, J MED CHEM, V54, P7567, DOI 10.1021/jm200920s	41	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93899	10.1371/journal.pone.0093899	http://dx.doi.org/10.1371/journal.pone.0093899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705933	Green Submitted, Green Published, gold			2022-12-27	WOS:000334107500090
J	Guo, XY; Lin, MY; Rockowitz, S; Lachman, HM; Zheng, DY				Guo, Xingyi; Lin, Mingyan; Rockowitz, Shira; Lachman, Herbert M.; Zheng, Deyou			Characterization of Human Pseudogene- Derived Non- Coding RNAs for Functional Potential	PLOS ONE			English	Article							REGULATE GENE-EXPRESSION; SMALL INTERFERING RNAS; GENOME-WIDE SURVEY; PROCESSED PSEUDOGENES; NONCODING RNAS; TRANSCRIBED PSEUDOGENE; MESSENGER-RNAS; ANTISENSE; PROTEIN; REVEALS	Thousands of pseudogenes exist in the human genome and many are transcribed, but their functional potential remains elusive and understudied. To explore these issues systematically, we first developed a computational pipeline to identify transcribed pseudogenes from RNA-Seq data. Applying the pipeline to datasets from 16 distinct normal human tissues identified,3,000 pseudogenes that could produce non-coding RNAs in a manner of low abundance but high tissue specificity under normal physiological conditions. Cross-tissue comparison revealed that the transcriptional profiles of pseudogenes and their parent genes showed mostly positive correlations, suggesting that pseudogene transcription could have a positive effect on the expression of their parent genes, perhaps by functioning as competing endogenous RNAs (ceRNAs), as previously suggested and demonstrated with the PTEN pseudogene, PTENP1. Our analysis of the ENCODE project data also found many transcriptionally active pseudogenes in the GM12878 and K562 cell lines; moreover, it showed that many human pseudogenes produced small RNAs (sRNAs) and some pseudogene-derived sRNAs, especially those from antisense strands, exhibited evidence of interfering with gene expression. Further integrated analysis of transcriptomics and epigenomics data, however, demonstrated that trimethylation of histone 3 at lysine 9 (H3K9me3), a posttranslational modification typically associated with gene repression and heterochromatin, was enriched at many transcribed pseudogenes in a transcription-level dependent manner in the two cell lines. The H3K9me3 enrichment was more prominent in pseudogenes that produced sRNAs at pseudogene loci and their adjacent regions, an observation further supported by the co- enrichment of SETDB1 ( a H3K9 methyltransferase), suggesting that pseudogene sRNAs may have a role in regional chromatin repression. Taken together, our comprehensive and systematic characterization of pseudogene transcription uncovers a complex picture of how pseudogene ncRNAs could influence gene and pseudogene expression, at both epigenetic and post-transcriptional levels.	[Guo, Xingyi; Zheng, Deyou] Albert Einstein Coll Med, Saul R Korey Dept Neurol, New York, NY USA; [Lin, Mingyan; Rockowitz, Shira; Lachman, Herbert M.; Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, New York, NY USA; [Lachman, Herbert M.; Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, New York, NY USA; [Lachman, Herbert M.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, New York, NY USA	Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University	Zheng, DY (corresponding author), Albert Einstein Coll Med, Saul R Korey Dept Neurol, New York, NY USA.	deyou.zheng@einstein.yu.edu	lin, mingyan/HDL-9420-2022	Zheng, Deyou/0000-0003-4354-5337	NIH/NIMH [R21MH099452]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099452] Funding Source: NIH RePORTER	NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the NIH/NIMH (R21MH099452). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blahnik KR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017121; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chan WL, 2013, NUCLEIC ACIDS RES, V41, P3734, DOI 10.1093/nar/gkt047; Chen L, 2012, EPIGENETICS-US, V7, P758, DOI 10.4161/epi.20706; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Frith MC, 2006, PLOS GENET, V2, P504, DOI 10.1371/journal.pgen.0020023; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Gertz J, 2012, GENOME RES, V22, P134, DOI 10.1101/gr.127373.111; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo XY, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000449; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Han YJ, 2011, FASEB J, V25, P2305, DOI 10.1096/fj.10-177808; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Hawkins PG, 2010, TRANSCR-AUSTIN, V1, P165, DOI 10.4161/trns.1.3.13332; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hon G.C., 2011, GENOME RES; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Kalyana-Sundaram S, 2012, CELL, V149, P1622, DOI 10.1016/j.cell.2012.04.041; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kerin T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003479; Khachane AN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-435; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Korneev SA, 2005, J NEUROSCI, V25, P1188, DOI 10.1523/JNEUROSCI.4671-04.2005; Korneev SA, 1999, J NEUROSCI, V19, P7711; Korneev SA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01027; Lam HYK, 2009, NUCLEIC ACIDS RES, V37, pD738, DOI 10.1093/nar/gkn758; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Maida Y, 2011, BIOL CHEM, V392, P299, DOI 10.1515/BC.2011.035; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Malecova B, 2010, CURR OPIN MOL THER, V12, P214; Marques AC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r102; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Muro EM, 2011, BIOCHIMIE, V93, P1916, DOI 10.1016/j.biochi.2011.07.024; Muro EM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-338; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Ohshima K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r74; Olovnikov I, 2012, CURR OPIN GENET DEV, V22, P164, DOI 10.1016/j.gde.2012.01.002; OTA T, 1995, MOL BIOL EVOL, V12, P94, DOI 10.1093/oxfordjournals.molbev.a040194; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Peng JC, 2013, CURR OPIN CELL BIOL, V25, P190, DOI 10.1016/j.ceb.2013.01.010; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Poliseno L, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002858; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Rubio-Somoza I, 2011, CELL, V147, P1431, DOI 10.1016/j.cell.2011.12.003; Sakai H, 2007, GENE, V389, P196, DOI 10.1016/j.gene.2006.11.007; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sasidharan R, 2008, NATURE, V453, P729, DOI 10.1038/453729a; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Svensson O, 2006, PLOS COMPUT BIOL, V2, P358, DOI 10.1371/journal.pcbi.0020046; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trinklein ND, 2007, GENOME RES, V17, P720, DOI 10.1101/gr.5716607; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wen YZ, 2011, P NATL ACAD SCI USA, V108, P8345, DOI 10.1073/pnas.1103894108; Wierzbicki AT, 2012, GENE DEV, V26, P1825, DOI 10.1101/gad.197772.112; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yano Y, 2004, J MOL MED, V82, P414, DOI 10.1007/s00109-004-0550-3; Yu N, 2004, GENETICS, V166, P1375, DOI 10.1534/genetics.166.3.1375; Zhang ZL, 2006, BIOINFORMATICS, V22, P1437, DOI 10.1093/bioinformatics/btl116; Zhang ZL, 2004, CURR OPIN GENET DEV, V14, P328, DOI 10.1016/j.gde.2004.06.003; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zheng DY, 2007, TRENDS GENET, V23, P219, DOI 10.1016/j.tig.2007.03.003; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307; Zheng DY, 2005, J MOL BIOL, V349, P27, DOI 10.1016/j.jmb.2005.02.072; Zhong XH, 2012, NAT STRUCT MOL BIOL, V19, P870, DOI 10.1038/nsmb.2354; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zhu JC, 2007, PLOS COMPUT BIOL, V3, P2498, DOI 10.1371/journal.pcbi.0030247	99	45	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93972	10.1371/journal.pone.0093972	http://dx.doi.org/10.1371/journal.pone.0093972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699680	gold, Green Published, Green Submitted			2022-12-27	WOS:000334105000130
J	Kim, Y; Lee, JM; Peters, BP; Gaesser, GA; Welk, GJ				Kim, Youngwon; Lee, Jung-Min; Peters, Bradley P.; Gaesser, Glenn A.; Welk, Gregory J.			Examination of Different Accelerometer Cut-Points for Assessing Sedentary Behaviors in Children	PLOS ONE			English	Article							MEASURED PHYSICAL-ACTIVITY; UNITED-STATES; RT3 ACCELEROMETER; TIME SPENT; CALIBRATION; VALIDATION; ACTIGRAPH; ADOLESCENTS; OVERWEIGHT; AGREEMENT	Background: Public health research on sedentary behavior (SB) in youth has heavily relied on accelerometers. However, it has been limited by the lack of consensus on the most accurate accelerometer cut-points as well as by unknown effects caused by accelerometer position (wrist vs. hip) and output (single axis vs. multiple axes). The present study systematically evaluates classification accuracy of different Actigraph cut-points for classifying SB using hip and wrist-worn monitors and establishes new cut-points to enable use of the 3-dimensional vector magnitude data (for both hip and wrist placement). Methods: A total of 125 children ages 7-13 yrs performed 12 randomly selected activities (from a set of 24 different activities) for 5 min each while wearing tri-axial Actigraph accelerometers on both the hip and wrist. The accelerometer data were categorized as either sedentary or non-sedentary minutes using six previously studied cut-points: 100counts-perminute (CPM), 200CPM, 300CPM, 500CPM, 800CPM and 1100CPM. Classification accuracy was evaluated with Cohen's Kappa (kappa) and new cut-points were identified from Receiver Operating Characteristic (ROC). Results: Of the six cut-points, the 100CPM value yielded the highest classification accuracy (kappa = 0.81) for hip placement. For wrist placement, all of the cut-points produced low classification accuracy (ranges of kappa from 0.44 to 0.67). Optimal sedentary cut-points derived from ROC were 554.3CPM (ROC-AUC of 0.99) for vector magnitude for hip, 1756CPM (ROC-AUC of 0.94) for vertical axis for wrist, and 3958.3CPM (ROC-AUC of 0.93) for vector magnitude for wrist placement. Conclusions: The 100CPM was supported for use with vertical axis for hip placement, but not for wrist placement. The ROCderived cut-points can be used to classify youth SB with the wrist and with vector magnitude data.	[Kim, Youngwon; Peters, Bradley P.; Welk, Gregory J.] Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA; [Lee, Jung-Min] Univ Nebraska, Sch Hlth Phys Educ & Recreat, Coll Educ, Omaha, NE 68182 USA; [Gaesser, Glenn A.] Arizona State Univ, Sch Nutr & Hlth Promot, Phoenix, AZ USA	Iowa State University; University of Nebraska System; Arizona State University; Arizona State University-Downtown Phoenix	Kim, Y (corresponding author), Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA.	myungshingo@gmail.com	Lee, Jung-Min/L-8227-2016	Lee, Jung-Min/0000-0002-8033-0725	National Institutes of Health [R01 HL910006]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the National Institutes of Health grant (R01 HL910006) (URL:http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Atkin AJ, 2013, MED SCI SPORT EXER, V45, P1097, DOI 10.1249/MSS.0b013e318282190e; Bailey DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057101; Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345; Chinapaw MJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036657; Chu EYW, 2007, MED SCI SPORT EXER, V39, P2085, DOI 10.1249/mss.0b013e318148436c; Cliff DP, 2013, OBESITY, V21, P382, DOI 10.1002/oby.20005; Crouter SE, 2013, MED SCI SPORT EXER, V45, P1403, DOI 10.1249/MSS.0b013e318285f03b; Dasgupta K, 2006, CIRCULATION, V114, P2663, DOI 10.1161/CIRCULATIONAHA.106.624536; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Fischer C, 2012, PEDIATR EXERC SCI, V24, P220, DOI 10.1123/pes.24.2.220; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e; Freedson PS, 2011, J APPL PHYSIOL, V111, P1804, DOI 10.1152/japplphysiol.00309.2011; Hanggi JM, 2013, J SCI MED SPORT, V16, P40, DOI 10.1016/j.jsams.2012.05.012; Hart TL, 2011, MED SCI SPORT EXER, V43, P449, DOI 10.1249/MSS.0b013e3181ef5a93; Brodersen NH, 2007, BRIT J SPORT MED, V41, P140, DOI 10.1136/bjsm.2006.031138; Janz KF, 2005, AM J PREV MED, V29, P171, DOI 10.1016/j.amepre.2005.06.001; Kim Y, 2013, J SCI MED SPORT, V16, P129, DOI 10.1016/j.jsams.2012.05.015; King AC, 2011, EUR J PUBLIC HEALTH, V21, P424, DOI 10.1093/eurpub/ckq104; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mackintosh KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036919; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Ortega FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060871; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Pate RR, 2011, BRIT J SPORT MED, V45, P906, DOI 10.1136/bjsports-2011-090192; Pulsford RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021822; Ridgers ND, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-15; Robinson Thomas N, 2003, Ethn Dis, V13, pS65; Rowlands AV, 2004, MED SCI SPORT EXER, V36, P518, DOI 10.1249/01.MSS.0000117158.14542.E7; Ruiz JR, 2011, AM J EPIDEMIOL, V174, P173, DOI 10.1093/aje/kwr068; Santos R, 2014, BRIT J SPORT MED, V48, P1508, DOI 10.1136/bjsports-2012-091610; Sardinha LB, 2008, DIABETES CARE, V31, P569, DOI 10.2337/dc07-1286; Steele RM, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-88; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; van Grieken A, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-61; van Sluijs EMF, 2010, BRIT J SPORT MED, V44, P747, DOI 10.1136/bjsm.2008.049783; Vanhelst J, 2010, J SPORT SCI, V28, P381, DOI 10.1080/02640410903508821	43	34	34	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e90630	10.1371/journal.pone.0090630	http://dx.doi.org/10.1371/journal.pone.0090630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699259	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000012
J	Maes, P; Harries, AD; Van den Bergh, R; Noor, A; Snow, RW; Tayler-Smith, K; Hinderaker, SG; Zachariah, R; Allan, R				Maes, Peter; Harries, Anthony D.; Van den Bergh, Rafael; Noor, Abdisalan; Snow, Robert W.; Tayler-Smith, Katherine; Hinderaker, Sven Gudmund; Zachariah, Rony; Allan, Richard			Can Timely Vector Control Interventions Triggered by Atypical Environmental Conditions Prevent Malaria Epidemics? A Case-Study from Wajir County, Kenya	PLOS ONE			English	Article							RIFT-VALLEY FEVER; OUTBREAK	Background: Atypical environmental conditions with drought followed by heavy rainfall and flooding in arid areas in sub-Saharan Africa can lead to explosive epidemics of malaria, which might be prevented through timely vector-control interventions. Objectives: Wajir County in Northeast Kenya is classified as having seasonal malaria transmission. The aim of this study was to describe in Wajir town the environmental conditions, the scope and timing of vector-control interventions and the associated resulting burden of malaria at two time periods (1996-1998 and 2005-2007). Methods: This is a cross-sectional descriptive and ecological study using data collected for routine program monitoring and evaluation. Results: In both time periods, there were atypical environmental conditions with drought and malnutrition followed by massive monthly rainfall resulting in flooding and animal/human Rift Valley Fever. In 1998, this was associated with a large and explosive malaria epidemic (weekly incidence rates peaking at 54/1,000 population/week) with vector-control interventions starting over six months after the massive rainfall and when the malaria epidemic was abating. In 2007, vector-control interventions started sooner within about three months after the massive rainfall and no malaria epidemic was recorded with weekly malaria incidence rates never exceeding 0.5 per 1,000 population per week. Discussion and Conclusion: Did timely vector-control interventions in Wajir town prevent a malaria epidemic? In 2007, the neighboring county of Garissa experienced similar climatic events as Wajir, but vector-control interventions started six months after the heavy un-seasonal rainfall and large scale flooding resulted in a malaria epidemic with monthly incidence rates peaking at 40/1,000 population. In conclusion, this study suggests that atypical environmental conditions can herald a malaria outbreak in certain settings. In turn, this should alert responsible stakeholders about the need to act rapidly and preemptively with appropriate and wide-scale vector-control interventions to mitigate the risk.	[Maes, Peter] Operat Ctr Brussels, Water Hyg & Sanitat Unit, Dept Med, Brussels, Belgium; [Harries, Anthony D.] Int Union TB & Lung Dis Union, Paris, France; [Harries, Anthony D.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Van den Bergh, Rafael; Tayler-Smith, Katherine; Zachariah, Rony] Operat Ctr Brussels, Operat Res Unit LuxOR, Dept Med, Luxembourg, Luxembourg; [Noor, Abdisalan; Snow, Robert W.] KEMRI Univ Oxford Wellcome Trust Collaborat Progr, Malaria Publ Hlth Dept, Nairobi, Kenya; [Noor, Abdisalan; Snow, Robert W.] Univ Oxford, Ctr Trop Med, Oxford, England; [Hinderaker, Sven Gudmund] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Allan, Richard] Mentor Initiat, Crawley, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Bergen	Maes, P (corresponding author), Operat Ctr Brussels, Water Hyg & Sanitat Unit, Dept Med, Brussels, Belgium.	Peter.Maes@brussels.msf.org	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088; zachariah, rony/0000-0002-2915-9328; Van den Bergh, Rafael/0000-0001-6277-8713	Department for International Development, UK; Medecins Sans Frontieres, Luxembourg; Wellcome Trust [095127, 079080, 092654]	Department for International Development, UK; Medecins Sans Frontieres, Luxembourg; Wellcome Trust(Wellcome TrustEuropean Commission)	Funding for the course was from the innumerable donors who collectively provide in 85% of the total MSF budget; was from the Department for International Development, UK; and was from Medecins Sans Frontieres, Luxembourg. AMN is supported by the Wellcome Trust as an Intermediate Fellow (# 095127); RWS is supported by the Wellcome Trust as Principal Research Fellow (# 079080) and both acknowledge the support provided by the Wellcome Trust Major Overseas Programme grant to the KEMRI/Wellcome Trust Research Programme (#092654). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba S, 2011, INT J EPIDEMIOL, V40, P405, DOI 10.1093/ije/dyq240; Allan R, 1998, LANCET, V351, P1966, DOI 10.1016/S0140-6736(05)78661-X; Allan R, 2013, BASIC DATA SHEET EXT; Brown V, 1998, LANCET, V352, P1356, DOI 10.1016/S0140-6736(05)60747-7; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; Grandesso F, 2007, INVESTIGATION RIFT V, P3; Hay S, 2003, TRENDS PARASITOL, V19, P394, DOI 10.1016/S1471-4922(03)00190-9; Hay SI, 2001, TRENDS PARASITOL, V17, P95, DOI 10.1016/S1471-4922(00)01763-3; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Khogali M, 2011, PUBLIC HEALTH ACTION, V1, P16, DOI 10.5588/pha.11.0008; Lengeler C, 2009, COCHRANE LIB; LINTHICUM KJ, 1983, MOSQ NEWS, V43, P464; Nguku PM, 2010, AM J TROP MED HYG, V83, P5, DOI 10.4269/ajtmh.2010.09-0288; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; Peterson AT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-59; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Reiter P, 2004, LANCET INFECT DIS, V4, P323, DOI 10.1016/S1473-3099(04)01038-2; Sang R, 2010, AM J TROP MED HYG, V83, P28, DOI 10.4269/ajtmh.2010.09-0319; Snow B, 2006, RAPID SITUATION ANAL; Snow R. W., 1999, EPIDEMIOLOGY POLITIC; USAID, 2006, UND NUTR DAT CAUS MA; WHO (World Health Organization), 2001, WHOCDSRBM200132; Woods CW, 2002, EMERG INFECT DIS, V8, P138, DOI 10.3201/eid0802.010023; World Health Organization, 2011, WHO GLOB MAL REP 201; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100	27	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92386	10.1371/journal.pone.0092386	http://dx.doi.org/10.1371/journal.pone.0092386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699034	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000334105000024
J	Matsumoto, M; Hagio, M; Inoue, R; Mitani, T; Yajima, M; Hara, H; Yajima, T				Matsumoto, Megumi; Hagio, Masahito; Inoue, Ryo; Mitani, Tomohiro; Yajima, Masako; Hara, Hiroshi; Yajima, Takaji			Long-Term Oral Feeding of Lutein-Fortified Milk Increases Voluntary Running Distance in Rats	PLOS ONE			English	Article							GREEN TEA EXTRACT; PHYSICAL-ACTIVITY; METABOLIC SYNDROME; SKELETAL-MUSCLE; DIETARY LUTEIN; VITAMIN-E; EXERCISE; MICE; SUPPLEMENTATION; PLASMA	To evaluate the effects of lutein-fortified milk administration on running exercise, a voluntary wheel-running model was performed in rats. Four-week-old F344 rats were administered test milk (10 mL/kg) daily following a 4-h fasting period, and their running distances were measured each day for a 9-week period. Total weekly running distance significantly increased from the sixth week until the end of the test period in lutein-supplemented rats (lutein-fortified milk administered) compared with control rats (vehicle administered). This increase was not apparent in rats administered lutein alone. In the lutein-fortified-milk exercise group compared with the sedentary control group, carnitine palitroyltransferase 1 (CPT-1), total AMP-activated protein kinase (tAMPK), and phosphorylated AMP-activated protein kinase (pAMPK) contents were significantly increased in the gastrocnemius muscle, with a concomitant decrease in triglyceride and total cholesterol levels in the blood and liver. Furthermore, the lutein level in blood of lutein-administered rats significantly decreased with exercise. These results suggest that lutein-fortified milk may enhance the effect of exercise by effective utilization of lipids when combined with voluntary running.	[Matsumoto, Megumi] Nihon Univ, Coll Humanities & Sci, Dept Phys Educ, Setagaya Ku, Tokyo, Japan; [Hagio, Masahito; Mitani, Tomohiro; Hara, Hiroshi] Hokkaido Univ, Res Fac Agr, Kita Ku, Sapporo, Hokkaido, Japan; [Hagio, Masahito] Toyo Univ, Fac Life Sci, Itakura, Gunma, Japan; [Inoue, Ryo] Kyoto Prefectural Univ, Lab Anim Sci, Shimogamo, Kyoto, Japan; [Yajima, Masako; Yajima, Takaji] Hokkaido Univ, Grad Sch Med, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University; Toyo University; Hokkaido University	Matsumoto, M (corresponding author), Nihon Univ, Coll Humanities & Sci, Dept Phys Educ, Setagaya Ku, 3-25-40 Sakurajosui, Tokyo, Japan.	matsumegrace@gmail.com	HARA, HIROSHI/A-4581-2012	HARA, HIROSHI/0000-0001-5925-5751	Meiji Co.	Meiji Co.	The work was funded by Meiji Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi W, 2008, BIOCHEM BIOPH RES CO, V366, P892, DOI 10.1016/j.bbrc.2007.12.019; Arias EB, 2007, AM J PHYSIOL-ENDOC M, V292, pE1191, DOI 10.1152/ajpendo.00602.2006; Bo S, 2008, EUR J ENDOCRINOL, V159, P685, DOI 10.1530/EJE-08-0334; Calderon F, 2007, J DAIRY SCI, V90, P5651, DOI 10.3168/jds.2007-0264; Call JA, 2008, J APPL PHYSIOL, V105, P923, DOI 10.1152/japplphysiol.00028.2008; Cureton KJ, 2009, J APPL PHYSIOL, V107, P1095, DOI 10.1152/japplphysiol.00234.2009; FOLCH J, 1957, J BIOL CHEM, V226, P497; Granado-Lorencio F, 2010, J NUTR BIOCHEM, V21, P133, DOI 10.1016/j.jnutbio.2008.12.002; Hagio M, 2010, J APPL PHYSIOL, V109, P663, DOI 10.1152/japplphysiol.00777.2009; Hammond BR, 2008, NUTR REV, V66, P695, DOI 10.1111/j.1753-4887.2008.00121.x; Hayes K, 2001, AM J CLIN NUTR, V74, P211; Hulshof PJM, 2006, J FOOD COMPOS ANAL, V19, P67, DOI 10.1016/j.jfca.2005.04.005; Jeneson JAL, 2007, ACTA PHYSIOL, V190, P151, DOI 10.1111/j.1748-1716.2007.01680.x; Johnson EJ, 2008, NUTR NEUROSCI, V11, P75, DOI 10.1179/147683008X301450; Kanda A, 2012, J AGR FOOD CHEM, V60, P11403, DOI 10.1021/jf302277a; KEREN G, 1980, J SPORT MED PHYS FIT, V20, P145; Lee SP, 2009, EUR J APPL PHYSIOL, V107, P587, DOI 10.1007/s00421-009-1159-6; Li L, 2010, J NUTR BIOCHEM, V21, P544, DOI 10.1016/j.jnutbio.2009.03.002; Liu SM, 2001, CURR OPIN LIPIDOL, V12, P395, DOI 10.1097/00041433-200108000-00005; MANGELS AR, 1993, J AM DIET ASSOC, V93, P284, DOI 10.1016/0002-8223(93)91553-3; Matsumoto M, 2009, BRIT J NUTR, V102, P1324, DOI 10.1017/S0007114509990365; McAnulty SR, 2005, J NUTR BIOCHEM, V16, P530, DOI 10.1016/j.jnutbio.2005.02.001; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mirmiran P, 2005, INT J OBESITY, V29, P115, DOI 10.1038/sj.ijo.0802838; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Moreno FS, 2007, CHEM-BIOL INTERACT, V168, P221, DOI 10.1016/j.cbi.2007.04.011; Murase T, 2006, AM J PHYSIOL-REG I, V290, pR1550, DOI 10.1152/ajpregu.00752.2005; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Orozco LJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003054.pub3; Pal S, 2010, OBESITY, V18, P1354, DOI 10.1038/oby.2009.397; Perseghin G, 2007, DIABETES CARE, V30, P683, DOI 10.2337/dc06-2032; Pfeuffer M, 2007, OBES REV, V8, P109, DOI 10.1111/j.1467-789X.2006.00265.x; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; SALLIS JF, 1986, PREV MED, V15, P331, DOI 10.1016/0091-7435(86)90001-0; Sommerburg O, 1998, BRIT J OPHTHALMOL, V82, P907, DOI 10.1136/bjo.82.8.907; Speakman JR, 2003, P NUTR SOC, V62, P621, DOI 10.1079/PNS2003282; Sumida S, 1997, FREE RADICAL RES, V27, P607, DOI 10.3109/10715769709097864; Yajima M, 2013, BIOMED RES-TOKYO, V34, P197, DOI 10.2220/biomedres.34.197	39	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93529	10.1371/journal.pone.0093529	http://dx.doi.org/10.1371/journal.pone.0093529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699440	gold, Green Published, Green Submitted			2022-12-27	WOS:000334105000065
J	Rhein, C; Muhle, C; Richter-Schmidinger, T; Alexopoulos, P; Doerfler, A; Kornhuber, J				Rhein, Cosima; Muehle, Christiane; Richter-Schmidinger, Tanja; Alexopoulos, Panagiotis; Doerfler, Arnd; Kornhuber, Johannes			Neuroanatomical Correlates of Intelligence in Healthy Young Adults: The Role of Basal Ganglia Volume	PLOS ONE			English	Article							FALSE DISCOVERY RATE; GENERAL INTELLIGENCE; CRYSTALLIZED INTELLIGENCE; COGNITIVE FUNCTIONS; PARKINSONS-DISEASE; HIPPOCAMPAL VOLUME; GENETIC DISSECTION; FLUID INTELLIGENCE; PREFRONTAL CORTEX; AGE-DIFFERENCES	Background: In neuropsychiatric diseases with basal ganglia involvement, higher cognitive functions are often impaired. In this exploratory study, we examined healthy young adults to gain detailed insight into the relationship between basal ganglia volume and cognitive abilities under non-pathological conditions. Methodology/Principal Findings: We investigated 137 healthy adults that were between the ages of 21 and 35 years with similar educational backgrounds. Magnetic resonance imaging (MRI) was performed, and volumes of basal ganglia nuclei in both hemispheres were calculated using FreeSurfer software. The cognitive assessment consisted of verbal, numeric and figural aspects of intelligence for either the fluid or the crystallised intelligence factor using the intelligence test Intelligenz-Struktur- Test (I-S-T 2000 R). Our data revealed significant correlations of the caudate nucleus and pallidum volumes with figural and numeric aspects of intelligence, but not with verbal intelligence. Interestingly, figural intelligence associations were dependent on sex and intelligence factor; in females, the pallidum volumes were correlated with crystallised figural intelligence (r=0.372, p=0.01), whereas in males, the caudate volumes were correlated with fluid figural intelligence (r=0.507, p=0.01). Numeric intelligence was correlated with right-lateralised caudate nucleus volumes for both females and males, but only for crystallised intelligence (r=0.306, p=0.04 and r=0.459, p=0.04, respectively). The associations were not mediated by prefrontal cortical subfield volumes when controlling with partial correlation analyses. Conclusions/Significance: The findings of our exploratory analysis indicate that figural and numeric intelligence aspects, but not verbal aspects, are strongly associated with basal ganglia volumes. Unlike numeric intelligence, the type of figural intelligence appears to be related to distinct basal ganglia nuclei in a sex-specific manner. Subcortical brain structures thus may contribute substantially to cognitive performance.	[Rhein, Cosima; Muehle, Christiane; Richter-Schmidinger, Tanja; Alexopoulos, Panagiotis; Kornhuber, Johannes] Univ Erlangen Nurnberg, Univ Hosp, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany; [Alexopoulos, Panagiotis] Tech Univ Munich, Klinikum Rechts Isar, Dept Psychiat & Psychotherapy, D-80290 Munich, Germany; [Doerfler, Arnd] Univ Erlangen Nurnberg, Univ Hosp, Dept Neuroradiol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; Technical University of Munich; University of Munich; University of Erlangen Nuremberg	Rhein, C (corresponding author), Univ Erlangen Nurnberg, Univ Hosp, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany.	Cosima.Rhein@uk-erlangen.de	Kornhuber, Johannes/B-9613-2014; MÃhle, Christiane/AAE-7043-2019	Kornhuber, Johannes/0000-0002-8096-3987; Rhein, Cosima/0000-0002-3010-2169; Muhle, Christiane/0000-0001-7517-9154	Deutsche Forschungsgemeinschaft; Friedrich-Alexander-University Erlangen-Nuremberg; Department of Psychiatry	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-University Erlangen-Nuremberg; Department of Psychiatry	Intramural funding sources of the Department of Psychiatry. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-University Erlangen-Nuremberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos P, 2011, J ALZHEIMERS DIS, V26, P207, DOI 10.3233/JAD-2011-110356; ANDREASEN NC, 1993, AM J PSYCHIAT, V150, P130; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blinkhorn S, 2005, NATURE, V438, P31, DOI 10.1038/438031a; Burgaleta M, 2013, HUM BRAIN MAPP  0802; Burgaleta M, 2012, INTELLIGENCE, V40, P60, DOI 10.1016/j.intell.2011.10.006; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; Colom R, 2006, NEUROIMAGE, V31, P1359, DOI 10.1016/j.neuroimage.2006.01.006; Colom R, 2013, INTELLIGENCE, V41, P129, DOI 10.1016/j.intell.2013.01.002; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Duff BJ, 2013, SCHIZOPHR RES, V147, P1, DOI 10.1016/j.schres.2013.03.015; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Flynn JR, 2011, PERS INDIV DIFFER, V50, P799, DOI 10.1016/j.paid.2010.12.035; Geary D. C., 2005, ORIGIN MIND EVOLUTIO, DOI DOI 10.1037/10871-000; Gong QY, 2005, NEUROIMAGE, V25, P1175, DOI 10.1016/j.neuroimage.2004.12.044; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Haier RJ, 2005, NEUROIMAGE, V25, P320, DOI 10.1016/j.neuroimage.2004.11.019; HORN JL, 1967, ACTA PSYCHOL, V26, P107, DOI 10.1016/0001-6918(67)90011-X; Humblet O, 2013, ENVIRON HEALTH PERSP, V121, P111, DOI 10.1289/ehp.1205278; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Langen M, 2013, BIOL PSYCHIAT   0930; Lawrence AD, 1998, TRENDS COGN SCI, V2, P379, DOI 10.1016/S1364-6613(98)01231-5; Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003; Liang SY, 2013, NEURO-ONCOLOGY, V15, P1543, DOI 10.1093/neuonc/not127; Liepmann D.V., 2001, INTELLIGENZ STRUKTUR; LINN MC, 1985, CHILD DEV, V56, P1479, DOI 10.1111/j.1467-8624.1985.tb00213.x; Luders E, 2009, INTELLIGENCE, V37, P156, DOI 10.1016/j.intell.2008.07.002; McDaniel MA, 2005, INTELLIGENCE, V33, P337, DOI 10.1016/j.intell.2004.11.005; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; Moffat SD, 2007, CEREB CORTEX, V17, P1274, DOI 10.1093/cercor/bhl036; Moore AB, 2013, BRAIN LANG, V125, P316, DOI 10.1016/j.bandl.2012.05.003; Navas-Sanchez FJ, 2013, HUM BRAIN MAPP  0903; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; Neubauer AC, 2002, INTELLIGENCE, V30, P515, DOI 10.1016/S0160-2896(02)00091-0; Nisbett RE, 2012, AM PSYCHOL, V67, P130, DOI 10.1037/a0026699; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048895; Osborn MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072737; Ragozzino ME, 2002, BRAIN RES, V953, P205, DOI 10.1016/S0006-8993(02)03287-0; Raz N, 2008, CEREB CORTEX, V18, P718, DOI 10.1093/cercor/bhm108; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Richter-Schmidinger T, 2011, J NEURAL TRANSM, V118, P249, DOI 10.1007/s00702-010-0539-8; Rojas DC, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-56; Sears LL, 1999, PROG NEURO-PSYCHOPH, V23, P613, DOI 10.1016/S0278-5846(99)00020-2; Sidiropoulos C, 2011, ACTA NEUROPSYCHIATR, V23, P132, DOI 10.1111/j.1601-5215.2011.00546.x; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; van Asselen M, 2009, NEUROPSYCHOLOGIA, V47, P1269, DOI 10.1016/j.neuropsychologia.2009.01.008; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; Weller JI, 1998, GENETICS, V150, P1699; Wolff JJ, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-12	54	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93623	10.1371/journal.pone.0093623	http://dx.doi.org/10.1371/journal.pone.0093623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699871	Green Submitted, Green Published, gold			2022-12-27	WOS:000334105000081
J	Al-Kuhlani, M; Rothchild, J; Pal, S; de la Maza, LM; Ouburg, S; Morre, SA; Dean, D; Ojcius, DM				Al-Kuhlani, Mufadhal; Rothchild, James; Pal, Sukumar; de la Maza, Luis M.; Ouburg, Sander; Morre, Servaas A.; Dean, Deborah; Ojcius, David M.			TRAIL-R1 Is a Negative Regulator of Pro-Inflammatory Responses and Modulates Long-Term Sequelae Resulting from Chlamydia trachomatis Infections in Humans	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; NF-KAPPA-B; TOLL-LIKE RECEPTOR-4; PROTEIN-KINASE PKR; EPITHELIAL-CELLS; IMMUNE-RESPONSES; ACTIVATION; WOMEN; MICE; DEATH	The immune system eliminates Chlamydia trachomatis infection through inflammation. However, uncontrolled inflammation can enhance pathology. In mice, TNF-related apoptosis-inducing ligand receptor (TRAIL-R), known for its effects on apoptosis, also regulates inflammation. In humans, the four homologues of TRAIL-R had never been investigated for effects on inflammation. Here, we examined whether TRAIL-R regulates inflammation during chlamydial infection. We examined TRAIL-R1 single nucleotide polymorphisms (SNPs) in an Ecuadorian cohort with and without C. trachomatis infections. There was a highly significant association for the TRAIL+626 homozygous mutant GG for infection vs no infection in this population. To confirm the results observed in the human population, primary lung fibroblasts and bone marrow-derived macrophages (BMDMs) were isolated from wildtype (WT) and TRAIL-R-deficient mice, and TRAIL-R1 levels in human cervical epithelial cells were depleted by RNA interference. Infection of BMDMs and primary lung fibroblasts with C. trachomatis strain L-2, or the murine pathogen C. muridarum, led to higher levels of MIP2 mRNA expression or IL-1 beta secretion from TRAIL-R-deficient cells than WT cells. Similarly, depletion of TRAIL-R1 expression in human epithelial cells resulted in a higher level of IL-8 mRNA expression and protein secretion during C. trachomatis infection. We conclude that human TRAIL-R1 SNPs and murine TRAIL-R modulate the innate immune response against chlamydial infection. This is the first evidence that human TRAIL-R1 is a negative regulator of inflammation and plays a role in modulating Chlamydia pathogenesis.	[Al-Kuhlani, Mufadhal; Ojcius, David M.] Univ Calif Merced, Dept Mol Cell Biol, Merced, CA 95343 USA; [Al-Kuhlani, Mufadhal; Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Pal, Sukumar; de la Maza, Luis M.] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA; [Ouburg, Sander; Morre, Servaas A.] Vrije Univ Amsterdam, Med Ctr, Res Sch V ICI, Lab Immunogenet Med Microbiol & Infect Prevent, Amsterdam, Netherlands; [Morre, Servaas A.] Univ Maastricht, Res Sch GROW, Dept Genet & Cell Biol, Inst Publ Hlth Genom, Maastricht, Netherlands; [Rothchild, James; Dean, Deborah] Childrens Hosp Oakland, Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA; [Dean, Deborah] Univ Calif Berkeley, Grad Program Bioengn, Berkeley, CA 94720 USA; [Dean, Deborah] Univ Calif San Francisco, Grad Program Bioengn, San Francisco, CA 94143 USA; [Dean, Deborah] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California Merced; University of California System; University of California Merced; University of California System; University of California Irvine; Vrije Universiteit Amsterdam; Maastricht University; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ojcius, DM (corresponding author), Univ Calif Merced, Dept Mol Cell Biol, Merced, CA 95343 USA.	david.ojcius@gmail.com	Ouburg, Sander/H-5775-2019; Ojcius, David/ABE-6557-2020	Ouburg, Sander/0000-0002-2092-0002; Ojcius, David/0000-0003-1461-4495	Public Health Service grant from the National Institutes of Health [R56 AI078419]; University of California; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI078419, R01AI032248] Funding Source: NIH RePORTER	Public Health Service grant from the National Institutes of Health; University of California(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by Public Health Service grant from the National Institutes of Health R56 AI078419 and a University of California Presidential Chair for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2010, MICROBES INFECT, V12, P652, DOI 10.1016/j.micinf.2010.04.008; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Atik B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003600; Azenabor AA, 2003, J INFECTION, V46, P120, DOI 10.1053/jinf.2002.1098; Bailey RL, 2009, DRUG TODAY, V45, P45; Bannerman DD, 2002, J CLIN INVEST, V109, P419, DOI 10.1172/JCI14774; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Buchholz KR, 2006, CELL MICROBIOL, V8, P1768, DOI 10.1111/j.1462-5822.2006.00747.x; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Byrne GI, 2010, J INFECT DIS, V201, pS126, DOI 10.1086/652398; Cabanski M, 2008, AM J RESP CELL MOL, V38, P26, DOI 10.1165/rcmb.2007-0010OC; CAMPBELL LA, 1993, FERTIL STERIL, V59, P45; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Centers for Disease Control, 2010, SEX TRANSM DIS SURV; Clayton D, 2002, PROGRAM ESTIMATING F; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; Cretney E, 2003, J EXP MED, V198, P491, DOI 10.1084/jem.20030634; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Dean D, 2008, PLOS MED, V5, P57, DOI 10.1371/journal.pmed.0050014; den Hartog JE, 2009, DRUG TODAY, V45, P75; Dessus-Babus S, 2000, CELL MICROBIOL, V2, P317, DOI 10.1046/j.1462-5822.2000.00058.x; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706; Herring A, 2006, SEX TRANSM INFECT, V82, P23, DOI 10.1136/sti.2006.023143; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Iwami K, 2000, J IMMUNOL, V165, P6682, DOI 10.4049/jimmunol.165.12.6682; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Joyee AG, 2008, CURR PHARM DESIGN, V14, P593, DOI 10.2174/138161208783885344; Karimi O, 2009, DRUG TODAY, V45, P67; Kim SO, 2003, J EXP MED, V197, P1441, DOI 10.1084/jem.20021842; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; KIVIAT NB, 1986, AM J OBSTET GYNECOL, V154, P865, DOI 10.1016/0002-9378(86)90473-4; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kuang AA, 2000, J BIOL CHEM, V275, P25065, DOI 10.1074/jbc.C000284200; La Verda D, 1994, Immunol Ser, V60, P381; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; LeBouder E, 2003, J IMMUNOL, V171, P6680, DOI 10.4049/jimmunol.171.12.6680; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lu B., 2012, NATURE; Lu H, 2000, J IMMUNOL, V165, P1463, DOI 10.4049/jimmunol.165.3.1463; McCartney-Francis N, 2004, J IMMUNOL, V172, P3814, DOI 10.4049/jimmunol.172.6.3814; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Meissner TB, 2012, MICROBES INFECT, V14, P477, DOI 10.1016/j.micinf.2011.12.007; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Ouburg S, 2009, DRUG TODAY, V45, P83; Pal S, 2005, INFECT IMMUN, V73, P8153, DOI 10.1128/IAI.73.12.8153-8160.2005; Perfettini JL, 2003, J BIOL CHEM, V278, P9496, DOI 10.1074/jbc.M211275200; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ramsey KH, 1998, INFECT IMMUN, V66, P835, DOI 10.1128/IAI.66.2.835-838.1998; Ramsey KH, 2009, INFECT IMMUN, V77, P3284, DOI 10.1128/IAI.00147-09; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; Richards KH, 2011, MICROBES INFECT, V13, P291, DOI 10.1016/j.micinf.2010.12.007; Said-Sadier Najwane, 2012, Biomed J, V35, P437, DOI 10.4103/2319-4170.104408; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Schaefer U, 2007, FRONT BIOSCI, V12, P3813, DOI 10.2741/2354; Shimada K, 2012, MICROBES INFECT, V14, P1301, DOI 10.1016/j.micinf.2012.08.004; Srinivasan T, 2012, J BACTERIOL, V194, P617, DOI 10.1128/JB.06268-11; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sun RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.178798; Taylor BD, 2013, J INFECT DIS, V207, P940, DOI 10.1093/infdis/jis922; Taylor BD, 2012, J INFECT DIS, V205, P603, DOI 10.1093/infdis/jir822; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wang S, 2008, ONCOGENE, V27, P6207, DOI 10.1038/onc.2008.298; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu GS, 1999, CANCER RES, V59, P2770; WYRICK PB, 1978, INFECT IMMUN, V19, P1054, DOI 10.1128/IAI.19.3.1054-1060.1978; Ying Songmin, 2007, Curr Immunol Rev, V3, P31, DOI 10.2174/157339507779802179; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000; Zhande R, 2007, MOL CELL BIOL, V27, P7394, DOI 10.1128/MCB.00600-07	76	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93939	10.1371/journal.pone.0093939	http://dx.doi.org/10.1371/journal.pone.0093939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695582	Green Published, gold			2022-12-27	WOS:000334103000132
J	Bellinger, MA; Bean, JS; Rader, MA; Heinz-Taheny, KM; Nunes, JS; Haas, JV; Michael, LF; Rekhter, MD				Bellinger, Melissa A.; Bean, James S.; Rader, Melissa A.; Heinz-Taheny, Kathleen M.; Nunes, Jairo S.; Haas, Joseph V.; Michael, Laura F.; Rekhter, Mark D.			Concordant Changes of Plasma and Kidney MicroRNA in the Early Stages of Acute Kidney Injury: Time Course in a Mouse Model of Bilateral Renal Ischemia-Reperfusion	PLOS ONE			English	Article							TARGETS; BIOMARKERS; EXPRESSION; DIAGNOSIS; MIRBASE; URINE	Background: Acute kidney injury (AKI) is a syndrome characterized by the rapid loss of the kidney excretory function and is strongly associated with increased early and long-term patient morbidity and mortality. Early diagnosis of AKI is challenging; therefore we profiled plasma microRNA in an effort to identify potential diagnostic circulating markers of renal failure. The goal of the present study was to investigate the dynamic relationship of circulating and renal microRNA profiles within the first 24 hours after bilateral ischemia-reperfusion kidney injury in mice. Methodology/Principal Findings: Bilateral renal ischemia was induced in C57Bl/6 mice (n = 10 per group) by clamping the renal pedicle for 27 min. Ischemia-reperfusion caused highly reproducible, progressive, concordant elevation of miR-714, miR-1188, miR-1897-3p, miR-877*, and miR-1224 in plasma and kidneys at 3, 6 and 24 hours after acute kidney injury compared to the sham-operated mice (n = 5). These dynamics correlated with histologic findings of kidney injury and with a conventional plasma marker of renal dysfunction (creatinine). Pathway analysis revealed close association between miR1897-3p and Nucks1 gene expression, which putative downstream targets include genes linked to renal injury, inflammation and apoptosis. Conclusions/Significance: Systematic profiling of renal and plasma microRNAs in the early stages of experimental AKI provides the first step in advancing circulating microRNAs to the level of promising novel biomarkers.	[Bellinger, Melissa A.; Bean, James S.; Rader, Melissa A.; Michael, Laura F.; Rekhter, Mark D.] Eli Lilly & Co, Lilly Res Labs, Cardiometab Dis & Diabet Complicat, Indianapolis, IN 46285 USA; [Heinz-Taheny, Kathleen M.] Eli Lilly & Co, Lilly Res Labs, Invest Pathol, Indianapolis, IN 46285 USA; [Nunes, Jairo S.] Covance Labs, Greenfield, IN USA; [Haas, Joseph V.] Eli Lilly & Co, Lilly Res Labs, Stat Discovery Dev, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Covance; Eli Lilly	Rekhter, MD (corresponding author), Eli Lilly & Co, Lilly Res Labs, Cardiometab Dis & Diabet Complicat, Indianapolis, IN 46285 USA.	rekhter_mark@lilly.com			Lilly Research Laboratories	Lilly Research Laboratories(Eli Lilly)	The work is funded by Lilly Research Laboratories that employs all the authors except JSN. Lilly Research Laboratories supported preparation of the manuscript and its submission. The funder has no role in study design, data collection and analysis.	Aronson D, 2012, PHARMACOL THERAPEUT, V135, P1, DOI 10.1016/j.pharmthera.2012.03.002; Basile DP, 1996, AM J PHYSIOL-RENAL, V270, pF500, DOI 10.1152/ajprenal.1996.270.3.F500; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Chandrasekaran K, 2012, KIDNEY INT, V81, P617, DOI 10.1038/ki.2011.448; De Guire V, 2013, CLIN BIOCHEM, V46, P846, DOI 10.1016/j.clinbiochem.2013.03.015; Du J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063390; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gui T, 2012, LAB INVEST, V92, P1250, DOI 10.1038/labinvest.2012.85; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Hunsberger JG, 2012, AM J TRANSL RES, V4, P316; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kriegel AJ, 2012, CLIN SCI, V122, P439, DOI 10.1042/CS20110159; Lan YF, 2012, J AM SOC NEPHROL, V23, P2012, DOI 10.1681/ASN.2012050438; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JYZ, 2010, NEPHROLOGY, V15, P599, DOI 10.1111/j.1440-1797.2010.01363.x; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Millikin GJ, 2009, ANAL MESSY DATA; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Rayner KJ, 2013, J LIPID RES; Saikumar J, 2012, TOXICOL SCI, V129, P256, DOI 10.1093/toxsci/kfs210; Shapiro MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023011; Vanmassenhove J, 2013, NEPHROL DIAL TRANSPL, V28, P254, DOI 10.1093/ndt/gfs380; Vlaskou D, 2000, CLIN CHIM ACTA, V297, P103, DOI 10.1016/S0009-8981(00)00238-2; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051140; Xu L, 2013, J CELL PHYSIOL, V228, P1713, DOI 10.1002/jcp.24344; Xu XL, 2012, KIDNEY INT, V82, P1167, DOI 10.1038/ki.2012.241	35	39	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93297	10.1371/journal.pone.0093297	http://dx.doi.org/10.1371/journal.pone.0093297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695114	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000057
J	Smura, T; Blomqvist, S; Vuorinen, T; Ivanova, O; Samoilovich, E; Al-Hello, H; Savolainen-Kopra, C; Hovi, T; Roivainen, M				Smura, Teemu; Blomqvist, Soile; Vuorinen, Tytti; Ivanova, Olga; Samoilovich, Elena; Al-Hello, Haider; Savolainen-Kopra, Carita; Hovi, Tapani; Roivainen, Merja			The Evolution of Vp1 Gene in Enterovirus C Species Sub-Group That Contains Types CVA-21, CVA-24, EV-C95, EV-C96 and EV-C99	PLOS ONE			English	Article							NON-POLIO ENTEROVIRUSES; MOLECULAR CHARACTERIZATION; PHYLOGENETIC ANALYSIS; POPULATION-DYNAMICS; COXSACKIEVIRUS A21; HIGH-FREQUENCY; IDENTIFICATION; EPIDEMIOLOGY; SELECTION; ADAPTATION	Genus Enterovirus (Family Picornaviridae,) consists of twelve species divided into genetically diverse types by their capsid protein VP1 coding sequences. Each enterovirus type can further be divided into intra-typic sub-clusters (genotypes). The aim of this study was to elucidate what leads to the emergence of novel enterovirus clades (types and genotypes). An evolutionary analysis was conducted for a sub-group of Enterovirus C species that contains types Coxsackievirus A21 (CVA-21), CVA-24, Enterovirus C95 (EV-C95), EV-C96 and EV-C99. VP1 gene datasets were collected and analysed to infer the phylogeny, rate of evolution, nucleotide and amino acid substitution patterns and signs of selection. In VP1 coding gene, high intra-typic sequence diversities and robust grouping into distinct genotypes within each type were detected. Within each type the majority of nucleotide substitutions were synonymous and the non-synonymous substitutions tended to cluster in distinct highly polymorphic sites. Signs of positive selection were detected in some of these highly polymorphic sites, while strong negative selection was indicated in most of the codons. Despite robust clustering to intra-typic genotypes, only few genotype-specific 'signature' amino acids were detected. In contrast, when different enterovirus types were compared, there was a clear tendency towards fixation of type-specific 'signature' amino acids. The results suggest that permanent fixation of type-specific amino acids is a hallmark associated with evolution of different enterovirus types, whereas neutral evolution and/or (frequency-dependent) positive selection in few highly polymorphic amino acid sites are the dominant forms of evolution when strains within an enterovirus type are compared.	[Smura, Teemu; Blomqvist, Soile; Al-Hello, Haider; Savolainen-Kopra, Carita; Hovi, Tapani; Roivainen, Merja] Natl Inst Hlth & Welf THL, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Smura, Teemu] Univ Helsinki, Fac Med, Haartman Inst, Dept Virol, Helsinki, Finland; [Vuorinen, Tytti] Univ Turku, Dept Virol, Turku, Finland; [Ivanova, Olga] Russian Acad Med Sci, MP Chumakov Inst Poliomyelitis & Viral Encephalit, Moscow, Russia; [Samoilovich, Elena] Republican Res & Pract Ctr Epidemiol & Microbiol, Minsk, BELARUS	Finland National Institute for Health & Welfare; University of Helsinki; University of Turku; Russian Academy of Medical Sciences	Smura, T (corresponding author), Natl Inst Hlth & Welf THL, Dept Infect Dis Surveillance & Control, Helsinki, Finland.	Teemu.Smura@thl.fi	Smura, Teemu/K-6421-2012; Ivanova, Olga E/D-9734-2014; Hovi, Tapani/AAJ-4828-2020; Hovi, Tapani/AAG-9156-2020; Smura, Teemu P/C-4063-2016	Smura, Teemu/0000-0002-9187-3151; Ivanova, Olga E/0000-0003-1784-4827; Al-Hello, Haider/0000-0001-8206-1226	Academy of Finland	Academy of Finland(Academy of Finland)	This study was supported by Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostol LN, 2012, J MED VIROL, V84, P624, DOI 10.1002/jmv.23242; Apostol LNG, 2012, VIRUS GENES, V45, P207, DOI 10.1007/s11262-012-0776-z; Arita M, 2005, J VIROL, V79, P12650, DOI 10.1128/JVI.79.20.12650-12657.2005; Bailly JL, 2011, INFECT GENET EVOL, V11, P276, DOI 10.1016/j.meegid.2010.06.019; Bailly JL, 2009, INFECT GENET EVOL, V9, P699, DOI 10.1016/j.meegid.2008.04.009; Bessaud M, 2012, J CLIN MICROBIOL, V50, P1650, DOI 10.1128/JCM.06657-11; Bessaud M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024823; Bhatt S, 2011, MOL BIOL EVOL, V28, P2443, DOI 10.1093/molbev/msr044; Bhatt S, 2010, INFECT GENET EVOL, V10, P421, DOI 10.1016/j.meegid.2009.06.001; Bingjun T, 2008, J MED VIROL, V80, P670, DOI 10.1002/jmv.21122; Biologicals DoVa, 2003, GUID ENV SURV POL CI; Blomqvist S, 2008, J CLIN MICROBIOL, V46, P2410, DOI 10.1128/JCM.00313-08; Brown B, 2003, J VIROL, V77, P8973, DOI 10.1128/JVI.77.16.8973-8984.2003; Brown BA, 2009, J GEN VIROL, V90, P1713, DOI 10.1099/vir.0.008540-0; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; Cabrerizo M, 2014, J MED VIROL, V86, P857, DOI 10.1002/jmv.23741; Cabrerizo M, 2012, ARCH VIROL, V157, P551, DOI 10.1007/s00705-011-1207-5; Chu PY, 2011, INFECT GENET EVOL, V11, P1426, DOI 10.1016/j.meegid.2011.05.010; Chu PY, 2010, INFECT GENET EVOL, V10, P777, DOI 10.1016/j.meegid.2010.04.004; Chu PY, 2009, J CLIN VIROL, V45, P285, DOI 10.1016/j.jcv.2009.04.013; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Egea R, 2008, NUCLEIC ACIDS RES, V36, pW157, DOI 10.1093/nar/gkn337; Gullberg M, 2010, J VIROL, V84, P9695, DOI 10.1128/JVI.00071-10; Henquell C, 2013, J VIROL, V87, P12249, DOI 10.1128/JVI.02075-13; HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218; Hovi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066836; Howley PM, 2007, FIELDS VIROLOGY, V1, P839; Jegouic S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000412; Jiang P, 2007, P NATL ACAD SCI USA, V104, P9457, DOI 10.1073/pnas.0700451104; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Leitch ECM, 2012, J VIROL, V86, P2676, DOI 10.1128/JVI.06065-11; Leitch ECM, 2010, J VIROL, V84, P9292, DOI 10.1128/JVI.00783-10; Leitch ECM, 2009, J VIROL, V83, P2109, DOI 10.1128/JVI.02109-08; LENNETTE EH, 1958, AM J HYG, V68, P272, DOI 10.1093/oxfordjournals.aje.a119969; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lukashev AN, 2012, J GEN VIROL, V93, P2357, DOI 10.1099/vir.0.043216-0; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MIRKOVIC RR, 1974, INTERVIROLOGY, V4, P119, DOI 10.1159/000149850; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Oberste MS, 2013, J VIROL, V87, P558, DOI 10.1128/JVI.00837-12; Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Oberste MS, 2000, J CLIN MICROBIOL, V38, P1170, DOI 10.1128/JCM.38.3.1170-1174.2000; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Rakoto-Andrianarivelo M, 2005, J CLIN MICROBIOL, V43, P242, DOI 10.1128/JCM.43.1.242-249.2005; Rakoto-Andrianarivelo M, 2007, PLOS PATHOG, V3, P1950, DOI 10.1371/journal.ppat.0030191; Rambaut A, 2007, TRACER V 1 4; Sadeuh-Mba SA, 2013, J CLIN MICROBIOL, V51, P759, DOI 10.1128/JCM.02119-12; Samoilovich E, 2003, J MED VIROL, V71, P274, DOI 10.1002/jmv.10480; Savolainen-Kopra C, 2011, VIRUS GENES, V42, P28, DOI 10.1007/s11262-010-0536-x; Smura T, 2007, J GEN VIROL, V88, P2520, DOI 10.1099/vir.0.82866-0; Smura T, 2013, INFECT GENET EVOL, V16, P234, DOI 10.1016/j.meegid.2013.02.011; Smura T, 2011, FUTURE VIROL, V6, P109, DOI 10.2217/FVL.10.62; Smura T, 2009, ARCH VIROL, V154, P1157, DOI 10.1007/s00705-009-0418-5; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Williamson S, 2003, MOL BIOL EVOL, V20, P1318, DOI 10.1093/molbev/msg144; Xiang ZC, 2012, EMERG INFECT DIS, V18, P821, DOI 10.3201/eid1805.111376; Xiao CA, 2005, STRUCTURE, V13, P1019, DOI 10.1016/j.str.2005.04.011; Xu AQ, 2011, VIRUS GENES, V42, P323, DOI 10.1007/s11262-011-0584-x	67	11	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93737	10.1371/journal.pone.0093737	http://dx.doi.org/10.1371/journal.pone.0093737			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695547	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000114
J	Wang, F; Tian, XZ; Zhou, YH; Tan, DX; Zhu, SE; Dai, YP; Liu, GS				Wang, Feng; Tian, XiuZhi; Zhou, YanHua; Tan, DunXian; Zhu, ShiEn; Dai, YunPing; Liu, GuoShi			Melatonin Improves the Quality of In Vitro Produced (IVP) Bovine Embryos: Implications for Blastocyst Development, Cryotolerance, and Modifications of Relevant Gene Expression	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; CULTURE SYSTEM; OOCYTE MATURATION; CATTLE EMBRYOS; SEX-RATIO; VIVO; PROTEIN; DIFFERENTIATION; FERTILIZATION; INCREASES	To evaluate the potential effects of melatonin on the kinetics of embryo development and quality of blastocyst during the process of in vitro bovine embryo culture. Bovine cumulus-oocyte complexes (COCs) were fertilized after in vitro maturation. The presumed zygotes were cultured in in vitro culture medium supplemented with or without 10(-7) M melatonin. The cleavage rate, 8-cell rate and blastocyst rate were examined to identify the kinetics of embryo development. The hatched blastocyst rate, mortality rate after thawing and the relevant transcript abundance were measured to evaluate the quality of blastocyst. The results showed that melatonin significantly promoted the cleavage rate and 8-cell embryo yield of in vitro produced bovine embryo. In addition, significantly more blastocysts were observed by Day 7 of embryo culture at the presence of melatonin. These results indicated that melatonin accelerated the development of in vitro produced bovine embryos. Following vitrification at Day 7 of embryo culture, melatonin (10(-7) M) significantly increased the hatched blastocyst rate from 24 h to 72 h and decreased the mortality rate from 48 h to 72 h after thawing. The presence of melatonin during the embryo culture resulted in a significant increase in the gene expressions of DNMT3A, OCC, CDH1 and decrease in that of AQP3 after thawing. In conclusion, melatonin not only promoted blastocyst yield and accelerated in vitro bovine embryo development, but also improved the quality of blastocysts which was indexed by an elevated cryotolerance and the up-regulated expressions of developmentally important genes.	[Wang, Feng; Tian, XiuZhi; Zhou, YanHua; Zhu, ShiEn; Liu, GuoShi] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding,Minist Agr, State Key Lab Anim Nutr,Key Lab Anim Genet & Bree, Beijing 100094, Peoples R China; [Tan, DunXian] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Dai, YunPing] China Agr Univ, Coll Biol Sci, State Key Labs Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; University of Texas System; University of Texas Health San Antonio; China Agricultural University	Liu, GS (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding,Minist Agr, State Key Lab Anim Nutr,Key Lab Anim Genet & Bree, Beijing 100094, Peoples R China.	gshliu@cau.edu.cn			National Natural Science Foundation of China [31372306]; Beijing Natural Science Foundation [6122019]; Beijing dairy industry and technology system; New Century Excellent Talents in University [NETC-10-0782];  [2011BAD19B02-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing dairy industry and technology system; New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); 	This research was supported by Program for the National Natural Science Foundation of China (31372306), Beijing Natural Science Foundation (6122019), Beijing dairy industry and technology system, New Century Excellent Talents in University (NETC-10-0782), and other national grants as follows: 2011BAD19B02-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecia JA, 2002, VET RES COMMUN, V26, P151, DOI 10.1023/A:1014099719034; Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032; Boni R, 1999, BIOL REPROD, V61, P1050, DOI 10.1095/biolreprod61.4.1050; Bonilla E, 2004, J PINEAL RES, V36, P73, DOI 10.1046/j.1600-079X.2003.00105.x; Crosier AE, 2001, BIOL REPROD, V64, P1375, DOI 10.1095/biolreprod64.5.1375; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Duby R. T., 1997, Theriogenology, V47, P332, DOI 10.1016/S0093-691X(97)82459-4; Enright BP, 2000, THERIOGENOLOGY, V54, P659, DOI 10.1016/S0093-691X(00)00381-2; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Galli C, 2003, THERIOGENOLOGY, V59, P599, DOI 10.1016/S0093-691X(02)01243-8; Galli C, 2001, THERIOGENOLOGY, V55, P1341, DOI 10.1016/S0093-691X(01)00486-1; Gao C, 2012, J PINEAL RES, V52, P305, DOI 10.1111/j.1600-079X.2011.00944.x; Gutierrez-Adan A, 2001, THERIOGENOLOGY, V55, P1117, DOI 10.1016/S0093-691X(01)00471-X; Hasler JF, 2000, HUM REPROD, V15, P47, DOI 10.1093/humrep/15.suppl_5.47; HASLER JF, 1995, THERIOGENOLOGY, V43, P141, DOI 10.1016/0093-691X(94)00020-U; Hussain SA, 2006, SAUDI MED J, V27, P1483; Ishizuka B, 2000, J PINEAL RES, V28, P48, DOI 10.1034/j.1600-079x.2000.280107.x; Jablonski EM, 2007, CANCER LETT, V250, P36, DOI 10.1016/j.canlet.2006.09.013; Kaidi S, 1998, ANIM REPROD SCI, V52, P39, DOI 10.1016/S0378-4320(98)00089-X; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kang JT, 2009, J PINEAL RES, V46, P22, DOI 10.1111/j.1600-079X.2008.00602.x; Khurana NK, 2000, BIOL REPROD, V62, P847, DOI 10.1095/biolreprod62.4.847; Kim J, 2004, MOL CELLS, V17, P248; Knijn HM, 2005, REPROD FERT DEVELOP, V17, P775, DOI 10.1071/RD05038; Knijn HM, 2002, REPRODUCTION, V124, P365, DOI 10.1530/rep.0.1240365; Kuzmany A, 2011, THERIOGENOLOGY, V75, P482, DOI 10.1016/j.theriogenology.2010.09.016; LEIBFRIEDRUTLEDGE ML, 1987, BIOL REPROD, V36, P376, DOI 10.1095/biolreprod36.2.376; LEIBO SP, 1993, THERIOGENOLOGY, V39, P81, DOI 10.1016/0093-691X(93)90025-Z; Lonergan P, 1999, J REPROD FERTIL, V117, P159, DOI 10.1530/jrf.0.1170159; Lopes AS, 2007, THERIOGENOLOGY, V68, P223, DOI 10.1016/j.theriogenology.2007.04.055; Manjunatha BM, 2009, REPROD DOMEST ANIM, V44, P12, DOI 10.1111/j.1439-0531.2007.00982.x; Mehaisen GMK, 2013, ZYGOTE, V28, P1; Minami N, 2001, BIOL REPROD, V64, P30, DOI 10.1095/biolreprod64.1.30; Niemann H, 2000, THERIOGENOLOGY, V53, P21, DOI 10.1016/S0093-691X(99)00237-X; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Papis K, 2007, J PINEAL RES, V43, P321, DOI 10.1111/j.1600-079X.2007.00479.x; Pappolla MA, 2000, J NEURAL TRANSM, V107, P203, DOI 10.1007/s007020050018; Pomar FJR, 2005, THERIOGENOLOGY, V63, P2254, DOI 10.1016/j.theriogenology.2004.10.015; Reiter RJ, 2009, BIOL REPROD, V81, P445, DOI 10.1095/biolreprod.108.075655; Rizos D, 2003, BIOL REPROD, V68, P236, DOI 10.1095/biolreprod.102.007799; Rizos D, 2002, BIOL REPROD, V66, P589, DOI 10.1095/biolreprod66.3.589; Rizos D, 2002, MOL REPROD DEV, V61, P234, DOI 10.1002/mrd.1153; Rizos D, 2001, THERIOGENOLOGY, V56, P1, DOI 10.1016/S0093-691X(01)00538-6; Rodriguez-Osorio N, 2007, J PINEAL RES, V43, P283, DOI 10.1111/j.1600-079X.2007.00475.x; Sandra O, 2012, REPROD FERT DEVELOP, V24, P68, DOI 10.1071/RD11908; Sheth B, 2000, MECH DEVELOP, V97, P93, DOI 10.1016/S0925-4773(00)00416-0; Shi JM, 2009, J PINEAL RES, V47, P318, DOI 10.1111/j.1600-079X.2009.00717.x; SHIELS A, 1993, CURR EYE RES, V12, P913, DOI 10.3109/02713689309020398; Tamura H, 2009, FERTIL STERIL, V92, P328, DOI 10.1016/j.fertnstert.2008.05.016; Thompson JG, 1997, REPROD FERT DEVELOP, V9, P341, DOI 10.1071/R96079; VanSoom A, 1997, BIOL REPROD, V57, P1041, DOI 10.1095/biolreprod57.5.1041; Vazquez MI, 2010, THERIOGENOLOGY, V74, P618, DOI 10.1016/j.theriogenology.2010.03.007; Viuff D, 2001, BIOL REPROD, V65, P204, DOI 10.1095/biolreprod65.1.204; Wang F, 2014, J PINEAL RES, V56, P333, DOI 10.1111/jpi.12126; Wang F, 2013, J PINEAL RES, V55, P267, DOI 10.1111/jpi.12069; Wrenzycki C, 2001, HUM REPROD, V16, P893, DOI 10.1093/humrep/16.5.893; Yoshioka K, 1997, THERIOGENOLOGY, V48, P997, DOI 10.1016/S0093-691X(97)00326-9	57	51	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93641	10.1371/journal.pone.0093641	http://dx.doi.org/10.1371/journal.pone.0093641			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695534	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000096
J	Wang, J; Ge, Y; Chen, T; Bai, Y; Qian, BY; Zhang, CB				Wang, Jiang; Ge, Yuan; Chen, Tong; Bai, Yi; Qian, Bao Ying; Zhang, Chong Bang			Facilitation Drives the Positive Effects of Plant Richness on Trace Metal Removal in a Biodiversity Experiment	PLOS ONE			English	Article							SPECIES RICHNESS; PRODUCTIVITY RELATIONSHIPS; FUNCTIONAL DIVERSITY; STRESS; SELECTION; MALONDIALDEHYDE; COMPLEMENTARITY; COMPETITION; ECOSYSTEMS; SUCCESSION	Background: Phytoextraction is an environmentally acceptable and inexpensive technique for mine tailing rehabilitation that uses metallophyte plants. These plants reduce the soil trace metal contents to environmentally acceptable levels by accumulating trace metals. Recently, whether more trace metals can be removed by species-rich communities of these plants received great attention, as species richness has been reported having positive effects on ecosystem functions. However, how the species richness affects trace metals removal of plant communities of mine tailing is rarely known. Methodology/Principal Findings: We examined the effects of species richness on soil trace metal removal in both natural and experimental plant communities. The root lengths and stem heights of each plant species were measured in order to calculate the functional diversity indices. Our results showed that trace metal (Cu, Cd, Pb and Zn) concentrations in mine tailing soil declined as species richness increased in both the natural and experimental plant communities. Species richness, rather than functional diversity, positively affected the mineralomass of the experimental plant communities. The intensity of plant-plant facilitation increased with the species richness of experimental communities. Due to the incremental role of plant-plant facilitation, most of the species had higher biomasses, higher trace metal concentrations in their plant tissues and lower malondialdehyde concentrations in their leaves. Consequently, the positive effects of species richness on mineralomass were mostly attributable to facilitation among plants. Conclusions/Significance: Our results provide clear evidence that, due to plant-plant facilitation, species richness positively affects the removal of trace metals from mine tailing soil through phytoextraction and provides further information on diversity conservation and environmental remediation in a mine tailing environment.	[Wang, Jiang; Chen, Tong; Bai, Yi; Qian, Bao Ying; Zhang, Chong Bang] Taizhou Univ, Sch Life Sci, Linhai, Peoples R China; [Ge, Yuan] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Earth Res Inst, Santa Barbara, CA 93106 USA	Taizhou University; University of California System; University of California Santa Barbara	Ge, Y (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Earth Res Inst, Santa Barbara, CA 93106 USA.	gyuan@bren.ucsb.edu	Ge, Yuan/D-2997-2009	Ge, Yuan/0000-0003-0234-5638	National Natural Science Foundation of China [31000256]; Natural Science Foundation of Zhejiang Province, China [Y13C030015]; Ecology Key Disciplines of Zhejiang Province in Taizhou University [EKD2013-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Ecology Key Disciplines of Zhejiang Province in Taizhou University	This research was financially supported by the National Natural Science Foundation of China (Project 31000256), the Natural Science Foundation of Zhejiang Province, China (Y13C030015) and the Ecology Key Disciplines of Zhejiang Province in Taizhou University (EKD2013-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Baumeister D, 2006, ECOLOGY, V87, P1816, DOI 10.1890/0012-9658(2006)87[1816:FBPFDS]2.0.CO;2; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cardinale BJ, 2013, ECOLOGY IN PRESS; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Choler P, 2001, ECOLOGY, V82, P3295, DOI 10.1890/0012-9658(2001)082[3295:FACOGI]2.0.CO;2; Choudhary M, 2007, ECOTOX ENVIRON SAFE, V66, P204, DOI 10.1016/j.ecoenv.2006.02.002; Cooke SJ, 2008, BIOSCIENCE, V58, P957, DOI 10.1641/B581009; Dhir B, 2004, AQUAT TOXICOL, V66, P141, DOI 10.1016/j.aquatox.2003.08.005; Drake JM, 2003, P ROY SOC B-BIOL SCI, V270, P1713, DOI 10.1098/rspb.2003.2423; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gomez-Sagasti MT, 2012, WATER AIR SOIL POLL, V223, P3249, DOI 10.1007/s11270-012-1106-8; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Huston M A, 2000, Science, V289, P1255; Kaneryd L, 2012, ECOL EVOL, V2, P858, DOI 10.1002/ece3.218; Kawai T, 2007, P R SOC B, V274, P2503, DOI 10.1098/rspb.2007.0871; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Kondratyev K., 2002, GLOBAL ENV CHANGE MO; Lei PF, 2012, OECOLOGIA, V169, P1105, DOI 10.1007/s00442-012-2259-2; Li SP, 2012, J APPL ECOL, V49, P261, DOI 10.1111/j.1365-2664.2011.02091.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Maestre FT, 2010, PHILOS T R SOC B, V365, P2057, DOI 10.1098/rstb.2010.0016; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; MCGRATH SP, 1985, J SCI FOOD AGR, V36, P794, DOI 10.1002/jsfa.2740360906; Meeinkuirt W, 2012, INT J PHYTOREMEDIAT, V14, P925, DOI 10.1080/15226514.2011.636403; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; Midgley GF, 2012, SCIENCE, V335, P174, DOI 10.1126/science.1217245; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; Naeem S., 2000, B ECOL SOC AM, V81, P241; Novo LAB, 2013, INT J MIN RECLAM ENV, V27, P215, DOI 10.1080/17480930.2013.779061; Odadi WO, 2011, SCIENCE, V333, P1753, DOI 10.1126/science.1208468; Page AL, 1982, SOIL ANAL PART, V2, P595; Parraga-Aguado I, 2013, ENVIRON POLLUT, V176, P134, DOI 10.1016/j.envpol.2013.01.023; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Sheng XF, 2008, J HAZARD MATER, V155, P17, DOI 10.1016/j.jhazmat.2007.10.107; Spaekova I, 2001, ECOL LETT, V4, P585, DOI 10.1046/j.1461-0248.2001.00277.x; Suran J, 2013, J ENVIRON SCI HEAL B, V48, P147, DOI 10.1080/03601234.2013.727672; Thompson PL, 2012, J ANIM ECOL, V81, P251, DOI 10.1111/j.1365-2656.2011.01908.x; TILMAN D, 2001, FUNCTIONAL CONSEQUEN, P9; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Wang J, 2013, OECOLOGIA, V171, P227, DOI 10.1007/s00442-012-2400-2; Wang JA, 2011, ENVIRON EARTH SCI, V62, P779, DOI 10.1007/s12665-010-0565-8; Zhang SJ, 2012, ENVIRON SCI POLLUT R, V19, P3879, DOI 10.1007/s11356-012-1060-4	52	13	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93733	10.1371/journal.pone.0093733	http://dx.doi.org/10.1371/journal.pone.0093733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695538	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000113
J	Hung, CY; Sun, PL; Chiang, SJ; Jaw, FS				Hung, Chien-Ya; Sun, Pei-Lun; Chiang, Shu-Jen; Jaw, Fu-Shan			In Vitro Differential Diagnosis of Clavus and Verruca by a Predictive Model Generated from Electrical Impedance	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; STRATUM-CORNEUM; SKIN IMPEDANCE; CANCER; TISSUES; LESIONS; TOOL	Background: Similar clinical appearances prevent accurate diagnosis of two common skin diseases, clavus and verruca. In this study, electrical impedance is employed as a novel tool to generate a predictive model for differentiating these two diseases. Materials and Methods: We used 29 clavus and 28 verruca lesions. To obtain impedance parameters, a LCR-meter system was applied to measure capacitance (C), resistance (Re), impedance magnitude (Z), and phase angle (h). These values were combined with lesion thickness (d) to characterize the tissue specimens. The results from clavus and verruca were then fitted to a univariate logistic regression model with the generalized estimating equations (GEE) method. In model generation, log Z(SD) and theta(SD) were formulated as predictors by fitting a multiple logistic regression model with the same GEE method. The potential nonlinear effects of covariates were detected by fitting generalized additive models (GAM). Moreover, the model was validated by the goodness-of-fit (GOF) assessments. Results: Significant mean differences of the index d, Re, Z, and h are found between clavus and verruca (p<0.001). A final predictive model is established with Z and h indices. The model fits the observed data quite well. In GOF evaluation, the area under the receiver operating characteristics (ROC) curve is 0.875 (>0.7), the adjusted generalized R-2 is 0.512 (>0.3), and the p value of the Hosmer-Lemeshow GOF test is 0.350 (>0.05). Conclusions: This technique promises to provide an approved model for differential diagnosis of clavus and verruca. It could provide a rapid, relatively low-cost, safe and non-invasive screening tool in clinic use.	[Hung, Chien-Ya; Jaw, Fu-Shan] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Sun, Pei-Lun] Mackay Mem Hosp, Dept Dermatol, Taipei, Taiwan; [Chiang, Shu-Jen] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan	National Taiwan University; Mackay Memorial Hospital; Academia Sinica - Taiwan; National Taiwan University	Jaw, FS (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	jaw@ntu.edu.tw			National Science Council, Taiwan [NSC 100-2923-E-002-007-MY3, NSC 101-2221-E-002-016]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council (NSC 100-2923-E-002-007-MY3, and NSC 101-2221-E-002-016), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg P, 2003, SKIN RES TECHNOL, V9, P257, DOI 10.1034/j.1600-0846.2003.00017.x; Aberg P, 2004, IEEE T BIO-MED ENG, V51, P2097, DOI 10.1109/TBME.2004.836523; Beetner DG, 2003, IEEE T BIO-MED ENG, V50, P1020, DOI 10.1109/TBME.2003.814534; Birgersson U, 2011, PHYSIOL MEAS, V32, P1, DOI 10.1088/0967-3334/32/1/001; Curdy C, 2004, INT J PHARMACEUT, V271, P251, DOI 10.1016/j.ijpharm.2003.11.016; DeLauro TM, 2012, FITZPATRICKS DERMATO, P1111; Dua R, 2004, IEEE T BIO-MED ENG, V51, P66, DOI 10.1109/TBME.2003.820387; Emtestam L, 1998, DERMATOLOGY, V197, P313, DOI 10.1159/000018023; Faes TJC, 1999, PHYSIOL MEAS, V20, pR1, DOI 10.1088/0967-3334/20/4/201; Glickman YA, 2003, SKIN RES TECHNOL, V9, P262, DOI 10.1034/j.1600-0846.2003.00022.x; Goldsmith L, 2012, FITZPATRICKS DERMATO, V8th, P2421; GRIMNES S, 1983, MED BIOL ENG COMPUT, V21, P739, DOI 10.1007/BF02464037; Gupta D, 2004, AM J CLIN NUTR, V80, P1634, DOI 10.1093/ajcn/80.6.1634; Johnsen Gorm Krogh, 2009, Open Biomed Eng J, V3, P8, DOI 10.2174/1874120700903010008; Kuzmina N, 2005, SKIN RES TECHNOL, V11, P196, DOI 10.1111/j.1600-0846.2005.00120.x; Lindholm-Sethson B, 1998, CHEMOMETR INTELL LAB, V44, P381, DOI 10.1016/S0169-7439(98)00164-6; Martinsen OG, 1997, MED BIOL ENG COMPUT, V35, P172, DOI 10.1007/BF02530033; Martinsen OG, 2001, DERMATOLOGY, V202, P87, DOI 10.1159/000051604; Miklavcic D, 2006, WILEY ENCY BIOMEDICA, P1; MIZE MM, 1989, ARCH DERMATOL, V125, P647, DOI 10.1001/archderm.125.5.647; Nicander I, 1997, Skin Res Technol, V3, P252, DOI 10.1111/j.1600-0846.1997.tb00194.x; Nicander I, 1996, BRIT J DERMATOL, V134, P221; Nicander I, 1998, Skin Res Technol, V4, P213, DOI 10.1111/j.1600-0846.1998.tb00113.x; Nyren M, 2003, J AM ACAD DERMATOL, V48, P394, DOI 10.1067/mjd.2003.96; OLLMAR S, 1994, BRIT J DERMATOL, V130, P29, DOI 10.1111/j.1365-2133.1994.tb06878.x; OTT M, 1995, J ACQ IMMUN DEF SYND, V9, P20; Team RDC, 2010, R LANG ENV STAT COMP; Wirth R, 2010, ARCH GERONTOL GERIAT, V51, P290, DOI 10.1016/j.archger.2009.12.002; YAMAMOTO T, 1976, MED BIOL ENG, V14, P151, DOI 10.1007/BF02478741	29	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93647	10.1371/journal.pone.0093647	http://dx.doi.org/10.1371/journal.pone.0093647			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705282	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500052
J	Ma, CY; Li, Y; Zeng, J; Wu, XL; Liu, XM; Wang, YJ				Ma, Chunyan; Li, Yong; Zeng, Jin; Wu, Xiaoling; Liu, Xiaoming; Wang, Yujiong			Mycobacterium bovis BCG Triggered MyD88 Induces miR-124 Feedback Negatively Regulates Immune Response in Alveolar Epithelial Cells	PLOS ONE			English	Article							MICRORNAS; TUBERCULOSIS; MACROPHAGES; QUANTIFICATION; PROLIFERATION; TRANSITION; SUPPRESSOR; INDUCTION; PATHWAYS; ALPHA	The emerging roles of microRNAs (miRNAs) and pulmonary epithelial cells in regulating the immune response against microbial invasion has attracted increasing attention in recent years, however, the immunoregulatory roles of miRNAs in the pulmonary epithelial cells in response to mycobacterial infection has not been fully demonstrated. In this study, we show that miR-124 expression is induced upon Mycobacterium bovis Bacillus Calmette-Guerin (BCG) infection in A549 alveolar epithelial cells and murine lungs. miR-124 is able to modulate Toll-like receptor (TLR) signaling in A459 cells. In this regard, multiple components, including TLR6, myeloid differentiation factor 88 (MyD88), TNFR-associated factor 6 and tumor necrosis factor-a of the TLR signaling cascade are directly regulated by miR-124 in response to BCG stimulation. In addition, miR-124 expression was induced upon MyD88 overexpression and/or BCG stimulation, while silencing MyD88 expression by small interfering RNA dramatically down-regulated miR-124 transcription in A549 cells. These results indicate an underlying negative feedback mechanism between miR-124 and MyD88 in alveolar epithelial cells to prevent an excessive inflammatory response during mycobacterial infection. These observations suggest that miR-124 is a potential target for preventive and therapeutic intervention against the pulmonary tuberculosis, an infectious disease caused by Mycobacterium tuberculosis infection.	[Ma, Chunyan; Li, Yong; Zeng, Jin; Wu, Xiaoling; Liu, Xiaoming; Wang, Yujiong] Minist Educ Conservat & Utilizat Special Biol Res, Key Lab, Ningxia, Peoples R China; [Ma, Chunyan; Li, Yong; Zeng, Jin; Wu, Xiaoling; Liu, Xiaoming; Wang, Yujiong] Ningxia Univ, Coll Life Sci, Ningxia, Peoples R China	Ningxia University	Liu, XM (corresponding author), Minist Educ Conservat & Utilizat Special Biol Res, Key Lab, Ningxia, Peoples R China.	lxm1966@nxu.edu.cn; wyj@nxu.edu.cn		LIU, XIAOMING/0000-0002-3902-9105	National Key Basic Research Program of China [2012CB126301, 2012CB518801]; National Natural Science Foundation of China [31172278, 31160515, 31260615, 31060335]; National program for scientific and technological support of China [2012BAD12B07-4]; Doctoral fund of Ministry of Education of China [20126401110001]; Natural Science Foundation of Ningxia Hui Autonomous Region of China [NZ1042]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National program for scientific and technological support of China; Doctoral fund of Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Ningxia Hui Autonomous Region of China	This work was supported by grants (Nos. 2012CB126301 and 2012CB518801) from National Key Basic Research Program of China, grants (Nos. 31172278, 31160515, 31260615 and 31060335) from National Natural Science Foundation of China, a grant from National program for scientific and technological support of China (No. 2012BAD12B07-4), a grant from Doctoral fund of Ministry of Education of China (No. 20126401110001) and a grant from Natural Science Foundation of Ningxia Hui Autonomous Region of China (Grant No: NZ1042). The funders had no role in study design, data collection and analysis, decision for publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Chen JF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-694; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chuquimia OD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032125; Diamond G, 2000, IMMUNOL REV, V173, P27, DOI 10.1034/j.1600-065X.2000.917304.x; Gereke M, 2009, AM J RESP CRIT CARE, V179, P344, DOI 10.1164/rccm.200804-592OC; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Guilliams M, 2013, MUCOSAL IMMUNOL, V6, P464, DOI 10.1038/mi.2013.14; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kaufmann SHE, 2005, J EXP MED, V201, P1693, DOI 10.1084/jem.20050842; Koch M, 2012, P NATL ACAD SCI USA, V109, pE1153, DOI 10.1073/pnas.1116125109; Koukos G, 2013, GASTROENTEROLOGY, V145, P842, DOI 10.1053/j.gastro.2013.07.001; Lee MR, 2010, STEM CELLS, V28, P1550, DOI 10.1002/stem.490; Lewin A, 2003, J VET MED B, V50, P505, DOI 10.1046/j.1439-0450.2003.00715.x; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Li Y, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/791392; Liang YJ, 2013, CARCINOGENESIS, V34, P713, DOI 10.1093/carcin/bgs383; Lin YG, 1998, INFECT IMMUN, V66, P1121, DOI 10.1128/IAI.66.3.1121-1126.1998; Liu KJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/867537; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Mayer AK, 2007, ARCH IMMUNOL THER EX, V55, P353, DOI 10.1007/s00005-007-0041-7; McCoy CE, 2011, FRONT BIOSCI-LANDMRK, V16, P2161, DOI 10.2741/3845; MCDONOUGH KA, 1995, INFECT IMMUN, V63, P4802, DOI 10.1128/IAI.63.12.4802-4811.1995; Mendez-Samperio P, 2008, CELL IMMUNOL, V251, P37, DOI 10.1016/j.cellimm.2008.03.002; Mendez-Samperio P, 2008, ARCH MED RES, V39, P33, DOI 10.1016/j.arcmed.2007.06.019; Nahid MA, 2011, J IMMUNOL, V186, P1723, DOI 10.4049/jimmunol.1002311; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poirier V, 2012, MICROBES INFECT, V14, P1211, DOI 10.1016/j.micinf.2012.07.001; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Wei J, 2013, CANCER RES, V73, P3913, DOI 10.1158/0008-5472.CAN-12-4318; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Xia HP, 2012, J BIOL CHEM, V287, P9962, DOI 10.1074/jbc.M111.332627; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145; ZHU SY, 2013, HYPERFINE INTERACT, V220, P1, DOI DOI 10.1007/s10751-012-0749-6	45	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92419	10.1371/journal.pone.0092419	http://dx.doi.org/10.1371/journal.pone.0092419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705038	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500017
J	Rutar, M; Valter, K; Natoli, R; Provis, JM				Rutar, Matt; Valter, Krisztina; Natoli, Riccardo; Provis, Jan M.			Synthesis and Propagation of Complement C3 by Microglia/Monocytes in the Aging Retina	PLOS ONE			English	Article							SENILE MACULAR DEGENERATION; FACTOR-H POLYMORPHISM; PARA-INFLAMMATION; GENE-EXPRESSION; IMMUNE; CELLS; DEFICIENCY; RISK; MICROGLIA; RECRUITMENT	Introduction: Complement activation is thought to contribute to the pathogenesis of age-related macular degeneration (AMD), which may be mediated in part by para-inflammatory processes. We aimed to investigate the expression and localization of C3, a crucial component of the complement system, in the retina during the course of aging. Methods: SD rats were born and reared in low-light conditions, and euthanized at post-natal (P) days 100, 450, or 750. Expression of C3, IBA1, and Ccl- and Cxcl- chemokines was assessed by qPCR, and in situ hybridization. Thickness of the ONL was assessed in retinal sections as a measure of photoreceptor loss, and counts were made of C3-expressing monocytes. Results: C3 expression increased significantly at P750, and correlated with thinning of the ONL, at P750, and up-regulation of GFAP. In situ hybridization showed that C3 was expressed by microglia/monocytes, mainly from within the retinal vasculature, and occasionally the ONL. The number of C3-expressing microglia increased significantly by P750, and coincided spatiotemporally with thinning of the ONL, and up-regulation of Ccl- and Cxcl- chemokines. Conclusions: Our data suggest that recruited microglia/monocytes contribute to activation of complement in the aging retina, through local expression of C3 mRNA. C3 expression coincides with age-related thinning of the ONL at P750, although it is unclear whether the C3-expressing monocytes are a cause or consequence. These findings provide evidence of activation of complement during natural aging, and may have relevance to cellular events underling the pathogenesis of age-related retinal diseases.	[Rutar, Matt; Valter, Krisztina; Natoli, Riccardo; Provis, Jan M.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Valter, Krisztina; Natoli, Riccardo; Provis, Jan M.] Australian Natl Univ, Sch Med, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Australian National University	Rutar, M (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	matt.rutar@anu.edu.au	Valter, Krisztina/L-3015-2016; Provis, Jan/C-9529-2009	Natoli, Riccardo/0000-0002-9350-0439; Provis, Jan/0000-0002-6405-2868; Rutar, Matthew/0000-0002-8893-5120; Valter, Krisztina/0000-0002-2033-0408	Australian Research Council Centres of Excellence Program Grant [CE0561903]	Australian Research Council Centres of Excellence Program Grant(Australian Research Council)	Funding provided by Australian Research Council Centres of Excellence Program Grant (CE0561903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Ambati J, 2011, INVEST OPHTH VIS SCI, V52, P2166, DOI 10.1167/iovs.11-7328; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Bonnel S, 2003, EXP GERONTOL, V38, P825, DOI 10.1016/S0531-5565(03)00093-7; Botto M, 1998, EXP CLIN IMMUNOGENET, V15, P231, DOI 10.1159/000019076; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; Cashman SM, 2011, INVEST OPHTH VIS SCI, V52, P3436, DOI 10.1167/iovs.10-6002; Chen M, 2007, EXP EYE RES, V84, P635, DOI 10.1016/j.exer.2006.11.015; Chen M, 2012, GLIA, V60, P833, DOI 10.1002/glia.22315; Chen M, 2010, INVEST OPHTH VIS SCI, V51, P5888, DOI 10.1167/iovs.09-5103; Cherepanoff S, 2010, BRIT J OPHTHALMOL, V94, P918, DOI 10.1136/bjo.2009.165563; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Cornish EE, 2005, VISUAL NEUROSCI, V22, P447, DOI 10.1017/S0952523805224069; DAVIES KA, 1994, SPRINGER SEMIN IMMUN, V15, P397, DOI 10.1007/BF01837367; Despriet DDG, 2009, OPHTHALMOLOGY, V116, P474, DOI 10.1016/j.ophtha.2008.09.055; DIAZARAYA CM, 1995, J COMP NEUROL, V363, P53, DOI 10.1002/cne.903630106; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Ezzat MK, 2008, BRIT J OPHTHALMOL, V92, P976, DOI 10.1136/bjo.2007.129742; GAO H, 1992, INVEST OPHTH VIS SCI, V33, P1; GARTNER S, 1981, BRIT J OPHTHALMOL, V65, P23, DOI 10.1136/bjo.65.1.23; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Gasque P, 2000, IMMUNOPHARMACOLOGY, V49, P171, DOI 10.1016/S0162-3109(00)80302-1; Gullstrand B, 2009, CLIN EXP IMMUNOL, V156, P303, DOI 10.1111/j.1365-2249.2009.03896.x; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hollyfield JG, 2010, INVEST OPHTH VIS SCI, V51, P1276, DOI 10.1167/iovs.09-4478; Jakobsdottir J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002199; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Kaneko H, 2008, INVEST OPHTH VIS SCI, V49, P4162, DOI 10.1167/iovs.08-1738; Karagianni N, 2010, ADV EXP MED BIOL, V703, P1, DOI 10.1007/978-1-4419-5635-4_1; Kennedy CJ, 1995, EYE, V9, P763, DOI 10.1038/eye.1995.192; Klein R, 2005, MACULAR DEGENERATION, P79; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Korb LC, 1997, J IMMUNOL, V158, P4525; Lau LI, 2011, INVEST OPHTH VIS SCI, V52, P6832, DOI 10.1167/iovs.11-7815; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Ma W, 2012, NEUROBIOL AGING; Ma WX, 2013, NEUROBIOL AGING, V34, P2310, DOI 10.1016/j.neurobiolaging.2013.03.022; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Natoli R, 2008, MOL VIS, V14, P1983; Navratil JS, 1999, IMMUNOPHARMACOLOGY, V42, P47, DOI 10.1016/S0162-3109(99)00018-1; Newman AM, 2012, GENOME MED, V4, DOI [10.1186/PREACCEPT-1418491035586234, 10.1186/gm315]; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Park KH, 2009, INVEST OPHTH VIS SCI, V50, P3386, DOI 10.1167/iovs.08-3231; Patel M, 2008, SEMIN IMMUNOPATHOL, V30, P97, DOI 10.1007/s00281-008-0112-9; PENFOLD P, 1984, AUST J OPHTHALMOL, V12, P23; PENFOLD PL, 1987, GRAEF ARCH CLIN EXP, V225, P70, DOI 10.1007/BF02155808; PENFOLD PL, 1986, INVEST OPHTH VIS SCI, V27, P364; PENFOLD PL, 1985, GRAEF ARCH CLIN EXP, V223, P69, DOI 10.1007/BF02150948; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Rapp L, 1985, RETINAL DEGENERATION, P421; Rein DB, 2009, ARCH OPHTHALMOL-CHIC, V127, P533, DOI 10.1001/archophthalmol.2009.58; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-221; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P5347, DOI 10.1167/iovs.10-7119; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P2379, DOI 10.1167/iovs.10-6010; Rutar M, 2010, CURR EYE RES, V35, P631, DOI 10.3109/02713681003682925; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Sennlaub F, 2013, EMBO MOL MED, V5, P1775, DOI 10.1002/emmm.201302692; Sim RB, 2007, IMMUNOBIOLOGY, V212, P355, DOI 10.1016/j.imbio.2007.04.001; SLAGBOOM PE, 1990, MECH AGEING DEV, V53, P243, DOI 10.1016/0047-6374(90)90042-E; Spencer KL, 2008, HUM MOL GENET, V17, P1821, DOI 10.1093/hmg/ddn075; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wong JG, 2001, INVEST OPHTH VIS SCI, V42, pS227; Wu KHC, 2003, BRIT J OPHTHALMOL, V87, P1159, DOI 10.1136/bjo.87.9.1159; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yoshida S, 2002, INVEST OPHTH VIS SCI, V43, P2554	76	38	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93343	10.1371/journal.pone.0093343	http://dx.doi.org/10.1371/journal.pone.0093343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705166	Green Published, gold			2022-12-27	WOS:000334107500032
J	Faryammanesh, R; Lange, T; Magbanua, E; Haas, S; Meyer, C; Wicklein, D; Schumacher, U; Hahn, U				Faryammanesh, Rassa; Lange, Tobias; Magbanua, Eileen; Haas, Sina; Meyer, Cindy; Wicklein, Daniel; Schumacher, Udo; Hahn, Ulrich			SDA, a DNA Aptamer Inhibiting E- and P-Selectin Mediated Adhesion of Cancer and Leukemia Cells, the First and Pivotal Step in Transendothelial Migration during Metastasis Formation	PLOS ONE			English	Article							IN-VITRO SELECTION; MOLECULES; INSIGHTS; LIGANDS; BINDING; MODEL	Endothelial (E-) and platelet (P-) selectin mediated adhesion of tumor cells to vascular endothelium is a pivotal step of hematogenous metastasis formation. Recent studies have demonstrated that selectin deficiency significantly reduces metastasis formation in vivo. We selected an E-and P-Selectin specific DNA Aptamer (SDA) via SELEX (Systematic Evolution of Ligands by EXponential enrichment) with a K-d value of approximately 100 nM and the capability of inhibiting the interaction between selectin and its ligands. Employing human colorectal cancer (HT29) and leukemia (EOL-1) cell lines we could demonstrate an anti-adhesive effect for SDA in vitro. Under physiological shear stress conditions in a laminar flow adhesion assay, SDA inhibited dynamic tumor cell adhesion to immobilized E-or P-selectin. The stability of SDA for more than two hours allowed its application in cell-cell adhesion assays in cell culture medium. When adhesion of HT29 cells to TNF alpha-stimulated E-selectin presenting human pulmonary microvascular endothelial cells was analyzed, inhibition via SDA could be demonstrated as well. In conclusion, SDA is a potential new therapeutic agent that antagonizes selectin-mediated adhesion during metastasis formation in human malignancies.	[Faryammanesh, Rassa; Magbanua, Eileen; Haas, Sina; Meyer, Cindy; Hahn, Ulrich] Univ Hamburg, MIN Fac, Inst Biochem & Mol Biol, Dept Chem, Hamburg, Germany; [Lange, Tobias; Wicklein, Daniel; Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr, Inst Anat & Expt Morphol, Hamburg, Germany	University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hahn, U (corresponding author), Univ Hamburg, MIN Fac, Inst Biochem & Mol Biol, Dept Chem, Hamburg, Germany.	uli.hahn@uni-hamburg.de	Hahn, Ulrich/E-8069-2010; Lange, Tobias/K-8689-2015	Hahn, Ulrich/0000-0002-6526-0693; Meyer, Cindy/0000-0003-3807-8383	Forschungs- und Wissenschaftsstiftung Hamburg in the Forschungsverbund "Cell surface targeting"; FAZIT-STIFTUNG	Forschungs- und Wissenschaftsstiftung Hamburg in the Forschungsverbund "Cell surface targeting"; FAZIT-STIFTUNG	Forschungs- und Wissenschaftsstiftung Hamburg in the Forschungsverbund "Cell surface targeting". Grant of the FAZIT-STIFTUNG to R. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BRANDLEY BK, 1990, CELL, V63, P861, DOI 10.1016/0092-8674(90)90487-Y; Burnette AD, 2011, NUCLEIC ACID THER, V21, P275, DOI 10.1089/nat.2010.0270; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; ERBE DV, 1993, J CELL BIOL, V120, P1227, DOI 10.1083/jcb.120.5.1227; Ernst B, 2009, NAT REV DRUG DISCOV, V8, P661, DOI 10.1038/nrd2852; FIDLER IJ, 1978, CANCER RES, V38, P2651; Gebauer F, 2013, GUT, V62, P741, DOI 10.1136/gutjnl-2011-300629; Gutsaeva DR, 2011, BLOOD, V117, P727, DOI 10.1182/blood-2010-05-285718; Jenison RD, 1998, ANTISENSE NUCLEIC A, V8, P265, DOI 10.1089/oli.1.1998.8.265; Keefe AD, 2008, CURR OPIN PHARMACOL, V8, P147, DOI 10.1016/j.coph.2007.12.005; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kohler S, 2010, BRIT J CANCER, V102, P602, DOI 10.1038/sj.bjc.6605492; LARSEN GR, 1992, J BIOL CHEM, V267, P11104; LASKY LA, 1991, J CELL BIOCHEM, V45, P139, DOI 10.1002/jcb.240450204; Mann AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013050; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; Mayer Guenter, 2009, V535, P19, DOI 10.1007/978-1-59745-557-2_2; Pendergrast P Shannon, 2005, J Biomol Tech, V16, P224; Revelle BM, 1996, J BIOL CHEM, V271, P4289; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Richter U, 2012, HISTOCHEM CELL BIOL, V137, P687, DOI 10.1007/s00418-012-0916-5; Richter U, 2011, HISTOCHEM CELL BIOL, V135, P499, DOI 10.1007/s00418-011-0804-4; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Sheikh S, 2003, BLOOD, V102, P2828, DOI 10.1182/blood-2003-01-0080; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Strell Carina, 2008, Cell Commun Signal, V6, P10, DOI 10.1186/1478-811X-6-10; Sun ChengLong, 2011, Agricultural Science & Technology - Hunan, V12, P363; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wicklein D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070139; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	24	28	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93173	10.1371/journal.pone.0093173	http://dx.doi.org/10.1371/journal.pone.0093173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699049	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000044
J	Kwok, L; Zhang, JC; Guo, Z; Gesudu, QM; Zheng, Y; Qiao, JM; Huo, DX; Zhang, HP				Kwok, Lai-yu; Zhang, Jiachao; Guo, Zhuang; Gesudu, Qimu; Zheng, Yi; Qiao, Jianmin; Huo, Dongxue; Zhang, Heping			Characterization of Fecal Microbiota across Seven Chinese Ethnic Groups by Quantitative Polymerase Chain Reaction	PLOS ONE			English	Article							REAL-TIME PCR; GROUP-SPECIFIC PRIMERS; HUMAN GUT MICROBIOME; HUMAN FECES; PREDOMINANT BACTERIA; GENETIC-RELATIONSHIP; DNA-EXTRACTION; HAN CHINESE; POPULATIONS; HEALTH	The human gut microbiota consists of complex microbial communities, which possibly play crucial roles in physiological functioning and health maintenance. China has evolved into a multicultural society consisting of the major ethnic group, Han, and 55 official ethnic minority groups. Nowadays, these minority groups inhabit in different Chinese provinces and some of them still keep their unique culture and lifestyle. Currently, only limited data are available on the gut microbiota of these Chinese ethnic groups. In this study, 10 major fecal bacterial groups of 314 healthy individuals from 7 Chinese ethnic origins were enumerated by quantitative polymerase chain reaction. Our data confirmed that the selected bacterial groups were common to all 7 surveyed ethnicities, but the amount of the individual bacterial groups varied to different degree. By principal component and canonical variate analyses of the 314 individuals or the 91 Han subjects, no distinct group clustering pattern was observed. Nevertheless, weak differences were noted between the Han and Zhuang from other ethnic minority groups, and between the Heilongjiang Hans from those of the other provinces. Thus, our results suggest that the ethnic origin may contribute to shaping the human gut microbiota.	[Kwok, Lai-yu; Zhang, Jiachao; Guo, Zhuang; Gesudu, Qimu; Zheng, Yi; Qiao, Jianmin; Huo, Dongxue; Zhang, Heping] Inner Mongolia Agr Univ, Dept Food Sci & Engn, Educ Minist PR China, Key Lab Dairy Biotechnol & Bioengn, Hohhot, Inner Mongolia, Peoples R China		Zhang, HP (corresponding author), Inner Mongolia Agr Univ, Dept Food Sci & Engn, Educ Minist PR China, Key Lab Dairy Biotechnol & Bioengn, Hohhot, Inner Mongolia, Peoples R China.	hepingdd@vip.sina.com	Zhang, jiachao/L-1332-2013; Zhang, He/GXN-0028-2022	Zhang, jiachao/0000-0001-8099-6749; Zhang, Jiachao/0000-0002-3339-7345	National Natural Science Foundation of China [31025019]; Innovation Team Development of the Ministry of Education of China [IRT0967]; China Agriculture Research System [CARS-37]; Key Laboratory Major Open Project Fund of Inner Mongolia [20130902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Team Development of the Ministry of Education of China; China Agriculture Research System; Key Laboratory Major Open Project Fund of Inner Mongolia	This research was supported by the National Natural Science Foundation of China (Grant No. 31025019), the Innovation Team Development of the Ministry of Education of China (Grant No. IRT0967), the China Agriculture Research System (Grant No. CARS-37), and the Key Laboratory Major Open Project Fund of Inner Mongolia (Grant No. 20130902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baquero F, 2012, CLIN MICROBIOL INFEC, V18, P2, DOI 10.1111/j.1469-0691.2012.03916.x; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Duncan SH, 2013, MATURITAS; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fite A, 2004, GUT, V53, P523, DOI 10.1136/gut.2003.031245; Ge KY, 1997, AM J CLIN NUTR, V65, P1290, DOI 10.1093/ajcn/65.4.1290S; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hormannsperger G, 2012, J ALLERGY CLIN IMMUN, V129, P1452, DOI 10.1016/j.jaci.2011.12.993; Inglis GD, 2012, J AOAC INT, V95, P5, DOI 10.5740/jaoacint.SGE_Inglis; Kikuchi E, 2002, MICROBIOL IMMUNOL, V46, P353, DOI 10.1111/j.1348-0421.2002.tb02706.x; Kirkma TW, 1996, STAT USE; Kuwahara T, 2011, DNA RES, V18, P291, DOI 10.1093/dnares/dsr022; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005; Lin HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009895; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Maukonen J, 2012, FEMS MICROBIOL ECOL, V79, P697, DOI 10.1111/j.1574-6941.2011.01257.x; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Nam YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022109; Nechvatal JM, 2008, J MICROBIOL METH, V72, P124, DOI 10.1016/j.mimet.2007.11.007; Peris-Bondia F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022448; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Scher JU, 2011, NAT REV RHEUMATOL, V7, P569, DOI 10.1038/nrrheum.2011.121; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Unger J, 1997, B CONCERN ASIA SCHOL, V29, P67; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhai Fengying, 2007, Wei Sheng Yan Jiu, V36, P539	44	29	32	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93631	10.1371/journal.pone.0093631	http://dx.doi.org/10.1371/journal.pone.0093631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699404	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000083
J	Palafox, B; Patouillard, E; Tougher, S; Goodman, C; Hanson, K; Kleinschmidt, I; Rueda, ST; Kiefer, S; O'Connell, KA; Zinsou, C; Phok, S; Akulayi, L; Arogundade, E; Buyungo, P; Mpasela, F; Chavasse, D				Palafox, Benjamin; Patouillard, Edith; Tougher, Sarah; Goodman, Catherine; Hanson, Kara; Kleinschmidt, Immo; Rueda, Sergio Torres; Kiefer, Sabine; O'Connell, Kathryn A.; Zinsou, Cyprien; Phok, Sochea; Akulayi, Louis; Arogundade, Ekundayo; Buyungo, Peter; Mpasela, Felton; Chavasse, Desmond			Understanding Private Sector Antimalarial Distribution Chains: A Cross-Sectional Mixed Methods Study in Six Malaria-Endemic Countries	PLOS ONE			English	Article							COMBINATION THERAPIES; FEBRILE ILLNESS; CASE-MANAGEMENT; ANTI-MALARIALS; RETAIL SECTOR; MARKET SHARE; DRUG SHOPS; HEALTH; PROVIDERS; AVAILABILITY	Background: Private for-profit outlets are important treatment sources for malaria in most endemic countries. However, these outlets constitute only the last link in a chain of businesses that includes manufacturers, importers and wholesalers, all of which influence the availability, price and quality of antimalarials patients can access. We present evidence on the composition, characteristics and operation of these distribution chains and of the businesses that comprise them in six endemic countries (Benin, Cambodia, Democratic Republic of Congo, Nigeria, Uganda and Zambia). Methods and Findings: We conducted nationally representative surveys of antimalarial wholesalers during 2009-2010 using an innovative sampling approach that captured registered and unregistered distribution channels, complemented by in-depth interviews with a range of stakeholders. Antimalarial distribution chains were pyramidal in shape, with antimalarials passing through a maximum of 4-6 steps between manufacturer and retailer; however, most likely pass through 2-3 steps. Less efficacious non-artemisinin therapies (e. g. chloroquine) dominated weekly sales volumes among African wholesalers, while volumes for more efficacious artemisinin-based combination therapies (ACTs) were many times smaller. ACT sales predominated only in Cambodia. In all countries, consumer demand was the principal consideration when selecting products to stock. Selling prices and reputation were key considerations regarding supplier choice. Business practices varied across countries, with large differences in the proportions of wholesalers offering credit and delivery services to customers, and the types of distribution models adopted by businesses. Regulatory compliance also varied across countries, particularly with respect to licensing. The proportion of wholesalers possessing any up-to-date licence from national regulators was lowest in Benin and Nigeria, where vendors in traditional markets are important antimalarial supply sources. Conclusions: The structure and characteristics of antimalarial distribution chains vary across countries; therefore, understanding the wholesalers that comprise them should inform efforts aiming to improve access to quality treatment through the private sector.	[Palafox, Benjamin; Patouillard, Edith; Tougher, Sarah; Goodman, Catherine; Hanson, Kara; Kleinschmidt, Immo; Rueda, Sergio Torres] London Sch Hyg & Trop Med, London WC1, England; [Kiefer, Sabine] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [O'Connell, Kathryn A.; Chavasse, Desmond] Populat Serv Int, Malaria & Child Survival Dept, Nairobi, Kenya; [Zinsou, Cyprien] Populat Serv Int, Assoc Beninoise Mkt Social, Cotonou, Benin; [Phok, Sochea] Populat Serv Int Cambodia, Phnom Penh, Cambodia; [Akulayi, Louis] Assoc Sante Familiale, Kinshasa, DEM REP CONGO; [Arogundade, Ekundayo] Soc Family Hlth, Abuja, Nigeria; [Buyungo, Peter] Programme Accessible Hlth Commun & Educ, Kampala, Uganda; [Mpasela, Felton] Soc Family Hlth, Lusaka, Zambia	University of London; London School of Hygiene & Tropical Medicine; University of Basel; Swiss Tropical & Public Health Institute	Palafox, B (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	benjamin.palafox@lshtm.ac.uk		Tougher, Sarah/0000-0001-7990-4368; Goodman, Catherine/0000-0002-2241-3485; Patouillard, Edith/0000-0001-7347-2824	Bill and Melinda Gates Foundation [058992]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	ACTwatch is funded by the Bill and Melinda Gates Foundation (www.gatesfoundation.org, grant #058992). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-163; Awor P, 2012, AM J TROP MED HYG, V87, P92, DOI 10.4269/ajtmh.2012.11-0791; Berman P, 1996, HEALTH POLICY PLANN, V11, P142, DOI 10.1093/heapol/11.2.142; Chaturvedi HK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-301; Cohen JM, 2012, SCIENCE, V338, P612, DOI 10.1126/science.1229045; Djankov S, 2002, Q J ECON, V117, P1, DOI 10.1162/003355302753399436; Hanson K, 1998, HEALTH POLICY PLANN, V13, P195, DOI 10.1093/heapol/13.3.195; Hanson K, 2011, GLOBAL HLTH DIS PROG; Kahabuka C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058789; Kamat V. R., 1997, PRIVATE HLTH PROVIDE, P124; Kangwana BP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000437; Kaplan WA, 2005, LOCAL PRODUCTION PHA; Lalchhuanawma R, 2012, INT HEALTH, V4, P314, DOI 10.1016/j.inhe.2012.06.003; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-328; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; Nonaka D, 2009, ACTA TROP, V112, P283, DOI 10.1016/j.actatropica.2009.08.013; Noor AM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-100; O'Cathain A, 2006, QUALITATIVE RES HLTH; O'Connell KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-326; Okeke TA, 2010, HEALTH POLICY, V95, P62, DOI 10.1016/j.healthpol.2009.11.005; Onwujekwe O, 2010, HEALTH POLICY, V94, P144, DOI 10.1016/j.healthpol.2009.09.010; Orem JN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-175; Patouillard E, 2012, EC ANAL MARKET MALAR; Patouillard E, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-50; Pope C, 2006, QUALITATIVE RES HLTH; Rutebemberwa E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-45; Rutta Edmund, 2009, Prog Community Health Partnersh, V3, P145, DOI 10.1353/cpr.0.0063; Sabot OJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006857; Shewchuk T, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-325; Smith N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-316; StataCorp, 2011, STAT STAT SOFTW REL, P173; StataCorp, 2021, STATA STAT SOFTWARE; Talisuna AO, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-356; Taylor J., 2009, PUSH LOCAL PRODUCTIO; Tougher S, 2012, LANCET, V380, P1916, DOI 10.1016/S0140-6736(12)61732-2; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Yeung S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-243	37	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93763	10.1371/journal.pone.0093763	http://dx.doi.org/10.1371/journal.pone.0093763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699934	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000334105000102
J	Rebaud, S; Simon, A; Wang, CK; Mason, L; Blum, L; Hofmann, A; Girard-Egrot, A				Rebaud, Samuel; Simon, Anne; Wang, Conan K.; Mason, Lyndel; Blum, Loic; Hofmann, Andreas; Girard-Egrot, Agnes			Comparison of VILIP-1 and VILIP-3 Binding to Phospholipid Monolayers	PLOS ONE			English	Article							CALCIUM SENSOR PROTEINS; VISININ-LIKE PROTEIN-1; SUBCELLULAR-LOCALIZATION; MYRISTOYL SWITCH; MEMBRANE; PEPTIDES; FAMILY; TRANSLOCATION; RECOVERIN; CELLS	The neuronal calcium sensor proteins Visinin-like Proteins 1 (VILIP-1) and 3 (VILIP-3) are effectors of guanylyl cyclase and acetyl choline receptors, and transduce calcium signals in the brain. The "calcium-myristoyl" switch, which involves a post-translationally added myristoyl moiety and calcium binding, is thought to regulate their membrane binding capacity and therefore, play a critical role in their mechanism of action. In the present study, we investigated the effect of membrane composition and solvent conditions on the membrane binding mechanisms of both VILIPs using lipid monolayers at the air/buffer interface. Results based on comparison of the adsorption kinetics of the myristoylated and non-myristoylated proteins confirm the pivotal role of calcium and the exposed myristol moiety for sustaining the membrane-bound state of both VILIPs. However, we also observed binding of both VILIP proteins in the absence of calcium and/or myristoyl conjugation. We propose a two-stage membrane binding mechanism for VILIP-1 and VILIP-3 whereby the proteins are initially attracted to the membrane surface by electrostatic interactions and possibly by specific interactions with highly negatively charged lipids head groups. The extrusion of the conjugated myristoyl group, and the subsequent anchoring in the membrane constitutes the second stage of the binding mechanism, and ensures the sustained membrane-bound form of these proteins.	[Rebaud, Samuel; Simon, Anne; Blum, Loic; Girard-Egrot, Agnes] Univ Lyon 1, CNRS, ICBMS, UMR 5246,Inst Chim & Biochim Mol & Supramol, F-69622 Villeurbanne, France; [Wang, Conan K.; Mason, Lyndel; Hofmann, Andreas] Griffith Univ, Eskitis Inst, Struct Chem Program, Brisbane, Qld 4111, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Griffith University	Simon, A (corresponding author), Univ Lyon 1, CNRS, ICBMS, UMR 5246,Inst Chim & Biochim Mol & Supramol, Bat Curien,43 Bd 11 Nov 1918, F-69622 Villeurbanne, France.	Anne.Simon@univ-lyon1.fr	Wang, Conan K/D-1481-2010; SIMON, Anne/D-6046-2011; Hofmann, Andreas/M-9870-2019; Hofmann, Andreas/B-9515-2008; GIRARD-EGROT, Agnès/AAP-5586-2020	Wang, Conan K/0000-0002-7973-7632; Hofmann, Andreas/0000-0003-4408-5467; Hofmann, Andreas/0000-0003-4408-5467; GIRARD-EGROT, Agnès/0000-0003-2612-3124	National Health and Medical Research Council [37677]; French Ministry of Science and Education fellowship; Fundacao Bial; Rebecca Cooper Foundation; BQR from UniversitA(C) Lyon 1	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); French Ministry of Science and Education fellowship; Fundacao Bial(Bial Foundation); Rebecca Cooper Foundation; BQR from UniversitA(C) Lyon 1	C.K.W. was supported by a National Health and Medical Research Council postdoctoral training fellowship (37677). S. R. was supported by a French Ministry of Science and Education fellowship. This work was supported in parts by Fundacao Bial and the Rebecca Cooper Foundation (to A. H.) and by BQR from UniversitA(C) Lyon 1 (to A. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Bernstein HG, 1999, J NEUROCYTOL, V28, P655, DOI 10.1023/A:1007056731551; Bernstein HG, 2002, NEUROREPORT, V13, P393, DOI 10.1097/00001756-200203250-00006; Boekhoff I, 1997, EUR J CELL BIOL, V72, P151; Braunewell KH, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00020; Braunewell KH, 2010, AUST J CHEM, V63, P350, DOI 10.1071/CH09355; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Braunewell KH, 2001, DEMENT GERIATR COGN, V12, P110, DOI 10.1159/000051244; Braunewell KH, 2001, J NEUROCHEM, V78, P1277, DOI 10.1046/j.1471-4159.2001.00506.x; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Bussieres S, 2012, LANGMUIR, V28, P3516, DOI 10.1021/la203896n; Calvez P, 2011, LANGMUIR, V27, P1373, DOI 10.1021/la104097n; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; Chen KC, 2009, J PEPT SCI, V15, P89, DOI 10.1002/psc.1097; COX JA, 1994, J BIOL CHEM, V269, P32807; Desmeules P, 2007, BIOPHYS J, V93, P2069, DOI 10.1529/biophysj.106.103481; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; Girard-Egrot A, 2004, J MOL BIOL, V335, P321, DOI 10.1016/j.jmb.2003.10.028; Guillemin Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009066; Jheng FF, 2006, PROTEIN J, V25, P250, DOI 10.1007/s10930-006-9008-5; LADANT D, 1995, J BIOL CHEM, V270, P3179; Lenz SE, 1996, BIOCHEM BIOPH RES CO, V225, P1078, DOI 10.1006/bbrc.1996.1298; Li CM, 2011, J BIOL CHEM, V286, P6354, DOI 10.1074/jbc.M110.173724; Lin L, 2002, BIOCHEM BIOPH RES CO, V296, P827, DOI 10.1016/S0006-291X(02)00943-9; Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5; Mahloogi H, 2003, CANCER RES, V63, P4997; Meyer T, 1999, NAT CELL BIOL, V1, pE93, DOI 10.1038/12090; O'Callaghan DW, 2005, BIOCHEM J, V391, P231, DOI 10.1042/BJ20051001; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Sallese M, 2000, BBA-MOL CELL RES, V1498, P112, DOI 10.1016/S0167-4889(00)00088-4; Senin Ivan I., 2007, BMC Biochemistry, V8, P24, DOI 10.1186/1471-2091-8-24; Spilker C, 2003, MOL CELL NEUROSCI, V24, P766, DOI 10.1016/S1044-7431(03)00242-2; Spilker C, 2002, BBA-PROTEINS PROTEOM, V1600, P118, DOI 10.1016/S1570-9639(02)00452-1; Spilker C, 2002, J NEUROSCI, V22, P7331; Spilker C, 1999, J NEUROCHEM, V73, pS206; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Wang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026793	38	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93948	10.1371/journal.pone.0093948	http://dx.doi.org/10.1371/journal.pone.0093948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699524	Green Submitted, Green Published, gold			2022-12-27	WOS:000334105000125
J	Sidaway, P; Teramoto, N				Sidaway, Peter; Teramoto, Noriyoshi			L-Type Ca2+ Channel Sparklets Revealed by TIRF Microscopy in Mouse Urinary Bladder Smooth Muscle	PLOS ONE			English	Article							RYANODINE RECEPTORS; CALCIUM-CHANNELS; CA(V)1.2 CHANNELS; HEART-CELLS; CONTRACTION; ACTIVATION; MECHANISMS; EXCITATION; RELEASE; SIGNALS	Calcium is a ubiquitous second messenger in urinary bladder smooth muscle (UBSM). In this study, small discrete elevations of intracellular Ca2+, referred to as Ca2+ sparklets have been detected in an intact detrusor smooth muscle electrical syncytium using a TIRF microscopy Ca2+ imaging approach. Sparklets were virtually abolished by the removal of extracellular Ca2+ (0.035 +/- 0.01 vs. 0.23 +/- 0.07 Hz/mm(2); P<0.05). Co-loading of smooth muscle strips with the slow Ca2+ chelator EGTA-AM (10 mM) confirmed that Ca2+ sparklets are restricted to the cell membrane. Ca2+ sparklets were inhibited by the calcium channel inhibitors R-(+)-Bay K 8644 (1 mu M) (0.034 +/- 0.02 vs. 0.21 +/- 0.08 Hz/mm(2); P<0.05), and diltiazem (10 mu M) (0.097 +/- 0.04 vs. 0.16 +/- 0.06 Hz/mm(2); P<0.05). Ca2+ sparklets were unaffected by inhibition of P2X(1) receptors a, alpha,beta-meATP (10 mu M) whilst sparklet frequencies were significantly reduced by atropine (1 mu M). Ca2+ sparklet frequency was significantly reduced by PKC inhibition with Go6976 (100 nM) (0.030 +/- 0.01 vs. 0.30 +/- 0.1 Hz/mm(2); P<0.05), demonstrating that Ca2+ sparklets are PKC dependant. In the presence of CPA (10 mu M), there was no apparent change in the overall frequency of Ca2+ sparklets, although the sparklet frequencies of each UBSM became statistically independent of each other (Spearman's rank correlation 0.2, P>0.05), implying that Ca2+ store mediated signals regulate Ca2+ sparklets. Under control conditions, inhibition of store operated Ca2+ entry using ML-9 (100 mu M) had no significant effect. Amplitudes of Ca2+ sparklets were unaffected by any agonists or antagonists, suggesting that these signals are quantal events arising from activation of a single channel, or complex of channels. The effects of CPA and ML-9 suggest that Ca2+ sparklets regulate events in the cell membrane, and contribute to cytosolic and sarcoplasmic Ca2+ concentrations.	[Sidaway, Peter; Teramoto, Noriyoshi] Saga Univ, Fac Med, Dept Pharmacol, Saga 840, Japan	Saga University	Sidaway, P (corresponding author), Saga Univ, Fac Med, Dept Pharmacol, Saga 840, Japan.	psidaway439@gmail.com			Japan Society for the Promotion of Science (JSPS) [PE12064]; JSPS [LS096]; Grants-in-Aid for Scientific Research [26282148] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Dr. Peter Sidaway was awarded by a Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship (Short-Term) for Foreign Researcher, PE12064 to Prof. Noriyoshi Teramoto). The research was also supported by the JSPS Funding Program for Next Generation World-Leading Researchers (Prof. Noriyoshi Teramoto, Grant Number LS096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg GC, 2007, J PHYSIOL-LONDON, V579, P187, DOI 10.1113/jphysiol.2006.124420; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Cheng HP, 2002, FRONT BIOSCI, V7, pD1867, DOI 10.2741/cheng; Choppin A, 2001, BRIT J PHARMACOL, V133, P1035, DOI 10.1038/sj.bjp.0704165; Francis M, 2012, AM J PHYSIOL-CELL PH, V303, pC236, DOI 10.1152/ajpcell.00016.2012; Ganitkevich VY, 1999, CELL CALCIUM, V25, P29, DOI 10.1054/ceca.1998.0001; Hashitani H, 2001, J PHYSIOL-LONDON, V530, P273, DOI 10.1111/j.1469-7793.2001.0273l.x; Hill-Eubanks DC, 2011, COLD SPRING HARB PER, V3, P2; Karaki H, 1997, PHARMACOL REV, V49, P157; Kiselyov K, 2001, BIOCHEM J, V360, P17, DOI 10.1042/0264-6021:3600017; Kobayter S, 2012, BRIT J PHARMACOL, V165, P401, DOI 10.1111/j.1476-5381.2011.01543.x; Liu L, 2006, AM J PHYSIOL-CELL PH, V290, pC1239, DOI 10.1152/ajpcell.00440.2005; McCarron JG, 2009, J GEN PHYSIOL, V133, P439, DOI 10.1085/jgp.200810189; Meng E, 2008, NEUROUROL URODYNAM, V27, P79, DOI 10.1002/nau.20456; Navedo MF, 2007, AM J PHYSIOL-HEART C, V293, pH1359, DOI 10.1152/ajpheart.00450.2007; Navedo MF, 2006, J GEN PHYSIOL, V127, P611, DOI 10.1085/jgp.200609519; Navedo MF, 2005, P NATL ACAD SCI USA, V102, P11112, DOI 10.1073/pnas.0500360102; Nieves-Cintron M, 2008, P NATL ACAD SCI USA, V105, P15623, DOI 10.1073/pnas.0808759105; Ouanounou A, 1999, J NEUROSCI, V19, P906; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Parker I, 2010, J GEN PHYSIOL, V136, P119, DOI 10.1085/jgp.200910390; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Rubart M, 1996, J GEN PHYSIOL, V107, P459, DOI 10.1085/jgp.107.4.459; Sanders KM, 2008, NEUROGASTROENT MOTIL, V20, P39, DOI 10.1111/j.1365-2982.2008.01108.x; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Takeda Y, 2011, AM J PHYSIOL-HEART C, V301, pH2285, DOI 10.1152/ajpheart.00488.2011; Trepakova ES, 2001, J BIOL CHEM, V276, P7782, DOI 10.1074/jbc.M010104200; Vial C, 2000, BRIT J PHARMACOL, V131, P1489, DOI 10.1038/sj.bjp.0703720; Wang SQ, 2001, NATURE, V410, P592, DOI 10.1038/35069083; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Willmott NJ, 1996, FEBS LETT, V394, P159, DOI 10.1016/0014-5793(96)00939-8; Wu C, 2001, AM J PHYSIOL-CELL PH, V280, pC1090, DOI 10.1152/ajpcell.2001.280.5.C1090; Yamamura H, 2012, BIOCHEM BIOPH RES CO, V427, P54, DOI 10.1016/j.bbrc.2012.08.145; Young JS, 2008, J PHYSIOL-LONDON, V586, P5743, DOI 10.1113/jphysiol.2008.162040	35	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93803	10.1371/journal.pone.0093803	http://dx.doi.org/10.1371/journal.pone.0093803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699670	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000109
J	Siqueiros-Garcia, JM; Hernandez-Lemus, E; Garcia-Herrera, R; Robina-Galatas, A				Siqueiros-Garcia, Jesus M.; Hernandez-Lemus, Enrique; Garcia-Herrera, Rodrigo; Robina-Galatas, Andrea			Mapping the Structure and Dynamics of Genomics-Related MeSH Terms Complex Networks	PLOS ONE			English	Article							CYTOSCAPE	It has been proposed that the history and evolution of scientific ideas may reflect certain aspects of the underlying sociocognitive frameworks in which science itself is developing. Systematic analyses of the development of scientific knowledge may help us to construct models of the collective dynamics of science. Aiming at scientific rigor, these models should be built upon solid empirical evidence, analyzed with formal tools leading to ever-improving results that support the related conclusions. Along these lines we studied the dynamics and structure of the development of research in genomics as represented by the entire collection of genomics related scientific papers contained in the PubMed database. The analyzed corpus consisted in more than 49,000 articles published in the years 1987 (first appeareance of the term Genomics) to 2011, categorized by means of the Medical Subheadings (MeSH) content-descriptors. Complex networks were built where two MeSH terms were connected if they are descriptors of the same article(s). The analysis of such networks revealed a complex structure and dynamics that to certain extent resembled small-world networks. The evolution of such networks in time reflected interesting phenomena in the historical development of genomic research, including what seems to be a phase-transition in a period marked by the completion of the first draft of the Human Genome Project. We also found that different disciplinary areas have different dynamic evolution patterns in their MeSH connectivity networks. In the case of areas related to science, changes in topology were somewhat fast while retaining a certain core-stucture, whereas in the humanities, the evolution was pretty slow and the structure resulted highly redundant and in the case of technology related issues, the evolution was very fast and the structure remained tree-like with almost no overlapping terms.	[Siqueiros-Garcia, Jesus M.; Robina-Galatas, Andrea] Natl Inst Genom Med, Eth Legal & Social Studies Dept, Mexico City, DF, Mexico; [Hernandez-Lemus, Enrique; Garcia-Herrera, Rodrigo] Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico; [Hernandez-Lemus, Enrique] Univ Nacl Autonoma Mexico, Ctr Complex Sci, Mexico City 04510, DF, Mexico	Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico	Siqueiros-Garcia, JM (corresponding author), Natl Inst Genom Med, Eth Legal & Social Studies Dept, Mexico City, DF, Mexico.	jsiqueiros@inmegen.gob.mx	Siqueiros-García, Jesús Mario/ABG-7535-2021	Siqueiros-García, Jesús Mario/0000-0001-8008-6198; Hernandez-Lemus, Enrique/0000-0002-1872-1397; Garcia Herrera, Ricardo/0000-0003-2456-4727; Garcia-Herrera, Rodrigo/0000-0002-7972-5746				[Anonymous], 2014, INTRO MESH; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2012, NAT PHYS, V8, P14, DOI 10.1038/nphys2188; Cardillo A, 2006, PHYSICA A, V372, P333, DOI 10.1016/j.physa.2006.08.059; Christakis Nicholas, 2013, NY TIMES; Dorogovtsev S.N., 2004, PHYSICS, V71, P47; Dupr? John., 2008, GENOMES WHAT MAKE TH; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Keller Evelyn Fox, 2000, CENTURY GENE; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pan RK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00551; Pan RK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00902; Pan RK, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/68006; Perc M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01720; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sun XL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01069; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yan EJ, 2012, J AM SOC INF SCI TEC, V63, P1313, DOI 10.1002/asi.22680; Yousefi-Nooraie Reza, 2008, Health Res Policy Syst, V6, P9, DOI 10.1186/1478-4505-6-9	27	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92639	10.1371/journal.pone.0092639	http://dx.doi.org/10.1371/journal.pone.0092639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699262	Green Submitted, gold, Green Published			2022-12-27	WOS:000334105000031
J	Ferraresso, S; Bresolin, S; Arico, A; Comazzi, S; Gelain, ME; Riondato, F; Bargelloni, L; Marconato, L; Kronnie, GT; Aresu, L				Ferraresso, Serena; Bresolin, Silvia; Arico, Arianna; Comazzi, Stefano; Gelain, Maria Elena; Riondato, Fulvio; Bargelloni, Luca; Marconato, Laura; Kronnie, Geertruy te; Aresu, Luca			Epigenetic Silencing of TFPI-2 in Canine Diffuse Large B-Cell Lymphoma	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR-2; TUMOR-SUPPRESSOR GENE; PROMOTER HYPERMETHYLATION; FUNDAMENTAL ROLE; DNA METHYLATION; CPG ISLAND; CANCER; EXPRESSION; MODEL; PROGRESSION	Epigenetic modifications are important early events during carcinogenesis. In particular, hypermethylation of CpG islands in the promoter region of tumor suppressor genes is a well-known mechanism of gene silencing that contributes to cancer development and progression. Tissue factor pathway inhibitor 2 (TFPI-2) is a tumor suppressor involved in invasiveness inhibition. Although TFPI-2 transcriptional silencing, through promoter hypermethylation, has been widely reported in several human malignancies, it has never been explored in lymphoma. In the present study TFPI-2 methylation and gene expression have been investigated in canine Diffuse Large B-cell lymphomas (cDLBCL). The methylation level of 23 CpGs located within the TFPI-2 promoter was investigated by bisulfite-specific PCR and next generation amplicon deep sequencing (GS Junior 454, Roche) in 22 cDLBCLs and 9 controls. For the same specimens, TFPI-2 gene expression was assessed by means of Real-time RT-PCR. Sequence analysis clearly demonstrated that TFPI2 is frequently hypermethylated in cDLBCL. Hypermethylation of the TFPI-2 promoter was found in 77% of DLBCLs ( 17 out of 22) and in one normal lymph node. Globally, dogs with DLBCL showed a mean methylation level significantly increased compared to controls (p<0.01) and analysis of hypermethylation by site identified 19 loci out of 23 ( 82%) with mean methylation levels from 2- to 120-fold higher in cDLBCL. Gene expression analysis confirmed a significant down-regulation of TFPI-2 ( p<0.05) in DLBCLs compared with normal lymph nodes, suggesting that TFPI-2 hypermethylation negatively regulates its transcription. In addition, a significant positive correlation ( p<0.01) was found between TFPI-2 methylation levels and age providing the first indication of age-associated epigenetic modifications in canine DLBCL. To conclude, our findings demonstrated that epigenetic dysregulation of TFPI-2, leading to its reduced expression, is frequently detected in canine DLBCL. In the next future, the aberrant TFPI-2 promoter hypermethylation may be considered in association with prognosis and therapy.	[Ferraresso, Serena; Arico, Arianna; Gelain, Maria Elena; Bargelloni, Luca; Aresu, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy; [Bresolin, Silvia; Kronnie, Geertruy te] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Comazzi, Stefano] Univ Milan, Dept Anim Pathol Hyg & Vet Publ Hlth, Milan, Italy; [Riondato, Fulvio] Univ Turin, Dept Vet Sci, Turin, Italy; [Marconato, Laura] Ctr Oncol Vet, Sasso Marconi, Italy	University of Padua; University of Padua; University of Milan; University of Turin	Ferraresso, S (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy.	serena.ferraresso@unipd.it	Bresolin, Silvia/K-6576-2016; riondato, fulvio/AAE-5929-2021; Marconato, Laura/AAD-7263-2020; Kronnie, Geertruy te/L-1014-2016; Aresu, Luca/J-9788-2018; Comazzi, Stefano/K-8062-2017; Arico, Arianna/J-4873-2018	Bresolin, Silvia/0000-0001-7677-7084; Marconato, Laura/0000-0002-7843-615X; Aresu, Luca/0000-0002-7893-1740; Comazzi, Stefano/0000-0002-1567-8055; te Kronnie, Geertruy/0000-0001-7143-4795; /0000-0001-5636-1006; Arico, Arianna/0000-0002-2397-0064; Ferraresso, Serena/0000-0001-5928-9361; riondato, fulvio/0000-0002-4814-2273; gelain, maria elena/0000-0002-8633-0988	Ministry of Health (PRIN)	Ministry of Health (PRIN)(Ministry of Education, Universities and Research (MIUR))	This work was founded by a grant from Ministry of Health (PRIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aresu L, 2014, VET COMP ONCOL, V12, P29, DOI 10.1111/j.1476-5829.2012.00328.x; Arico A, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-94; Bresolin S, 2013, HAEMATOLOGICA, V98, P353; Bryan JN, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-73; Clozel T, 2013, CANCER DISCOV, V3, P1002, DOI 10.1158/2159-8290.CD-13-0117; Daniel FI, 2011, CANCER-AM CANCER SOC, V117, P677, DOI 10.1002/cncr.25482; Galm O, 2006, BLOOD REV, V20, P1, DOI 10.1016/j.blre.2005.01.006; Gaud G, 2011, J CELL MOL MED, V15, P196, DOI 10.1111/j.1582-4934.2009.00989.x; Gaurnier-Hausser A, 2011, CLIN CANCER RES, V17, P4661, DOI 10.1158/1078-0432.CCR-10-3310; Glockner SC, 2009, CANCER RES, V69, P4691, DOI 10.1158/0008-5472.CAN-08-0142; Guo HS, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-110; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Herman MP, 2001, J CLIN INVEST, V107, P1117, DOI 10.1172/JCI10403; Hibi K, 2010, ANTICANCER RES, V30, P4131; Hube F, 2003, BIOL CHEM, V384, P1029, DOI 10.1515/BC.2003.115; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jian P, 2012, J PEDIAT HEMATOL ONC, V34, P43, DOI 10.1097/MPH.0b013e3182277276; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Keller U, 2005, ONCOGENE, V24, P6231, DOI 10.1038/sj.onc.1208779; Konduri SD, 2003, INT J ONCOL, V22, P1277; Lavergne M, 2013, FEBS OPEN BIO, V3, P291, DOI 10.1016/j.fob.2013.06.004; Lutsik P, 2011, NUCLEIC ACIDS RES, V39, pW551, DOI 10.1093/nar/gkr312; Marconato L, 2014, CLIN CANCER RES, V20, P668, DOI 10.1158/1078-0432.CCR-13-2283; Mudaliar MAV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072591; Ponce F, 2010, VET PATHOL, V47, P414, DOI 10.1177/0300985810363902; Rosenwald A, 2003, LEUKEMIA LYMPHOMA, V44, pS41, DOI 10.1080/10428190310001623775; Schoofs T, 2013, LEUKEMIA IN PRESS; Sun YN, 2006, LARYNGOSCOPE, V116, P596, DOI 10.1097/01.mlg.0000205589.84020.d2; Takada H, 2010, CANCER GENET CYTOGEN, V197, P16, DOI 10.1016/j.cancergencyto.2009.11.004; Wang SM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-617; Wong CM, 2007, HEPATOLOGY, V45, P1129, DOI 10.1002/hep.21578; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	34	25	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92707	10.1371/journal.pone.0092707	http://dx.doi.org/10.1371/journal.pone.0092707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695110	Green Published, gold			2022-12-27	WOS:000334103000026
J	Gardiner, JM; Atema, J; Hueter, RE; Motta, PJ				Gardiner, Jayne M.; Atema, Jelle; Hueter, Robert E.; Motta, Philip J.			Multisensory Integration and Behavioral Plasticity in Sharks from Different Ecological Niches	PLOS ONE			English	Article							ANTERIOR LATERAL-LINE; MEXICAN CAVE FISH; PREY-CAPTURE; MOTTLED SCULPIN; SENSORY BASIS; NURSE SHARK; OYSTER TOADFISH; FLOW; ELECTRORECEPTION; CONSEQUENCES	The underwater sensory world and the sensory systems of aquatic animals have become better understood in recent decades, but typically have been studied one sense at a time. A comprehensive analysis of multisensory interactions during complex behavioral tasks has remained a subject of discussion without experimental evidence. We set out to generate a general model of multisensory information extraction by aquatic animals. For our model we chose to analyze the hierarchical, integrative, and sometimes alternate use of various sensory systems during the feeding sequence in three species of sharks that differ in sensory anatomy and behavioral ecology. By blocking senses in different combinations, we show that when some of their normal sensory cues were unavailable, sharks were often still capable of successfully detecting, tracking and capturing prey by switching to alternate sensory modalities. While there were significant species differences, odor was generally the first signal detected, leading to upstream swimming and wake tracking. Closer to the prey, as more sensory cues became available, the preferred sensory modalities varied among species, with vision, hydrodynamic imaging, electroreception, and touch being important for orienting to, striking at, and capturing the prey. Experimental deprivation of senses showed how sharks exploit the many signals that comprise their sensory world, each sense coming into play as they provide more accurate information during the behavioral sequence of hunting. The results may be applicable to aquatic hunting in general and, with appropriate modification, to other types of animal behavior.	[Gardiner, Jayne M.; Motta, Philip J.] Univ S Florida, Dept Integrat Biol, Tampa, FL 33606 USA; [Gardiner, Jayne M.; Hueter, Robert E.] Mote Marine Lab, Ctr Shark Res, Sarasota, FL 34236 USA; [Atema, Jelle] Boston Univ, Dept Biol, Boston, MA 02215 USA	State University System of Florida; University of South Florida; Mote Marine Laboratory & Aquarium; Boston University	Gardiner, JM (corresponding author), Univ S Florida, Dept Integrat Biol, Tampa, FL 33606 USA.	jayne@mote.org		Gardiner, Jayne/0000-0002-9989-2891	National Science Foundation [IOS-0843440, IOS-0841478, IOS-081502]; Lerner-Gray Grant for Marine Research; American Elasmobranch Society Donald R. Nelson Behavior Research Award; American Society for Ichthyologists and Herpetologists Raney Fund Award; Porter Family Foundation; University of South Florida Presidential Doctoral Fellowship	National Science Foundation(National Science Foundation (NSF)); Lerner-Gray Grant for Marine Research; American Elasmobranch Society Donald R. Nelson Behavior Research Award; American Society for Ichthyologists and Herpetologists Raney Fund Award; Porter Family Foundation; University of South Florida Presidential Doctoral Fellowship	This work was funded by a collaborative National Science Foundation grant, www.nsf.gov [IOS-0843440 to JA, IOS-0841478 to REH, and IOS-081502 to PJM]; a Lerner-Gray Grant for Marine Research to JMG, www.amnh.org; an American Elasmobranch Society Donald R. Nelson Behavior Research Award to JMG, www.elasmo.org, an American Society for Ichthyologists and Herpetologists Raney Fund Award to JMG, www.asih.org; and by the Porter Family Foundation. JMG was supported by a University of South Florida Presidential Doctoral Fellowship, www.usf.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD GP, 1974, BIOL REV, V49, P515, DOI 10.1111/j.1469-185X.1974.tb01173.x; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; ARONSON LR, 1967, B MAR SCI, V17, P249; Atema J., 1988, SENSORY BIOL AQUATIC; Atema J, 2012, CHEMICAL ECOLOGY IN AQUATIC SYSTEMS, P1; Baker CF, 1999, J COMP PHYSIOL A, V184, P519, DOI 10.1007/s003590050351; Baker CF, 2002, J COMP PHYSIOL A, V188, P553, DOI 10.1007/s00359-002-0329-3; Barry KP, 2002, THESIS LOUISIANA STA; Bateson William, 1890, J MAR BIOL ASSOC UK, V1, P225, DOI [DOI 10.1017/S0025315400072118, 10.1017/S0025315400072118]; Bedore CN, 2014, ZOOLOGY IN PRESS; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaxter J.H.S., 1989, P481; Castro JI, 1996, B MAR SCI, V59, P508; Castro JI, 2000, ENVIRON BIOL FISH, V58, P1, DOI 10.1023/A:1007698017645; Chagnaud BP, 2008, J NEUROSCI, V28, P4479, DOI 10.1523/JNEUROSCI.4959-07.2008; Collin S. P., 2003, SENSORY PROCESSING A; COOMBS S, 1994, J EXP BIOL, V190, P109; Coombs S, 2001, J EXP BIOL, V204, P337; Cornett AD, 2006, ECOMORPHOLOGY SHARK; Cortes E, 1996, B MAR SCI, V58, P353; Curio E., 1976, ETHOLOGY PREDATION; Denton E.J., 1988, P595; DUNTLEY SQ, 1963, J OPT SOC AM, V53, P214, DOI 10.1364/JOSA.53.000214; Faucher K, 2006, AQUAT TOXICOL, V76, P278, DOI 10.1016/j.aquatox.2005.10.004; Faucher K, 2006, AQUACULTURE, V252, P462, DOI 10.1016/j.aquaculture.2005.07.004; Faucher K, 2010, ANIM BEHAV, V79, P679, DOI 10.1016/j.anbehav.2009.12.020; Ferry-Graham LA, 1998, J EXP BIOL, V201, P2433; Ferry-Graham LA, 2001, J MORPHOL, V248, P99, DOI 10.1002/jmor.1023; Ferry-Graham LA, 2003, ZOOLOGY, V106, P159, DOI 10.1078/0944-2006-00110; Fouts WR, 1999, COPEIA, P304; FRAZZETTA TH, 1987, COPEIA, P979, DOI 10.2307/1445562; Gardiner J.M., 2014, FLOW SENSING AIR WAT, P127, DOI [10.1007/978-3-642-41446-6_5, DOI 10.1007/978-3-642-41446-6_5]; Gardiner JM, 2007, J EXP BIOL, V210, P1925, DOI 10.1242/jeb.000075; Gardiner JM, 2012, ZOOLOGY, V115, P78, DOI 10.1016/j.zool.2011.09.004; Gardiner JM, 2010, CURR BIOL, V20, P1187, DOI 10.1016/j.cub.2010.04.053; Gardiner JM, 2012, THESIS U S FLORIDA T; Grasso FW, 2002, ENVIRON FLUID MECH, V2, P95, DOI 10.1023/A:1016275516949; Haine OS, 2001, MAR FRESHWATER RES, V52, P291, DOI 10.1071/MF00036; Hamasaki D. I., 1965, Bulletin of Marine Science of the Gulf and Caribbean, V15, P1051; Hassan E.S., 1989, P217; HASSAN ES, 1992, J COMP PHYSIOL A, V171, P413; Haverly JE, 1996, COPEIA, P419; Higham TE, 2005, J EXP BIOL, V208, P2653, DOI 10.1242/jeb.01682; Higham TE, 2006, J EXP BIOL, V209, P2713, DOI 10.1242/jeb.02315; HOBSON EDMUND S., 1963, PACIFIC SCI, V17, P171; HODGSON ES, 1971, ANN NY ACAD SCI, V188, P175, DOI 10.1111/j.1749-6632.1971.tb13096.x; Holzman R, 2009, LIMNOL OCEANOGR, V54, P2201, DOI 10.4319/lo.2009.54.6.2201; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hueter RE, 1991, J EXP ZOOL         S, V5, P130; Janssen J, 1996, ENVIRON BIOL FISH, V47, P51, DOI 10.1007/BF00002379; JANSSEN J, 1990, ENVIRON BIOL FISH, V29, P43, DOI 10.1007/BF00000567; Jordan LK, 2009, J EXP BIOL, V212, P3044, DOI 10.1242/jeb.028738; Kajiura SM, 2003, MAR BIOL, V143, P603, DOI 10.1007/s00227-003-1099-3; Kajiura SM, 2002, J EXP BIOL, V205, P3609; Kajiura SM, 2001, ENVIRON BIOL FISH, V61, P125, DOI 10.1023/A:1011028312787; Kajiura SM, 2009, ZOOLOGY, V112, P241, DOI 10.1016/j.zool.2008.07.001; Kalmijn A.J., 1988, P83; Kalmijn A.J., 1974, P147; KALMIJN AJ, 1971, J EXP BIOL, V55, P371; KALMIJN AJ, 1982, SCIENCE, V218, P916, DOI 10.1126/science.7134985; KALMIJN AJ, 1972, SCRIPPS I OCEANOGRAP, V72, P1; KAUS S, 1987, ACTA OTO-LARYNGOL, V103, P291, DOI 10.3109/00016488709107796; Konietschke F., 2012, NPARCOMP PERFORM MUL; KROESE ABA, 1982, HEARING RES, V6, P183, DOI 10.1016/0378-5955(82)90053-3; Lyon EP, 1904, AM J PHYSIOL, V12, P149, DOI 10.1152/ajplegacy.1904.12.2.149; Mann DA, 2007, MAR ECOL PROG SER, V338, P307, DOI 10.3354/meps338307; MATHEWSON RF, 1972, COMP BIOCHEM PHYSIOL, V42, P79, DOI 10.1016/0300-9629(72)90369-6; MATSUURA S, 1971, JPN J PHYSIOL, V21, P579; McComb DM, 2009, J EXP BIOL, V212, P4010, DOI 10.1242/jeb.032615; MCFALLNGAI MJ, 1990, AM ZOOL, V30, P175; McGowan DW, 2009, J EXP BIOL, V212, P1544, DOI 10.1242/jeb.025247; Monroy JA, 2011, J EXP ZOOL PART A, V315A, P61, DOI 10.1002/jez.601; MOSS SA, 1972, AM MIDL NAT, V88, P496, DOI 10.2307/2424384; Motta PJ, 2008, J MORPHOL, V269, P1041, DOI 10.1002/jmor.10626; Motta PJ, 2012, CRC MAR BIOL SER, P153; MYRBERG AA, 1972, B MAR SCI, V22, P926; Myrberg AA, 2001, ENVIRON BIOL FISH, V60, P31; MYRBERG AA, 1974, COPEIA, P358; Nauwelaerts S, 2007, J R SOC INTERFACE, V4, P341, DOI 10.1098/rsif.2006.0180; NELSON DONALD R., 1963, SCIENCE, V142, P975, DOI 10.1126/science.142.3594.975; Packard GC, 1999, COMP BIOCHEM PHYS A, V122, P37, DOI 10.1016/S1095-6433(98)10170-8; Page RA, 2012, NATURWISSENSCHAFTEN, V99, P505, DOI 10.1007/s00114-012-0920-6; Palmer LM, 2005, J EXP BIOL, V208, P3441, DOI 10.1242/jeb.01766; Palmer LM, 2004, J NEUROPHYSIOL, V92, P1034, DOI 10.1152/jn.01151.2003; PARKER GH, 1914, B US BUR FISH, V33, P61; Peach MB, 2003, J FISH BIOL, V62, P793, DOI 10.1046/j.1095-8649.2003.00065.x; Piep M, 2008, ANIM BEHAV, V75, P871, DOI 10.1016/j.anbehav.2007.07.008; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pohlmann K, 2004, J EXP BIOL, V207, P2971, DOI 10.1242/jeb.01129; Raguso RA, 2005, CHEM SENSES, V30, pI295, DOI 10.1093/chemse/bjh231; Roberts B.L., 1978, P331; Ruxton GD, 2009, PHILOS T R SOC B, V364, P549, DOI 10.1098/rstb.2008.0228; Sheldon RE, 1911, J EXP ZOOL, V10, P51, DOI 10.1002/jez.1400100105; Sokal R.R., 2012, BIOMETRY; Srisuradetchai P, 2013, SKILLINGS MACK SKILL; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Team RC, 2013, R LANGUAGE ENV STAT; Tester AL., 1963, SHARKS SURVIVAL, P255; TESTER ALBERT L., 1963, PACIFIC SCI, V17, P145; Tierney KB, 2010, AQUAT TOXICOL, V96, P2, DOI 10.1016/j.aquatox.2009.09.019; Torisawa S, 2011, J FISH BIOL, V79, P1291, DOI 10.1111/j.1095-8649.2011.03113.x; Vasconcelos RO, 2007, J EXP BIOL, V210, P2104, DOI 10.1242/jeb.004317; Vergassola M, 2007, NATURE, V445, P406, DOI 10.1038/nature05464; Vickers NJ, 2000, BIOL BULL, V198, P203, DOI 10.2307/1542524; Viitasalo M, 1998, MAR ECOL PROG SER, V175, P129, DOI 10.3354/meps175129; von Uexkull Joseph D., 2010, FORAY WORLDS ANIMALS; Webster D. R., 2007, TRACE CHEM SENSING E, P109; Wilga CD, 2000, J EXP BIOL, V203, P2781; Windsor SP, 2010, J EXP BIOL, V213, P3819, DOI 10.1242/jeb.040741; Windsor SP, 2010, J EXPT BIOL, V213; Wueringer BE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041605	111	47	48	38	277	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93036	10.1371/journal.pone.0093036	http://dx.doi.org/10.1371/journal.pone.0093036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695492	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000034
J	Johnson, H; Solensky, MJ; Satterfield, DA; Davis, AK				Johnson, Haley; Solensky, Michelle J.; Satterfield, Dara A.; Davis, Andrew K.			Does Skipping a Meal Matter to a Butterfly's Appearance? Effects of Larval Food Stress on Wing Morphology and Color in Monarch Butterflies	PLOS ONE			English	Article							LEPIDOPTERA; NUTRITION; MIGRATION; DENSITY; TRAITS; FLIGHT; MELANIZATION; POPULATIONS; SELECTION; MELANISM	In animals with complex life cycles, all resources needed to form adult tissues are procured at the larval stage. For butterflies, the proper development of wings involves synthesizing tissue during metamorphosis based on the raw materials obtained by larvae. Similarly, manufacture of pigment for wing scales also requires resources acquired by larvae. We conducted an experiment to test the effects of food deprivation in the larval stage on multiple measures of adult wing morphology and coloration of monarch butterflies (Danaus plexippus), a species in which long distance migration makes flight efficiency critical. In a captive setting, we restricted food (milkweed) from late-stage larvae for either 24 hrs or 48 hrs, then after metamorphosis we used image analysis methods to measure forewing surface area and elongation (length/width), which are both important for migration. We also measured the brightness of orange pigment and the intensity of black on the wing. There were correlations between several wing features, including an unexpected association between wing elongation and melanism, which will require further study to fully understand. The clearest effect of food restriction was a reduction in adult wing size in the high stress group (by approximately 2%). Patterns observed for other wing traits were ambiguous: monarchs in the low stress group (but not the high) had less elongated and paler orange pigmentation. There was no effect on wing melanism. Although some patterns obtained in this study were unclear, our results concerning wing size have direct bearing on the monarch migration. We show that if milkweed is limited for monarch larvae, their wings become stunted, which could ultimately result in lower migration success.	[Johnson, Haley; Solensky, Michelle J.] Univ Jamestown, Dept Biol, Jamestown, ND USA; [Satterfield, Dara A.; Davis, Andrew K.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Davis, AK (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	akdavis@uga.edu	Satterfield, Dara/N-4484-2017	Satterfield, Dara/0000-0003-3036-5580				Altizer SM, 2000, ECOL ENTOMOL, V25, P125, DOI 10.1046/j.1365-2311.2000.00246.x; Altizer S, 2010, EVOLUTION, V64, P1018, DOI 10.1111/j.1558-5646.2010.00946.x; Atterholt AL, 2010, J ENTOMOL SCI, V45, P366, DOI 10.18474/0749-8004-45.4.366; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Barros-Bellanda Helen C. H., 2002, Iheringia, Sér. Zool., V92, P93, DOI 10.1590/S0073-47212002000100009; Bauerfeind SS, 2009, ENTOMOL EXP APPL, V130, P229, DOI 10.1111/j.1570-7458.2008.00814.x; Boggs CL, 2005, OECOLOGIA, V144, P353, DOI 10.1007/s00442-005-0076-6; Bowlin MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002154; Brower Lincoln P., 1995, Journal of the Lepidopterists' Society, V49, P304; Clusella Trullas S, 2007, J THERM BIOL, V32, P235, DOI 10.1016/j.jtherbio.2007.01.013; Copete JL, 1999, BIRD STUDY, V46, P100, DOI 10.1080/00063659909461119; Davis A.K., 2009, PSYCHE, V2009, P705780, DOI [10.1155/2009/705780, DOI 10.1155/2009/705780]; Davis AK, 2005, J THERM BIOL, V30, P410, DOI 10.1016/j.jtherbio.2005.04.003; Davis AK, 2007, ANN ENTOMOL SOC AM, V100, P339, DOI 10.1603/0013-8746(2007)100[339:WCPFMS]2.0.CO;2; Davis AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041323; Dmitriew C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017399; Ellers J, 2004, BIOL J LINN SOC, V82, P79, DOI 10.1111/j.1095-8312.2004.00319.x; Ethier J, 2012, J INSECT PHYSIOL, V58, P67, DOI 10.1016/j.jinsphys.2011.09.018; Flockhart DTT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045080; GIBO DL, 1993, CAN J ZOOL, V71, P76, DOI 10.1139/z93-012; GIBO DL, 1979, CAN J ZOOL, V57, P1393, DOI 10.1139/z79-180; Hahn DA, 2005, J INSECT PHYSIOL, V51, P1210, DOI 10.1016/j.jinsphys.2005.06.011; Hanley D, 2013, BEHAV ECOL, V24, P1108, DOI 10.1093/beheco/art037; Howard E, 2004, MONARCH BUTTERFLY BIOLOGY AND CONSERVATION, P105; Kemp DJ, 2008, EVOLUTION, V62, P2346, DOI 10.1111/j.1558-5646.2008.00461.x; Knuttel H, 2001, J EXP BIOL, V204, P2447; LAFONT R, 1977, J INSECT PHYSIOL, V23, P277, DOI 10.1016/0022-1910(77)90042-7; Lindsey E, 2009, ECOL ENTOMOL, V34, P551, DOI 10.1111/j.1365-2311.2009.01107.x; McCord JW, 2010, J INSECT BEHAV, V23, P405, DOI 10.1007/s10905-010-9224-x; Nijhout HF, 2010, SCIENCE, V330, P1693, DOI 10.1126/science.1197292; Pellegroms B, 2009, ECOL ENTOMOL, V34, P387, DOI 10.1111/j.1365-2311.2009.01090.x; Pleasants JM, 2013, INSECT CONSERV DIVER, V6, P135, DOI 10.1111/j.1752-4598.2012.00196.x; Sander Sarah E., 2013, Insects, V4, P447, DOI 10.3390/insects4030447; Satterfield DA, ANIMAL MIGR IN PRESS; Satterfield DA, 2013, CURR ZOOL, V59, P393, DOI 10.1093/czoolo/59.3.393; SCOTT DE, 1994, ECOLOGY, V75, P1383, DOI 10.2307/1937462; Statistica, 2003, STAT VERS 6 1; Talloen W, 2004, EVOLUTION, V58, P360, DOI 10.1111/j.0014-3820.2004.tb01651.x; Telang A, 2004, J INSECT PHYSIOL, V50, P677, DOI 10.1016/j.jinsphys.2004.05.001; Tigreros N, 2013, EVOL ECOL, V27, P1145, DOI 10.1007/s10682-013-9647-x; Tigreros N, 2013, FUNCT ECOL, V27, P145, DOI 10.1111/1365-2435.12006; Van Dyck H, 1998, ECOL ENTOMOL, V23, P465, DOI 10.1046/j.1365-2311.1998.00151.x	42	17	17	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93492	10.1371/journal.pone.0093492	http://dx.doi.org/10.1371/journal.pone.0093492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695643	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000081
J	Luz, PM; Grinsztejn, B; Velasque, L; Pacheco, AG; Veloso, VG; Moore, RD; Struchiner, CJ				Luz, Paula M.; Grinsztejn, Beatriz; Velasque, Luciane; Pacheco, Antonio G.; Veloso, Valdilea G.; Moore, Richard D.; Struchiner, Claudio J.			Long-Term CD4+Cell Count in Response to Combination Antiretroviral Therapy	PLOS ONE			English	Article							T-CELL COUNTS; CLINICAL-RESPONSES; INFECTED PATIENTS; CD4 COUNT; RECOVERY; AGE; IMPACT; AIDS; INDIVIDUALS; MORTALITY	Objective: There is a continuous debate on how to adequately evaluate long-term CD4+ cell count in response to combination antiretroviral therapy (ART) among human immunodeficiency virus (HIV)-infected individuals. Our study evaluated the long-term CD4+ cell count response (up to ten years) after initiation of ART and described the differences in the CD4+ cell count response stratified by pretreatment CD4+ cell count, and other socio-demographic, behavioral, and clinical factors. Methods: The study population included patients starting ART in the clinical cohorts of Rio de Janeiro, Brazil, and Baltimore, United States. Inverse probability of censoring weighting was used to estimate mean annual CD4+ cell counts while adjusting for choice of initial ART regimen, ART discontinuation and losses-to-follow-up. Results: From 1997 to 2011, 3116 individuals started ART; preferred initial regimen was NNRTI-based (63%). The median follow-up time was 5 years, 10% of the individuals had nine or more years of follow-up. Observed CD4+ cell counts increased throughout the ten years of follow-up. Weighted results, in contrast, increased up to year four and plateaued thereafter with 50% of the population reaching CD4+ cell counts of 449/mu L or more. Out of all stratification variables considered, only individuals with pre-treatment CD4+ cell counts >= 350/mu L showed increasing CD4+ cell counts over time with 76% surpassing the CD4+ cell count >500/mu L threshold at year ten. Conclusion: The present study corroborates the growing body of knowledge advocating early start of ART by showing that only patients who start ART early fully recover to normal CD4+ cell counts.	[Luz, Paula M.; Grinsztejn, Beatriz; Velasque, Luciane; Veloso, Valdilea G.] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Velasque, Luciane] Univ Fed Estado Rio de Janeiro, Dept Matemat & Estat, Rio De Janeiro, Brazil; [Moore, Richard D.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Pacheco, Antonio G.; Struchiner, Claudio J.] Fundacao Oswaldo Cruz, Programa Computacao Cient, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Estado do Rio de Janeiro; Johns Hopkins University; Fundacao Oswaldo Cruz	Luz, PM (corresponding author), Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil.	paula.luz@ipec.fiocruz.br	Struchiner, Claudio Jose/HGB-9492-2022; Struchiner, Claudio J/M-9360-2013; Pacheco, Antonio Guilherme/E-6378-2013	Struchiner, Claudio J/0000-0003-2114-847X; Pacheco, Antonio Guilherme/0000-0003-3095-1774; Luz, Paula/0000-0001-9746-719X	National Council of Technological and Scientific Development (CNPq); Research Funding Agency of the State of Rio de Janeiro (FAPERJ); NIH [R01 DA116092, P30 AI094189]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA036935, R01DA011602] Funding Source: NIH RePORTER	National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Funding Agency of the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	PML, BG, AGP, and CJS acknowledge funding from the National Council of Technological and Scientific Development (CNPq) and the Research Funding Agency of the State of Rio de Janeiro (FAPERJ). RDM acknowledges funding from NIH R01 DA116092, P30 AI094189. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achhra AC, 2011, CURR OPIN HIV AIDS, V6, P258, DOI 10.1097/COH.0b013e3283476c72; Baker JV, 2008, JAIDS-J ACQ IMM DEF, V48, P541, DOI 10.1097/QAI.0b013e31817bebb3; Bastard M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-27; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Cuzin L, 2007, CLIN INFECT DIS, V45, P654, DOI 10.1086/520652; Gandhi RT, 2007, CLIN INFECT DIS, V44, P438, DOI 10.1086/510682; Grabar S, 2004, AIDS, V18, P2029, DOI 10.1097/00002030-200410210-00007; Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b; Haynes L, 2009, CURR OPIN IMMUNOL, V21, P414, DOI 10.1016/j.coi.2009.05.009; Hsieh MM, 2007, ANN INTERN MED, V146, P486, DOI 10.7326/0003-4819-146-7-200704030-00004; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Kolber MA, 2007, HIV MED, V8, P401, DOI 10.1111/j.1468-1293.2007.00479.x; Le Moing V, 2007, HIV MED, V8, P156, DOI 10.1111/j.1468-1293.2007.00446.x; Lok JJ, 2010, AIDS, V24, P1867, DOI 10.1097/QAD.0b013e32833adbcf; Malta M, 2008, ADDICTION, V103, P1242, DOI 10.1111/j.1360-0443.2008.02269.x; Maman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031078; Maskew M, 2013, J WOMENS HEALTH, V22, P113, DOI 10.1089/jwh.2012.3585; McGovern BH, 2007, CLIN INFECT DIS, V44, P431, DOI 10.1086/509580; Ministerio da Saude, 2014, GUID ANT TREATM; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Monforte AD, 2005, ARCH INTERN MED, V165, P416; Moore RD, 1998, J ACQ IMMUN DEF SYND, V17, pS38, DOI 10.1097/00042560-199801001-00011; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Moreira RI, 2011, JAIDS-J ACQ IMM DEF, V57, pS171, DOI 10.1097/QAI.0b013e31821e9d59; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; NIH, 2014, CLIN GUID PORT; O'Connor JL, 2013, J INFECT DIS, V208, P40, DOI 10.1093/infdis/jis731; Potter M, 2010, AIDS, V24, P1857, DOI 10.1097/QAD.0b013e32833adbb5; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Tumbarello M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-46; Tumbarello M, 2003, AIDS, V17, P128, DOI 10.1097/00002030-200301030-00020; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; Zucchetto A, 2010, CLIN INFECT DIS, V51, P1099, DOI 10.1086/656629	33	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93039	10.1371/journal.pone.0093039	http://dx.doi.org/10.1371/journal.pone.0093039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695533	gold, Green Published, Green Submitted			2022-12-27	WOS:000334103000036
J	Riquelme, C; Acuna, MJ; Torrejon, J; Rebolledo, D; Cabrera, D; Santos, RA; Brandan, E				Riquelme, Cecilia; Jose Acuna, Maria; Torrejon, Javiera; Rebolledo, Daniela; Cabrera, Daniel; Santos, Robson A.; Brandan, Enrique			ACE2 Is Augmented in Dystrophic Skeletal Muscle and Plays a Role in Decreasing Associated Fibrosis	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; DUCHENNE MUSCULAR-DYSTROPHY; MOLECULAR-MECHANISMS; ANGIOTENSIN-(1-7); OVEREXPRESSION; REGENERATION; ANGIOTENSIN-CONVERTING-ENZYME-2; FIBROBLASTS; DECORIN; PATHWAY	Duchenne muscular dystrophy (DMD) is the most common inherited neuromuscular disease and is characterized by absence of the cytoskeletal protein dystrophin, muscle wasting, and fibrosis. We previously demonstrated that systemic infusion or oral administration of angiotensin-(1-7) (Ang-(1-7)), a peptide with opposing effects to angiotensin II, normalized skeletal muscle architecture, decreased local fibrosis, and improved muscle function in mdx mice, a dystrophic model for DMD. In this study, we investigated the presence, activity, and localization of ACE2, the enzyme responsible for Ang-(1-7) production, in wild type (wt) and mdx skeletal muscle and in a model of induced chronic damage in wt mice. All dystrophic muscles studied showed higher ACE2 activity than wt muscle. Immunolocalization studies indicated that ACE2 was localized mainly at the sarcolemma and, to a lesser extent, associated with interstitial cells. Similar results were observed in the model of chronic damage in the tibialis anterior (TA) muscle. Furthermore, we evaluated the effect of ACE2 overexpression in mdx TA muscle using an adenovirus containing human ACE2 sequence and showed that expression of ACE2 reduced the fibrosis associated with TA dystrophic muscles. Moreover, we observed fewer inflammatory cells infiltrating the mdx muscle. Finally, mdx gastrocnemius muscles from mice infused with Ang-(1-7), which decreases fibrosis, contain less ACE2 associated with the muscle. This is the first evidence supporting ACE2 as an important therapeutic target to improve the dystrophic skeletal muscle phenotype.	[Riquelme, Cecilia; Jose Acuna, Maria; Torrejon, Javiera; Rebolledo, Daniela; Cabrera, Daniel; Brandan, Enrique] Catholic Univ Chile, Fac Biol Sci, CARE Chile UC, Ctr Aging & Regenerat, Santiago, Chile; [Riquelme, Cecilia; Jose Acuna, Maria; Torrejon, Javiera; Rebolledo, Daniela; Cabrera, Daniel; Brandan, Enrique] Catholic Univ Chile, Fac Biol Sci, Dept Cell & Mol Biol, Santiago, Chile; [Santos, Robson A.] Univ Fed Minas Gerais, INCT Nanobio Far, Inst Biol Sci, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidade Federal de Minas Gerais	Brandan, E (corresponding author), Catholic Univ Chile, Fac Biol Sci, CARE Chile UC, Ctr Aging & Regenerat, Santiago, Chile.	ebrandan@bio.puc.cl	Acuna, Maria Jose/V-5926-2019; CABRERA, DANIEL/AAR-5027-2020; Rebolledo, Daniela/GXG-6724-2022; Santos, Robson A S/C-9336-2011; Brandan, Enrique/A-7063-2017	Acuna, Maria Jose/0000-0002-7117-3844; CABRERA, DANIEL/0000-0001-9634-725X; Rebolledo, Daniela/0000-0002-6240-6669; Santos, Robson A S/0000-0001-8738-5852; Brandan, Enrique/0000-0002-6820-5059	FONDECYT [1110426]; CARE [PFB12/2007]; Fundacion Chilena para Biologia Celular	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CARE; Fundacion Chilena para Biologia Celular	This study was supported by research grants from FONDECYT 1110426, CARE PFB12/2007 and Fundacion Chilena para Biologia Celular. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna MJ, 2013, HUM MOL GENET; Alvarez K, 2002, J CELL BIOCHEM, V85, P703, DOI 10.1002/jcb.10184; Bader M, 2012, J RENIN-ANGIO-ALDO S, V13, P505, DOI 10.1177/1470320312466519; Bedair HS, 2008, AM J SPORT MED, V36, P1548, DOI 10.1177/0363546508315470; BENTER IF, 1995, AM J PHYSIOL-HEART C, V269, pH313, DOI 10.1152/ajpheart.1995.269.1.H313; BRANDAN E, 1992, J NEUROSCI RES, V32, P51, DOI 10.1002/jnr.490320107; Brandan E, 2013, FEBS J; Burks TN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002227; Cabello-Verrugio C, 2011, J CELL MOL MED; Caceres S, 2000, EUR J CELL BIOL, V79, P173, DOI 10.1078/S0171-9335(04)70020-5; Casar JC, 2004, J CELL SCI, V117, P73, DOI 10.1242/jcs.00828; De la Porte S, 1999, INT REV CYTOL, V191, P99, DOI 10.1016/S0074-7696(08)60158-8; Desguerre I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004347; Dias-Peixoto MF, 2008, HYPERTENSION, V52, P542, DOI 10.1161/HYPERTENSIONAHA.108.114280; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Echeverria-Rodriguez O, 2014, PEPTIDES, V51, P26, DOI 10.1016/j.peptides.2013.10.022; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Epelman S, 2009, J CARD FAIL, V15, P565, DOI 10.1016/j.cardfail.2009.01.014; Fadic R, 2005, BIOL RES, V38, P375, DOI 10.4067/S0716-97602005000400010; Fadic R, 2006, J CELL MOL MED, V10, P758, DOI 10.1111/j.1582-4934.2006.tb00435.x; Fernandes T, 2010, BRAZ J MED BIOL RES, V43, P837, DOI 10.1590/S0100-879X2010000900005; Ferrario CM, 2011, CURR OPIN NEPHROL HY, V20, P1, DOI 10.1097/MNH.0b013e3283406f57; Ferrario CM, 2005, AM J PHYSIOL-HEART C, V289, pH2281, DOI 10.1152/ajpheart.00618.2005; Ferreira AJ, 2001, HYPERTENSION, V38, P665, DOI 10.1161/01.HYP.38.3.665; Fraga-Silva RA, 2012, THROMB HAEMOSTASIS, V108, P1089, DOI 10.1160/TH12-06-0396; Morales MG, 2011, J PATHOL, V225, P490, DOI 10.1002/path.2952; Grobe JL, 2007, CLIN SCI, V113, P357, DOI 10.1042/CS20070160; Grobe JL, 2007, AM J PHYSIOL-HEART C, V292, pH736, DOI 10.1152/ajpheart.00937.2006; Guo LT, 2005, NEUROMUSCULAR DISORD, V15, P786, DOI 10.1016/j.nmd.2005.06.019; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Iwata M, 2005, AM J PHYSIOL-HEART C, V289, pH2356, DOI 10.1152/ajpheart.00317.2005; Jin HY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042432, 10.1371/journal.pone.0038502]; Jorgensen LH, 2007, AM J PATHOL, V171, P1599, DOI 10.2353/ajpath.2007.070435; MacDonald EM, 2012, CURR OPIN RHEUMATOL, V24, P628, DOI 10.1097/BOR.0b013e328358df34; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Marangoni RA, 2006, PEPTIDES, V27, P1770, DOI 10.1016/j.peptides.2006.02.002; Mercure C, 2008, CIRC RES, V103, P1319, DOI 10.1161/CIRCRESAHA.108.184911; Morales MG, 2013, HUM MOL GENET UNPUB; Murca TM, 2012, REGUL PEPTIDES, V177, P107, DOI 10.1016/j.regpep.2012.05.093; Paulis L, 2012, NAT REV CARDIOL, V9, P276, DOI 10.1038/nrcardio.2012.33; Pessina P, 2014, SKELETAL MU IN PRESS; Porter JD, 2004, HUM MOL GENET, V13, P257, DOI 10.1093/hmg/ddh033; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2008, EXP PHYSIOL, V93, P519, DOI 10.1113/expphysiol.2008.042002; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Simoes ESAC, 2013, BR J PHARM; Steckelings UM, 2012, CURR OPIN NEPHROL HY, V21, P142, DOI 10.1097/MNH.0b013e328350261b; Tallant EA, 2005, AM J PHYSIOL-HEART C, V289, pH1560, DOI 10.1152/ajpheart.00941.2004; Varga G, 2005, FIBROSIS RES METHODS, P117; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Watchko JF, 2002, J APPL PHYSIOL, V93, P407, DOI 10.1152/japplphysiol.01242.2001; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xia HJ, 2013, CIRC RES, V113, P1087, DOI 10.1161/CIRCRESAHA.113.301811; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zhou L, 2010, J NEUROPATH EXP NEUR, V69, P771, DOI 10.1097/NEN.0b013e3181e9a34b	56	49	49	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93449	10.1371/journal.pone.0093449	http://dx.doi.org/10.1371/journal.pone.0093449			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695436	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000074
J	Senel, M; Tumani, H; Lauda, F; Presslauer, S; Mojib-Yezdani, R; Otto, M; Brettschneider, J				Senel, Makbule; Tumani, Hayrettin; Lauda, Florian; Presslauer, Stefan; Mojib-Yezdani, Rehaneh; Otto, Markus; Brettschneider, Johannes			Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; OLIGOCLONAL BANDS; PREDICT CONVERSION; LAMBDA; DISEASES; SERUM; NEUROBORRELIOSIS; BIOMARKERS; DIAGNOSIS; CRITERIA	Background: Oligoclonal bands (OCB) are the most widely used CSF test to support the diagnosis of MS and to predict conversion of clinically isolated syndrome (CIS) to multiple sclerosis (MS). Since OCB tests are based on non-quantitative and difficult to standardise techniques, measurement of immunoglobulin kappa free light chains (KFLC) may represent an easier to use quantitative test. Methods: KFLC were measured in CSF and serum of 211 patients using ELISA. These include patients without any inflammatory central nervous system reaction (NIND, n = 77), MS (n = 20), viral CNS infections (V- CNS-I, n = 10), neuroborreliosis (NB, n = 17) and other bacterial CNS infections (B-CNS-I, n = 10). Furthermore a cohort of 77 patients with CIS, including 39 patients that remained CIS over follow- up of two years (CIS-CIS) and 38 patients that developed MS over the same follow-up time (CIS-MS). Results: CSF-serum ratio of KFLC (Q KFLC) was elevated in all patients with MS, 86.8% of patients with CIS-MS and 61.5% of patients with CIS-CIS. It was significantly elevated in CIS with presence of OCB (p<0.001). Q KFLC significantly correlated with other CSF variables such as CSF leukocyte count (p<0.001, R = 0.46), CSF CXCL13 levels (p<0.001, R = 0.64) and also intrathecal IgG synthesis (p<0.001, R = 0.74) as determined by nephelometry and quotient diagram. OCB were detected in 66.7% of CIS-CIS and in 92.1% of CIS-MS. Conclusions: Although the measurement of CSF KFLC is a rapid and quantitative easy to standardize tool, it is almost equal but not superior to OCB with regard to diagnostic sensitivity and specificity in patients with early MS.	[Senel, Makbule; Tumani, Hayrettin; Lauda, Florian; Mojib-Yezdani, Rehaneh; Otto, Markus; Brettschneider, Johannes] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany; [Presslauer, Stefan] Wilhelminenspital Stadt Wien, Dept Neurol, Vienna, Austria	Ulm University; Wilhelminenspital	Tumani, H (corresponding author), Univ Ulm, Dept Neurol, D-89069 Ulm, Germany.	hayrettin.tumani@uni-ulm.de	Senel, Makbule/AAU-8687-2020; Senel, Makbule/AAQ-4635-2021; Otto, Markus/F-4304-2015	Senel, Makbule/0000-0002-2737-7495; Otto, Markus/0000-0003-4273-4267	University of Ulm; BMBF	University of Ulm; BMBF(Federal Ministry of Education & Research (BMBF))	The study was funded by the University of Ulm, and this work was in part supported by the BMBF grant (competence net multiple sclerosis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 1998, CLIN EXP IMMUNOL, V111, P457; Abraham RS, 2002, CLIN CHEM, V48, P1805; ANDERSSON M, 1994, J NEUROL NEUROSUR PS, V57, P897, DOI 10.1136/jnnp.57.8.897; Andlovic A, 2012, CLIN NEUROL NEUROSUR, V114, P659, DOI 10.1016/j.clineuro.2011.12.051; Arneth B, 2009, ACTA NEUROL SCAND, V119, P39, DOI 10.1111/j.1600-0404.2008.01058.x; Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; Bosca I, 2010, J NEUROIMMUNOL, V226, P143, DOI 10.1016/j.jneuroim.2010.05.032; Bradwell AR, 2001, CLIN CHEM, V47, P673; Brettschneider J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011986; Brettschneider J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007638; Comabella M, 2010, BRAIN, V133, P1082, DOI 10.1093/brain/awq035; DECARLI C, 1987, NEUROLOGY, V37, P1334, DOI 10.1212/WNL.37.8.1334; Desplat-Jego S, 2005, J CLIN IMMUNOL, V25, P338, DOI 10.1007/s10875-005-5371-9; FAGNART OC, 1988, J NEUROIMMUNOL, V19, P119, DOI 10.1016/0165-5728(88)90041-0; FELGENHAUER K, 1976, J NEUROL SCI, V30, P113, DOI 10.1016/0022-510X(76)90259-8; Fischer C, 2004, CLIN CHEM, V50, P1809, DOI 10.1373/clinchem.2004.033977; Franciotta D, 2007, CLIN CHEM, V53, P1557, DOI 10.1373/clinchem.2007.089052; Giovannoni G, 2006, DIS MARKERS, V22, P187, DOI 10.1155/2006/509476; Goodin DS, 2009, MULT SCLER, V15, P1175, DOI 10.1177/1352458509107007; Gout O, 2011, MULT SCLER, V17, P164, DOI 10.1177/1352458510385506; HOPPER JE, 1986, CELL IMMUNOL, V101, P122, DOI 10.1016/0008-8749(86)90191-7; Kaiser R, 1998, J NEUROL, V245, P247, DOI 10.1007/s004150050214; Kaplan B, 2011, THESCIENTIFICWORLDJO, V11, P726, DOI 10.1100/tsw.2011.65; Kaplan B, 2010, J NEUROIMMUNOL, V229, P263, DOI 10.1016/j.jneuroim.2010.09.002; KEIR G, 1990, ANN CLIN BIOCHEM, V27, P436, DOI 10.1177/000456329002700504; Krakauer M, 1998, ACTA NEUROL SCAND, V98, P161, DOI 10.1111/j.1600-0404.1998.tb07287.x; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LAMERS KJB, 1995, J NEUROIMMUNOL, V62, P19, DOI 10.1016/0165-5728(95)00086-H; Link H, 2006, J NEUROIMMUNOL, V180, P17, DOI 10.1016/j.jneuroim.2006.07.006; Meinl E, 2006, ANN NEUROL, V59, P880, DOI 10.1002/ana.20890; Meinl E, 2011, J NEUROL SCI, V306, P180, DOI 10.1016/j.jns.2010.08.009; Miller DH, 2012, LANCET NEUROL, V11, P157, DOI 10.1016/S1474-4422(11)70274-5; NEWCOMBE RG, 1992, BRIT MED J, V304, P381, DOI 10.1136/bmj.304.6823.381-c; Petzold A, 2013, J NEUROIMMUNOL, V262, P1, DOI 10.1016/j.jneuroim.2013.06.014; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Presslauer S, 2008, J NEUROL, V255, P1508, DOI 10.1007/s00415-008-0954-z; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Reiber H, 2001, CLIN CHEM LAB MED, V39, P324, DOI 10.1515/CCLM.2001.051; RUDICK RA, 1989, NEUROLOGY, V39, P964, DOI 10.1212/WNL.39.7.964; Sellner J, 2010, J NEUROL, V257, P1602, DOI 10.1007/s00415-010-5601-9; Senel M, 2010, J NEUROL NEUROSUR PS, V81, P929, DOI 10.1136/jnnp.2009.195438; Stangel M, 2013, NAT REV NEUROL, V9, P267, DOI 10.1038/nrneurol.2013.41; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Thrower BW, 2007, NEUROLOGY, V68, pS12, DOI 10.1212/01.wnl.0000277704.56189.85; Tintore M, 2008, NEUROLOGY, V70, P1079, DOI 10.1212/01.wnl.0000280576.73609.c6; Tumani H, 2011, ANN NEUROL, V70, P520, DOI 10.1002/ana.22508; Tumani H, 2009, NEUROBIOL DIS, V35, P117, DOI 10.1016/j.nbd.2009.04.010; van der Heijden M, 2006, EUR J PHARMACOL, V533, P319, DOI 10.1016/j.ejphar.2005.12.065	48	54	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e88680	10.1371/journal.pone.0088680	http://dx.doi.org/10.1371/journal.pone.0088680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695382	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000002
J	Williams, SM; Farmer, VL; Taylor, BJ; Taylor, RW				Williams, Sheila M.; Farmer, Victoria L.; Taylor, Barry J.; Taylor, Rachael W.			Do More Active Children Sleep More? A Repeated Cross-Sectional Analysis Using Accelerometry	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; DURATION; ACTIGRAPHY; ASSOCIATIONS; CHILDHOOD; OBESITY; HOME	Aim: To determine whether levels of daytime physical activity are associated with sleep duration and night waking in children assessed using accelerometry, and if these associations change over time. Methods: 24-hour accelerometry data were obtained from 234 children at 3, 5 and 7 years of age for at least 5 days at each time. Sleep duration was estimated using the Sadeh algorithm. Time spent in sedentary, light and moderate-vigorous (MVPA) activity was established using published cut-points. Appropriate statistical techniques were utilised to account for the closed nature of the data ( 24-hour periods). Results: Time spent asleep was related more to sedentary or light activity and not to MVPA. The most active (95th percentile) children spent 55-84 fewer minutes asleep and 16-19 more minutes awake at night compared to the least active (5th percentile) children. Children with later bedtimes slept less at night (30-40 minutes) and undertook more sedentary (10-15 minutes) but also more light (18-23 minutes) activity during the day. However, no differences in MVPA were apparent according to bedtime. Children slept slightly less on weekend nights ( 11 minutes) compared with week-nights, but only at 3 years of age. Most relationships were broadly similar at 3, 5 and 7 years of age. Conclusion: Children who are more physically active during the day have shorter total sleep time and are more awake at night than less active children. The protective effect of sleep on obesity does not appear to be mediated by increased physical activity.	[Williams, Sheila M.] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; [Farmer, Victoria L.; Taylor, Rachael W.] Univ Otago, Dept Med, Dunedin, New Zealand; [Taylor, Barry J.] Univ Otago, Dept Womens & Childrens Hlth, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Taylor, RW (corresponding author), Univ Otago, Dept Med, Dunedin, New Zealand.	rachael.taylor@otago.ac.nz	Taylor, Barry j/G-1410-2010; Williams, Sheila/L-4028-2019	Taylor, Barry/0000-0002-6450-8677	University of Otago; Child Health Research Foundation; Dean's Bequest - AAW Jones Trust	University of Otago; Child Health Research Foundation; Dean's Bequest - AAW Jones Trust	Funding was obtained from the University of Otago, the Child Health Research Foundation, and the Dean's Bequest - AAW Jones Trust. The funders had no role in study design; or in the collection, analysis, and interpretation of data; or in the writing of the report or the decision to submit the article for publication.	Aitchison J, 2002, J R STAT SOC C-APPL, V51, P375, DOI 10.1111/1467-9876.00275; Buis M., FMLOGIT MODULE FITTI; Carter PJ, 2011, BMJ-BRIT MED J, V342, pd2717, DOI DOI 10.1136/bmj.d2717; Chen XL, 2008, OBESITY, V16, P265, DOI 10.1038/oby.2007.63; Cliff DP, 2009, J SCI MED SPORT, V12, P557, DOI 10.1016/j.jsams.2008.10.008; Colley RC, 2012, HEALTH REP, V23, P45; Crawford D, 2010, INT J OBESITY, V34, P1177, DOI 10.1038/ijo.2010.57; Dwyer GM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-86; Ekstedt M, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-82; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Foti KE, 2011, AM J PREV MED, V41, P596, DOI 10.1016/j.amepre.2011.08.009; Garaulet M, 2011, INT J OBESITY, V35, P1308, DOI 10.1038/ijo.2011.149; Hense S, 2011, SLEEP, V34, P633, DOI 10.1093/sleep/34.5.633; Klingenberg L, 2012, OBES REV, V13, P565, DOI 10.1111/j.1467-789X.2012.00991.x; Kuczmarski Robert J, 2002, Vital Health Stat 11, P1; Meltzer LJ, 2011, SLEEP MED, V12, P793, DOI 10.1016/j.sleep.2011.03.011; Morgenthaler T, 2007, SLEEP, V30, P519, DOI 10.1093/sleep/30.4.519; Nixon GM, 2008, SLEEP, V31, P71, DOI 10.1093/sleep/31.1.71; Olds T, 2012, HEALTH EDUC BEHAV, V39, P732, DOI 10.1177/1090198111429822; Olds TS, 2011, SLEEP, V34, P1299, DOI 10.5665/SLEEP.1266; Oliver M, 2007, SPORTS MED, V37, P1045, DOI 10.2165/00007256-200737120-00004; Ortega FB, 2011, EUR J APPL PHYSIOL, V111, P2615, DOI 10.1007/s00421-011-1883-6; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; Pesonen AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022958; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Spruyt K, 2011, J SLEEP RES, V20, P223, DOI 10.1111/j.1365-2869.2010.00857.x; Yu Mong-Lin, 2011, Health Promot J Austr, V22, P203	27	57	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93117	10.1371/journal.pone.0093117	http://dx.doi.org/10.1371/journal.pone.0093117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695112	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000042
J	Zhou, Y; Liu, P; Liu, BJ; Liu, XJ; Zhang, XM; Wang, F; Yang, HS				Zhou, Yi; Liu, Peng; Liu, Bingjian; Liu, Xujia; Zhang, Xiaomei; Wang, Feng; Yang, Hongsheng			Restoring Eelgrass (Zostera marina L.) Habitats Using a Simple and Effective Transplanting Technique	PLOS ONE			English	Article							CHESAPEAKE BAY; SEAGRASS ECOSYSTEMS; NATURAL-WATERS; RESTORATION; TEMPERATURE; PHOSPHORUS; AUSTRALIA; SEDIMENTS; MARYLAND; SULFIDE	Eelgrass beds in coastal waters of China have declined substantially over the past 30 years. In this study, a simple new transplanting technique was developed for eelgrass ( Zostera marina L.) restoration. To assist in anchoring single shoots, several rhizomes of rooted shoots were bound to a small elongate stone ( 50-150 g) with biodegradable thread ( cotton or hemp), and then the bound packet was buried at an angle in the sediments at a depth of 2-4 cm. This stone anchoring method was used to transplant eelgrass in early November 2009 and late May 2010 in Huiquan Bay, Qingdao. The method led to high success. Three month survivorship of the transplanted shoots at the two transplant sites was >95%. From April 20 to November 19, 2012, the following characteristics of the 2009 and 2010 transplanted eelgrass beds were monitored: morphological changes, shoot density, shoot height, leaf biomass, and sediment particle size. Results showed that the sexual reproduction period of the planted eelgrass was from April to August, and vegetative reproduction reached its peak in autumn. Maximum shoot height and biomass were observed in June and July. After becoming established, the transplanted eelgrass beds were statistically equal to natural eelgrass beds nearby in terms of shoot height, biomass, and seasonal variations. This indicates that the transplant technique is effective for eelgrass restoration in coastal waters.	[Zhou, Yi; Liu, Peng; Liu, Bingjian; Liu, Xujia; Zhang, Xiaomei; Wang, Feng; Yang, Hongsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Liu, Peng; Liu, Bingjian; Zhang, Xiaomei; Wang, Feng] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Xujia] Guangxi Inst Oceanol, Key Lab Marine Biol Technol, Beihai, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, Y (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	yizhou@qdio.ac.cn	Liu, Peng/AAC-4167-2021; Zhou, Yi/F-4219-2011	Liu, Peng/0000-0002-3347-649X; Zhou, Yi/0000-0001-7300-0173	National Natural Science Foundation of China [41121064/41176140]; National Marine Public Welfare Research Project [201305043/201005009]; Key Projects in the National Science & Technology Pillar Program [2011BAD13B06]; Science & Technology Development Project of Qingdao City South District [2009517HY]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Marine Public Welfare Research Project; Key Projects in the National Science & Technology Pillar Program; Science & Technology Development Project of Qingdao City South District	This research was supported by the National Natural Science Foundation of China (No. 41121064/41176140), the National Marine Public Welfare Research Project (201305043/201005009), the Key Projects in the National Science & Technology Pillar Program during the 12th Five-year Plan Period (2011BAD13B06), and the Science & Technology Development Project of Qingdao City South District (2009517HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SEAGRASSES BIOL ECOL, DOI DOI 10.1007/978-1-4020-2983-7; Balestri E, 2012, J APPL ECOL, V49, P1426, DOI 10.1111/j.1365-2664.2012.02197.x; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bastyan GR, 2008, ESTUAR COAST SHELF S, V79, P289, DOI 10.1016/j.ecss.2008.04.012; Bell SS, 2008, RESTOR ECOL, V16, P407, DOI 10.1111/j.1526-100X.2007.00308.x; Bos AR, 2007, ESTUAR COAST SHELF S, V74, P344, DOI 10.1016/j.ecss.2007.04.006; Bouma TJ, 2005, ECOLOGY, V86, P2187, DOI 10.1890/04-1588; Bradley MP, 2006, AQUAT BOT, V84, P121, DOI 10.1016/j.aquabot.2005.08.003; Busch KE, 2010, RESTOR ECOL, V18, P490, DOI 10.1111/j.1526-100X.2010.00690.x; Calleja ML, 2007, ESTUAR COAST SHELF S, V73, P583, DOI 10.1016/j.ecss.2007.02.016; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cunha AH, 2012, RESTOR ECOL, V20, P427, DOI 10.1111/j.1526-100X.2012.00878.x; Davis RC, 1997, AQUAT BOT, V59, P1, DOI 10.1016/S0304-3770(97)00034-X; Duarte Carlos M., 2008, P281, DOI 10.1017/CBO9780511751790.025; Fishman JR, 2004, RESTOR ECOL, V12, P214, DOI 10.1111/j.1061-2971.2004.00314.x; Fishman JR, 1996, J EXP MAR BIOL ECOL, V198, P11, DOI 10.1016/0022-0981(95)00176-X; FONSECA M. S., 1994, RESTOR ECOL, V2, P198, DOI DOI 10.1111/J.1526-100X.1994.TB00067.X; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Golden RR, 2010, RESTOR ECOL, V18, P501, DOI 10.1111/j.1526-100X.2010.00691.x; Greiner JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072469; Harwell MC, 1999, AQUAT BOT, V64, P51, DOI 10.1016/S0304-3770(99)00008-X; Heck KL, 2006, J EXP MAR BIOL ECOL, V330, P420, DOI 10.1016/j.jembe.2005.12.044; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Koch MS, 2007, J EXP MAR BIOL ECOL, V341, P91, DOI 10.1016/j.jembe.2006.10.004; Lavery PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073748; Lee KS, 2008, MAR POLLUT BULL, V56, P1015, DOI 10.1016/j.marpolbul.2008.02.010; Lee KS, 2007, J EXP MAR BIOL ECOL, V350, P144, DOI 10.1016/j.jembe.2007.06.016; Liu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058293; Orth RJ, 2000, MAR ECOL PROG SER, V200, P277, DOI 10.3354/meps200277; Orth RJ, 1999, AQUAT BOT, V64, P77, DOI 10.1016/S0304-3770(99)00007-8; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Orth RJ, 2009, AQUAT BOT, V90, P204, DOI 10.1016/j.aquabot.2008.07.004; Paling EI, 2001, ECOL ENG, V16, P331, DOI 10.1016/S0925-8574(00)00119-1; Park JI, 2010, ECOL ENG, V36, P450, DOI 10.1016/j.ecoleng.2009.11.012; Phillips R., 1990, SEAGRASS RES METHODS; PHILLIPS RC, 1974, AQUACULTURE, V4, P161, DOI 10.1016/0044-8486(74)90031-3; Shafer D, 2010, RESTOR ECOL, V18, P481, DOI 10.1111/j.1526-100X.2010.00689.x; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Short FT, 2002, MAR ECOL PROG SER, V227, P253, DOI 10.3354/meps227253; SOLORZANO L, 1980, LIMNOL OCEANOGR, V25, P754, DOI 10.4319/lo.1980.25.4.0754; van der Heide T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042060; van Katwijk MM, 2000, CHALLENGES WADDEN SE; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; WEST RJ, 1990, MAR POLLUT BULL, V21, P197, DOI 10.1016/0025-326X(90)90502-Y; Zhou Y, 2003, WATER RES, V37, P3875, DOI 10.1016/S0043-1354(03)00267-7	47	31	35	2	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92982	10.1371/journal.pone.0092982	http://dx.doi.org/10.1371/journal.pone.0092982			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695414	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000032
J	Navdaev, A; Subramanian, H; Petunin, A; Clemetson, KJ; Gambaryan, S; Walter, U				Navdaev, Alexey; Subramanian, Hariharan; Petunin, Alexey; Clemetson, Kenneth J.; Gambaryan, Stepan; Walter, Ulrich			Echicetin Coated Polystyrene Beads: A Novel Tool to Investigate GPIb-Specific Platelet Activation and Aggregation	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; GLYCOPROTEIN IB-ALPHA; DEPENDENT PROTEIN-KINASE; SIGNALING PATHWAY; THROMBUS FORMATION; INTEGRIN ALPHA(IIB)BETA(3); VONWILLEBRAND-FACTOR; HIGH-SHEAR; IGM-KAPPA; RISTOCETIN	von Willebrand factor/ristocetin (vWF/R) induces GPIb-dependent platelet agglutination and activation of alpha IIb beta 3 integrin, which also binds vWF. These conditions make it difficult to investigate GPIb-specific signaling pathways in washed platelets. Here, we investigated the specific mechanisms of GPIb signaling using echicetin-coated polystyrene beads, which specifically activate GPIb. We compared platelet activation induced by echicetin beads to vWF/R. Human platelets were stimulated with polystyrene beads coated with increasing amounts of echicetin and platelet activation by echicetin beads was then investigated to reveal GPIb specific signaling. Echicetin beads induced alpha IIb beta 3-dependent aggregation of washed platelets, while under the same conditions vWF/R treatment led only to alpha IIb beta 3-independent platelet agglutination. The average distance between the echicetin molecules on the polystyrene beads must be less than 7 nm for full platelet activation, while the total amount of echicetin used for activation is not critical. Echicetin beads induced strong phosphorylation of several proteins including p38, ERK and PKB. Synergistic signaling via P2Y(12) and thromboxane receptor through secreted ADP and TxA(2), respectively, were important for echicetin bead triggered platelet activation. Activation of PKG by the NO/sGC/cGMP pathway inhibited echicetin bead-induced platelet aggregation. Echicetin-coated beads are powerful and reliable tools to study signaling in human platelets activated solely via GPIb and GPIb-triggered pathways.	[Navdaev, Alexey; Subramanian, Hariharan; Gambaryan, Stepan] Univ Wurzburg, Inst Clin Biochem & Pathobiochem, Wurzburg, Germany; [Petunin, Alexey] Russian Acad Sci, Inst Biophys, Siberian Branch, Krasnoyarsk, Russia; [Clemetson, Kenneth J.] Univ Bern, Theodor Kocher Inst, Bern, Switzerland; [Gambaryan, Stepan] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg 196140, Russia; [Walter, Ulrich] Univ Med Ctr Mainz, CTH, Mainz, Germany	University of Wurzburg; Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Biophysics Institute, Siberian Branch, Russian Academy of Sciences; University of Bern; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; Johannes Gutenberg University of Mainz	Gambaryan, S (corresponding author), Univ Wurzburg, Inst Clin Biochem & Pathobiochem, Wurzburg, Germany.	gambaryan@klin-biochem.uni-wuerzburg.de	Walter, ulrich/W-2478-2017; Gambaryan, Stepan/I-3940-2016	Walter, ulrich/0000-0001-6784-2307; Gambaryan, Stepan/0000-0002-1470-0791	DFG [SFB688, TP A2, GA 1561/1-1]; BMBF [01EO1003]; Rudolf-Marx-stipendium; Gesellschaft fur Thrombose- und Hamostaseforschung (GTH)	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Rudolf-Marx-stipendium; Gesellschaft fur Thrombose- und Hamostaseforschung (GTH)	This study was supported by DFG (SFB688, TP A2, and grant GA 1561/1-1), BMBF (01EO1003) and Rudolf-Marx-stipendium 2014 funded by Gesellschaft fur Thrombose- und Hamostaseforschung (GTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya M, 2003, J THROMB HAEMOST, V1, P1150, DOI 10.1046/j.1538-7836.2003.00295.x; Clemetson KJ, 1996, BIOMEMBRANES MULTIVO, P231; COLLER BS, 1977, J CLIN INVEST, V60, P302, DOI 10.1172/JCI108778; Dong JF, 2001, BLOOD, V97, P162, DOI 10.1182/blood.V97.1.162; Gambaryan S, 2008, J THROMB HAEMOST, V6, P1376, DOI 10.1111/j.1538-7836.2008.03014.x; Gambaryan S, 2004, BLOOD, V103, P2593, DOI 10.1182/blood-2003-09-3349; Gambaryan S, 2010, J BIOL CHEM, V285, P18352, DOI 10.1074/jbc.M109.077602; GANGAROSA EJ, 1960, ARCH INTERN MED, V105, P83, DOI 10.1001/archinte.1960.00270130099012; Garcia A, 2005, BLOOD, V106, P3410, DOI 10.1182/blood-2005-05-1933; Goto S, 2002, CIRCULATION, V105, P2531, DOI 10.1161/01.CIR.0000016703.93845.AF; HOWARD MA, 1971, THROMB DIATH HAEMOST, V26, P362; Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x; JENKINS CSP, 1979, J LAB CLIN MED, V93, P220; Jurk K, 2003, FASEB J, V17, P1490, DOI 10.1096/fj.02-0830fje; Kasirer-Friede A, 2004, BLOOD, V103, P3403, DOI 10.1182/blood-2003-10-3664; Li ZY, 2001, J BIOL CHEM, V276, P42226, DOI 10.1074/jbc.M106129200; Li ZY, 2003, CELL, V112, P77, DOI 10.1016/S0092-8674(02)01254-0; Liu J, 2004, J THROMB HAEMOST, V2, P2213, DOI 10.1111/j.1538-7836.2004.01023.x; Liu JL, 2005, BLOOD, V106, P2750, DOI 10.1182/blood-2005-04-1667; Marshall SJ, 2002, BIOCHEM J, V361, P297, DOI 10.1042/0264-6021:3610297; Marshall SJ, 2004, BLOOD, V103, P2601, DOI 10.1182/blood-2003-09-3319; Naseem KM, 2008, J THROMB HAEMOST, V6, P1373, DOI 10.1111/j.1538-7836.2008.03035.x; Navdaev A, 2002, J BIOL CHEM, V277, P45928, DOI 10.1074/jbc.M206129200; Navdaev A, 2001, BLOOD, V97, P2333, DOI 10.1182/blood.V97.8.2333; PENG ML, 1993, BLOOD, V81, P2321; Penz SM, 2007, THROMB HAEMOSTASIS, V97, P435, DOI 10.1160/TH06-07-0415; Reininger AJ, 2008, HAEMOPHILIA, V14, P11, DOI 10.1111/j.1365-2516.2008.01848.x; Reininger AJ, 2008, THROMB RES, V122, pS9, DOI 10.1016/S0049-3848(08)70028-8; Ruggeri ZM, 2007, THROMB RES, V120, pS5, DOI 10.1016/j.thromres.2007.03.011; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; SCOTT JP, 1991, J BIOL CHEM, V266, P8149; Springer TA, 2011, J THROMB HAEMOST, V9, P130, DOI 10.1111/j.1538-7836.2011.04320.x; Wu Y, 2003, BLOOD, V101, P3469, DOI 10.1182/blood-2002-03-0806; Yin H, 2008, BLOOD, V112, P1139, DOI 10.1182/blood-2008-02-140970; Yin H, 2008, BLOOD, V111, P658, DOI 10.1182/blood-2007-04-085514; Zarpellon A, 2011, P NATL ACAD SCI USA, V108, P8628, DOI 10.1073/pnas.1017042108	36	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93569	10.1371/journal.pone.0093569	http://dx.doi.org/10.1371/journal.pone.0093569			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705415	Green Submitted, Green Published, gold			2022-12-27	WOS:000334107500042
J	Ostergren, JE; Hammer, RR; Dingel, MJ; Koenig, BA; McCormick, JB				Ostergren, Jenny E.; Hammer, Rachel R.; Dingel, Molly J.; Koenig, Barbara A.; McCormick, Jennifer B.			Challenges in Translational Research: The Views of Addiction Scientists	PLOS ONE			English	Article							PUBLIC-HEALTH GENOMICS; NICOTINE ADDICTION; SCIENCE; ERA; POPULATION; MEDICINE; GENETICS; BEDSIDE; NETWORK; VISION	Objectives: To explore scientists' perspectives on the challenges and pressures of translating research findings into clinical practice and public health policy. Methods: We conducted semi-structured interviews with a purposive sample of 20 leading scientists engaged in genetic research on addiction. We asked participants for their views on how their own research translates, how genetic research addresses addiction as a public health problem and how it may affect the public's view of addiction. Results: Most scientists described a direct translational route for their research, positing that their research will have significant societal benefits, leading to advances in treatment and novel prevention strategies. However, scientists also pointed to the inherent pressures they feel to quickly translate their research findings into actual clinical or public health use. They stressed the importance of allowing the scientific process to play out, voicing ambivalence about the recent push to speed translation. Conclusions: High expectations have been raised that biomedical science will lead to new prevention and treatment modalities, exerting pressure on scientists. Our data suggest that scientists feel caught in the push for immediate applications. This overemphasis on rapid translation can lead to technologies and applications being rushed into use without critical evaluation of ethical, policy, and social implications, and without balancing their value compared to public health policies and interventions currently in place.	[Ostergren, Jenny E.] Univ Michigan, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA; [Hammer, Rachel R.] Mayo Clin, Coll Med, Biomed Eth Res Unit, Rochester, MN USA; [Hammer, Rachel R.] Mayo Clin, Coll Med, Rochester, MN USA; [Dingel, Molly J.] Univ Minnesota, Ctr Learning Innovat, Rochester, MI USA; [Koenig, Barbara A.] Univ Calif San Francisco, Dept Social & Behav Sci, San Francisco, CA USA; [Koenig, Barbara A.] Univ Calif San Francisco, Dept Anthropol, San Francisco, CA USA; [Koenig, Barbara A.] Univ Calif San Francisco, Dept Hist, San Francisco, CA USA; [Koenig, Barbara A.] Univ Calif San Francisco, Dept Social Med, San Francisco, CA 94143 USA; [McCormick, Jennifer B.] Mayo Clin, Div Gen Internal Med, Rochester, MN 55905 USA; [McCormick, Jennifer B.] Mayo Clin, Div Hlth Care Policy Res, Rochester, MN USA; [McCormick, Jennifer B.] Mayo Clin, Biomed Eth Program, Rochester, MN USA	University of Michigan System; University of Michigan; Mayo Clinic; Mayo Clinic; University of Minnesota System; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Mayo Clinic; Mayo Clinic; Mayo Clinic	McCormick, JB (corresponding author), Mayo Clin, Div Gen Internal Med, Rochester, MN 55905 USA.	McCormick.JB@mayo.edu		Dingel, Molly/0000-0001-9265-3153	National Institute on Drug Abuse [R01 DA014577]; National Center on Research Resources [UL1 RR024150]; Mayo Clinic S.C. Johnson Genomics of Addiction Program; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P20HG007243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014577] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Center on Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Mayo Clinic S.C. Johnson Genomics of Addiction Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported by R01 DA014577 from the National Institute on Drug Abuse, UL1 RR024150 from the National Center on Research Resources, and the Mayo Clinic S.C. Johnson Genomics of Addiction Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, PASTEURS QUADRANT; Bize R, 2009, COCHRANE DB SYST REV, V2009, DOI [10.1002/14651858.CD14004705.pub14651853, DOI 10.1002/14651858.CD14004705.PUB14651853]; Burke W, 2006, GENET MED, V8, P451, DOI 10.1097/01.gim.0000228213.72256.8c; Burke W, 2010, GENET MED, V12, P785, DOI 10.1097/GIM.0b013e3182011222; Caron L, 2005, NICOTINE TOB RES, V7, P181, DOI 10.1080/14622200500055251; Clarke A. E., 2005, SITUATIONAL ANAL GRO; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Dingel MJ, 2012, PUBLIC HEALTH GENOM, V15, P46, DOI 10.1159/000328861; Dingel MJ, 2011, SOC SCI QUART, V92, P1363, DOI 10.1111/j.1540-6237.2011.00822.x; Dougherty D, 2008, JAMA-J AM MED ASSOC, V299, P2319, DOI 10.1001/jama.299.19.2319; Fang FC, 2010, INFECT IMMUN, V78, P563, DOI 10.1128/IAI.01318-09; Fischer ARH, 2011, INTERDISCIPL SCI REV, V36, P341, DOI 10.1179/030801811X13160755918688; Fullerton SM, 2012, GENET MED, V14, P424, DOI 10.1038/gim.2012.15; Gardner EL, 2011, ADV PSYCHOSOM MED, V30, P22, DOI 10.1159/000324065; Gundle KR, 2010, ADDICTION, V105, P974, DOI 10.1111/j.1360-0443.2010.02940.x; Guttmacher AE, 2003, NEW ENGL J MED, V349, P996, DOI 10.1056/NEJMe038132; Holtzman NA, 2006, COMMUNITY GENET, V9, P8, DOI 10.1159/000090688; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Kushner HI, 2010, BIOSOCIETIES, V5, P8, DOI 10.1057/biosoc.2009.6; Levin LA, 2010, JAMA-J AM MED ASSOC, V303, P1533, DOI 10.1001/jama.2010.463; Marteau T, 2004, AM J MED GENET A, V128A, P285, DOI 10.1002/ajmg.a.30102; Marteau TM, 2006, SOC SCI MED, V62, P1360, DOI 10.1016/j.socscimed.2005.08.005; Merikangas KR, 2003, SCIENCE, V302, P599, DOI 10.1126/science.1091468; National Institute on Drug Abuse, 2011, UND DRUG AB ADD; National Institutes of Health, 2012, RFA HG 12 009 CLIN S; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Rogowski WH, 2009, NAT REV GENET, V10, P489, DOI 10.1038/nrg2606; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; TEDMED, 2012, F COLL TEDMED 2012; WOLF S, 1974, NEW ENGL J MED, V290, P802, DOI 10.1056/NEJM197404042901411; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867; Zerhouni EA, 2005, NEW ENGL J MED, V353, P1621, DOI 10.1056/NEJMsb053723	33	11	11	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93482	10.1371/journal.pone.0093482	http://dx.doi.org/10.1371/journal.pone.0093482			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6MJ	24705385	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500038
J	Qi, HS; Li, SS; Zhao, SM; Huang, D; Xia, ML; Wen, JP				Qi, Haishan; Li, Shanshan; Zhao, Sumin; Huang, Di; Xia, Menglei; Wen, Jianping			Model-Driven Redox Pathway Manipulation for Improved Isobutanol Production in Bacillus subtilis Complemented with Experimental Validation and Metabolic Profiling Analysis	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; ESCHERICHIA-COLI; OVEREXPRESSION; BIOSYNTHESIS; GENES; YIELD; BUTANOL; UDHA	To rationally guide the improvement of isobutanol production, metabolic network and metabolic profiling analysis were performed to provide global and profound insights into cell metabolism of isobutanol-producing Bacillus subtilis. The metabolic flux distribution of strains with different isobutanol production capacity (BSUL03, BSUL04 and BSUL05) drops a hint of the importance of NADPH on isobutanol biosynthesis. Therefore, the redox pathways were redesigned in this study. To increase NADPH concentration, glucose-6-phosphate isomerase was inactivated (BSUL06) and glucose-6-phosphate dehydrogenase was overexpressed (BSUL07) successively. As expected, NADPH pool size in BSUL07 was 4.4-fold higher than that in parental strain BSUL05. However, cell growth, isobutanol yield and production were decreased by 46%, 22%, and 80%, respectively. Metabolic profiling analysis suggested that the severely imbalanced redox status might be the primary reason. To solve this problem, gene udhA of Escherichia coli encoding transhydrogenase was further overexpressed (BSUL08), which not only well balanced the cellular ratio of NAD(P)H/NAD(P)(+), but also increased NADH and ATP concentration. In addition, a straightforward engineering approach for improving NADPH concentrations was employed in BSUL05 by overexpressing exogenous gene pntAB and obtained BSUL09. The performance for isobutanol production by BSUL09 was poorer than BSUL08 but better than other engineered strains. Furthermore, in fed-batch fermentation the isobutanol production and yield of BSUL08 increased by 11% and 19%, up to the value of 6.12 g/L and 0.37 C-mol isobutanol/C-mol glucose (63% of the theoretical value), respectively, compared with parental strain BSUL05. These results demonstrated that model-driven complemented with metabolic profiling analysis could serve as a useful approach in the strain improvement for higher bio-productivity in further application.	[Qi, Haishan; Li, Shanshan; Zhao, Sumin; Huang, Di; Xia, Menglei; Wen, Jianping] Tianjin Univ, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China; [Qi, Haishan; Li, Shanshan; Zhao, Sumin; Huang, Di; Xia, Menglei; Wen, Jianping] Tianjin Univ, Sch Chem Engn & Technol, Dept Biochem Engn, Tianjin 300072, Peoples R China; [Wen, Jianping] Collaborat Innovat Ctr Chem Sci & Engn, Tianjin, Peoples R China	Tianjin University; Tianjin University	Wen, JP (corresponding author), Tianjin Univ, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China.	jpwen@tju.edu.cn	Wen, Jianping/A-1866-2015		National Basic Research Program of China ("973'' Program) [2013CB733600]; Key Program of National Natural Science Foundation of China [21236005]; Specialized Research Fund for the Doctoral Program of Higher Education [20110032130005]; Programme of Introducing Talents of Discipline to Universities [B06006]	National Basic Research Program of China ("973'' Program)(National Basic Research Program of China); Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Programme of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This research was financially supported by the National Basic Research Program of China ("973'' Program: 2013CB733600), the Key Program of National Natural Science Foundation of China (21236005), Specialized Research Fund for the Doctoral Program of Higher Education (20110032130005) and the Programme of Introducing Talents of Discipline to Universities (B06006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Atsumi S, 2010, APPL MICROBIOL BIOT, V85, P651, DOI 10.1007/s00253-009-2085-6; Atsumi S, 2009, APPL ENVIRON MICROB, V75, P6306, DOI 10.1128/AEM.01160-09; Baez A, 2011, APPL MICROBIOL BIOT, V90, P1681, DOI 10.1007/s00253-011-3173-y; Bartek T, 2010, BIOTECHNOL PROGR, V26, P361, DOI 10.1002/btpr.345; Bastian S, 2011, METAB ENG, V13, P345, DOI 10.1016/j.ymben.2011.02.004; Bi CH, 2009, APPL ENVIRON MICROB, V75, P5743, DOI 10.1128/AEM.01180-09; Blombach B, 2011, APPL ENVIRON MICROB, V77, P3300, DOI 10.1128/AEM.02972-10; Borden JR, 2007, APPL ENVIRON MICROB, V73, P3061, DOI 10.1128/AEM.02296-06; BOWLES LK, 1985, APPL ENVIRON MICROB, V50, P1165, DOI 10.1128/AEM.50.5.1165-1170.1985; Canonaco F, 2001, FEMS MICROBIOL LETT, V204, P247, DOI 10.1111/j.1574-6968.2001.tb10892.x; Chemler JA, 2010, METAB ENG, V12, P96, DOI 10.1016/j.ymben.2009.07.003; Chen X, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-21; Chin JW, 2009, BIOTECHNOL BIOENG, V102, P209, DOI 10.1002/bit.22060; Fuhrer T, 2009, J BACTERIOL, V191, P2112, DOI 10.1128/JB.01523-08; Ghosh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027316; Gyan S, 2006, J BACTERIOL, V188, P7062, DOI 10.1128/JB.00601-06; Higashide W, 2011, APPL ENVIRON MICROB, V77, P2727, DOI 10.1128/AEM.02454-10; Jia XQ, 2012, APPL BIOCHEM BIOTECH, V168, P1, DOI 10.1007/s12010-011-9268-1; Karabektas M, 2009, RENEW ENERG, V34, P1554, DOI 10.1016/j.renene.2008.11.003; Kim YM, 2011, BIOTECHNOL BIOENG, V108, P2941, DOI 10.1002/bit.23259; Lee HC, 2010, J BIOTECHNOL, V149, P24, DOI 10.1016/j.jbiotec.2010.06.011; Lee WH, 2007, APPL MICROBIOL BIOT, V76, P329, DOI 10.1007/s00253-007-1016-7; Lerondel G, 2006, J BACTERIOL, V188, P4727, DOI 10.1128/JB.00167-06; Li SS, 2012, BIOTECHNOL LETT, V34, P2253, DOI 10.1007/s10529-012-1041-1; Li SS, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-101; Li SS, 2011, APPL MICROBIOL BIOT, V91, P577, DOI 10.1007/s00253-011-3280-9; Lim SJ, 2002, J BIOSCI BIOENG, V93, P543, DOI 10.1016/S1389-1723(02)80235-3; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Maugeri DA, 2003, MOL BIOCHEM PARASIT, V130, P117, DOI 10.1016/S0166-6851(03)00173-7; Nielsen DR, 2009, METAB ENG, V11, P262, DOI 10.1016/j.ymben.2009.05.003; PRASAD C, 1974, J BACTERIOL, V118, P1111, DOI 10.1128/JB.118.3.1111-1122.1974; Romero S, 2007, APPL ENVIRON MICROB, V73, P5190, DOI 10.1128/AEM.00625-07; Ruhl M, 2010, BIOTECHNOL BIOENG, V105, P795, DOI 10.1002/bit.22591; Sanchez AM, 2006, BIOTECHNOL PROGR, V22, P420, DOI 10.1021/bp050375u; Sauer U, 1997, NAT BIOTECHNOL, V15, P448, DOI 10.1038/nbt0597-448; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Selvarasu S, 2012, BIOTECHNOL BIOENG, V109, P1415, DOI 10.1002/bit.24445; Shi AQ, 2013, METAB ENG, V16, P1, DOI 10.1016/j.ymben.2012.11.008; Shimizu K, 2009, BIOCHEM ENG J, V46, P235, DOI 10.1016/j.bej.2009.06.006; Siedler S, 2011, APPL MICROBIOL BIOT, V92, P929, DOI 10.1007/s00253-011-3374-4; Singh A, 2011, METAB ENG, V13, P76, DOI 10.1016/j.ymben.2010.10.006; Singh A, 2009, METAB ENG, V11, P347, DOI 10.1016/j.ymben.2009.07.002; Trinh CT, 2011, APPL ENVIRON MICROB, V77, P4894, DOI 10.1128/AEM.00382-11; Veit A, 2008, MICROB BIOTECHNOL, V1, P382, DOI 10.1111/j.1751-7915.2008.00033.x; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308; von Kamp A, 2006, BIOINFORMATICS, V22, P1930, DOI 10.1093/bioinformatics/btl267; Wang ZW, 2011, BIORESOURCE TECHNOL, V102, P3934, DOI 10.1016/j.biortech.2010.11.120; Winder CL, 2008, ANAL CHEM, V80, P2939, DOI 10.1021/ac7023409; Zhang YHP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000456	51	18	21	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93815	10.1371/journal.pone.0093815	http://dx.doi.org/10.1371/journal.pone.0093815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705866	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500069
J	Alkoby, D; Rimon, A; Burdak, M; Patino-Ruiz, M; Calinescu, O; Fendler, K; Padan, E				Alkoby, Dudu; Rimon, Abraham; Burdak, Maral; Patino-Ruiz, Miyer; Calinescu, Octavian; Fendler, Klaus; Padan, Etana			NhaA Na+/H+ Antiporter Mutants That Hardly React to the Membrane Potential	PLOS ONE			English	Article							ESCHERICHIA-COLI; STRUCTURAL INTERACTIONS; PHYSIOLOGICAL-ROLE; ION-TRANSPORT; PH REGULATION; SODIUM; PROTEIN; GENE; IV; EXCHANGERS	pH and Na+ homeostasis in all cells requires Na+/H+ antiporters. The crystal structure, obtained at pH 4, of NhaA, the main antiporter of Escherichia coli, has provided general insights into an antiporter mechanism and its unique pH regulation. Here, we describe a general method to select various NhaA mutants from a library of randomly mutagenized NhaA. The selected mutants, A167P and F267C are described in detail. Both mutants are expressed in Escherichia coli EP432 cells at 70-95% of the wild type but grow on selective medium only at neutral pH, A167P on Li+ (0.1 M) and F267C on Na+ (0.6 M). Surprising for an electrogenic secondary transporter, and opposed to wild type NhaA, the rates of A167P and F267C are almost indifferent to membrane potential. Detailed kinetic analysis reveals that in both mutants the rate limiting step of the cation exchange cycle is changed from an electrogenic to an electroneutral reaction.	[Alkoby, Dudu; Rimon, Abraham; Padan, Etana] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Burdak, Maral; Patino-Ruiz, Miyer; Calinescu, Octavian; Fendler, Klaus] Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany	Hebrew University of Jerusalem; Max Planck Society	Padan, E (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	etana@vms.huji.ac.il	Calinescu, Octavian/P-4278-2014	Calinescu, Octavian/0000-0001-8003-0442; Patino-Ruiz, Miyer Fabian/0000-0003-0607-4281; Fendler, Klaus/0000-0002-5699-7060	ISRAEL SCIENCE FOUNDATION [284/12]; Deutsche Forschungsgemeinschaft [SFB 807]	ISRAEL SCIENCE FOUNDATION(Israel Science Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	ISRAEL SCIENCE FOUNDATION (grant No. 284/12) to EP and by the Deutsche Forschungsgemeinschaft SFB 807 to KF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; DAVIS BD, 1950, J BACTERIOL, V60, P17, DOI 10.1128/JB.60.1.17-28.1950; Fliegel L, 2008, J MOL CELL CARDIOL, V44, P228, DOI 10.1016/j.yjmcc.2007.11.016; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Jardetzky O, 1996, PROG BIOPHYS MOL BIO, V65, P171, DOI 10.1016/S0079-6107(96)00010-7; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Maes M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.391128; Mager T, 2013, J BIOL CHEM, V288, P24666, DOI 10.1074/jbc.M113.484071; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Mitchell P., 1968, CHEMIOSMOTIC COUPLIN; Nozaki K, 1998, BBA-BIOMEMBRANES, V1369, P213, DOI 10.1016/S0005-2736(97)00223-X; OHYAMA T, 1994, J BACTERIOL, V176, P4311, DOI 10.1128/jb.176.14.4311-4315.1994; Olami Y, 1997, J BIOL CHEM, V272, P1761, DOI 10.1074/jbc.272.3.1761; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; PADAN E, 1989, J BIOL CHEM, V264, P20297; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; PADAN E, 1976, EUR J BIOCHEM, V63, P533, DOI 10.1111/j.1432-1033.1976.tb10257.x; Padan E, 2014, BIOCH BIOPH IN PRESS; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; PINNER E, 1993, J BIOL CHEM, V268, P1729; PINNER E, 1994, J BIOL CHEM, V269, P26274; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Radchenko MV, 2006, J BIOL CHEM, V281, P19822, DOI 10.1074/jbc.M600333200; Rimon A, 1998, J BIOL CHEM, V273, P26470, DOI 10.1074/jbc.273.41.26470; Rimon A, 2012, BIOCHEMISTRY-US, V51, P9560, DOI 10.1021/bi301030x; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Tsuboi Y, 2003, J BIOL CHEM, V278, P21467, DOI 10.1074/jbc.M301932200; Tzubery T, 2004, J BIOL CHEM, V279, P3265, DOI 10.1074/jbc.M309021200; Tzubery T, 2008, J BIOL CHEM, V283, P15975, DOI 10.1074/jbc.M800482200; Wakabayashi S, 2003, J BIOL CHEM, V278, P43580, DOI 10.1074/jbc.M306690200; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	46	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93200	10.1371/journal.pone.0093200	http://dx.doi.org/10.1371/journal.pone.0093200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699187	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000046
J	Hetz, S; Acikgoez, A; Voss, U; Nieber, K; Holland, H; Hegewald, C; Till, H; Metzger, R; Metzger, M				Hetz, Susan; Acikgoez, Ali; Voss, Ulrike; Nieber, Karen; Holland, Heidrun; Hegewald, Cindy; Till, Holger; Metzger, Roman; Metzger, Marco			In Vivo Transplantation of Neurosphere-Like Bodies Derived from the Human Postnatal and Adult Enteric Nervous System: A Pilot Study	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; NEURAL PROGENITORS; RAT; GUT; THERAPY; DIFFERENTIATE; NEUROGENESIS; BIOLOGY; PLEXUS; FETAL	Recent advances in the in vitro characterization of human adult enteric neural progenitor cells have opened new possibilities for cell-based therapies in gastrointestinal motility disorders. However, whether these cells are able to integrate within an in vivo gut environment is still unclear. In this study, we transplanted neural progenitor-containing neurosphere-like bodies (NLBs) in a mouse model of hypoganglionosis and analyzed cellular integration of NLB-derived cell types and functional improvement. NLBs were propagated from postnatal and adult human gut tissues. Cells were characterized by immunohistochemistry, quantitative PCR and subtelomere fluorescence in situ hybridization (FISH). For in vivo evaluation, the plexus of murine colon was damaged by the application of cationic surfactant benzalkonium chloride which was followed by the transplantation of NLBs in a fibrin matrix. After 4 weeks, grafted human cells were visualized by combined in situ hybridization (Alu) and immunohistochemistry (PGP9.5, GFAP, SMA). In addition, we determined nitric oxide synthase (NOS)-positive neurons and measured hypertrophic effects in the ENS and musculature. Contractility of treated guts was assessed in organ bath after electrical field stimulation. NLBs could be reproducibly generated without any signs of chromosomal alterations using subtelomere FISH. NLB-derived cells integrated within the host tissue and showed expected differentiated phenotypes i.e. enteric neurons, glia and smooth muscle-like cells following in vivo transplantation. Our data suggest biological effects of the transplanted NLB cells on tissue contractility, although robust statistical results could not be obtained due to the small sample size. Further, it is unclear, which of the NLB cell types including neural progenitors have direct restoring effects or, alternatively may act via 'bystander' mechanisms in vivo. Our findings provide further evidence that NLB transplantation can be considered as feasible tool to improve ENS function in a variety of gastrointestinal disorders.	[Hetz, Susan; Holland, Heidrun; Hegewald, Cindy; Metzger, Marco] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Hetz, Susan] Fraunhofer Inst Cell Therapy & Immunol, Clin Oriented Therapy Assessment Unit, Leipzig, Germany; [Acikgoez, Ali] St Georges Hosp Leipzig, Dept Gen & Visceral Surg, Leipzig, Germany; [Voss, Ulrike; Nieber, Karen] Univ Leipzig, Inst Pharm, D-04109 Leipzig, Germany; [Till, Holger] Med Univ Graz, Dept Pediat & Adolescent Surg, Graz, Austria; [Metzger, Roman] Salzburg Cty Hosp, Dept Pediat & Adolescent Med, Salzburg, Austria; [Metzger, Marco] Univ Hosp Wurzburg, Fraunhofer IGB Project Grp Regenerat Technol Onco, Wurzburg, Germany	Leipzig University; Fraunhofer Gesellschaft; Leipzig University; Medical University of Graz; University of Wurzburg	Metzger, M (corresponding author), Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany.	marco.metzger@igb.fraunhofer.de	Metzger, Marco/F-9706-2019		German Federal Ministry of Education and Research (BMBF) [0313909]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The work presented in this paper was funded by the German Federal Ministry of Education and Research (BMBF, PtJ-Bio, 0313909; to S. H., H. H., C. H. and M. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond S, 2007, GUT, V56, P489, DOI 10.1136/gut.2006.094565; Amiel J, 2001, J MED GENET, V38, P729, DOI 10.1136/jmg.38.11.729; Anitha M, 2008, GASTROENTEROLOGY, V134, P1424, DOI 10.1053/j.gastro.2008.02.018; Azan G, 2011, CELL TISSUE RES, V344, P217, DOI 10.1007/s00441-011-1130-9; Bondurand N, 2003, DEVELOPMENT, V130, P6387, DOI 10.1242/dev.00857; Brothman AR, 2009, CYTOGENET GENOME RES, V127, P1, DOI 10.1159/000279442; Burns AJ, 2004, NEUROGASTROENT MOTIL, V16, P3, DOI 10.1111/j.1743-3150.2004.00466.x; Cracco C, 1997, ADV EXP MED BIOL, V429, P159; De GR, 2004, NEUROGASTROENTERO S1, V16, P143; Di Nardo G, 2008, ALIMENT PHARM THER, V28, P25, DOI 10.1111/j.1365-2036.2008.03707.x; Dong YL, 2008, TRANSPL P, V40, P3646, DOI 10.1016/j.transproceed.2008.06.107; Estrada-Mondaca S, 2007, DEV DYNAM, V236, P20, DOI 10.1002/dvdy.20954; Geisbauer CL, 2012, J SURG RES, V176, P20, DOI 10.1016/j.jss.2011.05.014; Gershon MD, 2007, GUT, V56, P459, DOI 10.1136/gut.2006.107748; Hanani M, 2003, J COMP NEUROL, V462, P315, DOI 10.1002/cne.10721; Heanue TA, 2011, STEM CELLS, V29, P128, DOI 10.1002/stem.557; Hegewald C, 2011, NEUROGASTROENT MOTIL, V23, pE412, DOI 10.1111/j.1365-2982.2011.01761.x; Holland H, 2012, PATHOL RES PRACT, V208, P325, DOI 10.1016/j.prp.2012.03.010; Hotta R, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01411.x; Hotta R, 2011, CURR OPIN PHARMACOL, V11, P617, DOI 10.1016/j.coph.2011.09.004; Hotta R, 2009, SEMIN PEDIATR SURG, V18, P263, DOI 10.1053/j.sempedsurg.2009.07.008; Just L, 2003, J NEUROSCI METH, V126, P69, DOI 10.1016/S0165-0270(03)00065-7; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Kulkarni S, 2012, GUT, V61, P613, DOI 10.1136/gut.2010.235614; Lindley RM, 2008, GASTROENTEROLOGY, V135, P205, DOI 10.1053/j.gastro.2008.03.035; Liu MT, 2009, J NEUROSCI, V29, P9683, DOI 10.1523/JNEUROSCI.1145-09.2009; Liu W, 2007, NEUROGASTROENT MOTIL, V19, P1001, DOI 10.1111/j.1365-2982.2007.00981.x; Martucciello G, 2007, EUR J PEDIATR SURG, V17, P34, DOI 10.1055/s-2007-964952; Metzger M, 2010, ARCH ITAL BIOL, V148, P73; Metzger M, 2009, GASTROENTEROLOGY, V137, P2063, DOI 10.1053/j.gastro.2009.06.038; Metzger M, 2009, GASTROENTEROLOGY, V136, P2214, DOI 10.1053/j.gastro.2009.02.048; Micci MA, 2007, DEV DYNAM, V236, P33, DOI 10.1002/dvdy.20975; Pan WK, 2011, J SURG RES, V167, pE221, DOI 10.1016/j.jss.2011.01.016; Poli E, 2001, NEUROCHEM RES, V26, P1085, DOI 10.1023/A:1012313424144; Rauch U, 2006, INT J COLORECTAL DIS, V21, P554, DOI 10.1007/s00384-005-0051-z; Schafer KH, 2009, NEUROGASTROENT MOTIL, V21, P103, DOI 10.1111/j.1365-2982.2008.01257.x; Silva AT, 2008, BRAIN RES, V1218, P47, DOI 10.1016/j.brainres.2008.04.051; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Suarez-Rodriguez R, 2004, STEM CELLS, V22, P1373, DOI 10.1634/stemcells.2003-0049; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Thapar N, 2009, J PEDIATR GASTR NUTR, V48, pS92, DOI 10.1097/MPG.0b013e3181a15d62; Tsai YH, 2011, NEUROGASTROENT MOTIL, V23, P362, DOI 10.1111/j.1365-2982.2010.01656.x; Wallace AS, 2009, NEUROGASTROENT MOTIL, V21, P768, DOI 10.1111/j.1365-2982.2009.01309.x; Young HM, 2005, GASTROENTEROLOGY, V129, P2092, DOI 10.1053/j.gastro.2005.10.033; Young HM, 2003, J COMP NEUROL, V456, P1, DOI 10.1002/cne.10448	45	40	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93605	10.1371/journal.pone.0093605	http://dx.doi.org/10.1371/journal.pone.0093605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699866	gold, Green Published, Green Submitted			2022-12-27	WOS:000334105000080
J	Honkavuori, KS; Briese, T; Krauss, S; Sanchez, MD; Jain, K; Hutchison, SK; Webster, RG; Lipkin, WI				Honkavuori, Kirsi S.; Briese, Thomas; Krauss, Scott; Sanchez, Maria D.; Jain, Komal; Hutchison, Stephen K.; Webster, Robert G.; Lipkin, W. Ian			Novel Coronavirus and Astrovirus in Delaware Bay Shorebirds	PLOS ONE			English	Article							POULT ENTERITIS SYNDROME; AVIAN NEPHRITIS VIRUS; INFLUENZA-A VIRUSES; WILD AQUATIC BIRDS; MOLECULAR CHARACTERIZATION; GUINEA-FOWL; INFECTION; TURKEY	Background: Wild birds are an important but to some extent under-studied reservoir for emerging pathogens. We used unbiased sequencing methods for virus discovery in shorebird samples from the Delaware Bay, USA; an important feeding ground for thousands of migratory birds. Findings: Analysis of shorebird fecal samples indicated the presence of a novel astrovirus and coronavirus. A sanderling sample yielded sequences with distant homology to avian nephritis virus 1, an astrovirus associated with acute nephritis in poultry. A ruddy turnstone sample yielded sequences with homology to deltacoronaviruses. Conclusions: Our findings highlight shorebirds as a virus reservoir and the need to closely monitor wild bird populations for the emergence of novel virus variants.	[Honkavuori, Kirsi S.; Briese, Thomas; Sanchez, Maria D.; Jain, Komal; Lipkin, W. Ian] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA; [Krauss, Scott; Webster, Robert G.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Hutchison, Stephen K.] 454 Life Sci, Branford, CT USA	Columbia University; St Jude Children's Research Hospital	Briese, T (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA.	thomas.briese@columbia.edu	Lipkin, W. Ian/ABE-6216-2020	Lipkin, W. Ian/0000-0002-8768-9386	National Institutes of Health [AI57158, HHSN266200700005C]; National Institute of Allergy and Infectious Diseases; United States Agency for International Development's (USAID) Emerging Pandemic Threats (EPT) Program; PREDICT project [GHN-A-OO-09-00010-00]; Google.org; US Department of Defense; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Agency for International Development's (USAID) Emerging Pandemic Threats (EPT) Program(United States Agency for International Development (USAID)); PREDICT project; Google.org; US Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI57158 (Northeast Biodefense Center-Lipkin) and contract number HHSN266200700005C, the National Institute of Allergy and Infectious Diseases, the United States Agency for International Development's (USAID) Emerging Pandemic Threats (EPT) Program, PREDICT project, under terms of Cooperative Agreement Number GHN-A-OO-09-00010-00, and awards from Google.org and the US Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cheung PP, 2009, J CLIN VIROL, V46, P90, DOI 10.1016/j.jcv.2009.06.016; Chu DKW, 2011, J VIROL, V85, P12815, DOI 10.1128/JVI.05838-11; De Battisti C, 2012, ARCH VIROL, V157, P1329, DOI 10.1007/s00705-012-1311-1; Fu Y, 2009, J GEN VIROL, V90, P1104, DOI 10.1099/vir.0.008599-0; Hanson BA, 2008, J WILDLIFE DIS, V44, P351, DOI 10.7589/0090-3558-44.2.351; Imada T, 2000, J VIROL, V74, P8487, DOI 10.1128/JVI.74.18.8487-8493.2000; Jindal N, 2010, POULTRY SCI, V89, P217, DOI 10.3382/ps.2009-00424; Jindal N, 2009, POULTRY SCI, V88, P949, DOI 10.3382/ps.2008-00490; Koci MD, 2002, AVIAN PATHOL, V31, P213, DOI 10.1080/03079450220136521; Kofstad T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025964; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; Lai M.M.C., 2007, FIELDS VIROLOGY, P1305; Mendez E., 2007, FIELDS VIROLOGY, V5, P981; Muradrasoli S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013640; NICHOLAS RAJ, 1988, VET REC, V123, P398, DOI 10.1136/vr.123.15.398; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Pantin-Jackwood MJ, 2011, ARCH VIROL, V156, P235, DOI 10.1007/s00705-010-0849-z; Pantin-Jackwood MJ, 2006, AVIAN DIS, V50, P397, DOI 10.1637/7512-020606R.1; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Reed Kurt D, 2003, Clin Med Res, V1, P5; Takase K, 2000, J VET MED SCI, V62, P1327, DOI 10.1292/jvms.62.1327; Toffan A, 2012, AVIAN PATHOL, V41, P429, DOI 10.1080/03079457.2012.704980; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11; Zhao W, 2011, ARCH VIROL, V156, P1559, DOI 10.1007/s00705-011-1034-8; Zhao W, 2011, AVIAN PATHOL, V40, P361, DOI 10.1080/03079457.2011.587792	29	18	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93395	10.1371/journal.pone.0093395	http://dx.doi.org/10.1371/journal.pone.0093395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699424	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000057
J	Loiselle, S; Cozar, A; Adgo, E; Ballatore, T; Chavula, G; Descy, JP; Harper, DM; Kansiime, F; Kimirei, I; Langenberg, V; Ma, RH; Sarmento, H; Odada, E				Loiselle, Steven; Cozar, Andres; Adgo, Enyew; Ballatore, Thomas; Chavula, Geoffrey; Descy, Jean Pierre; Harper, David M.; Kansiime, Frank; Kimirei, Ismael; Langenberg, Victor; Ma, Ronghua; Sarmento, Hugo; Odada, Eric			Decadal Trends and Common Dynamics of the Bio-Optical and Thermal Characteristics of the African Great Lakes	PLOS ONE			English	Article							DECREASED PRIMARY PRODUCTIVITY; RAINFALL VARIABILITY; DISSOLVED SILICA; CLIMATE-CHANGE; TANGANYIKA; TRANSPARENCY	The Great Lakes of East Africa are among the world's most important freshwater ecosystems. Despite their importance in providing vital resources and ecosystem services, the impact of regional and global environmental drivers on this lacustrine system remains only partially understood. We make a systematic comparison of the dynamics of the bio-optical and thermal properties of thirteen of the largest African lakes between 2002 and 2011. Lake surface temperatures had a positive trend in all Great Lakes outside the latitude of 0 degrees to 8 degrees south, while the dynamics of those lakes within this latitude range were highly sensitive to global inter-annual climate drivers (i.e. El Nino Southern Oscillation). Lake surface temperature dynamics in nearly all lakes were found to be sensitive to the latitudinal position of the Inter Tropical Convergence Zone. Phytoplankton dynamics varied considerably between lakes, with increasing and decreasing trends. Intra-lake differences in both surface temperature and phytoplankton dynamics occurred for many of the larger lakes. This inter-comparison of bio-optical and thermal dynamics provides new insights into the response of these ecosystems to global and regional drivers.	[Loiselle, Steven] Univ Siena, Consorzio Sviluppo Sistemi Grande Interfase, Dipartimento Biotecnol Chim & Farm, I-53100 Siena, Italy; [Cozar, Andres] Univ Cadiz, Dept Biol, Puerto Real, Spain; [Adgo, Enyew] Bahir Dar Univ, Coll Agr & Environm Sci, Bahir Dar, Ethiopia; [Ballatore, Thomas] Lake Basin Act Network, Moriyama, Japan; [Chavula, Geoffrey] Univ Malawi Polytech, Dept Civil Engn, Blantrye, Malawi; [Descy, Jean Pierre] Univ Namur, Dept Biol, Namur, Belgium; [Harper, David M.] Univ Leicester, Dept Biol, Leicester, Leics, England; [Kansiime, Frank] Makerere Univ, Dept Environm Management, Kampala, Uganda; [Kimirei, Ismael] Tanzanian Fisheries Res Inst, Kigoma Res Ctr, Kigoma, Tanzania; [Langenberg, Victor] DELTARES, Delft, Netherlands; [Ma, Ronghua] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Nanjing, Jiangsu, Peoples R China; [Sarmento, Hugo] Univ Fed Sao Carlos, Dept Hydrobiol, BR-13560 Sao Carlos, SP, Brazil; [Odada, Eric] Univ Nairobi, Dept Geol, Nairobi, Kenya	University of Siena; Universidad de Cadiz; Bahir Dar University; University of Namur; University of Leicester; Makerere University; Deltares; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Universidade Federal de Sao Carlos; University of Nairobi	Loiselle, S (corresponding author), Univ Siena, Consorzio Sviluppo Sistemi Grande Interfase, Dipartimento Biotecnol Chim & Farm, Via Laterina 8, I-53100 Siena, Italy.	loiselle@unisi.it	Kimirei, Ismael Aaron/F-7385-2012; Loiselle, Steven/ABA-3324-2020; Sarmento, Hugo/W-3805-2019; ma, rong/GVU-3096-2022; Sarmento, Hugo/A-7655-2008; Harper, David M/A-1765-2011; Cozar, Andres/G-2141-2016	Kimirei, Ismael Aaron/0000-0002-1101-5262; Loiselle, Steven/0000-0001-7414-0389; Sarmento, Hugo/0000-0001-5220-7992; Sarmento, Hugo/0000-0001-5220-7992; Cozar, Andres/0000-0003-1370-9935; Descy, Jean-Pierre/0000-0003-1649-7800	NERC ESPA grant [NE/1003266/1]; AGLOM project [CGL2010-11556-E]; Natural Environment Research Council [NE/I003266/1] Funding Source: researchfish; NERC [NE/I003266/1] Funding Source: UKRI	NERC ESPA grant; AGLOM project; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by the NERC ESPA grant (NE/1003266/1) AND THE AGLOM project (CGL2010-11556-E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker J. G., 2007, EOS T AGU, V88, P14, DOI [DOI 10.1029/2007EO020003, 10.1029/2007EO020003]; Bergamino N, 2010, REMOTE SENS ENVIRON, V114, P772, DOI 10.1016/j.rse.2009.11.013; Bergamino N, 2007, ECOL MODEL, V204, P156, DOI 10.1016/j.ecolmodel.2006.12.031; Bosilovich MG, 2008, J APPL METEOROL CLIM, V47, P2279, DOI 10.1175/2008JAMC1921.1; Coulter GW., 1991, LAKE TANGANYIKA ITS, P49; Cozar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029962; Descy JP, 2010, HYDROBIOLOGIA, V653, P29, DOI 10.1007/s10750-010-0343-3; Hecky RE, 2010, FRESHWATER BIOL, V55, P19, DOI 10.1111/j.1365-2427.2009.02374.x; Hecky R.E., 1987, Advances in Limnology, V25, P197; Horion S, 2010, REMOTE SENS ENVIRON, V114, P781, DOI 10.1016/j.rse.2009.11.012; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Lele MI, 2010, J CLIMATE, V23, P3984, DOI 10.1175/2010JCLI3277.1; Nicholson SE, 2000, GLOBAL PLANET CHANGE, V26, P137, DOI 10.1016/S0921-8181(00)00040-0; O'Reilly CM, 2003, NATURE, V424, P766, DOI 10.1038/nature01833; OgutuOhwayo R, 1997, ENVIRON BIOL FISH, V50, P117, DOI 10.1023/A:1007320932349; Olaka LA, 2010, J PALEOLIMNOL, V44, P629, DOI 10.1007/s10933-010-9442-4; Pasche N, 2010, J PALEOLIMNOL, V44, P931, DOI 10.1007/s10933-010-9465-x; PATTERSON G, 1995, FISHERY POTENTIAL PR, P1; Plisnier PD, 1999, HYDROBIOLOGIA, V407, P45, DOI 10.1023/A:1003762119873; Sarmento H, 2012, AQUAT ECOL SER, V5, P67, DOI 10.1007/978-94-007-4243-7_5; Sarvala J, 2006, INT VER THEOR ANGEW, V29, P2339; Sorensen K, 2008, ESA; Stager JC, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008362; Stager JC, 2009, QUATERNARY RES, V72, P47, DOI 10.1016/j.yqres.2009.04.003; Talling J.F., 1998, ECOLOGICAL DYNAMICS; Tierney JE, 2011, EARTH PLANET SC LETT, V307, P103, DOI 10.1016/j.epsl.2011.04.038; Tierney JE, 2010, NAT GEOSCI, V3, P422, DOI [10.1038/ngeo865, 10.1038/NGEO865]; Verburg P, 2006, INT VER THEOR ANGEW, V29, P2335; Verburg P, 2011, LIMNOL OCEANOGR, V56, P910, DOI 10.4319/lo.2011.56.3.0910; Wolff C, 2011, SCIENCE, V333, P743, DOI 10.1126/science.1203724; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336	32	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93656	10.1371/journal.pone.0093656	http://dx.doi.org/10.1371/journal.pone.0093656			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699528	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000087
J	Morganti, JM; Jopson, TD; Liu, S; Gupta, N; Rosi, S				Morganti, Josh M.; Jopson, Timothy D.; Liu, Sharon; Gupta, Nalin; Rosi, Susanna			Cranial Irradiation Alters the Brain's Microenvironment and Permits CCR2(+) Macrophage Infiltration	PLOS ONE			English	Article							CHEMOKINE RECEPTOR 2; TRANSGENIC MOUSE MODEL; COGNITIVE IMPAIRMENTS; IONIZING-RADIATION; RAT-BRAIN; MICROVASCULAR NETWORKS; CYTOKINE PRODUCTION; AMYLOID PATHOLOGY; MYELOID CELLS; BONE-MARROW	Therapeutic irradiation is commonly used to treat primary or metastatic central nervous system tumors. It is believed that activation of neuroinflammatory signaling pathways contributes to the development of common adverse effects, which may ultimately contribute to cognitive dysfunction. Recent studies identified the chemokine (C-C motif) receptor (CCR2), constitutively expressed by cells of the monocyte-macrophage lineage, as a mediator of cognitive impairments induced by irradiation. In the present study we utilized a unique reporter mouse (CCR2(RFP/+) CX3CR1(GFP/+)) to accurately delineate the resident (CX3CR1(+)) versus peripheral (CCR2(+)) innate immune response in the brain following cranial irradiation. Our results demonstrate that a single dose of 10Gy cranial gamma-irradiation induced a significant decrease in the percentage of resident microglia, while inducing an increase in the infiltration of peripherally derived CCR2(+) macrophages. Although reduced in percentage, there was a significant increase in F4/80(+) activated macrophages in irradiated animals compared to sham. Moreover, we found that there were altered levels of pro-inflammatory cytokines, chemokines, adhesion molecules, and growth factors in the hippocampi of wild type irradiated mice as compared to sham. All of these molecules are implicated in the recruitment, adhesion, and migration of peripheral monocytes to injured tissue. Importantly, there were no measureable changes in the expression of multiple markers associated with blood-brain barrier integrity; implicating the infiltration of peripheral CCR2(+) macrophages may be due to inflammatory induced chemotactic signaling. Cumulatively, these data provide evidence that therapeutic levels of cranial radiation are sufficient to alter the brain's homeostatic balance and permit the influx of peripherally-derived CCR2(+) macrophages as well as the regional susceptibility of the hippocampal formation to ionizing radiation.	[Morganti, Josh M.; Jopson, Timothy D.; Rosi, Susanna] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Morganti, Josh M.; Jopson, Timothy D.; Rosi, Susanna] Univ Calif San Francisco, Dept Phys Therapy, San Francisco, CA 94143 USA; [Morganti, Josh M.; Jopson, Timothy D.; Rosi, Susanna] Univ Calif San Francisco, Dept Rehabil Sci, San Francisco, CA 94143 USA; [Liu, Sharon; Gupta, Nalin; Rosi, Susanna] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rosi, S (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA.	rosis@ptrehab.ucsf.edu	Morganti, Josh/AAL-9727-2020	Morganti, Josh/0000-0002-4183-0049	NIH-NCI [R01 CA133216]; Pediatric Brain Tumor Foundation; NATIONAL CANCER INSTITUTE [R01CA133216] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pediatric Brain Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH-NCI R01 CA133216 (SR) and the Pediatric Brain Tumor Foundation (NG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; Andres RH, 2011, STROKE, V42, P2923, DOI 10.1161/STROKEAHA.110.606368; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Babcock AA, 2003, J NEUROSCI, V23, P7922; Banisadr G, 2005, J COMP NEUROL, V492, P178, DOI 10.1002/cne.20729; Belarbi K, 2013, CANCER RES, V73, P1201, DOI 10.1158/0008-5472.CAN-12-2989; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Chen M, 2012, GLIA, V60, P833, DOI 10.1002/glia.22315; Dimitrijevic OB, 2006, J CEREBR BLOOD F MET, V26, P797, DOI 10.1038/sj.jcbfm.9600229; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fauquette W, 2012, BRAIN RES, V1433, P114, DOI 10.1016/j.brainres.2011.11.022; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Gilmore SA, 2003, EXP NEUROL, V182, P169, DOI 10.1016/S0014-4886(03)00118-3; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Kim SH, 2002, J KOREAN MED SCI, V17, P242, DOI 10.3346/jkms.2002.17.2.242; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; LEE SC, 1993, J IMMUNOL, V150, P2659; Lee WH, 2011, RADIAT RES, V176, P753, DOI 10.1667/RR2647.1; Lerman OZ, 2010, BLOOD, V116, P3669, DOI 10.1182/blood-2009-03-213629; Linard C, 2004, INT J RADIAT ONCOL, V58, P427, DOI 10.1016/j.ijrobp.2003.09.039; LJUBIMOVA NV, 1991, BRIT J RADIOL, V64, P934, DOI 10.1259/0007-1285-64-766-934; Lloyd CM, 2008, J IMMUNOL METHODS, V334, P70, DOI 10.1016/j.jim.2008.02.005; Lund EL, 2004, INT J CANCER, V108, P833, DOI 10.1002/ijc.11662; Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655; Man SM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003197; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Mizumatsu S, 2003, CANCER RES, V63, P4021; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Moravan MJ, 2011, RADIAT RES, V176, P459, DOI 10.1667/RR2587.1; Morganti JM, 2012, J NEUROSCI, V32, P14592, DOI 10.1523/JNEUROSCI.0539-12.2012; Naert G, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00051; Naert G, 2012, MOL MED, V18, P297, DOI 10.2119/molmed.2011.00306; Naert G, 2011, J NEUROSCI, V31, P6208, DOI 10.1523/JNEUROSCI.0299-11.2011; Nguyen V, 2000, RADIAT RES, V154, P531, DOI 10.1667/0033-7587(2000)154[0531:LEOIRO]2.0.CO;2; Nordal RA, 2005, INT J RADIAT ONCOL, V62, P279, DOI 10.1016/j.ijrobp.2005.01.039; Olah M, 2012, GLIA, V60, P306, DOI 10.1002/glia.21266; Panagiotakos G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000588; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Prinz M, 2010, J NEUROIMMUNOL, V224, P80, DOI 10.1016/j.jneuroim.2010.05.015; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Roberts TK, 2012, LAB INVEST, V92, P1213, DOI 10.1038/labinvest.2012.80; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rosi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031094; Rosi S, 2008, CANCER RES, V68, P9763, DOI 10.1158/0008-5472.CAN-08-1861; Roth NM, 1999, RADIAT RES, V151, P270, DOI 10.2307/3579938; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schellenberg AE, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-10; Schilling M, 2009, BRAIN RES, V1289, P79, DOI 10.1016/j.brainres.2009.06.054; Semple BD, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-67; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Stamatovic SM, 2012, MOL CELL BIOL, V32, P3414, DOI 10.1128/MCB.06678-11; Stasinopoulos I, 2009, CANCER BIOL THER, V8, P31, DOI 10.4161/cbt.8.1.7079; Steiner J, 2008, NEUROSCIENCE, V154, P496, DOI 10.1016/j.neuroscience.2008.03.060; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Szmydynger-Chodobska J, 2012, J CEREBR BLOOD F MET, V32, P93, DOI 10.1038/jcbfm.2011.111; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Varol C, 2009, IMMUNOL CELL BIOL, V87, P30, DOI 10.1038/icb.2008.90; Varvel NH, 2012, P NATL ACAD SCI USA, V109, P18150, DOI 10.1073/pnas.1210150109; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; Wu GF, 2006, CARDIOVASC RES, V69, P512, DOI 10.1016/j.cardiores.2005.09.019; Wu KL, 2010, INT J RADIAT ONCOL, V76, P220, DOI 10.1016/j.ijrobp.2009.08.017; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zuurman MW, 2003, GLIA, V41, P327, DOI 10.1002/glia.10156	79	67	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93650	10.1371/journal.pone.0093650	http://dx.doi.org/10.1371/journal.pone.0093650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695541	gold, Green Published, Green Submitted			2022-12-27	WOS:000334103000097
J	Batool, K; Niazi, MA				Batool, Komal; Niazi, Muaz A.			Towards a Methodology for Validation of Centrality Measures in Complex Networks	PLOS ONE			English	Article							INFORMATION-FLOW; DIFFUSION; DYNAMICS; SYSTEMS; MODELS	Background: Living systems are associated with Social networks - networks made up of nodes, some of which may be more important in various aspects as compared to others. While different quantitative measures labeled as "centralities'' have previously been used in the network analysis community to find out influential nodes in a network, it is debatable how valid the centrality measures actually are. In other words, the research question that remains unanswered is: how exactly do these measures perform in the real world? So, as an example, if a centrality of a particular node identifies it to be important, is the node actually important? Purpose: The goal of this paper is not just to perform a traditional social network analysis but rather to evaluate different centrality measures by conducting an empirical study analyzing exactly how do network centralities correlate with data from published multidisciplinary network data sets. Method: We take standard published network data sets while using a random network to establish a baseline. These data sets included the Zachary's Karate Club network, dolphin social network and a neural network of nematode Caenorhabditis elegans. Each of the data sets was analyzed in terms of different centrality measures and compared with existing knowledge from associated published articles to review the role of each centrality measure in the determination of influential nodes. Results: Our empirical analysis demonstrates that in the chosen network data sets, nodes which had a high Closeness Centrality also had a high Eccentricity Centrality. Likewise high Degree Centrality also correlated closely with a high Eigenvector Centrality. Whereas Betweenness Centrality varied according to network topology and did not demonstrate any noticeable pattern. In terms of identification of key nodes, we discovered that as compared with other centrality measures, Eigenvector and Eccentricity Centralities were better able to identify important nodes.	[Batool, Komal] Natl Univ Sci & Technol, Islamabad, Pakistan; [Niazi, Muaz A.] Bahria Univ, Islamabad, Pakistan; [Niazi, Muaz A.] Univ Stirling, COSIPRA Lab, Stirling, Scotland	National University of Sciences & Technology - Pakistan; University of Stirling	Niazi, MA (corresponding author), Bahria Univ, Islamabad, Pakistan.	muaz.niazi@ieee.org	Niazi, Muaz/B-7567-2009	Niazi, Muaz/0000-0002-2259-6824				[Anonymous], 2009, NETWORKS INTRO; Askari-Sichani O, 2013, COMPLEX ADAPT SYST M, V1, DOI 10.1186/2194-3206-1-11; Bampo M, 2008, INFORM SYST RES, V19, P273, DOI 10.1287/isre.1070.0152; Barabasi AL, 2004, EUR PHYS J B, V38, P169, DOI 10.1140/epjb/e2004-00022-4; BECKER MH, 1970, AM SOCIOL REV, V35, P267, DOI 10.2307/2093205; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Bouttier J, 2003, NUCL PHYS B, V663, P535, DOI 10.1016/S0550-3213(03)00355-9; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gershenson C, 2013, COMPLEX ADAPT SYST M, V1, DOI 10.1186/2194-3206-1-17; GRUHL D., 2004, SIGKDD EXPLORATIONS, V13, P491, DOI DOI 10.1145/1046456.1046462; Hogg T, 2009, P 3 INT AAAI C WEBL; Jalili M, 2012, PHYSICA A; Jalili M, 2013, SIMUL-T SOC MOD SIM, V89, P578, DOI 10.1177/0037549712462621; Kimura M, 2006, LECT NOTES ARTIF INT, V4213, P259; Kimura M, 2009, SOCIAL COMPUTING AND BEHAVIORAL MODELING, P138, DOI 10.1007/978-1-4419-0056-2_18; Leskovec J., 2008, P 17 INT C WORLD WID, P915, DOI [10.1145/1367497.1367620, DOI 10.1145/1367497.1367620]; Leskovec J, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P420; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Liben-Nowell D, 2008, P NATL ACAD SCI USA, V105, P4633, DOI 10.1073/pnas.0708471105; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; McCallum A, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P786; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Niazi M, 2011, SCIENTOMETRICS, V89, P479, DOI 10.1007/s11192-011-0468-9; Niazi MA, 2013, COMPLEX ADAPT SYST M, V1, DOI 10.1186/2194-3206-1-1; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Valente ThomasW., 1996, COMPUTATIONAL MATH O, V2, P163, DOI [10.1007/bf00240425, DOI 10.1007/BF00240425]; Valente TW, 1999, ANN AM ACAD POLIT SS, V566, P55, DOI 10.1177/0002716299566001005; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Wang ZL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01204; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu F, 2004, PHYSICA A, V337, P327, DOI 10.1016/j.physa.2004.01.030; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	34	66	66	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e90283	10.1371/journal.pone.0090283	http://dx.doi.org/10.1371/journal.pone.0090283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709999	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800007
J	Van Lange, PAM; Vinkhuyzen, AAE; Posthuma, D				Van Lange, Paul A. M.; Vinkhuyzen, Anna A. E.; Posthuma, Danielle			Genetic Influences Are Virtually Absent for Trust	PLOS ONE			English	Article							NETHERLANDS TWIN REGISTER; ENVIRONMENTAL-FACTORS; SOCIAL DILEMMAS; METAANALYSIS; EPIDEMIOLOGY; HERITABILITY; PREFERENCES; PSYCHOLOGY; DISORDERS; BEHAVIOR	Over the past decades, numerous twin studies have revealed moderate to high heritability estimates for individual differences in a wide range of human traits, including cognitive ability, psychiatric disorders, and personality traits. Even factors that are generally believed to be environmental in nature have been shown to be under genetic control, albeit modest. Is such heritability also present in social traits that are conceptualized as causes and consequences of social interactions or in other ways strongly shaped by behavior of other people? Here we examine a population-based sample of 1,012 twins and relatives. We show that the genetic influence on generalized trust in other people (trust-in-others: h(2) =5%, ns), and beliefs regarding other people's trust in the self (trust-in-self: h(2)= 13%, ns), is virtually absent. As test-retest reliability for both scales were found to be moderate or high (r =.76 and r =.53, respectively) in an independent sample, we conclude that all variance in trust is likely to be accounted for by non-shared environmental influences. We show that, relative to cognitive abilities, psychiatric disorders, and classic personality variables, genetic influences are smaller for trust, and propose that experiences with or observations of the behavior of other people shape trust more strongly than other traits.	[Van Lange, Paul A. M.; Posthuma, Danielle] Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands; [Vinkhuyzen, Anna A. E.; Posthuma, Danielle] Vrije Univ Amsterdam, CNCR, Dept Funct Genom, Dept Complex Trait Genet, Amsterdam, Netherlands; [Vinkhuyzen, Anna A. E.] Univ Queensland, QBI, St Lucia, Qld, Australia; [Posthuma, Danielle] Vrije Univ Amsterdam, Dept Clin Genet, Amsterdam, Netherlands; [Posthuma, Danielle] Erasmus Univ, Sophia Child Hosp, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Queensland; Vrije Universiteit Amsterdam; Erasmus University Rotterdam	Van Lange, PAM (corresponding author), Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands.	pam.van.lange@psy.vu.nl	Vinkhuyzen, Anna/N-8691-2013	Vinkhuyzen, Anna/0000-0003-3352-0603; Van Lange, Paul/0000-0001-7774-6984; Posthuma, Danielle/0000-0001-7582-2365	VU University Amsterdam, the department of biological psychology; VU University Amsterdam, the department of social and organizational psychology	VU University Amsterdam, the department of biological psychology; VU University Amsterdam, the department of social and organizational psychology	This research was supported by the VU University Amsterdam, the departments of biological psychology and social and organizational psychology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Anderson CA, 2002, SCIENCE, V295, P2377, DOI 10.1126/science.1070765; Balliet D, 2013, PSYCHOL BULL, V139, P1090, DOI 10.1037/a0030939; Balliet D, 2013, PERSPECT PSYCHOL SCI, V8, P363, DOI 10.1177/1745691613488533; Barefoot JC, 1998, J BEHAV MED, V21, P517, DOI 10.1023/A:1018792528008; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Bouchard TJ, 2004, CURR DIR PSYCHOL SCI, V13, P148, DOI 10.1111/j.0963-7214.2004.00295.x; Bowlby J., 1979, MAKING BREAKING AFFE; Cesarini D, 2008, P NATL ACAD SCI USA, V105, P3721, DOI 10.1073/pnas.0710069105; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Erikson E., 1963, YOUTH CHANGE CHALLEN; Falconer D. S., 1996, INTRO QUANTITATIVE G; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Keller MC, 2009, TWIN RES HUM GENET, V12, P8, DOI 10.1375/twin.12.1.8; Kendler KS, 2001, ARCH GEN PSYCHIAT, V58, P1005, DOI 10.1001/archpsyc.58.11.1005; Medland SE, 2009, TWIN RES HUM GENET, V12, P19, DOI 10.1375/twin.12.1.19; Neale MC, 1994, MX STAT MODELING; Plomin R, 2001, BEHAV GENET, V31, P497, DOI 10.1023/A:1013385125887; Posthuma D, 2000, BEHAV GENET, V30, P147, DOI 10.1023/A:1001959306025; Posthuma D, 2001, BEHAV GENET, V31, P593, DOI 10.1023/A:1013349512683; ROTTER JB, 1967, J PERS, V35, P651, DOI 10.1111/j.1467-6494.1967.tb01454.x; Rousseau DM, 1998, ACAD MANAGE REV, V23, P393, DOI 10.5465/AMR.1998.926617; Sturgis P, 2010, POLIT BEHAV, V32, P205, DOI 10.1007/s11109-009-9101-5; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Tazelaar MJA, 2004, J PERS SOC PSYCHOL, V87, P845, DOI 10.1037/0022-3514.87.6.845; Turkheimer E, 2000, CURR DIR PSYCHOL SCI, V9, P160, DOI 10.1111/1467-8721.00084; Van Lange PAM, 2013, ORGAN BEHAV HUM DEC, V120, P125, DOI 10.1016/j.obhdp.2012.11.003; Van Lange PAM, 2012, EUR J PERSONALITY, V26, P461, DOI 10.1002/per.845; Van Lange PAM, 2011, INT J PSYCHOPHYSIOL, V80, P246, DOI 10.1016/j.ijpsycho.2011.03.007; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733; Vinkhuyzen AAE, 2010, GENES BRAIN BEHAV, V9, P276, DOI 10.1111/j.1601-183X.2009.00554.x; Vinkhuyzen AAE, 2012, BEHAV GENET, V42, P187, DOI 10.1007/s10519-011-9507-9; Willemsen G, 2005, TWIN RES HUM GENET, V8, P312, DOI 10.1375/twin.8.4.312; Yamagishi T, 2011, SCI MIND, P1, DOI 10.1007/978-4-431-53936-0	37	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93880	10.1371/journal.pone.0093880	http://dx.doi.org/10.1371/journal.pone.0093880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709897	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800062
J	Wang, N; Truedsson, L; Elvin, K; Andersson, BA; Ronnelid, J; Mincheva-Nilsson, L; Lindkvist, A; Ludvigsson, JF; Hammarstrom, L; Dahle, C				Wang, Ning; Truedsson, Lennart; Elvin, Kerstin; Andersson, Bengt A.; Ronnelid, Johan; Mincheva-Nilsson, Lucia; Lindkvist, Annica; Ludvigsson, Jonas F.; Hammarstrom, Lennart; Dahle, Charlotte			Serological Assessment for Celiac Disease in IgA Deficient Adults	PLOS ONE			English	Article							DEAMIDATED GLIADIN PEPTIDES; IMMUNOGLOBULIN-A DEFICIENCY; TRANSGLUTAMINASE ANTIBODY-ASSAYS; TISSUE TRANSGLUTAMINASE; ANTITISSUE TRANSGLUTAMINASE; DIAGNOSTIC-ACCURACY; PREVALENCE; CHILDREN; SUSCEPTIBILITY; ANTIGLIADIN	Purpose: Selective immunoglobulin A deficiency is the most common primary immunodeficiency disorder that is strongly overrepresented among patients with celiac disease (CD). IgG antibodies against tissue transglutaminase (tTG) and deamidated gliadin peptides (DGP) serve as serological markers for CD in IgA deficient individuals, although the diagnostic value remains uncertain. The aim of this study was to investigate the prevalence of these markers in a large cohort of IgA deficient adults with confirmed or suspected CD and relate the findings to gluten free diet. Methods: Sera from 488,156 individuals were screened for CD in seven Swedish clinical immunology laboratories between 1998 and 2012. In total, 356 out of 1,414 identified IgA deficient adults agreed to participate in this study and were resampled. Forty-even IgA deficient blood donors served as controls. Analyses of IgG antibodies against tTG and DGP as well as HLA typing were performed and a questionnaire was used to investigate adherence to gluten free diet. Available biopsy results were collected. Results: Out of the 356 IgA deficient resampled adults, 67 (18.8%) were positive for IgG anti-tTG and 79 (22.2%) for IgG anti-DGP, 54 had biopsy confirmed CD. Among the 47 IgA deficient blood donors, 4 (9%) were positive for IgG anti-tTG and 8 (17%) for anti- DGP. Four were diagnosed with biopsy verified CD, however, 2 of the patients were negative for all markers. Sixty-eight of 69 individuals with positive IgG anti-tTG were HLA-DQ2/DQ8 positive whereas 7 (18.9%) of the 37 individuals positive for IgG anti-DGP alone were not. Conclusions: IgG anti- tTG seems to be a more reliable marker for CD in IgA deficient adults whereas the diagnostic specificity of anti-DGP appears to be lower. High levels of IgG antibodies against tTG and DGP were frequently found in IgA deficient adults despite adhering to gluten free diet.	[Wang, Ning; Lindkvist, Annica; Hammarstrom, Lennart] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Truedsson, Lennart] Lund Univ, Dept Lab Med, Sect Microbiol Immunol & Glycobiol, Lund, Sweden; [Elvin, Kerstin] Karolinska Inst, Dept Med, Clin Immunol & Allergy Unit, Stockholm, Sweden; [Andersson, Bengt A.] Sahlgrens Univ Hosp, Dept Immunol, Gothenburg, Sweden; [Ronnelid, Johan] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Mincheva-Nilsson, Lucia] Umea Univ, Dept Clin Microbiol, Umea, Sweden; [Ludvigsson, Jonas F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ludvigsson, Jonas F.] Orebro Univ Hosp, Dept Pediat, Orebro, Sweden; [Dahle, Charlotte] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden	Karolinska Institutet; Karolinska University Hospital; Lund University; Karolinska Institutet; Sahlgrenska University Hospital; Uppsala University; Umea University; Karolinska Institutet; Orebro University; Linkoping University	Hammarstrom, L (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Lab Med, Stockholm, Sweden.	Lennart.Hammarstrom@ki.se; Charlotte.Dahle@lio.se	Ludvigsson, Jonas F/A-8560-2012; lindkvist, Annica/GZN-1258-2022; Andersson, Bengt/B-7295-2019; Ronnelid, Johan/O-2077-2019	Ludvigsson, Jonas F/0000-0003-1024-5602; 	Swedish Research Council; County Council of Ostergotland, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); County Council of Ostergotland, Sweden	This work was supported by the Swedish Research Council and grants from the County Council of Ostergotland, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agardh D, 2007, CLIN GASTROENTEROL H, V5, P1276, DOI 10.1016/j.cgh.2007.05.024; [Anonymous], 2010, ANN BIOL CLIN-PARIS, V68, P149, DOI 10.1684/abc.2010.0398; Basso D, 2002, CLIN CHEM, V48, P2082; Basso D, 2009, CLIN CHEM, V55, P150, DOI 10.1373/clinchem.2008.110395; Bevan S, 1999, J MED GENET, V36, P687; Cataldo F, 1998, GUT, V42, P362, DOI 10.1136/gut.42.3.362; Cataldo F, 2000, GUT, V47, P366, DOI 10.1136/gut.47.3.366; Chow MA, 2012, J CLIN GASTROENTEROL, V46, P850, DOI 10.1097/MCG.0b013e31824b2277; COLLIN P, 1992, SCAND J GASTROENTERO, V27, P367, DOI 10.3109/00365529209000089; Collin P, 2007, J CLIN GASTROENTEROL, V41, P152, DOI 10.1097/01.mcg.0000212618.12455.a8; Conrad K, 2012, CLIN CHEM LAB MED, V50, P337, DOI [10.1515/CCLM.2011.760, 10.1515/cclm.2011.760]; CUNNINGHAMRUNDLES C, 1991, CLIN IMMUNOL IMMUNOP, V61, pS61, DOI 10.1016/S0090-1229(05)80039-X; Dahlbom I, 2005, CLIN DIAGN LAB IMMUN, V12, P254, DOI 10.1128/CDLI.12.2.254-258.2005; Dahle C, 2010, ALIMENT PHARM THER, V32, P254, DOI 10.1111/j.1365-2036.2010.04337.x; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; FERNANDEZARQUERO M, 1995, HUM IMMUNOL, V42, P295, DOI 10.1016/0198-8859(94)00108-3; Heneghan MA, 1997, J CLIN GASTROENTEROL, V25, P421, DOI 10.1097/00004836-199709000-00004; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Korponay-Szabo IR, 1999, J PEDIATR GASTR NUTR, V28, P26, DOI 10.1097/00005176-199901000-00008; Korponay-Szabo IR, 2003, GUT, V52, P1567, DOI 10.1136/gut.52.11.1567; Kumar V, 2002, CLIN DIAGN LAB IMMUN, V9, P1295, DOI 10.1128/CDLI.9.6.1295-1300.2002; Latiff AHA, 2007, ANN CLIN BIOCHEM, V44, P131, DOI 10.1258/000456307780117993; Lebwohl B, 2013, ALIMENT PHARM THER, V37, P332, DOI 10.1111/apt.12164; Lenhardt A, 2004, DIGEST LIVER DIS, V36, P730, DOI 10.1016/j.dld.2004.06.017; Lewis NR, 2006, ALIMENT PHARM THER, V24, P47, DOI 10.1111/j.1365-2036.2006.02967.x; Lindfors K, 2011, INT REV IMMUNOL, V30, P185, DOI 10.3109/08830185.2011.595854; Lowbeer C, 2010, CLIN CHIM ACTA, V411, P612, DOI 10.1016/j.cca.2010.01.020; Ludvigsson JF, 2011, J INTERN MED, V269, P560, DOI 10.1111/j.1365-2796.2011.02379.x; Ludvigsson JF, 2013, J CLIN IMMUNOL; McGowan KE, 2008, CLIN CHEM, V54, P1203, DOI 10.1373/clinchem.2008.103606; Meini A, 1996, ANN ALLERG ASTHMA IM, V77, P333, DOI 10.1016/S1081-1206(10)63329-7; Monzani A, 2011, J PEDIATR GASTR NUTR, V53, P55, DOI 10.1097/MPG.0b013e3182145511; Mozo L, 2012, J PEDIATR GASTR NUTR, V55, P50, DOI 10.1097/MPG.0b013e31824703c7; Mubarak A, 2012, WORLD J GASTROENTERO, V18, P4399, DOI 10.3748/wjg.v18.i32.4399; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Notarangelo LD, 2009, J ALLERGY CLIN IMMUN, V124, P1161, DOI 10.1016/j.jaci.2009.10.013; Olen O, 2012, J PEDIATR GASTR NUTR, V55, P695, DOI 10.1097/MPG.0b013e3182645c54; OLERUP O, 1990, NATURE, V347, P289, DOI 10.1038/347289a0; OLERUP O, 1993, TISSUE ANTIGENS, V41, P119, DOI 10.1111/j.1399-0039.1993.tb01991.x; Prause C, 2009, ANN NY ACAD SCI, V1173, P28, DOI 10.1111/j.1749-6632.2009.04638.x; Price P, 1999, IMMUNOL REV, V167, P257, DOI 10.1111/j.1600-065X.1999.tb01398.x; Prince HE, 2006, CLIN VACCINE IMMUNOL, V13, P150, DOI 10.1128/CVI.13.1.150-151.2006; Rostom A, 2005, GASTROENTEROLOGY, V128, pS38, DOI 10.1053/j.gastro.2005.02.028; SOLLID LM, 1993, GASTROENTEROLOGY, V105, P910, DOI 10.1016/0016-5085(93)90912-V; Tesei N, 2003, ALIMENT PHARM THERAP, V17, P1415, DOI 10.1046/j.1365-2036.2003.01595.x; Thomas HJ, 2009, SCAND J GASTROENTERO, V44, P1076, DOI 10.1080/00365520903100473; Tonutti E, 2009, J CLIN LAB ANAL, V23, P165, DOI 10.1002/jcla.20313; Trynka G, 2010, TRENDS MOL MED, V16, P537, DOI 10.1016/j.molmed.2010.09.003; van der Windt DAWM, 2010, JAMA-J AM MED ASSOC, V303, P1738, DOI 10.1001/jama.2010.549; Van Meensel B, 2004, CLIN CHEM, V50, P2125, DOI 10.1373/clinchem.2004.035832; Vermeersch P, 2010, CLIN CHIM ACTA, V411, P931, DOI 10.1016/j.cca.2010.02.060; Vermeersch P, 2010, CLIN CHIM ACTA, V411, P13, DOI 10.1016/j.cca.2009.09.030; Vermeersch P, 2009, CLIN CHIM ACTA, V410, P54, DOI 10.1016/j.cca.2009.09.021; Villalta D, 2007, ANN NY ACAD SCI, V1109, P212, DOI 10.1196/annals.1398.025; Villalta D, 2007, CLIN CHIM ACTA, V382, P95, DOI 10.1016/j.cca.2007.03.028; Villalta D, 2010, CLIN CHEM, V56, P464, DOI 10.1373/clinchem.2009.128132; Volta U, 2010, J CLIN GASTROENTEROL, V44, P186, DOI 10.1097/MCG.0b013e3181c378f6; Walker MM, 2010, GASTROENTEROLOGY, V139, P112, DOI 10.1053/j.gastro.2010.04.007	59	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93180	10.1371/journal.pone.0093180	http://dx.doi.org/10.1371/journal.pone.0093180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709954	Green Published, gold			2022-12-27	WOS:000334159800025
J	Ye, D; Hu, YK; Song, MH; Pan, X; Xie, XF; Liu, GF; Ye, XH; Dong, M				Ye, Duo; Hu, Yukun; Song, Minghua; Pan, Xu; Xie, Xiufang; Liu, Guofang; Ye, Xuehua; Dong, Ming			Clonality-Climate Relationships along Latitudinal Gradient across China: Adaptation of Clonality to Environments	PLOS ONE			English	Article							PLANT-SPECIES DIVERSITY; GLOBAL PATTERNS; LIFE; TRAITS; ECOLOGY; STRESS; LADAKH	Plant clonality, the ability of a plant species to reproduce itself vegetatively through ramets (shoot-root units), occurs in many plant species and is considered to be more frequent in cold or wet environments. However, a deeper understanding on the clonality-climate relationships along large geographic gradients is still scarce. In this study we revealed the clonality-climate relationships along latitudinal gradient of entire China spanning from tropics to temperate zones using clonality data for 4015 vascular plant species in 545 terrestrial communities. Structural equation modeling (SEM) showed that, in general, the preponderance of clonality increased along the latitudinal gradient towards cold, dry or very wet environments. However, the distribution of clonality in China was significantly but only weakly correlated with latitude and four climatic factors (mean annual temperature, temperature seasonality, mean annual precipitation, precipitation seasonality). Clonality of woody and herbaceous species had opposite responses to climatic variables. More precisely, woody clonality showed higher frequency in wet or climatically stable environments, while herbaceous clonality preferred cold, dry or climatically instable environments. Unexplained variation in clonality may be owed to the influences of other environmental conditions and to different clonal strategies and underlying traits adopted by different growth forms and phylogenetic lineages. Therefore, in-depth research in terms of more detailed clonal growth form, phylogeny and additional environmental variables are encouraged to further understand plant clonality response to climatic and/or edaphic conditions.	[Ye, Duo; Hu, Yukun; Pan, Xu; Xie, Xiufang; Liu, Guofang; Ye, Xuehua; Dong, Ming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Dong, Ming] Hangzhou Normal Univ, Coll Life & Environm Sci, Key Lab Hangzhou City Ecosyst Protect & Restorat, Hangzhou, Zhejiang, Peoples R China; [Song, Minghua] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Ye, Duo; Hu, Yukun; Pan, Xu; Xie, Xiufang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Hangzhou Normal University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, GF (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	liugf@ibcas.ac.cn; dongmingchina@126.com	Ye, Xuehua/I-3116-2013	Ye, Xuehua/0000-0002-5625-9877	NSFC [31261120580, 39825106, 31100333]; Innovative R & D grant of Hangzhou Normal University [PD12002002004001]	NSFC(National Natural Science Foundation of China (NSFC)); Innovative R & D grant of Hangzhou Normal University	This project was supported by the NSFC grant (grant no. 31261120580, 39825106) and the Innovative R & D grant of Hangzhou Normal University (grant no. PD12002002004001) to MD, and by the NSFC grants (grant no. 31100333) to GL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheplick GP, 1997, OIKOS, V79, P581, DOI 10.2307/3546902; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; de Bello F, 2011, PRESLIA, V83, P315; deKroon H, 1996, OECOLOGIA, V106, P73, DOI 10.1007/BF00334409; Del Tredici P, 2001, BOT REV, V67, P121, DOI 10.1007/BF02858075; DONG M, 1994, OIKOS, V70, P99, DOI 10.2307/3545704; Dong M., 1996, SURVEY OBSERVATION A; DORNBOS DL, 1989, CROP SCI, V29, P476, DOI 10.2135/cropsci1989.0011183X002900020047x; Editorial Committee of Flora Reipublicae Popularis Sinicae, 1961, FLORA REIPUBLICAE PO; Evette A, 2009, FOLIA GEOBOT, V44, P95, DOI 10.1007/s12224-009-9039-8; Fischer M, 2001, EVOL ECOL, V15, P565, DOI 10.1023/A:1016013721469; Fogel BN, 2004, J ECOL, V92, P589, DOI 10.1111/j.0022-0477.2004.00903.x; Grace JB, 2006, ECOL APPL, V16, P503, DOI 10.1890/1051-0761(2006)016[0503:ASEMAO]2.0.CO;2; Herben T, 2014, ANN BOT-LONDON, V114, P377, DOI 10.1093/aob/mct308; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hosaka N, 2005, NORTHEAST NAT, V12, P11, DOI 10.1656/1092-6194(2005)012[0011:TESOCG]2.0.CO;2; Jackson J. B. C., 1985, POPULATION BIOL EVOL; Jonsdottir I.S., 1997, ECOLOGY EVOLUTION CL, P109; Klimes L, 2003, BASIC APPL ECOL, V4, P317, DOI 10.1078/1439-1791-00163; Klimes L, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P1; Klimesova J, 2012, POL POLAR RES, V33, P421, DOI 10.2478/v10183-012-0019-y; Klimesova J, 2011, PLANT ECOL DIVERS, V4, P373, DOI 10.1080/17550874.2011.586734; Klimesova J, 2011, FOLIA GEOBOT, V46, P191, DOI 10.1007/s12224-010-9076-3; Klimesova J, 2009, J VEG SCI, V20, P511, DOI 10.1111/j.1654-1103.2009.01050.x; Lamb EG, 2008, ECOLOGY, V89, P216, DOI 10.1890/07-0393.1; Lamb EG, 2011, CAN J PLANT SCI, V91, P603, DOI [10.4141/CJPS2010-035, 10.4141/cjps2010-035]; Liu JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061060; McCullagh P, 1989, GEN LINEAR MODELS; Mikesell JE, 1997, INT J PLANT SCI, V158, P306, DOI 10.1086/297442; Moles AT, 2007, GLOBAL ECOL BIOGEOGR, V16, P109, DOI 10.1111/j.1466-8238.2006.00259.x; Moles AT, 2009, J ECOL, V97, P923, DOI 10.1111/j.1365-2745.2009.01526.x; Muthen, 2010, STAT ANAL LATENT VAR; Oborny B, 2000, ECOLOGY, V81, P3291; Oborny B., 1995, ABSTR BOT, V11, P115; PRACH K, 1994, SPEC FEAT VEGET SCI, V4, P307; R Development Core Team, 2012, R LANG ENV STAT COMP; SHAVER GR, 1976, FLORA, V165, P247; SIMON EW, 1976, NEW PHYTOL, V77, P301, DOI 10.1111/j.1469-8137.1976.tb01519.x; Song M., 2001, ACTA ECOL SIN, V21, P1095; Song MH, 2002, J VEG SCI, V13, P237, DOI 10.1111/j.1654-1103.2002.tb02044.x; Song MH, 2002, ECOL RES, V17, P705, DOI 10.1046/j.1440-1703.2002.00527.x; Sosnova M, 2010, AQUAT BOT, V92, P33, DOI 10.1016/j.aquabot.2009.09.005; Stuefer JF, 2001, EVOL ECOL, V15, P223, DOI 10.1023/A:1016017822027; Suzuki Jun-ichirou, 1999, Plant Species Biology, V14, P11, DOI 10.1046/j.1442-1984.1999.00002.x; vanGroenendael JM, 1996, PHILOS T ROY SOC B, V351, P1331, DOI 10.1098/rstb.1996.0116; Wellstein C, 2011, FOLIA GEOBOT, V46, P255, DOI 10.1007/s12224-010-9075-4; Woodward FI, 1997, J ECOL, V85, P899, DOI 10.2307/2960610; Yu FH, 2008, ANN BOT-LONDON, V102, P571, DOI 10.1093/aob/mcn119; Zobel M, 2010, OIKOS, V119, P802, DOI 10.1111/j.1600-0706.2010.18296.x	49	34	37	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94009	10.1371/journal.pone.0094009	http://dx.doi.org/10.1371/journal.pone.0094009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709992	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800085
J	Bosmans, JE; Beerepoot, MAJ; Prins, JM; ter Riet, G; Geerlings, SE				Bosmans, Judith E.; Beerepoot, Marielle A. J.; Prins, Jan M.; ter Riet, Gerben; Geerlings, Suzanne E.			Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial	PLOS ONE			English	Article							ESCHERICHIA-COLI; RESISTANCE; TRIMETHOPRIM; CONSUMPTION; VALIDATION; IMPUTATION; HEALTH; JUICE	Background: Urinary tract infections (UTIs) are common and result in an enormous economic burden. The increasing prevalence of antibiotic-resistant microorganisms has stimulated interest in non-antibiotic agents to prevent UTIs. Objective: To evaluate the cost-effectiveness of cranberry prophylaxis compared to antibiotic prophylaxis with trimethoprim-sulfamethoxazole (TMP-SMX) over a 12 month period in premenopausal women with recurrent UTIs. Materials and Methods: An economic evaluation was performed alongside a randomized trial. Primary outcome was the number of UTIs during 12 months. Secondary outcomes included satisfaction and quality of life. Healthcare utilization was measured using questionnaires. Missing data were imputed using multiple imputation. Bootstrapping was used to evaluate the cost-effectiveness of the treatments. Results: Cranberry prophylaxis was less effective than TMP-SMX prophylaxis, but the differences in clinical outcomes were not statistically significant. Costs after 12 months in the cranberry group were statistically significantly higher than in the TMP-SMX group (mean difference (sic)249, 95% confidence interval 70 to 516). Cost-effectiveness planes and cost-effectiveness acceptability curves showed that cranberry prophylaxis to prevent UTIs is less effective and more expensive than (dominated by) TMP-SMX prophylaxis. Conclusion: In premenopausal women with recurrent UTIs, cranberry prophylaxis is not cost-effective compared to TMP-SMX prophylaxis. However, it was not possible to take into account costs attributed to increased antibiotic resistance within the framework of this randomized trial; modeling studies are recommended to investigate these costs. Moreover, although we based the dosage of cranberry extract on available evidence, this may not be the optimal dosage. Results may change when this optimal dosage is identified.	[Bosmans, Judith E.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands; [Bosmans, Judith E.] Vrije Univ Amsterdam, Fac Earth & Life Sci, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Beerepoot, Marielle A. J.; Prins, Jan M.; Geerlings, Suzanne E.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [ter Riet, Gerben] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Bosmans, JE (corresponding author), Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands.	j.e.bosmans@vu.nl	Riet, Gerben ter/A-6943-2011; Prins, Jan M./AAF-4945-2020	Riet, Gerben ter/0000-0002-2231-7637; Prins, Jan/0000-0002-5415-8933; Bosmans, Judith/0000-0002-1443-1026	ZonMw [62000017]	ZonMw(Netherlands Organization for Health Research and Development)	This study was financially supported by ZonMw, grant number 62000017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Aston JL, 2006, PHARMACOTHERAPY, V26, P1314, DOI 10.1592/phco.26.9.1314; Beerepoot MAJ, 2011, ARCH INTERN MED, V171, P1270, DOI 10.1001/archinternmed.2011.306; BLACK WC, 1990, MED DECIS MAKING, V10, P212, DOI 10.1177/0272989X9001000308; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Briggs A, 2003, HEALTH ECON, V12, P377, DOI 10.1002/hec.766; Burton A, 2007, CLIN TRIALS, V4, P154, DOI 10.1177/1740774507076914; Clayson D, 2005, BJU INT, V96, P350, DOI 10.1111/j.1464-410X.2005.05630.x; Colgan R, 2004, CLIN DRUG INVEST, V24, P55, DOI 10.2165/00044011-200424010-00007; ECDC and EMEA Joint Working Group, 2009, ECDC EMEA JOINT TECH; EFRON B, 1994, J AM STAT ASSOC, V89, P463, DOI 10.2307/2290846; Ellis A K, 2000, J Am Board Fam Pract, V13, P392; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Foxman B, 2002, AM J MED, V113, p5S; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Guay DRP, 2009, DRUGS, V69, P775, DOI 10.2165/00003495-200969070-00002; Gupta K, 2003, INFECT DIS CLIN N AM, V17, P243, DOI 10.1016/S0891-5520(03)00006-0; Hakkaart-van Roijen L, 2011, HANDLEIDING KOSTENON; Hooton TM, 2001, INT J ANTIMICROB AG, V17, P259, DOI 10.1016/S0924-8579(00)00350-2; Howard D, 2001, CLIN INFECT DIS, V33, P1573, DOI 10.1086/323758; Howell AB, 2002, JAMA-J AM MED ASSOC, V287, P3082, DOI 10.1001/jama.287.23.3082; Howell AB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-94; Jepson RG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001321.pub5; Malterud K, 1999, SCAND J PRIM HEALTH, V17, P49; McMurdo MET, 2009, J ANTIMICROB CHEMOTH, V63, P389, DOI 10.1093/jac/dkn489; MURRAY BE, 1982, NEW ENGL J MED, V306, P130, DOI 10.1056/NEJM198201213060302; Neal DE, 2008, UROL CLIN N AM, V35, P13, DOI 10.1016/j.ucl.2007.09.010; Oostenbrink JB, 2005, HEALTH ECON, V14, P763, DOI 10.1002/hed.966; Raz R, 2004, CLIN INFECT DIS, V38, P1413, DOI 10.1086/386328; Rubin DB, 2004, MULTIPLE IMPUTATION; Stothers Lynn, 2002, Can J Urol, V9, P1558; Terris MK, 2001, UROLOGY, V57, P26, DOI 10.1016/S0090-4295(00)00884-0; Vasileiou I, 2013, NUTR RES, V33, P595, DOI 10.1016/j.nutres.2013.05.018; Willan AR, 2004, HEALTH ECON, V13, P461, DOI 10.1002/hec.843	34	13	13	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e91939	10.1371/journal.pone.0091939	http://dx.doi.org/10.1371/journal.pone.0091939			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705418	Green Submitted, Green Published, gold			2022-12-27	WOS:000334107500010
J	Ellison, A; Ball, KL; Moseley, P; Dowsett, J; Smith, DT; Weis, S; Lane, AR				Ellison, Amanda; Ball, Keira L.; Moseley, Peter; Dowsett, James; Smith, Daniel T.; Weis, Susanne; Lane, Alison R.			Functional Interaction between Right Parietal and Bilateral Frontal Cortices during Visual Search Tasks Revealed Using Functional Magnetic Imaging and Transcranial Direct Current Stimulation	PLOS ONE			English	Article							EYE FIELDS; PREFRONTAL CORTEX; WORKING-MEMORY; NEURAL SYSTEMS; ATTENTION; MODULATION; TMS; INVOLVEMENT; ACTIVATION; MECHANISMS	The existence of a network of brain regions which are activated when one undertakes a difficult visual search task is well established. Two primary nodes on this network are right posterior parietal cortex (rPPC) and right frontal eye fields. Both have been shown to be involved in the orientation of attention, but the contingency that the activity of one of these areas has on the other is less clear. We sought to investigate this question by using transcranial direct current stimulation (tDCS) to selectively decrease activity in rPPC and then asking participants to perform a visual search task whilst undergoing functional magnetic resonance imaging. Comparison with a condition in which sham tDCS was applied revealed that cathodal tDCS over rPPC causes a selective bilateral decrease in frontal activity when performing a visual search task. This result demonstrates for the first time that premotor regions within the frontal lobe and rPPC are not only necessary to carry out a visual search task, but that they work together to bring about normal function.	[Ellison, Amanda; Ball, Keira L.; Moseley, Peter; Smith, Daniel T.; Weis, Susanne; Lane, Alison R.] Univ Durham, Dept Psychol, Durham DH1 3LE, England; [Dowsett, James] Carl von Ossietzky Univ Oldenburg, Dept Psychol, D-26111 Oldenburg, Germany	Durham University; Carl von Ossietzky Universitat Oldenburg	Ellison, A (corresponding author), Univ Durham, Dept Psychol, Durham DH1 3LE, England.	amanda.ellison@durham.ac.uk	Smith, Daniel T./L-1365-2019; Smith, Daniel T/A-2230-2009	Smith, Daniel T./0000-0001-7030-6994; Smith, Daniel T/0000-0001-7030-6994; Dowsett, James/0000-0002-0949-8939; Moseley, Peter/0000-0002-9284-2509	Durham University NeuroImaging Collective	Durham University NeuroImaging Collective	Durham University NeuroImaging Collective. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashbridge E, 1997, NEUROPSYCHOLOGIA, V35, P1121, DOI 10.1016/S0028-3932(97)00003-1; Bai SW, 2012, BRAIN STIMUL, V5, P408, DOI 10.1016/j.brs.2011.07.004; Ball K, 2013, BRAIN STIMUL, V6, P959, DOI 10.1016/j.brs.2013.06.001; Baudewig J, 2001, MAGN RESON MED, V45, P196, DOI 10.1002/1522-2594(200102)45:2<196::AID-MRM1026>3.0.CO;2-1; Chang CF, 2013, HUM BRAIN MAPP, V34, P869, DOI 10.1002/hbm.21476; Cohen JY, 2007, J NEUROPHYSIOL, V98, P2580, DOI 10.1152/jn.00522.2007; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Corbetta M, 1998, PHILOS T ROY SOC B, V353, P1353, DOI 10.1098/rstb.1998.0289; Donner TH, 2002, NEUROIMAGE, V15, P16, DOI 10.1006/nimg.2001.0951; Ellison A, 2003, SUPPL CLIN NEUROPHYS, V56, P321; Ellison A, 2008, BRAIN STIMUL, V1, P259; Ellison A, 2007, CEREB CORTEX, V17, P2579, DOI 10.1093/cercor/bhl165; Ellison A, 2006, EXP BRAIN RES, V175, P618, DOI 10.1007/s00221-006-0582-8; Ellison A, 2009, NEUROPSYCHOLOGIA, V47, P1609, DOI 10.1016/j.neuropsychologia.2008.12.013; Fregni F, 2006, ARTHRITIS RHEUM-US, V54, P3988, DOI 10.1002/art.22195; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Higo T, 2011, P NATL ACAD SCI USA, V108, P4230, DOI 10.1073/pnas.1013361108; Kalla R, 2008, NEUROREPORT, V19, P1067, DOI 10.1097/WNR.0b013e328304d9c4; Lane AR, 2012, BRAIN STIMUL, V5, P11, DOI 10.1016/j.brs.2011.01.005; Lane AR, 2011, J COGNITIVE NEUROSCI, V23, P1964, DOI 10.1162/jocn.2010.21576; Malhotra P, 2009, BRAIN, V132, P645, DOI 10.1093/brain/awn350; Morgan HM, 2013, BRAIN STIMUL, V6, P122, DOI 10.1016/j.brs.2012.03.001; Muggleton N, 2007, NEUROPSYCHOLOGIA, V45, P1582, DOI 10.1016/j.neuropsychologia.2006.11.021; Muggleton NG, 2011, J NEUROPHYSIOL, V105, P2891, DOI 10.1152/jn.01149.2009; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P2220, DOI 10.1016/S1388-2457(03)00235-9; Peterchev AV, 2012, BRAIN STIMUL, V5, P435, DOI 10.1016/j.brs.2011.10.001; Rogalewski A, 2004, EUR J NEUROSCI, V20, P313, DOI 10.1111/j.0953-816X.2004.03450.x; Rossi AF, 2007, J NEUROSCI, V27, P11306, DOI 10.1523/JNEUROSCI.2939-07.2007; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Slotnick SD, 2003, BEHAV RES METH INS C, V35, P322, DOI 10.3758/BF03202559; Smith DT, 2005, NEUROPSYCHOLOGIA, V43, P1288, DOI 10.1016/j.neuropsychologia.2004.12.003; Stagg CJ, 2009, EUR J NEUROSCI, V30, P1412, DOI 10.1111/j.1460-9568.2009.06937.x; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Szczepanski SM, 2010, J NEUROSCI, V30, P148, DOI 10.1523/JNEUROSCI.3862-09.2010; Talairach J., 1988, COPLANAR STEREOTAXIC; Tseng P, 2012, J NEUROSCI, V32, P10554, DOI 10.1523/JNEUROSCI.0362-12.2012; Tseng P, 2010, NEUROPSYCHOLOGIA, V48, P1063, DOI 10.1016/j.neuropsychologia.2009.12.005; Venkatakrishnan A, 2011, IEEE ENG MED BIO, P8102, DOI 10.1109/IEMBS.2011.6091998; Woodman GF, 2007, CEREBRAL CORTEX S1, V1, pi118	44	22	22	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93767	10.1371/journal.pone.0093767	http://dx.doi.org/10.1371/journal.pone.0093767			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705681	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000334107500065
J	Keller, DB; Schultz, J				Keller, Daniela Barbara; Schultz, Joerg			Word Formation Is Aware of Morpheme Family Size	PLOS ONE			English	Article							GENOME EVOLUTION; BIRTH; DEATH; MODEL; NETWORKS; LANGUAGE; EVOLVE; LAW	Words are built from smaller meaning bearing parts, called morphemes. As one word can contain multiple morphemes, one morpheme can be present in different words. The number of distinct words a morpheme can be found in is its family size. Here we used Birth-Death-Innovation Models (BDIMs) to analyze the distribution of morpheme family sizes in English and German vocabulary over the last 200 years. Rather than just fitting to a probability distribution, these mechanistic models allow for the direct interpretation of identified parameters. Despite the complexity of language change, we indeed found that a specific variant of this pure stochastic model, the second order linear balanced BDIM, significantly fitted the observed distributions. In this model, birth and death rates are increased for smaller morpheme families. This finding indicates an influence of morpheme family sizes on vocabulary changes. This could be an effect of word formation, perception or both. On a more general level, we give an example on how mechanistic models can enable the identification of statistical trends in language change usually hidden by cultural influences.	[Keller, Daniela Barbara; Schultz, Joerg] Univ Wurzburg, Bioctr, Dept Bioinformat, D-97070 Wurzburg, Germany	University of Wurzburg	Schultz, J (corresponding author), Univ Wurzburg, Bioctr, Dept Bioinformat, D-97070 Wurzburg, Germany.	Joerg.Schultz@biozentrum.uni-wuerzburg.de	Schultz, Joerg/B-9346-2008		BMBF [01UA0815C]; German Research Foundation (DFG); University of Wuerzburg	BMBF(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	DBK was financed by the BMBF project 01UA0815C 'Interaction between linguistic and bioinformatic procedures, methods and algorithms.' This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anshen F, 1999, BRAIN LANG, V68, P16, DOI 10.1006/brln.1999.2068; Atkinson QD, 2008, SCIENCE, V319, P588, DOI 10.1126/science.1149683; Baayen H, 1999, BRAIN LANG, V68, P27, DOI 10.1006/brln.1999.2069; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bertram R, 2000, J MEM LANG, V42, P390, DOI 10.1006/jmla.1999.2681; Blythe RA, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525911003414; Burnard L, 2004, BNC BABY CD V 1 0; Campbell L, 2010, HIST LINGUISTICS INT; CARAMAZZA A, 1988, COGNITION, V28, P297, DOI 10.1016/0010-0277(88)90017-0; Creutz S, 2005, UNSUPERVISED MORPHEM; Croft W, 2001, EXPLAINING LANGUAGE; FELLER W., 1939, ACTA BIOTHEORETICA, V5, P11, DOI 10.1007/BF01602932; GREENBERG JH, 1960, INT J AM LINGUIST, V26, P178, DOI 10.1086/464575; Haspelmath M, 2010, UNDERSTANDING MORPHO, P224; Juhasz BJ, 2011, LANG COGNITIVE PROC, V26, P653, DOI 10.1080/01690965.2010.498668; Karev GP, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-18; Karev GP, 2003, BIOINFORMATICS, V19, P1889, DOI 10.1093/bioinformatics/btg351; Keller DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069945; KENDALL DG, 1948, ANN MATH STAT, V19, P1, DOI 10.1214/aoms/1177730285; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Kurimo M., 2010, P MORPH CHALL 2010 W, P7; Liberles DA, 2013, GENOME BIOL EVOL, V5, P2008, DOI 10.1093/gbe/evt151; Maruvka YE, 2010, J THEOR BIOL, V262, P245, DOI 10.1016/j.jtbi.2009.09.022; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Nelson-Sathi S, 2011, P ROY SOC B-BIOL SCI, V278, P1794, DOI 10.1098/rspb.2010.1917; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Novozhilov AS, 2006, BRIEF BIOINFORM, V7, P70, DOI 10.1093/bib/bbk006; Project Gutenberg, 2010, PROJ GUT ET 1913 WEB; Reed WJ, 2004, MATH BIOSCI, V189, P97, DOI 10.1016/j.mbs.2003.11.002; Schreuder R, 1997, J MEM LANG, V37, P118, DOI 10.1006/jmla.1997.2510; TAFT M, 1975, J VERB LEARN VERB BE, V14, P638, DOI 10.1016/S0022-5371(75)80051-X; Worterbuchnetz, 2011, KOMP EL ERSCHL PUBL; [No title captured]	33	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93978	10.1371/journal.pone.0093978	http://dx.doi.org/10.1371/journal.pone.0093978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6MJ	24705626	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500102
J	Lin, JW; Chang, YJ; Yang, WB; Yu, AL; Wong, CH				Lin, Juway; Chang, Ya-Jen; Yang, Wen-Bin; Yu, Alice L.; Wong, Chi-Huey			The Multifaceted Effects of Polysaccharides Isolated from Dendrobium huoshanense on Immune Functions with the Induction of Interleukin-1 Receptor Antagonist (IL-1ra) in Monocytes	PLOS ONE			English	Article							CHRONIC DESTRUCTIVE ARTHRITIS; JUVENILE CHRONIC ARTHRITIS; ANTI-CYTOKINE THERAPY; ACUTE-PHASE PROTEIN; GANODERMA-LUCIDUM; SEPSIS SYNDROME; REISHI POLYSACCHARIDES; SIGNAL-TRANSDUCTION; URINE INHIBITOR; GENE-EXPRESSION	Dendrobium huoshanense is a valuable and versatile Chinese herbal medicine with the anecdotal claims of cancer prevention and anti-inflammation. However, its immunological activities are limited to in vitro studies on a few cytokines and immune cell functions. First, we investigated the effects of polysaccharides isolated from DH (DH-PS) on inducing a panel of cytokines/chemokines in mice in vivo and human in vitro. We found that DH polysaccharides (DH-PS) induced TH1, TH2, inflammatory cytokines and chemokines in mouse in vivo and human cells in vitro. Secondly, we demonstrated that DH-PS expanded mouse splenocytes in vivo including CD4(+) T cells, CD8(+) T cells, B cells, NK cells, NKT cells, monocytes/ macrophages, granulocytes and regulatory T cells. Notably, DH-PS induced an anti-inflammatory molecule, IL-1ra, in mouse and human immune cells, especially monocytes. The serum level of IL-1ra elicited by the injection of DH-PS was over 10 folds of IL-1 beta, suggesting that DH-PS-induced anti-inflammatory activities might over-ride the inflammatory ones mediated by IL-1 beta. The signaling pathways of DH-PS-induced IL-1ra production was shown to involve ERK/ELK, p38 MAPK, PI3K and NF kappa B. Finally, we observed that IL-1ra level induced by DH-PS was significantly higher than that by F3, a polysaccharide extract isolated from another popular Chinese herbal medicine, Ganoderma lucidum. These results indicated that DH-PS might have potential applications for ameliorating IL-1-induced pathogenic conditions.	[Lin, Juway] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Lin, Juway; Yang, Wen-Bin; Yu, Alice L.; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chang, Ya-Jen] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Yu, Alice L.] Univ Calif San Diego, Ctr Med, Dept Pediat Hematol Oncol, San Diego, CA 92103 USA; [Yu, Alice L.] Chang Gung Mem Hosp, Ctr Stem Cell & Translat Canc Res, Taoyuan, Taiwan; [Wong, Chi-Huey] Scripps Res Inst, La Jolla, CA 92037 USA	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; University of California System; University of California San Diego; Chang Gung Memorial Hospital; Scripps Research Institute	Yu, AL (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	aliceyu@ucsd.edu; chwong@gate.sinica.edu.tw	Chang, Ya-Jen/O-1584-2018	Chang, Ya-Jen/0000-0003-1377-6142; yu, alice/0000-0003-2444-0505	Academia Sinica and National Science Council [NSC 101-2325-B-001-025]	Academia Sinica and National Science Council	This work is supported by Academia Sinica and National Science Council grants for A. L. Yu (NSC 101-2325-B-001-025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER HR, 1992, SURGERY, V112, P188; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; AREND WP, 1993, ADV IMMUNOL, V54, P167, DOI 10.1016/S0065-2776(08)60535-0; BALAVOINE JF, 1986, J CLIN INVEST, V78, P1120, DOI 10.1172/JCI112669; Bendele AM, 2000, ARTHRITIS RHEUM-US, V43, P2648, DOI 10.1002/1529-0131(200012)43:12<2648::AID-ANR4>3.0.CO;2-M; Brennan FM, 2001, ARTHRITIS RES, V3, P211, DOI 10.1186/ar302; Chen X, 2006, INT IMMUNOPHARMACOL, V6, P499, DOI 10.1016/j.intimp.2005.08.026; Darragh J, 2010, BIOCHEM J, V425, P595, DOI 10.1042/BJ20091062; DEBenedetti F, 1995, CLIN EXP RHEUMATOL, V13, P779; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1991, BLOOD, V77, P1627; DINARELLO CA, 1991, IMMUNOL TODAY, V12, P404, DOI 10.1016/0167-5699(91)90142-G; Dreyer MG, 2003, BIOCHEM J, V370, P591, DOI 10.1042/BJ20021270; DRIPPS DJ, 1991, J BIOL CHEM, V266, P10331; FISCHER E, 1992, BLOOD, V79, P2196; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; FISHER CJ, 1994, CRIT CARE MED, V22, P12, DOI 10.1097/00003246-199401000-00008; Flo TH, 2000, J IMMUNOL, V164, P2064, DOI 10.4049/jimmunol.164.4.2064; GABAY C, 1994, ARTHRITIS RHEUM, V37, P1744, DOI 10.1002/art.1780371206; Gabay C, 1997, J CLIN INVEST, V99, P2930, DOI 10.1172/JCI119488; Gao YH, 2005, IMMUNOL INVEST, V34, P171, DOI 10.1081/IMM-200055813; GRANOWTIZ EV, 1992, CYTOKINE, V4, P353, DOI 10.1016/1043-4666(92)90078-6; Grzelak I, 1996, J CLIN IMMUNOL, V16, P159, DOI 10.1007/BF01540914; Guthridge CJ, 1997, MOL CELL BIOL, V17, P1118, DOI 10.1128/MCB.17.3.1118; Hagaman DD, 2001, AM J RESP CELL MOL, V25, P685, DOI 10.1165/ajrcmb.25.6.4541; Hsieh YSY, 2008, BIOORGAN MED CHEM, V16, P6054, DOI 10.1016/j.bmc.2008.04.042; Hsu HY, 2004, J IMMUNOL, V173, P5989, DOI 10.4049/jimmunol.173.10.5989; Hsu MJ, 2003, BRIT J PHARMACOL, V139, P289, DOI 10.1038/sj.bjp.0705243; Hua KF, 2007, J CELL PHYSIOL, V212, P537, DOI 10.1002/jcp.21050; Irikura VM, 2002, J IMMUNOL, V169, P393, DOI 10.4049/jimmunol.169.1.393; Joosten LAB, 1996, ARTHRITIS RHEUM, V39, P797, DOI 10.1002/art.1780390513; KUPPER TS, 1987, J CLIN INVEST, V80, P430, DOI 10.1172/JCI113090; Lai CY, 2010, VACCINE, V28, P4945, DOI 10.1016/j.vaccine.2010.05.037; LENNARD AC, 1995, CRIT REV IMMUNOL, V15, P77, DOI 10.1615/CritRevImmunol.v15.i1.30; Liao SF, 2013, P NATL ACAD SCI USA, V110, P13809, DOI 10.1073/pnas.1312457110; Malyak M, 1998, J IMMUNOL, V161, P2004; MCCARTHY PL, 1991, BLOOD, V78, P1915; Meng LZ, 2013, MOLECULES, V18, P5779, DOI 10.3390/molecules18055779; MIYAZAKI T, 1981, CHEM PHARM BULL, V29, P3611; Molnarfi N, 2005, J IMMUNOL, V174, P2974, DOI 10.4049/jimmunol.174.5.2974; Ohmori Y, 1996, J IMMUNOL, V157, P2058; PRIEUR AM, 1987, LANCET, V2, P1240; Pruitt JH, 1996, BLOOD, V87, P3282; Puri P, 1993, CLIN EXP IMMUNOL, V93, P218; SECKINGER P, 1987, Annales de l'Institut Pasteur Immunology, V138, P486; SECKINGER P, 1987, J IMMUNOL, V139, P1541; SECKINGER P, 1987, J IMMUNOL, V139, P1546; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; STYLIANOU E, 1992, J BIOL CHEM, V267, P15836; THOMPSON RC, 1991, AGENT ACTION SUPPL, V35, P41; van den Berg WB, 2001, ARTHRITIS RES, V3, P18, DOI 10.1186/ar136; Vey E, 1997, CYTOKINE, V9, P480, DOI 10.1006/cyto.1997.0191; Wang SY, 1997, INT J CANCER, V70, P699, DOI 10.1002/(SICI)1097-0215(19970317)70:6&lt;699::AID-IJC12&gt;3.0.CO;2-5; Wang YY, 2002, BIOORGAN MED CHEM, V10, P1057, DOI 10.1016/S0968-0896(01)00377-7; Wei M, 2007, BIOTECHNOL LETT, V29, P495, DOI 10.1007/s10529-006-9248-7; Zha XQ, 2007, PHARM BIOL, V45, P71, DOI 10.1080/13880200601028420	57	63	71	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94040	10.1371/journal.pone.0094040	http://dx.doi.org/10.1371/journal.pone.0094040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705413	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500114
J	Paro, HBMS; Silveira, PSP; Perotta, B; Gannam, S; Enns, SC; Giaxa, RRB; Bonito, RF; Martins, MA; Tempski, PZ				Paro, Helena B. M. S.; Silveira, Paulo S. P.; Perotta, Bruno; Gannam, Silmar; Enns, Sylvia C.; Giaxa, Renata R. B.; Bonito, Rosuita F.; Martins, Milton A.; Tempski, Patricia Z.			Empathy among Medical Students: Is There a Relation with Quality of Life and Burnout?	PLOS ONE			English	Article							PHYSICIAN EMPATHY; JEFFERSON SCALE; GENDER; DECLINE; HEALTH; SATISFACTION; ATTITUDES; MOOD; PROFESSIONALISM; EDUCATION	Background: We aimed to assess medical students' empathy and its associations with gender, stage of medical school, quality of life and burnout. Method: A cross-sectional, multi-centric (22 medical schools) study that employed online, validated, self-reported questionnaires on empathy (Interpersonal Reactivity Index), quality of life (The World Health Organization Quality of Life Assessment) and burnout (the Maslach Burnout Inventory) in a random sample of medical students. Results: Out of a total of 1,650 randomly selected students, 1,350 (81.8%) completed all of the questionnaires. Female students exhibited higher dispositional empathic concern and experienced more personal distress than their male counterparts (p < 0.05; d >= 0.5). There were minor differences in the empathic dispositions of students in different stages of their medical training (p < 0.05; f < 0.25). Female students had slightly lower scores for physical and psychological quality of life than male students (p < 0.05; d < 0.5). Female students scored higher on emotional exhaustion and lower on depersonalization than male students (p < 0.001; d < 0.5). Students in their final stage of medical school had slightly higher scores for emotional exhaustion, depersonalization and personal accomplishment (p < 0.05; f < 0.25). Gender (beta = 0.27; p < 0.001) and perspective taking (beta = 0.30; p < 0.001) were significant predictors of empathic concern scores. Depersonalization was associated with lower empathic concern (beta = -0.18) and perspective taking (beta = -0.14) (p < 0.001). Personal accomplishment was associated with higher perspective taking (beta = 0.21; p < 0.001) and lower personal distress (beta = -0.26; p < 0.001) scores. Conclusions: Female students had higher empathic concern and personal distress dispositions. The differences in the empathy scores of students in different stages of medical school were small. Among all of the studied variables, personal accomplishment held the most important association with decreasing personal distress and was also a predicting variable for perspective taking.	[Paro, Helena B. M. S.] Univ Fed Uberlandia, Dept Obstet & Gynecol, BR-38400 Uberlandia, MG, Brazil; [Bonito, Rosuita F.] Univ Fed Uberlandia, Dept Publ Hlth, BR-38400 Uberlandia, MG, Brazil; [Paro, Helena B. M. S.; Martins, Milton A.; Tempski, Patricia Z.] Univ Sao Paulo, Sch Med, Dept Med, Sao Paulo, Brazil; [Silveira, Paulo S. P.] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil; [Enns, Sylvia C.; Martins, Milton A.; Tempski, Patricia Z.] Univ Sao Paulo, Sch Med, Ctr Dev Med Educ, Sao Paulo, Brazil; [Perotta, Bruno] Evangel Med Sch Parana, Curitiba, Parana, Brazil; [Gannam, Silmar] Univ City Sao Paulo, Sao Paulo, Brazil; [Giaxa, Renata R. B.] Univ Fortaleza, Fortaleza, Ceara, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Cidade de Sao Paulo; Universidade Fortaleza	Paro, HBMS (corresponding author), Univ Fed Uberlandia, Dept Obstet & Gynecol, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	helenaparo@terra.com.br	Silveira, Paulo SP/C-9077-2014; Paro, Helena B M S/H-1330-2019; Martins, Milton A/L-7541-2017; Giaxa, Renata Rocha Barreto/H-2170-2019; Martins, Milton A/D-6658-2012; Gannam, Silmar/D-6974-2011	Paro, Helena B M S/0000-0001-6226-3074; Giaxa, Renata Rocha Barreto/0000-0003-0813-2107; Gannam, Silmar/0000-0001-5242-3329; Sergio Panse Silveira, Paulo/0000-0003-4110-1038	CAPES; CNPq	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the following Brazilian scientific agencies: CAPES (http://www.capes.gov.br) and CNPq (http://www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimoglu MK, 2011, ADV PHYSIOL EDUC, V35, P33, DOI 10.1152/advan.00100.2010; Anderson MB, 1999, ACAD MED, V74, P13; [Anonymous], 2013, STAT POWER ANAL BEHA; [Anonymous], 1995, BECOMING PERSON THER; Babaria P, 2009, ACAD MED, V84, P859, DOI 10.1097/ACM.0b013e3181a8130c; Bellini LM, 2005, ACAD MED, V80, P164, DOI 10.1097/00001888-200502000-00013; Bellini LM, 2002, JAMA-J AM MED ASSOC, V287, P3143, DOI 10.1001/jama.287.23.3143; Bombeke K, 2011, PATIENT EDUC COUNS, V84, P310, DOI 10.1016/j.pec.2011.03.007; Brazeau CMLR, 2010, ACAD MED, V85, pS33, DOI 10.1097/ACM.0b013e3181ed4c47; Chandavarkar U, 2007, DEPRESS ANXIETY, V24, P103, DOI 10.1002/da.20185; Cochran W., 1986, SAMPLING TECHNIQUES; Colliver JA, 2010, ACAD MED, V85, P588, DOI 10.1097/ACM.0b013e3181d281dc; Costa P, 2013, ADV HEALTH SCI EDUC, V18, P509, DOI 10.1007/s10459-012-9390-z; DAVIS CM, 1990, PHYS THER, V70, P707, DOI 10.1093/ptj/70.11.707; Davis M, 1980, JSAS CATALOG SELECTE, V10; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Decety J, 2012, SO NEUROSCI SER, P1; Duan CM, 1996, J COUNS PSYCHOL, V43, P261, DOI 10.1037/0022-0167.43.3.261; Dyrbye LN, 2014, ACAD MED, V89, P443, DOI 10.1097/ACM.0000000000000134; Dyrbye LN, 2012, ACAD MED, V87, P1024, DOI 10.1097/ACM.0b013e31825cfa35; Dyrbye LN, 2010, JAMA-J AM MED ASSOC, V304, P1173, DOI 10.1001/jama.2010.1318; Dyrbye LN, 2006, ACAD MED, V81, P374, DOI 10.1097/00001888-200604000-00010; EISENBERG N, 1983, PSYCHOL BULL, V94, P100, DOI 10.1037/0033-2909.94.1.100; Fleck MPA, 2000, REV SAUDE PUBL, V34, P178, DOI 10.1590/S0034-89102000000200012; Galan F, 2011, INT ARCH OCC ENV HEA, V84, P453, DOI 10.1007/s00420-011-0623-x; General Medical Council, 2009, TOM DOCT OUTC STAND; Gruhn D, 2008, EMOTION, V8, P753, DOI 10.1037/a0014123; Haas JS, 2000, J GEN INTERN MED, V15, P122, DOI 10.1046/j.1525-1497.2000.02219.x; HOGAN R, 1969, J CONSULT CLIN PSYCH, V33, P307, DOI 10.1037/h0027580; Hojat M, 2005, MED TEACH, V27, P625, DOI 10.1080/01421590500069744; Hojat M, 2004, MED EDUC, V38, P934, DOI 10.1111/j.1365-2929.2004.01911.x; Hojat M, 2001, EDUC PSYCHOL MEAS, V61, P349, DOI 10.1177/00131640121971158; Hojat M, 1999, MED EDUC, V33, P342, DOI 10.1046/j.1365-2923.1999.00331.x; Hojat M, 2007, EMPATHY PATIENT CARE; Hojat M, 2013, MED TEACH, V35, P996, DOI 10.3109/0142159X.2013.802300; Hojat M, 2009, ACAD MED, V84, P1182, DOI 10.1097/ACM.0b013e3181b17e55; Kataoka HU, 2009, ACAD MED, V84, P1192, DOI 10.1097/ACM.0b013e3181b180d4; Kjeldstadli Kari, 2006, BMC Med Educ, V6, P48, DOI 10.1186/1472-6920-6-48; Koller S. H., 2001, ESTUD PSICOL-CAMPINA, V18, P43, DOI [DOI 10.1590/S0103-166X2001000300004, 10.1590/S0103-166X2001000300004]; Lautert L., 1995, THESIS U PONTIFICIA; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; Magalhaes E, 2012, MED TEACH, V34, P807, DOI 10.3109/0142159X.2012.702248; Magalhaes E, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-52; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Maslach C., 1996, MASLACH BURNOUT INVE; Neumann M, 2011, ACAD MED, V86, P996, DOI 10.1097/ACM.0b013e318221e615; Newton BW, 2008, ACAD MED, V83, P244, DOI 10.1097/ACM.0b013e3181637837; Novack DH, 1997, JAMA-J AM MED ASSOC, V278, P502, DOI 10.1001/jama.278.6.502; Ogle J, 2013, MED EDUC, V47, P824, DOI 10.1111/medu.12232; PARKERSON GR, 1990, ACAD MED, V65, P586, DOI 10.1097/00001888-199009000-00009; Paro HBMS, 2010, MED EDUC, V44, P227, DOI 10.1111/j.1365-2923.2009.03587.x; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Quince TA, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-90; Rahimi-Madiseh M, 2010, MED TEACH, V32, pE471, DOI 10.3109/0142159X.2010.509419; Risberg G, 2011, MED EDUC, V45, P613, DOI 10.1111/j.1365-2923.2010.03920.x; ROGERS CR, 1975, COUNS PSYCHOL, V5, P2, DOI 10.1177/001100007500500202; Rosen IM, 2006, ACAD MED, V81, P82, DOI 10.1097/00001888-200601000-00020; Shanafelt TD, 2005, J GEN INTERN MED, V20, P559, DOI 10.1007/s11606-005-0102-8; Shapiro Johanna, 2004, Educ Health (Abingdon), V17, P73; Shapiro SL, 1998, J BEHAV MED, V21, P581, DOI 10.1023/A:1018700829825; Stepien KA, 2006, J GEN INTERN MED, V21, P524, DOI 10.1111/j.1525-1497.2006.00443.x; Stratton TD, 2008, TEACH LEARN MED, V20, P279, DOI 10.1080/10401330802199625; Thomas MR, 2007, J GEN INTERN MED, V22, P177, DOI 10.1007/s11606-006-0039-6; Tyssen R, 2009, SOC PSYCH PSYCH EPID, V44, P47, DOI 10.1007/s00127-008-0403-4; VERBRUGGE LM, 1985, J HEALTH SOC BEHAV, V26, P156, DOI 10.2307/2136750; Wallace DS, 2005, REV GEN PSYCHOL, V9, P214, DOI 10.1037/1089-2680.9.3.214; Willcock SM, 2004, MED J AUSTRALIA, V181, P357, DOI 10.5694/j.1326-5377.2004.tb06325.x; WOLF TM, 1994, MED EDUC, V28, P8, DOI 10.1111/j.1365-2923.1994.tb02679.x; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049714	69	103	114	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94133	10.1371/journal.pone.0094133	http://dx.doi.org/10.1371/journal.pone.0094133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6MJ	24705887	Green Submitted, gold, Green Published			2022-12-27	WOS:000334107500127
J	Tojo, M; Fujita, T; Ainoda, Y; Nagamatsu, M; Hayakawa, K; Mezaki, K; Sakurai, A; Masui, Y; Yazaki, H; Takahashi, H; Miyoshi-Akiyama, T; Totsuka, K; Kirikae, T; Ohmagari, N				Tojo, Masayoshi; Fujita, Takahiro; Ainoda, Yusuke; Nagamatsu, Maki; Hayakawa, Kayoko; Mezaki, Kazuhisa; Sakurai, Aki; Masui, Yoshinori; Yazaki, Hirohisa; Takahashi, Hiroshi; Miyoshi-Akiyama, Tohru; Totsuka, Kyoichi; Kirikae, Teruo; Ohmagari, Norio			Evaluation of an Automated Rapid Diagnostic Assay for Detection of Gram-Negative Bacteria and Their Drug-Resistance Genes in Positive Blood Cultures	PLOS ONE			English	Article							NUCLEIC-ACID TEST; MOLECULAR DIAGNOSIS; STREAM INFECTIONS; IDENTIFICATION; ORGANISMS; SEPSIS; THERAPY; MARKERS; SYSTEM; IMPACT	We evaluated the performance of the Verigene Gram-Negative Blood Culture Nucleic Acid Test (BC-GN; Nanosphere, Northbrook, IL, USA), an automated multiplex assay for rapid identification of positive blood cultures caused by 9 Gramnegative bacteria (GNB) and for detection of 9 genes associated with beta-lactam resistance. The BC-GN assay can be performed directly from positive blood cultures with 5 minutes of hands-on and 2 hours of run time per sample. A total of 397 GNB positive blood cultures were analyzed using the BC-GN assay. Of the 397 samples, 295 were simulated samples prepared by inoculating GNB into blood culture bottles, and the remaining were clinical samples from 102 patients with positive blood cultures. Aliquots of the positive blood cultures were tested by the BC-GN assay. The results of bacterial identification between the BC-GN assay and standard laboratory methods were as follows: Acinetobacter spp. (39 isolates for the BC-GN assay/39 for the standard methods), Citrobacter spp. (7/7), Escherichia coli (87/87), Klebsiella oxytoca (13/13), and Proteus spp. (11/11); Enterobacter spp. (29/30); Klebsiella pneumoniae (62/72); Pseudomonas aeruginosa (124/125); and Serratia marcescens (18/21); respectively. From the 102 clinical samples, 104 bacterial species were identified with the BC-GN assay, whereas 110 were identified with the standard methods. The BC-GN assay also detected all beta-lactam resistance genes tested (233 genes), including 54 bla(CTX-M), 119 bla(IMP), 8 bla(KPC), 16 bla(NDM), 24 bla(OXA-23), 1 bla(OXA-24/40), 1 bla(OXA-48), 4 bla(OXA-58), and 6 bla(VIM). The data shows that the BC-GN assay provides rapid detection of GNB and beta-lactam resistance genes in positive blood cultures and has the potential to contributing to optimal patient management by earlier detection of major antimicrobial resistance genes.	[Tojo, Masayoshi; Nagamatsu, Maki; Hayakawa, Kayoko; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Res Inst, Tokyo, Japan; [Tojo, Masayoshi; Nagamatsu, Maki; Miyoshi-Akiyama, Tohru; Kirikae, Teruo] Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Tokyo, Japan; [Fujita, Takahiro; Ainoda, Yusuke; Totsuka, Kyoichi] Tokyo Womens Med Univ, Dept Infect Dis, Tokyo, Japan; [Mezaki, Kazuhisa] Natl Ctr Global Hlth & Med, Dept Clin Lab, Tokyo, Japan; [Sakurai, Aki] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Pulm Med, Chiba, Japan; [Masui, Yoshinori] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Internal Med, Chiba, Japan; [Yazaki, Hirohisa] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Takahashi, Hiroshi] East West Diagnost Theranost LLC, San Francisco, CA USA	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Tokyo Women's Medical University; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Kirikae, T (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Tokyo, Japan.	tkirikae@ri.ncgm.go.jp	Ohmagari, Norio/GLN-5290-2022; Hayakawa, Kayoko/GNW-2394-2022	Ohmagari, Norio/0000-0002-4622-8970; Ainoda, Yusuke/0000-0002-1009-8414	National Center for Global Health and Medicine [24-207]; East-West Diagnostics/Theranostics, LLC	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); East-West Diagnostics/Theranostics, LLC	This work was supported by the grant of National Center for Global Health and Medicine (24-207). East-West Diagnostics/Theranostics, LLC provided support in the form of salaries for author HT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alby K, 2013, J CLIN MICROBIOL, V51, P3869, DOI 10.1128/JCM.01587-13; Altun O, 2013, J CLIN MICROBIOL, V51, P4130, DOI 10.1128/JCM.01835-13; Beal SG, 2013, J CLIN MICROBIOL, V51, P3988, DOI 10.1128/JCM.01889-13; Buchan BW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001478; Bush K., 2010, ANTIMICROB AGENTS CH, V54, P969, DOI [DOI 10.1128/AAC.01009-09, 10.1128/aac.01009-09]; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Clinical Laboratory Standards Institute, 2009, M07A7 CLIN LAB STAND; European Centre for disease prevention and Control (ECDC), 2012, HEALTHC ASS INF, P212; Fujita S, 2011, J CLIN MICROBIOL, V49, P1483, DOI 10.1128/JCM.01976-10; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; Kouyama Y, 2012, J INFECT CHEMOTHER, V18, P522, DOI 10.1007/s10156-012-0374-y; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; Leggieri N, 2010, CURR OPIN INFECT DIS, V23, P311, DOI 10.1097/QCO.0b013e32833bfc44; Liesenfeld O, 2014, EUR J MICRO IN PRESS; Mancini N, 2008, J MED MICROBIOL, V57, P601, DOI 10.1099/jmm.0.47732-0; Mestas J, 2014, J CLIN MICROBIOL, V52, P283, DOI 10.1128/JCM.02322-13; Morgan M, 2010, J CLIN MICROBIOL, V48, P2268, DOI 10.1128/JCM.00166-10; Nagao M, 2012, CLIN MICROBIOL INFEC; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Petti C, 2011, MANUAL CLIN MICROBIO, V10th, P15; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Samuel LP, 2013, J CLIN MICROBIOL, V51, P1188, DOI 10.1128/JCM.02982-12; Sango A, 2013, J CLIN MICROBIOL, V51, P4008, DOI 10.1128/JCM.01951-13; Seki M, 2013, J MED MICROBIOL, V62, P801, DOI 10.1099/jmm.0.051334-0; Shorr AF, 2011, CRIT CARE MED, V39, P46, DOI 10.1097/CCM.0b013e3181fa41a7; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Sontakke S, 2009, J MICROBIOL METH, V76, P217, DOI 10.1016/j.mimet.2008.11.002; Sullivan KV, 2013, J CLIN MICROBIOL, V51, P3579, DOI 10.1128/JCM.01224-13; Tissari P, 2010, LANCET, V375, P224, DOI 10.1016/S0140-6736(09)61569-5; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wojewoda CM, 2013, J CLIN MICROBIOL, V51, P2072, DOI 10.1128/JCM.00831-13; Zhang CX, 2009, INT J SYST EVOL MICR, V59, P1603, DOI 10.1099/ijs.0.65718-0	33	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94064	10.1371/journal.pone.0094064	http://dx.doi.org/10.1371/journal.pone.0094064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705449	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500116
J	Klein, M; Brouwer, MC; Angele, B; Geldhoff, M; Marquez, G; Varona, R; Hacker, G; Schmetzer, H; Hacker, H; Hammerschmidt, S; van der Ende, A; Pfister, HW; van de Beek, D; Koedel, U				Klein, Matthias; Brouwer, Matthijs C.; Angele, Barbara; Geldhoff, Madelijn; Marquez, Gabriel; Varona, Rosa; Haecker, Georg; Schmetzer, Helga; Haecker, Hans; Hammerschmidt, Sven; van der Ende, Arie; Pfister, Hans-Walter; van de Beek, Diederik; Koedel, Uwe			Leukocyte Attraction by CCL20 and Its Receptor CCR6 in Humans and Mice with Pneumococcal Meningitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; IMMUNE-RESPONSE; STREPTOCOCCUS-PNEUMONIAE; CHEMOTACTIC ACTIVITY; PROTEIN EXPRESSION; ENDOTHELIAL-CELLS; DENDRITIC CELLS; CHEMOKINE; RECRUITMENT; INFLAMMATION	We previously identified CCL20 as an early chemokine in the cerebrospinal fluid (CSF) of patients with pneumococcal meningitis but its functional relevance was unknown. Here we studied the role of CCL20 and its receptor CCR6 in pneumococcal meningitis. In a prospective nationwide study, CCL20 levels were significantly elevated in the CSF of patients with pneumococcal meningitis and correlated with CSF leukocyte counts. CCR6 deficient mice with pneumococcal meningitis and WT mice with pneumococcal meningitis treated with anti-CCL20 antibodies both had reduced CSF white blood cell counts. The reduction in CSF pleocytosis was also accompanied by an increase in brain bacterial titers. Additional in vitro experiments showed direct chemoattractant activity of CCL20 for granulocytes. In summary, our results identify the CCL20-CCR6 axis as an essential component of the innate immune defense against pneumococcal meningitis, controlling granulocyte recruitment.	[Klein, Matthias; Angele, Barbara; Pfister, Hans-Walter; Koedel, Uwe] Univ Munich, Dept Neurol, D-80539 Munich, Germany; [Brouwer, Matthijs C.; Geldhoff, Madelijn; van de Beek, Diederik] Univ Amsterdam, Dept Neurol, Amsterdam, Netherlands; [Brouwer, Matthijs C.; Geldhoff, Madelijn; van der Ende, Arie; van de Beek, Diederik] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Marquez, Gabriel] Genetrix, Madrid, Spain; [Varona, Rosa] Ctr Natl Biotecnol, Dept Immunol & Oncol, Madrid, Spain; [Haecker, Georg] Univ Freiburg, Inst Med Microbiol & Hyg, D-79106 Freiburg, Germany; [Schmetzer, Helga] Univ Munich, Dept Med 3, Munich, Germany; [Haecker, Hans] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Greifswald, Germany; [van der Ende, Arie] Univ Amsterdam, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	University of Munich; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Freiburg; University of Munich; St Jude Children's Research Hospital; Ernst Moritz Arndt Universitat Greifswald; University of Amsterdam	Klein, M (corresponding author), Univ Munich, Dept Neurol, D-80539 Munich, Germany.	matthias.klein@med.uni-muenchen.de	Hammerschmidt, Sven/G-2598-2010; van de Beek, Diederik/Y-2713-2019; Haecker, Hans/F-6826-2013; Klein, Matthias/F-4118-2017	Hammerschmidt, Sven/0000-0002-6382-6681; van de Beek, Diederik/0000-0002-4571-044X; Haecker, Hans/0000-0001-5971-0451; Klein, Matthias/0000-0001-9064-6865; Brouwer, Matthijs/0000-0001-7775-7843; van der Ende, Arie/0000-0003-1298-3086	Meningitis Research Foundation (MRF); Deutsche Forschungsgemeinschaft (DFG); University of Munich; Friedrich Baur Stiftung; Else Kroener Fresenius Foundation (EKFS); American Lebanese Syrian Associated Charities (ALSAC); Netherlands Organization for Health Research and Development (ZonMw NWO-Veni) [916.76.023]; Netherlands Organization for Health Research and Development (ZonMw NWO406 Vidi) [917.11.358]; Academic Medical Center (AMC); European Research Council (ERC) [281156]	Meningitis Research Foundation (MRF)(Meningitis Research Foundation (MRF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Munich; Friedrich Baur Stiftung; Else Kroener Fresenius Foundation (EKFS); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); Netherlands Organization for Health Research and Development (ZonMw NWO-Veni)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Netherlands Organization for Health Research and Development (ZonMw NWO406 Vidi); Academic Medical Center (AMC); European Research Council (ERC)(European Research Council (ERC)European Commission)	The financial aid of the Meningitis Research Foundation (MRF), the Deutsche Forschungsgemeinschaft (DFG), the University of Munich (FoFoLe), the Friedrich Baur Stiftung, and the Else Kroener Fresenius Foundation (EKFS) to M. K., U. K., and H. W. P. is highly appreciated. Also, the authors thank the American Lebanese Syrian Associated Charities (ALSAC) for support of H. H. The support from the Netherlands Organization for Health Research and Development (ZonMw NWO-Veni grant 2006 [916.76.023] and ZonMw NWO406 Vidi grant 2010 [917.11.358], both to D. B.), the Academic Medical Center (AMC Fellowship 2008 to D. B.), and European Research Council (ERC Starting Grant [281156] to D. B.) are appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2010, CYTOKINE, V51, P101, DOI 10.1016/j.cyto.2010.03.001; Bennouna S, 2003, J IMMUNOL, V171, P6052, DOI 10.4049/jimmunol.171.11.6052; Bermpohl D, 2005, J CLIN INVEST, V115, P1607, DOI 10.1172/JCI23223; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Brouwer MC, 2010, NEUROLOGY, V75, P1533, DOI 10.1212/WNL.0b013e3181f96297; Comerford I, 2010, BIOESSAYS, V32, P1067, DOI 10.1002/bies.201000063; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Frommhold D, 2010, BLOOD, V116, P841, DOI 10.1182/blood-2009-09-244293; Gaida MM, 2008, CLIN EXP IMMUNOL, V154, P216, DOI 10.1111/j.1365-2249.2008.03745.x; Hieshima K, 1997, J BIOL CHEM, V272, P5846, DOI 10.1074/jbc.272.9.5846; Hirst RA, 2004, CLIN EXP IMMUNOL, V138, P195, DOI 10.1111/j.1365-2249.2004.02611.x; Hoegen T, 2011, J IMMUNOL, V187, P5440, DOI 10.4049/jimmunol.1100790; Hromas R, 1997, BLOOD, V89, P3315; Kastenbauer S, 2005, J NEUROIMMUNOL, V164, P134, DOI 10.1016/j.jneuroim.2005.03.009; Keller M, 2005, J IMMUNOL, V175, P7678, DOI 10.4049/jimmunol.175.11.7678; Klein M, 2009, EXPERT OPIN PHARMACO, V10, P2609, DOI 10.1517/14656560903277210; Klein M, 2008, J INFECT DIS, V198, P1028, DOI 10.1086/591626; Klein M, 2006, MICROBES INFECT, V8, P974, DOI 10.1016/j.micinf.2005.10.013; Koedel U, 2004, BRAIN, V127, P1437, DOI 10.1093/brain/awh171; Koedel U, 2003, J IMMUNOL, V170, P438, DOI 10.4049/jimmunol.170.1.438; Koedel U, 1999, J IMMUNOL, V163, P1237; Koedel U, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000461; Kohler RE, 2003, J IMMUNOL, V170, P6298, DOI 10.4049/jimmunol.170.12.6298; Lee AYS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00194; Lee JS, 2008, SCAND J IMMUNOL, V67, P77, DOI 10.1111/j.1365-3083.2007.02040.x; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11; Nakanishi T, 2005, J ENDODONT, V31, P84, DOI 10.1097/01.don.0000143414.22112.57; Ravindran R, 2007, P NATL ACAD SCI USA, V104, P12075, DOI 10.1073/pnas.0701363104; Rohrl J, 2010, J BIOL CHEM, V285, P7028, DOI 10.1074/jbc.M109.091090; Rossi DL, 1997, J IMMUNOL, V158, P1033; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Tanida S, 2009, CYTOKINE, V47, P112, DOI 10.1016/j.cyto.2009.05.009; Tomimori K, 2007, INFECT IMMUN, V75, P5223, DOI 10.1128/IAI.00731-07; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; Varona R, 2003, EUR J IMMUNOL, V33, P2937, DOI 10.1002/eji.200324347; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wang L, 2008, BIOCHEM BIOPH RES CO, V366, P852, DOI 10.1016/j.bbrc.2007.12.030; Wen HT, 2007, EUR J IMMUNOL, V37, P2487, DOI 10.1002/eji.200737370; Winder AA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-96; Woehrl B, 2011, J CLIN INVEST, V121, P3943, DOI 10.1172/JCI57522; Wu YY, 2007, INFECT IMMUN, V75, P4357, DOI 10.1128/IAI.01660-06; Yamashiro S, 2000, BLOOD, V96, P3958, DOI 10.1182/blood.V96.12.3958.h8003958_3958_3963; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yoshida A, 2009, CLIN IMMUNOL, V130, P290, DOI 10.1016/j.clim.2008.09.016; Zysk G, 2001, INFECT IMMUN, V69, P845, DOI 10.1128/IAI.69.2.845-852.2001	47	16	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93057	10.1371/journal.pone.0093057	http://dx.doi.org/10.1371/journal.pone.0093057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699535	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000040
J	Ruchonnet-Metrailler, I; Bessieres, B; Bonnet, D; Vibhushan, S; Delacourt, C				Ruchonnet-Metrailler, Isabelle; Bessieres, Bettina; Bonnet, Damien; Vibhushan, Shamila; Delacourt, Christophe			Pulmonary Hypoplasia Associated with Congenital Heart Diseases: A Fetal Study	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; LUNG-FUNCTION; EXERCISE CAPACITY; VEGF-A; TETRALOGY; FALLOT; SURGERY; REPAIR; MORPHOGENESIS; CIRCULATION	Background: Abnormalities of the fetal pulmonary vasculature may affect lung morphogenesis. Postnatal studies have suggested that pulmonary hypoplasia (PH) may be associated with congenital heart diseases (CHDs). Objective: To determine the prevalence of PH associated with CHDs, and to evaluate whether CHDs with right outflow obstruction were associated with the highest risk of lung growth impairment. Methods: Between January 2006 and December 2010, fetuses with CHD obtained following the termination of pregnancies due to fetal abnormalities were examined in a prospective manner for the detection of heart and lung defects. CHDs were classified into five pathophysiological groups. Lung weight (LW), body weight (BW), and LW/BW ratio were analyzed for each case. The expression of CD31 and VEGF in the lung was evaluated by immunohistochemistry. Results: Fetuses with CHDs and right outflow obstruction had significantly lower LW for a given BW, and significantly lower LW/BW ratios for a given gestational age. When defining PH as a fetal LW/BW ratio <0.015 before 28 weeks, and <0.012 after 28 weeks, PH was detected in 15 of the 119 fetuses analyzed (13%). It was significantly associated with CHD with right outflow obstruction, independently of chromosomal abnormalities and associated extracardiac abnormalities (p<0.03). Right outflow obstruction was detected in 60% of the fetuses with CHD and PH, but in only 32% of those with CHD but no PH. In fetuses with right outflow obstruction, no difference was observed between those with PH and those without PH, in terms of the ratio of pulmonary artery diameter to aortic diameter, lung CD31 expression, or lung VEGF expression. Conclusion: CHDs with right outflow obstruction are a significant risk factor for prenatally acquired PH. The occurrence of fetal PH is not correlated with abnormalities of the pulmonary vasculature, suggesting the involvement of perfusion-independent mechanisms.	[Ruchonnet-Metrailler, Isabelle; Delacourt, Christophe] Hop Necker Enfants Malad, AP HP, Serv Pneumol Pediat, Ctr Reference Malad Resp Rares Enfant, Paris, France; [Bessieres, Bettina] Hop Necker Enfants Malad, AP HP, Serv Histoembryol & Cytogenet, Paris, France; [Bessieres, Bettina; Delacourt, Christophe] INSERM UMR 781, Paris, France; [Bonnet, Damien] Hop Necker Enfants Malad, AP HP, Ctr Reference Malformat Cardiaques Congenitale Co, Paris, France; [Bonnet, Damien; Delacourt, Christophe] Univ Paris 05, Paris, France; [Vibhushan, Shamila] INSERM, IMRB, Equipe 04, U955, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Delacourt, C (corresponding author), Hop Necker Enfants Malad, AP HP, Serv Pneumol Pediat, Ctr Reference Malad Resp Rares Enfant, Paris, France.	christophe.delacourt@nck.aphp.fr	Delacourt, Christophe/K-6161-2019; Ruchonnet-Métrailler, Isabelle/E-9921-2017	Ruchonnet-Métrailler, Isabelle/0000-0003-4771-875X; Vibhushan, Shamila/0000-0001-6196-2295	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This study is funded by INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeson AL, 2003, DEV BIOL, V264, P443, DOI 10.1016/j.ydbio.2003.09.004; Boucherat O, 2010, AM J PHYSIOL-LUNG C, V298, pL849, DOI 10.1152/ajplung.00333.2009; DETROYER A, 1977, CIRCULATION, V56, P647, DOI 10.1161/01.CIR.56.4.647; Ercisli M, 2005, CHEST, V128, P1010, DOI 10.1378/chest.128.2.1010; Filby CE, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-42; GAULTIER C, 1986, CHEST, V89, P561, DOI 10.1378/chest.89.4.561; Greenberg JM, 2002, DEV DYNAM, V224, P144, DOI 10.1002/dvdy.10095; HAWORTH SG, 1977, THORAX, V32, P129, DOI 10.1136/thx.32.2.129; Izbicki G, 2008, ISR MED ASSOC J, V10, P564; JOHNSON RJ, 1982, THORAX, V37, P893, DOI 10.1136/thx.37.12.893; JONSSON H, 1994, J THORAC CARDIOV SUR, V108, P1002, DOI 10.1016/S0022-5223(94)70141-5; Khoshnood B, 2012, HEART, V98, P1667, DOI 10.1136/heartjnl-2012-302543; Laudy JAM, 2000, ULTRASOUND OBST GYN, V16, P482, DOI 10.1046/j.1469-0705.2000.00252.x; Lazarus A, 2011, DEVELOPMENT, V138, P2359, DOI 10.1242/dev.060723; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Pianosi PT, 2009, CONGENIT HEART DIS, V4, P2, DOI 10.1111/j.1747-0803.2008.00244.x; RABINOVITCH M, 1981, CIRCULATION, V64, P1234, DOI 10.1161/01.CIR.64.6.1234; ROWE SA, 1991, J AM COLL CARDIOL, V17, P461, DOI 10.1016/S0735-1097(10)80116-0; Rudolph AM, 2010, ARCH DIS CHILD-FETAL, V95, pF132, DOI 10.1136/adc.2007.128777; Sandaite I, 2013, PRENATAL DIAG, V33, P318, DOI 10.1002/pd.4070; Sulc J, 1996, PEDIATR CARDIOL, V17, P1, DOI 10.1007/BF02505804; Sulc J, 1998, HEART, V80, P484; Trojnarska O, 2010, INT J CARDIOL, V139, P241, DOI 10.1016/j.ijcard.2008.10.025; Velozo LF, 2010, PEDIATR DEVEL PATHOL, V13, P95, DOI 10.2350/08-02-0422.1; Voelkel NF, 2006, AM J PHYSIOL-LUNG C, V290, pL209, DOI 10.1152/ajplung.00185.2005; WALLEN LD, 1994, AM J RESP CRIT CARE, V149, P1005, DOI 10.1164/ajrccm.149.4.8143035; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; WEIBEL ER, 1997, LUNG SCI FDN, P333; WESSEL HU, 1981, J THORAC CARDIOV SUR, V82, P616; WIGGLESWORTH JS, 1981, ARCH DIS CHILD, V56, P601, DOI 10.1136/adc.56.8.601; Xu YQ, 2012, EXP LUNG RES, V38, P355, DOI 10.3109/01902148.2012.708385; Yamamoto H, 2007, DEV BIOL, V308, P44, DOI 10.1016/j.ydbio.2007.04.042; Zeng X, 1998, DEV DYNAM, V211, P215, DOI 10.1002/(SICI)1097-0177(199803)211:3<215::AID-AJA3>3.0.CO;2-K	33	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93557	10.1371/journal.pone.0093557	http://dx.doi.org/10.1371/journal.pone.0093557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699523	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000068
J	Allen, SJ; Tyne, JA; Kobryn, HT; Bejder, L; Pollock, KH; Loneragan, NR				Allen, Simon J.; Tyne, Julian A.; Kobryn, Halina T.; Bejder, Lars; Pollock, Kenneth H.; Loneragan, Neil R.			Patterns of Dolphin Bycatch in a North-Western Australian Trawl Fishery	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; MARINE MAMMALS; NEW-ZEALAND; BY-CATCH; DELPHINUS-DELPHIS; HECTORS DOLPHIN; MANAGEMENT; BEHAVIOR; POPULATIONS; EXTINCTION	The bycatch of small cetaceans in commercial fisheries is a global wildlife management problem. We used data from skippers' logbooks and independent observers to assess common bottlenose dolphin (Tursiops truncatus) bycatch patterns between 2003 and 2009 in the Pilbara Trawl Fishery, Western Australia. Both datasets indicated that dolphins were caught in all fishery areas, across all depths and throughout the year. Over the entire datasets, observer reported bycatch rates (n = 52 dolphins in 4,124 trawls, or 12.6 dolphins/1,000 trawls) were ca. double those reported by skippers (n = 180 dolphins in 27,904 trawls, or 6.5 dolphins/1,000 trawls). Generalised Linear Models based on observer data, which better explained the variation in dolphin bycatch, indicated that the most significant predictors of dolphin catch were: (1) vessel - one trawl vessel caught significantly more dolphins than three others assessed; (2) time of day - the lowest dolphin bycatch rates were between 00: 00 and 05: 59; and (3) whether nets included bycatch reduction devices (BRDs) - the rate was reduced by ca. 45%, from 18.8 to 10.3 dolphins/1,000 trawls, after their introduction. These results indicated that differences among vessels (or skippers' trawling techniques) and dolphin behavior (a diurnal pattern) influenced the rates of dolphin capture; and that spatial or seasonal adjustments to trawling effort would be unlikely to significantly reduce dolphin bycatch. Recent skipper's logbook data show that dolphin bycatch rates have not declined since those reported in 2006, when BRDs were introduced across the fishery. Modified BRDs, with top-opening escape hatches from which dolphins might escape to the surface, may be a more effective means of further reducing dolphin bycatch. The vulnerability of this dolphin population to trawling-related mortality cannot be assessed in the absence of an ongoing observer program and without information on trawler-associated dolphin community size, broader dolphin population size and connectivity with adjacent populations.	[Allen, Simon J.; Tyne, Julian A.; Kobryn, Halina T.; Bejder, Lars; Pollock, Kenneth H.; Loneragan, Neil R.] Murdoch Univ, Sch Vet & Life Sci, Ctr Fish Fisheries & Aquat Ecosyst Res, Cetacean Res Unit, Murdoch, WA 6150, Australia; [Pollock, Kenneth H.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	Murdoch University; University of North Carolina; North Carolina State University	Allen, SJ (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Ctr Fish Fisheries & Aquat Ecosyst Res, Cetacean Res Unit, Murdoch, WA 6150, Australia.	S.Allen@murdoch.edu.au	Loneragan, Neil/A-3386-2008; Bejder, Lars/D-1772-2017; Kobryn, Halina/E-5051-2012	Loneragan, Neil/0000-0003-2536-8656; Bejder, Lars/0000-0001-8138-8606; Allen, Simon/0000-0002-2260-8143; Tyne, Julian/0000-0002-0676-5659; Kobryn, Halina/0000-0003-1004-7593	Australian Government's Fisheries Research and Development Corporation; Western Australian Government's Development of Better Industry Fund; Nickol Bay Professional Fishers Association Inc. through the FRDC's Tactical Research Fund [2008/048]	Australian Government's Fisheries Research and Development Corporation(Fisheries R&D Corp); Western Australian Government's Development of Better Industry Fund; Nickol Bay Professional Fishers Association Inc. through the FRDC's Tactical Research Fund	The Australian Government's Fisheries Research and Development Corporation (http://frdc.com.au/Pages/home.aspx), the Western Australian Government's Development of Better Industry Fund, and the Nickol Bay Professional Fishers Association Inc. funded this research through the FRDC's Tactical Research Fund (Project No. 2008/048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen S, 2010, REDUCING DOLPHIN BYC; Allen Simon J., 2012, Pacific Conservation Biology, V18, P56; Althaus F, 2006, 10 N W SHELF JOINT E; [Anonymous], [No title captured]; Ansmann IC, 2012, ANIM BEHAV, V84, P575, DOI 10.1016/j.anbehav.2012.06.009; Bannister J, 1996, ACTION PLAN AUSTR CE; Brewer D, 2006, FISH RES, V81, P176, DOI 10.1016/j.fishres.2006.07.009; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chilvers BL, 2001, P ROY SOC B-BIOL SCI, V268, P1901, DOI 10.1098/rspb.2001.1732; Cox TM, 2004, BIOL CONSERV, V115, P203, DOI 10.1016/S0006-3207(03)00108-3; Cramer KL, 2008, MAR ECOL PROG SER, V369, P273, DOI 10.3354/meps07606; Daura-Jorge FG, 2012, BIOL LETTERS, V8, P702, DOI 10.1098/rsbl.2012.0174; Dawson S, 2001, MAR MAMMAL SCI, V17, P366, DOI 10.1111/j.1748-7692.2001.tb01278.x; Dawson SM, 2013, ENDANGER SPECIES RES, V19, P201, DOI 10.3354/esr00464; Diver G, 2012, 2009048 FRDC DIV; Donaldson R., 2010, Pacific Conservation Biology, V16, P157; Fernandez-Contreras MM, 2010, ICES J MAR SCI, V67, P1732, DOI 10.1093/icesjms/fsq077; Fletcher W.J., 2013, STATUS REPORTS FISHE; Fletcher WJ, 2011, 201011 DEP FISH; Hale P, 2008, MAMMALS AUSTR, P839; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; Hall MA, 1998, REV FISH BIOL FISHER, V8, P1, DOI 10.1023/A:1008854816580; Hamer DJ, 2013, BIOL CONSERV, V157, P386, DOI 10.1016/j.biocon.2012.07.010; Hamer D. J., 2011, Endangered Species Research, V14, P203, DOI 10.3354/esr00353; Hamer DJ, 2008, BIOL CONSERV, V141, P2865, DOI 10.1016/j.biocon.2008.08.024; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Jaiteh VF, 2013, MAR MAMMAL SCI, V29, pE266, DOI 10.1111/j.1748-7692.2012.00620.x; Jaramillo-Legorreta A, 2007, CONSERV BIOL, V21, P1653, DOI 10.1111/j.1523-1739.2007.00825.x; Kelleher Kieran, 2005, FAO FISHERIES TECHNI; KENNELLY SJ, 1995, REV FISH BIOL FISHER, V5, P213; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lusseau D, 2005, MAR ECOL PROG SER, V295, P265, DOI 10.3354/meps295265; Lyle JM, 2008, DOLPHIN SEAL INTERAC; Moore JE, 2010, BIOL CONSERV, V143, P795, DOI 10.1016/j.biocon.2009.12.023; Northridge S., 2003, MF0726 DEFRA; Northridge S, 2011, BYCATCH VULNERABLE S; Northridge SP, 1991, 251 FAO, P1; Northridge SP, 2005, DOLPHIN BYCATCH OBSE; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Perrin William F., 1994, Reports of the International Whaling Commission Special Issue, V15, P1; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rayment W, 2011, MAR MAMMAL SCI, V27, P398, DOI 10.1111/j.1748-7692.2010.00407.x; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Reeves RR, 2013, ENDANGER SPECIES RES, V20, P71, DOI 10.3354/esr00481; Rice D. W., 1998, SPECIAL PUBLICATION, V4; Ross G.J., 2006, REV CONSERVATION STA; Sainsbury KJ, 1987, BIOL FISHERIES MANAG; SHANE SH, 1986, MAR MAMMAL SCI, V2, P34, DOI 10.1111/j.1748-7692.1986.tb00026.x; Shaughnessy Peter, 2003, P136; Slooten E, 2006, BIOL CONSERV, V128, P576, DOI 10.1016/j.biocon.2005.10.013; Slooten E, 2013, ENDANGER SPECIES RES, V20, P121, DOI 10.3354/esr00483; Smith H, 2008, TOURISM MANAGE, V29, P994, DOI 10.1016/j.tourman.2008.01.001; Soto AB, 2013, ENDANGER SPECIES RES, V20, P271, DOI 10.3354/esr00495; Stephenson P., 2006, 171 DEP FISH, P24; Stephenson P.C., 2003, BYCATCH PILBARA TRAW; Stephenson PC, 2006, 173 DEP FISH FISH RE; Svane I, 2005, FISH RES, V76, P317, DOI 10.1016/j.fishres.2005.07.012; Thompson S. K., 2002, SAMPLING, VSecond; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Waples DM, 2013, BIOL CONSERV, V157, P163, DOI 10.1016/j.biocon.2012.07.012; WARING GT, 1990, FISH B-NOAA, V88, P347; Zeeberg J, 2006, FISH RES, V78, P186, DOI 10.1016/j.fishres.2006.01.012	64	28	28	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93178	10.1371/journal.pone.0093178	http://dx.doi.org/10.1371/journal.pone.0093178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695338	gold, Green Published			2022-12-27	WOS:000334103000045
J	Botta, V; Louppe, G; Geurts, P; Wehenkel, L				Botta, Vincent; Louppe, Gilles; Geurts, Pierre; Wehenkel, Louis			Exploiting SNP Correlations within Random Forest for Genome-Wide Association Studies	PLOS ONE			English	Article							COMPLEX TRAITS	The primary goal of genome-wide association studies (GWAS) is to discover variants that could lead, in isolation or in combination, to a particular trait or disease. Standard approaches to GWAS, however, are usually based on univariate hypothesis tests and therefore can account neither for correlations due to linkage disequilibrium nor for combinations of several markers. To discover and leverage such potential multivariate interactions, we propose in this work an extension of the Random Forest algorithm tailored for structured GWAS data. In terms of risk prediction, we show empirically on several GWAS datasets that the proposed T-Trees method significantly outperforms both the original Random Forest algorithm and standard linear models, thereby suggesting the actual existence of multivariate non-linear effects due to the combinations of several SNPs. We also demonstrate that variable importances as derived from our method can help identify relevant loci. Finally, we highlight the strong impact that quality control procedures may have, both in terms of predictive power and loci identification. Variable importance results and T-Trees source code are all available at www.montefiore.ulg.ac.be/similar to botta/ttrees/ and github.com/0asa/TTree-source respectively.	[Botta, Vincent] Univ Liege, Dept EE & CS, B-4000 Liege, Belgium; Univ Liege, GIGA Res, B-4000 Liege, Belgium	University of Liege; University of Liege	Botta, V (corresponding author), Univ Liege, Dept EE & CS, B-4000 Liege, Belgium.	vincent.botta@ulg.ac.be	Louppe, Gilles/D-1923-2017	Louppe, Gilles/0000-0002-2082-3106	Wellcome Trust Case-Control Consortium; Wellcome Trust [076113, 085475]; Belgian Fonds de la Recherche Scientifique (FNRS); French Community of Belgium (ARC REFRACT)	Wellcome Trust Case-Control Consortium(Wellcome Trust); Wellcome Trust(Wellcome Trust); Belgian Fonds de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); French Community of Belgium (ARC REFRACT)	This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under awards 076113 and 085475. Gilles Louppe is a research fellow of the Belgian Fonds de la Recherche Scientifique (FNRS) and acknowledges its financial support. This work was partially funded by the French Community of Belgium (ARC REFRACT). Part of this work was done when Vincent Botta was a research fellow of the Fund of Research in Industry and Agriculture (FRIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham G, 2013, GENET EPIDEMIOL, V37, P184, DOI 10.1002/gepi.21698; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bewick V, 2004, CRIT CARE, V8, P46, DOI 10.1186/cc2428; Botta V, 2013, WALK RANDOM FORESTS; Botta V, 2008, P MLSB 2008 2 WORKSH; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2002, MANUAL SETTING USING; Breiman L., 2017, CLASSIFICATION REGRE; Bureau A, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S64; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; De Lobel L, 2010, EUR J HUM GENET, V18, P1127, DOI 10.1038/ejhg.2010.48; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Goldstein BA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-49; Gonzalez-Recio O, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-7; Hailpern SM, 2003, INTERPRETATION, V318, P0356; Heidema AG, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-23; Jiang R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S65; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Louppe G, 2013, ADV NEURAL INFORM PR, V26, P9; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meng YA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-78; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Murthy S. K., 1994, CS9408103 ARXIV; Nicodemus KK, 2011, BRIEF BIOINFORM, V12, P369, DOI 10.1093/bib/bbr016; Nicodemus KK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-110; Nicodemus KK, 2009, BIOINFORMATICS, V25, P1884, DOI 10.1093/bioinformatics/btp331; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramos EM, 2013, EUROPEAN J HUMAN GEN; Touw WG, 2012, BRIEFINGS BIOINFORMA; Wang H, 2012, GENET RES, V94, P73, DOI 10.1017/S0016672312000274; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Winham SJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-164; Ziegler A, 2011, BREAST CANCER RES TR, V128, P197, DOI 10.1007/s10549-010-1295-z	40	45	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93379	10.1371/journal.pone.0093379	http://dx.doi.org/10.1371/journal.pone.0093379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695491	gold, Green Published, Green Submitted			2022-12-27	WOS:000334103000064
J	Wang, Y; Jing, XL; Lv, K; Wu, B; Bai, YQ; Luo, YJ; Chen, SG; Li, YH				Wang, Yue; Jing, Xiaolu; Lv, Ke; Wu, Bin; Bai, Yanqiang; Luo, Yuejia; Chen, Shanguang; Li, Yinghui			During the Long Way to Mars: Effects of 520 Days of Confinement (Mars500) on the Assessment of Affective Stimuli and Stage Alteration in Mood and Plasma Hormone Levels	PLOS ONE			English	Article							COGNITIVE PERFORMANCE; CIRCADIAN-RHYTHMS; DEPRESSION; SPACE; SLEEP; ANXIETY; HYPOTHESIS; SEROTONIN; EXPOSURE; SPACEFLIGHT	For future interplanetary manned spaceflight, mental issues, as well as physiological problems, must inevitably be considered and solved. Mars500 is a high-fidelity ground simulation experiment that involved 520 days of confined isolation for six multinational crewmembers. This experiment provided a good opportunity to perform psycho-physiological and psycho-social researches on such missions. To investigate emotional responses and psychological adaptation over long-term confinement, the International Affective Pictures System (IAPS) was selected as the visual emotional stimuli in this study. Additional data collected and analyzed included the Profile of Mood States (POMS) questionnaire and the levels of four types of plasma hormones: cortisol, 5-hydroxy tryptamine, dopamine, and norepinephrine. The results demonstrated an obvious bias on valence rating for unpleasant stimuli with time (p<0.05), and the correlation between psychological and biochemical data was identified (p<0.05). Overall, we concluded that the confined crew tended to assign positive ratings to negative pictures with time, which might be driven by a defensive system. There was a stage- changing pattern of psychological adaptation of the Mars500 crew, which is similar to the third-quarter phenomenon.	[Wang, Yue] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Wang, Yue; Lv, Ke; Wu, Bin; Bai, Yanqiang; Li, Yinghui] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China; [Jing, Xiaolu] China Astronaut Res & Training Ctr, Beijing, Peoples R China; [Luo, Yuejia] Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China; [Chen, Shanguang] China Astronaut Res & Training Ctr, Natl Lab Human Factors Engn, Beijing, Peoples R China	Beijing Normal University; Shenzhen University	Luo, YJ (corresponding author), Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China.	luoyj@bnu.edu.cn; tigercsg@163.com; yinghuidd@vip.sina.com			Ministry of Science & Technology (973 Program) [2011CB711001]; National Natural Science Foundation of China [91132704, 30930031]	Ministry of Science & Technology (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Ministry of Science & Technology (973 Program, 2011CB711001), and National Natural Science Foundation of China (91132704, 30930031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basner M, 2013, P NATL ACAD SCI USA, V110, P2635, DOI 10.1073/pnas.1212646110; Belavy DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060090; Bolmont B, 2000, PHYSIOL BEHAV, V71, P469, DOI 10.1016/S0031-9384(00)00362-0; Clore GL, 2007, TRENDS COGN SCI, V11, P393, DOI 10.1016/j.tics.2007.08.005; Courtine G, 2004, EXP BRAIN RES, V158, P86, DOI 10.1007/s00221-004-1877-2; De La Torre GG, 2012, ACTA ASTRONAUT, V81, P587, DOI 10.1016/j.actaastro.2012.08.013; Del Seppia C, 2006, NEUROSCI LETT, V400, P197, DOI 10.1016/j.neulet.2006.02.045; Eddy DR, 1998, ACTA ASTRONAUT, V43, P193, DOI 10.1016/S0094-5765(98)00154-4; Ellis S, 2001, BEHAV PERFORMANCE HU; Feichtinger E, 2012, AER C 2012 IEEE; Firk C, 2007, J PSYCHOPHARMACOL, V21, P538, DOI 10.1177/0269881106075588; Gilbert P, 1998, BRIT J MED PSYCHOL, V71, P447, DOI 10.1111/j.2044-8341.1998.tb01002.x; Grippo AJ, 2005, PSYCHOPHARMACOLOGY, V179, P769, DOI 10.1007/s00213-004-2103-4; Hess Z, 2007, Vnitr Lek, V53, P1040; Hughes JW, 2004, J PSYCHOSOM RES, V57, P353, DOI 10.1016/j.jpsychores.2004.02.016; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Kanas N, 2009, ACTA ASTRONAUT, V64, P659, DOI 10.1016/j.actaastro.2008.12.005; Koganemaru S, 2012, EUR J NEUROSCI, V35, P1637, DOI 10.1111/j.1460-9568.2012.08098.x; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; Mallis MM, 2005, AVIAT SPACE ENVIR MD, V76, pB94; Manzey D, 1998, BRAIN RES REV, V28, P215, DOI 10.1016/S0165-0173(98)00041-1; Mikels JA, 2005, BEHAV RES METHODS, V37, P626, DOI 10.3758/BF03192732; Palinkas L, 2011, PSYCHOSOCIAL CHARACT; Palinkas L A, 2001, Gravit Space Biol Bull, V14, P25; Palinkas LA, 2000, ENVIRON BEHAV, V32, P128, DOI 10.1177/00139160021972469; Palinkas LA, 2007, PHYSIOL BEHAV, V92, P790, DOI 10.1016/j.physbeh.2007.06.008; Palinkas LA, 2008, LANCET, V371, P153, DOI 10.1016/S0140-6736(07)61056-3; Perlovsky L, 2012, BEHAV BRAIN SCI, V35, P157, DOI 10.1017/S0140525X11001555; Porter RJ, 2004, PSYCHOPHARMACOLOGY, V173, P1, DOI 10.1007/s00213-004-1774-1; Reed HL, 2001, J CLIN ENDOCR METAB, V86, P110, DOI 10.1210/jc.86.1.110; Sandal GM, 2007, LIFE EXTREME ENV, P399; SCHILDKRAUT JJ, 1965, AM J PSYCHIAT, V122, P509, DOI 10.1176/ajp.122.5.509; Schneider S, 2013, BEHAV BRAIN RES, V236, P1, DOI 10.1016/j.bbr.2012.08.022; SEPPING P, 1977, ACTA PSYCHIAT SCAND, V56, P1, DOI 10.1111/j.1600-0447.1977.tb06657.x; Smith JC, 2005, BIOL PSYCHOL, V69, P247, DOI 10.1016/j.biopsycho.2004.09.001; STAMPI C, 1994, J CLIN PHARMACOL, V34, P518, DOI 10.1002/j.1552-4604.1994.tb04996.x; Storey JD, 2006, BEHAV BRAIN RES, V166, P220, DOI 10.1016/j.bbr.2005.08.002; Tempesta D, 2010, BRAIN RES BULL, V82, P104, DOI 10.1016/j.brainresbull.2010.01.014; vanPraag HM, 1996, EUR PSYCHIAT, V11, P57, DOI 10.1016/0924-9338(96)84782-1; vanPraag HM, 1996, PSYCHIAT RES, V65, P143, DOI 10.1016/S0165-1781(96)02923-X; VANPRAAG HM, 1978, ACTA PSYCHIAT SCAND, V57, P389, DOI 10.1111/j.1600-0447.1978.tb06908.x; Wang Y, 2012, AER C 2012 IEEE; Weinberg A, 2011, PSYCHOPHYSIOLOGY, V48, P842, DOI 10.1111/j.1469-8986.2010.01149.x; Xu Chengli, 2003, Int J Circumpolar Health, V62, P255; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007	47	27	29	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e87087	10.1371/journal.pone.0087087	http://dx.doi.org/10.1371/journal.pone.0087087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695321	Green Submitted, gold, Green Published			2022-12-27	WOS:000334103000001
J	Li, J; Zhou, XL				Li, Jia; Zhou, Xiaolin			Sex, Attractiveness, and Third-Party Punishment in Fairness Consideration	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; BEAUTIFUL; MAINTENANCE; SUCCESS; GENDER	Social evaluation of others is often influenced by the physical attractiveness of the person being judged, leading to either a beauty premium or penalty depending on the circumstances. Here we asked Chinese participants to act as an interest-free third party in a dictator game and to evaluate the fairness level of monetary allocation by attractive and less attractive proposers of the same or opposite sex. We also instructed participants to express their willingness to punish the proposers by using a visual analogue scale. Results confirmed that the reasonableness evaluation was mainly affected by the reasonableness of offers. However, participants' intention to punish the proposers was affected by the level of reasonableness in the asset distribution and by both the sex and attractiveness of the proposers. Overall, male proposers were punished more severely than female proposers. Moreover, the same-sex proposers were punished more severely than opposite-sex proposers when they were physically attractive; this pattern was reversed when the proposers were less physically attractive. These results demonstrate social responses following an individual's unfair asset distribution can be affected by both social norms and the personal characteristics of the individual.	[Li, Jia] Southeast Univ, Res Ctr Learning Sci, Nanjing, Jiangsu, Peoples R China; [Li, Jia] Southeast Univ, Key Lab Child Dev & Learning Sci, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Li, Jia; Zhou, Xiaolin] Peking Univ, Ctr Brain & Cognit Sci, Beijing 100871, Peoples R China; [Li, Jia; Zhou, Xiaolin] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Zhou, Xiaolin] Peking Univ, Key Lab Machine Percept, Minist Educ, Beijing 100871, Peoples R China; [Zhou, Xiaolin] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China	Southeast University - China; Southeast University - China; Peking University; Peking University; Peking University; Peking University	Li, J (corresponding author), Southeast Univ, Res Ctr Learning Sci, Nanjing, Jiangsu, Peoples R China.	normilee@gmail.com; xz104@pku.edu.cn			Natural Science Foundation of China [30110972, 91232708]; National Basic Research Program (973 Program) of China [2010CB833904]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program) of China(National Basic Research Program of China)	This study was supported by grants from the Natural Science Foundation of China (30110972, 91232708) and by the National Basic Research Program (973 Program: 2010CB833904) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agthe M., 2009, OPEN PSYCHOL J, V2, P19, DOI DOI 10.2174/1874350100902010019; Agthe M, 2011, PERS SOC PSYCHOL B, V37, P1042, DOI 10.1177/0146167211410355; Agthe M, 2010, J EXP SOC PSYCHOL, V46, P1151, DOI 10.1016/j.jesp.2010.05.007; Agthe M, 2008, PERS SOC PSYCHOL B, V34, P1627, DOI 10.1177/0146167208324446; Andreoni J, 2008, J ECON PSYCHOL, V29, P73, DOI 10.1016/j.joep.2007.07.008; Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; Buunk AP, 2007, SYD SYM SOC PSYCHOL, P213; DION K, 1972, J PERS SOC PSYCHOL, V24, P285, DOI 10.1037/h0033731; EAGLY AH, 1991, PSYCHOL BULL, V110, P109, DOI 10.1037/0033-2909.110.1.109; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; FEINGOLD A, 1992, PSYCHOL BULL, V111, P304, DOI 10.1037/0033-2909.111.2.304; Hosoda M, 2003, PERS PSYCHOL, V56, P431, DOI 10.1111/j.1744-6570.2003.tb00157.x; Iranzo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043781; Lemay EP, 2010, PERS SOC PSYCHOL B, V36, P339, DOI 10.1177/0146167209359700; Luxen MF, 2006, J ORGAN BEHAV, V27, P241, DOI 10.1002/job.357; Maner JK, 2007, J PERS SOC PSYCHOL, V93, P389, DOI 10.1037/0022-3514.93.3.389; Maner JK, 2009, J EXP SOC PSYCHOL, V45, P174, DOI 10.1016/j.jesp.2008.08.002; Miyaji K, 2013, CHAOS SOLITON FRACT, V56, P13, DOI 10.1016/j.chaos.2013.05.007; Mulford M, 1998, AM J SOCIOL, V103, P1565, DOI 10.1086/231401; SIMPSON JA, 1990, J PERS SOC PSYCHOL, V59, P1192, DOI 10.1037/0022-3514.59.6.1192; Sinatra R, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/09/P09012; Solnick SJ, 1999, ORGAN BEHAV HUM DEC, V79, P199, DOI 10.1006/obhd.1999.2843; Wilson RK, 2006, POLIT RES QUART, V59, P189, DOI 10.1177/106591290605900202	23	6	7	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94004	10.1371/journal.pone.0094004	http://dx.doi.org/10.1371/journal.pone.0094004			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7EP	24709987	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800084
J	MacPherson, H; Vertosick, E; Lewith, G; Linde, K; Sherman, KJ; Witt, CM; Vickers, AJ				MacPherson, Hugh; Vertosick, Emily; Lewith, George; Linde, Klaus; Sherman, Karen J.; Witt, Claudia M.; Vickers, Andrew J.		Acupuncture Trialists Collaboratio	Influence of Control Group on Effect Size in Trials of Acupuncture for Chronic Pain: A Secondary Analysis of an Individual Patient Data Meta-Analysis	PLOS ONE			English	Article							LOW-BACK-PAIN; RANDOMIZED CONTROLLED-TRIAL; TENSION-TYPE HEADACHE; NECK PAIN; KNEE OSTEOARTHRITIS; PLACEBO NEEDLE; MULTICENTER; SHAM; PHYSIOTHERAPY; EXERCISE	Background: In a recent individual patient data meta-analysis, acupuncture was found to be superior to both sham and non-sham controls in patients with chronic pain. In this paper we identify variations in types of sham and non-sham controls used and analyze their impact on the effect size of acupuncture. Methods: Based on literature searches of acupuncture trials involving patients with headache and migraine, osteoarthritis, and back, neck and shoulder pain, 29 trials met inclusion criteria, 20 involving sham controls (n = 5,230) and 18 non-sham controls (n = 14,597). For sham controls, we analysed non-needle sham, penetrating sham needles and non-penetrating sham needles. For non-sham controls, we analysed non-specified routine care and protocol-guided care. Using meta-regression we explored impact of choice of control on effect of acupuncture. Findings: Acupuncture was significantly superior to all categories of control group. For trials that used penetrating needles for sham control, acupuncture had smaller effect sizes than for trials with non-penetrating sham or sham control without needles. The difference in effect size was -0.45 (95% C.l. -0.78, -0.12; p = 0.007), or -0.19 (95% Cl. -0.39, 0.01; p = 0.058) after exclusion of outlying studies showing very large effects of acupuncture. In trials with non-sham controls, larger effect sizes associated with acupuncture vs. non-specified routine care than vs. protocol-guided care. Although the difference in effect size was large (0.26), it was not significant with a wide confidence interval (95% C.l. -0.05, 0.57, p = 0.1). Conclusion: Acupuncture is significantly superior to control irrespective of the subtype of control. While the choice of control should be driven by the study question, our findings can help inform study design in acupuncture, particularly with respect to sample size. Penetrating needles appear to have important physiologic activity. We recommend that this type of sham be avoided.	[MacPherson, Hugh] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Vertosick, Emily; Vickers, Andrew J.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Lewith, George] Univ Southampton, Fac Med Primary Care & Populat Sci, Southampton SO9 5NH, Hants, England; [Linde, Klaus] Tech Univ Munich, Inst Gen Practice, D-80290 Munich, Germany; [Sherman, Karen J.] Grp Hlth Res Inst, Seattle, WA USA; [Witt, Claudia M.] Univ Zurich Hosp, Ctr Complementary & Integrat Med, CH-8091 Zurich, Switzerland; [Witt, Claudia M.] Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany	University of York - UK; Memorial Sloan Kettering Cancer Center; University of Southampton; Technical University of Munich; University of Zurich; University Zurich Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	MacPherson, H (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	hugh.macpherson@york.ac.uk	Witt, Claudia M./AAX-2370-2021; Brinkhaus, Benno/AAU-2428-2021; Lao, Lixing/P-9107-2019	Witt, Claudia M./0000-0002-5440-7805; Brinkhaus, Benno/0000-0001-6290-744X; Lao, Lixing/0000-0003-0198-9714; Linde, Klaus/0000-0002-2902-970X; Vickers, Andrew/0000-0003-1525-6503; Lewith, George/0000-0002-2364-3960; Vertosick, Emily/0000-0001-6948-9850; MacPherson, Hugh/0000-0003-4255-4768	National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health (NIH) [R21 (AT004189I)]; Samueli Institute; National Institute for Health Research (NIHR) [RP-PG-0707-10186]; Carstens Foundation within the grant for the Chair for Complementary Medicine Research; National Institute for Health Research [RP-PG-0707-10186] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006794] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Samueli Institute; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Carstens Foundation within the grant for the Chair for Complementary Medicine Research; National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Acupuncture Trialists' Collaboration is funded by an R21 (AT004189I from the National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health (NIH) to Dr Vickers) and by a grant from the Samueli Institute. Dr MacPherson's work on this project was funded in part by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research scheme (RP-PG-0707-10186). Dr. Witt's work has been supported by the Carstens Foundation within the grant for the Chair for Complementary Medicine Research. The views expressed in this publication are those of the author(s) and not necessarily those of the NCCAM, NHS, NIHR or the Department of Health in England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, OFF J EUR UNION, VL037, P19; Berman BM, 2004, ANN INTERN MED, V141, P901, DOI 10.7326/0003-4819-141-12-200412210-00006; Birch S, 2006, J ALTERN COMPLEM MED, V12, P303, DOI 10.1089/acm.2006.12.303; Birch S, 1999, UNDERSTANDING ACUPUN; Brinkhaus B, 2006, ARCH INTERN MED, V166, P450; Carlsson CPO, 2001, CLIN J PAIN, V17, P296, DOI 10.1097/00002508-200112000-00003; Cherkin DC, 2001, ARCH INTERN MED, V161, P1081, DOI 10.1001/archinte.161.8.1081; de Hoyos JAG, 2004, PAIN, V112, P289, DOI 10.1016/j.pain.2004.08.030; Diener HC, 2006, LANCET NEUROL, V5, P310, DOI 10.1016/S1474-4422(06)70382-9; Endres Heinz G, 2007, J Headache Pain, V8, P306, DOI 10.1007/s10194-007-0416-5; Foster NE, 2007, BMJ-BRIT MED J, V335, P436, DOI 10.1136/bmj.39280.509803.BE; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Han JS, 2011, NEUROSCI BIOBEHAV R, V35, P680, DOI 10.1016/j.neubiorev.2010.08.006; Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; Irnich D, 2001, BMJ-BRIT MED J, V322, P1574, DOI 10.1136/bmj.322.7302.1574; Jena S, 2008, CEPHALALGIA, V28, P969, DOI 10.1111/j.1468-2982.2008.01640.x; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Kennedy S, 2008, COMPLEMENT THER MED, V16, P139, DOI 10.1016/j.ctim.2007.03.001; Kleinhenz J, 1999, PAIN, V83, P235, DOI 10.1016/S0304-3959(99)00107-4; Linde K, 2005, JAMA-J AM MED ASSOC, V293, P2118, DOI 10.1001/jama.293.17.2118; Linde K, 2010, FORSCH KOMPLEMENTMED, V17, P259, DOI 10.1159/000320374; Lund Irene, 2006, Acupunct Med, V24, P13; Melchart D, 2005, BMJ-BRIT MED J, V331, P376, DOI 10.1136/bmj.38512.405440.8F; Salter GC, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-99; Scharf HP, 2006, ANN INTERN MED, V145, P12, DOI 10.7326/0003-4819-145-1-200607040-00005; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Thomas KJ, 2006, BMJ-BRIT MED J, V333, P623, DOI 10.1136/bmj.38878.907361.7C; Vas J, 2008, RHEUMATOLOGY, V47, P887, DOI 10.1093/rheumatology/ken040; Vas J, 2004, BMJ-BRIT MED J, V329, P1216, DOI 10.1136/bmj.38238.601447.3A; Vas J, 2006, PAIN, V126, P245, DOI 10.1016/j.pain.2006.07.002; Vickers AJ, 2004, BRIT MED J, V328, P744, DOI 10.1136/bmj.38029.421863.EB; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; Vickers AJ, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-90; White P, 2004, ANN INTERN MED, V141, P911, DOI 10.7326/0003-4819-141-12-200412210-00007; Williamson L, 2007, RHEUMATOLOGY, V46, P1445, DOI 10.1093/rheumatology/kem119; Witt C, 2005, LANCET, V366, P136, DOI 10.1016/S0140-6736(05)66871-7; Witt CM, 2006, PAIN, V125, P98, DOI 10.1016/j.pain.2006.05.013; Witt CM, 2006, ARTHRITIS RHEUM-US, V54, P3485, DOI 10.1002/art.22154; Witt CM, 2006, AM J EPIDEMIOL, V164, P487, DOI 10.1093/aje/kwj224; Witt CM, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-148	40	69	72	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93739	10.1371/journal.pone.0093739	http://dx.doi.org/10.1371/journal.pone.0093739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705624	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500063
J	Svahn, KS; Goransson, U; Chryssanthou, E; Olsen, B; Sjolin, J; Stromstedt, AA				Svahn, K. Stefan; Goransson, Ulf; Chryssanthou, Erja; Olsen, Bjorn; Sjolin, Jan; Stromstedt, Adam A.			Induction of Gliotoxin Secretion in Aspergillus fumigatus by Bacteria-Associated Molecules	PLOS ONE			English	Article							PATHOGEN RECOGNITION; LIPOTEICHOIC ACID; CANDIDA-ALBICANS; INNATE; MICE; PEPTIDOGLYCAN; PENICILLIUM; SYSTEM	Aspergillus fumigatus is the most common causative agent of mold diseases in humans, giving rise to life-threatening infections in immunocompromised individuals. One of its secreted metabolites is gliotoxin, a toxic antimicrobial agent. The aim of this study was to determine whether the presence of pathogen-associated molecular patterns in broth cultures of A. fumigatus could induce gliotoxin production. Gliotoxin levels were analyzed by ultra-performance liquid chromatography and mass spectrometry. The presence of a bacteria-derived lipopolysaccharide, peptidoglycan, or lipoteichoic acid in the growth media at a concentration of 5 mu g/ml increased the gliotoxin concentration in the media by 37%, 65%, and 35%, respectively. The findings reveal a correlation between the concentrations of pathogen-associated molecular patterns and gliotoxin secretion. This shows that there is a yet uncharacterized detection system for such compounds within fungi. Inducing secondary metabolite production by such means in fungi is potentially relevant for drug discovery research. Our results also give a possible explanation for the increased virulence of A. fumigatus during bacterial co-infection, one that is important for the transition from colonization to invasiveness in this pulmonary disease.	[Svahn, K. Stefan; Goransson, Ulf; Stromstedt, Adam A.] Uppsala Univ, Dept Med Chem, Uppsala, Sweden; [Chryssanthou, Erja] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Chryssanthou, Erja] Karolinska Inst, Stockholm, Sweden; [Olsen, Bjorn; Sjolin, Jan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Uppsala University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University	Stromstedt, AA (corresponding author), Uppsala Univ, Dept Med Chem, Uppsala, Sweden.	adam.stromstedt@fkog.uu.se	Strömstedt, Adam/I-8820-2018	Strömstedt, Adam/0000-0001-9070-6944; Goransson, Ulf/0000-0002-5005-9612; Olsen, Bjorn/0000-0002-4646-691X	Swedish Governmental Agency for Innovation Systems - VINNOVA	Swedish Governmental Agency for Innovation Systems - VINNOVA(Vinnova)	This work has been financially supported by the Swedish Governmental Agency for Innovation Systems - VINNOVA (http://www.vinnova.se/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACKUS MP, 1955, MYCOLOGIA, V47, P429, DOI 10.2307/3755661; Baxter CG, 2013, THORAX, V68, P652, DOI 10.1136/thoraxjnl-2012-202412; Ben-Ami R, 2010, BRIT J HAEMATOL, V150, P406, DOI 10.1111/j.1365-2141.2010.08283.x; Bonnett CR, 2006, INFECT IMMUN, V74, P6528, DOI 10.1128/IAI.00909-06; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Comera C, 2007, MICROBES INFECT, V9, P47, DOI 10.1016/j.micinf.2006.10.009; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Forseth RR, 2011, J AM CHEM SOC, V133, P9678, DOI 10.1021/ja2029987; GALE D, 1957, J BACTERIOL, V73, P616, DOI 10.1128/JB.73.5.616-624.1957; Grice CM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00026; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Houbraken J, 2011, IMA FUNGUS, V2, P87, DOI 10.5598/imafungus.2011.02.01.12; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kobayashi DY, 2009, ANNU REV PHYTOPATHOL, V47, P63, DOI 10.1146/annurev-phyto-080508-081729; Kousha M, 2011, EUR RESPIR REV, V20, P156, DOI 10.1183/09059180.00001011; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Maffei ME, 2012, NAT PROD REP, V29, P1288, DOI 10.1039/c2np20053h; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; NEELY AN, 1986, INFECT IMMUN, V52, P200, DOI 10.1128/IAI.52.1.200-204.1986; Otte JM, 2003, J GASTROENTEROL, V38, P717, DOI 10.1007/s00535-003-1136-5; Pardo J, 2006, J CELL BIOL, V174, P509, DOI 10.1083/jcb.200604044; Pettit RK, 2011, MICROB BIOTECHNOL, V4, P471, DOI 10.1111/j.1751-7915.2010.00196.x; Pettit RK, 2009, APPL MICROBIOL BIOT, V83, P19, DOI 10.1007/s00253-009-1916-9; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rao XJ, 2010, DEV COMP IMMUNOL, V34, P1119, DOI 10.1016/j.dci.2010.06.007; Ray A, 2013, BIOCHIMIE, V95, P33, DOI 10.1016/j.biochi.2012.06.007; RODRIGUEZ PL, 1992, J VIROL, V66, P1971, DOI 10.1128/JVI.66.4.1971-1976.1992; Roeder A, 2004, TRENDS MICROBIOL, V12, P44, DOI 10.1016/j.tim.2003.11.003; Scharf DH, 2012, APPL MICROBIOL BIOT, V93, P467, DOI 10.1007/s00253-011-3689-1; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Svahn K. Stefan, 2012, Infection Ecology & Epidemiology, V2, P11591, DOI 10.3402/iee.v2i0.11591; TROWN PW, 1972, ANTIMICROB AGENTS CH, V2, P261, DOI 10.1128/AAC.2.4.261; Xu XL, 2008, CELL HOST MICROBE, V4, P28, DOI 10.1016/j.chom.2008.05.014; Yoshimura A, 1999, J IMMUNOL, V163, P1	35	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93685	10.1371/journal.pone.0093685	http://dx.doi.org/10.1371/journal.pone.0093685			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705440	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500056
J	Birkett, NJ				Birkett, Nicholas J.			The Impact of Taxation Reduction on Smoking in Youth between 1990 and 1999: Results from a Reconstructed Cohort Analysis of the Canadian Community Health Surveys	PLOS ONE			English	Article							TOBACCO TAX CUTS; CIGARETTE-SMOKING; ELASTICITIES; INITIATION	Background: Increases in taxation can contribute to smoking control. In the early 1990's, tobacco smuggling rates in Canada increased dramatically. Governments responded with a substantial reduction in taxes on tobacco products. This study examines the impact of these tax changes on smoking in youth in Canada. Methods: Data on smoking from three consecutive cycles of the Canadian Community Health Surveys were combined and analyzed using a reconstructed cohort approach. Age, sex and calendar year specific rates of smoking experimentation and the onset of daily smoking were estimated for youth. Estimates apply to the entire Canadian population. Results: There was a strong increase in smoking in youth in the years following the reduction in tobacco taxes. The increase was stronger in women. The rates returned to pre-1990 rates by about 2002. The number of excess daily smokers for people born between 1977 and 1985 that can be linked to the taxation reduction is about 190,000. Interpretation: There is strong evidence that reduction of tobacco taxes to combat smuggling had an adverse impact on smoking rates in youth.	[Birkett, Nicholas J.] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Birkett, Nicholas J.] Univ Ottawa, RS McLaughlin Ctr Populat Hlth Risk Assessment, Ottawa, ON, Canada	University of Ottawa; University of Ottawa	Birkett, NJ (corresponding author), Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada.	Nicholas.Birkett@uottawa.ca			Canadian Physicians for a Smoke-free Canada	Canadian Physicians for a Smoke-free Canada	This research was supported through a personal-services contract provided by the Canadian Physicians for a Smoke-free Canada. The funders defined the research area to be addressed in the contract. However, they had no role in the detailed study design and analysis, the interpretation of the results, the decision to publish the results, or the preparation of the manuscript.	[Anonymous], 2011, EFFECTIVENESS TAX PR; [Anonymous], 2011, 2011 NATL HOUSEHOLD; Bilal U, 2014, AM J EPIDEMIOL, V179, P15, DOI 10.1093/aje/kwt224; Birkett NJ, 1997, PREV MED, V26, P534, DOI 10.1006/pmed.1997.0169; Collishaw N, 2009, HIST TOABACCO CONTRO; Fatima N., 2011, CAN TAX J, V59, P221; Gabler N., 2010, CONTRABAND TOBACCO C; Gallet CA, 2003, HEALTH ECON, V12, P821, DOI 10.1002/hec.765; Gruber J, 2003, J HEALTH ECON, V22, P821, DOI 10.1016/S0167-6296(03)00058-4; Guindon E, 2010, DENYING UNDENIABLE C; Hamilton VH, 1997, CAN MED ASSOC J, V156, P187; HARRIS JE, 1983, JNCI-J NATL CANCER I, V71, P473; Joossens L, 2008, TOB CONTROL, V17, P399, DOI 10.1136/tc.2008.026567; Ouelett J-F, 2010, FAILURE TAX POLICIES; Pinheiro L, 2010, IMPACT TAXES TABAGIS; Schneider J, 2010, RJ REYNOLDS AGREES P; Segal D, 1999, WASHINGTON POST; Sen A, 2010, HEALTH ECON, V19, P1264, DOI 10.1002/hec.1548; Stephens T, 1995, CHRONIC DIS CANADA, V16, P27; SUGARMAN SD, 2001, REGULATING TOBACCO, P245; White MA, 2012, COMPR PSYCHIAT, V53, P403, DOI 10.1016/j.comppsych.2011.05.007; Zhang B, 2006, AM J PREV MED, V30, P474, DOI 10.1016/j.amepre.2006.02.001	22	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93412	10.1371/journal.pone.0093412	http://dx.doi.org/10.1371/journal.pone.0093412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LR	24699515	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000059
J	Gooskens, J; Zevenhoven-Dobbe, JC; Claas, EC; Kroes, ACM; Posthuma, CC				Gooskens, Jairo; Zevenhoven-Dobbe, Jessika C.; Claas, Eric C.; Kroes, Aloys C. M.; Posthuma, Clara C.			Mass Spectrometry-Based Comparative Sequence Analysis for the Genetic Monitoring of Influenza A(H1N1) pdm09 Virus	PLOS ONE			English	Article							PANDEMIC INFLUENZA; A VIRUS; RESISTANT; TRANSMISSION	The pandemic influenza A (H1N1) 2009 virus (pH1N1) contains novel gene segments of zoonotic origin that lack virulence and antiviral resistance markers. We aimed to evaluate the applicability and accuracy of mass spectrometry-based comparative sequence analysis (MSCSA) to detect genetic mutations associated with increased virulence or antiviral resistance in pH1N1. During the 2009 H1N1 pandemic, routine surveillance specimens and clinical antiviral resistance monitoring specimens were analyzed. Routine surveillance specimens obtained from 70 patients with pH1N1 infection were evaluated for mutations associated with increased virulence (PB1-F2, PB2 and NS1 genes) or antiviral resistance (neuraminidase gene, NA) using MSCSA and Sanger sequencing. MSCSA and Sanger sequencing results revealed a high concordance (nucleotides >99%, SNPs similar to 94%). Virulence or resistance markers were not detected in routine surveillance specimens: all identified SNPs encoded for silent mutations or non-relevant amino acid substitutions. In a second study population, the presence of H275Y oseltamivir resistant virus was identified by real-time PCR in 19 of 35 clinical antiviral resistance monitoring specimens obtained from 4 immunocompromised patients with >14 days prolonged pH1N1 excretion. MSCSA detected H275Y in 24% (4/19) of positive specimens and Sanger sequencing in 89% (17/19). MSCSA only detected H275Y when the mutation was dominant in the analyzed specimens. In conclusion, MSCSA may be used as a rapid screening tool during molecular surveillance of pH1N1. The low sensitivity for the detection of H275Y mutation in mixed viral populations suggests that MSCSA is not suitable for antiviral resistance monitoring in the clinical setting.	[Gooskens, Jairo; Zevenhoven-Dobbe, Jessika C.; Claas, Eric C.; Kroes, Aloys C. M.; Posthuma, Clara C.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Posthuma, CC (corresponding author), Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands.	c.c.posthuma@lumc.nl		Kroes, Aloysius/0000-0002-9866-2461; Gooskens, Jairo/0000-0002-8381-7870				Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Carr S, 2011, PEDIATR INFECT DIS J, V30, P284, DOI 10.1097/INF.0b013e3181ff863b; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Deyde VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013293; Deyde VM, 2010, ANTIMICROB AGENTS CH, V54, P1102, DOI 10.1128/AAC.01417-09; European Commission, 2009, OFFICIAL J EUROPEAN, V110; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Gooskens J, 2009, J INFECT DIS, V199, P1435, DOI 10.1086/598684; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Harvala H, 2010, EURO SURVEILL, V15; Honisch C, 2007, P NATL ACAD SCI USA, V104, P10649, DOI 10.1073/pnas.0704152104; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jeng K, 2012, J CLIN VIROL, V54, P332, DOI 10.1016/j.jcv.2012.05.002; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Liu QF, 2012, J VIROL, V86, P1233, DOI 10.1128/JVI.05699-11; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; Meijer A, 2009, J CLIN VIROL, V45, P179, DOI 10.1016/j.jcv.2009.06.003; Moore C, 2011, J INFECT DIS, V203, P18, DOI 10.1093/infdis/jiq007; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Octaviani CP, 2011, VIRUS RES, V156, P147, DOI 10.1016/j.virusres.2010.12.014; Ozawa M, 2011, J VIROL, V85, P4596, DOI 10.1128/JVI.00029-11; Pascalis H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043742; Pizzorno A, 2011, J INFECT DIS, V203, P25, DOI 10.1093/infdis/jiq010; Posthuma CC, 2011, J CLIN VIROL, V51, P25, DOI 10.1016/j.jcv.2011.01.015; Rahamat-Langendoen JC, 2012, J CLIN VIROL, V54, P135, DOI 10.1016/j.jcv.2012.02.010; Renaud C, 2011, EMERG INFECT DIS, V17, P653, DOI 10.3201/eid1704.101429; Seibert CW, 2010, J VIROL, V84, P11219, DOI 10.1128/JVI.01424-10; Tramontana AR, 2010, EMERG INFECT DIS, V16, P1068, DOI 10.3201/eid1607.091691; Tu WW, 2010, J VIROL, V84, P6527, DOI 10.1128/JVI.00519-10; van der Vries E, 2010, J CLIN VIROL, V47, P34, DOI 10.1016/j.jcv.2009.09.030; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; World Health Organization, 2010, PAND H1N1 2009 UPD 1; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034	34	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92970	10.1371/journal.pone.0092970	http://dx.doi.org/10.1371/journal.pone.0092970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699508	Green Submitted, gold, Green Published			2022-12-27	WOS:000334105000038
J	Orlic-Milacic, M; Kaufman, L; Mikhailov, A; Cheung, AYL; Mahmood, H; Ellis, J; Gianakopoulos, PJ; Minassian, BA; Vincent, JB				Orlic-Milacic, Marija; Kaufman, Liana; Mikhailov, Anna; Cheung, Aaron Y. L.; Mahmood, Huda; Ellis, James; Gianakopoulos, Peter J.; Minassian, Berge A.; Vincent, John B.			Over-Expression of Either MECP2_e1 or MECP2_e2 in Neuronally Differentiated Cells Results in Different Patterns of Gene Expression	PLOS ONE			English	Article							SEVERE MENTAL-RETARDATION; RETT-SYNDROME PHENOTYPES; CPG-BINDING PROTEIN-2; CONGENITAL VARIANT; LANGUAGE DISORDER; FOXG1 MUTATIONS; TARGET GENES; COPY NUMBER; ISOFORM; AUTISM	Mutations in MECP2 are responsible for the majority of Rett syndrome cases. MECP2 is a regulator of transcription, and has two isoforms, MECP2_e1 and MECP2_e2. There is accumulating evidence that MECP2_e1 is the etiologically relevant variant for Rett. In this study we aim to detect genes that are differentially transcribed in neuronal cells over-expressing either of these two MECP2 isoforms. The human neuroblastoma cell line SK-N-SH was stably infected by lentiviral vectors over-expressing MECP2_e1, MECP2_e2, or eGFP, and were then differentiated into neurons. The same lentiviral constructs were also used to infect mouse Mecp2 knockout (Mecp2(tm1.1Bird)) fibroblasts. RNA from these cells was used for microarray gene expression analysis. For the human neuronal cells, similar to 800 genes showed >three-fold change in expression level with the MECP2_e1 construct, and similar to 230 with MECP2_e2 (unpaired t-test, uncorrected p value <0.05). We used quantitative RT-PCR to verify microarray results for 41 of these genes. We found significant up-regulation of several genes resulting from overexpression of MECP2_e1 including SRPX2, NAV3, NPY1R, SYN3, and SEMA3D. DOCK8 was shown via microarray and qRT-PCR to be upregulated in both SK-N-SH cells and mouse fibroblasts. Both isoforms up-regulated GABRA2, KCNA1, FOXG1 and FOXP2. Down-regulation of expression in the presence of MECP2_e1 was seen with UNC5C and RPH3A. Understanding the biology of these differentially transcribed genes and their role in neurodevelopment may help us to understand the relative functions of the two MECP2 isoforms, and ultimately develop a better understanding of RTT etiology and determine the clinical relevance of isoform-specific mutations.	[Orlic-Milacic, Marija; Kaufman, Liana; Mikhailov, Anna; Mahmood, Huda; Gianakopoulos, Peter J.; Vincent, John B.] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Mol Neuropsychiat & Dev Lab, Toronto, ON, Canada; [Cheung, Aaron Y. L.; Ellis, James] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Minassian, Berge A.] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; [Minassian, Berge A.] Hosp Sick Children, Dept Paediat, Div Neurol, Toronto, ON M5G 1X8, Canada; [Vincent, John B.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Vincent, John B.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Vincent, JB (corresponding author), Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Mol Neuropsychiat & Dev Lab, Toronto, ON, Canada.	john.vincent@camh.ca	Ellis, James/F-4789-2011	Ellis, James/0000-0002-4400-0091; Orlic-Milacic, Marija/0000-0002-3218-5631	International Rett Syndrome Foundation; Ontario Mental Health Foundation; Cure Autism Now	International Rett Syndrome Foundation; Ontario Mental Health Foundation; Cure Autism Now	This work was supported by funding from International Rett Syndrome Foundation, Ontario Mental Health Foundation, and Cure Autism Now to JBV and BAM. JBV is a National Alliance for Research on Schizophrenia and Depression Independent Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ariani F, 2008, AM J HUM GENET, V83, P89, DOI 10.1016/j.ajhg.2008.05.015; Bi WM, 2002, GENOME RES, V12, P713, DOI 10.1101/gr.73702; Bissonnette JM, 2007, AUTON NEUROSCI-BASIC, V136, P82, DOI 10.1016/j.autneu.2007.04.007; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Dastidar SG, 2012, J NEUROSCI, V32, P2846, DOI 10.1523/JNEUROSCI.5841-11.2012; Dragich JM, 2007, J COMP NEUROL, V501, P526, DOI 10.1002/cne.21264; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Fatemi SH, 2009, J AUTISM DEV DISORD, V39, P223, DOI 10.1007/s10803-008-0646-7; Fichou Y, 2009, NEUROGENETICS, V10, P127, DOI 10.1007/s10048-008-0161-1; Filges I, 2011, CLIN GENET, V79, P79, DOI 10.1111/j.1399-0004.2010.01590.x; Gianakopoulos PJ, 2012, AM J MED GENET B, V159B, P210, DOI 10.1002/ajmg.b.32015; Griggs BL, 2008, GENOMICS, V91, P195, DOI 10.1016/j.ygeno.2007.10.011; GRUNDEMAR L, 1993, GEN PHARMACOL-VASC S, V24, P785, DOI 10.1016/0306-3623(93)90151-M; HERZOG H, 1992, P NATL ACAD SCI USA, V89, P5794, DOI 10.1073/pnas.89.13.5794; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Itoh M, 2012, J BIOL CHEM, V287, P13859, DOI 10.1074/jbc.M111.309864; Kakinuma H, 2008, AM J MED GENET B, V147B, P973, DOI 10.1002/ajmg.b.30663; Kerr B, 2012, EUR J HUM GENET, V20, P69, DOI 10.1038/ejhg.2011.145; Kortum F, 2011, J MED GENET, V48, P396, DOI 10.1136/jmg.2010.087528; Kriaucionis S, 2004, NUCLEIC ACIDS RES, V32, P1818, DOI 10.1093/nar/gkh349; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Le Meur N, 2010, J MED GENET, V47, P22, DOI 10.1136/jmg.2009.069732; Lin CC, 2007, J CELL PHYSIOL, V211, P316, DOI 10.1002/jcp.20938; Liu Y, 2005, J NEUROSCI, V25, P10556, DOI 10.1523/JNEUROSCI.2710-05.2005; Ma DQ, 2005, AM J HUM GENET, V77, P377, DOI 10.1086/433195; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Meinnel T, 2005, BIOCHIMIE, V87, P701, DOI 10.1016/j.biochi.2005.03.011; Mencarelli MA, 2010, J MED GENET, V47, P49, DOI 10.1136/jmg.2009.067884; Mnatzakanian GN, 2004, NAT GENET, V36, P339, DOI 10.1038/ng1327; Nectoux J, 2010, J CELL MOL MED, V14, P1962, DOI 10.1111/j.1582-4934.2010.01107.x; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; Philippe C, 2010, J MED GENET, V47, P59, DOI 10.1136/jmg.2009.067355; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; PREIS PN, 1988, CANCER RES, V48, P6530; Rastegar M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006810; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Roll P, 2010, HUM MOL GENET, V19, P4848, DOI 10.1093/hmg/ddq415; Saunders CJ, 2009, AM J MED GENET A, V149A, P1019, DOI 10.1002/ajmg.a.32776; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Smith R, 2007, J NEUROCHEM, V103, P115, DOI 10.1111/j.1471-4159.2007.04703.x; STANLEY BG, 1989, PHYSIOL BEHAV, V46, P173, DOI 10.1016/0031-9384(89)90251-5; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; Vincent JB, 2006, J MED GENET, V43, P429, DOI 10.1136/jmg.2005.039693; Wolman MA, 2004, J NEUROSCI, V24, P8428, DOI 10.1523/JNEUROSCI.2349-04.2004; Yakabe S, 2008, GENES GENET SYST, V83, P199, DOI 10.1266/ggs.83.199; Yasui DH, 2014, HUM MOL GENET; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071; Zweier M, 2010, HUM MUTAT, V31, P722, DOI 10.1002/humu.21253	54	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e91742	10.1371/journal.pone.0091742	http://dx.doi.org/10.1371/journal.pone.0091742			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699272	gold, Green Submitted, Green Published			2022-12-27	WOS:000334105000015
J	Trappl, K; Mathew, MA; Joseph, S				Trappl, Krista; Mathew, Merrill A.; Joseph, Simpson			Thermodynamic and Kinetic Insights into Stop Codon Recognition by Release Factor	PLOS ONE			English	Article							POLYPEPTIDE RELEASE; TRANSLATION TERMINATION; MESSENGER-RNA; RIBOSOME; TRANSLOCATION; BINDING; RF2	Stop codon recognition is a crucial event during translation termination and is performed by class I release factors (RF1 and RF2 in bacterial cells). Recent crystal structures showed that stop codon recognition is achieved mainly through a network of hydrogen bonds and stacking interactions between the stop codon and conserved residues in domain II of RF1/RF2. Additionally, previous studies suggested that recognition of stop codons is coupled to proper positioning of RF1 on the ribosome, which is essential for triggering peptide release. In this study we mutated four conserved residues in Escherichia coli RF1 (Gln185, Arg186, Thr190, and Thr198) that are proposed to be critical for discriminating stop codons from sense codons. Our thermodynamic and kinetic analysis of these RF1 mutants showed that the mutations inhibited the binding of RF1 to the ribosome. However, the mutations in RF1 did not affect the rate of peptide release, showing that imperfect recognition of the stop codon does not affect the proper positioning of RF1 on the ribosome.	[Trappl, Krista; Mathew, Merrill A.; Joseph, Simpson] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Joseph, S (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	sjoseph@ucsd.edu			National Science Foundation [1158127]; Max Kade Foundation, Inc.	National Science Foundation(National Science Foundation (NSF)); Max Kade Foundation, Inc.	This work was supported by National Science Foundation grant 1158127 to SJ and a postdoctoral research exchange grant from the Max Kade Foundation, Inc. to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.nsf.gov http://maxkadefoundation.org	BEAUDET AL, 1970, NATURE, V227, P38, DOI 10.1038/227038a0; CAPECCHI MR, 1970, NATURE, V226, P1029, DOI 10.1038/2261029a0; Feinberg JS, 2006, RNA, V12, P580, DOI 10.1261/rna.2290706; Field A, 2010, BIOCHEMISTRY-US, V49, P9385, DOI 10.1021/bi1012047; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; He SL, 2010, NAT STRUCT MOL BIOL, V17, P465, DOI 10.1038/nsmb.1766; Hetrick B, 2009, BIOCHEMISTRY-US, V48, P11178, DOI 10.1021/bi901577d; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 1998, P NATL ACAD SCI USA, V95, P8165, DOI 10.1073/pnas.95.14.8165; Korostelev A, 2010, EMBO J, V29, P2577, DOI 10.1038/emboj.2010.139; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; POWERS T, 1991, EMBO J, V10, P2203, DOI 10.1002/j.1460-2075.1991.tb07756.x; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Studer SM, 2003, J MOL BIOL, V327, P369, DOI 10.1016/S0022-2836(03)00146-3; Sund J, 2010, NATURE, V465, P947, DOI 10.1038/nature09082; Uno M, 2002, P NATL ACAD SCI USA, V99, P1819, DOI 10.1073/pnas.032457599; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Yoshimura K, 1999, GENES CELLS, V4, P253, DOI 10.1046/j.1365-2443.1999.00260.x	19	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e94058	10.1371/journal.pone.0094058	http://dx.doi.org/10.1371/journal.pone.0094058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699820	Green Submitted, Green Published, gold			2022-12-27	WOS:000334105000136
J	Cotten, M; Munnink, BO; Canuti, M; Deijs, M; Watson, SJ; Kellam, P; van der Hoek, L				Cotten, Matthew; Munnink, Bas Oude; Canuti, Marta; Deijs, Martin; Watson, Simon J.; Kellam, Paul; van der Hoek, Lia			Full Genome Virus Detection in Fecal Samples Using Sensitive Nucleic Acid Preparation, Deep Sequencing, and a Novel Iterative Sequence Classification Algorithm	PLOS ONE			English	Article							HEPATITIS NON-A; B-ASSOCIATED SUBSTANCE; IMMUNODEFICIENCY-VIRUS; METAGENOMIC ANALYSIS; DIVERSITY; VIROME; DIARRHEA; IDENTIFICATION; VIDISCA-454; GENOTYPES	We have developed a full genome virus detection process that combines sensitive nucleic acid preparation optimised for virus identification in fecal material with Illumina MiSeq sequencing and a novel post-sequencing virus identification algorithm. Enriched viral nucleic acid was converted to double-stranded DNA and subjected to Illumina MiSeq sequencing. The resulting short reads were processed with a novel iterative Python algorithm SLIM for the identification of sequences with homology to known viruses. De novo assembly was then used to generate full viral genomes. The sensitivity of this process was demonstrated with a set of fecal samples from HIV-1 infected patients. A quantitative assessment of the mammalian, plant, and bacterial virus content of this compartment was generated and the deep sequencing data were sufficient to assembly 12 complete viral genomes from 6 virus families. The method detected high levels of enteropathic viruses that are normally controlled in healthy adults, but may be involved in the pathogenesis of HIV-1 infection and will provide a powerful tool for virus detection and for analyzing changes in the fecal virome associated with HIV-1 progression and pathogenesis.	[Cotten, Matthew; Watson, Simon J.; Kellam, Paul] Wellcome Trust Sanger Inst, Hinxton, England; [Munnink, Bas Oude; Canuti, Marta; Deijs, Martin; van der Hoek, Lia] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol,Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands; [Kellam, Paul] UCL, Dept Infect, London, England	Wellcome Trust Sanger Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London	Cotten, M (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	mc13@sanger.ac.uk	Canuti, Marta/I-3145-2019; van der Hoek, Lia/Y-6412-2019	Canuti, Marta/0000-0002-9959-128X; Kellam, Paul/0000-0003-3166-4734; Cotten, Matthew/0000-0002-3361-3351	European Community [223498]	European Community(European Commission)	This work was supported by the Wellcome Trust and the European Community's Seventh Framework Programme (FP7/2007_2013) under the project EMPERIE, European Community grant agreement number 223498. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; BURCKHARDT J, 1988, IMMUN INFEKT, V16, P97; BURCKHARDT J, 1988, IMMUN INFEKT, V16, P91; Cantalupo PG, 2011, MBIO, V2, DOI 10.1128/mBio.00180-11; Canuti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029140; Chu DKW, 2012, J CLIN VIROL, V55, P209, DOI 10.1016/j.jcv.2012.07.001; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 2011, J VIROL, V85, P7284, DOI 10.1128/JVI.02472-10; de Vries M, 2008, J CLIN MICROBIOL, V46, P759, DOI 10.1128/JCM.02009-07; de Vries M, 2012, VIRUSES-BASEL, V4, P1328, DOI 10.3390/v4081328; de Vries M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016118; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Endoh D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni064; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jelcic I, 2004, J VIROL, V78, P7498, DOI 10.1128/JVI.78.14.7498-7507.2004; Kapoor A, 2008, P NATL ACAD SCI USA, V105, P20482, DOI 10.1073/pnas.0807979105; Kapusinszky B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036685; Law J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060595; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Malboeuf CM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks794; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Munnink BBO, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-22; Munnink BBO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078454; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Phan TG, 2012, J VIROL, V86, P11024, DOI 10.1128/JVI.01427-12; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Rousseau GM, 2009, APPL ENVIRON MICROB, V75, P5336, DOI 10.1128/AEM.00761-09; SEELIG R, 1983, DEV BIOL STAND, V54, P497; SEELIG R, 1988, IMMUN INFEKT, V16, P85; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Snijders F, 1997, CLIN INFECT DIS, V24, P1107, DOI 10.1086/513643; Terry FFN, 2012, J VIROL, V86, P12161, DOI 10.1128/JVI.00869-12; Phan TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072787; van der Heijden M, 2012, J VIROL METHODS, V185, P152, DOI 10.1016/j.jviromet.2012.05.019; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Watson SJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0205; Woolhouse M, 2012, PHILOS T R SOC B, V367, P2864, DOI 10.1098/rstb.2011.0354; Yu GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049449; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078470	45	55	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93269	10.1371/journal.pone.0093269	http://dx.doi.org/10.1371/journal.pone.0093269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695106	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000334103000055
J	Mott, KR; Allen, SJ; Zandian, M; Konda, B; Sharifi, BG; Jones, C; Wechsler, SL; Town, T; Ghiasi, H				Mott, Kevin R.; Allen, Sariah J.; Zandian, Mandana; Konda, Bindu; Sharifi, Behrooz G.; Jones, Clinton; Wechsler, Steven L.; Town, Terrence; Ghiasi, Homayon			CD8 alpha Dendritic Cells Drive Establishment of HSV-1 Latency	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; CD8(+) T-CELLS; TRIGEMINAL GANGLIA; CROSS-PRESENTATION; STROMAL KERATITIS; LANGERHANS CELLS; GAMMA-INTERFERON; INFECTION; REACTIVATION; CD4(+)	It is generally accepted that CD8 T cells play the key role to maintain HSV-1 latency in trigeminal ganglia of ocularly infected mice. Yet, comparably little is known about the role of innate immunity in establishment of viral latency. In the current study, we investigated whether CD8 alpha DCs impact HSV-1 latency by examining latency in the trigeminal ganglia (TG) of wildtype (WT) C57BL/6 versus CD8 alpha(-/-) (lack functional CD8 T cells and CD8 alpha(+) DCs), CD8 beta(-/-) (have functional CD8 alpha(+) T cells and CD8 alpha(+) DCs), and beta 2m(-/-) (lack functional CD8 T cells but have CD8 alpha(+) DCs) mice as well as BXH2 (have functional CD8 T cells but lack CD8 alpha(+) DCs) versus WT C3H (have functional CD8 alpha T cells and CD8 alpha(+) DCs) mice. We also determined whether the phenotype of CD8 alpha(-/-) and BXH2 mice could be restored to that of WT mice by adoptive transfer of WT CD8(+) T cells or bone marrow (BM) derived CD8 alpha(+) DCs. Our results clearly demonstrate that CD8 alpha DCs, rather than CD8 T cells, are responsible for enhanced viral latency and recurrences.	[Mott, Kevin R.; Allen, Sariah J.; Zandian, Mandana; Ghiasi, Homayon] Cedars Sinai Burns & Allen Res Inst, Ctr Neurobiol & Vaccine Dev, Dept Surg, Los Angeles, CA 90048 USA; [Konda, Bindu] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Konda, Bindu] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Sharifi, Behrooz G.] Cedars Sinai Med Ctr, Dept Med, Div Cardiol, Los Angeles, CA 90048 USA; [Jones, Clinton] Univ Nebraska, Sch Vet Med & Biomed Sci, Nebraska Ctr Virol, Lincoln, NE USA; [Wechsler, Steven L.] Univ Calif Irvine, Sch Med, Gavin Herbert Eye Inst, Dept Ophthalmol,Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Wechsler, Steven L.] Univ Calif Irvine, Sch Med, Ctr Virus Res, Irvine, CA 92717 USA; [Town, Terrence] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol, Los Angeles, CA 90033 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Southern California	Ghiasi, H (corresponding author), Cedars Sinai Burns & Allen Res Inst, Ctr Neurobiol & Vaccine Dev, Dept Surg, Los Angeles, CA 90048 USA.	ghiasih@cshs.org		Allen, Sariah J./0000-0001-8118-2413	Public Health Service [AI093941, EY13615, T32 AI89553]; NATIONAL EYE INSTITUTE [R01EY013615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089553, R21AI093941] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants AI093941, EY13615, and T32 AI89553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED R, 1987, J VIROL, V61, P1571, DOI 10.1128/JVI.61.5.1571-1576.1987; Alaniz RC, 2004, J IMMUNOL, V172, P3725, DOI 10.4049/jimmunol.172.6.3725; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Allen SJ, 2011, J VIROL, V85, P4184, DOI 10.1128/JVI.02290-10; Allenspach EJ, 2008, IMMUNITY, V29, P795, DOI 10.1016/j.immuni.2008.08.013; Balkhi MY, 2004, J LEUKOCYTE BIOL, V75, P874, DOI 10.1189/jlb.1003476; BARRON BA, 1994, OPHTHALMOLOGY, V101, P1871; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Braaten Douglas C, 2006, PLoS Pathog, V2, pe37, DOI 10.1371/journal.ppat.0020037; Brown DM, 2012, J VIROL, V86, P6792, DOI 10.1128/JVI.07172-11; COREY L, 1994, SEX TRANSM DIS, V21, pS38; CROOKS MEC, 1994, IMMUNITY, V1, P277; Dawson C R, 1984, Clin Dermatol, V2, P56, DOI 10.1016/0738-081X(84)90066-X; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Devine L, 2000, J IMMUNOL, V164, P833, DOI 10.4049/jimmunol.164.2.833; DOBSON AT, 1990, NEURON, V5, P353, DOI 10.1016/0896-6273(90)90171-B; DOYMAZ MZ, 1992, INVEST OPHTH VIS SCI, V33, P2165; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Frank GM, 2012, J IMMUNOL, V188, P1350, DOI 10.4049/jimmunol.1101968; FRASER NW, 1993, MICROB PATHOGENESIS, V15, P83, DOI 10.1006/mpat.1993.1059; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; GORDON YJ, 1990, ADV EXP MED BIOL, V278, P205; GORMAN SD, 1988, J IMMUNOL, V140, P3646; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Kaufman HE, 2005, INVEST OPHTH VIS SCI, V46, P241, DOI 10.1167/iovs.04-0614; Kautz-Neu K, 2011, J EXP MED, V208, P885, DOI 10.1084/jem.20102318; Kawamura K, 2006, BLOOD, V107, P1031, DOI 10.1182/blood-2005-04-1737; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Kobelt D, 2003, CURR TOP MICROBIOL, V276, P145; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Liu T, 2001, J VIROL, V75, P11178, DOI 10.1128/JVI.75.22.11178-11184.2001; Lombardi V, 2012, MUCOSAL IMMUNOL, V5, P432, DOI 10.1038/mi.2012.20; Maldonado-Lopez R, 2001, SEMIN IMMUNOL, V13, P275, DOI 10.1006/smim.2001.0323; Mott KR, 2008, J VIROL, V82, P9870, DOI 10.1128/JVI.00566-08; Mott KR, 2007, J VIROL, V81, P12962, DOI 10.1128/JVI.01442-07; Mott KR, 2007, MOL VIS, V13, P1802; Mott KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-56; Mott KR, 2009, J VIROL, V83, P2246, DOI 10.1128/JVI.02234-08; Mott KR, 2008, CLIN VACCINE IMMUNOL, V15, P1859, DOI 10.1128/CVI.00318-08; Oh J O, 1976, Surv Ophthalmol, V21, P106, DOI 10.1016/0039-6257(76)90087-4; Osorio Y, 2003, J VIROL, V77, P5774, DOI 10.1128/JVI.77.10.5774-5783.2003; Paroli M, 2000, J NEUROIMMUNOL, V107, P201, DOI 10.1016/S0165-5728(00)00228-9; PAVANLANGSTON D, 1983, MED CLIN N AM, V67, P973, DOI 10.1016/S0025-7125(16)31162-2; PERNG GC, 1994, J VIROL, V68, P8045, DOI 10.1128/JVI.68.12.8045-8055.1994; ROCK DL, 1987, J VIROL, V61, P3820, DOI 10.1128/JVI.61.12.3820-3826.1987; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Stefanidou M, 2013, J VIROL, V87, P1443, DOI 10.1128/JVI.01302-12; Steiner I, 1996, IMMUNOL REV, V152, P157, DOI 10.1111/j.1600-065X.1996.tb00915.x; STEVENS JG, 1989, MICROBIOL REV, V53, P318, DOI 10.1128/MMBR.53.3.318-332.1989; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Turcotte K, 2004, BLOOD, V103, P2343, DOI 10.1182/blood-2003-06-1852; WECHSLER SL, 1988, J GEN VIROL, V69, P3101, DOI 10.1099/0022-1317-69-12-3101; Wilhelmus KR, 1996, BRIT J OPHTHALMOL, V80, P969, DOI 10.1136/bjo.80.11.969; Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553; ZAMOYSKA R, 1994, IMMUNITY, V1, P243, DOI 10.1016/1074-7613(94)90075-2; Zhou Y, 2012, J EXP MED, V209, P1481, DOI 10.1084/jem.20111906; [No title captured]	71	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93444	10.1371/journal.pone.0093444	http://dx.doi.org/10.1371/journal.pone.0093444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695322	Green Published, gold			2022-12-27	WOS:000334103000072
J	Passaris, I; Ghosh, A; Cenens, W; Michiels, CW; Lammertyn, J; Aertsen, A				Passaris, Ioannis; Ghosh, Anirban; Cenens, William; Michiels, Chris W.; Lammertyn, Jeroen; Aertsen, Abram			Isolation and Validation of an Endogenous Fluorescent Nucleoid Reporter in Salmonella Typhimurium	PLOS ONE			English	Article							ESCHERICHIA-COLI CHROMOSOME; COMPLETE GENOME SEQUENCE; RIBOSOMAL-RNA OPERONS; ACTIVE TRANSCRIPTION; ORGANIZATION; PROTEIN; GENE; BACTERIA; SEGREGATION; EXPRESSION	In this study we adapted a Mud-based delivery system to construct a random yfp reporter gene (encoding the yellow fluorescent protein) insertion library in the genome of Salmonella Typhimurium LT2, and used fluorescence activated cell sorting and fluorescence microscopy to screen for translational fusions that were able to clearly and specifically label the bacterial nucleoid. Two such fusions were obtained, corresponding to a translational yfp insertion in iscR and iolR, respectively. Both fusions were further validated, and the IscR::YFP fluorescent nucleoid reporter together with time-lapse fluorescence microscopy was subsequently used to monitor nucleoid dynamics in response to the filamentation imposed by growth of LT2 at high hydrostatic pressure (40-45 MPa). As such, we were able to reveal that upon decompression the apparently entangled LT2 chromosomes in filamentous cells rapidly and efficiently segregate, after which septation of the filament occurs. In the course of the latter process, however, cells with a "trilobed" nucleoid were regularly observed, indicative for an imbalance between septum formation and chromosome segregation.	[Aertsen, Abram] Univ Leuven, Fac Biosci Engn, Dept Microbial & Mol Syst M2S, Lab Food Micobiol,KU Leuven, Louvain, Belgium; [Lammertyn, Jeroen] Univ Leuven, KU Leuven, Fac Biosci Engn, BIOSYST MeBios, Louvain, Belgium	KU Leuven; KU Leuven	Aertsen, A (corresponding author), Univ Leuven, Fac Biosci Engn, Dept Microbial & Mol Syst M2S, Lab Food Micobiol,KU Leuven, Louvain, Belgium.	abram.aertsen@biw.kuleuven.be	Cenens, William/J-6345-2015; Michiels, Chris/I-6847-2013	Cenens, William/0000-0002-0856-4703; Michiels, Chris/0000-0002-7710-6802; Aertsen, Abram/0000-0002-1897-2305	Flemish Agency for Innovation by Science and Technology (IWT-Vlaanderen); Erasmus Mundus External Cooperation Window [EMECW13-Eurindia]; KU Leuven Research Fund [STRT1/10/036, IDO/10/012, DBOF/12/035]; Research Foundation of Flanders (FWO-Vlaanderen) [G.0580.11]	Flemish Agency for Innovation by Science and Technology (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Erasmus Mundus External Cooperation Window; KU Leuven Research Fund(KU Leuven); Research Foundation of Flanders (FWO-Vlaanderen)(FWO)	This work was supported by doctoral fellowships from the Flemish Agency for Innovation by Science and Technology (IWT-Vlaanderen; to IP) and the Erasmus Mundus External Cooperation Window (EMECW13-Eurindia; to AG), and grants from the KU Leuven Research Fund (STRT1/10/036, IDO/10/012 and DBOF/12/035) and the Research Foundation of Flanders (FWO-Vlaanderen; G.0580.11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertsen A, 2008, BIOCHEM BIOPH RES CO, V367, P435, DOI 10.1016/j.bbrc.2007.12.151; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cabrera JE, 2006, J BACTERIOL, V188, P4007, DOI 10.1128/JB.01893-05; Cabrera JE, 2009, J BACTERIOL, V191, P4180, DOI 10.1128/JB.01707-08; Cenens W, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003269; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; Dorman CJ, 2013, NAT REV MICROBIOL, V11, P349, DOI 10.1038/nrmicro3007; Esnault E, 2007, PLOS GENET, V3, P2486, DOI 10.1371/journal.pgen.0030226; Fisher JK, 2013, CELL, V153, P882, DOI 10.1016/j.cell.2013.04.006; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; HUGHES KT, 1988, GENETICS, V119, P9; Keyamura K, 2013, J BIOL CHEM; KLECKNER N, 1991, METHOD ENZYMOL, V204, P139; Kroger C, 2009, J BACTERIOL, V191, P545, DOI 10.1128/JB.01253-08; Kwon YM, 2000, J MICROBIOL METH, V41, P195, DOI 10.1016/S0167-7012(00)00159-7; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Maloy SR., 1996, GENETIC ANAL PATHOGE; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Nagashima K, 2006, J BIOL CHEM, V281, P30941, DOI 10.1074/jbc.M606566200; Petrushenko ZM, 2010, EMBO J, V29, P1126, DOI 10.1038/emboj.2009.414; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Rajagopalan S, 2013, STUDIES ISCR REVEAL; Rovinskiy N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002845; Sambrook J., 2001, MOL CLONING LAB MANU; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; SUSSKIND MM, 1980, J MOL BIOL, V138, P685, DOI 10.1016/0022-2836(80)90060-1; von Freiesleben U, 2000, EMBO J, V19, P6240, DOI 10.1093/emboj/19.22.6240; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Wang XD, 2013, NAT REV GENET, V14, P191, DOI 10.1038/nrg3375; Wilson K., 2001, CURR PROTOC MOL BIOL, V56, P2, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]; Yazdi NH, 2012, MOL MICROBIOL, V86, P1318, DOI 10.1111/mmi.12071; Zahradka K, 2009, J BACTERIOL, V191, P1677, DOI 10.1128/JB.01877-07; ZOBELL CE, 1964, J BACTERIOL, V87, P710, DOI 10.1128/JB.87.3.710-719.1964	37	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93785	10.1371/journal.pone.0093785	http://dx.doi.org/10.1371/journal.pone.0093785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695782	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000121
J	Rueness, EK; Naidenko, S; Trosvik, P; Stenseth, NC				Rueness, Eli K.; Naidenko, Sergei; Trosvik, Pal; Stenseth, Nils Chr.			Large-Scale Genetic Structuring of a Widely Distributed Carnivore - The Eurasian Lynx (Lynx lynx)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA PHYLOGEOGRAPHY; POPULATION-STRUCTURE; HOLARCTIC PHYLOGEOGRAPHY; POSTGLACIAL COLONIZATION; LINKAGE DISEQUILIBRIUM; CLIMATIC OSCILLATIONS; ICE-AGE; DISPERSAL; DIFFERENTIATION; PLEISTOCENE	Over the last decades the phylogeography and genetic structure of a multitude of species inhabiting Europe and North America have been described. The flora and fauna of the vast landmasses of north-eastern Eurasia are still largely unexplored in this respect. The Eurasian lynx is a large felid that is relatively abundant over much of the Russian sub-continent and the adjoining countries. Analyzing 148 museum specimens collected throughout its range over the last 150 years we have described the large-scale genetic structuring in this highly mobile species. We have investigated the spatial genetic patterns using mitochondrial DNA sequences (D-loop and cytochrome b) and 11 microsatellite loci, and describe three phylogenetic clades and a clear structuring along an east-west gradient. The most likely scenario is that the contemporary Eurasian lynx populations originated in central Asia and that parts of Europe were inhabited by lynx during the Pleistocene. After the Last Glacial Maximum (LGM) range expansions lead to colonization of north-western Siberia and Scandinavia from the Caucasus and north-eastern Siberia from a refugium further east. No evidence of a Berinigan refugium could be detected in our data. We observed restricted gene flow and suggest that future studies of the Eurasian lynx explore to what extent the contemporary population structure may be explained by ecological variables.	[Rueness, Eli K.; Trosvik, Pal; Stenseth, Nils Chr.] Univ Oslo, Dept Biosci, CEES, Oslo, Norway; [Naidenko, Sergei] Russian Acad Sci, AN Severtsov Inst Ecol & Evolut, Moscow, Russia	University of Oslo; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution	Rueness, EK (corresponding author), Univ Oslo, Dept Biosci, CEES, Oslo, Norway.	e.k.rueness@ibv.uio.no	Stenseth, Nils Chr./G-5212-2016	Stenseth, Nils Chr./0000-0002-1591-5399	Research Counsel of Norways, Centre for Ecological and Evolutionary Synthesis [RCN 179569/V40]	Research Counsel of Norways, Centre for Ecological and Evolutionary Synthesis	The study was funded by the Research Counsel of Norways project RCN 179569/V40, Centre for Ecological and Evolutionary Synthesis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alroy J, 2002, SYNONYMIES REIDENTIF; [Anonymous], 1995, PLANN PEOPL PROSP; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bannikova AA, 2010, BIOL J LINN SOC, V101, P721, DOI 10.1111/j.1095-8312.2010.01510.x; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Baryshnikov GF, 2011, QUATERN INT, V245, P350, DOI 10.1016/j.quaint.2011.02.035; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; BREITENMOSER U, 1993, J ZOOL, V231, P449, DOI 10.1111/j.1469-7998.1993.tb01931.x; Brunhoff C, 2003, MOL ECOL, V12, P957, DOI 10.1046/j.1365-294X.2003.01796.x; Croteau EK, 2010, CAN J ZOOL, V88, P536, DOI 10.1139/Z10-024; Din JU, 2010, J ANIM PLANT SCI, V20, P17; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias SA, 1996, NATURE, V382, P60, DOI 10.1038/382060a0; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fedorov VB, 2008, MOL ECOL, V17, P598, DOI 10.1111/j.1365-294X.2007.03595.x; Fedorov VB, 2003, MOL ECOL, V12, P725, DOI 10.1046/j.1365-294X.2003.01776.x; Flagstad O, 2003, EVOLUTION, V57, P658; Greenacre Michael, 1984, THEORY APPL CORRES A; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Gugolz D, 2008, J ZOOL, V275, P201, DOI 10.1111/j.1469-7998.2008.00428.x; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hellborg L, 2002, CONSERV GENET, V3, P97, DOI 10.1023/A:1015217723287; Heptner VG, 1992, MAMMALS SOVIET UNION, VII; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hubberten HW, 2004, QUATERNARY SCI REV, V23, P1333, DOI 10.1016/j.quascirev.2003.12.012; Hundertmark KJ, 2002, MOL PHYLOGENET EVOL, V22, P375, DOI 10.1006/mpev.2001.1058; JANCZEWSKI DN, 1995, MOL BIOL EVOL, V12, P690; Jedrzejewski W, 1996, ECOGRAPHY, V19, P122, DOI 10.1111/j.1600-0587.1996.tb00163.x; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; JUKES T H, 1969, P21; Korsten M, 2009, MOL ECOL, V18, P1963, DOI 10.1111/j.1365-294X.2009.04163.x; Kurten B., 1980, PLEISTOCENE MAMMALS; Kutschera VE, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-114; Leonard JA, 2000, P NATL ACAD SCI USA, V97, P1651, DOI 10.1073/pnas.040453097; Linnell JDC, 2001, ENVIRON MANAGE, V27, P869; Lister A, 2004, PHILOS T R SOC B, V359, P195; Ludt CJ, 2004, MOL PHYLOGENET EVOL, V31, P1064, DOI 10.1016/j.ympev.2003.10.003; MANTEL N, 1967, CANCER RES, V27, P209; Marmi J, 2006, MOL ECOL, V15, P1007, DOI 10.1111/j.1365-294X.2006.02747.x; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Munoz-Fuentes V, 2009, J BIOGEOGR, V36, P1516, DOI 10.1111/j.1365-2699.2008.02067.x; Nenadic O., 2007, J STAT SOFTW, V20, P3, DOI [DOI 10.18637/JSS.V020.I03, DOI 10.3354/MEPS086063]; Nowell K., 1996, WILD CATS; Pilot M, 2012, PLOS ONE, P7; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Poole KG, 1997, J WILDLIFE MANAGE, V61, P497, DOI 10.2307/3802607; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2007, TRACER V1 5; Ratkiewicz M, 2012, ANIM CONSERV, V15, P603, DOI 10.1111/j.1469-1795.2012.00556.x; Reding DM, 2012, MOL ECOL, V21, P3078, DOI 10.1111/j.1365-294X.2012.05595.x; Row JR, 2012, CONSERV GENET, V13, P1259, DOI 10.1007/s10592-012-0369-3; Rueness EK, 2003, NATURE, V425, P69, DOI 10.1038/nature01942; Rueness EK, 2003, MOL ECOL, V12, P2623, DOI 10.1046/j.1365-294X.2003.01952.x; Ruiz-Gonzalez A, 2013, BIOL J LINN SOC, V109, P1, DOI 10.1111/bij.12046; Sacks BN, 2008, MOL BIOL EVOL, V25, P1384, DOI 10.1093/molbev/msn082; Samelius G, 2012, J ZOOL, V286, P120, DOI 10.1111/j.1469-7998.2011.00857.x; Schmidt K, 1998, ACTA THERIOL, V43, P391, DOI 10.4098/AT.arch.98-50; Schmidt K, 2009, CONSERV GENET, V10, P497, DOI 10.1007/s10592-008-9795-7; Sharma DK, 2004, P ROY SOC B-BIOL SCI, V271, pS1, DOI 10.1098/rsbl.2003.0071; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; SLATKIN M, 1994, GENETICS, V137, P331; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; Stenseth NC, 2004, P NATL ACAD SCI USA, V101, P10632, DOI 10.1073/pnas.0308674101; Stenseth NC, 2004, P NATL ACAD SCI USA, V101, P6056, DOI 10.1073/pnas.0307123101; Sunquist ME, 2002, WILD CATS WORLD; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarkhnishvili D, 2012, BIOL J LINN SOC, V105, P231, DOI 10.1111/j.1095-8312.2011.01788.x; Teacher AGF, 2011, BMC EVOLUTIONARY BIO, P11; Tsoukala Evangelia, 1999, Beitraege zur Palaeontologie, V24, P207; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; WASER PM, 1983, Q REV BIOL, V58, P355, DOI 10.1086/413385	82	29	31	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93675	10.1371/journal.pone.0093675	http://dx.doi.org/10.1371/journal.pone.0093675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695745	Green Submitted, Green Published, gold			2022-12-27	WOS:000334103000102
J	Gupta, AK; David, W				Gupta, Ashwani K.; David, Waseem			Does Erythropoietin Cause Hemoglobin Variability- Is It 'Normal'?	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; SERUM-ALBUMIN; LEVEL VARIABILITY; HEMODIALYSIS-PATIENTS; ANEMIA MANAGEMENT; DIALYSIS PATIENTS; INFLAMMATION; MORTALITY; ASSOCIATION; CYTOKINES	Hemoglobin variability (Hb-var) in patients with chronic kidney disease has been stipulated to be a result of exogenous treatment with erythropoiesis stimulating agents (ESA) and has been related to mortality in dialysis patients. We hypothesized the existence of Hb-var independent of ESA administration and compared it to that in healthy adults using data from the Scripps-Kaiser and NHANES III databases. We studied the Hb-var in 1571 peritoneal dialysis patients which included 116 patients not requiring treatment with erythropoietin. We systematically studied the differences between the groups that needed ESA therapy and those who did not. White race and male sex were significant predictors of need for erythropoietin therapy. We found peritoneal dialysis patients to exhibit significantly increased Hb-var independent of treatment with exogenous erythropoietin (0.99 gm/dL vs. 1.17 gm/dL, p-value<0.001). We found age to be a significant determinant of Hb-var in the ESA treated group. Hb-var in younger patients (<30 years) was increased by 50% compared to young healthy adults. The Hb-var in elderly (>60 years) peritoneal dialysis patients was similar to that seen in healthy elders, suggesting similarity with anemia of aging. We conclude that exogenous ESA administration does not explain Hb-var entirely but may enhance it. Intrinsic factors affecting erythropoiesis including age may be the major determinants of Hb-var.	[Gupta, Ashwani K.; David, Waseem] Univ Florida, Dept Nephrol, Jacksonville, FL USA	State University System of Florida; University of Florida	Gupta, AK (corresponding author), Univ Florida, Dept Nephrol, Jacksonville, FL USA.	akgupta@ufl.edu						AHMAD R, 1987, NEW ENGL J MED, V317, P169; Arneson TJ, 2009, NEPHROL DIAL TRANSPL, V24, P1378, DOI 10.1093/ndt/gfp018; Ashby DR, 2010, HAEMATOL-HEMATOL J, V95, P505, DOI 10.3324/haematol.2009.013136; Ashby DR, 2009, KIDNEY INT, V75, P976, DOI 10.1038/ki.2009.21; Berns JS, 2003, KIDNEY INT, V64, P1514, DOI 10.1046/j.1523-1755.2003.00229.x; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; Bian XX, 2010, NEUROL MED-CHIR, V50, P361, DOI 10.2176/nmc.50.361; Brunelli SM, 2008, CLIN J AM SOC NEPHRO, V3, P1733, DOI 10.2215/CJN.02390508; Canavese C, 2002, CLIN NEPHROL, V58, P438; Canavesi Elena, 2012, World J Nephrol, V1, P166, DOI 10.5527/wjn.v1.i6.166; Chen Ho-Ching, 2012, Chang Gung Med J, V35, P79; Cooper AC, 2003, J AM SOC NEPHROL, V14, P1776, DOI 10.1097/01.ASN.0000071514.36428.61; Ebben JP, 2006, CLIN J AM SOC NEPHRO, V1, P1205, DOI 10.2215/CJN.01110306; Eckardt KU, 2010, J AM SOC NEPHROL, V21, P1765, DOI 10.1681/ASN.2009101017; Eschbach J W, 1988, Contrib Nephrol, V66, P63; FAQUIN WC, 1992, BLOOD, V79, P1987; Ferrucci L, 2008, SEMIN HEMATOL, V45, P242, DOI 10.1053/j.seminhematol.2008.06.001; Fishbane S, 2005, KIDNEY INT, V68, P1337, DOI 10.1111/j.1523-1755.2005.00532.x; Gilbertson DT, 2008, CLIN J AM SOC NEPHRO, V3, P133, DOI 10.2215/CJN.01610407; Gilbertson DT, 2009, AM J NEPHROL, V30, P491, DOI 10.1159/000243565; Ishani A, 2008, NEPHROL DIAL TRANSPL, V23, P1682, DOI 10.1093/ndt/gfm845; Johansen KL, 2010, AM J KIDNEY DIS, V55, P535, DOI 10.1053/j.ajkd.2009.12.018; Kainz A, 2012, TRANSPL INT, V25, P323, DOI 10.1111/j.1432-2277.2012.01428.x; Kainz A, 2010, NEPHROL DIAL TRANSPL, V25, P3701, DOI 10.1093/ndt/gfq287; Kaufman JS, 2008, AM J KIDNEY DIS, V52, P1035, DOI 10.1053/j.ajkd.2008.10.002; Kausz AT, 2005, AM J KIDNEY DIS, V45, P136, DOI 10.1053/j.ajkd.2004.08.042; Kaysen GA, 2000, KIDNEY INT, V58, P346, DOI 10.1046/j.1523-1755.2000.00172.x; Kaysen GA, 2004, KIDNEY INT, V65, P1408, DOI 10.1111/j.1523-1755.2004.00520.x; Kaysen GA, 2002, KIDNEY INT, V61, P2240, DOI 10.1046/j.1523-1755.2002.00076.x; Kaysen GA, 2001, KIDNEY INT, V60, P333, DOI 10.1046/j.1523-1755.2001.00804.x; Lacson E, 2008, AM J KIDNEY DIS, V52, P1104, DOI 10.1053/j.ajkd.2008.07.026; Lau JH, 2010, NEPHROL DIAL TRANSPL, V25, P4002, DOI 10.1093/ndt/gfq330; Massimetti C, 1998, BLOOD PURIFICAT, V16, P317, DOI 10.1159/000014351; McCranor BJ, 2013, HAEMATOLOGICA, V98, P1633, DOI 10.3324/haematol.2013.087114; Selby NM, 2012, PERITON DIALYSIS INT, V32, P177, DOI 10.3747/pdi.2010.00299; Shen Y, 2010, TRANSPL P, V42, P1595, DOI 10.1016/j.transproceed.2009.11.050; Singh AK, 2008, KIDNEY INT, V74, P679, DOI 10.1038/ki.2008.59; van der Putten K, 2009, INT J ARTIF ORGANS, V32, P787, DOI 10.1177/039139880903201104; Walker R, 2009, NEPHROLOGY, V14, P689, DOI 10.1111/j.1440-1797.2009.01166.x; Weinhandl ED, 2011, AM J KIDNEY DIS, V57, P255, DOI 10.1053/j.ajkd.2010.06.013; Yang W, 2007, J AM SOC NEPHROL, V18, P3164, DOI 10.1681/ASN.2007010058; Yeun J Y, 1998, Am J Kidney Dis, V32, pS118, DOI 10.1016/S0272-6386(98)70174-X; Yeun JY, 1997, AM J KIDNEY DIS, V30, P923, DOI 10.1016/S0272-6386(97)90105-0; Yilmaz MI, 2011, BLOOD PURIFICAT, V32, P220, DOI 10.1159/000328037	44	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e92890	10.1371/journal.pone.0092890	http://dx.doi.org/10.1371/journal.pone.0092890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709756	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800020
J	Su, SS; He, H; Kong, LB; Zhang, YG; Zhao, SX; Wang, RQ; Zheng, HW; Sun, DX; Nan, YM; Yu, J				Su, Shan-shan; He, Huan; Kong, Ling-bo; Zhang, Yu-guo; Zhao, Su-xian; Wang, Rong-qi; Zheng, Huan-wei; Sun, Dian-xing; Nan, Yue-min; Yu, Jun			Regulatory Phenotype, PD-1 and TLR3 Expression in T Cells and Monocytes from HCV Patients Undergoing Antiviral Therapy: A Randomized Clinical Trial	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; SUSTAINED VIROLOGICAL RESPONSE; FUNCTIONAL RESTORATION; RECEPTOR-3 EXPRESSION; PEGINTERFERON; INFECTION; RIBAVIRIN; BLOCKADE; IMMUNITY; ASSOCIATION	Background & Aims: The cellular immunity has a profound impact on the status of hepatitis C virus (HCV) infection. However, the response of cellular immunity on the virological response in patients with antiviral treatment remains largely unclear. We aimed to clarify the response of peripheral T cells and monocytes in chronic hepatitis C patients with antiviral treatment. Methods: Patients with chronic hepatitis C were treated either with interferon alpha-2b plus ribavirin (n=37) or with pegylated interferon alpha-2a plus ribavirin (n=33) for up to 24 weeks. Frequencies of peripheral regulatory T-cells (Tregs), programmed death-1 (PD-1) expressing CD4(+) T-cells or CD8(+) T-cells and toll-like receptor (TLR) 3 expressing CD14(+) monocytes were evaluated by flow cytometry in patients at baseline, 12 and 24 weeks following treatment and in 20 healthy controls. Results: Frequencies of Tregs, PD-1 and TLR3 expressing cells were higher in patients than those in control subjects (P < 0.05). Patients with complete early virological response (cEVR) showed lower Tregs, PD-1 expressing CD4(+) or CD8(+) T-cells than those without cEVR at 12 weeks (P < 0.05). Patients with low TLR3 expressing CD14(+) monocytes at baseline had a high rate of cEVR (P < 0.05). Conclusions: Low peripheral TLR3 expressing CD14(+) monocytes at baseline could serve as a predictor for cEVR of antiviral therapy in chronic HCV-infected patients. The cEVR rates were significantly increased in the patients with reduced circulating Tregs, PD-1 expressing CD4(+) or CD8(+) T-cells. Trial Registration: Chinese Clinical Trial Registry ChiCTR10001090.	[Su, Shan-shan; He, Huan; Kong, Ling-bo; Zhang, Yu-guo; Zhao, Su-xian; Wang, Rong-qi; Nan, Yue-min] Hebei Med Univ, Hosp 3, Dept Tradit & Western Med Hepatol, Shijiazhuang, Peoples R China; [Zheng, Huan-wei] Fifth Hosp Shijiazhuang City, Dept Infect Dis, Shijiazhuang, Peoples R China; [Sun, Dian-xing] Bethune Int Peace Hosp, Dept Liver Dis, Shijiazhuang, Peoples R China; [Yu, Jun] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Yu, Jun] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut, State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China	Hebei Medical University; Chinese University of Hong Kong; Chinese University of Hong Kong	Nan, YM (corresponding author), Hebei Med Univ, Hosp 3, Dept Tradit & Western Med Hepatol, Shijiazhuang, Peoples R China.	nanyuemin@163.com	Yu, Jun/D-8569-2015	Yu, Jun/0000-0001-5008-2153	Key Program for Science and Technology Development of Hebei Province named Study on Prevention and Control of Viral Hepatitis [10276102D]	Key Program for Science and Technology Development of Hebei Province named Study on Prevention and Control of Viral Hepatitis	This study was supported by the Key Program for Science and Technology Development of Hebei Province named Study on Prevention and Control of Viral Hepatitis (10276102D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Chung HJ, 2013, INTERVIROLOGY, V56, P178, DOI 10.1159/000345539; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Fitzmaurice K, 2008, CURR PHARM DESIGN, V14, P1666, DOI 10.2174/138161208784746806; Frebel H, 2010, EUR J IMMUNOL, V40, P654, DOI 10.1002/eji.200940102; [高英堂 Gao Yingtang], 2004, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V27, P690; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Golden-Mason L, 2008, J IMMUNOL, V180, P3637, DOI 10.4049/jimmunol.180.6.3637; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Hackl D, 2011, EUR J IMMUNOL, V41, P1334, DOI 10.1002/eji.201041014; Hadigan C, 2011, JAMA-J AM MED ASSOC, V306, P294, DOI 10.1001/jama.2011.975; Hashad DI, 2011, SCAND J CLIN LAB INV, V71, P641, DOI 10.3109/00365513.2011.624196; Huang CF, 2010, J GASTROEN HEPATOL, V25, P758, DOI 10.1111/j.1440-1746.2009.06148.x; Kamal SM, 2002, GASTROENTEROLOGY, V123, P1070, DOI 10.1053/gast.2002.36045; Langhans B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042094; Liao XW, 2011, ANTIVIR THER, V16, P141, DOI 10.3851/IMP1703; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Missale G, 2012, GUT, V61, P1076, DOI 10.1136/gutjnl-2011-300515; Munir S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-296; Nakamoto N, 2008, GASTROENTEROLOGY, V134, P1927, DOI 10.1053/j.gastro.2008.02.033; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Raziorrouh B, 2011, GASTROENTEROLOGY, V141, P1422, DOI 10.1053/j.gastro.2011.07.004; Rodriguez-Torres M, 2010, J VIRAL HEPATITIS, V17, P139, DOI 10.1111/j.1365-2893.2009.01157.x; Rutebemberwa A, 2008, J IMMUNOL, V181, P8215, DOI 10.4049/jimmunol.181.12.8215; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarikonda G, 2011, METHODS MOL BIOL, V677, P431, DOI 10.1007/978-1-60761-869-0_27; Schroder M, 2005, TRENDS IMMUNOL, V26, P462, DOI 10.1016/j.it.2005.07.002; Seigel B, 2013, GASTROENTEROLOGY, V144, P426, DOI 10.1053/j.gastro.2012.10.047; Shen T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-279; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shiina M, 2008, HEPATOLOGY, V47, P385, DOI 10.1002/hep.21996; Speletas M, 2011, MEDIAT INFLAMM, V827565, P1; Thomas A, 2007, ANTIMICROB AGENTS CH, V51, P2969, DOI 10.1128/AAC.00268-07; Tseng KC, 2012, J GASTROENTEROL, V47, P823, DOI 10.1007/s00535-012-0544-9; Urbani S, 2008, J HEPATOL, V48, P548, DOI 10.1016/j.jhep.2007.12.014; Villacres MC, 2008, J VIRAL HEPATITIS, V15, P137, DOI 10.1111/j.1365-2893.2007.00904.x; Yao S, 2009, BLOOD, V113, P5811, DOI 10.1182/blood-2009-02-203141; Yuki N, 2010, J VIRAL HEPATITIS, V17, P130, DOI 10.1111/j.1365-2893.2009.01155.x; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	42	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93620	10.1371/journal.pone.0093620	http://dx.doi.org/10.1371/journal.pone.0093620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709775	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800040
J	Ye, GP; Zhu, YX; Liu, J; Chen, XX; Huang, KH				Ye, Gengping; Zhu, Yongxing; Liu, Jin; Chen, Xingxiang; Huang, Kehe			Preparation of Glycerol-Enriched Yeast Culture and Its Effect on Blood Metabolites and Ruminal Fermentation in Goats	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; DAIRY-COWS; RUMEN FERMENTATION; EARLY LACTATION; PERFORMANCE; LAMBS; ACCUMULATION; AMMONIA; INVITRO; SHEEP	The aim of this study was to isolate a glycerol-producing yeast strain from nature to prepare glycerol-enriched yeast culture (GY), and preliminarily evaluate the effects of GY on blood metabolites and ruminal fermentation in goats. During the trial, six isolates were isolated from unprocessed honey, and only two isolates with higher glycerol yield were identified by analysis of 26S ribosomal DNA sequences. One of the two isolates was identified as Saccharomyces cerevisiae, a direct-fed microbe permitted by the FDA. This isolate was used to prepare GY. The fermentation parameters were optimized through single-factor and orthogonal design methods to maximize the glycerol yield and biomass. The final GY contained 38.7 +/- 0.6 g/L glycerol and 12.6 +/- 0.5 g/L biomass. In vivo, eight castrated male goats with ruminal fistula were used in a replicated 464 Latin square experiment with four consecutive periods of 15 d. Treatments were as follows: control, LGY, MGY, and HGY with 0, 100, 200, and 300 mL GY per goat per day, respectively. The GY was added in two equal portions at 08: 00 and 17: 00 through ruminal fistula. Samples of blood and ruminal fluid were collected on the last one and two days of each period, respectively. Results showed that the plasma concentrations of triglyceride and total cholesterol were not affected by the supplemented GY. Compared with the control, goats supplemented with MGY and HGY had significantly higher(P < 0.05) concentrations of plasma glucose and total protein, ruminal volatile fatty acid and molar proportion of propionate, and significantly lower (P < 0.05) ruminal pH and ammonia nitrogen. These parameters changed linearly with increasing GY supplementation level (P < 0.05). In conclusion, GY has great potential to be developed as a feed additive with dual effects of glycerol and yeast for ruminants.	[Ye, Gengping; Zhu, Yongxing; Liu, Jin; Chen, Xingxiang; Huang, Kehe] Nanjing Agr Univ, Inst Nutr & Metab Disorders Domest Anim & Fowls, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Huang, KH (corresponding author), Nanjing Agr Univ, Inst Nutr & Metab Disorders Domest Anim & Fowls, Nanjing, Jiangsu, Peoples R China.	khhuang@njau.edu.cn			science and technology support plan project of Jiangsu Province, China [BE2011364]; Research Fund for the Doctoral Program of Higher Education of China [20110097110014, 20120097130002]; Priority Academic Program Development of Jiangsu Higher Education Institutions	science and technology support plan project of Jiangsu Province, China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions	The project was supported by science and technology support plan project of Jiangsu Province, China (Grant number BE2011364), the Research Fund for the Doctoral Program of Higher Education of China (Grant number 20110097110014, 20120097130002), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshaikh MA, 2002, ASIAN AUSTRAL J ANIM, V15, P352, DOI 10.5713/ajas.2002.352; [Anonymous], 2011, AM J BIOCH MOL BIOL, DOI DOI 10.3923/AJBMB.2011.158.167; BERTICS SJ, 1992, J DAIRY SCI, V75, P1914, DOI 10.3168/jds.S0022-0302(92)77951-X; BRODERICK GA, 1980, J DAIRY SCI, V63, P64, DOI 10.3168/jds.S0022-0302(80)82888-8; Chaucheyras-Durand F, 2001, REPROD NUTR DEV, V41, P57, DOI 10.1051/rnd:2001112; Chung YH, 2007, J DAIRY SCI, V90, P5682, DOI 10.3168/jds.2007-0426; Cori C F, 1935, Science, V82, P134, DOI 10.1126/science.82.2119.134-a; Donkin SS, 2007, TRI-STATE DAIRY NUTRITION CONFERENCE, PROCEEDINGS, P97; ERASMUS LJ, 1992, J DAIRY SCI, V75, P3056, DOI 10.3168/jds.S0022-0302(92)78069-2; FORD EJH, 1980, RES VET SCI, V29, P346, DOI 10.1016/S0034-5288(18)32640-7; GARTON GA, 1961, J GEN MICROBIOL, V25, P215, DOI 10.1099/00221287-25-2-215; Goff J. P., 2001, Journal of Dairy Science, V84, P153; Gunn P. J., 2010, Professional Animal Scientist, V26, P298; Haddad SG, 2005, ANIM FEED SCI TECH, V118, P343, DOI 10.1016/j.anifeedsci.2004.10.003; Hippen AR, 2008, FLOR RUM NUTR S, P1; JOHNS A. T., 1953, New Zealand Journal of Science and Technology, Section A, V35, P262; Kalmus P, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-32; Khalid MF, 2011, AFR J AGR RES, V6, P5198; Krehbiel CR, 2008, J ANIM SCI S, V86, P392, DOI DOI 10.2527/JAS.2007-0788; Kurtzman C. P., 1998, P3, DOI 10.1016/B978-044481312-1/50004-6; LAMBERT M, 1950, CAN J RES B, V28, P83, DOI 10.1139/cjr50b-013; Liu YQ, 2002, BIOTECHNOL LETT, V24, P1137, DOI 10.1023/A:1016170600048; Looke M, 2011, BIOTECHNIQUES, V50, P325, DOI 10.2144/000113672; NAGODAWITHANA TW, 1976, APPL ENVIRON MICROB, V31, P158, DOI 10.1128/AEM.31.2.158-162.1976; nal F, 2010, KAFKAS U VET FAK DER, V16, P799; OMORI T, 1995, J FERMENT BIOENG, V79, P560, DOI 10.1016/0922-338X(95)94748-G; Petrovska B, 1999, CAN J MICROBIOL, V45, P695, DOI 10.1139/cjm-45-8-695; REED RH, 1987, APPL ENVIRON MICROB, V53, P2119, DOI 10.1128/AEM.53.9.2119-2123.1987; REID R. L., 1960, AUSTRALIAN JOUR AGRIC RES, V11, P42, DOI 10.1071/AR9600042; REMOND B, 1993, ANIM FEED SCI TECH, V41, P121, DOI 10.1016/0377-8401(93)90118-4; RUSSELL JB, 1992, J ANIM SCI, V70, P3551, DOI 10.2527/1992.70113551x; SATTER LD, 1974, BRIT J NUTR, V32, P199, DOI 10.1079/BJN19740073; Taqarort N, 2008, WORLD J MICROB BIOT, V24, P3031, DOI 10.1007/s11274-008-9849-5; Wang C, 2009, ANIM FEED SCI TECH, V151, P12, DOI 10.1016/j.anifeedsci.2008.10.009; Yalcin S, 2011, ASIAN AUSTRAL J ANIM, V24, P1377, DOI 10.5713/ajas.2011.11060; Zhuge J, 2001, APPL MICROBIOL BIOT, V55, P686, DOI 10.1007/s002530100596	36	7	9	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94410	10.1371/journal.pone.0094410	http://dx.doi.org/10.1371/journal.pone.0094410			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709881	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800141
J	Aydinonat, D; Penn, DJ; Smith, S; Moodley, Y; Hoelzl, F; Knauer, F; Schwarzenberger, F				Aydinonat, Denise; Penn, Dustin J.; Smith, Steve; Moodley, Yoshan; Hoelzl, Franz; Knauer, Felix; Schwarzenberger, Franz			Social Isolation Shortens Telomeres in African Grey Parrots (Psittacus erithacus erithacus)	PLOS ONE			English	Article							QUANTITATIVE PCR; DNA-DAMAGE; LIFE-STYLE; STRESS; LENGTH; DYNAMICS; MORTALITY; STEREOTYPIES; DYSFUNCTION; SENESCENCE	Telomeres, the caps of eukaryotic chromosomes, control chromosome stability and cellular senescence, but aging and exposure to chronic stress are suspected to cause attrition of telomere length. We investigated the effect of social isolation on telomere length in the highly social and intelligent African Grey parrot (Psittacus erithacus erithacus). Our study population consisted of single-housed (n = 26) and pair-housed (n = 19) captive individuals between 0.75 to 45 years of age. Relative telomere length of erythrocyte DNA was measured by quantitative real-time PCR. We found that telomere length declined with age (p<0.001), and socially isolated parrots had significantly shorter telomeres compared to pair-housed birds (p<0.001) - even among birds of similar ages. Our findings provide the first evidence that social isolation affects telomere length, which supports the hypothesis that telomeres provide a biomarker indicating exposure to chronic stress.	[Aydinonat, Denise; Schwarzenberger, Franz] Univ Vet Med, Dept Biomed Sci, Vienna, Austria; [Aydinonat, Denise; Penn, Dustin J.; Smith, Steve; Moodley, Yoshan] Univ Vet Med, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, Vienna, Austria; [Hoelzl, Franz; Knauer, Felix] Univ Vet Med, Res Inst Wildlife Ecol, Dept Integrat Biol & Evolut, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Penn, DJ (corresponding author), Univ Vet Med, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, Vienna, Austria.	dustin.penn@vetmeduni.ac.at	Schwarzenberger, Franz/A-9236-2013	Schwarzenberger, Franz/0000-0002-2961-0545; Smith, Steve/0000-0002-1318-0018; Hoelzl, Franz/0000-0001-9717-4338; Moodley, Yoshan/0000-0003-4216-2924	University of Veterinary Medicine, Vienna (Austria)	University of Veterinary Medicine, Vienna (Austria)	This Study was supported by funds from the University of Veterinary Medicine, Vienna (Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett ELB, 2013, MOL ECOL, V22, P249, DOI 10.1111/mec.12110; Barton K, 2020, MUMIN MULTIMODEL INF; Beery AK, 2012, BIOL LETTERS, V8, P1063, DOI 10.1098/rsbl.2012.0747; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Brouwer K., 2000, International Zoo Yearbook, V37, P299, DOI 10.1111/j.1748-1090.2000.tb00735.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carroll JE, 2013, PSYCHOSOM MED, V75, P171, DOI 10.1097/PSY.0b013e31828233bf; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Correia-Melo Clara, 2014, Longev Healthspan, V3, P1, DOI 10.1186/2046-2395-3-1; Criscuolo F, 2009, J AVIAN BIOL, V40, P342, DOI 10.1111/j.1600-048X.2008.04623.x; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; DAVIS CS, 1991, VET CLIN N AM-SMALL, V21, P1281, DOI 10.1016/S0195-5616(91)50138-8; Dickens MJ, 2013, GEN COMP ENDOCR, V191, P177, DOI 10.1016/j.ygcen.2013.06.014; Drury SS, 2012, MOL PSYCHIATR, V17, P719, DOI 10.1038/mp.2011.53; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Foote CG, 2013, MOL ECOL RESOUR, V13, P417, DOI 10.1111/1755-0998.12079; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Garner JP, 2006, APPL ANIM BEHAV SCI, V96, P153, DOI 10.1016/j.applanim.2005.09.009; Garner JP, 2003, BEHAV BRAIN RES, V145, P125, DOI 10.1016/S0166-4328(03)00115-3; Haussmann MF, 2005, BIOL LETTERS, V1, P212, DOI 10.1098/rsbl.2005.0301; Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385; Heidbreder CA, 2000, NEUROSCIENCE, V100, P749, DOI 10.1016/S0306-4522(00)00336-5; Henriques CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003214; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Ilmonen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002143; Joeng KS, 2004, NAT GENET, V36, P607, DOI 10.1038/ng1356; Johnstone CP, 2012, J COMP PHYSIOL B, V182, P861, DOI 10.1007/s00360-012-0656-9; Juniper T, 1998, PARROTS GUIDE PARROT; Kikusui T, 2006, PHILOS T R SOC B, V361, P2215, DOI 10.1098/rstb.2006.1941; Kotrschal A, 2007, BIOL LETTERS, V3, P128, DOI 10.1098/rsbl.2006.0594; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Meehan CL, 2004, DEV PSYCHOBIOL, V44, P209, DOI 10.1002/dev.20007; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; Nalapareddy K, 2008, EXP GERONTOL, V43, P998, DOI 10.1016/j.exger.2008.09.002; Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Price LH, 2013, BIOL PSYCHIAT, V73, P15, DOI 10.1016/j.biopsych.2012.06.025; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008; Schmid R, 2006, APPL ANIM BEHAV SCI, V98, P293, DOI 10.1016/j.applanim.2005.09.002; Serra M, 2003, J NEUROCHEM, V85, P257, DOI 10.1046/j.1471-4159.2003.01680.x; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; Smith S, 2011, HEREDITY, V107, P372, DOI 10.1038/hdy.2011.14; Song ZF, 2010, AGING CELL, V9, P607, DOI 10.1111/j.1474-9726.2010.00583.x; Turbill C, 2012, BIOL LETTERS, V8, P304, DOI 10.1098/rsbl.2011.0758; Ujvari B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007493; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vallejo AN, 2004, TRENDS MOL MED, V10, P119, DOI 10.1016/j.molmed.2004.01.002; van Zeeland YRA, 2009, APPL ANIM BEHAV SCI, V121, P75, DOI 10.1016/j.applanim.2009.09.006; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Wolkowitz OM, 2010, DEPRESS ANXIETY, V27, P327, DOI 10.1002/da.20686; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	61	38	38	6	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93839	10.1371/journal.pone.0093839	http://dx.doi.org/10.1371/journal.pone.0093839			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705445	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500075
J	Esposito, F; Otto, T; Zijlstra, FRH; Goebel, R				Esposito, Fabrizio; Otto, Tobias; Zijlstra, Fred R. H.; Goebel, Rainer			Spatially Distributed Effects of Mental Exhaustion on Resting-State FMRI Networks	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; BOLD SIGNAL FLUCTUATIONS; FUNCTIONAL CONNECTIVITY; SUSTAINED ATTENTION; ASL PERFUSION; ALPHA-BAND; BASE-LINE; ACTIVATION; FATIGUE; PERFORMANCE	Brain activity during rest is spatially coherent over functional connectivity networks called resting-state networks. In restingstate functional magnetic resonance imaging, independent component analysis yields spatially distributed network representations reflecting distinct mental processes, such as intrinsic (default) or extrinsic (executive) attention, and sensory inhibition or excitation. These aspects can be related to different treatments or subjective experiences. Among these, exhaustion is a common psychological state induced by prolonged mental performance. Using repeated functional magnetic resonance imaging sessions and spatial independent component analysis, we explored the effect of several hours of sustained cognitive performances on the resting human brain. Resting-state functional magnetic resonance imaging was performed on the same healthy volunteers in two days, with and without, and before, during and after, an intensive psychological treatment (skill training and sustained practice with a flight simulator). After each scan, subjects rated their level of exhaustion and performed an N-back task to evaluate eventual decrease in cognitive performance. Spatial maps of selected resting-state network components were statistically evaluated across time points to detect possible changes induced by the sustained mental performance. The intensive treatment had a significant effect on exhaustion and effort ratings, but no effects on N-back performances. Significant changes in the most exhausted state were observed in the early visual processing and the anterior default mode networks (enhancement) and in the fronto-parietal executive networks (suppression), suggesting that mental exhaustion is associated with a more idling brain state and that internal attention processes are facilitated to the detriment of more extrinsic processes. The described application may inspire future indicators of the level of fatigue in the neural attention system.	[Esposito, Fabrizio] Univ Salerno, Dept Med & Surg, I-84100 Salerno, Italy; [Esposito, Fabrizio; Goebel, Rainer] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Otto, Tobias; Zijlstra, Fred R. H.] Maastricht Univ, Dept Work & Social Psychol, Maastricht, Netherlands; [Goebel, Rainer] Netherlands Inst Neurosci, Dept Vis & Cognit, Amsterdam, Netherlands	University of Salerno; Maastricht University; Maastricht University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Esposito, F (corresponding author), Univ Salerno, Dept Med & Surg, I-84100 Salerno, Italy.	faesposito@unisa.it	Esposito, Fabrizio/M-8555-2015	Esposito, Fabrizio/0000-0002-5099-9786; Goebel, Rainer/0000-0003-1780-2467; Zijlstra, Fred/0000-0002-3505-9753				Ackerman PL, 2009, J EXP PSYCHOL-APPL, V15, P163, DOI 10.1037/a0015719; Albert NB, 2009, CURR BIOL, V19, P1023, DOI 10.1016/j.cub.2009.04.028; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Barnes A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006626; BARTLETT EJ, 1988, J CEREBR BLOOD F MET, V8, P502, DOI 10.1038/jcbfm.1988.91; Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boksem MAS, 2006, BIOL PSYCHOL, V72, P123, DOI 10.1016/j.biopsycho.2005.08.007; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Colby CL, 1996, COGNITIVE BRAIN RES, V5, P105, DOI 10.1016/S0926-6410(96)00046-8; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1998, NEUROPSYCHOLOGIA, V36, P1325, DOI 10.1016/S0028-3932(98)00035-9; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Demeter E, 2011, NEUROIMAGE, V54, P1518, DOI 10.1016/j.neuroimage.2010.09.026; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; Esposito F, 2013, BRAIN, V136, P710, DOI 10.1093/brain/awt007; Esposito F, 2011, CURR OPIN NEUROL, V24, P378, DOI 10.1097/WCO.0b013e32834897a5; Esposito F, 2010, NEUROIMAGE, V53, P534, DOI 10.1016/j.neuroimage.2010.06.061; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Gordon EM, 2012, HUMAN BRAIN MAPPING; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Grigg O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013311; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; HACKER W, 1978, ERGONOMICS, V21, P187, DOI 10.1080/00140137808931712; Hockey GRJ, 1997, BIOL PSYCHOL, V45, P73; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Kamei T, 1998, PERCEPT MOTOR SKILL, V87, P1419, DOI 10.2466/pms.1998.87.3f.1419; Khalili-Mahani N., 2011, HUM BRAIN MAPP; Kim J, 2006, NEUROIMAGE, V31, P376, DOI 10.1016/j.neuroimage.2005.11.035; Koric L, 2011, HUM BRAIN MAPP; Langdon DW, 2011, CURR OPIN NEUROL, V24, P244, DOI 10.1097/WCO.0b013e328346a43b; Lee HL, 2013, NEUROIMAGE, V65, P216, DOI 10.1016/j.neuroimage.2012.10.015; Lewin JS, 1996, J COMPUT ASSIST TOMO, V20, P695, DOI 10.1097/00004728-199609000-00002; Lewis JW, 2011, HUM BRAIN MAPP, V32, P2241, DOI 10.1002/hbm.21185; Licata SC, 2013, NEUROIMAGE, V70, P211, DOI 10.1016/j.neuroimage.2012.12.055; Lim JL, 2013, NEUROIMAGE, V76, P81, DOI 10.1016/j.neuroimage.2013.03.018; Lim J, 2010, NEUROIMAGE, V49, P3426, DOI 10.1016/j.neuroimage.2009.11.020; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Ogg RJ, 2008, MAGN RESON IMAGING, V26, P504, DOI 10.1016/j.mri.2007.09.004; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Schrauf M., 2011, P HUMAN FACTORS ERGO, DOI [10.1177/1071181311551045, DOI 10.1177/1071181311551045]; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Soares JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066500; Sonnentag S, 2006, J APPL PSYCHOL, V91, P330, DOI 10.1037/0021-9010.91.2.330; Tamaki M, 1999, PSYCHIAT CLIN NEUROS, V53, P273, DOI 10.1046/j.1440-1819.1999.00548.x; Vahdat S, 2011, J NEUROSCI, V31, P16907, DOI 10.1523/JNEUROSCI.2737-11.2011; Valdez P, 2008, MIND BRAIN EDUC, V2, P7, DOI 10.1111/j.1751-228X.2008.00023.x; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; van de Ven V, 2009, NEUROIMAGE, V47, P1982, DOI 10.1016/j.neuroimage.2009.05.057; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; van der Linden D, 2003, ACTA PSYCHOL, V113, P45, DOI 10.1016/S0001-6918(02)00150-6; Waites AB, 2005, HUM BRAIN MAPP, V24, P59, DOI 10.1002/hbm.20069; Worden MS, 2000, J NEUROSCI, V20; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zijlstra F. R. H., 1993, EFFICIENCY WORK BEHA	73	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94222	10.1371/journal.pone.0094222	http://dx.doi.org/10.1371/journal.pone.0094222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705397	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500134
J	Leingartner, A; Hoiss, B; Krauss, J; Steffan-Dewenter, I				Leingaertner, Annette; Hoiss, Bernhard; Krauss, Jochen; Steffan-Dewenter, Ingolf			Combined Effects of Extreme Climatic Events and Elevation on Nutritional Quality and Herbivory of Alpine Plants	PLOS ONE			English	Article							MANIPULATION EXPERIMENTS; GLOBAL CHANGE; RESPONSES; DROUGHT; SNOWMELT; ECOSYSTEMS; ABUNDANCE; NITROGEN; INSECTS; EUROPE	Climatic extreme events can cause the shift or disruption of plant-insect interactions due to altered plant quality, e. g. leaf carbon to nitrogen ratios, and phenology. However, the response of plant-herbivore interactions to extreme events and climatic gradients has been rarely studied, although climatic extremes will increase in frequency and intensity in the future and insect herbivores represent a highly diverse and functionally important group. We set up a replicated climate change experiment along elevational gradients in the German Alps to study the responses of three plant guilds and their herbivory by insects to extreme events (extreme drought, advanced and delayed snowmelt) versus control plots under different climatic conditions on 15 grassland sites. Our results indicate that elevational shifts in CN (carbon to nitrogen) ratios and herbivory depend on plant guild and season. CN ratios increased with altitude for grasses, but decreased for legumes and other forbs. In contrast to our hypotheses, extreme climatic events did not significantly affect CN ratios and herbivory. Thus, our study indicates that nutritional quality of plants and antagonistic interactions with insect herbivores are robust against seasonal climatic extremes. Across the three functional plant guilds, herbivory increased with nitrogen concentrations. Further, increased CN ratios indicate a reduction in nutritional plant quality with advancing season. Although our results revealed no direct effects of extreme climatic events, the opposing responses of plant guilds along elevation imply that competitive interactions within plant communities might change under future climates, with unknown consequences for plant-herbivore interactions and plant community composition.	[Leingaertner, Annette; Hoiss, Bernhard; Krauss, Jochen; Steffan-Dewenter, Ingolf] Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany	University of Wurzburg	Leingartner, A (corresponding author), Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany.	annette.leingaertner@uni-wuerzburg.de	Krauss, Jochen/C-6216-2014	Krauss, Jochen/0000-0003-2304-9117; Steffan-Dewenter, Ingolf/0000-0003-1359-3944	Bavarian Climate Programme; FAZIT-STIFTUNG; German Research Foundation (DFG); University of Wuerzburg	Bavarian Climate Programme; FAZIT-STIFTUNG; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This study was pursued within the framework of the joint research centre FORKAST and was funded by the "Bavarian Climate Programme 2020''. [http://www.bayceer.uni-bayreuth.de/forkast/, http://www.stmwfk.bayern.de/start/] Annette Leingartner was partly funded by the FAZIT-STIFTUNG. [http://www.fazit-stiftung.de/] This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2009, FUNCT ECOL, V23, P680, DOI 10.1111/j.1365-2435.2009.01566.x; Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; Beier C, 2004, ECOSYSTEMS, V7, P583, DOI 10.1007/s10021-004-0178-8; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; Beniston M, 2003, CLIMATIC CHANGE, V59, P5, DOI 10.1023/A:1024458411589; Beniston M, 2012, J HYDROL, V412, P291, DOI 10.1016/j.jhydrol.2010.06.046; Butof A, 2012, GLOBAL CHANGE BIOL, V18, P127, DOI 10.1111/j.1365-2486.2011.02539.x; Cornelius C, 2013, J EXP BOT, V64, P241, DOI 10.1093/jxb/ers321; Crawley M.J., 2007, R BOOK; de Sassi C, 2012, ECOLOGY, V93, P1892, DOI 10.1890/11-1839.1; Dunne JA, 2004, ECOLOGY, V85, P904, DOI 10.1890/03-8003; Dunne JA, 2003, ECOL MONOGR, V73, P69, DOI 10.1890/0012-9615(2003)073[0069:SMFPRT]2.0.CO;2; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Garibaldi Lucas A., 2011, Oecologia (Berlin), V167, P117, DOI 10.1007/s00442-011-1978-0; Gutbrodt B, 2011, OIKOS, V120, P1732, DOI 10.1111/j.1600-0706.2011.19558.x; Hansen AH, 2006, OECOLOGIA, V147, P1, DOI 10.1007/s00442-005-0233-y; Hill JK, 2011, ANNU REV ENTOMOL, V56, P143, DOI 10.1146/annurev-ento-120709-144746; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Jentsch A, 2011, J ECOL, V99, P689, DOI 10.1111/j.1365-2745.2011.01817.x; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; KORNER C, 1989, OECOLOGIA, V81, P379, DOI 10.1007/BF00377088; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Kreyling J, 2010, BASIC APPL ECOL, V11, P65, DOI 10.1016/j.baae.2009.07.008; Laghari AN, 2012, HYDROLOG SCI J, V57, P103, DOI 10.1080/02626667.2011.637040; Lloret F, 2012, GLOBAL CHANGE BIOL, V18, P797, DOI 10.1111/j.1365-2486.2011.02624.x; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Pauli H, 2012, SCIENCE, V336, P353, DOI 10.1126/science.1219033; Pellissier L, 2012, ECOL EVOL, V2, P1818, DOI 10.1002/ece3.296; R Core Team, 2012, R LANG ENV STAT COMP; Raisanen J, 2012, CLIM DYNAM, V38, P2575, DOI 10.1007/s00382-011-1076-3; Rasmann S, 2013, FUNCT ECOL; Rowell DP, 2009, J CLIMATE, V22, P2813, DOI 10.1175/2008JCLI2713.1; Roy BA, 2004, ECOLOGY, V85, P2570, DOI 10.1890/03-0182; Sardans J, 2012, PERSPECT PLANT ECOL, V14, P33, DOI 10.1016/j.ppees.2011.08.002; Sardans J, 2008, GLOBAL CHANGE BIOL, V14, P2304, DOI 10.1111/j.1365-2486.2008.01656.x; Sarkar D., 2019, NLME LINEAR NONLINEA; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Stewart IT, 2009, HYDROL PROCESS, V23, P78, DOI 10.1002/hyp.7128; Strong D., 1984, INSECTS PLANTS COMMU; Torp M, 2010, ECOSYSTEMS, V13, P741, DOI 10.1007/s10021-010-9351-4; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Welker JM, 2005, OIKOS, V109, P167, DOI 10.1111/j.0030-1299.2005.13264.x; WHITE TCR, 1984, OECOLOGIA, V63, P90, DOI 10.1007/BF00379790; Wipf S, 2006, GLOBAL CHANGE BIOL, V12, P1496, DOI 10.1111/j.1365-2486.2006.01185.x; Wipf S, 2010, POLAR RES-SWEDEN, V29, P95, DOI 10.1111/j.1751-8369.2010.00153.x	50	14	14	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93881	10.1371/journal.pone.0093881	http://dx.doi.org/10.1371/journal.pone.0093881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705715	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500083
J	Moser, B; Janik, S; Schiefer, AI; Mullauer, L; Bekos, C; Scharrer, A; Mildner, M; Renyi-Vamos, F; Klepetko, W; Ankersmit, HJ				Moser, Bernhard; Janik, Stefan; Schiefer, Ana-Iris; Muellauer, Leonhard; Bekos, Christine; Scharrer, Anke; Mildner, Michael; Renyi-Vamos, Ferenc; Klepetko, Walter; Ankersmit, Hendrik Jan			Expression of RAGE and HMGB1 in Thymic Epithelial Tumors, Thymic Hyperplasia and Regular Thymic Morphology	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; MYASTHENIA-GRAVIS; SOLUBLE RECEPTOR; THERAPEUTIC TARGET; DENDRITIC CELLS; T-CELLS; PATHOGENESIS; THYMOMA; CLASSIFICATION; BLOCKADE	Recently, a role of the receptor for advanced glycation endproducts (RAGE) in myasthenia gravis was described. RAGE and its ligand high mobility group box 1 (HMGB1) play key roles in autoimmunity and cancer. To test whether these molecules are involved in patients with thymic abnormalities we applied immunohistochemical analysis in 33 cases of thymic epithelial tumors, comprising 27 thymomas and 6 thymic carcinomas, and 21 nonneoplastic thymuses. Both molecules were detected in neoplastic epithelial cells: RAGE staining was most intense in WHO type B2 thymomas and thymic carcinomas (p<0.001). HMGB1 nuclear staining was strongest in A and AB, and gradually less in B1 = B2>B3> thymic carcinoma (p<0.001). Conversely, HMGB1 cytoplasmic staining intensities were as follows: A and AB (none), B1 (strong), B2 (moderate), B3 and thymic carcinoma (weak); (p<0.001). Fetal thymic tissue showed a distinct expression of RAGE and HMGB1 in subcapsular cortical epithelial cells which was found in 50% of myasthenic patients. Furthermore RAGE and HMGB1 were expressed in thymocytes, macrophages, Hassall's corpuscles, thymic medulla, and germinal center cells in myasthenic patients. Immunohistochemistry results were complemented by systemic measurements (immunosorbent assay): serum levels of soluble RAGE were significantly reduced in patients with epithelial tumors (p = 0.008); and in invasive tumors (p = 0.008). Whereas RAGE was equally reduced in thymic hyperplasia and epithelial tumors (p = 0.003), HMGB1 was only elevated in malignancies (p = 0.036). Results were most pronounced in thymic carcinomas. Thus, RAGE and HMGB1 are involved in the (patho-) physiology of thymus, as evidenced by differentiated thymic and systemic expression patterns that may act as diagnostic or therapeutic targets in autoimmune disease and cancer.	[Moser, Bernhard; Janik, Stefan; Bekos, Christine; Klepetko, Walter; Ankersmit, Hendrik Jan] Med Univ Vienna, Div Surg, Dept Thorac Surg, Vienna, Austria; [Schiefer, Ana-Iris; Muellauer, Leonhard; Scharrer, Anke] Med Univ Vienna, Dept Pathol, Vienna, Austria; [Bekos, Christine; Ankersmit, Hendrik Jan] Med Univ Vienna, Christian Doppler Lab Diag & Regenerat Cardiac &, Vienna, Austria; [Mildner, Michael] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Renyi-Vamos, Ferenc] Natl Inst Oncol, Dept Gen & Thorac Surg, Budapest, Hungary	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; National Institute of Oncology Hungary	Moser, B (corresponding author), Med Univ Vienna, Div Surg, Dept Thorac Surg, Vienna, Austria.	bernhard.moser@meduniwien.ac.at	Moser, Bernhard/ABA-9436-2020; Schiefer, Ana-Iris/AAX-8123-2020; Müllauer, Leonhard/GSN-9884-2022	Moser, Bernhard/0000-0002-6037-5475; Müllauer, Leonhard/0000-0002-3399-078X; Mildner, Michael/0000-0002-6892-925X; Ankersmit, Hendrik Jan/0000-0002-8761-3517; Bekos, Christine/0000-0003-4038-6860	FOLAB - Research Laboratories of the Department of Surgery, Medical University Vienna; Christian Doppler Laboratory for the Diagnosis and Regeneration of Cardiac and Thoracic Diseases	FOLAB - Research Laboratories of the Department of Surgery, Medical University Vienna; Christian Doppler Laboratory for the Diagnosis and Regeneration of Cardiac and Thoracic Diseases	Funding sources: FOLAB - Research Laboratories of the Department of Surgery, Medical University Vienna. Christian Doppler Laboratory for the Diagnosis and Regeneration of Cardiac and Thoracic Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron S, 2005, J BIOL CHEM, V280, P31314, DOI 10.1074/jbc.M503063200; BURNET M, 1957, BRIT MED J, V1, P779, DOI 10.1136/bmj.1.5022.779; Calder AE, 2011, NEUROIMMUNOMODULAT, V18, P281, DOI 10.1159/000329496; Castleman B, 1955, ATLAS TUMOR PATHOLOG; Cataldegirmen G, 2005, J EXP MED, V201, P473, DOI 10.1084/jem.20040934; Cavalcante P, 2011, MUSCLE NERVE, V44, P467, DOI 10.1002/mus.22103; Chen G, 2002, CANCER, V95, P420, DOI 10.1002/cncr.10665; COSGROVE D, 1992, INT IMMUNOL, V4, P707, DOI 10.1093/intimm/4.6.707; Detterbeck F, 2010, J THORAC ONCOL, V5, P1, DOI 10.1097/JTO.0b013e3181c59224; Detterbeck FC, 2011, J THORAC ONCOL, V6, pS1710, DOI 10.1097/JTO.0b013e31821e8cff; Dougan M, 2008, J EXP MED, V205, P267, DOI 10.1084/jem.20080136; Duwe BV, 2005, CHEST, V128, P2893, DOI 10.1378/chest.128.4.2893; Engels EA, 2010, J THORAC ONCOL, V5, pS260, DOI 10.1097/JTO.0b013e3181f1f62d; Fujii Y, 2011, THORAC SURG CLIN, V21, P125, DOI 10.1016/j.thorsurg.2010.08.002; Gao Ke, 2008, Zhonghua Yixue Yichuanxue Zazhi, V25, P311; Halayko AJ, 2009, CAN J PHYSIOL PHARM, V87, P743, DOI 10.1139/Y09-054; Hiwatashi K, 2008, ANN SURG ONCOL, V15, P923, DOI 10.1245/s10434-007-9698-8; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hohlfeld R, 2008, J NEUROIMMUNOL, V201, P21, DOI 10.1016/j.jneuroim.2008.05.020; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Jablonska-Mestanova V, 2013, BRATISL MED J, V114, P402, DOI 10.4149/BLL_2013_086; Jiao L, 2011, CANCER EPIDEM BIOMAR, V20, P1430, DOI 10.1158/1055-9965.EPI-11-0066; Jiao L, 2011, CANCER RES, V71, P3582, DOI 10.1158/0008-5472.CAN-10-2573; Johnson SB, 2001, ONCOLOGIST, V6, P239, DOI 10.1634/theoncologist.6-3-239; Kalea AZ, 2011, FRONT BIOSCI-LANDMRK, V16, P2756, DOI 10.2741/3884; Kang R, 2013, CLIN CANCER RES, V19, P4046, DOI 10.1158/1078-0432.CCR-13-0495; KONDO K, 1990, AM J SURG PATHOL, V14, P1139, DOI 10.1097/00000478-199012000-00006; Kuniyasu H, 2003, ONCOL REP, V10, P445; Lara PN, 2000, CANCER TREAT REV, V26, P127; LE PT, 1991, J EXP MED, V174, P1147, DOI 10.1084/jem.174.5.1147; Leclerc Estelle, 2010, Cardiovasc Psychiatry Neurol, V2010, P539581, DOI 10.1155/2010/539581; Li Ronghua, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P823; Lin LG, 2012, J CANCER RES CLIN, V138, P11, DOI 10.1007/s00432-011-1067-0; Little AJ, 2013, NUCLEIC ACIDS RES, V41, P3289, DOI 10.1093/nar/gks1461; Livesey KM, 2012, CANCER RES, V72, P1996, DOI 10.1158/0008-5472.CAN-11-2291; Ma CY, 2012, SCAND J IMMUNOL, V75, P614, DOI 10.1111/j.1365-3083.2012.02691.x; Marx A, 2013, AUTOIMMUN REV, V12, P875, DOI 10.1016/j.autrev.2013.03.007; Miyata T, 1996, J CLIN INVEST, V98, P1088, DOI 10.1172/JCI118889; Moser B, 2007, AM J TRANSPLANT, V7, P293, DOI 10.1111/j.1600-6143.2006.01617.x; Moser B, 2007, J IMMUNOL, V179, P8051, DOI 10.4049/jimmunol.179.12.8051; Moser B, 2014, THORAC CARDIOV SURG, V62, P153, DOI 10.1055/s-0032-1322611; Moser B, 2012, BIOCHEM BIOPH RES CO, V420, P96, DOI 10.1016/j.bbrc.2012.02.121; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Omatsu M, 2012, GEN THORAC CARDIOVAS, V60, P803, DOI 10.1007/s11748-012-0160-x; PAPATESTAS AE, 1971, AM J MED, V50, P465, DOI 10.1016/0002-9343(71)90336-6; Papoudou-Bai A, 2012, IN VIVO, V26, P985; Pisetsky DS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2440; Pullerits R, 2005, ARTHRITIS RES THER, V7, pR817, DOI 10.1186/ar1749; Raica M, 2007, Rom J Morphol Embryol, V48, P101; Raica M, 2006, ANN ANAT, V188, P345, DOI 10.1016/j.aanat.2006.01.012; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Roithmaier S, 2007, J HEART LUNG TRANSPL, V26, P845, DOI 10.1016/j.healun.2007.05.019; Rosai J, 1976, ATLAS TUMOR PATHOLOG; Ruffini E, 2011, J THORAC ONCOL, V6, P614, DOI 10.1097/JTO.0b013e318207cd74; Sasahira T, 2005, VIRCHOWS ARCH, V446, P411, DOI 10.1007/s00428-005-1210-x; Savchenko AS, 2006, CELL TISSUE RES, V325, P455, DOI 10.1007/s00441-006-0202-8; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Sims GP, 2001, J IMMUNOL, V167, P1935, DOI 10.4049/jimmunol.167.4.1935; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Strobel P, 2005, SURG TODAY, V35, P805, DOI 10.1007/s00595-005-3047-y; Tafani M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-32; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; THOMAS L, 1982, YALE J BIOL MED, V55, P329; Urbonaviciute V, 2011, J INTERN MED, V270, P309, DOI 10.1111/j.1365-2796.2011.02432.x; Vincent A, 2002, NAT REV IMMUNOL, V2, P797, DOI 10.1038/nri916; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Weksler B, 2012, ANN THORAC SURG, V93, P884, DOI 10.1016/j.athoracsur.2011.05.089; Xu XC, 2013, INT J IMMUNOPATH PH, V26, P485, DOI 10.1177/039463201302600222; Yan SS, 2003, NAT MED, V9, P287, DOI 10.1038/nm831; Zhu XJ, 2013, CELL BIOCHEM BIOPHYS, V66, P843, DOI 10.1007/s12013-013-9515-x; Zuckerman NS, 2010, EUR J IMMUNOL, V40, P1150, DOI 10.1002/eji.200939914	73	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94118	10.1371/journal.pone.0094118	http://dx.doi.org/10.1371/journal.pone.0094118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705787	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500125
J	Durrwald, R; Kolodziejek, J; Weissenbock, H; Nowotny, N				Duerrwald, Ralf; Kolodziejek, Jolanta; Weissenboeck, Herbert; Nowotny, Norbert			The Bicolored White-Toothed Shrew Crocidura leucodon (HERMANN 1780) Is an Indigenous Host of Mammalian Borna Disease Virus	PLOS ONE			English	Article							INFECTION; RESERVOIR; ANTIBODIES; TRANSMISSION; CONSERVATION; ORGANIZATION; SEQUENCES; SYSTEM; BIRDS; FIELD	Borna disease (BD) is a sporadic neurologic disease of horses and sheep caused by mammalian Borna disease virus (BDV). Its unique epidemiological features include: limited occurrence in certain endemic regions of central Europe, yearly varying disease peaks, and a seasonal pattern with higher disease frequencies in spring and a disease nadir in autumn. It is most probably not directly transmitted between horses and sheep. All these features led to the assumption that an indigenous virus reservoir of BDV other than horses and sheep may exist. The search for such a reservoir had been unsuccessful until a few years ago five BDV-infected shrews were found in a BD-endemic area in Switzerland. So far, these data lacked further confirmation. We therefore initiated a study in shrews in endemic areas of Germany. Within five years 107 shrews of five different species were collected. BDV infections were identified in 14 individuals of the species bicolored white-toothed shrew (Crocidura leucodon, HERMANN 1780), all originating from BD-endemic territories. Immunohistological analysis showed widespread distribution of BDV antigen both in the nervous system and in epithelial and mesenchymal tissues without pathological alterations. Large amounts of virus, demonstrated by presence of viral antigen in epithelial cells of the oral cavity and in keratinocytes of the skin, may be a source of infection for natural and spill-over hosts. Genetic analyses reflected a close relationship of the BDV sequences obtained from the shrews with the regional BDV cluster. At one location a high percentage of BDV-positive shrews was identified in four consecutive years, which points towards a self-sustaining infection cycle in bicolored white-toothed shrews. Analyses of behavioral and population features of this shrew species revealed that the bicolored white-toothed shrew may indeed play an important role as an indigenous host of BDV.	[Duerrwald, Ralf] IDT Biol GmbH IDT, Dessau Rosslau, Germany; [Kolodziejek, Jolanta; Nowotny, Norbert] Univ Vet Med Vienna, Inst Virol, Dept Pathobiol, Viral Zoonoses Emerging & Vector Borne Infect Grp, Vienna, Austria; [Weissenboeck, Herbert] Univ Vet Med Vienna, Inst Pathol & Forens Vet Med, Dept Pathobiol, Vienna, Austria; [Nowotny, Norbert] Sultan Qaboos Univ, Dept Microbiol & Immunol, Coll Med & Hlth Sci, Muscat, Oman	IDT Biologika; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Sultan Qaboos University	Nowotny, N (corresponding author), Univ Vet Med Vienna, Inst Virol, Dept Pathobiol, Viral Zoonoses Emerging & Vector Borne Infect Grp, Vienna, Austria.	Norbert.Nowotny@vetmeduni.ac.at	Nowotny, Norbert/A-5474-2019	Nowotny, Norbert/0000-0002-3548-571X; Weissenbock, Herbert/0000-0001-8197-6379	Institute of Virology, University of Veterinary Medicine, Vienna	Institute of Virology, University of Veterinary Medicine, Vienna	This study was funded by own institutional funds of the Institute of Virology, University of Veterinary Medicine, Vienna, granted to NN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Authenrieth CF, 1823, UEBER HITZIGE K S19P; Balloux F, 1998, EVOLUTION, V52, P1230, DOI 10.1111/j.1558-5646.1998.tb01851.x; Belyi VA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001030; Berg M, 2001, EPIDEMIOL INFECT, V127, P173, DOI 10.1017/S0950268801005702; Billich C, 2002, BIOL PSYCHIAT, V51, P979, DOI 10.1016/S0006-3223(02)01387-2; BODE L, 1992, J MED VIROL, V36, P309, DOI 10.1002/jmv.1890360414; Bourg M, 2013, EMERG INFECT DIS, V19, P2064, DOI 10.3201/eid1912.131076; BRIESE T, 1994, P NATL ACAD SCI USA, V91, P4362, DOI 10.1073/pnas.91.10.4362; CANTONI D, 1989, ANIM BEHAV, V38, P205, DOI 10.1016/S0003-3472(89)80083-1; Caplazi P, 1999, SCHWEIZ ARCH TIERH, V141, P521; Chvala S, 2004, J COMP PATHOL, V131, P176, DOI 10.1016/j.jcpa.2004.03.004; CORBET G, 1980, MAMMALS BRITAIN EURO; CUBITT B, 1994, J VIROL, V68, P1382, DOI 10.1128/JVI.68.3.1382-1396.1994; D?rrwald R., 1993, THESIS FREIE U BERLI; Duarte LC, 2003, EVOLUTION, V57, P638; Durrwald R, 2007, REV MED VIROL, V17, P181, DOI 10.1002/rmv.530; Durrwald R, 2006, MICROBES INFECT, V8, P917, DOI 10.1016/j.micinf.2005.08.013; Durrwald R, 1997, J VET MED B, V44, P147, DOI 10.1111/j.1439-0450.1997.tb00962.x; Duwel D, 1957, THESIS TIERARZTLICHE; Encarnacao JA, 2013, J WILDLIFE DIS, V49, P860, DOI 10.7589/2012-10-262; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; GOSZTONYI G, 1995, CURR TOP MICROBIOL, V190, P39; Gungor S, 2005, PEDIATR INFECT DIS J, V24, P833, DOI 10.1097/01.inf.0000178307.70429.75; Hausmann J, 1999, P NATL ACAD SCI USA, V96, P9769, DOI 10.1073/pnas.96.17.9769; Herter K, 1977, GRZIMEKS TIERLEBEN E, V1, P169; HERZOG S, 1984, MED MICROBIOL IMMUN, V173, P171, DOI 10.1007/BF02122108; HERZOG S, 1991, J GEN VIROL, V72, P535, DOI 10.1099/0022-1317-72-3-535; Hilbe M, 2006, EMERG INFECT DIS, V12, P675, DOI 10.3201/eid1204.051418; Holmes EC, 2002, VIROLOGY, V292, P247, DOI 10.1006/viro.2001.1271; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Hornig M, 2012, MOL PSYCHIATR, V17, P486, DOI 10.1038/mp.2011.179; Ihlenburg H, 1957, ARCH EXP VETERINARME, V11, P635; Jacobsen B, 2010, J COMP PATHOL, V143, P203, DOI 10.1016/j.jcpa.2010.01.009; Joest E, 1911, Z INF KRKH HAUSTIERE, P198; Karasek E., 1963, Monatshefte fur Veterinarmedizin, V18, P868; Katz JB, 1998, J VET DIAGN INVEST, V10, P338, DOI 10.1177/104063879801000405; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Kinnunen PM, 2007, J CLIN VIROL, V38, P64, DOI 10.1016/j.jcv.2006.10.003; Kinnunen PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023622; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Kobayashi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024403; Kolodziejek J, 2005, J GEN VIROL, V86, P385, DOI 10.1099/vir.0.80587-0; Kraft R, 2008, MAUSE SPITZMAUSE BAY; Kraft Richard, 1999, Bonner Zoologische Beitraege, V49, P115; Leistner E, 1948, THESIS LUDWIG MAXIMI; MACPHEE RDE, 1993, MAMMAL PHYLOGENY : PLACENTALS, P13; MARTENS JM, 1980, Z SAUGETIERKD, V45, P188; Metzler A, 1976, Schweiz Arch Tierheilkd, V118, P483; Netzer F, 1952, THESIS LUDWIG MAXIMI; Nowotny N, 2000, J VIROL, V74, P5655, DOI 10.1128/JVI.74.12.5655-5658.2000; Okamoto M, 2003, ARCH VIROL, V148, P1557, DOI 10.1007/s00705-003-0120-y; Pleschka S, 2001, J GEN VIROL, V82, P2681, DOI 10.1099/0022-1317-82-11-2681; Pletnikov Mikhail V., 2002, P125; Priestnall SL, 2011, VET REC, V168, P380, DOI 10.1136/vr.c6405; Puorger ME, 2010, VET PATHOL, V47, P236, DOI 10.1177/0300985809351849; Reichelt U, 2009, THESIS FREIE U BERLI; Richter H., 1963, Zoologische Abhandlungen, V26, P219; Sauder C, 2003, J VIROL, V77, P12886, DOI 10.1128/JVI.77.23.12886-12890.2003; SCHNEIDER PA, 1994, J VIROL, V68, P63, DOI 10.1128/JVI.68.1.63-68.1994; Schuppel K-F, 1994, 36 INT S ERKR ZOOT K, P11; Schwemmle M, 1999, LANCET, V354, P1973, DOI 10.1016/S0140-6736(99)04703-0; Schwemmle M, 2005, VIRUS TAXONOMY, P615; SORG I, 1995, J CLIN MICROBIOL, V33, P821, DOI 10.1128/JCM.33.4.821-823.1995; Staeheli P, 2000, J GEN VIROL, V81, P2123, DOI 10.1099/0022-1317-81-9-2123; Staeheli P, 2010, J VIROL, V84, P6269, DOI 10.1128/JVI.02567-09; Stitz L, 1998, J VIROL, V72, P8884, DOI 10.1128/JVI.72.11.8884-8892.1998; STITZ L, 1991, J IMMUNOL, V147, P3581; STITZ L, 1991, J VIROL, V65, P457, DOI 10.1128/JVI.65.1.457-460.1991; Suchy A, 2000, EQUINE PRACT, V22, P26; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vahlenkamp TW, 2002, J VIROL, V76, P9735, DOI 10.1128/JVI.76.19.9735-9743.2002; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; WEAVER SC, 1992, CURR TOP MICROBIOL, V176, P99; Weber B, 1983, SAUGETIERKD INF, V2, P69; Weissenbock H, 1998, VET REC, V143, P21, DOI 10.1136/vr.143.1.21; Weissenbock H, 1998, J CLIN MICROBIOL, V36, P2127; Weissenbock H, 2000, BRAIN PATHOL, V10, P260, DOI 10.1111/j.1750-3639.2000.tb00259.x; Weissenbock H, 2009, J VIROL, V83, P11367, DOI 10.1128/JVI.01343-09; Weissenbock H, 2009, EMERG INFECT DIS, V15, P1453, DOI 10.3201/eid1509.090353; Zimmermann G, 1953, THESIS LUDWIG MAXIMI; Zwick W., 1939, HDB VIRUSKRANKHEITEN, P254	81	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93659	10.1371/journal.pone.0093659	http://dx.doi.org/10.1371/journal.pone.0093659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699636	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000088
J	Mizuno, T; Mizuno, S; Kanda, T				Mizuno, Takuro; Mizuno, Shigeru; Kanda, Tsugiyasu			Effects of Vaccination and the New Neuraminidase Inhibitor, Laninamivir, on Influenza Infection	PLOS ONE			English	Article							OSELTAMIVIR; CHILDREN	Background: Evidence of the effectiveness of influenza vaccination in children and elderly adults is limited, although this population has the highest risk for influenza infection. Materials and Methods: We enrolled 4443 participants, aged 3-97 years, who had influenza-kit-positive resultsduring seasons 2007-12, including 2135 with influenza A, 534 with A/H1N1, and 1643 with influenza B. Eligible subjects completed a questionnaire to identify past influenza infection and vaccination history. For the diagnosis of current influenza infection, subjects were examined, and pharyngeal swabs were collected and tested using the Capilia flu rapid diagnosis kit to confirm influenza infection. An interim analysis was performed using clinician-based surveillance data for the entire four seasons of influenza infection in Japan. Results: In 3035 adultsaged 14-64 years, administration of the influenza vaccine significantly reduced the frequency of infection (P<0.01) in the 2008 and 2010 seasons, but not in the 2009 and 2011 seasons. Moreover, the vaccine did not reduce the frequency of infection in children (aged <13 years) and older adults (aged >65 years) significantly. Laninamivir, oseltamivir phosphate, zanamivir hydrate, and amantadine hydrochloride were administered to 1381, 2432, 1044, and 100 patients, respectively. They were effective in >97% of patients, with no significant differences being found. Adverse effects were few. However, the recurrence rate of influenza infection after treatment was significantly reduced in patients who received laninamivir compared with that in those who received oseltamivir and zanamivir (P<0.01). The effectiveness of laninamivirdid not decrease. Conclusions: The vaccines administered had limited efficacy in reducing the frequency of influenza infection in young adults. Laninamivir significantly reduced the recurrence of influenza infection when compared with other neuraminidase inhibitors.	[Mizuno, Takuro; Kanda, Tsugiyasu] Kanazawa Med Univ, Himi Municipal Hosp, Dept Community Med, Himi, Toyama, Japan; [Mizuno, Shigeru] Mizuno Clin, Osaka, Japan		Kanda, T (corresponding author), Kanazawa Med Univ, Himi Municipal Hosp, Dept Community Med, Himi, Toyama, Japan.	kandat@kanazawa-med.ac.jp						Bresee J, 2013, NEW ENGL J MED, V368, P589, DOI 10.1056/NEJMp1300375; Dolin R, 2012, HARRISONS PRINCIPLES; Huang YC, 2003, PEDIATR INFECT DIS J, V22, P366; Infectious Disease Surveillance Center National Institute of Infectious Diseases, IS DET INFL VIR JAP; Jefferson T, 2010, COCHRANE DB SYST REV, V17, DOI DOI 10.1002/14651858.CD004876.PUB3; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004879.pub5, 10.1002/14651858.CD004879.pub4]; Lang PO, 2012, CLIN INTERV AGING, V7, P55, DOI 10.2147/CIA.S25215; Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636; Miyamoto A, 2011, J GEN FAM MED, V12, P51, DOI 10.14442/general.12.51; Murasko DM, 2002, EXP GERONTOL, V37, P427, DOI 10.1016/S0531-5565(01)00210-8; Narwaney KJ, 2013, VACCINE, V31, P1123, DOI 10.1016/j.vaccine.2012.12.026; Okumura A, 2005, BRAIN DEV-JPN, V27, P271, DOI 10.1016/j.braindev.2004.07.005; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Rondy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059681; Saito R, 2010, PEDIATR INFECT DIS J, V29, P898, DOI 10.1097/INF.0b013e3181de9d24; Shobugawa Y, 2012, J INFECT CHEMOTHER, V18, P858, DOI 10.1007/s10156-012-0428-1; Vavricka CJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002249; Watanabe A, 2010, CLIN INFECT DIS, V51, P1167, DOI 10.1086/656802; Yin JK, 2011, INFLUENZA OTHER RESP, V5, P299, DOI 10.1111/j.1750-2659.2011.00229.x	19	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92601	10.1371/journal.pone.0092601	http://dx.doi.org/10.1371/journal.pone.0092601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699254	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000030
J	Zhang, CL; Xu, YJ; Zhong, QN; Li, XP; Gao, P; Feng, CY; Chu, Q; Chen, Y; Liu, D				Zhang, Chengliang; Xu, Yanjiao; Zhong, Qiaoni; Li, Xiping; Gao, Ping; Feng, Chengyang; Chu, Qian; Chen, Yuan; Liu, Dong			In Vitro Evaluation of the Inhibitory Potential of Pharmaceutical Excipients on Human Carboxylesterase 1A and 2	PLOS ONE			English	Article							P-GLYCOPROTEIN FUNCTION; CREMOPHOR EL; TRANSCRIPTIONAL REGULATION; INTESTINAL TRANSPORT; SITU ABSORPTION; COA REDUCTASE; POLOXAMER 407; C57BL/6 MICE; RAT; METABOLISM	Two major forms of human carboxylesterase (CES), CES1A and CES2, dominate the pharmacokinetics of most prodrugs such as imidapril and irinotecan (CPT-11). Excipients, largely used as insert vehicles in formulation, have been recently reported to affect drug enzyme activity. The influence of excipients on the activity of CES remains undefined. In this study, the inhibitory effects of 25 excipients on the activities of CES1A1 and CES2 were evaluated. Imidapril and CPT-11 were used as substrates and cultured with liver microsomes in vitro. Imidapril hydrolase activities of recombinant CES1A1 and human liver microsomes (HLM) were strongly inhibited by sodium lauryl sulphate (SLS) and polyoxyl 40 hydrogenated castor oil (RH40) [Inhibition constant (K-i) = 0.04 +/- 0.01 mu g/ml and 0.20 +/- 0.09 mu g/ml for CES1A1, and 0.12 +/- 0.03 mu g/ml and 0.76 +/- 0.33 mu g/ml, respectively, for HLM]. The enzyme hydrolase activity of recombinant CES2 was substantially inhibited by Tween 20 and polyoxyl 35 castor oil (EL35) (K-i = 0.93 +/- 0.36 mu g/ml and 4.4 +/- 1.24 mu g/ml, respectively). Thus, these results demonstrate that surfactants such as SLS, RH40, Tween 20 and EL35 may attenuate the CES activity; such inhibition should be taken into consideration during drug administration.	[Zhang, Chengliang; Xu, Yanjiao; Li, Xiping; Feng, Chengyang; Liu, Dong] Huazhong Univ Sci & Technol, Tongji Med Sch, Tongji Hosp, Dept Pharm, Wuhan 430074, Hubei, Peoples R China; [Zhong, Qiaoni] Hubei Pharmaceut Ind Res Inst Co Ltd, Wuhan, Hubei, Peoples R China; [Gao, Ping] Wuhan Childrens Hosp, Dept Pharm, Wuhan, Hubei, Peoples R China; [Chu, Qian; Chen, Yuan] Huazhong Univ Sci & Technol, Tongji Med Sch, Tongji Hosp, Dept Oncol, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, D (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Sch, Tongji Hosp, Dept Pharm, Wuhan 430074, Hubei, Peoples R China.	ld2069@outlook.com	Zhang, Cheng/GRS-8698-2022; Chu, Qian/K-2996-2017	Chu, Qian/0000-0001-8192-7630	National Natural Science Foundation of China [81301953]; Fundamental Research Funds for the Central Universities [HUST: 2013ZHYX013]; Hubei Pharmaceutical Industry Research Institute Co. Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Pharmaceutical Industry Research Institute Co. Ltd.	This work is supported by the National Natural Science Foundation of China (No: 81301953) and the Fundamental Research Funds for the Central Universities (HUST: 2013ZHYX013). Hubei Pharmaceutical Industry Research Institute Co. Ltd. only provided support in the form of a salary for author QZ, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahuja N, 2007, EUR J PHARM BIOPHARM, V65, P26, DOI 10.1016/j.ejpb.2006.07.007; Blonder JM, 1999, LIFE SCI, V65, pPL261, DOI 10.1016/S0024-3205(99)00495-6; Buggins TR, 2007, ADV DRUG DELIVER REV, V59, P1482, DOI 10.1016/j.addr.2007.08.017; Cornaire G, 2004, INT J PHARMACEUT, V278, P119, DOI 10.1016/j.ijpharm.2004.03.001; EMA, 2005, EMACHMPPEG1948102005; Engel A, 2012, MOL PHARMACEUT, V9, P2577, DOI 10.1021/mp3001815; Fukami T, 2010, DRUG METAB DISPOS, V38, P2173, DOI 10.1124/dmd.110.034454; Godin SJ, 2007, DRUG METAB DISPOS, V35, P1664, DOI 10.1124/dmd.107.015388; GOLIGHTLY LK, 1988, MED TOXICOL ADV DRUG, V3, P128, DOI 10.1007/BF03259937; Gonzalez RCB, 2004, BIOPHARM DRUG DISPOS, V25, P37, DOI 10.1002/bdd.383; Hamid KA, 2009, INT J PHARMACEUT, V379, P100, DOI 10.1016/j.ijpharm.2009.06.018; Hatfield MJ, 2011, EXPERT OPIN THER PAT, V21, P1159, DOI 10.1517/13543776.2011.586339; Hirama S, 2004, TOXICOLOGY, V199, P137, DOI 10.1016/j.tox.2004.02.017; Hosokawa M, 2007, DRUG METAB REV, V39, P1, DOI 10.1080/03602530600952164; Humerickhouse R, 2000, CANCER RES, V60, P1189; Imai T, 2006, DRUG METAB PHARMACOK, V21, P173, DOI 10.2133/dmpk.21.173; Iwase K, 2004, TOXICOL LETT, V154, P143, DOI 10.1016/j.toxlet.2004.08.003; Johnston TP, 1999, J CARDIOVASC PHARM, V34, P831, DOI 10.1097/00005344-199912000-00010; JOHNSTON TP, 1993, BIOCHEM PHARMACOL, V46, P1037, DOI 10.1016/0006-2952(93)90668-M; Johnston TP, 1997, J CARDIOVASC PHARM, V29, P580, DOI 10.1097/00005344-199705000-00003; Johnston TP, 2000, ATHEROSCLEROSIS, V149, P303, DOI 10.1016/S0021-9150(99)00339-1; Lin YL, 2007, BIOL PHARM BULL, V30, P1301, DOI 10.1248/bpb.30.1301; Maruichi T, 2010, BIOCHEM PHARMACOL, V79, P288, DOI 10.1016/j.bcp.2009.08.019; Maxwell DM, 2001, J APPL TOXICOL, V21, pS103, DOI 10.1002/jat.833; Nahata MC, 2009, ARCH DIS CHILD-FETAL, V94, pF392, DOI 10.1136/adc.2009.160192; Rege BD, 2002, EUR J PHARM SCI, V16, P237, DOI 10.1016/S0928-0987(02)00055-6; Ren XH, 2009, EUR J PHARM SCI, V36, P401, DOI 10.1016/j.ejps.2008.11.002; Ross MK, 2007, J BIOCHEM MOL TOXIC, V21, P187, DOI 10.1002/jbt.20178; Sachs-Barrable K, 2007, J PHARM PHARM SCI, V10, P319; Satoh T, 2002, DRUG METAB DISPOS, V30, P488, DOI 10.1124/dmd.30.5.488; Schwer H, 1997, BIOCHEM BIOPH RES CO, V233, P117, DOI 10.1006/bbrc.1997.6413; Shen Q, 2006, INT J PHARMACEUT, V313, P49, DOI 10.1016/j.ijpharm.2006.01.020; Shen Q, 2008, J PHARM PHARMACOL, V60, P1633, DOI 10.1211/jpp/60.12.0009; Shono Y, 2004, J PHARM SCI-US, V93, P877, DOI 10.1002/jps.20017; Sintov AC, 2004, J CONTROL RELEASE, V95, P173, DOI 10.1016/j.jconrel.2003.11.004; Takahashi S, 2009, DRUG METAB DISPOS, V37, P956, DOI 10.1124/dmd.108.024331; Takahashi S, 2008, J PHARM SCI-US, V97, P5434, DOI 10.1002/jps.21376; Thackaberry EA, 2010, TOXICOL SCI, V117, P485, DOI 10.1093/toxsci/kfq207; Tompkins L, 2010, PHARM RES-DORDR, V27, P1703, DOI 10.1007/s11095-010-0170-2; Ursino MG, 2011, REGUL TOXICOL PHARM, V60, P93, DOI 10.1016/j.yrtph.2011.02.010; Vandecruys R, 2007, INT J PHARMACEUT, V342, P168, DOI 10.1016/j.ijpharm.2007.05.006; Wasan KM, 2003, J PHARM PHARM SCI, V6, P189; Watanabe A, 2009, DRUG METAB DISPOS, V37, P1513, DOI 10.1124/dmd.109.026567; Xu YJ, 2013, DRUG METAB PHARMACOK; Zhang CL, 2012, J HUAZHONG U SCI-MED, V32, P798, DOI 10.1007/s11596-012-1037-z; Zhu SJ, 2009, EUR J PHARM SCI, V37, P573, DOI 10.1016/j.ejps.2009.05.001	46	19	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93819	10.1371/journal.pone.0093819	http://dx.doi.org/10.1371/journal.pone.0093819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699684	Green Submitted, gold, Green Published			2022-12-27	WOS:000334105000112
J	Fraisier, C; Papa, A; Granjeaud, S; Hintzen, R; Martina, B; Camoin, L; Almeras, L				Fraisier, Christophe; Papa, Anna; Granjeaud, Samuel; Hintzen, Rogier; Martina, Byron; Camoin, Luc; Almeras, Lionel			Cerebrospinal Fluid Biomarker Candidates Associated with Human WNV Neuroinvasive Disease	PLOS ONE			English	Article							WEST-NILE-VIRUS; CENTRAL-NERVOUS-SYSTEM; ENCEPHALITIS-VIRUS; PROTEIN BIOMARKERS; INNATE IMMUNITY; PEROXIREDOXIN 2; CHOROID-PLEXUS; INFECTION; DEFENSINS; BRAIN	During the last decade, the epidemiology of WNV in humans has changed in the southern regions of Europe, with high incidence of West Nile fever (WNF) cases, but also of West Nile neuroinvasive disease (WNND). The lack of human vaccine or specific treatment against WNV infection imparts a pressing need to characterize indicators associated with neurological involvement. By its intimacy with central nervous system (CNS) structures, modifications in the cerebrospinal fluid (CSF) composition could accurately reflect CNS pathological process. Until now, few studies investigated the association between imbalance of CSF elements and severity of WNV infection. The aim of the present study was to apply the iTRAQ technology in order to identify the CSF proteins whose abundances are modified in patients with WNND. Forty-seven proteins were found modified in the CSF of WNND patients as compared to control groups, and most of them are reported for the first time in the context of WNND. On the basis of their known biological functions, several of these proteins were associated with inflammatory response. Among them, Defensin-1 alpha (DEFA1), a protein reported with anti-viral effects, presented the highest increasing fold-change (FC>12). The augmentation of DEFA1 abundance in patients with WNND was confirmed at the CSF, but also in serum, compared to the control individual groups. Furthermore, the DEFA1 serum level was significantly elevated in WNND patients compared to subjects diagnosed for WNF. The present study provided the first insight into the potential CSF biomarkers associated with WNV neuroinvasion. Further investigation in larger cohorts with kinetic sampling could determine the usefulness of measuring DEFA1 as diagnostic or prognostic biomarker of detrimental WNND evolution.	[Fraisier, Christophe; Almeras, Lionel] Aix Marseille Univ, CNRS 7278, Inserm 1095,UM63, Unite Rech Malad Infect & Trop Emergentes,IRD 198, Marseille, France; [Fraisier, Christophe; Almeras, Lionel] IRBA, URBEP, Marseille, France; [Papa, Anna] Aristotle Univ Thessaloniki, Sch Med, Dept Microbiol, GR-54006 Thessaloniki, Greece; [Granjeaud, Samuel; Camoin, Luc] Inserm, CRCM, Marseille Prote, U1068, Marseille, France; [Granjeaud, Samuel] Aix Marseille Univ, UM 105, Marseille, France; [Hintzen, Rogier] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Martina, Byron] Erasmus MC, Dept Virol, Rotterdam, Netherlands	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Aristotle University of Thessaloniki; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Almeras, L (corresponding author), Aix Marseille Univ, CNRS 7278, Inserm 1095,UM63, Unite Rech Malad Infect & Trop Emergentes,IRD 198, Marseille, France.	almeras.lionel@gmail.com	Camoin, Luc/AAB-3856-2019; Granjeaud, Samuel/AAE-6488-2022	Camoin, Luc/0000-0002-1230-4787; Granjeaud, Samuel/0000-0001-9245-1535; Martina, Byron/0000-0003-4980-4619; ALMERAS, Lionel/0000-0003-0490-5774	European Community [261466]; Delegation Generale pour l'Armement (DGA) [ArthroSer 10Ca 401]	European Community(European Commission); Delegation Generale pour l'Armement (DGA)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007 - 2 013) under the project "VECTORIE", EC grant agreement number 261466. This study was also supported by Delegation Generale pour l'Armement (DGA, ArthroSer 10Ca 401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Anticona EMF, 2012, CASE REP INFECT DIS, V2012, DOI 10.1155/2012/839458; Bayer SB, 2013, FASEB J, V27, P3315, DOI 10.1096/fj.13-227298; Beasley DW, 2013, ANTIVIRAL RES; Berard JL, 2012, GLIA, V60, P1145, DOI 10.1002/glia.22342; Bi FF, 2013, P NATL ACAD SCI USA, V110, P4069, DOI 10.1073/pnas.1218497110; Botia B, 2008, J MOL NEUROSCI, V36, P61, DOI 10.1007/s12031-008-9075-5; Briolant S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-141; Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467; Carson PJ, 2003, CLIN INFECT DIS, V37, pE12, DOI 10.1086/375692; Chakraborty S, 2012, BBA-REV CANCER, V1826, P129, DOI 10.1016/j.bbcan.2012.03.008; Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12; Crichlow R, 2004, J AM BOARD FAM PRACT, V17, P470, DOI 10.3122/jabfm.17.6.470; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; Danis K, 2011, EMERG INFECT DIS, V17, P1868, DOI 10.3201/eid1710.110525; Dauphin G, 2007, VACCINE, V25, P5563, DOI 10.1016/j.vaccine.2006.12.005; De Filette M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-16; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Fraisier C, 2013, VIRUS RES IN PRESS; Fraisier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068318; GANZ T, 1994, CURR OPIN IMMUNOL, V6, P584, DOI 10.1016/0952-7915(94)90145-7; Gasche Y, 2006, FRONT BIOSCI-LANDMRK, V11, P1289, DOI 10.2741/1883; Gonzalez H, 2009, J PROTEOMICS, V71, P670, DOI 10.1016/j.jprot.2008.11.014; Hamdan A, 2002, Transpl Infect Dis, V4, P160, DOI 10.1034/j.1399-3062.2002.01014.x; Jarczak J, 2013, HUM IMMUNOL, V74, P1069, DOI 10.1016/j.humimm.2013.05.008; Jordan I, 2000, J INFECT DIS, V182, P1214, DOI 10.1086/315847; Jordan M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/697418; Kalil AC, 2005, CLIN INFECT DIS, V40, P764, DOI 10.1086/427945; Kapoor H, 2004, J CLIN VIROL, V31, P289, DOI 10.1016/j.jcv.2004.05.017; Laspiur JP, 2007, J NEUROIMMUNOL, V192, P157, DOI 10.1016/j.jneuroim.2007.08.004; Lee S, 2011, J BIOL CHEM, V286, P43855, DOI 10.1074/jbc.M111.299248; Leis AA, 2012, MUSCLE NERVE, V45, P826, DOI 10.1002/mus.23241; Lim SM, 2011, VIRUSES-BASEL, V3, P811, DOI 10.3390/v3060811; Loginova S. Ya., 2009, Antibiotiki i Khimioterapiya, V54, P17; Markowitz J, 2013, BBA-REV CANCER, V1835, P100, DOI 10.1016/j.bbcan.2012.10.003; Marques F, 2008, J CEREBR BLOOD F MET, V28, P450, DOI 10.1038/sj.jcbfm.9600557; Marques F, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00033; Miller F, 2012, VIRULENCE, V3, P222, DOI 10.4161/viru.19697; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Neghina AM, 2011, VECTOR-BORNE ZOONOT, V11, P1289, DOI 10.1089/vbz.2010.0206; Nixon ML, 2006, J CLIN VIROL, V37, P174, DOI 10.1016/j.jcv.2006.07.005; Niyonsaba F, 2006, CRIT REV IMMUNOL, V26, P545, DOI 10.1615/CritRevImmunol.v26.i6.60; Omalu BI, 2003, BRAIN PATHOL, V13, P465, DOI 10.1111/j.1750-3639.2003.tb00477.x; Papa A., 2010, EUROSURVEILLANCE, V2010, P15; Papa A, 2012, EXPERT REV ANTI-INFE, V10, P743, DOI [10.1586/ERI.12.59, 10.1586/eri.12.59]; Paz S, 2013, INT J ENV RES PUB HE, V10, P3543, DOI 10.3390/ijerph10083543; Petzold A, 2010, MUSCLE NERVE, V41, P42, DOI 10.1002/mus.21448; Poynton RA, 2013, BIOCH BIOPHYS ACTA; Prince HE, 2005, CLIN DIAGN LAB IMMUN, V12, P231, DOI 10.1128/CDLI.12.1.231-233.2005; Rizzo C., 2012, EURO SURVEILL, V17; Root JJ, 2013, ARCH VIROL, V158, P735, DOI 10.1007/s00705-012-1516-3; Rossi SL, 2010, CLIN LAB MED, V30, P47, DOI 10.1016/j.cll.2009.10.006; Salvatore M, 2007, J INFECT DIS, V196, P835, DOI 10.1086/521027; Sambri V, 2013, CLIN MICROBIOL INFEC; Sathyanesan M, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.64; Sayao AL, 2004, CAN J NEUROL SCI, V31, P194, DOI 10.1017/S031716710005383X; Schutzer SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017287; Shahim P, 2013, EUR J PAEDIATR NEURO, V17, P7, DOI 10.1016/j.ejpn.2012.09.005; Sharma A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-197; Shimoni Z, 2001, EMERG INFECT DIS, V7, P759; Shores KS, 2007, J PROTEOME RES, V6, P3739, DOI 10.1021/pr070293w; Srikrishna G, 2012, J INNATE IMMUN, V4, P31, DOI 10.1159/000330095; Thibert KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050430; Tyler KL, 2006, NEUROLOGY, V66, P361, DOI 10.1212/01.wnl.0000195890.70898.1f; Unwin RD, 2010, NAT PROTOC, V5, P1574, DOI 10.1038/nprot.2010.123; Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025	67	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93637	10.1371/journal.pone.0093637	http://dx.doi.org/10.1371/journal.pone.0093637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695528	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000095
J	Sepuru, KM; Poluri, KM; Rajarathnam, K				Sepuru, Krishna Mohan; Poluri, Krishna Mohan; Rajarathnam, Krishna			Solution Structure of CXCL5-A Novel Chemokine and Adipokine Implicated in Inflammation and Obesity	PLOS ONE			English	Article							GROWTH-STIMULATING ACTIVITY; MONOMER-DIMER EQUILIBRIUM; GLYCOSAMINOGLYCAN INTERACTIONS; SIGNAL-TRANSDUCTION; BIOLOGICAL-ACTIVITY; INTERLEUKIN-8 IL-8; HYDROGEN-EXCHANGE; CXC CHEMOKINES; NMR STRUCTURE; WEB SERVER	The chemokine CXCL5 is selectively expressed in highly specialized cells such as epithelial type II cells in the lung and white adipose tissue macrophages in muscle, where it mediates diverse functions from combating microbial infections by regulating neutrophil trafficking to promoting obesity by inhibiting insulin signaling. Currently very little is known regarding the structural basis of how CXCL5 mediates its novel functions. Towards this missing knowledge, we have solved the solution structure of the CXCL5 dimer by NMR spectroscopy. CXCL5 is a member of a subset of seven CXCR2-activating chemokines (CAC) that are characterized by the highly conserved ELR motif in the N-terminal tail. The structure shows that CXCL5 adopts the typical chemokine fold, but also reveals several distinct differences in the 30 s loop and N-terminal residues; not surprisingly, crosstalk between N-terminal and 30 s loop residues have been implicated as a major determinant of receptor activity. CAC function also involves binding to highly sulfated glycosaminoglycans ( GAG), and the CXCL5 structure reveals a distinct distribution of positively charged residues, suggesting that differences in GAG interactions also influence function. The availability of the structure should now facilitate the design of experiments to better understand the molecular basis of various CXCL5 functions, and also serve as a template for the design of inhibitors for use in a clinical setting.	[Sepuru, Krishna Mohan; Poluri, Krishna Mohan; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Rajarathnam, Krishna] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Rajarathnam, K (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	krrajara@utmb.edu	Poluri, Krishna Mohan/H-6083-2013; Sepuru, Krishna Mohan/K-5321-2014	Poluri, Krishna Mohan/0000-0003-3801-7134; Sepuru, Krishna Mohan/0000-0002-3675-6294	NIH [HL-107152]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107152] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH HL-107152 grant to K. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN ET, 1991, P NATL ACAD SCI USA, V88, P502, DOI 10.1073/pnas.88.2.502; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURROWS SD, 1994, BIOCHEMISTRY-US, V33, P12741, DOI 10.1021/bi00209a002; Byeon IJL, 2003, J MOL BIOL, V333, P141, DOI 10.1016/S0022-2836(03)00928-8; Chavey C, 2009, AGING-US, V1, P674, DOI 10.18632/aging.100064; Chavey C, 2009, CELL METAB, V9, P339, DOI 10.1016/j.cmet.2009.03.002; CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; Colditz IG, 2007, THROMB HAEMOSTASIS, V97, P688, DOI 10.1160/TH07-02-0105; Damaj BB, 1996, J BIOL CHEM, V271, P20540, DOI 10.1074/jbc.271.34.20540; Das ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011754; Dawes JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002193; FAIRBROTHER WJ, 1994, J MOL BIOL, V242, P252, DOI 10.1006/jmbi.1994.1577; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Gangavarapu P, 2012, J LEUKOCYTE BIOL, V91, P259, DOI 10.1189/jlb.0511239; Goddard D., 2008, SPARKY 3; HESSELGESSER J, 1995, J BIOL CHEM, V270, P11472, DOI 10.1074/jbc.270.19.11472; Jeyaseelan S, 2005, AM J RESP CELL MOL, V32, P531, DOI 10.1165/rcmb.2005-0063OC; Joseph PRB, 2013, BIOCHEM J, V456, P241, DOI 10.1042/BJ20130148; Joseph PRB, 2013, BIOPHYS J, V105, P1491, DOI 10.1016/j.bpj.2013.08.008; Joseph PRB, 2010, J BIOL CHEM, V285, P29262, DOI 10.1074/jbc.M110.146555; KIM KS, 1994, J BIOL CHEM, V269, P32909; KOCH AE, 1994, J CLIN INVEST, V94, P1012, DOI 10.1172/JCI117414; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuo PL, 2011, J CELL PHYSIOL, V226, P1224, DOI 10.1002/jcp.22445; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEONG SR, 1994, J BIOL CHEM, V269, P19343; Levashova ZB, 2007, J AM SOC NEPHROL, V18, P2359, DOI 10.1681/ASN.2006040380; Li AH, 2011, AM J PATHOL, V178, P1340, DOI 10.1016/j.ajpath.2010.11.058; Li RH, 1999, PROTEIN SCI, V8, P1571, DOI 10.1110/ps.8.8.1571; Lowman HB, 1997, PROTEIN SCI, V6, P598; Lowman HB, 1996, J BIOL CHEM, V271, P14344, DOI 10.1074/jbc.271.24.14344; Maity H, 2005, P NATL ACAD SCI USA, V102, P4741, DOI 10.1073/pnas.0501043102; Mei JJ, 2010, IMMUNITY, V33, P106, DOI 10.1016/j.immuni.2010.07.009; Mohan PMK, 2009, PROTEINS, V75, P40, DOI 10.1002/prot.22219; Mortier A, 2010, J BIOL CHEM, V285, P29750, DOI 10.1074/jbc.M110.119388; Murphy PM, 1997, SEMIN HEMATOL, V34, P311; Nufer O, 1999, BIOCHEMISTRY-US, V38, P636, DOI 10.1021/bi981294s; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; Park SH, 2012, NATURE, V491, P779, DOI 10.1038/nature11580; Pickens SR, 2011, ANGIOGENESIS, V14, P443, DOI 10.1007/s10456-011-9227-z; Poluri KM, 2013, J BIOL CHEM, V288, P25143, DOI 10.1074/jbc.M113.492579; Qian YQ, 1999, J MOL BIOL, V294, P1065, DOI 10.1006/jmbi.1999.3333; Rajagopalan L, 2007, BIOPHYS J, V93, P2129, DOI 10.1529/biophysj.107.108761; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Rajarathnam K, 1997, J BIOL CHEM, V272, P1725, DOI 10.1074/jbc.272.3.1725; Rajarathnam K, 1997, METHOD ENZYMOL, V287, P89; RAJARATHNAM K, 1995, BIOCHEMISTRY-US, V34, P12983, DOI 10.1021/bi00040a008; Rajarathnam K, 1999, BIOCHEMISTRY-US, V38, P7653, DOI 10.1021/bi990033v; Rajarathnam K, 1996, FEBS LETT, V399, P43, DOI 10.1016/S0014-5793(96)01277-X; Ravindran A, 2013, J BIOL CHEM, V288, P12244, DOI 10.1074/jbc.M112.443762; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rot A, 2010, FRONT BIOSCI-LANDMRK, V15, P645, DOI 10.2741/3638; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Stillie R, 2009, J LEUKOCYTE BIOL, V86, P529, DOI 10.1189/jlb.0208125; Tanino Y, 2010, J IMMUNOL, V184, P2677, DOI 10.4049/jimmunol.0903274; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Young H, 1999, BIOCHEM J, V338, P591, DOI 10.1042/0264-6021:3380591; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	64	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93228	10.1371/journal.pone.0093228	http://dx.doi.org/10.1371/journal.pone.0093228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695525	Green Submitted, Green Published, gold			2022-12-27	WOS:000334103000050
J	Dold, HMH; Frund, I				Dold, Hannah M. H.; Fruend, Ingo			Joint Bayesian Inference Reveals Model Properties Shared between Multiple Experimental Conditions	PLOS ONE			English	Article							PSYCHOMETRIC FUNCTION	Statistical modeling produces compressed and often more easily interpretable descriptions of experimental data in form of model parameters. When experimental manipulations target selected parameters, it is necessary for their interpretation that other model components remain constant. For example, psychophysicists use dose rate models to describe how behavior changes as a function of a single stimulus variable. The main interest is on shifts of this function induced by experimental manipulation, assuming invariance in other aspects of the function. Combining several experimental conditions in a joint analysis that takes such invariance constraints into account can result in a complex model for which no robust standard procedures are available. We formulate a solution for the joint analysis through repeated applications of standard procedures by allowing an additional assumption. This way, experimental conditions can be analyzed separately such that all conditions are implicitly taken into account. We investigate the validity of the supplementary assumption through simulations. Furthermore, we present a natural way to check whether a joint treatment is appropriate. We illustrate the method for the specific case of the psychometric function; however the procedure applies to other models that encompass multiple experimental conditions.	[Dold, Hannah M. H.; Fruend, Ingo] Tech Univ Berlin, AG Modellierung Kognitiver Prozesse, Berlin, Germany; [Dold, Hannah M. H.; Fruend, Ingo] Bernstein Ctr Computat Neurosci, Berlin, Germany	Technical University of Berlin	Frund, I (corresponding author), Tech Univ Berlin, AG Modellierung Kognitiver Prozesse, Berlin, Germany.	mail@ingofruend.net			German Federal Ministry of Education and Research (BMBF) through the Bernstein Computational Neuroscience Program Berlin [FKZ: 01GQ0414]; German Research Foundation [DFG Sachbeihilfe FR 2854/1-1]	German Federal Ministry of Education and Research (BMBF) through the Bernstein Computational Neuroscience Program Berlin(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Federal Ministry of Education and Research (BMBF) through the Bernstein Computational Neuroscience Program Berlin (FKZ: 01GQ0414) and by the German Research Foundation (DFG Sachbeihilfe FR 2854/1-1 awarded to IF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown SD, 2008, COGNITIVE PSYCHOL, V57, P153, DOI 10.1016/j.cogpsych.2007.12.002; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; Dobson AJ, 2008, INTRO GEN LINEAR MOD; Eaton DL, 2001, CASARETT DOULS TOXIC; Fruend I, 2011, J VISION, V11, DOI 10.1167/11.6.16; Garcia-Perez MA, 2007, BRIT J MATH STAT PSY, V60, P147, DOI 10.1348/000711006X104596; Gelman A, 2000, J ROY STAT SOC C-APP, V49, P247, DOI 10.1111/1467-9876.00190; Kuss M, 2005, J VISION, V5, P478, DOI 10.1167/5.5.8; Lodewyckx T, 2011, J MATH PSYCHOL, V55, P331, DOI 10.1016/j.jmp.2011.06.001; MALONEY LT, 1990, PERCEPT PSYCHOPHYS, V47, P127, DOI 10.3758/BF03205977; McCullagh P, 1989, GEN LINEAR MODELS; NACHMIAS J, 1981, VISION RES, V21, P215, DOI 10.1016/0042-6989(81)90115-2; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ritz C, 2010, ENVIRON TOXICOL CHEM, V29, P220, DOI 10.1002/etc.7; Roverato A, 2012, INT J APPROXIMATE RE, V53; Rubin D.B., 1988, BAYESIAN STAT, V3; SMITH AFM, 1992, AM STAT, V46, P84, DOI 10.2307/2684170; Smith PJ, 2000, SIGHT SOUND, V10, P53; Treutwein B, 1999, PERCEPT PSYCHOPHYS, V61, P87, DOI 10.3758/BF03211951; Tuerlinckx F, 2006, BRIT J MATH STAT PSY, V59, P225, DOI 10.1348/000711005x79857; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; WICHMANN FA, 1999, THESIS OXFORD U	22	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e91710	10.1371/journal.pone.0091710	http://dx.doi.org/10.1371/journal.pone.0091710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710070	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800009
J	Erezyilmaz, DF; Hayward, A; Huang, Y; Paps, J; Acs, Z; Delgado, JA; Collantes, F; Kathirithamby, J				Erezyilmaz, Deniz F.; Hayward, Alex; Huang, Yan; Paps, Jordi; Acs, Zoltan; Delgado, Juan A.; Collantes, Francisco; Kathirithamby, Jeyaraney			Expression of the Pupal Determinant broad during Metamorphic and Neotenic Development of the Strepsipteran Xenos vesparum Rossi	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; STATUS-QUO ACTION; JUVENILE-HORMONE; TOBACCO HORNWORM; MANDUCA-SEXTA; DROSOPHILA METAMORPHOSIS; BTB DOMAIN; TRIBOLIUM-CASTANEUM; ISOFORM EXPRESSION; TEMPORAL PATTERNS	Derived members of the endoparasitic order Strepsiptera have acquired an extreme form of sexual dimorphism whereby males undergo metamorphosis and exist as free-living adults while females remain larviform, reaching sexual maturity within their hosts. Expression of the transcription factor, broad (br) has been shown to be required for pupal development in insects in which both sexes progress through metamorphosis. A surge of br expression appears in the last larval instar, as the epidermis begins pupal development. Here we ask if br is also up-regulated in the last larval instar of male Xenos vesparum Rossi (Stylopidae), and whether such expression is lost in neotenic larviform females. We clone three isoforms of br from X. vesparum (Xv'br), and show that they share greatest similarity to the Z1, Z3 and Z4 isoforms of other insect species. By monitoring Xv'br expression throughout development, we detect elevated levels of total br expression and the Xv'Z1, Xv'Z3, and Xv'Z4 isoforms in the last larval instar of males, but not females. By focusing on Xv'br expression in individual samples, we show that the levels of Xv'BTB and Xv'Z3 in the last larval instar of males are bimodal, with some males expressing 3X greater levels of Xv'br than fourth instar femlaes. Taken together, these data suggest that neoteny (and endoparasitism) in females of Strepsiptera Stylopidia could be linked to the suppression of pupal determination. Our work identifies a difference in metamorphic gene expression that is associated with neoteny, and thus provides insights into the relationship between metamorphic and neotenic development.	[Erezyilmaz, Deniz F.; Huang, Yan] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Paps, Jordi; Kathirithamby, Jeyaraney] Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Acs, Zoltan] Kaposvar Univ, Fac Anim Sci, Kaposvar, Hungary; [Delgado, Juan A.; Collantes, Francisco] Univ Murcia, Fac Biol, Dept Zool, Murcia, Spain	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Uppsala University; Hungarian University of Agriculture & Life Sciences; Kaposvar University; University of Murcia	Erezyilmaz, DF (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	deniz.erezyilmaz@stonybrook.edu	Paps, Jordi/B-2098-2012; Collantes, Francisco/M-4798-2017; Collantes, Francisco/L-5937-2019	Paps, Jordi/0000-0003-2636-6636; Collantes, Francisco/0000-0002-8085-6399; Collantes, Francisco/0000-0002-8085-6399; Hayward, Alexander/0000-0001-7413-718X	Leverhulme Trust [F/08502/G]; Stony Brook University	Leverhulme Trust(Leverhulme Trust); Stony Brook University	Leverhulme Trust Research Grant to JK (no. No. F/08502/G) (http://www.leverhulme.ac.uk), Stony Brook University startup funds to DE (http://www.stonybrook.edu). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KF, 1998, P NATL ACAD SCI USA, V95, P12123, DOI 10.1073/pnas.95.21.12123; Bayer CA, 1996, DEV BIOL, V177, P1, DOI 10.1006/dbio.1996.0140; BELYAEVA ES, 1980, CHROMOSOMA, V81, P281, DOI 10.1007/BF00285954; Cossgrove K, 1996, DEV BIOL, V180, P745; DIBELLO PR, 1991, GENETICS, V129, P385; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erezyilmaz DF, 2006, P NATL ACAD SCI USA, V103, P6925, DOI 10.1073/pnas.0509983103; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; HEMING BS, 1973, CAN J ZOOL, V51, P1211, DOI 10.1139/z73-175; Hodin J, 1998, DEV GENES EVOL, V208, P304, DOI 10.1007/s004270050186; Hodin J, 2000, DEV GENES EVOL, V210, P358, DOI 10.1007/s004270000079; Huang J. H., 2012, BIOCHIM BIOPHYS ACTA, V1830, P2178; KATHIRITHAMBY J, 1989, SYST ENTOMOL, V14, P41, DOI 10.1111/j.1365-3113.1989.tb00265.x; KATHIRITHAMBY J, 1984, ZOOL J LINN SOC-LOND, V82, P335, DOI 10.1111/j.1096-3642.1984.tb00647.x; Kathirithamby J, 2009, ANNU REV ENTOMOL, V54, P227, DOI 10.1146/annurev.ento.54.110807.090525; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kinzelbach RK, 1971, MORPHOLOGISCHE BEFUN, Vscheverlagsbuchhandlung, P256; KISS I, 1978, MOL GEN GENET, V164, P77, DOI 10.1007/BF00267601; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Konopova B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028728; Melnick A, 2000, MOL CELL BIOL, V20, P6550, DOI 10.1128/MCB.20.17.6550-6567.2000; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Minakuchi C, 2011, INSECT BIOCHEM MOLEC, V41, P125, DOI 10.1016/j.ibmb.2010.11.004; Mugat B, 2000, DEV BIOL, V227, P104, DOI 10.1006/dbio.2000.9879; NIJHOUT HF, 1982, Q REV BIOL, V57, P109, DOI 10.1086/412671; Parthasarathy R, 2008, MECH DEVELOP, V125, P299, DOI 10.1016/j.mod.2007.11.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piulachs MD, 2010, INSECT BIOCHEM MOLEC, V40, P468, DOI 10.1016/j.ibmb.2010.04.006; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Reza AMS, 2004, COMP BIOCHEM PHYS B, V139, P753, DOI 10.1016/j.cbpc.2004.09.009; RIDDIFORD LM, 1978, GEN COMP ENDOCR, V34, P438, DOI 10.1016/0016-6480(78)90284-8; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; RIDDIFORD LM, 1981, AM ZOOL, V21, P751; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suzuki Y, 2008, DEVELOPMENT, V135, P569, DOI 10.1242/dev.015263; Trieblmayr K, 1981, MIKROSKOPIE, V38, P97; TRUMAN JW, 1974, DEV BIOL, V39, P247, DOI 10.1016/S0012-1606(74)80028-X; Uhlirova M, 2003, P NATL ACAD SCI USA, V100, P15607, DOI 10.1073/pnas.2136837100; VONKALM L, 1994, EMBO J, V13, P3505, DOI 10.1002/j.1460-2075.1994.tb06657.x; Wheeler WC, 1990, ANN ENTOMOL SOC AM, V83, P91; Zhou BH, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-39; Zhou BH, 1998, DEV BIOL, V203, P233, DOI 10.1006/dbio.1998.9059; Zhou BH, 2001, DEV BIOL, V231, P125, DOI 10.1006/dbio.2000.0143; Zhou XF, 2002, DEVELOPMENT, V129, P2259; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	46	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93614	10.1371/journal.pone.0093614	http://dx.doi.org/10.1371/journal.pone.0093614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709670	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000334159800039
J	Liu, D; Li, A; Mao, XG; Jing, RL				Liu, Dan; Li, Ang; Mao, Xinguo; Jing, Ruilian			Cloning and Characterization of TaPP2AbB"-alpha, a Member of the PP2A Regulatory Subunit in Wheat	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; LATERAL ROOT DEVELOPMENT; CATALYTIC SUBUNIT; GENE-EXPRESSION; AUXIN REDISTRIBUTION; STRESS-RESPONSE; SALT STRESS; SYSTEM; FAMILY; ORGANIZATION	Protein phosphatase 2A (PP2A), a major Serine/Threonine protein phosphatase, consists of three subunits; a highly conserved structural subunit A, a catalytic subunit C, and a highly variable regulatory subunit B which determines the substrate specificity. Although the functional mechanism of PP2A in signaling transduction in Arabidopsis is known, their physiological roles in wheat remain to be characterized. In this study, we identified a novel regulatory subunit B, TaPP2AbB"-alpha, in wheat (Triticum aestivum L.). Subcellular localization indicated that TaPP2AbB"-alpha is located in the cell membrane, cytoplasm and nucleus. It interacts with both TaPP2Aa and TaPP2Ac. Expression pattern analyses revealed that TaPP2AbB"-a is strongly expressed in roots, and responds to NaCl, polyethylene glycol (PEG), cold and abscisic acid (ABA) stresses at the transcription level. Transgenic Arabidopsis plants overexpressing TaPP2AbB"-alpha developed more lateral roots, especially when treated with mannitol or NaCl. These results suggest that TaPP2AbB"-alpha, in conjunction with the other two PP2A subunits, is involved in multi-stress response, and positively regulates lateral root development under osmotic stress.	[Liu, Dan; Li, Ang; Mao, Xinguo; Jing, Ruilian] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Jing, RL (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	jingrl@caas.net.cn	Xinguo, Mao/AAF-3195-2020	Xinguo, Mao/0000-0003-4712-437X	National Natural Science Foundation of China [31201206]; Science and Technology Project for Outstanding Ph.D. Supervisor of Beijing [YB20088210101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project for Outstanding Ph.D. Supervisor of Beijing	This study was supported by the National Natural Science Foundation of China (31201206, http://www.nsfc.gov.cn/), and Science and Technology Project for Outstanding Ph.D. Supervisor of Beijing (YB20088210101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolin-Llovera M, 2011, PLANT SIGNAL BEHAV, V6, P1127, DOI 10.4161/psb.6.8.16363; Ballesteros I, 2013, PLANT J, V73, P862, DOI 10.1111/tpj.12078; Blakeslee JJ, 2008, PLANT PHYSIOL, V146, P539, DOI 10.1104/pp.107.112995; Brandt B, 2012, P NATL ACAD SCI USA, V109, P10593, DOI 10.1073/pnas.1116590109; Chen HM, 2008, PLANT PHYSIOL, V146, P368, DOI 10.1104/pp.107.111740; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Ditengou FA, 2008, P NATL ACAD SCI USA, V105, P18818, DOI 10.1073/pnas.0807814105; Farkas I, 2007, TRENDS PLANT SCI, V12, P169, DOI 10.1016/j.tplants.2007.03.003; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Garbers C, 1996, EMBO J, V15, P2115, DOI 10.1002/j.1460-2075.1996.tb00565.x; Gentry MS, 2002, MOL BIOL CELL, V13, P3477, DOI 10.1091/mbc.02-05-0065; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Harris DM, 1999, PLANT PHYSIOL, V121, P609, DOI 10.1104/pp.121.2.609; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Ito K, 2006, PHYSIOL PLANTARUM, V127, P260, DOI 10.1111/j.1399-3054.2006.00657.x; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kirik A, 2012, PLANT CELL, V24, P1158, DOI 10.1105/tpc.111.094367; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; Lavenus J, 2013, TRENDS PLANT SCI, V18, P455, DOI 10.1016/j.tplants.2013.04.006; Leung HT, 2013, AM J NEURO, V4, P46; Liu JL, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00075; Liu ShiHang, 2010, Scientia Agricultura Sinica, V43, P2197; Louis JV, 2011, P NATL ACAD SCI USA, V108, P6957, DOI 10.1073/pnas.1018777108; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Malamy JE, 2001, PLANT PHYSIOL, V127, P899, DOI 10.1104/pp.010406; Mao XG, 2010, J EXP BOT, V61, P683, DOI 10.1093/jxb/erp331; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Munoz-Romero V, 2010, PLANT SOIL, V326, P97, DOI 10.1007/s11104-009-9983-3; Chavez-Aviles MN, 2013, PLANT SOIL, V368, P591, DOI 10.1007/s11104-012-1540-9; Pang XiaoBin, 2007, Acta Agronomica Sinica, V33, P333; Park S, 2013, CELL CALCIUM, V53, P217, DOI 10.1016/j.ceca.2012.12.001; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Reiter W, 2013, MOL CELL BIOL, V33, P1057, DOI 10.1128/MCB.00834-12; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Shi JF, 2010, AGR SCI CHINA, V9, P325, DOI 10.1016/S1671-2927(09)60100-0; Slupe A. M, 2011, ENZYME RES, V2011; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang WQ, 2011, NAT CELL BIOL, V13, P124, DOI 10.1038/ncb2151; Tian SJ, 2013, J EXP BOT, V64, P2063, DOI 10.1093/jxb/ert072; Wu G, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001258; Xu CY, 2007, ANN BOT-LONDON, V99, P439, DOI 10.1093/aob/mcl285; Yang L, 2004, MOL GENET GENOMICS, V272, P433, DOI 10.1007/s00438-004-1066-9; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu RMK, 2005, PLANTA, V222, P757, DOI 10.1007/s00425-005-0018-x; Yu RMK, 2003, PLANT MOL BIOL, V51, P295, DOI 10.1023/A:1020771906524; Zhao JQ, 2010, GENE REGUL SYST BIO, V4, P135, DOI 10.4137/GRSB.S6065; Zhao YK, 2011, NEW PHYTOL, V189, P1122, DOI 10.1111/j.1469-8137.2010.03545.x	52	6	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94430	10.1371/journal.pone.0094430	http://dx.doi.org/10.1371/journal.pone.0094430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709994	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800145
J	Luo, QJ; Zhu, ZG; Zhu, ZJ; Yang, R; Qian, FJ; Chen, HM; Yan, XJ				Luo, Qijun; Zhu, Zhenggang; Zhu, Zhujun; Yang, Rui; Qian, Feijian; Chen, Haimin; Yan, Xiaojun			Different Responses to Heat Shock Stress Revealed Heteromorphic Adaptation Strategy of Pyropia haitanensis ( Bangiales, Rhodophyta)	PLOS ONE			English	Article							D-ISOFLORIDOSIDE; RED ALGAE; FLORIDOSIDE; PORPHYRA; METABOLISM; EXPRESSION; PROFILES; MANNITOL; DEFENSE; PLANTS	Pyropia has a unique heteromorphic life cycle with alternation stages between thallus and conchocelis, which lives at different water temperatures in different seasons. To better understand the different adaptation strategies for temperature stress, we tried to observe comparative biochemical changes of Pyropia haitanensis based on a short term heat shock model. The results showed that: (1) At normal temperature, free-living conchocelis contains significantly higher levels of H2O2, fatty acid-derived volatiles, the copy number of Phrboh and Phhsp70 genes, the activities of NADPH oxidase and floridoside than those in thallus. The released H2O2 and NADPH oxidase activity of conchocelis were more than 7 times higher than those of thallus. The copy number of Phrboh in conchocelis was 32 times that in thallus. (2) After experiencing heat shock at 35 degrees C for 30 min, the H2O2 contents, the mRNA levels of Phrboh and Phhsp70, NADPH oxidase activity and the floridoside content in thallus were all significantly increased. The mRNA levels of Phrboh increased 5.78 times in 5 min, NADPH oxidase activity increased 8.45 times in 20 min. (3) Whereas, in conchocelis, the changes in fatty acids and their down-stream volatiles predominated, significantly increasing levels of saturated fatty acids and decreasing levels of polyunsaturated fatty acids occurred, and the 8-carbon volatiles were accumulated. However, the changes in H2O2 content and expression of oxidant-related genes and enzymatic activity were not obvious. Overall, these results indicate that conchocelis maintains a high level of active protective apparatus to endure its survival at high temperature, while thallus exhibit typical stress responses to heat shock. It is concluded that Pyropia haitanensis has evolved a delicate strategy for temperature adaptation for its heteromorphic life cycle.	[Luo, Qijun; Zhu, Zhenggang; Zhu, Zhujun; Yang, Rui; Qian, Feijian; Chen, Haimin] Minist Educ, Key Lab Appl Marine Biotechnol, Ningbo, Zhejiang, Peoples R China; [Yan, Xiaojun] Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University	Chen, HM (corresponding author), Minist Educ, Key Lab Appl Marine Biotechnol, Ningbo, Zhejiang, Peoples R China.	chenhaimin@nbu.edu.cn; xiaojunyan@hotmail.com	LUO, QI/GQH-7209-2022	Yan, Xiaojun/0000-0003-0257-0157; Zhu, Zhenggang/0000-0002-6085-525X	National Science Foundation (NSFC) [81370532]; National Spark Major Project [2013GA701001]; Ningbo Programs for Science and Technology Development [201201C1011016]; Zhejiang Major Technology Project for Breeding of New Variety [2012C12907-6]; K.C. Wong Magna Fund in Ningbo University; 151 talents Project	National Science Foundation (NSFC)(National Natural Science Foundation of China (NSFC)National Science Foundation (NSF)); National Spark Major Project; Ningbo Programs for Science and Technology Development; Zhejiang Major Technology Project for Breeding of New Variety; K.C. Wong Magna Fund in Ningbo University; 151 talents Project	This project was funded by National Science Foundation (NSFC) project (81370532), National Spark Major Project (No. 2013GA701001), Ningbo Programs for Science and Technology Development (201201C1011016), Zhejiang Major Technology Project for Breeding of New Variety (2012C12907-6), K.C. Wong Magna Fund in Ningbo University; and 151 talents Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanda-Nkpwatt D, 2006, BIOCONTROL, V51, P279, DOI 10.1007/s10526-005-4362-3; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Asamizu E, 2003, J PHYCOL, V39, P923, DOI 10.1046/j.1529-8817.2003.03003.x; Blouin NA, 2011, TRENDS PLANT SCI, V16, P29, DOI 10.1016/j.tplants.2010.10.004; Chitarra GS, 2004, APPL ENVIRON MICROB, V70, P2823, DOI 10.1128/AEM.70.5.2823-2829.2004; d'Ippolito G, 2005, ORG BIOMOL CHEM, V3, P4065, DOI 10.1039/b510640k; Eggert A, 2010, CELL ORIG LIFE EXTRE, V13, P443, DOI 10.1007/978-90-481-3795-4_24; Hahn A, 2011, PLANT CELL, V23, P741, DOI 10.1105/tpc.110.076018; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Herve C, 2006, CURR GENET, V49, P190, DOI 10.1007/s00294-005-0044-z; Hou HS, 2008, J LIAONING NORM U NA, V31, P487; Iwamoto K, 2005, MAR BIOTECHNOL, V7, P407, DOI 10.1007/s10126-005-0029-4; Jennings DB, 1998, P NATL ACAD SCI USA, V95, P15129, DOI 10.1073/pnas.95.25.15129; Ji M.H., 2004, SEAWEED CHEM, P518; KARSTEN U, 1993, PLANT PHYSIOL, V103, P485, DOI 10.1104/pp.103.2.485; Klahn S, 2010, J BACTERIOL, V192, P4403, DOI 10.1128/JB.00481-10; Knowles LO, 2012, J AGR FOOD CHEM, V60, P11173, DOI 10.1021/jf303299n; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Li SY, 2002, J PHYCOL, V38, P931, DOI 10.1046/j.1529-8817.2002.01143.x; Li SY., 1988, MAR SCI, V4, P58; Li YX, 2010, J AGR FOOD CHEM, V58, P578, DOI 10.1021/jf902811j; Liu W., 2012, J NINGBO U IN CHINES, V25, P17, DOI [10.3969/j.issn.1001-5132.2012.02.004, DOI 10.3969/J.ISSN.1001-5132.2012.02.004]; [鹿宁 Lu Ning], 2010, [武汉大学学报. 理学版, Journal of Wuhan University. Natural Science Edition], V56, P570; Rousch JM, 2003, J EXP MAR BIOL ECOL, V295, P145, DOI 10.1016/S0022-0981(03)00293-4; Sahoo D, 2002, CURR SCI INDIA, V83, P1313; SUKENIK A, 1993, AQUACULTURE, V117, P313, DOI 10.1016/0044-8486(93)90328-V; Sung DY, 2003, TRENDS PLANT SCI, V8, P179, DOI 10.1016/S1360-1385(03)00047-5; Wang SG, 2013, CHIN J OCEANOL LIMN, V44, P1378; Wang XJ, 2013, J APPL PHYCOL, V25, P1895, DOI 10.1007/s10811-013-0009-4; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; Weinberger F, 2007, BIOL BULL-US, V213, P290, DOI 10.2307/25066646; William LM, 1988, ANAL CHEM, V60, P2711; Xie CT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-107; Yang R, 2013, BOT MAR, V56, P249, DOI 10.1515/bot-2012-0178; Zhang Yuan, 2011, Journal of Fisheries of China, V35, P379; [周文君 ZHOU Wenjun], 2006, [中国水产科学, Journal of Fishery Sciences of China], V13, P217	36	24	27	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94354	10.1371/journal.pone.0094354	http://dx.doi.org/10.1371/journal.pone.0094354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709783	Green Submitted, Green Published, gold			2022-12-27	WOS:000334159800139
J	Jespersen, L; Abildstrom, SZ; Hvelplund, A; Madsen, JK; Galatius, S; Pedersen, F; Hojberg, S; Prescott, E				Jespersen, Lasse; Abildstrom, Steen Z.; Hvelplund, Anders; Madsen, Jan K.; Galatius, Soren; Pedersen, Frants; Hojberg, Soren; Prescott, Eva			Burden of Hospital Admission and Repeat Angiography in Angina Pectoris Patients with and without Coronary Artery Disease: A Registry-Based Cohort Study	PLOS ONE			English	Article							ISCHEMIA-SYNDROME-EVALUATION; STABLE ANGINA; CHEST-PAIN; WOMEN; HEART	Aims: To evaluate risk of hospitalization due to cardiovascular disease (CVD) and repeat coronary angiography (CAG) in stable angina pectoris (SAP) with no obstructive coronary artery disease (CAD) versus obstructive CAD, and asymptomatic reference individuals. Methods and Results: We followed 11,223 patients with no prior CVD having a first-time CAG in 1998-2009 due to SAP symptoms and 5,695 asymptomatic reference individuals from the Copenhagen City Heart Study through registry linkage for 7.8 years (median). In recurrent event survival analysis, patients with SAP had 3-4-fold higher risk of hospitalization for CVD irrespective of CAG findings and cardiovascular comorbidity. Multivariable adjusted hazard ratios(95%CI) for patients with angiographically normal coronary arteries was 3.0(2.5-3.5), for angiographically diffuse non-obstructive CAD 3.9(3.3-4.6) and for 1-3-vessel disease 3.6-4.1(range)(all P<0.001). Mean accumulated hospitalization time was 3.5(3.0-4.0)(days/10 years follow-up) in reference individuals and 4.5(3.8-5.2)/7.0(5.4-8.6)/6.7(5.2-8.1)/6.1(5.2-7.4)/8.6(6.6-10.7) in patients with angiographically normal coronary arteries/angiographically diffuse non-obstructive CAD/1-, 2-, and 3-vessel disease, respectively (all P<0.05, age-adjusted). SAP symptoms predicted repeat CAG with multivariable adjusted hazard ratios for patients with angiographically normal coronary arteries being 2.3(1.9-2.9), for angiographically diffuse non-obstructive CAD 5.5(4.4-6.8) and for obstructive CAD 6.6-9.4(range)(all P<0.001). Conclusions: Patients with SAP symptoms and angiographically normal coronary arteries or angiographically diffuse non-obstructive CAD suffer from considerably greater CVD burdens in terms of hospitalization for CVD and repeat CAG compared with asymptomatic reference individuals even after adjustment for cardiac risk factors and exclusion of cardiovascular comorbidity as cause. Contrary to common perception, excluding obstructive CAD by CAG in such patients does not ensure a benign cardiovascular prognosis.	[Jespersen, Lasse; Abildstrom, Steen Z.; Hojberg, Soren; Prescott, Eva] Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark; [Hvelplund, Anders] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Hvelplund, Anders; Madsen, Jan K.; Galatius, Soren] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Pedersen, Frants] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark; [Prescott, Eva] Bispebjerg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Jespersen, L (corresponding author), Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark.	lasjes@gmail.com	Prescott, Eva/AAJ-7441-2020	Hoejberg, Soeren/0000-0001-8385-587X; Prescott, Eva/0000-0002-4134-0349	Research Unit of the Department of Cardiology, Bispebjerg University Hospital	Research Unit of the Department of Cardiology, Bispebjerg University Hospital	The work was funded by the Research Unit of the Department of Cardiology, Bispebjerg University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Buchthal SD, 2000, NEW ENGL J MED, V342, P829, DOI 10.1056/NEJM200003233421201; Bugiardini R, 2004, CIRCULATION, V109, P2518, DOI 10.1161/01.CIR.0000128208.22378.E3; CANNON RO, 1988, AM J CARDIOL, V61, P1338, DOI 10.1016/0002-9149(88)91180-0; CHAMBERS J, 1990, PROG CARDIOVASC DIS, V33, P161, DOI 10.1016/0033-0620(90)90007-O; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Gulati M, 2009, ARCH INTERN MED, V169, P843, DOI 10.1001/archinternmed.2009.50; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Hemingway H, 2007, EUR J CARDIOV PREV R, V14, P373, DOI 10.1097/01.hjr.0000230106.01396.a2; Jespersen L, 2013, CLIN RES CARDIOL, V102, P571, DOI 10.1007/s00392-013-0568-z; Jespersen L, 2012, EUR HEART J, V33, P734, DOI 10.1093/eurheartj/ehr331; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Ong P, 2012, J AM COLL CARDIOL, V59, P655, DOI 10.1016/j.jacc.2011.11.015; PAPANICOLAOU MN, 1986, AM J CARDIOL, V58, P1181, DOI 10.1016/0002-9149(86)90378-4; Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054; PROUDFIT WL, 1980, CIRCULATION, V62, P712, DOI 10.1161/01.CIR.62.4.712; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; Shaw LJ, 2006, CIRCULATION, V114, P894, DOI 10.1161/CIRCULATIONAHA.105.609990	18	51	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93170	10.1371/journal.pone.0093170	http://dx.doi.org/10.1371/journal.pone.0093170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705387	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500028
J	Leye, S; Ewald, R; Uhrmacher, AM				Leye, Stefan; Ewald, Roland; Uhrmacher, Adelinde M.			Composing Problem Solvers for Simulation Experimentation: A Case Study on Steady State Estimation	PLOS ONE			English	Article							ALGORITHM	Simulation experiments involve various sub-tasks, e. g., parameter optimization, simulation execution, or output data analysis. Many algorithms can be applied to such tasks, but their performance depends on the given problem. Steady state estimation in systems biology is a typical example for this: several estimators have been proposed, each with its own (dis-)advantages. Experimenters, therefore, must choose from the available options, even though they may not be aware of the consequences. To support those users, we propose a general scheme to aggregate such algorithms to so-called synthetic problem solvers, which exploit algorithm differences to improve overall performance. Our approach subsumes various aggregation mechanisms, supports automatic configuration from training data (e. g., via ensemble learning or portfolio selection), and extends the plugin system of the open source modeling and simulation framework James II. We show the benefits of our approach by applying it to steady state estimation for cell-biological models.	[Leye, Stefan; Ewald, Roland; Uhrmacher, Adelinde M.] Univ Rostock, Inst Comp Sci, D-18055 Rostock, Germany	University of Rostock	Leye, S (corresponding author), Univ Rostock, Inst Comp Sci, D-18055 Rostock, Germany.	stefan.leye@uni-rostock.de			German Reseach Foundation (DFG), under the project Alesia; German Reseach Foundation (DFG), under the project CoSA	German Reseach Foundation (DFG), under the project Alesia(German Research Foundation (DFG)); German Reseach Foundation (DFG), under the project CoSA(German Research Foundation (DFG))	The research was funded by the German Reseach Foundation (DFG), under the projects Alesia and CoSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, C4 5 PROGRAMS MACHIN; Asmussen S., 1992, ACM Transactions on Modeling and Computer Simulation, V2, P130, DOI 10.1145/137926.137932; Ay F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007992; Banga J, 2008, BMC SYSTEMS BIOL, V2, p47+; Beckman B, 2012, COMMUN ACM, V55, P38, DOI 10.1145/2133806.2133820; Boukerche A, 2001, IPDPS; Box G. E., 1970, J AM STAT ASSOC, V65, P1509, DOI [10.1080/01621459.1970.10481180, DOI 10.1080/01621459.1970.10481180]; CASH CR, 1992, 1992 WINTER SIMULATION CONFERENCE PROCEEDINGS, P577, DOI 10.1145/167293.167640; Das SR, 1996, TENTH WORKSHOP ON PARALLEL AND DISTRIBUTED SIMULATION - PADS 96, PROCEEDINGS, P186; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; EMSHOFF JR, 1970, DESIGN USE COMPUTER; Ewald R., 2011, AUTOMATIC ALGORITHM; Ewald R, 2009, P INT C SIM TOOLS TE; Ewald R, 2010, BRIEF BIOINFORM, V11, P290, DOI 10.1093/bib/bbp067; Ferscha A., 1995, Proceedings. Ninth Workshop on Parallel and Distributed Simulation. (PADS'95) (Cat. No.95TB8096), P120, DOI 10.1109/PADS.1995.404309; Figge F, 2004, BIODIVERS CONSERV, V13, P827, DOI 10.1023/B:BIOC.0000011729.93889.34; Gafarian A. V., 1976, 1976 Bicentennial Winter Simulation Conference, P49; GAFARIAN AV, 1978, NAV RES LOG, V25, P511, DOI 10.1002/nav.3800250312; Gagliolo M, 2004, TECHNICAL REPORT; Gagliolo M, 2006, P INT S ART INT MATH; Garg A, 2007, P INT C RES COMP MOL; Ghosh S, 2011, NAT REV GENET, V12, P821, DOI 10.1038/nrg3096; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gomes CP, 2001, ARTIF INTELL, V126, P43, DOI 10.1016/S0004-3702(00)00081-3; Goodwin P, 2010, FORESIGHT INT J APPL; Helms T., 2013, P 27 WORKSH PRINC AD, P11, DOI [DOI 10.1145/2486092.2486095, 10.1145/2486092.2486095]; HIGHAM DJ, 1993, APPL NUMER MATH, V12, P315, DOI 10.1016/0168-9274(93)90007-E; Himmelspach J, 2008, P 2008 WINT SIM C, P827; Himmelspach J, 2007, PROC ANNU SIMUL SYMP, P137, DOI 10.1109/ANSS.2007.34; Hoad K, 2008, 2008 WINTER SIMULATION CONFERENCE, VOLS 1-5, P532, DOI 10.1109/WSC.2008.4736110; Houstis EN, 2000, ACM T MATH SOFTWARE, V26, P227, DOI 10.1145/353474.353475; Huberman BA, 1997, SCIENCE, V275, P51, DOI 10.1126/science.275.5296.51; IBM, 2001, AUT COMP IBMS PERSP; Jeschke M, 2011, J COMPUT PHYS, V230, P2562, DOI 10.1016/j.jcp.2010.12.030; Jolliffe Ian, 2011, PRINCIPAL COMPONENT; Kaddi C, 2008, IEEE ENG MED BIO, P4613, DOI 10.1109/IEMBS.2008.4650241; Kima M, 2007, INT J REFRIG, V31, P791; Kitano H, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.40; Lee YH, 1997, COMPUT IND ENG, V33, P805, DOI 10.1016/S0360-8352(97)00242-8; Leye S, 2010, P INT C SIM TOOLS TE; Lipniacki T, 2008, J THEOR BIOL, V254, P110, DOI 10.1016/j.jtbi.2008.05.001; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Maus C, 2011, BMC SYSTEMS BIOL, V5, P77; McKinley PK, 2004, COMPUTER, V37, P56, DOI 10.1109/MC.2004.48; Meraji C. T. Sina, 2010, P 24 WORKSH PRINC AD, P1; MILNER R, 1992, INFORM COMPUT, V100, P41, DOI 10.1016/0890-5401(92)90009-5; Minson R, 2007, 21ST INTERNATIONAL WORKSHOP ON PRINCIPLES OF ADVANCED AND DISTRIBUTED SIMULATION, PROCEEDINGS, P53, DOI 10.1109/PADS.2007.11; Muggleton SH, 2005, LECT NOTES ARTIF INT, V3625, P416; Norvig P, 1997, PC AI, V11, P27; Ostertag E., 1992, ACM Transactions on Software Engineering and Methodology, V1, P205, DOI 10.1145/131736.131739; PAWLIKOWSKI K, 1990, COMPUT SURV, V22, P123, DOI 10.1145/78919.78921; Phillips A, EXAMPLES SPIM; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Rice J. R., 1976, Advances in computers, vol.15, P65, DOI 10.1016/S0065-2458(08)60520-3; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Rybacki S, 2011, WINT SIMUL C PROC, P716, DOI 10.1109/WSC.2011.6147799; SCHRUBEN LW, 1982, OPER RES, V30, P569, DOI 10.1287/opre.30.3.569; Seacord RC, 2001, EUROMICRO CONF PROC, P56, DOI 10.1109/EURMIC.2001.952438; Smith-Miles KA, 2008, ACM COMPUT SURV, V41, DOI 10.1145/1456650.1456656; Spratt SC, 1998, THESIS U VIRGINIA; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Vitali Roberto, 2010, Proceedings 18th IEEE/ACM International Symposium on Modelling, Analysis & Simulation of Computer and Telecommunication Systems (MASCOTS 2010), P319, DOI 10.1109/MASCOTS.2010.40; White KP, 2000, PROCEEDINGS OF THE 2000 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, P755, DOI 10.1109/WSC.2000.899843; White KP, 1997, SIMULATION, V69, P323, DOI 10.1177/003754979706900601; WILSON JR, 1978, SIMULATION, V31, P55, DOI 10.1177/003754977803100204; WILSON JR, 1978, SIMULATION, V31, P79, DOI 10.1177/003754977803100303; Woods Yvonne L, 2003, Hematol J, V4, P233, DOI 10.1038/sj.thj.6200260; Xu L, 2008, J ARTIF INTELL RES, V32, P565, DOI 10.1613/jair.2490; Yang P., 2010, CURRENT BIOINFORMATI, V5, P12	70	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e91948	10.1371/journal.pone.0091948	http://dx.doi.org/10.1371/journal.pone.0091948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705453	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500011
J	Segal, L; Katz, LS; Shapira, H; Sandbank, J; Geras-Raaka, E; Gershengorn, MC; Oron, Y				Segal, Liora; Katz, Liora S.; Shapira, Hagit; Sandbank, Judith; Geras-Raaka, Elizabeth; Gershengorn, Marvin C.; Oron, Yoram			PAR-3 Knockdown Enhances Adhesion Rate of PANC-1 Cells via Increased Expression of Integrin alpha v and E-Cadherin	PLOS ONE			English	Article							THROMBIN RECEPTOR EXPRESSION; CANCER INVASION	The balance between the adhesion of cancer cells to extracellular matrix and their migratory potential, as well as their proteolytic activity, are important parameters that determine cancer cells invasiveness and metastasis. Since thrombin has been implicated in cancer progression, we studied the role(s) of thrombin-activated receptors in the adhesion process. We stably knocked down proteinase-activated receptors (PARs) -1, or -3 in human pancreatic adenocarcinoma PANC-1 cells. PANC-1 cells exhibit rapid adhesion to cell culture treated plastic and much faster kinetics of adhesion to Matrigel coated surface. Knockdown of PAR-1 had no effect on cells' adhesiveness, while PAR-3 knockdowns (KDs) exhibited much faster adhesion kinetics. PAR-3 KDs also exhibited slower in vitro wound closure than vector-control and PAR-1 KD cells. To study the molecular mechanism(s) of PAR-3 KD cells' enhanced rate of adhesion, we assayed the expression of the molecules that mediate cell-surface and cell-cell adhesion. ITG alpha v, as well as ITG alpha 6 and ITG alpha 10 mRNAs, were greatly enriched (>40-fold) in a rapidly-adhering sub-population of PAR-3 KD cells. The whole population of both PAR-1 and -3 KDs exhibited enhanced expression of a number of integrins (ITGs) mRNAs. However, ITGav mRNA and protein expression was increased in PAR-3 KD and markedly decreased in PAR-1 KD. PAR-3 KD cells also expressed more E-cadherin mRNA and protein. The enhanced adhesion kinetics of PAR-3 KDs was almost fully inhibited by calcium chelation, or by a HAV-motive decapeptide that affects E-cadherin intermolecular interactions. We propose that the enhanced rate of adhesion of PAR-3 KDs results from enhanced expression of E-cadherin, leading to a greater adhesion of free-floating cells to cells rapidly bound to the surface via their integrins, and particularly ITGav.	[Segal, Liora; Oron, Yoram] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Ramat Aviv, Israel; [Katz, Liora S.; Geras-Raaka, Elizabeth; Gershengorn, Marvin C.] NIDDK, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Shapira, Hagit] Inst Pathol, Cent Lab, Rehovot, Israel; [Sandbank, Judith] Assaf Harofe Hosp, Inst Pathol, Ramat Aviv, Israel; [Sandbank, Judith] Tel Aviv Univ, Sackler Fac Med, Dept Pathol, Ramat Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Tel Aviv University; Sackler Faculty of Medicine	Oron, Y (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Ramat Aviv, Israel.	medfair@post.tau.ac.il			Andy Lebach Chair of Clinical Pharmacology and Toxicology, Tel Aviv University, YO incumbent	Andy Lebach Chair of Clinical Pharmacology and Toxicology, Tel Aviv University, YO incumbent	Supported in part by the Andy Lebach Chair of Clinical Pharmacology and Toxicology, Tel Aviv University, YO incumbent. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand R, 2004, DM-DIS MON, V50, P545, DOI 10.1016/j.disamonth.2004.09.001; Bretschneider E, 2003, THROMB HAEMOSTASIS, V90, P704, DOI 10.1160/TH03-04-0203; Canel M, 2013, J CELL SCI, V126, P393, DOI 10.1242/jcs.100115; Deshet N, 2008, J CELL PHYSIOL, V216, P632, DOI 10.1002/jcp.21441; Elste AP, 2010, J MOL HISTOL, V41, P89, DOI 10.1007/s10735-010-9274-6; Franchini M, 2012, SEMIN THROMB HEMOST, V38, P95, DOI 10.1055/s-0031-1300955; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Fujimoto D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-443; Gritsenko PG, 2012, J PATHOL, V226, P185, DOI 10.1002/path.3031; Iovanne J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00006; Kaufmann R, 2002, INT J ONCOL, V20, P177; Kaushal V, 2006, PROSTATE, V66, P273, DOI 10.1002/pros.20326; Kobayashi N, 2006, J PHARMACOL EXP THER, V317, P309, DOI 10.1124/jpet.105.097535; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; McLaughlin JN, 2007, P NATL ACAD SCI USA, V104, P5662, DOI 10.1073/pnas.0700763104; Perlikos F, 2013, CRIT REV ONCOL HEMAT, V87, P1, DOI 10.1016/j.critrevonc.2012.12.007; Segal L, 2014, PANCREAS, V43, P103, DOI 10.1097/MPA.0b013e31829f0b81; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183	20	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93879	10.1371/journal.pone.0093879	http://dx.doi.org/10.1371/journal.pone.0093879			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699825	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000117
J	Sofeu, CL; Warszawski, J; Ndongo, FA; Penda, IC; Ndiang, ST; Guemkam, G; Makwet, N; Owona, F; Kfutwah, A; Tchendjou, P; Texier, G; Tchuente, M; Faye, A; Tejiokem, MC				Sofeu, Casimir Ledoux; Warszawski, Josiane; Ndongo, Francis Ateba; Penda, Ida Calixte; Ndiang, Suzie Tetang; Guemkam, Georgette; Makwet, Nicaise; Owona, Felicite; Kfutwah, Anfumbom; Tchendjou, Patrice; Texier, Gaetan; Tchuente, Maurice; Faye, Albert; Tejiokem, Mathurin Cyrille		ANRS-PEDIACAM Study Grp	Low Birth Weight in Perinatally HIV-Exposed Uninfected Infants: Observations in Urban Settings in Cameroon	PLOS ONE			English	Article							INFECTED PREGNANT-WOMEN; FOR-GESTATIONAL-AGE; ANTIRETROVIRAL THERAPY; PROSPECTIVE COHORT; CHILDREN BORN; FETAL-GROWTH; OUTCOMES; DISEASE; TRANSMISSION; PREVENTION	Background: The consequences of maternal HIV infection for fetal growth are controversial. Here, we estimated the frequency of small for gestational age and gender (SGAG) among neonates born to HIV-infected or uninfected mothers and assessed the contribution, if any, of maternal HIV to the risk of SGAG. Methods: The data used were obtained from the ANRS-Pediacam cohort in Cameroon. Pairs of newborns, one to a HIV-infected mother and the other to an uninfected mother, were identified during the first week of life, and matched on gender and recruitment site from 2007-2010. SGAG was defined in line with international recommendations as a birth weight Z-score adjusted for gestational age at delivery and gender more than two standard deviations below the mean (- 2SD). Considering the matched design, logistic regression modeling was adjusted on site and gender to explore the effect of perinatal HIV exposure on SGAG. Results: Among the 4104 mother-infant pairs originally enrolled, no data on birth weight and/or gestational age were available for 108; also, 259 were twins and were excluded. Of the remaining 3737 mother-infant pairs, the frequency of SGAG was 5.3% (95% CI: 4.6-6.0), and was significantly higher among HIV-infected infants (22.4% vs. 6.3%; p<.001) and lower among HIV-unexposed uninfected infants (3.5% vs. 6.3%; p<.001) than among HIV-exposed uninfected infants. Similarly, SGAG was significantly more frequent among HIV-infected infants (aOR: 4.1; 2.0-8.1) and less frequent among HIV-unexposed uninfected infants (aOR: 0.5; 0.4-0.8) than among HIV-exposed uninfected infants. Primiparity (aOR: 1.9; 1.3-2.7) and the presence of any disease during pregnancy (aOR: 1.4; 1.0-2.0) were identified as other contributors to SGAG. Conclusion: Maternal HIV infection was independently associated with SGAG for HIV-exposed uninfected infants. This provides further evidence of the need for adapted monitoring of pregnancy in HIV-infected women, especially if they are symptomatic, to minimize additional risk factors for SGAG.	[Sofeu, Casimir Ledoux; Owona, Felicite; Tchendjou, Patrice; Texier, Gaetan; Tejiokem, Mathurin Cyrille] Membre Reseau Int Inst Pasteur, Ctr Pasteur Cameroun, Serv Epidemiol & Sante Publ, Yaounde, Cameroon; [Sofeu, Casimir Ledoux; Tchuente, Maurice] Univ Yaounde I, IRD UMI UMMISCO 209, Yaounde, Cameroon; [Sofeu, Casimir Ledoux; Tchuente, Maurice] Equipe Idasco, Lab Int Rech Informat & Math Appl, Yaounde, Cameroon; [Warszawski, Josiane; Tejiokem, Mathurin Cyrille] Equipe 4 VIH & IST INSERM U1018 CESP, Le Kremlin Bicetre, France; [Warszawski, Josiane] Hop Bicetre, AP HP, Serv Epidemiol & Sante Publ, Le Kremlin Bicetre, France; [Warszawski, Josiane] Univ Paris 11, Paris, France; [Ndongo, Francis Ateba; Guemkam, Georgette] Fdn Chantal Biya, Ctr Mere & Enfant, Yaounde, Cameroon; [Penda, Ida Calixte; Makwet, Nicaise] Hop Laquintinie, Hop Jour, Douala, Cameroon; [Penda, Ida Calixte] Univ Douala, Fac Med & Sci Pharmaceut, Douala, Cameroon; [Ndiang, Suzie Tetang] Ctr Hosp Essos, Serv Pediat, Yaounde, Cameroon; [Guemkam, Georgette] Hop Cent, Yaounde, Cameroon; [Kfutwah, Anfumbom] Membre Reseau Int Inst Pasteur, Serv Virol, Ctr Pasteur Cameroun, Yaounde, Cameroon; [Texier, Gaetan] Univ Aix Marseille, SESSTIM UMR 912, Marseille, France; [Faye, Albert] Hop Robert Debre, AP HP, F-75019 Paris, France; [Faye, Albert] Univ Paris 07, Sorbonne Paris Cite, Paris, France	Centre Pasteur du Cameroun; UDICE-French Research Universities; Sorbonne Universite; Cadi Ayyad University of Marrakech; Hanoi University of Science & Technology; Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; University of Yaounde I; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre Pasteur du Cameroun; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Tejiokem, MC (corresponding author), Membre Reseau Int Inst Pasteur, Ctr Pasteur Cameroun, Serv Epidemiol & Sante Publ, Yaounde, Cameroon.	tejiokem@pasteur-yaounde.org		Baril, Laurence/0000-0003-2346-883X; Penda, Calixte Ida/0000-0002-1070-2108	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR))	This study is sponsored by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS). The authors also acknowledge the material support of the "Fondation Total'' to this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey RC, 1999, INT J EPIDEMIOL, V28, P532, DOI 10.1093/ije/28.3.532; BBS/UNICEF, 2005, NAT LOW BIRTH WEIGHT; Bernstein PS, 1997, CLIN OBSTET GYNECOL, V40, P723, DOI 10.1097/00003081-199712000-00006; Briand N, 2006, PEDIATR INFECT DIS J, V25, P325, DOI 10.1097/01.inf.0000207398.10466.0d; Briand N, 2009, AIDS, V23, P1235, DOI 10.1097/QAD.0b013e32832be0df; Castetbon K, 1999, J TROP PEDIATRICS, V45, P152, DOI 10.1093/tropej/45.3.152; Clerici M, 2000, BLOOD, V96, P3866, DOI 10.1182/blood.V96.12.3866.h8003866_3866_3871; Dreyfuss ML, 2001, AM J CLIN NUTR, V74, P814; Ebrahim GJ, 1996, J TROP PEDIATRICS, V42, P62, DOI 10.1093/tropej/42.2.62; Ekouevi DK, 2008, AIDS, V22, P1815, DOI 10.1097/QAD.0b013e32830b8ab9; Faye A, 2007, CLIN EXP IMMUNOL, V149, P430, DOI 10.1111/j.1365-2249.2007.03411.x; Filteau S, 2009, TROP MED INT HEALTH, V14, P276, DOI 10.1111/j.1365-3156.2009.02220.x; Floridia M, 2008, HIV CLIN TRIALS, V9, P287, DOI 10.1310/hct0905-287; Isanaka S, 2009, NUTR REV, V67, P343, DOI 10.1111/j.1753-4887.2009.00207.x; Kalanda B. F., 2005, Archives of Disease in Childhood Fetal and Neonatal Edition, V90, pF161, DOI 10.1136/adc.2004.054650; Kfutwah A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008114; Kourtis AP, 2001, JAMA-J AM MED ASSOC, V285, P709, DOI 10.1001/jama.285.6.709; Lee PA, 2003, PEDIATRICS, V111, P1253, DOI 10.1542/peds.111.6.1253; Lepage P, 1996, PEDIATR INFECT DIS J, V15, P479, DOI 10.1097/00006454-199606000-00003; Makasa M, 2007, TROP MED INT HEALTH, V12, P594, DOI 10.1111/j.1365-3156.2007.01836.x; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; McGrath CJ, 2012, J NUTR, V142, P757, DOI 10.3945/jn.111.148874; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Moye J, 1996, J PEDIATR-US, V128, P58, DOI 10.1016/S0022-3476(96)70428-6; Mwanyumba F, 2001, J Obstet Gynaecol, V21, P27, DOI 10.1080/01443610020022078; Naniche D, 2009, AM J TROP MED HYG, V80, P870, DOI 10.4269/ajtmh.2009.80.870; Ndirangu J, 2012, HUM REPROD, V27, P1846, DOI 10.1093/humrep/des090; Newell ML, 2003, JAIDS-J ACQ IMM DEF, V32, P380, DOI 10.1097/00126334-200304010-00006; Rollins NC, 2007, JAIDS-J ACQ IMM DEF, V44, P321, DOI 10.1097/QAI.0b013e31802ea4b0; RYDER RW, 1989, NEW ENGL J MED, V320, P1637, DOI 10.1056/NEJM198906223202501; Sombie I, 1999, Sante, V9, P173; Stengel B, 1995, EPIDEMIOLOGIE PRINCI; Stratton P, 1999, J ACQ IMMUN DEF SYND, V20, P179, DOI 10.1097/00042560-199902010-00011; Tejiokem MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021840; Townsend CL, 2007, AIDS, V21, P1019, DOI 10.1097/QAD.0b013e328133884b; Venkatesh KK, 2010, TROP MED INT HEALTH, V15, P1364, DOI 10.1111/j.1365-3156.2010.02634.x; Verhoeff FH, 2001, EUR J CLIN NUTR, V55, P682, DOI 10.1038/sj.ejcn.1601200; Watson-Jones D, 2007, B WORLD HEALTH ORGAN, V85, P9, DOI 10.2471/BLT.06.033258; Wei RL, 2004, PEDIATR INFECT DIS J, V23, P530, DOI 10.1097/01.inf.0000129691.42964.eb; WHO, 2006, MED ANT TRAIT FEMM E	40	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93554	10.1371/journal.pone.0093554	http://dx.doi.org/10.1371/journal.pone.0093554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24705410	Green Submitted, gold, Green Published			2022-12-27	WOS:000334105000067
J	Audouze, K; Tromelin, A; Le Bon, AM; Belloir, C; Petersen, RK; Kristiansen, K; Brunak, S; Taboureau, O				Audouze, Karine; Tromelin, Anne; Le Bon, Anne Marie; Belloir, Christine; Petersen, Rasmus Koefoed; Kristiansen, Karsten; Brunak, Soren; Taboureau, Olivier			Identification of Odorant-Receptor Interactions by Global Mapping of the Human Odorome	PLOS ONE			English	Article							FUNCTIONAL EXPRESSION; OLFACTORY RECEPTORS; MOLECULAR-BASIS; NETWORK; SMELL; DATABASE; BIOLOGY; REPERTOIRE; MODULATION; LIGANDS	The human olfactory system recognizes a broad spectrum of odorants using approximately 400 different olfactory receptors ( hORs). Although significant improvements of heterologous expression systems used to study interactions between ORs and odorant molecules have been made, screening the olfactory repertoire of hORs remains a tremendous challenge. We therefore developed a chemical systems level approach based on protein-protein association network to investigate novel hOR-odorant relationships. Using this new approach, we proposed and validated new bioactivities for odorant molecules and OR2W1, OR51E1 and OR5P3. As it remains largely unknown how human perception of odorants influence or prevent diseases, we also developed an odorant-protein matrix to explore global relationships between chemicals, biological targets and disease susceptibilities. We successfully experimentally demonstrated interactions between odorants and the cannabinoid receptor 1 (CB1) and the peroxisome proliferator-activated receptor gamma ( PPAR gamma). Overall, these results illustrate the potential of integrative systems chemical biology to explore the impact of odorant molecules on human health, i.e. human odorome.	[Audouze, Karine; Brunak, Soren; Taboureau, Olivier] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Tromelin, Anne; Le Bon, Anne Marie; Belloir, Christine] Univ Bourgogne, INRA UMR1324, CNRS UMR6265, Ctr Sci Gout & Alimentat, Dijon, France; [Petersen, Rasmus Koefoed; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Taboureau, Olivier] Paris Diderot Univ, INSERM, UMR S973, Paris, France	Technical University of Denmark; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; University of Copenhagen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Taboureau, O (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark.	otab@cbs.dtu.dk	Kristiansen, Karsten/J-5148-2014; Audouze, Karine/AAU-5996-2020; Tromelin, Anne/A-2722-2009; Brunak, Soren/O-6621-2016	Kristiansen, Karsten/0000-0002-6024-0917; Audouze, Karine/0000-0001-7525-4089; Tromelin, Anne/0000-0002-3322-951X; Brunak, Soren/0000-0003-0316-5866	GENDINOB project; Danish Council for Strategic Research; Innovative Medicines Initiative Joint Undertaking (IMI-JU) [115002]	GENDINOB project; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Innovative Medicines Initiative Joint Undertaking (IMI-JU)	The work was supported by the GENDINOB project granted by the Danish Council for Strategic Research and the Innovative Medicines Initiative Joint Undertaking (IMI-JU) for the eTOX project (115002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adipietro KA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002821; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Araneda RC, 2004, J PHYSIOL-LONDON, V555, P743, DOI 10.1113/jphysiol.2003.058040; Arctander S., 1969, PERFUME FLAVOR CHEM, VI; Audouze K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000788; Baba T, 2011, MOVEMENT DISORD, V26, P621, DOI 10.1002/mds.23602; Bachtiar LR, 2013, NEURAL COMPUT, V25, P259, DOI 10.1162/NECO_a_00386; Baraldi PG, 2010, J MED CHEM, V53, P5085, DOI 10.1021/jm100062h; Bassaganya-Riera J, 2010, CURR OPIN CLIN NUTR, V13, P569, DOI 10.1097/MCO.0b013e32833b648e; Bellocchio L, 2006, CURR OPIN PHARMACOL, V6, P586, DOI 10.1016/j.coph.2006.09.001; Benbernou N, 2007, J HERED, V98, P500, DOI 10.1093/jhered/esm054; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Binkowski BF, 2011, METHODS MOL BIOL, V756, P263, DOI 10.1007/978-1-61779-160-4_14; Bonferroni CE, 1935, STUDI ONORE PROFESSO, P13; Boyle SM, 2013, ELIFE, V2, DOI 10.7554/eLife.01120; Breunig E, 2010, RESULTS PROBL CELL D, V52, P139, DOI 10.1007/978-3-642-14426-4_11; Brown RD, 1996, J CHEM INF COMP SCI, V36, P572, DOI 10.1021/ci9501047; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412; Cases M, 2009, DRUG DISCOV TODAY, V14, P479, DOI 10.1016/j.drudis.2009.02.010; Castro JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073289; Christensen KB, 2010, PHYTOTHER RES, V24, pS129, DOI 10.1002/ptr.3005; Cravatt BF, 2003, CURR OPIN CHEM BIOL, V7, P469, DOI 10.1016/S1367-5931(03)00079-6; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Deeb J, 2010, QJM-INT J MED, V103, P941, DOI 10.1093/qjmed/hcq142; DeMaria S, 2010, J CELL BIOL, V191, P443, DOI 10.1083/jcb.201008163; Du HZ, 2011, BRIT J PHARMACOL, V163, P1533, DOI 10.1111/j.1476-5381.2011.01444.x; Furudono Y, 2009, CHEM SENSES, V34, P151, DOI 10.1093/chemse/bjn071; Gautam H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044781; Goldsmith BR, 2011, ACS NANO, V5, P5408, DOI 10.1021/nn200489j; Golebiowski J, 2012, FLAVOUR FRAG J, V27, P445, DOI 10.1002/ffj.3121; Grandjean P, 2011, ENV HLTH, V10; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Jacquier V, 2006, J NEUROCHEM, V97, P537, DOI 10.1111/j.1471-4159.2006.03771.x; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kessler A, 2012, FLAVOUR FRAG J, V27, P297, DOI 10.1002/ffj.3099; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Kjaerulff SK, 2013, NUCLEIC ACIDS RES, V41, pD464, DOI 10.1093/nar/gks1166; Kraft P, 2000, ANGEW CHEM INT EDIT, V39, P2981; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lage K, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.36; Launay G, 2012, PROTEIN ENG DES SEL, V25, P377, DOI 10.1093/protein/gzs037; Liu XY, 2011, BIOINFORMATICS, V27, P2302, DOI 10.1093/bioinformatics/btr385; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Martinez-Mayorga K, 2011, J CHEMOMETR, V25, P550, DOI 10.1002/cem.1399; Matsui A, 2010, MOL BIOL EVOL, V27, P1192, DOI 10.1093/molbev/msq003; Mori K, 2003, BIOCHEM SOC T, V31, P134, DOI 10.1042/bst0310134; Nara K, 2011, J NEUROSCI, V31, P9179, DOI 10.1523/JNEUROSCI.1282-11.2011; Neuhaus W, 2008, PLANTA MED, V74, P1338, DOI 10.1055/s-2008-1081343; O'Donovan C, 2011, METHODS MOL BIOL, V694, P25, DOI 10.1007/978-1-60761-977-2_2; Oprea TI, 2007, NAT CHEM BIOL, V3, P447, DOI 10.1038/nchembio0807-447; Ortega-Hernandez OD, 2009, AUTOIMMUNITY, V42, P80, DOI 10.1080/08916930802366140; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Passali GC, 2008, CURR OPIN ALLERGY CL, V8, P238, DOI 10.1097/ACI.0b013e3282ffd6bb; Penkett CJ, 2006, NUCLEIC ACIDS RES, V34, pW330, DOI 10.1093/nar/gkl311; Pick H, 2009, J BIOL CHEM, V284, P30547, DOI 10.1074/jbc.M109.040964; Ruijschop RMAJ, 2010, CHEM SENSES, V35, P91, DOI 10.1093/chemse/bjp086; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sanz G, 2008, CHEM SENSES, V33, P639, DOI 10.1093/chemse/bjn032; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; SCHIFFMAN SS, 1974, ANN NY ACAD SCI, V237, P164, DOI 10.1111/j.1749-6632.1974.tb49852.x; Schiniedeberg K, 2007, J STRUCT BIOL, V159, P400, DOI 10.1016/j.jsb.2007.04.013; Schmuker M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-11; Skoufos E, 2000, NUCLEIC ACIDS RES, V28, P341, DOI 10.1093/nar/28.1.341; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stary A, 2007, BIOCHEM BIOPH RES CO, V361, P941, DOI 10.1016/j.bbrc.2007.07.137; Stevenson RJ, 2003, PSYCHOL REV, V110, P340, DOI 10.1037/0033-295X.110.2.340; Stevenson RJ, 2005, PSYCHON B REV, V12, P244, DOI 10.3758/BF03196369; Stevenson RJ, 2001, Q J EXP PSYCHOL-A, V54, P561, DOI 10.1080/02724980042000246; Taboureau O, 2011, NUCLEIC ACIDS RES, V39, pD367, DOI 10.1093/nar/gkq906; Vandevoorde S, 2003, J MED CHEM, V46, P4373, DOI 10.1021/jm0340795; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Zarzo M, 2007, BIOL REV, V82, P455, DOI 10.1111/j.1469-185X.2007.00019.x; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200	80	32	32	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93037	10.1371/journal.pone.0093037	http://dx.doi.org/10.1371/journal.pone.0093037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695519	gold, Green Published			2022-12-27	WOS:000334103000035
J	Shi, Y; Luo, LF; Liu, XM; Zhou, Q; Xu, SZ; Lei, TC				Shi, Ying; Luo, Long-Fei; Liu, Xiao-Ming; Zhou, Qiong; Xu, Shi-Zheng; Lei, Tie-Chi			Premature Graying as a Consequence of Compromised Antioxidant Activity in Hair Bulb Melanocytes and Their Precursors	PLOS ONE			English	Article							STEM-CELLS; FOLLICLE PIGMENTATION; NICHE; SKIN; MELANOGENESIS; TRANSPLANTATION; KERATINOCYTES; EXPRESSION; GROWTH; REGION	Intricate coordinated mechanisms that govern the synchrony of hair growth and melanin synthesis remain largely unclear. These two events can be uncoupled in prematurely gray hair, probably due to oxidative insults that lead to the death of oxidative stress-sensitive melanocytes. In this study, we examined the gene expression profiles of middle (bulge) and lower (hair bulb) segments that had been micro-dissected from unpigmented and from normally pigmented hair follicles from the same donors using quantitative real-time RT-PCR (qPCR) arrays. We found a significant down-regulation of melanogenesis-related genes (TYR, TYRP1, MITF, PAX3, POMC) in unpigmented hair bulbs and of marker genes typical for melanocyte precursor cells (PAX3, SOX10, DCT) in unpigmented mid-segments compared with their pigmented analogues. qPCR, western blotting and spin trapping assays revealed that catalase protein expression and hydroxyl radical scavenging activities are strongly repressed in unpigmented hair follicles. These data provide the first clear evidence that compromised antioxidant activity in gray hair follicles simultaneously affects mature hair bulb melanocytes and their immature precursor cells in the bulge region.	[Shi, Ying; Luo, Long-Fei; Liu, Xiao-Ming; Zhou, Qiong; Xu, Shi-Zheng; Lei, Tie-Chi] Wuhan Univ, Renmin Hosp, Dept Dermatol, Wuhan 430072, Hubei Province, Peoples R China	Wuhan University	Lei, TC (corresponding author), Wuhan Univ, Renmin Hosp, Dept Dermatol, Wuhan 430072, Hubei Province, Peoples R China.	tchlei@whu.edu.cn	LEI, TIE-CHI/AAE-4276-2020	Lei, Tie-Chi/0000-0003-2304-827X	National Natural Science Foundation of China [8107138]; CMA-L'Oreal China Hair Grant [H2010040414]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CMA-L'Oreal China Hair Grant	This work was supported by grants from the National Natural Science Foundation of China (No. 8107138) and a CMA-L'Oreal China Hair Grant (No. H2010040414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arck PC, 2006, FASEB J, V20, P1567, DOI 10.1096/fj.05-4039fje; Chang CY, 2013, NATURE, V495, P98, DOI 10.1038/nature11847; Choi HI, 2011, BRIT J DERMATOL, V165, P1183, DOI 10.1111/j.1365-2133.2011.10625.x; Commo S, 2004, BRIT J DERMATOL, V150, P435, DOI 10.1046/j.1365-2133.2004.05787.x; Erdogan T, 2013, INTERNAL MED, V52, P29, DOI 10.2169/internalmedicine.52.7842; Gho CG, 2010, J DERMATOL TREAT, V21, P337, DOI 10.3109/09546630903359814; Harris ML, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003644; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jiang S, 2010, FREE RADICAL BIO MED, V48, P1144, DOI 10.1016/j.freeradbiomed.2010.01.033; Kauser S, 2011, J INVEST DERMATOL, V131, P979, DOI 10.1038/jid.2010.397; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Liu XM, 2011, FREE RADICAL BIO MED, V50, P1177, DOI 10.1016/j.freeradbiomed.2011.01.017; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Nishimura EK, 2011, PIGM CELL MELANOMA R, V24, P401, DOI 10.1111/j.1755-148X.2011.00855.x; Onda M, 2008, DERMATOL SURG, V34, P1683, DOI 10.1111/j.1524-4725.2008.34346.x; Panhard S, 2012, BRIT J DERMATOL, V167, P865, DOI 10.1111/j.1365-2133.2012.11095.x; PLONKA P, 1995, ARCH DERMATOL RES, V287, P687, DOI 10.1007/BF00371744; Plonka PM, 2009, EXP DERMATOL, V18, P472, DOI 10.1111/j.1600-0625.2009.00883.x; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; SLOMINSKI A, 1994, J INVEST DERMATOL, V102, P862, DOI 10.1111/1523-1747.ep12382606; SLOMINSKI A, 1991, J INVEST DERMATOL, V96, P172, DOI 10.1111/1523-1747.ep12460956; Sviderskaya EV, 2009, FASEB J, V23, P3179, DOI 10.1096/fj.08-123596; Tobin D. J., 2008, International Journal of Cosmetic Science, V30, P233, DOI 10.1111/j.1468-2494.2008.00456.x; Tobin DJ, 2011, PIGM CELL MELANOMA R, V24, P75, DOI 10.1111/j.1755-148X.2010.00803.x; Tobin Desmond J, 2009, Int J Trichology, V1, P83, DOI 10.4103/0974-7753.58550; Wang X, 2012, J HUAZHONG U SCI-MED, V32, P648, DOI 10.1007/s11596-012-1012-8; Waseem A, 1999, J INVEST DERMATOL, V112, P362, DOI 10.1046/j.1523-1747.1999.00535.x; Wood JM, 2009, FASEB J, V23, P2065, DOI 10.1096/fj.08-125435; Yu H, 2010, J INVEST DERMATOL, V130, P1227, DOI 10.1038/jid.2009.322	33	26	27	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93589	10.1371/journal.pone.0093589	http://dx.doi.org/10.1371/journal.pone.0093589			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695442	Green Submitted, Green Published, gold			2022-12-27	WOS:000334103000091
J	Hung, SK; Lee, MS; Chiou, WY; Lee, CC; Chen, YC; Lai, CL; Chien, NC; Hsu, WL; Liu, DW; Su, YC; Li, SC; Lai, HC; Tsai, SJ; Hsu, FC; Lin, HY				Hung, Shih-Kai; Lee, Moon-Sing; Chiou, Wen-Yen; Lee, Ching-Chih; Chen, Yi-Chun; Lai, Chun-Liang; Chien, Nai-Chuan; Hsu, Wen-Lin; Liu, Dai-Wei; Su, Yu-Chieh; Li, Szu-Chi; Lai, Hung-Chih; Tsai, Shiang-Jiun; Hsu, Feng-Chun; Lin, Hon-Yi			High Incidence of Ischemic Stroke Occurrence in Irradiated Lung Cancer Patients: A Population-Based Surgical Cohort Study	PLOS ONE			English	Article							INCREASED RISK; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; VASCULAR DAMAGE; FOLLOW-UP; RADIOTHERAPY; PREVALENCE; CARCINOMA; SURVIVORS; MORTALITY	Background and Purpose: A high risk of stroke occurrence has been reported in several types of irradiated cancer patients. However, clinical data are lacking in irradiated lung cancer patients. The present study intended to explore a risk level of ischemic stroke occurrence in irradiated lung cancer patients. Methods: A nationwide population-based database obtained from the Taiwan National Health Insurance was analyzed. Between 2003 and 2006, we recruited 560 resected lung cancer patients into two study groups: surgery-plus-irradiation (n = 112) and surgery-alone (n = 448). Patients treated with chemotherapy were excluded. Propensity score match was used for pairing cases with a ratio of 1:4. Two-year ischemic-stroke-free survival was defined as the primary endpoint. Results: Three observations supported a high risk of ischemic stroke occurrence in patients with postoperative irradiation when compared with those patients with surgery alone: first, a high incidence per 1,000 person-year (22.3 versus 11.2, 1.99 folds); second, a low two-year ischemic-stroke-free survival rate (92.2% versus 98.1%, P = 0.019); and third, a high adjusted hazard ratio (HR, 4.19; 95% CI, 1.44-12.22; P = 0.009). More notably, the highest risk of ischemic stroke occurrence was found in irradiated patients who had diabetes mellitus (HR, 34.74; 95% CI,6.35-> 100; P < 0.0001). Conclusions: A high incidence of ischemic stroke was observed in irradiated lung cancer patients, especially in those with diabetes mellitus. For these patients, close clinical surveillance and strict diabetes control should be considered. Further studies to define detail biological mechanisms are encouraged.	[Hung, Shih-Kai; Lee, Moon-Sing; Chiou, Wen-Yen; Tsai, Shiang-Jiun; Hsu, Feng-Chun; Lin, Hon-Yi] Buddhist Dalin Tzu Chi Hosp, Radiat Dept, Dept Oncol, Dalin, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Hosp, Dept Otolaryngol, Dalin, Taiwan; [Chen, Yi-Chun] Buddhist Dalin Tzu Chi Hosp, Div Nephrol, Dalin, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Hosp, Div Chest Med, Dalin, Taiwan; [Chien, Nai-Chuan] Buddhist Dalin Tzu Chi Hosp, Div Thorac Surg, Dalin, Taiwan; [Su, Yu-Chieh; Li, Szu-Chi; Lai, Hung-Chih] Buddhist Dalin Tzu Chi Hosp, Div Hematol Oncol, Dalin, Taiwan; [Hsu, Wen-Lin; Liu, Dai-Wei] Buddhist Dalin Tzu Chi Hosp, Dept Radiat Oncol, Hualien, Taiwan; [Hung, Shih-Kai; Lee, Moon-Sing; Chiou, Wen-Yen; Lee, Ching-Chih; Chen, Yi-Chun; Lai, Chun-Liang; Chien, Nai-Chuan; Hsu, Wen-Lin; Liu, Dai-Wei; Su, Yu-Chieh; Li, Szu-Chi; Lai, Hung-Chih; Lin, Hon-Yi] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lin, Hon-Yi] Natl Chung Cheng Univ, Inst Mol Biol, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Buddhist Tzu Chi General Hospital; Buddhist Tzu Chi General Hospital; Buddhist Tzu Chi General Hospital; Buddhist Tzu Chi General Hospital; Buddhist Tzu Chi General Hospital; Buddhist Tzu Chi General Hospital; Tzu Chi University; National Chung Cheng University	Lin, HY (corresponding author), Buddhist Dalin Tzu Chi Hosp, Radiat Dept, Dept Oncol, Dalin, Taiwan.	doc16021@gmail.com	Chen, Yi-Chun/GYJ-2065-2022	Hung, Shih-Kai/0000-0002-4945-528X; Su, Yu-Chieh/0000-0002-1771-9017; Chiou, Wen-Yen/0000-0002-5541-6834	Buddhist Dalin Tzu Chi Hospital [DTCRD-99-I-12, DTCRD-100(2)-I-14]	Buddhist Dalin Tzu Chi Hospital	This study is supported by research grants of Buddhist Dalin Tzu Chi Hospital: DTCRD-99-I-12 and DTCRD-100(2)-I-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agur AMR, 2009, GRANTS ATLAS ANATOMY, Vxvi; Chen PC, 2011, STROKE, V42, P3034, DOI 10.1161/STROKEAHA.111.615534; Chien KL, 2010, STROKE, V41, P1858, DOI 10.1161/STROKEAHA.110.586222; Cui RZ, 2011, STROKE, V42, P2611, DOI 10.1161/STROKEAHA.111.614313; De Bruin ML, 2009, JNCI-J NATL CANCER I, V101, P928, DOI 10.1093/jnci/djp147; Dorresteijn LD, 2006, J CLIN ONCOL, V24, P1480, DOI 10.1200/JCO.2005.04.8538; Dorresteijn LDA, 2005, EUR J CANCER, V41, P1026, DOI 10.1016/j.ejca.2005.01.020; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; Fatehi-Hassanabad Z, 2010, EUR J PHARMACOL, V636, P8, DOI 10.1016/j.ejphar.2010.03.048; Granone P, 2000, EUR J CARDIO-THORAC, V18, P418, DOI 10.1016/S1010-7940(00)00539-X; Greene FL, 2006, AJCC CANC STAGING AT, Vix; Hall EJ., 2012, RADIOBIOLOGY RADIOLO, V7th; Halle M, 2011, J INTERN MED, V269, P469, DOI 10.1111/j.1365-2796.2011.02353.x; Huang YS, 2011, ORAL ONCOL, V47, P1092, DOI 10.1016/j.oraloncology.2011.07.024; Institutes TNHR, 2014, TAIW CANC CTR ACCR; Katz MH, 2010, EVALUATING CLIN PUBL; Lee CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050163; Lee CC, 2011, INT J RADIAT ONCOL, V81, pE833, DOI 10.1016/j.ijrobp.2010.11.036; Lee EJ, 2013, INT J STROKE; Levitt SH, 2003, INT J RADIAT ONCOL, V55, P645, DOI 10.1016/S0360-3016(02)04076-2; Lin HC, 2007, J URBAN HEALTH, V84, P604, DOI 10.1007/s11524-007-9195-1; Lin HW, 2011, LANCET ONCOL, V12, P900, DOI 10.1016/S1470-2045(11)70165-6; Maruyama K, 2005, NEW ENGL J MED, V352, P146, DOI 10.1056/NEJMoa040907; Moore KL, 2011, ESSENTIAL CLIN ANATO, Vxxviii; Moser EC, 2006, BLOOD, V107, P2912, DOI 10.1182/blood-2005-08-3392; Mueller S, 2013, INT J RADIAT ONCOL, V86, P649, DOI 10.1016/j.ijrobp.2013.03.034; Mueller S, 2013, INT J RADIAT ONCOL, V86, P643, DOI 10.1016/j.ijrobp.2013.03.004; Muhammad S, 2009, J ALZHEIMERS DIS, V16, P775, DOI 10.3233/JAD-2009-0982; National Comprehensive Cancer Network (NCCN), 2013, CLIN PRACT GUID ONC; Numico G, 2005, CANCER, V103, P994, DOI 10.1002/cncr.20893; Owonikoko TK, 2013, ONCOLOGIST; Phillips TL, 2010, LEIBEL PHILLIPS TXB; Rami-Porta R, 2009, ANN THORAC CARDIOVAS, V15, P4; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Romzova M, 2006, HUM IMMUNOL, V67, P706, DOI 10.1016/j.humimm.2006.05.006; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Schwartz F, 2009, J RURAL HEALTH, V25, P226, DOI 10.1111/j.1748-0361.2009.00222.x; Stang P, 2000, CHEST, V117, p354S, DOI 10.1378/chest.117.5_suppl_2.354S; Stewart FA, 2010, RADIAT RES, V174, P865, DOI 10.1667/RR1862.1; Steyerberg EW, 2019, CLIN PREDICTION MODE, V2nd, DOI 10.1007/978-0-387-77244-8; Stokes EL, 2011, INT J RADIAT ONCOL, V80, P403, DOI 10.1016/j.ijrobp.2010.02.041; Trodella L, 2002, RADIOTHER ONCOL, V62, P11, DOI 10.1016/S0167-8140(01)00478-9; Tsai SJ, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-41; Tsan YT, 2013, J CLIN ONCOL, V31, P1514, DOI 10.1200/JCO.2012.44.6831; VanderWeele TJ, 2013, EUR J EPIDEMIOL, V28, P113, DOI 10.1007/s10654-013-9770-6; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Walkey AJ, 2011, JAMA-J AM MED ASSOC, V306, P2248, DOI 10.1001/jama.2011.1615; Zoller B, 2012, EUR J CANCER, V48, P1875, DOI 10.1016/j.ejca.2012.01.005	49	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94377	10.1371/journal.pone.0094377	http://dx.doi.org/10.1371/journal.pone.0094377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709837	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800140
J	Pan, N; Lv, XW; Liang, R; Wang, LM; Liu, QL				Pan, Ning; Lv, Xiangwei; Liang, Rui; Wang, Liming; Liu, Qinlong			Suppression of Graft Regeneration, Not Ischemia/Reperfusion Injury, Is the Primary Cause of Small-for-Size Syndrome after Partial Liver Transplantation in Mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ADULT LIVING DONOR; N-TERMINAL-KINASE; HEPATIC ISCHEMIA; CYCLIN D1; MOUSE; EXPRESSION; PROLIFERATION; PROGRESSION; MECHANISMS	Background: Ischemia/reperfusion injury (IRI) is commonly considered to play a crucial role in the pathogenesis of small-for-size syndrome (SFSS) after liver transplantation. Rapid regeneration is also considered essential for the survival of SFS grafts. Methods: Mouse models of full-size orthotopic liver transplantation, 50% partial liver transplantation and 30% partial liver transplantation were established. Survival rate and serum alanine aminotransferase were observed. IRI was assessed by hepatic pathologic alterations, apoptosis and necrosis. Regeneration response was detected by mitotic index, BrdU incorporation and PCNA, Cyclin D1 and Cyclin E expression. The expression of mTOR, AKT, ERK, JNK2 and p70S6K, also involved in regeneration signaling pathways, were analyzed as well. Results: 30% partial liver graft resulted in a significantly low 7-day survival rate (P = 0.002) with no marked difference in tissue injury compared with the 50% partial graft group. Serum alanine aminotransferase levels were not significantly different between partial transplantation and full-size transplantation. Western blot analysis of caspase-3 and TUNEL staining also indicated no significant difference in apoptosis response between 30% partial transplantation and half-size or full-size transplantation (P = 0.436, P = 0.113, respectively). However, liver regeneration response indicators, mitotic index (P, 0.0001) and BrdU (P = 0.0022), were markedly lower in 30% LTx compared with 50% LTx. Suppressed expression of PCNA, cyclin D1, cyclin E, mTOR, JNK2, AKT, ERK and p70S6K was also detected by western blot. Conclusions: Liver regeneration is markedly suppressed in SFSS, and is more likely the primary cause of SFSS, rather than ischemia/reperfusion injury. Therapy for recovering graft regeneration could be a potentially important strategy to reduce the incidence of SFSS.	[Lv, Xiangwei; Liang, Rui; Wang, Liming; Liu, Qinlong] Dalian Med Univ, Affiliated Hosp 2, Dept Gen Surg, Dalian, Liaoning Provin, Peoples R China; [Pan, Ning] Dalian Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Dalian, Liaoning Provin, Peoples R China	Dalian Medical University; Dalian Medical University	Liu, QL (corresponding author), Dalian Med Univ, Affiliated Hosp 2, Dept Gen Surg, Dalian, Liaoning Provin, Peoples R China.	qinlongliu@163.com			National Natural Science Foundation of China [81272368]; Supporting Plan for Talents in Colleges and Universities of Liaoning Province; Department of Education of Liaoning Province [LJQ2013099]; Industry and Technology Bureau of Dalian [2013J21DW022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Supporting Plan for Talents in Colleges and Universities of Liaoning Province; Department of Education of Liaoning Province; Industry and Technology Bureau of Dalian	National Natural Science Foundation of China(81272368). Supporting Plan for Talents in Colleges and Universities of Liaoning Province. Department of Education of Liaoning ProvinceNumber: LJQ2013099 Mechanisms of Mitochondrial Regeneration for Hepatic Regeneration after Small-for-size transplantation and Partial Hepatectomy. Industry and Technology Bureau of Dalian Number: 2013J21DW022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buitrago-Molina LE, 2009, HEPATOLOGY, V50, P500, DOI 10.1002/hep.23014; Cheng YF, 2009, AM J TRANSPLANT, V9, P1382, DOI 10.1111/j.1600-6143.2009.02626.x; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Cursio R, 1999, FASEB J, V13, P253, DOI 10.1096/fasebj.13.2.253; Dahm F, 2005, AM J TRANSPLANT, V5, P2605, DOI 10.1111/j.1600-6143.2005.01081.x; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2012, J HEPATOL, V57, P692, DOI 10.1016/j.jhep.2012.04.016; Fernandez L, 2003, TRANSPLANTATION, V76, P282, DOI 10.1097/01.TP.0000067529.82245.4E; Fu QX, 2013, APOPTOSIS, V18, P998, DOI 10.1007/s10495-013-0849-z; Fu WY, 2013, HEPATOL RES, V43, P300, DOI 10.1111/j.1872-034X.2012.01071.x; Furukawa H, 1999, TRANSPLANT P, V31, P1952, DOI 10.1016/S0041-1345(99)00225-0; Guo JY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-79; Hong FF, 2012, J SURG RES, V178, P1015, DOI 10.1016/j.jss.2012.07.061; Humar A, 2004, LIVER TRANSPLANT, V10, P374, DOI 10.1002/lt.20096; KAWASAKI S, 1992, LANCET, V339, P580, DOI 10.1016/0140-6736(92)90867-3; Kiuchi T, 1999, TRANSPLANTATION, V67, P321, DOI 10.1097/00007890-199901270-00024; Kiuchi T, 2003, LIVER TRANSPLANT, V9, pS29, DOI 10.1053/jlts.2003.50198; Zuluaga GLL, 2013, TRANSPL P, V45, P25, DOI 10.1016/j.transproceed.2012.02.031; Liu HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065644; Liu Q, 2012, AM J TRANSPLANT, V12, P2052, DOI 10.1111/j.1600-6143.2012.04069.x; Liu Q, 2012, HPBSURGERY, V2012, P1; Lu CH, 2012, CLIN TRANSPLANT, V26, pE143, DOI 10.1111/j.1399-0012.2012.01621.x; Man K, 2001, ARCH SURG-CHICAGO, V136, P280, DOI 10.1001/archsurg.136.3.280; Mangnall D, 2003, LIVER INT, V23, P124, DOI 10.1034/j.1600-0676.2003.00812.x; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Nelsen CJ, 2001, CANCER RES, V61, P8564; Nevzorova YA, 2009, GASTROENTEROLOGY, V137, P691, DOI 10.1053/j.gastro.2009.05.003; Oka K, 2013, BIOCHEM BIOPH RES CO, V435, P120, DOI 10.1016/j.bbrc.2013.04.052; Rehman H, 2011, TRANSPLANTATION, V91, P406, DOI 10.1097/TP.0b013e318204bdb2; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Selzner M, 1999, HEPATOLOGY, V30, P469, DOI 10.1002/hep.510300215; STRASBERG SM, 1994, HEPATOLOGY, V20, P829, DOI 10.1002/hep.1840200410; Suzuki S, 2008, CURR OPIN ORGAN TRAN, V13, P142, DOI 10.1097/MOT.0b013e3282f6a164; Taki-Eldin A, 2012, EUR SURG RES, V48, P139, DOI 10.1159/000337865; Teoh NC, 2003, J GASTROEN HEPATOL, V18, P891, DOI 10.1046/j.1440-1746.2003.03056.x; Theruvath TP, 2008, AM J TRANSPLANT, V8, P1819, DOI 10.1111/j.1600-6143.2008.02336.x; Tian YH, 2006, P NATL ACAD SCI USA, V103, P4598, DOI 10.1073/pnas.0600499103; Tian YH, 2003, LIVER TRANSPLANT, V9, P789, DOI 10.1053/jlts.2003.50170; Tucker ON, 2005, CURR OPIN CRIT CARE, V11, P150, DOI 10.1097/01.ccx.0000157080.11117.45; Yao AH, 2010, J SURG RES, V161, P328, DOI 10.1016/j.jss.2009.02.013; Yao AH, 2007, TRANSPL IMMUNOL, V18, P37, DOI 10.1016/j.trim.2007.02.002; Zhang S, 2013, INT J CLIN EXP PATHO, V6, P870; Zhong Z, 2006, TRANSPLANTATION, V82, P241, DOI 10.1097/01.tp.0000228867.98158.d2	43	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93636	10.1371/journal.pone.0093636	http://dx.doi.org/10.1371/journal.pone.0093636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709852	gold, Green Published			2022-12-27	WOS:000334159800041
J	Voigtsberger, S; Urner, M; Hasler, M; Z'Graggen, BR; Booy, C; Spahn, DR; Beck-Schimmer, B				Voigtsberger, Stefanie; Urner, Martin; Hasler, Melanie; Z'Graggen, Birgit Roth; Booy, Christa; Spahn, Donat R.; Beck-Schimmer, Beatrice			Modulation of Early Inflammatory Response by Different Balanced and Non-Balanced Colloids and Crystalloids in a Rodent Model of Endotoxemia	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; ACUTE KIDNEY INJURY; GELATINASE-ASSOCIATED LIPOCALIN; SEVERE SEPSIS; HYDROXYETHYLSTARCH; MICROCIRCULATION; PATHOPHYSIOLOGY; RESUSCITATION; EXPRESSION; BIOMARKERS	The use of hydroxyethyl starch (HES) in sepsis has been shown to increase mortality and acute kidney injury. However, the knowledge of the exact mechanism by which several fluids, especially starch preparations may impair end-organ function particularly in the kidney, is still missing. The aim of this study was to measure the influence of different crystalloid and colloid fluid compositions on the inflammatory response in the kidney, the liver and the lung using a rodent model of acute endotoxemia. Rats were anesthetized and mechanically ventilated. Lipopolysaccharide (5 mg/kg) was administered intravenously. After one hour crystalloids [lactate- buffered (RLac) or acetate-buffered (RAc)] were infused i.v. (30 ml/kg) in all groups. At 2 hours rats either received different crystalloids (75 ml/kg of RLac or RAc) or colloids (25 ml/kg of HES in saline or HES in RAc or gelatin in saline). Expression of messenger RNA for cytokine-induced neutrophil chemoattractant-1 (CINC-1), monocyte chemotactic protein-1 (MCP-1), necrosis factor a (TNFa) and intercellular adhesion molecule 1 (ICAM-1) was assessed in kidney, liver and lung tissue by real-time PCR after 4 hours. The use of acetate-buffered solutions was associated with a significantly higher expression of CINC-1 and TNFa mRNA in the liver, in the kidney and in the lung. Only marginal effects of gelatin and hydroxyethyl starch on mRNA expression of inflammatory mediators were observed. The study provides evidence that the type of buffering agent of different colloidal and crystalloid solutions might be a crucial factor determining the extent of early end-organ inflammatory response in sepsis.	[Voigtsberger, Stefanie; Urner, Martin; Hasler, Melanie; Spahn, Donat R.; Beck-Schimmer, Beatrice] Univ Zurich Hosp, Inst Anesthesiol, CH-8091 Zurich, Switzerland; [Urner, Martin; Z'Graggen, Birgit Roth; Booy, Christa; Beck-Schimmer, Beatrice] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Urner, Martin; Z'Graggen, Birgit Roth; Booy, Christa; Beck-Schimmer, Beatrice] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Beck-Schimmer, B (corresponding author), Univ Zurich Hosp, Inst Anesthesiol, CH-8091 Zurich, Switzerland.	beatrice.beckschimmer@uzh.ch	Urner, Martin/AAK-5701-2020	Urner, Martin/0000-0003-1133-4885	Swiss National Science Foundation Grant [3200B0-122305]; B. Braun, Melsungen, Germany; University of Zurich	Swiss National Science Foundation Grant(Swiss National Science Foundation (SNSF)); B. Braun, Melsungen, Germany; University of Zurich	This work was supported by the Swiss National Science Foundation Grant Nr. 3200B0-122305 and B. Braun, Melsungen, Germany. The project was supported by the University of Zurich with a grant for "protected research time'' for the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu U, 2012, SHOCK, V37, P205, DOI 10.1097/SHK.0b013e31823ca89c; Bienholz A, 2012, AM J PHYSIOL-RENAL, V303, pF56, DOI 10.1152/ajprenal.00070.2012; BINGEL M, 1987, LANCET, V1, P14; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; DASILVA AMT, 1993, NEW ENGL J MED, V328, P1457, DOI 10.1056/NEJM199305203282005; Davies PG, 2011, CRIT CARE, V15, DOI 10.1186/cc9966; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Doi K, 2009, J CLIN INVEST, V119, P2868, DOI 10.1172/JCI39421; Ernandez T, 2009, KIDNEY INT, V76, P262, DOI 10.1038/ki.2009.142; Ertmer C, 2011, CRIT CARE MED, V39, P783, DOI 10.1097/CCM.0b013e318206d403; Feldkamp T, 2004, AM J PHYSIOL-RENAL, V286, pF749, DOI 10.1152/ajprenal.00276.2003; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Godet G, 2001, LANCET, V358, P581, DOI 10.1016/S0140-6736(01)05719-1; Goldstein SL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-135; Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358; Guidet B, 2010, CRIT CARE, V14, DOI 10.1186/cc9230; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Han M, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-25; Handa O, 2006, J CLIN BIOCHEM NUTR, V38, P51, DOI 10.3164/jcbn.38.51; Hoffmann JN, 2002, ANESTHESIOLOGY, V97, P460, DOI 10.1097/00000542-200208000-00025; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Neveu H, 1996, NEPHROL DIAL TRANSPL, V11, P293, DOI 10.1093/oxfordjournals.ndt.a027256; Rabelink TJ, 2010, NAT REV NEPHROL, V6, P404, DOI 10.1038/nrneph.2010.65; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Schick MA, 2010, INTENS CARE MED, V36, P541, DOI 10.1007/s00134-009-1704-0; Selby NM, 2006, ASAIO J, V52, P62, DOI 10.1097/01.mat.0000189725.93808.58; Simon TP, 2012, CRIT CARE, V16, DOI 10.1186/cc11161; Soni N, 2012, CRIT CARE, V16, DOI 10.1186/cc11155; Thaha M, 2005, Acta Med Indones, V37, P145; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Urbschat A, 2011, BIOMARKERS, V16, pS22, DOI 10.3109/1354750X.2011.587129; VEECH RL, 1988, ADV ENZYME REGUL, V27, P313, DOI 10.1016/0065-2571(88)90024-6; Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5; WATANABE K, 1992, EXP MOL PATHOL, V56, P60, DOI 10.1016/0014-4800(92)90023-5; Wittlinger M, 2010, ANESTH ANALG, V110, P531, DOI 10.1213/ANE.0b013e3181c03c97; [No title captured]	42	12	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93863	10.1371/journal.pone.0093863	http://dx.doi.org/10.1371/journal.pone.0093863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709833	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000334159800060
J	Hermansen, TS; Thomsen, VO; Lillebaek, T; Ravn, P				Hermansen, Thomas Stig; Thomsen, Vibeke Ostergaard; Lillebaek, Troels; Ravn, Pernille			Non-Tuberculous Mycobacteria and the Performance of Interferon Gamma Release Assays in Denmark	PLOS ONE			English	Article							LATENT TUBERCULOSIS INFECTION; AVIUM COMPLEX; ACTIVE TUBERCULOSIS; LUNG-DISEASE; CHANGING EPIDEMIOLOGY; CLINICAL-FEATURES; PULMONARY-DISEASE; BOVIS BCG; DIAGNOSIS; PREVALENCE	Background: The QuantiFERON-TB-Gold Test (QFT) is more specific than the Mantoux skin-test to discriminate between Mycobacterium tuberculosis (MTB) and non-tuberculous mycobacterial (NTM) infections. Here we study the performance of the QFT in patients with NTM disease. Methods: From 2005 to 2011, nationwide patient data on positive NTM cultures (n = 925) were combined with nationwide data on QFT results (n = 16,133), both retrieved from the International Reference Laboratory of Mycobacteriology, Denmark. A total of 112 patients with NTM infections had a QFT performed, 53 patients had definite NTM disease, 10 had possible disease and 49 had NTM colonization. Results: QFT was positive in 8% (4/53) of patients with definite disease, 40% (4/10) with possible disease and 31% (15/49) with colonization. Positivity rate was lowest among patients with definite disease infected with NTM without the RD1 region 4% (2/50). None of the 15 children with MAC lymphadenitis had a positive QFT. Conclusion: This study is one of the largest assessing IGRAs in patients with NTM disease in a TB low-incidence setting. Our study showed that the QFT holds potential to discriminate between NTM and MTB infections. We found no positive IGRA test results among children with NTM not sharing the RD1-region of MTB resulting in a 100% specificity and we suggest that a QFT in a child presenting with cervical lymphadenitis may be helpful in distinguishing NTM from TB lymphadenitis.	[Hermansen, Thomas Stig; Ravn, Pernille] Nordsjaelland Hosp, Dept Thorac Med & Infect Dis, Hillerod, Denmark; [Hermansen, Thomas Stig; Thomsen, Vibeke Ostergaard; Lillebaek, Troels] Statens Serum Inst, Int Reference Lab Mycobacteriol, DK-2300 Copenhagen, Denmark	Statens Serum Institut	Hermansen, TS (corresponding author), Nordsjaelland Hosp, Dept Thorac Med & Infect Dis, Hillerod, Denmark.	thomasstighermansen@hotmail.com	Thomsen, Vibeke Østergaard/H-9370-2013	Thomsen, Vibeke Ostergaard/0000-0002-1653-6294; Lillebaek, Troels/0000-0002-2601-2718	research council of Hillerod Hospital, North Zealand Hospital, Hillerod; Olga Bryde Nielsens Fond, North Zealand Hospital, Hillerod	research council of Hillerod Hospital, North Zealand Hospital, Hillerod; Olga Bryde Nielsens Fond, North Zealand Hospital, Hillerod	This work was supported by a research grant from the research council of Hillerod Hospital, North Zealand Hospital, Hillerod. This work was supported by a research grant from Olga Bryde Nielsens Fond, North Zealand Hospital, Hillerod. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LV, 2008, SCAND J INFECT DIS, V40, P196, DOI 10.1080/00365540701642179; Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; Andrejak C, 2010, AM J RESP CRIT CARE, V181, P514, DOI 10.1164/rccm.200905-0778OC; [Anonymous], EUR RESP J, V35, P619; Billinger ME, 2009, EMERG INFECT DIS, V15, P1562, DOI 10.3201/eid1510.090196; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Detjen AK, 2007, CLIN INFECT DIS, V45, P322, DOI 10.1086/519266; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Falkinham JO, 2002, CLIN CHEST MED, V23, P529, DOI 10.1016/S0272-5231(02)00014-X; Freeman Joshua, 2007, N Z Med J, V120, pU2580; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Hernandez-Garduno E, 2009, INT J TUBERC LUNG D, V13, P1086; Hoffmann M, 2010, EUR INFECT DIS, V4, P23; Hoffmann M, 2010, SWISS MED WKLY, V140, P286, DOI smw-12960; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Kobashi Y, 2009, INT J TUBERC LUNG D, V13, P1422; Kobashi Y, 2006, CLIN INFECT DIS, V43, P1540, DOI 10.1086/509327; Kuznetcova TI, 2012, INT OPHTHALMOL; Lee SK, 2012, SCAND J INFECT DIS, V44, P733, DOI 10.3109/00365548.2012.681695; Leidl L, 2010, EUR RESPIR J, V35, P619, DOI 10.1183/09031936.00045509; Lein AD, 1999, CLIN DIAGN LAB IMMUN, V6, P606, DOI 10.1128/CDLI.6.4.606-609.1999; Ling DI, 2011, PAEDIATR RESPIR REV, V12, P9, DOI 10.1016/j.prrv.2010.09.009; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Park SY, 2009, SCAND J INFECT DIS, V41, P818, DOI 10.3109/00365540903214298; Prevots DR, 2010, AM J RESP CRIT CARE, V182, P970, DOI 10.1164/rccm.201002-0310OC; Ra SW, 2011, INT J TUBERC LUNG D, V15, P635, DOI 10.5588/ijtld.10.0485; Riazi S, 2012, ALLERGY ASTHMA PROC, V33, P217, DOI 10.2500/aap.2012.33.3574; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Siddiqi UR, 2012, TOHOKU J EXP MED, V226, P313, DOI 10.1620/tjem.226.313; Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510; Thomson RM, 2010, EMERG INFECT DIS, V16, P1576, DOI 10.3201/eid1610.091201; Tsai CF, 2011, T ROY SOC TROP MED H, V105, P148, DOI 10.1016/j.trstmh.2010.11.005; van Ingen J, 2012, EMERG INFECT DIS, V18, P653, DOI 10.3201/eid1804.110888; van Ingen J, 2009, J BACTERIOL, V191, P5865, DOI 10.1128/JB.00683-09; van Leeuwen RML, 2007, EUR RESPIR J, V29, P605, DOI 10.1183/09031936.00066506; Vincenti D, 2007, CLIN EXP IMMUNOL, V150, P91, DOI 10.1111/j.1365-2249.2007.03462.x; VONREYN CF, 1993, J CLIN MICROBIOL, V31, P3227, DOI 10.1128/JCM.31.12.3227-3230.1993; Wang JY, 2007, EMERG INFECT DIS, V13, P553, DOI 10.3201/eid1304.051195; Winthrop KL, 2010, AM J RESP CRIT CARE, V182, P977, DOI 10.1164/rccm.201003-0503OC	41	55	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93986	10.1371/journal.pone.0093986	http://dx.doi.org/10.1371/journal.pone.0093986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705675	gold, Green Published			2022-12-27	WOS:000334107500103
J	Mayaphi, SH; Brauer, M; Morobadi, DM; Mazanderani, AH; Mafuyeka, RT; Olorunju, SAS; Tintinger, GR; Stoltz, A				Mayaphi, Simnikiwe H.; Brauer, Marieke; Morobadi, Daniel M.; Mazanderani, Ahmad H.; Mafuyeka, Rendani T.; Olorunju, Steve A. S.; Tintinger, Gregory R.; Stoltz, Anton			Cytomegalovirus Viral Load Kinetics in Patients with HIV/AIDS Admitted to a Medical Intensive Care Unit: A Case for Pre-Emptive Therapy	PLOS ONE			English	Article							TRANSPLANT RECIPIENTS; DISEASE; CMV; RISK; QUANTIFICATION; CORRELATE; VIREMIA; BURDEN; BLOOD; PCR	Background: Cytomegalovirus (CMV) infection is associated with severe diseases in immunosuppressed patients; however, there is a lack of data for pre-emptive therapy in patients with HIV/AIDS. Method: This was a retrospective study, which enrolled patients diagnosed with HIV/AIDS (CD4 < 200 cells/mu l), who had detectable CMV viral load (VL) during their stay in an adult medical intensive care unit between 2009-2012. Results: After screening 82 patients' records, 41 patients met the enrolment criteria. Their median age was 37 (interquartile range [IQR]: 31-46), and median CD4 count was 29 cells/mu l (IQR: 5-55). Sixteen patients (39%) had serial measurements of CMV VL before treatment with ganciclovir. Patients whose baseline CMV VL values were between 1,000-3,000 copies/ml had significantly higher values (median of 14,650 copies/ml) on follow-up testing done 4-12 days later. Those with undetectable VLs at baseline testing had detectable VLs (median of 1,590 copies/ml) mostly within 20 days of follow-up testing. Patients who had VLs > 1,000 copies/ml at baseline testing had significantly higher mortality compared to those who had < 1,000 copies/ml {hazard ratio of 3.46, p=0.003 [95% confidence interval (CI): 1.55-7.71]}. Analysis of the highest CMV VL per patient showed that patients who had VLs of > 5,100 copies/ml and did not receive ganciclovir had 100% mortality compared to 58% mortality in those who received ganciclovir at VLs of > 5,100 copies/ml, 50% mortality in those who were not treated and had low VLs of < 5,100 copies/ml, and 44% mortality in those who had ganciclovir treatment at VLs of < 5,100 copies/ml (p=0.084, 0.046, 0.037, respectively). Conclusion: This study showed a significantly increased mortality in patients with HIV/AIDS who had high CMV VLs, and suggests that a threshold value of 1,000 copies/ml may be appropriate for pre-emptive treatment in this group.	[Mayaphi, Simnikiwe H.; Brauer, Marieke; Morobadi, Daniel M.; Mazanderani, Ahmad H.; Mafuyeka, Rendani T.] Univ Pretoria, Dept Med Virol, NHLS TAD, ZA-0001 Pretoria, South Africa; [Olorunju, Steve A. S.] MRC, Biostat Unit, Pretoria, South Africa; [Tintinger, Gregory R.; Stoltz, Anton] Univ Pretoria, Dept Internal Med, ZA-0002 Pretoria, South Africa	University of Pretoria; University of Pretoria	Mayaphi, SH (corresponding author), Univ Pretoria, Dept Med Virol, NHLS TAD, ZA-0001 Pretoria, South Africa.	sim.mayaphi@up.ac.za		Mayaphi, Simnikiwe/0000-0002-5453-4353; Brauer, Marieke/0000-0001-6759-4921				Atkinson C, 2011, J CLIN VIROL, V51, P219, DOI 10.1016/j.jcv.2011.04.007; Ayoub T, 2008, J ROY SOC MED, V101, P177, DOI 10.1258/jrsm.2008.070479; Barron M. A., 2005, Clinical Microbiology Newsletter, V27, P99, DOI 10.1016/j.clinmicnews.2005.06.001; Bloch EM, 2012, TRANSFUS MED REV, V26, P164, DOI 10.1016/j.tmrv.2011.07.006; Chemaly RF, 2004, J CLIN MICROBIOL, V42, P2168, DOI 10.1128/JCM.42.5.2168-2172.2004; De Keyzer K, 2011, AM J KIDNEY DIS, V58, P118, DOI 10.1053/j.ajkd.2011.04.010; de la Hoz RE, 2002, J CLIN VIROL, V25, pS1, DOI 10.1016/S1386-6532(02)00091-4; Durier N, 2013, CLIN INFECT DIS, V57, P147, DOI 10.1093/cid/cit173; Eid AJ, 2010, AM J TRANSPLANT, V10, P157, DOI 10.1111/j.1600-6143.2009.02861.x; El Amari EB, 2011, HIV MED, V12, P394, DOI 10.1111/j.1468-1293.2010.00900.x; Fielding K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025571; GALLANT JE, 1992, J INFECT DIS, V166, P1223, DOI 10.1093/infdis/166.6.1223; Ganzenmueller T, 2009, J CLIN VIROL, V46, P254, DOI 10.1016/j.jcv.2009.08.008; Griffiths PD, 2012, LANCET INFECT DIS, V12, P790, DOI 10.1016/S1473-3099(12)70197-4; Halfon P, 2011, J MED VIROL, V83, P490, DOI 10.1002/jmv.21996; Henke-Gendo C, 2012, J MED VIROL, V84, P890, DOI 10.1002/jmv.23285; Kirubakaran S. I., 2004, Clinical Microbiology Newsletter, V26, P137, DOI 10.1016/j.clinmicnews.2004.09.001; Laher F, 2012, S AFR J HIV MED, P68; Levitsky J, 2008, CLIN TRANSPLANT, V22, P222, DOI 10.1111/j.1399-0012.2007.00778.x; Li HJ, 2003, J CLIN MICROBIOL, V41, P187, DOI 10.1128/JCM.41.1.187-191.2003; Martin-Gandul C, 2013, J CLIN VIROL, V56, P13, DOI 10.1016/j.jcv.2012.09.017; Metras D, 1999, EUR J CARDIO-THORAC, V15, P490, DOI 10.1016/S1010-7940(99)00059-7; Mizushima D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065348; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Preiser W, 2001, J CLIN VIROL, V20, P59, DOI 10.1016/S1386-6532(00)00156-6; Rasmussen L, 1997, J INFECT DIS, V176, P1146, DOI 10.1086/514106; Robberts FJL, 2007, DIAGN MICR INFEC DIS, V58, P385, DOI 10.1016/j.diagmicrobio.2007.02.014; Ruell J, 2007, BONE MARROW TRANSPL, V40, P55, DOI 10.1038/sj.bmt.1705671; Spector SA, 1996, NEW ENGL J MED, V334, P1491, DOI 10.1056/NEJM199606063342302; Spector SA, 1998, J CLIN INVEST, V101, P497, DOI 10.1172/JCI1101	30	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93702	10.1371/journal.pone.0093702	http://dx.doi.org/10.1371/journal.pone.0093702			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699683	gold, Green Published, Green Submitted			2022-12-27	WOS:000334105000092
J	Shasteen, JR; Sasson, NJ; Pinkham, AE				Shasteen, Jonathon R.; Sasson, Noah J.; Pinkham, Amy E.			Eye Tracking the Face in the Crowd Task: Why Are Angry Faces Found More Quickly?	PLOS ONE			English	Article							VISUAL-SEARCH; FACIAL EXPRESSIONS; ANGER-SUPERIORITY; REAL FACES; MOVEMENTS; PARALLEL; EMOTION	Among a crowd of distractor faces, threatening or angry target faces are identified more quickly and accurately than are nonthreatening or happy target faces, a finding known as the "face in the crowd effect." Two perceptual explanations of the effect have been proposed: (1) the "target orienting" hypothesis (i.e., threatening targets orient attention more quickly than do nonthreatening targets and (2) the "distractor processing" hypothesis (i.e., nonthreatening distractors paired with a threatening target are processed more efficiently than vice versa, leading to quicker detection of threatening targets). Using a task, with real faces and multiple identities, the current study replicated the face in the crowd effect and then, via eye tracking, found greater support for the target orienting hypothesis. Across both the classical search asymmetry paradigm (i.e., one happy target in a crowd of angry distractors vs. one angry target in a crowd of happy distractors) and the constant distractor paradigm (i.e., one happy target in a crowd of neutral distractors vs. one angry target in a crowd of neutral distractors), fewer distractors were fixated before first fixating angry targets relative to happy targets, with no difference in the processing efficiency of distractors. These results suggest that the face in the crowd effect on this task is supported to a greater degree by attentional patterns associated with properties of target rather those of the crowd.	[Shasteen, Jonathon R.; Sasson, Noah J.] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX 75230 USA; [Pinkham, Amy E.] So Methodist Univ, Dept Psychol, Dallas, TX 75275 USA; [Pinkham, Amy E.] Univ Texas Southwestern, Sch Med, Dallas, TX USA	University of Texas System; University of Texas Dallas; Southern Methodist University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sasson, NJ (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX 75230 USA.	nsasson@utdallas.edu						Becker DV, 2011, J EXP PSYCHOL GEN, V140, P637, DOI 10.1037/a0024060; Belopolsky AV, 2011, VIS COGN, V19, P27, DOI 10.1080/13506285.2010.536186; Calvo MG, 2008, J EXP PSYCHOL GEN, V137, P471, DOI 10.1037/a0012771; Ceccarini F, 2013, VIS COGN, V21, P498, DOI 10.1080/13506285.2013.807901; Damjanovic L, 2014, Q J EXP PSYCHOL, V67, P1004, DOI 10.1080/17470218.2013.839724; Damjanovic L, 2010, J COGN CULT, V10, P85, DOI 10.1163/156853710X497185; Eastwood JD, 2001, PERCEPT PSYCHOPHYS, V63, P1004, DOI 10.3758/BF03194519; Eastwood JD, 2005, VIS COGN, V12, P159, DOI 10.1080/13506280444000175; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Findlay JM, 1997, VISION RES, V37, P617, DOI 10.1016/S0042-6989(96)00218-0; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Fox E, 2006, EMOTION, V6, P534, DOI 10.1037/1528-3542.6.3.534; Friesen E., 1978, CONSULTING PSYCHOL P, V3, P1; Frischen A, 2008, PSYCHOL BULL, V134, P662, DOI 10.1037/0033-2909.134.5.662; Gur RC, 2002, J NEUROSCI METH, V115, P137, DOI 10.1016/S0165-0270(02)00006-7; HAMPTON C, 1989, B PSYCHONOMIC SOC, V27, P563; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Horstmann G, 2006, EMOTION, V6, P193, DOI 10.1037/1528-3542.6.2.193; Horstmann G, 2012, J VISION, V12, DOI 10.1167/12.5.7; Juth P, 2005, EMOTION, V5, P379, DOI 10.1037/1528-3542.5.4.379; Leppanen JM, 2003, J PSYCHOPHYSIOL, V17, P113, DOI 10.1027//0269-8803.17.3.113; Lundqvist D, 2013, COGNITION E IN PRESS; Mermillod M, 2009, COGNITION, V110, P346, DOI 10.1016/j.cognition.2008.11.009; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Pinkham AE, 2014, J ABNORM PS IN PRESS; Pinkham AE, 2010, EMOTION, V10, P141, DOI 10.1037/a0017387; Purcell DG, 2010, ATTEN PERCEPT PSYCHO, V72, P2115, DOI 10.3758/APP.72.8.2115; Reynolds MG, 2009, VIS COGN, V17, P318, DOI 10.1080/13506280701623704; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Sasson NJ, 2010, J NONVERBAL BEHAV, V34, P207, DOI 10.1007/s10919-010-0092-z; Shen J, 2001, PERCEPT PSYCHOPHYS, V63, P464, DOI 10.3758/BF03194413; Turatto M, 2000, VISION RES, V40, P1639, DOI 10.1016/S0042-6989(00)00061-4; Williams DE, 1997, CAN J EXP PSYCHOL, V51, P151, DOI 10.1037/1196-1961.51.2.151; Williams MA, 2005, VIS COGN, V12, P29, DOI 10.1080/13506280444000193; Zelinsky GJ, 1997, J EXP PSYCHOL HUMAN, V23, P244, DOI 10.1037/0096-1523.23.1.244	36	19	20	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93914	10.1371/journal.pone.0093914	http://dx.doi.org/10.1371/journal.pone.0093914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LR	24699880	Green Published, Green Submitted			2022-12-27	WOS:000334105000120
J	Van Yperen, NW; Blaga, M; Postmes, T				Van Yperen, Nico W.; Blaga, Monica; Postmes, Tom			A Meta-Analysis of Self-Reported Achievement Goals and Nonself-Report Performance across Three Achievement Domains (Work, Sports, and Education)	PLOS ONE			English	Article							HIERARCHICAL MODEL; PHYSICAL-EDUCATION; PUBLICATION BIAS; MODERATING ROLE; ORIENTATION; MOTIVATION; TASK; MASTERY; ABILITY; PROFILES	During the past three decades, the achievement goal approach to achievement motivation has emerged as an influential area of research, and is dedicated to understanding the reasons behind the individual's drive to achieve competence and performance. However, the current literature on achievement goals is segmented rather than integrated. That is, citations across the three major and distinct achievement domains (work, education, and sports) are more the exception than the rule and similarities and differences between findings for the different achievement domains have yet to be tested. The purpose of the present study was to examine the relationships between self-reported achievement goals and nonself-report performance through meta-analysis, and the moderating potential of achievement domain. Identifying achievement domain as moderator improves our understanding to which contexts we can (not) generalize conclusions to, it helps to understand seemingly inconsistent findings, and opens avenues for future research on the underlying processes. Because the achievement goal (AG) measure used in a study is partially confounded with achievement domain, we examined the moderating role of this variable as well. Our findings suggest that - overall - approach goals (either mastery or performance) were associated positively with performance attainment, whereas avoidance goals (either mastery or performance) were associated negatively with performance attainment. These relationships were moderated by achievement domain. For example, relative to the education or work domain, in the sports domain, we did not observe negative correlations between avoidance goals and performance. The absence of statistical moderation due to AG measure suggests that the observed moderation of achievement domain cannot be explained by the AG measure utilized. We suggest further steps to integrate the achievement goal literature, and accordingly, to broaden and deepen understanding of performance attainment in competence-relevant settings, including the workplace, the sports field, and the classroom.	[Van Yperen, Nico W.; Blaga, Monica; Postmes, Tom] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands	University of Groningen	Van Yperen, NW (corresponding author), Univ Groningen, Dept Psychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	N.van.Yperen@rug.nl	Postmes, Tom/A-9004-2010; Van Yperen, Nico W./C-2341-2012	Postmes, Tom/0000-0002-8029-7398; Van Yperen, Nico W./0000-0003-2116-8841				Aiken L. S., 1991, MULTIPLE REGRESSION; AMES C, 1992, J EDUC PSYCHOL, V84, P261, DOI 10.1037/0022-0663.84.3.261; Baranik LE, 2010, HUM PERFORM, V23, P265, DOI 10.1080/08959285.2010.488463; Barron K.E., 2003, INT J EDUC RES, V39, P357, DOI [DOI 10.1016/J.IJER.2004.06.004, 10.1016/j.ijer.2004.06.004]; Becker G. S, 1957, EC DISCRIMINATION; Bell BS, 2002, PERS PSYCHOL, V55, P267, DOI 10.1111/j.1744-6570.2002.tb00111.x; Bell BS, 2002, J APPL PSYCHOL, V87, P497, DOI 10.1037//0021-9010.87.3.497; Bodmann SM, 2007, ANN M AM ED RES ASS; Bois JE, 2009, SPORT PSYCHOL, V23, P252, DOI 10.1123/tsp.23.2.252; Breland BT, 2005, HUM PERFORM, V18, P23, DOI 10.1207/s15327043hup1801_2; Brett JF, 1999, J APPL PSYCHOL, V84, P863, DOI 10.1037/0021-9010.84.6.863; Button SB, 1996, ORGAN BEHAV HUM DEC, V67, P26, DOI 10.1006/obhd.1996.0063; Carr S, 2006, J SPORT SCI, V24, P281, DOI 10.1080/02640410500131886; Chen G, 2008, ORGAN BEHAV HUM DEC, V106, P21, DOI 10.1016/j.obhdp.2007.11.001; Conroy DE, 2003, J SPORT EXERCISE PSY, V25, P456, DOI 10.1123/jsep.25.4.456; Cury F, 2002, PERCEPT MOTOR SKILL, V95, P233, DOI 10.2466/pms.2002.95.1.233; Darnon C, 2007, MOTIV EMOTION, V31, P61, DOI 10.1007/s11031-006-9049-2; Darnon C, 2006, J EDUC PSYCHOL, V98, P766, DOI 10.1037/0022-0663.98.4.766; Davis WD, 2007, HUM PERFORM, V20, P1, DOI 10.1207/s15327043hup2001_1; Day EA, 2003, CONTEMP EDUC PSYCHOL, V28, P434, DOI 10.1016/S0361-476X(02)00043-7; DeShon RP, 2005, J APPL PSYCHOL, V90, P1096, DOI 10.1037/0021-9010.90.6.1096; Duda J. L., 2001, ADV MOTIVATION SPORT, P129, DOI DOI 10.1007/978-1-4899-2271-7; Duda J. L., 1995, MOTIVATION SPORT EXE, P57; DUDA JL, 1992, J EDUC PSYCHOL, V84, P290, DOI 10.1037/0022-0663.84.3.290; Durik AM, 2009, CONTEMP EDUC PSYCHOL, V34, P113, DOI 10.1016/j.cedpsych.2008.11.002; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; DWECK CS, 1986, AM PSYCHOL, V41, P1040, DOI 10.1037/0003-066X.41.10.1040; Dweck's, 2005, HDB COMPETENCE MOTIV, P52; Dysvik A, 2013, BRIT J SOC PSYCHOL, V52, P412, DOI 10.1111/j.2044-8309.2011.02090.x; Elliot AJ, 1999, J PERS SOC PSYCHOL, V76, P628, DOI 10.1037//0022-3514.76.4.628; Elliot AJ, 1999, EDUC PSYCHOL-US, V34, P169, DOI 10.1207/s15326985ep3403_3; Elliot AJ, 2001, J PERS SOC PSYCHOL, V80, P501, DOI 10.1037//0022-3514.80.3.501; Elliot AJ, 1997, J PERS SOC PSYCHOL, V72, P218, DOI 10.1037/0022-3514.72.1.218; Elliot AJ, 1996, J PERS SOC PSYCHOL, V70, P461, DOI 10.1037/0022-3514.70.3.461; Elliot AJ, 2001, EDUC PSYCHOL REV, V13, P139, DOI 10.1023/A:1009057102306; Elliot AJ, 2008, J EDUC PSYCHOL, V100, P613, DOI 10.1037/0022-0663.100.3.613; Elliot AJ, 2006, J SPORT EXERCISE PSY, V28, P344, DOI 10.1123/jsep.28.3.344; Elliot AJ, 2011, J EDUC PSYCHOL, V103, P632, DOI 10.1037/a0023952; Farr J.L., 1993, INT REV IND ORG PSYC, P193; Ferguson CJ, 2012, PSYCHOL METHODS, V17, P120, DOI 10.1037/a0024445; Fisher SL, 1998, PERS PSYCHOL, V51, P397, DOI 10.1111/j.1744-6570.1998.tb00731.x; Harackiewicz JM, 2002, J EDUC PSYCHOL, V94, P638, DOI 10.1037//0022-0663.94.3.638; Harackiewicz JM, 2002, J EDUC PSYCHOL, V94, P562, DOI 10.1037//0022-0663.94.3.562; Harackiewicz JM, 2008, J EDUC PSYCHOL, V100, P105, DOI 10.1037/0022-0663.100.1.105; HAU KT, 1990, EDUC STUD, V16, P17, DOI 10.1080/0305569900160102; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Hendricks JW, 2007, HUM PERFORM, V20, P317; Higgins ET, 2000, AM PSYCHOL, V55, P1217, DOI 10.1037/0003-066X.55.11.1217; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Horvath M, 2004, ANN M SOC IND ORG PS; Hulleman CS, 2008, J EDUC PSYCHOL, V100, P398, DOI 10.1037/0022-0663.100.2.398; Hulleman CS, 2010, PSYCHOL BULL, V136, P422, DOI 10.1037/a0018947; Janssen O, 2004, ACAD MANAGE J, V47, P368, DOI 10.2307/20159587; Klein WM, 1997, J PERS SOC PSYCHOL, V72, P763, DOI 10.1037/0022-3514.72.4.763; KRUGLANSKI AW, 1975, PSYCHOL REV, V82, P387, DOI 10.1037/0033-295X.82.6.387; Le Bars H, 2009, SCAND J MED SCI SPOR, V19, P274, DOI 10.1111/j.1600-0838.2008.00786.x; Lee FK, 2003, J APPL PSYCHOL, V88, P256, DOI 10.1037/0021-9010.88.2.256; Levy I., 2004, SOC PSYCHOL EDUC, V7, P129; Linnenbrink-Garcia L, 2008, REV INT PSYCHOL SOC, V21, P19; Lipsey M. W., 2001, PRACTICAL METAANALYS, V49; McCabe KO, 2013, J RES PERS, V47, P698, DOI 10.1016/j.jrp.2013.06.003; Midgley C, 1998, CONTEMP EDUC PSYCHOL, V23, P113, DOI 10.1006/ceps.1998.0965; Midgley C, 2001, J EDUC PSYCHOL, V93, P77, DOI 10.1037//0022-0663.93.1.77; NICHOLLS JG, 1984, PSYCHOL REV, V91, P328, DOI 10.1037/0033-295X.91.3.328; Nien CL, 2008, PSYCHOL SPORT EXERC, V9, P352, DOI 10.1016/j.psychsport.2007.05.002; Ntoumanis N, 2009, J SPORT SCI, V27, P1471, DOI 10.1080/02640410903150459; Park LE, 2007, PERS SOC PSYCHOL B, V33, P1503, DOI 10.1177/0146167207305538; Payne SC, 2007, J APPL PSYCHOL, V92, P128, DOI 10.1037/0021-9010.92.1.128; Peterson SJ, 2006, PERS INDIV DIFFER, V40, P1099, DOI 10.1016/j.paid.2005.11.005; Phillips JM, 1997, J APPL PSYCHOL, V82, P792, DOI 10.1037/0021-9010.82.5.792; Pintrich PR, 2000, CONTEMP EDUC PSYCHOL, V25, P92, DOI 10.1006/ceps.1999.1017; Podsakoff PM, 2000, J MANAGE, V26, P513, DOI 10.1177/014920630002600306; Poortvliet PM, 2007, PERS SOC PSYCHOL B, V33, P1435, DOI 10.1177/0146167207305536; Poortvliet PM, 2012, J BUS ETHICS, V106, P401, DOI 10.1007/s10551-011-1005-8; Potosky D, 2002, HUM PERFORM, V15, P275, DOI 10.1207/S15327043HUP1503_03; Rawsthorne L J, 1999, Pers Soc Psychol Rev, V3, P326, DOI 10.1207/s15327957pspr0304_3; Roberts GC, 1998, J SPORT SCI, V16, P337, DOI 10.1080/02640419808559362; Rosenberg MS, 2005, EVOLUTION, V59, P464, DOI 10.1111/j.0014-3820.2005.tb01004.x; Schmidt AM, 2003, PERS PSYCHOL, V56, P405, DOI 10.1111/j.1744-6570.2003.tb00156.x; Seijts GH, 2004, ACAD MANAGE J, V47, P227, DOI 10.2307/20159574; Senko C, 2011, EDUC PSYCHOL-US, V46, P26, DOI 10.1080/00461520.2011.538646; Sideridis G. D., 2005, READ WRIT Q, V21, P331, DOI DOI 10.1080/10573560591002268; Sideridis GD, 2008, STRESS HEALTH, V24, P55, DOI 10.1002/smi.1160; Silver LS, 2006, J PERS SELL SALES M, V26, P27, DOI 10.2753/PSS0885-3134260103; Skaalvik EM, 1997, J EDUC PSYCHOL, V89, P71, DOI 10.1037/0022-0663.89.1.71; Spiegel S, 2004, EUR J SOC PSYCHOL, V34, P39, DOI 10.1002/ejsp.180; Stoeber J, 2009, J SPORT EXERCISE PSY, V31, P211, DOI 10.1123/jsep.31.2.211; Van Yperen NW, 2006, PERS SOC PSYCHOL B, V32, P1432, DOI 10.1177/0146167206292093; Van Yperen NW, 2013, J ECON PSYCHOL, V38, P71, DOI 10.1016/j.joep.2012.08.013; Van Yperen NW, 2011, BRIT J MANAGE, V22, pS5, DOI 10.1111/j.1467-8551.2010.00702.x; Van Yperen NW, 2003, J PERS SOC PSYCHOL, V85, P1006, DOI 10.1037/0022-3514.85.6.1006; Van Yperen NW, 2002, ACAD MANAGE J, V45, P1161, DOI 10.2307/3069431; Van Yperen NW, 2014, PERSON SOC PSYCHOL B, Vxx, pxxx; Van Yperen NW, 2003, EUROPEAN J WORK ORG, V12, P229, DOI DOI 10.1080/13594320344000110; VandeWalle D, 1997, EDUC PSYCHOL MEAS, V57, P995, DOI 10.1177/0013164497057006009; VandeWalle D, 1999, J APPL PSYCHOL, V84, P249, DOI 10.1037/0021-9010.84.2.249; Vandewalle D, 2001, ORGAN DYN, V30, P162, DOI 10.1016/S0090-2616(01)00050-X; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wang CKJ, 2007, PSYCHOL SPORT EXERC, V8, P147, DOI 10.1016/j.psychsport.2005.08.012; Wang M, 2007, PERS INDIV DIFFER, V43, P1493, DOI 10.1016/j.paid.2007.04.024; WHEELER L, 1992, J PERS SOC PSYCHOL, V62, P760, DOI 10.1037/0022-3514.62.5.760; White JB, 2006, J ADULT DEV, V13, P36, DOI 10.1007/s10804-006-9005-0; Wilson D. B., 2010, METAANALYSIS MACROS	103	139	140	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93594	10.1371/journal.pone.0093594	http://dx.doi.org/10.1371/journal.pone.0093594			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LR	24699695	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000075
J	Zheng, Y; Wang, DD; Wang, W; Pan, K; Huang, CY; Li, YF; Wang, QJ; Yuan, SQ; Jiang, SS; Qiu, HB; Chen, YM; Zhang, XF; Zhao, BW; Mai, C; Xia, JC; Zhou, ZW				Zheng, Yan; Wang, Dan-dan; Wang, Wei; Pan, Ke; Huang, Chun-yu; Li, Yuan-fang; Wang, Qi-Jing; Yuan, Shu-qiang; Jiang, Shan-shan; Qiu, Hai-bo; Chen, Yong-ming; Zhang, Xiao-fei; Zhao, Bai-wei; Mai, Cong; Xia, Jian-chuan; Zhou, Zhi-Wei			Reduced Expression of Uroplakin 1A Is Associated with the Poor Prognosis of Gastric Adenocarcinoma Patients	PLOS ONE			English	Article							GENE; PHOSPHORYLATION; CHINA; IB; IA	Background: The aim of this study was to investigate the expression and prognostic significance of Uroplakin1A (UPK1A) in gastric adenocarcinoma patients. Functional studies were also analyzed in vitro. Methodology/Principal Findings: Real-time quantitative PCR (RT-qPCR), western blotting, and immunohistochemical (IHC) staining methods were used to analyze the expression of UPK1A in primary gastric adenocarcinoma tissue samples. Compared with matched adjacent non-tumor, the expression of UPK1A in fresh surgical specimens was reduced, which was confirmed by RT-qPCR (P<0.01) and western blotting analysis (P<0.01). The paraffin specimens from a consecutive series of 445 gastric adenocarcinoma patients who underwent surgery between 2003 and 2006 were analyzed by IHC staining. The relationship between UPK1A expression, clinicopathological factors, and survival were evaluated. IHC staining analysis revealed that the reduced expression of UPK1A was observed in 224 cases (50.3%). Additionally, the correlation analysis of clinicopathological factors demonstrated that reduced expression of UPK1A was significantly associated with histological grade (P = 0.022), node metastasis (P<0.001) and tumor node metastasis (TNM) stage (P = 0.008) (7th edition of the International Union Against Cancer (UICC)). Furthermore, Kaplan-Meier survival analysis revealed that the reduced expression of UPK1A was significantly associated with poor prognosis (P = 0.043). Cox hazards model analysis indicated that UPK1A expression was an independent risk factor at the 0.1 level (P = 0.094). The function of UPK1A in cell cycle, migration, and invasion was investigated by overexpressing UPK1A in the MKN45 gastric cancer cell line. The elevated expression of UPK1A cells induced G1 phase arrest and significantly inhibited migration and invasion. Conclusions/Significance: The reduced expression of UPK1A might play a role in the progression of gastric cancer. Thus, UPK1A could be a potential favorable biomarker associated with gastric cancer prognosis.	[Zheng, Yan; Wang, Dan-dan; Wang, Wei; Pan, Ke; Huang, Chun-yu; Li, Yuan-fang; Wang, Qi-Jing; Yuan, Shu-qiang; Jiang, Shan-shan; Qiu, Hai-bo; Chen, Yong-ming; Zhang, Xiao-fei; Zhao, Bai-wei; Mai, Cong; Xia, Jian-chuan; Zhou, Zhi-Wei] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, Yan; Wang, Dan-dan; Wang, Wei; Pan, Ke; Huang, Chun-yu; Li, Yuan-fang; Wang, Qi-Jing; Yuan, Shu-qiang; Jiang, Shan-shan; Qiu, Hai-bo; Chen, Yong-ming; Zhang, Xiao-fei; Zhao, Bai-wei; Mai, Cong; Xia, Jian-chuan; Zhou, Zhi-Wei] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, Yan; Wang, Wei; Li, Yuan-fang; Yuan, Shu-qiang; Qiu, Hai-bo; Chen, Yong-ming; Zhao, Bai-wei; Mai, Cong; Zhou, Zhi-Wei] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Dan-dan] Shandong Acad Med Sci, Med Biotechnol Res Ctr, Jinan, Shandong, Peoples R China; [Huang, Chun-yu] Sun Yat Sen Univ, Ctr Canc, Dept Endoscopy, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Sun Yat Sen University	Zhou, ZW (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	xiajch@sysucc.org.cn; zhouzhw@sysucc.org.cn	Li, Yuan/GXV-1310-2022; Chen, Yongming/E-3656-2015; Qiu, Haibo/AAS-9047-2021	Chen, Yongming/0000-0003-2843-5543; Qiu, Haibo/0000-0001-8589-4717	National Natural Science Foundation of China [81172080, 81201773]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100171110084, 20120171120114]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This project supported by the National Natural Science Foundation of China (Grant No. 81172080 and 81201773) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20100171110084 and 20120171120114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WQ, 2013, CHIN J CANCER, V32, P106, DOI 10.5732/cjc.013.10018; Hall GD, 2005, BBA-GENE STRUCT EXPR, V1729, P126, DOI 10.1016/j.bbaexp.2005.04.004; Japanese Gastric Cancer A, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/PL00011681]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kong KL, 2010, CANCER RES, V70, P8832, DOI 10.1158/0008-5472.CAN-10-0779; Lobban ED, 1998, AM J PATHOL, V153, P1957, DOI 10.1016/S0002-9440(10)65709-4; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Ohtsuka Y, 2006, BJU INT, V97, P1322, DOI 10.1111/j.1464-410X.2006.06158.x; Schnegelsberg B, 2010, AM J PHYSIOL-REG I, V298, pR534, DOI 10.1152/ajpregu.00367.2009; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wang Yong-chuan, 2012, Cancer Biology Medicine, V9, P128, DOI 10.3969/j.issn.2095-3941.2012.02.009; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Xie B, 2006, J BIOL CHEM, V281, P14644, DOI 10.1074/jbc.M600877200; YU J, 1994, J CELL BIOL, V125, P171, DOI 10.1083/jcb.125.1.171; Zupancic D, 2011, VIRCHOWS ARCH, V458, P603, DOI 10.1007/s00428-011-1045-6	17	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93073	10.1371/journal.pone.0093073	http://dx.doi.org/10.1371/journal.pone.0093073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24698999	gold, Green Published, Green Submitted			2022-12-27	WOS:000334105000043
J	Dishaw, LJ; Flores-Torres, J; Lax, S; Gemayel, K; Leigh, B; Melillo, D; Mueller, MG; Natale, L; Zucchetti, I; De Santis, R; Pinto, MR; Litman, GW; Gilbert, JA				Dishaw, Larry J.; Flores-Torres, Jaime; Lax, Simon; Gemayel, Kristina; Leigh, Brittany; Melillo, Daniela; Mueller, M. Gail; Natale, Lenina; Zucchetti, Ivana; De Santis, Rosaria; Pinto, Maria Rosaria; Litman, Gary W.; Gilbert, Jack A.			The Gut of Geographically Disparate Ciona intestinalis Harbors a Core Microbiota	PLOS ONE			English	Article							AEROBIC CULTURABLE BACTERIA; COMMUNITIES; DIVERSITY; COLONIZATION; ASSOCIATIONS; MUCUS; MODEL	It is now widely understood that all animals engage in complex interactions with bacteria (or microbes) throughout their various life stages. This ancient exchange can involve cooperation and has resulted in a wide range of evolved host-microbial interdependencies, including those observed in the gut. Ciona intestinalis, a filter-feeding basal chordate and classic developmental model that can be experimentally manipulated, is being employed to help define these relationships. Ciona larvae are first exposed internally to microbes upon the initiation of feeding in metamorphosed individuals; however, whether or not these microbes subsequently colonize the gut and whether or not Ciona forms relationships with specific bacteria in the gut remains unknown. In this report, we show that the Ciona gut not only is colonized by a complex community of bacteria, but also that samples from three geographically isolated populations reveal striking similarity in abundant operational taxonomic units (OTUs) consistent with the selection of a core community by the gut ecosystem.	[Dishaw, Larry J.; Litman, Gary W.] Univ S Florida, Coll Med, USF Hlth, Dept Pediat,Div Mol Genet, St Petersburg, FL 33701 USA; [Flores-Torres, Jaime] Univ S Florida, Coll Med, USF Hlth, Div Neonatol, St Petersburg, FL 33701 USA; [Lax, Simon; Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Gemayel, Kristina] Univ S Florida, Coll Med, PostBaccalaureate Program Interdisciplinary Med, Tampa, FL USA; [Leigh, Brittany] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Melillo, Daniela; Natale, Lenina; Zucchetti, Ivana; De Santis, Rosaria; Pinto, Maria Rosaria] Dept Anim Physiol & Evolut, Stn Zool Anton Dohrn, Naples, Italy; [Mueller, M. Gail] Univ S Florida, All Childrens Hosp, Dept Mol Genet, St Petersburg, FL 33701 USA; [Gilbert, Jack A.] Univ Chicago, Argonne Natl Lab, Biosci Div, Chicago, IL 60637 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Chicago; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Stazione Zoologica Anton Dohrn di Napoli; State University System of Florida; University of South Florida; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Dishaw, LJ (corresponding author), Univ S Florida, Coll Med, USF Hlth, Dept Pediat,Div Mol Genet, St Petersburg, FL 33701 USA.	ldishaw@health.usf.edu	Dishaw, Larry/ABZ-9621-2022; Dishaw, Larry J/A-9930-2010; Gilbert, Jack/AAF-3270-2019	Dishaw, Larry/0000-0002-2705-4573; Dishaw, Larry J/0000-0002-2705-4573; 	U.S. Dept. of Energy [DE-AC02-06CH11357]; National Institute of Health [NIH AI23338]; All Children's Hospital Foundation Research Grant; USF College of Medicine Internal Award; Por Campania FSE Project Modo - Model Organism; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023338, R56AI023338, R37AI023338] Funding Source: NIH RePORTER	U.S. Dept. of Energy(United States Department of Energy (DOE)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); All Children's Hospital Foundation Research Grant; USF College of Medicine Internal Award; Por Campania FSE Project Modo - Model Organism(Regione Campania); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the U.S. Dept. of Energy under Contract DE-AC02-06CH11357 (JAG) and the National Institute of Health (NIH AI23338) (GWL), by an All Children's Hospital Foundation Research Grant and a USF College of Medicine Internal Award (LJD), and by Por Campania FSE 2007-2013 Project Modo - Model Organism (DM, LN, and IZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini S, 2012, CORAL REEFS, V31, P147, DOI 10.1007/s00338-011-0831-6; Bayer T, 2013, APPL ENVIRON MICROB, V79, P4759, DOI 10.1128/AEM.00695-13; Bayer T, 2013, MAR ECOL PROG SER, V479, P75, DOI 10.3354/meps10197; Blasiak LC, 2013, ISME J; Brenner DJ, 2005, BERGEYS MANUAL SYSTE; Caporaso JG, 2012, ISME J, V6, P1089, DOI 10.1038/ismej.2011.162; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caputi L, 2007, P NATL ACAD SCI USA, V104, P9364, DOI 10.1073/pnas.0610158104; Carlos C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01624; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Correa H, 2013, MICROB ECOL, V66, P972, DOI 10.1007/s00248-013-0267-3; Dishaw LJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00096; Dishaw LJ, 2011, P NATL ACAD SCI USA, V108, P16747, DOI 10.1073/pnas.1109687108; Fan L, 2012, P NATL ACAD SCI USA, V109, pE1878, DOI 10.1073/pnas.1203287109; Franzenburg S, 2013, ISME J, V7, P781, DOI 10.1038/ismej.2012.156; Gibbons SM, 2013, P NATL ACAD SCI USA, V110, P4651, DOI 10.1073/pnas.1217767110; Goffredi SK, 2007, APPL ENVIRON MICROB, V73, P2314, DOI 10.1128/AEM.01986-06; Gordon JI, 2012, SCIENCE, V336, P1251, DOI 10.1126/science.1224686; Iannelli F, 2007, TRENDS GENET, V23, P419, DOI 10.1016/j.tig.2007.07.001; IBRAHIM A, 1993, FEMS MICROBIOL LETT, V114, P173, DOI 10.1016/0378-1097(93)90515-4; Jensen S, 2010, FEMS MICROBIOL ECOL, V74, P523, DOI 10.1111/j.1574-6941.2010.00981.x; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; King GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051475; Kuczynski J, 2012, CURR PROTOC MICROBIO; Kurahashi M, 2007, SYST APPL MICROBIOL, V30, P202, DOI 10.1016/j.syapm.2006.07.003; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Li M, 2009, MICROB ECOL, V58, P892, DOI 10.1007/s00248-009-9550-8; Mao-Jones J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000345; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; McFall-Ngai MJ, 2002, DEV BIOL, V242, P1, DOI 10.1006/dbio.2001.0522; Morrow KM, 2012, APPL ENVIRON MICROB, V78, P6438, DOI 10.1128/AEM.01162-12; Nydam ML, 2010, MOL PHYLOGENET EVOL, V56, P718, DOI 10.1016/j.ympev.2010.03.042; PLANTE CJ, 1990, ANNU REV ECOL SYST, V21, P93, DOI 10.1146/annurev.es.21.110190.000521; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Rhee KJ, 2004, J IMMUNOL, V172, P1118, DOI 10.4049/jimmunol.172.2.1118; Roux C, 2013, MOL BIOL EVOL; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Stackebrandt E, 1993, HDB NEW BACTERIAL SY, P152; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vezzulli L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067745; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang XC, 2013, J GEN APPL MICROBIOL, V59, P1; Zhang XC, 2012, J GEN APPL MICROBIOL, V58, P447, DOI 10.2323/jgam.58.447; Zielinski FU, 2009, ENVIRON MICROBIOL, V11, P1150, DOI 10.1111/j.1462-2920.2008.01847.x	50	86	89	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93386	10.1371/journal.pone.0093386	http://dx.doi.org/10.1371/journal.pone.0093386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695540	Green Submitted, Green Published, gold			2022-12-27	WOS:000334103000066
J	Huang, RY; Chu, YL; Huang, QC; Chen, XM; Jiang, ZB; Zhang, X; Zeng, X				Huang, Run-Yue; Chu, Yong-Liang; Huang, Qing-Chun; Chen, Xiu-Min; Jiang, Ze-Bo; Zhang, Xian; Zeng, Xing			18 beta-Glycyrrhetinic Acid Suppresses Cell Proliferation through Inhibiting Thromboxane Synthase in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							EXPRESSION; CARCINOMA; APOPTOSIS; CYCLOOXYGENASE-2; GROWTH; A(2)	18 beta-glycyrrhetinic acid (18 beta-GA) is a bioactive component of licorice. The anti-cancer activity of 18 beta-GA has been studied in many cancer types, whereas its effects in lung cancer remain largely unknown. We first showed that 18 beta-GA effectively suppressed cell proliferation and inhibited expression as well as activity of thromboxane synthase (TxAS) in non-small cell lung cancer (NSCLC) cells A549 and NCI-H460. In addition, the administration of 18 beta-GA did not have any additional inhibitory effect on the decrease of cell proliferation induced by transfection with TxAS small interference RNA (siRNA). Moreover, 18 beta-GA failed to inhibit cell proliferation in the immortalized human bronchial epithelial cells 16HBE-T and another NSCLC cell line NCI-H23, both of which expressed minimal level of TxAS as compared to A549 and NCI-H460. However, 18 beta-GA abolished the enhancement of cell proliferation induced by transfection of NCI-H23 with pCMV6-TxAS plasmid. Further study found that the activation of both extracellular signal-regulated kinase (ERK)1/2 and cyclic adenosine monophosphate response element binding protein (CREB) induced by TxAS cDNA transfection could be totally blocked by 18 beta-GA. Altogether, we have delineated that, through inhibiting TxAS and its initiated ERK/CREB signaling, 18 beta-GA suppresses NSCLC cell proliferation. Our study has highlighted the significance of 18 beta-GA with respect to prevention and treatment of NSCLC.	[Huang, Run-Yue; Chu, Yong-Liang; Huang, Qing-Chun; Chen, Xiu-Min] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Dept Rheumatol, Guangzhou, Guangdong, Peoples R China; [Jiang, Ze-Bo; Zhang, Xian; Zeng, Xing] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Cent Lab, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Huang, RY (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Dept Rheumatol, Guangzhou, Guangdong, Peoples R China.	ry_huang@hotmail.com; zengxing-china@163.com	zhang, xu/GYE-3558-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xuan/AAN-9914-2020; zhang, xu/GRX-9733-2022; zhang, xian/GYA-0290-2022	zhang, xuan/0000-0001-8775-1699; 	National Natural Science Foundation of China [81302799]; China Postdoctoral Science Foundation [2013M531838]; Excellent Young Scientist Foundation from Guangzhou University of Chinese Medicine [KAB111133K08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Excellent Young Scientist Foundation from Guangzhou University of Chinese Medicine	Grant support: This study was supported by National Natural Science Foundation of China (No. 81302799), China Postdoctoral Science Foundation (No. 2013M531838) and 2012 Excellent Young Scientist Foundation from Guangzhou University of Chinese Medicine (No. KAB111133K08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton AW, 1999, J BIOL CHEM, V274, P35562, DOI 10.1074/jbc.274.50.35562; Cathcart MC, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-25; Cathcart MC, 2010, BBA-REV CANCER, V1805, P153, DOI 10.1016/j.bbcan.2010.01.006; Chen GG, 2006, CANCER LETT, V234, P193, DOI 10.1016/j.canlet.2005.03.032; Ekambaram P, 2011, CANCER METAST REV, V30, P397, DOI 10.1007/s10555-011-9297-9; Ermert L, 2003, CLIN CANCER RES, V9, P1604; FUJIMORI A, 1989, CALCIFIED TISSUE INT, V44, P186, DOI 10.1007/BF02556563; Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822; Huang RY, 2011, ONCOGENE, V30, P106, DOI 10.1038/onc.2010.390; Huang RY, 2013, J MOL CELL BIOL, V5, P380, DOI 10.1093/jmcb/mjt038; Huang RY, 2011, BBA-REV CANCER, V1815, P158, DOI 10.1016/j.bbcan.2010.11.005; Huang Wei, 2003, Zhongguo Fei Ai Za Zhi, V6, P254, DOI 10.3779/j.issn.1009-3419.2003.04.02; Jariyawat S, 1997, BIOCHEM MOL BIOL INT, V42, P113; Kalani K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074761; Kuttan G, 2011, PHARM BIOL, V49, P995, DOI 10.3109/13880209.2011.559476; Lallemand B, 2013, J PHARM PHARMACOL, V65, P402, DOI 10.1111/j.2042-7158.2012.01603.x; Lee CS, 2010, EUR J PHARMACOL, V649, P354, DOI 10.1016/j.ejphar.2010.09.047; Lim J, 2013, MOL CELLS, V36, P340, DOI 10.1007/s10059-013-0123-9; Logashenko EB, 2011, CHEMBIOCHEM, V12, P784, DOI 10.1002/cbic.201000618; Ming LJ, 2013, NAT PROD COMMUN, V8, P415; Moussa O, 2008, ONCOGENE, V27, P55, DOI 10.1038/sj.onc.1210629; Moussa O, 2008, CANCER RES, V68, P4097, DOI 10.1158/0008-5472.CAN-07-6560; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; Ni YF, 2011, J SURG RES, V165, pE29, DOI 10.1016/j.jss.2010.10.004; Nie DT, 2004, AM J PATHOL, V164, P429, DOI 10.1016/S0002-9440(10)63133-1; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Satomi Y, 2005, ANTICANCER RES, V25, P4043; Sharma G, 2012, J CELL PHYSIOL, V227, P1923, DOI 10.1002/jcp.22920; Wei J, 2007, BIOCHEM PHARMACOL, V74, P787, DOI 10.1016/j.bcp.2007.06.008; Wei JY, 2010, LUNG CANCER, V69, P26, DOI 10.1016/j.lungcan.2009.09.009; Zarogoulidis K, 2013, J THORAC DIS, V5, pS389, DOI 10.3978/j.issn.2072-1439.2013.07.10	31	27	29	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93690	10.1371/journal.pone.0093690	http://dx.doi.org/10.1371/journal.pone.0093690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695790	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000105
J	Kuligowski, J; Torres-Cuevas, I; Quintas, G; Rook, D; van Goudoever, JB; Cubells, E; Asensi, M; Lliso, I; Nunez, A; Vento, M; Escobar, J				Kuligowski, Julia; Torres-Cuevas, Isabel; Quintas, Guillermo; Rook, Denise; van Goudoever, Johannes B.; Cubells, Elena; Asensi, Miguel; Lliso, Isabel; Nunez, Antonio; Vento, Maximo; Escobar, Javier			Assessment of Oxidative Damage to Proteins and DNA in Urine of Newborn Infants by a Validated UPLC-MS/MS Approach	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; QUANTITATIVE-DETERMINATION; MASS-SPECTROMETRY; OXYGEN; 8-HYDROXY-2'-DEOXYGUANOSINE; RESUSCITATION; STRESS; BIOMARKERS; TYROSINE; MARKERS	The assessment of oxidative stress is highly relevant in clinical Perinatology as it is associated to adverse outcomes in newborn infants. This study summarizes results from the validation of an Ultra Performance Liquid Chromatography-tandem Mass Spectrometry (UPLC-MS/MS) method for the simultaneous quantification of the urinary concentrations of a set of endogenous biomarkers, capable to provide a valid snapshot of the oxidative stress status applicable in human clinical trials, especially in the field of Perinatology. The set of analytes included are phenylalanine (Phe), para-tyrosine (p-Tyr), ortho-tyrosine (o-Tyr), meta-tyrosine (m-Tyr), 3-NO2-tyrosine (3NO(2)-Tyr), 3-Cl-tyrosine (3Cl-Tyr), 2'-deoxyguanosine (2dG) and 8-hydroxy-2'-deoxyguanosine (8OHdG). Following the FDA-based guidelines, appropriate levels of accuracy and precision, as well as adequate levels of sensitivity with limits of detection (LODs) in the low nanomolar (nmol/L) range were confirmed after method validation. The validity of the proposed UPLC-MS/MS method was assessed by analysing urine samples from a clinical trial in extremely low birth weight (ELBW) infants randomized to be resuscitated with two different initial inspiratory fractions of oxygen.	[Kuligowski, Julia; Torres-Cuevas, Isabel; Cubells, Elena; Lliso, Isabel; Nunez, Antonio; Vento, Maximo; Escobar, Javier] Hosp La Fe, Neonatal Res Grp, Hlth Res Inst, Valencia, Spain; [Quintas, Guillermo] Leitat Technol Ctr, BioInVitro Div, Valencia, Spain; [Rook, Denise; van Goudoever, Johannes B.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Div Neonatol, Dept Pediat, Rotterdam, Netherlands; [van Goudoever, Johannes B.] Free Univ Amsterdam, Med Ctr Amsterdam, Dept Pediat, Amsterdam, Netherlands; [van Goudoever, Johannes B.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Asensi, Miguel] Univ Valencia, Dept Physiol, Valencia, Spain; [Vento, Maximo] Univ & Polytech Hosp La Fe, Div Neonatol, Valencia, Spain	Hospital Universitari i Politecnic La Fe; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Valencia	Escobar, J (corresponding author), Hosp La Fe, Neonatal Res Grp, Hlth Res Inst, Valencia, Spain.	justo.escobar@uv.es	Vento, Maximo/F-3596-2015; van Goudoever, Johannes Bernard/Y-4520-2018; Quintas, Guillermo/AAS-1138-2020; Miralles, Miguel A Asensi/I-2756-2015; Quintas, Guillermo/G-8953-2017; Nunez, Antonio/AAG-1818-2021; Torres-Cuevas, Isabel/T-8140-2017; Kuligowski, Julia/M-3285-2017	Vento, Maximo/0000-0003-0061-4742; Quintas, Guillermo/0000-0002-4240-9846; Miralles, Miguel A Asensi/0000-0003-1922-7777; Torres-Cuevas, Isabel/0000-0002-8098-1106; Kuligowski, Julia/0000-0001-6979-2235; Escobar, Javier/0000-0002-5044-991X; van Goudoever, Johannes (Hans)/0000-0003-3960-1703; Cubells Garcia, Elena/0000-0003-0845-8422; Cubells Garcia, Elena/0000-0002-9509-1210	Instituto Carlos III (Ministry of Economy and Competitiveness) [CD11/00154, CD12/00667, PFIS FI12/00109, FIS PI11/0313]; Spanish Ministry of Health, Social Services and Equality [EC11-244]; Ministerio de Economia y Competitividad [SAF2012-39948]	Instituto Carlos III (Ministry of Economy and Competitiveness); Spanish Ministry of Health, Social Services and Equality(Spanish Government); Ministerio de Economia y Competitividad(Spanish Government)	Javier Escobar acknowledges his personal grant Sara Borrell CD11/00154 from the Instituto Carlos III (Ministry of Economy and Competitiveness); Julia Kuligowski acknowledges her personal grant Sara Borrell CD12/00667 from the Instituto Carlos III (Ministry of Economy and Competitiveness); Isabel Torres-Cuevas acknowledges her personal grant PFIS FI12/00109 from the Instituto Carlos III (Ministry of Economy and Competitiveness); Maximo Vento acknowledges FIS PI11/0313 grant from the Instituto Carlos III (Ministry of Economy and Competitiveness) and EC11-244 from the Spanish Ministry of Health, Social Services and Equality; and Guillermo Quintas acknowledges financial support from the Ministerio de Economia y Competitividad(SAF2012-39948). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldini G., 2010, BIOMARKERS ANTIOXIDA; Araujo V, 1998, BIOFACTORS, V8, P143, DOI 10.1002/biof.5520080124; Conde SV, 2012, ADV EXP MED BIOL, V758, P315, DOI 10.1007/978-94-007-4584-1_43; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; Davies MJ, 1999, FREE RADICAL BIO MED, V27, P1151, DOI 10.1016/S0891-5849(99)00206-3; DEGROOT LJ, 1977, METABOLISM, V26, P665, DOI 10.1016/0026-0495(77)90088-9; Escobar J, 2011, NEOREVIEWS, V12, pE613, DOI [10.1542/neo.12-11-e613, DOI 10.1542/NEO.12-11-E613]; Escobar J, 2013, NEONATOLOGY, V103, P193, DOI 10.1159/000345194; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Halliwell B, 2012, NUTR REV, V70, P257, DOI 10.1111/j.1753-4887.2012.00476.x; Holmberg I, 1999, FREE RADICAL BIO MED, V26, P129, DOI 10.1016/S0891-5849(98)00181-6; Hosozumi C, 2012, J CHROMATOGR B, V893, P173, DOI 10.1016/j.jchromb.2012.02.043; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Lam PMW, 2012, FREE RADICAL BIO MED, V52, P2057, DOI 10.1016/j.freeradbiomed.2012.03.004; Lubec G, 1997, PEDIATRICS, V100, P700, DOI 10.1542/peds.100.4.700; Matayatsuk C, 2007, REDOX REP, V12, P219, DOI 10.1179/135100007X200272; Mulholland M, 1997, J CHROMATOGR A, V762, P73, DOI 10.1016/S0021-9673(96)00976-4; Muniz P, 2000, IUBMB LIFE, V49, P497; Orhan H, 2004, J CHROMATOGR B, V799, P245, DOI 10.1016/j.jchromb.2003.10.056; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Sabatini L, 2005, RAPID COMMUN MASS SP, V19, P147, DOI 10.1002/rcm.1763; Saravanabhavan G, 2010, J CHROMATOGR A, V1217, P3269, DOI 10.1016/j.chroma.2010.01.048; Solberg R, 2007, PEDIATR RES, V62, P559, DOI 10.1203/PDR.0b013e318156e8aa; TAGESSON C, 1995, EUR J CANCER, V31A, P934, DOI 10.1016/0959-8049(94)00490-0; Therond P, 2000, Curr Opin Clin Nutr Metab Care, V3, P373, DOI 10.1097/00075197-200009000-00009; U.S. FDA, 1998, GUIDANCE IND BIOANAL; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Vento M, 2001, PEDIATRICS, V107, P642, DOI 10.1542/peds.107.4.642; Vento M, 2012, J MATERN-FETAL NEO M, V25, P45, DOI 10.3109/14767058.2012.663175; Vento M, 2012, CLIN PERINATOL, V39, P165, DOI 10.1016/j.clp.2011.12.014; Vento M, 2011, NEONATOLOGY, V99, P342, DOI 10.1159/000326626; Vento M, 2009, ANTIOXID REDOX SIGN, V11, P2945, DOI 10.1089/ars.2009.2671; Vento M, 2009, PEDIATRICS, V124, pE439, DOI 10.1542/peds.2009-0434; Vieux R, 2010, PEDIATRICS, V125, pE1186, DOI 10.1542/peds.2009-1426; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010	38	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93703	10.1371/journal.pone.0093703	http://dx.doi.org/10.1371/journal.pone.0093703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695409	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000107
J	Matesanz, S; Theiss, KE; Holsinger, KE; Sultan, SE				Matesanz, Silvia; Theiss, Kathryn E.; Holsinger, Kent E.; Sultan, Sonia E.			Genetic Diversity and Population Structure in Polygonum cespitosum: Insights to an Ongoing Plant Invasion	PLOS ONE			English	Article							EVOLUTION; GENOTYPE; PROGRAM; HISTORY; MARKERS; DIFFERENTIATION; INCREASES; INFERENCE; PATTERNS; SHRUB	Molecular markers can help elucidate how neutral evolutionary forces and introduction history contribute to genetic variation in invaders. We examined genetic diversity, population structure and colonization patterns in the invasive Polygonum cespitosum, a highly selfing, tetraploid Asian annual introduced to North America. We used nine diploidized polymorphic microsatellite markers to study 16 populations in the introduced range ( northeastern North America), via the analyses of 516 individuals, and asked the following questions: 1) Do populations have differing levels of within-population genetic diversity? 2) Do populations form distinct genetic clusters? 3) Does population structure reflect either geographic distances or habitat similarities? We found low heterozygosity in all populations, consistent with the selfing mating system of P. cespitosum. Despite the high selfing levels, we found substantial genetic variation within and among P. cespitosum populations, based on the percentage of polymorphic loci, allelic richness, and expected heterozygosity. Inferences from individual assignment tests ( Bayesian clustering) and pairwise F-ST values indicated high among-population differentiation, which indicates that the effects of gene flow are limited relative to those of genetic drift, probably due to the high selfing rates and the limited seed dispersal ability of P. cespitosum. Population structure did not reflect a pattern of isolation by distance nor was it related to habitat similarities. Rather, population structure appears to be the result of the random movement of propagules across the introduced range, possibly associated with human dispersal. Furthermore, the high population differentiation, genetic diversity, and fine-scale genetic structure ( populations founded by individuals from different genetic sources) in the introduced range suggest that multiple introductions to this region may have occurred. High genetic diversity may further contribute to the invasive success of P. cespitosum in its introduced range.	[Matesanz, Silvia] Univ Rey Juan Carlos, Dept Biol & Geol, Area Biodiversidad & Conservac, Mostoles, Spain; [Theiss, Kathryn E.] Willamette Univ, Dept Biol, Salem, OR 97301 USA; [Theiss, Kathryn E.; Holsinger, Kent E.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA; [Sultan, Sonia E.] Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA	Universidad Rey Juan Carlos; Willamette University; University of Connecticut; Wesleyan University	Matesanz, S (corresponding author), Univ Rey Juan Carlos, Dept Biol & Geol, Area Biodiversidad & Conservac, Mostoles, Spain.	silvia.matesanzgarcia@gmail.com	Matesanz, Silvia/L-5153-2014; Matesanz, Silvia/U-3009-2019; Holsinger, Kent/A-7435-2009	Matesanz, Silvia/0000-0003-0060-6136; Holsinger, Kent/0000-0003-4312-3804	Marie Curie IOF Fellowship (European Commission FP7); Howard Hughes Medical Institute	Marie Curie IOF Fellowship (European Commission FP7); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The study was funded by a Marie Curie IOF Fellowship (European Commission FP7) awarded to S. Matesanz and by support from the Howard Hughes Medical Institute for student assistants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjen L., 2003, SMALL, V5, P277; Baker H. G., 1965, The genetics of colonizing species., P147; Barrett S.C.H., 1986, P21; Barrett S. C. H., 1990, Plant population genetics, breeding, and genetic resources., P254; Blair AC, 2004, ECOLOGY, V85, P3035, DOI 10.1890/04-0341; BLAKE SF, 1932, RHODORA J N ENGL BOT, V34, P146; Cmokrak P, 2002, TRENDS ECOL EVOL, V17, P501; Cornuet JM, 1996, GENETICS, V144, P2001; DeWalt SJ, 2011, AM J BOT, V98, P1128, DOI 10.3732/ajb.1000297; DeWalt SJ, 2004, AM J BOT, V91, P1155, DOI 10.3732/ajb.91.8.1155; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Durka W, 2005, MOL ECOL, V14, P1697, DOI 10.1111/j.1365-294X.2005.02521.x; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Group CIPW, 2012, CONN INV PLANT LIST; Hardesty BD, 2012, DIVERS DISTRIB, V18, P147, DOI 10.1111/j.1472-4642.2011.00832.x; HUSBAND BC, 1991, HEREDITY, V66, P287, DOI 10.1038/hdy.1991.36; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kim ST, 2008, P NATL ACAD SCI USA, V105, P12370, DOI 10.1073/pnas.0805141105; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Lambrinos JG, 2004, ECOLOGY, V85, P2061, DOI 10.1890/03-8013; Latta RG, 2002, TRENDS ECOL EVOL, V17, P501, DOI 10.1016/S0169-5347(02)02601-0; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Le Roux JJ, 2008, DIVERS DISTRIB, V14, P935, DOI 10.1111/j.1472-4642.2008.00504.x; Legendre P., 2012, NUMERICAL ECOLOGY; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Markwith SH, 2006, MOL ECOL NOTES, V6, P586, DOI 10.1111/j.1471-8286.2006.01345.x; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Marrs RA, 2008, BIOL INVASIONS, V10, P561, DOI 10.1007/s10530-007-9153-6; Matesanz S, 2013, BIOL INVASI IN PRESS; Matesanz S, 2013, ECOLOGY, V94, P2464, DOI 10.1890/12-1359.1; Matesanz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044955; Matesanz S, 2011, AM J BOT, V98, pE180, DOI 10.3732/ajb.1100053; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Mehrhoff L.J., 2003, IPANE INVASIVE PLANT; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Novak SJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P201; NOVAK SJ, 1993, HEREDITY, V71, P167, DOI 10.1038/hdy.1993.121; Okada M, 2009, DIVERS DISTRIB, V15, P148, DOI 10.1111/j.1472-4642.2008.00530.x; Paterson A.K., 2000, BARTONIA, V60, P57; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Porcher E, 2006, GENET RES, V87, P1, DOI 10.1017/S0016672306007920; Pritchard JK, 2000, GENETICS, V155, P945; Rambuda TD, 2004, DIVERS DISTRIB, V10, P409, DOI 10.1111/j.1366-9516.2004.00100.x; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Sultan SE, 1998, J ECOL, V86, P363, DOI 10.1046/j.1365-2745.1998.00265.x; Sultan SE, 2013, EVOL APPL, V6, P266, DOI 10.1111/j.1752-4571.2012.00287.x; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wichmann MC, 2009, P ROY SOC B-BIOL SCI, V276, P523, DOI 10.1098/rspb.2008.1131; Wright S, 1943, GENETICS, V28, P114; Yonekura K., 2006, FLORA JAPAN A, P122; Zhan AB, 2012, ECOL EVOL, V2, P1331, DOI 10.1002/ece3.258	65	15	16	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93217	10.1371/journal.pone.0093217	http://dx.doi.org/10.1371/journal.pone.0093217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695495	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000049
J	Pinna, G; Pascale, C; Fornengo, P; Arras, S; Piras, C; Panzarasa, P; Carmosino, G; Franza, O; Semeraro, V; Lenti, S; Pietrelli, S; Panzone, S; Bracco, C; Fiorini, R; Rastelli, G; Bergandi, D; Zampaglione, B; Musso, R; Marengo, C; Santoro, G; Zamboni, S; Traversa, B; Barattini, M; Bruno, G				Pinna, Giuliano; Pascale, Claudio; Fornengo, Paolo; Arras, Sebastiana; Piras, Carmela; Panzarasa, Pietro; Carmosino, Gianpaolo; Franza, Orietta; Semeraro, Vincenzo; Lenti, Salvatore; Pietrelli, Susanna; Panzone, Sergio; Bracco, Christian; Fiorini, Roberto; Rastelli, Giovanni; Bergandi, Daniela; Zampaglione, Bruno; Musso, Roberto; Marengo, Claudio; Santoro, Giancarlo; Zamboni, Sergio; Traversa, Barbara; Barattini, Maddalena; Bruno, Graziella			Hospital Admissions for Hypertensive Crisis in the Emergency Departments: A Large Multicenter Italian Study	PLOS ONE			English	Article							URGENCIES; PREVALENCE; MANAGEMENT; PATTERNS	Epidemiological data on the impact of hypertensive crises (emergencies and urgencies) on referral to the Emergency Departments (EDs) are lacking, in spite of the evidence that they may be life-threatening conditions. We performed a multicenter study to identify all patients aged 18 years and over who were admitted to 10 Italian EDs during 2009 for hypertensive crises (systolic blood pressure >= 220 mmHg and/or diastolic blood pressure >= 120 mmHg). We classified patients as affected by either hypertensive emergencies or hypertensive urgencies depending on the presence or the absence of progressive target organ damage, respectively. Logistic regression analysis was then performed to assess variables independently associated with hypertensive emergencies with respect to hypertensive urgencies. Of 333,407 patients admitted to the EDs over the one-year period, 1,546 had hypertensive crises (4.6/1,000, 95% CI 4.4-4.9), and 23% of them had unknown hypertension. Hypertensive emergencies (n = 391, 25.3% of hypertensive crises) were acute pulmonary edema (30.9%), stroke (22.0%,), myocardial infarction (17.9%), acute aortic dissection (7.9%), acute renal failure (5.9%) and hypertensive encephalopathy (4.9%). Men had higher frequency than women of unknown hypertension (27.9% vs 18.5%, p<0.001). Even among known hypertensive patients, a larger proportion of men than women reported not taking antihypertensive drug (12.6% among men and 9.4% among women (p<0.001). Compared to women of similar age, men had higher likelihood of having hypertensive emergencies than urgencies (OR = 1.34, 95% CI 1.06-1.70), independently of presenting symptoms, creatinine, smoking habit and known hypertension. This study shows that hypertensive crises involved almost 5 out of 1,000 patients-year admitted to EDs. Sex differences in frequencies of unknown hypertension, compliance to treatment and risk of hypertensive emergencies might have implications for public health programs.	[Pinna, Giuliano; Pascale, Claudio] Osped Cottolengo, Dept Internal Med, Turin, Italy; [Arras, Sebastiana; Piras, Carmela] Osped Civile, Emergency Dept, Sassari, Italy; [Panzarasa, Pietro; Carmosino, Gianpaolo] Osped Umberto Parini, Emergency Dept, Aosta, Italy; [Franza, Orietta; Semeraro, Vincenzo] Osped Cardinal Massaia, Emergency Dept, Aosta, Italy; [Lenti, Salvatore; Pietrelli, Susanna] Osped San Donato, Emergency Dept, Arezzo, Italy; [Panzone, Sergio; Bracco, Christian] Azienda Osped Santa Croce & Carle, Emergency Dept, Cuneo, Italy; [Fiorini, Roberto; Rastelli, Giovanni] Presidio Osped, Emergency Dept, Parma, Italy; [Bergandi, Daniela; Zampaglione, Bruno] Presidio Osped Martini, Emergency Dept, Turin, Italy; [Musso, Roberto; Marengo, Claudio] Osped Santa Croce, Emergency Dept, Turin, Italy; [Santoro, Giancarlo; Zamboni, Sergio] Osped Civile, Emergency Dept, Rovigo, Italy; [Traversa, Barbara; Barattini, Maddalena] Osped SS Antonio & Margherita, Emergency Dept, Tortona, Italy; [Bruno, Graziella] Univ Turin, Dept Med Sci, Turin, Italy	Azienda USL della Valle d'Aosta; IRCCS Policlinico San Donato; University of Parma; University Hospital of Parma; University of Turin	Fornengo, P (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	paolo.fornengo@unito.it		BRUNO, Graziella/0000-0002-3011-8304	Societa Italiana dell'Ipertensione Arteriosa	Societa Italiana dell'Ipertensione Arteriosa	The funder is the Societa Italiana dell'Ipertensione Arteriosa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cerrillo MR, 2002, REV CLIN ESP, V202, P255, DOI 10.1016/S0014-2565(02)71046-1; Cherney D, 2002, J GEN INTERN MED, V17, P937, DOI 10.1046/j.1525-1497.2002.20389.x; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Elijovich F, 2010, HYPERTENSION, V56, P808, DOI 10.1161/HYPERTENSIONAHA.110.159038; Hu D, 2010, NUTR METAB CARDIOVAS, V20, P394, DOI 10.1016/j.numecd.2010.02.016; Katz JN, 2009, AM HEART J, V158, P599, DOI 10.1016/j.ahj.2009.07.020; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Liu LS, 2006, INT J STROKE, V1, P150, DOI 10.1111/j.1747-4949.2006.00041.x; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Marik PE, 2007, CHEST, V131, P1949, DOI 10.1378/chest.06-2490; Martin Jose Fernando Vilela, 2004, Arq Bras Cardiol, V83, P131; National High Blood Pressure Education Program, 2004, NIH PUBLICATION, V04-5230; Perez MI, 2008, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003653.pub3; Saguner AM, 2010, AM J HYPERTENS, V23, P775, DOI 10.1038/ajh.2010.71; Slama M, 2006, CURR OPIN CARDIOL, V21, P279, DOI 10.1097/01.hco.0000231396.56738.d8; Vilela Martin JF, 2010, HYPERTENS RES, V1, P1; Vlcek M, 2008, J HYPERTENS, V26, P657, DOI 10.1097/HJH.0b013e3282f4e8b6; WEBSTER J, 1993, Q J MED, V86, P485, DOI 10.1093/qjmed/86.8.485; World Health Organization Statistical Information System (WHOSIS), 2004, EST WHO REG; Zampaglione B, 1996, HYPERTENSION, V27, P144, DOI 10.1161/01.HYP.27.1.144	20	61	69	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93542	10.1371/journal.pone.0093542	http://dx.doi.org/10.1371/journal.pone.0093542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695800	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000086
J	Knox, PC; Wolohan, FDA				Knox, Paul C.; Wolohan, Felicity D. A.			Cultural Diversity and Saccade Similarities: Culture Does Not Explain Saccade Latency Differences between Chinese and Caucasian Participants	PLOS ONE			English	Article							EXPRESS SACCADES; REACTION-TIMES; EYE-MOVEMENTS; NEUROSCIENCE; VALIDITY; VALUES; MIND; PERCEPTION	A central claim of cultural neuroscience is that the culture to which an individual belongs plays a key role in shaping basic cognitive processes and behaviours, including eye movement behaviour. We previously reported a robust difference in saccade behaviour between Chinese and Caucasian participants; Chinese participants are much more likely to execute low latency express saccades, in circumstances in which these are normally discouraged. To assess the extent to which this is the product of culture we compared a group of 70 Chinese overseas students (whose primary cultural exposure was that of mainland China), a group of 45 participants whose parents were Chinese but who themselves were brought up in the UK (whose primary cultural exposure was western European) and a group of 70 Caucasian participants. Results from the Schwartz Value Survey confirmed that the UK-Chinese group were culturally similar to the Caucasian group. However, their patterns of saccade latency were identical to the mainland Chinese group, and different to the Caucasian group. We conclude that at least for the relatively simple reflexive saccade behaviour we have investigated, culture cannot explain the observed differences in behaviour.	[Knox, Paul C.; Wolohan, Felicity D. A.] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Knox, PC (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England.	pcknox@liv.ac.uk	Knox, Paul/Q-1920-2019	Knox, Paul/0000-0002-2578-7335; Wolohan, Felicity/0000-0002-8403-1730	Leverhulme Trust [RPG329]	Leverhulme Trust(Leverhulme Trust)	This study was supported by a project grant from the Leverhulme Trust (RPG329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatya N, 2011, EXP BRAIN RES, V210, P117, DOI 10.1007/s00221-011-2609-z; Biscaldi M, 1996, J NEUROPHYSIOL, V76, P199, DOI 10.1152/jn.1996.76.1.199; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Bohns VK, 2011, J EXP SOC PSYCHOL, V47, P676, DOI 10.1016/j.jesp.2011.01.001; Cavegn D, 1996, EXP BRAIN RES, V109, P101; Chang FM, 1996, HUM GENET, V98, P91, DOI 10.1007/s004390050166; Chiao JY, 2013, PERSPECT PSYCHOL SCI, V8, P56, DOI 10.1177/1745691612469032; Chiao JY, 2010, SOC COGN AFFECT NEUR, V5, P356, DOI 10.1093/scan/nsq063; Chiao JY, 2010, P ROY SOC B-BIOL SCI, V277, P529, DOI 10.1098/rspb.2009.1650; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Datler G, 2013, SOC SCI RES, V42, P906, DOI 10.1016/j.ssresearch.2012.12.009; de Fockert JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026337; Denkhaus R, 2012, BIOSOCIETIES, V7, P433, DOI 10.1057/biosoc.2012.30; Dorris MC, 1997, J NEUROSCI, V17, P8566; Edelman JA, 1996, J NEUROPHYSIOL, V76, P908, DOI 10.1152/jn.1996.76.2.908; FISCHER B, 1993, BEHAV BRAIN SCI, V16, P553, DOI 10.1017/S0140525X00031575; FISCHER B, 1993, EXP BRAIN RES, V92, P528; FISCHER B, 1983, BRAIN RES, V260, P21, DOI 10.1016/0006-8993(83)90760-6; Fischer R, 2011, J CROSS CULT PSYCHOL, V42, P1127, DOI 10.1177/0022022110381429; Gezeck S, 1997, VISION RES, V37, P2119, DOI 10.1016/S0042-6989(97)00022-9; Goh JOS, 2011, SOCIAL COGNITIVE AFF; Goh JO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008238; Goh JOS, 2010, SOC COGN AFFECT NEUR, V5, P227, DOI 10.1093/scan/nsq060; Heine SJ, 2002, J PERS SOC PSYCHOL, V82, P903, DOI 10.1037//0022-3514.82.6.903; Ji LJ, 2000, J PERS SOC PSYCHOL, V78, P943, DOI 10.1037/0022-3514.78.5.943; KALESNYKAS RP, 1987, EXP BRAIN RES, V68, P115; Kelly DJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00095; Kelly DJ, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00006; Kim HS, 2010, SOC COGN AFFECT NEUR, V5, P212, DOI 10.1093/scan/nsp040; KINGSTONE A, 1993, PERCEPT PSYCHOPHYS, V54, P260, DOI 10.3758/BF03211762; Kitayama S, 2003, PSYCHOL SCI, V14, P201, DOI 10.1111/1467-9280.02432; Kitayama S, 2011, ANNU REV PSYCHOL, V62, P419, DOI 10.1146/annurev-psych-120709-145357; Knox PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047688; Kobayashi C, 2006, BRAIN LANG, V98, P210, DOI 10.1016/j.bandl.2006.04.013; Losin EAR, 2010, SOC COGN AFFECT NEUR, V5, P148, DOI 10.1093/scan/nsp058; Mateo MM, 2012, NEUROSCI BIOBEHAV R, V36, P152, DOI 10.1016/j.neubiorev.2011.05.006; McKone E, 2010, VISION RES, V50, P1540, DOI 10.1016/j.visres.2010.05.010; Peng KP, 1997, PSYCHOL METHODS, V2, P329, DOI 10.1037/1082-989X.2.4.329; Petrova K, 2013, VISION RES, V84, P43, DOI 10.1016/j.visres.2013.03.008; SASLOW MG, 1967, J OPT SOC AM, V57, P1024, DOI 10.1364/JOSA.57.001024; SCHILLER PH, 1987, J NEUROPHYSIOL, V57, P1033, DOI 10.1152/jn.1987.57.4.1033; Schwartz S. H., 2009, USERS MANUA IN PRESS; Schwartz SH, 2004, J RES PERS, V38, P230, DOI 10.1016/S0092-6566(03)00069-2; SCHWARTZ SH, 1995, J CROSS CULT PSYCHOL, V26, P92, DOI 10.1177/0022022195261007; Schwartz SH, 2001, J CROSS CULT PSYCHOL, V32, P519, DOI 10.1177/0022022101032005001; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; Schwartz SH, 2012, ONLINE READINGS PSYC; Tan CBY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029714; Valsiner J, 2009, CULT PSYCHOL, V15, P5, DOI 10.1177/1354067X08101427; Wang Q, 2009, COGNITION, V111, P123, DOI 10.1016/j.cognition.2009.01.004; WENBANSMITH MG, 1991, EXP BRAIN RES, V87, P218; Wu SL, 2007, PSYCHOL SCI, V18, P600, DOI 10.1111/j.1467-9280.2007.01946.x	52	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94424	10.1371/journal.pone.0094424	http://dx.doi.org/10.1371/journal.pone.0094424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7EP	24709988	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800144
J	Taloni, A; Alemi, AA; Ciusani, E; Sethna, JP; Zapperi, S; La Porta, CAM				Taloni, Alessandro; Alemi, Alexander A.; Ciusani, Emilio; Sethna, James P.; Zapperi, Stefano; La Porta, Caterina A. M.			Mechanical Properties of Growing Melanocytic Nevi and the Progression to Melanoma	PLOS ONE			English	Article							TUMOR-GROWTH; MALIGNANT PHENOTYPE; CELL POPULATIONS; CANCER-CELLS; HUMAN SKIN; IN-VITRO; STRESS; BEHAVIOR; PROLIFERATION; SPHEROIDS	Melanocytic nevi are benign proliferations that sometimes turn into malignant melanoma in a way that is still unclear from the biochemical and genetic point of view. Diagnostic and prognostic tools are then mostly based on dermoscopic examination and morphological analysis of histological tissues. To investigate the role of mechanics and geometry in the morpholgical dynamics of melanocytic nevi, we study a computation model for cell proliferation in a layered non-linear elastic tissue. Numerical simulations suggest that the morphology of the nevus is correlated to the initial location of the proliferating cell starting the growth process and to the mechanical properties of the tissue. Our results also support that melanocytes are subject to compressive stresses that fluctuate widely in the nevus and depend on the growth stage. Numerical simulations of cells in the epidermis releasing matrix metalloproteinases display an accelerated invasion of the dermis by destroying the basal membrane. Moreover, we suggest experimentally that osmotic stress and collagen inhibit growth in primary melanoma cells while the effect is much weaker in metastatic cells. Knowing that morphological features of nevi might also reflect geometry and mechanics rather than malignancy could be relevant for diagnostic purposes.	[Taloni, Alessandro; Zapperi, Stefano] CNR, Ist Energet & Interfasi, I-20133 Milan, Italy; [Alemi, Alexander A.; Sethna, James P.] Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Ciusani, Emilio] Ist Neurol Carlo Besta, Milan, Italy; [Zapperi, Stefano] Inst Sci Interchange Fdn, Turin, Italy; [La Porta, Caterina A. M.] Univ Milan, Dept Biosci, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Cornell University; IRCCS Istituto Neurologico Besta; University of Milan	La Porta, CAM (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	caterina.laporta@unimi.it	Taloni, Alessandro/AAF-1641-2020; Ciusani, Emilio/J-9822-2016; Taloni, Alessandro/N-3121-2016; Zapperi, Stefano/C-9473-2009; la porta, caterina/K-7345-2013	Taloni, Alessandro/0000-0002-8863-7166; Ciusani, Emilio/0000-0002-7285-123X; Taloni, Alessandro/0000-0002-8863-7166; Zapperi, Stefano/0000-0001-5692-5465; la porta, caterina/0000-0002-3010-8966	National Science Foundation [PHY-1066293]; NCI [U54CA143876]; European Research Council [AdG-2011 SIZEFFECTS]; MIUR [PRIN2010];  [NSF-PHY-0941095]; Division Of Materials Research [1312160] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [U54CA143876] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Research Council(European Research Council (ERC)European Commission); MIUR(Ministry of Education, Universities and Research (MIUR)); ; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CAMLP, JPS and SZ acknowledge the hospitality of the Aspen Center for Physics, which is supported by the National Science Foundation, Grant PHY-1066293. AA is supported by NSF-PHY-0941095; JSP by NCI U54CA143876; AT and SZ by the European Research Council AdG-2011 SIZEFFECTS; CAMLP by MIUR PRIN2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008511; Baraldi MM, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/02/P02032; Baxter LL, 2013, WIRES DEV BIOL, V2, P379, DOI 10.1002/wdev.72; Bitzek E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.170201; BONNETGONNET C, 1994, LANGMUIR, V10, P4012, DOI 10.1021/la00023a019; Chatelain Cyrille, 2011, Boissiera, V64, P13; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; CLARK WH, 1984, HUM PATHOL, V15, P1147, DOI 10.1016/S0046-8177(84)80310-X; CRAMER S F, 1988, Pediatric Pathology, V8, P253; Drasdo D, 2005, PHYS BIOL, V2, P133, DOI 10.1088/1478-3975/2/3/001; DRASDO D, 1995, PHYS REV E, V52, P6635, DOI 10.1103/PhysRevE.52.6635; Drasdo D, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/055025; Eikenberry S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000362; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Hendriks FM, 2003, SKIN RES TECHNOL, V9, P274, DOI 10.1034/j.1600-0846.2003.00019.x; Hendriks FM, 2006, MED ENG PHYS, V28, P259, DOI 10.1016/j.medengphy.2005.07.001; Hendriks FM, 2005, THESIS TU EINDHOVEN; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Holcombe M, 2012, INTEGR BIOL-UK, V4, P53, DOI 10.1039/c1ib00042j; Howell D, 1999, PHYS REV LETT, V82, P5241, DOI 10.1103/PhysRevLett.82.5241; JAMES AG, 1975, J APPL POLYM SCI, V19, P2033, DOI 10.1002/app.1975.070190723; Kim JK, 2012, GIORN ITAL DERMAT V, V147, P141; Kittler H, 2000, ARCH DERMATOL, V136, P316, DOI 10.1001/archderm.136.3.316; Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476; La Porta CAM, 2009, CURR CANCER DRUG TAR, V9, P391, DOI 10.2174/156800909788166574; Lekka M, 1999, EUR BIOPHYS J BIOPHY, V28, P312, DOI 10.1007/s002490050213; Long R, 2011, BIOPHYS J, V101, P643, DOI 10.1016/j.bpj.2011.06.049; Montel F, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/055008; Montel F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.188102; MSC Software Corporation, 2001, THEOR US INF VERS 20; Nielsen MB, 2008, AM J PHYSIOL-CELL PH, V294, pC1046, DOI 10.1152/ajpcell.00134.2007; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Plank MJ, 2012, J R SOC INTERFACE, V9, P2983, DOI 10.1098/rsif.2012.0319; Racz B, 2007, BONE, V40, P1536, DOI 10.1016/j.bone.2007.02.011; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Simonsen TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040006; Simpson MJ, 2013, B MATH BIOL, V75, P871, DOI 10.1007/s11538-013-9839-0; Taghizadeh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015183; Thingnes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040377; Treloar KK, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-137; Tse JM, 2012, P NATL ACAD SCI USA, V109, P911, DOI 10.1073/pnas.1118910109; Unna PG, 1893, BERL KLIN WOCHENSCHR, V30; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Walker DC, 2004, BIOSYSTEMS, V76, P89, DOI 10.1016/j.biosystems.2004.05.025; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Wu M, 2013, J THEOR BIOL, V320, P131, DOI 10.1016/j.jtbi.2012.11.031; Zalaudek I, 2009, SEMIN CUTAN MED SURG, V28, P149, DOI 10.1016/j.sder.2009.06.005; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	49	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94229	10.1371/journal.pone.0094229	http://dx.doi.org/10.1371/journal.pone.0094229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709938	Green Submitted, gold, Green Published			2022-12-27	WOS:000334159800122
J	Zhang, TJ; Tully, DC; Zhou, SJ; He, N				Zhang, Tiejun; Tully, Damien C.; Zhou, Sujuan; He, Na			Characteristics of HCV Co-Infection among HIV Infected Individuals from an Area with High Risk of Blood-Borne Infections in Central China	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; NATURAL-HISTORY; LIVER FIBROSIS; DONORS; PROGRESSION; DISEASE; SEQUENCES; GENOTYPES	Objective: Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection has been proved to be a growing public health concern. The prevalence and genotypic pattern vary with geographic locations. Limited information is available to date with regard to HCV genotype and its clinical implications among those former commercial blood donor communities. The aims of this study were to genetically define the HCV genotype and associated clinical characteristics of HIV/ HCV co-infected patients from a region with commercial blood donation history in central China. Methods: A cross sectional study, including 164 HIV infected subjects, was conducted in Shanxi province central China. Serum samples were collected and HCV antibody testing, AST and ALT testing were performed. Seropositive samples were further subjected to RT-PCR followed by direct sequence coupled with phylogenetic analysis of Core-E1 and NS5B regions performed in comparison with known reference genotypes. Findings: A total of 139 subjects were HCV antibody positive. Genotype could be determined for 88 isolates. Phylogenetic analysis revealed that the predominant circulating subtype was HCV 1b (65.9%), followed by HCV 2a (34.1%). The HCV viral load in the subjects infected with HIV1b was significantly higher than those infected with HCV 2a (P = 0.006). No significant difference for HCV RNA level was detected between ART status, CD4+ cell count level and HIV RNA level. Serum AST and ALT level were likely to increase with HCV RNA level, although no significance was observed. Those who had conducted commercial donation later than 1991 (OR 3.43, 95% CI: 1.12-10.48) and had a short duration of donation (OR 0.35, 95% CI: 0.13-0.96) were more likely to be infected with HCV 1b. Conclusion: These results suggest that HCV subtype 1b predominates in this population, and the impact of HIV status and ART on HCV disease progression is not significantly correlated.	[Zhang, Tiejun; Zhou, Sujuan; He, Na] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China; [Zhang, Tiejun; Zhou, Sujuan; He, Na] Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Shanghai 200433, Peoples R China; [Tully, Damien C.] MIT, Ragon Inst MGH, Boston, MA USA; [Tully, Damien C.] Harvard Univ, Sch Med, Boston, MA USA	Fudan University; Fudan University; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School	He, N (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China.	nhe@shmu.edu.cn	Zhang, Tiejun/HDM-7091-2022; zhang, Tiejun/HGD-6858-2022	Tully, Damien/0000-0002-7620-9340	Program of excellent public health young talent of Shanghai [08GWQ058]; National Nature Science Foundation of China [81072345]; Shanghai Leading Disciplinary Project [GWZX0101]; National Science Foundation of China [81373062]; Doctoral Fund of Ministry of Education of China [20120071120050]	Program of excellent public health young talent of Shanghai; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Disciplinary Project; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This study was supported by Program of excellent public health young talent of Shanghai (08GWQ058), National Nature Science Foundation of China (81072345), Shanghai Leading Disciplinary Project (grant no. GWZX0101), National Science Foundation of China (grant no. 81373062) and Doctoral Fund of Ministry of Education of China (Grant No. 20120071120050 to TZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2002, HEPATOLOGY, V36, pS93, DOI 10.1053/jhep.2002.36389; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Bonacini M, 1999, J VIRAL HEPATITIS, V6, P203, DOI 10.1046/j.1365-2893.1999.00153.x; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cohen J, 2004, SCIENCE, V304, P1438, DOI 10.1126/science.304.5676.1438; Danta M, 2008, J INFECT DIS, V197, P1558, DOI 10.1086/587843; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fu Y, 2011, J VIRAL HEPATITIS, V18, P42, DOI 10.1111/j.1365-2893.2010.01280.x; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Liu J, 2011, AIDS RES HUM RETROVI; Liu PP, 2008, AIDS RES HUM RETROV, V24, P1, DOI 10.1089/aid.2007.0144; Liu Zhen, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P464; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Piroth L, 1998, AIDS, V12, P381, DOI 10.1097/00002030-199804000-00006; Qian HZ, 2006, AIDS, V20, P1429, DOI 10.1097/01.aids.0000233577.33973.fa; Ragni MV, 2001, J INFECT DIS, V183, P1112, DOI 10.1086/319273; Romeo R, 1996, J VIRAL HEPATITIS, V3, P183, DOI 10.1111/j.1365-2893.1996.tb00093.x; Sabin CA, 1997, J INFECT DIS, V175, P164, DOI 10.1093/infdis/175.1.164; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; Shi Xiao-ming, 2006, Zhonghua Yufang Yixue Zazhi, V40, P427; Simmonds P, 1999, J HEPATOL, V31, P54, DOI 10.1016/S0168-8278(99)80375-4; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3; Sulkowski MS, 2000, CLIN INFECT DIS, V30, pS77, DOI 10.1086/313842; SUN YD, 1991, CHINESE MED J-PEKING, V104, P975; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Verma S, 2006, CLIN INFECT DIS, V42, P262, DOI 10.1086/499055; WU ZY, 1995, LANCET, V346, P61, DOI 10.1016/S0140-6736(95)92698-4; Zein NN, 2000, CLIN MICROBIOL REV, V13, P223, DOI 10.1128/CMR.13.2.223-235.2000; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhang MD, 2005, EMERG INFECT DIS, V11, P17, DOI 10.3201/eid1101.031005	34	6	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94219	10.1371/journal.pone.0094219	http://dx.doi.org/10.1371/journal.pone.0094219			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709894	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800121
J	Ahmed, T; Zhang, TT; Wang, ZY; He, KL; Bai, SX				Ahmed, Tofael; Zhang, Tian-tao; Wang, Zhen-ying; He, Kang-lai; Bai, Shu-xiong			Three Amino Acid Residues Bind Corn Odorants to McinOBP1 in the Polyembryonic Endoparasitoid of Macrocentrus cingulum Brischke	PLOS ONE			English	Article							PHEROMONE-BINDING; CRYSTAL-STRUCTURE; CHEMOSENSORY PROTEINS; OSTRINIA-FURNACALIS; ANOPHELES-GAMBIAE; SEXUAL ATTRACTION; NMR STRUCTURE; GYPSY-MOTH; PLANT BUG; I-TASSER	Odorant binding proteins (OBPs) play a central role in transporting odorant molecules from the sensillum lymph to olfactory receptors to initiate behavioral responses. In this study, the OBP of Macrocentrus cingulum McinOBP1 was expressed in Escherichia coli and purified by Ni ion affinity chromatography. Real-time PCR experiments indicate that the McinOBP1 is expressed mainly in adult antennae, with expression levels differing by sex. Ligand-binding experiments using N-phenyl-naphthylamine (1-NPN) as a fluorescent probe demonstrated that the McinOBP1 can bind green-leaf volatiles, including aldehydes and terpenoids, but also can bind aliphatic alcohols with good affinity, in the order trans-2-nonenal>cis-3-hexen-1-ol>trans-caryophelle, suggesting a role of McinOBP1 in general odorant chemoreception. We chose those three odorants for further homology modeling and ligand docking based on their binding affinity. The Val58, Leu62 and Glu130 are the key amino acids in the binding pockets that bind with these three odorants. The three mutants, Val58, Leu62 and Glu130, where the valine, leucine and glutamic residues were replaced by alanine, proline and alanine, respectively; showed reduced affinity to these odorants. This information suggests, Val58, Leu62 and Glu130 are involved in the binding of these compounds, possibly through the specific recognition of ligands that forms hydrogen bonds with the ligands functional groups.	[Ahmed, Tofael; Zhang, Tian-tao; Wang, Zhen-ying; He, Kang-lai; Bai, Shu-xiong] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Ahmed, Tofael] Bangladesh Sugarcane Res Inst, Ishurdi, Pabna, Bangladesh	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Bangladesh Sugarcane Research Institute (BSRI)	Wang, ZY (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	zywang@ippcaas.cn		Zhang, Tiantao/0000-0002-7746-7931	specific fund for Agro-Scientific Research in the public interest [201303026]; China Agriculture Research System [CARS-02]	specific fund for Agro-Scientific Research in the public interest; China Agriculture Research System	This work was funded by the specific fund for Agro-Scientific Research in the public interest (201303026) and China Agriculture Research System (CARS-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED T, 2013, MICRON; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Ban LP, 2002, BIOCHEM BIOPH RES CO, V293, P50, DOI 10.1016/S0006-291X(02)00185-7; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; Damberger FF, 2007, J MOL BIOL, V373, P811, DOI 10.1016/j.jmb.2007.07.078; Edwards OR, 1999, ECOL ENTOMOL, V24, P7, DOI 10.1046/j.1365-2311.1999.00165.x; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gong YM, 2011, CHEM SENSES, V36, P291, DOI 10.1093/chemse/bjq130; Gong Y, 2009, CHEM BIOL, V16, P162, DOI 10.1016/j.chembiol.2009.01.005; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; Gu SH, 2010, CHINESE SCI BULL, V55, P3911, DOI 10.1007/s11434-010-4153-9; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hartlieb Elke, 1999, P315; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Honson NS, 2005, RECENT ADV PHYTOCHEM, V39, P227; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Hu J, 2003, J INSECT PHYSIOL, V49, P367, DOI 10.1016/S0022-1910(03)00021-0; Huang CH, 2009, INSECT SCI, V16, P311, DOI 10.1111/j.1744-7917.2009.01257.x; HUILIN Y, 2010, ENVIRON ENTOMOL, V39, P600; Krieger J, 1999, SCIENCE, V286, P720, DOI 10.1126/science.286.5440.720; Lagarde A, 2011, J MOL BIOL, V414, P401, DOI 10.1016/j.jmb.2011.10.005; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Ochieng SA, 2000, ARTHROPOD STRUCT DEV, V29, P231, DOI 10.1016/S1467-8039(01)00008-1; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Shiojiri K, 2000, APPL ENTOMOL ZOOL, V35, P87, DOI 10.1303/aez.2000.87; Spinelli S, 2012, INSECT BIOCHEM MOLEC, V42, P41, DOI 10.1016/j.ibmb.2011.10.005; Sun YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055132; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; VANDENBERG MJ, 1991, J INSECT PHYSIOL, V37, P79, DOI 10.1016/0022-1910(91)90022-R; Vincent F, 2000, J MOL BIOL, V300, P127, DOI 10.1006/jmbi.2000.3820; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, 2002, J EXP BIOL, V205, P719; Wang SY, 2013, INSECT MOL BIOL, V22, P172, DOI 10.1111/imb.12012; WATANABE C, 1967, Insecta Matsumurana, V30, P1; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Xu PJ, 2010, MOL BIOL REP, V37, P2265, DOI 10.1007/s11033-009-9715-z; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Yang G, 2011, PROTEIN EXPRES PURIF, V75, P165, DOI 10.1016/j.pep.2010.09.004; Yin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033589; Zhang SA, 2009, CHEM SENSES, V34, P503, DOI 10.1093/chemse/bjp027; Zhang TT, 2011, BIOCHEM BIOPH RES CO, V407, P393, DOI 10.1016/j.bbrc.2011.03.032; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou D.R., 1980, ACTA PHYTOPHYL SIN, V7, P113; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou JJ, 2009, J MOL BIOL, V389, P529, DOI 10.1016/j.jmb.2009.04.015	60	15	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93501	10.1371/journal.pone.0093501	http://dx.doi.org/10.1371/journal.pone.0093501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705388	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500039
J	Feng, TA; Sun, XW; Niu, WX; Wu, HJ; Jiang, CH				Feng, Tienan; Sun, Xiwen; Niu, Wenxin; Wu, Hengjing; Jiang, Chenghua			Evaluation of an Intervention to Improve Skills in Diagnostic Radiology of Rural Physicians over One Year in Four Rural Hospitals	PLOS ONE			English	Article							CONTINUING MEDICAL-EDUCATION; CHINA; DOCTORS	Background: Primary health care and patient triage are two basic functions of rural hospitals. As a routine test, the diagnostic radiology is still unavailable in some rural hospitals in China. Therefore, high-level hospitals are often the first choice of rural residents when they feel unwell. It brings serious social problems. This study was designed to propose an on-the- job drilling schema with integration of practical medical recordings and experienced radiological doctors as tutors to improve skills in diagnostic radiology of rural physicians. Methods: The information technology was used to help the contact between rural doctors and tutors. In a longitudinal pre/post- test control study design, a cohort of 20 young physicians, each of whom was working in a rural hospital and had a work experience less than two years, were established as the trial group over one year. Another 20 similar counterparts were established as the control group. Participants' performances were evaluated in four categories at five-time point (TP). Results: The trial group significantly outscored the control group on the style of writing at the second TP (d = 2.28); on the accuracy of the image description at final TP (d = 1.11); on the accuracy of the diagnosis at the fourth TP (d = 3.62); and on the correct treatment selection at the third TP (d = 6.45). The aspects with the most improvement were the accuracies of the diagnosis and the treatment selection. Conclusion: This study provided the detailed evidences that applying the on-the- job drilling schema has a significant effect on the skills improvement in diagnostic radiology of rural physicians. It was also concluded that the educational intervention based on practical cases was better than that only based on didactic slides presentation.	[Feng, Tienan] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Sun, Xiwen] Tongji Univ, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China; [Feng, Tienan; Niu, Wenxin; Wu, Hengjing; Jiang, Chenghua] Tongji Univ, Sch Med, Eastern Hosp, Dept Disaster & Emergency Med, Shanghai 200092, Peoples R China	Tongji University; Tongji University; Tongji University	Jiang, CH (corresponding author), Tongji Univ, Sch Med, Eastern Hosp, Dept Disaster & Emergency Med, Shanghai 200092, Peoples R China.	jch@tongji.edu.cn		Niu, Wenxin/0000-0003-1349-4524	integrated demonstration of rural remote areas disaster early warning and key rescue technology [NC2010RD0080]; The National Key Technology RD Program [2014BAL05B00]	integrated demonstration of rural remote areas disaster early warning and key rescue technology; The National Key Technology RD Program(National Key Technology R&D Program)	This work was supported by integrated demonstration of rural remote areas disaster early warning and key rescue technology (NC2010RD0080), and The National Key Technology R&D Program (Grant No. 2014BAL05B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apolinario D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060084; Buck G, 1990, GESNERUS, V48, P7; Chib A, 2013, CHIN J COMMUN, V6, P62, DOI 10.1080/17544750.2013.753500; Curran VR, 2005, MED EDUC, V39, P561, DOI 10.1111/j.1365-2929.2005.02173.x; Doherty J, 2012, SAMJ S AFR MED J, V102, P833, DOI [10.7196/SAMJ.5960, 10.7196/samj.5960]; Dollar D., 2007, WORLD BANK POLICY RE; Frehywot S, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-4; Ganatra HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004620; Hamm MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064922; Harden RM, 2005, J CONTIN EDUC HEALTH, V25, P43, DOI 10.1002/chp.8; Issa N, 2013, MED EDUC, V47, P388, DOI 10.1111/medu.12127; Jiangang P, 2008, REGIONAL EC DISPARIT; Khan AR., 2012, J ED PRACTICE, V3, P233; Krousel-Wood M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039020; Li XM, 2013, POSTGRAD MED J, V89, P202, DOI 10.1136/postgradmedj-2012-131094; McGaghie WC, 2010, MED EDUC, V44, P50, DOI 10.1111/j.1365-2923.2009.03547.x; Meng QY, 2012, GLOB PUBLIC HEALTH, V7, P124, DOI 10.1080/17441692.2011.616517; Peled JU, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000069; Rowe AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023783; Ruiz JG, 2006, ACAD MED, V81, P207, DOI 10.1097/00001888-200603000-00002; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Tienan F, 2012, SCI J ED TECHNOLOGY, V2, P7; Vyas R, 2012, Educ Health (Abingdon), V25, P70	23	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93889	10.1371/journal.pone.0093889	http://dx.doi.org/10.1371/journal.pone.0093889			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705822	Green Submitted, Green Published, gold			2022-12-27	WOS:000334107500085
J	Kirti, A; Rajaram, H; Apte, SK				Kirti, Anurag; Rajaram, Hema; Apte, Shree Kumar			The Hypothetical Protein 'All4779', and Not the Annotated 'Alr0088' and 'Alr7579' Proteins, Is the Major Typical Single-Stranded DNA Binding Protein of the Cyanobacterium, Anabaena sp PCC7120	PLOS ONE			English	Article							NITROGEN-FIXING CYANOBACTERIUM; SP STRAIN PCC7120; ESCHERICHIA-COLI; DEINOCOCCUS-RADIODURANS; GENETIC-RECOMBINATION; COMPLEXES; SSB; IDENTIFICATION; OVERPRODUCTION; TOLERANCE	Single-stranded DNA binding (SSB) proteins are essential for all DNA-dependent cellular processes. Typical SSB proteins have an N-terminal Oligonucleotide-Binding (OB) fold, a Proline/Glycine rich region, followed by a C-terminal acidic tail. In the genome of the heterocystous nitrogen-fixing cyanobacterium, Anabaena sp. strain PCC7120, alr0088 and alr7579 are annotated as coding for SSB, but are truncated and have only the OB-fold. In silico analysis of whole genome of Anabaena sp. strain PCC7120 revealed the presence of another ORF 'all4779', annotated as a hypothetical protein, but having an N-terminal OB-fold, a P/G-rich region and a C-terminal acidic tail. Biochemical characterisation of all three purified recombinant proteins revealed that they exist either as monomer or dimer and bind ssDNA, but differently. The All4779 bound ssDNA in two binding modes i.e. (All4779)(35) and (All4779)(66) depending on salt concentration and with a binding affinity similar to that of Escherichia coli SSB. On the other hand, Alr0088 bound in a single binding mode of 50-mer and Alr7579 only to large stretches of ssDNA, suggesting that All4779, in all likelihood, is the major typical bacterial SSB in Anabaena. Overexpression of All4779 in Anabaena sp. strain PCC7120 led to enhancement of tolerance to DNA-damaging stresses, such as gamma-rays, UV-irradiation, desiccation and mitomycinC exposure. The tolerance appears to be a consequence of reduced DNA damage or efficient DNA repair due to increased availability of All4779. The ORF all4779 is proposed to be re-annotated as Anabaena ssb gene.	[Kirti, Anurag; Rajaram, Hema; Apte, Shree Kumar] Bhabha Atom Res Ctr, Div Mol Biol, Bombay 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Rajaram, H (corresponding author), Bhabha Atom Res Ctr, Div Mol Biol, Bombay 400085, Maharashtra, India.	hemaraj@barc.gov.in						Apte Shree Kumar, 2001, PINSA-B, V67, P285; Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; Carlini L, 1998, FEBS LETT, V430, P197, DOI 10.1016/S0014-5793(98)00655-3; CASTENHOLZ RW, 1988, METHOD ENZYMOL, V167, P68; Chaurasia AK, 2008, J MICROBIOL METH, V73, P133, DOI 10.1016/j.mimet.2008.01.013; Curth U, 1996, NUCLEIC ACIDS RES, V24, P2706, DOI 10.1093/nar/24.14.2706; CURTH U, 1994, EUR J BIOCHEM, V221, P435, DOI 10.1111/j.1432-1033.1994.tb18756.x; Eggington JM, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-2; Kidane D, 2012, CRIT REV BIOCHEM MOL, V47, P531, DOI 10.3109/10409238.2012.729562; Kirti A, 2013, PHOTOSYNTH RES, V118, P147, DOI 10.1007/s11120-013-9904-4; Kozlov AG, 2010, J BIOL CHEM, V285, P17246, DOI 10.1074/jbc.M110.118273; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; MacKinney G, 1941, J BIOL CHEM, V140, P315; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; MOLINEUX IJ, 1975, NUCLEIC ACIDS RES, V2, P1821, DOI 10.1093/nar/2.10.1821; MOREAU PL, 1987, J MOL BIOL, V194, P621, DOI 10.1016/0022-2836(87)90239-7; MOREAU PL, 1988, J BACTERIOL, V170, P2493, DOI 10.1128/jb.170.6.2493-2500.1988; Nakasugi K, 2006, MICROBIOL-SGM, V152, P3623, DOI 10.1099/mic.0.29189-0; Olszewski M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-260; Ponomarev VA, 2003, J MOL MICROB BIOTECH, V5, P225, DOI 10.1159/000071074; Raghavan PS, 2011, PLANT MOL BIOL, V77, P407, DOI 10.1007/s11103-011-9821-x; Rajaram H, 2010, ARCH MICROBIOL, V192, P729, DOI 10.1007/s00203-010-0601-9; RECKMANN B, 1985, EUR J BIOCHEM, V152, P633, DOI 10.1111/j.1432-1033.1985.tb09242.x; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Singh H, 2013, PHOTOSYNTH RES, V118, P71, DOI 10.1007/s11120-013-9936-9; Singh H, 2010, J BIOSCIENCES, V35, P427, DOI 10.1007/s12038-010-0048-9; Wadsworth RIM, 2001, NUCLEIC ACIDS RES, V29, P914, DOI 10.1093/nar/29.4.914; Yadav T, 2012, NUCLEIC ACIDS RES, V40, P5546, DOI 10.1093/nar/gks173; Yoon HS, 1998, SCIENCE, V282, P935, DOI 10.1126/science.282.5390.935; Yura K, 1999, DNA Res, V6, P75, DOI 10.1093/dnares/6.2.75	33	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93592	10.1371/journal.pone.0093592	http://dx.doi.org/10.1371/journal.pone.0093592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705540	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500046
J	Sharma, R; Arya, S; Patil, SD; Sharma, A; Jain, PK; Navani, NK; Pathania, R				Sharma, Rajnikant; Arya, Sankalp; Patil, Supriya Deepak; Sharma, Atin; Jain, Pradeep Kumar; Navani, Naveen Kumar; Pathania, Ranjana			Identification of Novel Regulatory Small RNAs in Acinetobacter baumannii	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS REVEALS; ESCHERICHIA-COLI; NONCODING RNAS; SOLUBLE-RNAS; MULTIDRUG-RESISTANCE; WEB SERVER; GENES; PREDICTION; VIRULENCE; SEQUENCE	Small RNA (sRNA) molecules are non-coding RNAs that have been implicated in regulation of various cellular processes in living systems, allowing them to adapt to changing environmental conditions. Till date, sRNAs have not been reported in Acinetobacter baumannii (A. baumannii), which has emerged as a significant multiple drug resistant nosocomial pathogen. In the present study, a combination of bioinformatic and experimental approach was used for identification of novel sRNAs. A total of 31 putative sRNAs were predicted by a combination of two algorithms, sRNAPredict and QRNA. Initially 10 sRNAs were chosen on the basis of lower E- value and three sRNAs (designated as AbsR11, 25 and 28) showed positive signal on Northern blot. These sRNAs are novel in nature as they do not have homologous sequences in other bacterial species. Expression of the three sRNAs was examined in various phases of bacterial growth. Further, the effect of various stress conditions on sRNA gene expression was determined. A detailed investigation revealed differential expression profile of AbsR25 in presence of varying amounts of ethidium bromide (EtBr), suggesting that its expression is influenced by environmental or internal signals such as stress response. A decrease in expression of AbsR25 and concomitant increase in the expression of bioinformatically predicted targets in presence of high EtBr was reverberated by the decrease in target gene expression when AbsR25 was overexpressed. This hints at the negative regulation of target genes by AbsR25. Interestingly, the putative targets include transporter genes and the degree of variation in expression of one of them (A1S_ 1331) suggests that AbsR25 is involved in regulation of a transporter. This study provides a perspective for future studies of sRNAs and their possible involvement in regulation of antibiotic resistance in bacteria specifically in cryptic A. baumannii.	[Sharma, Rajnikant; Arya, Sankalp; Patil, Supriya Deepak; Sharma, Atin; Navani, Naveen Kumar; Pathania, Ranjana] Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee, Uttarakhand, India; [Jain, Pradeep Kumar] Natl Res Ctr Plant Biotechnol, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB)	Pathania, R (corresponding author), Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee, Uttarakhand, India.	ranjanapathania@gmail.com	Sharma, Rajnikant/AGO-9487-2022; Patil, Supriya Deepak/AAL-6757-2020; Sharma, Atin/N-5204-2015; Sharma, Atin/HII-8073-2022	Arya, Sankalp/0000-0002-9081-1485; Pathania, Ranjana/0000-0002-7965-8176; Sharma, Atin/0000-0002-9422-1853	Indian Council of Medical Research grant [AMR/15/2011-ECD-I]; National Agricultural Innovation Project of Indian Council of Agricultural Research grant [C4/C30032]; Ministry of Human Resource Development (MHRD), Government of India; Council of Scientific and Industrial Research (CSIR), Government of India	Indian Council of Medical Research grant; National Agricultural Innovation Project of Indian Council of Agricultural Research grant; Ministry of Human Resource Development (MHRD), Government of India(Ministry of Human Resource Development (MHRD), Government of India); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Indian Council of Medical Research grant AMR/15/2011-ECD-I and National Agricultural Innovation Project of Indian Council of Agricultural Research grant C4/C30032 to Ranjana Pathania and Naveen Kumar Navani. Rajnikant Sharma is thankful to Ministry of Human Resource Development (MHRD), Government of India for financial support. Supriya Deepak Patil and Atin Sharma are thankful to the Council of Scientific and Industrial Research (CSIR), Government of India for financial support. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altier C, 2000, MOL MICROBIOL, V35, P635, DOI 10.1046/j.1365-2958.2000.01734.x; Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Backofen R, 2010, RNA BIOL, V7, P33, DOI 10.4161/rna.7.1.10655; Bohn C, 2010, NUCLEIC ACIDS RES, V38, P6620, DOI 10.1093/nar/gkq462; BOUVET PJM, 1986, INT J SYST BACTERIOL, V36, P228, DOI 10.1099/00207713-36-2-228; Burrowes E, 2005, RES MICROBIOL, V156, P7, DOI 10.1016/j.resmic.2004.07.004; Cao Y, 2009, BIOINFORMATION, V3, P364, DOI 10.6026/97320630003364; Caswell CC, 2012, MOL MICROBIOL, V85, P345, DOI 10.1111/j.1365-2958.2012.08117.x; Chen YL, 2011, MBIO, V2, DOI 10.1128/mBio.00340-10; Consales G, 2011, J CRIT CARE, V26, P453, DOI 10.1016/j.jcrc.2010.12.016; Coornaert A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003156; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P4389, DOI 10.1128/AAC.00155-10; Damier-Piolle L, 2008, ANTIMICROB AGENTS CH, V52, P557, DOI 10.1128/AAC.00732-07; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Felden B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002006; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; Gottesman S, 2006, COLD SPRING HARB SYM, V71, P1, DOI 10.1101/sqb.2006.71.016; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C; Iyer VR, 2012, MOL CELL PHARM, V4, P17; Jain R, 2004, ANN PHARMACOTHER, V38, P1449, DOI 10.1345/aph.1D592; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Koo JT, 2011, P NATL ACAD SCI USA, V108, pE709, DOI 10.1073/pnas.1101655108; Lease RA, 2004, J BACTERIOL, V186, P6179, DOI 10.1128/JB.186.18.6179-6185.2004; Lenz DH, 2005, MOL MICROBIOL, V58, P1186, DOI 10.1111/j.1365-2958.2005.04902.x; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Livermore DM, 2003, ANN MED, V35, P226, DOI 10.1080/07853890310001609; Livny J, 2005, NUCLEIC ACIDS RES, V33, P4096, DOI 10.1093/nar/gki715; Livny J, 2006, NUCLEIC ACIDS RES, V34, P3484, DOI 10.1093/nar/gkl453; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Magnet S, 2001, ANTIMICROB AGENTS CH, V45, P3375, DOI 10.1128/AAC.45.12.3375-3380.2001; Marti S, 2006, ENFERM INFEC MICR CL, V24, P77, DOI 10.1157/13085012; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Miller PF, 1996, MOL MICROBIOL, V21, P441, DOI 10.1111/j.1365-2958.1996.tb02553.x; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Mraheil MA, 2011, NUCLEIC ACIDS RES, V39, P4235, DOI 10.1093/nar/gkr033; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Nordmann P, 2004, PATHOL BIOL, V52, P301, DOI 10.1016/j.patbio.2004.03.001; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Roca I, 2009, ANTIMICROB AGENTS CH, V53, P4013, DOI 10.1128/AAC.00584-09; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Sambrook J., 2001, MOL CLONING; Smith C, 2010, NUCLEIC ACIDS RES, V38, pW373, DOI 10.1093/nar/gkq316; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Sonnleitner E, 2012, RNA BIOL, V9, P364, DOI 10.4161/rna.19231; Sonnleitner E, 2011, MOL MICROBIOL, V80, P868, DOI 10.1111/j.1365-2958.2011.07620.x; Su XZ, 2005, ANTIMICROB AGENTS CH, V49, P4362, DOI 10.1128/AAC.49.10.4362-4364.2005; Tesorero RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064021; Wagenvoort JHT, 2002, EUR J CLIN MICROBIOL, V21, P326, DOI 10.1007/s10096-002-0716-2; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Wilson SJ, 2004, AM J INFECT CONTROL, V32, P342, DOI 10.1016/j.ajic.2004.02.008; Yachie N, 2006, GENE, V372, P171, DOI 10.1016/j.gene.2005.12.034; Zimmerman JM, 2002, NUCLEIC ACIDS RES, V30, P5425, DOI 10.1093/nar/gkf687	64	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93833	10.1371/journal.pone.0093833	http://dx.doi.org/10.1371/journal.pone.0093833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705412	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500074
J	Ziermans, T; de Wit, S; Schothorst, P; Sprong, M; van Engeland, H; Kahn, R; Durston, S				Ziermans, Tim; de Wit, Sanne; Schothorst, Patricia; Sprong, Mirjam; van Engeland, Herman; Kahn, Rene; Durston, Sarah			Neurocognitive and Clinical Predictors of Long-Term Outcome in Adolescents at Ultra-High Risk for Psychosis: A 6-Year Follow-Up	PLOS ONE			English	Article							SCHIZOPHRENIA; INDIVIDUALS; CHILDREN; INTERVENTION; CONVERSION; DISORDER; YOUTH; STATE	Background: Most studies aiming to predict transition to psychosis for individuals at ultra-high risk (UHR) have focused on either neurocognitive or clinical variables and have made little effort to combine the two. Furthermore, most have focused on a dichotomous measure of transition to psychosis rather than a continuous measure of functional outcome. We aimed to investigate the relative value of neurocognitive and clinical variables for predicting both transition to psychosis and functional outcome. Methods: Forty-three UHR individuals and 47 controls completed an extensive clinical and neurocognitive assessment at baseline and participated in long-term follow-up approximately six years later. UHR adolescents who had converted to psychosis (UHR-P; n = 10) were compared to individuals who had not (UHR-NP; n = 33) and controls on clinical and neurocognitive variables. Regression analyses were performed to determine which baseline measures best predicted transition to psychosis and long-term functional outcome for UHR individuals. Results: Low IQ was the single neurocognitive parameter that discriminated UHR-P individuals from UHR-NP individuals and controls. The severity of attenuated positive symptoms was the only significant predictor of a transition to psychosis and disorganized symptoms were highly predictive of functional outcome. Conclusions: Clinical measures are currently the most important vulnerability markers for long-term outcome in adolescents at imminent risk of psychosis.	[Ziermans, Tim] Leiden Univ, Dept Clin Child & Adolescent Studies, Leiden, Netherlands; [de Wit, Sanne; Schothorst, Patricia; Sprong, Mirjam; van Engeland, Herman; Kahn, Rene; Durston, Sarah] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands	Leiden University; Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center	Ziermans, T (corresponding author), Leiden Univ, Dept Clin Child & Adolescent Studies, Leiden, Netherlands.	t.b.ziermans@fsw.leidenuniv.nl		Ziermans, Tim/0000-0001-5224-1365	ZON-MW, the Netherlands organization for health research and development [2630.0001]; COFAS Marie Curie fellowship grant	ZON-MW, the Netherlands organization for health research and development(Netherlands Organization for Health Research and DevelopmentNetherlands Government); COFAS Marie Curie fellowship grant	This study was supported by a grant from ZON-MW, the Netherlands organization for health research and development (project # 2630.0001). Tim Ziermans was supported by a COFAS Marie Curie fellowship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 2012, ANNU REV CLIN PSYCHO, V8, P269, DOI 10.1146/annurev-clinpsy-032511-143146; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Brewer WJ, 2005, AM J PSYCHIAT, V162, P71, DOI 10.1176/appi.ajp.162.1.71; Cannon TD, 2008, ARCH GEN PSYCHIAT, V65, P28, DOI 10.1001/archgenpsychiatry.2007.3; Carr VJ, 2004, BRIT J PSYCHIAT, V184, P517, DOI 10.1192/bjp.184.6.517; Carrion RE, 2013, JAMA PSYCHIAT, V70, P1133, DOI 10.1001/jamapsychiatry.2013.1909; Cornblatt BA, 2000, CONTINUOUS PERFORMAN; Cornblatt BA, 2012, SCHIZOPHRENIA BULL, V38, P1247, DOI 10.1093/schbul/sbr136; Fusar-Poli P, 2013, ACTA PSYCHIAT SCAND, V127, P248, DOI 10.1111/acps.12028; Fusar-Poli P, 2014, SCHIZOPHRENIA BULL, V40, P120, DOI 10.1093/schbul/sbs136; Fusar-Poli P, 2013, JAMA PSYCHIAT, V70, P107, DOI 10.1001/jamapsychiatry.2013.269; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P562, DOI 10.1001/archgenpsychiatry.2011.1592; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P220, DOI 10.1001/archgenpsychiatry.2011.1472; Giuliano AJ, 2012, CURR PHARM DESIGN, V18, P399; HALL RCW, 1995, PSYCHOSOMATICS, V36, P267, DOI 10.1016/S0033-3182(95)71666-8; Kelleher I, 2013, SCHIZOPHRENIA B, V39; Lencz T, 2006, BIOL PSYCHIAT, V59, P863, DOI 10.1016/j.biopsych.2005.09.005; Lin A, 2011, SCHIZOPHR RES, V132, P1, DOI 10.1016/j.schres.2011.06.014; Lin A. H., 2013, PSYCHOL MED, P1; Maxwell M., 1992, MANUAL FOR THE FIGS; McGlashan T, 2001, STRUCTURED INTERVIEW; McGlashan TH, 1996, SCHIZOPHRENIA BULL, V22, P201, DOI 10.1093/schbul/22.2.201; Niendam TA, 2007, SCHIZOPHRENIA BULL, V33, P772, DOI 10.1093/schbul/sbm020; Nitzburg GC, 2014, SCHIZOPHR RES, V152, P223, DOI 10.1016/j.schres.2013.11.023; Pukrop R, 2007, SCHIZOPHR RES, V92, P116, DOI 10.1016/j.schres.2007.01.020; Pukrop R, 2010, NEUROTOX RES, V18, P272, DOI 10.1007/s12640-010-9191-1; Rey A, 1964, LEXAMEN CLINIQUE PSY; Riecher-Rossler A, 2009, BIOL PSYCHIAT, V66, P1023, DOI 10.1016/j.biopsych.2009.07.020; Rombouts RP, 2002, FINGER TAPPING TEST; Rombouts RP, 2002, SPATIAL WORKING MEMO; Rombouts RP, 2002, CARD SORTING TEST CD; Ruhrmann S, 2010, ARCH GEN PSYCHIAT, V67, P241, DOI 10.1001/archgenpsychiatry.2009.206; Saan R. J., 1986, 15 WOORDENTAAK A B; Schimmelmann BG, 2012, EUR CHILD ADOLES PSY, V21, P239, DOI 10.1007/s00787-012-0271-z; Schimmelmann BG, 2013, CAN J PSYCHIAT, V58, P32, DOI 10.1177/070674371305800107; Schlosser DA, 2012, SCHIZOPHRENIA BULL, V38, P1225, DOI 10.1093/schbul/sbr098; Schultze-Lutter F, 2002, BONN SCALE ASSESSMEN; Schultze-Lutter F, 2010, SCHIZOPHRENIA BULL, V36, P182, DOI 10.1093/schbul/sbn072; Seidman LJ, 2010, ARCH GEN PSYCHIAT, V67, P578, DOI 10.1001/archgenpsychiatry.2010.66; Simon AE, 2009, SCHIZOPHR RES, V108, P265, DOI 10.1016/j.schres.2008.12.018; Sprong M, 2008, SCHIZOPHR RES, V99, P38, DOI 10.1016/j.schres.2007.10.031; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wechsler D, 2002, WECHSLER INTELLIGENC, Vfourth; Wechsler D., 1997, WECHSLER ADULT INTEL; Wigman JTW, 2011, SCHIZOPHRENIA BULL, V37, P850, DOI 10.1093/schbul/sbp154; Woodberry KA, 2010, SCHIZOPHR RES, V123, P188, DOI 10.1016/j.schres.2010.06.021; Yung AR, 2010, SCHIZOPHR RES, V120, P1, DOI 10.1016/j.schres.2010.03.014; Yung AR, 2006, SCHIZOPHR RES, V84, P57, DOI 10.1016/j.schres.2006.03.014; Zammit S, 2004, ARCH GEN PSYCHIAT, V61, P354, DOI 10.1001/archpsyc.61.4.354; Ziermans T, 2011, J PSYCHIATR NEUROSCI, V36, P127, DOI 10.1503/jpn.100063; Ziermans Tim B, 2013, Front Psychiatry, V4, P161, DOI 10.3389/fpsyt.2013.00161; Ziermans TB, 2012, SCHIZOPHRENIA BULL, V38, P519, DOI 10.1093/schbul/sbq113; Ziermans TB, 2011, SCHIZOPHR RES, V126, P58, DOI 10.1016/j.schres.2010.10.022	53	58	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93994	10.1371/journal.pone.0093994	http://dx.doi.org/10.1371/journal.pone.0093994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6MJ	24705808	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500106
J	Erdozain, AM; Morentin, B; Bedford, L; King, E; Tooth, D; Brewer, C; Wayne, D; Johnson, L; Gerdes, HK; Wigmore, P; Callado, LF; Carter, WG				Erdozain, Amaia M.; Morentin, Benito; Bedford, Lynn; King, Emma; Tooth, David; Brewer, Charlotte; Wayne, Declan; Johnson, Laura; Gerdes, Henry K.; Wigmore, Peter; Callado, Luis F.; Carter, Wayne G.			Alcohol-Related Brain Damage in Humans	PLOS ONE			English	Article							L-ISOASPARTYL METHYLTRANSFERASE; GENE-EXPRESSION; FRONTAL-CORTEX; ACETALDEHYDE ADDUCTS; NA+/K+-ATPASE; RAT-BRAIN; ETHANOL; NA,K-ATPASE; PROTEOMICS; TUBULIN	Chronic excessive alcohol intoxications evoke cumulative damage to tissues and organs. We examined prefrontal cortex (Brodmann's area (BA) 9) from 20 human alcoholics and 20 age, gender, and postmortem delay matched control subjects. H & E staining and light microscopy of prefrontal cortex tissue revealed a reduction in the levels of cytoskeleton surrounding the nuclei of cortical and subcortical neurons, and a disruption of subcortical neuron patterning in alcoholic subjects. BA 9 tissue homogenisation and one dimensional polyacrylamide gel electrophoresis (PAGE) proteomics of cytosolic proteins identified dramatic reductions in the protein levels of spectrin beta II, and alpha- and beta-tubulins in alcoholics, and these were validated and quantitated by Western blotting. We detected a significant increase in a-tubulin acetylation in alcoholics, a non-significant increase in isoaspartate protein damage, but a significant increase in protein isoaspartyl methyltransferase protein levels, the enzyme that triggers isoaspartate damage repair in vivo. There was also a significant reduction in proteasome activity in alcoholics. One dimensional PAGE of membrane-enriched fractions detected a reduction in beta-spectrin protein levels, and a significant increase in transmembranous alpha 3 (catalytic) subunit of the Na+, K+-ATPase in alcoholic subjects. However, control subjects retained stable oligomeric forms of a-subunit that were diminished in alcoholics. In alcoholics, significant loss of cytosolic alpha-and beta-tubulins were also seen in caudate nucleus, hippocampus and cerebellum, but to different levels, indicative of brain regional susceptibility to alcohol-related damage. Collectively, these protein changes provide a molecular basis for some of the neuronal and behavioural abnormalities attributed to alcoholics.	[Erdozain, Amaia M.; Brewer, Charlotte; Wayne, Declan; Johnson, Laura; Gerdes, Henry K.; Carter, Wayne G.] Univ Nottingham, Sch Med, Royal Derby Hosp Ctr, Derby, England; [Erdozain, Amaia M.; Callado, Luis F.] Univ Basque Country, Dept Pharmacol, Bilbao, Spain; [Erdozain, Amaia M.; Callado, Luis F.] Ctr Invest Biomed Red Salud Mental, Madrid, Spain; [Morentin, Benito] Basque Inst Legal Med, Sect Forens Pathol, Bilbao, Spain; [Bedford, Lynn; King, Emma; Tooth, David; Callado, Luis F.] Univ Nottingham, Sch Life Sci, Queens Med Ctr, Nottingham NG7 2RD, England	University of Nottingham; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Carter, WG (corresponding author), Univ Nottingham, Sch Med, Royal Derby Hosp Ctr, Derby, England.	wayne.carter@nottingham.ac.uk	Callado, Luis F./A-7024-2008; Erdozain, Amaia/AAD-1883-2021; Erdozain, Amaia M/Q-9664-2018	Callado, Luis F./0000-0001-9941-012X; CALLADO HERNANDO, LUIS FELIPE/0000-0002-5564-3447; Erdozain, Amaia Maite/0000-0003-0207-9122	Basque Government [IT-616/13, SAIOTEK S-PE10UN14]; Plan Nacional sobre Drogas [PI 2006I045]; University of the Basque Country [UFI 11/35]; Wellcome Trust; University of Nottingham; Parkinson&quot;s UK [F-0702] Funding Source: researchfish	Basque Government(Basque Government); Plan Nacional sobre Drogas; University of the Basque Country; Wellcome Trust(Wellcome TrustEuropean Commission); University of Nottingham; Parkinson&quot;s UK(Parkinson&apos;s UK)	The authors are grateful to the following funding sources: AME was a recipient of a predoctoral fellowship from the Basque Government which supported her home studies, and work undertaken in the laboratory of WGC. LJ was funded by a Wellcome Trust Summer Scholarship. LFC was supported by grants from Plan Nacional sobre Drogas, (PI 2006I045), the Basque Government (IT-616/13, SAIOTEK S-PE10UN14), and University of the Basque Country (UFI 11/35). WGC was supported by a Wellcome Trust Value in People grant and by the University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Alexander-Kaufman K, 2006, MOL PSYCHIATR, V11, P56, DOI 10.1038/sj.mp.4001741; ASWAD DW, 1983, J NEUROCHEM, V41, P1702, DOI 10.1111/j.1471-4159.1983.tb00883.x; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; BLANCO G, 1994, P NATL ACAD SCI USA, V91, P8542, DOI 10.1073/pnas.91.18.8542; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Botta P, 2010, NEUROPSYCHOPHARMACOL, V35, P1984, DOI 10.1038/npp.2010.76; Brust JCM, 2010, INT J ENV RES PUB HE, V7, P1540, DOI 10.3390/ijerph7041540; Carter WG, 2008, BIOCHEMISTRY-US, V47, P10757, DOI 10.1021/bi8013467; Carter WG, 2010, J CHROMATOGR B, V878, P1312, DOI 10.1016/j.jchromb.2009.10.018; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Donnet C, 2001, J BIOL CHEM, V276, P7357, DOI 10.1074/jbc.M009131200; Etheridge N, 2009, PROTEOM CLIN APPL, V3, P730, DOI 10.1002/prca.200800202; Furuchi T, 2010, CHEM BIODIVERS, V7, P1337, DOI 10.1002/cbdv.200900273; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GOODMAN SR, 1986, AM J PHYSIOL, V250, pC347, DOI 10.1152/ajpcell.1986.250.3.C347; Harper C, 2007, HUM EXP TOXICOL, V26, P251, DOI 10.1177/0960327107070499; Harper C, 2009, ALCOHOL ALCOHOLISM, V44, P136, DOI 10.1093/alcalc/agn102; Hipolito L, 2007, CURR DRUG METAB, V8, P716, DOI 10.2174/138920007782109797; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Jung T, 2008, IUBMB LIFE, V60, P743, DOI 10.1002/iub.114; Kharbanda KK, 2007, J HEPATOL, V46, P1119, DOI 10.1016/j.jhep.2007.01.026; Kharbanda KK, 2009, BIOCHEM BIOPH RES CO, V381, P523, DOI 10.1016/j.bbrc.2009.02.082; Kirshenbaum GS, 2011, P NATL ACAD SCI USA, V108, P18144, DOI 10.1073/pnas.1108416108; Kokubo J, 2008, CELL STRUCT FUNCT, V33, P51, DOI 10.1247/csf.07038; Lewohl JM, 2000, ALCOHOL CLIN EXP RES, V24, P1873, DOI 10.1111/j.1530-0277.2000.tb01993.x; Lewohl JM, 2004, ANN NY ACAD SCI, V1025, P14, DOI 10.1196/annals.1316.002; Lingrel JB, 2007, J BIOENERG BIOMEMBR, V39, P385, DOI 10.1007/s10863-007-9107-9; Liu JW, 2007, ALCOHOL CLIN EXP RES, V31, P1460, DOI 10.1111/j.1530-0277.2007.00444.x; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Matsumoto I, 2009, ALCOHOL ALCOHOLISM, V44, P171, DOI 10.1093/alcalc/agn104; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Najbauer J, 1996, BIOCHEMISTRY-US, V35, P5183, DOI 10.1021/bi953063g; Nakamura K, 2003, ARCH TOXICOL, V77, P591, DOI 10.1007/s00204-003-0465-8; Neely MD, 1999, J NEUROCHEM, V72, P2323, DOI 10.1046/j.1471-4159.1999.0722323.x; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Ren Y, 2003, J NEUROSCI, V23, P3316; RIEDERER BM, 1990, FEBS LETT, V277, P49, DOI 10.1016/0014-5793(90)80807-U; Rintala J, 2000, ALCOHOL ALCOHOLISM, V35, P458, DOI 10.1093/alcalc/35.5.458; Shepard BD, 2010, WORLD J GASTROENTERO, V16, P1358, DOI 10.3748/wjg.v16.i11.1358; Shepard BD, 2009, WORLD J GASTROENTERO, V15, P1219, DOI 10.3748/wjg.15.1219; SMITH SL, 1989, J CLIN INVEST, V84, P337, DOI 10.1172/JCI114159; Stewart BJ, 2007, CHEM RES TOXICOL, V20, P1111, DOI 10.1021/tx700106v; Thomson A D, 2012, Alcohol Alcohol, V47, P84, DOI 10.1093/alcalc/ags009; TUMA DJ, 1991, ANN NY ACAD SCI, V625, P786, DOI 10.1111/j.1749-6632.1991.tb33920.x; Upadhya SC, 2002, ALCOHOL CLIN EXP RES, V26, P856, DOI 10.1097/00000374-200206000-00016; Vigneswara V, 2006, J BIOL CHEM, V281, P32619, DOI 10.1074/jbc.M605421200; Zahr NM, 2011, NAT REV NEUROL, V7, P284, DOI 10.1038/nrneurol.2011.42; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200	50	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93586	10.1371/journal.pone.0093586	http://dx.doi.org/10.1371/journal.pone.0093586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699688	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000074
J	Harding, AMS; Kusama, N; Hattori, T; Gautam, M; Benson, CJ				Harding, Anne Marie S.; Kusama, Nobuyoshi; Hattori, Tomonori; Gautam, Mamta; Benson, Christopher J.			ASIC2 Subunits Facilitate Expression at the Cell Surface and Confer Regulation by PSD-95	PLOS ONE			English	Article							SENSING ION CHANNELS; MAMMALIAN DEGENERIN MDEG; INDUCED NEURONAL DEATH; ACID-EVOKED CURRENTS; BRAIN NA+ CHANNEL; SENSORY NEURONS; ACTIVATED CURRENTS; PROTEIN PICK1; HIPPOCAMPAL-NEURONS; SENSITIVE CHANNELS	Acid-sensing ion channels (ASICs) are Na+ channels activated by changes in pH within the peripheral and central nervous systems. Several different isoforms of ASICs combine to form trimeric channels, and their properties are determined by their subunit composition. ASIC2 subunits are widely expressed throughout the brain, where they heteromultimerize with their partnering subunit, ASIC1a. However, ASIC2 contributes little to the pH sensitivity of the channels, and so its function is not well understood. We found that ASIC2 increased cell surface levels of the channel when it is coexpressed with ASIC1a, and genetic deletion of ASIC2 reduced acid-evoked current amplitude in mouse hippocampal neurons. Additionally, ASIC2a interacted with the neuronal synaptic scaffolding protein PSD-95, and PSD-95 reduced cell surface expression and current amplitude in ASICs that contain ASIC2a. Overexpression of PSD-95 also reduced acid-evoked current amplitude in hippocampal neurons. This result was dependent upon ASIC2 since the effect of PSD-95 was abolished in ASIC2-/- neurons. These results lend support to an emerging role of ASIC2 in the targeting of ASICs to surface membranes, and allows for interaction with PSD-95 to regulate these processes.	[Harding, Anne Marie S.; Kusama, Nobuyoshi; Hattori, Tomonori; Gautam, Mamta; Benson, Christopher J.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Harding, Anne Marie S.; Gautam, Mamta; Benson, Christopher J.] Dept Vet Med Ctr, Iowa City, IA USA	University of Iowa	Benson, CJ (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	chris-benson@uiowa.edu		Benson, Christopher/0000-0001-6600-8193	National Institute of Health, National Heart, Lung, and Blood Institute [R01 HL076419]; Department of Veterans Affairs [BX000776]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER	National Institute of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Health, National Heart, Lung, and Blood Institute (R01 HL076419), and Department of Veterans Affairs (Merit Award BX000776). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai N, 2002, J BIOL CHEM, V277, P16655, DOI 10.1074/jbc.M201087200; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Babinski K, 2000, J BIOL CHEM, V275, P28519, DOI 10.1074/jbc.M004114200; Baron A, 2002, J BIOL CHEM, V277, P50463, DOI 10.1074/jbc.M208848200; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Baron A, 2013, TOXICON, V75, P187, DOI 10.1016/j.toxicon.2013.04.008; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Benson CJ, 1999, CIRC RES, V84, P921; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Coryell MW, 2008, J NEUROSCI, V28, P13738, DOI 10.1523/JNEUROSCI.3907-08.2008; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Deval E, 2006, J BIOL CHEM, V281, P1796, DOI 10.1074/jbc.M509669200; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Donier E, 2008, EUR J NEUROSCI, V28, P74, DOI 10.1111/j.1460-9568.2008.06282.x; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; Duan B, 2012, J NEUROSCI, V32, P6351, DOI 10.1523/JNEUROSCI.4479-11.2012; Duggan A, 2002, J BIOL CHEM, V277, P5203, DOI 10.1074/jbc.M104748200; Eshcol JO, 2008, AM J PHYSIOL-CELL PH, V295, pC732, DOI 10.1152/ajpcell.00514.2007; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Gautam M, 2013, FASEB J, V27, P793, DOI 10.1096/fj.12-220400; Gregersen N, 2012, EUR J HUM GENET, V20, P84, DOI 10.1038/ejhg.2011.148; GRUNDER S, NEUROREPORT, V11, P1607; Hattori T, 2009, CIRC RES, V105, P279, DOI 10.1161/CIRCRESAHA.109.202036; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Hruska-Hageman AM, 2002, BIOCHEM J, V361, P443, DOI 10.1042/0264-6021:3610443; Hruska-Hageman AM, 2004, J BIOL CHEM, V17, P17; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jovov B, 2003, HISTOCHEM CELL BIOL, V119, P437, DOI 10.1007/s00418-003-0525-4; Kang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035225; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kuryatov A, 1997, J NEUROSCI, V17, P9035; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Price MP, 2013, GENES BRAIN BEHAV; Roza C, 2004, J PHYSIOL-LONDON, V558, P659, DOI 10.1113/jphysiol.2004.066001; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Squassina A, 2011, PHARMACOGENOMICS, V12, P1559, DOI [10.2217/PGS.11.102, 10.2217/pgs.11.102]; Stone JL, 2007, HUM MOL GENET, V16, P704, DOI 10.1093/hmg/ddm015; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Wu LJ, 2004, J BIOL CHEM, V279, P43716, DOI 10.1074/jbc.M403557200; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Zeng WZ, 2013, J NEUROSCI, V33, P7066, DOI 10.1523/JNEUROSCI.5206-12.2013; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103; Zha XM, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-1; Zha XM, 2009, J NEUROSCI, V29, P8438, DOI 10.1523/JNEUROSCI.1284-09.2009; Zha XM, 2009, P NATL ACAD SCI USA, V106, P3573, DOI 10.1073/pnas.0813402106; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	61	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93797	10.1371/journal.pone.0093797	http://dx.doi.org/10.1371/journal.pone.0093797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699665	gold, Green Submitted, Green Published			2022-12-27	WOS:000334105000108
J	Padwal, MK; Sarma, U; Saha, B				Padwal, Mahesh Kumar; Sarma, Uddipan; Saha, Bhaskar			Comprehensive Logic Based Analyses of Toll-Like Receptor 4 Signal Transduction Pathway	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR RECEPTOR; FUNCTIONAL-ANALYSIS; NEGATIVE-FEEDBACK; POSITIVE-FEEDBACK; CELL-SURVIVAL; C-FOS; INTERFERON; NETWORKS	Among the 13 TLRs in the vertebrate systems, only TLR4 utilizes both Myeloid differentiation factor 88 (MyD88) and Toll/Interleukin-1 receptor (TIR)-domain-containing adapter interferon-beta-inducing Factor (TRIF) adaptors to transduce signals triggering host-protective immune responses. Earlier studies on the pathway combined various experimental data in the form of one comprehensive map of TLR signaling. But in the absence of adequate kinetic parameters quantitative mathematical models that reveal emerging systems level properties and dynamic inter-regulation among the kinases/phosphatases of the TLR4 network are not yet available. So, here we used reaction stoichiometry-based and parameter independent logical modeling formalism to build the TLR4 signaling network model that captured the feedback regulations, interdependencies between signaling kinases and phosphatases and the outcome of simulated infections. The analyses of the TLR4 signaling network revealed 360 feedback loops, 157 negative and 203 positive; of which, 334 loops had the phosphatase PP1 as an essential component. The network elements' interdependency (positive or negative dependencies) in perturbation conditions such as the phosphatase knockout conditions revealed interdependencies between the dual-specific phosphatases MKP-1 and MKP-3 and the kinases in MAPK modules and the role of PP2A in the auto-regulation of Calmodulin kinase-II. Our simulations under the specific kinase or phosphatase gene-deficiency or inhibition conditions corroborated with several previously reported experimental data. The simulations to mimic Yersinia pestis and E. coli infections identified the key perturbation in the network and potential drug targets. Thus, our analyses of TLR4 signaling highlights the role of phosphatases as key regulatory factors in determining the global interdependencies among the network elements; uncovers novel signaling connections; identifies potential drug targets for infections.	[Padwal, Mahesh Kumar; Sarma, Uddipan; Saha, Bhaskar] Natl Ctr Cell Sci, Lab 5, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Sarma, U (corresponding author), Inst Mol Biol, Biol Modelling Grp, Mainz, Germany.	uddipans@gmail.com; sahab@nccs.res.in		PADWAL, MAHESH/0000-0003-4715-1108	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The work has been funded by the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Baldwin AS, 2012, IMMUNOL REV, V246, P327, DOI 10.1111/j.1600-065X.2012.01095.x; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bonvin C, 2002, CELL SIGNAL, V14, P123, DOI 10.1016/S0898-6568(01)00219-4; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Chaudhri VK, 2010, J BIOL CHEM, V285, P1296, DOI 10.1074/jbc.M109.055863; Chen NJ, 2008, P NATL ACAD SCI USA, V105, P12429, DOI 10.1073/pnas.0806585105; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Daley WP, 2009, DEV BIOL, V336, P169, DOI 10.1016/j.ydbio.2009.09.037; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; DePaolo RW, 2008, CELL HOST MICROBE, V4, P350, DOI 10.1016/j.chom.2008.09.004; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Keating SE, 2009, J BIOL CHEM, V284, P8211, DOI 10.1074/jbc.R800038200; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Lu RZ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002597; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Ray N, 2006, INT IMMUNOL, V18, P671, DOI 10.1093/intimm/dxl004; RONALD A, 2002, DIS MON, V113, P14; Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Samaga R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000438; Sarma U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039898; Schlatter R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000595; Selvarajoo K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003430; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; SWANTEK JL, 2000, J IMMUNOL, V15, P1; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yang CH, 2005, J BIOL CHEM, V280, P31530, DOI 10.1074/jbc.M503120200; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911	49	14	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92481	10.1371/journal.pone.0092481	http://dx.doi.org/10.1371/journal.pone.0092481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699232	gold, Green Submitted, Green Published			2022-12-27	WOS:000334105000028
J	Wiklund, AKE; Adolfsson-Erici, M; Liewenborg, B; Gorokhova, E				Wiklund, Ann-Kristin Eriksson; Adolfsson-Erici, Margaretha; Liewenborg, Birgitta; Gorokhova, Elena			Sucralose Induces Biochemical Responses in Daphnia magna	PLOS ONE			English	Article							OXIDATIVE STRESS; ACETYLCHOLINESTERASE ACTIVITY; SWEETENER SUCRALOSE; MULTIPLE STRESSORS; EXPOSURE; GROWTH; NEUROTOXICITY; CONTAMINANTS; ENHANCEMENT; INHIBITORS	The intense artificial sweetener sucralose has no bioconcentration properties, and no adverse acute toxic effects have been observed in standard ecotoxicity tests, suggesting negligible environmental risk. However, significant feeding and behavioural alterations have been reported in non-standard tests using aquatic crustaceans, indicating possible sublethal effects. We hypothesized that these effects are related to alterations in acetylcholinesterase (AChE) and oxidative status in the exposed animals and investigated changes in AChE and oxidative biomarkers (oxygen radical absorbing capacity, ORAC, and lipid peroxidation, TBARS) in the crustacean Daphnia magna exposed to sucralose (0.0001-5 mg L-1). The sucralose concentration was a significant positive predictor for ORAC, TBARS and AChE in the daphnids. Moreover, the AChE response was linked to both oxidative biomarkers, with positive and negative relationships for TBARS and ORAC, respectively. These joint responses support our hypothesis and suggest that exposure to sucralose may induce neurological and oxidative mechanisms with potentially important consequences for animal behaviour and physiology.	[Wiklund, Ann-Kristin Eriksson; Adolfsson-Erici, Margaretha; Liewenborg, Birgitta; Gorokhova, Elena] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden	Stockholm University	Wiklund, AKE (corresponding author), Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden.	annkristin.eriksson@itm.su.se	Gorokhova, Elena/E-7105-2018	Gorokhova, Elena/0000-0002-4192-6956	Swedish Environmental Protection Agency	Swedish Environmental Protection Agency	This work was funded by the Swedish Environmental Protection Agency (http://www.swedishepa.se/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Donia MB, 2008, J TOXICOL ENV HEAL A, V71, P1415, DOI 10.1080/15287390802328630; Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Altshuler I, 2011, INTEGR COMP BIOL, V51, P623, DOI 10.1093/icb/icr103; Bainy Afonso Celso Dias, 2006, Biotemas, V19, P35; Behra M, 2002, NAT NEUROSCI, V5, P111, DOI 10.1038/nn788; Bocquene Gilles, 1998, ICES Techniques in Marine Environmental Sciences, V22, P1; Campbell AK, 2004, COMP BIOCHEM PHYS B, V139, P225, DOI 10.1016/j.cbpc.2004.07.004; CARPENTER SR, 1987, ECOLOGY, V68, P1863, DOI 10.2307/1939878; Corotto FS, 2002, J CHEM ECOL, V28, P1117, DOI 10.1023/A:1016273431866; Das KC, 2002, P NATL ACAD SCI USA, V99, P9617, DOI 10.1073/pnas.162369199; Dobson AJ, 2008, INTRO GEN LINEAR MOD; El-Merhibi A, 2004, ECOTOX ENVIRON SAFE, V57, P202, DOI 10.1016/S0147-6513(03)00082-4; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Finn JP, 2000, FOOD CHEM TOXICOL, V38, pS7, DOI 10.1016/S0278-6915(00)00024-7; Glaholt SP, 2012, SCI TOTAL ENVIRON, V432, P57, DOI 10.1016/j.scitotenv.2012.05.074; Gorokhova E, 2013, AQUAT TOXICOL, V127, P46, DOI 10.1016/j.aquatox.2012.01.022; Hjorth M, 2010, CHEM ECOL, V26, P385, DOI 10.1080/02757540.2010.504672; Holth TF, 2012, AQUAT TOXICOL, V112, P92, DOI 10.1016/j.aquatox.2011.10.019; Huggett DB, 2011, FOOD CHEM TOXICOL, V49, P2575, DOI 10.1016/j.fct.2011.06.073; JACOBS JM, 1981, NEUROTOXICOLOGY, V2, P405; Jemec A, 2007, COMP BIOCHEM PHYS C, V144, P303, DOI 10.1016/j.cbpc.2006.10.002; Johannsson OE, 2009, AQUAT BIOL, V5, P249, DOI 10.3354/ab00111; Kunz PY, 2010, REV ENVIRON CONTAM T, V205, P1, DOI 10.1007/978-1-4419-5623-1_1; Lange FT, 2012, ANAL BIOANAL CHEM, V403, P2503, DOI 10.1007/s00216-012-5892-z; Lehtonen KK, 2003, AQUAT TOXICOL, V64, P461, DOI 10.1016/S0166-445X(03)00101-2; Lillicrap A, 2011, ENVIRON TOXICOL CHEM, V30, P673, DOI 10.1002/etc.433; Lionetto MG, 2003, MAR POLLUT BULL, V46, P324, DOI 10.1016/S0025-326X(02)00403-4; Loney GC, 2012, CHEM SENSES, V37, P445, DOI 10.1093/chemse/bjr126; Loos R, 2009, J CHROMATOGR A, V1216, P1126, DOI 10.1016/j.chroma.2008.12.048; Mead RN, 2009, MAR CHEM, V116, P13, DOI 10.1016/j.marchem.2009.09.005; Melo JB, 2003, NEUROSCI RES, V45, P117, DOI 10.1016/S0168-0102(02)00201-8; Minten J, 2011, INT J ENVIRON AN CH, V91, P357, DOI 10.1080/03067310903582333; Motwani HV, 2011, FOOD CHEM TOXICOL, V49, P750, DOI 10.1016/j.fct.2010.11.037; Nussey DH, 2009, FUNCT ECOL, V23, P809, DOI 10.1111/j.1365-2435.2009.01555.x; Pan GZ, 1998, ENVIRON RES, V79, P133, DOI 10.1006/enrs.1998.3868; Penalva-Arana DC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-79; Pokhrel LR, 2013, EXPERT OPIN ENV BIOL, V2, P1; Prior RL, 2003, J AGR FOOD CHEM, V51, P3273, DOI 10.1021/jf0262256; Ranjbar A, 2002, HUM EXP TOXICOL, V21, P179, DOI 10.1191/0960327102ht238oa; Remmel EJ, 2011, LIMNOL OCEANOGR, V56, P461, DOI 10.4319/lo.2011.56.2.0461; Rodero AB, 2009, INT J MORPHOL, V27, P239, DOI 10.4067/S0717-95022009000100040; Rosemberg DB, 2010, NEUROSCIENCE, V171, P683, DOI 10.1016/j.neuroscience.2010.09.030; Schallreuter KU, 2007, LIFE SCI, V80, P2221, DOI 10.1016/j.lfs.2007.01.028; SHLAFER M, 1984, ANAL BIOCHEM, V137, P269, DOI 10.1016/0003-2697(84)90084-8; Sibley P. K., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P117, DOI 10.1023/A:1009967213300; Soh L, 2011, ENVIRON SCI TECHNOL, V45, P1363, DOI 10.1021/es102719d; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; SPECTOR AC, 1988, CHEM SENSES, V13, P95, DOI 10.1093/chemse/13.1.95; Srivatsan M, 1999, CHEM-BIOL INTERACT, V119, P371, DOI 10.1016/S0009-2797(99)00048-4; SZABO GY, 1992, J LEUKOCYTE BIOL, V52, P602, DOI 10.1002/jlb.52.6.602; Tessier AJ, 2000, ECOLOGY, V81, P826, DOI 10.1890/0012-9658(2000)081[0826:AFTOIR]2.0.CO;2; Thome GR, 2011, NICOTINE TOB RES, V13, P1210, DOI 10.1093/ntr/ntr154; Tierney M, 2008, J EXP MAR BIOL ECOL, V367, P65, DOI 10.1016/j.jembe.2008.07.046; Toiber D, 2005, NEUROCHEM RES, V30, P909, DOI 10.1007/s11064-005-6963-8; Tollefsen KE, 2012, SCI TOTAL ENVIRON, V438, P510, DOI 10.1016/j.scitotenv.2012.08.060; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Viberg H, 2011, NUTRITION, V27, P81, DOI 10.1016/j.nut.2009.10.007; Wiklund AKE, 2012, CHEMOSPHERE, V86, P50, DOI 10.1016/j.chemosphere.2011.08.049; Wilson SM, 2012, COMP BIOCHEM PHYS A, V162, P212, DOI 10.1016/j.cbpa.2012.02.023; Wu HH, 2011, CHEMOSPHERE, V83, P599, DOI 10.1016/j.chemosphere.2010.12.004; Yang D, 2008, TOXICOL APPL PHARM, V228, P32, DOI 10.1016/j.taap.2007.11.005	63	22	24	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92771	10.1371/journal.pone.0092771	http://dx.doi.org/10.1371/journal.pone.0092771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699280	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000034
J	Cronin, KA; Pieper, BA; van Leeuwen, EJC; Mundry, R; Haun, DBM				Cronin, Katherine A.; Pieper, Bridget A.; van Leeuwen, Edwin J. C.; Mundry, Roger; Haun, Daniel B. M.			Problem Solving in the Presence of Others: How Rank and Relationship Quality Impact Resource Acquisition in Chimpanzees (Pan troglodytes)	PLOS ONE			English	Article							WILD CHIMPANZEES; COOPERATIVE TASK; NATIONAL-PARK; BEHAVIOR; COMMUNITIES; STRATEGIES; EVOLUTION; TANZANIA; BONOBOS; PREFER	In the wild, chimpanzees ( Pan troglodytes) are often faced with clumped food resources that they may know how to access but abstain from doing so due to social pressures. To better understand how social settings influence resource acquisition, we tested fifteen semi-wild chimpanzees from two social groups alone and in the presence of others. We investigated how resource acquisition was affected by relative social dominance, whether collaborative problem solving or ( active or passive) sharing occurred amongst any of the dyads, and whether these outcomes were related to relationship quality as determined from six months of observational data. Results indicated that chimpanzees obtained fewer rewards when tested in the presence of others compared to when they were tested alone, and this loss tended to be greater when paired with a higher ranked individual. Individuals demonstrated behavioral inhibition; chimpanzees who showed proficient skill when alone often abstained from solving the task when in the presence of others. Finally, individuals with close social relationships spent more time together in the problem solving space, but collaboration and sharing were infrequent and sessions in which collaboration or sharing did occur contained more instances of aggression. Group living provides benefits and imposes costs, and these findings highlight that one cost of group living may be diminishing productive individual behaviors.	[Cronin, Katherine A.; van Leeuwen, Edwin J. C.; Haun, Daniel B. M.] Max Planck Inst Evolutionary Anthropol, Comparat Cognit Anthropol Res Grp, D-04103 Leipzig, Germany; [Cronin, Katherine A.; van Leeuwen, Edwin J. C.; Haun, Daniel B. M.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Pieper, Bridget A.] Dane Cty Humane Soc, Madison, WI USA; [Mundry, Roger] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Haun, Daniel B. M.] Univ Portsmouth, Portsmouth, Hants, England	Max Planck Society; Max Planck Society; Max Planck Society; University of Portsmouth	Cronin, KA (corresponding author), Max Planck Inst Evolutionary Anthropol, Comparat Cognit Anthropol Res Grp, D-04103 Leipzig, Germany.	Katherine.Cronin@mpi.nl			Comparative Cognitive Anthropology Group of the Max Planck Society; Netherlands Organization for Scientific Research (Veni grant)	Comparative Cognitive Anthropology Group of the Max Planck Society; Netherlands Organization for Scientific Research (Veni grant)(Netherlands Organization for Scientific Research (NWO))	This work was financially supported by the Comparative Cognitive Anthropology Group of the Max Planck Society (www.mpg.de), and by the Netherlands Organization for Scientific Research (Veni grant to KAC, www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Boesch Christophe, 2002, BEHAV DIVERSITY CHIM; Bullinger AF, 2011, ANIM BEHAV, V82, P1135, DOI 10.1016/j.anbehav.2011.08.008; Chalmeau R, 1996, PRIMATES, V37, P39, DOI 10.1007/BF02382918; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; Cronin KA, 2005, ANIM BEHAV, V69, P133, DOI 10.1016/j.anbehav.2004.02.024; Cronin KA, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S021952591250066X; de Waal FBM, 2010, PHILOS T R SOC B, V365, P2711, DOI 10.1098/rstb.2010.0119; Drea CM, 1999, P NATL ACAD SCI USA, V96, P12965, DOI 10.1073/pnas.96.22.12965; Gilby IC, 2008, ANIM BEHAV, V75, P351, DOI 10.1016/j.anbehav.2007.06.008; Gilby IC, 2013, BEHAV ECOL SOCIOBIOL, V67, P373, DOI 10.1007/s00265-012-1457-6; Gilby IC, 2006, ANIM BEHAV, V71, P953, DOI 10.1016/j.anbehav.2005.09.009; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hare B, 2007, CURR BIOL, V17, P619, DOI 10.1016/j.cub.2007.02.040; Hirata S, 2007, PRIMATES, V48, P13, DOI 10.1007/s10329-006-0022-1; Humle T, 2004, INT J PRIMATOL, V25, P551, DOI 10.1023/B:IJOP.0000023575.93644.f4; Jaeggi AV, 2010, AM J PHYS ANTHROPOL, V143, P41, DOI 10.1002/ajpa.21288; Lonsdorf EV, 2005, ANIM BEHAV, V70, P673, DOI 10.1016/j.anbehav.2004.12.014; MCGREW WC, 1979, MAN, V14, P185, DOI 10.2307/2801563; Melis AP, 2006, ANIM BEHAV, V72, P275, DOI 10.1016/j.anbehav.2005.09.018; Mitani JC, 2009, ANIM BEHAV, V77, P633, DOI 10.1016/j.anbehav.2008.11.021; Nishida T., 1979, GREAT APES, P73; Nishida T., 2011, CHIMPANZEES LAKESHOR; Nishida T., 2010, CHIMPANZEE BEHAV WIL; PACKER C, 1988, AM NAT, V132, P159, DOI 10.1086/284844; PETIT O, 1992, ETHOLOGY, V90, P107; Povinelli DJ, 2000, UNDERSTANDING OTHER, P459; Reader SM, 2001, INT J PRIMATOL, V22, P787, DOI 10.1023/A:1012069500899; Rekers Y, 2011, CURR BIOL, V21, P1756, DOI 10.1016/j.cub.2011.08.066; Ron T, 1988, PRIMATES CONSERV, V9, P37; Sanz CM, 2009, INT J PRIMATOL, V30, P411, DOI 10.1007/s10764-009-9350-5; Schneider AC, 2012, P ROY SOC B-BIOL SCI, V279, P4946, DOI 10.1098/rspb.2012.1948; van Leeuwen EJC, 2012, P ROY SOC B-BIOL SCI, V279, P4362, DOI 10.1098/rspb.2012.1543; VANSCHAIK CP, 1983, BEHAVIOUR, V87, P120, DOI 10.1163/156853983X00147; WESTEBERHARD MJ, 1979, P AM PHILOS SOC, V123, P222; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; YAMAKOSHI G, 1995, PRIMATES, V36, P489, DOI 10.1007/BF02382871	38	15	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93204	10.1371/journal.pone.0093204	http://dx.doi.org/10.1371/journal.pone.0093204			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695486	Green Published, gold			2022-12-27	WOS:000334103000048
J	Haack, AK; Sheth, C; Schwager, AL; Sinclair, MS; Tandon, S; Taha, SA				Haack, Andrew K.; Sheth, Chandni; Schwager, Andrea L.; Sinclair, Michael S.; Tandon, Shashank; Taha, Sharif A.		Brain Inst	Lesions of the Lateral Habenula Increase Voluntary Ethanol Consumption and Operant Self-Administration, Block Yohimbine-Induced Reinstatement of Ethanol Seeking, and Attenuate Ethanol-Induced Conditioned Taste Aversion	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; FOS-LIKE IMMUNOREACTIVITY; DOPAMINE NEURONS; COCAINE SEEKING; LONG-EVANS; RATS; ALCOHOL; BEHAVIOR; NUCLEUS; STRESS	The lateral habenula (LHb) plays an important role in learning driven by negative outcomes. Many drugs of abuse, including ethanol, have dose-dependent aversive effects that act to limit intake of the drug. However, the role of the LHb in regulating ethanol intake is unknown. In the present study, we compared voluntary ethanol consumption and self-administration, yohimbine-induced reinstatement of ethanol seeking, and ethanol-induced conditioned taste aversion in rats with sham or LHb lesions. In rats given home cage access to 20% ethanol in an intermittent access two bottle choice paradigm, lesioned animals escalated their voluntary ethanol consumption more rapidly than sham-lesioned control animals and maintained higher stable rates of voluntary ethanol intake. Similarly, lesioned animals exhibited higher rates of responding for ethanol in operant self-administration sessions. In addition, LHb lesion blocked yohimbine-induced reinstatement of ethanol seeking after extinction. Finally, LHb lesion significantly attenuated an ethanol-induced conditioned taste aversion. Our results demonstrate an important role for the LHb in multiple facets of ethanol-directed behavior, and further suggest that the LHb may contribute to ethanol-directed behaviors by mediating learning driven by the aversive effects of the drug.	[Haack, Andrew K.; Schwager, Andrea L.; Sinclair, Michael S.; Tandon, Shashank; Taha, Sharif A.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; [Haack, Andrew K.; Schwager, Andrea L.; Taha, Sharif A.] Univ Utah, Sch Med, Interdept Program Neurosci, Salt Lake City, UT USA; [Sheth, Chandni] Univ Utah, Sch Med, Dept Pharmacol & Toxicol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Taha, SA (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA.	s.taha@utah.edu		Sinclair, Michael/0000-0002-3636-5920; Haack, Andrew/0000-0003-2958-3273	National Institutes Health [MH094870]; March of Dimes Foundation; University of Utah; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094870] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); University of Utah; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding support was provided by the National Institutes Health under award MH094870, the March of Dimes Foundation, and the University of Utah. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; Blednov YA, 2008, GENES BRAIN BEHAV, V7, P1, DOI 10.1111/j.1601-183X.2007.00309.x; Broadbent J, 2002, BEHAV NEUROSCI, V116, P138, DOI 10.1037//0735-7044.116.1.138; Brown PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060678; Camicella S, 2009, ALCOHOL, V43, P35, DOI 10.1016/j.alcohol.2008.12.001; Carr KD, 1998, BRAIN RES, V779, P26, DOI 10.1016/S0006-8993(97)01074-3; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; DONOVICK PJ, 1970, J COMP PHYSIOL PSYCH, V71, P376, DOI 10.1037/h0029114; DONOVICK PJ, 1969, PHYSIOL BEHAV, V4, P45, DOI 10.1016/0031-9384(69)90011-0; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Friedman A, 2011, NEUROPHARMACOLOGY, V60, P381, DOI 10.1016/j.neuropharm.2010.10.006; Friedman A, 2010, NEUROPHARMACOLOGY, V59, P452, DOI 10.1016/j.neuropharm.2010.06.008; Gill MJ, 2013, PHARMACOL BIOCHEM BE, V111, P24, DOI 10.1016/j.pbb.2013.08.002; Gilpin NW, 2008, ALCOHOL RES HEALTH, V31, P185; Green AS, 2008, ALCOHOL, V42, P1, DOI 10.1016/j.alcohol.2007.10.005; Heldt SA, 2006, BRAIN RES, V1073, P229, DOI 10.1016/j.brainres.2005.12.053; Jhou TC, 2013, J NEUROSCI, V33, P7501, DOI 10.1523/JNEUROSCI.3634-12.2013; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; King AC, 2013, BIOL PSYCHIAT; King AC, 2011, ARCH GEN PSYCHIAT, V68, P389, DOI 10.1001/archgenpsychiatry.2011.26; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lax E, 2013, NEUROPHARMACOLOGY, V75, P246, DOI 10.1016/j.neuropharm.2013.06.034; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026701; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; PINEL JPJ, 1976, PHYSIOL BEHAV, V16, P693, DOI 10.1016/0031-9384(76)90238-9; Schramm-Sapyta NL, 2010, ALCOHOL CLIN EXP RES, V34, P2061, DOI 10.1111/j.1530-0277.2010.01302.x; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Schulteis G, 2006, ALCOHOL, V39, P21, DOI 10.1016/j.alcohol.2006.06.008; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Shumake J, 2010, J NEUROSCI, V30, P5876, DOI 10.1523/JNEUROSCI.3604-09.2010; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Simms JA, 2011, PSYCHOPHARMACOLOGY, V218, P101, DOI 10.1007/s00213-011-2451-9; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; THORNTON EW, 1989, PHYSIOL BEHAV, V45, P929, DOI 10.1016/0031-9384(89)90217-5; Timofeeva E, 2001, J COMP NEUROL, V441, P71, DOI 10.1002/cne.1398; Verendeev A, 2013, BEHAV PHARMACOL, V24, P363, DOI 10.1097/FBP.0b013e32836413d5; Vetter-O'Hagen C, 2009, ALCOHOL ALCOHOLISM, V44, P547, DOI 10.1093/alcalc/agp048; Watts AG, 2010, PHYSIOL BEHAV, V100, P472, DOI 10.1016/j.physbeh.2010.04.010; WEISS F, 1993, J PHARMACOL EXP THER, V267, P250; WIRTSHAFTER D, 1994, BRAIN RES, V633, P21, DOI 10.1016/0006-8993(94)91517-2; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034; Zapata A, 2006, NEUROPSYCHOPHARMACOL, V31, P396, DOI 10.1038/sj.npp.1300833	44	54	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92701	10.1371/journal.pone.0092701	http://dx.doi.org/10.1371/journal.pone.0092701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695107	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000025
J	Nawroth, C; von Borell, E; Langbein, J				Nawroth, Christian; von Borell, Eberhard; Langbein, Jan			Exclusion Performance in Dwarf Goats (Capra aegagrus hircus) and Sheep (Ovis orientalis aries)	PLOS ONE			English	Article							MONKEYS CEBUS-APELLA; FIND HIDDEN FOOD; PARROTS PSITTACUS-ERITHACUS; CHOICE TASK; GREAT APES; SEA LIONS; LOCATION; CUES; DISCRIMINATION; INFERENCES	Using a comparative approach, we investigated the ability of dwarf goats and sheep to use direct and indirect information about the location of a food reward in an object-choice task. Subjects had to choose between two cups with only one covering a reward. Before making a choice, subjects received information about the baited (direct information) or non-baited cup (indirect information). Both goats and sheep were able to use direct information (presence of food) in the object choice task. After controlling for local enhancement, we found that goats rather than sheep were able to use indirect information (i.e., the absence of food) to find a reward. The actual test setup could not clarify whether individual goats were able to inferentially reason about the content of the baited cup when only shown the content of the non-baited cup or if they simply avoided the empty cup in that situation. As browsing species, feral and wild goats exhibit highly selective feeding behaviour compared to the rather unselective grazing sheep. The potential influence of this species-specific foraging flexibility of goats and sheep for using direct and indirect information to find a food reward is discussed in relation to a higher aversion to losses in food acquisition in goats compared to sheep.	[Nawroth, Christian; von Borell, Eberhard] Univ Halle Wittenberg, Inst Agr & Nutr Sci, Dept Anim Husb & Ecol, D-06108 Halle, Germany; [Langbein, Jan] Leibniz Inst Farm Anim Biol, Inst Behav Physiol, Dummerstorf, Germany	Martin Luther University Halle Wittenberg; Forschungsinstitut fur Nutztierbiologie (FBN)	Langbein, J (corresponding author), Leibniz Inst Farm Anim Biol, Inst Behav Physiol, Dummerstorf, Germany.	langbein@fbn-dummerstorf.de	Langbein, Jan/AFO-8965-2022; Nawroth, Christian/C-4017-2018	Nawroth, Christian/0000-0003-4582-4057; Langbein, Jan/0000-0002-1170-5431	Martin-Luther-University Halle-Wittenberg	Martin-Luther-University Halle-Wittenberg	The study was internally funded from resources of the graduate program of Martin-Luther-University Halle-Wittenberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aust U, 2008, ANIM COGN, V11, P587, DOI 10.1007/s10071-008-0149-0; Beran MJ, 2002, J EXP ANAL BEHAV, V78, P497, DOI 10.1901/jeab.2002.78-497; Briefer EF, 2013, APPL ANIM BEHAV SCI, V146, P45, DOI 10.1016/j.applanim.2013.03.007; Briefer EF, 2012, P ROY SOC B-BIOL SCI, V279, P3749, DOI 10.1098/rspb.2012.0986; Call J, 2004, J COMP PSYCHOL, V118, P232, DOI 10.1037/0735-7036.118.2.232; Call J, 2006, ANIM COGN, V9, P393, DOI 10.1007/s10071-006-0037-4; Clement TS, 2003, PSYCHON B REV, V10, P959, DOI 10.3758/BF03196558; de Kort SR, 2006, P ROY SOC B-BIOL SCI, V273, P417, DOI 10.1098/rspb.2005.3350; Doyle RE, 2010, BEHAV PROCESS, V83, P349, DOI 10.1016/j.beproc.2010.01.019; Doyle RE, 2010, APPL ANIM BEHAV SCI, V122, P28, DOI 10.1016/j.applanim.2009.11.003; Erdohegyi A, 2007, ANIM BEHAV, V74, P725, DOI 10.1016/j.anbehav.2007.03.004; Gibson B, 2009, BEHAV PROCESS, V80, P278, DOI 10.1016/j.beproc.2008.11.013; Haun DBM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028801; Heilbronner SR, 2008, BIOL LETTERS, V4, P246, DOI 10.1098/rsbl.2008.0081; Heimbauer LA, 2012, ANIM COGN, V15, P45, DOI 10.1007/s10071-011-0430-5; HERMAN LM, 1984, COGNITION, V16, P129, DOI 10.1016/0010-0277(84)90003-9; HEYES CM, 1993, ANIM BEHAV, V46, P177, DOI 10.1006/anbe.1993.1173; Hill A, 2011, J COMP PSYCHOL, V125, P91, DOI 10.1037/a0020867; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; HOSOI E, 1995, APPL ANIM BEHAV SCI, V44, P37, DOI 10.1016/0168-1591(95)00572-A; JE Davidson, 1995, NATURE INSIGHT, P465; Kamil Alan C., 1998, P1, DOI 10.1016/B978-012077030-4/50053-2; Kaminski J, 2005, ANIM BEHAV, V69, P11, DOI 10.1016/j.anbehav.2004.05.008; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Kastak CR, 2002, J EXP ANAL BEHAV, V78, P449, DOI 10.1901/jeab.2002.78-449; Katz JS, 2007, COMP COGN BEHAV REV, V2, P79, DOI 10.3819/ccbr.2008.20005; KENDRICK KM, 1995, ANIM BEHAV, V49, P1665, DOI 10.1016/0003-3472(95)90088-8; Kendrick KM, 2001, NATURE, V414, P165, DOI 10.1038/35102669; Kohler W., 1925, MENTALITY APES; Kojima S, 2001, ANIM COGN, V4, P231, DOI [10.1007/s10071-001-0118-3, DOI 10.1007/S10071-001-0118-3]; Langbein J, 2007, J COMP PSYCHOL, V121, P447, DOI 10.1037/0735-7036.121.4.447; Langbein J, 2009, APPL ANIM BEHAV SCI, V120, P150, DOI 10.1016/j.applanim.2009.07.006; Macphail EM, 2001, BIOL REV, V76, P341; Maille A, 2012, ANIM COGN, V15, P1075, DOI 10.1007/s10071-012-0531-9; Meyer S, 2012, ANIM COGN, V15, P567, DOI 10.1007/s10071-012-0485-y; Mikolasch S, 2012, ANIM COGN, V15, P73, DOI 10.1007/s10071-011-0434-1; Mikolasch S, 2011, BIOL LETTERS, V7, P875, DOI 10.1098/rsbl.2011.0500; Olton D.S., 1981, P333; Paukner A, 2009, J COMP PSYCHOL, V123, P26, DOI 10.1037/a0013128; Penn DC, 2007, ANNU REV PSYCHOL, V58, P97, DOI 10.1146/annurev.psych.58.110405.085555; Pepperberg IM, 2013, J COMP PSYCHOL, V127, P272, DOI 10.1037/a0031641; PREMACK D, 1994, COGNITION, V50, P347, DOI 10.1016/0010-0277(94)90035-3; Premack D., 1995, ORIGINS HUMAN BRAIN, P286; Sabbatini G, 2008, J COMP PSYCHOL, V122, P156, DOI 10.1037/0735-7036.122.2.156; Schloegl C, 2012, P ROY SOC B-BIOL SCI, V279, P4135, DOI 10.1098/rspb.2012.1292; Schloegl C, 2011, J COMP PSYCHOL, V125, P162, DOI 10.1037/a0023045; Schloegl C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006368; Schmitt V, 2009, J COMP PSYCHOL, V123, P316, DOI 10.1037/a0016218; SCHUSTERMAN RJ, 1993, ANIM LEARN BEHAV, V21, P377, DOI 10.3758/BF03198004; Shaw RC, 2013, J COMP PSYCHOL, V127, P428, DOI 10.1037/a0032010; Stuth J.W., 1991, GRAZING MANAGEMENT E, P259; Tornick JK, 2013, ANIM COGN, V16, P583, DOI 10.1007/s10071-013-0595-1	52	37	37	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93534	10.1371/journal.pone.0093534	http://dx.doi.org/10.1371/journal.pone.0093534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695781	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000084
J	Six, I; Okazaki, H; Gross, P; Cagnard, J; Boudot, C; Maizel, J; Drueke, TB; Massy, ZA				Six, Isabelle; Okazaki, Hirokazu; Gross, Priscilla; Cagnard, Joanna; Boudot, Cedric; Maizel, Julien; Drueke, Tilman B.; Massy, Ziad A.			Direct, Acute Effects of Klotho and FGF23 on Vascular Smooth Muscle and Endothelium	PLOS ONE			English	Article							GROWTH-FACTOR 23; NITRIC-OXIDE; PHOSPHATE; DYSFUNCTION; GENE; POPULATION; RESISTANCE; PROTECTS	Chronic kidney disease (CKD) is regarded as a state of Klotho deficiency and FGF23 excess. In patients with CKD a strong association has been found between increased serum FGF23 and mortality risk, possibly via enhanced atherosclerosis, vascular stiffness, and vascular calcification. The aim of this study was to examine the hypothesis that soluble Klotho and FGF23 exert direct, rapid effects on the vessel wall. We used three in vitro models: mouse aorta rings, human umbilical vein endothelial cells, and human vascular smooth muscle cells (HVSMC). Increasing medium concentrations of soluble Klotho and FGF23 both stimulated aorta contractions and increased ROS production in HVSMC. Klotho partially reverted FGF23 induced vasoconstriction, induced relaxation on phosphate preconstricted aorta and enhanced endothelial NO production in HUVEC. Thus Klotho increased both ROS production in HVSMC and NO production in endothelium. FGF23 induced contraction in phosphate preconstricted vessels and increased ROS production. Phosphate, Klotho and FGF23 together induced no change in vascular tone despite increased ROS production. Moreover, the three compounds combined inhibited relaxation despite increased NO production, probably owing to the concomitant increase in ROS production. In conclusion, although phosphate, soluble Klotho and FGF23 separately stimulate aorta contraction, Klotho mitigates the effects of phosphate and FGF23 on contractility via increased NO production, thereby protecting the vessel to some extent against potentially noxious effects of high phosphate or FGF23 concentrations. This novel observation is in line with the theory that Klotho deficiency is deleterious whereas Klotho sufficiency is protective against the negative effects of phosphate and FGF23 which are additive.	[Six, Isabelle; Okazaki, Hirokazu; Gross, Priscilla; Cagnard, Joanna; Boudot, Cedric; Maizel, Julien; Drueke, Tilman B.; Massy, Ziad A.] Jules Verne Univ Picardie, INSERM Unit 1088, Amiens, France; [Maizel, Julien; Massy, Ziad A.] Amiens Univ, Med Ctr, Amiens, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Massy, ZA (corresponding author), Jules Verne Univ Picardie, INSERM Unit 1088, Amiens, France.	ziad.massy@apr.aphp.fr	DRUEKE, Tilman B./B-4958-2010	DRUEKE, Tilman B./0000-0002-0700-7681	Conseil Regional de Picardie, Amiens, France (Marno-MPCC); Conseil Regional de Picardie, Amiens, France (Feder)	Conseil Regional de Picardie, Amiens, France (Marno-MPCC)(Region Hauts-de-France); Conseil Regional de Picardie, Amiens, France (Feder)(Region Hauts-de-France)	Hirokazu Okazaki and Priscilla Gross were supported by grants from Conseil Regional de Picardie, Amiens, France (Marno-MPCC for HO and Feder for PG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal I, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000584; Canalejo R, 2010, J AM SOC NEPHROL, V21, P1125, DOI 10.1681/ASN.2009040427; Carracedo J, 2012, MECH AGEING DEV, V133, P647, DOI 10.1016/j.mad.2012.09.002; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Galitzer H, 2010, KIDNEY INT, V77, P211, DOI 10.1038/ki.2009.464; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Izquierdo MC, 2012, NEPHROL DIAL TRANSPL, V27, piv6, DOI 10.1093/ndt/gfs426; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lim K, 2012, CIRCULATION, V125, P2243, DOI 10.1161/CIRCULATIONAHA.111.053405; Lindberg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060658; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Mirza MAI, 2009, ATHEROSCLEROSIS, V205, P385, DOI 10.1016/j.atherosclerosis.2009.01.001; Montezano AC, 2012, BASIC CLIN PHARMACOL, V110, P87, DOI 10.1111/j.1742-7843.2011.00785.x; Nagano N, 2006, KIDNEY INT, V69, P531, DOI 10.1038/sj.ki.5000020; Nakai K, 2010, J NEPHROL, V23, P619; Nakamura T, 2002, JPN J PHARMACOL, V89, P149, DOI 10.1254/jjp.89.149; Prie D, 2009, KIDNEY INT, V75, P882, DOI 10.1038/ki.2008.643; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Rakugi H, 2007, ENDOCRINE, V31, P82, DOI 10.1007/s12020-007-0016-9; Recio-Mayoral A, 2011, ATHEROSCLEROSIS, V216, P446, DOI 10.1016/j.atherosclerosis.2011.02.017; Saito T, 2009, INT J PEDIATR ENDOCR, DOI 10.1155/2009/496514; Saito Y, 2000, BIOCHEM BIOPH RES CO, V276, P767, DOI 10.1006/bbrc.2000.3470; Saito Y, 1998, BIOCHEM BIOPH RES CO, V248, P324, DOI 10.1006/bbrc.1998.8943; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Six I, 2012, CARDIOVASC RES, V96, P130, DOI 10.1093/cvr/cvs240; Stam F, 2006, J AM SOC NEPHROL, V17, P537, DOI 10.1681/ASN.2005080834; Yang K, 2012, TOXICOL LETT, V215, P77, DOI 10.1016/j.toxlet.2012.10.004	28	83	94	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93423	10.1371/journal.pone.0093423	http://dx.doi.org/10.1371/journal.pone.0093423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695641	gold, Green Submitted, Green Published			2022-12-27	WOS:000334103000070
J	Lee, JB; Kim, TW; Min, YK; Yang, HM				Lee, Jeong-Beom; Kim, Tae-Wook; Min, Young-Ki; Yang, Hun-Mo			Long Distance Runners Present Upregulated Sweating Responses than Sedentary Counterparts	PLOS ONE			English	Article							SKIN BLOOD-FLOW; SUDOMOTOR FUNCTION; HEAT ACCLIMATION; EXERCISE; TEMPERATURE; SENSITIVITY; GLAND; RATS; ACETYLCHOLINE; VASODILATION	Relatively few studies have investigated peripheral sweating mechanisms of long-distance runners. The aim of this study was to compare peripheral sweating mechanisms in male long-distance runners, and sedentary counterparts. Thirty six subjects, including 20 sedentary controls and 16 long-distance runners (with 7-12 years of athletic training, average 9.2 +/- 2.1 years) were observed. Quantitative sudomotor axon reflex testing (QSART) with iontophoresis (2 mA for 5 min) and 10% acetylcholine (ACh) were performed to determine axon reflex-mediated and directly activated (DIR, muscarinic receptor) sweating. Sweat onset time, sweat rate, number of activated sweat glands, sweat output per gland and skin temperature were measured at rest while maximum oxygen uptake (VO(2)max) were measured during maximal cycling. Sweat rate, activated sweat glands, sweat output per gland, skin temperature and VO(2)max were significantly higher in the trained runners than in the sedentary controls. Sweat onset time was significantly shorter for the runners. In the group of long-distance runners, significant correlations were found between VO(2)max and sweat onset time (r(2) = 0.543, P < 0.01, n = 16), DIR sweat rate (r(2) = 0.584, P < 0.001, n = 16), sweat output per gland (r(2) = 0.539, P < 0.01, n = 16). There was no correlation between VO(2)max and activated sweat glands. These findings suggest that habitual long-distance running results in upregulation of the peripheral sweating mechanisms in humans. Additional research is needed to determine the molecular mechanism underlying these changes. These findings complement the existing sweating data in long-distance runners.	[Lee, Jeong-Beom; Min, Young-Ki; Yang, Hun-Mo] Soonchunhyang Univ, Coll Med, Dept Physiol, Cheonan, Chungcheongnamd, South Korea; [Kim, Tae-Wook] Soonchunhyang Univ, Grad Sch, Dept Hlth Care, Asan, Chungcheongnamd, South Korea	Soonchunhyang University; Soonchunhyang University	Kim, TW (corresponding author), Soonchunhyang Univ, Grad Sch, Dept Hlth Care, Asan, Chungcheongnamd, South Korea.	kimtw@sch.ac.kr						ARAKI T, 1981, J APPL PHYSIOL, V51, P1526, DOI 10.1152/jappl.1981.51.6.1526; Bae JS, 2006, PFLUG ARCH EUR J PHY, V453, P67, DOI 10.1007/s00424-006-0098-x; BAUM E, 1976, J APPL PHYSIOL, V40, P404, DOI 10.1152/jappl.1976.40.3.404; Bickel A, 2004, J NEUROL NEUROSUR PS, V75, P275; BITTEL JHM, 1980, EXPERIENTIA, V36, P560, DOI 10.1007/BF01965800; BUONO M J, 1992, Journal of Dermatological Science, V4, P33, DOI 10.1016/0923-1811(92)90053-E; BUONO MJ, 1988, J APPL PHYSIOL, V65, P811, DOI 10.1152/jappl.1988.65.2.811; BUONO MJ, 1991, AGE AGEING, V20, P439, DOI 10.1093/ageing/20.6.439; Chemali KR, 2001, ANN NEUROL, V49, P453; Chen H, 1998, CHINESE J PHYSIOL, V41, P161; Cheng LJ, 1999, J BIOMED SCI, V6, P22, DOI 10.1159/000025367; Cotter JD, 1997, EUR J APPL PHYSIOL O, V76, P181, DOI 10.1007/s004210050232; CRAWSHAW LI, 1975, PFLUG ARCH EUR J PHY, V354, P19, DOI 10.1007/BF00584500; Dawson B, 1989, J SPORT SCI, V7, P189, DOI 10.1080/02640418908729840; DELP MD, 1995, MED SCI SPORT EXER, V27, P1152; DiPasquale DM, 2003, JPN J PHYSIOL, V53, P427, DOI 10.2170/jjphysiol.53.427; Gonzalez-Alonso J, 1999, J APPL PHYSIOL, V86, P1032, DOI 10.1152/jappl.1999.86.3.1032; HENANE R, 1977, J APPL PHYSIOL, V43, P822, DOI 10.1152/jappl.1977.43.5.822; Heylen E, 2008, J SPORT MED PHYS FIT, V48, P246; IRION GL, 1987, AVIAT SPACE ENVIR MD, V58, P948; Kondo N, 2001, J APPL PHYSIOL, V90, P1877, DOI 10.1152/jappl.2001.90.5.1877; Lee JB, 2009, INT J BIOMETEOROL, V53, P149, DOI 10.1007/s00484-008-0197-9; Lee JB, 2008, KOREAN J PHYSIOL PHA, V12, P349, DOI 10.4196/kjpp.2008.12.6.349; Low PA, 2004, CLIN NEUROPHYSIOL, V115, P1506, DOI 10.1016/j.clinph.2004.01.023; LOW PA, 1983, ANN NEUROL, V14, P573, DOI 10.1002/ana.410140513; MCMURRAY RG, 1979, J APPL PHYSIOL, V46, P1086, DOI 10.1152/jappl.1979.46.6.1086; Merry TL, 2010, ACTA PHYSIOL, V198, P179, DOI 10.1111/j.1748-1716.2009.02051.x; Midgley AW, 2007, SPORTS MED, V37, P857, DOI 10.2165/00007256-200737100-00003; Mora-Rodriguez R, 2013, APPL PHYSIOL NUTR ME, V38, P73, DOI 10.1139/apnm-2012-0174; Morris SJ, 1996, J PHYSIOL-LONDON, V496, P531, DOI 10.1113/jphysiol.1996.sp021704; Noguchi M, 2002, NEUROPEPTIDES, V36, P327, DOI 10.1016/S0143-4179(02)00090-2; OGAWA T, 1986, JPN J PHYSIOL, V36, P417, DOI 10.2170/jjphysiol.36.417; PIWONKA RW, 1967, J APPL PHYSIOL, V22, P9, DOI 10.1152/jappl.1967.22.1.9; ROBERTS MF, 1977, J APPL PHYSIOL, V43, P133, DOI 10.1152/jappl.1977.43.1.133; SATO K, 1983, AM J PHYSIOL, V245, pR203, DOI 10.1152/ajpregu.1983.245.2.R203; Shibasaki Manabu, 2010, Front Biosci (Schol Ed), V2, P685; STROMME SB, 1977, J APPL PHYSIOL, V42, P833, DOI 10.1152/jappl.1977.42.6.833; SUGENOYA J, 1995, EUR J APPL PHYSIOL O, V71, P33, DOI 10.1007/BF00511230; TAYLOR NAS, 1986, SPORTS MED, V3, P387, DOI 10.2165/00007256-198603060-00001	39	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93976	10.1371/journal.pone.0093976	http://dx.doi.org/10.1371/journal.pone.0093976			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709823	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800080
J	Niemi, NM; Sacoman, JL; Westrate, LM; Gaither, LA; Lanning, NJ; Martin, KR; MacKeigan, JP				Niemi, Natalie M.; Sacoman, Juliana L.; Westrate, Laura M.; Gaither, L. Alex; Lanning, Nathan J.; Martin, Katie R.; MacKeigan, Jeffrey P.			The Pseudophosphatase MK-STYX Physically and Genetically Interacts with the Mitochondrial Phosphatase PTPMT1	PLOS ONE			English	Article							PROTEIN; MYOTUBULARIN; CARDIOLIPIN; APOPTOSIS; COMPLEXES; MAP	We previously performed an RNA interference (RNAi) screen and found that the knockdown of the catalytically inactive phosphatase, MK-STYX [MAPK (mitogen-activated protein kinase) phospho-serine/threonine/tyrosine-binding protein], resulted in potent chemoresistance. Our follow-up studies demonstrated that knockdown of MK-STYX prevents cells from undergoing apoptosis through a block in cytochrome c release, but that MK-STYX does not localize proximal to the molecular machinery currently known to control this process. In an effort to define its molecular mechanism, we utilized an unbiased proteomics approach to identify proteins that interact with MK-STYX. We identified the mitochondrial phosphatase, PTPMT1 (PTP localized to mitochondrion 1), as the most significant and unique interaction partner of MK-STYX. We previously reported that knockdown of PTPMT1, an important component of the cardiolipin biosynthetic pathway, is sufficient to induce apoptosis and increase chemosensitivity. Accordingly, we hypothesized that MK-STYX and PTPMT1 interact and serve opposing functions in mitochondrial-dependent cell death. We confirmed that MK-STYX and PTPMT1 interact in cells and, importantly, found that MK-STYX suppresses PTPMT1 catalytic activity. Furthermore, we found that knockdown of PTPMT1 resensitizes MK-STYX knockdown cells to chemotherapeutics and restores the ability to release cytochrome c. Taken together, our data support a model in which MK-STYX controls apoptosis by negatively regulating PTPMT1. Given the important role of PTPMT1 in the production of cardiolipin and other phospholipids, this raises the possibility that dysregulated mitochondrial lipid metabolism may facilitate chemoresistance.	[Niemi, Natalie M.; Sacoman, Juliana L.; Westrate, Laura M.; Lanning, Nathan J.; Martin, Katie R.; MacKeigan, Jeffrey P.] Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI 49503 USA; [Gaither, L. Alex] Novartis Inst BioMed Res, Dev & Mol Pathways Dept, Cambridge, MA USA	Van Andel Institute; Novartis	MacKeigan, JP (corresponding author), Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI 49503 USA.	jeff.mackeigan@vai.org	Niemi, Natalie/AAH-6963-2021; Lanning, Nathan/AAI-2532-2019	Niemi, Natalie/0000-0002-5174-4005; Lanning, Nathan/0000-0002-0983-7451; MacKeigan, Jeffrey/0000-0002-0198-5679; Martin, Katie/0000-0002-3689-4814	National Institutes of Health National Cancer Institute grants [R01CA138651]; Novartis Institutes for BioMedical Research; NATIONAL CANCER INSTITUTE [R01CA138651] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Novartis Institutes for BioMedical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health National Cancer Institute grants R01CA138651 (J.P.M.). Novartis Institutes for BioMedical Research provided support in the form of a salary for author L.A.G., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions'' section.	Berg J. M., 2002, BIOCHEMISTRY-US; Berger P, 2006, HUM MOL GENET, V15, P569, DOI 10.1093/hmg/ddi473; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Copeland R. A., 2005, EVALUATION ENZYME IN; Doughty-Shenton D, 2010, J PHARMACOL EXP THER, V333, P584, DOI 10.1124/jpet.109.163329; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HILL HD, 1968, ANAL BIOCHEM, V24, P9, DOI 10.1016/0003-2697(68)90054-7; Hinton SD, 2010, BIOCHEM J, V427, P349, DOI 10.1042/BJ20091383; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kim SA, 2003, P NATL ACAD SCI USA, V100, P4492, DOI 10.1073/pnas.0431052100; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Mochizuki Y, 2003, P NATL ACAD SCI USA, V100, P9768, DOI 10.1073/pnas.1333958100; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Nandurkar HH, 2003, P NATL ACAD SCI USA, V100, P8660, DOI 10.1073/pnas.1033097100; Niemi NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053803; Niemi NM, 2011, MOL CELL BIOL, V31, P1357, DOI 10.1128/MCB.00788-10; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Pagliarini DJ, 2004, J BIOL CHEM, V279, P38590, DOI 10.1074/jbc.M404959200; Potting C, 2013, CELL METAB, V18, P287, DOI 10.1016/j.cmet.2013.07.008; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tierno MB, 2007, NAT PROTOC, V2, P1134, DOI 10.1038/nprot.2007.155; Wishart MJ, 1998, TRENDS BIOCHEM SCI, V23, P301, DOI 10.1016/S0968-0004(98)01241-9; Zhang J, 2011, CELL METAB, V13, P690, DOI 10.1016/j.cmet.2011.04.007; Zou J, 2009, J BIOL CHEM, V284, P2064, DOI 10.1074/jbc.M804292200	32	19	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93896	10.1371/journal.pone.0093896	http://dx.doi.org/10.1371/journal.pone.0093896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709986	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800064
J	Oh, SW; Kim, S; Na, KY; Kim, KW; Chae, DW; Chin, HJ				Oh, Se Won; Kim, Sejoong; Na, Ki Young; Kim, Ki Woong; Chae, Dong-Wan; Chin, Ho Jun			Glomerular Filtration Rate and Proteinuria: Association with Mortality and Renal Progression in a Prospective Cohort of a Community- Based Elderly Population	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR MORTALITY; GENERAL-POPULATION; ALL-CAUSE; ALBUMINURIA; RISK; AGE; DECLINE; EPIDEMIOLOGY; PREDICTORS	Limited prospective data are available on the importance of estimated glomerular filtration rate (GFR) and proteinuria in the prediction of all-cause mortality (ACM) in community-based elderly populations. We examined the relationship between GFR or proteinuria and ACM in 949 randomly selected community-dwelling elderly subjects (aged >= 65 years) over a 5-year period. A spot urine sample was used to measure proteinuria by the dipstick test, and GFR was estimated using the chronic kidney disease-epidemiology collaboration (CKD-EPI) equation. Information about mortality and causes of death was collected by direct enquiry with the subjects and from the national mortality data. Compared to subjects without proteinuria, those with proteinuria of grade >= 1+ had a 1.725-fold (1.134-2.625) higher risk of ACM. Compared to subjects with GFR >= 90 ml/min/1.73 m(2), those with GFR, 45 ml/min/1.73 m(2) had a 2.357 -fold (1.170-4.750) higher risk for ACM. Among the 403 subjects included in the analysis of renal progression, the annual rate of GFR change during follow-up period was -0.52 +/- 2.35 ml/min/1.73 m(2) /year. The renal progression rate was 7.315-fold (1.841-29.071) higher in subjects with GFR<60 ml/min/1.73 m(2) than in those with GFR >= 60 ml/min/1.73 m(2). Among a community-dwelling elderly Korean population, decreased GFR of <45 ml/min/1.73 m(2) and proteinuria were independent risk factors for ACM.	[Oh, Se Won] Inje Univ, Coll Med, Dept Internal Med, Goyang City, Gyeonggi Do, South Korea; [Kim, Sejoong; Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun] Seoul Natl Univ, Bundang Hopsital, Songnam, South Korea; [Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul 151, South Korea	Inje University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Chin, HJ (corresponding author), Inje Univ, Coll Med, Dept Internal Med, Goyang City, Gyeonggi Do, South Korea.	mednep@snubh.org	Kim, Sejoong/J-5356-2015; Oh, Se Won/G-2632-2017	Kim, Sejoong/0000-0002-7238-9962; Oh, Se Won/0000-0003-3795-9322	Pfizer Global Pharmaceuticals [06-05-039]; Seongnam City Government in Korea [800-20050211]	Pfizer Global Pharmaceuticals(Pfizer); Seongnam City Government in Korea	This work was supported by an independent Research Grant (IRG) from Pfizer Global Pharmaceuticals (grant number 06-05-039) and a Grant for developing Seongnam Health Promotion Program for the Elderly from Seongnam City Government in Korea (grant number 800-20050211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowling CB, 2012, J GERONTOL A-BIOL, V67, P1379, DOI 10.1093/gerona/gls173; Bowling CB, 2011, CLIN J AM SOC NEPHRO, V6, P2822, DOI 10.2215/CJN.06770711; Chin HJ, 2008, NEPHROL DIAL TRANSPL, V23, P2810, DOI 10.1093/ndt/gfn132; Christensson A, 2011, NEPHRON CLIN PRACT, V117, pC40, DOI 10.1159/000319646; Clase CM, 2011, ANN INTERN MED, V154, P310, DOI 10.7326/0003-4819-154-5-201103010-00005; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; Dalrymple LS, 2011, J GEN INTERN MED, V26, P379, DOI 10.1007/s11606-010-1511-x; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Glassock Richard J, 2009, Trans Am Clin Climatol Assoc, V120, P419; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Imai E, 2008, HYPERTENS RES, V31, P433, DOI 10.1291/hypres.31.433; Kim S, 2009, J KOREAN MED SCI, V24, pS11, DOI 10.3346/jkms.2009.24.S1.S11; Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649; Lee CS, 2010, J KOREAN MED SCI, V25, P1616, DOI 10.3346/jkms.2010.25.11.1616; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Muntner P, 2011, CLIN J AM SOC NEPHRO, V6, P2200, DOI 10.2215/CJN.02030311; Nerpin E, 2011, NEPHROL DIAL TRANSPL, V26, P2820, DOI 10.1093/ndt/gfq848; O'Hare AM, 2006, J AM SOC NEPHROL, V17, P846, DOI 10.1681/ASN.2005090986; Rifkin DE, 2010, NEPHROL DIAL TRANSPL, V25, P1560, DOI 10.1093/ndt/gfp646; Smink PA, 2012, AM J KIDNEY DIS, V60, P804, DOI 10.1053/j.ajkd.2012.06.017; Stengel B, 2011, NEPHROL DIAL TRANSPL, V26, P3286, DOI 10.1093/ndt/gfr323; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; van der Velde M, 2010, CLIN J AM SOC NEPHRO, V5, P2053, DOI 10.2215/CJN.08851209	29	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94120	10.1371/journal.pone.0094120	http://dx.doi.org/10.1371/journal.pone.0094120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709896	gold, Green Submitted, Green Published			2022-12-27	WOS:000334159800102
J	Uher, R; Brooks, SJ; Bartholdy, S; Tchanturia, K; Campbell, IC				Uher, Rudolf; Brooks, Samantha J.; Bartholdy, Savani; Tchanturia, Kate; Campbell, Iain C.			Increasing Cognitive Load Reduces Interference from Masked Appetitive and Aversive but Not Neutral Stimuli	PLOS ONE			English	Article							EMOTIONAL FACIAL EXPRESSIONS; WORKING-MEMORY; SELECTIVE ATTENTION; NEURAL MECHANISMS; TASK-PERFORMANCE; FEARFUL FACES; AMYGDALA; INFORMATION; AROUSAL; ANXIETY	Interactions between cognition and emotion are important for survival, often occurring in the absence of awareness. These interactions have been proposed to involve competition between cognition and emotion for attentional resources. Emotional stimuli have been reported to impair performance on cognitive tasks of low, but not high, load if stimuli are consciously perceived. This study explored whether this load-dependent interference effect occurred in response to subliminal emotional stimuli. Masked emotional (appetitive and aversive), but not neutral, stimuli interfered with performance accuracy but not response time on a cognitive task (n-back) at low (1-back), but not high (2-back) load. These results show that a load-dependent interference effect applies to masked emotional stimuli and that the effect generalises across stimulus categories with high motivational value. This supports models of selective attention that propose that cognition and emotion compete for attentional resources. More specifically, interference from masked emotional stimuli at low load suggests that attention is biased towards salient stimuli, while dissipation of interference under high load involves top-down regulation of attention. Our data also indicate that top-down goal-directed regulation of attention occurs in the absence of awareness and does not require metacognitive monitoring or evaluation of bias over behaviour, i.e., some degree of self-regulation occurs at a non-conscious level.	[Uher, Rudolf; Brooks, Samantha J.; Bartholdy, Savani; Tchanturia, Kate; Campbell, Iain C.] Kings Coll London, Inst Psychiat, London, England	University of London; King's College London	Bartholdy, S (corresponding author), Kings Coll London, Inst Psychiat, London, England.	savani.bartholdy@kcl.ac.uk	Tchanturia, Kate/H-1474-2011; Uher, Rudolf/A-5477-2008; Brooks, Samantha/AAJ-2159-2020	Tchanturia, Kate/0000-0001-8988-3265; Uher, Rudolf/0000-0002-2998-0546; Bartholdy, Savani/0000-0002-4083-5809; Brooks, Samantha/0000-0002-9146-6257	Wellcome Trust [065862]; Nina Jackson Fellowship, Research Into Eating Disorders (RIED), part of the Psychiatry Research Trust, KCL; Department of Health NIHR [RPPG-0606-1043]; National Institute for Health Research (NIHR) [Mental Health Biomedical Research Centre and/or Dementia Biomedical Research Unit] at South London and Maudsley NHS Foundation Trust	Wellcome Trust(Wellcome TrustEuropean Commission); Nina Jackson Fellowship, Research Into Eating Disorders (RIED), part of the Psychiatry Research Trust, KCL; Department of Health NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) [Mental Health Biomedical Research Centre and/or Dementia Biomedical Research Unit] at South London and Maudsley NHS Foundation Trust	R. Uher was supported by a Wellcome Trust Travelling Research Fellowship (No. 065862), S. Brooks was supported by the Nina Jackson Fellowship, Research Into Eating Disorders (RIED), part of the Psychiatry Research Trust, KCL, S. Bartholdy was supported by a Department of Health NIHR Programme Grant for Applied Research (Reference number RPPG-0606-1043) and a studentship awarded by the National Institute for Health Research (NIHR) [Mental Health Biomedical Research Centre and/or Dementia Biomedical Research Unit] at South London and Maudsley NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 2005, J EXP PSYCHOL GEN, V134, P258, DOI 10.1037/0096-3445.134.2.258; Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bertocci MA, 2012, PSYCHOL MED, V42, P1417, DOI 10.1017/S003329171100242X; Blair KS, 2007, NEUROIMAGE, V35, P430, DOI 10.1016/j.neuroimage.2006.11.048; Brignell C, 2009, APPETITE, V52, P299, DOI 10.1016/j.appet.2008.10.007; Castellanos EH, 2009, INT J OBESITY, V33, P1063, DOI 10.1038/ijo.2009.138; Charles L, 2013, NEUROIMAGE; Clarke R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00228; Dalgleish T, 2003, J CLIN CHILD ADOLESC, V32, P10, DOI 10.1207/S15374424JCCP3201_02; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; de Jong PJ, 2003, COGNITION EMOTION, V17, P521, DOI 10.1080/02699930302305; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dresler T, 2009, PSYCHOL RES-PSYCH FO, V73, P364, DOI 10.1007/s00426-008-0154-6; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Drobes DJ, 2001, BIOL PSYCHOL, V57, P153, DOI 10.1016/S0301-0511(01)00093-X; Eder AB, 2010, COGNITION EMOTION, V24, P1053, DOI 10.1080/02699930903056836; Erk S, 2007, NEUROIMAGE, V37, P623, DOI 10.1016/j.neuroimage.2007.05.006; ESTEVES F, 1993, SCAND J PSYCHOL, V34, P1, DOI 10.1111/j.1467-9450.1993.tb01096.x; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; First MB, 2002, STRUCTURED CLIN INTE; Glascher J, 2003, J NEUROSCI, V23, P10274; Hart SJ, 2010, NEUROIMAGE, V49, P2662, DOI 10.1016/j.neuroimage.2009.10.076; Hartikainen KM, 2000, NEUROPSYCHOLOGIA, V38, P1576, DOI 10.1016/S0028-3932(00)00072-5; Hermans D, 2003, CAN J EXP PSYCHOL, V57, P97, DOI 10.1037/h0087416; Ladouceur CD, 2005, J ABNORM CHILD PSYCH, V33, P165, DOI 10.1007/s10802-005-1825-z; Ladouceur CD, 2009, EMOTION, V9, P855, DOI 10.1037/a0017747; LANG PJ, 1996, INT AFFECTIVE PICTUR; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Lavie N, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P175; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Lavie N, 2006, VIS COGN, V14, P863, DOI 10.1080/13506280500195953; Lee M, 2004, CLIN PSYCHOL REV, V24, P215, DOI 10.1016/j.cpr.2003.10.004; Levens SA, 2008, EMOTION, V8, P267, DOI 10.1037/1528-3542.8.2.267; Liddell BJ, 2004, J COGNITIVE NEUROSCI, V16, P479, DOI 10.1162/089892904322926809; Merikle P. M., 1998, J CONSCIOUSNESS STUD, V5, P5; Mitchell DGV, 2008, NEUROIMAGE, V40, P859, DOI 10.1016/j.neuroimage.2007.08.002; Mitchell DGV, 2007, NEUROIMAGE, V34, P1299, DOI 10.1016/j.neuroimage.2006.10.012; MOGG K, 1993, BEHAV RES THER, V31, P559, DOI 10.1016/0005-7967(93)90107-6; Mogg K, 1998, BEHAV RES THER, V36, P227, DOI 10.1016/S0005-7967(97)00062-4; Mori T, 1997, JPN J PSYCHOL, V68, P371, DOI 10.4992/jjpsy.68.371; Nelson H., 1991, NATL ADULT READING T; Oliveira L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00364; Pashler H, 2001, ANNU REV PSYCHOL, V52, P629, DOI 10.1146/annurev.psych.52.1.629; Pessoa L, 2006, CEREB CORTEX, V16, P366, DOI 10.1093/cercorbhi115; Pessoa L, 2005, NEUROIMAGE, V28, P249, DOI 10.1016/j.neuroimage.2005.05.048; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Rolls E.T., 1999, BRAIN EMOTIONS; Shafer AT, 2012, J COGNITIVE NEUROSCI, V24, P1233, DOI 10.1162/jocn_a_00206; Skjaervo I, 2010, ATTENTIONAL BIAS SUP; TURVEY MT, 1973, PSYCHOL REV, V80, P1, DOI 10.1037/h0033872; Van Dillen LF, 2012, EMOTION, V12, P1340, DOI 10.1037/a0028624; Van Dillen LF, 2009, COGNITION EMOTION, V23, P1106, DOI 10.1080/02699930802338178; Van Dillen LF, 2009, NEUROIMAGE, V45, P1212, DOI 10.1016/j.neuroimage.2009.01.016; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Whalen PJ, 1998, J NEUROSCI, V18, P411; Williams LM, 2006, HUM BRAIN MAPP, V27, P652, DOI 10.1002/hbm.20208; Winkielman P, 2005, PERS SOC PSYCHOL B, V31, P121, DOI 10.1177/0146167204271309; WRIGHT RA, 1984, MOTIV EMOTION, V8, P171, DOI 10.1007/BF00993072; Yantis S, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P73	61	14	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94417	10.1371/journal.pone.0094417	http://dx.doi.org/10.1371/journal.pone.0094417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7EP	24709953	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800143
J	Kaczocha, M; Rebecchi, MJ; Ralph, BP; Teng, YHG; Berger, WT; Galbavy, W; Elmes, MW; Glaser, ST; Wang, LQ; Rizzo, RC; Deutsch, DG; Ojima, I				Kaczocha, Martin; Rebecchi, Mario J.; Ralph, Brian P.; Teng, Yu-Han Gary; Berger, William T.; Galbavy, William; Elmes, Matthew W.; Glaser, Sherrye T.; Wang, Liqun; Rizzo, Robert C.; Deutsch, Dale G.; Ojima, Iwao			Inhibition of Fatty Acid Binding Proteins Elevates Brain Anandamide Levels and Produces Analgesia	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-ALPHA; CANNABINOID RECEPTOR; AMIDE HYDROLASE; MULTIPLE-SCLEROSIS; COST-EFFECTIVENESS; INFLAMMATORY PAIN; NUCLEAR RECEPTORS; MOUSE-BRAIN; MICE; ATHEROSCLEROSIS	The endocannabinoid anandamide (AEA) is an antinociceptive lipid that is inactivated through cellular uptake and subsequent catabolism by fatty acid amide hydrolase (FAAH). Fatty acid binding proteins (FABPs) are intracellular carriers that deliver AEA and related N-acylethanolamines (NAEs) to FAAH for hydrolysis. The mammalian brain expresses three FABP subtypes: FABP3, FABP5, and FABP7. Recent work from our group has revealed that pharmacological inhibition of FABPs reduces inflammatory pain in mice. The goal of the current work was to explore the effects of FABP inhibition upon nociception in diverse models of pain. We developed inhibitors with differential affinities for FABPs to elucidate the subtype(s) that contributes to the antinociceptive effects of FABP inhibitors. Inhibition of FABPs reduced nociception associated with inflammatory, visceral, and neuropathic pain. The antinociceptive effects of FABP inhibitors mirrored their affinities for FABP5, while binding to FABP3 and FABP7 was not a predictor of in vivo efficacy. The antinociceptive effects of FABP inhibitors were mediated by cannabinoid receptor 1 (CB1) and peroxisome proliferator-activated receptor alpha (PPAR(proportional to)) and FABP inhibition elevated brain levels of AEA, providing the first direct evidence that FABPs regulate brain endocannabinoid tone. These results highlight FABPs as novel targets for the development of analgesic and antiinflammatory therapeutics.	[Kaczocha, Martin; Rebecchi, Mario J.; Galbavy, William] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA; [Ralph, Brian P.; Elmes, Matthew W.; Wang, Liqun; Deutsch, Dale G.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Teng, Yu-Han Gary; Berger, William T.; Ojima, Iwao] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Teng, Yu-Han Gary; Berger, William T.; Ojima, Iwao] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Glaser, Sherrye T.] Kingsborough Community Coll, Dept Biol Sci, Brooklyn, NY USA; [Rizzo, Robert C.] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; City University of New York (CUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kaczocha, M (corresponding author), SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA.	Martin.Kaczocha@Stonybrook.edu		Galbavy, William/0000-0003-0948-9538; Kaczocha, Martin/0000-0002-2527-1398; Ojima, Iwao/0000-0002-3628-1161	National Institutes of Health [DA035923, DA032232, DA016419]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035923, R01DA016419, R21DA032232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants DA035923, DA032232, and DA016419. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Babaev VR, 2011, ARTERIOSCL THROM VAS, V31, P1283, DOI 10.1161/ATVBAHA.111.225839; Balius TE, 2013, J COMPUT CHEM, V34, P1226, DOI 10.1002/jcc.23245; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Berger WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050968; Bestard JA, 2010, PAIN PRACT; Binas B, 1999, FASEB J, V13, P805, DOI 10.1096/fasebj.13.8.805; Boneva NB, 2010, NEUROSCI RES, V68, P94, DOI 10.1016/j.neures.2010.07.2028; Boneva NB, 2011, HIPPOCAMPUS, V21, P162, DOI 10.1002/hipo.20732; Booker L, 2012, BRIT J PHARMACOL, V165, P2485, DOI 10.1111/j.1476-5381.2011.01445.x; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Clapper JR, 2010, NAT NEUROSCI, V13, P1265, DOI 10.1038/nn.2632; Cravatt BF, 2004, J NEUROBIOL, V61, P149, DOI 10.1002/neu.20080; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; DeLeon M, 1996, J NEUROSCI RES, V44, P283; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Dinh TP, 2004, MOL PHARMACOL, V66, P1260, DOI 10.1124/mol.104.002071; Egertova M, 2003, NEUROSCIENCE, V119, P481, DOI 10.1016/S0306-4522(03)00145-3; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Flachenecker P, 2013, EXPERT REV NEUROTHER, V13, P15, DOI [10.1586/ern.13.1, 10.1586/ERN.13.1]; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Gaskin DJ, 2012, J PAIN, V13, P715, DOI 10.1016/j.jpain.2012.03.009; Gerstner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015890; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Hui XY, 2010, J BIOL CHEM, V285, P10273, DOI 10.1074/jbc.M109.097907; Kaczocha M, 2012, J BIOL CHEM, V287, P3415, DOI 10.1074/jbc.M111.304907; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Kinsey SG, 2011, NEUROPHARMACOLOGY, V60, P244, DOI 10.1016/j.neuropharm.2010.09.004; Lichtman AH, 2004, PAIN, V109, P319, DOI 10.1016/j.pain.2004.01.022; Liu JW, 2008, J NEUROCHEM, V106, P2015, DOI 10.1111/j.1471-4159.2008.05507.x; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; LoVerme J, 2006, J PHARMACOL EXP THER, V319, P1051, DOI 10.1124/jpet.106.111385; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Mukherjee S, 2010, J CHEM INF MODEL, V50, P1986, DOI 10.1021/ci1001982; Notcutt W, 2012, MULT SCLER J, V18, P219, DOI 10.1177/1352458511419700; Owada Y, 1996, J CHEM NEUROANAT, V12, P113, DOI 10.1016/S0891-0618(96)00192-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reynolds JM, 2007, J IMMUNOL, V179, P313, DOI 10.4049/jimmunol.179.1.313; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Shioda N, 2010, J NEUROSCI, V30, P3146, DOI 10.1523/JNEUROSCI.4140-09.2010; SMITH PB, 1994, J PHARMACOL EXP THER, V270, P219; Sulsky R, 2007, BIOORG MED CHEM LETT, V17, P3511, DOI 10.1016/j.bmcl.2006.12.044; Turk DC, 2002, CLIN J PAIN, V18, P355, DOI 10.1097/00002508-200211000-00003; Yamamoto T, 2009, BIOTECHNOL LETT, V31, P1695, DOI 10.1007/s10529-009-0065-7	53	89	94	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94200	10.1371/journal.pone.0094200	http://dx.doi.org/10.1371/journal.pone.0094200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705380	gold, Green Published			2022-12-27	WOS:000334107500132
J	Lu, RN; Wang, Q; Han, YL; Li, JY; Yang, XJ; Miao, DS				Lu, Ruinan; Wang, Qian; Han, Yongli; Li, Jianyong; Yang, Xiang-Jiao; Miao, Dengshun			Parathyroid Hormone Administration Improves Bone Marrow Microenvironment and Partially Rescues Haematopoietic Defects in Bmi1-Null Mice	PLOS ONE			English	Article							STEM-CELL NICHE; OSTEOBLAST DIFFERENTIATION; SELF-RENEWAL; NULL MICE; TRANSCRIPTION FACTOR; PROGENITOR CELLS; PTH; BMI-1; SKELETAL; ABNORMALITIES	The epigenetic regulator Bmi1 is key in haematopoietic stem cells, and its inactivation leads to defects in haematopoiesis. Parathyroid hormone (PTH), an important modulator of bone homeostasis, also regulates haematopoiesis, so we asked whether PTH administration improves bone marrow microenvironment and rescues the haematopoietic defects in Bmi1-null mice. The mice were treated with PTH1-34 (containing the first 34 residues of mature PTH), an anabolic drug currently used for treating osteoporosis, and compared with the vehicle-treated Bmi1(-/-) and wild-type littermates in terms of skeletal and haematopoietic phenotypes. We found that the administration significantly increased all parameters related to osteoblastic bone formation and significantly reduced the adipocyte number and PPAR gamma expression. The bone marrow cellularity, numbers of haematopoietic progenitors and stem cells in the femur, and numbers of lymphocytes and other white blood cells in the peripheral blood all increased significantly when compared to vehicle-treated Bmi1(-/-) mice. Moreover, the number of Jagged1-positive cells and percentage of Notch intracellular domain-positive bone marrow cells and protein expression levels of Jagged1 and NICD in bone tissue were also increased in Bmi1(-/-) mice upon PTH1-34 administration, whereas the up-regulation of PTH on both Notch1 and Jagged1 gene expression was blocked by the Notch inhibitor DAPT administration. These results thus indicate that PTH administration activates the notch pathway and partially rescues haematopoietic defects in Bmi1-null mice, further suggesting that haematopoietic defects in the animals are not only a result of reduced self-renewal of haematopoietic stem cells but also due to impaired bone marrow microenvironment.	[Lu, Ruinan; Wang, Qian; Han, Yongli; Miao, Dengshun] Nanjing Med Univ, Dept Human Anat, Res Ctr Bone & Stem Cells, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Lu, Ruinan; Li, Jianyong] Nanjing Med Univ, Affiliated Hosp 1, Dept Hematol, Nanjing, Jiangsu, Peoples R China; [Yang, Xiang-Jiao] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada; [Yang, Xiang-Jiao] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ, Canada	Nanjing Medical University; Nanjing Medical University; McGill University; McGill University; McGill University	Miao, DS (corresponding author), Nanjing Med Univ, Dept Human Anat, Res Ctr Bone & Stem Cells, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	dsmiao@njmu.edu.cn		Miao, Dengshun/0000-0002-2682-3502	National Basic Research Program of China [2012CB966902]; MOST in China; CIHR in Canada [30911120486]	National Basic Research Program of China(National Basic Research Program of China); MOST in China; CIHR in Canada(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the National Basic Research Program of China (2012CB966902 to D. M.) and by a joint health research initiative grant supported by the MOST in China and the CIHR in Canada (30911120486 to D. M. and X.J.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Brunner S, 2008, EXP HEMATOL, V36, P1157, DOI 10.1016/j.exphem.2008.03.014; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; LEE K, 1993, BONE, V14, P341, DOI 10.1016/8756-3282(93)90162-4; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Lo Celso C, 2011, J CELL SCI, V124, P3529, DOI 10.1242/jcs.074112; Lyritis GP, 2010, ANN NY ACAD SCI, V1205, P277, DOI 10.1111/j.1749-6632.2010.05666.x; Miao DS, 2002, J CLIN INVEST, V109, P1173, DOI 10.1172/JCI200214817; Miao DS, 2004, ENDOCRINOLOGY, V145, P3554, DOI 10.1210/en.2003-1695; Miao DS, 2004, ENDOCRINOLOGY, V145, P2046, DOI 10.1210/en.2003-1097; Miao DS, 2002, J HISTOCHEM CYTOCHEM, V50, P333, DOI 10.1177/002215540205000305; Miao DS, 2005, J CLIN INVEST, V115, P2402, DOI 10.1172/JCI24918; Miao DS, 2001, ENDOCRINOLOGY, V142, P926, DOI 10.1210/en.142.2.926; Miyakoshi N, 2001, ENDOCRINOLOGY, V142, P4349, DOI 10.1210/en.142.10.4349; Trevisani VFM, 2008, SAO PAULO MED J, V126, P279, DOI 10.1590/S1516-31802008000500007; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pajcini KV, 2011, LEUKEMIA, V25, P1525, DOI 10.1038/leu.2011.127; Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Ren YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023060; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Tsomaia N, 2004, BIOCHEMISTRY-US, V43, P690, DOI 10.1021/bi035703i; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; WATSON P, 1995, BONE, V16, P357, DOI 10.1016/8756-3282(94)00051-4; Whitfield JF, 2005, J CELL BIOCHEM, V96, P278, DOI 10.1002/jcb.20526; Xue YB, 2005, J BONE MINER RES, V20, P1766, DOI 10.1359/JBMR.050608; Xue YB, 2005, HUM MOL GENET, V14, P1515, DOI 10.1093/hmg/ddi160; Yang D, 2007, BONE, V40, P1453, DOI 10.1016/j.bone.2007.02.001; Zhang HW, 2010, J BONE MINER RES, V25, P640, DOI 10.1359/jbmr.090812; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	41	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93864	10.1371/journal.pone.0093864	http://dx.doi.org/10.1371/journal.pone.0093864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705625	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500081
J	Pan, HS; Liu, B; Lu, YH; Desneux, N				Pan, Hongsheng; Liu, Bing; Lu, Yanhui; Desneux, Nicolas			Identification of the Key Weather Factors Affecting Overwintering Success of Apolygus lucorum Eggs in Dead Host Tree Branches	PLOS ONE			English	Article							HEMIPTERA-MIRIDAE; MEYER-DUR; BT COTTON; SEASONAL ABUNDANCE; LOW-TEMPERATURE; CLIMATE-CHANGE; LYGUS-LUCORUM; PLANT BUG; POPULATION; OUTBREAKS	Understanding the effects of weather on insect population dynamics is crucial to simulate and forecast pest outbreaks, which is becoming increasingly important with the effects of climate change. The mirid bug Apolygus lucorum is an important pest on cotton, fruit trees and other crops in China, and primarily lays its eggs on dead parts of tree branches in the fall for subsequent overwintering. As such, the eggs that hatch the following spring are most strongly affected by ambient weather factors, rather than by host plant biology. In this study, we investigated the effects of three major weather factors: temperature, relative humidity and rainfall, on the hatching rate of A. lucorum eggs overwintering on dead branches of Chinese date tree (Ziziphus jujuba). Under laboratory conditions, rainfall (simulated via soaking) was necessary for the hatching of overwintering A. lucorum eggs. In the absence of rainfall (unsoaked branches), very few nymphs successfully emerged under any of the tested combinations of temperature and relative humidity. In contrast, following simulated rainfall, the hatching rate of the overwintering eggs increased dramatically. Hatching rate and developmental rate were positively correlated with relative humidity and temperature, respectively. Under field conditions, the abundance of nymphs derived from overwintering eggs was positively correlated with rainfall amount during the spring seasons of 2009-2013, while the same was not true for temperature and relative humidity. Overall, our findings indicate that rainfall is the most important factor affecting the hatching rate of overwintering A. lucorum eggs on dead plant parts and nymph population levels during the spring season. It provides the basic information for precisely forecasting the emergence of A. lucorum and subsequently timely managing its population in spring, which will make it possible to regional control of this insect pest widely occurring in multiple crops in summer.	[Pan, Hongsheng; Liu, Bing; Lu, Yanhui] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Desneux, Nicolas] French Natl Inst Agr Res INRA, Sophia Antipolis, France	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; INRAE	Lu, YH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yhlu@ippcaas.cn	Desneux, Nicolas/J-6262-2013	Lu, Yanhui/0000-0002-6552-0248	Special Fund for Agro-scientific Research in the Public Interest [201103012]; National Natural Science Funds [31222046, 31321004]	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Funds(National Natural Science Foundation of China (NSFC))	This research was supported by the Special Fund for Agro-scientific Research in the Public Interest (201103012) and the National Natural Science Funds (No. 31222046, 31321004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadis SS, 2013, J PEST SCI, V86, P409, DOI 10.1007/s10340-013-0490-1; [Anonymous], 2007, AR4 CLIM CHANG 2007; Boggs CL, 2012, ECOL LETT, V15, P502, DOI 10.1111/j.1461-0248.2012.01766.x; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; Cao C. Y., 1983, MANAGEMENT COTTON MI; [陈培育 CHEN Pei-yu], 2010, [河南农业大学学报, Journal of Henan Agricultural University], V44, P83; CHU H. F., 1958, ACTA ENT SINICA, V8, P97; Day WH, 2006, T AM ENTOMOL SOC, V132, P445; Dong YC, 2013, J PEST SCI, V86, P429, DOI 10.1007/s10340-013-0493-y; Feng HQ, 2012, ENVIRON ENTOMOL, V41, P1606, DOI 10.1603/EN12099; Geng HH, 2012, APPL ENTOMOL ZOOL, V47, P191, DOI 10.1007/s13355-012-0107-9; Guo K, 2009, GLOBAL CHANGE BIOL, V15, P2539, DOI 10.1111/j.1365-2486.2009.01861.x; Gutierrez AP, 2008, J APPL ECOL, V45, P524, DOI 10.1111/j.1365-2664.2007.01356.x; Jepsen JU, 2008, J ANIM ECOL, V77, P257, DOI 10.1111/j.1365-2656.2007.01339.x; Liu HM, 1991, ACTA PHYTOPHYL SIN, V18, P147; Liu XF, 2013, J PEST SCI, V86, P449, DOI 10.1007/s10340-013-0488-8; Lu Y., 2008, BIOL CONTROL COTTON; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Lu YanHui, 2011, Outlooks on Pest Management, V22, P248, DOI 10.1564/22dec02; Lu YH, 2011, APPL ENTOMOL ZOOL, V46, P421, DOI 10.1007/s13355-011-0058-6; Lu YH, 2010, APPL ENTOMOL ZOOL, V45, P387, DOI 10.1303/aez.2010.387; Lu YH, 2010, CROP PROT, V29, P1026, DOI 10.1016/j.cropro.2010.03.017; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Men Xing-Yuan, 2008, Acta Entomologica Sinica, V51, P1216; Morimoto N, 1998, APPL ENTOMOL ZOOL, V33, P147, DOI 10.1303/aez.33.147; Mullens BA, 2005, J MED ENTOMOL, V42, P705, DOI 10.1603/0022-2585(2005)042[0705:RBRASF]2.0.CO;2; Niu SG, 2011, ACTA AGR JIANGXI, V23, P97; Pan HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068980; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Pizzol J, 2010, J PEST SCI, V83, P447, DOI 10.1007/s10340-010-0327-0; Shang ZhaoTang, 2012, Agricultural Science & Technology - Hunan, V13, P784; [商兆堂 Shang Zhaotang], 2010, [植物保护, Plant Protection], V36, P92; Shang ZT, 2012, AGR SCI TECHNOL, V13, P887; Simoglou KB, 2012, J PEST SCI, V85, P169, DOI 10.1007/s10340-012-0418-1; Ting YQ, 1964, ACTA ENTOMOL SINICA, V13, P298; Wang ZhenLiang, 2011, Journal of Northwest A & F University - Natural Science Edition, V39, P148; Wheeler Jr A. G., 2001, BIOL PLANT BUGS; White TCR, 2008, BIOL REV, V83, P227, DOI 10.1111/j.1469-185X.2008.00041.x; WILLMER PG, 1982, ADV INSECT PHYSIOL, V16, P1, DOI 10.1016/S0065-2806(08)60151-4; Wilstermann A, 2013, J PEST SCI, V86, P419, DOI 10.1007/s10340-013-0496-8; Wu Gang, 2011, Chinese Journal of Applied Entomology, V48, P1170; Wu K, 2002, CROP PROT, V21, P997, DOI 10.1016/S0261-2194(02)00080-7; Zhuo De-Gan, 2011, Acta Entomologica Sinica, V54, P136; [No title captured]	46	6	8	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94190	10.1371/journal.pone.0094190	http://dx.doi.org/10.1371/journal.pone.0094190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705353	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500131
J	Chagne, D; Crowhurst, RN; Pindo, M; Thrimawithana, A; Deng, C; Ireland, H; Fiers, M; Dzierzon, H; Cestaro, A; Fontana, P; Bianco, L; Lu, A; Storey, R; Knabel, M; Saeed, M; Montanari, S; Kim, YK; Nicolini, D; Larger, S; Stefani, E; Allan, AC; Bowen, J; Harvey, I; Johnston, J; Malnoy, M; Troggio, M; Perchepied, L; Sawyer, G; Wiedow, C; Won, K; Viola, R; Hellens, RP; Brewer, L; Bus, VGM; Schaffer, RJ; Gardiner, SE; Velasco, R				Chagne, David; Crowhurst, Ross N.; Pindo, Massimo; Thrimawithana, Amali; Deng, Cecilia; Ireland, Hilary; Fiers, Mark; Dzierzon, Helge; Cestaro, Alessandro; Fontana, Paolo; Bianco, Luca; Lu, Ashley; Storey, Roy; Knaebel, Mareike; Saeed, Munazza; Montanari, Sara; Kim, Yoon Kyeong; Nicolini, Daniela; Larger, Simone; Stefani, Erika; Allan, Andrew C.; Bowen, Judith; Harvey, Isaac; Johnston, Jason; Malnoy, Mickael; Troggio, Michela; Perchepied, Laure; Sawyer, Greg; Wiedow, Claudia; Won, Kyungho; Viola, Roberto; Hellens, Roger P.; Brewer, Lester; Bus, Vincent G. M.; Schaffer, Robert J.; Gardiner, Susan E.; Velasco, Riccardo			The Draft Genome Sequence of European Pear (Pyrus communis L. 'Bartlett')	PLOS ONE			English	Article							WALL-MODIFYING ENZYMES; GENETIC-LINKAGE MAPS; EXPANSIN GENES; APPLE; EXPRESSION; CLASSIFICATION; IDENTIFICATION; ALIGNMENT; ETHYLENE; JAPANESE	We present a draft assembly of the genome of European pear (Pyrus communis) `Bartlett'. Our assembly was developed employing second generation sequencing technology (Roche 454), from single-end, 2 kb, and 7 kb insert paired-end reads using Newbler (version 2.7). It contains 142,083 scaffolds greater than 499 bases (maximum scaffold length of 1.2 Mb) and covers a total of 577.3 Mb, representing most of the expected 600 Mb Pyrus genome. A total of 829,823 putative single nucleotide polymorphisms (SNPs) were detected using re-sequencing of `Louise Bonne de Jersey' and `Old Home'. A total of 2,279 genetically mapped SNP markers anchor 171 Mb of the assembled genome. Ab initio gene prediction combined with prediction based on homology searching detected 43,419 putative gene models. Of these, 1219 proteins (556 clusters) are unique to European pear compared to 12 other sequenced plant genomes. Analysis of the expansin gene family provided an example of the quality of the gene prediction and an insight into the relationships among one class of cell wall related genes that control fruit softening in both European pear and apple (Malusxdomestica). The `Bartlett' genome assembly v1.0 (http://www.rosaceae.org/species/pyrus/pyrus_communis/genome_v1.0) is an invaluable tool for identifying the genetic control of key horticultural traits in pear and will enable the wide application of marker-assisted and genomic selection that will enhance the speed and efficiency of pear cultivar development.	[Chagne, David; Dzierzon, Helge; Knaebel, Mareike; Saeed, Munazza; Montanari, Sara; Sawyer, Greg; Wiedow, Claudia; Gardiner, Susan E.] New Zealand Inst Plant & Food Res Ltd Plant & Foo, Palmerston North Res Ctr, Palmerston North, New Zealand; [Crowhurst, Ross N.; Thrimawithana, Amali; Deng, Cecilia; Ireland, Hilary; Storey, Roy; Allan, Andrew C.; Bowen, Judith; Harvey, Isaac; Johnston, Jason; Hellens, Roger P.; Schaffer, Robert J.] DSIR, Mt Albert Res Ctr, Auckland, New Zealand; [Pindo, Massimo; Cestaro, Alessandro; Fontana, Paolo; Bianco, Luca; Montanari, Sara; Nicolini, Daniela; Larger, Simone; Stefani, Erika; Malnoy, Mickael; Troggio, Michela; Viola, Roberto; Velasco, Riccardo] FEM, Res & Innovat Ctr, IASMA, Trento, Italy; [Fiers, Mark; Lu, Ashley] Lincoln Res Ctr, Lincoln, NE, New Zealand; [Knaebel, Mareike; Allan, Andrew C.; Schaffer, Robert J.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Saeed, Munazza] Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand; [Montanari, Sara; Perchepied, Laure] INRA, IRHS, F-49000 Angers, France; [Kim, Yoon Kyeong; Won, Kyungho] RDA, NIHHS, Naju, South Korea; [Brewer, Lester] Motueka Res Ctr, Motueka, New Zealand; [Bus, Vincent G. M.] Hawkes Bay Res Ctr, Havelock North, New Zealand	New Zealand Institute for Plant & Food Research Ltd; New Zealand Institute for Plant & Food Research Ltd; Fondazione Edmund Mach; University of Auckland; Massey University; INRAE; Universite d'Angers; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Chagne, D (corresponding author), New Zealand Inst Plant & Food Res Ltd Plant & Foo, Palmerston North Res Ctr, Palmerston North, New Zealand.	David.Chagne@plantandfood.co.nz	Ireland, Hilary/I-6314-2015; Wiedow, Claudia/O-9291-2016; Sawyer, Gregory M/G-1979-2012; Deng, Cecilia Hong/O-2891-2017; Crowhurst, Ross N/N-8892-2017; Gardiner, Susan Elizabeth/A-2477-2010; Fiers, Mark WEJ/E-6755-2010; Johnston, Jason/D-5947-2016; Knaebel, Mareike/O-5631-2016; Allan, Andrew C/L-3253-2016; malnoy, mickael/C-5007-2012; Chagne, David/A-2596-2010; Schaffer, Robert J/D-1018-2011; Thrimawithana, Amali H/O-4702-2017; Malnoy, Mickael/AAO-5431-2021; Bus, Vincent/B-1318-2011; Viola, Roberto/F-3657-2014	Ireland, Hilary/0000-0001-5072-7206; Wiedow, Claudia/0000-0003-3402-5460; Sawyer, Gregory M/0000-0002-8784-9327; Deng, Cecilia Hong/0000-0002-2954-762X; Crowhurst, Ross N/0000-0003-0608-2134; Gardiner, Susan Elizabeth/0000-0002-4884-8743; Fiers, Mark WEJ/0000-0001-5694-2409; Johnston, Jason/0000-0002-6326-4885; Knaebel, Mareike/0000-0002-0293-1250; Allan, Andrew C/0000-0003-1944-7067; malnoy, mickael/0000-0002-5158-534X; Chagne, David/0000-0003-4018-0694; Thrimawithana, Amali H/0000-0001-6325-2334; Malnoy, Mickael/0000-0002-5158-534X; Bus, Vincent/0000-0003-4071-4457; Viola, Roberto/0000-0002-8202-8503; Bianco, Luca/0000-0002-0196-8422; Schaffer, Robert/0000-0003-1272-667X; Pindo, Massimo/0000-0002-8516-9010; Hellens, Roger/0000-0003-2094-0887; Montanari, Sara/0000-0001-9224-056X; Cestaro, Alessandro/0000-0003-1439-5165; Storey, Roy/0000-0003-1375-7136; Velasco, Riccardo/0000-0002-8760-5031	research office of the Provincia autonoma di Trento; IASMA-FEM GMPF joint PhD school; Plant & Food Research internal investment 'Blue Skies' project; New Zealand Ministry of Science and Innovation [CO6X0705, 26015, CO6X0812]; NIHHS of RDA, Korea	research office of the Provincia autonoma di Trento; IASMA-FEM GMPF joint PhD school; Plant & Food Research internal investment 'Blue Skies' project; New Zealand Ministry of Science and Innovation; NIHHS of RDA, Korea	This project was supported by the research office of the Provincia autonoma di Trento, IASMA-FEM GMPF joint PhD school, a Plant & Food Research internal investment 'Blue Skies' project, New Zealand Ministry of Science and Innovation projects "Pipfruit: a juicy future" (Contract# CO6X0705), "Pipfruit Research Consortium 2" (Contract# 26015) and "HortGenomics" (Contract# CO6X0812), and NIHHS of RDA, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrusan G, 2009, BIOINFORMATICS, V25, P1329, DOI 10.1093/bioinformatics/btp084; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Brummell DA, 1999, PLANT CELL, V11, P2203, DOI 10.1105/tpc.11.11.2203; Celton Jean-Marc, 2009, BMC Res Notes, V2, P182, DOI 10.1186/1756-0500-2-182; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Costa F, 2008, TREE GENET GENOMES, V4, P575, DOI 10.1007/s11295-008-0133-5; Crowhurst RN, 2006, BIOVIEW ENTERPRISE B; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fonseca S, 2005, J EXP BOT, V56, P2029, DOI 10.1093/jxb/eri201; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Goulao LF, 2008, POSTHARVEST BIOL TEC, V48, P37, DOI 10.1016/j.postharvbio.2007.09.022; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Hiwasa K, 2003, PHYSIOL PLANTARUM, V117, P564, DOI 10.1034/j.1399-3054.2003.00064.x; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Illa E, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-9; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jung S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-129; Kende H, 2004, PLANT MOL BIOL, V55, P311, DOI 10.1007/s11103-004-0158-6; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kumar S, 2012, TREE GENET GENOMES, V8, P1, DOI 10.1007/s11295-011-0425-z; Kumar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036674; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Montanari S., 2013, PLOS ONE, V8; Mulder Nicola, 2007, V396, P59; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schaffer RJ, 2012, ANN BOT PLANTS; Schaffer RJ, 2007, PLANT PHYSIOL, V144, P1899, DOI 10.1104/pp.106.093765; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Smit A, 1996, REPEATMASKER OPEN 30; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tacken E, 2010, PLANT PHYSIOL, V153, P294, DOI 10.1104/pp.109.151092; Terakami S, 2006, THEOR APPL GENET, V113, P743, DOI 10.1007/s00122-006-0344-9; Trujillo DI, 2012, TREE GENET GENOMES, V8, P27, DOI 10.1007/s11295-011-0417-z; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; van Bakel H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r102; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Wakasa Y, 2003, EUR J HORTIC SCI, V68, P253; Wang J, 2008, PROTOCOL EXCHANGE; Wu J, 2012, GENOME RES; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yamamoto T, 2002, THEOR APPL GENET, V106, P9, DOI 10.1007/s00122-002-0966-5; Yamamoto T, 2002, EUPHYTICA, V124, P129, DOI 10.1023/A:1015677505602; Yamamoto T, 2007, BREEDING SCI, V57, P321, DOI 10.1270/jsbbs.57.321	61	171	186	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92644	10.1371/journal.pone.0092644	http://dx.doi.org/10.1371/journal.pone.0092644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699266	Green Submitted, Green Published, gold			2022-12-27	WOS:000334105000032
J	Huang, LK; Yan, HD; Jiang, XM; Yin, GH; Zhang, XQ; Qi, X; Zhang, Y; Yan, YH; Ma, X; Peng, Y				Huang, Linkai; Yan, Haidong; Jiang, Xiaomei; Yin, Guohua; Zhang, Xinquan; Qi, Xiao; Zhang, Yu; Yan, Yanhong; Ma, Xiao; Peng, Yan			Identification of Candidate Reference Genes in Perennial Ryegrass for Quantitative RT-PCR under Various Abiotic Stress Conditions	PLOS ONE			English	Article							SUPERIOR REFERENCE GENES; REVERSE TRANSCRIPTION; HOUSEKEEPING GENES; INTERNAL CONTROL; DROUGHT STRESS; EXPRESSION; VALIDATION; NORMALIZATION; RNA; QUANTIFICATION	Background: Quantitative real-time reverse-transcriptase PCR (qRT-PCR) is an important technique for analyzing differences gene expression due to its sensitivity, accuracy and specificity. However, the stability of the expression of reference genes is necessary to ensure accurate qRT-PCR assessment of expression in genes of interest. Perennial ryegrass (Lolium perenne L.) is important forage and turf grass species in temperate regions, but the expression stability of its reference genes under various stresses has not been well-studied. Methodology/Principal Findings: In this study, 11 candidate reference genes were evaluated for use as controls in qRT-PCR to quantify gene expression in perennial ryegrass under drought, high salinity, heat, waterlogging, and ABA (abscisic acid) treatments. Four approaches - Delta C-T, geNorm, BestKeeper and Normfinder were used to determine the stability of expression in these reference genes. The results are consistent with the idea that the best reference genes depend on the stress treatment under investigation. Eukaryotic initiation factor 4 alpha (eIF4A), Transcription elongation factor 1 (TEF1) and Tat binding protein-1 (TBP-1) were the three most stably expressed genes under drought stress and were also the three best genes for studying salt stress. eIF4A, TBP-1, and Ubiquitin-conjugating enzyme (E2) were the most suitable reference genes to study heat stress, while eIF4A, TEF1, and E2 were the three best reference genes for studying the effects of ABA. Finally, Ubiquitin (UBQ), TEF1, and eIF4A were the three best reference genes for waterlogging treatments. Conclusions/Significance: These results will be helpful in choosing the best reference genes for use in studies related to various abiotic stresses in perennial ryegrass. The stability of expression in these reference genes will enable better normalization and quantification of the transcript levels for studies of gene expression in such studies.	[Huang, Linkai; Yan, Haidong; Jiang, Xiaomei; Zhang, Xinquan; Zhang, Yu; Yan, Yanhong; Ma, Xiao; Peng, Yan] Sichuan Agr Univ, Anim Sci & Technol Coll, Dept Grassland Sci, Yaan, Sichuan, Peoples R China; [Yin, Guohua] Univ Arizona, Coll Agr & Life Sci, Tucson, AZ USA; [Qi, Xiao] Minist Agr, Natl Anim Husb Serv, Beijing, Peoples R China	Sichuan Agricultural University; University of Arizona; Ministry of Agriculture & Rural Affairs	Zhang, XQ (corresponding author), Sichuan Agr Univ, Anim Sci & Technol Coll, Dept Grassland Sci, Yaan, Sichuan, Peoples R China.	zhangxq@sicau.edu.cn	Yin, Guohua/B-6314-2014	Yin, Guohua/0000-0001-8327-061X	National Basic Research Program of China (973 Program) [2014CB138705]; Earmarked Fund for the Modern Agro-Industry Technology Research System [CARS-35-05]; National and Province Students Innovation Plan [201310626002]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Earmarked Fund for the Modern Agro-Industry Technology Research System; National and Province Students Innovation Plan	This work was supported by the National Basic Research Program of China (973 Program) (2014CB138705), the Earmarked Fund for the Modern Agro-Industry Technology Research System (#CARS-35-05) and the National and Province Students Innovation Plan (No. 201310626002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiard V, 2003, PLANT PHYSIOL, V132, P2218, DOI 10.1104/pp.103.022335; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 1991, TURFGRASS MANAGEMENT; Ayers Duncan, 2007, BMC Vet Res, V3, P7; Bogdanovic MD, 2013, PLANT MOL BIOL REP, V31, P55, DOI 10.1007/s11105-012-0474-y; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cassan-Wang H, 2012, PLANT CELL PHYSIOL, V53, P2101, DOI 10.1093/pcp/pcs152; Chao WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042839; Cheng T, 2012, J PLANT PHYSIOL, V169, P1134, DOI 10.1016/j.jplph.2012.04.006; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Oliveira LA, 2012, PLANT CELL PHYSIOL, V53, P405, DOI 10.1093/pcp/pcr187; Dean JD, 2002, PLANT MOL BIOL REP, V20, P347, DOI 10.1007/BF02772122; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Forster JW, 2008, PLANT GENOTYPING II: SNP TECHNOLOGY, P154, DOI 10.1079/9781845933821.0154; Fujii H, 2011, P NATL ACAD SCI USA, V108, P1717, DOI 10.1073/pnas.1018367108; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; Holland MJ, 2002, J BIOL CHEM, V277, P14363, DOI 10.1074/jbc.C200101200; Holmes William, 1980, GRASS ITS PRODUCTION; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hong SM, 2010, PLANT CELL PHYSIOL, V51, P1694, DOI 10.1093/pcp/pcq128; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jarosova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-146; Jia XY, 2009, PLANT MOL BIOL, V71, P51, DOI 10.1007/s11103-009-9508-8; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Liebao H, 2007, DROUGHT TOLERANT TRA, P273; Liu SW, 2010, PHYSIOL PLANTARUM, V139, P375, DOI 10.1111/j.1399-3054.2010.01374.x; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Martin RC, 2008, CROP SCI, V48, P1881, DOI 10.2135/cropsci2007.10.0597; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; NORRIS IB, 1985, GRASS FORAGE SCI, V40, P151, DOI 10.1111/j.1365-2494.1985.tb01732.x; OLLERENSHAW JH, 1985, PLANT SOIL, V85, P131, DOI 10.1007/BF02197806; Pearson A, 2011, THEOR APPL GENET, V122, P609, DOI 10.1007/s00122-010-1473-8; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tamura K, 2007, THEOR APPL GENET, V114, P273, DOI 10.1007/s00122-006-0430-z; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47; [袁伟 Wei Yuan], 2012, [植物学报, Chinese Bulletin of Botany], V47, P427; WILKINS PW, 1991, EUPHYTICA, V52, P201, DOI 10.1007/BF00029397; Wilkins PW, 2003, J AGR SCI-CAMBRIDGE, V140, P129, DOI 10.1017/S0021859603003058; Xiong YW, 2007, MOL BREEDING, V19, P125, DOI 10.1007/s11032-006-9050-1; Yu XQ, 2013, J EXP BOT, V64, P1537, DOI 10.1093/jxb/ert018; Zhang YQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031849, 10.1371/journal.pone.0030262]; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	59	61	62	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93724	10.1371/journal.pone.0093724	http://dx.doi.org/10.1371/journal.pone.0093724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699822	Green Submitted, Green Published, gold			2022-12-27	WOS:000334105000096
J	Kronborg, L; Bandholm, T; Palm, H; Kehlet, H; Kristensen, MT				Kronborg, Lise; Bandholm, Thomas; Palm, Henrik; Kehlet, Henrik; Kristensen, Morten Tange			Feasibility of Progressive Strength Training Implemented in the Acute Ward after Hip Fracture Surgery	PLOS ONE			English	Article							CUMULATED AMBULATION SCORE; FUNCTIONAL RECOVERY SCORE; KNEE-EXTENSION STRENGTH; GO TEST; MOBILITY SCORE; INTERTESTER RELIABILITY; BASIC MOBILITY; EXERCISE; PAIN; REHABILITATION	Importance: Patients with a hip fracture lose more than 50% knee-extension strength in the fractured limb within one week of surgery. Hence, immediate progressive strength training following hip fracture surgery may be rational, but the feasibility unknown. Objective: To examine the feasibility of in-hospital progressive strength training implemented in the acute ward following hip fracture surgery, based on pre-specified criteria for feasibility. Design, Setting and Patients: A prospective cohort study conducted in an acute orthopedic hip fracture unit at a university hospital. A consecutive sample of 36 patients, 18 with a cervical and 18 with a trochanteric hip fracture (27 women and 9 men, mean (SD) age of 79.4 (8.3) years) were included between June and December 2012. Intervention: A daily (on weekdays) program of progressive knee-extension strength training for the fractured limb, using ankle weight cuffs in 3 sets of 10 repetition maximum loadings. Main outcomes and Measures: The primary outcome was the change in training load (kg) during the knee-extension strength training. The secondary outcomes were changes in hip fracture-related pain and maximal isometric knee-extension strength. Results: The strength training was commenced at a mean of 2.4 (0.7) days after surgery. The training loads (kilograms lifted) increased from 1.6 (0.8) to 4.3 (1.7) kg over 4.3 (2.2) training sessions (P<.001). The maximal isometric knee-extension strength of the fractured limb increased from 0.37 (0.2) to 0.61 (0.3) Nm/kg (P<.001), while the average strength deficit in the fractured limb decreased from 50% to 32% (%non-fractured, P<.001). Only 3 of 212 sessions were not performed because of severe hip fracture-related pain. Conclusion and Relevance: Progressive knee-extension strength training of the fractured limb commenced in the acute ward seems feasible, and may reduce strength asymmetry between limbs without hip pain interfering. The clinical efficacy needs confirmation in a randomized controlled design.	[Kronborg, Lise; Bandholm, Thomas; Kristensen, Morten Tange] Copenhagen Univ Hosp, Phys Med & Rehabil Res Copenhagen PMR C, Hvidovre, Denmark; [Kronborg, Lise; Bandholm, Thomas; Kristensen, Morten Tange] Copenhagen Univ Hosp, Dept Phys Therapy, Hvidovre, Denmark; [Bandholm, Thomas] Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark; [Bandholm, Thomas; Palm, Henrik; Kristensen, Morten Tange] Copenhagen Univ Hosp, Dept Orthoped Surg, Hvidovre, Denmark; [Kehlet, Henrik] Univ Copenhagen, Rigshosp, Sect Surg Pathophysiol, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Kronborg, L (corresponding author), Copenhagen Univ Hosp, Phys Med & Rehabil Res Copenhagen PMR C, Hvidovre, Denmark.	lisekronborg@hotmail.com	Bandholm, Thomas/AAZ-8632-2020; Kristensen, Morten/L-3527-2019	Bandholm, Thomas/0000-0001-6884-1971; Kristensen, Morten/0000-0001-5868-4677; Kehlet, Henrik/0000-0002-2209-1711	Danish Physical Therapy Association; IMK foundation; Capital Region of Copenhagen; Hvidovre Hospital's Research Fund; Lundbeck foundation (UCSF), Denmark	Danish Physical Therapy Association; IMK foundation; Capital Region of Copenhagen; Hvidovre Hospital's Research Fund; Lundbeck foundation (UCSF), Denmark	This study was funded by grants from the Danish Physical Therapy Association, the IMK foundation and the Capital Region of Copenhagen, the Hvidovre Hospital's Research Fund, and the Lundbeck foundation (UCSF), Denmark. The funding agencies had no influence on the study design, methods, subjects, data collection, analyses or manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arain M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-67; Ariza-Vega P, 2014, DISABIL REHABIL, V36, P685, DOI 10.3109/09638288.2013.813081; Auais MA, 2012, PHYS THER, V92, P1437, DOI 10.2522/ptj.20110274; Binder EF, 2004, JAMA-J AM MED ASSOC, V292, P837, DOI 10.1001/jama.292.7.837; Bischoff-Ferrari HA, 2010, ARCH INTERN MED, V170, P813, DOI 10.1001/archinternmed.2010.67; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cornwall R, 2004, CLIN ORTHOP RELAT R, P64, DOI 10.1097/01.blo.0000132406.37763.b3; DELORME TL, 1945, J BONE JOINT SURG, V27, P645; Egan M, 2008, CLIN REHABIL, V22, P272, DOI 10.1177/0269215507081573; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foss NB, 2009, BRIT J ANAESTH, V102, P111, DOI 10.1093/bja/aen345; Foss NB, 2005, ANESTHESIOLOGY, V102, P1197, DOI 10.1097/00000542-200506000-00020; Foss NB, 2006, CLIN REHABIL, V20, P701, DOI 10.1191/0269215506cre987oa; Hung WW, 2012, JAMA-J AM MED ASSOC, V307, P2185, DOI 10.1001/jama.2012.4842; Hwang S, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-15; Jakobsen TL, 2012, DISABIL REHABIL, V34, P1034, DOI 10.3109/09638288.2011.629019; Kehlet H, 2011, LANGENBECK ARCH SURG, V396, P585, DOI 10.1007/s00423-011-0790-y; Kempen GIJM, 2008, AGE AGEING, V37, P45, DOI 10.1093/ageing/afm157; Kristensen MT, 2011, EUR J PHYS REHAB MED, V47, P257; Kristensen MT, 2009, PHYSIOTHER RES INT, V14, P30, DOI 10.1002/pri.414; Kristensen MT, 2010, ARCH PHYS MED REHAB, V91, P885, DOI 10.1016/j.apmr.2010.01.021; Kristensen MT, 2010, ACTA ORTHOP, V81, P296, DOI 10.3109/17453674.2010.487240; Kristensen MT, 2009, ARCH PHYS MED REHAB, V90, P1760, DOI 10.1016/j.apmr.2009.05.013; Kristensen MT, 2009, CLIN BIOMECH, V24, P218, DOI 10.1016/j.clinbiomech.2008.10.003; Kristensen MT, 2008, J REHABIL MED, V40, P589, DOI 10.2340/16501977-0217; Kristensen MT, 2013, PM&R, V5, P135, DOI 10.1016/j.pmrj.2012.10.006; Kristensen MT, 2012, DAN MED J, V59; Kristensen MT, 2012, DAN MED J, V59; Kristensen MT, 2011, J AM GERIATR SOC, V59, P565, DOI 10.1111/j.1532-5415.2010.03293.x; Kristensen MT, 2009, CLIN REHABIL, V23, P1116, DOI 10.1177/0269215509342330; Leino KA, 2011, ACTA ANAESTH SCAND, V55, P495, DOI 10.1111/j.1399-6576.2010.02373.x; Mag R, 2004, AM J PHYS MED REHAB, V83, P813, DOI 10.1097/01.PHM.0000143405.17932.78; Manini TM, 2007, J AM GERIATR SOC, V55, P451, DOI 10.1111/j.1532-5415.2007.01087.x; Oldmeadow LB, 2006, ANZ J SURG, V76, P607, DOI 10.1111/j.1445-2197.2006.03786.x; Orwig DL, 2011, ARCH INTERN MED, V171, P323, DOI 10.1001/archinternmed.2011.15; Overgaard J, 2013, WORLD J ORTHOP, V4, P248, DOI 10.5312/wjo.v4.i4.248; PARKER MJ, 1993, J BONE JOINT SURG BR, V75, P797, DOI 10.1302/0301-620X.75B5.8376443; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Portegijs E, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.04.003; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Rosell PAE, 2003, INJURY, V34, P529, DOI 10.1016/S0020-1383(02)00414-X; ROSSITERFORNOFF JE, 1995, J GERONTOL A-BIOL, V50, pM291, DOI 10.1093/gerona/50A.6.M291; Salbach NM, 2014, ARCH PHYS MED REHAB, V95, P117, DOI 10.1016/j.apmr.2013.06.017; Salpakoski A, 2011, GERONTOLOGY, V57, P19, DOI 10.1159/000315490; Schaubert KL, 2005, J STRENGTH COND RES, V19, P717, DOI 10.1519/R-15954.1; SECHZER PH, 1963, ANESTHESIOLOGY, V24, P779, DOI 10.1097/00000542-196311000-00005; Sherrington C, 2005, CLIN REHABIL, V19, P496, DOI 10.1191/0269215505cr833oa; Sherrington C, 2011, EUR J PHYS REHAB MED, V47, P297; Sherrington C, 2003, AUST J PHYSIOTHER, V49, P15, DOI 10.1016/S0004-9514(14)60184-7; Singh NA, 2012, J AM MED DIR ASSOC, V13, P24, DOI 10.1016/j.jamda.2011.08.005; Siu AL, 2006, ARCH INTERN MED, V166, P766, DOI 10.1001/archinte.166.7.766; Suetta C, 2004, J AM GERIATR SOC, V52, P2016, DOI 10.1111/j.1532-5415.2004.52557.x; Toigo M, 2006, EUR J APPL PHYSIOL, V97, P643, DOI 10.1007/s00421-006-0238-1; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Watson MJ, 2002, PHYSIOTHERAPY, V88, P386, DOI [10.1016/S0031_9406(05)61264_3, DOI 10.1016/S0031-9406(05)61264-3]; Zuckerman JD, 2000, J ORTHOP TRAUMA, V14, P20, DOI 10.1097/00005131-200001000-00005; Zuckerman JD, 2000, J ORTHOP TRAUMA, V14, P26, DOI 10.1097/00005131-200001000-00006	58	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93332	10.1371/journal.pone.0093332	http://dx.doi.org/10.1371/journal.pone.0093332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699276	gold, Green Published, Green Submitted			2022-12-27	WOS:000334105000052
J	Latino, L; Essoh, C; Blouin, Y; Thien, HV; Pourcel, C				Latino, Libera; Essoh, Christiane; Blouin, Yann; Hoang Vu Thien; Pourcel, Christine			A novel Pseudomonas aeruginosa Bacteriophage, Ab31, a Chimera Formed from Temperate Phage PAJU2 and P. putida Lytic Phage AF: Characteristics and Mechanism of Bacterial Resistance	PLOS ONE			English	Article							CYSTIC-FIBROSIS; MUCOID CONVERSION; GENOMIC ANALYSIS; GENE-EXPRESSION; LAMBDA-RECEPTOR; VIRULENCE; SEQUENCE; PROTEIN; PERSISTENCE; EVOLUTION	A novel temperate bacteriophage of Pseudomonas aeruginosa, phage vB_PaeP_Tr60_Ab31 (alias Ab31) is described. Its genome is composed of structural genes related to those of lytic P. putida phage AF, and regulatory genes similar to those of temperate phage PAJU2. The virion structure resembles that of phage AF and other lytic Podoviridae (S. enterica Epsilon 15 and E. coli phiv10) with similar tail spikes. Ab31 was able to infect P. aeruginosa strain PA14 and two genetically related strains called Tr60 and Tr162, out of 35 diverse strains from cystic fibrosis patients. Analysis of resistant host variants revealed different phenotypes, including induction of pigment and alginate overproduction. Whole genome sequencing of resistant variants highlighted the existence of a large deletion of 234 kbp in two strains, encompassing a cluster of genes required for the production of CupA fimbriae. Stable lysogens formed by Ab31 in strain Tr60, permitted the identification of the insertion site. During colonization of the lung in cystic fibrosis patients, P. aeruginosa adapts by modifying its genome. We suggest that bacteriophages such as Ab31 may play an important role in this adaptation by selecting for bacterial characteristics that favor persistence of bacteria in the lung.	[Latino, Libera; Essoh, Christiane; Blouin, Yann; Pourcel, Christine] Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Latino, Libera; Essoh, Christiane; Blouin, Yann; Pourcel, Christine] CNRS, F-91405 Orsay, France; [Hoang Vu Thien] Hop Armand Trousseau, AP HP, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Pourcel, C (corresponding author), Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France.	christine.pourcel@u-psud.fr	Pourcel, Christine/E-4949-2017	Pourcel, Christine/0000-0002-8951-466X	Direction Generale de l'Armement (DGA); Paris Saclay "Initiative d'excellence'' (IDEX)	Direction Generale de l'Armement (DGA); Paris Saclay "Initiative d'excellence'' (IDEX)	LL holds a PhD fellowship co-financed by the Direction Generale de l'Armement (DGA) and by the Paris Saclay "Initiative d'excellence'' (IDEX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDUJAILI AH, 1975, J HYG-CAMBRIDGE, V75, P195, DOI 10.1017/S0022172400047227; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Braid MD, 2004, J BACTERIOL, V186, P6560, DOI 10.1128/JB.186.19.6560-6574.2004; BROKOPP CD, 1977, J CLIN MICROBIOL, V5, P640; Brussow H, 2012, MBIO, V3, DOI 10.1128/mBio.00061-12; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; CAMERON JR, 1977, NUCLEIC ACIDS RES, V4, P1429, DOI 10.1093/nar/4.5.1429; Casjens SR, 2012, ADV EXP MED BIOL, V726, P143, DOI 10.1007/978-1-4614-0980-9_7; Casjens SR, 2005, CURR OPIN MICROBIOL, V8, P451, DOI 10.1016/j.mib.2005.06.014; Ceyssens PJ, 2010, FUTURE MICROBIOL, V5, P1041, DOI 10.2217/FMB.10.66; Cornelissen A, 2012, VIROLOGY; Cornelissen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018597; Cramer N, 2011, ENVIRON MICROBIOL, V13, P1690, DOI 10.1111/j.1462-2920.2011.02483.x; CROSA JH, 1989, MICROBIOL REV, V53, P517, DOI 10.1128/MMBR.53.4.517-530.1989; DEVRIES GE, 1984, P NATL ACAD SCI-BIOL, V81, P6080, DOI 10.1073/pnas.81.19.6080; Essoh C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060575; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Friman VP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075380; Hanlon GW, 2001, APPL ENVIRON MICROB, V67, P2746, DOI 10.1128/AEM.67.6.2746-2753.2001; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Hatfull GF, 2008, CURR OPIN MICROBIOL, V11, P447, DOI 10.1016/j.mib.2008.09.004; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Hossain MJ, 2012, MICROBIOL-SGM, V158, P474, DOI 10.1099/mic.0.054866-0; Hosseinidoust Z, 2013, APPL ENVIRON MICROB, V79, P6110, DOI 10.1128/AEM.01421-13; Hosseinidoust Z, 2013, APPL ENVIRON MICROB, V79, P2862, DOI 10.1128/AEM.03817-12; Jiang XF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-194; Juhala RJ, 2000, J MOL BIOL, V299, P27, DOI 10.1006/jmbi.2000.3729; Kropinski AM, 2007, VIROLOGY, V369, P234, DOI 10.1016/j.virol.2007.07.027; Krylov S V, 2012, Genetika, V48, P1057; Kwan T, 2006, J BACTERIOL, V188, P1184, DOI 10.1128/JB.188.3.1184-1187.2006; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Llanes C, 2013, J ANTIMICROB CHEMOTH, V68, P1763, DOI 10.1093/jac/dkt115; Lu SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062933; MILLER RV, 1984, J CLIN MICROBIOL, V19, P717, DOI 10.1128/JCM.19.5.717-719.1984; Mooij MJ, 2007, MICROBIOL-SGM, V153, P1790, DOI 10.1099/mic.0.2006/003533-0; PENKETH ARL, 1987, THORAX, V42, P526, DOI 10.1136/thx.42.7.526; Perry LL, 2009, FEMS MICROBIOL LETT, V292, P182, DOI 10.1111/j.1574-6968.2009.01511.x; Qiu DR, 2007, P NATL ACAD SCI USA, V104, P8107, DOI 10.1073/pnas.0702660104; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; RANDALLH.L, 1973, J BACTERIOL, V116, P1436, DOI 10.1128/JB.116.3.1436-1446.1973; Rau MH, 2012, ENVIRON MICROBIOL, V14, P2200, DOI 10.1111/j.1462-2920.2012.02795.x; Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109; Rodriguez-Rojas A, 2009, MICROBIOL-SGM, V155, P1050, DOI 10.1099/mic.0.024745-0; ROMLING U, 1994, APPL ENVIRON MICROB, V60, P1734; Roos WH, 2007, CELL MOL LIFE SCI, V64, P1484, DOI 10.1007/s00018-007-6451-1; Ruer S, 2007, J BACTERIOL, V189, P3547, DOI 10.1128/JB.00093-07; Schurks N, 2002, INT J BIOL MACROMOL, V30, P105, DOI 10.1016/S0141-8130(02)00002-8; STEVEN AC, 1988, J MOL BIOL, V200, P351, DOI 10.1016/0022-2836(88)90246-X; Uchiyama J, 2012, ARCH VIROL, V157, P733, DOI 10.1007/s00705-011-1210-x; Uchiyama J, 2009, VIRUS RES, V139, P131, DOI 10.1016/j.virusres.2008.10.005; Vallet-Gely I, 2007, J BACTERIOL, V189, P8667, DOI 10.1128/JB.01344-07; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593; Vu-Thien H, 2007, J CLIN MICROBIOL, V45, P3175, DOI 10.1128/JCM.00702-07; Webb JS, 2004, J BACTERIOL, V186, P8066, DOI 10.1128/JB.186.23.8066-8073.2004; Wei H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn182; WOZNIAK DJ, 1994, J BACTERIOL, V176, P6007, DOI 10.1128/jb.176.19.6007-6014.1994; Xu JL, 2013, J BACTERIOL, V195, P798, DOI 10.1128/JB.01770-12	58	23	24	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93777	10.1371/journal.pone.0093777	http://dx.doi.org/10.1371/journal.pone.0093777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699529	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000106
J	Ngufor, C; N'Guessan, R; Fagbohoun, J; Odjo, A; Malone, D; Akogbeto, M; Rowland, M				Ngufor, Corine; N'Guessan, Raphael; Fagbohoun, Josias; Odjo, Abibatou; Malone, David; Akogbeto, Martin; Rowland, Mark			Olyset Duo (R) (a Pyriproxyfen and Permethrin Mixture Net): An Experimental Hut Trial against Pyrethroid Resistant Anopheles gambiae and Culex quinquefasciatus in Southern Benin	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; COMBINATION NET; POTENTIAL USE; MOSQUITOS; DIPTERA; CARBAMATE; EFFICACY	Background: Alternative compounds which can complement pyrethroids on long-lasting insecticidal nets (LN) in the control of pyrethroid resistant malaria vectors are urgently needed. Pyriproxyfen (PPF), an insect growth regulator, reduces the fecundity and fertility of adult female mosquitoes. LNs containing a mixture of pyriproxyfen and pyrethroid could provide personal protection through the pyrethroid component and reduce vector abundance in the next generation through the sterilizing effect of pyriproxyfen. Method: The efficacy of Olyset Duo, a newly developed mixture LN containing pyriproxyfen and permethrin, was evaluated in experimental huts in southern Benin against pyrethroid resistant Anopheles gambiae and Culex quinquefasciatus. Comparison was made with Olyset Net (R) (permethrin alone) and a LN with pyriproxyfen alone (PPF LN). Laboratory tunnel tests were performed to substantiate the findings in the experimental huts. Results: Overall mortality of wild pyrethroid resistant An. gambiae s.s. was significantly higher with Olyset Duo than with Olyset Net (50% vs. 27%, P=0.01). Olyset DUO was more protective than Olyset Net (71% vs. 3%, P < 0.001). The oviposition rate of surviving blood-fed An. gambiae from the control hut was 37% whereas none of those from Olyset Duo and PPF LN huts laid eggs. The tunnel test results were consistent with the experimental hut results. Olyset Duo was more protective than Olyset Net in the huts against wild pyrethroid resistant Cx. quinquefasciatus although mortality rates of this species did not differ significantly between Olyset Net and Olyset Duo. There was no sterilizing effect on surviving blood-fed Cx. quinquefasciatus with the PPF-treated nets. Conclusion: Olyset Duo was superior to Olyset Net in terms of personal protection and killing of pyrethroid resistant An. gambiae, and sterilized surviving blood-fed mosquitoes. Mixing pyrethroid and pyriproxyfen on a LN shows potential for malaria control and management of pyrethroid resistant vectors by preventing further selection of pyrethroid resistant phenotypes.	[Ngufor, Corine; N'Guessan, Raphael; Rowland, Mark] London Sch Hyg & Trop Med, London WC1, England; [Ngufor, Corine; N'Guessan, Raphael; Fagbohoun, Josias; Odjo, Abibatou; Akogbeto, Martin] CREC, Cotonou, Benin; [Ngufor, Corine; N'Guessan, Raphael; Rowland, Mark] Pan African Malaria Vector Res Consortium PAMVERC, London, England; [Malone, David] Innovat Vector Control Consortium IVCC, Liverpool, Merseyside, England	University of London; London School of Hygiene & Tropical Medicine; Entomological Research Center of Cotonou (CREC)	Ngufor, C (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	corine.ngufor@lshtm.ac.uk		Ngufor, Corine/0000-0002-7755-9609	Innovative Vector Control Consortium, Liverpool, UK; Bill & Melinda Gates Foundation	Innovative Vector Control Consortium, Liverpool, UK; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Project grant from Innovative Vector Control Consortium, Liverpool, UK funded by a programme grant of the Bill & Melinda Gates Foundation. http://www.ivcc.com/. The Bill & Melinda Gates Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, the IVCC did advise on the study design via their Expert Scientific Committee.	Aiku A O, 2006, West Afr J Med, V25, P22; [Anonymous], 2019, GUID LAB FIELD TEST; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Asidi AN, 2004, MED VET ENTOMOL, V18, P134, DOI 10.1111/j.0269-283X.2004.00485.x; Chandre F, 1998, MED VET ENTOMOL, V12, P359, DOI 10.1046/j.1365-2915.1998.00120.x; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; CURTIS CF, 1985, B ENTOMOL RES, V75, P259, DOI 10.1017/S0007485300014346; DENHOLM I, 1992, ANNU REV ENTOMOL, V37, P91, DOI 10.1146/annurev.en.37.010192.000515; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Harris C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-144; Hill J, 2006, ADV PARASIT, V61, P77, DOI 10.1016/S0065-308X(05)61003-2; Invest J. F., 2008, 6th International Conference on Urban Pests, Budapest, Hungary, 13-16 July 2008, P239; Malima RC, 2009, MED VET ENTOMOL, V23, P317, DOI 10.1111/j.1365-2915.2009.00837.x; N'Guessan R, 2007, J MED ENTOMOL, V44, P270, DOI 10.1603/0022-2585(2007)44[270:EOIAOI]2.0.CO;2; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; N'Guessan R, 2010, T ROY SOC TROP MED H, V104, P758, DOI 10.1016/j.trstmh.2010.08.008; N'Guessan R, 2009, TROP MED INT HEALTH, V14, P389, DOI 10.1111/j.1365-3156.2009.02245.x; Ohashi K, 2012, J MED ENTOMOL, V49, P1052, DOI 10.1603/ME12006; Ohba S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067045; Oxborough RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055781; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Sihuincha M, 2005, J MED ENTOMOL, V42, P620, DOI 10.1603/0022-2585(2005)042[0620:PUOPFC]2.0.CO;2; Tungu P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-21; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2010, WOR HEALT REP, P1; WHO, 2006, WHO SPEC EV PUBL HLT; WHO, 2008, PYR DRINK WAT US VEC; World Health Organization, 2006, PEST THEIR APPL CONT; World Health Organization, 2012, WHO GLOB MAL PROGR G	30	47	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93603	10.1371/journal.pone.0093603	http://dx.doi.org/10.1371/journal.pone.0093603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699827	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000334105000079
J	Xiao, YM; Esser, L; Zhou, F; Li, C; Zhou, YH; Yu, CA; Qin, ZH; Xia, D				Xiao, Yu-Mei; Esser, Lothar; Zhou, Fei; Li, Chang; Zhou, Yi-Hui; Yu, Chang-An; Qin, Zhao-Hai; Xia, Di			Studies on Inhibition of Respiratory Cytochrome bc(1) Complex by the Fungicide Pyrimorph Suggest a Novel Inhibitory Mechanism	PLOS ONE			English	Article							X-RAY-STRUCTURE; MITOCHONDRIAL RESPIRATION; ELECTRON-TRANSFER; OXIDATION SITE; SUBUNIT; PROTEIN; MODE; SENSITIVITY; INVOLVEMENT; QUINONE	The respiratory chain cytochrome bc(1) complex (cyt bc(1)) is a major target of numerous antibiotics and fungicides. All cyt bc(1) inhibitors act on either the ubiquinol oxidation (Q(P)) or ubiquinone reduction (Q(N)) site. The primary cause of resistance to bc(1) inhibitors is target site mutations, creating a need for novel agents that act on alternative sites within the cyt bc(1) to overcome resistance. Pyrimorph, a synthetic fungicide, inhibits the growth of a broad range of plant pathogenic fungi, though little is known concerning its mechanism of action. In this study, using isolated mitochondria from pathogenic fungus Phytophthora capsici, we show that pyrimorph blocks mitochondrial electron transport by affecting the function of cyt bc(1). Indeed, pyrimorph inhibits the activities of both purified 11-subunit mitochondrial and 4-subunit bacterial bc(1) with IC50 values of 85.0 mu M and 69.2 mu M, respectively, indicating that it targets the essential subunits of cyt bc(1) complexes. Using an array of biochemical and spectral methods, we show that pyrimorph acts on an area near the Q(P) site and falls into the category of a mixed-type, noncompetitive inhibitor with respect to the substrate ubiquinol. In silico molecular docking of pyrimorph to cyt b from mammalian and bacterial sources also suggests that pyrimorph binds in the vicinity of the quinol oxidation site.	[Xiao, Yu-Mei; Li, Chang; Zhou, Yi-Hui; Qin, Zhao-Hai] China Agr Univ, Dept Appl Chem, Beijing 100094, Peoples R China; [Xiao, Yu-Mei; Esser, Lothar; Zhou, Fei; Zhou, Yi-Hui; Xia, Di] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Yu, Chang-An] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	China Agricultural University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Oklahoma State University System; Oklahoma State University - Stillwater	Qin, ZH (corresponding author), China Agr Univ, Dept Appl Chem, Beijing 100094, Peoples R China.	qinzhaohai@263.net; xiad@mail.nih.gov			Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; National Basic Research Science Foundation of China [2010CB126100]; NATIONAL CANCER INSTITUTE [ZIABC010319] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Basic Research Science Foundation of China(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, and by a grant from the National Basic Research Science Foundation of China (2010CB126100) to ZQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Berry EA, 2010, BBA-BIOENERGETICS, V1797, P360, DOI 10.1016/j.bbabio.2009.12.003; Blum M, 2010, MOL PLANT PATHOL, V11, P227, DOI 10.1111/j.1364-3703.2009.00604.x; Bolgunas S, 2006, J MED CHEM, V49, P4762, DOI 10.1021/jm060408s; Brasseur G, 1996, BBA-BIOENERGETICS, V1275, P61, DOI 10.1016/0005-2728(96)00051-5; Chen Xiao-xia, 2007, Nongyaoxue Xuebao, V9, P229; Dosnon-Olette R, 2011, ENVIRON SCI POLLUT R, V18, P1015, DOI 10.1007/s11356-011-0460-1; Du YN, 2008, MODERN AGROCHEM, V7, P44; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Esser L, 2013, CURR PHARM DES; Esser L, 2008, J BIOL CHEM, V283, P2846, DOI 10.1074/jbc.M708608200; Garrett R. H., 1999, BIOCHEMISTRY; Gaur M, 2005, J MOL MICROB BIOTECH, V9, P3, DOI 10.1159/000088141; Hatefi Y, 1978, Methods Enzymol, V53, P21; Hill P, 2003, ANTIMICROB AGENTS CH, V47, P2725, DOI 10.1128/AAC.47.9.2725-2731.2003; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Jordan DB, 1999, PESTIC SCI, V55, P105, DOI 10.1002/(SICI)1096-9063(199902)55:2&lt;105::AID-PS879&gt;3.0.CO;2-D; Keilin D, 1925, P R SOC LOND B-CONTA, V98, P312, DOI 10.1098/rspb.1925.0039; Kleinschroth T, 2011, BBA-BIOENERGETICS, V1807, P1606, DOI 10.1016/j.bbabio.2011.09.017; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Leadbeater A, 2011, FUNGICIDE RESISTANCE IN CROP PROTECTION: RISK AND MANAGEMENT, P141, DOI 10.1079/9781845939052.0141; LINK TA, 1993, J BIOENERG BIOMEMBR, V25, P221, DOI 10.1007/BF00762584; MATHER MW, 1995, J BIOL CHEM, V270, P28668, DOI 10.1074/jbc.270.48.28668; Mitani S, 2001, PESTIC BIOCHEM PHYS, V71, P107, DOI 10.1006/pest.2001.2569; MITCHELL P, 1975, FEBS LETT, V56, P1, DOI 10.1016/0014-5793(75)80098-6; Mu CW, 2007, CHEM J CHINESE U, V28, P1902; Nicklaus M.C SM, 2012, CADD GROUP CHEM TOOL; Pang ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056513; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Steinfeld U, 2001, PEST MANAG SCI, V57, P787, DOI 10.1002/ps.356; Sun HY, 2010, J PHYTOPATHOL, V158, P244, DOI 10.1111/j.1439-0434.2009.01606.x; Tian H, 1997, J BIOL CHEM, V272, P23722, DOI 10.1074/jbc.272.38.23722; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; VONJAGOW G, 1984, J BIOL CHEM, V259, P6318; VONJAGOW G, 1981, FEBS LETT, V136, P19, DOI 10.1016/0014-5793(81)81206-9; Wang HC, 2009, PLANT PATHOLOGY; Wood PM, 2003, PEST MANAG SCI, V59, P499, DOI 10.1002/ps.655; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Yan XJ, 2010, J AGR FOOD CHEM, V58, P2720, DOI 10.1021/jf902410x; Yoshida T, 2007, BIOCHEMISTRY-US, V46, P10365, DOI 10.1021/bi7010306; YU CA, 1982, BIOCHEMISTRY-US, V21, P4096, DOI 10.1021/bi00260a028; YU L, 1991, BIOCHEMISTRY-US, V30, P4934, DOI 10.1021/bi00234a014; Yu LD, 2009, METHOD ENZYMOL, V456, P459, DOI 10.1016/S0076-6879(08)04425-X; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	50	23	24	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93765	10.1371/journal.pone.0093765	http://dx.doi.org/10.1371/journal.pone.0093765			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699450	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000104
J	Ydreborg, M; Lisovskaja, V; Lagging, M; Christensen, PB; Langeland, N; Buhl, MR; Pedersen, C; Morch, K; Wejstal, R; Norkrans, G; Lindh, M; Farkkila, M; Westin, J				Ydreborg, Magdalena; Lisovskaja, Vera; Lagging, Martin; Christensen, Peer Brehm; Langeland, Nina; Buhl, Mads Rauning; Pedersen, Court; Morch, Kristine; Wejstal, Rune; Norkrans, Gunnar; Lindh, Magnus; Farkkila, Martti; Westin, Johan			A Novel Fibrosis Index Comprising a Non-Cholesterol Sterol Accurately Predicts HCV-Related Liver Cirrhosis	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; STANDARD LABORATORY TESTS; C VIRUS GENOTYPE-3; TRANSIENT ELASTOGRAPHY; INSULIN-RESISTANCE; HEPATIC-FIBROSIS; SERUM; STEATOSIS; MARKERS; BIOPSY	Diagnosis of liver cirrhosis is essential in the management of chronic hepatitis C virus (HCV) infection. Liver biopsy is invasive and thus entails a risk of complications as well as a potential risk of sampling error. Therefore, non-invasive diagnostic tools are preferential. The aim of the present study was to create a model for accurate prediction of liver cirrhosis based on patient characteristics and biomarkers of liver fibrosis, including a panel of non-cholesterol sterols reflecting cholesterol synthesis and absorption and secretion. We evaluated variables with potential predictive significance for liver fibrosis in 278 patients originally included in a multicenter phase III treatment trial for chronic HCV infection. A stepwise multivariate logistic model selection was performed with liver cirrhosis, defined as Ishak fibrosis stage 5-6, as the outcome variable. A new index, referred to as Nordic Liver Index (NoLI) in the paper, was based on the model:Log-odds (predicting cirrhosis) =-12.17+ (agex0.11) + (BMI (kg/m(2))x0.23) + (D-7-lathosterol (mu g/100 mg cholesterol)x(-0.013)) + (Platelet count (x10(9)/L)x(-0.018)) + (Prothrombin-INRx3.69). The area under the ROC curve (AUROC) for prediction of cirrhosis was 0.91 (95% CI 0.86-0.96). The index was validated in a separate cohort of 83 patients and the AUROC for this cohort was similar (0.90; 95% CI: 0.82-0.98). In conclusion, the new index may complement other methods in diagnosing cirrhosis in patients with chronic HCV infection.	[Ydreborg, Magdalena; Lagging, Martin; Wejstal, Rune; Norkrans, Gunnar; Lindh, Magnus; Westin, Johan] Univ Gothenburg, Inst Biomed, Dept Infect Dis Virol, Gothenburg, Sweden; [Lisovskaja, Vera] Chalmers Univ Technol, Dept Math Sci, S-41296 Gothenburg, Sweden; [Lisovskaja, Vera] Univ Gothenburg, Gothenburg, Sweden; [Christensen, Peer Brehm] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Langeland, Nina; Morch, Kristine] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Buhl, Mads Rauning] Aarhus Univ, Dept Infect Dis, Aarhus, Denmark; [Farkkila, Martti] Univ Helsinki, Inst Clin Med, Dept Gastroenterol, Helsinki, Finland	University of Gothenburg; Chalmers University of Technology; University of Gothenburg; University of Southern Denmark; Odense University Hospital; University of Bergen; Aarhus University; University of Helsinki	Westin, J (corresponding author), Univ Gothenburg, Inst Biomed, Dept Infect Dis Virol, Gothenburg, Sweden.	johan.westin@gu.se	Färkkilä, Martti/AAG-6970-2021; Lagging, Martin/D-7734-2015	Färkkilä, Martti/0000-0002-0250-8559; Lagging, Martin/0000-0002-7995-3626; Christensen, Peer Brehm/0000-0003-1394-058X	Sahlgrenska University Hospital; Gothenburg Society of Medicine; Roche affiliates in the Nordic region and MSD Sweden; Roche affiliates in the Nordic region; MSD Sweden	Sahlgrenska University Hospital; Gothenburg Society of Medicine; Roche affiliates in the Nordic region and MSD Sweden; Roche affiliates in the Nordic region; MSD Sweden	ALF Funds at Sahlgrenska University Hospital and The Gothenburg Society of Medicine supported this study. Unrestricted grants from Roche affiliates in the Nordic region and MSD Sweden also supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; Adinolfi LE, 2001, BRIT J HAEMATOL, V113, P590, DOI 10.1046/j.1365-2141.2001.02824.x; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; BJORKHEM I, 1987, J LIPID RES, V28, P1137; Boursier J, 2011, AM J GASTROENTEROL, V106, P1255, DOI 10.1038/ajg.2011.100; Cales P, 2005, HEPATOLOGY, V42, P1373, DOI 10.1002/hep.20935; Camma C, 2006, HEPATOLOGY, V43, P64, DOI 10.1002/hep.20983; Castera L, 2009, J HEPATOL, V50, P59, DOI 10.1016/j.jhep.2008.08.018; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Clark PJ, 2012, HEPATOLOGY, V56, P49, DOI 10.1002/hep.25631; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Cua IHY, 2008, HEPATOLOGY, V48, P723, DOI 10.1002/hep.22392; Degos F, 2010, J HEPATOL, V53, P1013, DOI 10.1016/j.jhep.2010.05.035; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Fontana RJ, 2008, HEPATOLOGY, V47, P789, DOI 10.1002/hep.22099; Fontana RJ, 2006, HEPATOLOGY, V44, P925, DOI 10.1002/hep.21335; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420; Gylling H, 2012, EUR J NUTR, V51, P615, DOI 10.1007/s00394-011-0249-5; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Islam S, 2005, SCAND J GASTROENTERO, V40, P867, DOI 10.1080/00365520510015674; Kumar D, 2002, HEPATOLOGY, V36, P1266, DOI 10.1053/jhep.2002.36370; Lagging M, 2008, HEPATOLOGY, V47, P1837, DOI 10.1002/hep.22253; Lok ASF, 2005, HEPATOLOGY, V42, P282, DOI 10.1002/hep.20772; MIETTINEN TA, 1988, J LIPID RES, V29, P43; MIETTINEN TA, 1990, AM J EPIDEMIOL, V131, P20, DOI 10.1093/oxfordjournals.aje.a115479; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; NIKKILA K, 1991, HEPATOLOGY, V13, P663, DOI 10.1002/hep.1840130409; Nikkila K, 2005, TRANSPL INT, V18, P221, DOI 10.1111/j.1432-2277.2004.00002.x; NIKKILA K, 1992, HEPATOLOGY, V15, P863, DOI 10.1002/hep.1840150519; Nikkila K, 2008, J HEPATOL, V49, P936, DOI 10.1016/j.jhep.2008.07.026; Parkes J, 2011, J VIRAL HEPATITIS, V18, P23, DOI 10.1111/j.1365-2893.2009.01263.x; PERRAULT J, 1978, GASTROENTEROLOGY, V74, P103; Pohl A, 2001, AM J GASTROENTEROL, V96, P3142, DOI 10.1111/j.1572-0241.2001.05268.x; Poynard T, 2003, HEPATOLOGY, V38, P75, DOI 10.1053/jhep.2003.50267; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 1997, J VIRAL HEPATITIS, V4, P199, DOI 10.1046/j.1365-2893.1997.00141.x; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sebastiani G, 2009, HEPATOLOGY, V49, P1821, DOI 10.1002/hep.22859; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Westin J, 2002, J HEPATOL, V37, P837, DOI 10.1016/S0168-8278(02)00299-4; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	46	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93601	10.1371/journal.pone.0093601	http://dx.doi.org/10.1371/journal.pone.0093601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699777	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000077
J	Carapella, V; Bordas, R; Pathmanathan, P; Lohezic, M; Schneider, JE; Kohl, P; Burrage, K; Grau, V				Carapella, Valentina; Bordas, Rafel; Pathmanathan, Pras; Lohezic, Maelene; Schneider, Jurgen E.; Kohl, Peter; Burrage, Kevin; Grau, Vicente			Quantitative Study of the Effect of Tissue Microstructure on Contraction in a Computational Model of Rat Left Ventricle	PLOS ONE			English	Article							MAGNETIC-RESONANCE; HEART; ARCHITECTURE; FIBER; ARRANGEMENT; STRESS; HEALTH; STRAIN; TOOLS	Tissue microstructure, in particular the alignment of myocytes ( fibre direction) and their lateral organisation into sheets, is fundamental to cardiac function. We studied the effect of microstructure on contraction in a computational model of rat left ventricular electromechanics. Different fibre models, globally rule-based or locally optimised to DT-MRI data, were compared, in order to understand whether a subject-specific fibre model would enhance the predictive power of our model with respect to the global ones. We also studied the impact of sheets on ventricular deformation by comparing: ( a) a transversely isotropic versus an orthotropic material law and (b) a linear model with a bimodal model of sheet transmural variation. We estimated ejection fraction, wall thickening and base-to-apex shortening and compared them with measures from cine-MRI. We also evaluated Lagrangian strains as local metrics of cardiac deformation. Our results show that the subject-specific fibre model provides little improvement in the metric predictions with respect to global fibre models while material orthotropy allows closer agreement with measures than transverse isotropy. Nonetheless, the impact of sheets in our model is smaller than that of fibres. We conclude that further investigation of the modelling of sheet dynamics is necessary to fully understand the impact of tissue structure on cardiac deformation.	[Carapella, Valentina; Bordas, Rafel; Pathmanathan, Pras; Burrage, Kevin] Univ Oxford, Dept Comp Sci, Oxford, England; [Lohezic, Maelene; Schneider, Jurgen E.] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England; [Schneider, Jurgen E.; Kohl, Peter] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Grau, Vicente] Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Oxford, England	University of Oxford; University of Oxford; Imperial College London; University of Oxford	Carapella, V (corresponding author), Univ Oxford, Dept Comp Sci, Oxford, England.	valentina.carapella@dtc.ox.ac.uk		Carapella, Valentina/0000-0001-9750-9425; Grau, Vicente/0000-0001-8139-3480; Burrage, Kevin/0000-0002-8111-1137; Kohl, Peter/0000-0003-0416-6270; Bordas, Rafel/0000-0002-0856-544X	BBSRC [E003443, BB/I012117]; British Heart Foundation New Horizon grant [NH/13/30238]; EPSRC [EP/J013250/1]; Systems Biology Doctoral Training Centre; EU FP7 AirPROM project [270194]; British Heart Foundation; European Research Council; Biotechnology and Biological Sciences Research Council [BB/I012117/1] Funding Source: researchfish; British Heart Foundation [FS/11/50/29038, NH/13/1/30238, FS/12/17/29532] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J013250/1] Funding Source: researchfish; BBSRC [BB/I012117/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation New Horizon grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Systems Biology Doctoral Training Centre; EU FP7 AirPROM project; British Heart Foundation(British Heart Foundation); European Research Council(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work presented here was supported by BBSRC grants E003443 and BB/I012117, by the British Heart Foundation New Horizon grant NH/13/30238, and by EPSRC grant EP/J013250/1. VC was partially funded by the EPSRC and would like to thank the Systems Biology Doctoral Training Centre. RB was funded by the EU FP7 AirPROM project (grant agreement no. 270194). JES is a BHF Senior Basic Science Research Fellow. PK acknowledges additional support by the British Heart Foundation and the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Sierra J, 2011, PROG BIOPHYS MOL BIO, V107, P147, DOI 10.1016/j.pbiomolbio.2011.06.014; Bishop MJ, 2009, LECT NOTES COMPUT SC, V5528, P87, DOI 10.1007/978-3-642-01932-6_10; Bourgeois EB, 2009, IEEE T BIO-MED ENG, V56, P855, DOI 10.1109/TBME.2008.2007501; Bovendeerd PHM, 2009, AM J PHYSIOL-HEART C, V297, pH1058, DOI 10.1152/ajpheart.01334.2008; Burton RAB, 2006, ANN NY ACAD SCI, V1080, P301, DOI 10.1196/annals.1380.023; Carapella V, 2013, LECT NOTES COMPUT SC, V7945, P46, DOI 10.1007/978-3-642-38899-6_6; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Cheng A, 2008, CIRCULATION, V118, P713, DOI 10.1161/CIRCULATIONAHA.107.744623; Connelly KA, 2006, AM J PHYSIOL-HEART C, V290, pH1699, DOI 10.1152/ajpheart.00577.2005; Coppola Benjamin A., 2008, Molecular & Cellular Biomechanics, V5, P183; DURRER D, 1970, CIRCULATION, V41, P899, DOI 10.1161/01.CIR.41.6.899; Eriksson TSE, 2013, MATH MECH SOLIDS, V18, P592, DOI 10.1177/1081286513485779; Geerts L, 2003, FUNCTIONAL IMAGING M, V2674, P1006; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Gilbert SH, 2007, EUR J CARDIO-THORAC, V32, P231, DOI 10.1016/j.ejcts.2007.03.032; Hales PW, 2012, PROG BIOPHYS MOL BIO, V110, P319, DOI 10.1016/j.pbiomolbio.2012.07.014; Hooks DA, 2007, CIRC RES, V101, pE103, DOI 10.1161/CIRCRESAHA.107.161075; Karadag IE, 2011, LECT NOTES COMPUT SC, V6666, P294, DOI 10.1007/978-3-642-21028-0_36; Kerckhoffs RCP, 2003, ANN BIOMED ENG, V31, P536, DOI 10.1114/1.1566447; Kohl P, 2010, CLIN PHARMACOL THER, V88, P25, DOI 10.1038/clpt.2010.92; Kroon W, 2009, MED IMAGE ANAL, V13, P346, DOI 10.1016/j.media.2008.06.015; LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571, DOI 10.1152/ajpheart.1995.269.2.H571; Lin DHS, 1998, J BIOMECH ENG-T ASME, V120, P504, DOI 10.1115/1.2798021; Mirams GR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002970; Niederer SA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000371; OMENS JH, 1993, J BIOMECH, V26, P665, DOI 10.1016/0021-9290(93)90030-I; Pathmanathan P, 2009, ANN BIOMED ENG, V37, P860, DOI 10.1007/s10439-009-9663-8; Plank G, 2009, PHILOS T R SOC A, V367, P2257, DOI 10.1098/rsta.2009.0056; Satoh H, 1996, BIOPHYS J, V70, P1494, DOI 10.1016/S0006-3495(96)79711-4; Scollan DF, 1998, AM J PHYSIOL-HEART C, V275, pH2308, DOI 10.1152/ajpheart.1998.275.6.H2308; STREETER DD, 1969, CIRC RES, V24, P339, DOI 10.1161/01.RES.24.3.339; Usyk TP, 2000, J ELASTICITY, V61, P143, DOI 10.1023/A:1010883920374; Vadakkumpadan F, 2010, WIRES SYST BIOL MED, V2, P489, DOI 10.1002/wsbm.76; Wang LJ, 2008, AM J PHYSIOL-HEART C, V294, pH2565, DOI 10.1152/ajpheart.01376.2007; Wise RG, 1998, J PHYSIOL-LONDON, V513, P873, DOI 10.1111/j.1469-7793.1998.873ba.x; Zhong XD, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-83	36	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92792	10.1371/journal.pone.0092792	http://dx.doi.org/10.1371/journal.pone.0092792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695115	Green Published, gold			2022-12-27	WOS:000334103000028
J	Karpurapu, M; Ranjan, R; Deng, J; Chung, SW; Lee, YG; Xiao, L; Nirujogi, TS; Jacobson, JR; Park, GY; Christman, JW				Karpurapu, Manjula; Ranjan, Ravi; Deng, Jing; Chung, Sangwoon; Lee, Yong Gyu; Xiao, Lei; Nirujogi, Teja Srinivas; Jacobson, Jeffrey R.; Park, Gye Young; Christman, John W.			Kruppel Like Factor 4 Promoter Undergoes Active Demethylation during Monocyte/Macrophage Differentiation	PLOS ONE			English	Article							DNA DEMETHYLATION; LINEAGE COMMITMENT; PU.1; METHYLATION; EXCISION; GENE; ACTIVATION; PROTEINS; KEY; 5-METHYLCYTOSINE	The role of different lineage specific transcription factors in directing hematopoietic cell fate towards myeloid lineage is well established but the status of epigenetic modifications has not been defined during this important developmental process. We used non proliferating, PU.1 inducible myeloid progenitor cells and differentiating bone marrow derived macrophages to study the PU.1 dependent KLF4 transcriptional regulation and its promoter demethylation during monocyte/macrophage differentiation. Expression of KLF4 was regulated by active demethylation of its promoter and PU.1 specifically bound to KLF4 promoter oligo harboring the PU.1 consensus sequence. Methylation specific quantitative PCR and Bisulfite sequencing indicated demethylation of CpG residues most proximal to the transcription start site of KLF4 promoter. Cloned KLF4 promoter in pGL3 Luciferase and CpG free pcpgf-bas vectors showed accentuated reporter activity when co-transfected with the PU.1 expression vector. In vitro methylation of both KLF4 promoter oligo and cloned KLF4 promoter vectors showed attenuated in vitro DNA binding activity and Luciferase/mouse Alkaline phosphotase reporter activity indicating the negative influence of KLF4 promoter methylation on PU.1 binding. The Cytosine deaminase, Activation Induced Cytidine Deaminase (AICDA) was found to be critical for KLF4 promoter demethylation. More importantly, knock down of AICDA resulted in blockade of KLF4 promoter demethylation, decreased F4/80 expression and other phenotypic characters of macrophage differentiation. Our data proves that AICDA mediated active demethylation of the KLF4 promoter is necessary for transcriptional regulation of KLF4 by PU.1 during monocyte/macrophage differentiation.	[Karpurapu, Manjula; Deng, Jing; Chung, Sangwoon; Lee, Yong Gyu; Nirujogi, Teja Srinivas; Christman, John W.] Ohio State Univ, Wexner Med Ctr, Davis Heart & Lung Res Inst, Sect Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Ranjan, Ravi; Xiao, Lei; Park, Gye Young] Univ Illinois, Coll Med, Sect Pulm Crit Care Sleep & Allergy, Chicago, IL USA; [Jacobson, Jeffrey R.] Univ Illinois, Dept Med, Inst Personalized Resp Med, Chicago, IL USA	University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Christman, JW (corresponding author), Ohio State Univ, Wexner Med Ctr, Davis Heart & Lung Res Inst, Sect Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA.	John.Christman@osumc.edu	Ranjan, Ravi/D-1614-2016	Ranjan, Ravi/0000-0002-8768-549X	National Institutes of Health [R01 HL075557, HL 103643, T32 HL082547]; Department of Veterans Affairs merit review grant [1I01BX000108]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075557, T32HL082547, R01HL103643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs merit review grant(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health (grants R01 HL075557, HL 103643, and T32 HL082547) and a Department of Veterans Affairs merit review grant (1I01BX000108, J.W.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2008, J IMMUNOL, V180, P5645, DOI 10.4049/jimmunol.180.8.5645; Arioka Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045031; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Cadet J, 2014, MUTAT RES-GEN TOX EN, V764, P18, DOI 10.1016/j.mrgentox.2013.09.001; Cao ZX, 2010, BLOOD, V116, P4404, DOI 10.1182/blood-2010-05-285353; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dahl R, 2003, BLOOD CELL MOL DIS, V31, P229, DOI 10.1016/S1079-9796(03)00152-9; Dalton SR, 2012, EPIGENOMICS-UK, V4, P459, DOI [10.2217/EPI.12.36, 10.2217/epi.12.36]; de la Rica L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r99; Engel N, 2009, EPIGENETICS-US, V4, P98, DOI 10.4161/epi.4.2.7858; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Fisher RC, 1998, STEM CELLS, V16, P25, DOI 10.1002/stem.160025; Fritz EL, 2010, GENE DEV, V24, P2107, DOI 10.1101/gad.1963010; Fu Y, 2012, CURR OPIN CHEM BIOL, V16, P516, DOI 10.1016/j.cbpa.2012.10.002; Gavin DP, 2013, NEUROPHARMACOLOGY, V75, P233, DOI 10.1016/j.neuropharm.2013.07.036; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Karpurapu M, 2011, BLOOD, V118, P5255, DOI 10.1182/blood-2011-03-341123; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Lehtonen A, 2005, J IMMUNOL, V175, P6570, DOI 10.4049/jimmunol.175.10.6570; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li YP, 2010, ARTHRITIS RHEUM-US, V62, P1438, DOI 10.1002/art.27363; Liu S, 2013, NUCLEIC ACIDS RES, V41, P6421, DOI 10.1093/nar/gkt360; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Nagamura-Inoue T, 2001, Int Rev Immunol, V20, P83, DOI 10.3109/08830180109056724; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Sanz LA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-110; Schafer A, 2013, ADV EXP MED BIOL, V793, P35, DOI 10.1007/978-1-4614-8289-5_3; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Singh H, 1999, COLD SPRING HARB SYM, V64, P13, DOI 10.1101/sqb.1999.64.13; Teperek-Tkacz M, 2011, REPRODUCTION, V142, P621, DOI 10.1530/REP-11-0148; Pham TH, 2013, NUCLEIC ACIDS RES, V41, P6391, DOI 10.1093/nar/gkt355; Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453; Tshori S, 2012, BBA-MOL BASIS DIS, V1822, P42, DOI 10.1016/j.bbadis.2010.12.024; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Wolff L, 2013, STEM CELLS, V31, P1237, DOI 10.1002/stem.1379; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	47	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93362	10.1371/journal.pone.0093362	http://dx.doi.org/10.1371/journal.pone.0093362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695324	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000060
J	Peng, JL; Hao, BH; Liu, L; Wang, SM; Ma, BG; Yang, Y; Xie, FL; Li, YG				Peng, Jieli; Hao, Baohai; Liu, Liu; Wang, Shanming; Ma, Binguang; Yang, Yi; Xie, Fuli; Li, Youguo			RNA-Seq and Microarrays Analyses Reveal Global Differential Transcriptomes of Mesorhizobium huakuii 7653R between Bacteroids and Free-Living Cells	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; NODULE-SPECIFIC GENES; AMINO-ACID PERMEASE; SINORHIZOBIUM-MELILOTI; RHIZOBIUM-LEGUMINOSARUM; NITROGEN-FIXATION; BRADYRHIZOBIUM-JAPONICUM; EXPRESSION PATTERNS; MEDICAGO-TRUNCATULA; CYCLE PROGRESSION	Mesorhizobium huakuii 7653R occurs either in nitrogen-fixing symbiosis with its host plant, Astragalus sinicus, or free-living in the soil. The M. huakuii 7653R genome has recently been sequenced. To better understand the complex biochemical and developmental changes that occur in 7653R during bacteroid development, RNA-Seq and Microarrays were used to investigate the differential transcriptomes of 7653R bacteroids and free-living cells. The two approaches identified several thousand differentially expressed genes. The most prominent up-regulation occurred in the symbiosis plasmids, meanwhile gene expression is concentrated to a set of genes (clusters) in bacteroids to fulfill corresponding functional requirements. The results suggested that the main energy metabolism is active while fatty acid metabolism is inactive in bacteroid and that most of genes relevant to cell cycle are down-regulated accordingly. For a global analysis, we reconstructed a protein-protein interaction (PPI) network for 7653R and integrated gene expression data into the network using Cytoscape. A highly inter-connected subnetwork, with function enrichment for nitrogen fixation, was found, and a set of hubs and previously uncharacterized genes participating in nitrogen fixation were identified. The results described here provide a broader biological landscape and novel insights that elucidate rhizobial bacteroid differentiation, nitrogen fixation and related novel gene functions.	[Peng, Jieli; Liu, Liu; Wang, Shanming; Xie, Fuli; Li, Youguo] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Hao, Baohai; Ma, Binguang; Yang, Yi] Huazhong Agr Univ, Sch Life Sci & Technol, Ctr Bioinformat, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Li, YG (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	youguoli@mail.hzau.edu.cn			National Basic Research Program of China (973 program) [2010CB126502]; Research Fund for the Doctoral Program of Higher Education of China [20110146110012]; National Natural Science Foundation of China [31371549, 31100602]; Fundamental Research Funds for the Central Universities [2009PY020, 2010QC016, 2011QC066]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by funds from the National Basic Research Program of China (973 program grant no. 2010CB126502), Research Fund for the Doctoral Program of Higher Education of China (20110146110012), the National Natural Science Foundation of China (grant no. 31371549 and 31100602), and the Fundamental Research Funds for the Central Universities (2009PY020, 2010QC016 and 2011QC066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampe F, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r15; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Barnes M, 2005, NUCLEIC ACIDS RES, V33, P5914, DOI 10.1093/nar/gki890; Barnett MJ, 2004, P NATL ACAD SCI USA, V101, P16636, DOI 10.1073/pnas.0407269101; Barnett MJ, 2001, J BACTERIOL, V183, P3204, DOI 10.1128/JB.183.10.3204-3210.2001; Becker A, 2004, MOL PLANT MICROBE IN, V17, P292, DOI 10.1094/MPMI.2004.17.3.292; BECKERANDRE M, 1989, NUCLEIC ACIDS RES, V17, P9437, DOI 10.1093/nar/17.22.9437; Beckering CL, 2002, J BACTERIOL, V184, P6395, DOI 10.1128/JB.184.22.6395-6402.2002; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Brechenimacher L, 2008, MOL PLANT MICROBE IN, V21, P631, DOI 10.1094/MPMI-21-5-0631; Capela D, 2006, MOL PLANT MICROBE IN, V19, P363, DOI 10.1094/MPMI-19-0363; Chen DS, 2007, PLANT CELL REP, V26, P1421, DOI 10.1007/s00299-007-0346-3; Chiaretti S, 2004, BLOOD, V103, P2771, DOI 10.1182/blood-2003-09-3243; deLivron MA, 2008, J BACTERIOL, V190, P5944, DOI 10.1128/JB.00763-08; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Farris M, 1998, MOL MICROBIOL, V28, P265, DOI 10.1046/j.1365-2958.1998.00793.x; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; GLAZEBROOK J, 1993, GENE DEV, V7, P1485, DOI 10.1101/gad.7.8.1485; Gonzalez V, 2006, P NATL ACAD SCI USA, V103, P3834, DOI 10.1073/pnas.0508502103; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Grant AJ, 2003, MOL MICROBIOL, V48, P507, DOI 10.1046/j.1365-2958.2003.t01-1-03447.x; Green LS, 2000, J BACTERIOL, V182, P2838, DOI 10.1128/JB.182.10.2838-2844.2000; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hentschel U, 2000, TRENDS MICROBIOL, V8, P226, DOI 10.1016/S0966-842X(00)01758-3; Hosie AHF, 2002, J BACTERIOL, V184, P4071, DOI 10.1128/JB.184.15.4071-4080.2002; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Ivanov S, 2010, CURR OPIN PLANT BIOL, V13, P372, DOI 10.1016/j.pbi.2010.04.005; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Kaneko T, 2000, DNA RES, V7, P381, DOI 10.1093/dnares/7.6.381; Karunakaran R, 2009, J BACTERIOL, V191, P4002, DOI 10.1128/JB.00165-09; Kiss E, 2004, MOL PLANT MICROBE IN, V17, P235, DOI 10.1094/MPMI.2004.17.3.235; Kogenaru S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-629; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krummenacher P, 2000, GENE, V241, P247, DOI 10.1016/S0378-1119(99)00490-4; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080475, 10.1371/journal.pone.0070390]; Lindemann A, 2010, FEMS MICROBIOL LETT, V312, P184, DOI 10.1111/j.1574-6968.2010.02115.x; Lodwig E, 2003, CRIT REV PLANT SCI, V22, P37, DOI 10.1080/713610850; Lodwig EM, 2003, NATURE, V422, P722, DOI 10.1038/nature01527; Lodwig EM, 2005, MOL PLANT MICROBE IN, V18, P67, DOI 10.1094/MPMI-18-0067; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; McGrath PT, 2006, CELL, V124, P535, DOI 10.1016/j.cell.2005.12.033; Mercer RG, 2010, J BACTERIOL, V192, P2701, DOI 10.1128/JB.00160-10; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Miller TR, 2006, ENVIRON MICROBIOL, V8, P1648, DOI 10.1111/j.1462-2920.2006.01071.x; Mitsui H, 2004, MOL GENET GENOMICS, V271, P416, DOI 10.1007/s00438-004-0992-x; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Neidig A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-77; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Pessi G, 2007, MOL PLANT MICROBE IN, V20, P1353, DOI 10.1094/MPMI-20-11-1353; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Prell J, 2006, TRENDS MICROBIOL, V14, P161, DOI 10.1016/j.tim.2006.02.005; Prell J, 2009, P NATL ACAD SCI USA, V106, P12477, DOI 10.1073/pnas.0903653106; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Resendis-Antonio O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-120; Rodriguez-Llorente I, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-63; ROMANOV VI, 1994, APPL ENVIRON MICROB, V60, P2339, DOI 10.1128/AEM.60.7.2339-2342.1994; RONSON CW, 1984, J BACTERIOL, V160, P903, DOI 10.1128/JB.160.3.903-909.1984; Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107; Sarma AD, 2006, PROTEOMICS, V6, P3008, DOI 10.1002/pmic.200500783; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Scott K, 2003, BRIT J BIOMED SCI, V60, P168, DOI 10.1080/09674845.2003.11978047; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shimoda Y, 2008, DNA RES, V15, P13, DOI 10.1093/dnares/dsm028; Skerker JM, 2004, NAT REV MICROBIOL, V2, P325, DOI 10.1038/nrmicro864; Streeter JG, 2006, APPL ENVIRON MICROB, V72, P4250, DOI 10.1128/AEM.00256-06; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998; Tan XJ, 2009, APPL MICROBIOL BIOT, V84, P519, DOI 10.1007/s00253-009-1959-y; Tate R, 1998, MOL PLANT MICROBE IN, V11, P188, DOI 10.1094/MPMI.1998.11.3.188; Terpolilli JJ, 2012, ADV MICROB PHYSIOL, V60, P325, DOI 10.1016/B978-0-12-398264-3.00005-X; Tsolis RM, 2002, P NATL ACAD SCI USA, V99, P12503, DOI 10.1073/pnas.212508599; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uchiumi T, 2004, J BACTERIOL, V186, P2439, DOI 10.1128/JB.186.8.2439-2448.2004; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; Van der Henst C, 2012, J BACTERIOL, V194, P5305, DOI 10.1128/JB.00699-12; Vercruysse M, 2011, MOL PLANT MICROBE IN, V24, P1553, DOI 10.1094/MPMI-05-11-0140; Walshaw DL, 1996, MOL MICROBIOL, V21, P1239, DOI 10.1046/j.1365-2958.1996.00078.x; Wang CX, 2007, J BACTERIOL, V189, P9050, DOI 10.1128/JB.01190-07; Wang SCE, 2006, J BACTERIOL, V188, P1497, DOI 10.1128/JB.188.4.1497-1508.2006; Wang YW, 2010, ACTA BIOCH BIOPH SIN, V42, P410, DOI 10.1093/abbs/gmq034; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; Yurgel SN, 2004, FEMS MICROBIOL REV, V28, P489, DOI 10.1016/j.femsre.2004.04.002	99	16	23	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93626	10.1371/journal.pone.0093626	http://dx.doi.org/10.1371/journal.pone.0093626			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695521	Green Submitted, Green Published, gold			2022-12-27	WOS:000334103000094
J	Zgraggen, S; Huggenberger, R; Kerl, K; Detmar, M				Zgraggen, Silvana; Huggenberger, Reto; Kerl, Katrin; Detmar, Michael			An Important Role of the SDF-1/CXCR4 Axis in Chronic Skin Inflammation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-DERIVED FACTOR; CHEMOKINE RECEPTOR CXCR4; T-CELL; IFN-GAMMA; VEGF; EXPRESSION; PSORIASIS; AMD3100; DISEASE	Inflammatory angiogenesis and vascular remodeling play key roles in the chronic inflammatory skin disease psoriasis, but little is known about the molecular mediators of vascular activation. Based on the reported elevated mRNA levels of the angiogenic chemokine stromal cell-derived factor-1 (SDF-1) and its receptor CXCR4 in psoriasis, we investigated the relevance of the SDF-1/CXCR4 axis in two experimental models of chronic psoriasis-like skin inflammation. The cutaneous expression of both SDF-1 and CXCR4 was upregulated in the inflamed skin of K14-VEGF-A transgenic mice and in imiquimod-induced skin inflammation, with expression of CXCR4 by blood vessels and macrophages. Treatment with the CXCR4 antagonist AMD3100 potently inhibited skin inflammation in both models, associated with reduced inflammatory angiogenesis and inflammatory cell accumulation, including dermal CD4(+) cells and intraepidermal CD8(+) T cells. Similar anti-inflammatory effects were seen after treatment with a neutralizing anti-SDF-1 antibody. In vitro, inhibition of CXCR4 blocked SDF-1-induced chemotaxis of CD11b(+) splenocytes, in agreement with the reduced number of macrophages after in vivo CXCR4 blockade. Our results reveal an important role of the SDF-1/CXCR4 axis in skin inflammation and inflammatory angiogenesis, and they indicate that inhibition of the SDF-1/CXCR4 axis might serve as a novel therapeutic strategy for chronic inflammatory skin diseases.	[Zgraggen, Silvana; Huggenberger, Reto; Detmar, Michael] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Swiss Fed Inst Technol, Zurich, Switzerland; [Kerl, Katrin] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital	Detmar, M (corresponding author), Swiss Fed Inst Technol, Inst Pharmaceut Sci, Swiss Fed Inst Technol, Zurich, Switzerland.	michael.detmar@pharma.ethz.ch			National Institutes of Health [CA69184]; Swiss National Science Foundation [3100A0-108207, 31003A_130627]; Commission of the European Communities [LSHC-CT-2005-518178]; Advanced European Research Council Grant LYVICAM; Leducq Foundation Transatlantic Network of Excellence grant Lymph Vessels in Obesity and Cardiovascular Disease, Oncosuisse; Krebsliga Zurich; NATIONAL CANCER INSTITUTE [R01CA069184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Commission of the European Communities(European Commission); Advanced European Research Council Grant LYVICAM; Leducq Foundation Transatlantic Network of Excellence grant Lymph Vessels in Obesity and Cardiovascular Disease, Oncosuisse(Leducq Foundation); Krebsliga Zurich; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant CA69184, Swiss National Science Foundation grants 3100A0-108207 and 31003A_130627, Commission of the European Communities grant LSHC-CT-2005-518178, Advanced European Research Council Grant LYVICAM, the Leducq Foundation Transatlantic Network of Excellence grant Lymph Vessels in Obesity and Cardiovascular Disease, Oncosuisse and Krebsliga Zurich (to M.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Bhushan M, 1999, BRIT J DERMATOL, V141, P1054, DOI 10.1046/j.1365-2133.1999.03205.x; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; De Klerck B, 2005, ARTHRITIS RES THER, V7, pR1208, DOI 10.1186/ar1806; DETMAR M, 1994, J EXP MED, V180, P1141, DOI 10.1084/jem.180.3.1141; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Forster R, 1998, J IMMUNOL, V160, P1522; Fuentes-Duculan J, 2010, J INVEST DERMATOL, V130, P2412, DOI 10.1038/jid.2010.165; Halin C, 2008, AM J PATHOL, V173, P265, DOI 10.2353/ajpath.2008.071074; Halin C, 2007, BLOOD, V110, P3158, DOI 10.1182/blood-2007-01-066811; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Hirakawa S, 2003, AM J PATHOL; Huggenberger R, 2011, J INVEST DERM SYMP P, V15, P24, DOI 10.1038/jidsymp.2011.5; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; Kanazawa S, 2001, AM J GASTROENTEROL, V96, P822; Kerfoot SM, 2008, AM J PHYSIOL-HEART C, V294, pH2524, DOI 10.1152/ajpheart.00984.2007; KIEFER F, 2011, JCELL MOL LIFE SCI, V68, P2811; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Kuhn DJ, 2011, BLOOD, V118, P421; Kunstfeld R, 2004, BLOOD, V104, P1048, DOI 10.1182/blood-2003-08-2964; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; Matthys P, 2001, J IMMUNOL, V167, P4686, DOI 10.4049/jimmunol.167.8.4686; Mikami S, 2008, J PHARMACOL EXP THER, V327, P383, DOI 10.1124/jpet.108.141085; Mirshahi F, 2000, THROMB RES, V99, P587, DOI 10.1016/S0049-3848(00)00292-9; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Pablos JL, 1999, AM J PATHOL, V155, P1577, DOI 10.1016/S0002-9440(10)65474-0; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Salcedo R, 1999, AM J PATHOL, V154, P1125, DOI 10.1016/S0002-9440(10)65365-5; Samarasekera EJ, 2013, J INVEST DERMATOL, V133, P2340, DOI 10.1038/jid.2013.149; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schonthaler HB, 2009, P NATL ACAD SCI USA, V106, P21264, DOI 10.1073/pnas.0907550106; Senger DR, 1996, AM J PATHOL, V149, P293; Suarez-Farinas M, 2011, J INVEST DERMATOL, V131, P391, DOI 10.1038/jid.2010.280; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Volin MV, 1998, BIOCHEM BIOPH RES CO, V242, P46, DOI 10.1006/bbrc.1997.7890; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793; Zgraggen S, 2013, J ALLERGY, V2013, DOI DOI 10.1155/2013/672381; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	43	47	52	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93665	10.1371/journal.pone.0093665	http://dx.doi.org/10.1371/journal.pone.0093665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695674	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000334103000101
J	Zhu, XB; Richael, C; Chamberlain, P; Busse, JS; Bussan, AJ; Jiang, JM; Bethke, PC				Zhu, Xiaobiao; Richael, Craig; Chamberlain, Patrick; Busse, James S.; Bussan, Alvin J.; Jiang, Jiming; Bethke, Paul C.			Vacuolar Invertase Gene Silencing in Potato (Solanum tuberosum L.) Improves Processing Quality by Decreasing the Frequency of Sugar-End Defects	PLOS ONE			English	Article							RUSSET-BURBANK POTATOES; FREE AMINO-ACIDS; ACRYLAMIDE FORMATION; MAILLARD REACTION; REDUCING SUGAR; BASAL PORTIONS; STARCH CONTENT; DNA VARIATION; FRENCH FRIES; WATER-STRESS	Sugar-end defect is a tuber quality disorder and persistent problem for the French fry processing industry that causes unacceptable darkening of one end of French fries. This defect appears when environmental stress during tuber growth increases post-harvest vacuolar acid invertase activity at one end of the tuber. Reducing sugars produced by invertase form dark-colored Maillard reaction products during frying. Acrylamide is another Maillard reaction product formed from reducing sugars and acrylamide consumption has raised health concerns worldwide. Vacuolar invertase gene (VInv) expression was suppressed in cultivars Russet Burbank and Ranger Russet using RNA interference to determine if this approach could control sugar-end defect formation. Acid invertase activity and reducing sugar content decreased at both ends of tubers. Sugar-end defects and acrylamide in fried potato strips were strongly reduced in multiple transgenic potato lines. Thus vacuolar invertase silencing can minimize a long-standing French fry quality problem while providing consumers with attractive products that reduce health concerns related to dietary acrylamide.	[Zhu, Xiaobiao; Chamberlain, Patrick; Bussan, Alvin J.; Jiang, Jiming; Bethke, Paul C.] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Richael, Craig] JR Simplot Co, Simplot Plant Sci, Boise, ID 83707 USA; [Busse, James S.; Bethke, Paul C.] USDA, Vegetable Crops Res Unit, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA)	Richael, C (corresponding author), JR Simplot Co, Simplot Plant Sci, Boise, ID 83707 USA.	Craig.Richael@simplot.com; jjiang1@wisc.edu; paul.bethke@ars.usda.gov	Jiang, Jiming/A-9614-2009; Jiang, Jiming/V-6060-2019	Jiang, Jiming/0000-0002-6435-6140; Jiang, Jiming/0000-0002-6435-6140; Bethke, Paul/0000-0001-7507-9962	WI DATCP Specialty Crop Research Initiative Block Grant Program; USDA NIFA Specialty Crop Research Initiative; Hatch funds	WI DATCP Specialty Crop Research Initiative Block Grant Program; USDA NIFA Specialty Crop Research Initiative; Hatch funds	This research was supported by grants from the WI DATCP Specialty Crop Research Initiative Block Grant Program and the USDA NIFA Specialty Crop Research Initiative to A.J.B., J.J., and P.C.B., and Hatch funds to J.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein TM, 2003, J AGR FOOD CHEM, V51, P5556, DOI 10.1021/jf034344v; Becalski A, 2004, J AGR FOOD CHEM, V52, P3801, DOI 10.1021/jf0349376; Bethke PC, 2013, AM J POTATO RES, V90, P403, DOI 10.1007/s12230-013-9321-4; Bhaskar PB, 2010, PLANT PHYSIOL, V154, P939, DOI 10.1104/pp.110.162545; Chawla R, 2012, PLANT BIOTECHNOL J, V10, P913, DOI 10.1111/j.1467-7652.2012.00720.x; Chen X, 2001, THEOR APPL GENET, V102, P284, DOI 10.1007/s001220051645; Chuda Y, 2003, BIOSCI BIOTECH BIOCH, V67, P1188, DOI 10.1271/bbb.67.1188; Draffehn AM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-271; EC, 2011, COMM REC 10 1 2011 I; Eldredge EP, 1996, AM POTATO J, V73, P517, DOI 10.1007/BF02851697; Halford NG, 2012, J AGR FOOD CHEM, V60, P12044, DOI 10.1021/jf3037566; HEDLEY PE, 1994, GENE, V145, P211, DOI 10.1016/0378-1119(94)90007-8; Hogervorst JGF, 2010, CRIT REV TOXICOL, V40, P485, DOI 10.3109/10408440903524254; IRITANI WM, 1973, AM POTATO J, V50, P389, DOI 10.1007/BF02852203; IRITANI WM, 1973, AM POTATO J, V50, P24, DOI 10.1007/BF02851516; IRITANI WM, 1978, AM POTATO J, V55, P239, DOI 10.1007/BF02852131; IRITANI WM, 1973, AM POTATO J, V50, P223, DOI 10.1007/BF02849356; IRITANI WM, 1981, AM POTATO J, V58, P71, DOI 10.1007/BF02855381; Jackson LS, 2009, J AGR FOOD CHEM, V57, P8161, DOI 10.1021/jf900628u; KINCAID DC, 1993, AM POTATO J, V70, P711, DOI 10.1007/BF02848677; Kumar D, 2004, ANN APPL BIOL, V145, P247, DOI 10.1111/j.1744-7348.2004.tb00380.x; Li L, 2005, GENETICS, V170, P813, DOI 10.1534/genetics.104.040006; Li L, 2008, THEOR APPL GENET, V116, P1167, DOI 10.1007/s00122-008-0746-y; Li L, 2013, THEOR APPL GENET, V126, P1039, DOI 10.1007/s00122-012-2035-z; Lineback DR, 2012, ANNU REV FOOD SCI T, V3, P15, DOI 10.1146/annurev-food-022811-101114; Liu X, 2011, MOL GENET GENOMICS, V286, P109, DOI 10.1007/s00438-011-0632-1; LOISELLE F, 1990, AM POTATO J, V67, P633, DOI 10.1007/BF03043449; Mottram DS, 2002, NATURE, V419, P448, DOI 10.1038/419448a; NASS USDA, 2012, CROP PROD NOV 2012; National Potato Council (US), 2012, 2012 POT STAT YB; Parker JK, 2012, J AGR FOOD CHEM, V60, P9321, DOI 10.1021/jf302415n; Pavlista A.D., 1997, PROCESSING VEGETABLE, P237; PRITCHARD MK, 1992, AM POTATO J, V69, P805, DOI 10.1007/BF02854188; Richael CM, 2008, TRANSGENIC RES, V17, P905, DOI 10.1007/s11248-008-9175-6; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; SHOCK CC, 1994, AM POTATO J, V71, P77, DOI 10.1007/BF02849111; SHOCK CC, 1993, AM POTATO J, V70, P227, DOI 10.1007/BF02849311; SHOCK CC, 1992, AM POTATO J, V69, P793, DOI 10.1007/BF02854186; SOWOKINOS JR, 1985, PLANT PHYSIOL, V78, P489, DOI 10.1104/pp.78.3.489; Sowokinos JR, 2000, AM J POTATO RES, V77, P47, DOI 10.1007/BF02853661; Sowokinos JR, 2001, AM J POTATO RES, V78, P221, DOI 10.1007/BF02883548; Stadler RH, 2002, NATURE, V419, P449, DOI 10.1038/419449a; Stark J.C, 2003, POTATO PRODUCTION SY; Tareke E, 2002, J AGR FOOD CHEM, V50, P4998, DOI 10.1021/jf020302f; Thompson AL, 2008, AM J POTATO RES, V85, P375, DOI 10.1007/s12230-008-9034-2; van Boekel MAJS, 2006, BIOTECHNOL ADV, V24, P230, DOI 10.1016/j.biotechadv.2005.11.004; Vinci RM, 2012, FOOD CHEM, V133, P1138, DOI 10.1016/j.foodchem.2011.08.001; Wu L, 2011, CROP SCI, V51, P981, DOI 10.2135/cropsci2010.08.0473; Ye J, 2010, J AGR FOOD CHEM, V58, P12162, DOI 10.1021/jf1032262; ZHOU DB, 1994, PLANT PHYSIOL, V106, P397, DOI 10.1104/pp.106.1.397; Zrenner R, 1996, PLANTA, V198, P246, DOI 10.1007/BF00206250	51	28	32	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93381	10.1371/journal.pone.0093381	http://dx.doi.org/10.1371/journal.pone.0093381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695527	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000065
J	Jeong, CW; Lee, S; Jung, JW; Lee, BK; Jeong, SJ; Hong, SK; Byun, SS; Lee, SE				Jeong, Chang Wook; Lee, Sangchul; Jung, Jin-Woo; Lee, Byung Ki; Jeong, Seong Jin; Hong, Sung Kyu; Byun, Seok-Soo; Lee, Sang Eun			Mobile Application-Based Seoul National University Prostate Cancer Risk Calculator: Development, Validation, and Comparative Analysis with Two Western Risk Calculators in Korean Men	PLOS ONE			English	Article							EXTERNAL VALIDATION; RADICAL PROSTATECTOMY; BIOPSY; ANTIGEN; MORTALITY; SERUM; POPULATION; STATISTICS; NOMOGRAMS; OUTCOMES	Objectives: We developed a mobile application-based Seoul National University Prostate Cancer Risk Calculator (SNUPC-RC) that predicts the probability of prostate cancer ( PC) at the initial prostate biopsy in a Korean cohort. Additionally, the application was validated and subjected to head-to-head comparisons with internet-based Western risk calculators in a validation cohort. Here, we describe its development and validation. Patients and Methods: As a retrospective study, consecutive men who underwent initial prostate biopsy with more than 12 cores at a tertiary center were included. In the development stage, 3,482 cases from May 2003 through November 2010 were analyzed. Clinical variables were evaluated, and the final prediction model was developed using the logistic regression model. In the validation stage, 1,112 cases from December 2010 through June 2012 were used. SNUPC-RC was compared with the European Randomized Study of Screening for PC Risk Calculator (ERSPC-RC) and the Prostate Cancer Prevention Trial Risk Calculator (PCPT-RC). The predictive accuracy was assessed using the area under the receiver operating characteristic curve (AUC). The clinical value was evaluated using decision curve analysis. Results: PC was diagnosed in 1,240 (35.6%) and 417 (37.5%) men in the development and validation cohorts, respectively. Age, prostate-specific antigen level, prostate size, and abnormality on digital rectal examination or transrectal ultrasonography were significant factors of PC and were included in the final model. The predictive accuracy in the development cohort was 0.786. In the validation cohort, AUC was significantly higher for the SNUPC-RC (0.811) than for ERSPC-RC (0.768, p, 0.001) and PCPT-RC (0.704, p, 0.001). Decision curve analysis also showed higher net benefits with SNUPC-RC than with the other calculators. Conclusions: SNUPC-RC has a higher predictive accuracy and clinical benefit than Western risk calculators. Furthermore, it is easy to use because it is available as a mobile application for smart devices.	[Jeong, Chang Wook; Lee, Sangchul; Jung, Jin-Woo; Lee, Byung Ki; Jeong, Seong Jin; Hong, Sung Kyu; Byun, Seok-Soo; Lee, Sang Eun] Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea; [Jeong, Chang Wook; Lee, Sangchul; Jeong, Seong Jin; Hong, Sung Kyu; Byun, Seok-Soo; Lee, Sang Eun] Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, SE (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea.	selee@snubh.org						Batura D, 2013, J ANTIMICROB CHEMOTH, V68, P247, DOI 10.1093/jac/dks401; Bjurlin MA, 2013, J UROLOGY, V189, P2039, DOI 10.1016/j.juro.2013.02.072; Carignan A, 2012, EUR UROL, V62, P453, DOI 10.1016/j.eururo.2012.04.044; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Chun FKH, 2007, EUR UROL, V52, P436, DOI 10.1016/j.eururo.2006.08.039; Chun FKH, 2007, WORLD J UROL, V25, P131, DOI 10.1007/s00345-007-0146-y; Chun FKH, 2007, J UROLOGY, V177, P510, DOI 10.1016/j.juro.2006.09.025; Cullen Jennifer, 2012, J Carcinog, V11, P7, DOI 10.4103/1477-3163.94025; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Falzarano SM, 2011, ADV ANAT PATHOL, V18, P159, DOI 10.1097/PAP.0b013e31820cb506; Fine SW, 2012, EUR UROL, V62, P20, DOI 10.1016/j.eururo.2012.02.055; Greene KL, 2013, J UROLOGY, V189, pS2, DOI 10.1016/j.juro.2012.11.014; Jeong CW, 2008, UROL INT, V81, P179, DOI 10.1159/000144057; Jung KW, 2013, CANCER RES TREAT, V45, P15, DOI 10.4143/crt.2013.45.1.15; Karakiewicz PI, 2005, J UROLOGY, V173, P1930, DOI 10.1097/01.ju.0000158039.94467.5d; Kibel AS, 2013, J UROLOGY, V189, P796, DOI 10.1016/j.juro.2012.12.015; Kranse R, 2008, PROSTATE, V68, P1674, DOI 10.1002/pros.20840; Ku JH, 2002, UROLOGY, V60, P475, DOI 10.1016/S0090-4295(02)01807-1; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Nam RK, 2010, J UROLOGY, V183, P963, DOI 10.1016/j.juro.2009.11.043; Porter CR, 2005, UROLOGY, V65, P937, DOI 10.1016/j.urology.2004.11.049; Roobol MJ, 2013, NAT REV UROL, V10, P38, DOI 10.1038/nrurol.2012.225; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Shariat SF, 2008, CLIN CANCER RES, V14, P4400, DOI 10.1158/1078-0432.CCR-07-4713; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Steyerberg EW, 2008, MED DECIS MAKING, V28, P146, DOI 10.1177/0272989X07312725; Suzuki H, 2006, UROLOGY, V67, P131, DOI 10.1016/j.urology.2005.07.040; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Walz J, 2006, EUR UROL, V50, P498, DOI 10.1016/j.eururo.2006.03.026; Welch HG, 2005, J NATL CANCER I, V97, P1132, DOI 10.1093/jnci/dji205; Yanke BV, 2006, BJU INT, V98, P783, DOI 10.1111/j.1464-410X.2006.06388.x; Yoon DK, 2012, PROSTATE, V72, P721, DOI 10.1002/pros.21475	38	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94441	10.1371/journal.pone.0094441	http://dx.doi.org/10.1371/journal.pone.0094441			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710020	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800146
J	Cakebread, JA; Haitchi, HM; Xu, YH; Holgate, ST; Roberts, G; Davies, DE				Cakebread, Julie A.; Haitchi, Hans Michael; Xu, Yunhe; Holgate, Stephen T.; Roberts, Graham; Davies, Donna E.			Rhinovirus-16 Induced Release of IP-10 and IL-8 Is Augmented by Th2 Cytokines in a Pediatric Bronchial Epithelial Cell Model	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE; ASTHMA; EXPRESSION; INFECTION; EXACERBATIONS; RECEPTOR; INNATE; ICAM-1; SUPPRESSION; INHIBITION	Background: In response to viral infection, bronchial epithelial cells increase inflammatory cytokine release to activate the immune response and curtail viral replication. In atopic asthma, enhanced expression of Th2 cytokines is observed and we postulated that Th2 cytokines may augment the effects of rhinovirus-induced inflammation. Methods: Primary bronchial epithelial cell cultures from pediatric subjects were treated with Th2 cytokines for 24 h before infection with RV16. Release of IL-8, IP-10 and GM-CSF was measured by ELISA. Infection was quantified using RTqPCR and TCID50. Phosphatidyl inositol 3-kinase (PI3K) and P38 mitogen activated protein kinase (MAPK) inhibitors and dexamethasone were used to investigate differences in signaling pathways. Results: The presence of Th2 cytokines did not affect RV replication or viral titre, yet there was a synergistic increase in IP-10 release from virally infected cells in the presence of Th2 cytokines. Release of IL-8 and GM-CSF was also augmented. IP-10 release was blocked by a PI3K inhibitor and IL-8 by dexamethasone. Conclusion: Th2 cytokines increase release of inflammatory cytokines in the presence of rhinovirus infection. This increase is independent of effects of virus replication. Inhibition of the PI3K pathway inhibits IP-10 expression.	[Cakebread, Julie A.; Haitchi, Hans Michael; Xu, Yunhe; Holgate, Stephen T.; Roberts, Graham; Davies, Donna E.] Univ Southampton, Southampton Univ Hosp, Fac Med, Acad Unit Clin & Expt Sci, Southampton, Hants, England; [Holgate, Stephen T.; Roberts, Graham; Davies, Donna E.] Southampton Univ Hosp, NIHR Resp Biomed Res Unit, Southampton, Hants, England	University of Southampton; University of Southampton	Cakebread, JA (corresponding author), Ruakura Res Ctr, Hamilton, New Zealand.	Julie.Cakebread@agresearch.co.nz	Davies, Donna E/H-2993-2012	Davies, Donna/0000-0002-5117-2991; Roberts, Graham/0000-0003-2252-1248; Haitchi, Hans Michael/0000-0001-8603-302X; Cakebread, Julie/0000-0001-5937-6705	Asthma UK; Medical Research Council (UK) [G0501506]; Asthma, Allergy & Inflammation Research Charity; Medical Research Council [G0802804, G0501506, G0900453] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10021] Funding Source: researchfish; Asthma UK [06/053, 10/060] Funding Source: researchfish; MRC [G0900453, G0802804, G0501506] Funding Source: UKRI	Asthma UK; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma, Allergy & Inflammation Research Charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Asthma UK, (http://www.asthma.org.uk/) a Medical Research Council (UK) grant (G0501506)(http://www.mrc.ac.uk/index.htm) and the Asthma, Allergy & Inflammation Research Charity (http://www.aaircharity.org/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andrews AL, 2006, J ALLERGY CLIN IMMUN, V118, P858, DOI 10.1016/j.jaci.2006.06.041; Bianco A, 1998, EUR RESPIR J, V12, P619, DOI 10.1183/09031936.98.12030619; Bossios A, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-114; Brightling CE, 2002, J ALLERGY CLIN IMMUN, V110, P899, DOI 10.1067/mai.2002.129698; Bucchieri F, 2002, AM J RESP CELL MOL, V27, P179, DOI 10.1165/ajrcmb.27.2.4699; Bulek K, 2010, IMMUNOL CELL BIOL, V88, P257, DOI 10.1038/icb.2009.113; Chang MMJ, 2001, AM J PHYSIOL-LUNG C, V280, pL107, DOI 10.1152/ajplung.2001.280.1.L107; Edwards MR, 2006, AM J RESP CELL MOL, V34, P616, DOI 10.1165/rcmb.2005-0385OC; Gern JE, 2000, AM J RESP CRIT CARE, V162, P2226, DOI 10.1164/ajrccm.162.6.2003019; Green RM, 2002, BMJ-BRIT MED J, V324, P763, DOI 10.1136/bmj.324.7340.763; Griego SD, 2000, J IMMUNOL, V165, P5211, DOI 10.4049/jimmunol.165.9.5211; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hollams EM, 2009, J ALLERGY CLIN IMMUN, V124, P463, DOI 10.1016/j.jaci.2009.06.019; Hu LM, 2000, CLIN CANCER RES, V6, P880; HURD SZ, 1991, J ALLERGY CLIN IMMUN, V88, P808; Jackson DJ, 2010, J ALLERGY CLIN IMMUN, V125, P1178, DOI 10.1016/j.jaci.2010.04.021; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Korpi-Steiner NL, 2010, CLIN EXP ALLERGY, V40, P1203, DOI 10.1111/j.1365-2222.2010.03546.x; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Lachowicz-Scroggins ME, 2010, AM J RESP CELL MOL, V43, P652, DOI 10.1165/rcmb.2009-0244OC; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Papi A, 1999, J BIOL CHEM, V274, P9707, DOI 10.1074/jbc.274.14.9707; Papi A, 1997, CLIN EXP ALLERGY, V27, P721, DOI 10.1046/j.1365-2222.1997.00090.x; Parry DE, 2000, J ALLERGY CLIN IMMUN, V105, P692, DOI 10.1067/mai.2000.104785; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Robinson DS, 2000, BRIT MED BULL, V56, P956, DOI 10.1258/0007142001903625; Skevaki CL, 2009, CLIN EXP ALLERGY, V39, P1700, DOI 10.1111/j.1365-2222.2009.03307.x; Sly PD, 2008, LANCET, V372, P1100, DOI 10.1016/S0140-6736(08)61451-8; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Striz I, 1999, AM J PHYSIOL-LUNG C, V277, pL58, DOI 10.1152/ajplung.1999.277.1.L58; SUBAUSTE MC, 1995, J CLIN INVEST, V96, P549, DOI 10.1172/JCI118067; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wark PAB, 2007, J ALLERGY CLIN IMMUN, V120, P586, DOI 10.1016/j.jaci.2007.04.046; Wood LG, 2011, RESPIROLOGY, V16, P291, DOI 10.1111/j.1440-1843.2010.01897.x; Xatzipsalti M, 2008, CLIN EXP ALLERGY, V38, P466, DOI 10.1111/j.1365-2222.2007.02906.x	41	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94010	10.1371/journal.pone.0094010	http://dx.doi.org/10.1371/journal.pone.0094010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705919	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500110
J	Chouchani, ET; Methner, C; Buonincontri, G; Hu, CH; Logan, A; Sawiak, SJ; Murphy, MP; Krieg, T				Chouchani, Edward T.; Methner, Carmen; Buonincontri, Guido; Hu, Chou-Hui; Logan, Angela; Sawiak, Stephen J.; Murphy, Michael P.; Krieg, Thomas			Complex I Deficiency Due to Selective Loss of Ndufs4 in the Mouse Heart Results in Severe Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							MITOCHONDRIA; CARDIOPROTECTION; MICE; MYOCARDIUM; METABOLISM; REDUCTION; RADICALS; SUBUNIT; SWITCH; PORE	Mitochondrial complex I, the primary entry point for electrons into the mitochondrial respiratory chain, is both critical for aerobic respiration and a major source of reactive oxygen species. In the heart, chronic dysfunction driving cardiomyopathy is frequently associated with decreased complex I activity, from both genetic and environmental causes. To examine the functional relationship between complex I disruption and cardiac dysfunction we used an established mouse model of mild and chronic complex I inhibition through heart-specific Ndufs4 gene ablation. Heart-specific Ndufs4-null mice had a decrease of similar to 50% in complex I activity within the heart, and developed severe hypertrophic cardiomyopathy as assessed by magnetic resonance imaging. The decrease in complex I activity, and associated cardiac dysfunction, occurred absent an increase in mitochondrial hydrogen peroxide levels in vivo, accumulation of markers of oxidative damage, induction of apoptosis, or tissue fibrosis. Taken together, these results indicate that diminished complex I activity in the heart alone is sufficient to drive hypertrophic cardiomyopathy independently of alterations in levels of mitochondrial hydrogen peroxide or oxidative damage.	[Chouchani, Edward T.; Methner, Carmen; Hu, Chou-Hui; Krieg, Thomas] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Chouchani, Edward T.; Logan, Angela; Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge, England; [Buonincontri, Guido; Sawiak, Stephen J.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge CB2 1TN, England	University of Cambridge; University of Cambridge	Krieg, T (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.	tk382@medschl.cam.ac.uk	Murphy, Michael P/C-2120-2009; Chouchani, Edward T./HCH-3775-2022; Sawiak, Stephen J/I-8944-2012; Buonincontri, Guido/L-5207-2017	Murphy, Michael P/0000-0003-1115-9618; Sawiak, Stephen J/0000-0003-4210-9816; Krieg, Thomas/0000-0002-5192-580X; Buonincontri, Guido/0000-0002-8386-639X; Chouchani, Edward/0000-0002-9203-8094	International Society for Heart Research (ISHRES/SERVIER research fellowship); Gates Cambridge Trust; Canadian Institutes of Health Research; UK Medical Research Council; British Heart Foundation [PG/12/42/29655]; Medical Research Council [MC_U105663142] Funding Source: researchfish; MRC [MC_U105663142] Funding Source: UKRI	International Society for Heart Research (ISHRES/SERVIER research fellowship); Gates Cambridge Trust; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the International Society for Heart Research (ISHRES/SERVIER research fellowship to C.M, the Gates Cambridge Trust and the Canadian Institutes of Health Research (doctoral scholarship and postdoctoral fellowship to E.T.C.), the UK Medical Research Council (E.T.C.,G.B., M.P.M. and A.L.), and the British Heart Foundation (PG/12/42/29655 to T.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225; Blinova K, 2008, BIOCHEMISTRY-US, V47, P9636, DOI 10.1021/bi800307y; Bridges HR, 2011, BIOCHEM SOC T, V39, P799, DOI 10.1042/BST0390799; Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006; Buonincontri G, 2013, J MAGN RESON IMAGING, V38, P468, DOI 10.1002/jmri.24001; Burwell LS, 2009, J MOL CELL CARDIOL, V46, P804, DOI 10.1016/j.yjmcc.2009.02.026; CHANCE B, 1961, J BIOL CHEM, V236, P1534; Chappell J. B., 1972, SUBCELLULAR COMPONEN, P77; Chen L, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003012; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Cocheme HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003; Di Lisa F, 1998, BBA-BIOENERGETICS, V1366, P69, DOI 10.1016/S0005-2728(98)00121-2; Fassone E, 2011, J MED GENET, V48, P691, DOI 10.1136/jmedgenet-2011-100340; Halestrap A, 2005, NATURE, V434, P578, DOI 10.1038/434578a; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; Heiberg Einar, 2010, BMC Med Imaging, V10, P1, DOI 10.1186/1471-2342-10-1; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; Ingraham CA, 2009, MITOCHONDRION, V9, P204, DOI 10.1016/j.mito.2009.02.001; Jung C, 2008, CARDIOVASC RES, V77, P766, DOI 10.1093/cvr/cvm089; Ke BX, 2012, P NATL ACAD SCI USA, V109, P6165, DOI 10.1073/pnas.1113987109; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Marin-Garcia J, 2004, J CARD FAIL, V10, P55, DOI 10.1016/S1071-9164(03)00129-5; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Noureldin RA, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-17; Petruzzella V, 2001, HUM MOL GENET, V10, P529, DOI 10.1093/hmg/10.5.529; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Quintana A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042904; Russell LK, 2005, J MOL CELL CARDIOL, V38, P81, DOI 10.1016/j.yjmcc.2004.10.010; Sterky FH, 2012, HUM MOL GENET, V21, P1078, DOI 10.1093/hmg/ddr537	32	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94157	10.1371/journal.pone.0094157	http://dx.doi.org/10.1371/journal.pone.0094157			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705922	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500129
J	Cote, IM; Darling, ES; Malpica-Cruz, L; Smith, NS; Green, SJ; Curtis-Quick, J; Layman, C				Cote, Isabelle M.; Darling, Emily S.; Malpica-Cruz, Luis; Smith, Nicola S.; Green, Stephanie J.; Curtis-Quick, Jocelyn; Layman, Craig			What Doesn't Kill You Makes You Wary? Effect of Repeated Culling on the Behaviour of an Invasive Predator	PLOS ONE			English	Article							FLIGHT INITIATION DISTANCE; INDO-PACIFIC LIONFISH; CORAL-REEFS; FISH; COMMUNITIES; COMPLEXITY; TRAITS; SIZE	As a result of being hunted, animals often alter their behaviour in ways that make future encounters with predators less likely. When hunting is carried out for conservation, for example to control invasive species, these behavioural changes can inadvertently impede the success of future efforts. We examined the effects of repeated culling by spearing on the behaviour of invasive predatory lionfish (Pterois volitans/miles) on Bahamian coral reef patches. We compared the extent of concealment and activity levels of lionfish at dawn and midday on 16 coral reef patches off Eleuthera, The Bahamas. Eight of the patches had been subjected to regular daytime removals of lionfish by spearing for two years. We also estimated the distance at which lionfish became alert to slowly approaching divers on culled and unculled reef patches. Lionfish on culled reefs were less active and hid deeper within the reef during the day than lionfish on patches where no culling had occurred. There were no differences at dawn when removals do not take place. Lionfish on culled reefs also adopted an alert posture at a greater distance from divers than lionfish on unculled reefs. More crepuscular activity likely leads to greater encounter rates by lionfish with more native fish species because the abundance of reef fish outside of shelters typically peaks at dawn and dusk. Hiding deeper within the reef could also make remaining lionfish less likely to be encountered and more difficult to catch by spearfishers during culling efforts. Shifts in the behaviour of hunted invasive animals might be common and they have implications both for the impact of invasive species and for the design and success of invasive control programs.	[Cote, Isabelle M.; Darling, Emily S.; Malpica-Cruz, Luis; Smith, Nicola S.; Green, Stephanie J.] Simon Fraser Univ, Dept Biol Sci, Earth Oceans Res Grp, Burnaby, BC V5A 1S6, Canada; [Smith, Nicola S.] Marine Resources & Local Govt, Dept Marine Resources, Minist Agr, Nassau, Bahamas; [Curtis-Quick, Jocelyn] Cape Eleuthera Inst, Rock Sound, Eleuthera, Bahamas; [Layman, Craig] N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA	Simon Fraser University; University of North Carolina; North Carolina State University	Cote, IM (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Oceans Res Grp, Burnaby, BC V5A 1S6, Canada.	imcote@sfu.ca	Cote, Isabelle/ABD-5898-2021; Malpica-Cruz, Luis/E-3298-2016; Green, Stephanie/AGE-1160-2022	Malpica-Cruz, Luis/0000-0003-0750-1652; Darling, Emily/0000-0002-1048-2838; Green, Stephanie/0000-0003-4705-7859; Smith, Nicola/0000-0002-1569-7790	Global Environment Facility/United Nations Environment Programme grant; Natural Sciences and Engineering Research Council of Canada Discovery grant; CONACyT scholarship from Mexico; NSERC Canada Graduate Fellowship; NOAA Coral Reef Conservation Grant; Carrow Foundation; Stone Family Foundation	Global Environment Facility/United Nations Environment Programme grant; Natural Sciences and Engineering Research Council of Canada Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); CONACyT scholarship from Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NSERC Canada Graduate Fellowship; NOAA Coral Reef Conservation Grant; Carrow Foundation; Stone Family Foundation	This research was supported by a Global Environment Facility/United Nations Environment Programme grant to the government of The Bahamas through the MTIASIC project (NSS), and a Natural Sciences and Engineering Research Council of Canada Discovery grant to IMC. LMC was supported by CONACyT scholarship from Mexico, SJG by an NSERC Canada Graduate Fellowship and NOAA Coral Reef Conservation Grant. Support to JCQ was provided by the Carrow Foundation and Stone Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins L, 2012, INVASIVE LIONFISH GU, P24; Alos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048030; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Biro PA, 2008, P NATL ACAD SCI USA, V105, P2919, DOI 10.1073/pnas.0708159105; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; Brown GE, 2003, FISH FISH, V4, P227, DOI 10.1046/j.1467-2979.2003.00132.x; Brown Grant E., 2005, P34; Bshary R, 2002, ANIM COGN, V5, P1, DOI 10.1007/s10071-001-0116-5; Campbell K, 2005, CONSERV BIOL, V19, P1362, DOI 10.1111/j.1523-1739.2005.00228.x; Caro TM, 1999, BIOL CONSERV, V91, P91, DOI 10.1016/S0006-3207(99)00033-6; Casas F, 2009, ANIM CONSERV, V12, P346, DOI 10.1111/j.1469-1795.2009.00259.x; Ciuti S, 2012, P ROY SOC B-BIOL SCI, V279, P4407, DOI 10.1098/rspb.2012.1483; Cote IM, 2013, HDB METAANALYSIS ECO, P37; Cote IM, 2010, MAR ECOL PROG SER, V404, P219, DOI 10.3354/meps08458; Cruz F, 2005, BIOL CONSERV, V121, P473, DOI 10.1016/j.biocon.2004.05.018; Cure K, 2012, MAR ECOL PROG SER, V467, P181, DOI 10.3354/meps09942; Dill LM, 2003, ECOLOGY, V84, P1151, DOI 10.1890/0012-9658(2003)084[1151:BMIIIM]2.0.CO;2; Feary DA, 2011, CONSERV BIOL, V25, P341, DOI 10.1111/j.1523-1739.2010.01613.x; GALZIN R, 1987, MAR ECOL PROG SER, V41, P137, DOI 10.3354/meps041137; Gotanda KM, 2009, BEHAV ECOL SOCIOBIOL, V63, P1563, DOI 10.1007/s00265-009-0750-5; Green SJ, 2013, CORAL REEFS, V32, P413, DOI 10.1007/s00338-012-0987-8; Green SJ, 2014, ECOLOGICAL IN PRESS; GREEN SJ, 2011, MAR ECOL PROG SER, V433, P159, DOI DOI 10.3354/meps09208; Green SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032596; Guidetti P, 2008, J MAR BIOL ASSOC UK, V88, P625, DOI 10.1017/S0025315408000933; Helfman G.S., 1993, BEHAV TELEOST FISHES, V2, P479; HOBSON ES, 1972, FISH BULL NATL OC AT, V70, P715; Holway DA, 1999, TRENDS ECOL EVOL, V14, P328, DOI 10.1016/S0169-5347(99)01636-5; Januchowski-Hartley FA, 2012, MAR ECOL PROG SER, V469, P113, DOI 10.3354/meps09971; Januchowski-Hartley FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022761; Jud ZR, 2012, J EXP MAR BIOL ECOL, V414, P69, DOI 10.1016/j.jembe.2012.01.015; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Sutherland WJ, 2010, TRENDS ECOL EVOL, V25, P1, DOI 10.1016/j.tree.2009.10.003; Taylor AR, 2003, WILDLIFE SOC B, V31, P1263; Uusi-Heikkila S, 2008, TRENDS ECOL EVOL, V23, P419, DOI 10.1016/j.tree.2008.04.006; Warburton K, 2003, FISH FISH, V4, P203, DOI 10.1046/j.1467-2979.2003.00125.x	36	55	58	1	160	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94248	10.1371/journal.pone.0094248	http://dx.doi.org/10.1371/journal.pone.0094248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705447	Green Submitted, Green Published, gold			2022-12-27	WOS:000334107500137
J	Felisberti, FM; Sear, R				Felisberti, Fatima M.; Sear, Rebecca			Postdoctoral Researchers in the UK: A Snapshot at Factors Affecting Their Research Output	PLOS ONE			English	Article							FAMILY-SIZE; GENDER	Postdoctoral training is a typical step in the course of an academic career, but very little is known about postdoctoral researchers (PDRs) working in the UK. This study used an online survey to explore, for the first time, relevant environmental factors which may be linked to the research output of PDRs in terms of the number of peer-reviewed articles per year of PDR employment. The findings showed reliable links between the research output and research institutions, time spent as PDR, and parental education, whereas no clear links were observed between PDRs' output and research area, nationality, gender, number of siblings, or work environment. PDRs based in universities tended to publish, on average, more than the ones based in research centres. PDRs with children tended to stay longer in postdoctoral employment than PDRs without children. Moreover, research output tended to be higher in PDRs with fathers educated at secondary or higher level. The work environment did not affect output directly, but about 1/5 of PDRs were not satisfied with their job or institutional support and about 2/3 of them perceived their job prospects as "difficult''. The results from this exploratory study raise important questions, which need to be addressed in large-scale studies in order to understand (and monitor) how PDRs' family and work environment interact with their research output-an essential step given the crucial role of PDRs in research and development in the country.	[Felisberti, Fatima M.] Univ Kingston, Dept Psychol, London, England; [Sear, Rebecca] Univ London London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1E 7HT, England	Kingston University; University of London; London School of Hygiene & Tropical Medicine	Felisberti, FM (corresponding author), Univ Kingston, Dept Psychol, London, England.	f.felisberti@kingston.ac.uk	Sear, Rebecca/K-9616-2019; Felisberti, Fatima M/F-3166-2010	Sear, Rebecca/0000-0002-4315-0223; Felisberti, Fatima M/0000-0002-8703-4400				Akerlind GS, 2005, HIGH EDU RES DEV, V24, P21, DOI [10.1080/0729436052000318550, DOI 10.1080/0729436052000318550]; [Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Baron-Cohen S., 2003, ESSENTIAL DIFFERENCE; Bell N, 2002, P NSF CPST PROF SOC; BELMONT L, 1973, SCIENCE, V182, P1096, DOI 10.1126/science.182.4117.1096; Bridgstock R, 2005, ASSISTING WOMEN ASSI; Browne Kingsley R., 2005, CARDOZO WOMENS LAW J, V11, P509; Christenson S., 1992, SCHOOL PSYCHOL QUART, V7, P178, DOI DOI 10.1037/H0088259; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cropley M., 2003, EUR J WORK ORGAN PSY, V12, P195, DOI [10.1080/13594320344000093, DOI 10.1080/13594320344000093]; Davis G., 2009, SCI ENG CAREERS US A; Dillon N, 2001, EMBO REP, V2, P746, DOI 10.1093/embo-reports/kve190; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Flaherty C, 2013, MOM PENALTY; Garson G.D., 2012, TESTING STAT ASSUMPT; GATI I, 1995, J COUNS PSYCHOL, V42, P204, DOI 10.1037/0022-0167.42.2.204; Ghayur M, 2008, J POSTGRADUATES MED, P156; Henderson A., 1994, NEW GENERATION EVIDE; Hill ST, 2004, INSTITUTIONALISIERTE, P1; Horta H, 2009, HIGH EDUC, V58, P689, DOI 10.1007/s10734-009-9221-1; JACOBS JA, 1995, SOCIOL EDUC, V68, P81, DOI 10.2307/2112776; Kim Hae-Young, 2013, Restor Dent Endod, V38, P52, DOI 10.5395/rde.2013.38.1.52; Kroto H, 2007, GUARDIAN, P1; Lariviere V, 2006, J AM SOC INF SCI TEC, V57, P997, DOI 10.1002/asi.20349; McWhinnie S, 2011, MAPPING FUTURE SURVE; Medawar PB, 1979, ADVICE YOUNG SCI; Nerad M, 1999, SCIENCE, V285, P1533, DOI 10.1126/science.285.5433.1533; NISBET JD, 1967, BRIT J EDUC PSYCHOL, V37, P188, DOI 10.1111/j.2044-8279.1967.tb01927.x; Peters J, 2002, SET FAIR REPORT WOME; RESKIN BF, 1976, AM SOCIOL REV, V41, P597, DOI 10.2307/2094838; Sanders KA, 2012, J COGN PSYCHOTHER, V26, P226, DOI 10.1891/0889-8391.26.3.226; Sanford R, 2010, NATURE, V467, P624; Scaffidi AK, 2011, HIGH EDUC, V62, P685, DOI 10.1007/s10734-011-9407-1; Stephan P, 2013, BIOSCIENCE, V63, P245, DOI 10.1525/bio.2013.63.4.2; Su XH, 2013, J HIGH EDUC, V84, P239, DOI 10.1353/jhe.2013.0014; Wakeford J, 2004, GUARDIAN; Wei TE, 2012, SCI PUBL POLICY, V39, P60, DOI 10.1093/scipol/scr006	37	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93890	10.1371/journal.pone.0093890	http://dx.doi.org/10.1371/journal.pone.0093890			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6MJ	24705885	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500086
J	Huysentruyt, K; Alliet, P; Raes, M; Willekens, J; De Schutter, I; De Wachter, E; Malfroot, A; Devreker, T; Goyens, P; Vandenplas, Y; De Schepper, J				Huysentruyt, Koen; Alliet, Philippe; Raes, Marc; Willekens, Julie; De Schutter, Iris; De Wachter, Elke; Malfroot, Anne; Devreker, Thierry; Goyens, Philippe; Vandenplas, Yvan; De Schepper, Jean			Nutritional Status of Children Hospitalized for Parapneumonic Effusion	PLOS ONE			English	Article							RISK-FACTORS; EMPYEMA; PNEUMONIA; MALNUTRITION; ADMISSIONS; MANAGEMENT; BACTERIAL; OUTCOMES	Background & Aims: Among children hospitalized for pneumonia, those with parapneumonic effusion (PPE) are at particular risk for nutritional deterioration. This study aimed to 1) investigate the evolution of the nutritional status during hospitalization and at outpatient follow-up; 2) determine clinical risk factors for weight loss during hospitalization; 3) describe the nutritional interventions for these children. Methods: Retrospective chart review (January `07 - September `12) of 56 children with pneumonia, complicated by PPE in two Belgian hospitals for data on body weight and height at admission (t(0)) and discharge (t(1)), and two weeks (t(2)) and one month (t(3)) after discharge. Length of hospitalization (LoS), length of stay in paediatric intensive care (LoS(PICU)) and maximal in-hospital weight loss (t(max)) were calculated and nutritional interventions were recorded. Results: The median (range) age was 3.5 (1.0-14.8) years. Weight or height was lacking in five (8.9%) children at t(0) and in 28 (50%) at t(1); 21.4% was weighed only once during hospitalization. At t(max), respectively 17/44 and 5/44 children lost >= 5% and >= 10% of their weight. Median (range) LoS and LoS(PICU) were 18.0 (10-41) and 4.0 (0-23) days. One-fourth received a nutritional intervention. Weight for height at admission (WFH(t(0))) significantly predicted maximal weight loss (beta (95% CI) = -0.34 (-2.0--0.1); p = 0.03). At t(2) and t(3), 13/32 and 5/22 of the children with available follow-up data did not reach WFH(t(0)), whilst in 4/35 and 5/26 body weight remained >= 5% under the weight(t(0)). Conclusions: One-third of children with pneumonia complicated by PPE and monitored for weight and height, lost >= 5% of their body weight during hospitalization. One-fourth did not reach initial WFH one month after discharge. Those with a higher WFH at admission were at higher risk of weight loss. More attention for monitoring of weight loss and the nutritional policy during and after hospitalization is warranted.	[Huysentruyt, Koen] VUB, Univ Ziekenhuis Brussel, Dept Paediat, Brussels, Belgium; [Alliet, Philippe; Raes, Marc] Jessa Hosp, Dept Paediat, Hasselt, Belgium; [Willekens, Julie; De Schutter, Iris; De Wachter, Elke; Malfroot, Anne] VUB, Univ Ziekenhuis Brussel, Cyst Fibrosis Clin & Paediat Infect Dis, Dept Paediat Pulmonol, Brussels, Belgium; [Devreker, Thierry; Vandenplas, Yvan] VUB, Univ Ziekenhuis Brussel, Dept Paediat Gastroenterol, Brussels, Belgium; [Goyens, Philippe] Univ Childrens Hosp Queen Fabiola, Dept Paediat, Nutr & Metab Unit, Brussels, Belgium; [De Schepper, Jean] VUB, Univ Ziekenhuis Brussel, Dept Paediat Endocrinol, Brussels, Belgium	University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel	De Schepper, J (corresponding author), VUB, Univ Ziekenhuis Brussel, Dept Paediat Endocrinol, Brussels, Belgium.	Jean.Deschepper@uzbrussel.be						Byington CL, 2002, CLIN INFECT DIS, V34, P434, DOI 10.1086/338460; Caksen H, 2003, J EMERG MED, V24, P474, DOI 10.1016/S0736-4679(03)00051-9; Chalmers JD, 2009, THORAX, V64, P592, DOI 10.1136/thx.2008.105080; Cirino Luís Marcelo Inaco, 2004, Sao Paulo Med. J., V122, P269, DOI 10.1590/S1516-31802004000600008; Clark JE, 2007, ARCH DIS CHILD, V92, P394, DOI 10.1136/adc.2006.097402; Cohen E, 2012, ARCH PEDIAT ADOL MED, V166, P999, DOI 10.1001/archpediatrics.2012.1055; Flood RG, 2008, PEDIATR INFECT DIS J, V27, P95, DOI 10.1097/INF.0b013e318157aced; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Grijalva CG, 2010, CLIN INFECT DIS, V50, P805, DOI 10.1086/650573; HARTMAN C, 2012, CLIN NUTR S, V7, P191; Huysentruyt K, 2013, ACTA PAEDIATR, V102, pE460, DOI 10.1111/apa.12344; Islam S, 2012, J PEDIATR SURG, V47, P2101, DOI 10.1016/j.jpedsurg.2012.07.047; Joosten KFM, 2008, CURR OPIN PEDIATR, V20, P590, DOI 10.1097/MOP.0b013e32830c6ede; Koshy E, 2010, THORAX, V65, P770, DOI 10.1136/thx.2010.137802; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; NWILOH J, 1989, J NATL MED ASSOC, V81, P525; O'Connor J, 2004, J PAEDIATR CHILD H, V40, P295, DOI 10.1111/j.1440-1754.2004.00367.x; Paraskakis E, 2012, CURR MED RES OPIN, V28, P1179, DOI 10.1185/03007995.2012.684674; Proesmans M, 2009, EUR J PEDIATR, V168, P639, DOI 10.1007/s00431-009-0929-9; Rocha Geila A., 2006, J. Pediatr. (Rio J.), V82, P70, DOI 10.2223/JPED.1440; Roelants M, 2009, ANN HUM BIOL, V36, P680, DOI 10.3109/03014460903049074; Sermet-Gaudelus I, 2000, AM J CLIN NUTR, V72, P64; Shouman B, 2012, EUR J PEDIATR, V171, P811, DOI 10.1007/s00431-011-1619-y; TAN TQ, 2002, PEDIATRICS, V110, pNIL81; van Wayenburg CAM, 2010, J PRIM HEALTH CARE, V2, P16, DOI 10.1071/HC10016; World Health Organization, 1999, MAN SEV MALN MAN PHY	26	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94242	10.1371/journal.pone.0094242	http://dx.doi.org/10.1371/journal.pone.0094242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705414	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500136
J	Kamali, M; Marek, PE; Peery, A; Antonio-Nkondjio, C; Ndo, C; Tu, ZJ; Simard, F; Sharakhov, IV				Kamali, Maryam; Marek, Paul E.; Peery, Ashley; Antonio-Nkondjio, Christophe; Ndo, Cyrille; Tu, Zhijian; Simard, Frederic; Sharakhov, Igor V.			Multigene Phylogenetics Reveals Temporal Diversification of Major African Malaria Vectors	PLOS ONE			English	Article							ANOPHELES-NILI GROUP; MOLECULAR-IDENTIFICATION; POPULATION-GENETICS; CYTOGENETIC MAP; GENOME SEQUENCE; GAMBIAE; CULICIDAE; DIPTERA; DIFFERENTIATION; DIVERGENCE	The major vectors of malaria in sub-Saharan Africa belong to subgenus Cellia. Yet, phylogenetic relationships and temporal diversification among African mosquito species have not been unambiguously determined. Knowledge about vector evolutionary history is crucial for correct interpretation of genetic changes identified through comparative genomics analyses. In this study, we estimated a molecular phylogeny using 49 gene sequences for the African malaria vectors An. gambiae, An. funestus, An. nili, the Asian malaria mosquito An. stephensi, and the outgroup species Culex quinquefasciatus and Aedes aegypti. To infer the phylogeny, we identified orthologous sequences uniformly distributed approximately every 5 Mb in the five chromosomal arms. The sequences were aligned and the phylogenetic trees were inferred using maximum likelihood and neighbor-joining methods. Bayesian molecular dating using a relaxed log normal model was used to infer divergence times. Trees from individual genes agreed with each other, placing An. nili as a basal clade that diversified from the studied malaria mosquito species 47.6 million years ago (mya). Other African malaria vectors originated more recently, and independently acquired traits related to vectorial capacity. The lineage leading to An. gambiae diverged 30.4 mya, while the African vector An. funestus and the Asian vector An. stephensi were the most closely related sister taxa that split 20.8 mya. These results were supported by consistently high bootstrap values in concatenated phylogenetic trees generated individually for each chromosomal arm. Genome-wide multigene phylogenetic analysis is a useful approach for discerning historic relationships among malaria vectors, providing a framework for the correct interpretation of genomic changes across species, and comprehending the evolutionary origins of this ubiquitous and deadly insect-borne disease.	[Kamali, Maryam; Marek, Paul E.; Peery, Ashley; Sharakhov, Igor V.] Virginia Polytech Inst & State Univ, Dept Entomol, Blacksburg, VA 24061 USA; [Antonio-Nkondjio, Christophe; Ndo, Cyrille] OCEAC, Malaria Res Lab, Yaounde, Cameroon; [Ndo, Cyrille; Simard, Frederic] IRD, MIVEGEC, UMR IRD224, CNRS5290,UM1,UM2, Montpellier, France; [Ndo, Cyrille] Univ Douala, Fac Med & Pharmaceut Sci, Douala, Cameroon; [Tu, Zhijian] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Virginia Polytechnic Institute & State University	Sharakhov, IV (corresponding author), Virginia Polytech Inst & State Univ, Dept Entomol, Blacksburg, VA 24061 USA.	igor@vt.edu	Sharakhov, Igor/B-1972-2008; SIMARD, Frederic/J-9489-2016; Kamali, Maryam/AAH-4252-2020; Frederic, SIMARD/AFV-5001-2022	Sharakhov, Igor/0000-0003-0752-3747; SIMARD, Frederic/0000-0002-2871-5329; Frederic, SIMARD/0000-0002-2871-5329; Antonio Nkondjio, Christophe/0000-0003-0073-1578	National Institutes of Health [5R21AI079350, 5R21AI094289]; Wellcome Trust [WTO86423MA]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094289, R21AI079350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (http://www.nih.gov/) grants 5R21AI079350 and 5R21AI094289 (to I. V. S). C. A.-N. was supported by a Wellcome Trust (http://www.wellcome.ac.uk/) Intermediate Fellowship in Public Health and Tropical medicine (WTO86423MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, BIODIVERSITE PALUDIS; Antonio-Nkondjio C, 2006, J MED ENTOMOL, V43, P1215, DOI 10.1603/0022-2585(2006)43[1215:COTMVS]2.0.CO;2; Antonio-Nkondjio C, 2009, ACTA TROP, V112, P270, DOI 10.1016/j.actatropica.2009.08.009; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Awono-Ambene HP, 2006, AM J TROP MED HYG, V75, P656, DOI 10.4269/ajtmh.2006.75.656; Awono-Ambene HP, 2004, J MED ENTOMOL, V41, P561, DOI 10.1603/0022-2585-41.4.561; AWONOAMBENE HP, 2009, AFRICA SCI MED AFR, V1, P13; Ayala D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-307; Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; Besansky NJ, 2003, P NATL ACAD SCI USA, V100, P10818, DOI 10.1073/pnas.1434337100; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Cockerell TDA, 1919, NATURE, V103, P44, DOI 10.1038/103044b0; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Fitch WM, 2000, TRENDS GENET, V16, P227, DOI 10.1016/S0168-9525(00)02005-9; Fontenille D, 2004, COMP IMMUNOL MICROB, V27, P357, DOI 10.1016/j.cimid.2004.03.005; Gao F, 2013, MOL PHYLOGENET EVOL, V68, P55, DOI 10.1016/j.ympev.2013.03.018; Garros C, 2005, J MED ENTOMOL, V42, P522, DOI 10.1603/0022-2585(2005)042[0522:MAAMPO]2.0.CO;2; George P, 2010, INSECT MOL BIOL, V19, P675, DOI 10.1111/j.1365-2583.2010.01025.x; Gingerich P.D., 2003, CAUSES CONSEQUENCES, V369, P463; Harbach RE, 2004, B ENTOMOL RES, V94, P537, DOI 10.1079/BER2004321; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hittinger CT, 2010, P NATL ACAD SCI USA, V107, P1476, DOI 10.1073/pnas.0910449107; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kamali M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002960; Kamali M, 2011, J HERED, V102, P719, DOI 10.1093/jhered/esr072; Kengne P, 2003, MED VET ENTOMOL, V17, P67, DOI 10.1046/j.1365-2915.2003.00411.x; Koepfli KP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-10; Krzywinski J, 2003, ANNU REV ENTOMOL, V48, P111, DOI 10.1146/annurev.ento.48.091801.112647; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Marshall JC, 2005, AM J TROP MED HYG, V73, P749, DOI 10.4269/ajtmh.2005.73.749; Megy K, 2012, NUCLEIC ACIDS RES, V40, pD729, DOI 10.1093/nar/gkr1089; Michel AP, 2005, INSECT MOL BIOL, V14, P375, DOI 10.1111/j.1365-2583.2005.00568.x; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Ndo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058862; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Neafsey DE, 2013, G3-GENES GENOM GENET, V3, P1191, DOI 10.1534/g3.113.006247; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Peery A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-202; Poinar G. O. Jr., 2000, Acta Geologica Hispanica, V35, P119; RAMBAUT A, 2012, FIGTREEAPPLICATION J; Reidenbach KR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-298; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sallum MAM, 2002, SYST ENTOMOL, V27, P361, DOI 10.1046/j.1365-3113.2002.00182.x; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Shalchian-Tabrizi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002098; Sharakhova MV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r5; Sharakhova MV, 2013, INFECT GENET EVOL, V16, P341, DOI 10.1016/j.meegid.2013.03.010; Sharakhova MV, 2011, INFECT GENET EVOL, V11, P746, DOI 10.1016/j.meegid.2010.06.015; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Zavortink TJ, 2000, ANN ENTOMOL SOC AM, V93, P1230, DOI 10.1603/0013-8746(2000)093[1230:ANDSND]2.0.CO;2	60	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93580	10.1371/journal.pone.0093580	http://dx.doi.org/10.1371/journal.pone.0093580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705448	Green Published, gold			2022-12-27	WOS:000334107500043
J	Sotelo, P; Farfan, P; Benitez, ML; Bu, GJ; Marzolo, MP				Sotelo, Pablo; Farfan, Pamela; Luisa Benitez, Maria; Bu, Guojun; Marzolo, Maria-Paz			Sorting Nexin 17 Regulates ApoER2 Recycling and Reelin Signaling	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AMYLOID PRECURSOR PROTEIN; TYROSINE PHOSPHORYLATION; SYNAPTIC PLASTICITY; GAMMA-SECRETASE; P-SELECTIN; COFILIN PHOSPHORYLATION; HIPPOCAMPAL-NEURONS; PLASMA-MEMBRANE; BETA PRODUCTION	ApoER2 is a member of the low density-lipoprotein receptor (LDL-R) family. As a receptor for reelin, ApoER2 participates in neuronal migration during development as well as synaptic plasticity and survival in the adult brain. A previous yeast two-hybrid screen showed that ApoER2 is a binding partner of sorting nexin 17 (SNX17) -a cytosolic adaptor protein that regulates the trafficking of several membrane proteins in the endosomal pathway, including LRP1, P-selectin and integrins. However, no further studies have been performed to investigate the role of SNX17 in ApoER2 trafficking and function. In this study, we present evidence based on GST pull-down and inmunoprecipitation assays that the cytoplasmic NPxY endocytosis motif of ApoER2 interacts with the FERM domain of SNX17. SNX17 stimulates ApoER2 recycling in different cell lines including neurons without affecting its endocytic rate and also facilitates the transport of ApoER2 from the early endosomes to the recycling endosomes. The reduction of SNX17 was associated with accumulation of an ApoER2 carboxyterminal fragment (CTF). In addition, in SNX17 knockdown cells, constitutive ApoER2 degradation was not modified, whereas reelin-induced ApoER2 degradation was increased, implying that SNX17 is a regulator of the receptor's half-life. Finally, in SNX17 silenced hippocampal and cortical neurons, we underscored a positive role of this endosomal protein in the development of the dendritic tree and reelin signaling. Overall, these results establish the role of SNX17 in ApoER2 trafficking and function and aid in identifying new links between endocytic trafficking and receptor signaling.	[Sotelo, Pablo; Farfan, Pamela; Luisa Benitez, Maria; Marzolo, Maria-Paz] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Cellular & Mol Biol, Millenium Nucleus Renerat Biol MINREB, Santiago, Chile; [Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Pontificia Universidad Catolica de Chile; Mayo Clinic	Marzolo, MP (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Cellular & Mol Biol, Millenium Nucleus Renerat Biol MINREB, Santiago, Chile.	mmarzolo@bio.puc.cl	Torres, Pablo Hernán Sotelo/X-7012-2019	Torres, Pablo Hernán Sotelo/0000-0002-6473-2134	Fondo Nacional de Ciencia y Tecnologia, FONDECYT [1110382]; Millenium Nucleus in Regenerative Biology (MINREB) [P-07-011-F]; NATIONAL INSTITUTE ON AGING [R01AG027924, P01AG030128] Funding Source: NIH RePORTER	Fondo Nacional de Ciencia y Tecnologia, FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millenium Nucleus in Regenerative Biology (MINREB); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Fondo Nacional de Ciencia y Tecnologia, FONDECYT, grant # 1110382 and the Millenium Nucleus in Regenerative Biology (MINREB), P-07-011-F (Iniciativa Cientifica Milenio, Ministerio de Economia, Fomento y Turismo) to MPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2010, BBA-MOL CELL RES, V1803, P553, DOI 10.1016/j.bbamcr.2010.02.011; Aniento Fernando, 2004, Curr Protoc Protein Sci, VChapter 4, DOI 10.1002/0471140864.ps0403s32; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Beffert U, 2006, J NEUROSCI, V26, P2041, DOI 10.1523/JNEUROSCI.4566-05.2006; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Benhayon D, 2003, MOL BRAIN RES, V112, P33, DOI 10.1016/S0169-328X(03)00032-9; Betts GN, 2008, J BIOL CHEM, V283, P15656, DOI 10.1074/jbc.M709514200; Bock HH, 2003, J BIOL CHEM, V278, P38772, DOI 10.1074/jbc.M306416200; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Burden JJ, 2004, J BIOL CHEM, V279, P16237, DOI 10.1074/jbc.M313689200; Carlton JG, 2005, CURR BIOL, V15, pR819, DOI 10.1016/j.cub.2005.10.012; Chai Xuejun, 2009, Commun Integr Biol, V2, P375; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; Chen Y, 2005, J NEUROSCI, V25, P8209, DOI 10.1523/JNEUROSCI.1951-05.2005; Chyung JH, 2003, J BIOL CHEM, V278, P51035, DOI 10.1074/jbc.M304989200; Cuitino L, 2005, TRAFFIC, V6, P820, DOI 10.1111/j.1600-0854.2005.00320.x; Czubayko M, 2006, BIOCHEM BIOPH RES CO, V345, P1264, DOI 10.1016/j.bbrc.2006.04.129; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; Donoso M, 2009, MOL BIOL CELL, V20, P481, DOI 10.1091/mbc.E08-08-0805; Duit S, 2010, J BIOL CHEM, V285, P4896, DOI 10.1074/jbc.M109.025973; Dumanchin C, 1999, HUM MOL GENET, V8, P1263, DOI 10.1093/hmg/8.7.1263; Farfan P, 2013, TRAFFIC, V14, P823, DOI 10.1111/tra.12076; Florian V, 2001, BIOCHEM BIOPH RES CO, V281, P1045, DOI 10.1006/bbrc.2001.4467; Frotscher M, 2003, CEREB CORTEX, V13, P634, DOI 10.1093/cercor/13.6.634; Frykman S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008948; Fuentealba RA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-14; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; Ghai R, 2013, P NATL ACAD SCI USA, V110, pE643, DOI 10.1073/pnas.1216229110; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Herrick TM, 2004, MOL BRAIN RES, V126, P121, DOI 10.1016/j.molbrainres.2004.03.022; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hoe HS, 2006, J BIOL CHEM, V281, P3425, DOI 10.1074/jbc.M509380200; Hoe HS, 2005, MOL BRAIN RES, V137, P31, DOI 10.1016/j.molbrainres.2005.02.013; Hoe HS, 2008, J BIOL CHEM, V283, P6288, DOI 10.1074/jbc.M704140200; Hoe HS, 2007, J NEUROSCI, V27, P10895, DOI 10.1523/JNEUROSCI.3135-07.2007; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Kim DH, 1996, J BIOL CHEM, V271, P8373, DOI 10.1074/jbc.271.14.8373; Knauth P, 2005, J MOL BIOL, V347, P813, DOI 10.1016/j.jmb.2005.02.004; Kruger MT, 2010, EUR J NEUROSCI, V32, P1611, DOI 10.1111/j.1460-9568.2010.07433.x; Lah JJ, 2000, MOL CELL NEUROSCI, V16, P111, DOI 10.1006/mcne.2000.0861; Larios Jorge A, 2012, [Frontiers in Biology, 生物学前沿], V7, P113; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Lorenzetto E, 2008, EUR J NEUROSCI, V27, P12, DOI 10.1111/j.1460-9568.2007.05978.x; Mangasarian A, 1997, IMMUNITY, V6, P67, DOI 10.1016/S1074-7613(00)80243-5; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; May P, 2003, J BIOL CHEM, V278, P37386, DOI 10.1074/jbc.M305858200; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008; Novak S, 1996, J BIOL CHEM, V271, P11732, DOI 10.1074/jbc.271.20.11732; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Sacre SM, 2003, FEBS LETT, V540, P181, DOI 10.1016/S0014-5793(03)00261-8; Senturk A, 2011, NATURE, V472, P356, DOI 10.1038/nature09874; Sinagra M, 2005, J NEUROSCI, V25, P6127, DOI 10.1523/JNEUROSCI.1757-05.2005; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stockinger W, 2002, EMBO J, V21, P4259, DOI 10.1093/emboj/cdf435; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Trischler M, 1999, J CELL SCI, V112, P4773; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; van Kerkhof P, 2005, EMBO J, V24, P2851, DOI 10.1038/sj.emboj.7600756; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Williams R, 2004, MOL BIOL CELL, V15, P3095, DOI 10.1091/mbc.E04-02-0143; Wu P, 2008, BRAIN RES, V1208, P1, DOI 10.1016/j.brainres.2008.02.092; Yuseff MI, 2007, TRAFFIC, V8, P1215, DOI 10.1111/j.1600-0854.2007.00601.x; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	80	27	27	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93672	10.1371/journal.pone.0093672	http://dx.doi.org/10.1371/journal.pone.0093672			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705369	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500054
J	Xiang, QJ; Judelson, HS				Xiang, Qijun; Judelson, Howard S.			Myb Transcription Factors and Light Regulate Sporulation in the Oomycete Phytophthora infestans	PLOS ONE			English	Article							ASEXUAL SPORULATION; GENE-EXPRESSION; SPORANGIA; SEQUENCES; PCR; REVEALS; FUNGI; STAGE; CYCLE	Life cycle progression in eukaryotic microbes is often influenced by environment. In the oomycete Phytophthora infestans, which causes late blight on potato and tomato, sporangia have been reported to form mostly at night. By growing P. infestans under different light regimes at constant temperature and humidity, we show that light contributes to the natural pattern of sporulation by delaying sporulation until the following dark period. However, illumination does not permanently block sporulation or strongly affect the total number of sporangia that ultimately form. Based on measurements of sporulation-induced genes such as those encoding protein kinase Pks1 and Myb transcription factors Myb2R1 and Myb2R3, it appears that most spore-associated transcripts start to rise four to eight hours before sporangia appear. Their mRNA levels oscillate with the light/dark cycle and increase with the amount of sporangia. An exception to this pattern of expression is Myb2R4, which is induced several hours before the other genes and declines after cultures start to sporulate. Transformants over-expressing Myb2R4 produce twice the number of sporangia and ten-fold higher levels of Myb2R1 mRNA than wildtype, and chromatin immunoprecipitation showed that Myb2R4 binds the Myb2R1 promoter in vivo. Myb2R4 thus appears to be an early regulator of sporulation. We attempted to silence eight Myb genes by DNA-directed RNAi, but succeeded only with Myb2R3, which resulted in suppressed sporulation. Ectopic expression studies of seven Myb genes revealed that over-expression frequently impaired vegetative growth, and in the case of Myb3R6 interfered with sporangia dormancy. We observed that the degree of silencing induced by a hairpin construct was correlated with its copy number, and ectopic expression was often unstable due to epigenetic silencing and transgene excision.	[Xiang, Qijun; Judelson, Howard S.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Judelson, HS (corresponding author), Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.	howard.judelson@ucr.edu			National Institute of Agriculture of the United States Department of Agriculture; National Science Foundation; Div Of Molecular and Cellular Bioscience [1120225] Funding Source: National Science Foundation	National Institute of Agriculture of the United States Department of Agriculture; National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by awards to H.S.J. from the National Institute of Agriculture of the United States Department of Agriculture and the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Fong AMV, 2008, FUNGAL GENET BIOL, V45, P1197, DOI 10.1016/j.fgb.2008.05.009; Ah-Fong AMV, 2011, FUNGAL BIOL-UK, V115, P882, DOI 10.1016/j.funbio.2011.07.001; Aylor DE, 2001, PHYTOPATHOLOGY, V91, P1189, DOI 10.1094/PHYTO.2001.91.12.1189; Bahn YS, 2007, NAT REV MICROBIOL, V5, P57, DOI 10.1038/nrmicro1578; Barrantes I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-115; BERGMAN K, 1972, PLANTA, V107, P53, DOI 10.1007/BF00398014; Blanco FA, 2005, MOL MICROBIOL, V56, P638, DOI 10.1111/j.1365-2958.2005.04575.x; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; COHEN Y, 1975, CAN J BOT, V53, P2680, DOI 10.1139/b75-296; Collick A, 1996, EMBO J, V15, P1163, DOI 10.1002/j.1460-2075.1996.tb00455.x; DAHLBERG KR, 1982, ANNU REV PHYTOPATHOL, V20, P281, DOI 10.1146/annurev.py.20.090182.001433; Daiyasu H, 2004, GENES CELLS, V9, P479, DOI 10.1111/j.1356-9597.2004.00738.x; DE WEILLE G. A., 1963, EUROPEAN POTATO JOUR, V6, P121; DEKKER EJ, 1993, MECH DEVELOP, V40, P3, DOI 10.1016/0925-4773(93)90083-A; Erwin D. C., 1996, Phytophthora diseases worldwide.; Fladung M, 1999, MOL GEN GENET, V260, P574, DOI 10.1007/s004380050931; Fong AMVA, 2003, MOL MICROBIOL, V50, P487, DOI 10.1046/j.1365-2958.2003.03735.x; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Gaulin E, 2007, CAN J MICROBIOL, V53, P152, DOI 10.1139/W06-090; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hardham AR, 1997, ADV BOT RES, V24, P353; HARNISH WN, 1965, MYCOLOGIA, V57, P85, DOI 10.2307/3756711; HARRISON JG, 1989, PLANT PATHOL, V38, P585, DOI 10.1111/j.1365-3059.1989.tb01455.x; Judelson HS, 2008, MOL PLANT MICROBE IN, V21, P433, DOI 10.1094/MPMI-21-4-0433; Judelson HS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-700; JUDELSON HS, 1995, CURR GENET, V28, P571, DOI 10.1007/BF00518171; JUDELSON HS, 1992, MOL GEN GENET, V234, P138, DOI 10.1007/BF00272355; JUDELSON HS, 1993, MOL GEN GENET, V239, P241, DOI 10.1007/BF00281624; Jung T, 2002, MYCOL RES, V106, P397, DOI 10.1017/S0953756202005622; Kim KS, 2003, EUKARYOT CELL, V2, P1376, DOI 10.1128/EC.2.6.1376-1385.2003; Latijnhouwers M, 2003, EUKARYOT CELL, V2, P971, DOI 10.1128/EC.2.5.971-977.2003; MALTESE CE, 1995, MYCOL RES, V99, P1175, DOI 10.1016/S0953-7562(09)80273-6; Medeiros AO, 2009, FRESHWATER BIOL, V54, P142, DOI 10.1111/j.1365-2427.2008.02101.x; Mizubuti ESG, 2000, PHYTOPATHOLOGY, V90, P78, DOI 10.1094/PHYTO.2000.90.1.78; Nielsen B. J., 2007, Proceedings of the Tenth Workshop of an European Network for Development of an Integrated Control Strategy of Potato Late Blight, Bologna, Italy, 2-5 May 2007, P211; OERTEL B, 1986, PROTOPLASMA, V135, P173, DOI 10.1007/BF01277011; Olmedo M, 2013, FUNGAL BIOL REV, V27, P10, DOI 10.1016/j.fbr.2013.02.004; Park HS, 2012, CURR OPIN MICROBIOL, V15, P669, DOI 10.1016/j.mib.2012.09.006; Ribeiro OK., 1983, PHYTOPHTHORA ITS BIO, P55; Rodriguez-Romero J, 2010, ANNU REV MICROBIOL, V64, P585, DOI 10.1146/annurev.micro.112408.134000; ROTEM J, 1978, ANNU REV PHYTOPATHOL, V16, P83, DOI 10.1146/annurev.py.16.090178.000503; Ruger-Herreros C, 2011, GENETICS, V188, P809, DOI 10.1534/genetics.111.130096; Sakai R, 1957, ANN PHYTOPATHOL SOC, V22, P211; SARGENT ML, 1972, PLANT PHYSIOL, V50, P171, DOI 10.1104/pp.50.1.171; Sheppard DC, 2005, MOL BIOL CELL, V16, P5866, DOI 10.1091/mbc.E05-07-0617; Smaczniak C, 2012, P NATL ACAD SCI USA, V109, P1560, DOI 10.1073/pnas.1112871109; Stam M, 1997, ANN BOT-LONDON, V79, P3, DOI 10.1006/anbo.1996.0295; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Tani S, 2004, MOL PLANT MICROBE IN, V17, P330, DOI 10.1094/MPMI.2004.17.3.330; Tooley PW, 1997, APPL ENVIRON MICROB, V63, P1467, DOI 10.1128/AEM.63.4.1467-1475.1997; Tyler BM, 2002, ANNU REV PHYTOPATHOL, V40, P137, DOI 10.1146/annurev.phyto.40.120601.125310; Van der Horst MA, 2004, ACCOUNTS CHEM RES, V37, P13, DOI 10.1021/ar020219d; WALLIN JR, 1953, PHYTOPATHOLOGY, V43, P505; Whisson SC, 2005, MOL PLANT PATHOL, V6, P153, DOI 10.1111/J.1364-3703.2005.00272.X; Xiang QJ, 2010, GENE, V453, P1, DOI 10.1016/j.gene.2009.12.006; Xiang QJ, 2009, FUNGAL GENET BIOL, V46, P400, DOI 10.1016/j.fgb.2009.02.006; Yan HZ, 2006, FUNGAL GENET BIOL, V43, P430, DOI 10.1016/j.fgb.2006.01.010; Yarwood CE, 1937, J AGRIC RES, V54, P0365; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040246	60	26	27	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92086	10.1371/journal.pone.0092086	http://dx.doi.org/10.1371/journal.pone.0092086			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24704821	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500013
J	Yuan, XL; Wang, W; Wang, J; Yin, XH; Zhai, XY; Wang, LN; Li, K; Li, ZL				Yuan, Xiaoli; Wang, Wei; Wang, Juan; Yin, Xiaohui; Zhai, Xiaoyue; Wang, Lining; Li, Kai; Li, Zilong			Down-Regulation of Integrin beta 1 and Focal Adhesion Kinase in Renal Glomeruli under Various Hemodynamic Conditions	PLOS ONE			English	Article							IN-VIVO CRYOTECHNIQUE; ALPHA-3-BETA-1 INTEGRIN; PODOCYTE ADHESION; ISCHEMIC-INJURY; EXPRESSION; RATS; KIDNEY; GLOMERULOSCLEROSIS; NEPHROPATHY; EFFACEMENT	Given that integrin beta 1 is an important component of the connection to maintain glomerular structural integrity, by binding with multiple extracellular matrix proteins and mediating intracellular signaling. Focal adhesion kinase (FAK) is the most essential intracellular integrator in the integrin beta 1-FAK signalling pathway. Here, we investigated the changes of the two molecules and visualized the possbile interaction between them under various hemodynamic conditions in podocytes. Mice kidney tissues were prepared using in vivo cryotechnique (IVCT) and then were stained and observed using light microscopy, confocal laser scanning microscopy and immunoelectron microscopy. The expression of these molecules were examined by western blot. Under the normal condition, integrin beta 1 stained continually and evenly at the membrane, and FAK was located in the cytoplasm and nuclei of the podocytes. There were significant colocalized plaques of two molecules. But under acute hypertensive and cardiac arrest conditions, integrin beta 1 decreased and stained intermittently. Similarly, FAK decreased and appeared uneven. Additionally, FAK translocated to the nuclei of the podocytes. As a result, the colocalization of integrin beta 1 and FAK reduced obviously under these conditions. Western blot assay showed a consistent result with the immunostaining. Collectively, the abnormal redistribution and decreased expressions of integrin beta 1 and FAK are important molecular events in regulating the functions of podocytes under abnormal hemodynamic conditions. IVCT could offer considerable advantages for morphological analysis when researching renal diseases.	[Yuan, Xiaoli; Wang, Wei; Wang, Juan; Yin, Xiaohui; Wang, Lining; Li, Zilong] China Med Univ, Affiliated Hosp 1, Dept Nephrol, Shenyang, Peoples R China; [Zhai, Xiaoyue] China Med Univ, Dept Histol & Embryol, Inst Pathol & Pathophysiol, Shenyang, Peoples R China; [Li, Kai] China Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Shenyang, Peoples R China; [Yuan, Xiaoli] Shanxi Med Univ, Gen Hosp Tisco, Dept Nephrol, Taiyuan, Peoples R China	China Medical University; China Medical University; China Medical University; Shanxi Medical University	Li, ZL (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Nephrol, Shenyang, Peoples R China.	lzl1017@yahoo.com			Natural Science Foundation of Liaoning Province, China [20110294]	Natural Science Foundation of Liaoning Province, China(Natural Science Foundation of Liaoning Province)	This work was supported by Grants-in-Aid for Scientific Research from the Natural Science Foundation of Liaoning Province, China (20110294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay C, 2012, SENSORS-BASEL, V12, P5951, DOI 10.3390/s120505951; BARALDI A, 1994, NEPHRON, V66, P295, DOI 10.1159/000187826; Birn H, 2000, J CLIN INVEST, V105, P1353, DOI 10.1172/JCI8862; Brukamp K, 2007, AM J PHYSIOL-RENAL, V293, pF1397, DOI 10.1152/ajprenal.00133.2007; Chen CA, 2006, J LAB CLIN MED, V147, P74, DOI 10.1016/j.lab.2005.08.011; Chen HC, 2000, LIFE SCI, V67, P2345, DOI 10.1016/S0024-3205(00)00815-8; Christiansen REF, 2004, NEPHROL DIAL TRANSPL, V19, P1083, DOI 10.1093/ndt/gfh101; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; Dessapt C, 2009, NEPHROL DIAL TRANSPL, V24, P2645, DOI 10.1093/ndt/gfp204; GRIFFITH LD, 1967, LAB INVEST, V16, P220; Guerrot D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031974; HOLTHOFER H, 1991, LAB INVEST, V65, P548; Kojima K, 2000, AM J KIDNEY DIS, V35, P1175, DOI 10.1016/S0272-6386(00)70056-4; KRETZLER M, 1994, VIRCHOWS ARCH, V425, P181; Li Z, 2005, HISTOL HISTOPATHOL, V20, P807, DOI 10.14670/HH-20.807; Li Zhan-yu, 2007, Chinese Journal of Pathology, V36, P677; Li ZL, 2006, ARCH HISTOL CYTOL, V69, P147, DOI 10.1679/aohc.69.147; Li ZL, 2013, MICROSC RES TECHNIQ, V76, P113, DOI 10.1002/jemt.22149; Ma H, 2010, J AM SOC NEPHROL, V21, P1145, DOI 10.1681/ASN.2009090991; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Miner JH, 2011, PEDIATR NEPHROL, V26, P1413, DOI 10.1007/s00467-011-1785-1; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Ofstad J, 2005, AM J PHYSIOL-RENAL, V288, pF665, DOI 10.1152/ajprenal.00226.2004; Ohno S, 1996, VIRCHOWS ARCH, V427, P519; Pagtalunan ME, 1999, J AM SOC NEPHROL, V10, P366; RACUSEN LC, 1984, AM J PATHOL, V114, P157; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Wagner MC, 2008, J BIOL CHEM, V283, P35579, DOI 10.1074/jbc.M805507200; Wang G, 2009, AM J HYPERTENS, V22, P300, DOI 10.1038/ajh.2008.360; Xu JK, 2012, J BIOL CHEM, V287, P26200, DOI 10.1074/jbc.M112.349811; Yi XP, 2003, HYPERTENSION, V41, P1317, DOI 10.1161/01.HYP.0000072772.74183.5F; Zou MS, 2010, INTERNAL MED, V49, P2677, DOI 10.2169/internalmedicine.49.4174	32	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94212	10.1371/journal.pone.0094212	http://dx.doi.org/10.1371/journal.pone.0094212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705394	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500133
J	Huang, J; Zhang, HQ; Zeng, KF; Gao, QL				Huang, Jia; Zhang, Hongqi; Zeng, Kefeng; Gao, Qile			The Clinical Outcomes of Surgical Treatment of Noncontiguous Spinal Tuberculosis: A Retrospective Study in 23 Cases	PLOS ONE			English	Article							LUMBAR INTERBODY FUSION; POSTERIOR INSTRUMENTATION; MANAGEMENT; THORACOLUMBAR; DEBRIDEMENT; DEFORMITY	Study design: A retrospective clinical study. Objective: To evaluate the clinical efficacy of the surgical treatment of noncontiguous spinal tuberculosis (NSTB), and to discuss its therapeutic strategies. Methods: We performed a retrospective review of clinical and radiographic data that were prospectively collected on 550 consecutive spinal tubercular patients including 27 patients who were diagnosed and treated as NSTB in our institution from June 2005 to June 2011. Apart from 4 patients being treated conservatively, the remainder received surgery by posterior transforaminal debridement, interbody fusion with instrumentation, posterior instrumentation and anterior debridement with fusion in a single or two-stage operation. The clinical outcomes were evaluated before and after treatment in terms of hematologic and radiographic examinations, bone fusion and neurologic status. The Oswestry Disability Index score was determined before treatment and at the last follow-up visit. Results: 23 patients (15 M/8F), averaged 44.6 +/- 14.2 years old (range, 19 to 70 yd), who received surgical treatment, were followed up after surgery for a mean of 52.5 +/- 19.5 months (range, 24 to 72 months). The kyphotic angle was changed significantly between pre- and postoperation (P < 0.05). The mean amount of correction was 12.6 +/- 7.2 degrees, with a small loss of correction at last follow-up. All patients achieved solid bone fusion. No patients with neurological deficit deteriorated postoperatively. Neither mortalities nor any major complications were found. There was a significant difference of Oswestry Disability Index scores between preoperation and the final follow-up. Conclusion: The outcomes of follow-up showed that posterior and posterior-anterior surgical treatment methods were both viable surgical options for NSTB. Posterior transforaminal debridement, interbody fusion and posterior instrumentation, as a less invasive technique, was feasible and effective to treat specific tubercular foci.	[Huang, Jia; Zhang, Hongqi; Zeng, Kefeng; Gao, Qile] Cent S Univ, Xiangya Hosp, Dept Spine Surg, Changsha, Hunan, Peoples R China	Central South University	Zhang, HQ (corresponding author), Cent S Univ, Xiangya Hosp, Dept Spine Surg, Changsha, Hunan, Peoples R China.	zhq9996@qq.com						Abdul-Jabbar A, 2012, SPINE, V37, P1340, DOI 10.1097/BRS.0b013e318246a53a; Al-Sebai MW, 2001, INT ORTHOP, V25, P322, DOI 10.1007/s002640100259; BUCKNER CB, 1991, AM J ROENTGENOL, V156, P255, DOI 10.2214/ajr.156.2.1898796; DAVIS LA, 1993, SPINE, V18, P257, DOI 10.1097/00007632-199302000-00014; Fairbank J C, 1980, Physiotherapy, V66, P271; Frankel H L, 1969, Paraplegia, V7, P179; Garg RK, 2011, J SPINAL CORD MED, V34, P440, DOI 10.1179/2045772311Y.0000000023; Glassman SD, 2005, SPINE, V30, P2024, DOI 10.1097/01.brs.0000179086.30449.96; Hirakawa A, 2010, J SPINAL DISORD TECH, V23, P133, DOI 10.1097/BSD.0b013e31819a870f; Kaila R, 2007, J SPINAL DISORD TECH, V20, P78, DOI 10.1097/01.bsd.0000211250.82823.0f; Lee TC, 1999, J NEUROSURG, V91, P163, DOI 10.3171/spi.1999.91.2.0163; Machino M, 2010, SPINE, V35, pE1000, DOI 10.1097/BRS.0b013e3181dc9153; MOON MS, 1995, SPINE, V20, P1910, DOI 10.1097/00007632-199509000-00013; Polley P, 2009, EUR SPINE J, V18, P1096, DOI 10.1007/s00586-009-0966-0; Roussouly P, 2010, EUR SPINE J, V19, P1824, DOI 10.1007/s00586-010-1476-9; Shi JD, 2012, INT ORTHOP, V36, P1423, DOI 10.1007/s00264-011-1478-1; Toman K, 2004, TOMANS TUBERCULOSIST; Tuli S., 2004, TUBERCULOSIS SKELETA; Turgut M, 2001, NEUROSURG REV, V24, P8, DOI 10.1007/PL00011973; Yamasaki R, 2013, EUR SPINE J; Zaveri GR, 2009, J SPINAL DISORD TECH, V22, P257, DOI 10.1097/BSD.0b013e31818859d0; Zhang HQ, 2013, ARCH ORTHOP TRAUM SU, V133, P333, DOI 10.1007/s00402-012-1669-2; Zhang HQ, 2012, ARCH ORTHOP TRAUM SU, V132, P751, DOI 10.1007/s00402-012-1473-z; Zhang HQ, 2013, EUR SPINE J, V22, P616, DOI 10.1007/s00586-012-2470-1; Zhang HQ, 2013, EUR SPINE J	25	11	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93648	10.1371/journal.pone.0093648	http://dx.doi.org/10.1371/journal.pone.0093648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699518	gold, Green Published, Green Submitted			2022-12-27	WOS:000334105000086
J	Liu, SJ; Sun, J; Chen, X; Yu, YY; Liu, X; Liu, CM				Liu, Shijiang; Sun, Jie; Chen, Xing; Yu, Yingying; Liu, Xuan; Liu, Cunming			The Application of Transcutaneous CO2 Pressure Monitoring in the Anesthesia of Obese Patients Undergoing Laparoscopic Bariatric Surgery	PLOS ONE			English	Article							CARBON-DIOXIDE TENSION; GENERAL-ANESTHESIA; MECHANICAL VENTILATION; ARTERIAL; CHOLECYSTECTOMY; INFANTS; ADULTS	To investigate the correlation and accuracy of transcutaneous carbon dioxide partial pressure (PTCCO2) with regard to arterial carbon dioxide partial pressure (PaCO2) in severe obese patients undergoing laparoscopic bariatric surgery. Twenty-one patients with BMI>35 kg/m(2) were enrolled in our study. Their PaCO2, end-tidal carbon dioxide partial pressure (PetCO2), as well as PTCCO2 values were measured at before pneumoperitoneum and 30 min, 60 min, 120 min after pneumoperitoneum respectively. Then the differences between each pair of values (PetCO2-PaCO2) and. (PTCCO2-PaCO2) were calculated. Bland-Altman method, correlation and regression analysis, as well as exact probability method and two way contingency table were employed for the data analysis. 21 adults (aged 19-54 yr, mean 29, SD 9 yr; weight 86-160 kg, mean 119.3, SD 22.1 kg; BMI 35.3-51.1 kg/m(2), mean 42.1,SD 5.4 kg/m(2)) were finally included in this study. One patient was eliminated due to the use of vaso-excitor material phenylephrine during anesthesia induction. Eighty-four sample sets were obtained. The average PaCO2-PTCCO2 difference was 0.9 +/- 1.3 mmHg (mean +/- SD). And the average PaCO2-PetCO2 difference was 10.3 +/- 2.3 mmHg (mean +/- SD). The linear regression equation of PaCO2-PetCO2 is PetCO2 = 11.58+0.57xP(a)CO(2) (r(2) = 0.64, P<0.01), whereas the one of PaCO2-PTCCO2 is PTCCO2 = 0.60+0.97xP(a)CO(2) (r(2) = 0.89). The LOA (limits of agreement) of 95% average PaCO2-PetCO2 difference is 10.3 +/- 4.6 mmHg (mean +/- 1.96 SD), while the LOA of 95% average PaCO2-P(TC)CO2 difference is 0.9 +/- 2.6 mmHg (mean +/- 1.96 SD). In conclusion, transcutaneous carbon dioxide monitoring provides a better estimate of PaCO2 than PetCO2 in severe obese patients undergoing laparoscopic bariatric surgery.	[Liu, Shijiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China; [Sun, Jie] Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China; [Chen, Xing] Jiangsu New Energy Dev Co, Jiangsu Guoxin Investment Grp, Dept Project Management, Nanjing, Jiangsu, Peoples R China; [Liu, Xuan] Gen Hosp TISCO, Dept Anesthesiol, Taiyuan, Peoples R China; [Liu, Cunming] Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Shanxi Medical University; Nanjing Medical University	Liu, CM (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China.	mingliu870@sohu.com	yu, yingying/GRR-7851-2022		Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkenbosch JW, 2001, ANESTH ANALG, V92, P1427; Bozkurt P, 1999, ANAESTHESIA, V54, P831; CAPAN LM, 1985, CRIT CARE MED, V13, P810, DOI 10.1097/00003246-198510000-00007; Casati A, 2006, J CLIN ANESTH, V18, P436, DOI 10.1016/j.jclinane.2006.02.007; Cuvelier A, 2005, CHEST, V127, P1744, DOI 10.1378/chest.127.5.1744; Gandara V, 1997, SURG ENDOSC, V11, P707, DOI 10.1007/s004649900432; Girardis M, 1996, ANESTH ANALG, V83, P134, DOI 10.1097/00000539-199607000-00024; Griffin J, 2003, BRIT J ANAESTH, V91, P498, DOI 10.1093/bja/aeg217; Gursoy S, 2006, EUR J ANAESTH, V23, P496, DOI 10.1017/S0265021506000172; Maniscalco M, 2008, INTENS CARE MED, V34, P1340, DOI 10.1007/s00134-008-1078-8; Mizushima Akio, 2002, Masui, V51, P1331; MUZI M, 1992, ANESTH ANALG, V74, P877; Nishiyama T, 2006, EUR J ANAESTH, V23, P1049, DOI 10.1017/S0265021506001116; Nishiyama T, 2011, J CLIN MONIT COMPUT, V25, P323, DOI 10.1007/s10877-011-9311-3; Nishiyama T, 2007, J ANESTH, V21, P317, DOI 10.1007/s00540-006-0525-3; REID CW, 1992, CAN J ANAESTH, V39, P31, DOI 10.1007/BF03008669; RITHALIA SVS, 1982, RESUSCITATION, V10, P13, DOI 10.1016/0300-9572(82)90003-X; Rodriguez P, 2006, INTENS CARE MED, V32, P309, DOI 10.1007/s00134-005-0006-4; Rohling R, 1999, J CLIN MONITOR COMP, V15, P23, DOI 10.1023/A:1009950425204; Schroeder R, 2011, AM FAM PHYSICIAN, V84, P805; Sorensen LC, 2011, SCAND J CLIN LAB INV, V71, P548, DOI 10.3109/00365513.2011.590601; Tobias JD, 1997, ANESTH ANALG, V85, P55, DOI 10.1097/00000539-199707000-00010; Xue QS, 2010, ANESTH ANALG, V111, P417, DOI 10.1213/ANE.0b013e3181e30b54	23	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e91563	10.1371/journal.pone.0091563	http://dx.doi.org/10.1371/journal.pone.0091563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699267	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000014
J	Nikhil, K; Sharan, S; Chakraborty, A; Roy, P				Nikhil, Kumar; Sharan, Shruti; Chakraborty, Ajanta; Roy, Partha			Pterostilbene-Isothiocyanate Conjugate Suppresses Growth of Prostate Cancer Cells Irrespective of Androgen Receptor Status	PLOS ONE			English	Article							INDUCED APOPTOSIS; DOWN-REGULATION; INDUCTION; INHIBITION; EXPRESSION; PATHWAY; KINASE; CYCLE; PROLIFERATION; SULFORAPHANE	Chemotherapy and anti-hormonal therapies are the most common treatments for non-organ-confined prostate cancer (PCa). However, the effectiveness of these therapies is limited, thus necessitating the development of alternative approaches. The present study focused on analyzing the role of pterostilbene (PTER)-isothiocyanate (ITC) conjugate - a novel class of hybrid compound synthesized by appending an ITC moiety on PTER backbone - in regulating the functions of androgen receptor (AR), thereby causing apoptosis of PCa cells. The conjugate molecule caused 50% growth inhibition (IC50) at 40 +/- 1.12 and 45 +/- 1.50 mu M in AR positive (LNCaP) and negative (PC-3) cells, respectively. The reduced proliferation of PC-3 as well as LNCaP cells by conjugate correlated with accumulation of cells in G2/M phase and induction of caspase dependent apoptosis. Both PI3K/Akt and MAPK/ERK pathways played an important and differential role in conjugate-induced apoptosis of these PCa cells. While the inhibitor of Akt (A6730) or Akt-specific small interference RNA (siRNA) greatly sensitized PC-3 cells to conjugate-induced apoptosis, on the contrary, apoptosis was accelerated by inhibition of ERK (by PD98059 or ERK siRNA) in case of LNCaP cells, both ultimately culminating in the expression of cleaved caspase-3 protein. Moreover, anti-androgenic activity of the conjugate was mediated by decreased expression of AR and its co-activators (SRC-1, GRIP-1), thus interfering in their interactions with AR. All these data suggests that conjugate-induced inhibition of cell proliferation and induction of apoptosis are partly mediated by the down regulation of AR, Akt, and ERK signaling. These observations provide a rationale for devising novel therapeutic approaches for treating PCa by using conjugate alone or in combination with other therapeutics.	[Nikhil, Kumar; Sharan, Shruti; Chakraborty, Ajanta; Roy, Partha] Indian Inst Technol Roorkee, Dept Biotechnol, Mol Endocrinol Lab, Roorkee, Uttarakhand, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee	Roy, P (corresponding author), Indian Inst Technol Roorkee, Dept Biotechnol, Mol Endocrinol Lab, Roorkee, Uttarakhand, India.	paroyfbs@iitr.ernet.in		NIKHIL, KUMAR/0000-0002-9438-6578; SHARAN, SHRUTI/0000-0003-0405-8560	Council for Scientific and Industrial Research; Ministry of Human Resources and Development (MHRD), Government of India; Department of Biotechnology [BT/PR14836/AAQ/01/455/2010]; Department of Science and Technology [SR/SO/HS-39/2009]	Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Ministry of Human Resources and Development (MHRD), Government of India(Ministry of Human Resource Development (MHRD), Government of India); Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India))	This work was supported by research grants from Council for Scientific and Industrial Research and Ministry of Human Resources and Development (MHRD), Government of India as research fellowships to KN and project assistantship to PR, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Further PR would also like to tank other funding agencies, Department of Biotechnology (BT/PR14836/AAQ/01/455/2010) and Department of Science and Technology (SR/SO/HS-39/2009) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addanki PK, 2003, NEOPLASIA, V5, P255; Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; Agoulnik IU, 2005, CANCER RES, V65, P7959, DOI 10.1158/0008-5472.CAN-04-3541; Alosi JA, 2010, J SURG RES, V161, P195, DOI 10.1016/j.jss.2009.07.027; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Baniahmad A, 2005, J STEROID BIOCHEM, V93, P89, DOI 10.1016/j.jsbmb.2004.12.012; Bracarda S, 2005, CRIT REV ONCOL HEMAT, V56, P379, DOI 10.1016/j.critrevonc.2005.03.010; Caraglia M, 2007, J CELL PHYSIOL, V211, P533, DOI 10.1002/jcp.20960; Carter LG, 2014, ENDOCR-RELAT CANCER, V21, pR209, DOI 10.1530/ERC-13-0171; Cavell BE, 2011, BIOCHEM PHARMACOL, V81, P327, DOI 10.1016/j.bcp.2010.10.005; Cha TL, 2005, CANCER RES, V65, P2287, DOI 10.1158/0008-5472.CAN-04-3250; Chakraborty A, 2012, MOL CELL ENDOCRINOL, V355, P25, DOI 10.1016/j.mce.2012.01.009; Chakraborty A, 2010, TOXICOL IN VITRO, V24, P1215, DOI 10.1016/j.tiv.2010.02.007; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chiao JW, 2002, INT J ONCOL, V20, P631; Chiu FL, 2008, PROSTATE, V68, P61, DOI 10.1002/pros.20690; delPeso L, 1997, SCIENCE, V278, P687; Fimognari C, 2004, BIOCHEM PHARMACOL, V68, P1133, DOI 10.1016/j.bcp.2004.03.044; Fimognari C, 2012, MUTAT RES-REV MUTAT, V750, P107, DOI 10.1016/j.mrrev.2011.12.001; Fimognari C, 2009, ENVIRON MOL MUTAGEN, V50, P171, DOI 10.1002/em.20447; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Gregory CW, 2001, CANCER RES, V61, P4315; Grigoryev DN, 2000, J STEROID BIOCHEM, V75, P1, DOI 10.1016/S0960-0760(00)00131-X; Harada N, 2007, J NUTR SCI VITAMINOL, V53, P556, DOI 10.3177/jnsv.53.556; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; HEINLEIN CA, 2002, ENDOCR REV, V23, P175, DOI DOI 10.1210/ER.23.2.175; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; Ho SM, 2004, J CELL BIOCHEM, V91, P491, DOI 10.1002/jcb.10759; Hsu JC, 2005, CARCINOGENESIS, V26, P1896, DOI 10.1093/carcin/bgi155; Jasinski M, 2013, ANGIOGENESIS, V56, P60; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kang HY, 2001, P NATL ACAD SCI USA, V98, P3018, DOI 10.1073/pnas.061305498; Kapetanovic IM, 2011, CANCER CHEMOTH PHARM, V68, P593, DOI 10.1007/s00280-010-1525-4; Keum YS, 2004, MUTAT RES-FUND MOL M, V555, P191, DOI 10.1016/j.mrfmmm.2004.05.024; Kris-Etherton Penny M., 2002, American Journal of Medicine, V113, p71S; Li K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057542; Lin VCH, 2012, J AGR FOOD CHEM, V60, P6399, DOI 10.1021/jf301499e; Liu Chengfei, 2011, Genes Cancer, V2, P151, DOI 10.1177/1947601911409744; Nikhil K, 2014, EXP CELL RES, V320, P311, DOI 10.1016/j.yexcr.2013.10.015; ONATE SA, 1995, SCIENCE, V270, P1354; Pan MH, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep093; Papaioannou M, 2005, ANDROLOGIA, V37, P211, DOI 10.1111/j.1439-0272.2005.00690.x; Ren FG, 2000, ONCOGENE, V19, P1924, DOI 10.1038/sj.onc.1203511; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Sheikh MS, 2000, J CELL PHYSIOL, V182, P171, DOI 10.1002/(SICI)1097-4652(200002)182:2<171::AID-JCP5>3.0.CO;2-3; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang LG, 2006, CARCINOGENESIS, V27, P2124, DOI 10.1093/carcin/bgl075; Wang LG, 2004, INT J ONCOL, V24, P187; Wang TTY, 2010, MOL NUTR FOOD RES, V54, P335, DOI 10.1002/mnfr.200900143; Wang YM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-8; Wen Y, 2000, CANCER RES, V60, P6841; Wu X, 2009, ACTA PHARMACOL SIN, V30, P501, DOI 10.1038/aps.2009.50; Xiao D, 2002, CANCER RES, V62, P3615; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458; Yuan HQ, 2005, CARCINOGENESIS, V26, P793, DOI 10.1093/carcin/bgi021; Zelivianski S, 2003, INT J CANCER, V107, P478, DOI 10.1002/ijc.11413	58	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93335	10.1371/journal.pone.0093335	http://dx.doi.org/10.1371/journal.pone.0093335			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699278	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000053
J	Reijneveld, SA; Wiegersma, PA; Ormel, J; Verhulst, FC; Vollebergh, WAM; Jansen, DEMC				Reijneveld, Sijmen A.; Wiegersma, P. Auke; Ormel, Johan; Verhulst, Frank C.; Vollebergh, Wilma A. M.; Jansen, Danielle E. M. C.			Adolescents' Use of Care for Behavioral and Emotional Problems: Types, Trends, and Determinants	PLOS ONE			English	Article							SERVICE USE; PSYCHOSOCIAL PROBLEMS; HEALTH; CHILD; PATHWAYS; SAMPLE; LIFE	Objective: While adolescents use various types of care for behavioral and emotional problems, evidence on age trends and determinants per type is scarce. We aimed to assess use of care by adolescents because of behavioral and emotional problems, overall and by type, and its determinants, for ages 10-19 years. Methods: We obtained longitudinal data on 2,230 adolescents during ages 10-19 from four measurements regarding use of general care and specialized care (youth social care and mental healthcare) in the preceding 6 months, the Child Behavior Checklist (CBCL) and Youth Self-Report, and child and family characteristics. We analyzed data by multilevel logistic regression. Results: Overall rates of use increased from 20.1% at age 10/11 to 32.2% at age 19: general care was used most. At age 10/11 use was higher among boys, at age 19 among girls. Use of general care increased for both genders, whereas use of specialized care increased among girls but decreased among boys. This differential change was associated with CBCL externalizing and internalizing problems, school problems, family socioeconomic status, and parental divorce. Preceding CBCL problems predicted more use: most for mental health care and least for general care. Moreover, general care was used more frequently by low and medium socioeconomic status families, with odds ratios (95%-confidence intervals): 1.52 (1.23; 1.88) and 1.40 (1.17; 1.67); youth social care in case of parental divorce, 2.07 (1.36; 3.17); and of special education, 2.66 (1.78; 3.95); and mental healthcare in case of special education, 2.66 (1.60; 4.51). Discussion: Adolescents with behavioral and emotional problems use general care most frequently. Overall use increases with age. Determinants of use vary per type.	[Reijneveld, Sijmen A.; Wiegersma, P. Auke; Jansen, Danielle E. M. C.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Groningen, Netherlands; [Ormel, Johan] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Verhulst, Frank C.] Erasmus MC, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands; [Vollebergh, Wilma A. M.] Univ Utrecht, Dept Social Sci, Utrecht, Netherlands	University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Utrecht University	Reijneveld, SA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Groningen, Netherlands.	s.a.reijneveld@umcg.nl	Vollebergh, Wilma A M/C-2323-2012; ormel, johan/AAC-5584-2019; Ormel, Johan/C-6094-2013; Jansen, Danielle/E-9281-2013	Vollebergh, Wilma A M/0000-0003-3532-3072; ormel, johan/0000-0002-5463-037X; Reijneveld, Sijmen/0000-0002-1206-7523; Jansen, Danielle/0000-0002-2654-1038	Netherlands Organization for Scientific Research (NWO); ZonMW; GB-MaGW; Dutch Ministry of Justice; European Science Foundation; BBMRI-NL; Accare Center for Child and Adolescent Psychiatry	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ZonMW(Netherlands Organization for Health Research and Development); GB-MaGW; Dutch Ministry of Justice; European Science Foundation(European Science Foundation (ESF)European Commission); BBMRI-NL; Accare Center for Child and Adolescent Psychiatry	This research is part of the TRacking Adolescents' Individual Lives Survey (TRAILS). Participating centers of TRAILS include various departments of the University Medical Center and University of Groningen, the Erasmus University Medical Center Rotterdam, the University of Utrecht, the Radboud Medical Center Nijmegen, and the Parnassia Bavo group, all in the Netherlands. TRAILS has been financially supported by the Netherlands Organization for Scientific Research (NWO), ZonMW, GB-MaGW, the Dutch Ministry of Justice, the European Science Foundation, BBMRI-NL, the participating universities, and Accare Center for Child and Adolescent Psychiatry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 2007, MULTICULTURAL SUPPLE; Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Amone-P'Olak K, 2010, J AM ACAD CHILD PSY, V49, P647, DOI 10.1016/j.jaac.2010.03.007; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; de Winter AF, 2005, EUR J EPIDEMIOL, V20, P173, DOI 10.1007/s10654-004-4948-6; Ford T, 2008, CHILD ADOL MENT H-UK, V13, P32, DOI 10.1111/j.1475-3588.2007.00449.x; Ganzeboom H.B., 2003, ADV CROSS NATL COMP, P159, DOI DOI 10.1007/978-1-4419-9186-7_9; Goldberg DP., 1992, COMMON MENTAL DISORD; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Harland P, 2002, EUR CHILD ADOLES PSY, V11, P176, DOI 10.1007/s00787-002-0277-z; Jansen DEMC, 2013, EUR J PUBLIC HEALTH, V23, P236, DOI 10.1093/eurpub/cks087; Jaspers M, 2012, J ADOLESCENT HEALTH, V51, P475, DOI 10.1016/j.jadohealth.2012.02.007; Jorg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044704; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Muris P, 2003, PERS INDIV DIFFER, V35, P1791, DOI 10.1016/S0191-8869(03)00004-7; Ormel J, 1997, SOC SCI MED, V45, P1051, DOI 10.1016/S0277-9536(97)00032-4; Ormel J, 2012, J AM ACAD CHILD PSY, V51, P1020, DOI 10.1016/j.jaac.2012.08.004; Reijneveld SA, 2004, ARCH PEDIAT ADOL MED, V158, P811, DOI 10.1001/archpedi.158.8.811; Reijneveld SA, 1998, INT J EPIDEMIOL, V27, P33, DOI 10.1093/ije/27.1.33; Reijneveld SA, 2010, J ADOLESCENT HEALTH, V46, P189, DOI 10.1016/j.jadohealth.2009.06.004; Rubin DB, 2004, MULTIPLE IMPUTATION; Sadiraj K, 2013, DOES YOUTH CARE CONT; Sayal K, 2006, J CHILD PSYCHOL PSYC, V47, P649, DOI 10.1111/j.1469-7610.2005.01543.x; Smith JP, 2010, SOC SCI MED, V71, P110, DOI 10.1016/j.socscimed.2010.02.046; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Tick NT, 2008, EUR CHILD ADOLES PSY, V17, P373, DOI 10.1007/s00787-008-0679-7; Veenstra R, 2006, INT J BEHAV DEV, V30, P422, DOI 10.1177/0165025406071490; Verhulst F.C., 2013, HANDLEIDING ASEBA VR; Zwaanswijk M, 2005, J AM ACAD CHILD PSY, V44, P1292, DOI 10.1097/01.chi.0000181038.98712.c6	30	15	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93526	10.1371/journal.pone.0093526	http://dx.doi.org/10.1371/journal.pone.0093526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LR	24699408	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000064
J	Ren, Y; Wu, H; Ma, Y; Yuan, J; Liang, H; Liu, D				Ren, Yu; Wu, Haiqing; Ma, Yuzhen; Yuan, Jianlong; Liang, Hao; Liu, Dongjun			Potential of Adipose-Derived Mesenchymal Stem Cells and Skeletal Muscle-Derived Satellite Cells for Somatic Cell Nuclear Transfer Mediated Transgenesis in Arbas Cashmere Goats	PLOS ONE			English	Article							MARROW STROMAL CELLS; BONE-MARROW; TRANSFER EMBRYOS; PIG CLONING; DIFFERENTIATION; EXPRESSION; FIBROBLAST; EFFICIENCY; CATTLE; CYCLE	Somatic cell nuclear transfer is used to generate genetic models for research and new, genetically modified livestock varieties. Goat fetal fibroblast cells (gFFCs) are the predominant nuclear donors in Cashmere goat transgenic cloning, but have disadvantages. We evaluated the potential of goat adipose-derived mesenchymal stem cells (gADSCs) and goat skeletal muscle-derived satellite cells (gMDSCs) for somatic cell nuclear transfer, evaluating their proliferation, pluripotency, transfection efficiency and capacity to support full term development of embryos after additive gene transfer or homologous recombination. gADSCs and gMDSCs were isolated by enzyme digestion and differentiated into neurocytes, myotube cells and insulin-producing cells. Neuron-specific enolase, fast muscle myosin and insulin expression were determined by immunohistochemistry. Following somatic cell nuclear transfer with donor cells derived from gADSCs, gMDSCs and gFFCs, transfection and cloning efficiencies were compared. Red fluorescent protein levels were determined by quantitative PCR and western blotting. 5-Methylcytosine, H4K5, H4K12 and H3K18 were determined immunohistochemically. gADSCs and gMDSCs were maintained in culture for up to 65 passages, whereas gFFCs could be passaged barely more than 15 times. gADSCs and gMDSCs had higher fluorescent colony forming efficiency and greater convergence (20%) and cleavage (10%) rates than gFFCs, and exhibited differing H4K5 histone modification patterns after somatic cell nuclear transfer and in vitro cultivation. After transfection with a pDsRed2-1 expression plasmid, the integrated exogenous genes did not influence the pluripotency of gADSCs-pDsRed2-1 or gMDSCs-pDsRed2-1. DsRed2 mRNA expression by cloned embryos derived from gADSCs-pDsRed2-1 or gMDSCs-pDsRed2-1 was more than twice that of gFFCs-pDsRed2-1 embryos (P<0.01). Pregnancy rates of gADSCs-pDsRed2-1 and gMDSCs-pDsRed2-1 recipients were higher than those of gFFCs-pDsRed2-1 recipients (P<0.01). With their high proliferative capacity and transfection efficiency, gADSCs and gMDSCs are a valuable cell source for breeding new, genetically modified varieties of livestock by somatic cell nuclear transfer.	[Ren, Yu; Wu, Haiqing; Yuan, Jianlong; Liang, Hao; Liu, Dongjun] Inner Mongolia Univ, Minist Educ, Key Lab Mammalian Reprod Biol & Biotechnol, Hohhot, Inner Mongolia, Peoples R China; [Ma, Yuzhen] Inner Mongolia Peoples Hosp, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia University	Liu, D (corresponding author), Inner Mongolia Univ, Minist Educ, Key Lab Mammalian Reprod Biol & Biotechnol, Hohhot, Inner Mongolia, Peoples R China.	nmliudongjun@sina.com			National Genetically Modified Organisms Breeding Major Projects [2013ZX08008-002]	National Genetically Modified Organisms Breeding Major Projects	The National Genetically Modified Organisms Breeding Major Projects (Grant No. 2013ZX08008-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Aigner B, 2010, CURR OPIN ORGAN TRAN, V15, P201, DOI 10.1097/MOT.0b013e328336ba4a; Black IB, 2001, BLOOD CELL MOL DIS, V27, P632, DOI 10.1006/bcmd.2001.0423; Campbell KHS, 2005, REPROD DOMEST ANIM, V40, P256, DOI 10.1111/j.1439-0531.2005.00591.x; Chang YF, 2012, FOOD CHEM TOXICOL, V50, P3433, DOI 10.1016/j.fct.2012.07.032; Dai XP, 2010, J BIOL CHEM, V285, P31002, DOI 10.1074/jbc.M110.136085; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Faast R, 2006, CLONING STEM CELLS, V8, P166, DOI 10.1089/clo.2006.8.166; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Guo XD, 2009, SCI CHINA SER C, V52, P390, DOI 10.1007/s11427-009-0041-4; Hermann A, 2006, J NEUROSCI RES, V83, P1502, DOI 10.1002/jnr.20840; Huard Johnny, 2003, Birth Defects Research, V69, P230, DOI 10.1002/bdrc.10020; Inoue K, 2003, BIOL REPROD, V69, P1394, DOI 10.1095/biolreprod.103.017731; Jin HF, 2007, INT J DEV BIOL, V51, P85, DOI 10.1387/ijdb.062165hj; Klymiuk N, 2012, DIABETES, V61, P1527, DOI 10.2337/db11-1325; Klymiuk N, 2012, FASEB J, V26, P1086, DOI 10.1096/fj.11-185041; Kumar BM, 2007, DEV DYNAM, V236, P435, DOI 10.1002/dvdy.21042; Lakshmipathy U, 2004, STEM CELLS, V22, P531, DOI 10.1634/stemcells.22-4-531; Li ZC, 2013, CELL REPROGRAM, V15, P35, DOI 10.1089/cell.2012.0042; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Pandey A, 2010, CELL REPROGRAM, V12, P357, DOI 10.1089/cell.2009.0083; Petersen B, 2008, CLONING STEM CELLS, V10, P355, DOI 10.1089/clo.2008.0026; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Powell AM, 2004, BIOL REPROD, V71, P210, DOI 10.1095/biolreprod.104.027193; Ren Y, 2012, RES VET SCI, V93, P404, DOI 10.1016/j.rvsc.2011.08.014; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027; Salem SA, 2013, MALAYS J MED SCI, V20, P80; Tian J, 2012, REPROD DOMEST ANIM, V47, P544, DOI 10.1111/j.1439-0531.2011.01915.x; Urnov FD, 2001, ONCOGENE, V20, P2991, DOI 10.1038/sj.onc.1204323; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Wells DN, 2003, THERIOGENOLOGY, V59, P45, DOI 10.1016/S0093-691X(02)01273-6; Wolf E, 2000, EXP PHYSIOL, V85, P615, DOI 10.1017/S0958067000021102; Wu HQ, 2012, CELL BIOL INT, V36, P579, DOI 10.1042/CBI20110487	36	10	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93583	10.1371/journal.pone.0093583	http://dx.doi.org/10.1371/journal.pone.0093583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699686	Green Submitted, gold, Green Published			2022-12-27	WOS:000334105000073
J	Borsetti, A; Ferrantelli, F; Maggiorella, MT; Sernicola, L; Bellino, S; Gallinaro, A; Farcomeni, S; Mee, ET; Rose, NJ; Cafaro, A; Titti, F; Ensoli, B				Borsetti, Alessandra; Ferrantelli, Flavia; Maggiorella, Maria T.; Sernicola, Leonardo; Bellino, Stefania; Gallinaro, Alessandra; Farcomeni, Stefania; Mee, Edward T.; Rose, Nicola J.; Cafaro, Aurelio; Titti, Fausto; Ensoli, Barbara			Effect of MHC Haplotype on Immune Response upon Experimental SHIVSF162P4cy Infection of Mauritian Cynomolgus Macaques	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CLASS-I; DISEASE PROGRESSION; ALPHA-DEFENSINS; HIV-INFECTION; INNATE IMMUNITY; IL-10; SUSCEPTIBILITY; RESOLUTION; POINT	Little is known about the effects of Major Histocompatibility Complex (MHC) haplotypes on immunity to primate lentiviruses involving both acquired and innate immune responses. We present statistical evidence of the influence of MHC polymorphism on antiviral immunity of Mauritian cynomolgus macaques (MCM) following simian/human immunodeficiency virus SHIVSF162P4cy infection, involving the production of pro-and anti-inflammatory cytokines and alpha-defensins, which may modulate acquired immune responses. During the acute phase of infection, IL-10 correlated positively with viral load and negatively with CD4+T cell counts. Furthermore, alpha-defensins production was directly correlated with plasma viral RNA, particularly at peak of viral load. When the effects of the MHC were analyzed, a significant association between lower anti-Env binding and neutralizing antibody levels with class IB M4 haplotype and with class IA, IB M4 haplotype, respectively, was observed in the post-acute phase. Lower antibody responses may have resulted into a poor control of infection thus explaining the previously reported lower CD4 T cell counts in these monkeys. Class II M3 haplotype displayed significantly lower acute and post-acute IL-10 levels. In addition, significantly lower levels of alpha-defensins were detected in class IA M3 haplotype monkeys than in non-M3 macaques, in the post-acute phase of infection. These data indicate that the MHC could contribute to the delicate balance of pro-inflammatory mechanisms, particularly with regard to the association between IL-10 and alpha-defensins in lentivirus infection. Our results show that host genetic background, virological and immunological parameters should be considered for the design and interpretation of HIV-1 vaccine efficacy studies.	[Borsetti, Alessandra; Ferrantelli, Flavia; Maggiorella, Maria T.; Sernicola, Leonardo; Bellino, Stefania; Gallinaro, Alessandra; Farcomeni, Stefania; Cafaro, Aurelio; Titti, Fausto; Ensoli, Barbara] Ist Super Sanita, Natl AIDS Ctr, I-00161 Rome, Italy; [Mee, Edward T.; Rose, Nicola J.] Med & Healthcare Prod Regulatory Agcy, Natl Inst Biol Stand & Control, Div Virol, S Mimms, Herts, England	Istituto Superiore di Sanita (ISS); National Institute for Biological Standards & Control; The Medicines & Healthcare Products Regulatory Agency	Borsetti, A (corresponding author), Ist Super Sanita, Natl AIDS Ctr, Viale Regina Elena 299, I-00161 Rome, Italy.	alessandra.borsetti@iss.it	Ensoli, Barbara/J-9169-2016; maggiorella, maria teresa/K-4072-2016; Rose, Nicola/E-9366-2013; Cafaro, Aurelio/K-5314-2016; borsetti, alessandra/K-4103-2016; Gallinaro, Alessandra/J-2063-2018; Ferrantelli, Flavia/J-7794-2016; farcomeni, stefania/K-4640-2016	Ensoli, Barbara/0000-0002-0545-8737; maggiorella, maria teresa/0000-0001-5058-476X; borsetti, alessandra/0000-0002-5401-135X; Gallinaro, Alessandra/0000-0001-7618-8896; Ferrantelli, Flavia/0000-0002-0768-1078; farcomeni, stefania/0000-0001-5058-476X; Rose, Nicola/0000-0003-1102-5062; Bellino, Stefania/0000-0003-1149-3835; Cafaro, Aurelio/0000-0001-9675-6344	National Aids Program, Italian Ministry of Health [3H/5]; Italian Concerted Action on HIV-AIDS Vaccine Development (ICAV), European Commission [LSHP-CT-2004503487]; NIHR Centre for Research in Health Protection at the Health Protection Agency (UK)	National Aids Program, Italian Ministry of Health; Italian Concerted Action on HIV-AIDS Vaccine Development (ICAV), European Commission; NIHR Centre for Research in Health Protection at the Health Protection Agency (UK)	This work was supported by grants from the National Aids Program, Italian Ministry of Health (contract 3H/5), the Italian Concerted Action on HIV-AIDS Vaccine Development (ICAV), European Commission (LSHP-CT-2004503487), and in part by the NIHR Centre for Research in Health Protection at the Health Protection Agency (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnink A, 2011, IMMUNOGENETICS, V63, P267, DOI 10.1007/s00251-010-0504-6; Ahmed RKS, 2005, MOL IMMUNOL, V42, P251, DOI 10.1016/j.molimm.2004.06.027; Baroncelli S, 2007, AIDS RES HUM RETROV, V23, P287, DOI 10.1089/aid.2006.0142; Basu D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-76; Borsetti A, 2008, ARCH VIROL, V153, P463, DOI 10.1007/s00705-007-0009-2; Borsetti A, 2012, TISSUE ANTIGENS, V80, P36, DOI 10.1111/j.1399-0039.2012.01875.x; Budde ML, 2010, IMMUNOGENETICS, V62, P773, DOI 10.1007/s00251-010-0481-9; Eberly MD, 2009, J IMMUNOL, V182, P1439, DOI 10.4049/jimmunol.182.3.1439; Evans DT, 1999, IMMUNOL LETT, V66, P53, DOI 10.1016/S0165-2478(98)00151-5; Ferrantelli F, 2011, VACCINE, V29, P2918, DOI 10.1016/j.vaccine.2011.02.006; Filippi CM, 2008, J PATHOL, V214, P224, DOI 10.1002/path.2272; Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489; Giraldo-Vela JP, 2008, J VIROL, V82, P859, DOI 10.1128/JVI.01816-07; Haigwood NL, 2004, AIDS REV, V6, P187; Iwasaki A, 2012, IMMUNITY, V37, P389, DOI 10.1016/j.immuni.2012.08.011; Jan MS, 2006, JAIDS-J ACQ IMM DEF, V41, P6, DOI 10.1097/01.qai.0000188336.94090.14; Jenne CN, 2012, CELL HOST MICROBE, V12, P5, DOI 10.1016/j.chom.2012.07.002; Kaur G, 2009, TISSUE ANTIGENS, V73, P289, DOI 10.1111/j.1399-0039.2009.01220.x; Kwon DS, 2010, EUR CYTOKINE NETW, V21, P208, DOI 10.1684/ecn.2010.0201; Lifson JD, 1997, J VIROL, V71, P9508, DOI 10.1128/JVI.71.12.9508-9514.1997; Mackewicz CE, 2003, AIDS, V17, pF23, DOI 10.1097/00002030-200309260-00001; Mee ET, 2010, TISSUE ANTIGENS, V76, P223, DOI 10.1111/j.1399-0039.2010.01500.x; Mee ET, 2009, IMMUNOGENETICS, V61, P327, DOI 10.1007/s00251-009-0369-8; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Mueller YM, 2010, EUR CYTOKINE NETW, V21, P219, DOI 10.1684/ecn.2010.0198; Muhl T, 2002, J IMMUNOL, V169, P3438, DOI 10.4049/jimmunol.169.6.3438; Naicker DD, 2009, J INFECT DIS, V200, P448, DOI 10.1086/600072; Norris PJ, 2006, AIDS RES HUM RETROV, V22, P757, DOI 10.1089/aid.2006.22.757; Oleksyk TK, 2009, GENES IMMUN, V10, P309, DOI 10.1038/gene.2009.9; Pantaleo G, 1997, P NATL ACAD SCI USA, V94, P254, DOI 10.1073/pnas.94.1.254; Peppoloni Samuele, 2003, Expert Rev Vaccines, V2, P285, DOI 10.1586/14760584.2.2.285; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Ploquin MJY, 2012, AIDS, V26, P1269, DOI 10.1097/QAD.0b013e328353e46b; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Sauermann U, 2000, J INFECT DIS, V182, P716, DOI 10.1086/315800; Schmitz JE, 2003, J VIROL, V77, P2165, DOI 10.1128/JVI.77.3.2165-2173.2003; Shlomchik, 2002, IMMUNOBIOLOGY; Song W, 2011, AIDS RES HUM RETROV, V27, P639, DOI 10.1089/AID.2010.0161; Stone M, 2010, J VIROL, V84, P7083, DOI 10.1128/JVI.00481-10; Stylianou E, 1999, CLIN EXP IMMUNOL, V116, P115; Trowsdale J, 2011, IMMUNOL LETT, V137, P1, DOI 10.1016/j.imlet.2011.01.002; Wojcechowskyi JA, 2007, J VIROL, V81, P406, DOI 10.1128/JVI.01636-06; Zaragoza MM, 2011, J IMMUNOL, V186, P1589, DOI 10.4049/jimmunol.1002021	43	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93235	10.1371/journal.pone.0093235	http://dx.doi.org/10.1371/journal.pone.0093235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695530	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000051
J	Collste, O; Tornvall, P; Sundin, O; Alam, M; Frick, M				Collste, Olov; Tornvall, Per; Sundin, Orjan; Alam, Mahbubul; Frick, Mats			No Myocardial Vulnerability to Mental Stress in Takotsubo Stress Cardiomyopathy	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; TISSUE DOPPLER-ECHOCARDIOGRAPHY; RIGHT-VENTRICULAR INVOLVEMENT; APICAL BALLOONING SYNDROME; SYMPATHOVAGAL INTERACTION; PERFORMANCE INDEX; SPECTRAL-ANALYSIS; INFARCTION; MORTALITY; PRESSURE	Objectives: Due to the frequent use of coronary angiography the awareness of Takotsubo stress cardiomyopathy (TSC) has increased although the exact pathophysiology of TSC is still largely unknown. Our objective was to investigate the effects of mental stress on myocardial function, heart rate variability (HRV) and salivary cortisol (SC) in TSC patients. Design: This study is a case-control study and a sub-study of the Stockholm Myocardial Infarction with Normal Coronaries (SMINC) study. Setting: Mental stress test was performed more than 6 months after the acute event in TSC patients and age- and sex-matched controls. Standard echocardiography and tissue Doppler imaging (TDI) - derived time-phases of cardiac cycle were recorded to calculate myocardial performance index (MPI) to assess ventricular function before and during mental stress. Holter-ECG recording was made to estimate HRV before, during and after mental stress. SC was measured at baseline, before and 20 minutes after mental stress. Subjects: Twenty-two TSC patients and 22 sex-and age- matched controls were recruited from the SMINC-study and investigated with a mental stress test. All TSC patients had a previous normal cardiovascular magnetic resonance investigation. Results: There were no significant differences at rest or during mental stress for left and right ventricular MPI or other standard diastolic variables between TSC patients and controls. HRV did not differ between TSC patients and controls. There was a trend towards less increase in SC after mental stress in TSC patients compared to controls. Conclusion: Mental stress did not induce a significant difference in myocardial function or HRV response between TSC and controls. Moreover, no significant difference could be seen in SC response at baseline, during or after mental stress. This study indicates that myocardial vulnerability to mental stress does not persist in TSC patients.	[Collste, Olov; Tornvall, Per; Frick, Mats] Karolinska Inst, Dept Clin Sci, Sodersjukhuset, Stockholm, Sweden; [Collste, Olov; Tornvall, Per; Frick, Mats] Karolinska Inst, Dept Educ, Sodersjukhuset, Stockholm, Sweden; [Alam, Mahbubul] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden; [Sundin, Orjan] Mid Sweden Univ, Dept Psychol, Ostersund, Sweden	Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Sodersjukhuset Hospital; Danderyds Hospital; Karolinska Institutet; Mid-Sweden University	Collste, O (corresponding author), Karolinska Inst, Dept Clin Sci, Sodersjukhuset, Stockholm, Sweden.	olov.collste@sodersjukhuset.se		Sundin, Orjan/0000-0002-4116-5501	Swedish Heart-Lung Foundation	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	This study was supported by the Swedish Heart-Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnlov J, 2005, AM HEART J, V149, P902, DOI 10.1016/j.ahj.2004.07.022; Barutcu I, 2005, ANN NONINVAS ELECTRO, V10, P324, DOI 10.1111/j.1542-474X.2005.00636.x; CALLISTER R, 1992, J PHYSIOL-LONDON, V454, P373, DOI 10.1113/jphysiol.1992.sp019269; Collste O, 2013, J INTERN MED, V273, P189, DOI 10.1111/j.1365-2796.2012.02567.x; COLLSTE O, 2013, VULNERABILITY UNPUB; DeBeck LD, 2010, AM J PHYSIOL-REG I, V299, pR80, DOI 10.1152/ajpregu.00246.2009; Delaney JPA, 2000, PERCEPT MOTOR SKILL, V91, P515, DOI 10.2466/PMS.91.6.515-524; Duzenli MA, 2009, HEART VESSELS, V24, P8, DOI 10.1007/s00380-008-1069-2; Elesber AA, 2006, J AM COLL CARDIOL, V47, P1082, DOI 10.1016/j.jacc.2005.12.004; Haghi D, 2006, EUR HEART J, V27, P2433, DOI 10.1093/eurheartj/ehl274; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; IRONSON G, 1992, AM J CARDIOL, V70, P281, DOI 10.1016/0002-9149(92)90605-X; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Krstacic G, 2012, MED BIOL ENG COMPUT, V50, P1037, DOI 10.1007/s11517-012-0947-z; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; LAWLER KA, 1995, PSYCHOSOM MED, V57, P357, DOI 10.1097/00006842-199507000-00007; Margey R, 2009, EUR J ECHOCARDIOGR, V10, P395, DOI 10.1093/ejechocard/jen292; MASAOKA S, 1985, DIABETES CARE, V8, P64, DOI 10.2337/diacare.8.1.64; Mrdovic I, 2010, J AM COLL CARDIOL, V55, P1750, DOI 10.1016/j.jacc.2009.02.098; Nijm J, 2007, J INTERN MED, V262, P375, DOI 10.1111/j.1365-2796.2007.01817.x; PAGANI M, 1991, CIRCULATION, V83, P43; Pagani M, 1984, J Hypertens Suppl, V2, pS383; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Pilgrim TM, 2008, INT J CARDIOL, V124, P283, DOI 10.1016/j.ijcard.2007.07.002; SCHNEIDERMAN N, 1989, HDB RES METHODS CARD, P349; Sharkey SW, 2010, J AM COLL CARDIOL, V55, P333, DOI 10.1016/j.jacc.2009.08.057; Sicari R, 2008, EUR J ECHOCARDIOGR, V9, P415, DOI 10.1093/ejechocard/jen175; Silberbauer John, 2008, Eur J Echocardiogr, V9, P136; Su HM, 2006, ECHOCARDIOGR-J CARD, V23, P287, DOI 10.1111/j.1540-8175.2006.00222.x; Tei C, 1995, J Cardiol, V26, P357; Tekten T, 2003, ECHOCARDIOGR-J CARD, V20, P503, DOI 10.1046/j.1540-8175.2003.03086.x; TOWNEND JN, 1992, AM J CARDIOL, V69, P1587, DOI 10.1016/0002-9149(92)90708-7; TSUJI H, 1994, CIRCULATION, V90, P878, DOI 10.1161/01.CIR.90.2.878	33	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93697	10.1371/journal.pone.0093697	http://dx.doi.org/10.1371/journal.pone.0093697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695370	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000106
J	Couvillon, MJ; Schurch, R; Ratnieks, FLW				Couvillon, Margaret J.; Schuerch, Roger; Ratnieks, Francis L. W.			Waggle Dance Distances as Integrative Indicators of Seasonal Foraging Challenges	PLOS ONE			English	Article							POLLINATION SERVICES; HONEYBEE COLONIES; DECLINES; BUMBLEBEES; DURATION	Even as demand for their services increases, honey bees (Apis mellifera) and other pollinating insects continue to decline in Europe and North America. Honey bees face many challenges, including an issue generally affecting wildlife: landscape changes have reduced flower-rich areas. One way to help is therefore to supplement with flowers, but when would this be most beneficial? We use the waggle dance, a unique behaviour in which a successful forager communicates to nestmates the location of visited flowers, to make a 2-year survey of food availability. We "eavesdropped'' on 5097 dances to track seasonal changes in foraging, as indicated by the distance to which the bees as economic foragers will recruit, over a representative rural-urban landscape. In year 3, we determined nectar sugar concentration. We found that mean foraging distance/area significantly increase from springs (493 m, 0.8 km(2)) to summers (2156 m, 15.2 km(2)), even though nectar is not better quality, before decreasing in autumns (1275 m, 5.1 km(2)). As bees will not forage at long distances unnecessarily, this suggests summer is the most challenging season, with bees utilizing an area 22 and 6 times greater than spring or autumn. Our study demonstrates that dancing bees as indicators can provide information relevant to helping them, and, in particular, can show the months when additional forage would be most valuable.	[Couvillon, Margaret J.; Schuerch, Roger; Ratnieks, Francis L. W.] Univ Sussex, Sch Life Sci, Lab Apiculture & Social Insects, Brighton, E Sussex, England; [Schuerch, Roger] Univ Sussex, Sch Life Sci, Lab Social Evolut, Brighton, E Sussex, England	University of Sussex; University of Sussex	Couvillon, MJ (corresponding author), Univ Sussex, Sch Life Sci, Lab Apiculture & Social Insects, Brighton, E Sussex, England.	M.Couvillon@Sussex.ac.uk	Schurch, Roger/J-8744-2019	Schurch, Roger/0000-0001-9075-8912	Nineveh Charitable Trust; Swiss National Science Foundation [PA00P3_139731]; Waitrose Ltd.; Burt's Bees; Body Shop Foundation	Nineveh Charitable Trust; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Waitrose Ltd.; Burt's Bees; Body Shop Foundation	MJC is funded by the Nineveh Charitable Trust, and RS is funded by the Swiss National Science Foundation (Grant PA00P3_139731). Additional research funding was provided by Waitrose Ltd., Burt's Bees, and the Body Shop Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Allsopp MH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003128; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; Beekman M, 2004, FUNCT ECOL, V18, P829, DOI 10.1111/j.0269-8463.2004.00924.x; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Biesmeijer JC, 2006, APIDOLOGIE, V37, P240, DOI 10.1051/apido:2006014; BOCH R, 1957, Z VERGL PHYSIOL, V40, P289, DOI 10.1007/BF00340572; Brittain C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2767; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Carvell C, 2006, BIOL CONSERV, V132, P481, DOI 10.1016/j.biocon.2006.05.008; Couvillon MJ, 2012, INSECT SOC, V59, P297, DOI 10.1007/s00040-012-0224-z; Couvillon MJ, 2012, BIOL OPEN, V1, P467, DOI 10.1242/bio.20121099; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Frisch K. v., 1946, OESTERREICH ZOOL ZEITSCHR [ VIENNA], V1, P1; Garbuzov M, 2013, IVY UNDERAPPRECIATED; Gruter C, 2010, CURR BIOL, V20, pR683, DOI 10.1016/j.cub.2010.06.052; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kluser S., 2011, UNEP EMERGING ISSUES; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Levy S, 2011, NATURE, V479, P164, DOI 10.1038/479164a; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nowakowski M, 2011, OPERATION POLLINATOR; Pebesma E.J., 2005, R NEWS, V5; Plummer M, 2012, RJAGS BAYESIAN GRAPH; Plummer M., 2003, JAGS PROGRAM ANAL BA, P20; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R Core Team, 2012, R LANG ENV STAT COMP; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; SCHMIDHEMPEL P, 1987, J ANIM ECOL, V56, P219, DOI 10.2307/4811; SCHMIDHEMPEL P, 1987, J ANIM ECOL, V56, P209, DOI 10.2307/4810; Schurch R, 2013, J COMP PHYSIOL A, P1; Seeley T., 1995, WISDOM HIVE SOCIAL P; Seeley TD, 2000, J COMP PHYSIOL A, V186, P813, DOI 10.1007/s003590000134; SEELEY TD, 1994, BEHAV ECOL SOCIOBIOL, V34, P51, DOI 10.1007/BF00175458; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; von Frisch K., 1967, DANCE LANGUAGE ORIEN; WADDINGTON KD, 1994, BEHAV ECOL SOCIOBIOL, V35, P423, DOI 10.1007/BF00165845; Walsh B., 2014, TIME; Westphal C, 2006, ECOL ENTOMOL, V31, P389, DOI 10.1111/j.1365-2311.2006.00801.x; Winfree R, 2011, ANNU REV ECOL EVOL S, V42, P1, DOI 10.1146/annurev-ecolsys-102710-145042; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110; [No title captured]	50	106	108	8	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93495	10.1371/journal.pone.0093495	http://dx.doi.org/10.1371/journal.pone.0093495			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695678	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000334103000082
J	Linde, K; Friedrichs, C; Alscher, A; Wagenpfeil, S; Meissner, K; Schneider, A				Linde, Klaus; Friedrichs, Clara; Alscher, Anna; Wagenpfeil, Stefan; Meissner, Karin; Schneider, Antonius			The Use of Placebo and Non-Specific Therapies and Their Relation to Basic Professional Attitudes and the Use of Complementary Therapies among German Physicians - A Cross-Sectional Survey	PLOS ONE			English	Article							CLINICAL-PRACTICE; INTERVENTIONS; QUESTIONNAIRE; GPS	We aimed to investigate the use of placebos ( e. g. saline injections) and non-specific treatments ( e. g. vitamin supplements in individuals without a relevant deficiency) among physicians working in private practices in Germany, and how such use is associated with the belief in and the use of complementary and alternative treatments, and basic professional attitudes. A four-page questionnaire was sent to nationwide random samples of general practitioners ( GP), internists and orthopaedists working in private practices. The response rate was 46% ( 935 of 2018). 24% of GPs, 44% of internists and 57% of orthopaedists had neither used pure placebos nor non-specific therapies in the previous 12 months. 11% percent of GPs, 12% of internists and 7% of orthopaedists had exclusively used pure placebos; 30%, 33% and 26%, respectively, had exclusively used non-specific therapies; 35%, 12% and 9% had used both. Age, sex and agreement to the statement that physicians should harness placebo effects were not significantly associated with any pattern of use. Exclusive use of pure placebos was associated with being a GP, being an internist, and having unorthodox professional views. In addition to these three factors, a lower use of CAM therapies and a wish for having more time was associated with the exclusive use of nonspecific therapies. Among physicians using both pure placebo and non-specific therapies, heterodox views were also somewhat more pronounced. However, associations were particularly strong for being a GP ( Odds ratio 11.6 ( 95%CI 6.41; 21.3)) and having orthodox views ( Odds ratio 0.10 ( 95%CI 0.06; 0.18)) among this group. In conclusion, the use of placebos and non-specific treatments varies strongly between medical specialties and is associated with basic professional attitudes. The findings support the view that the use of placebos and, in particular, of non-specific therapies is primarily a coping behaviour for difficult and uncertain situations.	[Linde, Klaus; Friedrichs, Clara; Alscher, Anna; Schneider, Antonius] Tech Univ Munich, Inst Gen Practice, D-80290 Munich, Germany; [Wagenpfeil, Stefan] Univ Saarlandes Kliniken, Inst Med Biometry Epidemiol & Med Informat, Homburg, Germany; [Meissner, Karin] Univ Munich, Inst Med Psychol, D-80539 Munich, Germany	Technical University of Munich; Universitatsklinikum des Saarlandes; University of Munich	Linde, K (corresponding author), Tech Univ Munich, Inst Gen Practice, D-80290 Munich, Germany.	Klaus.Linde@tum.de	MEISSNER, Karin/AAS-2483-2021	Linde, Klaus/0000-0002-2902-970X	Institute of General Practice, Technische Universitat Munchen	Institute of General Practice, Technische Universitat Munchen	There was no external funding for the study. Costs were covered from the regular budget of the Institute of General Practice, Technische Universitat Munchen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babel P, 2012, EVAL HEALTH PROF, V35, P447, DOI 10.1177/0163278711420285; Bostick NA, 2008, J CLIN ETHIC, V19, P58; Bundesarztekammer, 2010, DTSCH ARZTEBL, V107, P1417; COMAROFF J, 1976, SOCIOL REV, V24, P79, DOI 10.1111/j.1467-954X.1976.tb00574.x; Fassler M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-15; Fassler M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-144; Henriksen K, 2004, SOC SCI MED, V59, P47, DOI 10.1016/j.socscimed.2003.10.004; Howick J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058247; Hrobjartsson A, 2003, EVAL HEALTH PROF, V26, P153, DOI 10.1177/0163278703026002002; Hrobjartsson A, 2008, J CLIN ETHIC, V19, P66; Kermen R, 2010, FAM MED, V42, P636; Kumar S, 2003, BMJ-BRIT MED J, V326, P138, DOI 10.1136/bmj.326.7381.138; Lichtenberg P, 2004, J MED ETHICS, V30, P551, DOI 10.1136/jme.2002.002832; Linde K, 2013, FORSCH KOMPLEMENTMED, V20, P361, DOI 10.1159/000356230; Louhiala P, 2012, J MED ETHICS, V38, P403, DOI 10.1136/medethics-2011-100420; Meissner K, 2012, FAM PRACT, V29, P79, DOI 10.1093/fampra/cmr045; Morris CJ, 2001, FAM PRACT, V18, P581, DOI 10.1093/fampra/18.6.581; O'Riordan Margaret, 2011, Qual Prim Care, V19, P175; SCHWARTZ RK, 1989, SOC SCI MED, V28, P577, DOI 10.1016/0277-9536(89)90252-9; Tilburt JC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1938; Weiss MC, 1997, PHARM J, V259, P339	21	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e92938	10.1371/journal.pone.0092938	http://dx.doi.org/10.1371/journal.pone.0092938			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695272	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000030
J	Luo, YLL; Cai, HJ; Song, HR				Luo, Yu L. L.; Cai, Huajian; Song, Hairong			A Behavioral Genetic Study of Intrapersonal and Interpersonal Dimensions of Narcissism	PLOS ONE			English	Article							PERSONALITY-INVENTORY; ORBITOFRONTAL CORTEX; GENERATION ME; SELF; TRAITS; TWIN; ENTITLEMENT; INCREASES; THREAT; MODEL	Narcissism, characterized by grandiose self-image and entitled feelings to others, has been increasingly prevalent in the past decades. This study examined genetic and environmental bases of two dimensions of narcissism: intrapersonal grandiosity and interpersonal entitlement. A total of 304 pairs of twins from Beijing, China completed the Narcissistic Grandiosity Scale and the Psychological Entitlement Scale. Both grandiosity (23%) and entitlement (35%) were found to be moderately heritable, while simultaneously showing considerable non-shared environmental influences. Moreover, the genetic and environmental influences on the two dimensions were mostly unique (92-93%), with few genetic and environmental effects in common (7-8%). The two dimensions of narcissism, intrapersonal grandiosity and interpersonal entitlement, are heritable and largely independent of each other in terms of their genetic and environmental sources. These findings extend our understanding of the heritability of narcissism on the one hand. On the other hand, the study demonstrates the rationale for distinguishing between intrapersonal and interpersonal dimensions of narcissism, and possibly personality in general as well.	[Luo, Yu L. L.; Cai, Huajian] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Song, Hairong] Univ Oklahoma, Dept Psychol, Norman, OK 73019 USA	Chinese Academy of Sciences; Institute of Psychology, CAS; University of Oklahoma System; University of Oklahoma - Norman	Cai, HJ (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	caihj@psych.ac.cn			Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-8]; National Natural Science Foundation of China [31070919, 31300871]; Hundred Talents Program [Y1CX153003]; Young Scientists Fund, Institute of Psychology, Chinese Academy of Sciences [Y1CX273005]	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Program(Chinese Academy of Sciences); Young Scientists Fund, Institute of Psychology, Chinese Academy of Sciences	This research is supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-8), National Natural Science Foundation of China (31070919, 31300871), Hundred Talents Program (Y1CX153003), and the Young Scientists Fund, Institute of Psychology, Chinese Academy of Sciences (Y1CX273005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman RA, 2011, ASSESSMENT, V18, P67, DOI 10.1177/1073191110382845; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Beer JS, 2010, NEUROIMAGE, V49, P2671, DOI 10.1016/j.neuroimage.2009.10.075; Boker S. M., 2012, OPENMX 1 2 USER GUID; Bollen KA, 1989, STRUCTURAL EQUATIONS; Brown RP, 2009, PERS SOC PSYCHOL B, V35, P951, DOI 10.1177/0146167209335461; Campbell WK, 2002, PERS SOC PSYCHOL B, V28, P358, DOI 10.1177/0146167202286007; Campbell WK, 2004, J PERS ASSESS, V83, P29, DOI 10.1207/s15327752jpa8301_04; Campbell WK, 2000, J RES PERS, V34, P329, DOI 10.1006/jrpe.2000.2282; Cater TE, 2011, PERS INDIV DIFFER, V51, P935, DOI 10.1016/j.paid.2011.07.023; Chen J, 2013, TWIN RES HUM GENET, V16, P91, DOI 10.1017/thg.2012.115; Chen J, 2010, TWIN RES HUM GENET, V13, P194, DOI 10.1375/twin.13.2.194; Corry N, 2008, J PERS ASSESS, V90, P593, DOI 10.1080/00223890802388590; EMMONS RA, 1984, J PERS ASSESS, V48, P291, DOI 10.1207/s15327752jpa4803_11; EMMONS RA, 1987, J PERS SOC PSYCHOL, V52, P11, DOI 10.1037/0022-3514.52.1.11; Fan Y, 2011, PSYCHOL MED, V41, P1641, DOI 10.1017/S003329171000228X; Fan Y, 2011, NEUROSCI BIOBEHAV R, V35, P903, DOI 10.1016/j.neubiorev.2010.10.009; Hart CM, 2011, J RES PERS, V45, P238, DOI 10.1016/j.jrp.2011.01.002; Horton RS, 2009, J PERS, V77, P1493, DOI 10.1111/j.1467-6494.2009.00590.x; Hughes BL, 2013, J COGNITIVE NEUROSCI, V25, P613, DOI 10.1162/jocn_a_00343; Hughes BL, 2012, NEUROIMAGE, V61, P889, DOI 10.1016/j.neuroimage.2012.03.011; Hughes BL, 2012, CEREB CORTEX, V22, P1372, DOI 10.1093/cercor/bhr213; Kendler KS, 2008, ARCH GEN PSYCHIAT, V65, P1438, DOI 10.1001/archpsyc.65.12.1438; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Kubarych TS, 2004, PERS INDIV DIFFER, V36, P857, DOI 10.1016/S0191-8869(03)00158-2; Leary T., 1957, INTERPERSONAL DIAGNO; Livesley WJ, 1998, ARCH GEN PSYCHIAT, V55, P941, DOI 10.1001/archpsyc.55.10.941; Loehlin JC, 1996, BEHAV GENET, V26, P65, DOI 10.1007/BF02361160; Luo YLL, 2014, J RES PERS, V49, P52, DOI 10.1016/j.jrp.2014.01.001; MCGUE M, 1984, BEHAV GENET, V14, P325, DOI 10.1007/BF01080045; Miller JD, 2012, ASSESSMENT, V19, P8, DOI 10.1177/1073191111429390; Morf C. C., 2011, HDB SELF ENHANCEMENT, P399; Paulhus DL, 1998, J PERS, V66, P1025, DOI 10.1111/1467-6494.00041; R Development Core Team, 2012, LANG ENV STAT COMP; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; RASKIN R, 1988, J PERS SOC PSYCHOL, V54, P890, DOI 10.1037/0022-3514.54.5.890; RASKIN RN, 1979, PSYCHOL REP, V45, P590, DOI 10.2466/pr0.1979.45.2.590; Stein J., 2013, MILLENNIALS ME ME ME; Tamborski M, 2012, PERS INDIV DIFFER, V52, P942, DOI 10.1016/j.paid.2012.01.030; Torgersen S, 2000, COMPR PSYCHIAT, V41, P416, DOI 10.1053/comp.2000.16560; Trzesniewski KH, 2008, J PERS, V76, P903, DOI 10.1111/j.1467-6494.2008.00508.x; Trzesniewski KH, 2010, PERSPECT PSYCHOL SCI, V5, P58, DOI 10.1177/1745691609356789; Turkheimer E, 2000, CURR DIR PSYCHOL SCI, V9, P160, DOI 10.1111/1467-8721.00084; Twenge JM, 2010, SOC PSYCHOL PERS SCI, V1, P99, DOI 10.1177/1948550609355719; Twenge JM, 2008, J RES PERS, V42, P1619, DOI 10.1016/j.jrp.2008.06.014; Vernon PA, 2008, PERS INDIV DIFFER, V44, P445, DOI 10.1016/j.paid.2007.09.007; Vonk J, 2013, PERS INDIV DIFFER, V54, P396, DOI 10.1016/j.paid.2012.10.010; Wiggins JS, 1979, J PERS SOC PSYCHOL, V37, P295	48	4	5	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93403	10.1371/journal.pone.0093403	http://dx.doi.org/10.1371/journal.pone.0093403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695616	Green Submitted, gold, Green Published			2022-12-27	WOS:000334103000069
J	Mangieri, LR; Mader, BJ; Thomas, CE; Taylor, CA; Luker, AM; Tse, TE; Huisingh, C; Shacka, JJ				Mangieri, Leandra R.; Mader, Burton J.; Thomas, Cailin E.; Taylor, Charles A.; Luker, Austin M.; Tse, Tonia E.; Huisingh, Carrie; Shacka, John J.			ATP6V0C Knockdown in Neuroblastoma Cells Alters Autophagy-Lysosome Pathway Function and Metabolism of Proteins that Accumulate in Neurodegenerative Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; H+-ATPASE-C; ALPHA-SYNUCLEIN; V-ATPASE; DEGRADATION; BAFILOMYCIN; PARKINSONS; SUBUNIT; MODELS; DEATH	ATP6V0C is the bafilomycin A1-binding subunit of vacuolar ATPase, an enzyme complex that critically regulates vesicular acidification. We and others have shown previously that bafilomycin A1 regulates cell viability, autophagic flux and metabolism of proteins that accumulate in neurodegenerative disease. To determine the importance of ATP6V0C for autophagy-lysosome pathway function, SH-SY5Y human neuroblastoma cells differentiated to a neuronal phenotype were nucleofected with non-target or ATP6V0C siRNA and following recovery were treated with either vehicle or bafilomycin A1 (0.3-100 nM) for 48 h. ATP6V0C knockdown was validated by quantitative RT-PCR and by a significant decrease in Lysostracker Red staining. ATP6V0C knockdown significantly increased basal levels of microtubule-associated protein light chain 3-II (LC3-II), alpha-synuclein high molecular weight species and APP C-terminal fragments, and inhibited autophagic flux. Enhanced LC3 and LAMP-1 co-localization following knockdown suggests that autophagic flux was inhibited in part due to lysosomal degradation and not by a block in vesicular fusion. Knockdown of ATP6V0C also sensitized cells to the accumulation of autophagy substrates and a reduction in neurite length following treatment with 1 nM bafilomycin A1, a concentration that did not produce such alterations in non-target control cells. Reduced neurite length and the percentage of propidium iodide-positive dead cells were also significantly greater following treatment with 3 nM bafilomycin A1. Together these results indicate a role for ATP6V0C in maintaining constitutive and stress-induced ALP function, in particular the metabolism of substrates that accumulate in age-related neurodegenerative disease and may contribute to disease pathogenesis.	[Mangieri, Leandra R.; Mader, Burton J.; Thomas, Cailin E.; Taylor, Charles A.; Luker, Austin M.; Tse, Tonia E.; Shacka, John J.] Univ Alabama Birmingham, Dept Pathol, Div Neuropathol, Birmingham, AL 35294 USA; [Huisingh, Carrie; Shacka, John J.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Mader, Burton J.] Birmingham Vet Adm Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Shacka, JJ (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Neuropathol, Birmingham, AL 35294 USA.	shacka@uab.edu		Huisingh, Carrie/0000-0002-7010-2024; Mangieri, Leandra/0000-0001-8981-0103	VA Merit Award [1 I01 BX000957-01]; UAB Dept. Pathology; UAB Comprehensive Center for Healthy Aging; Alzheimer's of Central Alabama; UAB Center for Clinical and Translational Science (CCTS)	VA Merit Award(US Department of Veterans Affairs); UAB Dept. Pathology; UAB Comprehensive Center for Healthy Aging; Alzheimer's of Central Alabama; UAB Center for Clinical and Translational Science (CCTS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by: 1) VA Merit Award 1 I01 BX000957-01 to John J. Shacka. Role: provided funds to carry out studies submitted for publication. 2) a pilot study from the UAB Center for Clinical and Translational Science (CCTS, co-sponsored by the UAB Dept. Pathology and the UAB Comprehensive Center for Healthy Aging), to John J. Shacka (URL: www.uab.edu/ccts). Role: provided funds to carry out studies submitted for publication. 3) a grant from Alzheimer's of Central Alabama to Burton J. Mader (URL: www.alzca.org). Role: provided funds to carry out studies submitted for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; Bowman BJ, 2002, J BIOL CHEM, V277, P3965, DOI 10.1074/jbc.M109756200; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Byun YJ, 2007, NEUROSCI LETT, V425, P183, DOI 10.1016/j.neulet.2007.08.027; Byun YJ, 2011, J CELL BIOCHEM, V112, P1985, DOI 10.1002/jcb.23105; Di Giovanni J, 2010, NEURON, V67, P268, DOI 10.1016/j.neuron.2010.06.024; Ebrahimi-Fakhari D, 2012, ACTA NEUROPATHOL, V124, P153, DOI 10.1007/s00401-012-1004-6; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; El Far O, 2011, J NEUROCHEM, V117, P603, DOI 10.1111/j.1471-4159.2011.07234.x; Esposito LA, 2011, METHODS MOL BIOL, V670, P71, DOI 10.1007/978-1-60761-744-0_6; Evin G, 2003, J NEUROSCI RES, V74, P386, DOI 10.1002/jnr.10745; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Jin D, 2012, NEUROCHEM INT, V61, P907, DOI 10.1016/j.neuint.2011.12.021; Kaur G, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00079; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klucken J, 2012, AUTOPHAGY, V8, P754, DOI 10.4161/auto.19371; Kurzawa-Akanbi M, 2012, J NEUROCHEM, V123, P298, DOI 10.1111/j.1471-4159.2012.07879.x; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lim JH, 2007, MOL PHARMACOL, V71, P942, DOI 10.1124/mol.106.030296; Liu QY, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-4; Lovati MR, 2013, FASEB J, V27; Mader BJ, 2012, ACS CHEM NEUROSCI, V3, P1063, DOI 10.1021/cn300145z; Marzinke MA, 2013, ARCH BIOCHEM BIOPHYS, V540, P94, DOI 10.1016/j.abb.2013.10.012; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Moriya K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037892; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Pivtoraiko VN, 2010, J NEUROCHEM, V114, P1193, DOI 10.1111/j.1471-4159.2010.06838.x; Pivtoraiko VN, 2009, ANTIOXID REDOX SIGN, V11, P481, DOI [10.1089/ars.2008.2263, 10.1089/ARS.2008.2263]; Plowey ED, 2008, JNEUROCHEM; Qiao L., 2008, MOL BRAIN, V1, P1; Ruan QM, 2010, NEUROBIOL DIS, V37, P330, DOI 10.1016/j.nbd.2009.10.011; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Shacka JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P718, DOI 10.2741/2714; Shacka JJ, 2012, BRAIN RES BULL, V88, P43, DOI 10.1016/j.brainresbull.2012.03.003; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Sun-Wada GH, 2000, DEV BIOL, V228, P315, DOI 10.1006/dbio.2000.9963; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Tofaris GK, 2012, MOVEMENT DISORD, V27, P1364, DOI 10.1002/mds.25136; Vingtdeux V, 2007, NEUROBIOL DIS, V25, P686, DOI 10.1016/j.nbd.2006.09.019; Wang YR, 2005, J BIOL CHEM, V280, P40481, DOI 10.1074/jbc.M509106200; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; You HY, 2009, CANCER LETT, V280, P110, DOI 10.1016/j.canlet.2009.02.023; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	52	40	43	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93257	10.1371/journal.pone.0093257	http://dx.doi.org/10.1371/journal.pone.0093257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695574	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000054
J	Yadav, V; Sainburg, RL				Yadav, Vivek; Sainburg, Robert L.			Limb Dominance Results from Asymmetries in Predictive and Impedance Control Mechanisms	PLOS ONE			English	Article							HUMAN MULTIJOINT ARM; MANUAL ASYMMETRIES; MOVEMENT CONTROL; HEMISPHERIC-ASYMMETRY; MOTOR LATERALIZATION; JOINT MOVEMENTS; RIGHT-HANDERS; HANDEDNESS; STIFFNESS; POSITION	Handedness is a pronounced feature of human motor behavior, yet the underlying neural mechanisms remain unclear. We hypothesize that motor lateralization results from asymmetries in predictive control of task dynamics and in control of limb impedance. To test this hypothesis, we present an experiment with two different force field environments, a field with a predictable magnitude that varies with the square of velocity, and a field with a less predictable magnitude that varies linearly with velocity. These fields were designed to be compatible with controllers that are specialized in predicting limb and task dynamics, and modulating position and velocity dependent impedance, respectively. Because the velocity square field does not change the form of the equations of motion for the reaching arm, we reasoned that a forward dynamic-type controller should perform well in this field, while control of linear damping and stiffness terms should be less effective. In contrast, the unpredictable linear field should be most compatible with impedance control, but incompatible with predictive dynamics control. We measured steady state final position accuracy and 3 trajectory features during exposure to these fields: Mean squared jerk, Straightness, and Movement time. Our results confirmed that each arm made straighter, smoother, and quicker movements in its compatible field. Both arms showed similar final position accuracies, which were achieved using more extensive corrective sub-movements when either arm performed in its incompatible field. Finally, each arm showed limited adaptation to its incompatible field. Analysis of the dependence of trajectory errors on field magnitude suggested that dominant arm adaptation occurred by prediction of the mean field, thus exploiting predictive mechanisms for adaptation to the unpredictable field. Overall, our results support the hypothesis that motor lateralization reflects asymmetries in specific motor control mechanisms associated with predictive control of limb and task dynamics, and modulation of limb impedance.	[Sainburg, Robert L.] Penn State Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA USA; [Sainburg, Robert L.] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Hershey, PA 17033 USA; [Yadav, Vivek; Sainburg, Robert L.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Yadav, V (corresponding author), Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA.	vxy10@psu.edu; rls45@psu.edu		Sainburg, Robert/0000-0003-2627-1258	National Institutes of Health (NIH): NICHD [R01 HD059783]; American Heart Association's, Great Rivers Affiliate, Post-doctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059783] Funding Source: NIH RePORTER	National Institutes of Health (NIH): NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Heart Association's, Great Rivers Affiliate, Post-doctoral Fellowship(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by #R01 HD059783 from the National Institutes of Health (NIH): NICHD, and American Heart Association's, Great Rivers Affiliate, Post-doctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNETT J, 1979, Q J EXP PSYCHOL, V31, P641, DOI 10.1080/14640747908400755; Bagesteiro LB, 2003, J NEUROPHYSIOL, V90, P1503, DOI 10.1152/jn.00189.2003; Bagesteiro LB, 2002, J NEUROPHYSIOL, V88, P2408, DOI 10.1152/jn.00901.2001; Berret B, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000194; BOROD JC, 1984, BRIT J PSYCHOL, V75, P177, DOI 10.1111/j.2044-8295.1984.tb01889.x; Boulinguez P, 2001, CORTEX, V37, P101, DOI 10.1016/S0010-9452(08)70561-6; BRYDEN MP, 1977, NEUROPSYCHOLOGIA, V15, P617, DOI 10.1016/0028-3932(77)90067-7; CARSON RG, 1990, NEUROPSYCHOLOGIA, V28, P1215, DOI 10.1016/0028-3932(90)90056-T; Duff SV, 2007, EXP BRAIN RES, V179, P551, DOI 10.1007/s00221-006-0811-1; ELLIOTT D, 1993, CAN J EXP PSYCHOL, V47, P570, DOI 10.1037/h0078856; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Franklin DW, 2003, EXP BRAIN RES, V152, P211, DOI 10.1007/s00221-003-1540-3; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; Gomi H, 1998, J NEUROSCI, V18, P8965; Gottlieb G L, 1996, Exerc Sport Sci Rev, V24, P1; GOTTLIEB GL, 1993, J MOTOR BEHAV, V25, P153, DOI 10.1080/00222895.1993.9942046; Gottlieb GL, 1998, J NEUROPHYSIOL, V80, P1860, DOI 10.1152/jn.1998.80.4.1860; Haaland KY, 2004, J COGNITIVE NEUROSCI, V16, P621, DOI 10.1162/089892904323057344; Haaland KY, 2007, MOTOR CONTROL S, V11, pS7; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hellige JB, 1996, ACTA NEUROBIOL EXP, V56, P485; HIRAYAMA M, 1993, J MOTOR BEHAV, V25, P162, DOI 10.1080/00222895.1993.9942047; Hogan N, 2009, J MOTOR BEHAV, V41, P529, DOI 10.3200/35-09-004-RC; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; Mani S, 2013, BRAIN, V136, P1288, DOI 10.1093/brain/aws283; Mutha PK, 2007, HUM MOVEMENT SCI, V26, P808, DOI 10.1016/j.humov.2007.06.001; Mutha PK, 2011, BRAIN, V134, P3644, DOI 10.1093/brain/awr275; Mutha PK, 2011, J NEUROSCI, V31, P6972, DOI 10.1523/JNEUROSCI.6432-10.2011; Mutha PK, 2008, BRAIN RES, V1246, P54, DOI 10.1016/j.brainres.2008.09.061; NELSON WL, 1983, BIOL CYBERN, V46, P135, DOI 10.1007/BF00339982; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osu R, 1999, J NEUROPHYSIOL, V81, P1458, DOI 10.1152/jn.1999.81.4.1458; Przybyla A, 2013, NEUROSCIENCE, V228, P349, DOI 10.1016/j.neuroscience.2012.10.046; ROY EA, 1989, Q J EXP PSYCHOL-A, V41, P501, DOI 10.1080/14640748908402379; ROY EA, 1986, CAN J PSYCHOL, V40, P109, DOI 10.1037/h0080087; Sainburg R. L., 2010, VISION GOAL DIRECTED, P219; Sainburg RL, 2005, EXERC SPORT SCI REV, V33, P206, DOI 10.1097/00003677-200510000-00010; Sainburg RL, 2000, J NEUROPHYSIOL, V83, P2661, DOI 10.1152/jn.2000.83.5.2661; Sainburg RL, 2002, EXP BRAIN RES, V142, P241, DOI 10.1007/s00221-001-0913-8; Schabowsky CN, 2007, EXP BRAIN RES, V182, P567, DOI 10.1007/s00221-007-1017-x; Schaefer SY, 2007, MOTOR CONTROL S, V11, pS113; Schaefer SY, 2005, DIFFERENTIAL HEMISPH; Schaefer SY, 2007, SOC NEUR ABSTR; Schaefer SY, 2007, BRAIN, V130, P2146, DOI 10.1093/brain/awm145; Schaefer SY, 2012, CEREB CORTEX, V22, P1407, DOI 10.1093/cercor/bhr237; Schaefer SY, 2009, BRAIN RES, V1298, P78, DOI 10.1016/j.brainres.2009.08.063; Schaefer SY, 2009, NEUROPSYCHOLOGIA, V47, P2953, DOI 10.1016/j.neuropsychologia.2009.06.025; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; Scheidt RA, 2007, J NEUROPHYSIOL, V98, P3600, DOI 10.1152/jn.00121.2007; Scott SH, 2012, TRENDS COGN SCI, V16, P541, DOI 10.1016/j.tics.2012.09.008; Shabbott BA, 2008, J NEUROPHYSIOL, V100, P565, DOI 10.1152/jn.90349.2008; SHADMEHR R, 1992, BIOL CYBERN, V66, P463, DOI 10.1007/BF00204111; Takahashi CD, 2001, J NEUROPHYSIOL, V86, P1047, DOI 10.1152/jn.2001.86.2.1047; TODOR JI, 1980, J MOTOR BEHAV, V12, P57; TODOR JI, 1985, J MOTOR BEHAV, V17, P355, DOI 10.1080/00222895.1985.10735354; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Wang, 2008, EXP BRAIN RES, V187, P2790, DOI [10.1007/s00221-008-1393-x, DOI 10.1007/S00221-008-1393-X]; Wang JS, 2004, J NEUROPHYSIOL, V92, P349, DOI 10.1152/jn.00960.2003; Wei KL, 2010, J NEUROPHYSIOL, V104, P3053, DOI 10.1152/jn.01025.2009; WINSTEIN CJ, 1995, EXP BRAIN RES, V105, P163; Winstein CJ, 1997, J NEUROPHYSIOL, V77, P1581, DOI 10.1152/jn.1997.77.3.1581; Yadav V, 2011, NEUROSCIENCE, V196, P153, DOI 10.1016/j.neuroscience.2011.08.039	64	38	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93892	10.1371/journal.pone.0093892	http://dx.doi.org/10.1371/journal.pone.0093892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LC	24695543	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000130
J	Zimov, S; Zimov, N				Zimov, Sergey; Zimov, Nikita			Role of Megafauna and Frozen Soil in the Atmospheric CH4 Dynamics	PLOS ONE			English	Article							ABRUPT CLIMATE-CHANGE; LAST GLACIAL MAXIMUM; CARBON STORAGE; METHANE; GREENLAND; LAKES; PERMAFROST; ANTARCTICA; GRADIENT; RECORDS	Modern wetlands are the world's strongest methane source. But what was the role of this source in the past? An analysis of global C-14 data for basal peat combined with modelling of wetland succession allowed us to reconstruct the dynamics of global wetland methane emission through time. These data show that the rise of atmospheric methane concentrations during the Pleistocene-Holocene transition was not connected with wetland expansion, but rather started substantially later, only 9 thousand years ago. Additionally, wetland expansion took place against the background of a decline in atmospheric methane concentration. The isotopic composition of methane varies according to source. Owing to ice sheet drilling programs past dynamics of atmospheric methane isotopic composition is now known. For example over the course of Pleistocene-Holocene transition atmospheric methane became depleted in the deuterium isotope, which indicated that the rise in methane concentrations was not connected with activation of the deuterium-rich gas clathrates. Modelling of the budget of the atmospheric methane and its isotopic composition allowed us to reconstruct the dynamics of all main methane sources. For the late Pleistocene, the largest methane source was megaherbivores, whose total biomass is estimated to have exceeded that of present-day humans and domestic animals. This corresponds with our independent estimates of herbivore density on the pastures of the late Pleistocene based on herbivore skeleton density in the permafrost. During deglaciation, the largest methane emissions originated from degrading frozen soils of the mammoth steppe biome. Methane from this source is unique, as it is depleted of all isotopes. We estimated that over the entire course of deglaciation (15,000 to 6,000 year before present), soils of the mammoth steppe released 300-550 Pg (10(15) g) of methane. From current study we conclude that the Late Quaternary Extinction significantly affected the global methane cycle.	[Zimov, Sergey; Zimov, Nikita] Russian Acad Sci, Pacific Inst Geog, Northeast Sci Stn, Cherskii, Russia	Pacific Geographical Institute of the Far Eastern Branch of the Russian Academy of Sciences; Russian Academy of Sciences	Zimov, S (corresponding author), Russian Acad Sci, Pacific Inst Geog, Northeast Sci Stn, Cherskii, Russia.	sazimov55@mail.ru	Zimov, Sergey/K-3009-2018	Zimov, Sergey/0000-0002-0053-6599	Directorate For Geosciences [1107892] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Adams JM, 1998, GLOBAL PLANET CHANGE, V17, P3; ADAMS JM, 1990, NATURE, V348, P711, DOI 10.1038/348711a0; Anthony KMW, 2012, NAT GEOSCI, V5, P419, DOI [10.1038/ngeo1480, 10.1038/NGEO1480]; Bousquet P, 2011, ATMOS CHEM PHYS, V11, P3689, DOI 10.5194/acp-11-3689-2011; Brook EJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P559, DOI 10.1029/1999GB001182; Brosius LS, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001810; Chappellaz J, 1997, J GEOPHYS RES-ATMOS, V102, P15987, DOI 10.1029/97JD01017; CHAPPELLAZ J, 1993, NATURE, V366, P443, DOI 10.1038/366443a0; Cicerone RJ, 1988, GLOBAL BIOGEOCHEM CY, V2, P299, DOI 10.1029/GB002i004p00299; CRUTZEN P J, 1986, Tellus Series B Chemical and Physical Meteorology, V38, P271; Dallenbach A, 2000, GEOPHYS RES LETT, V27, P1005, DOI 10.1029/1999GL010873; Ferretti DF, 2005, SCIENCE, V309, P1714, DOI 10.1126/science.1115193; Fischer H, 2008, NATURE, V452, P864, DOI 10.1038/nature06825; Gajewski K, 2001, GLOBAL BIOGEOCHEM CY, V15, P297, DOI 10.1029/2000GB001286; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Johnson CN, 2008, P R SOC B, DOI [10.1098/rsb.2008.1921, DOI 10.1098/RSB.2008.1921]; Kennet JP, 2003, METHANE HYDRATES QUA; Kennett JP, 2000, SCIENCE, V288, P128, DOI 10.1126/science.288.5463.128; Kessler JD, 2011, SCIENCE, V331, P312, DOI 10.1126/science.1199697; MacDonald GM, 2006, SCIENCE, V314, P285, DOI 10.1126/science.1131722; Marlon JR, 2009, P NATL ACAD SCI USA, V106, P2519, DOI 10.1073/pnas.0808212106; Petrenko VV, 2009, SCIENCE, V324, P506, DOI 10.1126/science.1168909; Quay P, 1999, GLOBAL BIOGEOCHEM CY, V13, P445, DOI 10.1029/1998GB900006; Rivkina E.M., 2006, EARTH CRYOSPHERE, V10, P23; Ruddiman WF, 2008, QUATERNARY SCI REV, V27, P1291, DOI 10.1016/j.quascirev.2008.03.007; Schirrmeister L, 2002, QUATERN INT, V89, P97, DOI 10.1016/S1040-6182(01)00083-0; Severinghaus JP, 1998, NATURE, V391, P141, DOI 10.1038/34346; Shakhova N, 2010, SCIENCE, V327, P1246, DOI 10.1126/science.1182221; Smith FA, 2010, NAT GEOSCI, V3, P374, DOI 10.1038/ngeo877; Sowers T, 2006, SCIENCE, V311, P838, DOI 10.1126/science.1121235; Sowers T, 2010, QUATERNARY SCI REV, V29, P213, DOI 10.1016/j.quascirev.2009.05.023; Syroechkovskii V.E., 1986, SEVERNII OLEN AGROPR; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; VANDEWATER PK, 1994, SCIENCE, V264, P239, DOI 10.1126/science.264.5156.239; Vasilchuk Y.K., 2000, PRINCIPLES ISOTOPE G, P616; Vera Frans W.M., 2009, British Wildlife, V20, P28; Walter Anthony KM, 2014, NATURE UNPUB; Walter KM, 2007, SCIENCE, V318, P633, DOI 10.1126/science.1142924; Walter KM, 2006, NATURE, V443, P71, DOI 10.1038/nature05040; YU ZC, 2010, GEOPHYS RES LETT, V37, DOI DOI 10.1029/2010GL043584; Zech, 2010, CLIM DISCUSS, V6, P2199, DOI [10.5194/CPD-6-2199-2010, DOI 10.5194/CPD-6-2199-2010]; Zeng N, 2003, ADV ATMOS SCI, V20, P677, DOI 10.1007/BF02915395; Zimov NS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036332; Zimov SA, 2012, QUATERNARY SCI REV, V57, P26, DOI 10.1016/j.quascirev.2012.10.005; Zimov SA, 1999, SCIENCE, V284, P1973, DOI 10.1126/science.284.5422.1973; Zimov SA, 1997, SCIENCE, V277, P800, DOI 10.1126/science.277.5327.800; Zimov SA, 2005, SCIENCE, V308, P796, DOI 10.1126/science.1113442; Zimov SA., 2001, PERMAFROST RESPONSE, Vvol 76, P511; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908; Zimov Sergey A., 2012, P193	50	9	9	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93331	10.1371/journal.pone.0093331	http://dx.doi.org/10.1371/journal.pone.0093331			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695117	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000058
J	Cheng, JD; Huang, TL; Li, YF; Guo, YB; Zhu, YZ; Wang, QJ; Tan, XJ; Chen, WS; Zhang, YN; Cheng, WJ; Yamamoto, T; Jing, XB; Huang, JX				Cheng, Jidong; Huang, Tianliang; Li, Youfeng; Guo, Yubai; Zhu, Yuzhang; Wang, Qingjia; Tan, Xiaojun; Chen, Weisheng; Zhang, Yongneng; Cheng, Weijie; Yamamoto, Tetsuya; Jing, Xubin; Huang, Jiexiong			AMP-Activated Protein Kinase Suppresses the In Vitro and In Vivo Proliferation of Hepatocellular Carcinoma	PLOS ONE			English	Article							PEUTZ-JEGHERS-SYNDROME; METABOLIC SYNDROME; CELLULAR-ENERGY; CANCER CELLS; PHOSPHORYLATION; METFORMIN; RISK; SENSOR; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE-1-BETA-D-RIBOFURANOSIDE; CLASSIFICATION	AMP-activated protein kinase (AMPK) is a central metabolic sensor and plays an important role in regulating glucose, lipid and cholesterol metabolism. Therefore, AMPK is a key therapeutic target in diabetes. Recent pilot studies have suggested that diabetes drugs may reduce the risk of cancer by affecting the AMPK pathway. However, the association between AMPK and the proliferation of hepatocellular carcinoma (HCC) is unknown. In this study, we investigated the relationship between AMPK activity and the proliferation of HCC in cell lines, nude mice and human clinic samples. We first investigated the relationship between AMPK activity and cell proliferation in two HCC cell lines, PLC/PRF/5 and HepG2, by two AMPK activators, 5-aminoimidazole-4-carboxamide-1-h-D-ribofuranoside (AICAR) and metformain. AICAR and metformin treatment significantly inhibited the proliferation of HCC cells and induced cell cycle arrest at G1-S checkpoint. We then observed that metformin abrogated the growth of HCC xenografts in nude mice. The clinical pathology of AMPK activity in HCC, including cell proliferation, differential grade, tumor size and microvessel density, was studied by using 30 clinical tissue samples. In HCC tissue samples, phosphorylated AMPK was expressed mainly in cytoplasm. AMPK activity decreased significantly in HCC in comparison with paracancerous liver tissues (P < 0.05). AMPK activity was negatively correlated with the level of Ki-67 (a marker of cell proliferation), differential degradation and tumor size (P < 0.05), but not with microvessel density, hemorrhage or necrosis in HCC. Our findings suggest that AMPK activity inhibits the proliferation of HCC and AMPK might be an effective target for prevention and treatment of HCC.	[Cheng, Jidong; Huang, Tianliang; Li, Youfeng; Zhu, Yuzhang; Wang, Qingjia; Tan, Xiaojun; Chen, Weisheng; Zhang, Yongneng; Cheng, Weijie; Jing, Xubin] Shantou Univ, Affiliated Hosp 1, Dept Internal Med, Coll Med, Shantou, Guangdong, Peoples R China; [Guo, Yubai; Huang, Jiexiong] Shantou Univ, Affiliated Hosp 1, Dept Pathol, Coll Med, Shantou, Guangdong, Peoples R China; [Yamamoto, Tetsuya] Hyogo Coll Med, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan	Shantou University; Shantou University; Hyogo College of Medicine	Cheng, JD (corresponding author), Shantou Univ, Affiliated Hosp 1, Dept Internal Med, Coll Med, Shantou, Guangdong, Peoples R China.	chengjidong36@hotmail.com; xbjing@stu.edu.cn; hjxcyjhx@21cn.com	tan, xiao/GZL-0264-2022		National Natural Science Foundation of China [81070673, 81172263]; Special Foundation of Guangdong Province College Talent Introduction [10027425]; Natural Science Foundation of Guangdong province [10151503102000013, S2011010005102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation of Guangdong Province College Talent Introduction; Natural Science Foundation of Guangdong province(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from the National Natural Science Foundation of China (81070673 and 81172263), the Special Foundation of Guangdong Province College Talent Introduction (10027425), and the Natural Science Foundation of Guangdong province (10151503102000013 and S2011010005102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Chen HP, 2013, GUT, V62, P606, DOI 10.1136/gutjnl-2011-301708; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hearle N, 2006, CLIN CANCER RES, V12, P3209, DOI 10.1158/1078-0432.CCR-06-0083; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Koomagi R, 1999, INT J CANCER, V84, P239, DOI 10.1002/(SICI)1097-0215(19990621)84:3<239::AID-IJC7>3.0.CO;2-S; Kyriakis John M, 2003, J Biol, V2, P26, DOI 10.1186/1475-4924-2-26; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Nakau M, 2002, CANCER RES, V62, P4549; Nam M, 2008, ARCH BIOCHEM BIOPHYS, V479, P74, DOI 10.1016/j.abb.2008.07.029; Qu Z, 2012, HEPATOL RES, V42, P922, DOI 10.1111/j.1872-034X.2012.01007.x; Rahman MA, 2001, CLIN CANCER RES, V7, P1325; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Short JD, 2010, MOL CARCINOGEN, V49, P429, DOI 10.1002/mc.20613; Siegel AB, 2009, CANCER-AM CANCER SOC, V115, P5651, DOI 10.1002/cncr.24687; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Wang W, 2009, ACTA PHYSIOL, V196, P55, DOI 10.1111/j.1748-1716.2009.01980.x; WOOD WJ, 1988, AM J SURG, V155, P663, DOI 10.1016/S0002-9610(88)80139-9; Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133	35	47	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93256	10.1371/journal.pone.0093256	http://dx.doi.org/10.1371/journal.pone.0093256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709998	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800027
J	Markiewicz, A; Ksiazkiewicz, M; Welnicka-Jaskiewicz, M; Seroczynska, B; Skokowski, J; Szade, J; Zaczek, AJ				Markiewicz, Aleksandra; Ksiazkiewicz, Magdalena; Welnicka-Jaskiewicz, Marzena; Seroczynska, Barbara; Skokowski, Jaroslaw; Szade, Jolanta; Zaczek, Anna J.			Mesenchymal Phenotype of CTC-Enriched Blood Fraction and Lymph Node Metastasis Formation Potential	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; BREAST-CANCER CELLS; RT-PCR DETECTION; PERIPHERAL-BLOOD; MESSENGER-RNA; MOLECULAR-DETECTION; BONE-MARROW; CARCINOEMBRYONIC ANTIGEN; PROGNOSTIC-SIGNIFICANCE; E-CADHERIN	Introduction: Circulating tumor cells (CTCs) that present mesenchymal phenotypes can escape standard methods of isolation, thus limiting possibilities for their characterization. Whereas mesenchymal CTCs are considered to be more malignant than epithelial CTCs, factors responsible for this aggressiveness have not been thoroughly defined. This study analyzed the molecular profile related to metastasis formation potential of CTC-enriched blood fractions obtained by marker unbiased isolation from breast cancer patients without (N-) and with lymph nodes metastases (N+). Materials and Methods: Blood samples drawn from 117 patients with early-stage breast cancer were enriched for CTCs using density gradient centrifugation and negative selection with anti-CD45 covered magnetic particles. In the resulting CTC-enriched blood fractions, expression of CK19, MGB1, VIM, TWIST1, SNAIL, SLUG, HER2, CXCR4 and uPAR was analyzed with qPCR. Results were correlated with patients' clinicopathological data. Results: CTCs (defined as expression of either CK19, MGB1 or HER2) were detected in 41%(20/49) of N- and 69% (34/49) of N+ patients (P = 0.004). CTC-enriched blood fractions of N+ patients were more frequently VIM (P = 0.02), SNAIL (P = 0.059) and uPAR-positive (P = 0.03). Positive VIM, CXCR4 and uPAR status correlated with > 3 lymph nodes involved (P = 0.003, P = 0.01 and P = 0.045, respectively). In the multivariate logistic regression MGB1 and VIM-positivity were independently related to lymph node involvement with corresponding overall risk of 3.2 and 4.2. Moreover, mesenchymal CTC-enriched blood fractions (CK192/VIM+ and MGB1+ or HER2+) had 4.88 and 7.85-times elevated expression of CXCR4 and uPAR, respectively, compared with epithelial CTC-enriched blood fractions (CK19+/VIM2 and MGB1+ or HER2+). Conclusions: Tumors of N+ patients have superior CTC-seeding and metastatic potential compared with N- patients. These differences can be attributed to VIM, uPAR and CXCR4 expression, which endow tumor cells with particularly malignant phenotypes.	[Markiewicz, Aleksandra; Ksiazkiewicz, Magdalena; Zaczek, Anna J.] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Med Biotechnol, PL-80952 Gdansk, Poland; [Markiewicz, Aleksandra; Ksiazkiewicz, Magdalena; Zaczek, Anna J.] Med Univ Gdansk, Gdansk, Poland; [Markiewicz, Aleksandra] Med Univ Warsaw, Postgrad Sch Mol Med, Warsaw, Poland; [Welnicka-Jaskiewicz, Marzena] Med Univ Gdansk, Dept Radiotherapy & Oncol, Gdansk, Poland; [Seroczynska, Barbara; Skokowski, Jaroslaw] Med Univ Gdansk, Dept Med Lab Diagnost, Bank Frozen Tissues & Genet Specimens, Gdansk, Poland; [Skokowski, Jaroslaw] Med Univ Gdansk, Dept Surg Oncol, Gdansk, Poland; [Szade, Jolanta] Med Univ Gdansk, Dept Pathomorphol, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Medical University of Warsaw; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Zaczek, AJ (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Med Biotechnol, PL-80952 Gdansk, Poland.	azaczek@gumed.edu.pl	; Markiewicz, Aleksandra/C-1493-2013	Szade, Jolanta/0000-0003-0429-0677; Markiewicz, Aleksandra/0000-0003-4590-4698; Welnicka-Jaskiewicz, Marzena/0000-0003-4578-6302; Zaczek, Anna J/0000-0003-1482-6068; Skokowski, Jaroslaw/0000-0002-3079-3502	National Centre for Research and Development [LIDER/13/117/L-1/09/NCBiR/2010]; system project "InnoDoktorant-Scholarships for PhD students, IIIrd edition''; European Union; European Commission from the FP7 project MOBI4Health	National Centre for Research and Development(National Centre for Research & Development, Poland); system project "InnoDoktorant-Scholarships for PhD students, IIIrd edition''; European Union(European Commission); European Commission from the FP7 project MOBI4Health	This work was supported by the National Centre for Research and Development LIDER/13/117/L-1/09/NCBiR/2010. In addition, this work was supported by the system project "InnoDoktorant-Scholarships for PhD students, IIIrd edition''. The project is co-financed by the European Union in the frame of the European Social Fund. Publication cost supported by the European Commission from the FP7 project MOBI4Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpaugh ML, 2002, ONCOGENE, V21, P3631, DOI 10.1038/sj.onc.1205389; Andergassen Ulrich, 2013, Cancers (Basel), V5, P1212, DOI 10.3390/cancers5041212; Andergassen U, 2013, INT J MOL SCI, V14, P1093, DOI 10.3390/ijms14011093; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Ashworth T R, 1869, MED J AUSTRALIA, V14, P146; Banys M, 2013, CLIN CHIM ACTA, V423, P39, DOI 10.1016/j.cca.2013.03.029; Benoy IH, 2006, BRIT J CANCER, V94, P672, DOI 10.1038/sj.bjc.6602985; Bidard FC, 2010, ANN ONCOL, V21, P729, DOI 10.1093/annonc/mdp391; Bonnomet A, 2012, ONCOGENE, V31, P3741, DOI 10.1038/onc.2011.540; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Bossolasco P, 2002, CANCER DETECT PREV, V26, P60, DOI 10.1016/S0361-090X(02)00009-0; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen Y, 2010, INT J BIOL MARKER, V25, P59, DOI 10.1177/172460081002500201; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Corradini P, 2001, ANN ONCOL, V12, P1693, DOI 10.1023/A:1013573108945; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Daskalaki A, 2009, BRIT J CANCER, V101, P589, DOI 10.1038/sj.bjc.6605183; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Giordano A, 2012, MOL CANCER THER, V11, P2526, DOI 10.1158/1535-7163.MCT-12-0460; Giuliano M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2907; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hemsen A, 2003, INT J CANCER, V107, P903, DOI 10.1002/ijc.11488; HEYNS W, 1983, J STEROID BIOCHEM, V19, P1689, DOI 10.1016/0022-4731(83)90345-X; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Ignatiadis M, 2008, CLIN CANCER RES, V14, P2593, DOI 10.1158/1078-0432.CCR-07-4758; Inokuchi M, 2003, BRIT J CANCER, V89, P1750, DOI 10.1038/sj.bjc.6601248; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kataoka A, 2000, INT J ONCOL, V16, P1147; Konigsberg R, 2011, ACTA ONCOL, V50, P700, DOI 10.3109/0284186X.2010.549151; Kundu GC, 1996, P NATL ACAD SCI USA, V93, P2915, DOI 10.1073/pnas.93.7.2915; Lakhani SR, 2012, WHO CLASSIFICATION T; Lasa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074079; Leygue E, 1999, J PATHOL, V189, P28, DOI 10.1002/(SICI)1096-9896(199909)189:1<28::AID-PATH389>3.0.CO;2-H; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Lucci A, 2012, LANCET ONCOL, V13, P688, DOI 10.1016/S1470-2045(12)70209-7; Marchetti A, 2001, J PATHOL, V195, P186, DOI 10.1002/path.943; Markiewicz Aleksandra, 2013, Cancers (Basel), V5, P1485, DOI 10.3390/cancers5041485; Markou A, 2011, CLIN CHEM, V57, P421, DOI 10.1373/clinchem.2010.154328; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Mego M, 2012, INT J CANCER, V130, P808, DOI 10.1002/ijc.26037; Meng S, 2006, P NATL ACAD SCI USA, V103, P17361, DOI 10.1073/pnas.0608113103; Molloy TJ, 2011, BRIT J CANCER, V104, P1913, DOI 10.1038/bjc.2011.164; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Pecot CV, 2011, CANCER DISCOV, V1, P580, DOI 10.1158/2159-8290.CD-11-0215; Pierga JY, 2004, CLIN CANCER RES, V10, P1392, DOI 10.1158/1078-0432.CCR-0102-03; Rack BK, 2010, J CLIN ONCOLOGY; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; Raynor MP, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-24; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Reinholz MM, CLIN CANC RES, V17, P7183; Stathopoulou A, 2002, J CLIN ONCOL, V20, P3404, DOI 10.1200/JCO.2002.08.135; Stoecklein NH, 2010, INT J CANCER, V126, P589, DOI 10.1002/ijc.24916; Strati A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3395; Tamaki Y, 2009, CLIN CANCER RES, V15, P2879, DOI 10.1158/1078-0432.CCR-08-1881; Theys J, 2011, RADIOTHER ONCOL, V99, P392, DOI 10.1016/j.radonc.2011.05.044; Vazquez-Martin A, 2010, CELL CYCLE, V9, P3807, DOI 10.4161/cc.9.18.13131; Wulfing P, 2006, CLIN CANCER RES, V12, P1715, DOI 10.1158/1078-0432.CCR-05-2087; Xenidis N, 2009, J CLIN ONCOL, V27, P2177, DOI 10.1200/JCO.2008.18.0497; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zaczek AJ, 2012, ONCOLOGIST, V17, P1246, DOI 10.1634/theoncologist.2012-0023; Zhao S, 2013, CELL BIOCHEM BIOPHYS, V65, P263, DOI 10.1007/s12013-012-9426-2; Zhao S, 2011, BREAST CANCER RES TR, V130, P809, DOI 10.1007/s10549-011-1379-4	62	35	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93901	10.1371/journal.pone.0093901	http://dx.doi.org/10.1371/journal.pone.0093901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709997	Green Submitted, gold, Green Published			2022-12-27	WOS:000334159800065
J	Schogor, ALB; Huws, SA; Santos, GTD; Scollan, ND; Hauck, BD; Winters, AL; Kim, EJ; Petit, HV				Schogor, Ana L. B.; Huws, Sharon A.; Santos, Geraldo T. D.; Scollan, Nigel D.; Hauck, Barbara D.; Winters, Ana L.; Kim, Eun J.; Petit, Helene V.			Ruminal Prevotella spp. May Play an Important Role in the Conversion of Plant Lignans into Human Health Beneficial Antioxidants	PLOS ONE			English	Article							HUMAN INTESTINAL BACTERIA; COWS FED DIETS; POLYUNSATURATED FATTY-ACIDS; IN-VITRO METABOLISM; DAIRY-COWS; MAMMALIAN LIGNANS; SECOISOLARICIRESINOL DIGLUCOSIDE; FLAXSEED LIGNANS; PERENNIAL RYEGRASS; FECAL MICROBIOTA	Secoisolariciresinol diglucoside (SDG), the most abundant lignan in flaxseed, is metabolized by the ruminal microbiota into enterolignans, which are strong antioxidants. Enterolactone (EL), the main mammalian enterolignan produced in the rumen, is transferred into physiological fluids, with potentially human health benefits with respect to menopausal symptoms, hormone-dependent cancers, cardiovascular diseases, osteoporosis and diabetes. However, no information exists to our knowledge on bacterial taxa that play a role in converting plant lignans into EL in ruminants. In order to investigate this, eight rumen cannulated cows were used in a double 4x4 Latin square design and fed with four treatments: control with no flax meal (FM), or 5%, 10% and 15% FM (on a dry matter basis). Concentration of EL in the rumen increased linearly with increasing FM inclusion. Total rumen bacterial 16S rRNA concentration obtained using Q-PCR did not differ among treatments. PCR-T-RFLP based dendrograms revealed no global clustering based on diet indicating between animal variation. PCR-DGGE showed a clustering by diet effect within four cows that had similar basal ruminal microbiota. DNA extracted from bands present following feeding 15% FM and absent with no FM supplementation were sequenced and it showed that many genera, in particular Prevotella spp., contributed to the metabolism of lignans. A subsequent in vitro study using selected pure cultures of ruminal bacteria incubated with SDG indicated that 11 ruminal bacteria were able to convert SDG into secoisolariciresinol (SECO), with Prevotella spp. being the main converters. These data suggest that Prevotella spp. is one genus playing an important role in the conversion of plant lignans to human health beneficial antioxidants in the rumen.	[Schogor, Ana L. B.; Huws, Sharon A.; Scollan, Nigel D.; Hauck, Barbara D.; Winters, Ana L.] Aberystwyth Univ, IBERS, Aberystwyth, Dyfed, Wales; [Santos, Geraldo T. D.] Univ Estadual Maringa, Dept Zootecnia, Maringa, Parana, Brazil; [Kim, Eun J.] Kyungpook Natl Univ, Dept Anim Sci, Sangju, South Korea; [Petit, Helene V.] Agr & Agri Food Canada, Dairy & Swine Res & Dev Ctr, Sherbrooke, PQ, Canada	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Universidade Estadual de Maringa; Kyungpook National University; Agriculture & Agri Food Canada	Petit, HV (corresponding author), Agr & Agri Food Canada, Dairy & Swine Res & Dev Ctr, Sherbrooke, PQ, Canada.	helene.petit@agr.gc.ca	Huws, Sharon/A-7768-2015; Kim, Eun Joong/HGF-1639-2022; SANTOS, GERALDO TADEU/AAP-3943-2020	Huws, Sharon/0000-0002-0966-5354; Kim, Eun Joong/0000-0002-5962-6994; SANTOS, GERALDO TADEU/0000-0003-3720-5790; Huws, Sharon/0000-0002-9284-2453	Agriculture and Agri-Food Canada; Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University; BBSRC [BBS/E/W/10963A01D, BBS/E/W/10964A01A, BBS/E/W/10964A01B, BBS/E/W/10964A01C] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/W/10963A01D, BBS/E/W/10964A01C, BBS/E/W/10964A01A, BBS/E/W/10964A01B] Funding Source: researchfish	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The present study was funded by Agriculture and Agri-Food Canada and the molecular analysis was funded by the Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlercreutz H, 1997, ANN MED, V29, P95, DOI 10.3109/07853899709113696; Antignac JP, 2004, FOOD CHEM, V87, P275, DOI 10.1016/j.foodchem.2003.12.013; Aura AM, 2006, EUR J NUTR, V45, P45, DOI 10.1007/s00394-005-0561-z; Beaud D, 2005, MICROBIOL-SGM, V151, P2323, DOI 10.1099/mic.0.27712-0; Blackwood CB, 2003, APPL ENVIRON MICROB, V69, P926, DOI 10.1128/AEM.69.2.926-932.2003; BORRIELLO SP, 1985, J APPL BACTERIOL, V58, P37, DOI 10.1111/j.1365-2672.1985.tb01427.x; Casamayor EO, 2002, ENVIRON MICROBIOL, V4, P338, DOI 10.1046/j.1462-2920.2002.00297.x; Clavel T, 2006, FEMS MICROBIOL ECOL, V55, P471, DOI 10.1111/j.1574-6941.2005.00057.x; Clavel T, 2005, APPL ENVIRON MICROB, V71, P6077, DOI 10.1128/AEM.71.10.6077-6085.2005; Clavel T, 2006, ANAEROBE, V12, P140, DOI 10.1016/j.anaerobe.2005.11.002; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Cortes C, 2008, J APPL MICROBIOL, V105, P1585, DOI 10.1111/j.1365-2672.2008.03922.x; Cortes C, 2013, BRIT J NUTR, V109, P433, DOI 10.1017/S0007114512001341; Enwall K, 2009, LETT APPL MICROBIOL, V48, P145, DOI 10.1111/j.1472-765X.2008.02498.x; Gagnon N, 2009, J DAIRY RES, V76, P455, DOI 10.1017/S0022029909990082; Gagnon N, 2009, BRIT J NUTR, V102, P1015, DOI 10.1017/S0007114509344104; Heinonen S, 2001, J AGR FOOD CHEM, V49, P3178, DOI 10.1021/jf010038a; Hobson PN, 1969, METHODS MICROBIOLOGY, V3, P133, DOI DOI 10.1016/S0580-9517(08)70504-X; Hojer A, 2012, J DAIRY SCI, V95, P4526, DOI 10.3168/jds.2011-5226; Holma R, 2013, BRIT J NUTR, V7, P1; Hu C, 2007, FOOD CHEM TOXICOL, V45, P2219, DOI 10.1016/j.fct.2007.05.017; Huws SA, 2007, J MICROBIOL METH, V70, P565, DOI 10.1016/j.mimet.2007.06.013; Huws SA, 2013, J APPL MICROBIOL, V115, P1081, DOI 10.1111/jam.12314; Huws SA, 2013, LETT APPL MICROBIOL, V56, P186, DOI 10.1111/lam.12033; Huws SA, 2011, ENVIRON MICROBIOL, V13, P1500, DOI 10.1111/j.1462-2920.2011.02452.x; Jin JS, 2011, FOOD CHEM, V124, P895, DOI 10.1016/j.foodchem.2010.07.015; Kim EJ, 2008, J NUTR, V138, P889, DOI 10.1093/jn/138.5.889; Krause DO, 2003, FEMS MICROBIOL REV, V27, P663, DOI 10.1016/S0168-6445(03)00072-X; Landete JM, 2012, FOOD RES INT, V46, P410, DOI 10.1016/j.foodres.2011.12.023; Lee MRF, 2002, ANIM SCI, V74, P587, DOI 10.1017/S1357729800052747; Liu Z, 2006, J NUTR, V136, P906, DOI 10.1093/jn/136.4.906; Matumoto-Pintro PT, 2011, J DAIRY RES, V78, P111, DOI 10.1017/S0022029910000853; Morris D.H., 2007, FLAX HLTH NUTR PRIME; *NAT RES COUNC, 2001, NUTR REQU DAIR CATTL; Nesbitt PD, 1999, AM J CLIN NUTR, V69, P549; OFFERT ED, 1993, GUIDE CARE USE EXPT; Penalvo JL, 2005, J AGR FOOD CHEM, V53, P9342, DOI 10.1021/jf051488w; Petit HV, 2011, ANIM FEED SCI TECH, V169, P46, DOI 10.1016/j.anifeedsci.2011.05.008; Petit HV, 2009, ANIMAL, V3, P1428, DOI 10.1017/S1751731109990346; Petit HV, 2009, ANIM FEED SCI TECH, V152, P103, DOI 10.1016/j.anifeedsci.2009.04.004; Petit HV, 2009, J DAIRY RES, V76, P257, DOI 10.1017/S0022029909003999; Prasad, 2000, Int J Angiol, V9, P220, DOI 10.1007/s005470000038; Prasad K, 1997, MOL CELL BIOCHEM, V168, P117, DOI 10.1023/A:1006847310741; Raffaelli B, 2002, J CHROMATOGR B, V777, P29, DOI 10.1016/S1570-0232(02)00092-2; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; Steinshamn H, 2008, J DAIRY SCI, V91, P2715, DOI 10.3168/jds.2007-0857; THOMPSON LU, 1991, NUTR CANCER, V16, P43, DOI 10.1080/01635589109514139; Wang CZ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-115; Wang LQ, 2000, CHEM PHARM BULL, V48, P1606, DOI 10.1248/cpb.48.1606; Wang LQ, 2002, J CHROMATOGR B, V777, P289, DOI 10.1016/S1570-0232(02)00281-7; Zhou W, 2009, ANIM FEED SCI TECH, V150, P18, DOI 10.1016/j.anifeedsci.2008.07.006	52	35	41	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e87949	10.1371/journal.pone.0087949	http://dx.doi.org/10.1371/journal.pone.0087949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709940	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800004
J	Gjidoda, A; Tagore, M; McAndrew, MJ; Woods, A; Floer, M				Gjidoda, Alison; Tagore, Mohita; McAndrew, Michael J.; Woods, Alexander; Floer, Monique			Nucleosomes Are Stably Evicted from Enhancers but Not Promoters upon Induction of Certain Pro-Inflammatory Genes in Mouse Macrophages	PLOS ONE			English	Article							CHROMATIN ARCHITECTURE; TRANSCRIPTION FACTORS; IMMUNE-RESPONSE; BETA ENHANCER; HUMAN GENOME; EXPRESSION; DNA; C/EBP; CELLS; RECOGNITION	Chromatin is thought to act as a barrier for binding of cis-regulatory transcription factors (TFs) to their sites on DNA and recruitment of the transcriptional machinery. Here we have analyzed changes in nucleosome occupancy at the enhancers as well as at the promoters of three pro-inflammatory genes when they are induced by bacterial lipopolysaccharides (LPS) in primary mouse macrophages. We find that nucleosomes are removed from the distal enhancers of IL12B and IL1A, as well as from the distal and proximal enhancers of IFNB1, and that clearance of enhancers correlates with binding of various cis-regulatory TFs. We further show that for IFNB1 the degree of nucleosome removal correlates well with the level of induction of the gene under different conditions. Surprisingly, we find that nucleosome occupancy at the promoters of IL12B and IL1A does not change significantly when the genes are induced, and that a considerably fraction of the cells is occupied by nucleosomes at any given time. We hypothesize that competing nucleosomes at the promoters of IL12B and IL1A may play a role in limiting the size of transcriptional bursts in individual cells, which may be important for controlling cytokine production in a population of immune cells.	[Gjidoda, Alison; Tagore, Mohita; McAndrew, Michael J.; Woods, Alexander; Floer, Monique] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Floer, M (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	floer@msu.edu		McAndrew, Michael/0000-0003-3479-0576; Tagore, Mohita/0000-0002-2586-1427	American Heart Association [13SDG17260004]	American Heart Association(American Heart Association)	This work was supported by a Scientist-Development-Grant from the American Heart Association (13SDG17260004) to MF. http://www.heart.org/HEARTORG/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Berrozpe G, 2013, CELL REP, V4, P445, DOI 10.1016/j.celrep.2013.07.001; Bert AG, 2007, MOL CELL BIOL, V27, P2870, DOI 10.1128/MCB.02323-06; BRETZ JD, 1994, P NATL ACAD SCI USA, V91, P7306, DOI 10.1073/pnas.91.15.7306; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gervais AL, 2010, NUCLEIC ACIDS RES, V38, pW308, DOI 10.1093/nar/gkq485; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; GROVE M, 1993, MOL CELL BIOL, V13, P5276, DOI 10.1128/MCB.13.9.5276; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lefevre P, 2005, J BIOL CHEM, V280, P27552, DOI 10.1074/jbc.M502422200; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nociari M, 2007, J VIROL, V81, P4145, DOI 10.1128/JVI.02685-06; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Rahman SM, 2012, J BIOL CHEM, V287, P34349, DOI 10.1074/jbc.M112.410613; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; SHARMA RC, 1993, BIOTECHNIQUES, V14, P176; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang X, 2011, NAT STRUCT MOL BIOL, V18, P507, DOI 10.1038/nsmb.2017; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zeng L, 2010, J IMMUNOL, V185, P2324, DOI 10.4049/jimmunol.0903052; Zhao MW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001249; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhou L, 2007, MOL CELL BIOL, V27, P2698, DOI 10.1128/MCB.00788-06	50	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93971	10.1371/journal.pone.0093971	http://dx.doi.org/10.1371/journal.pone.0093971			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705533	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500099
J	Malhotra, A; Nair, P; Dhawan, DK				Malhotra, Anshoo; Nair, Praveen; Dhawan, Devinder Kumar			Study to Evaluate Molecular Mechanics behind Synergistic Chemo-Preventive Effects of Curcumin and Resveratrol during Lung Carcinogenesis	PLOS ONE			English	Article							CANCER; P53; GROWTH; INHIBITION; EXPRESSION; APOPTOSIS; TUMORS; CELLS	Background: The combination approach is the future of the war against cancer and the present study evaluated molecular mechanics behind the synergistic effects of curcumin and resveratrol during lung carcinogenesis. Methods: The mice were segregated into five groups which included normal control, Benzo[a] pyrene[BP] treated, BP+ curcumin treated, BP+ resveratrol treated and BP+ curcumin+resveratrol treated. Results: The morphological analyses of tumor nodules confirmed lung carcinogenesis in mice after 22 weeks of single intraperitoneal[i.p] injection of BP at a dose of 100 mg/Kg body weight. The BP treatment resulted in a significant increase in the protein expressions of p53 in the BP treated mice. Also, a significant increase in the protein expression of phosphorylated p53[ser15] confirmed p53 hyper-phosphorylation in BP treated mice. On the other hand, enzyme activities of caspase 3 and caspase 9 were noticed to be significantly decreased following BP treatment. Further, radiorespirometric studies showed a significant increase in the C-14-glucose turnover as well as C-14-gulcose uptake in the lung slices of BP treated mice. Moreover, a significant rise in the cell proliferation was confirmed indirectly by enhanced uptake of H-3-thymidine in the lung slices of BP treated mice. Interestingly, combined treatment of curcumin and resveratrol to BP treated animals resulted in a significant decrease in p53 hyper-phosphorylation, C-14 glucose uptakes/turnover and H-3-thymidine uptake in the BP treated mice. However, the enzyme activities of caspase 3 and caspase 9 showed a significant increase upon treatment with curcumin and resveratrol. Conclusion: The study, therefore, concludes that molecular mechanics behind chemo-preventive synergism involved modulation of p53 hyper-phosphorylation, regulation of caspases and cellular metabolism enzymes.	[Malhotra, Anshoo] PGIMER, Dept Biophys, Chandigarh, India; [Nair, Praveen; Dhawan, Devinder Kumar] Panjab Univ, Dept Biophys, Chandigarh 160014, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Panjab University	Dhawan, DK (corresponding author), Panjab Univ, Dept Biophys, Chandigarh 160014, India.	coordnucmed@pu.ac.in						[Anonymous], METHODS ENZYMATIC AN; Aziz MH, 2005, FASEB J, V19, P1193, DOI 10.1096/fj.04-3582fje; Bergmeyer H. U., 1963, METHOD ENZYMAT AN, P283; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boyle P, 2000, BRIT MED J, V321, P805, DOI 10.1136/bmj.321.7264.805; Chung F. L., 2006, Alcohol, tobacco and cancer, P268, DOI 10.1159/000095078; CRANE RK, 1960, BIOCHIM BIOPHYS ACTA, V45, P460, DOI 10.1016/0006-3002(60)91482-7; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Gallo D, 2008, J NUTR, V138, P1360, DOI 10.1093/jn/138.7.1360; Gunning WT, 2003, CLIN CANCER RES, V9, P1927; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malhotra A, 2012, HUM EXP TOXICOL, V31, P1199, DOI 10.1177/0960327112440113; Malhotra A, 2012, ULTRASTRUCT PATHOL, V36, P179, DOI 10.3109/01913123.2011.652765; Malhotra A, 2011, EUR J CANCER PREV, V20, P411, DOI 10.1097/CEJ.0b013e3283481d71; Malhotra A, 2010, PHYTOTHER RES, V24, P1271, DOI 10.1002/ptr.3087; Melnikova VO, 2003, ONCOGENE, V22, P5958, DOI 10.1038/sj.onc.1206595; Olivier Magali, 2004, IARC Sci Publ, P247; Panani AD, 2008, CANCER LETT, V266, P99, DOI 10.1016/j.canlet.2008.02.053; Parker B., 2004, CHEST, V125, P123; Peng ZH, 2001, WORLD J GASTROENTERO, V7, P88; Pise-Masison CA, 2000, AIDS RES HUM RETROV, V16, P1669, DOI 10.1089/08892220050193128; Sen S, 2005, BIOCHEM BIOPH RES CO, V331, P1245, DOI 10.1016/j.bbrc.2005.04.044; SHRIVASTAVA GC, 1962, NATURE, V196, P876, DOI 10.1038/196876a0; Swarnakar S, 2005, J BIOL CHEM, V280, P9409, DOI 10.1074/jbc.M413398200; Xiao B, 2000, WORLD J GASTROENTERO, V6, P89, DOI 10.3748/wjg.v6.i1.89; Zhu JW, 2002, WORLD J GASTROENTERO, V8, P153, DOI 10.3748/wjg.v8.i1.153	27	47	48	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93820	10.1371/journal.pone.0093820	http://dx.doi.org/10.1371/journal.pone.0093820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705375	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500072
J	Manco, M; Castagneto-Gissey, L; Arrighi, E; Carnicelli, A; Brufani, C; Luciano, R; Mingrone, G				Manco, Melania; Castagneto-Gissey, Lidia; Arrighi, Eugenio; Carnicelli, Annamaria; Brufani, Claudia; Luciano, Rosa; Mingrone, Geltrude			Insulin Dynamics in Young Women with Polycystic Ovary Syndrome and Normal Glucose Tolerance across Categories of Body Mass Index	PLOS ONE			English	Article							BETA-CELL DYSFUNCTION; FAMILY-HISTORY; PLASMA-GLUCOSE; SENSITIVITY; RESISTANCE; SECRETION; DEFECTS; OBESITY; INTOLERANCE; PREVALENCE	Background: Evidence favours insulin resistance and compensatory hyperinsulinemia as the predominant, perhaps primary, defects in polycystic ovary syndrome (PCOS). The aim of the present study was to evaluate insulin metabolism in young women with PCOS but normal glucose tolerance as compared with age, body mass index and insulin resistance-matched controls to answer the question whether women with PCOS hypersecrete insulin in comparison to appropriately insulin resistance-matched controls. Research Design and Methods: Sixty-nine cases were divided according to their body mass index (BMI) in normal-weight (N = 29), overweight (N = 24) and obese patients (N = 16). Controls were 479 healthy women (age 16-49 y). Whole body Insulin Sensitivity (WBISI), fasting, and total insulin secretion were estimated following an oral glucose tolerance test (C-peptide deconvolution method). Results: Across classes of BMI, PCOS patients had greater insulin resistance than matched controls (p<0.0001 for all the comparisons), but they showed higher fasting and total insulin secretion than their age, BMI and insulin resistance-matched peers (p<0.0001 for all the comparisons). Conclusion: Women with PCOS show higher insulin resistance but also larger insulin secretion to maintain normal glucose homeostasis than age-, BMI- and insulin resistance-matched controls.	[Manco, Melania; Brufani, Claudia; Luciano, Rosa] Bambino Gesu Children Hosp, Res Unit Multifactorial Dis Obes & Diabet, Sci Directorate, Rome, Italy; [Castagneto-Gissey, Lidia; Arrighi, Eugenio; Carnicelli, Annamaria; Mingrone, Geltrude] Univ Cattolica Sacro Cuore, Sch Med, Dept Internal Med, I-00168 Rome, Italy	IRCCS Bambino Gesu; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Manco, M (corresponding author), Bambino Gesu Children Hosp, Res Unit Multifactorial Dis Obes & Diabet, Sci Directorate, Rome, Italy.	melania.manco@opbg.net	Castagneto-Gissey, Lidia/AAH-1506-2019; Mingrone, Geltrude/AAB-9681-2019; Manco, Melania/M-1058-2013	Castagneto-Gissey, Lidia/0000-0002-3800-167X; Carnicelli, Annamaria/0000-0003-3980-2898; Manco, Melania/0000-0002-6581-975X; Mingrone, Geltrude/0000-0003-2021-528X	Italian Ministry of Health [RF-OPG-2008-1142374, GR-2010 2304957]; European Community [FP7-ICT-2012-600932 MD PAEDIGREE, FP7-ICT-2012-610440 DAPHNE]	Italian Ministry of Health(Ministry of Health, Italy); European Community(European Commission)	Melania Manco received funds from the Italian Ministry of Health (RF-OPG-2008-1142374; GR-2010 2304957) and from the European Community (FP7-ICT-2012-600932 MD PAEDIGREE; FP7-ICT-2012-610440 DAPHNE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 1998, J CLIN ENDOCR METAB, V83, P3350, DOI 10.1210/jc.83.9.3350; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Arslanian SA, 2001, J CLIN ENDOCR METAB, V86, P66, DOI 10.1210/jc.86.1.66; Best JD, 1996, DIABETES CARE, V19, P1018, DOI 10.2337/diacare.19.9.1018; Carmina E, 1999, J CLIN ENDOCR METAB, V84, P1897, DOI 10.1210/jc.84.6.1897; Ciampelli M, 1997, HUM REPROD, V12, P1897, DOI 10.1093/humrep/12.9.1897; Cibula D, 2002, HUM REPROD, V17, P76, DOI 10.1093/humrep/17.1.76; DIAMANTIKANDARAKIS E, 1995, METABOLISM, V44, P525, DOI 10.1016/0026-0495(95)90062-4; Dunaif A, 1999, ENDOCRIN METAB CLIN, V28, P341, DOI 10.1016/S0889-8529(05)70073-6; DUNAIF A, 1989, DIABETES, V38, P1165, DOI 10.2337/diabetes.38.9.1165; Dunaif A, 1996, J CLIN ENDOCR METAB, V81, P942, DOI 10.1210/jc.81.3.942; DUNAIF A, 1992, DIABETES, V41, P1257, DOI 10.2337/diabetes.41.10.1257; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; EHRMANN DA, 1995, J CLIN INVEST, V96, P520, DOI 10.1172/JCI118064; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440; Gennarelli G, 2000, HUM REPROD, V15, P2098, DOI 10.1093/humrep/15.10.2098; HOLTE J, 1995, J CLIN ENDOCR METAB, V80, P2586, DOI 10.1210/jc.80.9.2586; Legro RS, 2001, AM J MED, V111, P607, DOI 10.1016/S0002-9343(01)00948-2; Manco M, 2012, ACTA DIABETOL, V49, P435, DOI 10.1007/s00592-012-0384-3; Manco M, 2010, DIABETES CARE, V33, P2090, DOI 10.2337/dc09-2261; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mingrone G, 2008, DIABETES CARE, V31, P1872, DOI 10.2337/dc08-0432; Morin-Papunen LC, 2000, HUM REPROD, V15, P1266, DOI 10.1093/humrep/15.6.1266; Nolfe G, 2012, EUR J ENDOCRINOL, V166, P107, DOI 10.1530/EJE-11-0827; OMEARA NM, 1993, J CLIN ENDOCR METAB, V76, P1241, DOI 10.1210/jc.76.5.1241; OVESEN P, 1993, J CLIN ENDOCR METAB, V77, P1636, DOI 10.1210/jc.77.6.1636; Randeva HS, 2012, ENDOCR REV, V33, P812, DOI 10.1210/er.2012-1003; Retnakaran R, 2011, EUR J ENDOCRINOL, V165, P323; Toprak S, 2001, HORM RES, V55, P65, DOI 10.1159/000049972; VANCAUTER E, 1992, DIABETES, V41, P368, DOI 10.2337/diabetes.41.3.368; Vrbikova J, 2008, PHYSIOL RES, V57, P547, DOI 10.33549/physiolres.931275	32	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92995	10.1371/journal.pone.0092995	http://dx.doi.org/10.1371/journal.pone.0092995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705280	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500024
J	Marinazzo, D; Pellicoro, M; Wu, GR; Angelini, L; Cortes, JM; Stramaglia, S				Marinazzo, Daniele; Pellicoro, Mario; Wu, Guorong; Angelini, Leonardo; Cortes, Jesus M.; Stramaglia, Sebastiano			Information Transfer and Criticality in the Ising Model on the Human Connectome	PLOS ONE			English	Article							BRAIN; CONNECTIVITY; ORGANIZATION; NETWORKS	We implement the Ising model on a structural connectivity matrix describing the brain at two different resolutions. Tuning the model temperature to its critical value, i.e. at the susceptibility peak, we find a maximal amount of total information transfer between the spin variables. At this point the amount of information that can be redistributed by some nodes reaches a limit and the net dynamics exhibits signature of the law of diminishing marginal returns, a fundamental principle connected to saturated levels of production. Our results extend the recent analysis of dynamical oscillators models on the connectome structure, taking into account lagged and directional influences, focusing only on the nodes that are more prone to became bottlenecks of information. The ratio between the outgoing and the incoming information at each node is related to the the sum of the weights to that node and to the average time between consecutive time flips of spins. The results for the connectome of 66 nodes and for that of 998 nodes are similar, thus suggesting that these properties are scale-independent. Finally, we also find that the brain dynamics at criticality is organized maximally to a rich-club w.r.t. the network of information flows.	[Marinazzo, Daniele; Wu, Guorong] Univ Ghent, Fac Psychol & Educ Sci, Dept Data Anal, B-9000 Ghent, Belgium; [Pellicoro, Mario; Angelini, Leonardo; Stramaglia, Sebastiano] Univ Bari, Dipartimento Fis, Bari, Italy; [Pellicoro, Mario; Angelini, Leonardo; Stramaglia, Sebastiano] Ist Nazl Fis Nucl, I-70126 Bari, Italy; [Wu, Guorong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Cortes, Jesus M.] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Cortes, Jesus M.; Stramaglia, Sebastiano] Hosp Univ Cruces, Biocruces Hlth Res Inst, Baracaldo, Spain	Ghent University; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); University of Electronic Science & Technology of China; Basque Foundation for Science; Hospital Universitario Cruces	Marinazzo, D (corresponding author), Univ Ghent, Fac Psychol & Educ Sci, Dept Data Anal, B-9000 Ghent, Belgium.	daniele.marinazzo@ugent.be	Cortes, Jesus/D-9949-2012; Marinazzo, Daniele/H-4793-2019; stramaglia, sebastiano/H-7582-2015	Cortes, Jesus/0000-0002-9059-8194; Marinazzo, Daniele/0000-0002-9803-0122; stramaglia, sebastiano/0000-0002-5873-8564	Belgian Science Policy - IUAP Cerebnet; China Scholarship Council; Ikerbasque: The Basque Foundation for Science; Junta de Andalucia [P09-FQM-4682]	Belgian Science Policy - IUAP Cerebnet; China Scholarship Council(China Scholarship Council); Ikerbasque: The Basque Foundation for Science; Junta de Andalucia(Junta de Andalucia)	DM acknowledges financial support from Belgian Science Policy - IUAP Cerebnet. www.belspo.be. GW acknowledges support from the China Scholarship Council http://en.csc.edu.cn/. JMC is supported by Ikerbasque: The Basque Foundation for Science. www.ikerbasque.net/. JMC acknowledges financial support from Junta de Andalucia, grant P09-FQM-4682 www.juntadeandalucia.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barab?si AL., 2002, AM J PHYS, V71, P409, DOI [10.1119/1.1538577, DOI 10.1119/1.1538577]; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2001, PHYSICA A, V299, P559, DOI 10.1016/S0378-4371(01)00369-7; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Bossomaier T, 2012, TRANSFER ENTROPY LOG; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Cabral J, 2011, NEUROIMAGE, V57, P130, DOI 10.1016/j.neuroimage.2011.04.010; Chialvo DR, 2004, PHYSICA A, V340, P756, DOI 10.1016/j.physa.2004.05.064; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Dorogovtsev SN, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016104; Expert P, 2011, J R SOC INTERFACE, V8, P472, DOI 10.1098/rsif.2010.0416; Fraiman D, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061922; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; GLAUBER RJ, 1963, J MATH PHYS, V4, P294, DOI 10.1063/1.1703954; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Gu SJ, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/2/025002; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Haimovici A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.178101; Hasegawa T, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.026105; Herrero CP, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.067109; Herrero CP, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066110; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Lau HW, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022128; Liu YY, 2013, P NATL ACAD SCI USA, V110, P2460, DOI 10.1073/pnas.1215508110; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Marinazzo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045026; Marinazzo D, 2011, NEUROIMAGE, V58, P330, DOI 10.1016/j.neuroimage.2010.01.099; Marinazzo D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.144103; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Moretti P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3521; Nikoletopoulos T, 2004, J PHYS A-MATH GEN, V37, P6455, DOI 10.1088/0305-4470/37/25/003; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Pekalski A, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.057104; Pellicoro M, 2010, PHYSICA A, V389, P4747, DOI 10.1016/j.physa.2010.06.028; Roudi Y, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051915; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Samuelson P. A., 2001, MICROECONOMICS; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2011, RICH CLUB ORG HUMAN; Staniek M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158101; WOLFF U, 1989, PHYS REV LETT, V62, P361, DOI 10.1103/PhysRevLett.62.361	44	46	46	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93616	10.1371/journal.pone.0093616	http://dx.doi.org/10.1371/journal.pone.0093616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705627	Green Published, gold			2022-12-27	WOS:000334107500049
J	Valadez, JJ; Jeffery, C; Davis, R; Ouma, J; Lwanga, SK; Moxon, S				Valadez, Joseph J.; Jeffery, Caroline; Davis, Rosemary; Ouma, Joseph; Lwanga, Stephen K.; Moxon, Sarah			Putting the C Back into the ABCs: A Multi-Year, Multi-Region Investigation of Condom Use by Ugandan Youths 2003-2010	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SEXUAL-BEHAVIOR; SCHOOL-STUDENTS; RISK-REDUCTION; HIV PREVENTION; ASSOCIATION; ADOLESCENTS; WOMEN; INTERVENTIONS; INTERCOURSE	A major strategy for preventing transmission of HIV and other STIs is the consistent use of condoms during sexual intercourse. Condom use among youths is particularly important to reduce the number of new cases and the national prevalence. Condom use has been often promoted by the Uganda National AIDS Commission. Although a number of studies have established an association between condom use at one's sexual debut and future condom use, few studies have explored this association over time, and whether the results are generalizable across multiple locations. This multi time point, multi district study assesses the relationship between sexual debut and condom use and consistent use of condoms thereafter. Uganda has used Lot Quality Assurance Sampling surveys since 2003 to monitor district level HIV programs and improve access to HIV health services. This study includes 4518 sexually active youths interviewed at five time points (20032010) in up to 23 districts located across Uganda. Using logistic regression, we measured the association of condom use at first sexual intercourse on recent condom usage, controlling for several factors including: age, sex, education, marital status, age at first intercourse, geographical location, and survey year. The odds of condom use at last intercourse, using a condom at last intercourse with a non-regular partner, and consistently using a condom are, respectively, 9.63 (95%WaldCI = 8.03-11.56), 3.48 (95%WaldCI = 2.27-5.33), and 11.12 (95%WaldCI = 8.95-13.81) times more likely for those individuals using condoms during their sexual debut. These values did not decrease by more than 20% when controlling for potential confounders. The results suggest that HIV prevention programs should encourage condom use among youth during sexual debut. Success with this outcome may have a lasting influence on preventing HIV and other STIs later in life.	[Valadez, Joseph J.; Jeffery, Caroline; Davis, Rosemary; Moxon, Sarah] Monitoring & Evaluat Tech Assistance & Res Grp, Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool, Merseyside, England; [Ouma, Joseph; Lwanga, Stephen K.] Management Sci Hlth, Kampala, Uganda; [Valadez, Joseph J.; Jeffery, Caroline; Davis, Rosemary; Ouma, Joseph; Lwanga, Stephen K.; Moxon, Sarah] Lot Qual Assurance Sampling STAR E LQAS Project, Strengthening TB & AIDS Response Eastern Region, Kampala, Uganda	Liverpool School of Tropical Medicine	Jeffery, C (corresponding author), Monitoring & Evaluat Tech Assistance & Res Grp, Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool, Merseyside, England.	cjeffery@liv.ac.uk	Jeffery, Caroline/H-9975-2012	Jeffery, Caroline/0000-0002-8023-0708; Ameyan, Rosemary/0000-0003-1374-5514	United States Agency for International Development (USAID) [617-A-00-09-00006-00-LATH]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID) through Sub-award Number: 617-A-00-09-00006-00-LATH. The contents are the responsibility of the Liverpool School of Tropical Medicine and Management Science for Health and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Babalola Stella, 2006, Int J Adolesc Med Health, V18, P287; Baele J, 2001, J ADOLESCENT HEALTH, V28, P421, DOI 10.1016/S1054-139X(00)00215-9; Baker DP, 2011, AIDS BEHAV, V15, P1319, DOI 10.1007/s10461-010-9717-9; Bankole A, 2009, AM J MENS HEALTH, V3, P60, DOI 10.1177/1557988308322394; Bellan SE, 2013, LANCET, V381, P1561, DOI 10.1016/S0140-6736(12)61960-6; Berer M, 2006, REPROD HEALTH MATTER, V14, P6, DOI 10.1016/S0968-8080(06)28278-8; Beyeza-Kashesya J, 2011, BMC INFECT DIS, V11; Bogale GW, 2010, AIDS CARE, V22, P851, DOI 10.1080/09540120903483026; Cherutich P, 2008, AIDS BEHAV, V12, P923, DOI 10.1007/s10461-008-9445-6; Chin HB, 2012, AM J PREV MED, V42, P272, DOI 10.1016/j.amepre.2011.11.006; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; DiClemente RJ, 2004, JAMA-J AM MED ASSOC, V292, P171, DOI 10.1001/jama.292.2.171; Dodge HF, 1929, BELL SYST TECH J, V8, P613, DOI 10.1002/j.1538-7305.1929.tb01240.x; Foss AM, 2007, SEX TRANSM INFECT, V83, P510, DOI 10.1136/sti.2007.027144; Foss AM, 2004, BRIT MED J, V329, P185, DOI 10.1136/bmj.329.7459.185; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hendriksen ES, 2007, AM J PUBLIC HEALTH, V97, P1241, DOI 10.2105/AJPH.2006.086009; Hirsl-Hecej V, 2001, COLLEGIUM ANTROPOL, V25, P195; Kabiru CW, 2009, J SCHOOL HEALTH, V79, P425, DOI 10.1111/j.1746-1561.2009.00430.x; Kayiki Simon P, 2011, Afr J Reprod Health, V15, P57; Klavs I, 2005, AIDS, V19, P1215, DOI 10.1097/01.aids.0000176223.78979.26; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Maharaj P, 2005, WOMEN HEALTH, V41, P31, DOI 10.1300/J013v41n02_03; Maharaj P, 2006, REPROD HEALTH MATTER, V14, P104, DOI 10.1016/S0968-8080(06)28253-3; Maticka-Tyndale E, 2010, SOC SCI MED, V71, P616, DOI 10.1016/j.socscimed.2010.03.049; Ministry of Health ICF International Centers for Disease Control and Prevention U. S. Agency for International Development and WHO Uganda, 2012, UG AIDS IND SURV; Miranda AE, 2011, INT J STD AIDS, V22, P590, DOI 10.1258/ijsa.2009.009104; Msamanga Gernard, 2009, East Afr J Public Health, V6, P175; Mukaire J, 2004, ASSESSMENT HIV AIDS; Oyediran KA, 2011, J HEALTH POPUL NUTR, V29, P273, DOI 10.3329/jhpn.v29i3.7875; Papo JK, 2011, AIDS, V25, P247, DOI 10.1097/QAD.0b013e328341b9b8; Prata N, 2005, INT FAM PLAN PERSPEC, V31, P192, DOI 10.1363/3119205; Reid AE, 2011, PSYCHOL HEALTH, V26, P1499, DOI 10.1080/08870446.2011.572259; Rijsdijk LE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-334; Robertson SE, 2006, SOC SCI MED, V63, P1648, DOI 10.1016/j.socscimed.2006.04.011; Robertson Susan E., 1997, World Health Statistics Quarterly, V50, P199; Saile R, 2013, SOC SCI MED, V86, P17, DOI 10.1016/j.socscimed.2013.02.046; Schaalma H, 2009, SCAND J PUBLIC HEALT, V37, P87, DOI 10.1177/1403494808090632; Shafii T, 2007, AM J PUBLIC HEALTH, V97, P1090, DOI 10.2105/AJPH.2005.068437; Siegler AJ, 2012, SOC SCI MED, V75, P1685, DOI 10.1016/j.socscimed.2012.07.010; Smoak ND, 2006, JAIDS-J ACQ IMM DEF, V41, P374, DOI 10.1097/01.qai.0000185575.36591.fc; Sneed CD, 2001, AIDS CARE, V13, P303, DOI 10.1080/09540120120043955; Steiner MJ, 2006, NEW ENGL J MED, V354, P2642, DOI 10.1056/NEJMp068111; Stulhofer A, 2010, SOC SCI MED, V70, P2080, DOI 10.1016/j.socscimed.2010.02.030; Teixeira Ana Maria Ferreira Borges, 2006, Cad. Saúde Pública, V22, P1385, DOI 10.1590/S0102-311X2006000700004; The World Bank, 2007, IMPL COMPL REP UG HI; *UNAIDS, 2007, SUBS AFR AIDS EP UPD; UNAIDS, 2010, 2010 UNAIDS REP GLOB; Valadez JJ, 2007, ASSESSING COMMUNITY, V115; Valadez JJ, 1991, ASSESSING CHILD SURV; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; Yotebieng M, 2009, SAHARA J-J SOC ASP H, V6, P9, DOI 10.1080/17290376.2009.9724924; Younge SN, 2008, ADOLESCENCE, V43, P927	54	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93083	10.1371/journal.pone.0093083	http://dx.doi.org/10.1371/journal.pone.0093083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6MJ	24705381	Green Accepted, Green Published, gold			2022-12-27	WOS:000334107500027
J	Yang, YL; Luo, XP; Xian, L				Yang, Yan-Long; Luo, Xiu-Ping; Xian, Lei			The Prognostic Role of the Class III beta-Tubulin in Non-Small Cell Lung Cancer (NSCLC) Patients Receiving the Taxane/Vinorebine-Based Chemotherapy: A Meta-Analysis	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; CLINICAL-SIGNIFICANCE; RANDOMIZED-TRIAL; EXPRESSION; TAXANE; SURVIVAL; ERCC1; RESISTANCE; BENEFIT; STATISTICS	Background: A number of studies have examined the relationship between the expression of the class III beta-tubulin (TUBB3) and the treatment responses to the taxane/vinorebine-based chemotherapy in patients with non-small cell lung cancer (NSCLC). However, the results of these studies were inconsistent and inconclusive. Therefore, we conducted an up-to-date meta-analysis to evaluate the prognostic role of TUBB3 in the taxane/vinorebine-based chemotherapy. Methods: A literature search for relevant studies was conducted in PubMed, Embase, and CNKI. The inclusion criteria were the taxane/vinorebine-based chemotherapy in patients with NSCLC and the evaluation of the clinical outcomes in relation to the expression of TUBB3. The clinical outcomes analyzed in this study included the overall response rate (ORR), overall survival (OS), and event-free survival (EFS). Odds ratio (OR) or hazard ratio (HR) with 95% confidence interval (CI) were calculated to assess the risk associated with the TUBB3 expression in the taxane/vinorebine-based chemotherapy. Results: A total of 28 studies with 2401 NSCLC patients were qualified for this meta-analysis. We found that the positive or high level of TUBB3 expression was associated with a poorer ORR (OR = 0.24, 95% CI = 0.16-0.36, p<0.001), an unfavorable OS (HR = 1.52, 95% CI = 1.27-1.82, p<0.001), and a worse EFS (HR = 1.47, 95% CI = 1.24-1.74, p<0.001) compared to the negative or low level of TUBB3 expression. The statistically significant associations between TUBB3 and chemotherapy responses were also observed in the stratified subgroup analysis, which included the analysis by ethnic subgroup (Asian and Caucasian), chemotherapy regimen (taxane-based and vinorebine-based), TUBB3 detection method (IHC and PCR), and treatment strategy (surgery plus adjuvant chemotherapy and palliative chemotherapy). Conclusions: The expression level of TUBB3 may be a useful biomarker to predict the clinical outcomes of the taxane/vinorebine-based chemotherapy in patients with NSCLC.	[Yang, Yan-Long; Xian, Lei] Guangxi Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanning, Guangxi Zhuang, Peoples R China; [Luo, Xiu-Ping] Guangxi Med Univ, Clin Fac, Nanning, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Guangxi Medical University	Xian, L (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanning, Guangxi Zhuang, Peoples R China.	xianlei59@163.com			Guangxi Scientific Research and Technology Development projects [10124001A-592 44]	Guangxi Scientific Research and Technology Development projects	This work was supported by the Guangxi Scientific Research and Technology Development projects (grant no. 10124001A-592 44). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma K, 2009, LUNG CANCER, V64, P326, DOI 10.1016/j.lungcan.2008.09.002; Azuma K, 2009, CANCER CHEMOTH PHARM, V64, P565, DOI 10.1007/s00280-008-0907-3; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Custodio AB, 2009, J THORAC ONCOL, V4, P891, DOI 10.1097/JTO.0b013e3181a4b8fb; Chiou JF, 2003, LUNG, V181, P267, DOI 10.1007/s00408-003-1029-7; Christoph DC, 2012, BRIT J CANCER, V107, P823, DOI 10.1038/bjc.2012.324; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dumontet C, 1999, J CLIN ONCOL, V17, P1061, DOI 10.1200/JCO.1999.17.3.1061; Dumontet Charles, 2005, Bull Cancer, V92, pE25; Dumontet C, 2009, MOL CANCER THER, V8, P17, DOI 10.1158/1535-7163.MCT-08-0986; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Felip E, 2011, ANN ONCOL, V22, P1507, DOI 10.1093/annonc/mdr150; Ferrandina G, 2006, CLIN CANCER RES, V12, P2774, DOI 10.1158/1078-0432.CCR-05-2715; Galano G, 2011, CURR DRUG SAF, V6, P185, DOI 10.2174/157488611797579302; Gao LH, 2012, J NANTONG U MED SCI, V32, P188; [龚健 GONG Jian], 2009, [中国新药杂志, Chinese Journal New Drugs], V18, P815; Guilbert J J, 2003, Educ Health (Abingdon), V16, P230; Guo HQ, 2011, ONCOLOGY PROGR, V9, P420; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang CL, 2010, EXP THER MED, V1, P445, DOI 10.3892/etm_00000069; Ikeda N, 2009, ANN THORAC CARDIOVAS, V15, P144; Ikeda S, 2009, PATHOL INT, V59, P863, DOI 10.1111/j.1440-1827.2009.02463.x; *INT AG RES CANC, 2010, GLOBOCAN PROJ; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang H, 2013, EXP THER MED, V5, P1506, DOI 10.3892/etm.2013.1007; Kaira K, 2013, INT J CLIN ONCOL, V18, P371, DOI 10.1007/s10147-012-0386-8; Kang CH, 2010, LUNG CANCER, V68, P478, DOI 10.1016/j.lungcan.2009.07.004; Krawczyk P, 2012, CHEMOTHERAPY, V58, P60, DOI 10.1159/000336143; Liu P, 2013, J CLIN MED PRACTICE, V17, P12; MANTEL N, 1959, J NATL CANCER I, V22, P719; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Non-small Cell Lung Cancer Collaborative Group, 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002139; Okuda K, 2008, LUNG CANCER, V62, P105, DOI 10.1016/j.lungcan.2008.02.021; OYE RK, 1984, JAMA-J AM MED ASSOC, V252, P2722, DOI 10.1001/jama.252.19.2722; Pu Xiaolin, 2009, Zhongguo Fei Ai Za Zhi, V12, P49, DOI 10.3779/j.issn.1009-3419.2009.01.008; Reiman T, 2012, ANN ONCOL, V23, P86, DOI 10.1093/annonc/mdr033; Rosell R, 2003, ONCOGENE, V22, P3548, DOI 10.1038/sj.onc.1206419; Seve P, 2005, MOL CANCER THER, V4, P2001, DOI 10.1158/1535-7163.MCT-05-0244; Seve P, 2005, CLIN CANCER RES, V11, P5481, DOI 10.1158/1078-0432.CCR-05-0285; Seve P, 2008, LANCET ONCOL, V9, P168, DOI 10.1016/S1470-2045(08)70029-9; Seve P, 2007, CLIN CANCER RES, V13, P994, DOI 10.1158/1078-0432.CCR-06-1503; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stewart DJ, 2010, CRIT REV ONCOL HEMAT, V75, P173, DOI 10.1016/j.critrevonc.2009.11.006; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tommasi S, 2007, INT J CANCER, V120, P2078, DOI 10.1002/ijc.22557; Urano N, 2006, INT J ONCOL, V28, P375; Vilmar AC, 2011, CLIN CANCER RES, V17, P5205, DOI 10.1158/1078-0432.CCR-11-0658; [万一元 WAN Yiyuan], 2011, [中华内科杂志, Chinese Journal of Internal Medicine], V50, P469; Wells GA., 2003, NEWCASTLE OTTAWA SCA; Xiao YY, 2009, CHIN J LUNG CANC, V12, P14; Yang JQ, 2009, CHIN CLIN ONCOL, V14, P884; Yared JA, 2012, DRUG DES DEV THER, V6, P371, DOI 10.2147/DDDT.S28997; Zhang HL, 2012, LUNG CANCER, V77, P9, DOI 10.1016/j.lungcan.2012.01.005; Zhang JP, 2012, MED RECAPITULATE, V18, P2637; Zhang YL, 2013, ONCOL LETT, V6, P220, DOI 10.3892/ol.2013.1323; Zheng QH, 2012, J CHIN ONCOL, V18, P806	57	26	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93997	10.1371/journal.pone.0093997	http://dx.doi.org/10.1371/journal.pone.0093997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705847	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500107
J	Baranowski, E; Bergonier, D; Sagne, E; Hygonenq, MC; Ronsin, P; Berthelot, X; Citti, C				Baranowski, Eric; Bergonier, Dominique; Sagne, Eveline; Hygonenq, Marie-Claude; Ronsin, Patricia; Berthelot, Xavier; Citti, Christine			Experimental Infections with Mycoplasma agalactiae Identify Key Factors Involved in Colonization	PLOS ONE			English	Article							ELONGATION-FACTOR TU; CONTAGIOUS AGALACTIA; BINDING PROTEINS; GENES; PHASE; PATHOGENICITY; EVOLUTION; SUBUNIT; ENOLASE; SYSTEM	Mechanisms underlying pathogenic processes in mycoplasma infections are poorly understood, mainly because of limited sequence similarities with classical, bacterial virulence factors. Recently, large-scale transposon mutagenesis in the ruminant pathogen Mycoplasma agalactiae identified the NIF locus, including nifS and nifU, as essential for mycoplasma growth in cell culture, while dispensable in axenic media. To evaluate the importance of this locus in vivo, the infectivity of two knock-out mutants was tested upon experimental infection in the natural host. In this model, the parental PG2 strain was able to establish a systemic infection in lactating ewes, colonizing various body sites such as lymph nodes and the mammary gland, even when inoculated at low doses. In these PG2-infected ewes, we observed over the course of infection (i) the development of a specific antibody response and (ii) dynamic changes in expression of M. agalactiae surface variable proteins (Vpma), with multiple Vpma profiles co-existing in the same animal. In contrast and despite a sensitive model, none of the knock-out mutants were able to survive and colonize the host. The extreme avirulent phenotype of the two mutants was further supported by the absence of an IgG response in inoculated animals. The exact role of the NIF locus remains to be elucidated but these data demonstrate that it plays a key role in the infectious process of M. agalactiae and most likely of other pathogenic mycoplasma species as many carry closely related	[Baranowski, Eric; Bergonier, Dominique; Sagne, Eveline; Hygonenq, Marie-Claude; Berthelot, Xavier; Citti, Christine] INRA, IHAP, UMR 1225, F-31931 Toulouse, France; [Baranowski, Eric; Bergonier, Dominique; Sagne, Eveline; Hygonenq, Marie-Claude; Ronsin, Patricia; Berthelot, Xavier; Citti, Christine] Univ Toulouse, INP ENVT, UMR 1225, IHAP, Toulouse, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Citti, C (corresponding author), INRA, IHAP, UMR 1225, F-31931 Toulouse, France.	c.citti@envt.fr	Baranowski, Eric/I-2655-2013	BERTHELOT, Xavier/0000-0001-8508-4343; Citti, Christine/0000-0003-4754-6003; Baranowski, Eric/0000-0003-0660-1854	INRA (Animal Health Division, AAP); ENVT	INRA (Animal Health Division, AAP); ENVT	This work was supported by grants from INRA (Animal Health Division, AAP 2012) and ENVT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Baranowski E, 2010, INFECT IMMUN, V78, P1542, DOI 10.1128/IAI.01195-09; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bergonier D, 1997, REV SCI TECH OIE, V16, P848, DOI 10.20506/rst.16.3.1062; Buonavoglia D, 1999, MICROBIOLOGICA, V22, P27; Cacciotto C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057775; Chen HJ, 2011, MICROB PATHOGENESIS, V51, P285, DOI 10.1016/j.micpath.2011.03.012; Chopra-Dewasthaly R, 2005, INT J MED MICROBIOL, V294, P447, DOI 10.1016/j.ijmm.2004.09.010; Chopra-Dewasthaly R, 2008, MOL MICROBIOL, V67, P1196, DOI 10.1111/j.1365-2958.2007.06103.x; Chopra-Dewasthaly R, 2012, FEMS IMMUNOL MED MIC, V66, P307, DOI 10.1111/j.1574-695X.2012.01010.x; Citti C, 2010, FUTURE MICROBIOL, V5, P1073, DOI 10.2217/FMB.10.71; Corrales JC, 2007, SMALL RUMINANT RES, V68, P154, DOI 10.1016/j.smallrumres.2006.09.010; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Dumke R, 2011, MICROBIOL-SGM, V157, P2328, DOI 10.1099/mic.0.048298-0; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Glew MD, 2000, INFECT IMMUN, V68, P6027, DOI 10.1128/IAI.68.10.6027-6033.2000; Halbedel S, 2007, INT J MED MICROBIOL, V297, P37, DOI 10.1016/j.ijmm.2006.11.001; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Hidese R, 2011, APPL MICROBIOL BIOT, V91, P47, DOI 10.1007/s00253-011-3336-x; Huet G, 2005, J BACTERIOL, V187, P6137, DOI 10.1128/JB.187.17.6137-6146.2005; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; MACOWAN KJ, 1984, J HYG-CAMBRIDGE, V93, P455, DOI 10.1017/S0022172400065050; Marenda MS, 2005, MICROBIOL-SGM, V151, P475, DOI 10.1099/mic.0.27590-0; Nicholas RAJ, 2011, VET REC, V168, P459, DOI 10.1136/vr.d2468; Nouvel LX, 2009, J BACTERIOL, V191, P4111, DOI 10.1128/JB.00251-09; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Razin S, 2010, BIOLOGICALS, V38, P183, DOI 10.1016/j.biologicals.2009.11.008; Runyen-Janecky L, 2008, INFECT IMMUN, V76, P1083, DOI 10.1128/IAI.01211-07; Sanchis R, 1998, SMALL RUMINANT RES, V27, P31, DOI 10.1016/S0921-4488(96)00996-0; Sanchis R, 2000, VET RES, V31, P329, DOI 10.1051/vetres:2000104; Sirand-Pugnet P, 2007, RES MICROBIOL, V158, P754, DOI 10.1016/j.resmic.2007.09.007; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Skapski A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025291; Thomas C, 2013, MICROBIOL-SGM, V159, P352, DOI 10.1099/mic.0.061184-0; *WORLD ORG ANIM HL, 2012, OIE MAN DIAGN TESTS; Zimmerman CU, 2005, FEMS MICROBIOL LETT, V253, P315, DOI 10.1016/j.femsle.2005.09.054	39	17	17	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93970	10.1371/journal.pone.0093970	http://dx.doi.org/10.1371/journal.pone.0093970			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699671	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000129
J	de Goeij, MCM; Rotmans, JI; Eijgenraam, JW; Dekker, FW; Halbesma, N				de Goeij, Moniek C. M.; Rotmans, Joris I.; Eijgenraam, Jan-Willem; Dekker, Friedo W.; Halbesma, Nynke			Course of Symptoms and Health-Related Quality of Life during Specialized Pre-Dialysis Care	PLOS ONE			English	Article							STAGE RENAL-DISEASE; ILLNESS PERCEPTION QUESTIONNAIRE; CHRONIC KIDNEY-DISEASE; DIALYSIS INITIATION; START; HEMODIALYSIS; MORTALITY; SURVIVAL; REPRESENTATIONS; COMORBIDITY	Background:Concerns are present on the limited value of renal function alone in defining the optimal moment to start dialysis. Disease-related symptoms and health-related quality of life (HRQOL) may have additional clinical value in defining this moment, but little is known about how these parameters change during pre-dialysis care. The aims of our study were to describe the course of symptoms and HRQOL during pre-dialysis care and to investigate their association with poor health outcomes. Methods: In the prospective PREPARE-2 cohort, incident patients starting specialized pre-dialysis care were included when referred to one of the 25 participating Dutch outpatient clinics (2004-2011). In the present analysis, 436 patients with data available on symptoms and HRQOL were included. Clinical data, symptoms (revised illness perception questionnaire), and HRQOL (short form-36 questionnaire; physical and mental summary score) were collected every 6-month interval. A time-dependent Cox proportional hazard model was used to associate symptoms and HRQOL with the combined poor health outcome (i.e. starting dialysis, receiving a kidney transplant, and death). Results: All symptoms increased, especially fatigue and loss of strength, and both the physical and mental summary score decreased over time, with the most pronounced change during the last 6-12 months of follow-up. Furthermore, each additional symptom (adjusted HR 1.04 (95% CI, 1.00-1.09)) and each 3-point lower physical and mental summary score (adjusted HR 1.04 (1.02-1.06) and 1.04 (1.02-1.06) respectively) were associated with a higher risk of reaching the combined poor health outcome within the subsequent 6 months. Conclusions: The number of symptoms increased and both the physical and mental HRQOL score decreased during pre-dialysis care and these changes were associated with starting dialysis, receiving a kidney transplant, and death. These results may indicate that symptoms and HRQOL are good markers for the medical condition and disease stage of pre-dialysis patients.	[de Goeij, Moniek C. M.; Rotmans, Joris I.; Dekker, Friedo W.; Halbesma, Nynke] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Rotmans, Joris I.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Eijgenraam, Jan-Willem] Groene Hart Hosp, Dept Internal Med, Gouda, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Goeij, MCM (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands.	M.C.M.de_Goeij@lumc.nl	Rotmans, Joris I./G-8866-2014; Dekker, Friedo W/B-6452-2011	Rotmans, Joris I./0000-0001-9682-6234; Dekker, Friedo W/0000-0002-2433-2494	Dutch Kidney Foundation [SB 110]; Amgen; Baxter	Dutch Kidney Foundation; Amgen(Amgen); Baxter	This study was supported by a grant from the Dutch Kidney Foundation (SB 110, www.nierstichting.nl), and unrestricted grants from Amgen (www.amgen.nl) and Baxter (www.baxter.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Abdel-Kader K, 2009, CLIN J AM SOC NEPHRO, V4, P1057, DOI 10.2215/CJN.00430109; [Anonymous], 2011, ERA EDTA REG ANN REP; Beddhu S, 2003, J AM SOC NEPHROL, V14, P2305, DOI 10.1097/01.ASN.0000080184.67406.11; Chilcot J, 2013, ANN BEHAV MED, V45, P78, DOI 10.1007/s12160-012-9410-5; Chilcot J, 2012, PSYCHOL HEALTH MED, V17, P578, DOI 10.1080/13548506.2011.647702; Chin HJ, 2008, NEPHROL DIAL TRANSPL, V23, P2810, DOI 10.1093/ndt/gfn132; Clark WF, 2011, CAN MED ASSOC J, V183, P47, DOI 10.1503/cmaj.100349; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Covic A, 2004, NEPHROL DIAL TRANSPL, V19, P2078, DOI 10.1093/ndt/gfh254; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; DUBOIS D, 1989, NUTRITION, V5, P303; Dutch Federation of Nephrology, 2011, MULT GUID PRED; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; European Best Practice Guidelines Expert Group on Hemodialysis European Renal Association, 2002, Nephrol Dial Transplant, V17 Suppl 7, P7; Hwang SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2616, DOI 10.1093/ndt/gfq308; Jager KJ, 2012, NEPHROL DIAL TRANSPL, V27, P27, DOI 10.1093/ndt/gfs277; Kazmi WH, 2005, AM J KIDNEY DIS, V46, P887, DOI 10.1053/j.ajkd.2005.08.005; Kidney Disease: Improving Global Outcomes (KDIGO), 2011, CLIN PRACT GUID; Korevaar JC, 2001, LANCET, V358, P1046, DOI 10.1016/S0140-6736(01)06180-3; Krediet RT, 2010, NAT REV NEPHROL, V6, P563, DOI 10.1038/nrneph.2010.109; Kusek JW, 2002, AM J KIDNEY DIS, V39, P513, DOI 10.1053/ajkd.2002.31401; Lameire N, 2010, NEW ENGL J MED, V363, P678, DOI 10.1056/NEJMe1006669; Lassalle M, 2010, KIDNEY INT, V77, P700, DOI 10.1038/ki.2010.14; Leaf DE, 2009, KIDNEY INT, V75, P15, DOI 10.1038/ki.2008.414; Ledebo Ingrid, 2001, Nephrology Dialysis Transplantation, V16, P1132, DOI 10.1093/ndt/16.6.1132; Levey AS, 2000, J AM SOC NEPHROL, V11, p155A; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Pagels A, 2012, SCAND J CARING SCI, V26, P474, DOI 10.1111/j.1471-6712.2011.00952.x; Perlman RL, 2005, AM J KIDNEY DIS, V45, P658, DOI 10.1053/j.ajkd.2004.12.021; Rosansky SJ, 2011, ARCH INTERN MED, V171, P396, DOI 10.1001/archinternmed.2010.415; Rosansky SJ, 2009, KIDNEY INT, V76, P257, DOI 10.1038/ki.2009.161; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Stel VS, 2011, CAN MED ASSOC J, V183, P24, DOI 10.1503/cmaj.101636; Stel VS, 2010, NEPHROL DIAL TRANSPL, V25, P3315, DOI 10.1093/ndt/gfq209; Stel VS, 2009, NEPHROL DIAL TRANSPL, V24, P3175, DOI 10.1093/ndt/gfp264; Tattersall J, 2011, NEPHROL DIAL TRANSPL, V26, P2082, DOI 10.1093/ndt/gfr168; Termorshuizen F, 2003, NEPHROL DIAL TRANSPL, V18, P552, DOI 10.1093/ndt/18.3.552; Traynor JP, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025294.40179.E8; Tsai YC, 2010, NEPHROL DIAL TRANSPL, V25, P1621, DOI 10.1093/ndt/gfp671; Van Biesen W, 2010, NEPHROL DIAL TRANSPL, V25, P2405, DOI 10.1093/ndt/gfq391; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; van Dijk S, 2009, NEPHROL DIAL TRANSPL, V24, P3183, DOI 10.1093/ndt/gfp184; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Weisbord SD, 2005, J AM SOC NEPHROL, V16, P2487, DOI 10.1681/ASN.2005020157; Wright S, 2010, CLIN J AM SOC NEPHRO, V5, P1828, DOI 10.2215/CJN.06230909	48	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93069	10.1371/journal.pone.0093069	http://dx.doi.org/10.1371/journal.pone.0093069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LR	24699666	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000042
J	Molina, JFG; Zheng, L; Sertdemir, M; Dinter, DJ; Schonberg, S; Radle, M				Molina, Jose Fernando Garcia; Zheng, Lei; Sertdemir, Metin; Dinter, Dietmar J.; Schoenberg, Stefan; Raedle, Matthias			Incremental Learning with SVM for Multimodal Classification of Prostatic Adenocarcinoma	PLOS ONE			English	Article							CONTRAST-ENHANCED MRI; DIFFUSION-WEIGHTED MRI; INTENSITY NONUNIFORMITY; TEXTURAL FEATURES; CANCER; ENSEMBLE; SEGMENTATION; INHOMOGENEITY; LOCALIZATION; DIAGNOSIS	Robust detection of prostatic cancer is a challenge due to the multitude of variants and their representation in MR images. We propose a pattern recognition system with an incremental learning ensemble algorithm using support vector machines (SVM) tackling this problem employing multimodal MR images and a texture-based information strategy. The proposed system integrates anatomic, texture, and functional features. The data set was preprocessed using B-Spline interpolation, bias field correction and intensity standardization. First-and second-order angular independent statistical approaches and rotation invariant local phase quantization (RI-LPQ) were utilized to quantify texture information. An incremental learning ensemble SVM was implemented to suit working conditions in medical applications and to improve effectiveness and robustness of the system. The probability estimation of cancer structures was calculated using SVM and the corresponding optimization was carried out with a heuristic method together with a 3-fold cross-validation methodology. We achieved an average sensitivity of 0.844 +/- 0.068 and a specificity of 0.780 +/- 0.038, which yielded superior or similar performance to current state of the art using a total database of only 41 slices from twelve patients with histological confirmed information, including cancerous, unhealthy non-cancerous and healthy prostate tissue. Our results show the feasibility of an ensemble SVM being able to learn additional information from new data while preserving previously acquired knowledge and preventing unlearning. The use of texture descriptors provides more salient discriminative patterns than the functional information used. Furthermore, the system improves selection of information, efficiency and robustness of the classification. The generated probability map enables radiologists to have a lower variability in diagnosis, decrease false negative rates and reduce the time to recognize and delineate structures in the prostate.	[Molina, Jose Fernando Garcia; Zheng, Lei] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Expt Radiat Oncol, Dept Radiat Oncol, Mannheim, Germany; [Sertdemir, Metin; Dinter, Dietmar J.; Schoenberg, Stefan] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Clin Radiol & Nucl Med, Mannheim, Germany; [Raedle, Matthias] Univ Appl Sci, Hsch Mannheim, Inst Proc Control & Innovat Energy Convers PI, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Molina, JFG (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Inst Expt Radiat Oncol, Dept Radiat Oncol, Mannheim, Germany.	fernandogarcia.jm@gmail.com			Bundesministerium fur Wirtschaft und Technologie; SIEMENS AG; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Bundesministerium fur Wirtschaft und Technologie(Federal Ministry for Economic Affairs and Energy (BMWi)); SIEMENS AG(Siemens AG); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	This work was supported by Bundesministerium fur Wirtschaft und Technologie (http://www.zim-bmwi.de/) and SIEMENS AG. The authors acknowledge financial support by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzi R, 2007, EUR J RADIOL, V63, P335, DOI 10.1016/j.ejrad.2007.06.028; AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Arnold JB, 2001, NEUROIMAGE, V13, P931, DOI 10.1006/nimg.2001.0756; Artan Y, 2010, IEEE T IMAGE PROCESS, V19, P2444, DOI 10.1109/TIP.2010.2048612; Bagci U, 2010, P SPIE MEDICAL IMAGI, V7625; Bassett M, 2012, GROUP ADV PROSTATE M; Bergeest JP, 2008, BILDVERARBEITUNG MED, P36; Cancer Research UK, 2012, PROST CANC UK INC ST; Caragea C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-438; Chan I, 2003, MED PHYS, V30, P2390, DOI 10.1118/1.1593633; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Choi YJ, 2007, RADIOGRAPHICS, V27, P63, DOI 10.1148/rg.271065078; de C Cosme R, 2011, TECHNICAL REPORT; Dinter DJ, 2010, UROLOGE, V49, P963, DOI 10.1007/s00120-010-2338-0; Efron B, 1994, INTRO BOOTSTRAP; Ellison SLR, 2009, PRACTICAL STATISTICS FOR THE ANALYTICAL SCIENTIST: A BENCH GUIDE, SECOND EDITION, P1; Erdem Z, 2005, LECT NOTES COMPUT SC, V3541, P246; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; French RM, 1999, TRENDS COGN SCI, V3, P128, DOI 10.1016/S1364-6613(99)01294-2; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Futterer JJ, 2006, RADIOLOGY, V241, P449, DOI 10.1148/radiol.2412051866; Futterer JJ, 2007, EUR J RADIOL, V63, P328, DOI 10.1016/j.ejrad.2007.06.029; Gee, 2009, INSIGHT J, V9; Gibbons J.D., 2003, NONPARAMETRIC STAT I; Gonzalez R. C., 2007, DIGITAL IMAGE PROCES; Guan YF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s3; Haider MA, 2007, AM J ROENTGENOL, V189, P323, DOI 10.2214/AJR.07.2211; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hastie T., 2003, ELEMENTS STAT LEARNI; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Ibanez L, 2003, ITK SOFTWARE GUIDE I; Institut RK, 2012, TECHNICAL REPORT; Jiang Q, 2012, CHINESE MED J-PEKING, V125, P1523, DOI 10.3760/cma.j.issn.0366-6999.2012.09.001; Kim HC, 2003, PATTERN RECOGN, V36, P2757, DOI 10.1016/S0031-3203(03)00175-4; Kozlowski P, 2006, J MAGN RESON IMAGING, V24, P108, DOI 10.1002/jmri.20626; Kuncheva LI, 2010, IEEE T MED IMAGING, V29, P531, DOI 10.1109/TMI.2009.2037756; Lin HT, 2007, J MACHINE LEARNING H; Liney GP, 1998, JMRI-J MAGN RESON IM, V8, P994, DOI 10.1002/jmri.1880080432; Luboldt W, 2008, RADIOLOGY, V249, P1017, DOI 10.1148/radiol.2492080038; Mac Namee B, 2002, ARTIF INTELL MED, V24, P51, DOI 10.1016/S0933-3657(01)00092-6; Madabhushi A, 2005, IEEE T MED IMAGING, V24, P1611, DOI 10.1109/TMI.2005.859208; Madabhushi A, 2005, IEEE T MED IMAGING, V24, P561, DOI 10.1109/TMI.2004.843256; Madabhushi A, 2003, LECT NOTES COMPUT SC, V2878, P581; Mazaheri Y, 2008, RADIOLOGY, V246, P480, DOI 10.1148/radiol.2462070368; MCNEAL JE, 1981, PROSTATE, V2, P35, DOI 10.1002/pros.2990020105; Motulsky H, 2009, INTUITIVE BIOSTATIST; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Niaf E, 2012, PHYS MED BIOL, V57, P3833, DOI 10.1088/0031-9155/57/12/3833; Nyul LG, 2000, IEEE T MED IMAGING, V19, P143, DOI 10.1109/42.836373; Ocak I, 2007, AM J ROENTGENOL, V189, pW192, DOI 10.2214/AJR.06.1329; Ojala T, 2002, MULTIRESOLUTION GRAY; Ojansivu V, 2008, LECT NOTES COMPUT SC, V5099, P236, DOI 10.1007/978-3-540-69905-7_27; Ojansivu V, 2008, INT C PATT RECOG, P3596; Ozer S, 2010, MED PHYS, V37, P1873, DOI 10.1118/1.3359459; Pelzer AE, 2012, EUROPEAN J RADIOLOGY, V82, P814; Peng YH, 2006, COMPUT BIOL MED, V36, P553, DOI 10.1016/j.compbiomed.2005.04.001; Platt JC, 2000, ADV NEUR IN, P61; Polikar R., 2006, IEEE Circuits and Systems Magazine, V6, P21, DOI 10.1109/MCAS.2006.1688199; Polikar R, 2001, IEEE T SYST MAN CY C, V31, P497, DOI 10.1109/5326.983933; Reinsberg SA, 2007, AM J ROENTGENOL, V188, P91, DOI 10.2214/AJR.05.2198; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; SIMMONS A, 1994, MAGNET RESON MED, V32, P121, DOI 10.1002/mrm.1910320117; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Society AC, 2012, TECHNICAL REPORT; Styner M, 2000, IEEE T MED IMAGING, V19, P153, DOI 10.1109/42.845174; SUN CJ, 1983, COMPUT VISION GRAPH, V23, P341, DOI 10.1016/0734-189X(83)90032-4; Tf Wu, 2003, J MACHINE LEARNING R, V5; Tiwari P, 2013, MED IMAGE ANAL, V17, P219, DOI 10.1016/j.media.2012.10.004; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Udupa JK, 2006, COMPUT MED IMAG GRAP, V30, P75, DOI 10.1016/j.compmedimag.2005.12.001; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1; Viswanath S, 2009, PROC SPIE, V7260, DOI 10.1117/12.811899; Vos PC, 2008, MED PHYS, V35, P888, DOI 10.1118/1.2836419; Vos PC, 2010, PHYS MED BIOL, V55, P1719, DOI 10.1088/0031-9155/55/6/012; Yang PY, 2010, CURR BIOINFORM, V5, P296, DOI 10.2174/157489310794072508; Yu H, 2009, IEEE T MED IMAGING, V28, P374, DOI 10.1109/TMI.2008.2004425; Zhuge Y, 2009, COMPUT VIS IMAGE UND, V113, P1095, DOI 10.1016/j.cviu.2009.06.003; Zollner FG, 2013, J DIGIT IMAGING, V26, P344, DOI 10.1007/s10278-012-9510-6	80	32	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93600	10.1371/journal.pone.0093600	http://dx.doi.org/10.1371/journal.pone.0093600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699716	gold, Green Submitted, Green Published			2022-12-27	WOS:000334105000076
J	Sun, Y; Zhang, HX; Hu, RM; Sun, JY; Mao, X; Zhao, ZH; Chen, Q; Zhang, ZG				Sun, Yu; Zhang, Hongxia; Hu, Ruimin; Sun, Jianyong; Mao, Xing; Zhao, Zhonghua; Chen, Qi; Zhang, Zhigang			The Expression and Significance of Neuronal Iconic Proteins in Podocytes	PLOS ONE			English	Article							ACTIN-ASSOCIATED PROTEIN; TERMINAL HYDROLASE; NESTIN EXPRESSION; SYNAPTIC FUNCTION; SPINE APPARATUS; DENTATE GYRUS; RAT; ENOLASE; SYNAPTOPODIN; UCH-L1	Growing evidence suggests that there are many common cell biological features shared by neurons and podocytes; however, the mechanism of podocyte foot process formation remains unclear. Comparing the mechanisms of process formation between two cell types should provide useful guidance from the progress of neuron research. Studies have shown that some mature proteins of podocytes, such as podocin, nephrin, and synaptopodin, were also expressed in neurons. In this study, using cell biological experiments and immunohistochemical techniques, we showed that some neuronal iconic molecules, such as Neuron-specific enolase, nestin and Neuron-specific nuclear protein, were also expressed in podocytes. We further inhibited the expression of Neuron-specific enolase, nestin, synaptopodin and Ubiquitin carboxy terminal hydrolase-1 by Small interfering RNA in cultured mouse podocytes and observed the significant morphological changes in treated podocytes. When podocytes were treated with Adriamycin, the protein expression of Neuron-specific enolase, nestin, synaptopodin and Ubiquitin carboxy terminal hydrolase-1 decreased over time. Meanwhile, the morphological changes in the podocytes were consistent with results of the Small interfering RNA treatment of these proteins. The data demonstrated that neuronal iconic proteins play important roles in maintaining and regulating the formation and function of podocyte processes.	[Sun, Yu; Hu, Ruimin; Mao, Xing; Zhao, Zhonghua; Chen, Qi; Zhang, Zhigang] Fudan Univ, Sch Basic Med Sci, Shanghai Med Coll, Dept Pathol,Key Lab Mol Med,Chinese Minist Educ, Shanghai 200433, Peoples R China; [Zhang, Hongxia] Weifang Med Univ, Dept Pathol, Weifang, Shandong, Peoples R China; [Sun, Jianyong] Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Fudan University; Weifang Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhang, ZG (corresponding author), Fudan Univ, Sch Basic Med Sci, Shanghai Med Coll, Dept Pathol,Key Lab Mol Med,Chinese Minist Educ, Shanghai 200433, Peoples R China.	zzg@shmu.edu.cn			National Nature Science Foundation of China [NFSC: 81070566]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Nature Science Foundation of China (NFSC: 81070566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bertelli E, 2007, J HISTOCHEM CYTOCHEM, V55, P411, DOI 10.1369/jhc.6A7058.2007; BRADY ST, 1981, CELL, V23, P515, DOI 10.1016/0092-8674(81)90147-1; Cameron HA, 1998, NEUROSCIENCE, V82, P349; Cartier AE, 2009, J NEUROSCI, V29, P7857, DOI 10.1523/JNEUROSCI.1817-09.2009; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Deller T, 2003, P NATL ACAD SCI USA, V100, P10494, DOI 10.1073/pnas.1832384100; Deller T, 2000, J COMP NEUROL, V418, P164, DOI 10.1002/(SICI)1096-9861(20000306)418:2<164::AID-CNE4>3.0.CO;2-0; Deller T, 2000, HIPPOCAMPUS, V10, P569, DOI 10.1002/1098-1063(2000)10:5<569::AID-HIPO7>3.3.CO;2-D; Duggal N, 1997, BRAIN RES, V768, P1, DOI 10.1016/S0006-8993(97)00588-X; George B, 2012, SEMIN NEPHROL, V32, P307, DOI 10.1016/j.semnephrol.2012.06.002; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; Huber TB, 2006, J CLIN INVEST, V116, P1337, DOI 10.1172/JCI27400; Kang Yl, 2009, J APPL CLIN PEDIAT, V24, P383; Kobayashi N, 1998, CELL TISSUE RES, V291, P163, DOI 10.1007/s004410050988; Kobayashi Naoto, 2004, Anatomical Science International, V79, P1, DOI 10.1111/j.1447-073x.2004.00066.x; Kriz W, 2005, KIDNEY INT, V67, P404, DOI 10.1111/j.1523-1755.2005.67097.x; Krum JM, 1999, EXP NEUROL, V160, P348, DOI 10.1006/exnr.1999.7222; Lansbury PT, 2006, CELL, V126, P655, DOI 10.1016/j.cell.2006.08.011; [李俊岑 Li Juncen], 2010, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V25, P833; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Liu Y, 2009, J PATHOL, V217, P642, DOI 10.1002/path.2511; LOWE J, 1990, J PATHOL, V161, P153, DOI 10.1002/path.1711610210; Meyer-Schwesinger C, 2009, J PATHOL, V217, P452, DOI 10.1002/path.2446; Meyer-Schwesinger C, 2011, AM J PATHOL, V178, P2044, DOI 10.1016/j.ajpath.2011.01.017; Moeller MJ, 2000, J AM SOC NEPHROL, V11, P2306, DOI 10.1681/ASN.V11122306; MUNDEL P, 1991, J HISTOCHEM CYTOCHEM, V39, P1047, DOI 10.1177/39.8.1856454; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Parent JM, 1997, J NEUROSCI, V17, P3727; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Rao J, 2010, NEPHRON EXP NEPHROL, V115, pE38, DOI 10.1159/000313829; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Sakurai M, 2006, J CELL SCI, V119, P162, DOI 10.1242/jcs.02716; Shirato I, 2000, J AM SOC NEPHROL, V11, P2381, DOI 10.1681/ASN.V11122381; Shirato I, 1996, AM J PATHOL, V148, P1283; Siu Brian, 2006, BMC Nephrol, V7, P6, DOI 10.1186/1471-2369-7-6; Susor A, 2007, REPRODUCTION, V134, P559, DOI 10.1530/REP-07-0079; Tan H, 2008, CHINESE J INTEGRATED, V09, P6; VINORES SA, 1984, J HISTOCHEM CYTOCHEM, V32, P1295, DOI 10.1177/32.12.6389693; VINORES SA, 1986, HISTOPATHOLOGY, V10, P891; Wang G, 2007, NEPHRON CLIN PRACT, V106, P169, DOI 10.1159/000104428; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Yang Q, 2004, J HISTOCHEMISTRY CYT, V39; Yq Wen, 2008, CHIN J OBS GYNE PEDI, V04	49	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93999	10.1371/journal.pone.0093999	http://dx.doi.org/10.1371/journal.pone.0093999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699703	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000133
J	Christou, CM; Hadjisavvas, A; Kyratzi, M; Flouri, C; Neophytou, I; Anastasiadou, V; Loizidou, MA; Kyriacou, K				Christou, Charita M.; Hadjisavvas, Andreas; Kyratzi, Maria; Flouri, Christina; Neophytou, Ioanna; Anastasiadou, Violetta; Loizidou, Maria A.; Kyriacou, Kyriacos			The BRCA1 Variant p.Ser36Tyr Abrogates BRCA1 Protein Function and Potentially Confers a Moderate Risk of Breast Cancer	PLOS ONE			English	Article							DNA-SEQUENCE VARIANTS; UNKNOWN CLINICAL-SIGNIFICANCE; UBIQUITIN LIGASE ACTIVITY; NUCLEAR EXPORT SEQUENCE; MISSENSE VARIANTS; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSION; GENETIC-ANALYSIS; MUTATIONS; CLASSIFICATION	The identification of variants of unknown clinical significance (VUS) in the BRCA1 gene complicates genetic counselling and causes additional anxiety to carriers. In silico approaches currently used for VUS pathogenicity assessment are predictive and often produce conflicting data. Furthermore, functional assays are either domain or function specific, thus they do not examine the entire spectrum of BRCA1 functions and interpretation of individual assay results can be misleading. PolyPhen algorithm predicted that the BRCA1 p.Ser36Tyr VUS identified in the Cypriot population was damaging, whereas Align-GVGD predicted that it was possibly of no significance. In addition the BRCA1 p.Ser36Tyr variant was found to be associated with increased risk (OR=3.47, 95% CI 1.13-10.67, P=0.02) in a single case-control series of 1174 cases and 1109 controls. We describe a cellular system for examining the function of exogenous full-length BRCA1 and for classifying VUS. We achieved strong protein expression of full-length BRCA1 in transiently transfected HEK293T cells. The p.Ser36Tyr VUS exhibited low protein expression similar to the known pathogenic variant p.Cys61Gly. Co-precipitation analysis further demonstrated that it has a reduced ability to interact with BARD1. Further, co-precipitation analysis of nuclear and cytosolic extracts as well as immunofluorescence studies showed that a high proportion of the p.Ser36Tyr variant is withheld in the cytoplasm contrary to wild type protein. In addition the ability of p.Ser36Tyr to co-localize with conjugated ubiquitin foci in the nuclei of S-phase synchronized cells following genotoxic stress with hydroxyurea is impaired at more pronounced levels than that of the p.Cys61Gly pathogenic variant. The p.Ser36Tyr variant demonstrates abrogated function, and based on epidemiological, genetic, and clinical data we conclude that the p.Ser36Tyr variant is probably associated with a moderate breast cancer risk.	[Christou, Charita M.; Hadjisavvas, Andreas; Kyratzi, Maria; Flouri, Christina; Neophytou, Ioanna; Loizidou, Maria A.; Kyriacou, Kyriacos] Cyprus Inst Neurol & Genet, Dept Elect Microscopy Mol Pathol, Nicosia, Cyprus; [Kyratzi, Maria] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [Anastasiadou, Violetta] Cyprus Inst Neurol & Genet, Dept Clin Genet, Nicosia, Cyprus	University of Cyprus	Kyriacou, K (corresponding author), Cyprus Inst Neurol & Genet, Dept Elect Microscopy Mol Pathol, Nicosia, Cyprus.	kyriacos@cing.ac.cy	Loizidou, Maria A/C-6607-2009	Flouri, Christina/0000-0001-6341-6239	Cyprus Institute of Neurology and Genetics (TELETHON); Cyprus Research Promotion Foundation [YGEIA/1104/33, ERYEX/0308/14]; Cyprus Institute of Neurology and Genetics	Cyprus Institute of Neurology and Genetics (TELETHON); Cyprus Research Promotion Foundation; Cyprus Institute of Neurology and Genetics	This work was supported by grants from The Cyprus Institute of Neurology and Genetics (TELETHON 2009), the Cyprus Research Promotion Foundation (YGEIA/1104/33 and ERYEX/0308/14) and The Cyprus Institute of Neurology and Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Cyprus Institute of Neurology and Genetics URL: www.cing.ac.cy, Cyprus Research Promotion Foundation URL: http://www.research.org.cy.	Abkevich V, 2004, J MED GENET, V41, P492, DOI 10.1136/jmg.2003.015867; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Brzovic PS, 1998, J BIOL CHEM, V273, P7795, DOI 10.1074/jbc.273.14.7795; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Carvalho MA, 2007, CANCER RES, V67, P1494, DOI 10.1158/0008-5472.CAN-06-3297; Chang SW, 2009, J CLIN INVEST, V119, P3160, DOI 10.1172/JCI39836; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chen CF, 1996, J BIOL CHEM, V271, P32863, DOI 10.1074/jbc.271.51.32863; Chen SN, 2006, J CLIN ONCOL, V24, P863, DOI 10.1200/JCO.2005.03.6772; Chen YM, 1996, CANCER RES, V56, P3168; Chenevix-Trench G, 2006, CANCER RES, V66, P2019, DOI 10.1158/0008-5472.CAN-05-3546; Deffenbaugh AM, 2002, GENET TEST, V6, P119, DOI 10.1089/10906570260199375; Drost R, 2011, CANCER CELL, V20, P797, DOI 10.1016/j.ccr.2011.11.014; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Evans DG, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-155; Fabbro M, 2002, J BIOL CHEM, V277, P21315, DOI 10.1074/jbc.M200769200; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Garcia EBG, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2223; Goldgar DE, 2008, HUM MUTAT, V29, P1265, DOI 10.1002/humu.20897; Goldgar DE, 2004, AM J HUM GENET, V75, P535, DOI 10.1086/424388; Gomez-Garcia EB, 2005, J CLIN ONCOL, V23, P2185, DOI 10.1200/JCO.2005.07.013; Hadjisavvas A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-447; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hofmann W, 2000, J CANCER RES CLIN, V126, P487, DOI 10.1007/s004320000140; Kurian AW, 2010, CURR OPIN OBSTET GYN, V22, P72, DOI 10.1097/GCO.0b013e328332dca3; Kuznetsov SG, 2008, NAT MED, V14, P875, DOI 10.1038/nm.1719; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Lindor NM, 2011, HUM MUTAT; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Meza JE, 1999, J BIOL CHEM, V274, P5659, DOI 10.1074/jbc.274.9.5659; Millot GA, 2012, HUM MUTAT, V33, P1526, DOI 10.1002/humu.22150; Mirkovic N, 2004, CANCER RES, V64, P3790, DOI 10.1158/0008-5472.CAN-03-3009; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Morris JR, 2006, HUM MOL GENET, V15, P599, DOI 10.1093/hmg/ddi476; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Osorio A, 2007, HUM MUTAT, V28, P477, DOI 10.1002/humu.20470; Osorio A, 2002, INT J CANCER, V99, P305, DOI 10.1002/ijc.10337; Phelan CM, 2005, J MED GENET, V42, P138, DOI 10.1136/jmg.2004.024711; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Rodriguez JA, 2000, J BIOL CHEM, V275, P38589, DOI 10.1074/jbc.M003851200; Rodriguez JA, 2004, EXP CELL RES, V293, P14, DOI 10.1016/j.yexcr.2003.09.027; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Shakya R, 2011, SCIENCE, V334, P525, DOI 10.1126/science.1209909; Spearman AD, 2008, J CLIN ONCOL, V26, P5393, DOI 10.1200/JCO.2008.17.8228; Spurdle AB, 2008, J CLIN ONCOL, V26, P1657, DOI 10.1200/JCO.2007.13.2779; Spurdle AB, 2012, J MED GENET, V49, P525, DOI 10.1136/jmedgenet-2012-101037; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Thompson D, 2003, AM J HUM GENET, V73, P652, DOI 10.1086/378100; Thompson ME, 2005, J BIOL CHEM, V280, P21854, DOI 10.1074/jbc.M502676200; Tomlinson GE, 1998, CANCER RES, V58, P3237; Vallon-Christersson J, 2001, HUM MOL GENET, V10, P353, DOI 10.1093/hmg/10.4.353; Vega A, 2001, Hum Mutat, V17, P520, DOI 10.1002/humu.1136; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200	63	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93400	10.1371/journal.pone.0093400	http://dx.doi.org/10.1371/journal.pone.0093400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695549	gold, Green Submitted, Green Published			2022-12-27	WOS:000334103000067
J	Hudson, DM; Werther, R; Weis, M; Wu, JJ; Eyre, DR				Hudson, David M.; Werther, Rachel; Weis, MaryAnn; Wu, Jiann-Jiu; Eyre, David R.			Evolutionary Origins of C-Terminal (GPP) n 3-Hydroxyproline Formation in Vertebrate Tendon Collagen	PLOS ONE			English	Article							OSTEOGENESIS IMPERFECTA; POSTTRANSLATIONAL MODIFICATION; PROLYL 3-HYDROXYLATION; CONNECTIVE TISSUES; CROSS-LINKING; I COLLAGEN; MUTATIONS; EXPRESSION; ENZYMES; FAMILY	Approximately half the proline residues in fibrillar collagen are hydroxylated. The predominant form is 4-hydroxyproline, which helps fold and stabilize the triple helix. A minor form, 3-hydroxyproline, still has no clear function. Using peptide mass spectrometry, we recently revealed several previously unknown molecular sites of 3-hydroxyproline in fibrillar collagen chains. In fibril-forming A-clade collagen chains, four new partially occupied 3-hydroxyproline sites were found (A2, A3, A4 and (GPP)(n)) in addition to the fully occupied A1 site at Pro986. The C-terminal (GPP)(n) motif has five consecutive GPP triplets in alpha 1(I), four in alpha 2(I) and three in alpha 1(II), all subject to 3-hydroxylation. The evolutionary origins of this substrate sequence were investigated by surveying the pattern of its 3-hydroxyproline occupancy from early chordates through amphibians, birds and mammals. Different tissue sources of type I collagen (tendon, bone and skin) and type II collagen (cartilage and notochord) were examined by mass spectrometry. The (GPP)(n) domain was found to be a major substrate for 3-hydroxylation only in vertebrate fibrillar collagens. In higher vertebrates (mouse, bovine and human), up to five 3-hydroxyproline residues per (GPP)(n) motif were found in alpha 1(I) and four in alpha 2(I), with an average of two residues per chain. In vertebrate type I collagen the modification exhibited clear tissue specificity, with 3-hydroxyproline prominent only in tendon. The occupancy also showed developmental changes in Achilles tendon, with increasing 3-hydroxyproline levels with age. The biological significance is unclear but the level of 3-hydroxylation at the (GPP)(n) site appears to have increased as tendons evolved and shows both tendon type and developmental variations within a species.	[Hudson, David M.; Werther, Rachel; Weis, MaryAnn; Wu, Jiann-Jiu; Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Eyre, DR (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA.	deyre@uw.edu			National Institutes of Health from National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR37694, AR37318]; Ernest M. Burgess Endowed Chair research program of the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR037318, R01AR036794, R01AR037318] Funding Source: NIH RePORTER	National Institutes of Health from National Institute of Arthritis and Musculoskeletal and Skin Diseases; Ernest M. Burgess Endowed Chair research program of the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health grants AR37694 and AR37318 from National Institute of Arthritis and Musculoskeletal and Skin Diseases. This work was also supported by funds from the Ernest M. Burgess Endowed Chair research program of the University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey AJ, 2001, MECH AGEING DEV, V122, P735, DOI 10.1016/S0047-6374(01)00225-1; Brondijk THC, 2012, P NATL ACAD SCI USA, V109, P5253, DOI 10.1073/pnas.1112388109; Byers PH, 2012, ANNU REV GENET, V46, P475, DOI 10.1146/annurev-genet-110711-155608; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; Capellini TD, 2008, GENESIS, V46, P683, DOI 10.1002/dvg.20406; Cundy T, 2012, CALCIFIED TISSUE INT, V90, P439, DOI 10.1007/s00223-012-9588-3; Ehrlich H, 2010, NAT CHEM, V2, P1084, DOI 10.1038/NCHEM.899; Eyre DR, 2011, J BIOL CHEM, V286, P7732, DOI 10.1074/jbc.C110.195768; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Fernandes RJ, 2011, J BIOL CHEM, V286, P30662, DOI 10.1074/jbc.M111.267906; Ha-Vinh R, 2004, AM J MED GENET A, V131A, P115, DOI 10.1002/ajmg.a.30231; Hudson DM, 2013, CONNECT TISSUE RES, V54, P245, DOI 10.3109/03008207.2013.800867; Hudson DM, 2012, BIOCHEMISTRY-US, V51, P2417, DOI 10.1021/bi2019139; Hudson DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019336; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; LIGHT ND, 1979, FEBS LETT, V97, P183, DOI 10.1016/0014-5793(79)80080-0; Meeuwig MH, 2005, T AM FISH SOC, V134, P19, DOI 10.1577/FT03-206.1; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; Pokidysheva E, 2013, J BIOL CHEM, V288, P24742, DOI 10.1074/jbc.M113.464156; Pyott SM, 2011, HUM MOL GENET, V20, P1595, DOI 10.1093/hmg/ddr037; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Shadwick RE, 2002, COMP BIOCHEM PHYS A, V133, P1109, DOI 10.1016/S1095-6433(02)00215-5; SHADWICK RE, 1990, J APPL PHYSIOL, V68, P1033, DOI 10.1152/jappl.1990.68.3.1033; STEINMANN B, 1995, AM J HUM GENET, V57, P1505; Summers AP, 2002, COMP BIOCHEM PHYS A, V133, P1159, DOI 10.1016/S1095-6433(02)00241-6; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Vranka J, 2009, CELL STRUCT FUNCT, V34, P97, DOI 10.1247/csf.09002; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; WU JJ, 1985, ANN NY ACAD SCI, V460, P520, DOI 10.1111/j.1749-6632.1985.tb51228.x	34	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93467	10.1371/journal.pone.0093467	http://dx.doi.org/10.1371/journal.pone.0093467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695516	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000076
J	Mitchell, CL; Saul, MC; Lei, L; Wei, HR; Werner, T				Mitchell, Chelsea L.; Saul, Michael C.; Lei, Liang; Wei, Hairong; Werner, Thomas			The Mechanisms Underlying alpha-Amanitin Resistance in Drosophila melanogaster: A Microarray Analysis	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; VECTOR ANOPHELES-GAMBIAE; INSECTICIDE-RESISTANCE; CYTOCHROME-P450 GENES; DDT RESISTANCE; HETEROLOGOUS EXPRESSION; MYCOPHAGOUS DROSOPHILA; NATURAL-POPULATION; OVER-EXPRESSION; MUSCA-DOMESTICA	The rapid evolution of toxin resistance in animals has important consequences for the ecology of species and our economy. Pesticide resistance in insects has been a subject of intensive study; however, very little is known about how Drosophila species became resistant to natural toxins with ecological relevance, such as alpha-amanitin that is produced in deadly poisonous mushrooms. Here we performed a microarray study to elucidate the genes, chromosomal loci, molecular functions, biological processes, and cellular components that contribute to the alpha-amanitin resistance phenotype in Drosophila melanogaster. We suggest that toxin entry blockage through the cuticle, phase I and II detoxification, sequestration in lipid particles, and proteolytic cleavage of alpha-amanitin contribute in concert to this quantitative trait. We speculate that the resistance to mushroom toxins in D. melanogaster and perhaps in mycophagous Drosophila species has evolved as cross-resistance to pesticides, other xenobiotic substances, or environmental stress factors.	[Mitchell, Chelsea L.; Werner, Thomas] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA; [Saul, Michael C.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Lei, Liang; Wei, Hairong] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA	Michigan Technological University; University of Wisconsin System; University of Wisconsin Madison; Michigan Technological University	Werner, T (corresponding author), Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA.	twerner@mtu.edu	wei, hairong/GNM-7061-2022; Saul, Michael C./N-9303-2019	wei, hairong/0000-0002-3551-4998; Saul, Michael C./0000-0002-4916-8619	Michigan Technological University	Michigan Technological University	This work was supported by a start-up fund and a seed grant from Michigan Technological University to TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alias Z, 2007, PROTEOMICS, V7, P3618, DOI 10.1002/pmic.200700070; Amichot M, 2004, EUR J BIOCHEM, V271, P1250, DOI 10.1111/j.1432-1033.2004.04025.x; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Begun DJ, 2000, HEREDITY, V85, P184, DOI 10.1046/j.1365-2540.2000.00729.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogwitz MR, 2005, P NATL ACAD SCI USA, V102, P12807, DOI 10.1073/pnas.0503709102; Brandt A, 2002, INSECT MOL BIOL, V11, P337, DOI 10.1046/j.1365-2583.2002.00344.x; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Bricelj VM, 2005, NATURE, V434, P763, DOI 10.1038/nature03415; Brun A, 1996, INSECT BIOCHEM MOLEC, V26, P697, DOI 10.1016/S0965-1748(96)00036-7; CHAMBERS TC, 1990, J BIOL CHEM, V265, P7679; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; CLARK AG, 1986, PESTIC BIOCHEM PHYS, V25, P169, DOI 10.1016/0048-3575(86)90044-1; CLARK AG, 1984, PESTIC BIOCHEM PHYS, V22, P249, DOI 10.1016/0048-3575(84)90018-X; Daborn P, 2001, MOL GENET GENOMICS, V266, P556, DOI 10.1007/s004380100531; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; Dunkov BC, 1997, DNA CELL BIOL, V16, P1345, DOI 10.1089/dna.1997.16.1345; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Feldman CR, 2012, P NATL ACAD SCI USA, V109, P4556, DOI 10.1073/pnas.1113468109; Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x; Ffrench-Constant RH, 2013, GENETICS, V194, P807, DOI 10.1534/genetics.112.141895; FOURNIER D, 1992, J BIOL CHEM, V267, P1840; Giraudo M, 2010, PESTIC BIOCHEM PHYS, V97, P115, DOI 10.1016/j.pestbp.2009.06.009; Gunasekaran K, 2011, J MED ENTOMOL, V48, P561, DOI 10.1603/ME10194; Guzov VM, 1998, ARCH BIOCHEM BIOPHYS, V359, P231, DOI 10.1006/abbi.1998.0901; Hallen HE, 2007, P NATL ACAD SCI USA, V104, P19097, DOI 10.1073/pnas.0707340104; Hansen BH, 2008, GEN COMP ENDOCR, V158, P115, DOI 10.1016/j.ygcen.2008.05.013; Harrop TWR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084879; Howell B, 2008, J COLLOID INTERF SCI, V319, P81, DOI 10.1016/j.jcis.2007.11.018; Howell BA, 2010, MATERIALS, V3, P2483, DOI 10.3390/ma3042483; Huang QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050383; JAENIKE J, 1985, EVOLUTION, V39, P1295, DOI [10.2307/2408786, 10.1111/j.1558-5646.1985.tb05695.x]; JAENIKE J, 1983, SCIENCE, V221, P165, DOI 10.1126/science.221.4606.165; Joussen N, 2008, PEST MANAG SCI, V64, P65, DOI 10.1002/ps.1472; Jumbo-Lucioni PP, 2013, DIS MODEL MECH, V6, P84, DOI 10.1242/dmm.010207; Kadota K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-227; Kalajdzic P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040296; Kang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029800; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; Laing Emma, 2010, BMC Res Notes, V3, P221, DOI 10.1186/1756-0500-3-221; Le Goff G, 2003, INSECT BIOCHEM MOLEC, V33, P701, DOI 10.1016/S0965-1748(03)00064-X; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Luque T, 2002, EUR J BIOCHEM, V269, P819, DOI 10.1046/j.0014-2956.2001.02723.x; Mansuy D, 1998, COMP BIOCHEM PHYS C, V121, P5, DOI 10.1016/S0742-8413(98)10026-9; McDonnell CM, 2012, J MOL EVOL, V74, P281, DOI 10.1007/s00239-012-9506-3; Misra JR, 2011, GENE DEV, V25, P1796, DOI 10.1101/gad.17280911; Moskalev A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086051; Mullner H, 2004, ACTA BIOCHIM POL, V51, P323; Neal SJ, 2006, PHYSIOL GENOMICS, V25, P493, DOI 10.1152/physiolgenomics.00195.2005; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Peiren N, 2008, TOXICON, V52, P72, DOI 10.1016/j.toxicon.2008.05.003; Penilla RP, 1998, MED VET ENTOMOL, V12, P217, DOI 10.1046/j.1365-2915.1998.00123.x; Perlman SJ, 2003, EVOLUTION, V57, P544, DOI 10.1111/j.0014-3820.2003.tb01546.x; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; PHILLIPS JP, 1982, CAN J GENET CYTOL, V24, P151, DOI 10.1139/g82-014; PIMENTEL D, 1992, BIOSCIENCE, V42, P750, DOI 10.2307/1311994; PRAPANTHADARA LA, 1993, PESTIC BIOCHEM PHYS, V47, P119, DOI 10.1006/pest.1993.1070; Prapanthadara LA, 1996, INSECT BIOCHEM MOLEC, V26, P277, DOI 10.1016/0965-1748(95)00090-9; Rahman MM, 2006, J INSECT PHYSIOL, V52, P754, DOI 10.1016/j.jinsphys.2006.04.003; Ranson H, 2005, METHOD ENZYMOL, V401, P226, DOI 10.1016/S0076-6879(05)01014-1; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Saul MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038128; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stump AD, 2011, ENVIRON ENTOMOL, V40, P1604, DOI 10.1603/EN11136; Sun LJ, 2011, PESTIC BIOCHEM PHYS, V100, P7, DOI 10.1016/j.pestbp.2011.01.009; Sun W, 2006, INSECT MOL BIOL, V15, P455, DOI 10.1111/j.1365-2583.2006.00662.x; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Thomas AM, 2013, G3-GENES GENOM GENET, V3, P91, DOI 10.1534/g3.112.003996; Tuno N, 2007, J CHEM ECOL, V33, P311, DOI 10.1007/s10886-006-9228-3; Wan H, 2013, PEST MANAG SCI; WANG JY, 1991, MOL GEN GENET, V227, P260, DOI 10.1007/BF00259679; Wang LM, 2008, P NATL ACAD SCI USA, V105, P5657, DOI 10.1073/pnas.0801327105; Wang SP, 2012, ARCH INSECT BIOCHEM, V79, P264, DOI 10.1002/arch.21021; Wei HR, 2006, PLANT PHYSIOL, V142, P762, DOI 10.1104/pp.106.080358; Wei HR, 2013, J PLANT RES, V126, P305, DOI 10.1007/s10265-012-0524-4; Wei SH, 2001, INSECT BIOCHEM MOLEC, V31, P1145, DOI 10.1016/S0965-1748(01)00059-5; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004; Yepiskoposyan H, 2006, NUCLEIC ACIDS RES, V34, P4866, DOI 10.1093/nar/gkl606; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	88	9	10	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93489	10.1371/journal.pone.0093489	http://dx.doi.org/10.1371/journal.pone.0093489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695618	Green Published, gold			2022-12-27	WOS:000334103000080
J	Perez, NM; Ramakrishnan, G				Perez, Natalie Marie; Ramakrishnan, Girija			The Reduced Genome of the Francisella tularensis Live Vaccine Strain (LVS) Encodes Two Iron Acquisition Systems Essential for Optimal Growth and Virulence	PLOS ONE			English	Article							FERROUS IRON; MYCOBACTERIUM-TUBERCULOSIS; INTRACELLULAR BACTERIUM; SALMONELLA-ENTERICA; FULL VIRULENCE; MAJOR ROLE; FEOB; MACROPHAGES; SIDEROPHORE; TRANSPORTER	Bacterial pathogens require multiple iron-specific acquisition systems for survival within the iron-limiting environment of the host. Francisella tularensis is a virulent intracellular pathogen that can replicate in multiple cell-types. To study the interrelationship of iron acquisition capability and virulence potential of this organism, we generated single and double deletion mutants within the ferrous iron (feo) and ferric-siderophore (fsl) uptake systems of the live vaccine strain (LVS). The Feo system was disrupted by a partial deletion of the feoB gene (Delta feoB '), which led to a growth defect on iron-limited modified Muller Hinton agar plates. Fe-55 uptake assays verified that the Delta feoB ' mutant had lost the capacity for ferrous iron uptake but was still competent for Fe-55-siderophore-mediated ferric iron acquisition. Neither the Delta feoB ' nor the siderophore-deficient Delta fslA mutant was defective for replication within J774A.1 murine macrophage-like cells, thus demonstrating the ability of LVS to survive using either ferrous or ferric sources of intracellular iron. A LVS Delta fslA Delta feoB ' mutant defective for both ferrous iron uptake and siderophore production was isolated in the presence of exogenous F. tularensis siderophore. In contrast to the single deletion mutants, the Delta fslA Delta feoB ' mutant was unable to replicate within J774A.1 cells and was attenuated in virulence following intraperitoneal infection of C57BL/6 mice. These studies demonstrate that the siderophore and feoB-mediated ferrous uptake systems are the only significant iron acquisition systems in LVS and that they operate independently. While one system can compensate for loss of the other, both are required for optimal growth and virulence.	[Perez, Natalie Marie] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA; [Ramakrishnan, Girija] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Ramakrishnan, G (corresponding author), Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA.	girija@virginia.edu			National Institutes of Health (NIH) [AI056227, Al067823]; University of Virginia School of Medicine; NIH pre-doctoral Training Grant [T32AI055432]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI056227, T32AI007046, T32AI055432] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia School of Medicine; NIH pre-doctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants AI056227 and Al067823 (to G. R.) and by intramural funding from the University of Virginia School of Medicine. N.M.P was supported in part by the NIH pre-doctoral Training Grant T32AI055432. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002; Cartron ML, 2006, BIOMETALS, V19, P143, DOI 10.1007/s10534-006-0003-2; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Cendrowski S, 2004, MOL MICROBIOL, V51, P407, DOI 10.1046/j.1365-2958.2003.03861.x; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; EBERL L, 1994, MOL MICROBIOL, V12, P131, DOI 10.1111/j.1365-2958.1994.tb01002.x; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Fetherston JD, 2012, INFECT IMMUN, V80, P3880, DOI 10.1128/IAI.00086-12; FORTIER AH, 1995, INFECT IMMUN, V63, P1478, DOI 10.1128/IAI.63.4.1478-1483.1995; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; Kieffer TL, 2003, MICROBES INFECT, V5, P397, DOI 10.1016/S1286-4579(03)00052-2; Kim H, 2013, J BACTERIOL, V195, P3364, DOI 10.1128/JB.00343-13; Kim H, 2012, BIOCHEM BIOPH RES CO, V423, P733, DOI 10.1016/j.bbrc.2012.06.027; Kiss K, 2008, FEMS MICROBIOL LETT, V285, P270, DOI 10.1111/j.1574-6968.2008.01237.x; Larsson P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000472; Latunde-Dada GO, 2009, BIOESSAYS, V31, P1309, DOI 10.1002/bies.200900101; Lindgren H, 2009, INFECT IMMUN, V77, P4429, DOI 10.1128/IAI.00702-09; LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137, DOI 10.1128/CMR.6.2.137-149.1993; Marlovits TC, 2002, P NATL ACAD SCI USA, V99, P16243, DOI 10.1073/pnas.242338299; Naikare H, 2006, INFECT IMMUN, V74, P5433, DOI 10.1128/IAI.00052-06; Olakanmi O, 2010, ANTIMICROB AGENTS CH, V54, P244, DOI 10.1128/AAC.00655-09; Pan X, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-64; Pechous R, 2006, INFECT IMMUN, V74, P4452, DOI 10.1128/IAI.00666-06; Ramakrishnan G, 2008, J BACTERIOL, V190, P5353, DOI 10.1128/JB.00181-08; Ramakrishnan G, 2014, MICROBIOL-SGM, V160, P446, DOI 10.1099/mic.0.072835-0; Ramakrishnan G, 2012, J BIOL CHEM, V287, P25191, DOI 10.1074/jbc.M112.371856; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Reddy PV, 2013, J INFECT DIS, V208, P1255, DOI 10.1093/infdis/jit250; Robey M, 2002, INFECT IMMUN, V70, P5659, DOI 10.1128/IAI.70.10.5659-5669.2002; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; Rohmer L, 2006, INFECT IMMUN, V74, P6895, DOI 10.1128/IAI.01006-06; Runyen-Janecky LJ, 2003, INFECT IMMUN, V71, P1919, DOI 10.1128/IAI.71.4.1919-1928.2003; Salomonsson E, 2009, INFECT IMMUN, V77, P3424, DOI 10.1128/IAI.00196-09; Santiago AE, 2009, VACCINE, V27, P2426, DOI 10.1016/j.vaccine.2009.02.073; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sen B, 2010, INFECT IMMUN, V78, P4276, DOI 10.1128/IAI.00503-10; SHENKER M, 1995, SOIL SCI SOC AM J, V59, P1612, DOI 10.2136/sssaj1995.03615995005900060015x; Sjodin A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-268; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Sullivan JT, 2006, J BACTERIOL, V188, P3785, DOI 10.1128/JB.00027-06; Thomas-Charles CA, 2013, INFECT IMMUN, V81, P2828, DOI 10.1128/IAI.00170-13; Tsolis RM, 1996, INFECT IMMUN, V64, P4549, DOI 10.1128/IAI.64.11.4549-4556.1996; Velayudhan J, 2000, MOL MICROBIOL, V37, P274, DOI 10.1046/j.1365-2958.2000.01987.x; Weaver EA, 2013, J BACTERIOL, V195, P4826, DOI 10.1128/JB.00738-13; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x	54	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93558	10.1371/journal.pone.0093558	http://dx.doi.org/10.1371/journal.pone.0093558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695402	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000090
J	van der Laan, S; Golfetto, E; Vanacker, JM; Maiorano, D				van der Laan, Siem; Golfetto, Eleonora; Vanacker, Jean-Marc; Maiorano, Domenico			Cell Cycle-Dependent Expression of Dub3, Nanog and the p160 Family of Nuclear Receptor Coactivators (NCoAs) in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							ESTROGEN-RELATED RECEPTORS; ERR-ALPHA; THERAPEUTIC TARGET; PROSTATE-CANCER; ORPHAN; TRANSCRIPTION; PLURIPOTENCY; GROWTH; CDC25A; ESRRB	Pluripotency of embryonic stem cells (ESC) is tightly regulated by a network of transcription factors among which the estrogen-related receptor beta (Esrrb). Esrrb contributes to the relaxation of the G1 to S-phase (G1/S) checkpoint in mouse ESCs by transcriptional control of the deubiquitylase Dub3 gene, contributing to Cdc25A persistence after DNA damage. We show that in mESCs, Dub3 gene expression is cell cycle regulated and is maximal prior G1/S transition. In addition, following UV-induced DNA damage in G1, Dub3 expression markedly increases in S-phase also suggesting a role in checkpoint recovery. Unexpectedly, we also observed cell cycle-regulation of Nanog expression, and not Oct4, reaching high levels prior to G1/S transition, finely mirroring Cyclin E1 fluctuations. Curiously, while Esrrb showed only limited cell-cycle oscillations, transcript levels of the p160 family of nuclear receptor coactivators (NCoAs) displayed strong cell cycle-dependent fluctuations. Since NCoAs function in concert with Esrrb in transcriptional activation, we focussed on NCoA1 whose levels specifically increase prior onset of Dub3 transcription. Using a reporter assay, we show that NCoA1 potentiates Esrrb-mediated transcription of Dub3 and we present evidence of protein interaction between the SRC1 splice variant NCoA1 and Esrrb. Finally, we show a differential developmental regulation of all members of the p160 family during neural conversion of mESCs. These findings suggest that in mouse ESCs, changes in the relative concentration of a coactivator at a given cell cycle phase, may contribute to modulation of the transcriptional activity of the core transcription factors of the pluripotent network and be implicated in cell fate decisions upon onset of differentiation.	[van der Laan, Siem; Golfetto, Eleonora; Maiorano, Domenico] Inst Human Genet, CNRS, Dept Mol Bases Human Dis, Genome Surveillance & Stabil Lab,UPR1142, Montpellier, France; [Vanacker, Jean-Marc] Ecole Normale Super Lyon, Inst Genom Fonctionnelle Lyon, F-69364 Lyon, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Maiorano, D (corresponding author), Inst Human Genet, CNRS, Dept Mol Bases Human Dis, Genome Surveillance & Stabil Lab,UPR1142, Montpellier, France.	domenico.maiorano@igh.cnrs.fr	Maiorano, Domenico/N-5755-2017	Maiorano, Domenico/0000-0003-4229-5903; VAN DER LAAN, Siem/0000-0001-8169-1963	"Fondation ARC" pour la recherche sur le cancer [3156]; Fondation pour la Recherche Medicale; Ligue contre le Cancer; ERASMUS mobility grant from University of Padova (Italy)	"Fondation ARC" pour la recherche sur le cancer; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligue contre le Cancer(Ligue nationale contre le cancer); ERASMUS mobility grant from University of Padova (Italy)	Research in DM's laboratory was funded by grants from "Fondation ARC" pour la recherche sur le cancer (URL: http://www.arc-cancer.net/; grant No 3156 to DM and a personal fellowship to SVDL) and "Fondation pour la Recherche Medicale (URL: http://www.frm.org/; FRM Equipes). Work in J-MV's laboratory is funded by Ligue contre le Cancer (URL: http://www.ligue-cancer.net; comites Rhone and Drome). EG was supported by an ERASMUS mobility grant (URL: http://ec.europa.eu/programmes/erasmus-plus/index_en.htm) coming from the University of Padova (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Buschhorn BA, 2006, NAT CELL BIOL, V8, P209, DOI 10.1038/ncb0306-209; Busino L, 2004, ONCOGENE, V23, P2050, DOI 10.1038/sj.onc.1207394; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Deblois G, 2013, ONCOGENE, V32, P3483, DOI 10.1038/onc.2012.529; Deblois G, 2009, CANCER RES, V69, P6149, DOI 10.1158/0008-5472.CAN-09-1251; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; Feng Q, 2006, MOL CELL BIOL, V26, P7846, DOI 10.1128/MCB.00568-06; Frietze S, 2008, CANCER RES, V68, P301, DOI 10.1158/0008-5472.CAN-07-1983; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; Kalkhoven E, 1998, EMBO J, V17, P232, DOI 10.1093/emboj/17.1.232; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Lu DS, 2001, CANCER RES, V61, P6755; McFarlane C, 2010, CANCER RES, V70, P3329, DOI 10.1158/0008-5472.CAN-09-4152; Meijer OC, 2005, ENDOCRINOLOGY, V146, P1438, DOI 10.1210/en.2004-0411; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Naeem H, 2007, MOL CELL BIOL, V27, P120, DOI 10.1128/MCB.00815-06; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; Papp B, 2012, EMBO J, V31, P4255, DOI 10.1038/emboj.2012.285; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Percharde M, 2012, GENE DEV, V26, P2286, DOI 10.1101/gad.195545.112; Pereg Y, 2010, NAT CELL BIOL, V12, P400, DOI 10.1038/ncb2041; Roode M, 2012, DEV BIOL, V361, P358, DOI 10.1016/j.ydbio.2011.10.030; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Singh AM, 2013, STEM CELL REP, V1, P532, DOI 10.1016/j.stemcr.2013.10.009; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Tremblay Annie M, 2007, Nucl Recept Signal, V5, pe009, DOI 10.1621/nrs.05009; Uranishi K, 2013, MOL CELL BIOL, V33, P2056, DOI 10.1128/MCB.01520-12; van der Laan S, 2008, EUR J PHARMACOL, V585, P483, DOI 10.1016/j.ejphar.2008.01.060; van der Laan S, 2013, MOL CELL, V52, P366, DOI 10.1016/j.molcel.2013.10.003; Vanacker JM, 1999, MOL ENDOCRINOL, V13, P764, DOI 10.1210/me.13.5.764; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Xie W, 1999, MOL ENDOCRINOL, V13, P2151, DOI 10.1210/me.13.12.2151; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Yu S, 2008, ONCOGENE, V27, P3313, DOI 10.1038/sj.onc.1210986; Yu SA, 2007, CANCER RES, V67, P4904, DOI 10.1158/0008-5472.CAN-06-3855; Zhang X, 2009, J CELL BIOL, V184, P67, DOI 10.1083/jcb.200801009	40	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93663	10.1371/journal.pone.0093663	http://dx.doi.org/10.1371/journal.pone.0093663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695638	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000100
J	Zimmermann, AS; Morrison, SD; Hu, MS; Li, SL; Nauta, A; Sorkin, M; Meyer, NP; Walmsley, GG; Maan, ZN; Chan, DA; Gurtner, GC; Giaccia, AJ; Longaker, MT				Zimmermann, Andrew S.; Morrison, Shane D.; Hu, Michael S.; Li, Shuli; Nauta, Allison; Sorkin, Michael; Meyer, Nathaniel P.; Walmsley, Graham G.; Maan, Zeshaan N.; Chan, Denise A.; Gurtner, Geoffrey C.; Giaccia, Amato J.; Longaker, Michael T.			Epidermal or Dermal Specific Knockout of PHD-2 Enhances Wound Healing and Minimizes Ischemic Injury	PLOS ONE			English	Article							DIABETIC FOOT; HYPOXIA; EXPRESSION; INDUCTION; GROWTH; ANGIOGENESIS; THERAPY; OXYGEN; CELLS	Introduction: Hypoxia-inducible factor (HIF)-1 alpha, part of the heterodimeric transcription factor that mediates the cellular response to hypoxia, is critical for the expression of multiple angiogenic growth factors, cell motility, and the recruitment of endothelial progenitor cells. Inhibition of the oxygen-dependent negative regulator of HIF-1 alpha, prolyl hydroxylase domain-2 (PHD-2), leads to increased HIF-1 alpha and mimics various cellular and physiological responses to hypoxia. The roles of PHD-2 in the epidermis and dermis have not been clearly defined in wound healing. Methods: Epidermal and dermal specific PHD-2 knockout (KO) mice were developed in a C57BL/6J (wild type) background by crossing homozygous floxed PHD-2 mice with heterozygous K14-Cre mice and heterozygous Col1A2-Cre-ER mice to get homozygous floxed PHD-2/heterozygous K14-Cre and homozygous floxed PHD-2/heterozygous floxed Col1A2-Cre-ER mice, respectively. Ten to twelve-week-old PHD-2 KO and wild type (WT) mice were subjected to wounding and ischemic pedicle flap model. The amount of healing was grossly quantified with ImageJ software. Western blot and qRT-PCR was run on protein and RNA from primary cells cultured in vitro. Results: qRT-PCR demonstrated a significant decrease of PHD-2 in keratinocytes and fibroblasts derived from tissue specific KO mice relative to control mice (*p < 0.05). Western blot analysis showed a significant increase in HIF-1 alpha and VEGF protein levels in PHD-2 KO mice relative to control mice (*p < 0.05). PHD-2 KO mice showed significantly accelerated wound closure relative to WT (*p < 0.05). When ischemia was analyzed at day nine post-surgery in a flap model, the PHD-2 tissue specific knockout mice showed significantly more viable flaps than WT (*p < 0.05). Conclusions: PHD-2 plays a significant role in the rates of wound healing and response to ischemic insult in mice. Further exploration shows PHD-2 KO increases cellular levels of HIF-1 alpha and this increase leads to the transcription of downstream angiogenic factors such as VEGF.	[Zimmermann, Andrew S.; Morrison, Shane D.; Hu, Michael S.; Li, Shuli; Nauta, Allison; Sorkin, Michael; Meyer, Nathaniel P.; Walmsley, Graham G.; Maan, Zeshaan N.; Gurtner, Geoffrey C.; Longaker, Michael T.] Stanford Univ, Sch Med, Div Plast & Reconstruct Surg, Hagey Lab Pediat Regenerat Med,Dept Surg, Stanford, CA 94305 USA; [Hu, Michael S.] Univ Hawaii, John A Burns Sch Med, Dept Surg, Honolulu, HI 96822 USA; [Walmsley, Graham G.; Longaker, Michael T.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Chan, Denise A.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA; [Giaccia, Amato J.] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA	Stanford University; University of Hawaii System; Stanford University; University of California System; University of California San Francisco; Stanford University	Longaker, MT (corresponding author), Stanford Univ, Sch Med, Div Plast & Reconstruct Surg, Hagey Lab Pediat Regenerat Med,Dept Surg, Stanford, CA 94305 USA.	longaker@stanford.edu		Morrison, Shane/0000-0003-3868-3532; Maan, Zeshaan/0000-0002-7683-1914	NIA NIH HHS [R00 AG049958] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albina JE, 2001, AM J PHYSIOL-CELL PH, V281, pC1971, DOI 10.1152/ajpcell.2001.281.6.C1971; Catrina SB, 2004, DIABETES, V53, P3226, DOI 10.2337/diabetes.53.12.3226; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Chang EI, 2007, CIRCULATION, V116, P2818, DOI 10.1161/CIRCULATIONAHA.107.715847; Covello KL, 2004, CURR TOP DEV BIOL, V62, P37; Cross KJ, 2003, SURG CLIN N AM, V83, P531, DOI 10.1016/S0039-6109(02)00202-5; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Driver VR, 2010, J VASC SURG, V52, p17S, DOI 10.1016/j.jvs.2010.06.003; Elson DA, 2000, CANCER RES, V60, P6189; Fonder MA, 2008, J AM ACAD DERMATOL, V58, P185, DOI 10.1016/j.jaad.2007.08.048; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Hirota K, 2005, BIOCHEM BIOPH RES CO, V338, P610, DOI 10.1016/j.bbrc.2005.08.193; Holscher M, 2011, J BIOL CHEM, V286, P11185, DOI 10.1074/jbc.M110.186809; Huang M, 2008, CIRCULATION, V118, pS226, DOI 10.1161/CIRCULATIONAHA.107.760785; Huang M, 2009, CIRCULATION, V120, pS230, DOI 10.1161/CIRCULATIONAHA.108.841155; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kirsner RS, 2010, ARCH DERMATOL, V146, P857, DOI 10.1001/archdermatol.2010.164; Ko SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027844; Kranke P, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004123.pub3, 10.1002/14651858.CD004123.pub4]; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Loh SA, 2009, PLAST RECONSTR SURG, V123, p65S, DOI 10.1097/PRS.0b013e318191bdf4; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Thangarajah H, 2009, P NATL ACAD SCI USA, V106, P13505, DOI 10.1073/pnas.0906670106; Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X	28	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93373	10.1371/journal.pone.0093373	http://dx.doi.org/10.1371/journal.pone.0093373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695462	gold, Green Published, Green Submitted			2022-12-27	WOS:000334103000063
J	Gocha, ARS; Acharya, S; Groden, J				Gocha, April Renee Sandy; Acharya, Samir; Groden, Joanna			WRN Loss Induces Switching of Telomerase-Independent Mechanisms of Telomere Elongation	PLOS ONE			English	Article							PROMYELOCYTIC LEUKEMIA BODIES; WERNER-SYNDROME PROTEIN; HOMOLOGOUS RECOMBINATION; SYNDROME HELICASE; RECQ HELICASES; BLM HELICASE; CANCER-CELLS; DNA; ALT; MAINTENANCE	Telomere maintenance can occur in the presence of telomerase or in its absence, termed alternative lengthening of telomeres (ALT). ALT adds telomere repeats using recombination-based processes and DNA repair proteins that function in homologous recombination. Our previous work reported that the RecQ-like BLM helicase is required for ALT and that it unwinds telomeric substrates in vitro. WRN is also a RecQ-like helicase that shares many biochemical functions with BLM. WRN interacts with BLM, unwinds telomeric substrates, and co-localizes to ALT-associated PML bodies (APBs), suggesting that it may also be required for ALT processes. Using long-term siRNA knockdown of WRN in three ALT cell lines, we show that some, but not all, cell lines require WRN for telomere maintenance. VA-13 cells require WRN to prevent telomere loss and for the formation of APBs; Saos-2 cells do not. A third ALT cell line, U-2 OS, requires WRN for APB formation, however WRN loss results in p53-mediated apoptosis. In the absence of WRN and p53,U-2 OS cells undergo telomere loss for an intermediate number of population doublings (50-70), at which point they maintain telomere length even with the continued loss of WRN. WRN and the tumor suppressor BRCA1 co-localize to APBs in VA-13 and U-2 OS, but not in Saos-2 cells. WRN loss in U-2 OS is associated with a loss of BRCA1 from APBs. While the loss of WRN significantly increases telomere sister chromatid exchanges (T-SCE) in these three ALT cell lines, loss of both BRCA1 and WRN does not significantly alter TSCE. This work demonstrates that ALT cell lines use different telomerase-independent maintenance mechanisms that variably require the WRN helicase and that some cells can switch from one mechanism to another that permits telomere elongation in the absence of WRN. Our data suggest that BRCA1 localization may define these mechanisms.	[Gocha, April Renee Sandy; Acharya, Samir; Groden, Joanna] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Groden, J (corresponding author), Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	joanna.groden@osumc.edu			Ohio State University Pelotonia Fellowship Program; Blooma(sic)(TM)s Syndrome Foundation; National Institutes of Health [CA-117898]; National Center For Advancing Translational Sciences [8UL1TR000090-05, 8KL2TR000112-05, 8TL1TR000091-05]; NATIONAL CANCER INSTITUTE [R01CA117898, P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000091, KL2TR000112, UL1TR001070, UL1TR000090] Funding Source: NIH RePORTER	Ohio State University Pelotonia Fellowship Program; Blooma(sic)(TM)s Syndrome Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center For Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by The Ohio State University Pelotonia Fellowship Program [to AG]; The Blooma(sic)(TM) s Syndrome Foundation [to JG]; and the National Institutes of Health [CA-117898 to JG]. The project described was also supported by Award Number 8UL1TR000090-05, 8KL2TR000112-05, and 8TL1TR000091-05 from the National Center For Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Advancing Translational Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Ballal RD, 2009, J BIOL CHEM, V284, P36083, DOI 10.1074/jbc.M109.025825; Baynton K, 2003, J BIOL CHEM, V278, P36476, DOI 10.1074/jbc.M303885200; Bechter OE, 2004, CANCER RES, V64, P3444, DOI 10.1158/0008-5472.CAN-04-0323; Bhattacharyya S, 2009, J BIOL CHEM, V284, P14966, DOI 10.1074/jbc.M900195200; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Cheng WH, 2006, NUCLEIC ACIDS RES, V34, P2751, DOI 10.1093/nar/gkl362; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Du XB, 2004, MOL CELL BIOL, V24, P8437, DOI 10.1128/MCB.24.19.8437-8446.2004; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Fasching CL, 2005, CANCER RES, V65, P2722, DOI 10.1158/0008-5472.CAN-04-2881; Gocha ARS, 2013, AM J PATHOL, V182, P41, DOI 10.1016/j.ajpath.2012.10.001; Gocha ARS, 2013, MUT RES IN PRESS; Hagelstrom RT, 2010, P NATL ACAD SCI USA, V107, P15768, DOI 10.1073/pnas.1006338107; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Jiang WQ, 2005, MOL CELL BIOL, V25, P2708, DOI 10.1128/MCB.25.7.2708-2721.2005; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Li BM, 2008, MOL CELL BIOL, V28, P1892, DOI 10.1128/MCB.01364-07; Li BM, 2011, AGING-US, V3, P395, DOI 10.18632/aging.100308; Lillard-Wetherell K, 2004, HUM MOL GENET, V13, P1919, DOI 10.1093/hmg/ddh193; Lombard DB, 2000, MOL CELL BIOL, V20, P3286, DOI 10.1128/MCB.20.9.3286-3291.2000; Luciani JJ, 2006, J CELL SCI, V119, P2518, DOI 10.1242/jcs.02965; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Marciniak RA, 2005, CANCER RES, V65, P2730, DOI 10.1158/0008-5472.CAN-04-2888; McPherson JP, 2006, HUM MOL GENET, V15, P831, DOI 10.1093/hmg/ddl002; Mendez-Bermudez A, 2012, NUCLEIC ACIDS RES, V40, P10809, DOI 10.1093/nar/gks862; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Muntoni A, 2009, HUM MOL GENET, V18, P1017, DOI 10.1093/hmg/ddn436; Nabetani A, 2004, J BIOL CHEM, V279, P25849, DOI 10.1074/jbc.M312652200; Opresko PL, 2007, MECH AGEING DEV, V128, P423, DOI 10.1016/j.mad.2007.05.009; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Rusin M, 2009, MECH AGEING DEV, V130, P528, DOI 10.1016/j.mad.2009.06.005; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; Schulz VP, 1996, HUM GENET, V97, P750; Siddiqa A, 2012, J ONCOL, V2012, DOI 10.1155/2012/806382; Simons AM, 2006, CANCER RES, V66, P2012, DOI 10.1158/0008-5472.CAN-05-3296; Stavropoulos DJ, 2002, HUM MOL GENET, V11, P3135, DOI 10.1093/hmg/11.25.3135; Tahara H, 1997, ONCOGENE, V15, P1911, DOI 10.1038/sj.onc.1201377; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; VAZIRI H, 1993, AM J HUM GENET, V52, P661; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Wang Y, 2000, GENE DEV, V14, P927; Wu GK, 2000, J BIOL CHEM, V275, P30618, DOI 10.1074/jbc.C000390200; Wu GK, 2003, CANCER RES, V63, P2589; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Yankiwski V, 2000, P NATL ACAD SCI USA, V97, P5214, DOI 10.1073/pnas.090525897; Yeager TR, 1999, CANCER RES, V59, P4175; Zhong ZH, 2007, J BIOL CHEM, V282, P29314, DOI 10.1074/jbc.M701413200	61	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93991	10.1371/journal.pone.0093991	http://dx.doi.org/10.1371/journal.pone.0093991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709898	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800082
J	Berube-Simard, FA; Prudhomme, C; Jeannotte, L				Berube-Simard, Felix-Antoine; Prudhomme, Christelle; Jeannotte, Lucie			YY1 Acts as a Transcriptional Activator of Hoxa5 Gene Expression in Mouse Organogenesis	PLOS ONE			English	Article							ACID RESPONSE ELEMENT; MURINE HOX-4.2 GENE; YIN YANG 1; REGULATORY ELEMENTS; TRANSGENIC MICE; AXIAL SKELETON; MUTANT MICE; IN-VIVO; GROWTH; DIFFERENTIATION	The Hox gene family encodes homeodomain-containing transcriptional regulators that confer positional information to axial and paraxial tissues in the developing embryo. The dynamic Hox gene expression pattern requires mechanisms that differentially control Hox transcription in a precise spatio-temporal fashion. This implies an integrated regulation of neighbouring Hox genes achieved through the sharing and the selective use of defined enhancer sequences. The Hoxa5 gene plays a crucial role in lung and gut organogenesis. To position Hoxa5 in the regulatory hierarchy that drives organ morphogenesis, we searched for cis-acting regulatory sequences and associated trans-acting factors required for Hoxa5 expression in the developing lung and gut. Using mouse transgenesis, we identified two DNA regions included in a 1.5-kb XbaI-XbaI fragment located in the Hoxa4-Hoxa5 intergenic domain and known to control Hoxa4 organ expression. The multifunctional YY1 transcription factor binds the two regulatory sequences in vitro and in vivo. Moreover, the mesenchymal deletion of the Yy1 gene function in mice results in a Hoxa5-like lung phenotype with decreased Hoxa5 and Hoxa4 gene expression. Thus, YY1 acts as a positive regulator of Hoxa5 expression in the developing lung and gut. Our data also support a role for YY1 in the coordinated expression of Hox genes for correct organogenesis.	[Berube-Simard, Felix-Antoine; Prudhomme, Christelle; Jeannotte, Lucie] Univ Laval, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ, Canada; [Berube-Simard, Felix-Antoine; Prudhomme, Christelle; Jeannotte, Lucie] Univ Laval, Ctr Rech Canc, Quebec City, PQ, Canada; [Berube-Simard, Felix-Antoine; Prudhomme, Christelle; Jeannotte, Lucie] Ctr Hosp Univ Quebec, Ctr Rech, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Jeannotte, L (corresponding author), Univ Laval, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ, Canada.	lucie.jeannotte@crhdq.ulaval.ca		Jeannotte, Lucie/0000-0001-5578-420X	Canadian Institutes of Health Research [MOP- 15139]; National Sciences and Engineering Research Council of Canada [194559]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Canadian Institutes of Health Research (MOP- 15139; to L.J.) and the National Sciences and Engineering Research Council of Canada (194559; to L.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; AKAM M, 1987, DEVELOPMENT, V101, P1; Aparicio O., 2005, CURRENT PROTOCOLS MO, V21, P31; Aubin J, 1997, DEV BIOL, V192, P432, DOI 10.1006/dbio.1997.8746; Aubin J, 2002, DEVELOPMENT, V129, P4075; Aubin J, 1999, AM J PHYSIOL-CELL PH, V277, pC965, DOI 10.1152/ajpcell.1999.277.5.C965; Bhalla SS, 2001, J BIOL CHEM, V276, P11439, DOI 10.1074/jbc.M100208200; Boucherat O, 2013, AM J PHYSIOL-LUNG C, V304, pL817, DOI 10.1152/ajplung.00006.2013; Boucherat O, 2012, BIOL OPEN, V1, P677, DOI 10.1242/bio.20121701; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Charite J, 1998, DEVELOPMENT, V125, P4349; Chen HX, 2007, CANCER RES, V67, P8007, DOI 10.1158/0008-5472.CAN-07-1405; Coulombe Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010600; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; DONY C, 1987, EMBO J, V6, P2965, DOI 10.1002/j.1460-2075.1987.tb02602.x; Dupe V, 1997, DEVELOPMENT, V124, P399; Garin E, 2006, DEV DYNAM, V235, P1858, DOI 10.1002/dvdy.20822; Gendronneau G, 2012, ENDOCRINOLOGY, V153, P1484, DOI 10.1210/en.2011-1766; Gilthorpe J, 2002, DEVELOPMENT, V129, P3887; Gregoire S, 2013, CIRC RES, V112, P900, DOI 10.1161/CIRCRESAHA.113.259259; Herriges JC, 2012, DEV DYNAM, V241, P1432, DOI 10.1002/dvdy.23823; Hogan B, 1994, MANIPULATING MOUSE E; Houle M, 2000, MOL CELL BIOL, V20, P6579, DOI 10.1128/MCB.20.17.6579-6586.2000; JAFFE L, 1990, J IMMUNOL, V145, P3474; JEANNOTTE L, 1993, GENE DEV, V7, P2085, DOI 10.1101/gad.7.11.2085; Khang K, 2009, NUCLEIC ACIDS RES, V37, P2003; Kim SY, 2006, DEVELOPMENT, V133, P4957, DOI 10.1242/dev.02677; Klug J, 1996, MOL CELL BIOL, V16, P6398; Kobrossy L, 2006, J BIOL CHEM, V281, P25926, DOI 10.1074/jbc.M602555200; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Larochelle C, 1999, DEV DYNAM, V214, P127, DOI 10.1002/(SICI)1097-0177(199902)214:2<127::AID-AJA3>3.0.CO;2-F; Li JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002688; Maconochie MK, 1997, GENE DEV, V11, P1885, DOI 10.1101/gad.11.14.1885; Mainguy G, 2003, TRENDS GENET, V19, P476, DOI 10.1016/S0168-9525(03)00202-6; Marshall H, 1996, FASEB J, V10, P969, DOI 10.1096/fasebj.10.9.8801179; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Meccia E, 2003, BBA-GENE STRUCT EXPR, V1626, P1, DOI 10.1016/S0167-4781(03)00018-6; Meunier D, 2003, DEV DYNAM, V227, P367, DOI 10.1002/dvdy.10325; Moreau J, 2002, DNA SEQUENCE, V13, P203, DOI 10.1080/10425170290034507; Nolte C, 2003, MECH DEVELOP, V120, P325, DOI 10.1016/S0925-4773(02)00442-2; Oosterveen T, 2003, EMBO J, V22, P262, DOI 10.1093/emboj/cdg029; Packer AI, 1998, DEVELOPMENT, V125, P1991; Parrish M, 2009, NEW ENCY NEUROSCIENC, P1221; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pilon N, 2007, DEVELOPMENT, V134, P2315, DOI 10.1242/dev.001206; POPPERL H, 1992, EMBO J, V11, P3673, DOI 10.1002/j.1460-2075.1992.tb05452.x; POPPERL H, 1993, MOL CELL BIOL, V13, P257; Ren GL, 2009, INT J BIOCHEM CELL B, V41, P1094, DOI 10.1016/j.biocel.2008.10.015; Rezai-Zadeh N, 2003, GENE DEV, V17, P1019, DOI 10.1101/gad.1068003; Rhee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058828; Santini S, 2003, GENOME RES, V13, P1111, DOI 10.1101/gr.700503; Sharpe J, 1998, EMBO J, V17, P1788, DOI 10.1093/emboj/17.6.1788; Spitz F, 2008, ADV GENET, V61, P175, DOI 10.1016/S0065-2660(07)00006-5; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; Tabaries S, 2005, MOL CELL BIOL, V25, P1389, DOI 10.1128/MCB.25.4.1389-1401.2005; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Trask MC, 2012, DEV BIOL, V368, P273, DOI 10.1016/j.ydbio.2012.05.031; Wang CC, 2007, CANCER RES, V67, P4816, DOI 10.1158/0008-5472.CAN-07-0504; Wang ZX, 2006, DEV BIOL, V297, P433, DOI 10.1016/j.ydbio.2006.05.019; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; ZAKANY J, 1988, NEURON, V1, P679, DOI 10.1016/0896-6273(88)90167-5	66	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93989	10.1371/journal.pone.0093989	http://dx.doi.org/10.1371/journal.pone.0093989			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705708	Green Submitted, Green Published, gold			2022-12-27	WOS:000334107500104
J	Chi, XX; Zhang, XM; Chen, TW; Huang, XH; Yang, L; Tang, W; Xiao, B				Chi, Xiao Xiao; Zhang, Xiao Ming; Chen, Tian Wu; Huang, Xiao Hua; Yang, Lin; Tang, Wei; Xiao, Bo			The Normal Transverse Mesocolon and Involvement of the Mesocolon in Acute Pancreatitis: An MRI Study	PLOS ONE			English	Article							SMALL-BOWEL MESENTERY; COMPUTED-TOMOGRAPHY; CT; DIAGNOSIS; SEVERITY	Objective: To study the MRI findings of the normal transverse mesocolon and the involvement of the mesocolon in acute pancreatitis (AP) as well as the relationship between the involvement of the mesocolon and the severity of AP. Materials and Methods: Forty patients without pancreatic disorders were retrospectively analyzed to observe the normal transverse mesocolon using MRI; 210 patients with AP confirmed by clinical and laboratory tests were retrospectively analyzed using MRI to observe transverse-mesocolon involvement (TMI). The severity of TMI was recorded as zero points (no abnormalities and transverse-mesocolon vessel involvement), one point (linear and patchy signal in the transverse mesocolon) or two points (transverse-mesocolon effusion). The AP severity was graded by the MRI severity index (MRSI) and the Acute Physiology And Chronic Healthy Evaluation II (APACHE II) scoring system. The correlations of TMI with MRSI and APACHE-II were analyzed. Results: In a normal transverse mesocolon, the display rates of the middle colic artery, the middle colic vein and the gastrocolic trunk on MRI were 95.0%, 82.5% and 100.0%, respectively. Of the 210 patients with AP, 130 patients (61.9%) had TMI. According to the TMI grading, 40%, 39% and 20% of the patients were graded at zero, one and two points, respectively. TMI was strongly correlated with the MRSI score (r = 0.759, P = 0.000) and the APACHE-II score (r = 0.384, P = 0.000). Conclusion: MRI could be used to visualize transverse-mesocolon involvement. The severity of TMI could reflect that of AP in the clinical setting and imaging. TMI might be a supplementary indicator of the severity of AP.	[Chi, Xiao Xiao; Zhang, Xiao Ming; Chen, Tian Wu; Huang, Xiao Hua; Yang, Lin; Tang, Wei; Xiao, Bo] Affiliated Hosp North Sichuan, Coll Med, Dept Radiol, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China		Zhang, XM (corresponding author), Affiliated Hosp North Sichuan, Coll Med, Dept Radiol, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China.	cjr.zhxm@vip.163.com	Zhang, Xiao Ming/H-7104-2019; XIAO, BO/ABD-8858-2021	Zhang, Xiao Ming/0000-0001-5327-8506; Xiao, Bo/0000-0001-5862-974X; Chi, Xiaoxiao/0000-0001-6463-4115				Amano Y, 2001, ABDOM IMAGING, V26, P59, DOI 10.1007/s002610000104; Arvanitakis M, 2004, GASTROENTEROLOGY, V126, P715, DOI 10.1053/j.gastro.2003.12.006; BALTHAZAR EJ, 1990, RADIOLOGY, V174, P331, DOI 10.1148/radiology.174.2.2296641; Blachar A, 2001, RADIOLOGY, V221, P422, DOI 10.1148/radiol.2212010126; Gosset Johan, 2004, JOP, V5, P48; Hirota M, 2002, PANCREAS, V25, P63, DOI 10.1097/00006676-200207000-00015; Ishikawa K, 2006, EUR J RADIOL, V60, P445, DOI 10.1016/j.ejrad.2006.06.014; Ji YF, 2012, ACAD RADIOL, V19, P571, DOI 10.1016/j.acra.2012.01.004; Kim J H, 2000, Korean J Radiol, V1, P43; Kim YK, 2006, J MAGN RESON IMAGING, V24, P1342, DOI 10.1002/jmri.20801; Le O, 2013, WORLD J RADIOL, V5, P106, DOI 10.4329/wjr.v5.i3.106; Lee SK, 2007, KOREAN J MED, V73, P237; Low RN, 2005, SEMIN ULTRASOUND CT, V26, P224, DOI 10.1053/j.sult.2005.04.003; Ly JN, 2002, RADIOL CLIN N AM, V40, P1289, DOI 10.1016/S0033-8389(02)00056-8; MENDEZ G, 1980, AM J ROENTGENOL, V135, P463, DOI 10.2214/ajr.135.3.463; Mindelzun RE, 1996, AM J ROENTGENOL, V167, P61, DOI 10.2214/ajr.167.1.8659422; Okino Y, 2001, RADIOGRAPHICS, V21, P1475, DOI 10.1148/radiographics.21.6.g01nv121475; OLIPHANT M, 1993, ABDOM IMAGING, V18, P109; Pamuklar Ertan, 2005, Magn Reson Imaging Clin N Am, V13, P313, DOI 10.1016/j.mric.2005.03.012; Papachristou GI, 2010, AM J GASTROENTEROL, V105, P435, DOI 10.1038/ajg.2009.622; Peng R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072792; Rahman SH, 2004, GASTROENTEROLOGY, V126, P1312, DOI 10.1053/j.gastro.2004.02.002; Russo MW, 2004, GASTROENTEROLOGY; Scaglione M, 2008, SEMIN ULTRASOUND CT, V29, P322, DOI 10.1053/j.sult.2008.06.009; Servin-Torres E, 2009, CIR CIR, V77, P407; SILVERMAN PM, 1984, AM J ROENTGENOL, V143, P953, DOI 10.2214/ajr.143.5.953; Stimac D, 2007, AM J GASTROENTEROL, V102, P997, DOI 10.1111/j.1572-0241.2007.01164.x; Tang W, 2011, EUR J RADIOL, V80, P637, DOI 10.1016/j.ejrad.2010.08.020; Triester SL, 2002, J CLIN GASTROENTEROL, V34, P167, DOI 10.1097/00004836-200202000-00014; Viremouneix L, 2007, J MAGN RESON IMAGING, V26, P331, DOI 10.1002/jmri.21037; Yang R, 2012, EUR J RADIOL, V81, P3041, DOI 10.1016/j.ejrad.2012.04.005	31	7	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93687	10.1371/journal.pone.0093687	http://dx.doi.org/10.1371/journal.pone.0093687			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705446	Green Submitted, gold, Green Published			2022-12-27	WOS:000334107500057
J	Haslam, N; Loughnan, S; Perry, G				Haslam, Nick; Loughnan, Steve; Perry, Gina			Meta-Milgram: An Empirical Synthesis of the Obedience Experiments	PLOS ONE			English	Article								Milgram's famous experiment contained 23 small-sample conditions that elicited striking variations in obedient responding. A synthesis of these diverse conditions could clarify the factors that influence obedience in the Milgram paradigm. We assembled data from the 21 conditions (N = 740) in which obedience involved progression to maximum voltage (overall rate 43.6%) and coded these conditions on 14 properties pertaining to the learner, the teacher, the experimenter, the learner-teacher relation, the experimenter-teacher relation, and the experimental setting. Logistic regression analysis indicated that eight factors influenced the likelihood that teachers continued to the 450 volt shock: the experimenter's directiveness, legitimacy, and consistency; group pressure on the teacher to disobey; the indirectness, proximity, and intimacy of the relation between teacher and learner; and the distance between the teacher and the experimenter. Implications are discussed.	[Haslam, Nick; Loughnan, Steve; Perry, Gina] Univ Melbourne, Sch Psychol Sci, Parkville, Vic 3052, Australia	University of Melbourne	Haslam, N (corresponding author), Univ Melbourne, Sch Psychol Sci, Parkville, Vic 3052, Australia.	nhaslam@unimelb.edu.au	Haslam, Nick/D-9026-2011	Haslam, Nick/0000-0002-1913-2340				[Anonymous], 2010, ESSENTIAL SOCIAL PSY; Aronson E, 2005, SOZIALPSYCHOLOGIE; Blass T, 2009, AM PSYCHOL, V64, P37, DOI 10.1037/a0014434; Burger JM, 2009, AM PSYCHOL, V64, P1, DOI 10.1037/a0010932; FRANZOI SL, 2009, SOCIAL PSYCHOL; Gibson S, 2013, BRIT J SOC PSYCHOL, V52, P290, DOI 10.1111/j.2044-8309.2011.02070.x; Gilovich T., 2006, SOCIAL PSYCHOL; Hogg MA, 2005, INTRO SOCIAL PSYCHOL, V4th; KENRICK DT, 2005, SOCIAL PSYCHOL; Michener H.A., 2004, SOCIAL PSYCHOL; MILGRAM S., 1974, OBEDIENCE AUTHORITY; Myers D. G., 2013, SOCIAL PSYCHOL; Packer DJ, 2008, PERSPECT PSYCHOL SCI, V3, P301, DOI 10.1111/j.1745-6924.2008.00080.x; Perry G., 2012, SHOCK MACHINE UNTOLD; Reicher S, 2011, BRIT J SOC PSYCHOL, V50, P163, DOI 10.1111/j.2044-8309.2010.02015.x; Reicher SD, 2012, PERSPECT PSYCHOL SCI, V7, P315, DOI 10.1177/1745691612448482; Russell NJC, 2011, BRIT J SOC PSYCHOL, V50, P140, DOI 10.1348/014466610X492205; Slater M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000039; Smith E. R., 2000, SOCIAL PSYCHOL; SUTTON R, 2013, SOCIAL PSYCHOL	20	34	34	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93927	10.1371/journal.pone.0093927	http://dx.doi.org/10.1371/journal.pone.0093927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6MJ	24705407	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500095
J	Rafacho, A; Goncalves-Neto, LM; Santos-Silva, JC; Alonso-Magdalena, P; Merino, B; Taboga, SR; Carneiro, EM; Boschero, AC; Nadal, A; Quesada, I				Rafacho, Alex; Goncalves-Neto, Luiz M.; Santos-Silva, Junia C.; Alonso-Magdalena, Paloma; Merino, Beatriz; Taboga, Sebastiao R.; Carneiro, Everardo M.; Boschero, Antonio C.; Nadal, Angel; Quesada, Ivan			Pancreatic Alpha-Cell Dysfunction Contributes to the Disruption of Glucose Homeostasis and Compensatory Insulin Hypersecretion in Glucocorticoid-Treated Rats	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; GLUCAGON-LIKE PEPTIDE-1; ISLET CELLS; SECRETION; RESISTANCE; RECEPTORS; MASS; PREDNISOLONE; MECHANISMS; RESPONSIVENESS	Glucocorticoid (GC)-based therapies can cause insulin resistance (IR), glucose intolerance, hyperglycemia and, occasionally, overt diabetes. Understanding the mechanisms behind these metabolic disorders could improve the management of glucose homeostasis in patients undergoing GC treatment. For this purpose, adult rats were treated with a daily injection of dexamethasone (1 mg/kg b.w., i.p.) (DEX) or saline as a control for 5 consecutive days. The DEX rats developed IR, augmented glycemia, hyperinsulinemia and hyperglucagonemia. Treatment of the DEX rats with a glucagon receptor antagonist normalized their blood glucose level. The characteristic inhibitory effect of glucose on glucagon secretion was impaired in the islets of the DEX rats, while no direct effects were found on alpha-cells in islets that were incubated with DEX in vitro. A higher proportion of docked secretory granules was found in the DEX alpha-cells as well as a trend towards increased alpha-cell mass. Additionally, insulin secretion in the presence of glucagon was augmented in the islets of the DEX rats, which was most likely due to their higher glucagon receptor content. We also found that the enzyme 11 beta HSD-1, which participates in GC metabolism, contributed to the insulin hypersecretion in the DEX rats under basal glucose conditions. Altogether, we showed that GC treatment induces hyperglucagonemia, which contributes to an imbalance in glucose homeostasis and compensatory beta-cell hypersecretion. This hyperglucagonemia may result from altered alpha-cell function and, likely, alpha-cell mass. Additionally, blockage of the glucagon receptor seems to be effective in preventing the elevation in blood glucose levels induced by GC administration.	[Rafacho, Alex; Goncalves-Neto, Luiz M.] Fed Univ Santa Catarina UFSC, Ctr Biol Sci, Dept Physiol Sci, Florianopolis, SC, Brazil; [Santos-Silva, Junia C.; Carneiro, Everardo M.; Boschero, Antonio C.] State Univ Campinas UNICAMP, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil; [Santos-Silva, Junia C.; Carneiro, Everardo M.; Boschero, Antonio C.] State Univ Campinas UNICAMP, OCRC, Campinas, SP, Brazil; [Alonso-Magdalena, Paloma; Merino, Beatriz; Nadal, Angel; Quesada, Ivan] Miguel Hernandez Univ, Inst Bioengn, Elche, Spain; [Alonso-Magdalena, Paloma; Merino, Beatriz; Nadal, Angel; Quesada, Ivan] Miguel Hernandez Univ, Biomed Res Ctr Diabet & Associated Metab Disorder, Elche, Spain; [Taboga, Sebastiao R.] Sao Paulo State Univ UNESP, Dept Biol, Inst Biosci Humanities & Exact Sci, Sao Jose Do Rio Preto, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche; Universidade Estadual Paulista	Rafacho, A (corresponding author), Fed Univ Santa Catarina UFSC, Ctr Biol Sci, Dept Physiol Sci, Florianopolis, SC, Brazil.	alex.rafacho@ufsc.br; ivanq@umh.es	Alonso-Magdalena, Paloma/AAH-2076-2021; Ivan, Quesada/P-6541-2014; Carneiro, Everardo/D-4758-2012; Rafacho, Alex/O-8609-2016; Nadal, Angel/G-6721-2014; MERINO, BEATRIZ/V-4121-2017; Silva, Junia C Santos/E-5052-2015; Boschero, Antonio/O-7525-2014	Ivan, Quesada/0000-0002-9808-514X; Rafacho, Alex/0000-0002-8637-6097; Nadal, Angel/0000-0003-4178-2152; MERINO, BEATRIZ/0000-0002-4761-3977; Silva, Junia C Santos/0000-0002-8667-8140; Boschero, Antonio/0000-0003-3829-8570; ALONSO MAGDALENA, PALOMA/0000-0003-1065-5388; Taboga, Sebastiao/0000-0002-0970-4288	FAPESP; CNPq [471397/2011-3]; Instituto Nacional de Ciencia e Tecnologia: Obesidade e Diabetes; Ministerio de Ciencia e Innovacion [BFU2010-21773, BFU2011-28358]; Generalitat Valenciana [PROMETEO/2011/080, ACOMP/2013/022]; European Foundation for the Study of Diabetes	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia: Obesidade e Diabetes; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Foundation for the Study of Diabetes	GRANTS: This study was supported by grants from the Brazilian foundations FAPESP, CNPq (471397/2011-3), and the Instituto Nacional de Ciencia e Tecnologia: Obesidade e Diabetes, the Spanish foundations the Ministerio de Ciencia e Innovacion (BFU2010-21773; BFU2011-28358) and the Generalitat Valenciana (PROMETEO/2011/080; ACOMP/2013/022), and the European Foundation for the Study of Diabetes (EFSD/BI Basic Programme and the Albert Renold Travel Fellowships for Young Scientists). CIBERDEM is an initiative of the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaudry JL, 2013, ENDOCRINOLOGY, V154, P3197, DOI 10.1210/en.2012-2114; Cummings BP, 2013, J ENDOCRINOL, V216, P207, DOI 10.1530/JOE-12-0459; Diederich S, 2011, HORM METAB RES, V43, P66, DOI 10.1055/s-0030-1267170; Dirlewanger M, 2000, CLIN NUTR, V19, P29, DOI 10.1054/clnu.1999.0064; Gromada J, 1997, PFLUG ARCH EUR J PHY, V434, P515, DOI 10.1007/s004240050431; Henquin JC, 2011, DIABETOLOGIA, V54, P1720, DOI 10.1007/s00125-011-2118-4; Huypens P, 2000, DIABETOLOGIA, V43, P1012, DOI 10.1007/s001250051484; Jensen DH, 2012, DIABETOLOGIA, V55, P1406, DOI 10.1007/s00125-012-2459-7; Karlsson S, 2001, PANCREAS, V22, P148, DOI 10.1097/00006676-200103000-00007; MARCO J, 1976, DIABETOLOGIA, V12, P307, DOI 10.1007/BF00420973; Marroqui L, 2012, ENDOCRINOLOGY, V153, P1663, DOI 10.1210/en.2011-1623; Meier JJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE717, DOI 10.1152/ajpendo.00315.2010; Moens K, 1996, DIABETES, V45, P257, DOI 10.2337/diabetes.45.2.257; Moens K, 1998, DIABETES, V47, P66, DOI 10.2337/diabetes.47.1.66; Montanya E, 2009, METHODS MOL BIOL, V560, P137, DOI 10.1007/978-1-59745-448-3_11; Mu J, 2011, DIABETOLOGIA, V54, P2381, DOI 10.1007/s00125-011-2217-2; Nicod N, 2003, OBES RES, V11, P625, DOI 10.1038/oby.2003.90; Nunes EA, 2013, APPL PHYSIOL NUTR ME, V38, P1137, DOI 10.1139/apnm-2012-0456; Ortsater H., 2012, STATE ART THERAPEUTI, V1st, P1; Pereira CD, 2012, DIABETES OBES METAB, V14, P869, DOI 10.1111/j.1463-1326.2012.01582.x; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; Rafacho A, 2011, HORM METAB RES, V43, P275, DOI 10.1055/s-0030-1269896; Rafacho A, 2010, ACTA PHYSIOL, V200, P223, DOI 10.1111/j.1748-1716.2010.02146.x; Rafacho A, 2010, ENDOCRINOLOGY, V151, P85, DOI 10.1210/en.2009-0704; Rafacho A, 2009, AM J PHYSIOL-ENDOC M, V296, pE681, DOI 10.1152/ajpendo.90931.2008; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schneiter P, 1998, AM J PHYSIOL-ENDOC M, V275, pE806, DOI 10.1152/ajpendo.1998.275.5.E806; Soriano S, 2010, ENDOCRINOLOGY, V151, P3543, DOI 10.1210/en.2010-0008; Swali A, 2008, DIABETOLOGIA, V51, P2003, DOI 10.1007/s00125-008-1137-2; Turban S, 2012, DIABETES, V61, P642, DOI 10.2337/db11-1054; UNSON CG, 1989, PEPTIDES, V10, P1171, DOI 10.1016/0196-9781(89)90010-7; van Raalte DH, 2009, EUR J CLIN INVEST, V39, P81, DOI 10.1111/j.1365-2362.2008.02067.x; van Raalte DH, 2010, EUR J ENDOCRINOL, V162, P729, DOI 10.1530/EJE-09-1034; WAJNGOT A, 1992, P NATL ACAD SCI USA, V89, P6035, DOI 10.1073/pnas.89.13.6035; WISE JK, 1973, J CLIN INVEST, V52, P2774, DOI 10.1172/JCI107473	37	28	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93531	10.1371/journal.pone.0093531	http://dx.doi.org/10.1371/journal.pone.0093531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705399	Green Published, Green Submitted, gold			2022-12-27	WOS:000334107500041
J	Schnecker, J; Wild, B; Hofhansl, F; Alves, RJE; Barta, J; Capek, P; Fuchslueger, L; Gentsch, N; Gittel, A; Guggenberger, G; Hofer, A; Kienzl, S; Knoltsch, A; Lashchinskiy, N; Mikutta, R; Santruckova, H; Shibistova, O; Takriti, M; Urich, T; Weltin, G; Richter, A				Schnecker, Joerg; Wild, Birgit; Hofhansl, Florian; Alves, Ricardo J. Eloy; Barta, Jiri; Capek, Petr; Fuchslueger, Lucia; Gentsch, Norman; Gittel, Antje; Guggenberger, Georg; Hofer, Angelika; Kienzl, Sandra; Knoltsch, Anna; Lashchinskiy, Nikolay; Mikutta, Robert; Santruckova, Hana; Shibistova, Olga; Takriti, Mounir; Urich, Tim; Weltin, Georg; Richter, Andreas			Effects of Soil Organic Matter Properties and Microbial Community Composition on Enzyme Activities in Cryoturbated Arctic Soils	PLOS ONE			English	Article							ECOENZYMATIC STOICHIOMETRY; CARBON POOLS; DECOMPOSITION; DEPTH; BACTERIAL; DYNAMICS; ARCHAEAL; SURFACE	Enzyme-mediated decomposition of soil organic matter (SOM) is controlled, amongst other factors, by organic matter properties and by the microbial decomposer community present. Since microbial community composition and SOM properties are often interrelated and both change with soil depth, the drivers of enzymatic decomposition are hard to dissect. We investigated soils from three regions in the Siberian Arctic, where carbon rich topsoil material has been incorporated into the subsoil (cryoturbation). We took advantage of this subduction to test if SOM properties shape microbial community composition, and to identify controls of both on enzyme activities. We found that microbial community composition (estimated by phospholipid fatty acid analysis), was similar in cryoturbated material and in surrounding subsoil, although carbon and nitrogen contents were similar in cryoturbated material and topsoils. This suggests that the microbial community in cryoturbated material was not well adapted to SOM properties. We also measured three potential enzyme activities (cellobiohydrolase, leucine-amino-peptidase and phenoloxidase) and used structural equation models (SEMs) to identify direct and indirect drivers of the three enzyme activities. The models included microbial community composition, carbon and nitrogen contents, clay content, water content, and pH. Models for regular horizons, excluding cryoturbated material, showed that all enzyme activities were mainly controlled by carbon or nitrogen. Microbial community composition had no effect. In contrast, models for cryoturbated material showed that enzyme activities were also related to microbial community composition. The additional control of microbial community composition could have restrained enzyme activities and furthermore decomposition in general. The functional decoupling of SOM properties and microbial community composition might thus be one of the reasons for low decomposition rates and the persistence of 400 Gt carbon stored in cryoturbated material.	[Schnecker, Joerg; Wild, Birgit; Hofhansl, Florian; Fuchslueger, Lucia; Hofer, Angelika; Kienzl, Sandra; Knoltsch, Anna; Takriti, Mounir; Richter, Andreas] Univ Vienna, Dept Microbiol & Ecosyst Sci, Div Terr Ecosyst Res, Vienna, Austria; [Schnecker, Joerg; Wild, Birgit; Alves, Ricardo J. Eloy; Gittel, Antje; Knoltsch, Anna; Takriti, Mounir; Urich, Tim; Richter, Andreas] Austrian Polar Res Inst, Vienna, Austria; [Alves, Ricardo J. Eloy; Urich, Tim] Univ Vienna, Div Archaea Biol & Ecogen, Dept Ecogen & Syst Biol, Vienna, Austria; [Barta, Jiri; Capek, Petr; Santruckova, Hana] Univ South Bohemia, Dept Ecosyst Biol, Ceske Budejovice, Czech Republic; [Gentsch, Norman; Guggenberger, Georg; Mikutta, Robert; Shibistova, Olga] Leibniz Univ Hannover, Inst Bodenkunde, D-30167 Hannover, Germany; [Gittel, Antje] Univ Bergen, Dept Biol, Ctr Geobiol, Bergen, Norway; [Lashchinskiy, Nikolay] Russian Acad Sci, Cent Siberian Bot Garden, Siberian Branch, Novosibirsk, Russia; [Shibistova, Olga] Russian Acad Sci, VN Sukachev Inst Forest, Siberian Branch, Krasnoyarsk, Russia; [Weltin, Georg] IAEA, Joint FAO IAEA Div Nucl Techn Food & Agr, Soil & Water Management & Crop Nutr Lab, A-1400 Vienna, Austria	University of Vienna; University of Vienna; University of South Bohemia Ceske Budejovice; Leibniz University Hannover; University of Bergen; Central Siberian Botanical Garden; Russian Academy of Sciences; Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Sukachev Institute of Forest, Siberian Branch, Russian Academy of Sciences; International Atomic Energy Agency	Schnecker, J (corresponding author), Univ Vienna, Dept Microbiol & Ecosyst Sci, Div Terr Ecosyst Res, Vienna, Austria.	joerg.schnecker@univie.ac.at	Santruckova, Hana/D-7365-2016; Guggenberger, Georg/C-8423-2013; Richter, Andreas/D-8483-2012; Lashchinskiy, Nikolay/I-5409-2018; Alves, Ricardo Jorge Eloy/C-2530-2013; Urich, Tim/J-8241-2016; Čapek, Petr/I-1518-2016; Wild, Birgit/E-6476-2012; Fuchslueger, Lucia/E-6687-2012; Schnecker, Jörg/E-6546-2012; Shibistova, Olga/AAP-1594-2020; Hofhansl, Florian/E-6656-2012	Santruckova, Hana/0000-0001-9947-5687; Guggenberger, Georg/0000-0002-6962-8264; Richter, Andreas/0000-0003-3282-4808; Alves, Ricardo Jorge Eloy/0000-0002-7567-3205; Urich, Tim/0000-0002-5718-1354; Čapek, Petr/0000-0001-9362-6384; Wild, Birgit/0000-0002-9611-0815; Fuchslueger, Lucia/0000-0002-9615-4439; Schnecker, Jörg/0000-0002-5160-2701; Hofhansl, Florian/0000-0003-0073-0946; Barta, Jiri/0000-0002-7319-303X; Mikutta, Robert/0000-0002-7186-6528; Lasinskii, Nikolai/0000-0003-1085-1987; Takriti, Mounir/0000-0003-1794-8802	Austrian Science Fund (FWF) as a part of the international program CryoCARB (Long-term Carbon Storage in Cryoturbated Arctic Soils) [FWF - I370-B17]; Osterreichische Gesellschaft fur Polarforschung; Austrian Science Fund (FWF) [I 370] Funding Source: researchfish	Austrian Science Fund (FWF) as a part of the international program CryoCARB (Long-term Carbon Storage in Cryoturbated Arctic Soils)(Austrian Science Fund (FWF)); Osterreichische Gesellschaft fur Polarforschung; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding for this research was provided by the Austrian Science Fund (FWF) as a part of the international program CryoCARB (Long-term Carbon Storage in Cryoturbated Arctic Soils; FWF - I370-B17). JS received a Julius-Payer-Stipendium by the Osterreichische Gesellschaft fur Polarforschung. The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Allison SD, 2013, ECOLOGY, V94, P714, DOI 10.1890/12-1243.1; Alster CJ, 2013, SOIL BIOL BIOCHEM, V64, P68, DOI 10.1016/j.soilbio.2013.03.034; Blume E, 2002, APPL SOIL ECOL, V20, P171, DOI 10.1016/S0929-1393(02)00025-2; Bockheim JG, 2007, SOIL SCI SOC AM J, V71, P1335, DOI 10.2136/sssaj2006.0414N; Colman BP, 2013, SOIL BIOL BIOCHEM, V60, P65, DOI 10.1016/j.soilbio.2013.01.003; DeForest JL, 2012, BIOGEOCHEMISTRY, V109, P189, DOI 10.1007/s10533-011-9619-6; Djukic I, 2013, FEMS MICROBIOL ECOL, V83, P112, DOI 10.1111/j.1574-6941.2012.01449.x; Eilers KG, 2012, SOIL BIOL BIOCHEM, V50, P58, DOI 10.1016/j.soilbio.2012.03.011; Ekelund F, 2001, SOIL BIOL BIOCHEM, V33, P475, DOI 10.1016/S0038-0717(00)00188-7; Fierer N, 2003, GLOBAL CHANGE BIOL, V9, P1322, DOI 10.1046/j.1365-2486.2003.00663.x; FROSTEGARD A, 1991, J MICROBIOL METH, V14, P151, DOI 10.1016/0167-7012(91)90018-L; Gebauer RLE, 1996, PLANT SOIL, V178, P37, DOI 10.1007/BF00011161; Gittel A, 2014, ISME J, V8, P841, DOI 10.1038/ismej.2013.219; Grace JB., 2015, STRUCTURAL EQUATION; Harden JW, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051958; Harris D, 2001, SOIL SCI SOC AM J, V65, P1853, DOI 10.2136/sssaj2001.1853; Hartmann M, 2009, ENVIRON MICROBIOL, V11, P3045, DOI 10.1111/j.1462-2920.2009.02008.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hugelius G, 2010, PERMAFROST PERIGLAC, V21, P16, DOI 10.1002/ppp.677; IUSS Working Group WRB, 2006, WORLD REFERENCE BASE, V103; Kaiser C, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000258; Kaiser C, 2010, SOIL BIOL BIOCHEM, V42, P1650, DOI 10.1016/j.soilbio.2010.05.019; Kaiser C, 2010, NEW PHYTOL, V187, P843, DOI 10.1111/j.1469-8137.2010.03321.x; Kuhry P, 2010, PERMAFROST PERIGLAC, V21, P208, DOI 10.1002/ppp.684; Oelke C, 2004, PERMAFROST PERIGLAC, V15, P103, DOI 10.1002/ppp.485; Prosser JI, 2012, FEMS MICROBIOL ECOL, V81, P507, DOI 10.1111/j.1574-6941.2012.01435.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Santruckova H, 2010, BOREAL ENVIRON RES, V15, P357; Schimel JP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00348; Schnecker J, 2012, SOIL BIOL BIOCHEM, V51, P81, DOI 10.1016/j.soilbio.2012.03.029; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Sinsabaugh RL, 2011, BIOGEOCHEMISTRY, V102, P31, DOI 10.1007/s10533-010-9482-x; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Sinsabaugh RL, 2009, NATURE, V462, P795, DOI 10.1038/nature08632; Sistla SA, 2012, NEW PHYTOL, V196, P68, DOI 10.1111/j.1469-8137.2012.04234.x; Strickland MS, 2009, FUNCT ECOL, V23, P627, DOI 10.1111/j.1365-2435.2008.01515.x; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Talbot JM, 2013, SOIL BIOL BIOCHEM, V57, P282, DOI 10.1016/j.soilbio.2012.10.004; Waldrop MP, 2006, MICROB ECOL, V52, P470, DOI 10.1007/s00248-006-9100-6; Wild B, 2013, SOIL BIOL BIOCHEM, V67, P85, DOI 10.1016/j.soilbio.2013.08.004; Xu CH, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000846	42	49	52	4	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94076	10.1371/journal.pone.0094076	http://dx.doi.org/10.1371/journal.pone.0094076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705618	Green Published, Green Accepted, gold			2022-12-27	WOS:000334107500121
J	Senderskiy, IV; Timofeev, SA; Seliverstova, EV; Pavlova, OA; Dolgikh, VV				Senderskiy, Igor V.; Timofeev, Sergey A.; Seliverstova, Elena V.; Pavlova, Olga A.; Dolgikh, Viacheslav V.			Secretion of Antonospora (Paranosema) locustae Proteins into Infected Cells Suggests an Active Role of Microsporidia in the Control of Host Programs and Metabolic Processes	PLOS ONE			English	Article							PARASITE ENCEPHALITOZOON-CUNICULI; TYROSINE-PHOSPHATASE SHP-1; NF-KAPPA-B; THEILERIA-ANNULATA; PROTOZOAN PARASITES; GENE-EXPRESSION; NUCLEAR EXPORT; NOSEMA-GRYLLI; BINDING; GENOME	Molecular tools of the intracellular protozoan pathogens Apicomplexa and Kinetoplastida for manipulation of host cell machinery have been the focus of investigation for approximately two decades. Microsporidia, fungi-related microorganisms forming another large group of obligate intracellular parasites, are characterized by development in direct contact with host cytoplasm (the majority of species), strong minimization of cell machinery, and acquisition of unique transporters to exploit host metabolic system. All the aforementioned features are suggestive of the ability of microsporidia to modify host metabolic and regulatory pathways. Seven proteins of the microsporidium Antonospora (Paranosema) locustae with predicted signal peptides but without transmembrane domains were overexpressed in Escherichia coli. Western-blot analysis with antibodies against recombinant products showed secretion of parasite proteins from different functional categories into the infected host cell. Secretion of parasite hexokinase and alpha/beta-hydrolase was confirmed by immunofluorescence microscopy. In addition, this method showed specific accumulation of A. locustae hexokinase in host nuclei. Expression of hexokinase, trehalase, and two leucine-rich repeat proteins without any exogenous signal peptide led to their secretion in the yeast Pichia pastoris. In contrast, alpha/beta-hydrolase was not found in the culture medium, though a significant amount of this enzyme accumulated in the yeast membrane fraction. These results suggest that microsporidia possess a broad set of enzymes and regulatory proteins secreted into infected cells to control host metabolic processes and molecular programs.	[Senderskiy, Igor V.; Timofeev, Sergey A.; Pavlova, Olga A.; Dolgikh, Viacheslav V.] All Russian Inst Plant Protect, Lab Microbiol Control, St Petersburg, Pushkin, Russia; [Seliverstova, Elena V.] Sechenov Inst Evolutionary Physiol & Biochem, Lab Renal Physiol, St Petersburg, Russia	All-Russian Institute of Plant Protection; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Dolgikh, VV (corresponding author), All Russian Inst Plant Protect, Lab Microbiol Control, St Petersburg, Pushkin, Russia.	dol1slav@yahoo.com	Senderskiy, Igor/J-6839-2018; Seliverstova, Elena/AAN-4894-2020; Timofeev, Sergey/GWZ-8836-2022; Olga, Pavlova/AAO-4051-2020; Timofeev, Sergey/J-2236-2014	Senderskiy, Igor/0000-0001-8598-2282; Timofeev, Sergey/0000-0001-6664-3971; Olga, Pavlova/0000-0003-0528-5618; Seliverstova, Elena/0000-0003-2096-693X; Dolgikh, Viacheslav/0000-0002-2362-2633	Russian Foundation of Basic Research RFBR [N 12-04-01517]	Russian Foundation of Basic Research RFBR(Russian Foundation for Basic Research (RFBR))	This work was supported by the Russian Foundation of Basic Research RFBR, N 12-04-01517 [http://www.rfbr.ru/rffi/ru]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brosson D, 2006, PROTEOMICS, V6, P3625, DOI 10.1002/pmic.200500796; Campbell SE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003676; CANNING EU, 1962, J INSECT PATHOL, V4, P248; Carmen JC, 2007, MOL MICROBIOL, V64, P904, DOI 10.1111/j.1365-2958.2007.05714.x; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Cuomo CA, 2012, GENOME RES, V22, P2478, DOI 10.1101/gr.142802.112; DARWISH A, 1989, J PROTOZOOL, V36, P308, DOI 10.1111/j.1550-7408.1989.tb05369.x; del Aguila C, 2006, INT J PARASITOL, V36, P869, DOI 10.1016/j.ijpara.2006.04.002; Dolgikh Viacheslav V., 2000, Protistology, V1, P87; Dolgikh VV, 2011, EUKARYOT CELL, V10, P588, DOI 10.1128/EC.00283-10; Dolgikh VV, 2009, FEMS MICROBIOL LETT, V293, P285, DOI 10.1111/j.1574-6968.2009.01545.x; Dolgikh VV, 1997, J EUKARYOT MICROBIOL, V44, P246, DOI 10.1111/j.1550-7408.1997.tb05707.x; Gilbert LA, 2007, EUKARYOT CELL, V6, P73, DOI 10.1128/EC.00309-06; Halle M, 2009, J BIOL CHEM, V284, P6893, DOI 10.1074/jbc.M805861200; Heinz E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002979; Heussler VT, 2002, SCIENCE, V298, P1033, DOI 10.1126/science.1075462; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2010, GENOME BIOL EVOL, V2, P304, DOI 10.1093/gbe/evq022; Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindquist S, 2002, EUR J BIOCHEM, V269, P759, DOI 10.1046/j.0014-2956.2001.02666.x; Ling MF, 1995, NUCLEIC ACIDS RES, V23, P4924, DOI 10.1093/nar/23.23.4924; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Metenier G, 2001, MICROBES INFECT, V3, P407, DOI 10.1016/S1286-4579(01)01398-3; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Molestina RE, 2005, J CELL SCI, V118, P5785, DOI 10.1242/jcs.02709; MONSTADT GM, 1991, BIOCHEM J, V273, P739, DOI 10.1042/bj2730739; Nandan D, 2005, CLIN IMMUNOL, V114, P266, DOI 10.1016/j.clim.2004.07.017; Nandan D, 2002, J BIOL CHEM, V277, P50190, DOI 10.1074/jbc.M209210200; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Neary CL, 2010, BIOCHEM BIOPH RES CO, V394, P1075, DOI 10.1016/j.bbrc.2010.03.129; Pelaez R, 2009, J BIOL CHEM, V284, P20548, DOI 10.1074/jbc.M109.013730; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Ravindran S, 2008, TRAFFIC, V9, P647, DOI 10.1111/j.1600-0854.2008.00723.x; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; Scanlon M, 1999, J EUKARYOT MICROBIOL, V46, p34S; Schmuckli-Maurer J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004839; SELEZNEV KV, 1995, J EUKARYOT MICROBIOL, V42, P288, DOI 10.1111/j.1550-7408.1995.tb01582.x; Shiels BR, 2004, EUKARYOT CELL, V3, P495, DOI 10.1128/EC.3.2.495-505.2004; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; Sokolova YY, 2002, ACTA PROTOZOOL, V41, P229; Swan DG, 2003, CELL MICROBIOL, V5, P947, DOI 10.1046/j.1462-5822.2003.00340.x; Swan DG, 2001, J CELL SCI, V114, P2747; Tsaousis AD, 2008, NATURE, V453, P553, DOI 10.1038/nature06903; Undeen AH, 1999, J INVERTEBR PATHOL, V73, P294, DOI 10.1006/jipa.1998.4834; WANG CS, 1993, BIOCHIM BIOPHYS ACTA, V1166, P1, DOI 10.1016/0005-2760(93)90277-G	50	24	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93585	10.1371/journal.pone.0093585	http://dx.doi.org/10.1371/journal.pone.0093585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705470	Green Submitted, Green Published, gold			2022-12-27	WOS:000334107500044
J	Wang, MC; Zhang, W; Ding, W; Dai, DB; Zhang, HR; Xie, H; Chen, LN; Guo, YK; Xie, J				Wang, Minchao; Zhang, Wu; Ding, Wang; Dai, Dongbo; Zhang, Huiran; Xie, Hao; Chen, Luonan; Guo, Yike; Xie, Jiang			Parallel Clustering Algorithm for Large-Scale Biological Data Sets	PLOS ONE			English	Article							GENE-EXPRESSION DATA; PROTEIN-INTERACTION NETWORKS; AFFINITY PROPAGATION; MICROARRAY DATA; SUPERFAMILY; EVOLUTION; MODULES; ARRAY	Backgrounds: Recent explosion of biological data brings a great challenge for the traditional clustering algorithms. With increasing scale of data sets, much larger memory and longer runtime are required for the cluster identification problems. The affinity propagation algorithm outperforms many other classical clustering algorithms and is widely applied into the biological researches. However, the time and space complexity become a great bottleneck when handling the large-scale data sets. Moreover, the similarity matrix, whose constructing procedure takes long runtime, is required before running the affinity propagation algorithm, since the algorithm clusters data sets based on the similarities between data pairs. Methods: Two types of parallel architectures are proposed in this paper to accelerate the similarity matrix constructing procedure and the affinity propagation algorithm. The memory-shared architecture is used to construct the similarity matrix, and the distributed system is taken for the affinity propagation algorithm, because of its large memory size and great computing capacity. An appropriate way of data partition and reduction is designed in our method, in order to minimize the global communication cost among processes. Result: A speedup of 100 is gained with 128 cores. The runtime is reduced from serval hours to a few seconds, which indicates that parallel algorithm is capable of handling large-scale data sets effectively. The parallel affinity propagation also achieves a good performance when clustering large-scale gene data (microarray) and detecting families in large protein superfamilies.	[Wang, Minchao; Zhang, Wu; Ding, Wang; Dai, Dongbo; Zhang, Huiran; Chen, Luonan; Guo, Yike; Xie, Jiang] Shanghai Univ, Sch Comp Engn & Sci, Shanghai, Peoples R China; [Zhang, Wu] Shanghai Univ, Ctr High Performance Comp, Shanghai, Peoples R China; [Xie, Hao] Wuhan Univ, Coll Stomatol, Wuhan 430072, Peoples R China; [Chen, Luonan] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Guo, Yike] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England	Shanghai University; Shanghai University; Wuhan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Imperial College London	Xie, J (corresponding author), Shanghai Univ, Sch Comp Engn & Sci, Shanghai, Peoples R China.	jiangx@shu.edu.cn	郭, 伊可/GYD-3212-2022		Specialized Research Fund for the Doctoral Program of Higher Education [SRFDP 20113108120022]; Key Project of Science and Technology Commission of Shanghai Municipality [11510500300]; Major Research Plan of NSFC [91330116]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Project of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Major Research Plan of NSFC	This research is partially supported by the Specialized Research Fund for the Doctoral Program of Higher Education [SRFDP 20113108120022], the Key Project of Science and Technology Commission of Shanghai Municipality [No. 11510500300], and the Major Research Plan of NSFC [No. 91330116]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asyali MH, 2006, CURR BIOINFORM, V1, P55, DOI 10.2174/157489306775330615; Babbitt PC, 1996, BIOCHEMISTRY-US, V35, P16489, DOI 10.1021/bi9616413; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Blasberg RV, 2008, HPCF20088 UMBC; Blasberg RV, 2008, HPCF20085 UMBC; Blasberg RV, 2008, MVAPICH2 VS OPENMPI; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Borile C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-224; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Bustamam A, 2012, IEEE ACM T COMPUT BI, V9, P679, DOI 10.1109/TCBB.2011.68; Chen WY, 2011, IEEE T PATTERN ANAL, V33, P568, DOI 10.1109/TPAMI.2010.88; DAYHOFF MO, 1976, FED PROC, V35, P2132; Dembele D, 2003, BIOINFORMATICS, V19, P973, DOI 10.1093/bioinformatics/btg119; Ding W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061533; Dueck D, 2008, LECT N BIOINFORMAT, V4955, P360; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ekanayake J, 2011, IEEE T PARALL DISTR, V22, P998, DOI 10.1109/TPDS.2010.178; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fong J, 2008, LECT NOTES COMPUTER; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hanisch Daniel, 2002, Bioinformatics, V18 Suppl 1, pS145; Kerr G, 2008, COMPUT BIOL MED, V38, P283, DOI 10.1016/j.compbiomed.2007.11.001; Kiddle SJ, 2010, BIOINFORMATICS, V26, P355, DOI 10.1093/bioinformatics/btp673; Kurdziel M, 2012, LECT NOTES COMPUT SC, V7203, P599, DOI 10.1007/978-3-642-31464-3_61; Leone M, 2007, BIOINFORMATICS, V23, P2708, DOI 10.1093/bioinformatics/btm414; Lounkine E, 2011, J CHEM INF MODEL, V51, P3158, DOI 10.1021/ci2004994; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mazurie A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-59; Mishra VD, 2012, PROCEDIA ENGINEER, V38, P2124, DOI 10.1016/j.proeng.2012.06.255; Mndez MA, 2002, FEBS LETT, V522, P24; Paccanaro A, 2006, NUCLEIC ACIDS RES, V34, P1571, DOI 10.1093/nar/gkj515; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; Pham TD, 2006, CURR BIOINFORM, V1, P37, DOI 10.2174/157489306775330642; Pirim H, 2012, COMPUT OPER RES, V39, P3046, DOI 10.1016/j.cor.2012.03.008; Raghavachari N, 2007, CIRCULATION, V115, P1551, DOI 10.1161/CIRCULATIONAHA.106.658641; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Song JM, 2009, BIOINFORMATICS, V25, P3143, DOI 10.1093/bioinformatics/btp551; Soria D., 2009, International Journal of Knowledge Engineering and Soft Data Paradigms, V1, P195, DOI 10.1504/IJKESDP.2009.028814; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tung-Shou C, 2005, INT SIGN PROC COMM S, P405; Votavova H, 2011, PLACENTA, V32, P763, DOI 10.1016/j.placenta.2011.06.022; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141	47	12	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e91315	10.1371/journal.pone.0091315	http://dx.doi.org/10.1371/journal.pone.0091315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705246	Green Submitted, gold, Green Published			2022-12-27	WOS:000334107500003
J	Brankaer, C; Ghesquiere, P; De Smedt, B				Brankaer, Carmen; Ghesquiere, Pol; De Smedt, Bert			Children's Mapping between Non-Symbolic and Symbolic Numerical Magnitudes and Its Association with Timed and Untimed Tests of Mathematics Achievement	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; NUMBER WORDS; DYSCALCULIA; ACUITY; SKILLS; BRAIN	The ability to map between non-symbolic numerical magnitudes and Arabic numerals has been put forward as a key factor in children's mathematical development. This mapping ability has been mainly examined indirectly by looking at children's performance on a symbolic magnitude comparison task. The present study investigated mapping in a more direct way by using a task in which children had to choose which of two choice quantities (Arabic digits or dot arrays) matched the target quantity (dot array or Arabic digit), thereby focusing on small quantities ranging from 1 to 9. We aimed to determine the development of mapping over time and its relation to mathematics achievement. Participants were 36 first graders (M = 6 years 8 months) and 46 third graders (M = 8 years 8 months) who all completed mapping tasks, symbolic and non-symbolic magnitude comparison tasks and standardized timed and untimed tests of mathematics achievement. Findings revealed that children are able to map between non-symbolic and symbolic representations and that this mapping ability develops over time. Moreover, we found that children's mapping ability is related to timed and untimed measures of mathematics achievement, over and above the variance accounted for by their numerical magnitude comparison skills.	[Brankaer, Carmen; Ghesquiere, Pol; De Smedt, Bert] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Louvain, Belgium	KU Leuven	Brankaer, C (corresponding author), Katholieke Univ Leuven, Fac Psychol & Educ Sci, Louvain, Belgium.	carmen.brankaer@ppw.kuleuven.be	De Smedt, Bert/G-4729-2010; De Smedt, Bert/U-6124-2019; Ghesquière, Pol/B-9226-2009; De Smedt, Bert/Q-7020-2019	De Smedt, Bert/0000-0002-3313-3278; De Smedt, Bert/0000-0002-3313-3278; Ghesquière, Pol/0000-0001-9056-7550; 	Marguerite-Marie Delacroix Support Fund; Research Foundation Flanders (FWO), Belgium [G.0359.10]	Marguerite-Marie Delacroix Support Fund; Research Foundation Flanders (FWO), Belgium(FWO)	This study was supported by the Marguerite-Marie Delacroix Support Fund and by grant G.0359.10 of the Research Foundation Flanders (FWO), Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth H, 2008, DEV PSYCHOL, V44, P1466, DOI 10.1037/a0013046; Barth H, 2009, COGNITIVE DEV, V24, P248, DOI 10.1016/j.cogdev.2009.04.001; Bugden S, 2011, COGNITION, V118, P32, DOI 10.1016/j.cognition.2010.09.005; Butterworth B, 2011, SCIENCE, V332, P1049, DOI 10.1126/science.1201536; Castronovo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033832; De Smedt B, 2013, TRENDS NEUROSCI EDUC, V2, P48, DOI 10.1016/j.tine.2013.06.001; De Smedt B, 2011, J EXP CHILD PSYCHOL, V108, P278, DOI 10.1016/j.jecp.2010.09.003; De Smedt B, 2009, J EXP CHILD PSYCHOL, V103, P469, DOI 10.1016/j.jecp.2009.01.010; de Vos T., 1992, TEMPO TEST REKENEN H; Dehaene S., 2011, NUMBER SENSE MIND CR; Dudal P., 2000, LEERLINGVOLGSYSTEEM; GRIFFIN S, 2003, CP CO LE IN, P1; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Inglis M, 2014, ACTA PSYCHOL, V145, P147, DOI 10.1016/j.actpsy.2013.11.009; Izard V, 2008, COGNITION, V106, P1221, DOI 10.1016/j.cognition.2007.06.004; Kolkman ME, 2013, LEARN INSTR, V25, P95, DOI 10.1016/j.learninstruc.2012.12.001; Landerl K, 2004, COGNITION, V93, P99, DOI 10.1016/j.cognition.2003.11.004; Lipton JS, 2005, CHILD DEV, V76, P978, DOI 10.1111/j.1467-8624.2005.00891.x; Lyons IM, 2012, J EXP PSYCHOL GEN, V141, P635, DOI 10.1037/a0027248; Mazzocco MMM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023749; Mazzocco MMM, 2011, CHILD DEV, V82, P1224, DOI 10.1111/j.1467-8624.2011.01608.x; Mundy E, 2009, J EXP CHILD PSYCHOL, V103, P490, DOI 10.1016/j.jecp.2009.02.003; Mussolin C, 2010, COGNITION, V115, P10, DOI 10.1016/j.cognition.2009.10.006; Mussolin C, 2010, J COGNITIVE NEUROSCI, V22, P860, DOI 10.1162/jocn.2009.21237; Noel MP, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00165; Petrill S, 2012, J LEARN DISABIL-US, V45, P371, DOI 10.1177/0022219411407926; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Raven J, 2003, STANDARD PROGR MATRI; Rousselle L, 2007, COGNITION, V102, P361, DOI 10.1016/j.cognition.2006.01.005; Sasanguie D, 2013, J EXP CHILD PSYCHOL, V114, P418, DOI 10.1016/j.jecp.2012.10.012; Schneider W., 2002, E PRIME VERSION 20 C; SEKULER R, 1977, CHILD DEV, V48, P630, DOI 10.1111/j.1467-8624.1977.tb01208.x; Sullivan J, 2013, Q J EXP PSYCHOL, V66, P389, DOI 10.1080/17470218.2012.715655; Xu F, 2007, BRIT J DEV PSYCHOL, V25, P103, DOI 10.1348/026151005X90704	35	39	39	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93565	10.1371/journal.pone.0093565	http://dx.doi.org/10.1371/journal.pone.0093565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LR	24699664	gold, Green Published, Green Submitted			2022-12-27	WOS:000334105000070
J	Cartellieri, M; Koristka, S; Arndt, C; Feldmann, A; Stamova, S; von Bonin, M; Topfer, K; Kruger, T; Geib, M; Michalk, I; Temme, A; Bornhauser, M; Lindemann, D; Ehninger, G; Bachmann, MP				Cartellieri, Marc; Koristka, Stefanie; Arndt, Claudia; Feldmann, Anja; Stamova, Slava; von Bonin, Malte; Toepfer, Katrin; Krueger, Thomas; Geib, Mathias; Michalk, Irene; Temme, Achim; Bornhaeser, Martin; Lindemann, Dirk; Ehninger, Gerhard; Bachmann, Michael P.			A Novel Ex Vivo Isolation and Expansion Procedure for Chimeric Antigen Receptor Engrafted Human T Cells	PLOS ONE			English	Article							CD28 COSTIMULATION; ADOPTIVE TRANSFER; TUMOR-CELLS; CD8(+); LYMPHOCYTES; CANCER; IMMUNOTHERAPY; CD4(+); PROLIFERATION; REDIRECTION	Genetically engineered T lymphocytes are a promising option for cancer therapy. Prior to adoptive transfer they have to be expanded in vitro to reach therapeutically sufficient numbers. So far, no universal method exists for selective in vitro expansion of engineered T lymphocytes. In order to overcome this problem and for proof of concept we incorporated a novel unique peptide sequence of ten amino acids as epitope (E-Tag) into the binding domains of two novel chimeric antigen receptors (ECARs) directed against either prostate stem cell antigen (PSCA) for the treatment of prostate cancer (PCa) or CD33 for the treatment of acute myeloide leukemia (AML). The epitope tag then was utilized for expanding ECAR engrafted T cells by triggering the modified T cells via a monoclonal antibody directed against the E-Tag (Emab). Moreover, the E-Tag served as an efficient selection epitope for immunomagnetic isolation of modified T cells to high purity. ECAR engrafted T cells were fully functional and mediated profound anti-tumor effects in the respective models of PCa or AML both in vitro and in vivo. The method can be integrated straightforward into clinical protocols to improve therapeutic efficiency of tumor treatment with CAR modified T lymphocytes.	[Cartellieri, Marc; Koristka, Stefanie; Arndt, Claudia; Feldmann, Anja; Stamova, Slava; Krueger, Thomas; Geib, Mathias; Michalk, Irene; Bachmann, Michael P.] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Immunol, Dresden, Germany; [Cartellieri, Marc; Feldmann, Anja; Bachmann, Michael P.] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Dept Radioimmunol, Dresden, Germany; [von Bonin, Malte; Bornhaeser, Martin; Ehninger, Gerhard] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Med Clin & Polyclin, Dresden, Germany; [Toepfer, Katrin; Temme, Achim] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Neurosurg, Sect Expt Neurosurg & Tumor Immunol, Dresden, Germany; [Lindemann, Dirk] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Virol, Dresden, Germany; [Bornhaeser, Martin; Lindemann, Dirk; Bachmann, Michael P.] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden	Bachmann, MP (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Immunol, Dresden, Germany.	michael.bachman@tu-dresden.de	Lindemann, Dirk/H-5857-2013; Bachmann, Michael/AAA-5153-2020; Cartellieri, Marc/M-3281-2013; Feldmann, Anja/AAI-1809-2020; Arndt, Claudia/F-1648-2019; Cartellieri, Marc/AAL-8197-2020; Bachmann, Michael P/E-8850-2010	Lindemann, Dirk/0000-0002-0320-4223; Bachmann, Michael/0000-0002-8029-5755; Cartellieri, Marc/0000-0002-4672-3963; Feldmann, Anja/0000-0001-5099-2448; Arndt, Claudia/0000-0002-1285-5052; Bachmann, Michael P/0000-0002-8029-5755; Stamova, Slava/0000-0002-2543-1523; von Bonin, Malte/0000-0002-2995-3230	Medical faculty of the TU Dresden; Center for Regenerative Therapies Dresden (CRTD), TU Dresden, Dresden, Germany	Medical faculty of the TU Dresden; Center for Regenerative Therapies Dresden (CRTD), TU Dresden, Dresden, Germany	This study was supported by grants of the Medical faculty of the TU Dresden to Marc Cartellieri and seed grants given to Michael Bachmann by the Center for Regenerative Therapies Dresden (CRTD), TU Dresden, Dresden, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt C, 2014, LEUKEMIA, V28, P59, DOI 10.1038/leu.2013.243; Arndt C, 2013, LEUKEMIA, V27, P964, DOI 10.1038/leu.2013.18; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Brenner MK, 2010, CURR OPIN IMMUNOL, V22, P251, DOI 10.1016/j.coi.2010.01.020; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Cartellieri M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956304; Dannull J, 2000, CANCER RES, V60, P5522; Davila ML, 2012, ONCOIMMUNOLOGY, V1, P1577, DOI 10.4161/onci.22524; De Oliveira SN, 2013, HUM GENE THER, V24, P824, DOI 10.1089/hum.2012.202; Elinav E, 2008, GASTROENTEROLOGY, V134, P2014, DOI 10.1053/j.gastro.2008.02.060; Elinav E, 2009, GASTROENTEROLOGY, V136, P1721, DOI 10.1053/j.gastro.2009.01.049; Feldmann A, 2012, J IMMUNOL, V189, P3249, DOI 10.4049/jimmunol.1200341; Feldmann A, 2011, PROSTATE, V71, P998, DOI 10.1002/pros.21315; Finney HM, 2004, J IMMUNOL, V172, P104, DOI 10.4049/jimmunol.172.1.104; Finney HM, 1998, J IMMUNOL, V161, P2791; Grigorian A, 2009, IMMUNOL REV, V230, P232, DOI 10.1111/j.1600-065X.2009.00796.x; Ho YP, 2012, MOL THER, V20, P1167, DOI 10.1038/mt.2012.61; Hollyman D, 2009, J IMMUNOTHER, V32, P169, DOI 10.1097/CJI.0b013e318194a6e8; Hombach A, 2001, J IMMUNOL, V167, P6123, DOI 10.4049/jimmunol.167.11.6123; Hombach AA, 2013, CURR MOL MED, V13, P1079; Hombach AA, 2009, GENE THER, V16, P1088, DOI 10.1038/gt.2009.75; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kiessling A, 2008, EUR UROL, V53, P694, DOI 10.1016/j.eururo.2007.11.043; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Kloss CC, 2013, NAT BIOTECHNOL, V31, P71, DOI 10.1038/nbt.2459; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Koehler H, 2007, CANCER RES, V67, P2265, DOI 10.1158/0008-5472.CAN-06-2098; Koristka S, 2013, J AUTOIMMUN, V42, P105, DOI 10.1016/j.jaut.2013.01.002; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Mitsuyasu RT, 2000, BLOOD, V96, P785, DOI 10.1182/blood.V96.3.785.015k10_785_793; Morgenroth A, 2007, PROSTATE, V67, P1121, DOI 10.1002/pros.20608; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rasmussen AM, 2010, J IMMUNOL METHODS, V355, P52, DOI 10.1016/j.jim.2010.02.004; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; ROBERTS MR, 1994, BLOOD, V84, P2878; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Stamova S, 2011, LEUKEMIA, V25, P1053, DOI 10.1038/leu.2011.42; Stamova S, 2011, MOL IMMUNOL, V49, P474, DOI 10.1016/j.molimm.2011.09.019; Stirnnagel K, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-45; Suerth JD, 2012, CURR OPIN IMMUNOL, V24, P598, DOI 10.1016/j.coi.2012.08.007; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Themeli M, 2013, NAT BIOTECHNOL, V31, P928, DOI 10.1038/nbt.2678; Topfer K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/918471; Turtle CJ, 2012, CURR OPIN IMMUNOL, V24, P633, DOI 10.1016/j.coi.2012.06.004; von Bonin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060680; Walter RB, 2012, BLOOD, V119, P6198, DOI 10.1182/blood-2011-11-325050; Wang XL, 2011, BLOOD, V118, P1255, DOI 10.1182/blood-2011-02-337360	50	33	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93745	10.1371/journal.pone.0093745	http://dx.doi.org/10.1371/journal.pone.0093745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699869	Green Submitted, Green Published, gold			2022-12-27	WOS:000334105000098
J	Dietz, JA; Maes, ME; Huang, S; Yandell, BS; Schlamp, CL; Montgomery, AD; Allingham, RR; Hauser, MA; Nickells, RW				Dietz, Joel A.; Maes, Margaret E.; Huang, Shuang; Yandell, Brian S.; Schlamp, Cassandra L.; Montgomery, Angela D.; Allingham, R. Rand; Hauser, Michael A.; Nickells, Robert W.			Spink2 Modulates Apoptotic Susceptibility and Is a Candidate Gene in the Rgcs1 QTL That Affects Retinal Ganglion Cell Death after Optic Nerve Damage	PLOS ONE			English	Article							SERINE-PROTEASE INHIBITOR; OPEN-ANGLE GLAUCOMA; IRIS ATROPHY; DBA/2J MICE; EXPRESSION; OPTINEURIN; MUTATIONS; BAX; NEURODEGENERATION; INDUCTION	The Rgcs1 quantitative trait locus, on mouse chromosome 5, influences susceptibility of retinal ganglion cells to acute damage of the optic nerve. Normally resistant mice (DBA/2J) congenic for the susceptible allele from BALB/cByJ mice exhibit susceptibility to ganglion cells, not only in acute optic nerve crush, but also to chronic inherited glaucoma that is characteristic of the DBA/2J strain as they age. SNP mapping of this QTL has narrowed the region of interest to 1 Mb. In this region, a single gene (Spink2) is the most likely candidate for this effect. Spink2 is expressed in retinal ganglion cells and is increased after optic nerve damage. This gene is also polymorphic between resistant and susceptible strains, containing a single conserved amino acid change (threonine to serine) and a 220 bp deletion in intron 1 that may quantitatively alter endogenous expression levels between strains. Overexpression of the different variants of Spink2 in D407 tissue culture cells also increases their susceptibility to the apoptosis-inducing agent staurosporine in a manner consistent with the differential susceptibility between the DBA/2J and BALB/cByJ strains.	[Dietz, Joel A.; Maes, Margaret E.; Schlamp, Cassandra L.; Montgomery, Angela D.; Nickells, Robert W.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA; [Huang, Shuang; Yandell, Brian S.] Univ Wisconsin, Dept Biostat, Madison, WI USA; [Allingham, R. Rand; Hauser, Michael A.] Duke Univ, Med Ctr, Dept Med, Ctr Human Genet, Durham, NC 27710 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Duke University	Nickells, RW (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA.	nickells@wisc.edu		Maes, Margaret/0000-0001-9642-1085	National Eye Institute [R01EY018869, P30 EY016665]; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [P30EY016665, R01EY018869] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute grants R01EY018869 (RWN) and vision core grant P30 EY016665, and an unrestricted grant to the Department of Ophthalmology and Visual Sciences at the University of Wisconsin from Research to Prevent Blindness, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012839; Alward WLM, 2003, AM J OPHTHALMOL, V136, P904, DOI 10.1016/S0002-9394(03)00577-4; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Chang LK, 2002, BIOCHIMIE, V84, P223, DOI 10.1016/S0300-9084(02)01372-X; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Chen T, 2009, PROTEINS, V77, P209, DOI 10.1002/prot.22432; Chera S, 2006, J CELL SCI, V119, P846, DOI 10.1242/jcs.02807; Chera S, 2009, BBA-MOL CELL RES, V1793, P1432, DOI 10.1016/j.bbamcr.2009.03.010; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Dietz JA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-74; Ding C, 2011, EXP EYE RES, V92, P512, DOI 10.1016/j.exer.2011.03.016; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Fingert JH, 2011, HUM MOL GENET, V20, P2482, DOI 10.1093/hmg/ddr123; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Kawase K, 2012, EXP EYE RES, V96, P178, DOI 10.1016/j.exer.2011.12.021; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; LANDER ES, 1989, GENETICS, V121, P185; Lee B, 2011, J BIOL CHEM, V286, P29108, DOI 10.1074/jbc.M111.244905; Leung YF, 2003, INVEST OPHTH VIS SCI, V44, P3880, DOI 10.1167/iovs.02-0693; Li Y, 1999, INVEST OPHTH VIS SCI, V40, P1004; Li Y, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-19; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Nickells RW, 2012, ANNU REV NEUROSCI, V35, P153, DOI 10.1146/annurev.neuro.051508.135728; Ohmuraya M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00126; Ohmuraya M, 2011, EXP ANIM TOKYO, V60, P433; Ohta T, 2002, J CELL BIOL, V156, P87, DOI 10.1083/jcb.200108088; Pelzel HR, 2012, INVEST OPHTH VIS SCI, V53, P1428, DOI 10.1167/iovs.11-8872; Pelzel HR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-62; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Ramdas WD, 2011, HUM MOL GENET, V20, P2464, DOI 10.1093/hmg/ddr120; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Rodriguez-Muela N, 2012, CELL DEATH DIFFER, V19, P162, DOI 10.1038/cdd.2011.88; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Schlamp CL, 2013, MOL VIS, V19, P1387; Schlamp CT, 1996, J NEUROSCI, V16, P2164; Semaan SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-554; Sternberg C, 2010, BRAZ J MED BIOL RES, V43, P950, DOI 10.1590/S0100-879X2010001000005; Weidberg H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002355; Weishaupt JH, 2005, J MOL NEUROSCI, V26, P17, DOI 10.1385/JMN:26:1:017; Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281	50	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93564	10.1371/journal.pone.0093564	http://dx.doi.org/10.1371/journal.pone.0093564			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699552	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000069
J	Holmes, EE; Jung, M; Meller, S; Leisse, A; Sailer, V; Zech, J; Mengdehl, M; Garbe, LA; Uhl, B; Kristiansen, G; Dietrich, D				Holmes, Emily Eva; Jung, Maria; Meller, Sebastian; Leisse, Annette; Sailer, Verena; Zech, Julie; Mengdehl, Martina; Garbe, Leif-Alexander; Uhl, Barbara; Kristiansen, Glen; Dietrich, Dimo			Performance Evaluation of Kits for Bisulfite-Conversion of DNA from Tissues, Cell Lines, FFPE Tissues, Aspirates, Lavages, Effusions, Plasma, Serum, and Urine	PLOS ONE			English	Article							PROSTATE-CANCER; CLINICAL VALIDATION; ANTIGEN RECURRENCE; GENOMIC DNA; METHYLATION; EXTRACTION; BIOMARKER; SAMPLES; SHOX2; ASSAY	DNA methylation analyses usually require a preceding bisulfite conversion of the DNA. The choice of an appropriate kit for a specific application should be based on the specific performance requirements with regard to the respective sample material. In this study, the performance of nine kits was evaluated: EpiTect Fast FFPE Bisulfite Kit, EpiTect Bisulfite Kit, EpiTect Fast DNA Bisulfite Kit (Qiagen), EZ DNA Methylation-Gold Kit, EZ DNA Methylation-Direct Kit, EZ DNA Methylation-Lightning Kit (Zymo Research), innuCONVERT Bisulfite All-In-One Kit, innuCONVERT Bisulfite Basic Kit, innuCONVERT Bisulfite Body Fluids Kit (Analytik Jena). The kit performance was compared with regard to DNA yield, DNA degradation, DNA purity, conversion efficiency, stability and handling using qPCR, UV, clone sequencing, HPLC, and agarose gel electrophoresis. All kits yielded highly pure DNA suitable for PCR analyses without PCR inhibition. Significantly higher yields were obtained when using the EZ DNA Methylation-Gold Kit and the innuCONVERT Bisulfite kits. Conversion efficiency ranged from 98.7% (EpiTect Bisulfite Kit) to 99.9% (EZ DNA Methylation-Direct Kit). The inappropriate conversion of methylated cytosines to thymines varied between 0.9% (innuCONVERT Bisulfite kits) and 2.7% (EZ DNA Methylation-Direct Kit). Time-to-result ranged from 131 min (innuCONVERT kits) to 402 min (EpiTect Bisulfite Kit). Hands-on-time was between 66 min (EZ DNA Methylation-Lightning Kit) and 104 min (EpiTect Fast FFPE and Fast DNA Bisulfite kits). Highest yields from formalin-fixed and paraffin-embedded (FFPE) tissue sections without prior extraction were obtained using the innuCONVERT Bisulfite All-In-One Kit while the EZ DNA Methylation-Direct Kit yielded DNA with only low PCR-amplifiability. The innuCONVERT Bisulfite All-In-One Kit exhibited the highest versatility regarding different input sample materials (extracted DNA, tissue, FFPE tissue, cell lines, urine sediment, and cellular fractions of bronchial aspirates, pleural effusions, ascites). The innuCONVERT Bisulfite Body Fluids Kit allowed for the analysis of 3 ml plasma, serum, ascites, pleural effusions and urine.	[Holmes, Emily Eva; Jung, Maria; Meller, Sebastian; Leisse, Annette; Sailer, Verena; Uhl, Barbara; Kristiansen, Glen; Dietrich, Dimo] Univ Hosp Bonn UKB, Inst Pathol, Bonn, Germany; [Zech, Julie; Mengdehl, Martina; Garbe, Leif-Alexander] Berlin Inst Technol TU Berlin, Berlin, Germany	University of Bonn; Technical University of Berlin	Dietrich, D (corresponding author), Univ Hosp Bonn UKB, Inst Pathol, Bonn, Germany.	dimo.dietrich@gmail.com		Zech, Julie/0000-0003-1137-6604	AJ Innuscreen GmbH (Berlin, Germany)	AJ Innuscreen GmbH (Berlin, Germany)	The study was funded by AJ Innuscreen GmbH (Berlin, Germany). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banez LL, 2010, J UROLOGY, V184, P149, DOI 10.1016/j.juro.2010.03.012; Bonin S, 2010, VIRCHOWS ARCH, V457, P309, DOI 10.1007/s00428-010-0917-5; Boyd VL, 2004, ANAL BIOCHEM, V326, P278, DOI 10.1016/j.ab.2003.11.020; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; Darst Russell P, 2010, Curr Protoc Mol Biol, VChapter 7, DOI 10.1002/0471142727.mb0709s91; Darwiche K, 2013, ANN ONCOL, V24, P2866, DOI 10.1093/annonc/mdt365; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Dietrich D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084225; Dietrich D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077771; Dietrich D, 2013, J MOL DIAGN, V15, P270, DOI 10.1016/j.jmoldx.2012.11.002; Dietrich D, 2012, INT J ONCOL, V40, P825, DOI 10.3892/ijo.2011.1264; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Genereux DP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn691; Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65; Hayatsu H., 2004, NUCL ACIDS S SER OXF, V261, DOI [10.1093/nass/48.1.261, DOI 10.1093/NASS/48.1.261]; Hayatsu H, 2008, MUTAT RES-REV MUTAT, V659, P77, DOI 10.1016/j.mrrev.2008.04.003; Hayatsu Hikoya, 2008, Curr Protoc Nucleic Acid Chem, VChapter 6, DOI 10.1002/0471142700.nc0610s33; IISE P, 2013, CANCER GENOM PROTEOM, V10, P217; Jin LX, 2013, PHYS CHEM CHEM PHYS, V15, P9034, DOI 10.1039/c3cp51275d; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kneip C, 2011, J THORAC ONCOL, V6, P1632, DOI 10.1097/JTO.0b013e318220ef9a; Lee TH, 2001, TRANSFUSION, V41, P276, DOI 10.1046/j.1537-2995.2001.41020276.x; Millar DS, 2002, METHODS, V27, P108, DOI 10.1016/S1046-2023(02)00061-0; Mostegl MM, 2011, J VET DIAGN INVEST, V23, P1212, DOI 10.1177/1040638711425584; Niland EE, 2012, AM J TRANSL RES, V4, P198; RAIZIS AM, 1995, ANAL BIOCHEM, V226, P161, DOI 10.1006/abio.1995.1204; Schatz P, 2010, J MOL DIAGN, V12, P345, DOI 10.2353/jmoldx.2010.090088; Schmidt B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-600; Schwarzenbach H, 2009, CLIN CANCER RES, V15, P1032, DOI 10.1158/1078-0432.CCR-08-1910; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Shiraishi M, 2004, DNA RES, V11, P409, DOI 10.1093/dnares/11.6.409; Stemmer C, 2003, CLIN CHEM, V49, P1953, DOI 10.1373/clinchem.2003.020750; Stewart GD, 2013, J UROLOGY, V189, P1110, DOI 10.1016/j.juro.2012.08.219; Taga M, 2013, INT J CLIN EXP PATHO, V6, P76; Tanaka K, 2007, BIOORG MED CHEM LETT, V17, P1912, DOI 10.1016/j.bmcl.2007.01.040; Warnecke PM, 2002, METHODS, V27, P101, DOI 10.1016/S1046-2023(02)00060-9; Weiss G, 2009, J UROLOGY, V181, P1678, DOI 10.1016/j.juro.2008.11.120; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197	40	86	94	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93933	10.1371/journal.pone.0093933	http://dx.doi.org/10.1371/journal.pone.0093933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699908	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000121
J	Iida, R; Welner, RS; Zhao, WK; Alberola-lla, J; Medina, KL; Zhao, ZZJ; Kincade, PW				Iida, Ryuji; Welner, Robert S.; Zhao, Wanke; Alberola-lla, Josee; Medina, Kay L.; Zhao, Zhizhuang Joe; Kincade, Paul W.			Stem and Progenitor Cell Subsets Are Affected by JAK2 Signaling and Can Be Monitored by Flow Cytometry	PLOS ONE			English	Article							VERA-LIKE DISEASE; HEMATOPOIETIC STEM; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE NEOPLASMS; SELF-RENEWAL; BONE-MARROW; IN-VIVO; ESSENTIAL THROMBOCYTHEMIA; JAK2(V617F) EXPRESSION; ADAPTER PROTEIN	Although extremely rare, hematopoietic stem cells (HSCs) are divisible into subsets that differ with respect to differentiation potential and cell surface marker expression. For example, we recently found that CD86(-) CD150(+) CD48(-) HSCs have limited potential for lymphocyte production. This could be an important new tool for studying hematological abnormalities. Here, we analyzed HSC subsets with a series of stem cell markers in JAK2V617F transgenic (Tg) mice, where the mutation is sufficient to cause myeloproliferative neoplasia with lymphocyte deficiency. Total numbers of HSC were elevated 3 to 20 fold in bone marrow of JAK2V617F mice. Careful analysis suggested the accumulation involved multiple HSC subsets, but particularly those characterized as CD150(HI) CD86(-) CD18(Lo)CD41(+) and excluding Hoechst dye. Real-Time PCR analysis of their HSC revealed that the erythropoiesis associated gene transcripts Gata1, Klf1 and Epor were particularly high. Flow cytometry analyses based on two differentiation schemes for multipotent progenitors (MPP) also suggested alteration by JAK2 signals. The low CD86 on HSC and multipotent progenitors paralleled the large reductions we found in lymphoid progenitors, but the few that were produced functioned normally when sorted and placed in culture. Either of two HSC subsets conferred disease when transplanted. Thus, flow cytometry can be used to observe the influence of abnormal JAK2 signaling on stem and progenitor subsets. Markers that similarly distinguish categories of human HSCs might be very valuable for monitoring such conditions. They could also serve as indicators of HSC fitness and suitability for transplantation.	[Iida, Ryuji; Alberola-lla, Josee; Kincade, Paul W.] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA; [Welner, Robert S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Zhao, Wanke; Zhao, Zhizhuang Joe] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Medina, Kay L.] Mayo Clin, Dept Immunol, Rochester, MN USA	Oklahoma Medical Research Foundation; Harvard University; Beth Israel Deaconess Medical Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Mayo Clinic	Kincade, PW (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	kincade@omrf.org	Hofer, Benedikt/G-2183-2017	Hofer, Benedikt/0000-0002-4787-3373; alberola-ila, Jose/0000-0003-2439-553X	National Institutes of Health [AI020069, HL107138, R01 HL096108, HL079441]; Oklahoma Center for Adult Stem Cell Research [4340-04-09-0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096108, R01HL107138, R01HL079441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020069, R01AI020069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for Adult Stem Cell Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants AI020069, and HL107138 (PWK); R01 HL096108 (KLM); HL079441 (ZJZ) from the National Institutes of Health and 4340-04-09-0 from the Oklahoma Center for Adult Stem Cell Research. PWK holds the William H. and Rita Bell Endowed Chair in Biomedical Research and is Scientific Director, Oklahoma Center for Adult Stem Cell Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akada H, 2010, BLOOD, V115, P3589, DOI 10.1182/blood-2009-04-215848; Baran-Marszak F, 2010, BLOOD, V116, P5961, DOI 10.1182/blood-2009-12-256768; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Bersenev A, 2010, J CLIN INVEST, V120, P2058, DOI 10.1172/JCI42032; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Chen E, 2012, IMMUNITY, V36, P529, DOI 10.1016/j.immuni.2012.03.017; Chen E, 2010, CANCER CELL, V18, P524, DOI 10.1016/j.ccr.2010.10.013; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Esplin BL, 2011, J IMMUNOL, V186, P5367, DOI 10.4049/jimmunol.1003438; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; Gery S, 2009, J LEUKOCYTE BIOL, V85, P957, DOI 10.1189/jlb.0908575; Hasan S, 2013, BLOOD, V122, P1464, DOI 10.1182/blood-2013-04-498956; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Kent DG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001576; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Li J, 2011, DIS MODEL MECH, V4, P311, DOI 10.1242/dmm.006817; Li JA, 2010, BLOOD, V116, P1528, DOI 10.1182/blood-2009-12-259747; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Marty C, 2010, BLOOD, V116, P783, DOI 10.1182/blood-2009-12-257063; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Mullally A, 2013, BLOOD, V121, P3692, DOI 10.1182/blood-2012-05-432989; Mullally A, 2012, BLOOD, V120, P166, DOI 10.1182/blood-2012-01-402396; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Muller-Sieburg CE, 2012, BLOOD, V119, P3900, DOI 10.1182/blood-2011-12-376749; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Pecquet C, 2012, BLOOD, V119, P4625, DOI 10.1182/blood-2011-08-372524; Quintas-Cardama A, 2013, BLOOD, V122, P893, DOI 10.1182/blood-2012-07-442012; Shide K, 2008, LEUKEMIA, V22, P87, DOI 10.1038/sj.leu.2405043; Shimazu T, 2012, BLOOD, V119, P4889, DOI 10.1182/blood-2011-10-388736; SPANGRUDE GJ, 1993, BLOOD, V82, P3327; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Takaki S, 2002, J EXP MED, V195, P151, DOI 10.1084/jem.20011170; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Tong W, 2005, BLOOD, V105, P4604, DOI 10.1182/blood-2004-10-4093; Vainchenker W, 2011, BLOOD, V118, P1723, DOI 10.1182/blood-2011-02-292102; Van Etten RA, 2011, HAEMATOL-HEMATOL J, V96, P590, DOI 10.3324/haematol.2010.035675; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; Walz C, 2012, BLOOD, V119, P3550, DOI 10.1182/blood-2011-12-397554; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xing S, 2008, BLOOD, V111, P5109, DOI 10.1182/blood-2007-05-091579; Yan DQ, 2012, BLOOD, V119, P3539, DOI 10.1182/blood-2011-03-345215; Zaleskas VM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000018	55	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93643	10.1371/journal.pone.0093643	http://dx.doi.org/10.1371/journal.pone.0093643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699465	Green Submitted, gold, Green Published			2022-12-27	WOS:000334105000085
J	Ivanov, PC; Yuen, A; Perakakis, P				Ivanov, Plamen Ch.; Yuen, Ainslie; Perakakis, Pandelis			Impact of Stock Market Structure on Intertrade Time and Price Dynamics	PLOS ONE			English	Article							FLUCTUATIONS; MAKERS; TRADES; NYSE	We analyse times between consecutive transactions for a diverse group of stocks registered on the NYSE and NASDAQ markets, and we relate the dynamical properties of the intertrade times with those of the corresponding price fluctuations. We report that market structure strongly impacts the scale-invariant temporal organisation in the transaction timing of stocks, which we have observed to have long-range power-law correlations. Specifically, we find that, compared to NYSE stocks, stocks registered on the NASDAQ exhibit significantly stronger correlations in their transaction timing on scales within a trading day. Further, we find that companies that transfer from the NASDAQ to the NYSE show a reduction in the correlation strength of transaction timing on scales within a trading day, indicating influences of market structure. We also report a persistent decrease in correlation strength of intertrade times with increasing average intertrade time and with corresponding decrease in companies' market capitalization-a trend which is less pronounced for NASDAQ stocks. Surprisingly, we observe that stronger power-law correlations in intertrade times are coupled with stronger power-law correlations in absolute price returns and higher price volatility, suggesting a strong link between the dynamical properties of intertrade times and the corresponding price fluctuations over a broad range of time scales. Comparing the NYSE and NASDAQ markets, we demonstrate that the stronger correlations we find in intertrade times for NASDAQ stocks are associated with stronger correlations in absolute price returns and with higher volatility, suggesting that market structure may affect price behavior through information contained in transaction timing. These findings do not support the hypothesis of universal scaling behavior in stock dynamics that is independent of company characteristics and stock market structure. Further, our results have implications for utilising transaction timing patterns in price prediction and risk management optimization on different stock markets.	[Ivanov, Plamen Ch.; Perakakis, Pandelis] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [Ivanov, Plamen Ch.; Perakakis, Pandelis] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Ivanov, Plamen Ch.] Harvard Univ, Sch Med, Boston, MA USA; [Ivanov, Plamen Ch.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Ivanov, Plamen Ch.] Bulgarian Acad Sci, Inst Solid State Phys, Sofia, Bulgaria; [Yuen, Ainslie] Univ Cambridge, Dept Engn, Signal Proc Lab, Cambridge CB2 1PZ, England; [Perakakis, Pandelis] Univ Jaume 1, Lab Expt Econ, Castellon de La Plana, Spain; [Perakakis, Pandelis] Univ Granada, Mind Brain & Behav Res Ctr CIMCYC, Granada, Spain	Boston University; Boston University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Bulgarian Academy of Sciences; University of Cambridge; Universitat Jaume I; University of Granada	Ivanov, PC (corresponding author), Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA.	plamen@buphy.bu.edu	Perakakis, Pandelis/Y-9230-2019; Perakakis, Pandelis/AFR-1800-2022; Ivanov, Plamen Ch./E-8004-2012; Perakakis, Pandelis/F-9038-2010	Perakakis, Pandelis/0000-0002-9130-3247; Ivanov, Plamen Ch./0000-0001-7629-762X; Perakakis, Pandelis/0000-0002-9130-3247	Department of Engineering, Cambridge University; King's College, Cambridge; Spanish Ministry of Science and Innovation [JCI-2010-06790, ECO 2011-23634]; University Jaume I [P1-1B2012-27]	Department of Engineering, Cambridge University; King's College, Cambridge; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University Jaume I	Ainslie Yuen thanks the Department of Engineering, Cambridge University and King's College, Cambridge for financial support. Pandelis Perakakis was supported by grants JCI-2010-06790 and ECO 2011-23634 offered by the Spanish Ministry of Science and Innovation, and grant P1-1B2012-27 by University Jaume I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dayri K, 2011, NEW ECON WINDOWS, P155; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Bennett P, 2003, MARKET STRUCTURE FRA; Bessembinder H, 1997, J FINANC QUANT ANAL, V32, P287, DOI 10.2307/2331201; Bogle JC, 2003, WALL ST J       0919; Bonanno G, 2000, PHYSICA A, V280, P136, DOI 10.1016/S0378-4371(99)00629-9; Bouchaud JP, 2009, HANDB FINANC, P57, DOI 10.1016/B978-012374258-2.50006-3; Chen Z, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011104; CHRISTIE WG, 1994, J FINANC, V49, P1813, DOI 10.2307/2329272; Dufour A, 2000, J FINANC, V55, P2467, DOI 10.1111/0022-1082.00297; Eisler Z, 2006, EUR PHYS J B, V51, P145, DOI 10.1140/epjb/e2006-00189-6; Eisler Z, 2005, EUROPHYS LETT, V69, P664, DOI 10.1209/epl/i2004-10384-1; Engle RF, 1998, ECONOMETRICA, V66, P1127, DOI 10.2307/2999632; GALLANT AR, 1992, REV FINANC STUD, V5, P199, DOI 10.1093/rfs/5.2.199; Ghysels E, 1995, 95S32 CTR INT RES AN; Gontis V, 2008, PHYSICA A, V387, P3891, DOI 10.1016/j.physa.2008.02.078; Gopikrishnan P, 1999, PHYS REV E, V60, P5305, DOI 10.1103/PhysRevE.60.5305; Gopikrishnan P, 2000, PHYS REV E, V62, pR4493, DOI 10.1103/PhysRevE.62.R4493; HASBROUCK J, 1995, J FINANC, V50, P1175, DOI 10.2307/2329348; HASBROUCK J, 1993, J FINANC, V48, P1565, DOI 10.2307/2329060; HAUSMAN JA, 1992, J FINANC ECON, V31, P319, DOI 10.1016/0304-405X(92)90038-Y; Hechinger J, 2003, WALL ST J       1017; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Ivanov PC, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.056107; Jasiak J, 1999, PERSISTENCE INTERTRA; Jiang ZQ, 2008, PHYSICA A, V387, P5818, DOI 10.1016/j.physa.2008.06.039; Jiang ZQ, 2009, PHYSICA A, V388, P433, DOI 10.1016/j.physa.2008.10.028; JONES CM, 1994, REV FINANC STUD, V7, P631, DOI 10.1093/rfs/7.4.631; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; Lillo F, 2003, NATURE, V421, P129, DOI 10.1038/421129a; Liu YH, 1999, PHYS REV E, V60, P1390, DOI 10.1103/PhysRevE.60.1390; Ma QDY, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031101; Mainardi F, 2000, PHYSICA A, V287, P468, DOI 10.1016/S0378-4371(00)00386-1; Mandelbrot B. B, 1997, MULTIFRACTAL MODEL A; Masoliver J, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021112; Masulis RW, 2002, J FINANC QUANT ANAL, V37, P617, DOI 10.2307/3595014; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Perello J, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036108; Plerou V, 2000, PHYS REV E, V62, pR3023, DOI 10.1103/PhysRevE.62.R3023; Plerou V, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.037101; Politi M, 2008, PHYSICA A, V387, P2025, DOI 10.1016/j.physa.2007.11.018; Raberto M, 2002, PHYSICA A, V314, P749, DOI 10.1016/S0378-4371(02)01048-8; Romero NE, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/18004; Ruan YP, 2011, PHYSICA A, V390, P1646, DOI 10.1016/j.physa.2011.01.001; Sabatelli L, 2002, EUR PHYS J B, V27, P273, DOI 10.1140/epjb/e20020151; Smith JW, 1998, 9801 NASD; Solomon D, 2003, WALL ST J       1016; Taqqu MS, 1995, FRACTALS, V3, P785, DOI 10.1142/S0218348X95000692; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Weaver DG, 2002, INTRADAY VOLATILITY; Yuen A, 2005, PHYSICS0508203 ARXIV	51	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92885	10.1371/journal.pone.0092885	http://dx.doi.org/10.1371/journal.pone.0092885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LR	24699376	Green Submitted, Green Published, gold			2022-12-27	WOS:000334105000036
J	Kellawan, JM; Tschakovsky, ME				Kellawan, J. Mikhail; Tschakovsky, Michael E.			The Single-Bout Forearm Critical Force Test: A New Method to Establish Forearm Aerobic Metabolic Exercise Intensity and Capacity	PLOS ONE			English	Article							MUSCLE BLOOD-FLOW; CRITICAL POWER; OXYGEN-UPTAKE; RESPONSES; RELIABILITY; PERFORMANCE; ACTIVATION; CONTRACTIONS; FATIGUE; PROFILE	No non-invasive test exists for forearm exercise that allows identification of power-time relationship parameters (W', critical power) and thereby identification of the heavy-severe exercise intensity boundary and scaling of aerobic metabolic exercise intensity. The aim of this study was to develop a maximal effort handgrip exercise test to estimate forearm critical force (fCF; force analog of power) and establish its repeatability and validity. Ten healthy males (20-43 years) completed two maximal effort rhythmic handgrip exercise tests (repeated maximal voluntary contractions (MVC); 1 s contraction-2 s relaxation for 600 s) on separate days. Exercise intensity was quantified via peak contraction force and contraction impulse. There was no systematic difference between test 1 and 2 for fCF(peak force) (p = 0.11) or fCF(impulse) (p = 0.76). Typical error was small for both fCF(peak force) (15.3 N, 5.5%) and fCF(impulse) (15.7 N.s, 6.8%), and test re-test correlations were strong (fCF(peak force), r = 0.91, ICC = 0.94, p<0.01; fCF(impulse), r = 0.92, ICC = 0.95, p<0.01). Seven of ten subjects also completed time-to-exhaustion tests (TTE) at target contraction force equal to 10%<fCF(peak force) and 10%. fCF(peak force). TTE predicted by W' showed good agreement with actual TTE during the TTE tests (r = 0.97, ICC = 0.97, P<0.01; typical error 0.98 min, 12%; regression fit slope = 0.99 and y intercept not different from 0, p = 0.31). MVC did not predict fCF(peak force) (p = 0.37), fCF(impulse) (p = 0.49) or W' (p = 0.15). In conclusion, the poor relationship between MVC and fCF or W' illustrates the serious limitation of MVC in identifying metabolism-based exercise intensity zones. The maximal effort handgrip exercise test provides repeatable and valid estimates of fCF and should be used to normalize forearm aerobic metabolic exercise intensity instead of MVC.	[Kellawan, J. Mikhail; Tschakovsky, Michael E.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada	Queens University - Canada	Tschakovsky, ME (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	mt29@queensu.ca	Kellawan, Jeremy Mikhail/J-3599-2019	Kellawan, Jeremy Mikhail/0000-0001-7889-8146	Natural Sciences and Engineering Council of Canada (NSERC) [250367-06]; Canada Foundation for Innovation; Ontario Innovation Trust Infrastructure Grants; Queen's University Chancellor's Research Award; Ontario Graduate Scholarship; Ontario Graduate Scholarship in Science and Technology; R.S. McLaughlin Fellowship	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust Infrastructure Grants; Queen's University Chancellor's Research Award; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Ontario Graduate Scholarship in Science and Technology; R.S. McLaughlin Fellowship	M.E. Tschakovsky was funded by Natural Sciences and Engineering Council of Canada (NSERC) Discovery Grant 250367-06, Canada Foundation for Innovation and Ontario Innovation Trust Infrastructure Grants, Queen's University Chancellor's Research Award. J. Mikhail Kellawan was funded by the Ontario Graduate Scholarship, the Ontario Graduate Scholarship in Science and Technology, and the R.S. McLaughlin Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker T, 2006, EXP PHYSIOL, V91, P621, DOI 10.1113/expphysiol.2005.032789; Bland JM, 2010, INT J NURS STUD, V47, P931, DOI 10.1016/j.ijnurstu.2009.10.001; Burnley M, 2006, MED SCI SPORT EXER, V38, P1995, DOI 10.1249/01.mss.0000232024.06114.a6; Burnley M, 2009, J APPL PHYSIOL, V106, P975, DOI 10.1152/japplphysiol.91474.2008; Casey DP, 2011, J APPL PHYSIOL, V110, P687, DOI 10.1152/japplphysiol.00787.2010; Casey DP, 2009, J APPL PHYSIOL, V107, P429, DOI 10.1152/japplphysiol.00331.2009; Crecelius AR, 2011, J PHYSL, V589, P3871; Dekerle J, 2012, EUR J APPL PHYSIOL, V112, P327, DOI 10.1007/s00421-011-1979-z; DiMenna FJ, 2009, J EXERC SCI FIT, V7, P67, DOI 10.1016/S1728-869X(09)60009-5; Faisal A, 2010, J PHYSIOL-LONDON, V588, P3785, DOI 10.1113/jphysiol.2010.188698; Hamann JJ, 2005, J APPL PHYSIOL, V98, P2096, DOI 10.1152/japplphysiol.00400.2004; Herbert RD, 1996, J APPL PHYSIOL, V80, P1351, DOI 10.1152/jappl.1996.80.4.1351; Hogan MC, 1998, AM J PHYSIOL-ENDOC M, V274, pE397, DOI 10.1152/ajpendo.1998.274.3.E397; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, 2001, SPORTS MED, V31, P211, DOI 10.2165/00007256-200131030-00005; Jeukendrup A, 1996, MED SCI SPORT EXER, V28, P266, DOI 10.1097/00005768-199602000-00017; Jones AM, 2008, AM J PHYSIOL-REG I, V294, pR585, DOI 10.1152/ajpregu.00731.2007; Jones AM, 2010, MED SCI SPORT EXER, V42, P1876, DOI 10.1249/MSS.0b013e3181d9cf7f; KENTBRAUN JA, 1993, J APPL PHYSIOL, V75, P573, DOI 10.1152/jappl.1993.75.2.573; MCLELLAN TM, 1995, CAN J APPL PHYSIOL, V20, P39, DOI 10.1139/h95-003; POOLE DC, 1988, ERGONOMICS, V31, P1265, DOI 10.1080/00140138808966766; Saugen E, 1997, EXP PHYSIOL, V82, P213, DOI 10.1113/expphysiol.1997.sp004010; Saunders NR, 2004, J APPL PHYSIOL, V97, P1143, DOI 10.1152/japplphysiol.01284.2003; Schabort EJ, 1999, J SPORT SCI, V17, P627, DOI 10.1080/026404199365650; Taylor SA, 2002, EUR J APPL PHYSIOL, V87, P43, DOI 10.1007/s00421-002-0586-4; Todd G, 2003, J PHYSIOL-LONDON, V551, P661, DOI 10.1113/jphysiol.2003.044099; Vanhatalo A, 2008, EXP PHYSIOL, V93, P383, DOI 10.1113/expphysiol.2007.039883; Vanhatalo A, 2007, MED SCI SPORT EXER, V39, P548, DOI 10.1249/mss.0b013e31802dd3e6; Vanhatalo A, 2011, INT J SPORT PHYSIOL, V6, P128, DOI 10.1123/ijspp.6.1.128; Vanhatalo A, 2010, EXP PHYSIOL, V95, P528, DOI 10.1113/expphysiol.2009.050500; Wilson GJ, 1996, SPORTS MED, V22, P19, DOI 10.2165/00007256-199622010-00003	31	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93481	10.1371/journal.pone.0093481	http://dx.doi.org/10.1371/journal.pone.0093481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699366	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000063
J	Martini, P; Sales, G; Brugiolo, M; Gandaglia, A; Naso, F; De Pitta, C; Spina, M; Gerosa, G; Chemello, F; Romualdi, C; Cagnin, S; Lanfranchi, G				Martini, Paolo; Sales, Gabriele; Brugiolo, Mattia; Gandaglia, Alessandro; Naso, Filippo; De Pitta, Cristiano; Spina, Michele; Gerosa, Gino; Chemello, Francesco; Romualdi, Chiara; Cagnin, Stefano; Lanfranchi, Gerolamo			Tissue-Specific Expression and Regulatory Networks of Pig MicroRNAome	PLOS ONE			English	Article							SKELETAL-MUSCLE; PORCINE MICRORNAS; IDENTIFICATION; MIRNA; TRANSCRIPTOME; PREDICTION; PROFILES; CLONING; GENES; XENOTRANSPLANTATION	Background: Despite the economic and medical importance of the pig, knowledge about its genome organization, gene expression regulation, and molecular mechanisms involved in physiological processes is far from that achieved for mouse and rat, the two most used model organisms in biomedical research. MicroRNAs (miRNAs) are a wide class of molecules that exert a recognized role in gene expression modulation, but only 280 miRNAs in pig have been characterized to date. Results: We applied a novel computational approach to predict species-specific and conserved miRNAs in the pig genome, which were then subjected to experimental validation. We experimentally identified candidate miRNAs sequences grouped in high-confidence (424) and medium-confidence (353) miRNAs according to RNA-seq results. A group of miRNAs was also validated by PCR experiments. We established the subtle variability in expression of isomiRs and miRNA-miRNA star couples supporting a biological function for these molecules. Finally, miRNA and mRNA expression profiles produced from the same sample of 20 different tissue of the animal were combined, using a correlation threshold to filter miRNA-target predictions, to identify tissue-specific regulatory networks. Conclusions: Our data represent a significant progress in the current understanding of miRNAome in pig. The identification of miRNAs, their target mRNAs, and the construction of regulatory circuits will provide new insights into the complex biological networks in several tissues of this important animal model.	[Martini, Paolo; Sales, Gabriele; Brugiolo, Mattia; De Pitta, Cristiano; Chemello, Francesco; Romualdi, Chiara; Cagnin, Stefano; Lanfranchi, Gerolamo] Univ Padua, Dept Biol, Padua, Italy; [Martini, Paolo; Brugiolo, Mattia; Cagnin, Stefano; Lanfranchi, Gerolamo] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Gandaglia, Alessandro; Naso, Filippo; Gerosa, Gino] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy; [Spina, Michele] Univ Padua, Dept Biomed Sci, Padua, Italy	University of Padua; University of Padua; University of Padua; University of Padua	Cagnin, S (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	stefano.cagnin@unipd.it; gerolamo.lanfranchi@unipd.it	Gerosa, Gino/M-8106-2014; cagnin, stefano/E-9095-2011; Romualdi, Chiara/K-1132-2016; Spina, Michele/ABE-6014-2020; Martini, Paolo/AAG-7398-2020; Chemello, Francesco/ABB-3801-2020; De Pitta, Cristiano/AAY-7302-2020; Sales, Gabriele/K-5065-2016	Gerosa, Gino/0000-0002-6261-699X; cagnin, stefano/0000-0001-7271-4625; Romualdi, Chiara/0000-0003-4792-9047; Spina, Michele/0000-0001-6576-8182; Martini, Paolo/0000-0002-0146-1031; De Pitta, Cristiano/0000-0001-8013-8162; Naso, Filippo/0000-0002-8198-8799; Sales, Gabriele/0000-0003-2078-5661; Chemello, Francesco/0000-0002-3877-527X; Gandaglia, Alessandro/0000-0002-0227-5257	Regione Veneto; Ricerca Sanitaria Finalizzata [RSF 286/08]; Fondazione della Cassa di Risparmio di Padova e Rovigo	Regione Veneto(Regione Veneto); Ricerca Sanitaria Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); Fondazione della Cassa di Risparmio di Padova e Rovigo	This work was supported by a grant from Regione Veneto, Ricerca Sanitaria Finalizzata (RSF 286/08) to GG and by a grant from the Fondazione della Cassa di Risparmio di Padova e Rovigo (Excellence project 2010-2011) to GL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058306; Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; [Anonymous], 2005, MCGRAW HILL CONCISE; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Biscontin A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-44; Bissels U, 2009, RNA, V15, P2375, DOI 10.1261/rna.1754109; Brattelid T, 2011, PHYSIOL GENOMICS, V43, P604, DOI 10.1152/physiolgenomics.00131.2010; Cagnin S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-13; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Cox MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012132; Curry E, 2011, THERIOGENOLOGY, V76, P1532, DOI 10.1016/j.theriogenology.2011.06.025; Dawson HD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-332; Dudley AM, 2002, P NATL ACAD SCI USA, V99, P7554, DOI 10.1073/pnas.112683499; Ekser B, 2009, TRANSPL IMMUNOL, V21, P87, DOI 10.1016/j.trim.2008.10.005; Fairbairn L, 2013, J IMMUNOL, V190, P6389, DOI 10.4049/jimmunol.1300365; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Fosse J, 2009, ZOONOSES PUBLIC HLTH, V56, P429, DOI 10.1111/j.1863-2378.2008.01185.x; Foucar K., 2010, BONE MARROW PATHOLOG, V3rd ed; Freeman TC, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-90; Granada JF, 2009, EUROINTERVENTION, V5, P140, DOI 10.4244/EIJV5I1A22; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Helvik SA, 2007, BIOINFORMATICS, V23, P142, DOI 10.1093/bioinformatics/btl570; Hofacker IL, 2004, BIOINFORMATICS, V20, P186, DOI 10.1093/bioinformatics/btg388; Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Hulst M, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-18; Kadner A, 2000, EUR J CARDIO-THORAC, V17, P474, DOI 10.1016/S1010-7940(00)00362-6; Kikuchi K, 2012, ANNU REV CELL DEV BI, V28, P719, DOI 10.1146/annurev-cellbio-101011-155739; Kim HJ, 2006, GENOME, V49, P1283, DOI 10.1139/G06-120; Kim J, 2008, MAMM GENOME, V19, P570, DOI 10.1007/s00335-008-9111-3; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kragh PM, 2009, TRANSGENIC RES, V18, P545, DOI 10.1007/s11248-009-9245-4; Kronick MN, 2004, EXPERT REV PROTEOMIC, V1, P19, DOI 10.1586/14789450.1.1.19; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052256; Li HY, 2012, ANIM GENET, V43, P704, DOI 10.1111/j.1365-2052.2012.02332.x; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024883; Li MT, 2011, INT J INNOV COMPUT I, V7, P1055; Li MZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1854; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Lian CJ, 2012, FEBS J, V279, P964, DOI 10.1111/j.1742-4658.2012.08480.x; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu YK, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-7; Lu YJ, 2010, CIRCULATION, V122, P2378, DOI 10.1161/CIRCULATIONAHA.110.958967; Luo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011744; Ma YD, 2013, BIOCHEM PHARMACOL, V85, P223, DOI 10.1016/j.bcp.2012.10.025; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Martini P, 2013, INT J MOL SCI, V14, P23160, DOI 10.3390/ijms141123160; Maxmen A, 2012, NATURE, V486, P453, DOI 10.1038/486453a; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; McDaneld TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042039; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; McGregor CGA, 2011, J THORAC CARDIOV SUR, V141, P269, DOI 10.1016/j.jtcvs.2010.08.064; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Podolska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014494; Martins RP, 2013, DEV COMP IMMUNOL, V41, P100, DOI 10.1016/j.dci.2013.04.020; Rajani R, 2007, J HEART VALVE DIS, V16, P519; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Risso D, 2009, BIOINFORMATICS, V25, P2685, DOI 10.1093/bioinformatics/btp443; Ross JW, 2012, INVEST OPHTH VIS SCI, V53, P501, DOI 10.1167/iovs.11-8784; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Sandrin MS, 2001, J CARDIAC SURG, V16, P448, DOI 10.1111/j.1540-8191.2001.tb00549.x; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Siengdee P, 2013, ANIM GENET, V44, P398, DOI 10.1111/age.12032; Stangl K, 2002, BIOCHEM BIOPH RES CO, V291, P542, DOI 10.1006/bbrc.2002.6476; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Suzuki Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/195483; Timoneda O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055402; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Valdes-Gonzalez RA, 2005, EUR J ENDOCRINOL, V153, P419, DOI 10.1530/eje.1.01982; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Xu SY, 2009, FEBS J, V276, P175, DOI 10.1111/j.1742-4658.2008.06771.x; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yada H, 2007, CIRC RES, V101, P69, DOI 10.1161/CIRCRESAHA.106.146399; Zhang QS, 2013, GUT MICROBES, V4, P193, DOI 10.4161/gmic.23867; Zhao JJ, 2010, BLOOD, V115, P2630, DOI 10.1182/blood-2009-09-243147; Zhou B, 2010, ANIM GENET, V41, P499, DOI 10.1111/j.1365-2052.2010.02026.x; Zhou Y, 2013, REPROD DOMEST ANIM, V48, P112, DOI 10.1111/j.1439-0531.2012.02040.x	91	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e89755	10.1371/journal.pone.0089755	http://dx.doi.org/10.1371/journal.pone.0089755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699212	gold, Green Submitted, Green Published			2022-12-27	WOS:000334105000007
J	Martins-Melo, FR; Lima, MD; Ramos, AN; Alencar, CH; Heukelbach, J				Martins-Melo, Francisco Rogerlandio; Lima, Mauricelia da Silveira; Ramos, Alberto Novaes, Jr.; Alencar, Carlos Henrique; Heukelbach, Jorg			Mortality and Case Fatality Due to Visceral Leishmaniasis in Brazil: A Nationwide Analysis of Epidemiology, Trends and Spatial Patterns	PLOS ONE			English	Article							UNDERLYING-CAUSE; CHAGAS-DISEASE; AMERICA; SPREAD; DEATH; STATE	Background: Visceral leishmaniasis (VL) is a significant public health problem in Brazil and several regions of the world. This study investigated the magnitude, temporal trends and spatial distribution of mortality related to VL in Brazil. Methods: We performed a study based on secondary data obtained from the Brazilian Mortality Information System. We included all deaths in Brazil from 2000 to 2011, in which VL was recorded as cause of death. We present epidemiological characteristics, trend analysis of mortality and case fatality rates by joinpoint regression models, and spatial analysis using municipalities as geographical units of analysis. Results: In the study period, 12,491,280 deaths were recorded in Brazil. VL was mentioned in 3,322 (0.03%) deaths. Average annual age-adjusted mortality rate was 0.15 deaths per 100,000 inhabitants and case fatality rate 8.1%. Highest mortality rates were observed in males (0.19 deaths/100,000 inhabitants), <1 year-olds (1.03 deaths/100,000 inhabitants) and residents in Northeast region (0.30 deaths/100,000 inhabitants). Highest case fatality rates were observed in males (8.8%), >= 70 year-olds (43.8%) and residents in South region (17.7%). Mortality and case fatality rates showed a significant increase in Brazil over the period, with different patterns between regions: increasing mortality rates in the North (Annual Percent Change - APC: 9.4%; 95% confidence interval - CI: 5.3 to 13.6), and Southeast (APC: 8.1%; 95% CI: 2.6 to 13.9); and increasing case fatality rates in the Northeast (APC: 4.0%; 95% CI: 0.8 to 7.4). Spatial analysis identified a major cluster of high mortality encompassing a wide geographic range in North and Northeast Brazil. Conclusions: Despite ongoing control strategies, mortality related to VL in Brazil is increasing. Mortality and case fatality vary considerably between regions, and surveillance and control measures should be prioritized in high-risk clusters. Early diagnosis and treatment are fundamental strategies for reducing case fatality of VL in Brazil.	[Martins-Melo, Francisco Rogerlandio; Lima, Mauricelia da Silveira; Ramos, Alberto Novaes, Jr.; Alencar, Carlos Henrique; Heukelbach, Jorg] Univ Fed Ceara, Sch Med, Dept Community Hlth, Fortaleza, Ceara, Brazil; [Heukelbach, Jorg] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Anton Breinl Ctr Publ Hlth & Trop Med, Townsville, Qld 4811, Australia	Universidade Federal do Ceara; James Cook University	Heukelbach, J (corresponding author), Univ Fed Ceara, Sch Med, Dept Community Hlth, Fortaleza, Ceara, Brazil.	heukelbach@web.de	Júnior, Alberto Novaes Ramos/A-4276-2013; Martins-Melo, Francisco Rogerlandio/I-4868-2012	Júnior, Alberto Novaes Ramos/0000-0001-7982-1757; Martins-Melo, Francisco Rogerlandio/0000-0003-3690-5023; Alencar, Carlos Henrique/0000-0003-2967-532X; Heukelbach, Jorg/0000-0002-7845-5510				Alencar CH, 2012, TROP MED INT HEALTH, V17, P518, DOI 10.1111/j.1365-3156.2011.02945.x; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], 2010, 1 WHO; [Anonymous], 2006, MAN VIG CONTR LEISHM; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Borges BKA, 2008, CAD SAUDE PUBLICA, V24, P777, DOI 10.1590/S0102-311X2008000400007; Assuncao R M, 1998, Cad Saude Publica, V14, P713, DOI 10.1590/S0102-311X1998000400013; Belo VS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002182; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Bhunia GS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-64; Clegg LX, 2009, STAT MED, V28, P3670, DOI 10.1002/sim.3733; Cliff A. D., 1981, SPATIAL PROCESSES MO; Costa C H, 2001, Rev Soc Bras Med Trop, V34, P223; Cota GF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001153; Dantas-Torres Filipe, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P151, DOI 10.1590/S0036-46652006000300007; Dantas-Torres F, 2006, REV SOC BRAS MED TRO, V39, P352, DOI 10.1590/S0037-86822006000400007; de Almeida AS, 2011, AM J TROP MED HYG, V84, P681, DOI 10.4269/ajtmh.2011.10-0325; de Sousa-Gomes ML, 2011, EPIDEMIOL SERV SAUDE, V20, P519, DOI 10.5123/S1679-49742011000400011; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Goldacre MJ, 2003, J PUBLIC HEALTH MED, V25, P249, DOI 10.1093/pubmed/fdg058; Gontijo Célia Maria Ferreira, 2004, Rev. bras. epidemiol., V7, P338; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Lindoso JAL, 2009, REV INST MED TROP SP, V51, P247, DOI 10.1590/S0036-46652009000500003; Madalosso G, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/281572; Maia-Elkhoury Ana Nilce Silveira, 2007, Rev. Saúde Pública, V41, P931, DOI 10.1590/S0034-89102007000600007; Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024; Martins-Melo FR, 2014, T R SOC TRO IN PRESS; Martins-Melo FR, 2012, TROP MED INT HEALTH, V17, P1066, DOI 10.1111/j.1365-3156.2012.03043.x; Martins-Melo FR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001508; de Araujo VEM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001511; Costa CHN, 2010, REV SOC BRAS MED TRO, V43, P386, DOI 10.1590/S0037-86822010000400010; Oliveira CDL, 2008, CAD SAUDE PUBLICA, V24, P2953, DOI 10.1590/S0102-311X2008001200026; Oliveira Janaina Michelle de, 2010, Rev. Soc. Bras. Med. Trop., V43, P188; Queiroz Márcia J. A., 2004, J. Pediatr. (Rio J.), V80, P141, DOI 10.1590/S0021-75572004000200012; Redelings MD, 2006, EPIDEMIOLOGY, V17, P100, DOI 10.1097/01.ede.0000187177.96138.c6; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Santo AH, 2007, REV PANAM SALUD PUBL, V22, P178, DOI 10.1590/S1020-49892007000800004; Secretaria de Vigilancia em Saude, 2013, LEISHM VISC; Secretaria de Vigilancia em Saude, 2013, MAP ESTR LEISHM VISC; Secretaria de Vigilancia em Saude Ministerio da Saude, 2013, CAS CONF LEISHM VISC; Secretaria de Vigilancia em Saude Ministerio da Saude, 2011, LEISHM VISC REC CLIN; Werneck GL, 2002, EPIDEMIOLOGY, V13, P364, DOI 10.1097/00001648-200205000-00020; Werneck Guilherme L., 2002, Cad. Saúde Pública, V18, P633, DOI [10.1590/S0102-311X2002000300012, 10.1590/S0102-311X2002000300007]; Werneck Guilherme L., 2010, Cad. Saúde Pública, V26, P644, DOI 10.1590/S0102-311X2010000400001; Werneck GL, 2008, CAD SAUDE PUBLICA, V24, P2937, DOI 10.1590/S0102-311X2008001200023; WHO, 2010, CONTR LEISHM; Word Health Organization, 2007, STAT CLASS DIS REL H	48	76	79	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93770	10.1371/journal.pone.0093770	http://dx.doi.org/10.1371/journal.pone.0093770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6LR	24699517	Green Published, gold, Green Accepted			2022-12-27	WOS:000334105000105
J	Ruan, T; Lin, YJ; Hsu, TH; Lu, SH; Jow, GM; Kou, YR				Ruan, Ting; Lin, Yu-Jung; Hsu, Tien-Huan; Lu, Shing-Hwa; Jow, Guey-Mei; Kou, Yu Ru			Sensitization by Pulmonary Reactive Oxygen Species of Rat Vagal Lung C-Fibers: The Roles of the TRPV1, TRPA1, and P2X Receptors	PLOS ONE			English	Article							EXHALED BREATH CONDENSATE; AIRWAY SENSORY NERVES; INHALED WOOD SMOKE; ACID-PEPSIN INSULT; ANESTHETIZED RATS; OXIDATIVE STRESS; ION CHANNELS; AFFERENTS; CAPSAICIN; ASTHMA	Sensitization of vagal lung C-fibers (VLCFs) induced by mediators contributes to the pathogenesis of airway hypersensitivity, which is characterized by exaggerated sensory and reflex responses to stimulants. Reactive oxygen species (ROS) are mediators produced during airway inflammation. However, the role of ROS in VLCF-mediated airway hypersensitivity has remained elusive. Here, we report that inhalation of aerosolized 0.05% H2O2 for 90 s potentiated apneic responses to intravenous capsaicin (a TRPV1 receptor agonist), alpha,beta-methylene-ATP (a P2X receptor agonist), and phenylbiguanide (a 5HT(3) receptor agonist) in anesthetized rats. The apneic responses to these three stimulants were abolished by vagatomy or by perivagal capsaicin treatment, a procedure that blocks the neural conduction of VLCFs. The potentiating effect of H2O2 on the apneic responses to these VLCF stimulants was prevented by catalase (an enzyme that degrades H2O2) and by dimethylthiourea (a hydroxyl radical scavenger). The potentiating effect of H2O2 on the apneic responses to capsaicin was attenuated by HC-030031 (a TRPA1 receptor antagonist) and by iso-pyridoxalphosphate-6-azophenyl-2 ',5 '-disulphonate (a P2X receptor antagonist). The potentiating effect of H2O2 on the apneic responses to a, b-methylene-ATP was reduced by capsazepine (a TRPV1 receptor antagonist), and by HC-030031. The potentiating effect of H2O2 on the apneic responses to phenylbiguanide was totally abolished when all three antagonists were combined. Consistently, our electrophysiological studies revealed that airway delivery of aerosolized 0.05% H2O2 for 90 s potentiated the VLCF responses to intravenous capsaicin, alpha,beta-methylene-ATP, and phenylbiguanide. The potentiating effect of H2O2 on the VLCF responses to phenylbiguanide was totally prevented when all antagonists were combined. Inhalation of 0.05% H2O2 indeed increased the level of ROS in the lungs. These results suggest that 1) increased lung ROS sensitizes VLCFs, which leads to exaggerated reflex responses in rats and 2) the TRPV1, TRPA1, and P2X receptors are all involved in the development of this airway hypersensitivity.	[Ruan, Ting; Jow, Guey-Mei] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Lin, Yu-Jung; Kou, Yu Ru] Natl Yang Ming Univ, Sch Med, Dept Physiol, Taipei 112, Taiwan; [Hsu, Tien-Huan] Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan; [Lu, Shing-Hwa] Taipei City Hosp, Zhong Xiao Branch, Dept Urol, Taipei, Taiwan; [Ruan, Ting] Chung Shan Med Univ, Sch Med, Dept Physiol, Taichung, Taiwan	Fu Jen Catholic University; National Yang Ming Chiao Tung University; National Chung Hsing University; Taipei City Hospital; Chung Shan Medical University	Kou, YR (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Physiol, Taipei 112, Taiwan.	yrkou@ym.edu.tw	Lin, Yu-Jung/AAH-6195-2021	Kou, Yu Ru/0000-0002-4681-9009	National Science Council, Taiwan [NSC 101-2320-B-010-042-MY3, NSC 98-2628-B-030-001-MY3]; Taipei City Hospital [10201-62-063]; Ministry of Education, Aim for the Top University Plan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taipei City Hospital; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This study was supported by the following grants, NSC 101-2320-B-010-042-MY3 and NSC 98-2628-B-030-001-MY3 from the National Science Council, Taiwan, a grant 10201-62-063 from Taipei City Hospital, and a grant from Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Chen MJ, 2001, TOXICOL APPL PHARM, V171, P165, DOI 10.1006/taap.2000.9117; Chuang HH, 2009, P NATL ACAD SCI USA, V106, P20097, DOI 10.1073/pnas.0902675106; Comhair SAA, 2002, AM J PHYSIOL-LUNG C, V283, pL246, DOI 10.1152/ajplung.00491.2001; Dai Y, 2004, PAIN, V108, P258, DOI 10.1016/j.pain.2003.12.034; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Doherty MJ, 2000, THORAX, V55, P643, DOI 10.1136/thorax.55.8.643; Dozor AJ, 2010, ANN NY ACAD SCI, V1203, P133, DOI 10.1111/j.1749-6632.2010.05562.x; Fox AJ, 1996, NAT MED, V2, P814, DOI 10.1038/nm0796-814; FOX RB, 1984, J CLIN INVEST, V74, P1456, DOI 10.1172/JCI111558; Gu QH, 2003, J APPL PHYSIOL, V95, P1315, DOI 10.1152/japplphysiol.00107.2003; Ho CY, 2001, RESP PHYSIOL, V127, P113, DOI 10.1016/S0034-5687(01)00241-9; Ho CY, 2000, AM J RESP CRIT CARE, V162, P528, DOI 10.1164/ajrccm.162.2.9910059; Hsu CC, 2013, AM J PHYSIOL-REG I, V305, pR769, DOI 10.1152/ajpregu.00202.2013; Keating C, 2011, J IMMUNOL, V187, P1467, DOI 10.4049/jimmunol.1100423; KOU YR, 1995, J APPL PHYSIOL, V78, P2070, DOI 10.1152/jappl.1995.78.6.2070; Kou YR, 2011, RESP PHYSIOL NEUROBI, V178, P395, DOI 10.1016/j.resp.2011.03.004; Kuo YL, 2008, J APPL PHYSIOL, V105, P611, DOI 10.1152/japplphysiol.01099.2007; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lai CJ, 2005, J APPL PHYSIOL, V98, P620, DOI 10.1152/japplphysiol.00539.2004; Lai CJ, 1998, J APPL PHYSIOL, V84, P30, DOI 10.1152/jappl.1998.84.1.30; LEE BP, 1992, J APPL PHYSIOL, V72, P1050, DOI 10.1152/jappl.1992.72.3.1050; Lee LY, 2010, J PHYSIOL-LONDON, V588, P747, DOI 10.1113/jphysiol.2010.187286; Lee LY, 2009, CURR OPIN PHARMACOL, V9, P243, DOI 10.1016/j.coph.2009.02.002; Lee LY, 2001, RESP PHYSIOL, V125, P47, DOI 10.1016/S0034-5687(00)00204-8; LEE LY, 1993, RESP PHYSIOL, V93, P83, DOI 10.1016/0034-5687(93)90070-Q; Li GL, 2010, NEUROCHEM INT, V56, P984, DOI 10.1016/j.neuint.2010.04.010; Lin YS, 2010, J APPL PHYSIOL, V108, P1293, DOI 10.1152/japplphysiol.01048.2009; Lin YS, 2009, J APPL PHYSIOL, V106, P1142, DOI 10.1152/japplphysiol.91229.2008; Lin YJ, 2013, RESP PHYSIOL NEUROBI, V189, P1, DOI 10.1016/j.resp.2013.06.021; Lin YJ, 2013, J APPL PHYSIOL, V114, P361, DOI 10.1152/japplphysiol.00977.2012; Masuda H, 2008, BJU INT, V101, P775, DOI 10.1111/j.1464-410X.2007.07310.x; Riedl MA, 2008, CURR OPIN ALLERGY CL, V8, P49, DOI 10.1097/ACI.0b013e3282f3d913; Ruan T, 2005, J PHYSIOL-LONDON, V565, P563, DOI 10.1113/jphysiol.2005.086181; Ruan T, 2005, J PHYSIOL-LONDON, V565, P295, DOI 10.1113/jphysiol.2005.084319; Ruan T, 2003, J APPL PHYSIOL, V94, P1987, DOI 10.1152/japplphysiol.01047.2002; Ruan T, 2006, J APPL PHYSIOL, V101, P644, DOI 10.1152/japplphysiol.00192.2006; Shen MY, 2012, AM J PHYSIOL-REG I, V303, pR1175, DOI 10.1152/ajpregu.00227.2012; Susankova K, 2006, MOL PHARMACOL, V70, P383, DOI 10.1124/mol.106.023069; Taylor-Clark T, 2006, J APPL PHYSIOL, V101, P950, DOI 10.1152/japplphysiol.00222.2006; Taylor-Clark TE, 2011, RESP PHYSIOL NEUROBI, V178, P406, DOI 10.1016/j.resp.2011.05.003; Taylor-Clark TE, 2010, J PHYSIOL-LONDON, V588, P423, DOI 10.1113/jphysiol.2009.183301; Teng Y, 2011, CHEST, V140, P108, DOI 10.1378/chest.10-2816; Tsai TL, 2006, J APPL PHYSIOL, V101, P328, DOI 10.1152/japplphysiol.00064.2006; Tsai TL, 2009, J APPL PHYSIOL, V106, P1584, DOI 10.1152/japplphysiol.91517.2008; Ueno T, 2008, RESPIROLOGY, V13, P654, DOI 10.1111/j.1440-1843.2008.01315.x; Widdicombe JG, 2003, PULM PHARMACOL THER, V16, P23, DOI 10.1016/S1094-5539(02)00178-5; Zhang GF, 2008, J APPL PHYSIOL, V105, P128, DOI 10.1152/japplphysiol.01367.2007	49	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e91763	10.1371/journal.pone.0091763	http://dx.doi.org/10.1371/journal.pone.0091763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699274	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000016
J	Chen, Y; Dai, JH; Zhou, XQ; Liu, YJ; Zhang, W; Peng, GY				Chen, Yao; Dai, Jianhua; Zhou, Xueqian; Liu, Yunjie; Zhang, Wei; Peng, Guiyong			Raman Spectroscopy Analysis of the Biochemical Characteristics of Molecules Associated with the Malignant Transformation of Gastric Mucosa	PLOS ONE			English	Article							DNA; MICROSPECTROSCOPY; DISCRIMINATION; PROTEINS; CELLS	Objective: The purpose of this study was to comparatively analyze the signature Raman spectra of genomic DNA, nuclei, and tissue of normal gastric mucosa and gastric cancer and to investigate the biochemical transformation of molecules associated with gastric mucosa malignancy. Method: Genomic DNA, nuclei, and tissue from normal gastric mucosa and gastric cancer were analyzed by Raman spectroscopy. Results: 1) The Raman spectrum of gastric cancer genomic DNA showed that two peaks appeared, one at approximately 1090 cm(-1) with a higher intensity than the peak at 1050 cm(-1) in the spectrum. Characteristic peaks appeared at 950 cm-1, 1010 cm(- 1,) and 1100- 1600 cm(-1).2) Using a hematoxylin and eosin ( H& E)-stained section, the intensity of the characteristic peak of nucleic acids at 1085 cm(- 1) was increased and shifted to 1088 cm(- 1) in cancer cells. The relative intensity of the characteristic peaks of nucleoproteins at 755 cm (- 1) and 1607 cm (- 1) was significantly increased in cancer cells compared with normal cells. 3) Compared with normal tissues, the peak representing PO2- symmetric stretching vibration shifted from 1088 cm (- 1) to 1083 cm (- 1) in cancer tissue, and the characteristic peak for collagen at 938 cm (- 1) shifted to 944 cm (- 1). In addition, an extra characteristic peak indicating C = C stretching vibration appeared at 1379 cm (- 1) in the lipid spectrum in cancer tissue. Conclusions: The position, intensity, and shape of peaks in the Raman spectra of DNA, nuclei, and tissue from gastric cancer were significantly different compared with those of normal cells. These results indicate that the DNA phosphate backbone becomes unstable in cancer cells and might be broken; the relative content of histones is increased and stable; the relative collagen content is reduced, facilitating cancer cell metastasis; and the relative content of unsaturated fatty acids is increased, increasing the mobility of the plasma membrane of cancer cells.	[Chen, Yao; Dai, Jianhua; Zhou, Xueqian; Liu, Yunjie; Peng, Guiyong] Third Mil Med Univ, Southwest Hosp, Inst Gastroenterol, Chongqing, Peoples R China; [Zhang, Wei] Chinese Acad Sci, Chongqing Inst Green & Intelligent Technol, Key Lab Multiscale Mfg Technol, Chongqing, Peoples R China	Army Medical University; Chinese Academy of Sciences; Chongqing Institute of Green & Intelligent Technology, CAS	Peng, GY (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Gastroenterol, Chongqing, Peoples R China.	pgy63@163.com	Zhang, Wei/H-2082-2012; GUIYONG, PENG/AAM-7865-2020	Zhang, Wei/0000-0002-9756-9994; Zhou, Xueqian/0000-0003-1583-414X	National Natural Science Foundation of China [81272580]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was Supported by the National Natural Science Foundation of China (Grant No. 81272580). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergholt MS, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3556723; Chen YP, 2012, MED PHYS, V39, P5664, DOI 10.1118/1.4747269; Chowdary MVP, 2006, BIOPOLYMERS, V83, P556, DOI 10.1002/bip.20586; De Gelder J, 2007, J RAMAN SPECTROSC, V38, P1133, DOI 10.1002/jrs.1734; de Oliveira AF, 2010, ACTA CIR BRAS, V25, P434, DOI 10.1590/S0102-86502010000500009; Deng H, 2000, NUCLEIC ACIDS RES, V28, P3379, DOI 10.1093/nar/28.17.3379; Duraipandian S, 2012, ANAL CHEM, V84, P5913, DOI 10.1021/ac300394f; ERFURTH SC, 1975, BIOPOLYMERS, V14, P247, DOI 10.1002/bip.1975.360140202; Feng SY, 2011, BIOSENS BIOELECTRON, V26, P3167, DOI 10.1016/j.bios.2010.12.020; Huang ZW, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3420115; Huong PV, 1996, VIB SPECTROSC, V11, P17, DOI 10.1016/0924-2031(95)00057-7; Jangir DK, 2012, J PHOTOCH PHOTOBIO B, V114, P38, DOI 10.1016/j.jphotobiol.2012.05.005; Leslie DG, 2012, PEDIATR NEUROSURG, V48, P109, DOI 10.1159/000343285; Li SX, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.125003; Li XZ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.3.037003; Maiti NC, 2004, J AM CHEM SOC, V126, P2399, DOI 10.1021/ja0356176; Nemecek D, 2013, CURR PROTOC PROTEIN; PETICOLAS WL, 1995, METHOD ENZYMOL, V246, P389; PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0; Schweitzer-Stenner Reinhard, 2012, Methods Mol Biol, V895, P315, DOI 10.1007/978-1-61779-927-3_19; Shen AG, 2005, VIB SPECTROSC, V37, P225, DOI 10.1016/j.vibspec.2004.10.001; Stone N, 2000, LARYNGOSCOPE, V110, P1756, DOI 10.1097/00005537-200010000-00037; Takahashi Y, 2014, J MECH BEHAV BIOMED, V31, P77, DOI 10.1016/j.jmbbm.2013.02.014; [Yang Jipeng 杨继朋], 2005, Chinese Optics Letters, V3, P705; Zhou Y, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116021; Zhuang ZF, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.031103	26	34	37	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93906	10.1371/journal.pone.0093906	http://dx.doi.org/10.1371/journal.pone.0093906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710050	Green Submitted, gold, Green Published			2022-12-27	WOS:000334159800067
J	Hipp, AL; Eaton, DAR; Cavender-Bares, J; Fitzek, E; Nipper, R; Manos, PS				Hipp, Andrew L.; Eaton, Deren A. R.; Cavender-Bares, Jeannine; Fitzek, Elisabeth; Nipper, Rick; Manos, Paul S.			A Framework Phylogeny of the American Oak Clade Based on Sequenced RAD Data	PLOS ONE			English	Article							AFLP MARKER EVOLUTION; GENE FLOW; FOREST TREES; ROGUE TAXA; HYBRIDIZATION; FAGACEAE; ACCURACY; INTROGRESSION; TAXONOMY; DIFFERENTIATION	Previous phylogenetic studies in oaks (Quercus, Fagaceae) have failed to resolve the backbone topology of the genus with strong support. Here, we utilize next-generation sequencing of restriction-site associated DNA (RAD-Seq) to resolve a framework phylogeny of a predominantly American clade of oaks whose crown age is estimated at 23-33 million years old. Using a recently developed analytical pipeline for RAD-Seq phylogenetics, we created a concatenated matrix of 1.40 E06 aligned nucleotides, constituting 27,727 sequence clusters. RAD-Seq data were readily combined across runs, with no difference in phylogenetic placement between technical replicates, which overlapped by only 43-64% in locus coverage. 17% (4,715) of the loci we analyzed could be mapped with high confidence to one or more expressed sequence tags in NCBI Genbank. A concatenated matrix of the loci that BLAST to at least one EST sequence provides approximately half as many variable or parsimony-informative characters as equal-sized datasets from the non-EST loci. The EST-associated matrix is more complete (fewer missing loci) and has slightly lower homoplasy than non-EST subsampled matrices of the same size, but there is no difference in phylogenetic support or relative attribution of base substitutions to internal versus terminal branches of the phylogeny. We introduce a partitioned RAD visualization method (implemented in the R package RADami; http://cran.r-project.org/web/packages/RADami) to investigate the possibility that suboptimal topologies supported by large numbers of loci-due, for example, to reticulate evolution or lineage sorting-are masked by the globally optimal tree. We find no evidence for strongly-supported alternative topologies in our study, suggesting that the phylogeny we recover is a robust estimate of large-scale phylogenetic patterns in the American oak clade. Our study is one of the first to demonstrate the utility of RAD-Seq data for inferring phylogeny in a 23-33 million year-old clade.	[Hipp, Andrew L.; Fitzek, Elisabeth] Morton Arboretum, Lisle, IL 60532 USA; [Hipp, Andrew L.; Eaton, Deren A. R.] Field Museum, Dept Bot, Chicago, IL USA; [Eaton, Deren A. R.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Cavender-Bares, Jeannine] Univ Minnesota, Coll Biol Sci, St Paul, MN 55108 USA; [Nipper, Rick] Floragenex Inc, Eugene, OR USA; [Manos, Paul S.] Duke Univ, Dept Biol, Durham, NC USA	Field Museum of Natural History (Chicago); University of Chicago; University of Minnesota System; University of Minnesota Twin Cities; Duke University	Hipp, AL (corresponding author), Morton Arboretum, Lisle, IL 60532 USA.	ahipp@mortonarb.org	Cavender-Bares, Jeannine/K-5716-2013	Fitzek, Elisabeth/0000-0001-9423-2993; Cavender-Bares, Jeannine/0000-0003-3375-9630; Eaton, Deren/0000-0002-5922-2770	U.S. National Science Foundation DEB [1146488, 1146380, 1146102]; Field Museum, Lester Armour Graduate fellowship; Direct For Biological Sciences [1146488, 0843665] Funding Source: National Science Foundation	U.S. National Science Foundation DEB(National Science Foundation (NSF)); Field Museum, Lester Armour Graduate fellowship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by U.S. National Science Foundation DEB (http://nsf.gov/div/index.jsp?div = DEB) Awards #1146488 to AH, #1146380 to JCB, and #1146102 to PM, and a Field Museum (http://fieldmuseum.org) Lester Armour Graduate fellowship to DAE. Funding covered field work, lab work, data analysis, development of analytical tools, and manuscript preparation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer A.J., 2011, ROGUENAROK EFFICIENT; Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Aldrich P. R., 2011, WILD CROP RELATIVES, P89, DOI DOI 10.1007/978-3-642-21250-5_6; Althoff DM, 2007, SYST BIOL, V56, P477, DOI 10.1080/10635150701427077; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ane C, 2007, MOL BIOL EVOL, V24, P412; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Borgardt SJ, 1999, AM J BOT, V86, P307, DOI 10.2307/2656753; Bruneaux M, 2013, MOL ECOL, V22, P565, DOI 10.1111/j.1365-294X.2012.05749.x; Bryant D, 2012, MOL BIOL EVOL, V29, P1917, DOI 10.1093/molbev/mss086; Burgarella C, 2009, HEREDITY, V102, P442, DOI 10.1038/hdy.2009.8; Burger W. C., 1975, Taxon, V24, P45, DOI 10.2307/1218998; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Cavender-Bares J, 2009, AM J BOT, V96, P1690, DOI 10.3732/ajb.0800315; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Coyne J.A., 2004, SPECIATION; DAGHLIAN CP, 1983, AM J BOT, V70, P639, DOI 10.2307/2443119; Denk T, 2010, TAXON, V59, P351, DOI 10.1002/tax.592002; DumolinLapegue S, 1997, GENETICS, V146, P1475; Dzialuk A, 2007, ANN BOT-LONDON, V99, P959, DOI 10.1093/aob/mcm043; Eaton DAR, 2013, SYST BIOL, V62, P689, DOI 10.1093/sysbio/syt032; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FELSENSTEIN J, 1992, EVOLUTION, V46, P159, DOI [10.2307/2409811, 10.1111/j.1558-5646.1992.tb01991.x]; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez-Rodriguez A, 2004, AM J BOT, V91, P401, DOI 10.3732/ajb.91.3.401; Gugger PF, 2013, J BIOGEOGR, V40, P632, DOI 10.1111/j.1365-2699.2011.02610.x; Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023; HARDIN JW, 1975, J ARNOLD ARBORETUM, V56, P336; Hipp A., 2014, RADAMI R PACKAGE PHY; Hipp Andrew L., 2007, Aliso, V23, P193; Hipp AL, 2008, SYST BOT, V33, P148, DOI 10.1600/036364408783887320; Hoban SM, 2009, BIOL LETTERS, V5, P324, DOI 10.1098/rsbl.2009.0031; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Huang HT, 2010, SYST BIOL, V59, P573, DOI 10.1093/sysbio/syq047; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Garcia-Pereira MJ, 2010, MOL BIOL EVOL, V27, P988, DOI 10.1093/molbev/msp315; Knowles L.L., 2010, ESTIMATING SPECIES T; Koopman WJM, 2005, SYST BIOL, V54, P197, DOI 10.1080/10635150590924181; Kremer A, 2012, TREE GENET GENOMES, V8, P583, DOI 10.1007/s11295-012-0498-3; Kubatko LS, 2009, SYST BIOL, V58, P478, DOI 10.1093/sysbio/syp055; Lagache L, 2013, MOL ECOL, V22, P423, DOI 10.1111/mec.12121; Lepais O, 2009, MOL ECOL, V18, P2228, DOI 10.1111/j.1365-294X.2009.04137.x; LEQUESNE WJ, 1969, SYST ZOOL, V18, P201; Lewis ZA, 2007, GENETICS, V177, P1163, DOI 10.1534/genetics.107.078147; Lexer C, 2006, MOL ECOL, V15, P2007, DOI 10.1111/j.1365-294X.2006.02896.x; LI WH, 1986, GENETICS, V113, P187; Luo RY, 2007, STAT APPL GENET MOL, V6; Luo RY, 2009, ANN APPL STAT, V3, P222, DOI 10.1214/08-AOAS212; Lynch M, 2008, MOL BIOL EVOL, V25, P2409, DOI 10.1093/molbev/msn185; Manos PS, 1999, MOL PHYLOGENET EVOL, V12, P333, DOI 10.1006/mpev.1999.0614; Manos PS, 1987, SYSTEMATIC BOT, V12, P265; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Meng C, 2009, THEOR POPUL BIOL, V75, P35, DOI 10.1016/j.tpb.2008.10.004; Miller MR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r105; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Muir G, 2000, NATURE, V405, P1016, DOI 10.1038/35016640; Oh SH, 2008, TAXON, V57, P434, DOI 10.2307/25066014; Oksanen J., 2019, R PACKAGE VERSION; Pages H., 2013, BIOSTRINGS STRING OB; Pearse IS, 2009, P NATL ACAD SCI USA, V106, P18097, DOI 10.1073/pnas.0904867106; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Petit RJ, 2004, NEW PHYTOL, V161, P151, DOI 10.1046/j.1469-8137.2003.00944.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rubin BER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033394; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Sober E., 1991, RECONSTRUCTING PARSI; Stamatakis A, 2010, BIOINFORMATICS, V26, pi132, DOI 10.1093/bioinformatics/btq205; Stolting KN, 2013, MOL ECOL, V22, P842, DOI 10.1111/mec.12011; Thomson RC, 2010, SYST BIOL, V59, P42, DOI 10.1093/sysbio/syp075; Trueman JWH, 1998, SYST BIOL, V47, P733, DOI 10.1080/106351598260725; VANVALEN L, 1976, TAXON, V25, P233, DOI 10.2307/1219444; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Wang N, 2013, MOL ECOL, V22, P3098, DOI 10.1111/mec.12131; WHITTEMORE AT, 1991, P NATL ACAD SCI USA, V88, P2540, DOI 10.1073/pnas.88.6.2540; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Yilmaz A, 2011, CARYOLOGIA, V64, P297, DOI 10.1080/00087114.2011.10589795	81	163	169	0	184	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93975	10.1371/journal.pone.0093975	http://dx.doi.org/10.1371/journal.pone.0093975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705617	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500101
J	Chan, BK; Wilson, T; Fischer, KF; Kriesel, JD				Chan, Benjamin K.; Wilson, Theodore; Fischer, Kael F.; Kriesel, John D.			Deep Sequencing to Identify the Causes of Viral Encephalitis	PLOS ONE			English	Article							SHORT DNA-SEQUENCES; HUMAN GENOME; VIRUS; MICROARRAY; ETIOLOGIES	Deep sequencing allows for a rapid, accurate characterization of microbial DNA and RNA sequences in many types of samples. Deep sequencing (also called next generation sequencing or NGS) is being developed to assist with the diagnosis of a wide variety of infectious diseases. In this study, seven frozen brain samples from deceased subjects with recent encephalitis were investigated. RNA from each sample was extracted, randomly reverse transcribed and sequenced. The sequence analysis was performed in a blinded fashion and confirmed with pathogen-specific PCR. This analysis successfully identified measles virus sequences in two brain samples and herpes simplex virus type-1 sequences in three brain samples. No pathogen was identified in the other two brain specimens. These results were concordant with pathogen-specific PCR and partially concordant with prior neuropathological examinations, demonstrating that deep sequencing can accurately identify viral infections in frozen brain	[Chan, Benjamin K.; Kriesel, John D.] Univ Utah, Sch Med, Dept Internal Med, Div Infect Dis, Salt Lake City, UT 84112 USA; [Wilson, Theodore; Fischer, Kael F.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kriesel, JD (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Div Infect Dis, Salt Lake City, UT 84112 USA.	john.kriesel@hsc.utah.edu	Fischer, Kael/F-7756-2015	Fischer, Kael/0000-0002-7547-330X	National Institutes of Health NIH/NINDS [R21NS077023]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS077023] Funding Source: NIH RePORTER	National Institutes of Health NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health NIH/NINDS award # R21NS077023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiu CY, 2007, J CLIN MICROBIOL, V45, P2340, DOI 10.1128/JCM.00364-07; Chiu CY, 2006, CLIN INFECT DIS, V43, pE71, DOI 10.1086/507896; De Boer J, 1991, CWI Q, V4, P283; Gea-Banacloche J, 2004, ANN INTERN MED, V140, P545, DOI 10.7326/0003-4819-140-7-200404060-00015; Glaser CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330; Glaser CA, 2003, CLIN INFECT DIS, V36, P731, DOI 10.1086/367841; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; Jones E., 2001, SCIPY OPEN SOURCE SC; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kriesel JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031886; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lim ES, 2013, VIROLOGY, V436, P295, DOI 10.1016/j.virol.2012.12.005; Mailles A, 2009, CLIN INFECT DIS, V49, P1838, DOI 10.1086/648419; Patterson JB, 2001, VIROLOGY, V291, P215, DOI 10.1006/viro.2001.1182; PUCHHAMMERSTOCKL E, 1991, J CLIN MICROBIOL, V29, P1513; Relman DA, 2012, NATURE, V486, P194, DOI 10.1038/486194a; ROTA PA, 1995, J CLIN MICROBIOL, V33, P2485, DOI 10.1128/JCM.33.9.2485-2488.1995; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Steel CD, 2010, J NEUROIMMUNOL, V226, P81, DOI 10.1016/j.jneuroim.2010.05.034; Stevenson J, 2005, J CLIN MICROBIOL, V43, P2391, DOI 10.1128/JCM.43.5.2391-2398.2005; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	25	24	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93993	10.1371/journal.pone.0093993	http://dx.doi.org/10.1371/journal.pone.0093993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699691	Green Submitted, Green Published, gold			2022-12-27	WOS:000334105000132
J	Giubellino, A; Shankavaram, U; Bullova, P; Schovanek, J; Zhang, YQ; Shen, M; Patel, N; Elkahloun, A; Lee, MJ; Trepel, J; Ferrer, M; Pacak, K				Giubellino, Alessio; Shankavaram, Uma; Bullova, Petra; Schovanek, Jan; Zhang, Yaqin; Shen, Min; Patel, Nikita; Elkahloun, Abdel; Lee, Min-Jung; Trepel, Jane; Ferrer, Marc; Pacak, Karel			High-Throughput Screening for the Identification of New Therapeutic Options for Metastatic Pheochromocytoma and Paraganglioma	PLOS ONE			English	Article							GENETICS; COMBINATION; MUTATIONS; UPDATE; MODELS; MAX; MYC	Drug repurposing or repositioning is an important part of drug discovery that has been growing in the last few years for the development of therapeutic options in oncology. We applied this paradigm in a screening of a library of about 3,800 compounds (including FDA-approved drugs and pharmacologically active compounds) employing a model of metastatic pheochromocytoma, the most common tumor of the adrenal medulla in children and adults. The collection of approved drugs was screened in quantitative mode, testing the compounds in compound-titration series (dose-response curves). Analysis of the dose-response screening data facilitated the selection of 50 molecules with potential bioactivity in pheochromocytoma cells. These drugs were classified based on molecular/cellular targets and signaling pathways affected, and selected drugs were further validated in a proliferation assay and by flow cytometric cell death analysis. Using meta-analysis information from molecular targets of the top drugs identified by our screening with gene expression data from human and murine microarrays, we identified potential drugs to be used as single drugs or in combination. An example of a combination with a synergistic effect is presented. Our study exemplifies a promising model to identify potential drugs from a group of clinically approved compounds that can more rapidly be implemented into clinical trials in patients with metastatic pheochromocytoma or paraganglioma.	[Giubellino, Alessio; Bullova, Petra; Schovanek, Jan; Patel, Nikita; Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA; [Zhang, Yaqin; Shen, Min; Ferrer, Marc] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Elkahloun, Abdel] NHGRI, NIH, Bethesda, MD 20892 USA; [Lee, Min-Jung; Trepel, Jane] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA; [Shankavaram, Uma] NCI, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Bullova, Petra] Slovak Acad Sci, Inst Virol, Dept Mol Med, Bratislava, Slovakia; [Schovanek, Jan] Univ Hosp Olomouc, Dept Internal Med Nephrol Rheumatol & Endocrinol, Olomouc, Czech Republic	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Slovak Academy of Sciences; University Hospital Olomouc	Giubellino, A (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA.	giubella@mail.nih.gov; karel@mail.nih.gov	Schovanek, Jan/AAP-9273-2021; Bullova, Petra/ABG-5262-2020; Giubellino, Alessio/H-3432-2019	Schovanek, Jan/0000-0002-5776-6766; Bullova, Petra/0000-0002-5411-2185; Giubellino, Alessio/0000-0002-5352-0662	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZICSC006743] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200365] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Intramural Research funding of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjalle R, 2009, HORM METAB RES, V41, P687, DOI 10.1055/s-0029-1231025; Adler JT, 2008, ONCOLOGIST, V13, P779, DOI 10.1634/theoncologist.2008-0043; Ayala-Ramirez M, 2011, J CLIN ENDOCR METAB, V96, P717, DOI 10.1210/jc.2010-1946; Buffet A, 2012, HORM METAB RES, V44, P359, DOI 10.1055/s-0032-1304594; Burnichon N, 2012, HUM MOL GENET, V21, P5397, DOI 10.1093/hmg/dds374; Cascon A, 2012, CANCER RES, V72, P3119, DOI 10.1158/0008-5472.CAN-11-3891; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Collins FS, 2011, NAT REV DRUG DISCOV, V10, P397, DOI 10.1038/nrd3461; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Duenas-Gonzalez A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-82; Fliedner SMJ, 2010, SEMIN ONCOL, V37, P627, DOI 10.1053/j.seminoncol.2010.10.017; Fliedner SMJ, 2010, CELL TISSUE RES, V340, P607, DOI 10.1007/s00441-010-0965-9; Gimenez-Roqueplo AP, 2012, HORM METAB RES, V44, P328, DOI 10.1055/s-0031-1301302; Giubellino A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056083; Gray J, 2012, CANCER BIOL THER, V13, P614, DOI 10.4161/cbt.19848; HOPEWELL R, 1995, MOL CELL BIOL, V15, P3470; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jimenez C, 2013, CURR ONCOL REP; Karasek D, 2013, J HUM HYPERTENS, V27, P141, DOI 10.1038/jhh.2012.20; Killian JK, 2013, CANC DISCOV; King KS, 2011, J CLIN ONCOL, V29, P4137, DOI 10.1200/JCO.2011.34.6353; Martiniova L, 2011, ENDOCR-RELAT CANCER, V18, P143, DOI 10.1677/ERC-10-0090; Martiniova L, 2009, CLIN EXP METASTAS, V26, P239, DOI 10.1007/s10585-009-9236-0; Nakane M, 2003, ANN ONCOL, V14, P1449, DOI 10.1093/annonc/mdg358; Pacak K, 2012, INT J CANC; Powers JF, 2000, CELL TISSUE RES, V302, P309, DOI 10.1007/s004410000290; R Core Team, 2021, R LANGUAGE ENV STAT; Sardana D, 2011, BRIEF BIOINFORM, V12, P346, DOI 10.1093/bib/bbr021; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Shah U, 2012, MINERVA ENDOCRINOL, V37, P141; Shankavaram U, 2013, NEOPLASIA, V15, P435, DOI 10.1593/neo.122132; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tischler AS, 2004, HISTOL HISTOPATHOL, V19, P883, DOI 10.14670/HH-19.883; Vicha A, 2013, CURR OPIN ENDOCRINOL, V20, P186, DOI 10.1097/MED.0b013e32835fcc45; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Yang CZ, 2012, FASEB J, V26, P4506, DOI 10.1096/fj.12-210146	40	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e90458	10.1371/journal.pone.0090458	http://dx.doi.org/10.1371/journal.pone.0090458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699253	Green Submitted, Green Published, gold			2022-12-27	WOS:000334105000010
J	Meyer, AF; Diepenbrock, JP; Happel, MFK; Ohl, FW; Anemuller, J				Meyer, Arne F.; Diepenbrock, Jan-Philipp; Happel, Max F. K.; Ohl, Frank W.; Anemueller, Joern			Discriminative Learning of Receptive Fields from Responses to Non-Gaussian Stimulus Ensembles	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; SUPPORT VECTOR MACHINES; INFERIOR COLLICULUS; NATURAL SOUNDS; CORTICAL-NEURONS; SPECTRAL MOTION; NEURAL MODEL; CLASSIFICATION; INFORMATION; SELECTIVITY	Analysis of sensory neurons' processing characteristics requires simultaneous measurement of presented stimuli and concurrent spike responses. The functional transformation from high-dimensional stimulus space to the binary space of spike and non-spike responses is commonly described with linear-nonlinear models, whose linear filter component describes the neuron's receptive field. From a machine learning perspective, this corresponds to the binary classification problem of discriminating spike-eliciting from non-spike-eliciting stimulus examples. The classification-based receptive field (CbRF) estimation method proposed here adapts a linear large-margin classifier to optimally predict experimental stimulus-response data and subsequently interprets learned classifier weights as the neuron's receptive field filter. Computational learning theory provides a theoretical framework for learning from data and guarantees optimality in the sense that the risk of erroneously assigning a spike-eliciting stimulus example to the non-spike class (and vice versa) is minimized. Efficacy of the CbRF method is validated with simulations and for auditory spectro-temporal receptive field (STRF) estimation from experimental recordings in the auditory midbrain of Mongolian gerbils. Acoustic stimulation is performed with frequency-modulated tone complexes that mimic properties of natural stimuli, specifically non-Gaussian amplitude distribution and higher-order correlations. Results demonstrate that the proposed approach successfully identifies correct underlying STRFs, even in cases where second-order methods based on the spike-triggered average (STA) do not. Applied to small data samples, the method is shown to converge on smaller amounts of experimental recordings and with lower estimation variance than the generalized linear model and recent information theoretic methods. Thus, CbRF estimation may prove useful for investigation of neuronal processes in response to natural stimuli and in settings where rapid adaptation is induced by experimental design.	[Meyer, Arne F.; Anemueller, Joern] Carl von Ossietzky Univ Oldenburg, Dept Med Phys & Acoust, D-26111 Oldenburg, Germany; [Meyer, Arne F.; Anemueller, Joern] Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, D-26111 Oldenburg, Germany; [Diepenbrock, Jan-Philipp; Happel, Max F. K.; Ohl, Frank W.] Leibniz Inst Neurobiol, Dept Syst Physiol Learning, Magdeburg, Germany; [Happel, Max F. K.; Ohl, Frank W.] Guericke Univ, Inst Biol, Dept Neuroprosthet, Magdeburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Leibniz Institut fur Neurobiologie (LIN)	Meyer, AF (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Med Phys & Acoust, D-26111 Oldenburg, Germany.	arne.f.meyer@uni-oldenburg.de	Anemüller, Jörn/A-8090-2009	Happel, Max/0000-0002-9581-5856; Meyer, Arne/0000-0002-0468-3369	German Research Foundation (DFG) within the Collaborative Research Centre [SFB/TRR31]	German Research Foundation (DFG) within the Collaborative Research Centre(German Research Foundation (DFG))	This study was supported by the German Research Foundation (DFG) within the Collaborative Research Centre SFB/TRR31 "The Active Auditory System". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman TL, 2003, NEURON, V40, P823, DOI 10.1016/S0896-6273(03)00680-9; Andoni S, 2007, J NEUROSCI, V27, P4882, DOI 10.1523/JNEUROSCI.4342-06.2007; Andoni S, 2011, J NEUROSCI, V31, P16529, DOI 10.1523/JNEUROSCI.1306-11.2011; Atencio CA, 2012, J NEUROPHYSIOL, V107, P2594, DOI 10.1152/jn.01025.2011; Atencio CA, 2009, P NATL ACAD SCI USA, V106, P21894, DOI 10.1073/pnas.0908383106; Bartlett PL, 2006, J AM STAT ASSOC, V101, P138, DOI 10.1198/016214505000000907; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; BRUCKNER S, 1995, HEARING RES, V86, P1, DOI 10.1016/0378-5955(95)00048-9; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Calabrese A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016104; Cant NB, 2005, HEARING RES, V206, P12, DOI 10.1016/j.heares.2005.02.014; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Christianson GB, 2008, J NEUROSCI, V28, P446, DOI 10.1523/JNEUROSCI.1775-07.2007; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; David SV, 2007, NETWORK-COMP NEURAL, V18, P191, DOI 10.1080/09548980701609235; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; Dayan P., 2005, THEORETICAL NEUROSCI; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Eliades SJ, 2008, J NEUROSCI METH, V172, P201, DOI 10.1016/j.jneumeth.2008.04.029; Escabi MA, 2002, J NEUROSCI, V22, P4114, DOI 10.1523/JNEUROSCI.22-10-04114.2002; Fishbach A, 2003, J NEUROPHYSIOL, V90, P3663, DOI 10.1152/jn.00654.2003; Fishbach A, 2001, J NEUROPHYSIOL, V85, P2303, DOI 10.1152/jn.2001.85.6.2303; Fitzgerald JD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002249; Fitzgerald JD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001111; Franc V., 2011, PROC INT C MACHINE L, P665; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Garofolo JS, 1993, TIMIT ACOUSTIC PHONE; Gill P, 2006, J COMPUT NEUROSCI, V21, P5, DOI 10.1007/s10872-006-7059-4; Happel MFK, 2010, J NEUROSCI, V30, P11114, DOI 10.1523/JNEUROSCI.0689-10.2010; Hsu A, 2004, J NEUROSCI, V24, P9201, DOI 10.1523/JNEUROSCI.2449-04.2004; Kouh M, 2009, NETWORK-COMP NEURAL, V20, P49, DOI 10.1080/09548980902950891; Lesica NA, 2008, J NEUROSCI, V28, P5412, DOI 10.1523/JNEUROSCI.0073-08.2008; Lesica NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003060; Lin Y, 2002, DATA MIN KNOWL DISC, V6, P259, DOI 10.1023/A:1015469627679; Lin Y, 2000, MACH LEARN, P191; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; MCCULLOCH WS, 1990, B MATH BIOL, V52, P99, DOI 10.1016/S0092-8240(05)80006-0; Meyer AF, 2013, P 6 INT IEEE EMBS C; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nelken I, 2003, BIOL CYBERN, V89, P397, DOI 10.1007/s00422-003-0445-3; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Paninski L, 2003, NETWORK-COMP NEURAL, V14, P437, DOI 10.1088/0954-898X/14/3/304; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Park IM, 2013, ADV NEURAL INFORM PR, V26, P2454; Park M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002219; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pollak GD, 2011, HEARING RES, V274, P27, DOI 10.1016/j.heares.2010.05.010; Rabinowitz NC, 2011, NEURON, V70, P1178, DOI 10.1016/j.neuron.2011.04.030; Rieke F., 1997, SPIKES EXPLORING NEU; Schnupp JWH, 2001, NATURE, V414, P200, DOI 10.1038/35102568; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Sharpee TO, 2008, J NEUROPHYSIOL, V99, P2496, DOI 10.1152/jn.01397.2007; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Sharpee TO, 2011, CURRENT OPINION NEUR; Teeters JL, 2008, NEUROINFORMATICS, V6, P47, DOI 10.1007/s12021-008-9009-y; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Touryan J, 2002, J NEUROSCI, V22, P10811; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Vapnik V., 2013, NATURE STAT LAERNING; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536; Wu MCK, 2006, ANNU REV NEUROSCI, V29, P477, DOI 10.1146/annurev.neuro.29.051605.113024; Zhang T, 2004, ANN STAT, V32, P56	67	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93062	10.1371/journal.pone.0093062	http://dx.doi.org/10.1371/journal.pone.0093062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699631	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000041
J	Purahong, W; Kapturska, D; Pecyna, MJ; Schulz, E; Schloter, M; Buscot, F; Hofrichter, M; Kruger, D				Purahong, Witoon; Kapturska, Danuta; Pecyna, Marek J.; Schulz, Elke; Schloter, Michael; Buscot, Francois; Hofrichter, Martin; Krueger, Dirk			Influence of Different Forest System Management Practices on Leaf Litter Decomposition Rates, Nutrient Dynamics and the Activity of Ligninolytic Enzymes: A Case Study from Central European Forests	PLOS ONE			English	Article							MANGANESE PEROXIDASE; WOOD; INTENSITY; FUNGI; DEGRADATION; COMMUNITIES; VARIABILITY; CONVERSION; OXIDATION; LACCASES	Leaf litter decomposition is the key ecological process that determines the sustainability of managed forest ecosystems, however very few studies hitherto have investigated this process with respect to silvicultural management practices. The aims of the present study were to investigate the effects of forest management practices on leaf litter decomposition rates, nutrient dynamics (C, N, Mg, K, Ca, P) and the activity of ligninolytic enzymes. We approached these questions using a 473 day long litterbag experiment. We found that age-class beech and spruce forests (high forest management intensity) had significantly higher decomposition rates and nutrient release (most nutrients) than unmanaged deciduous forest reserves (P < 0.05). The site with near-to-nature forest management (low forest management intensity) exhibited no significant differences in litter decomposition rate, C release, lignin decomposition, and C/N, lignin/N and ligninolytic enzyme patterns compared to the unmanaged deciduous forest reserves, but most nutrient dynamics examined in this study were significantly faster under such near-to-nature forest management practices. Analyzing the activities of ligninolytic enzymes provided evidence that different forest system management practices affect litter decomposition by changing microbial enzyme activities, at least over the investigated time frame of 473 days (laccase, P < 0.0001; manganese peroxidase (MnP), P=0.0260). Our results also indicate that lignin decomposition is the rate limiting step in leaf litter decomposition and that MnP is one of the key oxidative enzymes of litter degradation. We demonstrate here that forest system management practices can significantly affect important ecological processes and services such as decomposition and nutrient cycling.	[Purahong, Witoon; Kapturska, Danuta; Schulz, Elke; Buscot, Francois; Krueger, Dirk] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany; [Purahong, Witoon] Tech Univ Munich, Chair Soil Sci, Oberschleissheim, Germany; [Kapturska, Danuta; Pecyna, Marek J.; Hofrichter, Martin] Tech Univ Dresden, Int Inst Zittau, Dept Bio & Environm Sci, Zittau, Germany; [Schloter, Michael] Helmholtz Zentrum Munchen, Res Unit Environm Genom, Oberschleissheim, Germany; [Buscot, Francois] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technical University of Munich; Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Purahong, W (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany.	witoon.purahong@ufz.de	Purahong, Witoon/AAX-8455-2021; Buscot, Francois/A-4125-2016; Schloter, 1Michael/H-9151-2013; Krüger, Dirk/C-3316-2012	Purahong, Witoon/0000-0002-4113-6428; Buscot, Francois/0000-0002-2364-0006; Krüger, Dirk/0000-0002-7305-5104; Hofrichter, Martin/0000-0001-5174-7604	DFG [KR 3587/1-1, KR 3587/3-2, SCHL 446/13-2., HO 1961/4-1, HO 1961/5-2]; Helmholtz Impulse and Networking Fund via the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE)	DFG(German Research Foundation (DFG)); Helmholtz Impulse and Networking Fund via the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE)	This work was funded in part by DFG Priority Program 1374 on 'Infrastructure-Biodiversity-Exploratories' (KR 3587/1-1, KR 3587/3-2, SCHL 446/13-2, HO 1961/4-1, HO 1961/5-2). W. Purahong and D. Kapturska also were kindly supported by the Helmholtz Impulse and Networking Fund via the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE). The funders DFG and HIGRADE had no input into the study design, the data collection and analysis, the decision to publish, or the preparation of the manuscript.	[Anonymous], 2010, GLOBAL FOREST RESOUR; Aubert M, 2010, FOREST ECOL MANAG, V259, P563, DOI 10.1016/j.foreco.2009.11.014; Ayres E, 2009, SOIL BIOL BIOCHEM, V41, P606, DOI 10.1016/j.soilbio.2008.12.022; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bates JD, 2007, J ARID ENVIRON, V70, P222, DOI 10.1016/j.jaridenv.2006.12.015; Brumelis G, 2011, SILVA FENN, V45, P807, DOI 10.14214/sf.446; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; COUTEAUX MM, 1995, TRENDS ECOL EVOL, V10, P63, DOI 10.1016/S0169-5347(00)88978-8; EFFLAND MJ, 1977, TAPPI, V60, P143; FARHANGRAZI ZS, 1994, BIOCHEMISTRY-US, V33, P5647, DOI 10.1021/bi00184a038; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Graca MAS, 2014, OECOLOGIA, V174, P1021, DOI 10.1007/s00442-013-2825-2; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Heinzkill M, 1998, APPL ENVIRON MICROB, V64, P1601; Hessenmoller D., 2011, Forstarchiv, V82, P171; Hofrichter M, 2002, ENZYME MICROB TECH, V30, P454, DOI 10.1016/S0141-0229(01)00528-2; Hofrichter M, 2001, APPL ENVIRON MICROB, V67, P4588, DOI 10.1128/AEM.67.10.4588-4593.2001; IPCC, 2003, GOOD PRACT GUID LAND; Jacob M, 2010, OECOLOGIA, V164, P1083, DOI 10.1007/s00442-010-1699-9; Jacob M, 2009, SOIL BIOL BIOCHEM, V41, P2122, DOI 10.1016/j.soilbio.2009.07.024; Leonowicz A, 2001, J BASIC MICROB, V41, P185, DOI 10.1002/1521-4028(200107)41:3/4&lt;185::AID-JOBM185&gt;3.0.CO;2-T; Liers C, 2011, FEMS MICROBIOL ECOL, V78, P91, DOI 10.1111/j.1574-6941.2011.01144.x; Lonsdale D, 2008, EUR J FOREST RES, V127, P1, DOI 10.1007/s10342-007-0182-6; Lummer D, 2012, OIKOS, V121, P1649, DOI 10.1111/j.1600-0706.2011.20073.x; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Luyssaert S, 2011, ECOL APPL, V21, P3272, DOI 10.1890/10-2395.1; Ma SY, 2010, FOREST ECOL MANAG, V259, P904, DOI 10.1016/j.foreco.2009.11.030; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; Martin A, 1997, ANN SCI FOREST, V54, P191, DOI 10.1051/forest:19970206; Moretto AS, 2001, APPL SOIL ECOL, V18, P31, DOI 10.1016/S0929-1393(01)00151-2; Muller J, 2007, EUR J FOREST RES, V126, P513, DOI 10.1007/s10342-007-0173-7; Naether A, 2012, APPL ENVIRON MICROB, V78, P7398, DOI 10.1128/AEM.01325-12; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Prescott CE, 2005, FOREST ECOL MANAG, V220, P66, DOI 10.1016/j.foreco.2005.08.005; Purahong W, 2011, FUNGAL DIVERS, V47, P1, DOI 10.1007/s13225-010-0083-8; Raiskila S, 2007, SILVA FENN, V41, P351, DOI 10.14214/sf.301; Salazar S, 2011, ECOL ENG, V37, P1123, DOI 10.1016/j.ecoleng.2011.02.007; Santa-Regina I, 2001, FORESTRY, V74, P11, DOI 10.1093/forestry/74.1.11; SANTA-REGINA I, 1995, ARID SOIL RES REHAB, V9, P201, DOI 10.1080/15324989509385886; Schall P, 2013, EUR J FOREST RES, V132, P379, DOI 10.1007/s10342-013-0681-6; Schliemann SA, 2011, FOREST ECOL MANAG, V261, P1143, DOI 10.1016/j.foreco.2011.01.011; Schoning I, 2013, PLANT SOIL, V370, P625, DOI 10.1007/s11104-013-1654-8; Steffen KT, 2007, RES MICROBIOL, V158, P447, DOI 10.1016/j.resmic.2007.04.002; Steffen KT, 2000, APPL MICROBIOL BIOT, V54, P819, DOI 10.1007/s002530000473; Torras O, 2008, FOREST ECOL MANAG, V255, P3322, DOI 10.1016/j.foreco.2008.02.013; Trum F., 2010, Proceedings of the 19th World Congress of Soil Science: Soil solutions for a changing world, Brisbane, Australia, 1-6 August 2010. Working Group 3.2 Forest soil processes and change, P40; Unterseher M, 2013, FUNGAL DIVERS, V60, P43, DOI 10.1007/s13225-013-0222-0; Waldchen J, 2013, FOREST ECOL MANAG, V289, P243, DOI 10.1016/j.foreco.2012.10.014; Waldrop MP, 2003, SOIL SCI SOC AM J, V67, P1250, DOI 10.2136/sssaj2003.1250; WARIISHI H, 1992, J BIOL CHEM, V267, P23688; Wubet T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047500; Xuluc-Tolosa FJ, 2003, FOREST ECOL MANAG, V174, P401, DOI 10.1016/S0378-1127(02)00059-2; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433	53	49	51	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93700	10.1371/journal.pone.0093700	http://dx.doi.org/10.1371/journal.pone.0093700			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699676	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000091
J	Qiu, Q; Scott, A; Scheerer, H; Sapkota, N; Lee, DK; Ma, LM; Yu, CR				Qiu, Qiang; Scott, Aaron; Scheerer, Hayley; Sapkota, Nirjal; Lee, Daniel K.; Ma, Limei; Yu, C. Ron			Automated Analyses of Innate Olfactory Behaviors in Rodents	PLOS ONE			English	Article							PSYCHOMETRIC FUNCTION; STIMULUS-CONTROL; ODOR MEMORY; DISCRIMINATION; RAT; MICE; ACCURACY; SPEED; MOUSE; PERFORMANCE	Olfaction based behavioral experiments are important for the investigation of sensory coding, perception, decision making and memory formation. The predominant experimental paradigms employ forced choice operant assays, which require associative learning and reinforced training. Animal performance in these assays not only reflects odor perception but also the confidence in decision making and memory. In this study, we describe a versatile and automated setup, "Poking-Registered Olfactory Behavior Evaluation System" (PROBES), which can be adapted to perform multiple olfactory assays. In addition to forced choice assays, we employ this system to examine animal's innate ability for odor detection, discrimination and preference without elaborate training procedures. These assays provide quantitative measurements of odor discrimination and robust readouts of odor preference. Using PROBES, we find odor detection thresholds are at lower concentrations in naive animals than those determined by forced choice assays. PROBES-based automated assays provide an efficient way of analyzing innate odor-triggered behaviors.	[Qiu, Qiang; Scott, Aaron; Scheerer, Hayley; Sapkota, Nirjal; Lee, Daniel K.; Ma, Limei; Yu, C. Ron] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Yu, C. Ron] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Yu, CR (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	cry@stowers.org		Scott, Aaron/0000-0002-1210-3731	Stowers Institute	Stowers Institute	This work is supported by funding from the Stowers Institute to C.R.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; [Anonymous], HDB OLFACTION GUSTAT; Barnes DC, 2008, NAT NEUROSCI, V11, P1378, DOI 10.1038/nn.2217; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Cleland TA, 2002, BEHAV NEUROSCI, V116, P222, DOI 10.1037//0735-7044.116.2.222; Clevenger AC, 2006, CHEM SENSES, V31, P9, DOI 10.1093/chemse/bjj001; DARLING FMC, 1994, PHYSIOL BEHAV, V55, P817, DOI 10.1016/0031-9384(94)90065-5; Doty R. L., 2003, HDB OLFACTION GUSTAT, P203, DOI DOI 10.1201/9780203911457; DUNCAN HJ, 1992, PHYSIOL BEHAV, V52, P617, DOI 10.1016/0031-9384(92)90357-8; Eichenbaum H., 2003, HDB OLFACTION GUSTAT, P409; Grosmaitre X, 2007, NAT NEUROSCI, V10, P348, DOI 10.1038/nn1856; HASTINGS L, 1991, CHEM SENSES, V16, P43, DOI 10.1093/chemse/16.1.43; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Hubener F, 2001, PHYSIOL BEHAV, V72, P511, DOI 10.1016/S0031-9384(00)00447-9; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Klein SA, 2001, PERCEPT PSYCHOPHYS, V63, P1421, DOI 10.3758/BF03194552; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Linster C, 1999, PHYSIOL BEHAV, V66, P701, DOI 10.1016/S0031-9384(99)00007-4; Lorig TS, 1999, BEHAV RES METH INS C, V31, P370, DOI 10.3758/BF03207734; Ma LM, 2012, P NATL ACAD SCI USA, V109, P5481, DOI 10.1073/pnas.1117491109; Mihalick SM, 2000, J EXP ANAL BEHAV, V73, P305, DOI 10.1901/jeab.2000.73-305; Moulton DG, 1977, CHEM SIGNALS VERTEBR, P455; NIGROSH BJ, 1975, J COMP PHYSIOL PSYCH, V89, P285, DOI 10.1037/h0076821; PASSE DH, 1985, NEUROSCI BIOBEHAV R, V9, P431, DOI 10.1016/0149-7634(85)90021-1; PFAFFMANN C, 1958, SCIENCE, V128, P1007, DOI 10.1126/science.128.3330.1007; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; SLOTNICK BM, 1991, PHYSIOL BEHAV, V50, P555, DOI 10.1016/0031-9384(91)90545-Y; SLOTNICK BM, 1974, PERCEPT MOTOR SKILL, V39, P583, DOI 10.2466/pms.1974.39.1.583; THIESSEN DD, 1971, ANIM BEHAV, V19, P505, DOI 10.1016/S0003-3472(71)80105-7; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VARLEY GC, 1953, NATURE, V171, P789, DOI 10.1038/172789a0; WALKER JC, 1986, CHEM SENSES, V11, P439, DOI 10.1093/chemse/11.4.439; Wesson DW, 2008, PLOS BIOL, V6, P717, DOI 10.1371/journal.pbio.0060082; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; [No title captured]	35	11	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93468	10.1371/journal.pone.0093468	http://dx.doi.org/10.1371/journal.pone.0093468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699673	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000062
J	Vergara, M; Becerra, S; Berrios, J; Osses, N; Reyes, J; Rodriguez-Moya, M; Gonzalez, R; Altamirano, C				Vergara, Mauricio; Becerra, Silvana; Berrios, Julio; Osses, Nelson; Reyes, Juan; Rodriguez-Moya, Maria; Gonzalez, Ramon; Altamirano, Claudia			Differential Effect of Culture Temperature and Specific Growth Rate on CHO Cell Behavior in Chemostat Culture	PLOS ONE			English	Article							HAMSTER OVARY CELLS; RECOMBINANT PROTEIN PRODUCTIVITY; INTERFERON-GAMMA PRODUCTION; MAMMALIAN-CELLS; TRANSCRIPTION LEVEL; DILUTION RATE; EXPRESSION; ERYTHROPOIETIN; SUSPENSION; ANTIBODY	Mild hypothermia condition in mammalian cell culture technology has been one of the main focuses of research for the development of breeding strategies to maximize productivity of these production systems. Despite the large number of studies that show positive effects of mild hypothermia on specific productivity of r-proteins, no experimental approach has addressed the indirect effect of lower temperatures on specific cell growth rate, nor how this condition possibly affects less specific productivity of r-proteins. To separately analyze the effects of mild hypothermia and specific growth rate on CHO cell metabolism and recombinant human tissue plasminogen activator productivity as a model system, high dilution rate (0.017 h(-1)) and low dilution rate (0.012 h(-1)) at two cultivation temperatures (37 and 33 degrees C) were evaluated using chemostat culture. The results showed a positive effect on the specific productivity of r-protein with decreasing specific growth rate at 33 degrees C. Differential effect was achieved by mild hypothermia on the specific productivity of r-protein, contrary to the evidence reported in batch culture. Interestingly, reduction of metabolism could not be associated with a decrease in culture temperature, but rather with a decrease in specific growth rate.	[Vergara, Mauricio; Becerra, Silvana; Berrios, Julio; Altamirano, Claudia] Pontificia Univ Catolica Valparaiso, Sch Biochem Engn, Valparaiso, Chile; [Becerra, Silvana; Altamirano, Claudia] GORE Valparaiso, CREAS CONICYT REG, Valparaiso, Chile; [Osses, Nelson; Reyes, Juan] Pontificia Univ Catolica Valparaiso, Inst Chem, Valparaiso, Chile; [Rodriguez-Moya, Maria; Gonzalez, Ramon] Rice Univ, Dept Chem & Biomol Engn, Houston, TX USA; [Gonzalez, Ramon] Rice Univ, Dept Bioengn, Houston, TX USA	Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Valparaiso; Rice University; Rice University	Altamirano, C (corresponding author), Pontificia Univ Catolica Valparaiso, Sch Biochem Engn, Valparaiso, Chile.	claudia.altamirano@ucv.cl	Osses, Nelson/V-9065-2019; Gonzalez, Ramon/B-1961-2010	Osses, Nelson/0000-0003-0974-1051; Becerra, Silvana/0000-0002-0604-398X; Berrios, Julio/0000-0002-6180-0023; Reyes, Juan G./0000-0001-5541-5172; Altamirano, Claudia/0000-0002-6389-086X	FONDECYT [1120667]; VRIEA-Pontificia Universidad Catolica de Valparaiso; CONICYT	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); VRIEA-Pontificia Universidad Catolica de Valparaiso; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by FONDECYT 1120667, VRIEA-Pontificia Universidad Catolica de Valparaiso, and by CONICYT Doctoral scholarship to MV and SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fageeh MB, 2006, BIOTECHNOL BIOENG, V93, P829, DOI 10.1002/bit.20789; Altamirano C, 2001, BIOTECHNOL PROGR, V17, P1032, DOI 10.1021/bp0100981; Baik JY, 2006, BIOTECHNOL BIOENG, V93, P361, DOI 10.1002/bit.20717; BAILEY JE, 1986, BIOCH ENG FUNDAMENTA, P373; Becerra S, 2012, BIOCHEM ENG J, V60, P1, DOI 10.1016/j.bej.2011.10.003; Berrios J, 2011, CHEM ENG SCI, V66, P2431, DOI 10.1016/j.ces.2011.03.011; Berrios J, 2009, BIOTECHNOL LETT, V31, P1493, DOI 10.1007/s10529-009-0050-1; Bi JX, 2004, BIOTECHNOL BIOENG, V85, P741, DOI 10.1002/bit.20025; Bollati-Fogolin M, 2005, BIOTECHNOL PROGR, V21, P17, DOI 10.1021/bp049825t; Burleigh SC, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-95; Carvalhal AV, 2003, BIOTECHNOL PROGR, V19, P69, DOI 10.1021/bp0255917; Diaz-Barrera A, 2012, J IND MICROBIOL BIOT, V39, P613, DOI 10.1007/s10295-011-1055-z; Fogolin MB, 2004, J BIOTECHNOL, V109, P179, DOI 10.1016/j.jbiotec.2003.10.035; Fox SR, 2004, BIOTECHNOL BIOENG, V85, P177, DOI 10.1002/bit.10861; Furukawa K, 1998, CYTOTECHNOLOGY, V26, P153, DOI 10.1023/A:1007934216507; HAYTER PM, 1993, BIOTECHNOL BIOENG, V42, P1077, DOI 10.1002/bit.260420909; Hendrick V, 2001, CYTOTECHNOLOGY, V36, P71, DOI 10.1023/A:1014088919546; Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0; Kaufmann H, 1999, BIOTECHNOL BIOENG, V63, P573, DOI 10.1002/(SICI)1097-0290(19990605)63:5<573::AID-BIT7>3.0.CO;2-Y; Kim JY, 2012, APPL MICROBIOL BIOT, V93, P917, DOI 10.1007/s00253-011-3758-5; Kou TC, 2011, J BIOSCI BIOENG, V111, P365, DOI 10.1016/j.jbiosc.2010.11.016; Krampe B, 2011, BIOTECHNOL BIOENG, V108, P1603, DOI 10.1002/bit.23100; Lim Y, 2010, BIOTECHNOL APPL BIOC, V55, P175, DOI 10.1042/BA20090363; LINARDOS TI, 1992, BIOTECHNOL BIOENG, V40, P359, DOI 10.1002/bit.260400305; Marchant RJ, 2008, MOL BIOTECHNOL, V39, P69, DOI 10.1007/s12033-008-9032-0; Masterton RJ, 2010, BIOTECHNOL BIOENG, V105, P215, DOI 10.1002/bit.22533; MILLER WM, 1988, BIOTECHNOL BIOENG, V32, P947, DOI 10.1002/bit.260320803; Nam JH, 2008, BIOTECHNOL BIOENG, V100, P1178, DOI 10.1002/bit.21853; Nam JH, 2009, CYTOTECHNOLOGY, V59, P81, DOI 10.1007/s10616-009-9196-x; Oguchi S, 2006, CYTOTECHNOLOGY, V52, P199, DOI 10.1007/s10616-007-9059-2; Omasa T, 2010, BIOPROC BIOSYST ENG, V33, P117, DOI 10.1007/s00449-009-0351-8; RAY NG, 1989, BIOTECHNOL BIOENG, V33, P724, DOI 10.1002/bit.260330610; ROBINSON DK, 1991, BIOTECHNOL BIOENG, V38, P972, DOI 10.1002/bit.260380903; Schatz SM, 2003, BIOTECHNOL BIOENG, V84, P433, DOI 10.1002/bit.10793; Shi M, 2005, BIOTECHNOL LETT, V27, P1879, DOI 10.1007/s10529-005-3897-9; Sinclair R, 1974, In Vitro, V10, P295, DOI 10.1007/BF02615311; Smales CM, 2004, BIOTECHNOL BIOENG, V88, P474, DOI 10.1002/bit.20272; Sonna LA, 2002, J APPL PHYSIOL, V92, P1725, DOI 10.1152/japplphysiol.01143.2001; Trummer E, 2006, BIOTECHNOL BIOENG, V94, P1033, DOI 10.1002/bit.21013; Vergara M, 2012, ELECTRON J BIOTECHN, V15, DOI 10.2225/vol15-issue6-fulltext-2; Visiongain Biosimilars and Follow-On Biologics, 2012, GLOB MARK OUTL 2010, V142; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yee JC, 2009, BIOTECHNOL BIOENG, V102, P246, DOI 10.1002/bit.22039; Yoon SK, 2005, BIOTECHNOL BIOENG, V89, P345, DOI 10.1002/bit.20353; Yoon SK, 2003, BIOTECHNOL BIOENG, V82, P289, DOI 10.1002/bit.10566; Yoon SK, 2003, BIOTECHNOL PROGR, V19, P1383, DOI 10.1021/bp034051m; Yoon SK, 2006, ENZYME MICROB TECH, V39, P362, DOI 10.1016/j.enzmictec.2005.11.029	47	43	45	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93865	10.1371/journal.pone.0093865	http://dx.doi.org/10.1371/journal.pone.0093865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699760	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000115
J	Knight, L; Muloiwa, R; Dlamini, S; Lehloenya, RJ				Knight, Lauren; Muloiwa, Rudzani; Dlamini, Sipho; Lehloenya, Rannakoe J.			Factors Associated with Increased Mortality in a Predominantly HIV-Infected Population with Stevens Johnson Syndrome and Toxic Epidermal Necrolysis	PLOS ONE			English	Article								Introduction: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening drug reactions with a higher incidence in HIV-infected persons. SJS/TEN are associated with skin and mucosal failure, predisposing to systemic bacterial infection (BSI), a major cause of death. There are limited data on risk factors associated with BSI and and mortality in HIV-infected people with SJS/TEN. Methods: We conducted a retrospective study of patients admitted to a university hospital with SJS/TEN over a 3 year period. We evaluated their underlying illnesses, eliciting drugs, predictive value of bacterial skin cultures and other factors associated with mortality and BSI in a predominantly HIV-infected population by comparing characteristics of the patients who demised and those who survived. Results: We admitted 86 cases during the study period and 67/86(78%) were HIV-infected. Tuberculosis was the commonest co-morbidity, diagnosed in 12/86(14%) cases. Skin cultures correlated with BSI by the same organism in 7/64(11%) cases and 6/7 were Gram-negative. Two of the 8 cases of Gram-negative BSI had an associated Gram-negative skin culture, although not always the same organism. All 8 fatalities had >30% epidermal detachment, 7 were HIV-infected, 6 died of BSI and 6 had tuberculosis. Conclusions: Having >30% epidermal detachment in SJS/TEN carries an increased risk of BSI and mortality. Tuberculosis and BSI are associated with higher risk of death in SJS/TEN. Our data suggests there may be an association between Gram-negative BSI and Gram-negative skin infection.	[Knight, Lauren] Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; [Muloiwa, Rudzani] Univ Cape Town, Dept Paediat & Child Hlth, ZA-7925 Cape Town, South Africa; [Dlamini, Sipho] Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Lehloenya, Rannakoe J.] Univ Cape Town, Dept Med, Div Dermatol, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town	Lehloenya, RJ (corresponding author), Univ Cape Town, Dept Med, Div Dermatol, ZA-7925 Cape Town, South Africa.	rannakoe.lehloenya@uct.ac.za	Muloiwa, Rudzani/AAY-7338-2020; Muloiwa, Rudzani/AAG-8139-2021; Lehloenya, Rannakoe J/C-5672-2012	Muloiwa, Rudzani/0000-0002-4527-0827; Lehloenya, Rannakoe J/0000-0002-1281-1789	Fogarty International Center [U2RTW007373]; Netcare through a Hamilton Naki Clinical Scholarship; Sanofi Pasteur; Discovery Foundation; Dermatological Society of South Africa; Carnergie Corporation Research Award	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Netcare through a Hamilton Naki Clinical Scholarship; Sanofi Pasteur; Discovery Foundation; Dermatological Society of South Africa; Carnergie Corporation Research Award	L.K. was partially supported by grant number U2RTW007373 from the Fogarty International Center; R.M. is supported by Netcare through a Hamilton Naki Clinical Scholarship and Sanofi Pasteur; R.J.L. was supported by the Discovery Foundation, Dermatological Society of South Africa and received Carnergie Corporation Research Award. S.D. has no financial disclosures to make. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastuji-Garin S, 2000, J INVEST DERMATOL, V115, P149, DOI 10.1046/j.1523-1747.2000.00061.x; COOPMAN SA, 1993, NEW ENGL J MED, V328, P1670, DOI 10.1056/NEJM199306103282304; de Prost N, 2010, MEDICINE, V89, P28, DOI 10.1097/MD.0b013e3181ca4290; EDELL DS, 1992, PEDIATRICS, V89, P429; Fritsch P O, 2000, Am J Clin Dermatol, V1, P349, DOI 10.2165/00128071-200001060-00003; George SMC, 2008, CRIT CARE, V12, DOI 10.1186/cc6141; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Inamadar Arun C, 2005, Indian J Dermatol Venereol Leprol, V71, P379; McGee T, 1998, PLAST RECONSTR SURG, V102, P1018, DOI 10.1097/00006534-199809040-00014; Montefour K, 2008, CRIT CARE NURSE, V28, P15; Powell N, 2006, POSTGRAD MED J, V82, DOI 10.1136/pgmj.2005.042952; REVUZ J, 1987, ARCH DERMATOL, V123, P1160, DOI 10.1001/archderm.123.9.1160; Roujeau Jean-Claude, 1997, Journal of Dermatology (Tokyo), V24, P726; Statistics South Africa, 2011, MID POP EST; Struck MF, 2010, INTENS CARE MED, V36, P22, DOI 10.1007/s00134-009-1659-1	15	14	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93543	10.1371/journal.pone.0093543	http://dx.doi.org/10.1371/journal.pone.0093543			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695805	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000087
J	Lu, SH; Li, T; Xi, XH; Chen, QG; Liu, XH; Zhang, BX; Ou, JX; Liu, J; Wang, Q; Zhu, BA; Liu, XN; Bai, CX; Qu, JM; Lu, HZ; Zhang, ZY; Song, YL				Lu, Shuihua; Li, Tao; Xi, Xiuhong; Chen, Qingguo; Liu, Xuhui; Zhang, Binxing; Ou, Jiaxian; Liu, Jie; Wang, Qin; Zhu, Biao; Liu, Xinian; Bai, Chunxue; Qu, Jieming; Lu, Hongzhou; Zhang, Zhiyong; Song, Yuanlin			Prognosis of 18 H7N9 Avian Influenza Patients in Shanghai	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; H1N1 2009 VIRUS; A H5N1 VIRUS; CLINICAL-FEATURES; HUMAN INFECTION; HUMAN-DISEASE; DIAGNOSIS	Purpose: To provide prognosis of an 18 patient cohort who were confirmed to have H7N9 lung infection in Shanghai. Methods: Patients' history, clinical manifestation, laboratory test, treatment strategy and mortality were followed and recorded for data analysis. Results: A total of 18 patients had been admitted into Shanghai Public Health Clinical Center from April 8(th) to July 29, 2013. 22.2% of the patients were found to have live poultry contact history and 80% were aged male patients with multiple co-morbidities including diabetes, hypertension and/or chronic obstructive pulmonary disease (COPD). This group of patients was admitted to the clinical center around 10 days after disease onset. According to laboratory examinations, increased C reactive protein (CRP), Procalcitonin (PCT), Plasma thromboplastin antecedent (PTA) and virus positive time (days) were indicative of patients' mortality. After multivariate analysis, only CRP level showed significant prediction of mortality (P = 0.013) while results of prothrombin time (PT) analysis almost reached statistical significance (P = 0.056). Conclusions: H7N9 infection induced pneumonia of different severity ranging from mild to severe pneumonia or acute lung injury/acute respiratory distress syndrome to multiple organ failure. Certain laboratory parameters such as plasma CRP, PCT, PTA and virus positive days predicted mortality of H7N9 infection and plasma CRP is an independent predictor of mortality in these patients.	[Lu, Shuihua; Li, Tao; Xi, Xiuhong; Chen, Qingguo; Liu, Xuhui; Zhang, Binxing; Liu, Xinian; Lu, Hongzhou; Zhang, Zhiyong; Song, Yuanlin] Shanghai Publ Hlth Clin Ctr, Dept TB, Shanghai, Peoples R China; [Ou, Jiaxian; Liu, Jie; Wang, Qin; Bai, Chunxue; Song, Yuanlin] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China; [Zhu, Biao] Fudan Univ, Zhongshan Hosp, Dept Surg, Shanghai 200433, Peoples R China; [Qu, Jieming] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China; [Song, Yuanlin] Qingpu Branch, Zhongshan Hosp, Dept Pulm Med, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Lu, SH (corresponding author), Shanghai Publ Hlth Clin Ctr, Dept TB, Shanghai, Peoples R China.	tubercle@shaphc.org; ylsong70@gmail.com		Bai, Chunxue/0000-0001-5798-3130	Shanghai Leading Academic Discipline Project [B115]; National Natural Science Foundation of China [30930090, 81100046, 81170056]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai Science and Technology Committee [11411951102, 12JC1402300]	Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This research was supported by Shanghai Leading Academic Discipline Project (B115), and National Natural Science Foundation of China (30930090, 81100046, 81170056). Dr. Yuanlin Song was supported by the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning and Key Medical grant from Shanghai Science and Technology Committee (11411951102, 12JC1402300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Chan JFW, 2011, CLIN VACCINE IMMUNOL, V18, P305, DOI 10.1128/CVI.00363-10; Chen Wei-wei, 2010, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V24, P331; Cheng VCC, 2012, CLIN MICROBIOL REV, V25, P223, DOI 10.1128/CMR.05012-11; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gordon CL, 2011, CLIN INFECT DIS, V52, P421, DOI 10.1093/cid/ciq082; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Gutierrez RL, 2010, EMERG INFECT DIS, V16, P565, DOI 10.3201/eid1603.091818; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Jartti A, 2011, ACTA RADIOL, V52, P297, DOI 10.1258/ar.2010.100379; Kim Sangsoo, 2011, Genomics & Informatics, V9, P1; Mak CM, 2011, J HUM GENET, V56, P617, DOI 10.1038/jhg.2011.63; Milbrandt EB, 2009, MOL MED, V15, P438, DOI 10.2119/molmed.2009.00091; Morens DM, 2013, MBIO, V4, DOI 10.1128/mBio.00445-13; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; Mu YP, 2010, QJM-INT J MED, V103, P311, DOI 10.1093/qjmed/hcq012; Oner AF, 2006, NEW ENGL J MED, V355, P2179, DOI 10.1056/NEJMoa060601; Papic N, 2012, INFLUENZA OTHER RESP, V6, pe2, DOI 10.1111/j.1750-2659.2011.00287.x; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; To KKW, 2010, POSTGRAD MED J, V86, P515, DOI 10.1136/pgmj.2009.096206; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Wu H, 2013, N ENGL J MED; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	31	18	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e88728	10.1371/journal.pone.0088728	http://dx.doi.org/10.1371/journal.pone.0088728			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695420	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000003
J	Pilling, D; Gomer, RH				Pilling, Darrell; Gomer, Richard H.			Persistent Lung Inflammation and Fibrosis in Serum Amyloid P Component (Apcs(-/-)) Knockout Mice	PLOS ONE			English	Article							INDUCED PULMONARY-FIBROSIS; ACUTE-PHASE REACTANTS; C-REACTIVE PROTEIN; PERIPHERAL-BLOOD FIBROCYTES; FC-GAMMA RECEPTORS; CIRCULATING FIBROCYTES; MACROPHAGE SUBPOPULATIONS; SPONTANEOUS AUTOIMMUNITY; APOPTOTIC CELLS; T-CELLS	Fibrosing diseases, such as pulmonary fibrosis, cardiac fibrosis, myelofibrosis, liver fibrosis, and renal fibrosis are chronic and debilitating conditions and are an increasing burden for the healthcare system. Fibrosis involves the accumulation and differentiation of many immune cells, including macrophages and fibroblast-like cells called fibrocytes. The plasma protein serum amyloid P component (SAP; also known as pentraxin-2, PTX2) inhibits fibrocyte differentiation in vitro, and injections of SAP inhibit fibrosis in vivo. SAP also promotes the formation of immuno-regulatory Mreg macrophages. To elucidate the endogenous function of SAP, we used bleomycin aspiration to induce pulmonary inflammation and fibrosis in mice lacking SAP. Compared to wildtype C57BL/6 mice, we find that in Apcs(-/-) "SAP knock-out'' mice, bleomycin induces a more persistent inflammatory response and increased fibrosis. In both C57BL/6 and Apcs(-/-) mice, injections of exogenous SAP reduce the accumulation of inflammatory macrophages and prevent fibrosis. The types of inflammatory cells present in the lungs following bleomycin-aspiration appear similar between C57BL/6 and Apcs(-/-) mice, suggesting that the initial immune response is normal in the Apcs(-/-) mice, and that a key endogenous function of SAP is to promote the resolution of inflammation and fibrosis.	[Pilling, Darrell; Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Pilling, D (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	dpilling@bio.tamu.edu; rgomer@tamu.edu		Pilling, Darrell/0000-0002-7413-2773; Gomer, Richard/0000-0003-2361-4307	Texas AM University; National Institutes of Health [HL083029]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083029] Funding Source: NIH RePORTER	Texas AM University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Texas A&M University and National Institutes of Health grant HL083029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Bharadwaj D, 2001, J IMMUNOL, V166, P6735, DOI 10.4049/jimmunol.166.11.6735; Biburger M, 2011, IMMUNITY, V35, P932, DOI 10.1016/j.immuni.2011.11.009; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Botto M, 1997, NAT MED, V3, P855, DOI 10.1038/nm0897-855; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Bygrave AE, 2004, PLOS BIOL, V2, P1081, DOI 10.1371/journal.pbio.0020243; Carlucci F, 2007, J IMMUNOL, V178, P2352, DOI 10.4049/jimmunol.178.4.2352; Castano AP, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000111; Chi M, 2002, J IMMUNOL, V168, P1413, DOI 10.4049/jimmunol.168.3.1413; Chung MP, 2003, AM J RESP CELL MOL, V29, P375, DOI 10.1165/rcmb.2003-0029OC; Cox N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045674; Crawford JR, 2012, J LEUKOCYTE BIOL, V92, P699, DOI 10.1189/jlb.0112033; Crawford JR, 2010, J IMMUNOL METHODS, V363, P9, DOI 10.1016/j.jim.2010.09.025; Daubeuf F, 2012, CURRENT PROTOCOLS MO, P167; Dillingh MR, 2013, PULM PHARMACOL THER, V26, P672, DOI 10.1016/j.pupt.2013.01.008; Ding JQ, 2011, J CLIN INVEST, V121, P1930, DOI 10.1172/JCI45260; Duan M, 2012, J IMMUNOL, V189, P946, DOI 10.4049/jimmunol.1200660; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Duffield JS, 2010, DRUG NEWS PERSPECT, V23, P305, DOI 10.1358/dnp.2010.23.5.1444206; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Gomer RH, 2013, CURRENT ALLERGY ASTH, P1; Gomer RH, 2009, WOUND REPAIR REGEN, V17, P397, DOI 10.1111/j.1524-475X.2009.00482.x; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Haston CK, 2002, HUM MOL GENET, V11, P1855, DOI 10.1093/hmg/11.16.1855; Haston CK, 1996, CANCER RES, V56, P2596; Haudek SB, 2008, P NATL ACAD SCI USA, V105, P10179, DOI 10.1073/pnas.0804910105; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; Heidari Y, 2006, GENES IMMUN, V7, P592, DOI 10.1038/sj.gene.6364335; Herlihy SE, 2013, J IMMUNOL, V190, P6468, DOI 10.4049/jimmunol.1202583; Huebner RH, 2008, BIOTECHNIQUES, V44, P507, DOI 10.2144/000112729; Ji Z, 2012, IMMUNOL CELL BIOL, V90, P388, DOI 10.1038/icb.2011.51; Johnston LK, 2012, AM J RESP CELL MOL, V47, P417, DOI 10.1165/rcmb.2012-0090OC; Kebaier C, 2012, J INFECT DIS, V205, P807, DOI 10.1093/infdis/jir846; KELLER R, 1990, EUR J IMMUNOL, V20, P2137, DOI 10.1002/eji.1830200937; Kulkarni AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063798; Kumar RK, 2005, METH MOLEC MED, V117, P179; Kumar V, 2005, ACUTE CHRONIC INFLAM, V7th, P47; LE PT, 1982, J IMMUNOL, V129, P665; Lu JH, 2012, IMMUNOL REV, V250, P230, DOI 10.1111/j.1600-065X.2012.01162.x; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; MacDonald SL, 2006, SCAND J IMMUNOL, V64, P48, DOI 10.1111/j.1365-3083.2006.01774.x; Maharjan AS, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-2; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mehrad B, 2007, BIOCHEM BIOPH RES CO, V353, P104, DOI 10.1016/j.bbrc.2006.11.149; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Mold C, 2002, J AUTOIMMUN, V19, P147, DOI 10.1006/jaut.2002.0615; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Moreira AP, 2010, J ALLERGY CLIN IMMUN, V126, P712, DOI 10.1016/j.jaci.2010.06.010; MORTENSEN RF, 1983, J IMMUNOL, V130, P885; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mouratis MA, 2011, CURR OPIN PULM MED, V17, P355, DOI 10.1097/MCP.0b013e328349ac2b; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Murray LA, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-11; Murray LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009683; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Naik-Mathuria B, 2008, WOUND REPAIR REGEN, V16, P266, DOI 10.1111/j.1524-475X.2008.00366.x; Niedermeier M, 2009, P NATL ACAD SCI USA, V106, P17892, DOI 10.1073/pnas.0906070106; Parker JC, 2004, AM J PHYSIOL-LUNG C, V286, pL231, DOI 10.1152/ajplung.00049.2003; PEPYS MB, 1979, NATURE, V278, P259, DOI 10.1038/278259a0; PEPYS MB, 1980, IMMUNOLOGY, V39, P249; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 1999, EUR J IMMUNOL, V29, P1041, DOI 10.1002/(SICI)1521-4141(199903)29:03<1041::AID-IMMU1041>3.0.CO;2-#; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Pilling D, 2009, J IMMUNOL METHODS, V351, P62, DOI 10.1016/j.jim.2009.09.011; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Pilling D, 2006, J LEUKOCYTE BIOL, V79, P1242, DOI 10.1189/jlb.0805456; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; SCHRIER DJ, 1983, AM REV RESPIR DIS, V127, P63, DOI 10.1164/arrd.1983.127.1.63; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Soma M, 2001, BIOCHEM BIOPH RES CO, V286, P200, DOI 10.1006/bbrc.2001.5364; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Togashi S, 1997, LAB INVEST, V77, P525; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Van Molle W, 2000, INFECT IMMUN, V68, P5026, DOI 10.1128/IAI.68.9.5026-5029.2000; Walters DM, 2008, MOUSE MODELS BLEOMYC; Wang DC, 2010, MOL THER, V18, P625, DOI 10.1038/mt.2009.317; Wynn Thomas A, 2011, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1422s93; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120; Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315	95	60	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93730	10.1371/journal.pone.0093730	http://dx.doi.org/10.1371/journal.pone.0093730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695531	Green Published, gold, Green Submitted			2022-12-27	WOS:000334103000112
J	Song, ZL; Yang, GH; Liu, XF; Yan, ZY; Yuan, YX; Liao, YZ				Song, Zilin; Yang, Gaihe; Liu, Xiaofeng; Yan, Zhiying; Yuan, Yuexiang; Liao, Yinzhang			Comparison of Seven Chemical Pretreatments of Corn Straw for Improving Methane Yield by Anaerobic Digestion	PLOS ONE			English	Article							DILUTE-ACID PRETREATMENT; BIOGAS PRODUCTION; FERMENTATION; ETHANOL; STOVER; SACCHARIFICATION; BIOMASS	Agriculture straw is considered a renewable resource that has the potential to contribute greatly to bioenergy supplies. Chemical pretreatment prior to anaerobic digestion can increase the anaerobic digestibility of agriculture straw. The present study investigated the effects of seven chemical pretreatments on the composition and methane yield of corn straw to assess their effectiveness of digestibility. Four acid reagents (H2SO4, HCl, H2O2, and CH3COOH) at concentrations of 1%, 2%, 3%, and 4% (w/w) and three alkaline reagents (NaOH, Ca(OH)(2), and NH3 center dot H2O) at concentrations of 4%, 6%, 8%, and 10% (w/w) were used for the pretreatments. All pretreatments were effective in the biodegradation of the lignocellulosic straw structure. The straw, pretreated with 3% H2O2 and 8% Ca(OH)(2), acquired the highest methane yield of 216.7 and 206.6 mL CH4 g VS-1 in the acid and alkaline pretreatments, which are 115.4% and 105.3% greater than the untreated straw. H2O2 and Ca(OH)(2) can be considered as the most favorable pretreatment methods for improving the methane yield of straw because of their effectiveness and low cost.	[Song, Zilin; Liu, Xiaofeng; Yuan, Yuexiang; Liao, Yinzhang] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Yang, Gaihe; Yan, Zhiying] Northwest A&F Univ, Res Ctr Recycle Agr Engn Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Northwest A&F University - China	Liu, XF (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China.	lxf3636@163.com; zhiyingyan2010@yeah.net	Feng, Yongzhong/F-5090-2012	Feng, Yongzhong/0000-0002-5202-4368	National 973 of China [2013CB733502]; Applied Basic Research Program of Sichuan Province, China [2013JY0050]; Chinese Academy of Sciences [KGZD-EW-304-1]	National 973 of China(National Basic Research Program of China); Applied Basic Research Program of Sichuan Province, China; Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the National 973 of China (No. 2013CB733502), Applied Basic Research Program of Sichuan Province, China (No. 2013JY0050) and Deployment Project of Chinese Academy of Sciences (No. KGZD-EW-304-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Amon T, 2007, BIORESOURCE TECHNOL, V98, P3204, DOI 10.1016/j.biortech.2006.07.007; Cao WX, 2012, BIORESOURCE TECHNOL, V111, P215, DOI 10.1016/j.biortech.2012.02.034; Cara C, 2008, BIORESOURCE TECHNOL, V99, P1869, DOI 10.1016/j.biortech.2007.03.037; Chandra R, 2012, ENERGY, V43, P273, DOI 10.1016/j.energy.2012.04.029; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Chengdu Institute of Biology Chinese Academy of Sciences, 1984, SCI TECHNOLOGY; Estevez MM, 2012, BIORESOURCE TECHNOL, V104, P749, DOI 10.1016/j.biortech.2011.11.017; Fernandez-Cegri V, 2013, J CHEM TECHNOL BIOT, V88, P924, DOI 10.1002/jctb.3922; Ferreira LC, 2013, BIORESOURCE TECHNOL, V143, P251, DOI 10.1016/j.biortech.2013.05.065; Gomez-Tovar F, 2012, BIORESOURCE TECHNOL, V116, P372, DOI 10.1016/j.biortech.2012.03.109; Gonzalez G, 2005, J CHEM TECHNOL BIOT, V80, P151, DOI 10.1002/jctb.1165; Guo P, 2011, BIORESOURCE TECHNOL, V102, P7526, DOI 10.1016/j.biortech.2011.04.083; Hwang MH, 2004, J BIOTECHNOL, V111, P297, DOI 10.1016/j.jbiotec.2004.04.024; Cuetos MJ, 2011, BIOTECHNOL BIOPROC E, V16, P1044, DOI 10.1007/s12257-011-0117-4; Kang KE, 2012, BIOPROC BIOSYST ENG, V35, P77, DOI 10.1007/s00449-011-0606-z; Li CL, 2010, BIORESOURCE TECHNOL, V101, P4900, DOI 10.1016/j.biortech.2009.10.066; Li Q, 2012, BIORESOURCE TECHNOL, V125, P193, DOI 10.1016/j.biortech.2012.08.095; Li ZL, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-119; Lin YQ, 2009, J HAZARD MATER, V170, P366, DOI 10.1016/j.jhazmat.2009.04.086; Michalska K, 2012, BIORESOURCE TECHNOL, V119, P72, DOI 10.1016/j.biortech.2012.05.105; Monlau F, 2013, APPL ENERG, V102, P1105, DOI 10.1016/j.apenergy.2012.06.042; Murphy JD, 2009, BIOMASS BIOENERG, V33, P504, DOI 10.1016/j.biombioe.2008.08.018; National Bureau of Statistics of China, 2010, CHIN STAT YB 2009; Pakarinen OM, 2011, INT J HYDROGEN ENERG, V36, P14401, DOI 10.1016/j.ijhydene.2011.08.028; Pang YZ, 2008, ENERG FUEL, V22, P2761, DOI 10.1021/ef800001n; Rocha MVP, 2009, APPL BIOCHEM BIOTECH, V155, P407, DOI 10.1007/s12010-008-8432-8; Saha BC, 2005, PROCESS BIOCHEM, V40, P3693, DOI 10.1016/j.procbio.2005.04.006; Sapci Z, 2013, BIORESOURCE TECHNOL, V128, P487, DOI 10.1016/j.biortech.2012.09.094; Silverstein RA, 2007, BIORESOURCE TECHNOL, V98, P3000, DOI 10.1016/j.biortech.2006.10.022; Song ZL, 2012, BIORESOURCES, V7, P3223; Taherzadeh MJ, 2008, INT J MOL SCI, V9, P1621, DOI 10.3390/ijms9091621; Teghammar A, 2010, BIORESOURCE TECHNOL, V101, P1206, DOI 10.1016/j.biortech.2009.09.029; Us E, 2012, CHEM ENG J, V181, P120, DOI 10.1016/j.cej.2011.11.038; Wang Y.W., 1987, MICROBIOLOGY, V2, P81; Xiao B, 2001, POLYM DEGRAD STABIL, V74, P307, DOI 10.1016/S0141-3910(01)00163-X; Zhang QH, 2011, BIORESOURCE TECHNOL, V102, P3958, DOI 10.1016/j.biortech.2010.12.031; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066845; Zheng MX, 2009, BIORESOURCE TECHNOL, V100, P5140, DOI 10.1016/j.biortech.2009.05.045; Zhong WZ, 2011, BIORESOURCE TECHNOL, V102, P11177, DOI 10.1016/j.biortech.2011.09.077; Zhou SX, 2012, ENERGY, V46, P644, DOI 10.1016/j.energy.2012.07.017; Zhu JY, 2010, BIORESOURCE TECHNOL, V101, P7523, DOI 10.1016/j.biortech.2010.04.060	42	73	78	8	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93801	10.1371/journal.pone.0093801	http://dx.doi.org/10.1371/journal.pone.0093801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695485	Green Submitted, Green Published, gold			2022-12-27	WOS:000334103000125
J	Gan, XB; Sun, HJ; Chen, D; Zhang, LL; Zhou, H; Chen, LY; Zhou, YB				Gan, Xian-Bing; Sun, Hai-Jian; Chen, Dan; Zhang, Ling-Li; Zhou, Hong; Chen, Li-Yan; Zhou, Ye-Bo			Intermedin in the Paraventricular Nucleus Attenuates Cardiac Sympathetic Afferent Reflex in Chronic Heart Failure Rats	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ADRENOMEDULLIN 2/INTERMEDIN-LIKE IMMUNOREACTIVITY; CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; ANGIOTENSIN-II; BLOOD-PRESSURE; ENDOTHELIAL-CELLS; HYPERTENSIVE-RATS; NAD(P)H OXIDASE; AT(1) RECEPTOR	Background and Aim: Intermedin (IMD) is a member of calcitonin/ calcitonin gene-related peptide (CGRP) family together with adrenomedullin (AM) and amylin. It has a wide distribution in the central nervous system (CNS) especially in hypothalamic paraventricular nucleus (PVN). Cardiac sympathetic afferent reflex (CSAR) is enhanced in chronic heart failure (CHF) rats. The aim of this study is to determine the effect of IMD in the PVN on CSAR and its related mechanisms in CHF rats. Methodology/ Principal Findings: Rats were subjected to left descending coronary artery ligation to induce CHF or shamoperation (Sham). Renal sympathetic nerve activity (RSNA), mean arterial pressure (MAP) and heart rate (HR) were recorded. CSAR was evaluated by the RSNA and MAP responses to epicardial application of capsaicin. Acute experiments were carried out 8 weeks after coronary ligation or sham surgery under anesthesia. IMD and angiotensin II (Ang II) levels in the PVN were up-regulated in CHF rats. Bilateral PVN microinjection of IMD caused greater decreases in CSAR and the baseline RSNA and MAP in CHF rats than those in Sham rats. The decrease of CSAR caused by IMD was prevented by pretreatment with AM receptor antagonist AM22-52, but not CGRP receptor antagonist CGRP8-37. Ang II in the PVN significantly enhanced CSAR and superoxide anions level, which was inhibited by PVN pretreatment with IMD or tempol (a superoxide anions scavenger) in Sham and CHF rats. Conclusion: IMD in the PVN inhibits CSAR via AM receptor, and attenuates the effects of Ang II on CSAR and superoxide anions level in CHF rats. PVN superoxide anions involve in the effect of IMD on attenuating Ang II-induced CSAR response.	[Gan, Xian-Bing; Sun, Hai-Jian; Zhang, Ling-Li; Zhou, Ye-Bo] Nanjing Med Univ, Dept Physiol, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China; [Gan, Xian-Bing; Chen, Dan] Anhui Univ Chinese Med, Dept Physiol, Hefei, Peoples R China; [Zhou, Hong] Nanjing Med Univ, Lab Ctr Basic Med Sci, Dept Med Physiol & Biochem, Nanjing, Jiangsu, Peoples R China; [Chen, Li-Yan] Harbin Med Univ, Affiliated Hosp 2, Dept Haematol, Harbin, Peoples R China	Nanjing Medical University; Anhui University of Chinese Medicine; Nanjing Medical University; Harbin Medical University	Zhou, YB (corresponding author), Nanjing Med Univ, Dept Physiol, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China.	zhouyebo666@njmu.edu.cn		Zhou, Yebo/0000-0001-9465-1338	National Natural Science Foundation of China [81000106]; Jiangsu Higher Education Institutions of China [10KJB310004]; Nanjing Medical University of China [09JC013, JX 10131801056, 09NJMUZ04]; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Higher Education Institutions of China; Nanjing Medical University of China; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine	This work was supported by the funds from the National Natural Science Foundation of China (grant no. 81000106), the Jiangsu Higher Education Institutions of China (grant no. 10KJB310004), the Nanjing Medical University of China (grant no. 09JC013, JX 10131801056 and 09NJMUZ04), and the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2004, CURR HYPERTENS REP, V6, P55, DOI 10.1007/s11906-004-0012-x; Badoer E, 2010, AM J PHYSIOL-RENAL, V298, pF839, DOI 10.1152/ajprenal.00734.2009; Bell D, 2008, CELL PHYSIOL BIOCHEM, V21, P409, DOI 10.1159/000129633; Bell D, 2012, J PHYSIOL-LONDON, V590, P1181, DOI 10.1113/jphysiol.2011.221895; Chen AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040748; Chen HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064757; Chen L, 2006, BRAIN RES, V1086, P42, DOI 10.1016/j.brainres.2006.02.128; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Coote JH, 2005, EXP PHYSIOL, V90, P169, DOI 10.1113/expphysiol.2004.029041; Cui H, 2008, AUTON NEUROSCI-BASIC, V142, P45, DOI 10.1016/j.autneu.2008.07.009; Du YH, 2007, J APPL PHYSIOL, V102, P9, DOI 10.1152/japplphysiol.01032.2006; Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061; Fujisawa Y, 2006, AM J PHYSIOL-HEART C, V290, pH1120, DOI 10.1152/ajpheart.00461.2005; Gan XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025784; Gao J, 2012, PFLUG ARCH EUR J PHY, V463, P297, DOI 10.1007/s00424-011-1036-0; Gao L, 2004, CIRC RES, V95, P937, DOI 10.1161/01.RES.0000146676.04359.64; Grassi G, 2009, CURR VASC PHARMACOL, V7, P137, DOI 10.2174/157016109787455699; Hagiwara M, 2008, AM J PHYSIOL-RENAL, V295, pF1735, DOI 10.1152/ajprenal.90427.2008; Han Y, 2007, EUR J HEART FAIL, V9, P967, DOI 10.1016/j.ejheart.2007.07.004; Hashimoto H, 2008, AUTON NEUROSCI-BASIC, V139, P46, DOI 10.1016/j.autneu.2008.01.003; Kang YM, 2011, BASIC RES CARDIOL, V106, P1087, DOI 10.1007/s00395-011-0215-7; Li DP, 2007, HYPERTENSION, V49, P916, DOI 10.1161/01.HYP.0000259666.99449.74; Li H, 2013, CARDIOVASC DIABETOL, V12, DOI [10.1186/1475-2840-12-133, 10.1186/1475-2840-12-91]; Li P, 2013, PEPTIDES, V47, P1, DOI 10.1016/j.peptides.2013.05.002; Liu K, 2013, CLIN LAB, V59, P589, DOI 10.7754/Clin.Lab.2012.120708; Malliani A, 2002, HYPERTENSION, V39, P63, DOI 10.1161/hy0102.099200; Oliver KR, 2001, EUR J NEUROSCI, V14, P618, DOI 10.1046/j.0953-816x.2001.01688.x; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Pearson LJ, 2009, CELL PHYSIOL BIOCHEM, V23, P97, DOI 10.1159/000204098; Qiao X, 2013, AM J PHYSIOL-RENAL, V304, pF112, DOI 10.1152/ajprenal.00054.2012; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; Sharma NM, 2011, CARDIOVASC RES, V92, P348, DOI 10.1093/cvr/cvr217; SWEDBERG K, 1990, CIRCULATION, V82, P1730, DOI 10.1161/01.CIR.82.5.1730; Takahashi K, 2006, PEPTIDES, V27, P1383, DOI 10.1016/j.peptides.2005.11.004; Takahashi K, 2011, J MOL NEUROSCI, V43, P182, DOI 10.1007/s12031-010-9413-2; Taylor MM, 2005, AM J PHYSIOL-REG I, V288, pR919, DOI 10.1152/ajpregu.00744.2004; Wang HJ, 2005, AUTON NEUROSCI-BASIC, V121, P56, DOI 10.1016/j.autneu.2005.07.003; Wang W, 2000, Heart Fail Rev, V5, P57; Yang JH, 2009, REGUL PEPTIDES, V158, P19, DOI 10.1016/j.regpep.2009.05.012; Yuan Y, 2012, J GERIATR CARDIOL, V9, P17, DOI 10.3724/SP.J.1263.2012.00017; Zhang SJ, 2012, J BIOMED RES, V26, P425, DOI 10.7555/JBR.26.20120035; Zhang Y, 2006, BRAIN RES, V1082, P132, DOI 10.1016/j.brainres.2006.01.113; Zhao L, 2012, PEPTIDES, V33, P329, DOI 10.1016/j.peptides.2011.12.016; Zhong MK, 2008, EXP PHYSIOL, V93, P746, DOI 10.1113/expphysiol.2007.041632; Zhou YB, 2014, HYPERTENSION, V63, P330, DOI 10.1161/HYPERTENSIONAHA.113.01681; Zhu GQ, 2004, J APPL PHYSIOL, V97, P1746, DOI 10.1152/japplphysiol.00573.2004; Zhu GQ, 2004, AM J PHYSIOL-HEART C, V287, pH1828, DOI 10.1152/ajpheart.01245.2003	47	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94234	10.1371/journal.pone.0094234	http://dx.doi.org/10.1371/journal.pone.0094234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709972	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800123
J	Moll, X; Garcia, F; Ferrer, RI; Santos, L; Aguilar, A; Andaluz, A				Moll, Xavier; Garcia, Felix; Isabel Ferrer, Rosa; Santos, Laura; Aguilar, Adria; Andaluz, Anna			Distribution of Methylene Blue after Injection into the Epidural Space of Anaesthetized Pregnant and Non-Pregnant Sheep	PLOS ONE			English	Article							VENOUS PLEXUS; ANESTHESIA; ANALGESIA; SPREAD; MIGRATION; BUPIVACAINE; COMPRESSION	The aim of the study was to determine the distribution of different volumes of methylene blue solution injected into the epidural space in anaesthetized pregnant and non-pregnant sheep, to evaluate its cranial distribution and to compare between them. Fifteen pregnant and fifteen non-pregnant sheep were included in the study. Sheep were anaesthetized and received 0.05, 0.1, or 0.2 mL/kg of a lumbosacral epidural solution containing 0.12% methylene blue in 0.9% saline. Thirty minutes after the epidural injection, the ewes were euthanized. The extension of the dye within the epidural space was measured, and the correlation between the volume of the dye injected and the number of stained vertebrae was evaluated. The cranial migration of the dye between pregnant and non-pregnant sheep was also compared. The results show that the volume of methylene blue injected epidurally into pregnant and non-pregnant sheep correlated directly with its cephalic distribution into the epidural space; and a volume of 0.1 mL/kg or 0.2 mL/kg stained up to the first lumbar segment in pregnant and non-pregnant sheep, respectively. Also, the results suggest that the volume of drugs administered into the epidural space of pregnant sheep should be half the volume that would be used in non-pregnant sheep.	[Moll, Xavier; Garcia, Felix; Isabel Ferrer, Rosa; Santos, Laura; Aguilar, Adria; Andaluz, Anna] Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, Bellaterra, Spain	Autonomous University of Barcelona	Moll, X (corresponding author), Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, Bellaterra, Spain.	xavier.moll@uab.cat	Moll, Xavier/H-3203-2018	Moll, Xavier/0000-0002-2992-9361; Andaluz, Anna/0000-0001-8097-8110				BARCLAY DL, 1968, AM J OBSTET GYNECOL, V101, P792, DOI 10.1016/0002-9378(68)90035-5; Batson OV, 1940, ANN SURG, V112, P138, DOI 10.1097/00000658-194007000-00016; Brenner L, 2011, BRIT J ANAESTH, V107, P229, DOI 10.1093/bja/aer128; Campagnol D, 2012, VET J, V192, P311, DOI 10.1016/j.tvjl.2011.08.019; DeRossi R, 2012, RES VET SCI, V92, P278, DOI 10.1016/j.rvsc.2010.11.006; Edmondson MA., 2012, SHEEP GOAT MED, P150, DOI [DOI 10.1016/B978-1-4377-2353-10008-3, 10.1016/B978-1-4377-2353-3.10008-3, DOI 10.1016/B978-1-4377-2353-3.10008-3]; Freire CD, 2010, VET ANAESTH ANALG, V37, P63, DOI 10.1111/j.1467-2995.2009.00493.x; Gorgi AA, 2006, AM J VET RES, V67, P219, DOI 10.2460/ajvr.67.2.219; Grau T, 2001, BRIT J ANAESTH, V86, P798, DOI 10.1093/bja/86.6.798; Hall L., 2001, VET ANAESTHESIA, P225; Hall L.W., 2001, VET ANAESTHESIA, V10, P341; Higuchi H, 2011, ANESTHESIOLOGY, V114, P1155, DOI 10.1097/ALN.0b013e31820a4c29; Hirabayashi Y, 1997, BRIT J ANAESTH, V78, P317, DOI 10.1093/bja/78.3.317; Igarashi T, 2000, ANESTHESIOLOGY, V92, P1631, DOI 10.1097/00000542-200006000-00021; Lansdowne JL, 2005, AM J VET RES, V66, P1324, DOI 10.2460/ajvr.2005.66.1324; Lee I, 2004, VET ANAESTH ANALG, V31, P190, DOI 10.1111/j.1467-2987.2004.00149.x; Lee I, 2004, VET ANAESTH ANALG, V31, P86, DOI 10.1111/j.1467-2987.2004.00150.x; Lee Inhyung, 2001, Vet Anaesth Analg, V28, P140, DOI 10.1046/j.1467-2987.2001.00042.x; Lopez MJ, 1997, AM J VET RES, V58, P786; MELLOR DJ, 1981, RES VET SCI, V30, P198, DOI 10.1016/S0034-5288(18)32581-5; Moll X, 2011, VET REC, V168, DOI 10.1136/vr.d164; Onuki E, 2010, ANESTH ANALG, V110, P148, DOI 10.1213/ANE.0b013e3181c04faf; Raffe MR, 2007, LUMB JONES VET ANEST; Scott PR, 1997, VET J, V154, P63, DOI 10.1016/S1090-0233(05)80009-7; SCOTT PR, 1994, THERIOGENOLOGY, V42, P891, DOI 10.1016/0093-691X(94)90457-T; Skarda RT, 1996, VET CLIN N AM-FOOD A, V12, P579, DOI 10.1016/S0749-0720(15)30390-X; Son WG, 2011, VET ANAESTH ANALG, V38, P510, DOI 10.1111/j.1467-2995.2011.00643.x; Takiguchi T, 2006, ANESTHESIOLOGY, V105, P848, DOI 10.1097/00000542-200610000-00033; Tranquilli WJ, 2007, LUMB JONESVETERINARY, V4th, P561; TRIM CM, 1989, J AM VET MED ASSOC, V194, P1292; Tusell JM, 2005, VET J, V169, P108, DOI 10.1016/j.tvjl.2004.01.030; VALVERDE A, 1989, CAN J ANAESTH, V36, P629, DOI 10.1007/BF03005412; Valverde A, 2008, VET CLIN N AM-SMALL, V38, P1205, DOI 10.1016/j.cvsm.2008.06.004; VERNON RG, 1981, BIOCHEM J, V200, P307, DOI 10.1042/bj2000307	34	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e92860	10.1371/journal.pone.0092860	http://dx.doi.org/10.1371/journal.pone.0092860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709655	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800019
J	Zebis, MK; Andersen, CH; Sundstrup, E; Pedersen, MT; Sjogaard, G; Andersen, LL				Zebis, Mette K.; Andersen, Christoffer H.; Sundstrup, Emil; Pedersen, Mogens T.; Sjogaard, Gisela; Andersen, Lars L.			Time-Wise Change in Neck Pain in Response to Rehabilitation with Specific Resistance Training: Implications for Exercise Prescription	PLOS ONE			English	Article							PHYSICAL-EXERCISE; INDUSTRIAL-WORKERS; UPPER EXTREMITY; FORCE CAPACITY; SHOULDER PAIN; SYMPTOMS; PROGRAMS; WOMEN; TRIAL; INTERVENTION	Purpose: To determine the time-wise effect of specific resistance training on neck pain among industrial technicians with frequent neck pain symptoms. Methods: Secondary analysis of a parallel-group cluster randomized controlled trial of 20 weeks performed at two large industrial production units in Copenhagen, Denmark. Women with neck pain > 30 mm VAS (N = 131) were included in the present analysis. The training group ( N = 77) performed specific resistance training for the neck/shoulder muscles three times a week, and the control group ( N = 54) received advice to stay active. Participants of both groups registered neck pain intensity (0-100 mm VAS) once a week. Results: Neck pain intensity was 55 mm (SD 23) at baseline. There was a significant group by time interaction for neck pain (F-value 2.61,P < 0.001, DF = 19). Between-group differences in neck pain reached significance after 4 weeks (11 mm, 95% Cl 2 to 20). The time-wise change in pain showed three phases; a rapid decrease in the training group compared with the control group during the initial 7 weeks, a slower decrease in pain during the following weeks (week 8-15), and a plateau during the last weeks (week 16-20). Adherence to training followed a two-phase pattern, i.e. weekly participation rate was between 70-86% during the initial 7 weeks, dropping towards 55-63% during the latter half of the training period. Conclusion: Four weeks of specific resistance training reduced neck pain significantly, but 15 weeks is required to achieve maximal pain reduction. The time-wise change in pain followed a three-phase pattern with a rapid effect during the initial 7 weeks followed by a slower but still positive effect, and finally a plateau from week 15 and onwards. Decreased participation rate may explain the decreased efficacy during the latter phase of the intervention.	[Zebis, Mette K.] Copenhagen Univ Hosp, Arthroscop Ctr Amager, Copenhagen S, Denmark; [Zebis, Mette K.] Copenhagen Univ Hosp, Gait Anal Lab, Hvidovre, Denmark; [Andersen, Christoffer H.; Sundstrup, Emil; Andersen, Lars L.] Natl Res Ctr Working Environm, Copenhagen O, Denmark; [Pedersen, Mogens T.] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen N, Denmark; [Sundstrup, Emil; Sjogaard, Gisela] Univ Southern Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark	University of Copenhagen; University of Copenhagen; National Research Centre for the Working Environment; University of Copenhagen; University of Southern Denmark	Zebis, MK (corresponding author), Copenhagen Univ Hosp, Arthroscop Ctr Amager, Copenhagen S, Denmark.	mettezebis@hotmail.com	Andersen, Lars Louis/AAQ-4802-2020; Pedersen, Mogens Theisen/C-6991-2015	Pedersen, Mogens Theisen/0000-0002-3178-6320; Sjogaard, Gisela/0000-0002-2961-7800; Sundstrup, Emil/0000-0001-7408-222X; Andersen, Lars L./0000-0003-2777-8085; Hojnicke Andersen, Christoffer/0000-0001-9568-4043	Danish Working Environment Research Fund [8-2007-3]	Danish Working Environment Research Fund	This study was financially supported by funding from the Danish Working Environment Research Fund (Grant 8-2007-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren C, 2001, J REHABIL MED, V33, P162, DOI 10.1080/165019701750300627; Andersen LL, 2008, J BIOMECH, V41, P2029, DOI 10.1016/j.jbiomech.2008.03.016; Andersen LL, 2008, MED SCI SPORT EXER, V40, P983, DOI 10.1249/MSS.0b013e3181676640; Andersen LL, 2008, ARTHRIT RHEUM-ARTHR, V59, P84, DOI 10.1002/art.23256; Andersen LL, 2012, INT ARCH OCC ENV HEA, V85, P615, DOI 10.1007/s00420-011-0709-5; Andersen LL, 2011, PAIN, V152, P440, DOI 10.1016/j.pain.2010.11.016; Andersen LL, 2009, J APPL PHYSIOL, V107, P1413, DOI 10.1152/japplphysiol.00555.2009; Andersen LL, 2008, CLIN BIOMECH, V23, P1237, DOI 10.1016/j.clinbiomech.2008.08.002; Andersen LL, 2008, J APPL PHYSIOL, V105, P1796, DOI 10.1152/japplphysiol.91057.2008; Andersen LL, 2011, OCCUP ENVIRON MED, V68, P590, DOI 10.1136/oem.2010.056259; Blangsted AK, 2008, SCAND J WORK ENV HEA, V34, P55, DOI 10.5271/sjweh.1192; Bot SDM, 2005, ANN RHEUM DIS, V64, P118, DOI 10.1136/ard.2003.019349; Dworkin RH, 2009, PAIN, V146, P238, DOI 10.1016/j.pain.2009.08.019; GRONNINGSAETER H, 1992, PSYCHOL HEALTH, V7, P147, DOI 10.1080/08870449208520016; Hagberg M, 2000, ARCH PHYS MED REHAB, V81, P1051, DOI 10.1053/apmr.2000.7582; Kamaleri Y, 2009, EUR J PAIN, V13, P426, DOI 10.1016/j.ejpain.2008.05.009; Kovacs FM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-43; Kraemer WJ, 2004, MED SCI SPORT EXER, V36, P674, DOI 10.1249/01.MSS.0000121945.36635.61; Kraemer WJ, 2002, MED SCI SPORT EXER, V34, P364, DOI 10.1097/00005768-200202000-00027; Larsson B, 2007, BEST PRACT RES CL RH, V21, P447, DOI 10.1016/j.berh.2007.02.015; Morken T, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-21; Pedersen MT, 2013, J STRENGTH COND RES, V27, P229, DOI 10.1519/JSC.0b013e3182541ceb; Rhea MR, 2002, J STRENGTH COND RES, V16, P250, DOI 10.1519/00124278-200205000-00013; Sjogren T, 2005, PAIN, V116, P119, DOI 10.1016/j.pain.2005.03.031; TAKALA EP, 1992, SCAND J WORK ENV HEA, V18, P257, DOI 10.5271/sjweh.1580; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; van Dongen JM, 2012, SCAND J WORK ENV HLT; Viljanen M, 2003, BRIT MED J, V327, P475, DOI 10.1136/bmj.327.7413.475; Ylinen J, 2007, Eura Medicophys, V43, P119; Ylinen J, 2003, JAMA-J AM MED ASSOC, V289, P2509, DOI 10.1001/jama.289.19.2509; Zebis MK, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-205	31	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93867	10.1371/journal.pone.0093867	http://dx.doi.org/10.1371/journal.pone.0093867			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709874	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800061
J	Bustos, FJ; Varela-Nallar, L; Campos, M; Henriquez, B; Phillips, M; Opazo, C; Aguayo, LG; Montecino, M; Constantine-Paton, M; Inestrosa, NC; van Zundert, B				Bustos, Fernando J.; Varela-Nallar, Lorena; Campos, Matias; Henriquez, Berta; Phillips, Marnie; Opazo, Carlos; Aguayo, Luis G.; Montecino, Martin; Constantine-Paton, Martha; Inestrosa, Nibaldo C.; van Zundert, Brigitte			PSD95 Suppresses Dendritic Arbor Development in Mature Hippocampal Neurons by Occluding the Clustering of NR2B-NMDA Receptors	PLOS ONE			English	Article							LONG-TERM POTENTIATION; MAGUK SCAFFOLDING PROTEINS; NMDA RECEPTOR; POSTSYNAPTIC DENSITY; SUBUNIT COMPOSITION; SYNAPSE STABILIZATION; DIFFERENTIAL ROLES; VISUAL-CORTEX; PSD-95; PLASTICITY	Considerable evidence indicates that the NMDA receptor (NMDAR) subunits NR2A and NR2B are critical mediators of synaptic plasticity and dendritogenesis; however, how they differentially regulate these processes is unclear. Here we investigate the roles of the NR2A and NR2B subunits, and of their scaffolding proteins PSD-95 and SAP102, in remodeling the dendritic architecture of developing hippocampal neurons (2-25 DIV). Analysis of the dendritic architecture and the temporal and spatial expression patterns of the NMDARs and anchoring proteins in immature cultures revealed a strong positive correlation between synaptic expression of the NR2B subunit and dendritogenesis. With maturation, the pruning of dendritic branches was paralleled by a strong reduction in overall and synaptic expression of NR2B, and a significant elevation in synaptic expression of NR2A and PSD95. Using constructs that alter the synaptic composition, we found that either over-expression of NR2B or knock-down of PSD95 by shRNA-PSD95 augmented dendritogenesis in immature neurons. Reactivation of dendritogenesis could also be achieved in mature cultured neurons, but required both manipulations simultaneously, and was accompanied by increased dendritic clustering of NR2B. Our results indicate that the developmental increase in synaptic expression of PSD95 obstructs the synaptic clustering of NR2B-NMDARs, and thereby restricts reactivation of dendritic branching. Experiments with shRNA-PSD95 and chimeric NR2A/NR2B constructs further revealed that C-terminus of the NR2B subunit (tail) was sufficient to induce robust dendritic branching in mature hippocampal neurons, and suggest that the NR2B tail is important in recruiting calcium-dependent signaling proteins and scaffolding proteins necessary for dendritogenesis.	[Bustos, Fernando J.; Varela-Nallar, Lorena; Campos, Matias; Henriquez, Berta; Montecino, Martin; van Zundert, Brigitte] Univ Andres Bello, Fac Biol Sci, Ctr Biomed Res, Santiago, Chile; [Bustos, Fernando J.; Varela-Nallar, Lorena; Campos, Matias; Henriquez, Berta; Montecino, Martin; van Zundert, Brigitte] Univ Andres Bello, Fac Med, Santiago, Chile; [Bustos, Fernando J.; Opazo, Carlos; Aguayo, Luis G.] Univ Concepcion, Fac Biol Sci, Concepcion, Chile; [Varela-Nallar, Lorena; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Mol & Cellular Biol, Santiago, Chile; [Phillips, Marnie; Constantine-Paton, Martha] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Bustos, Fernando J.; Montecino, Martin] FONDAP Ctr Genome Regulat, Santiago, Chile	Universidad Andres Bello; Universidad Andres Bello; Universidad de Concepcion; Pontificia Universidad Catolica de Chile; Massachusetts Institute of Technology (MIT)	van Zundert, B (corresponding author), Univ Andres Bello, Fac Biol Sci, Ctr Biomed Res, Santiago, Chile.	bvanzundert@unab.cl	Varela-Nallar, Lorena/AAV-3304-2021	Opazo, Carlos/0000-0003-3473-7548; Bustos, Fernando/0000-0002-0487-7032; Varela-Nallar, Lorena/0000-0003-2588-6437	Conicyt [24110099, PFB12/2007]; Fondecyt [11110012, 1100502, 1120156, 1101012]; FONDAP [15090007]; National Institutes of Health Grant [EY014074]; Anillo [ACT1114];  [3110138]; NATIONAL EYE INSTITUTE [R01EY014074] Funding Source: NIH RePORTER	Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDAP; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anillo(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Conicyt 24110099 (FJB), Fondecyt 11110012 (LVN), 3110138 (BH), Fondecyt 1100502 (LGA), FONDAP 15090007 (MM), National Institutes of Health Grant EY014074 (to MCP), Fondecyt 1120156 and CONICYT PFB12/2007 (NCI) and Fondecyt 1101012 and Anillo ACT1114 (BvZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Charych EI, 2006, J NEUROSCI, V26, P10164, DOI 10.1523/JNEUROSCI.2379-06.2006; Chen BS, 2011, J NEUROSCI, V31, P89, DOI 10.1523/JNEUROSCI.1034-10.2011; Chen XB, 2008, P NATL ACAD SCI USA, V105, P4453, DOI 10.1073/pnas.0800897105; Chen XB, 2011, J NEUROSCI, V31, P6329, DOI 10.1523/JNEUROSCI.5968-10.2011; Cline H, 2008, J PHYSIOL-LONDON, V586, P1509, DOI 10.1113/jphysiol.2007.150029; Cousins SL, 2012, J BIOL CHEM, V287, P13465, DOI 10.1074/jbc.M111.292862; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Elias GM, 2008, P NATL ACAD SCI USA, V105, P20953, DOI 10.1073/pnas.0811025106; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Espinosa JS, 2009, NEURON, V62, P205, DOI 10.1016/j.neuron.2009.03.006; Fallini C, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-17; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gambrill AC, 2011, P NATL ACAD SCI USA, V108, P5855, DOI 10.1073/pnas.1012676108; Henriquez B, 2013, MOL CELL NEUROSCI, V57, P130, DOI 10.1016/j.mcn.2013.07.012; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lim IA, 2003, NEUROPHARMACOLOGY, V45, P738, DOI 10.1016/S0028-3908(03)00276-4; Luo JH, 2002, NEUROPHARMACOLOGY, V42, P306, DOI 10.1016/S0028-3908(01)00188-5; Murata Y, 2013, J NEUROSCI, V33, P5040, DOI 10.1523/JNEUROSCI.2896-12.2013; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; de Arce KP, 2010, J NEUROSCI, V30, P3728, DOI 10.1523/JNEUROSCI.2024-09.2010; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sepulveda FJ, 2010, J NEUROPHYSIOL, V103, P1758, DOI 10.1152/jn.00823.2009; Stein V, 2003, J NEUROSCI, V23, P5503; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Sweet ES, 2011, J NEUROSCI, V31, P1038, DOI 10.1523/JNEUROSCI.1205-10.2011; Tovar KR, 1999, J NEUROSCI, V19, P4180; Townsend M, 2003, P NATL ACAD SCI USA, V100, P1340, DOI 10.1073/pnas.0335786100; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; Varela-Nallar L, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-41; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903; Zhao JP, 2013, P NATL ACAD SCI USA, V110, P707, DOI 10.1073/pnas.1215854110; Zheng CY, 2010, J NEUROSCI, V30, P4757, DOI 10.1523/JNEUROSCI.6108-09.2010	51	47	53	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94037	10.1371/journal.pone.0094037	http://dx.doi.org/10.1371/journal.pone.0094037			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705401	Green Published, gold			2022-12-27	WOS:000334107500113
J	Huang, ZQ; Tan, N; Guo, WJ; Wang, LL; Li, HG; Zhang, TY; Liu, XJ; Xu, Q; Li, JS; Guo, ZM				Huang, Zhiquan; Tan, Ning; Guo, Weijie; Wang, Lili; Li, Haigang; Zhang, Tianyu; Liu, Xiaojia; Xu, Qin; Li, Jinsong; Guo, Zhongmin			Overexpression of EMMPRIN Isoform 2 Is Associated with Head and Neck Cancer Metastasis	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE INDUCER; PLASMINOGEN-ACTIVATOR SYSTEM; SQUAMOUS-CELL CARCINOMA; CATHEPSIN-B; IN-VITRO; BASIGIN; CD147; EXPRESSION; INVASION; MARKER	Extracellular matrix metalloproteinase inducer (EMMPRIN), a plasma membrane protein of the immunoglobulin (Ig) superfamily, has been reported to promote cancer cell invasion and metastasis in several human malignancies. However, the roles of the different EMMPRIN isoforms and their associated mechanisms in head and neck cancer progression remain unknown. Using quantitative real-time PCR, we found that EMMPRIN isoform 2 (EMMPRIN-2) was the only isoform that was overexpressed in both head and neck cancer tissues and cell lines and that it was associated with head and neck cancer metastasis. To determine the effects of EMMPRIN-2 on head and neck cancer progression, we transfected head and neck cancer cells with an EMMPRIN-2 expression vector and EMMPRIN-2 siRNA to exogenously modulate EMMPRIN-2 expression and examined the functional importance of EMMPRIN-2 in head and neck cancer invasion and metastasis. We found that EMMPRIN-2 promoted head and neck cancer cell invasion, migration, and adhesion in vitro and increased lung metastasis in vivo. Mechanistic studies revealed that EMMPRIN-2 overexpression promoted the secretion of extracellular signaling molecules, including matrix metalloproteinases-2(MMP-2), urokinase-type plasminogen activator(uPA) and Cathepsin B, in head and neck cancer cells. While MMP-2 and uPA have been demonstrated to be important mediators of EMMPRIN signaling, the role of Cathepsin B in EMMPRIN-mediated molecular cascades and tumorigenesis has not been established. We found that EMMPRIN-2 overexpression and Cathepsin B down-regulation significantly inhibited the invasion, migration and adhesion of Tca8133 cells, suggesting that Cathepsin B is required for EMMPRIN-2 enhanced cell migration and invasion in head and neck cancer. The results of our study demonstrate the important role of EMMPRIN-2 in head and neck cancer progression for the first time and reveal that increased extracellular secretion of Cathepsin B may be a novel mechanism underlying EMMPRIN-2 enhanced tumor progression in head and neck cancer.	[Huang, Zhiquan; Li, Jinsong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Oral & Maxillofacial Surg, Guangzhou 510275, Guangdong, Peoples R China; [Tan, Ning; Xu, Qin] Guilin Med Coll, Guangxi Key Lab Mol Med Liver Injury & Repair, Guilin, Guangxi, Peoples R China; [Guo, Weijie] Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Guo, Weijie] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China; [Wang, Lili; Li, Haigang] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Tianyu] Guilin Med Coll, Dept Urinary Surg, Affiliated Hosp, Guilin, Guangxi, Peoples R China; [Liu, Xiaojia] Guilin Med Coll, Dept Pathol, Affiliated Hosp, Guilin, Guangxi, Peoples R China; [Guo, Zhongmin] Indiana Univ Sch Med, Med Sci Program, Bloomington, IN USA	Sun Yat Sen University; Guilin Medical University; Fudan University; Shanghai Jiao Tong University; Sun Yat Sen University; Guilin Medical University; Guilin Medical University; Indiana University System; Indiana University Bloomington	Li, JS (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Oral & Maxillofacial Surg, Guangzhou 510275, Guangdong, Peoples R China.	lijinsong1967@163.com; zguo@gopathlabs.com		Guo, Weijie/0000-0001-7167-9899	National Natural Science Foundation of China [81101592, 81272951]; Guangdong Province Natural Science Foundation [S2013010014794]; Flight Attendant Medical Research Institute [062545]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Flight Attendant Medical Research Institute	This work was supported by grants from the National Natural Science Foundation of China (#81101592, to Z. Huang) and Guangdong Province Natural Science Foundation (#S2013010014794, to Z. Huang), and by the awards from the Flight Attendant Medical Research Institute (#062545, to Z. Guo) and by grants from the National Natural Science Foundation of China (#81272951, to J.Li). The funders had no role in study design, data collection and analysis, decision topublish, or preparation of the manuscript.	Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Beckham TH, 2012, INT J CANCER, V131, P2034, DOI 10.1002/ijc.27480; Belton RJ, 2008, J BIOL CHEM, V283, P17805, DOI 10.1074/jbc.M801876200; Berditchevski F, 1997, J BIOL CHEM, V272, P29174, DOI 10.1074/jbc.272.46.29174; Bougatef F, 2009, BLOOD, V114, P5547, DOI 10.1182/blood-2009-04-217380; Chen BS, 2012, MOL CANCER RES, V10, P305, DOI 10.1158/1541-7786.MCR-11-0300; Colevas AD, 2006, J CLIN ONCOL, V24, P2644, DOI 10.1200/JCO.2005.05.3348; Coste I, 2001, BLOOD, V97, P3984, DOI 10.1182/blood.V97.12.3984; Dang DM, 2008, ANTICANCER RES, V28, P2049; Davidson B, 2003, CLIN EXP METASTAS, V20, P161, DOI 10.1023/A:1022696012668; Denaro N, 2012, ONCOLOGY-BASEL, V83, P108, DOI 10.1159/000339542; Galanski M, 2006, RECENT PAT ANTI-CANC, V1, P285, DOI 10.2174/157489206777442287; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hanna S Melanie, 2003, BMC Biochem, V4, P17, DOI 10.1186/1471-2091-4-17; Herszenyi L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-194; Huang ZQ, 2010, J CRANIOFAC SURG, V21, P1855, DOI 10.1097/SCS.0b013e3181f43f7e; Huang ZQ, 2009, J ORAL PATHOL MED, V38, P518, DOI 10.1111/j.1600-0714.2009.00775.x; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Igakura T, 1996, BIOCHEM BIOPH RES CO, V224, P33, DOI 10.1006/bbrc.1996.0980; Kikkawa Y, 2007, J BIOL CHEM, V282, P14853, DOI 10.1074/jbc.M611706200; Kuno N, 1998, FEBS LETT, V425, P191, DOI 10.1016/S0014-5793(98)00213-0; Lescaille G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-115; Liao CG, 2011, MOL CELL BIOL, V31, P2591, DOI 10.1128/MCB.05160-11; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Matarrese P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-207; Nabeshima K, 2006, PATHOL INT, V56, P359, DOI 10.1111/j.1440-1827.2006.01972.x; Nouh MA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-1; Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1305, DOI 10.1167/iovs.02-0552; Quemener C, 2007, CANCER RES, V67, P9, DOI 10.1158/0008-5472.CAN-06-2448; Rafn B, 2012, MOL CELL, V45, P764, DOI 10.1016/j.molcel.2012.01.029; Schlegel J, 2009, J MOL BIOL, V391, P518, DOI 10.1016/j.jmb.2009.05.080; Shang ZJ, 2006, INT J ORAL MAX SURG, V35, P539, DOI 10.1016/j.ijom.2006.01.004; Sier CFM, 2006, INT J CANCER, V118, P2991, DOI 10.1002/ijc.21778; Sumida T, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-141; Suzuki S, 2004, EXP CELL RES, V293, P259, DOI 10.1016/j.yexcr.2003.10.010; Tang Y, 2005, CANCER RES, V65, P3193, DOI 10.1158/0008-5472.CAN-04-3605; Toole BP, 2003, CURR TOP DEV BIOL, V54, P371, DOI 10.1016/S0070-2153(03)54015-7; Tsai WC, 2007, APMIS, V115, P929, DOI 10.1111/j.1600-0463.2007.apm_858.x; Vermorken JB, 2010, ANN ONCOL, V21, P252, DOI 10.1093/annonc/mdq453; Victor BC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3058; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Yu ZW, 2010, ORAL ONCOL, V46, P317, DOI 10.1016/j.oraloncology.2010.02.002; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Zucker S, 2001, AM J PATHOL, V158, P1921, DOI 10.1016/S0002-9440(10)64660-3	47	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e91596	10.1371/journal.pone.0091596	http://dx.doi.org/10.1371/journal.pone.0091596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705283	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500006
J	Kwee, RM; Dik, AK; Sosef, MN; Berendsen, RCM; Sassen, S; Lammering, G; Clarijs, R; Oostenbrug, LE; Blom, RLGM; Vliegen, RFA				Kwee, Robert M.; Dik, Alexander K.; Sosef, Meindert N.; Berendsen, Ralph C. M.; Sassen, Sander; Lammering, Guido; Clarijs, Ruud; Oostenbrug, Liekele E.; Blom, Rachel L. G. M.; Vliegen, Roy F. A.			Interobserver Reproducibility of Diffusion-Weighted MRI in Monitoring Tumor Response to Neoadjuvant Therapy in Esophageal Cancer	PLOS ONE			English	Article							PREOPERATIVE CHEMORADIOTHERAPY; SURVIVAL; CHEMOTHERAPY; CARCINOMA; VALUES	Objective: To investigate the reproducibility of diffusion-weighted magnetic resonance imaging (DW-MRI) in assessing tumor response early in the course of neoadjuvant chemoradiotherapy in patients with operable esophageal cancer. Methods: Eleven male patients (mean age 54.8 years) with newly diagnosed esophageal cancer underwent DW-MRI before and 10 days after start of chemoradiotherapy. Reproducibility of apparent diffusion coefficient (ADC) measurements by manual (freehand) and semi-automated volumetric methods was assessed. Results: Interobserver reproducibility for the assessment of mean tumor ADC by the manual measurement method was good, with an ICC of 0.69 (95% CI, 0.36 to 0.85; P = 0.001). Interobserver reproducibility for the assessment of mean tumor ADC by the semi-automated volumetric measurement method was very good, with an ICC of 0.96 (95% CI, 0.91 to 0.98; P, 0.001). Conclusion: Semi-automated volumetric ADC measurements have higher reproducibility than manual ADC measurements in assessing tumor response to chemoradiotherapy in patients with esophageal adenocarcinoma.	[Kwee, Robert M.; Dik, Alexander K.; Sassen, Sander; Vliegen, Roy F. A.] Atrium Med Ctr Parkstad, Dept Radiol, Heerlen, Netherlands; [Kwee, Robert M.] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [Sosef, Meindert N.] Atrium Med Ctr Parkstad, Dept Surg, Heerlen, Netherlands; [Sosef, Meindert N.] Surg Collaborat Network Limburg, Limburg, Netherlands; [Berendsen, Ralph C. M.] Atrium Med Ctr Parkstad, Dept Med Phys, Heerlen, Netherlands; [Lammering, Guido] MediClin Robert Janker Clin, Dept Radiat Oncol, Bonn, Germany; [Clarijs, Ruud] Atrium Med Ctr Parkstad, Dept Pathol, Heerlen, Netherlands; [Oostenbrug, Liekele E.] Atrium Med Ctr Parkstad, Dept Internal Med & Gastroenterol, Heerlen, Netherlands; [Blom, Rachel L. G. M.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands	Atrium Medical Center; Maastricht University; Atrium Medical Center; Atrium Medical Center; Atrium Medical Center; Atrium Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Kwee, RM (corresponding author), Atrium Med Ctr Parkstad, Dept Radiol, Heerlen, Netherlands.	rmkwee@gmail.com		Clarijs, Ruud/0000-0002-2139-7073				Ancona E, 2001, CANCER, V91, P2165, DOI 10.1002/1097-0142(20010601)91:11<2165::AID-CNCR1245>3.3.CO;2-8; Aoyagi T, 2012, EUR RADIOL, V22, P1172, DOI 10.1007/s00330-011-2359-0; Aoyagi T, 2011, DIGEST SURG, V28, P252, DOI 10.1159/000328770; Aoyagi T, 2010, EXP THER MED, V1, P847, DOI 10.3892/etm.2010.112; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chirieac LR, 2005, CANCER-AM CANCER SOC, V103, P1347, DOI 10.1002/cncr.20916; Donington JS, 2003, EUR J CARDIO-THORAC, V24, P631, DOI 10.1016/S1010-7940(03)00397-X; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Kwee RM, 2010, RADIOLOGY, V254, P707, DOI 10.1148/radiol.09091324; Lambregts DMJ, 2011, EUR RADIOL, V21, P2567, DOI 10.1007/s00330-011-2220-5; Malthaner RA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001556.pub2; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Sakurada A, 2009, EUR RADIOL, V19, P1461, DOI 10.1007/s00330-008-1291-4; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sjoquist KM, 2011, LANCET ONCOL, V12, P681, DOI 10.1016/S1470-2045(11)70142-5; Sun YS, 2011, AM J ROENTGENOL, V197, pW23, DOI 10.2214/AJR.10.4912; Thoeny HC, 2010, J MAGN RESON IMAGING, V32, P2, DOI 10.1002/jmri.22167; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088	19	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92211	10.1371/journal.pone.0092211	http://dx.doi.org/10.1371/journal.pone.0092211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24704912	gold, Green Published, Green Submitted			2022-12-27	WOS:000334107500014
J	Tidemalm, D; Haglund, A; Karanti, A; Landen, M; Runeson, B				Tidemalm, Dag; Haglund, Axel; Karanti, Alina; Landen, Mikael; Runeson, Bo			Attempted Suicide in Bipolar Disorder: Risk Factors in a Cohort of 6086 Patients	PLOS ONE			English	Article							BEHAVIOR; EPIDEMIOLOGY; METAANALYSIS	Objective: Bipolar disorder is associated with high risk of self-harm and suicide. We wanted to investigate risk factors for attempted suicide in bipolar patients. Method: This was a cohort study of 6086 bipolar patients (60% women) registered in the Swedish National Quality Register for Bipolar Disorder 2004-2011 and followed-up annually 2005-2012. Logistic regression was used to calculate adjusted odds ratios for fatal or non-fatal attempted suicide during follow-up. Results: Recent affective episodes predicted attempted suicide during follow-up (men: odds ratio = 3.63, 95% Cl = 1.76-7.51; women: odds ratio = 2.81, 95% Cl = 1.78-4.44), as did previous suicide attempts (men: odds ratio = 3.93, 95% Cl = 2.48-6.24; women: odds ratio = 4.24, 95% Cl = 3.06-5.88) and recent psychiatric inpatient care (men: odds ratio = 3.57, 95% Cl = 1.59-8.01; women: odds ratio = 2.68, 95% Cl = 1.60-4.50). Further, those with many lifetime depressive episodes were more likely to attempt suicide. Comorbid substance use disorder was a predictor in men; many lifetime mixed episodes, early onset of mental disorder, personality disorder, and social problems related to the primary group were predictors in women. Conclusion: The principal clinical implication of the present study is to pay attention to the risk of suicidal behaviour in bipolar patients with depressive features and more severe or unstable forms of the disorder.	[Tidemalm, Dag; Haglund, Axel; Runeson, Bo] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden; [Karanti, Alina; Landen, Mikael] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden; [Landen, Mikael] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Karolinska Institutet; University of Gothenburg; Karolinska Institutet	Tidemalm, D (corresponding author), Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden.	dag.tidemalm@ki.se	Landen, Mikael/AAD-7917-2020	Landen, Mikael/0000-0002-4496-6451; Runeson, Bo/0000-0003-4122-4636	Stockholm City Council [20120528]; Soderstrom-Konigska Sjukhemmet Foundation [SLS-307101]	Stockholm City Council; Soderstrom-Konigska Sjukhemmet Foundation	This work was supported by grants from the Stockholm City Council (Grant Number: 20120528) and Soderstrom-Konigska Sjukhemmet Foundation (Grant Number: SLS-307101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson IM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8508; Baldessarini RJ, 2004, HARVARD REV PSYCHIAT, V12, P1, DOI 10.1080/10673220490425915; Brent DA, 2005, AM J MED GENET C, V133C, P13, DOI 10.1002/ajmg.c.30042; Chen YW, 1996, BIOL PSYCHIAT, V39, P896, DOI 10.1016/0006-3223(95)00295-2; Connolly KR, 2011, PRIM CARE COMPANION, V13; Dennehy EB, 2011, J AFFECT DISORDERS, V133, P423, DOI 10.1016/j.jad.2011.04.036; Dutta R, 2007, PSYCHOL MED, V37, P839, DOI 10.1017/S0033291707000347; Gonda X, 2012, J AFFECT DISORDERS, V143, P16, DOI 10.1016/j.jad.2012.04.041; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hawton K, 2005, J CLIN PSYCHIAT, V66, P693, DOI 10.4088/JCP.v66n0604; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Laursen TM, 2011, SCHIZOPHR RES, V131, P101, DOI 10.1016/j.schres.2011.06.008; Mann JJ, 2002, ANN INTERN MED, V136, P302, DOI 10.7326/0003-4819-136-4-200202190-00010; Maris RW, 2002, LANCET, V360, P319, DOI 10.1016/S0140-6736(02)09556-9; Nordentoft M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055176; Nordentoft M, 2011, ARCH GEN PSYCHIAT, V68, P1058, DOI 10.1001/archgenpsychiatry.2011.113; Novick DM, 2010, BIPOLAR DISORD, V12, P1, DOI 10.1111/j.1399-5618.2009.00786.x; Oquendo MA, 2000, J AFFECT DISORDERS, V59, P107, DOI 10.1016/S0165-0327(99)00129-9; Osby U, 2001, ARCH GEN PSYCHIAT, V58, P844, DOI 10.1001/archpsyc.58.9.844; Pompili M, 2013, BIPOLAR DISORD, V15, P457, DOI 10.1111/bdi.12087; Rihmer Z, 2002, BIPOLAR DISORD, V4, P21, DOI 10.1034/j.1399-5618.4.s1.3.x; SALAR (SAoLAaR), 2007, NAT HEALTHC QUAL REG; Sanchez-Gistau V, 2009, ACTA PSYCHIAT SCAND, V120, P30, DOI 10.1111/j.1600-0447.2008.01341.x; Saunders KEA, 2013, BIPOLAR DISORD, V15, P575, DOI 10.1111/bdi.12065; Sellgren C, 2011, ACTA PSYCHIAT SCAND, V124, P447, DOI 10.1111/j.1600-0447.2011.01747.x; Tidemalm D, 2011, PSYCHOL MED, V41, P2527, DOI 10.1017/S0033291711000833; Tidemalm D, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2205; Tondo L, 2003, CNS DRUGS, V17, P491, DOI 10.2165/00023210-200317070-00003; Valtonen HM, 2008, BIPOLAR DISORD, V10, P588, DOI 10.1111/j.1399-5618.2007.00553.x; Valtonen HM, 2006, BIPOLAR DISORD, V8, P576, DOI 10.1111/j.1399-5618.2006.00341.x; Waern M, 2002, BMJ-BRIT MED J, V324, P1355, DOI 10.1136/bmj.324.7350.1355	31	60	62	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94097	10.1371/journal.pone.0094097	http://dx.doi.org/10.1371/journal.pone.0094097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6MJ	24705630	gold, Green Published			2022-12-27	WOS:000334107500122
J	Jackson, AR; Nagarkatti, P; Nagarkatti, M				Jackson, Austin R.; Nagarkatti, Prakash; Nagarkatti, Mitzi			Anandamide Attenuates Th-17 Cell-Mediated DelayedType Hypersensitivity Response by Triggering IL-10 Production and Consequent microRNA Induction	PLOS ONE			English	Article							NF-KAPPA-B; ENDOCANNABINOID SYSTEM; T-CELL; CYTOKINE PRODUCTION; TH1 POLARIZATION; IN-VITRO; CANNABINOIDS; SUPPRESSION; ACTIVATION; EXPRESSION	Endogenous cannabinoids [endocannabinoids] are lipid signaling molecules that have been shown to modulate immune functions. However, their role in the regulation of Th17 cells has not been studied previously. In the current study, we used methylated Bovine Serum Albumin [mBSA]-induced delayed type hypersensitivity [DTH] response in C57BL/6 mice, mediated by Th17 cells, as a model to test the anti-inflammatory effects of endocannabinoids. Administration of anandamide [AEA], a member of the endocannabinoid family, into mice resulted in significant mitigation of mBSA- induced inflammation, including foot pad swelling, cell infiltration, and cell proliferation in the draining lymph nodes [LN]. AEA treatment significantly reduced IL-17 and IFN-gamma production, as well as decreased ROR gamma t expression while causing significant induction of IL-10 in the draining LNs. IL-10 was critical for the AEA-induced mitigation of DTH response inasmuch as neutralization of IL-10 reversed the effects of AEA. We next analyzed miRNA from the LN cells and found that 100 out of 609 miRNA species were differentially regulated in AEA-treated mice when compared to controls. Several of these miRNAs targeted proinflammatory mediators. Interestingly, many of these miRNA were also upregulated upon in vitro treatment of LN cells with IL-10. Together, the current study demonstrates that AEA may suppress Th-17 mediated DTH response by inducing IL-10 which in turn triggers miRNA that target proinflammatory pathways.	[Jackson, Austin R.; Nagarkatti, Prakash; Nagarkatti, Mitzi] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Nagarkatti, M (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	mnagark@uscmed.sc.edu		Nagarkatti, Mitzi/0000-0002-5977-5615; Nagarkatti, Prakash/0000-0003-2663-0759	NIH [P01AT003961, R01AT006888, R01ES019313, R01MH094755, P20RR032684]; VA Merit Award [BX001357]; National Center for Complementary & Integrative Health [R01AT006888, P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094755] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funded by NIH grants P01AT003961, R01AT006888, R01ES019313, R01MH094755, P20RR032684 and VA Merit Award BX001357.	Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Berdyshev EV, 1997, EUR J PHARMACOL, V330, P231, DOI 10.1016/S0014-2999(97)01007-8; Cai BB, 2013, ONCOL REP, V29, P1769, DOI 10.3892/or.2013.2297; Callard RE, 2007, IMMUNOL CELL BIOL, V85, P300, DOI 10.1038/sj.icb.7100060; Cao L, 2012, INT J MOL MED, V30, P1095, DOI 10.3892/ijmm.2012.1092; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Correa F, 2011, BRAIN BEHAV IMMUN, V25, P736, DOI 10.1016/j.bbi.2011.01.020; Costola-de-Souza C, 2013, PLOS ONE, V8; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Do Y, 2004, J IMMUNOL, V173, P2373, DOI 10.4049/jimmunol.173.4.2373; Echigo R, 2012, ONCOL REP, V28, P1176, DOI 10.3892/or.2012.1937; Egan PJ, 2008, ARTHRITIS RHEUM-US, V58, P3720, DOI 10.1002/art.24075; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Greineisen WE, 2010, INT IMMUNOPHARMACOL, V10, P547, DOI 10.1016/j.intimp.2010.02.012; Guan HB, 2013, EUR J IMMUNOL, V43, P104, DOI 10.1002/eji.201242702; Hegde VL, 2008, MOL PHARMACOL, V74, P20, DOI 10.1124/mol.108.047035; Hegde VL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018281; Hegde VL, 2010, EUR J IMMUNOL, V40, P3358, DOI 10.1002/eji.201040667; Horvath B, 2012, AM J PATHOL, V180, P432, DOI 10.1016/j.ajpath.2011.11.003; Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265; Kosaka S, 2011, IMMUNOBIOLOGY, V216, P811, DOI 10.1016/j.imbio.2010.12.003; Kozela E, 2013, J NEUROIMMUNE PAHRM; Kozela E, 2011, BRIT J PHARMACOL, V163, P1507, DOI 10.1111/j.1476-5381.2011.01379.x; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee WW, 2010, BLOOD, V115, P530, DOI 10.1182/blood-2009-08-236521; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu DZ, 2010, ACTA PHARMACOL SIN, V31, P1611, DOI 10.1038/aps.2010.155; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; Maccarrone M, 2001, ARCH BIOCHEM BIOPHYS, V393, P321, DOI 10.1006/abbi.2001.2500; Mach CM, 2013, CANCER LETT, V335, P314, DOI 10.1016/j.canlet.2013.02.043; Mallat A, 2013, J HEPATOL, V59, P891, DOI 10.1016/j.jhep.2013.03.032; Marquez L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006893; Matias I, 2002, EUR J BIOCHEM, V269, P3771, DOI 10.1046/j.1432-1033.2002.03078.x; McKallip RJ, 2005, J IMMUNOL, V174, P3281, DOI 10.4049/jimmunol.174.6.3281; McKallip RJ, 2002, J PHARMACOL EXP THER, V302, P451, DOI 10.1124/jpet.102.033506; Mimeault M, 2003, PROSTATE, V56, P1, DOI 10.1002/pros.10190; Nagarkatti P, 2009, FUTURE MED CHEM, V1, P1333, DOI 10.4155/FMC.09.93; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nambu A, 2006, INT IMMUNOL, V18, P701, DOI 10.1093/intimm/dxl007; Newton CA, 2004, J LEUKOCYTE BIOL, V76, P854, DOI 10.1189/jlb.0304184; Pandey R, 2011, J PHARMACOL EXP THER, V338, P819, DOI 10.1124/jpet.111.182717; Pandey R, 2009, PHARMACOL RES, V60, P85, DOI 10.1016/j.phrs.2009.03.019; Sakai M, 2009, J TOXICOL SCI, V34, P483, DOI 10.2131/jts.34.483; Sarnstrand B, 1999, J PHARMACOL EXP THER, V288, P1174; SCHWARZ H, 1994, J NEUROIMMUNOL, V55, P107, DOI 10.1016/0165-5728(94)90152-X; Solberg OD, 2012, AM J RESP CRIT CARE, V186, P965, DOI 10.1164/rccm.201201-0027OC; Sugamura K, 2009, CIRCULATION, V119, P28, DOI 10.1161/CIRCULATIONAHA.108.811992; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tajiri K, 2013, CARDIOVASC DRUG THER, V27, P413, DOI 10.1007/s10557-013-6464-y; Takahashi H, 2012, CELLS; Wang L, 2013, MOL CELL BIOL, V33, P1956, DOI 10.1128/MCB.01580-12; Wu ZW, 2012, FEBS LETT, V586, P2459, DOI 10.1016/j.febslet.2012.06.004; Yao R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046082	56	41	41	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93954	10.1371/journal.pone.0093954	http://dx.doi.org/10.1371/journal.pone.0093954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699635	Green Submitted, gold, Green Published			2022-12-27	WOS:000334105000127
J	Kantor, R; Bettendorf, D; Bosch, RJ; Mann, M; Katzenstein, D; Cu-Uvin, S; D'Aquila, R; Frenkel, L; Fiscus, S; Coombs, R				Kantor, Rami; Bettendorf, Daniel; Bosch, Ronald J.; Mann, Marita; Katzenstein, David; Cu-Uvin, Susan; D'Aquila, Richard; Frenkel, Lisa; Fiscus, Susan; Coombs, Robert		ACTG A5077 Study Team	HIV-1 RNA Levels and Antiretroviral Drug Resistance in Blood and Non-Blood Compartments from HIV-1-Infected Men and Women enrolled in AIDS Clinical Trials Group Study A5077	PLOS ONE			English	Article							FEMALE GENITAL-TRACT; VIRUS TYPE-1 RNA; VIRAL LOAD; GENDER-DIFFERENCE; SEX-DIFFERENCES; PLASMA; TRANSMISSION; THERAPY; SEMEN; SECRETIONS	Background: Detectable HIV-1 in body compartments can lead to transmission and antiretroviral resistance. Although sex differences in viral shedding have been demonstrated, mechanisms and magnitude are unclear. We compared RNA levels in blood, genital-secretions and saliva; and drug resistance in plasma and genital-secretions of men and women starting/changing antiretroviral therapy (ART) in the AIDS Clinical Trials Group (ACTG) 5077 study. Methods: Blood, saliva and genital-secretions (compartment fluids) were collected from HIV-infected adults (>= 13 years) at 14 United-States sites, who were initiating or changing ART with plasma viral load (VL) >= 2,000 copies/mL. VL testing was performed on all compartment fluids and HIV resistance genotyping on plasma and genital-secretions. Spearman rank correlations were used to evaluate concordance and Fisher's and McNemar's exact tests to compare VL between sexes and among compartments. Results: Samples were available for 143 subjects; 36% treated (23 men, 29 women) and 64% 'untreated' (40 men, 51 women). RNA detection was significantly more frequent in plasma (100%) than genital-secretions (57%) and saliva (64%) (P<0.001). A higher proportion of men had genital shedding versus women (78% versus 41%), and RNA detection was more frequent in saliva versus genital-secretions in women when adjusted for censoring at the limit of assay detection. Inter-compartment fluid VL concordance was low in both sexes. In 22 (13 men, 9 women) paired plasma-genital-secretion genotypes from treated subjects, most had detectable resistance in both plasma (77%) and genital-secretions (68%). Resistance discordance was observed between compartments in 14% of subjects. Conclusions: HIV shedding and drug resistance detection prior to initiation/change of ART in ACTG 5077 subjects differed among tissues and between sexes, making the gold standard blood-plasma compartment assessment not fully representative of HIV at other tissue sites. Mechanisms of potential sex-dependent tissue compartmentalization should be further characterized to aid in optimizing treatment and prevention of HIV transmission.	[Kantor, Rami; Mann, Marita; Cu-Uvin, Susan] Brown Univ, Alpert Med Sch, Dept Med, Div Infect Dis, Providence, RI 02912 USA; [Bettendorf, Daniel; Bosch, Ronald J.] Harvard Univ, Harvard Sch Publ Hlth, Boston, MA USA; [Katzenstein, David] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA; [D'Aquila, Richard] Northwestern Univ, Dept Med, Div Infect Dis, Chicago, IL 60611 USA; [Frenkel, Lisa] Univ Washington, Sch Med, Dept Pediat & Lab Med, Seattle, WA USA; [Fiscus, Susan] Univ N Carolina, Ctr Infect Dis, Chapel Hill, NC USA; [Coombs, Robert] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [Coombs, Robert] Univ Washington, Sch Med, Dept Med, Div Infect Dis, Seattle, WA 98195 USA	Brown University; Harvard University; Harvard T.H. Chan School of Public Health; Stanford University; Northwestern University; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kantor, R (corresponding author), Brown Univ, Alpert Med Sch, Dept Med, Div Infect Dis, Providence, RI 02912 USA.	rkantor@brown.edu		Frenkel, Lisa M/0000-0001-9566-8959; katzenstein, david/0000-0002-8593-4560	AIDS Clinical Trials Group, under the National Institute of Allergy and Infectious Diseases [AI-68636, AI-68634, AI-38858, AI-38855, AI-27664]; NICHD Women's HIV Interdisciplinary Network (WHIN) [HD-40540]; Centers for AIDS Research [AI-27757, AI-50410]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD040540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068636, U01AI068636, UM1AI068634, UM1AI106701, U01AI038858, U01AI038855, U01AI068634, UM1AI069412, P30AI027757, UM1AI068632, U01AI027664, P30AI050410] Funding Source: NIH RePORTER	AIDS Clinical Trials Group, under the National Institute of Allergy and Infectious Diseases; NICHD Women's HIV Interdisciplinary Network (WHIN); Centers for AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the AIDS Clinical Trials Group, under the National Institute of Allergy and Infectious Diseases grants AI-68636, AI-68634, AI-38858 and AI-38855; AI-27664 and AI-38858; NICHD Women's HIV Interdisciplinary Network (WHIN) HD-40540; Centers for AIDS Research AI-27757 (UW) and AI-50410 (UNC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2011, INT J STD AIDS, V22, P61, DOI 10.1258/ijsa.2010.009594; Anton P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002329; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Aweeka FT, 2006, AIDS, V20, P1833, DOI 10.1097/01.aids.0000244202.18629.36; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Balamane Maya, 2010, Open Virol J, V4, P88, DOI 10.2174/1874357901004010088; Bull M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007122; Bull ME, 2013, J INFECT DIS, V207, P1206, DOI 10.1093/infdis/jit016; Campo J, 2006, ORAL DIS, V12, P219, DOI 10.1111/j.1601-0825.2005.01187.x; Castro H, 2013, J INFECT DIS, V208, P1459, DOI 10.1093/infdis/jit345; Cheng B, 2008, CURR OPIN HIV AIDS, V3, P495, DOI 10.1097/COH.0b013e328303e5f9; Coombs RW, 2001, J INFECT DIS, V184, P1187, DOI 10.1086/323660; Cu-Uvin S, 2000, AIDS, V14, P415, DOI 10.1097/00002030-200003100-00015; Cu-Uvin S, 2006, JAIDS-J ACQ IMM DEF, V42, P584, DOI 10.1097/01.qai.0000229997.52246.95; Cu-Uvin S, 2010, AIDS, V24, P2486, DOI 10.1097/QAD.0b013e32833e5043; De Pasquale MP, 2003, JAIDS-J ACQ IMM DEF, V34, P37, DOI 10.1097/00126334-200309010-00005; Delwart EL, 1998, J VIROL, V72, P617, DOI 10.1128/JVI.72.1.617-623.1998; Diem K, 2008, AIDS RES HUM RETROV, V24, P561, DOI 10.1089/aid.2007.0115; Donnelly CA, 2005, HIV MED, V6, P170, DOI 10.1111/j.1468-1293.2005.00285.x; Dumond JB, 2007, AIDS, V21, P1899, DOI 10.1097/QAD.0b013e328270385a; Else LJ, 2011, ANTIVIR THER, V16, P1149, DOI 10.3851/IMP1919; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Fiore JR, 2003, AIDS, V17, P2169, DOI 10.1097/00002030-200310170-00004; Fiscus S, 2012, WOMEN HIV 1 SUBTYPE; Fiscus SA, 2000, J CLIN MICROBIOL, V38, P2348; Fiscus SA, 2013, CLIN INFECT DIS, V57, P290, DOI 10.1093/cid/cit195; Frenkel LM, 2006, AIDS RES HUM RETROV, V22, P870, DOI 10.1089/aid.2006.22.870; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Graham SM, 2010, J INFECT DIS, V202, P1538, DOI 10.1086/656790; Grinsztejn B, 2011, ANTIVIR THER, V16, P1057, DOI 10.3851/IMP1872; Gunthard HF, 2001, J INFECT DIS, V183, P1318, DOI 10.1086/319864; Henning TR, 2010, J INFECT DIS, V202, P1543, DOI 10.1086/656720; Homans J, 2012, JAIDS-J ACQ IMM DEF, V60, P99, DOI 10.1097/QAI.0b013e31824aeaaa; Ivy W, 2012, JAIDS-J ACQ IMM DEF, V59, P207, DOI 10.1097/QAI.0b013e31823b4554; Kalichman SC, 2008, SEX TRANSM DIS, V35, P55, DOI 10.1097/OLQ.0b013e318141fe9b; Kemal KS, 2007, J INFECT DIS, V195, P535, DOI 10.1086/510855; Kemal KS, 2003, P NATL ACAD SCI USA, V100, P12972, DOI 10.1073/pnas.2134064100; Kovacs A, 2001, LANCET, V358, P1593, DOI 10.1016/S0140-6736(01)06653-3; Lambert-Niclot S, 2012, AIDS, V26, P971, DOI 10.1097/QAD.0b013e328352ae09; Launay O, 2011, ANTIVIR THER, V16, P843, DOI 10.3851/IMP1856; Lingappa JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005272; Maritz ER, 2011, PEDIATRICS, V128, pE579, DOI 10.1542/peds.2010-3109; Mkhize NN, 2010, J VIROL, V84, P10765, DOI 10.1128/JVI.00518-10; Napravnik S, 2002, JAIDS-J ACQ IMM DEF, V31, P11, DOI 10.1097/00126334-200209010-00002; Neely MN, 2007, JAIDS-J ACQ IMM DEF, V44, P38, DOI 10.1097/01.qai.0000248352.18007.1f; Pillai SK, 2005, J VIROL, V79, P1734, DOI 10.1128/JVI.79.3.1734-1742.2005; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rakhmanina N., 2011, Morbidity and Mortality Weekly Report, V60, P273; Reichelderfer PS, 2000, AIDS, V14, P2101, DOI 10.1097/00002030-200009290-00005; Robinson EK, 1999, AIDS, V13, P737, DOI 10.1097/00002030-199904160-00021; Sheth PM, 2012, MUCOSAL IMMUNOL, V5, P248, DOI 10.1038/mi.2012.1; Sheth PM, 2006, J INFECT DIS, V193, P45, DOI 10.1086/498576; Sheth PM, 2009, AIDS, V23, P2050, DOI 10.1097/QAD.0b013e3283303e04; Shugars DC, 2000, ORAL SURG ORAL MED O, V89, P432, DOI 10.1016/S1079-2104(00)70124-7; Shugars DC, 1998, J AM DENT ASSOC, V129, P851, DOI 10.14219/jada.archive.1998.0349; Si-Mohamed A, 2000, J INFECT DIS, V182, P112, DOI 10.1086/315679; Speck CE, 1999, AM J EPIDEMIOL, V150, P622, DOI 10.1093/oxfordjournals.aje.a010061; Sterling TR, 1999, J INFECT DIS, V180, P666, DOI 10.1086/314967; Tirado G, 2004, AIDS RES HUM RETROV, V20, P684, DOI 10.1089/0889222041217509; Wahl SM, 2011, JAIDS-J ACQ IMM DEF, V56, P401, DOI 10.1097/QAI.0b013e31820cdfdb; WHO, 2010, ANT THER HIV INF AD; Zuckerman RA, 2003, J INFECT DIS, V188, P142, DOI 10.1086/375741	62	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93537	10.1371/journal.pone.0093537	http://dx.doi.org/10.1371/journal.pone.0093537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699474	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000066
J	Schmidt, RS; Butikofer, P				Schmidt, Remo S.; Buetikofer, Peter			Autophagy in Trypanosoma brucei: Amino Acid Requirement and Regulation during Different Growth Phases	PLOS ONE			English	Article							AFRICAN TRYPANOSOMES; FLOW-CYTOMETRY; PROTEIN P67; PATHWAYS; FORMS; DEGRADATION; MECHANISMS; DEATH; YEAST; STATE	Autophagy in the protozoan parasite, Trypanosoma brucei, may be involved in differentiation between different life cycle forms and during growth in culture. We have generated multiple parasite cell lines stably expressing green fluorescent protein-or hemagglutinin-tagged forms of the autophagy marker proteins, TbAtg8.1 and TbAtg8.2, in T. brucei procyclic forms to establish a trypanosome system for quick and reliable determination of autophagy under different culture conditions using flow cytometry. We found that starvation-induced autophagy in T. brucei can be inhibited by addition of a single amino acid, histidine, to the incubation buffer. In addition, we show that autophagy is induced when parasites enter stationary growth phase in culture and that their capacity to undergo starvation-induced autophagy decreases with increasing cell density.	[Schmidt, Remo S.; Buetikofer, Peter] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Schmidt, Remo S.] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland	University of Bern; University of Bern	Butikofer, P (corresponding author), Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.	peter.buetikofer@ibmm.unibe.ch		Schmidt, Remo S./0000-0002-6599-9201	COST action [BM0802]; Swiss National Science Foundation [31003A_130815]	COST action(European Cooperation in Science and Technology (COST)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding came from COST action BM0802 http://www.cost.eu/, and Swiss National Science Foundation grant 31003A_130815, http://www.snf.ch/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DL, 2002, J CELL SCI, V115, P3253; Alvarez VE, 2008, AUTOPHAGY, V4, P361, DOI 10.4161/auto.5592; Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; Brennand A, 2011, MOL BIOCHEM PARASIT, V177, P83, DOI 10.1016/j.molbiopara.2011.02.003; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; BRUN R, 1979, ACTA TROP, V36, P289; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Cavalier-Smith T, 2010, BIOL LETTERS, V6, P342, DOI 10.1098/rsbl.2009.0948; Duszenko M, 2006, TRENDS PARASITOL, V22, P536, DOI 10.1016/j.pt.2006.08.010; Furger A, 1997, MOL CELL BIOL, V17, P4372, DOI 10.1128/MCB.17.8.4372; Goldshmidt H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000731; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Herman M, 2006, AUTOPHAGY, V2, P107, DOI 10.4161/auto.2.2.2369; Hundeshagen P, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-38; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2006, AUTOPHAGY, V2, P63, DOI 10.4161/auto.2.2.2418; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Li FJ, 2012, CELL MICROBIOL, V14, P1242, DOI 10.1111/j.1462-5822.2012.01795.x; McCann AK, 2008, MOL BIOCHEM PARASIT, V159, P146, DOI 10.1016/j.molbiopara.2008.02.003; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Merkel P, 2007, TOXICON, V50, P457, DOI 10.1016/j.toxicon.2007.04.022; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nair U, 2005, J BIOL CHEM, V280, P41785, DOI 10.1074/jbc.R500016200; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Peck RF, 2008, MOL MICROBIOL, V68, P933, DOI 10.1111/j.1365-2958.2008.06195.x; Picazarri K, 2008, INFECT IMMUN, V76, P278, DOI 10.1128/IAI.00636-07; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Roditi I, 2008, CURR OPIN MICROBIOL, V11, P345, DOI 10.1016/j.mib.2008.06.006; Sakai Y, 2006, BBA-MOL CELL RES, V1763, P1767, DOI 10.1016/j.bbamcr.2006.08.023; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Tolkovsky AM, 2009, BBA-MOL CELL RES, V1793, P1508, DOI 10.1016/j.bbamcr.2009.03.002; Uzcategui NL, 2007, AUTOPHAGY, V3, P626, DOI 10.4161/auto.4907; Vassella E, 2000, GENE DEV, V14, P615; Williams RA, 2006, MOL MICROBIOL, V61, P655, DOI 10.1111/j.1365-2958.2006.05274.x; Williams RAM, 2009, AUTOPHAGY, V5, P159, DOI 10.4161/auto.5.2.7328; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yan XH, 2012, AUTOPHAGY, V8, P213, DOI 10.4161/auto.8.2.18563	45	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93875	10.1371/journal.pone.0093875	http://dx.doi.org/10.1371/journal.pone.0093875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699810	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000116
J	Bohm, A; Halama, A; Meile, T; Zdichavsky, M; Lehmann, R; Weigert, C; Fritsche, A; Stefan, N; Konigsrainer, A; Haring, HU; de Angelis, MH; Adamski, J; Staiger, H				Boehm, Anja; Halama, Anna; Meile, Tobias; Zdichavsky, Marty; Lehmann, Rainer; Weigert, Cora; Fritsche, Andreas; Stefan, Norbert; Koenigsrainer, Alfred; Haering, Hans-Ulrich; de Angelis, Martin Hrabe; Adamski, Jerzy; Staiger, Harald			Metabolic Signatures of Cultured Human Adipocytes from Metabolically Healthy versus Unhealthy Obese Individuals	PLOS ONE			English	Article							ARACHIDONIC-ACID; ADIPOSE-TISSUE; GLUCOSE-UPTAKE; CYCLE FLUX; INSULIN; ASSOCIATION; SYSTEM; RISK; LIPOPROTEIN; MARKERS	Background and Aims: Among obese subjects, metabolically healthy and unhealthy obesity (MHO/MUHO) can be differentiated: the latter is characterized by whole-body insulin resistance, hepatic steatosis, and subclinical inflammation. Aim of this study was, to identify adipocyte-specific metabolic signatures and functional biomarkers for MHO versus MUHO. Methods: 10 insulin-resistant (IR) vs. 10 insulin-sensitive (IS) non-diabetic morbidly obese (BMI >40 kg/m(2)) Caucasians were matched for gender, age, BMI, and percentage of body fat. From subcutaneous fat biopsies, primary preadipocytes were isolated and differentiated to adipocytes in vitro. About 280 metabolites were investigated by a targeted metabolomic approach intracellularly, extracellularly, and in plasma. Results/Interpretation: Among others, aspartate was reduced intracellularly to one third (p = 0.0039) in IR adipocytes, pointing to a relative depletion of citric acid cycle metabolites or reduced aspartate uptake in MUHO. Other amino acids, already known to correlate with diabetes and/or obesity, were identified to differ between MUHO's and MHO's adipocytes, namely glutamine, histidine, and spermidine. Most species of phosphatidylcholines (PCs) were lower in MUHO's extracellular milieu, though simultaneously elevated intracellularly, e. g., PC aa C32:3, pointing to increased PC synthesis and/or reduced PC release. Furthermore, altered arachidonic acid (AA) metabolism was found: 15(S)-HETE (15-hydroxy-eicosatetraenoic acid; 0 vs. 120pM; p = 0.0014), AA (1.5-fold; p = 0.0055) and docosahexaenoic acid (DHA, C22:6; 2-fold; p = 0.0033) were higher in MUHO. This emphasizes a direct contribution of adipocytes to local adipose tissue inflammation. Elevated DHA, as an inhibitor of prostaglandin synthesis, might be a hint for counter-regulatory mechanisms in MUHO. Conclusion/Interpretation: We identified adipocyte-inherent metabolic alterations discriminating between MHO and MUHO.	[Boehm, Anja; Halama, Anna; Weigert, Cora; Haering, Hans-Ulrich; de Angelis, Martin Hrabe; Adamski, Jerzy; Staiger, Harald] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Genome Anal Ctr, Inst Expt Genet, Neuherberg, Germany; [Boehm, Anja; Lehmann, Rainer; Weigert, Cora; Fritsche, Andreas; Stefan, Norbert; Haering, Hans-Ulrich; Staiger, Harald] Univ Tubingen, Univ Hosp, Dept Internal Med 4, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Tubingen, Germany; [Boehm, Anja; Lehmann, Rainer; Weigert, Cora; Fritsche, Andreas; Stefan, Norbert; Haering, Hans-Ulrich; de Angelis, Martin Hrabe; Adamski, Jerzy; Staiger, Harald] German Ctr Diabet Res, Neuherberg, Germany; [Boehm, Anja; Lehmann, Rainer; Weigert, Cora; Fritsche, Andreas; Stefan, Norbert; Haering, Hans-Ulrich; Staiger, Harald] Univ Tubingen, Helmholtz Ctr Munchen, Inst Diabet Res & Metab Dis, Tubingen, Germany; [Meile, Tobias; Zdichavsky, Marty; Koenigsrainer, Alfred] Univ Tubingen, Univ Hosp, Dept Gen Visceral & Transplant Surg, Tubingen, Germany; [de Angelis, Martin Hrabe; Adamski, Jerzy] Tech Univ Munich, Chair Expt Genet, Freising Weihenstephan, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technical University of Munich	Bohm, A (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Genome Anal Ctr, Inst Expt Genet, Neuherberg, Germany.	anja.boehm@med.uni-tuebingen.de	Staiger, Harald/N-5871-2014; de Angelis, Martin Hrabe/F-5531-2012; Meile, Tobias/GYJ-6692-2022; Lehmann, Rainer/AAF-4281-2019	de Angelis, Martin Hrabe/0000-0002-7898-2353; Lehmann, Rainer/0000-0003-1218-6810; Staiger, Harald/0000-0002-9507-5333; Moller, Anja/0000-0002-5344-8533; Halama, Anna/0000-0003-4910-6255; Adamski, Jerzy/0000-0001-9259-0199; Stefan, Norbert/0000-0002-2186-9595	German Federal Ministry of Education and Research (BMBF) [01GI0925]; Heisenberg-Professorship from the German Research Foundation [STE 1096/3-1]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Heisenberg-Professorship from the German Research Foundation	This study was supported in part by a grant (01GI0925) from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). Norbert Stefan is currently funded by a Heisenberg-Professorship from the German Research Foundation (STE 1096/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi MC, 2000, DIABETES, V49, P1374, DOI 10.2337/diabetes.49.8.1374; Cole BK, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/851798; COREY EJ, 1983, P NATL ACAD SCI-BIOL, V80, P3581, DOI 10.1073/pnas.80.12.3581; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; EGAN JM, 1995, AM J PHYSIOL-ENDOC M, V269, pE61, DOI 10.1152/ajpendo.1995.269.1.E61; Floegel A, 2012, DIABETES; Gaster M, 2012, ARCH PHYSIOL BIOCHEM, V118, P156, DOI 10.3109/13813455.2012.656653; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Iwaki T, 2012, BRIT J HAEMATOL, V157, P291, DOI 10.1111/j.1365-2141.2012.09074.x; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Lee YT, 2005, EUR J PHARMACOL, V513, P145, DOI 10.1016/j.ejphar.2005.02.010; Lehmann R, 2013, DIABETES CARE, V36, P2331, DOI 10.2337/dc12-1760; Lucio M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013317; Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503; Malipa ACA, 2008, CELL BIOCHEM FUNCT, V26, P221, DOI 10.1002/cbf.1439; Massiera F, 2003, J LIPID RES, V44, P271, DOI 10.1194/jlr.M200346-JLR200; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; McLaughlin T, 2007, ARCH INTERN MED, V167, P642, DOI 10.1001/archinte.167.7.642; Moller T, 2012, FORMATION PALEOCLIMA, P46; Naruhn S, 2010, MOL PHARMACOL, V77, P171, DOI 10.1124/mol.109.060541; Nelson TL, 2012, J CLIN ENDOCR METAB, V97, P1695, DOI 10.1210/jc.2011-3026; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nieuwdorp M, 2005, CURR OPIN PHARMACOL, V5, P155, DOI 10.1016/j.coph.2004.10.003; Nugent C, 2001, J BIOL CHEM, V276, P9149, DOI 10.1074/jbc.M009817200; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; Obukowicz M, 1999, LIPIDS, V34, pS149, DOI 10.1007/BF02562269; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Romisch-Margl W, 2011, METABOLOMICS, V8, P133, DOI [DOI 10.1007/s11306-011-0293-4, DOI 10.1007/S11306-011-0293-4]; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Schling P, 1999, INT J OBESITY, V23, P336, DOI 10.1038/sj.ijo.0800821; Schrauwen P, 2008, DIABETOLOGIA, V51, P1694, DOI 10.1007/s00125-008-1069-x; Shappell SB, 2001, CANCER RES, V61, P497; Stefan N, 2008, DIABETOLOGIA, V51, P648, DOI 10.1007/s00125-008-0938-7; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Stefan N, 2013, NAT REV ENDOCRINOL, V9, P144, DOI 10.1038/nrendo.2012.258; Stunes AK, 2011, DIABETES OBES METAB, V13, P551, DOI 10.1111/j.1463-1326.2011.01378.x; Suhre K, 2011, NAT GENET, V43, P565, DOI 10.1038/ng.837; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Van de Craen B, 2012, THROMB RES, V130, P576, DOI 10.1016/j.thromres.2012.06.023; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Weijers RNM, 2012, CURR DIABETES REV, V8, P390, DOI 10.2174/157339912802083531; Zhao XJ, 2010, METABOLOMICS, V6, P362, DOI 10.1007/s11306-010-0203-1; Zukunft S, 2013, CHROMATOGRAPHIA, V76, P1295, DOI 10.1007/s10337-013-2429-3	44	29	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93148	10.1371/journal.pone.0093148	http://dx.doi.org/10.1371/journal.pone.0093148			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695116	Green Submitted, Green Published, gold			2022-12-27	WOS:000334103000043
J	Serckx, A; Huynen, MC; Bastin, JF; Hambuckers, A; Beudels-Jamar, RC; Vimond, M; Raynaud, E; Kuhl, HS				Serckx, Adeline; Huynen, Marie-Claude; Bastin, Jean-Francois; Hambuckers, Alain; Beudels-Jamar, Roseline C.; Vimond, Marie; Raynaud, Emilien; Kuehl, Hjalmar S.			Nest Grouping Patterns of Bonobos (Pan paniscus) in Relation to Fruit Availability in a Forest-Savannah Mosaic	PLOS ONE			English	Article							SALONGA NATIONAL-PARK; TROGLODYTES-SCHWEINFURTHII; ENVIRONMENTAL-INFLUENCES; DENSITY-ESTIMATION; LOWLAND GORILLAS; KALINZU FOREST; CHIMPANZEES; SIZE; BEHAVIOR; CENSUS	A topic of major interest in socio-ecology is the comparison of chimpanzees and bonobos' grouping patterns. Numerous studies have highlighted the impact of social and environmental factors on the different evolution in group cohesion seen in these sister species. We are still lacking, however, key information about bonobo social traits across their habitat range, in order to make accurate inter-species comparisons. In this study we investigated bonobo social cohesiveness at nesting sites depending on fruit availability in the forest-savannah mosaic of western Democratic Republic of Congo (DRC), a bonobo habitat which has received little attention from researchers and is characterized by high food resource variation within years. We collected data on two bonobo communities. Nest counts at nesting sites were used as a proxy for night grouping patterns and were analysed with regard to fruit availability. We also modelled bonobo population density at the site in order to investigate yearly variation. We found that one community density varied across the three years of surveys, suggesting that this bonobo community has significant variability in use of its home range. This finding highlights the importance of forest connectivity, a likely prerequisite for the ability of bonobos to adapt their ranging patterns to fruit availability changes. We found no influence of overall fruit availability on bonobo cohesiveness. Only fruit availability at the nesting sites showed a positive influence, indicating that bonobos favour food 'hot spots' as sleeping sites. Our findings have confirmed the results obtained from previous studies carried out in the dense tropical forests of DRC. Nevertheless, in order to clarify the impact of environmental variability on bonobo social cohesiveness, we will need to make direct observations of the apes in the forest-savannah mosaic as well as make comparisons across the entirety of the bonobos' range using systematic methodology.	[Serckx, Adeline; Huynen, Marie-Claude; Hambuckers, Alain; Vimond, Marie; Raynaud, Emilien] Univ Liege, Behav Biol Unit, Liege, Belgium; [Serckx, Adeline; Beudels-Jamar, Roseline C.] Royal Belgian Inst Nat Sci, Conservat Biol Unit, Brussels, Belgium; [Serckx, Adeline; Bastin, Jean-Francois] Univ Kinshasa, Ecole Reg Postuniv Amenagement & Gest Integres Fo, Kinshasa, DEM REP CONGO; [Serckx, Adeline; Kuehl, Hjalmar S.] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Bastin, Jean-Francois] Univ Libre Bruxelles, Landscape Ecol & Vegetal Prod Syst Unit, Brussels, Belgium; [Bastin, Jean-Francois] Univ Liege, Gembloux AgroBiotech, Biodivers & Landscape Architecture Unit, Gembloux, Belgium; [Kuehl, Hjalmar S.] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	University of Liege; Royal Belgian Institute of Natural Sciences; Universite de Kinshasa; Max Planck Society; Universite Libre de Bruxelles; University of Liege	Serckx, A (corresponding author), Univ Liege, Behav Biol Unit, Liege, Belgium.	adelineserckx@gmail.com	, Hambuckers/H-9911-2014	, Hambuckers/0000-0003-2594-2064	National Fund for Scientific Research (FNRS, Belgium); Fonds Leopold III from the Royal Belgian Institute of Natural Sciences (Belgium); Ecole Regionale post-universitaire d'Amenagement et de gestion Integres des Forets et Territoires tropicaux (ERAIFT, Democratic Republic of Congo)	National Fund for Scientific Research (FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds Leopold III from the Royal Belgian Institute of Natural Sciences (Belgium); Ecole Regionale post-universitaire d'Amenagement et de gestion Integres des Forets et Territoires tropicaux (ERAIFT, Democratic Republic of Congo)	This project was funded by the National Fund for Scientific Research (FNRS, Belgium), the Fonds Leopold III from the Royal Belgian Institute of Natural Sciences (Belgium) and the Ecole Regionale post-universitaire d'Amenagement et de gestion Integres des Forets et Territoires tropicaux (ERAIFT, Democratic Republic of Congo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancrenaz M, 2004, INT J PRIMATOL, V25, P983, DOI 10.1023/B:IJOP.0000043347.84757.9a; Basabose AK, 2002, INT J PRIMATOL, V23, P263, DOI 10.1023/A:1013879427335; Beaune D, 2013, J TROP ECOL, V29, P367, DOI 10.1017/S0266467413000515; Boesch Christophe, 1996, P101, DOI 10.1017/CBO9780511752414.010; Brekus Catherine A., OXFORD HIST PROTESTA, V2, P190; Brugiere D, 2001, J ZOOL, V255, P251, DOI 10.1017/S0952836901001315; Brummett R., 2009, FORESTS CONGO BASIN, P141; Buckland S.T., 2001, pi; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Chapman Colin A., 1994, P41; Devos C, 2011, LOCAL ASSESSMENT GOR; Devos C, 2008, AM J PRIMATOL, V70, P439, DOI 10.1002/ajp.20514; Djoufack SD, 2007, MANUEL IDENTIFICATIO; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; Fox J., 2019, R COMPANION APPL REG, V.; FRUTH B, 1993, ETHOLOGY, V94, P113; Fruth B, 1995, THESIS LUDWIG MAXIMI; Fruth Barbara, 1996, P225, DOI 10.1017/CBO9780511752414.019; Furuichi T, 2004, INT J PRIMATOL, V25, P755, DOI 10.1023/B:IJOP.0000029121.25284.7f; Furuichi T, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P156, DOI 10.1017/CBO9780511606397.016; Furuichi T, 1997, INT J PRIMATOL, V18, P855, DOI 10.1023/A:1026327627943; Furuichi T, 2001, INT J PRIMATOL, V22, P913, DOI 10.1023/A:1012057403512; Furuichi T, 2008, DEV PRIMATOL-PROG PR, P135, DOI 10.1007/978-0-387-74787-3_8; Furuichi T, 2009, PRIMATES, V50, P197, DOI 10.1007/s10329-009-0141-6; Grossmann F, 2008, DEV PRIMATOL-PROG PR, P189, DOI 10.1007/978-0-387-74787-3_11; HASHIMOTO C, 1995, PRIMATES, V36, P477, DOI 10.1007/BF02382870; Hernandez-Aguilar RA, 2013, AM J PRIMATOL, V75, P979, DOI 10.1002/ajp.22163; Hernandez-Aguilar RA, 2006, THESIS U SO CALIFORN; Hickey JR, 2013, BIODIVERS CONSERV, V22, P3085, DOI 10.1007/s10531-013-0572-7; Hohmann G, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P138, DOI 10.1017/CBO9780511606397.014; Hohmann Gottfried, 2006, P123; Idani G., 1990, African Study Monographs, V11, P153; Inogwabini BI, 2008, DEV PRIMATOL-PROG PR, P273, DOI 10.1007/978-0-387-74787-3_14; Inogwabini BI, 2007, ORYX, V41, P136; IUCN, 2013, IUCN RED LIST THREAT; IUCN & ICCN, 2012, BON PAN PAN CONS STR; Jackman S., 2012, PSCL CLASSES METHODS; Junker J, 2012, DIVERS DISTRIB, V18, P1077, DOI 10.1111/ddi.12005; Kano T., 1984, P233; Kano T., 1992, LAST APE PYGMY CHIMP; Kano T, 1992, LAST APE PYGMY CHIMP, P225; Kawamoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059660; Khl H., 2007, GORILLA J, V34, P20; Kideghesho JR, 2007, BIODIVERS CONSERV, V16, P2213, DOI 10.1007/s10531-006-9132-8; Koops K, 2011, THESIS U CAMBRIDGE; Koops K, 2012, INT J PRIMATOL, V33, P356, DOI 10.1007/s10764-012-9585-4; Kouakou CY, 2009, AM J PRIMATOL, V71, P447, DOI 10.1002/ajp.20673; Kuehl H.S., 2008, BEST PRACTICE GUIDEL; Lacambra Carmen, 2005, P83; Laing SE, 2003, J APPL ECOL, V40, P1102, DOI 10.1111/j.1365-2664.2003.00861.x; MALENKY RK, 1994, AM J PRIMATOL, V32, P1, DOI 10.1002/ajp.1350320102; Mathewson PD, 2008, ECOL APPL, V18, P208, DOI 10.1890/07-0385.1; Mohneke M, 2008, DEV PRIMATOL-PROG PR, P151, DOI 10.1007/978-0-387-74787-3_9; Mulavwa M, 2010, AM J PRIMATOL, V71, P1; Nyariki D. M., 2009, J SOC SCI, V19, P91, DOI DOI 10.1080/09718923.2009.11892696; PEN Prototype Questionnaire, 2008, PEN PROT QUEST; Plumptre AJ, 1996, INT J PRIMATOL, V17, P85, DOI 10.1007/BF02696160; Plumptre AJ, 1997, INT J PRIMATOL, V18, P475, DOI 10.1023/A:1026302920674; Pruetz JD, 2008, AM J PRIMATOL, V70, P393, DOI 10.1002/ajp.20508; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reinartz GE, 2006, INT J PRIMATOL, V27, P1229, DOI 10.1007/s10764-006-9053-0; Rothman JM, 2006, AM J PRIMATOL, V68, P361, DOI 10.1002/ajp.20230; Russon AE, 2007, ANIM COGN, V10, P189, DOI 10.1007/s10071-006-0058-z; Samson DR, 2013, PRIMATES, V54, P73, DOI 10.1007/s10329-012-0329-z; Samson DR, 2012, AM J PRIMATOL, V74, P811, DOI 10.1002/ajp.22031; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Shibia Mohamed G., 2010, Journal of Human Ecology, V30, P55; Stanford CB, 2008, AM J PRIMATOL, V70, P642, DOI 10.1002/ajp.20539; Stewart FA, 2011, THESIS U CAMBRIDGE; Stewart FA, 2007, AM J PRIMATOL, V69, P930, DOI 10.1002/ajp.20432; Sunderland-Groves JL, 2009, INT J PRIMATOL, V30, P253, DOI 10.1007/s10764-009-9340-7; Tailfer Y, 1989, FORET DENSE AFRIQUE; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Thompson JAM, 2001, DEV PRIMATOL, P75; TUTIN CEG, 1995, INT J PRIMATOL, V16, P53, DOI 10.1007/BF02700153; Van Krunkelsven E, 2001, BIOL CONSERV, V99, P387, DOI 10.1016/S0006-3207(00)00216-0; Vancutsem C, 2006, CARTE OCCUPATION REP; Venables WN., 2002, MODERN APPL STAT S 4; Warnes GR, 2013, GTOOLS VARIOUS R PRO; White F. J., 2007, AM J PRIMATOL, V69, P1; WHITE FJ, 1988, BEHAVIOUR, V105, P148, DOI 10.1163/156853988X00494; Wilks C, 2000, ARBRES GUINEE EQUATO; Wrangham RW, 2000, PRIMATE MALES, P248; WRANGHAM RW, 1993, HUM NATURE-INT BIOS, V4, P47, DOI 10.1007/BF02734089; Zeileis A, 2007, RES REPORT SERIES DE, V53	85	25	25	0	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93742	10.1371/journal.pone.0093742	http://dx.doi.org/10.1371/journal.pone.0093742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695637	gold, Green Published, Green Submitted			2022-12-27	WOS:000334103000117
J	Takeuchi, K; Noda, N; Someya, N				Takeuchi, Kasumi; Noda, Naomi; Someya, Nobutaka			Complete Genome Sequence of the Biocontrol Strain Pseudomonas protegens Cab57 Discovered in Japan Reveals Strain-Specific Diversity of This Species	PLOS ONE			English	Article							FLUORESCENS CHA0; BIOLOGICAL-CONTROL; 2,4-DIACETYLPHLOROGLUCINOL BIOSYNTHESIS; REGULATORY RNA; GENE CLUSTERS; BACTERIAL; AERUGINOSA; IDENTIFICATION; SPP.; PF-5	The biocontrol strain Pseudomonas sp. Cab57 was isolated from the rhizosphere of shepherd's purse growing in a field in Hokkaido by screening the antibiotic producers. The whole genome sequence of this strain was obtained by paired-end and whole-genome shotgun sequencing, and the gaps between the contigs were closed using gap-spanning PCR products. The P. sp. Cab57 genome is organized into a single circular chromosome with 6,827,892 bp, 63.3% G+C content, and 6,186 predicted protein-coding sequences. Based on 16S rRNA gene analysis and whole genome analysis, strain Cab57 was identified as P. protegens. As reported in P. protegens CHA0 and Pf-5, four gene clusters (phl, prn, plt, and hcn) encoding the typical antibiotic metabolites and the reported genes associated with Gac/Rsm signal transduction pathway of these strains are fully conserved in the Cab57 genome. Actually strain Cab57 exhibited typical Gac/Rsm activities and antibiotic production, and these activities were enhanced by knocking out the retS gene (for a sensor kinase acting as an antagonist of GacS). Two large segments (79 and 115 kb) lacking in the Cab57 genome, as compared with the Pf-5 genome, accounted for the majority of the difference (247 kb) between these genomes. One of these segments was the complete rhizoxin analog biosynthesis gene cluster (ca. 79 kb) and another one was the 115-kb mobile genomic island. A whole genome comparison of those relative strains revealed that each strain has unique gene clusters involved in metabolism such as nitrite/nitrate assimilation, which was identified in the Cab57 genome. These findings suggest that P. protegens is a ubiquitous bacterium that controls its biocontrol traits while building up strain-specific genomic repertoires for the biosynthesis of secondary metabolites and niche adaptation.	[Takeuchi, Kasumi; Noda, Naomi] Natl Inst Agrobiol Sci, Plant Microbe Interact Res Unit, Tsukuba, Ibaraki, Japan; [Someya, Nobutaka] Natl Agr & Food Res Org, Hokkaido Agr Res Ctr, Memuro, Hokkaido, Japan	National Institute of Agrobiological Sciences - Japan; National Agriculture & Food Research Organization - Japan	Takeuchi, K (corresponding author), Natl Inst Agrobiol Sci, Plant Microbe Interact Res Unit, Tsukuba, Ibaraki, Japan.	kasumit@affrc.go.jp		Takeuchi, Kasumi/0000-0002-6521-6748	Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	This work was supported by the Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMES GFL, 1985, EMBO J, V4, P539, DOI 10.1002/j.1460-2075.1985.tb03662.x; Blumer C, 1999, P NATL ACAD SCI USA, V96, P14073, DOI 10.1073/pnas.96.24.14073; de Souza JT, 2003, FEMS MICROBIOL ECOL, V43, P21, DOI 10.1111/j.1574-6941.2003.tb01042.x; Duffy BK, 1999, APPL ENVIRON MICROB, V65, P2429; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Gross H, 2007, CHEM BIOL, V14, P53, DOI 10.1016/j.chembiol.2006.11.007; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haas D, 2003, ANNU REV PHYTOPATHOL, V41, P117, DOI 10.1146/annurev.phyto.41.052002.095656; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; HOWELL CR, 1979, PHYTOPATHOLOGY, V69, P480, DOI 10.1094/Phyto-69-480; Humair B, 2009, ISME J, V3, P955, DOI 10.1038/ismej.2009.42; IWASAKI S, 1984, J ANTIBIOT, V37, P354, DOI 10.7164/antibiotics.37.354; Kay E, 2005, P NATL ACAD SCI USA, V102, P17136, DOI 10.1073/pnas.0505673102; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; KEEL C, 1992, MOL PLANT MICROBE IN, V5, P4, DOI 10.1094/MPMI-5-004; Keel C, 1996, APPL ENVIRON MICROB, V62, P552, DOI 10.1128/AEM.62.2.552-563.1996; Kim YC, 2011, APPL ENVIRON MICROB, V77, P1548, DOI 10.1128/AEM.01867-10; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lackner G, 2011, J BACTERIOL, V193, P783, DOI 10.1128/JB.01318-10; Langille MGI, 2010, NAT REV MICROBIOL, V8, P372, DOI 10.1038/nrmicro2350; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Loper JE, 2008, APPL ENVIRON MICROB, V74, P3085, DOI 10.1128/AEM.02848-07; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Maurhofer M, 1998, PHYTOPATHOLOGY, V88, P678, DOI 10.1094/PHYTO.1998.88.7.678; Mavrodi DV, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-8; Mavrodi OV, 2001, PHYTOPATHOLOGY, V91, P35, DOI 10.1094/PHYTO.2001.91.1.35; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Noriega C, 2005, CURR MICROBIOL, V51, P419, DOI 10.1007/s00284-005-0125-8; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Pechy-Tarr M, 2008, ENVIRON MICROBIOL, V10, P2368, DOI 10.1111/j.1462-2920.2008.01662.x; Raaijmakers JM, 1997, APPL ENVIRON MICROB, V63, P881, DOI 10.1128/AEM.63.3.881-887.1997; Ramette A, 2011, SYST APPL MICROBIOL, V34, P180, DOI 10.1016/j.syapm.2010.10.005; Reimmann C, 2005, J BACTERIOL, V187, P276, DOI 10.1128/JB.187.1.276-285.2005; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Romeo A, 2012, MICROBIOL-SGM, V158, P1543, DOI 10.1099/mic.0.053850-0; Sambrook J., 2001, MOL CLONING LAB MANU; Schnider-Keel U, 2000, J BACTERIOL, V182, P1215, DOI 10.1128/JB.182.5.1215-1225.2000; Siddiqui IA, 2005, APPL ENVIRON MICROB, V71, P5646, DOI 10.1128/AEM.71.9.5646-5649.2005; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Someya N, 2012, MICROBES ENVIRON, V27, P122, DOI 10.1264/jsme2.ME11237; Stockwell VO, 2007, PHYTOPATHOLOGY, V97, P244, DOI 10.1094/PHYTO-97-2-0244; STUTZ EW, 1986, PHYTOPATHOLOGY, V76, P181, DOI 10.1094/Phyto-76-181; Svercel M, 2007, J MICROBIOL METH, V70, P209, DOI 10.1016/j.mimet.2007.03.018; Takeuchi K, 2012, MOL PLANT MICROBE IN, V25, P1440, DOI 10.1094/MPMI-02-12-0034-R; Takeuchi K, 2009, J BIOL CHEM, V284, P34976, DOI 10.1074/jbc.M109.052571; Valverde C, 2003, MOL MICROBIOL, V50, P1361, DOI 10.1046/j.1365-2958.2003.03774.x; VOISARD C, 1994, MOLECULAR ECOLOGY OF RHIZOSPHERE MICROORGANISMS, P67, DOI 10.1002/9783527615810.ch6; VOISARD C, 1988, FEMS MICROBIOL LETT, V55, P9, DOI 10.1016/0378-1097(88)90143-7; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Youard ZA, 2007, J BIOL CHEM, V282, P35546, DOI 10.1074/jbc.M707039200	57	32	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93683	10.1371/journal.pone.0093683	http://dx.doi.org/10.1371/journal.pone.0093683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695768	Green Submitted, Green Published, gold			2022-12-27	WOS:000334103000103
J	Miura, S; Kondo, J; Takimoto, A; Sano-Takai, H; Guo, L; Shukunami, C; Tanaka, H; Hiraki, Y				Miura, Shigenori; Kondo, Jun; Takimoto, Aki; Sano-Takai, Hiroko; Guo, Long; Shukunami, Chisa; Tanaka, Hideyuki; Hiraki, Yuji			The N- Terminal Cleavage of Chondromodulin-I in Growth- Plate Cartilage at the Hypertrophic and Calcified Zones during Bone Development	PLOS ONE			English	Article							MOLECULAR-CLONING; MESSENGER-RNA; ANGIOGENESIS; EXPRESSION; CHONDROCYTES; MATRIX; LOCALIZATION; TENOMODULIN; INHIBITOR; INVASION	Chondromodulin- I ( ChM- I) is a 20- 25 kDa anti- angiogenic glycoprotein in cartilage matrix. In the present study, we identified a novel 14- kDa species of ChM- I by immunoblotting, and purified it by immunoprecipitation with a newly raised monoclonal antibody against ChM- I. The N-terminal amino acid sequencing indicated that it was an N-terminal truncated form of ChM- I generated by the proteolytic cleavage at Asp (37) -Asp(38). This 14- kDa ChM- I was shown by the modified Boyden chamber assay to have very little inhibitory activity on the VEGF-A- induced migration of vascular endothelial cells in contrast to the intact 20- 25 kDa form of ChM- I ( ID50 = 8 nM). Immunohistochemistry suggested that 20-25 kDa ChM-I was exclusively localized in the avascular zones, i.e. the resting, proliferating, and prehypertrophic zones, of the cartilaginous molds of developing long bone, whereas the 14-kDa form of ChM-I was found in hypertrophic and calcified zones. Immunoblotting demonstrated that mature growth-plate chondrocytes isolated from rat costal cartilage actively secrete ChM-I almost exclusively as the intact 20-25 kDa form into the medium in primary culture. Taken together, our results suggest that intact 20-25 kDa ChM-I is stored as a component of extracellular matrix in the avascular cartilage zones, but it is inactivated by a single N-terminal proteolytic cleavage in the hypertrophic zone of growth-plate cartilage.	[Miura, Shigenori; Takimoto, Aki; Sano-Takai, Hiroko; Guo, Long; Tanaka, Hideyuki; Hiraki, Yuji] Kyoto Univ, Inst Frontier Med Sci, Dept Cellular Differentiat, Kyoto, Japan; [Kondo, Jun] Sci & Technol Res Ctr Inc, Div Res & Dev, Mitsubishi Chem Grp, Kanagawa, Japan; [Shukunami, Chisa] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Dent & Med Biochem, Hiroshima, Japan	Kyoto University; Mitsubishi Chemical Holdings Corporation; Mitsubishi Chemical; Hiroshima University	Hiraki, Y (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Cellular Differentiat, Kyoto, Japan.	hiraki@frontier.kyoto-u.ac.jp	GUO, Long/T-5237-2019; Shukunami, Chisa/G-2887-2019; 重徳, 三浦/GRJ-5008-2022	GUO, Long/0000-0002-9660-6941; Shukunami, Chisa/0000-0001-5616-6761; 重徳, 三浦/0000-0001-9206-2986	Ministry of Education, Culture, Sports, Science, and Technology, Japan [21510224]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (no. 21510224 to Yuji Hiraki). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dietz UH, 1999, DEV DYNAM, V216, P233, DOI 10.1002/(SICI)1097-0177(199911)216:3<233::AID-DVDY2>3.0.CO;2-G; EISENSTEIN R, 1973, AM J PATHOL, V73, P765; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Fujii M, 2013, J ORTHOP RES, V31, P538, DOI 10.1002/jor.22257; Funaki H, 2001, INVEST OPHTH VIS SCI, V42, P1193; Hall Brian K., 2005, P316, DOI 10.1016/B978-012319060-4/50025-7; HIRAKI Y, 1991, BIOCHEM BIOPH RES CO, V175, P971, DOI 10.1016/0006-291X(91)91660-5; Hiraki Y, 1999, EUR J BIOCHEM, V260, P869, DOI 10.1046/j.1432-1327.1999.00227.x; Hiraki Y, 1997, J BIOL CHEM, V272, P32419, DOI 10.1074/jbc.272.51.32419; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; JAKOB W, 1978, EXP PATHOL-JENA, V15, P241, DOI 10.1016/S0014-4908(78)80064-7; Kondo J, 2011, J BONE MINER METAB, V29, P23, DOI 10.1007/s00774-010-0193-0; Kuettner K.E., 1983, SEFER RABIAH, V1, P281; Miura S, 2012, CANCER SCI, V103, P1311, DOI 10.1111/j.1349-7006.2012.02276.x; Miura S, 2010, EXP CELL RES, V316, P775, DOI 10.1016/j.yexcr.2009.12.009; Nakamichi Y, 2003, MOL CELL BIOL, V23, P636, DOI 10.1128/MCB.23.2.636-644.2003; NEAME PJ, 1990, J BIOL CHEM, V265, P9628; SHIMOMURA Y, 1975, CALC TISS RES, V19, P179, DOI 10.1007/BF02564002; Shukunami C, 1999, INT J DEV BIOL, V43, P39; Shukunami C, 1998, BIOCHEM BIOPH RES CO, V249, P885, DOI 10.1006/bbrc.1998.9233; Shukunami C, 2005, BIOCHEM BIOPH RES CO, V333, P299, DOI 10.1016/j.bbrc.2005.05.133; Shukunami C, 2007, CURR PHARM DESIGN, V13, P2101; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Takimoto A, 2009, DEV BIOL, V332, P196, DOI 10.1016/j.ydbio.2009.05.552; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang QY, 2012, ARCH ORAL BIOL, V57, P620, DOI 10.1016/j.archoralbio.2011.12.006; Yoshioka M, 2006, NAT MED, V12, P1151, DOI 10.1038/nm1476; Yukata K, 2008, BONE, V43, P1047, DOI 10.1016/j.bone.2008.08.111	28	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94239	10.1371/journal.pone.0094239	http://dx.doi.org/10.1371/journal.pone.0094239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710035	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800126
J	Williamson, TE; Brusatte, SL				Williamson, Thomas E.; Brusatte, Stephen L.			Small Theropod Teeth from the Late Cretaceous of the San Juan Basin, Northwestern New Mexico and Their Implications for Understanding Latest Cretaceous Dinosaur Evolution	PLOS ONE			English	Article							BEND NATIONAL-PARK; NORTH-AMERICA; BIG-BEND; TYRANNOSAURIDAE DINOSAURIA; SYSTEMATIC UTILITY; KIRTLAND FORMATION; WESTERN INTERIOR; AGUJA FORMATION; CREEK FORMATION; DIVERSITY	Studying the evolution and biogeographic distribution of dinosaurs during the latest Cretaceous is critical for better understanding the end-Cretaceous extinction event that killed off all non-avian dinosaurs. Western North America contains among the best records of Late Cretaceous terrestrial vertebrates in the world, but is biased against small-bodied dinosaurs. Isolated teeth are the primary evidence for understanding the diversity and evolution of small-bodied theropod dinosaurs during the Late Cretaceous, but few such specimens have been well documented from outside of the northern Rockies, making it difficult to assess Late Cretaceous dinosaur diversity and biogeographic patterns. We describe small theropod teeth from the San Juan Basin of northwestern New Mexico. These specimens were collected from strata spanning Santonian - Maastrichtian. We grouped isolated theropod teeth into several morphotypes, which we assigned to higher-level theropod clades based on possession of phylogenetic synapomorphies. We then used principal components analysis and discriminant function analyses to gauge whether the San Juan Basin teeth overlap with, or are quantitatively distinct from, similar tooth morphotypes from other geographic areas. The San Juan Basin contains a diverse record of small theropods. Late Campanian assemblages differ from approximately co-eval assemblages of the northern Rockies in being less diverse with only rare representatives of troodontids and a Dromaeosaurus-like taxon. We also provide evidence that erect and recurved morphs of a Richardoestesia- like taxon represent a single heterodont species. A late Maastrichtian assemblage is dominated by a distinct troodontid. The differences between northern and southern faunas based on isolated theropod teeth provide evidence for provinciality in the late Campanian and the late Maastrichtian of North America. However, there is no indication that major components of small-bodied theropod diversity were lost during the Maastrichtian in New Mexico. The same pattern seen in northern faunas, which may provide evidence for an abrupt dinosaur extinction.	[Williamson, Thomas E.] New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; [Brusatte, Stephen L.] Univ Edinburgh, Sch GeoSci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Williamson, TE (corresponding author), New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA.	thomas.williamson@state.nm.us	Williamson, Thomas/AAW-9320-2020; Brusatte, Stephen/O-9663-2014	Brusatte, Stephen/0000-0001-7525-7319; Williamson, Thomas/0000-0002-2856-9632	National Science Foundation [EAR 0207750, EAR 1325544]; Bureau of Land Management (BLM) Challenge Cost Share grants; BLM National Landscapes Conservation System grant; Directorate For Geosciences [1325544, 1325612] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Bureau of Land Management (BLM) Challenge Cost Share grants; BLM National Landscapes Conservation System grant; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	National Science Foundation, grants EAR 0207750 to TEW and EAR 1325544 to TEW and SLB provided support. Bureau of Land Management (BLM) Challenge Cost Share grants to TEW and a BLM National Landscapes Conservation System grant provided support to TEW and SLB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarante JFA, 2002, NEW MEXICO GEOLOGY, V24, P68; Anderson RY., 1960, STATE BUREAU MINES M, V6, P1; [Anonymous], 1983, MESOZOIC PALEOGEOGRA; ARMSTRONG-ZIEGLER J G, 1980, Fieldiana Geology, P1; ARMSTRONGZIEGLER JG, 1978, J PALEONTOL, V52, P480; Bakker R.T., 1988, HUNTERIA, V1, P1, DOI DOI 10.5281/ZEN0D0.1037529; Baltz EHJ, 1966, 524D524D US GEOL SUR, pD1; Barrett PM, 2009, P ROY SOC B-BIOL SCI, V276, P2667, DOI 10.1098/rspb.2009.0352; Baszio Sven, 1997, Courier Forschungsinstitut Senckenberg, V196, P33; Benson RBJ, 2008, J VERTEBR PALEONTOL, V28, P732, DOI 10.1671/0272-4634(2008)28[732:NIOSAT]2.0.CO;2; Bourdon J., 2011, NEW MEXICO MUSEUM NA, V52, P1; BOWN TM, 1981, PALAEOGEOGR PALAEOCL, V34, P31, DOI 10.1016/0031-0182(81)90057-2; Brusatte SL, 2012, B AM MUS NAT HIST, V366, P197; Brusatte SL, 2013, THESIS COLUMBIA U NE; Brusatte SL, 2007, J VERTEBR PALEONTOL, V27, P1052, DOI 10.1671/0272-4634(2007)27[1052:TSUOTE]2.0.CO;2; Brusatte SL, 2013, ACTA PALAEONTOL POL, V58, P47, DOI 10.4202/app.2011.0141; Brusatte SL, 2013, B AM MUS NAT HIST, P3; Brusatte SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1815; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Buckley LG, 2010, CAN J EARTH SCI, V47, P1227, DOI 10.1139/E10-029; Carr T.D., 2000, NEW MEXICO MUSEUM NA, V17, P113; Carr TD, 2005, J VERTEBR PALEONTOL, V25, P119, DOI 10.1671/0272-4634(2005)025[0119:ANGASO]2.0.CO;2; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Carr TD, 2011, NATURWISSENSCHAFTEN, V98, P241, DOI 10.1007/s00114-011-0762-7; Carr TD, 2010, J VERTEBR PALEONTOL, V30, P1, DOI 10.1080/02724630903413032; Cifelli Richard L., 2004, P21; Cifelli RL, 1997, P NATL ACAD SCI USA, V94, P11163, DOI 10.1073/pnas.94.21.11163; Clemens W.A., 1986, CONTRIBUTIONS GEOLOG, V3, P55, DOI DOI 10.2113/GSR0CKY.24.SPECIAL_; Clemens WA, 1973, CRETACEOUS TERTIARY, P154; Cope E. D., 1876, P ACAD NAT SCI PHILA, V28, P248; Currie P.J., 1990, P107, DOI 10.1017/CBO9780511608377.011; Currie P.J., 1987, Journal of Vertebrate Paleontology, V7, P72; Currie PJ, 1995, J VERTEBR PALEONTOL, V15, P576, DOI 10.1080/02724634.1995.10011250; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; D'Emic MD, 2011, J VERTEBR PALEONTOL, V31, P1072, DOI 10.1080/02724634.2011.595856; Denton R, 2004, J VERTEBR PALEONTOL, V24, p52A; Eaton J.G., 1999, UTAH GEOLOGICAL SURV, V99-1, P345; Eberth DA, 2013, CAN J EARTH SCI, V50, P701, DOI 10.1139/cjes-2012-0185; Erickson GM, 2010, CAN J EARTH SCI, V47, P1269, DOI 10.1139/E10-051; Evans DC, 2013, NATURWISSENSCHAFTEN, V100, P1041, DOI 10.1007/s00114-013-1107-5; Evans DC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2749; Fassett J.E., 2009, PALAEONTOL ELECTRON, V12, p3A; Fassett J.E., 2000, NEW MEXICO MUSEUM NA, V17, P221; Fassett JE, 2011, GEOLOGY, V39, P159, DOI 10.1130/G31466.1; Fassett James E., 1997, New Mexico Geological Society Field Conference Guidebook, V48, P239; Fassett JE, 2002, GEOL SOC AM SPEC PAP, V356, P307; Fassett JE, 1987, CRETACEOUS TERTIARY, P17; Fastovsky D. E., 2005, GSA TODAY, V15; Fiorillo AR, 2008, PALAIOS, V23, P322, DOI 10.2110/palo.2007.p07-036r; Fiorillo AR, 2000, J VERTEBR PALEONTOL, V20, P675, DOI 10.1671/0272-4634(2000)020[0675:TTFTPC]2.0.CO;2; Flynn LJ, 1986, LATE CRETACEOUS MAMM, P1; Fv Huene, 1914, FOSSILIUM CATALOGUS, V4, P1; Gates TA, 2010, PALAEOGEOGR PALAEOCL, V291, P371, DOI 10.1016/j.palaeo.2010.03.008; Gates TA, ACTA PALAEO IN PRESS; Gates TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042135; Gilmore C.W., 1924, CANADIAN B DEP GEOLO, V1, P1; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Hall JP, 1991, LOWER VERTEBRA UNPUB; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Heizler MT, 2013, GEOLOGICAL SOC AM AB; Hunter JP, 2010, J VERTEBR PALEONTOL, V30, P885, DOI 10.1080/02724631003763490; HUTCHINSON PJ, 1985, NEW MEXICO BUREAU MI, V195, P25; Jasinski SE., 2011, NEW MEXICO MUSEUM NA, V53, P216; Jasinski S, 2009, J VERTEBR PALEONTOL, V29, p122A; Johnson Sally C., 2003, New Mexico Geological Society Field Conference Guidebook, V54, P353; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kirkland JI, 1997, ABSTRACTS PROGRAMS G, V29; Larson DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054329; Larson DW, 2008, CAN J EARTH SCI, V45, P1455, DOI 10.1139/E08-070; Lehman T.M., 1981, P189; Lehman Thomas M., 2001, P310; Lehman Thomas M., 1997, P223; LEHMAN TM, 1987, PALAEOGEOGR PALAEOCL, V60, P189, DOI 10.1016/0031-0182(87)90032-0; Lehman TM, 1985, NEW MEXICO BUREAU MI, V195, P55; LEHMAN TM, 1984, J VERTEBR PALEONTOL, V4, P602; Lillegraven JA, 1986, AM MUS NOVIT, V2840, p1 ; Loewen MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079420; Lofgren Donald L., 2004, P43; Longrich Nick, 2008, P135; Lucas S.G., 2000, NEW MEXICO MUSEUM NA, V17, P95; Lucas S. G., 1988, NEW MEXICO BUREAU MI, V122, P49; Lucas S. G., 2009, PALAEONTOL ELECTRON, V12, P1; Lucas SG, 2003, NEW MEXICO MUSEUM NA, V17, P83; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; MADSEN JH, 1974, J PALEONTOL, V48, P27; Magana J, 2013, J VERTEBR PALEONTOL, P169; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Matthew WD, 1922, B AM MUS NAT HIST, V56, P367; Mcdonald AT, 2010, J VERTEBR PALEONTOL, V30, P799, DOI 10.1080/02724631003763516; Mitchell JS, 2012, P NATL ACAD SCI USA, V109, P18857, DOI 10.1073/pnas.1202196109; Osborn HF, 1905, B AM MUS NAT HIST, V21, P259; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Parrish J. Michael, 1999, P319; Pearson DA, 2002, GEOL S AM S, P145; Pence R, 1986, NEW MEXICO GEOLOGY, V8, P69; Peppe DJ, 2013, GEOLOGICAL SOC AM AB, P114; Rigby Jr J.K., 1987, GEOLOGICAL SOC AM SP, V209, P51, DOI [10.1130/SPE209-p51, DOI 10.1130/SPE209-P51]; Roberts EM, 2005, CRETACEOUS RES, V26, P307, DOI 10.1016/j.cretres.2005.01.002; Rowe T., 1992, Journal of Vertebrate Paleontology, V12, P472; Russell DA, 2002, GEOL S AM S, P169; Russell L. S., 1964, Contributions of the Royal Ontario Museum of Zoology, VNo. 61, P1; RUSSELL L S, 1975, P137; Samman T, 2005, ACTA PALAEONTOL POL, V50, P757; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sampson SD, 2005, J VERTEBR PALEONTOL, V25, P469, DOI 10.1671/0272-4634(2005)025[0469:TRFTUC]2.0.CO;2; Sankey JT, 2002, J PALEONTOL, V76, P751, DOI 10.1666/0022-3360(2002)076<0751:STABTF>2.0.CO;2; Sankey JT, 2005, LIFE O PAST, P127; Sankey JT, 2001, J PALEONTOL, V75, P208, DOI 10.1666/0022-3360(2001)075<0208:LCSDAF>2.0.CO;2; Sankey Julia T., 2001, Occasional Papers of the Museum of Natural Science Louisiana State University, V77, P1; Sankey Julia T., 2008, P61; Sankey Julia T., 2008, P117; Sereno PC, 2009, J SYST PALAEONTOL, V7, P455, DOI 10.1017/S1477201909990034; SLOAN RE, 1969, P N AM PAL CONV E, P00427; Smith JB, 2005, J VERTEBR PALEONTOL, V25, P865, DOI 10.1671/0272-4634(2005)025[0865:HITRIF]2.0.CO;2; Smith JB, 2005, ANAT REC PART A, V285A, P699, DOI 10.1002/ar.a.20206; Sullivan R.M., 2005, 56 FIELD C GUID GEOL, V56, P395; Sullivan RM, 2005, J PALEONTOL, V79, P564, DOI 10.1666/0022-3360(2005)079<0564:ROTCDT>2.0.CO;2; Sullivan Robert M., 2003, New Mexico Geological Society Field Conference Guidebook, V54, P369; Sullivan Robert M., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P7; Sullivan Robert M., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P253; Templeman T, 2013, J VERTEBR PALEONTOL, V2013, P224; Turner AH, 2012, B AM MUS NAT HIST, P5; Upchurch P, 2011, GEOL SOC SPEC PUBL, V358, P209, DOI 10.1144/SP358.14; Vavrek MJ, 2010, P NATL ACAD SCI USA, V107, P8265, DOI 10.1073/pnas.0913645107; Weishampel DB., 2004, DINOSAURIA; Williamson T.E., 1997, NEW MEXICO MUSEUM NA, V11, P51; Williamson TE, 1996, J VERTEBR PALEONTOL, V16, P421, DOI 10.1080/02724634.1996.10011331; Williamson TE, 1998, NEW MEXICO GEOLOGY, V20, P54; Williamson TE, 1989, NEW MEXICO GEOLOGICA, V40, P239; Williamson TE, 2005, LATEST CRETACEOUS TY; Williamson TE, 2013, NEW VERTEBRATE LOCAL; Williamson TE, 2001, NEW MEXICO GEOLOGY, V23, P64; WILLIAMSON TE, 2001, GEOLOGICAL SOC AM AB, V33, pA21; Williamson TE, 1996, B NEW MEXICO MUSEUM, V8, P1; Williamson T, 2003, J VERTEBR PALEONTOL, V23, p110A; Williamson Thomas E., 1998, Journal of Vertebrate Paleontology, V18, p86A; Williamson TE, 2008, J VERTEBR PALEONTOL, V28, P803, DOI 10.1671/0272-4634(2008)28[803:MMFTNM]2.0.CO;2; Williamson TE, 2008, J VERTEBR PALEONTOL, V28, P1218, DOI 10.1671/0272-4634-28.4.1218; Wilson Gregory P., 2005, Journal of Mammalian Evolution, V12, P53, DOI 10.1007/s10914-005-6943-4; Wilson GP, 2010, J VERTEBR PALEONTOL, V30, P499, DOI 10.1080/02724631003620955; Woodburne M.O., 2006, STRATIGRAPHY, V3, P229; Woodburne M. O., 2004, LATE CRETACEOUS CENO; Zanno LE, 2005, J VERTEBR PALEONTOL, V25, P897, DOI 10.1671/0272-4634(2005)025[0897:ANOTMF]2.0.CO;2; Zanno Lindsay E., 2013, P504; Zanno LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3827; Zanno LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024487; Zanno LE, 2011, HIST BIOL, V23, P317, DOI 10.1080/08912963.2010.543952	149	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93190	10.1371/journal.pone.0093190	http://dx.doi.org/10.1371/journal.pone.0093190			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709990	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800026
J	Zhuang, W; Gao, XL				Zhuang, Wen; Gao, Xuelu			Integrated Assessment of Heavy Metal Pollution in the Surface Sediments of the Laizhou Bay and the Coastal Waters of the Zhangzi Island, China: Comparison among Typical Marine Sediment Quality Indices	PLOS ONE			English	Article							ACID-VOLATILE SULFIDE; SIMULTANEOUSLY EXTRACTED METALS; PEARL RIVER ESTUARY; BOHAI SEA; PHYSICOCHEMICAL PROPERTIES; RISK-ASSESSMENT; TRACE-METALS; CONTAMINATION; FRACTIONATION; DISTRIBUTIONS	The total concentrations and chemical forms of heavy metals ( Cd, Cr, Cu, Ni, Pb and Zn) in the surface sediments of the Laizhou Bay and the surrounding marine area of the Zhangzi Island ( hereafter referred to as Zhangzi Island for short) were obtained and multiple indices and guidelines were applied to assess their contamination and ecological risks. The sedimentary conditions were fine in both of the two studied areas according to the marine sediment quality of China. Whereas the probable effects level guideline suggested that Ni might cause adverse biological effects to occur frequently in some sites. All indices used suggested that Cd posed the highest environmental risk in both the Laizhou Bay and the Zhangzi Island, though Cd may unlikely be harmful to human and ecological health due to the very low total concentrations. The enrichment factor ( EF) showed that a substantial portion of Cr was delivered from anthropogenic sources, whereas the risk assessment code ( RAC) indicated that most Cr was in an inactive state that it may not have any adverse effect either. Moreover, the results of EF and geoaccumulation index were consistent with the trend of the total metal concentrations except for Cd, while the results of RAC and potential ecological risk factor did not follow the same trend of their corresponding total metal concentrations. We also evaluated the effects of using different indices to assess the environmental impact of these heavy metals.	[Zhuang, Wen; Gao, Xuelu] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Environm Proc & Ecol Remediat, Yantai, Shandong, Peoples R China; [Zhuang, Wen] Zaozhuang Univ, Coll City & Architecture Engn, Zaozhuang, Shandong, Peoples R China; [Zhuang, Wen] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Zaozhuang University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, XL (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Environm Proc & Ecol Remediat, Yantai, Shandong, Peoples R China.	xlgao@yic.ac.cn		Gao, Xuelu/0000-0002-1885-2442	National Natural Science Foundation of China [41376083]; Department of Science and Technology of Shandong Province [2012GHY11535]; CAS/SAFEA International Partnership Program for Creative Research Teams (Representative Environmental Processes and Resources Effects in Coastal Zones)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Shandong Province; CAS/SAFEA International Partnership Program for Creative Research Teams (Representative Environmental Processes and Resources Effects in Coastal Zones)	This study was co-supported by the National Natural Science Foundation of China (41376083), the Department of Science and Technology of Shandong Province (2012GHY11535) and the CAS/SAFEA International Partnership Program for Creative Research Teams (Representative Environmental Processes and Resources Effects in Coastal Zones). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER CR, 1993, ESTUARIES, V16, P627, DOI 10.2307/1352800; Alloway B.J., 1990, HEAVY METALS SOILS; Beck M, 2013, MAR POLLUT BULL, V70, P100, DOI 10.1016/j.marpolbul.2013.02.017; Caeiro S, 2005, ECOL INDIC, V5, P151, DOI 10.1016/j.ecolind.2005.02.001; Carr RS, 1996, ENVIRON TOXICOL CHEM, V15, P1218, DOI 10.1002/etc.5620150730; Duan LQ, 2010, J HAZARD MATER, V183, P155, DOI 10.1016/j.jhazmat.2010.07.005; Duran I, 2012, MAR ENVIRON RES, V77, P43, DOI 10.1016/j.marenvres.2012.02.001; Fytianos K, 2004, ENVIRON INT, V30, P11, DOI 10.1016/S0160-4120(03)00143-0; Gao XL, 2014, ENVIRON INT, V62, P12, DOI 10.1016/j.envint.2013.09.019; Gao XL, 2013, MAR POLLUT BULL, V72, P281, DOI 10.1016/j.marpolbul.2013.02.007; Gao XL, 2012, MAR POLLUT BULL, V64, P1529, DOI 10.1016/j.marpolbul.2012.04.026; Gao XL, 2012, WATER RES, V46, P1901, DOI 10.1016/j.watres.2012.01.007; Gao XL, 2010, ESTUAR COAST SHELF S, V86, P369, DOI 10.1016/j.ecss.2009.10.012; Gaur VK, 2005, ENVIRON MONIT ASSESS, V102, P419, DOI 10.1007/s10661-005-6395-6; GILLIAM FS, 1988, J SOIL SCI, V39, P209, DOI 10.1111/j.1365-2389.1988.tb01207.x; Goh BPL, 1997, ENVIRON MONIT ASSESS, V44, P67, DOI 10.1023/A:1005763918958; Gomes FD, 2009, MAR POLLUT BULL, V59, P123, DOI 10.1016/j.marpolbul.2009.03.015; Guillen G, 1993, D7001A TEX WAT COMM; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Hinkey LM, 2005, MAR POLLUT BULL, V50, P1244, DOI 10.1016/j.marpolbul.2005.04.035; Hinkey LM, 2007, MAR POLLUT BULL, V54, P180, DOI 10.1016/j.marpolbul.2006.09.009; Hjorth T, 2004, ANAL CHIM ACTA, V526, P95, DOI 10.1016/j.aca.2004.08.007; HOROWITZ AJ, 1988, CHEM BIOL CHARACTERI, P114; Howari FM, 2001, WATER AIR SOIL POLL, V132, P43, DOI 10.1023/A:1012062814873; Hu BQ, 2013, ENVIRON MONIT ASSESS, V185, P5071, DOI 10.1007/s10661-012-2926-0; [胡宁静 Hu Ningjing], 2011, [海洋科学进展, Advances in Marine Science], V29, P63; Hyun S, 2007, MAR POLLUT BULL, V54, P1059, DOI 10.1016/j.marpolbul.2007.02.013; Jain CK, 2004, WATER RES, V38, P569, DOI 10.1016/j.watres.2003.10.042; Karbassi A. R., 2005, International Journal of Environmental Science and Technology, V1, P307, DOI 10.1007/BF03325847; Lambert R, 2007, SCI TOTAL ENVIRON, V378, P293, DOI 10.1016/j.scitotenv.2007.02.008; Larrose A, 2010, APPL GEOCHEM, V25, P1912, DOI 10.1016/j.apgeochem.2010.10.007; Li GG, 2013, MAR POLLUT BULL, V76, P420, DOI 10.1016/j.marpolbul.2013.08.032; Li XD, 2000, APPL GEOCHEM, V15, P567, DOI 10.1016/S0883-2927(99)00072-4; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039690; Long ER, 2000, ENVIRON TOXICOL CHEM, V19, P2598, DOI 10.1002/etc.5620191028; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; Lu XQ, 2005, ENVIRON INT, V31, P593, DOI 10.1016/j.envint.2004.10.018; Luo W, 2010, AMBIO, V39, P367, DOI 10.1007/s13280-010-0077-5; [罗先香 Luo Xianxiang], 2010, [生态环境学报, Ecology and Environmental Sciences], V19, P262; [马绍赛 Ma Chaosai], 2004, [海洋水产研究, Marine Fisheries Research], V25, P47; MacDonald DD, 1996, ECOTOXICOLOGY, V5, P253, DOI 10.1007/BF00118995; Muller G.M.M.G.M.G.M.G.P., 1969, GEOJOURNAL, V2, P108, DOI DOI 10.1055/S-2007-1023171; Pekey H, 2013, MICROCHEM J, V106, P233, DOI 10.1016/j.microc.2012.07.007; Perin G., 1985, HEAVY METALS TOXIC E, V2, P454, DOI DOI 10.1016/J.MEX.2018.03.005; Porstner U., 1989, MAR CHEM, P107, DOI DOI 10.1016/0304-4203(92)90073-J; Prica M, 2008, SCI TOTAL ENVIRON, V389, P235, DOI 10.1016/j.scitotenv.2007.09.006; RAPIN F, 1986, ENVIRON SCI TECHNOL, V20, P836, DOI 10.1021/es00150a014; Rath P, 2009, J HAZARD MATER, V163, P632, DOI 10.1016/j.jhazmat.2008.07.048; Rauret G, 1999, J ENVIRON MONITOR, V1, P57, DOI 10.1039/a807854h; Sakan SM, 2009, J ENVIRON MANAGE, V90, P3382, DOI 10.1016/j.jenvman.2009.05.013; SALOMONS W, 1980, ENVIRON TECHNOL LETT, V1, P506, DOI 10.1080/09593338009384007; SEPA (State Environmental Protection Administration of China), 2002, 186682002 SEPA GB; Sundaray SK, 2011, J HAZARD MATER, V186, P1837, DOI 10.1016/j.jhazmat.2010.12.081; TAYLOR SR, 1995, REV GEOPHYS, V33, P241, DOI 10.1029/95RG00262; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Turner A, 2010, MAR POLLUT BULL, V60, P159, DOI 10.1016/j.marpolbul.2009.12.004; van den Berg GA, 1999, WATER AIR SOIL POLL, V116, P567, DOI 10.1023/A:1005146927718; Varol M, 2011, J HAZARD MATER, V195, P355, DOI 10.1016/j.jhazmat.2011.08.051; Wang HJ, 2007, GLOBAL PLANET CHANGE, V57, P331, DOI 10.1016/j.gloplacha.2007.01.003; Wang HJ, 2006, GLOBAL PLANET CHANGE, V50, P212, DOI 10.1016/j.gloplacha.2006.01.005; Yang YQ, 2012, MAR POLLUT BULL, V64, P1947, DOI 10.1016/j.marpolbul.2012.04.024; Ytreberg E, 2008, ENVIRON SCI TECHNOL, V45, p3145 ; Yu GB, 2011, CHEMOSPHERE, V85, P1080, DOI 10.1016/j.chemosphere.2011.07.039; Yu Y, 2013, MAR POLLUT BULL, V68, P157, DOI 10.1016/j.marpolbul.2012.11.043; Zhang H, 2008, SCI TOTAL ENVIRON, V399, P113, DOI 10.1016/j.scitotenv.2008.03.036; Zhang J, 2002, ESTUAR COAST SHELF S, V54, P1051, DOI 10.1006/ecss.2001.0879; Zhang WG, 2009, ENVIRON POLLUT, V157, P1533, DOI 10.1016/j.envpol.2009.01.007; Zhao S, 2012, J HAZARD MATER, V241, P164, DOI 10.1016/j.jhazmat.2012.09.023; Zhuang W, 2013, MAR POLLUT BULL, V76, P128, DOI 10.1016/j.marpolbul.2013.09.016	69	95	98	2	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94145	10.1371/journal.pone.0094145	http://dx.doi.org/10.1371/journal.pone.0094145			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709993	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800105
J	Barrett, LT; Evans, JP; Gasparini, C				Barrett, Luke T.; Evans, Jonathan P.; Gasparini, Clelia			The Effects of Perceived Mating Opportunities on Patterns of Reproductive Investment by Male Guppies	PLOS ONE			English	Article							MALE MATE CHOICE; SPERM COMPETITION RISK; CRYPTIC MALE CHOICE; POECILIA-RETICULATA; TRINIDADIAN GUPPY; INSEMINATION EFFICIENCY; FEMALE PRESENCE; BEHAVIOR; PREFERENCES; EVOLUTION	Males pay considerable reproductive costs in acquiring mates (precopulatory sexual selection) and in producing ejaculates that are effective at fertilising eggs in the presence of competing ejaculates (postcopulatory sexual selection). Given these costs, males must balance their reproductive investment in a given mating to optimise their future reproductive potential. Males are therefore expected to invest in reproduction prudently according to the likelihood of obtaining future matings. In this study we tested this prediction by determining whether male reproductive investment varies with expected future mating opportunities, which were experimentally manipulated by visually exposing male guppies (Poecilia reticulata) to high or low numbers of females in the absence of competing males. Our experiment did not reveal consistent effects of perceived future mating opportunity on either precopulatory (male mate choice and mating behaviour) or postcopulatory (sperm quality and quantity) investment. However, we did find that male size and female availability interacted to influence mating behaviour; large males visually deprived of females during the treatment phase became more choosy and showed greater interest in their preferred female than those given continuous visual access to females. Overall, our results suggest males tailor pre- rather than postcopulatory traits according to local female availability, but critically, these effects depend on male size.	[Barrett, Luke T.; Evans, Jonathan P.; Gasparini, Clelia] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA, Australia	University of Western Australia	Gasparini, C (corresponding author), Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA, Australia.	clelia.gasparini@uwa.edu.au	Gasparini, Clelia/F-2159-2011; Evans, Jonathan/A-1992-2011; Barrett, Luke T/T-9622-2019	Barrett, Luke T/0000-0002-2820-0421	School of Animal Biology at the University of Western Australia; Marie Curie International Outgoing Fellowship within the European Community [272613]; Australian Research Council [DP120100773]	School of Animal Biology at the University of Western Australia; Marie Curie International Outgoing Fellowship within the European Community; Australian Research Council(Australian Research Council)	This research was funded by a student grant to L. T. B. from the School of Animal Biology at the University of Western Australia, a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (grant no. 272613) to C. G., and a Discovery Grant from the Australian Research Council to J.P.E. (grant no. DP120100773). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS MV, 1993, ANIM BEHAV, V45, P673, DOI 10.1006/anbe.1993.1082; [Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Arriaga LR, 2013, PEERJ, V1, DOI 10.7717/peerj.140; Barton K., 2013, MUMIN MULTI MODEL IN; BILLARD R, 1969, ANN BIOL ANIM BIOCH, V9, P251, DOI 10.1051/rnd:19690208; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Boschetto C, 2011, BEHAV ECOL SOCIOBIOL, V65, P813, DOI 10.1007/s00265-010-1085-y; Bozynski CC, 2003, ANIM BEHAV, V65, P53, DOI 10.1006/anbe.2002.2024; Brooks R, 2002, GENETICA, V116, P343, DOI 10.1023/A:1021228308636; Brooks R, 2001, EVOLUTION, V55, P1644, DOI 10.1111/j.0014-3820.2001.tb00684.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Byrne PG, 2006, P ROY SOC B-BIOL SCI, V273, P917, DOI 10.1098/rspb.2005.3372; Cornwallis CK, 2006, EVOLUTION, V60, P1486, DOI 10.1111/j.0014-3820.2006.tb01227.x; Development Core Team, 2013, R LANG ENV STAT COMP; Devigili A, 2013, BEHAV ECOL, V24, P740, DOI 10.1093/beheco/ars204; Dosen LD, 2004, ETHOLOGY, V110, P245, DOI 10.1111/j.1439-0310.2004.00965.x; Dosen LD, 2004, BEHAV ECOL SOCIOBIOL, V55, P266, DOI 10.1007/s00265-003-0710-4; Edward DA, 2011, TRENDS ECOL EVOL, V26, P647, DOI 10.1016/j.tree.2011.07.012; Engqvist L, 2005, J EVOLUTION BIOL, V18, P116, DOI 10.1111/j.1420-9101.2004.00792.x; Engqvist L, 2002, BEHAV ECOL, V13, P632, DOI 10.1093/beheco/13.5.632; Engqvist L, 2001, P ROY SOC B-BIOL SCI, V268, P729, DOI 10.1098/rspb.2000.1423; EVANS J.P., 2011, ECOLOGY EVOLUTION PO; Evans JP, 2009, NATURWISSENSCHAFTEN, V96, P771, DOI 10.1007/s00114-009-0529-6; Evans JP, 2001, P ROY SOC B-BIOL SCI, V268, P719, DOI 10.1098/rspb.2000.1577; Evans JP, 1999, ANIM BEHAV, V58, P1001, DOI 10.1006/anbe.1999.1212; Fox J., 2018, R COMPANION APPL REG, VThird; GARDINER DM, 1978, COMP BIOCHEM PHYS A, V59, P165, DOI 10.1016/0300-9629(78)90200-1; Gasparini C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3072; Gasparini C, 2012, NATURWISSENSCHAFTEN, V99, P417, DOI 10.1007/s00114-012-0908-2; Gasparini C, 2009, BIOL LETTERS, V5, P792, DOI 10.1098/rsbl.2009.0413; Guevara-Fiore P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1665, DOI 10.1007/s00265-010-0980-6; Herdman EJE, 2004, ETHOLOGY, V110, P97, DOI 10.1111/j.1439-0310.2003.00960.x; HIRSHFIELD MF, 1975, P NATL ACAD SCI USA, V72, P2227, DOI 10.1073/pnas.72.6.2227; Houde A.E., 1997, SEX COLOR MATE CHOIC; Jeswiet SB, 2012, BEHAV ECOL, V23, P195, DOI 10.1093/beheco/arr175; Jeswiet SB, 2011, ETHOLOGY, V117, P422, DOI 10.1111/j.1439-0310.2011.01891.x; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; Jordan LA, 2012, EVOLUTION, V66, P280, DOI 10.1111/j.1558-5646.2011.01421.x; Kelley JL, 1999, NATURE, V401, P661, DOI 10.1038/44314; Kelly CD, 2011, BIOL REV, V86, P863, DOI 10.1111/j.1469-185X.2011.00175.x; Kolluru GR, 2009, BEHAV ECOL, V20, P131, DOI 10.1093/beheco/arn124; Kuckuck Constanze, 1997, Zeitschrift fuer Fischkunde, V4, P73; Liley N. R., 1966, Behaviour Suppl, V13, P1; Makowicz AM, 2010, BEHAVIOUR, V147, P1657, DOI 10.1163/000579510X528206; Matthews IM, 1997, P ROY SOC B-BIOL SCI, V264, P695, DOI 10.1098/rspb.1997.0099; Middleton K, 2012, JNT JOHNSON NEYMAN T; Miller LK, 2005, EVOLUTION, V59, P2414; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; NAKATSURU K, 1982, SCIENCE, V216, P753, DOI 10.1126/science.216.4547.753; Parker G.A., 1983, P141; Pettersson LB, 2004, BEHAV ECOL SOCIOBIOL, V55, P461, DOI 10.1007/s00265-003-0727-8; Pilastro A, 2007, ANIM BEHAV, V74, P321, DOI 10.1016/j.anbehav.2006.09.016; Pilastro A, 1999, P ROY SOC B-BIOL SCI, V266, P1887, DOI 10.1098/rspb.1999.0862; Preston BT, 2001, NATURE, V409, P681, DOI 10.1038/35055617; Rahman MM, 2013, ECOL EVOL, V3, P2197, DOI 10.1002/ece3.632; Reinhold K, 2002, J EVOLUTION BIOL, V15, P201, DOI 10.1046/j.1420-9101.2002.00390.x; REYNOLDS JD, 1992, P ROY SOC B-BIOL SCI, V250, P57, DOI 10.1098/rspb.1992.0130; Rios-Cardenas O, 2011, ECOLOGY EVOLUTION PO; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8	59	14	14	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93780	10.1371/journal.pone.0093780	http://dx.doi.org/10.1371/journal.pone.0093780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705713	gold, Green Published			2022-12-27	WOS:000334107500066
J	Feng, LY; Hu, LP; Fu, XT; Liao, H; Li, X; Zhan, AB; Zhang, LL; Wang, S; Huang, XT; Bao, ZM				Feng, Liying; Hu, Liping; Fu, Xiaoteng; Liao, Huan; Li, Xuan; Zhan, Aibin; Zhang, Lingling; Wang, Shi; Huang, Xiaoting; Bao, Zhenmin			An Integrated Genetic and Cytogenetic Map for Zhikong Scallop, Chlamys farreri, Based on Microsatellite Markers	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CHROMOSOMAL LOCALIZATION; LINKAGE MAPS; PATINOPECTEN-YESSOENSIS; ARGOPECTEN-IRRADIANS; STAINING TECHNIQUES; RIBOSOMAL DNA; BIVALVIA; IDENTIFICATION; PRESTON	The reliability of genome analysis and proficiency of genetic manipulation requires knowledge of the correspondence between the genetic and cytogenetic maps. In the present study, we integrated cytogenetic and microsatellite-based linkage maps for Zhikong scallop, Chlamys farreri. Thirty-eight marker-anchored BAC clones standing for the 19 linkage groups were used to be FISH probes. Of 38 BAC clones, 30 were successfully located on single chromosome by FISH and used to integrate the genetic and cytogenetic map. Among the 19 linkage groups, 12 linkage groups were physically anchored by 2 markers, 6 linkage groups were anchored by 1 marker, and one linkage group was not anchored any makers by FISH. In addition, using two-color FISH, six linkage groups were distinguished by different chromosomal location; linkage groups LG6 and LG16 were placed on chromosome 10, LG8 and LG18 on chromosome 14. As a result, 18 of 19 linkage groups were localized to 17 pairs of chromosomes of C. farreri. We first integrated genetic and cytogenetic map for C. farreri. These 30 chromosome specific BAC clones in the cytogenetic map could be used to identify chromosomes of C. farreri. The integrated map will greatly facilitate molecular genetic studies that will be helpful for breeding applications in C. farreri and the upcoming genome projects of this species.	[Feng, Liying; Hu, Liping; Fu, Xiaoteng; Liao, Huan; Li, Xuan; Zhang, Lingling; Wang, Shi; Huang, Xiaoting; Bao, Zhenmin] Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding MGB, Qingdao, Peoples R China; [Hu, Liping] Yantai Fisheries Res Inst, Yantai, Peoples R China; [Zhan, Aibin] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Beijing, Peoples R China	Ocean University of China; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Huang, XT (corresponding author), Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding MGB, Qingdao, Peoples R China.	xthuang@ouc.edu.cn; zmbao@ouc.edu.cn	zhang, lingling/HDM-2189-2022; Zhan, Aibin/A-7240-2011	Li, Xuan/0000-0003-0066-2373	National Natural Science Foundation of China [31270027]; National Basic Research Program of China [2010CB126402]; National High Tech RD Program [2012AA10A410]; National Key Technology R&D Program of China [2011BAD45B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National High Tech RD Program(National High Technology Research and Development Program of China); National Key Technology R&D Program of China(National Key Technology R&D Program)	This research work was financially supported by National Natural Science Foundation of China (31270027), National Basic Research Program of China (2010CB126402), National High Tech R&D Program (2012AA10A410), and National Key Technology R&D Program of China (2011BAD45B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bureau of Fisheries, 2012, 2012 CHIN FISH STAT; Chen SP, 2005, ACTA OCEANOL SIN, V24, P107; Duke SE, 2007, CHROMOSOME RES, V15, P361, DOI 10.1007/s10577-007-1131-4; Guo XM, 1999, J SHELLFISH RES, V18, P19; Howell EC, 2002, GENETICS, V161, P1225; Hu LP, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/785831; Huan Pin, 2009, Marine Sciences (Beijing), V33, P10; Huan P, 2010, GENET MOL BIOL, V33, P36, DOI 10.1590/S1415-47572010005000015; Huan Pin, 2009, Yichuan, V31, P1241, DOI 10.3724/SP.J.1005.2009.01241; [黄超 Huang Chao], 2012, [海洋科学, Marine Sciences], V36, P1; Huang XT, 2007, J MOLLUS STUD, V73, P393, DOI 10.1093/mollus/eym036; Huang XT, 2007, GENES GENET SYST, V82, P257, DOI 10.1266/ggs.82.257; Huang XT, 2006, ACTA OCEANOL SIN, V25, P108; Huang YH, 2006, GENETICS, V173, P287, DOI 10.1534/genetics.105.053256; Hubert S, 2004, GENETICS, V168, P351, DOI 10.1534/genetics.104.027342; Insua A, 2006, GENETICA, V126, P291, DOI 10.1007/s10709-005-7408-7; Insua A, 1998, GENES GENET SYST, V73, P193, DOI 10.1266/ggs.73.193; Islam-Faridi MN, 2002, GENETICS, V161, P345; Kim JS, 2002, GENOME, V45, P402, DOI 10.1139/G01-141; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Li L, 2005, AQUACULTURE, V245, P63, DOI 10.1016/j.aquaculture.2004.12.015; Li Z, 2002, J OCEAN U QINGDAO, V32, P179; Lopez-Pinon MJ, 2005, J HERED, V96, P52, DOI 10.1093/jhered/esi001; Odierna G, 2006, GENETICA, V127, P341, DOI 10.1007/s10709-005-5366-8; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sandhu D, 2001, GENETICS, V157, P1735; Stratikopoulos EE, 2008, GENETICA, V133, P147, DOI 10.1007/s10709-007-9195-9; Waller T.R., 1991, Developments in Aquaculture and Fisheries Science, V21, P1; Wang LL, 2005, AQUAC RES, V36, P643, DOI 10.1111/j.1365-2109.2005.01268.x; Wang m., 1990, Journal of Ocean University of Qingdao, V20, P81; Wang S, 2004, J SHELLFISH RES, V23, P491; Wang YP, 2004, BIOL BULL-US, V207, P247, DOI 10.2307/1543213; Wang Yun-tao, 1999, Oceanologia et Limnologia Sinica, V30, P770; Xiao H, 2005, AQUACULTURE, V250, P602, DOI 10.1016/j.aquaculture.2005.05.002; Yoshido A, 2005, GENETICS, V170, P675, DOI 10.1534/genetics.104.040352; Zhan A, 2009, ANIM GENET, V40, P821, DOI 10.1111/j.1365-2052.2009.01920.x; Zhang FS, 1999, MAR SCI, V30, P38; Zhang LL, 2008, MAR BIOTECHNOL, V10, P151, DOI 10.1007/s10126-007-9045-x; Zhang LL, 2007, GENETICA, V130, P193, DOI 10.1007/s10709-006-9006-8; Zhao Bo-Song, 2013, Zhongguo Haiyang Daxue Xuebao, V43, P57; Zhao Y, 2002, J OCEAN U QINGDAO S, V32, P41	42	10	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e92567	10.1371/journal.pone.0092567	http://dx.doi.org/10.1371/journal.pone.0092567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705086	Green Submitted, gold, Green Published			2022-12-27	WOS:000334107500019
J	Muyoyeta, M; Maduskar, P; Moyo, M; Kasese, N; Milimo, D; Spooner, R; Kapata, N; Hogeweg, L; van Ginneken, B; Ayles, H				Muyoyeta, Monde; Maduskar, Pragnya; Moyo, Maureen; Kasese, Nkatya; Milimo, Deborah; Spooner, Rosanna; Kapata, Nathan; Hogeweg, Laurens; van Ginneken, Bram; Ayles, Helen			The Sensitivity and Specificity of Using a Computer Aided Diagnosis Program for Automatically Scoring Chest X-Rays of Presumptive TB Patients Compared with Xpert MTB/RIF in Lusaka Zambia	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RADIOGRAPHY; FILMLESS; COST; PERFORMANCE; ACCURACY; SYSTEMS; ASSAY	Objective: To determine the sensitivity and specificity of a Computer Aided Diagnosis (CAD) program for scoring chest x-rays (CXRs) of presumptive tuberculosis (TB) patients compared to Xpert MTB/RIF (Xpert). Method: Consecutive presumptive TB patients with a cough of any duration were offered digital CXR, and opt out HIV testing. CXRs were electronically scored as normal (CAD score <= 60) or abnormal (CAD score>60) using a CAD program. All patients regardless of CAD score were requested to submit a spot sputum sample for testing with Xpert and a spot and morning sample for testing with LED Fluorescence Microscopy-(FM). Results: Of 350 patients with evaluable data, 291 (83.1%) had an abnormal CXR score by CAD. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of CXR compared to Xpert were 100% (95% Cl 96.2- 100), 23.2% (95% Cl 18.2- 28.9), 33.0% (95% Cl 27.6- 38.7) and 100% (95% 93.9- 100), respectively. The area under the receiver operator curve (AUC) for CAD was 0.71 (95% Cl 0.66- 0.77). CXR abnormality correlated with smear grade (r = 0.30, p<0.0001) and with Xpert C-T(r = 0.37, p<0.0001). Conclusions: To our knowledge this is the first time that a CAD program for TB has been successfully tested in a real world setting. The study shows that the CAD program had high sensitivity but low specificity and PPV. The use of CAD with digital CXR has the potential to increase the use and availability of chest radiography in screening for TB where trained human resources are scarce.	[Muyoyeta, Monde; Moyo, Maureen; Kasese, Nkatya; Milimo, Deborah; Spooner, Rosanna; Ayles, Helen] Univ Zambia, Sch Med, Dept Med, ZAMBART Project, Lusaka, Zambia; [Maduskar, Pragnya; Hogeweg, Laurens; van Ginneken, Bram] Radboud Univ Nijmegen, Med Ctr, Diagnost Image Anal Grp, NL-6525 ED Nijmegen, Netherlands; [Kapata, Nathan] Minist Hlth, Natl TB program, Lusaka, Zambia; [Ayles, Helen] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England	University of Zambia; Radboud University Nijmegen; University of London; London School of Hygiene & Tropical Medicine	Muyoyeta, M (corresponding author), Univ Zambia, Sch Med, Dept Med, ZAMBART Project, Lusaka, Zambia.	monde@zambart.org.zm	van Ginneken, Bram/A-3728-2012; Kapata, Nathan/AAW-2469-2020	van Ginneken, Bram/0000-0003-2028-8972; Ayles, Helen/0000-0003-4108-2842; Kapata, Nathan/0000-0002-3877-8809	World Health Organization [T9-370-114]	World Health Organization(World Health Organization)	Funding sources: T9-370-114 World Health Organization through the stop TB partnership-TB REACH wave 2 grant. http://www.stoptb.org,/global/awards/tbreach/grantees2.asp, Sub grant-Delft Imaging systems-CAD4TBII, http://www.delftimagingsystems.com/tb-solutions/cad4tb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzhaeva Y, 2009, PATTERN RECOGN, V42, P1768, DOI 10.1016/j.patcog.2009.01.016; Balabanova Y, 2005, BMJ-BRIT MED J, V331, P379, DOI 10.1136/bmj.331.7513.379; BARNES PF, 1991, NEW ENGL J MED, V324, P1644, DOI 10.1056/NEJM199106063242307; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cepheid, 2009, XPERT MTB RIF 2 HOUR, P3; Chamie G, 2010, INT J TUBERC LUNG D, V14, P1295; Dawson R, 2010, INT J TUBERC LUNG D, V14, P52; Duda R.O., 2006, PATTERN CLASSIFICATI; Efron B., 1979, ANN STAT; Feldman C, 2011, AM J RESP CRIT CARE, V183; Graham S, 2002, INT J TUBERC LUNG D, V6, P137; Hogeweg L, 2010, LECT NOTES COMPUT SC, V6363, P650; Iademarco MF, 2012, INT J TUBERC LUNG D, V16, P1421, DOI 10.5588/ijtld.12.0774; Jaeger S, 2013, IEEE T MED IMAGING; Jaeger S, 2013, QUANT IMAG MED SURG, V3, P89, DOI 10.3978/j.issn.2223-4292.2013.04.03; Jaeger S, 2012, IEEE ENG MED BIO, P4978, DOI 10.1109/EMBC.2012.6347110; Kurihara Y, 2001, ST HEAL T, V84, P1166; Lewis JJ, 2009, AM J RESP CRIT CARE, V180, P1271, DOI 10.1164/rccm.200806-846OC; Maduskar P, 2013, INT J TUBERC LUNG D, V17, P1613, DOI 10.5588/ijtld.13.0325; Muto H, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-246; Naul LG, 2001, POSTGRAD MED, V109, P107, DOI 10.3810/pgm.2001.06.960; Ntinginya EN, 2012, INT J TUBERC LUNG D, V16, P1468, DOI 10.5588/ijtld.12.0127; Nyboe J, 1968, Bull Int Union Tuberc, V41, P115; O'Grady J, 2012, CLIN INFECT DIS, V55, P1171, DOI 10.1093/cid/cis631; Pai M, 2012, INT J TUBERC LUNG D, V16, P1281, DOI 10.5588/ijtld.12.0391; Pepper T, 2008, INT J TUBERC LUNG D, V12, P397; PITCHENIK AE, 1985, AM REV RESPIR DIS, V131, P393; Seghers D, 2007, IEEE T MED IMAGING, V26, P1115, DOI 10.1109/TMI.2007.896924; Sekadde MP, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-133; Shah S, 2009, JAIDS-J ACQ IMM DEF, V50, P537, DOI 10.1097/QAI.0b013e318196761c; SHAW NJ, 1990, SCOT MED J, V35, P140, DOI 10.1177/003693309003500505; Small PM, 2010, NEW ENGL J MED, V363, P1070, DOI 10.1056/NEJMe1008496; Story A, 2012, INT J TUBERC LUNG D, V16, P1461, DOI 10.5588/ijtld.11.0773; Theron G, 2012, EUR RESPIR J, V40, P161, DOI 10.1183/09031936.00145511; Toman K., 2004, TOMANS TUBERCULOSIS, V2nd; van Cleeff MRA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-111; Van Deun A, 2007, PRIORITIES TUBERCULO, P11; van Ginneken B, 2006, MED IMAGE ANAL, V10, P19, DOI 10.1016/j.media.2005.02.002; van't Hoog AH, 2011, INT J TUBERC LUNG D, V15, P1308, DOI 10.5588/ijtld.11.0004; World Health Organization, 2011, WHOHTMTB20112; Zachary D, 2012, PUBLIC HEALTH ACTION, V2, P56, DOI 10.5588/pha.12.0010	42	55	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93757	10.1371/journal.pone.0093757	http://dx.doi.org/10.1371/journal.pone.0093757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705629	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000334107500064
J	Zhang, QW; Li, HH; Feng, XJ; Liu, BF; Liu, X				Zhang, Qiwei; Li, Henghui; Feng, Xiaojun; Liu, Bi-Feng; Liu, Xin			Purification of Derivatized Oligosaccharides by Solid Phase Extraction for Glycomic Analysis	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; PERMETHYLATED N-GLYCANS; MALDI-MS; SERUM; ELECTROPHORESIS; GLYCOPROTEINS; SENSITIVITY; PROFILES; STRATEGY	Profiling of glycans released from proteins is very complex and important. To enhance the detection sensitivity, chemical derivatization is required for the analysis of carbohydrates. Due to the interference of excess reagents, a simple and reliable purification method is usually necessary for the derivatized oligosaccharides. Various SPE based methods have been applied for the clean-up process. To demonstrate the differences among these methods, seven types of self-packed SPE cartridges were systematically compared in this study. The optimized conditions were determined for each type of cartridge and it was found that microcrystalline cellulose was the most appropriate SPE material for the purification of derivatized oligosaccharide. Normal phase HPLC analysis of the derivatized maltoheptaose was realized with a detection limit of 0.12 pmol (S N-1 = 3) and a recovery over 70%. With the optimized SPE method, relative quantification analysis of N-glycans from model glycoproteins were carried out accurately and over 40 N-glycans from human serum samples were determined regardless of the isomers. Due to the high stability and sensitivity, microcrystalline cellulose cartridge showed potential applications in glycomics analysis.	[Zhang, Qiwei; Li, Henghui; Feng, Xiaojun; Liu, Bi-Feng; Liu, Xin] Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect,Dept Biomed Engn,Coll Li, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Feng, XJ (corresponding author), Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect,Dept Biomed Engn,Coll Li, Wuhan 430074, Peoples R China.	xfeng@mail.hust.edu.cn; xliu@mail.hust.edu.cn	li, henghui/AAH-3203-2019		National Natural Science Foundation of China [20905027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors gratefully acknowledge the financial support from the National Natural Science Foundation of China (20905027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley WR, 2012, J PROTEOME RES, V11, P2282, DOI 10.1021/pr201070k; Alley WR, 2010, ANAL CHEM, V82, P5095, DOI 10.1021/ac100131e; Anumula KR, 1999, ANAL BIOCHEM, V275, P236, DOI 10.1006/abio.1999.4323; Anumula KR, 2006, ANAL BIOCHEM, V350, P1, DOI 10.1016/j.ab.2005.09.037; Anumula KR, 1998, GLYCOBIOLOGY, V8, P685, DOI 10.1093/glycob/8.7.685; Arnold JN, 2011, J PROTEOME RES, V10, P1755, DOI 10.1021/pr101034t; Bynum MA, 2009, ANAL CHEM, V81, P8818, DOI 10.1021/ac901326u; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Desantos-Garcia JL, 2011, ELECTROPHORESIS, V32, P3516, DOI 10.1002/elps.201100378; Gornik O, 2007, GLYCOBIOLOGY, V17, P1321, DOI 10.1093/glycob/cwm106; Gornik O, 2009, GLYCOBIOLOGY, V19, P1547, DOI 10.1093/glycob/cwp134; Guttman A, 1996, ELECTROPHORESIS, V17, P412, DOI 10.1002/elps.1150170221; Hu YL, 2012, ELECTROPHORESIS, V33, P1768, DOI 10.1002/elps.201100703; Kamoda S, 2006, J CHROMATOGR A, V1133, P332, DOI 10.1016/j.chroma.2006.08.028; Kang P, 2008, RAPID COMMUN MASS SP, V22, P721, DOI 10.1002/rcm.3395; Kita Y, 2007, MOL CELL PROTEOMICS, V6, P1437, DOI 10.1074/mcp.T600063-MCP200; Lattova E, 2013, MASS SPECTROM REV, V32, P366, DOI 10.1002/mas.21367; Liu X, 2008, PROTEOMICS, V8, P2849, DOI 10.1002/pmic.200701093; Liu X, 2010, ANAL CHEM, V82, P8300, DOI 10.1021/ac101831t; Mysling S, 2010, ANAL CHEM, V82, P5598, DOI 10.1021/ac100530w; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Pabst M, 2009, ANAL BIOCHEM, V384, P263, DOI 10.1016/j.ab.2008.09.041; Prater BD, 2007, ANAL BIOCHEM, V369, P202, DOI 10.1016/j.ab.2007.07.011; Royle L, 2002, ANAL BIOCHEM, V304, P70, DOI 10.1006/abio.2002.5619; Royle L, 2008, ANAL BIOCHEM, V376, P1, DOI 10.1016/j.ab.2007.12.012; Ruhaak LR, 2010, ANAL BIOANAL CHEM, V397, P3457, DOI 10.1007/s00216-010-3532-z; Ruhaak LR, 2008, ANAL CHEM, V80, P6119, DOI 10.1021/ac800630x; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Selman MHJ, 2011, ANAL CHEM, V83, P2492, DOI 10.1021/ac1027116; Shental-Bechor D, 2009, CURR OPIN STRUC BIOL, V19, P524, DOI 10.1016/j.sbi.2009.07.002; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Volpi N, 2010, NAT PROTOC, V5, P993, DOI 10.1038/nprot.2010.48; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Yang HM, 2011, ANAL CHIM ACTA, V701, P45, DOI 10.1016/j.aca.2011.05.051; Yodoshi M, 2008, J CHROMATOGR A, V1203, P137, DOI 10.1016/j.chroma.2008.07.053	36	20	20	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94232	10.1371/journal.pone.0094232	http://dx.doi.org/10.1371/journal.pone.0094232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705408	gold, Green Submitted, Green Published			2022-12-27	WOS:000334107500135
J	Chou, CP; Huang, NC; Jhuang, SJ; Pan, HB; Peng, NJ; Cheng, JT; Chen, CF; Chen, JJ; Chang, TH				Chou, Chen-Pin; Huang, Nan-Chieh; Jhuang, Shu-Jhen; Pan, Huay-Ben; Peng, Nan-Jing; Cheng, Jiin-Tsuey; Chen, Chian-Feng; Chen, Jih-Jung; Chang, Tsung-Hsien			Ubiquitin-Conjugating Enzyme UBE2C Is Highly Expressed in Breast Microcalcification Lesions	PLOS ONE			English	Article							UBCH10 EXPRESSION; CANCER; OVEREXPRESSION; RNA; PROGRESSION; CARCINOMAS; DIAGNOSIS; MARKERS; INHIBITION; GENE	Ubiquitin-conjugating enzyme 2C (UBE2C) contributes to ubiquitin-mediated proteasome degradation of cell cycle progression in breast cancer. Microcalcification (MC) is the most common mammographic feature of early breast cancer. In this study, we evaluated whether UBE2C could be a tumor marker of early breast cancer with MC found on screening mammography. UBE2C protein and mRNA expression were measured in breast core biopsy pairs of MC and adjacent non-MC breast tissue from each subject. Immunohistochemistry revealed UBE2C positivity in 69.4% of MC samples and 77.6% negativity in non-MC samples (p<0.0001). On RT-qPCR, 56.1% of malignant MC lesion samples showed high mRNA level of UBE2C and 80% of benign MC lesion samples showed a low level of UBE2C (p = 0.1766). We investigated the carcinogenic role of UBE2C in MCF-7 breast cancer cells with UBE2C knockdown; UBE2C knockdown downregulated cell proliferation and activated the cellular apoptosis pathway to inhibit cell colony formation. Furthermore, UBE2C expression was associated with that of carcinogenic genes human epidermal growth factor receptor type 2 (HER2), cellular c-Ki-ras2 proto-oncogene (KRAS), vascular endothelial growth factor (VEGF), CXC chemokine receptor 4 (CXCR4), C-C motif chemokine 5 (CCL5), neural precursor cell expressed, developmentally downregulated 9 (NEDD9) and Ras homolog family member C (RhoC). UBE2C may be a marker for diagnosis of nonpalpable breast lesions but not benign or malignant tumors in mammography core biopsies. Suppression of UBE2C may be a potential therapy target in breast cancer.	[Chou, Chen-Pin; Pan, Huay-Ben] Kaohsiung Vet Gen Hosp, Dept Radiol, Kaohsiung, Taiwan; [Chou, Chen-Pin; Pan, Huay-Ben] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Huang, Nan-Chieh] Kaohsiung Armed Forces Gen Hosp, Zuoying Branch, Dept Family Med, Kaohsiung, Taiwan; [Jhuang, Shu-Jhen] Kaohsiung Vet Gen Hosp, Dept Pathol & Lab Med, Kaohsiung, Taiwan; [Jhuang, Shu-Jhen; Chang, Tsung-Hsien] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Jhuang, Shu-Jhen; Cheng, Jiin-Tsuey] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Pan, Huay-Ben] I Shou Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan; [Peng, Nan-Jing] Kaohsiung Vet Gen Hosp, Nucl Med Sect, Kaohsiung, Taiwan; [Chen, Chian-Feng] Natl Yang Ming Univ, VYM Genome Res Ctr, Taipei 112, Taiwan; [Chen, Jih-Jung; Chang, Tsung-Hsien] Tajen Univ, Grad Inst Pharmaceut Technol, Pingtung, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Sun Yat Sen University; I Shou University; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University	Chang, TH (corresponding author), Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan.	changth@vghks.gv.tw	Chang, Tsung-Hsien/AAG-9384-2019; chen, JJ/HGB-6029-2022	Chang, Tsung-Hsien/0000-0003-4806-7864; 	Kaohsiung Veterans General Hospital, Taiwan [VGHKS100-G02-4, VGHKS101-G02-3]; Zuoying Branch of Kaohsiung Armed Forces General Hospital, Taiwan [ZBH 103-10]	Kaohsiung Veterans General Hospital, Taiwan; Zuoying Branch of Kaohsiung Armed Forces General Hospital, Taiwan	This work was supported by grants of Kaohsiung Veterans General Hospital, Taiwan (VGHKS100-G02-4 and VGHKS101-G02-3, http://www.vghks.gov.tw/English/) and Zuoying Branch of Kaohsiung Armed Forces General Hospital, Taiwan (ZBH 103-10, http://806.mnd.gov.tw/english/index.php). The founders had no role in study design, data collection and analysis, preparation of the manuscript, decision to publish, or preparation of the manuscript.	Bavi P, 2011, AM J PATHOL, V178, P2109, DOI 10.1016/j.ajpath.2011.01.034; Berlingieri MT, 2007, EUR J CANCER, V43, P2729, DOI 10.1016/j.ejca.2007.09.003; Bernstein JR, 1996, SEMIN SURG ONCOL, V12, P290, DOI 10.1002/(SICI)1098-2388(199609/10)12:5<290::AID-SSU3>3.3.CO;2-2; Bureau of Health Promotion, 2009, ANN REP 2008 2009; Chen CC, 2006, ONCOLOGY-BASEL, V70, P438, DOI 10.1159/000098557; Cheng SH, 2000, BREAST CANCER RES TR, V63, P213, DOI 10.1023/A:1006468514396; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Chou CP, 2012, BREATS J, V18, P2; Donato G, 2008, CLIN NEUROPATHOL, V27, P219; Fujita T, 2008, CANC SCI; Fujita T, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-87; Giger ML, 2013, ANNU REV BIOMED ENG, V15, P327, DOI 10.1146/annurev-bioeng-071812-152416; Gondi CS, 2009, INT J ONCOL, V35, P851, DOI 10.3892/ijo_00000399; Guerriero E, 2010, CANCER CYTOPATHOL, V118, P157, DOI 10.1002/cncy.20046; Haka AS, 2002, CANCER RES, V62, P5375; Hofvind S, 2013, CANCER; Jancik S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/150960; Jiang L, 2010, J CANCER RES CLIN, V136, P211, DOI 10.1007/s00432-009-0651-z; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Lambros MBK, 2007, HUM PATHOL, V38, P1105, DOI 10.1016/j.humpath.2007.04.011; Loussouarn D, 2009, BRIT J CANCER, V101, P166, DOI 10.1038/sj.bjc.6605122; Misek DE, 2011, J PROTEOMICS, V2011; Pallante P, 2005, BRIT J CANCER, V93, P464, DOI 10.1038/sj.bjc.6602721; Parris TZ, 2013, INT J CANC; Psyrri A, 2012, ANN ONCOL, V23, P1422, DOI 10.1093/annonc/mdr527; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rawat A, 2013, CELL ONCOL DORDR; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Sabitha K, 2012, BIOINFORMATION, V8, P1047, DOI 10.6026/97320630081047; Shen ZH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-192; STOMPER PC, 1989, RADIOLOGY, V172, P235, DOI 10.1148/radiology.172.1.2544922; Summers MK, 2008, MOL CELL, V31, P544, DOI 10.1016/j.molcel.2008.07.014; Troncone G, 2009, HISTOPATHOLOGY, V54, P731, DOI 10.1111/j.1365-2559.2009.03296.x; van Ree JH, 2010, J CELL BIOL, V188, P83, DOI 10.1083/jcb.200906147; VOGELSTEIN B, 1994, CELL, V79, P1, DOI 10.1016/0092-8674(94)90393-X; Wagner KW, 2004, ONCOGENE, V23, P6621, DOI 10.1038/sj.onc.1207861; Wang HY, 2011, CANCER RES, V71, P4866, DOI 10.1158/0008-5472.CAN-10-4576; Wernicke AG, 2011, BREAST CANCER RES TR, V125, P893, DOI 10.1007/s10549-010-1167-6; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Yang G, 2004, J BIOL CHEM, V279, P4339, DOI 10.1074/jbc.M311153200	40	34	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93934	10.1371/journal.pone.0093934	http://dx.doi.org/10.1371/journal.pone.0093934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699941	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000122
J	Grijsen, ML; Wit, FWNM; Jurriaans, S; Kroon, FP; Schippers, EF; Koopmans, P; Gras, L; Lange, JMA; Prins, JM				Grijsen, Marlous L.; Wit, Ferdinand W. N. M.; Jurriaans, Suzanne; Kroon, Frank P.; Schippers, Emile F.; Koopmans, Peter; Gras, Luuk; Lange, Joep M. A.; Prins, Jan M.		Primo-SHM Study Grp	Temporary Treatment during Primary HIV Infection Does Not Affect Virologic Response to Subsequent Long-Term Treatment	PLOS ONE			English	Article							COURSE ANTIRETROVIRAL THERAPY; INTERRUPTION; NEVIRAPINE; SINGLE	Temporary cART during primary HIV-infection (PHI) did not select for drug resistance mutations after treatment interruption and did not affect the subsequent virological response to long-term cART. Our data demonstrate that fear of drug resistance development is not a valid argument to refrain from temporary early treatment during PHI.	[Grijsen, Marlous L.; Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Div Infect Dis,Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [Wit, Ferdinand W. N. M.; Lange, Joep M. A.] Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, Amsterdam, Netherlands; [Jurriaans, Suzanne] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Kroon, Frank P.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Schippers, Emile F.] Haga Hosp, Dept Internal Med, The Hague, Netherlands; [Koopmans, Peter] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Gras, Luuk] HIV Monitoring Fdn, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haga Hospital; Radboud University Nijmegen	Grijsen, ML (corresponding author), Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands.	m.l.grijsen@lumc.nl	Wit, Ferdinand/AAC-3803-2019; Prins, Jan M./AAF-4945-2020	Prins, Jan/0000-0002-5415-8933; Rijnders, Bart/0000-0003-3343-9610				El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fidler S, 2002, AIDS, V16, P2049, DOI 10.1097/00002030-200210180-00010; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Fox Z, 2008, AIDS, V22, P2279, DOI 10.1097/QAD.0b013e328311d16f; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; Hogan CM, 2012, J INFECT DIS, V205, P87, DOI 10.1093/infdis/jir699; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Taylor S, 2007, AIDS, V21, P1673, DOI 10.1097/QAD.0b013e3281c61394; Taylor S, 2012, J ANTIMICROB CHEMOTH, V67, P675, DOI 10.1093/jac/dkr491; Viread, 2006, SUMM PROC CHAR	11	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e89639	10.1371/journal.pone.0089639	http://dx.doi.org/10.1371/journal.pone.0089639			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699072	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000005
J	Huhn, C; Winter, C; Wolfsperger, T; Wuppenhorst, N; Smrdel, KS; Skuballa, J; Pfaffle, M; Petney, T; Silaghi, C; Dyachenko, V; Pantchev, N; Straubinger, RK; Schaarschmidt-Kiener, D; Ganter, M; Aardema, ML; von Loewenich, FD				Huhn, Christian; Winter, Christina; Wolfsperger, Timo; Wueppenhorst, Nicole; Smrdel, Katja Straek; Skuballa, Jasmin; Pfaefle, Miriam; Petney, Trevor; Silaghi, Cornelia; Dyachenko, Viktor; Pantchev, Nikola; Straubinger, Reinhard K.; Schaarschmidt-Kiener, Daniel; Ganter, Martin; Aardema, Matthew L.; von Loewenich, Friederike D.			Analysis of the Population Structure of Anaplasma phagocytophilum Using Multilocus Sequence Typing	PLOS ONE			English	Article							HUMAN GRANULOCYTIC EHRLICHIOSIS; HEDGEHOG ERINACEUS-EUROPAEUS; GENETIC-VARIANTS; INFECTION; IDENTIFICATION; DIVERSITY; STRAINS; AGENT; SHEEP; INFERENCE	Anaplasma phagocytophilum is a Gram-negative obligate intracellular bacterium that replicates in neutrophils. It is transmitted via tick-bite and causes febrile disease in humans and animals. Human granulocytic anaplasmosis is regarded as an emerging infectious disease in North America, Europe and Asia. However, although increasingly detected, it is still rare in Europe. Clinically apparent A. phagocytophilum infections in animals are mainly found in horses, dogs, cats, sheep and cattle. Evidence from cross-infection experiments that A. phagocytophilum isolates of distinct host origin are not uniformly infectious for heterologous hosts has led to several approaches of molecular strain characterization. Unfortunately, the results of these studies are not always easily comparable, because different gene regions and fragment lengths were investigated. Multilocus sequence typing is a widely accepted method for molecular characterization of bacteria. We here provide for the first time a universal typing method that is easily transferable between different laboratories. We validated our approach on an unprecedented large data set of almost 400 A. phagocytophilum strains from humans and animals mostly from Europe. The typability was 74% (284/383). One major clonal complex containing 177 strains was detected. However, 54% (49/90) of the sequence types were not part of a clonal complex indicating that the population structure of A. phagocytophilum is probably semiclonal. All strains from humans, dogs and horses from Europe belonged to the same clonal complex. As canine and equine granulocytic anaplasmosis occurs frequently in Europe, human granulocytic anaplasmosis is likely to be underdiagnosed in Europe. Further, wild boars and hedgehogs may serve as reservoir hosts of the disease in humans and domestic animals in Europe, because their strains belonged to the same clonal complex. In contrast, as they were only distantly related, roe deer, voles and shrews are unlikely to harbor A. phagocytophilum strains infectious for humans, domestic or farm animals.	[Huhn, Christian; Winter, Christina; Wolfsperger, Timo; Wueppenhorst, Nicole; von Loewenich, Friederike D.] Univ Freiburg, Inst Med Microbiol & Hyg, D-79106 Freiburg, Germany; [Smrdel, Katja Straek] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia; [Skuballa, Jasmin; Pfaefle, Miriam; Petney, Trevor] Karlsruhe Inst Technol, Dept Ecol & Parasitol, D-76021 Karlsruhe, Germany; [Silaghi, Cornelia] Univ Munich, Munich, Germany; [Dyachenko, Viktor; Straubinger, Reinhard K.] Univ Munich, Inst Infect Dis & Zoonoses, Munich, Germany; [Pantchev, Nikola] IDEXX Vet Med Lab, Ludwigsburg, Germany; [Schaarschmidt-Kiener, Daniel] Lab Zugersee, Hunenberg, Switzerland; [Ganter, Martin] Univ Vet Med Hannover, Clin Swine & Small Ruminants, Hannover, Germany; [Aardema, Matthew L.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of Freiburg; University of Ljubljana; Helmholtz Association; Karlsruhe Institute of Technology; University of Munich; University of Munich; University of Veterinary Medicine Hannover, Foundation; Princeton University	von Loewenich, FD (corresponding author), Univ Freiburg, Inst Med Microbiol & Hyg, Hugstetter Str 55, D-79106 Freiburg, Germany.	friederike.loewenich@uniklinik-freiburg.de	Loewenich, Friederike/AAL-1587-2020; Straubinger, Reinhard K/D-1719-2010	Pfaffle, Miriam/0000-0001-6486-7701; Straubinger, Reinhard/0000-0001-8382-7182	German Research Foundation [LO1163/1-2]	German Research Foundation(German Research Foundation (DFG))	This study was supported by the German Research Foundation (http://www.dfg.de/), grant number LO1163/1-2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Deborah A., 2012, Morbidity and Mortality Weekly Report, V59, P1; Barbet AF, 2013, PATHOGENS, V2, P544, DOI 10.3390/pathogens2030544; Blanco JR, 2002, CLIN MICROBIOL INFEC, V8, P763, DOI 10.1046/j.1469-0691.2002.00557.x; Bown KJ, 2007, J CLIN MICROBIOL, V45, P1771, DOI 10.1128/JCM.00365-07; Bown KJ, 2011, VECTOR-BORNE ZOONOT, V11, P947, DOI 10.1089/vbz.2010.0185; Bown KJ, 2009, EMERG INFECT DIS, V15, P1948, DOI 10.3201/eid1512.090178; Brown JR, 2001, SYST BIOL, V50, P497, DOI 10.1080/10635150117729; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Carlyon JA, 2005, CURR PROTOC MICROBIO, DOI [10.1002/9780471729259.mc03a02s00., DOI 10.1002/9780471729259.MC03A02S00]; Carrade DD, 2009, J VET INTERN MED, V23, P1129, DOI 10.1111/j.1939-1676.2009.0384.x; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Casey ANJ, 2004, MICROBIOL-SGM, V150, P727, DOI 10.1099/mic.0.26648-0; CHEN SM, 1994, J CLIN MICROBIOL, V32, P589, DOI 10.1128/JCM.32.3.589-595.1994; Cui F, 2013, AM J TROP MED HYG, V88, P510, DOI 10.4269/ajtmh.11-0760; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Dziegiel B, 2013, RES VET SCI, V95, P316, DOI 10.1016/j.rvsc.2013.05.010; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feil EJ, 2004, NAT REV MICROBIOL, V2, P483, DOI 10.1038/nrmicro904; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008265; Granquist EG, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-25; Hartelt K, 2008, PARASITOL RES, V103, pS109, DOI 10.1007/s00436-008-1059-4; Hartwig V, 2014, TICKS TICK BORNE DIS; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Henniger T, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-38; Herndon DR, 2013, INFECT IMMUN, V81, P1852, DOI 10.1128/IAI.00199-13; Ismail N, 2010, CLIN LAB MED, V30, P261, DOI 10.1016/j.cll.2009.10.004; Jakobsen IB, 1996, COMPUT APPL BIOSCI, V12, P291; Jin HT, 2012, VECTOR-BORNE ZOONOT, V12, P269, DOI 10.1089/vbz.2011.0753; Levin BR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000601; Li HY, 2011, INT J INFECT DIS, V15, pE859, DOI 10.1016/j.ijid.2011.09.008; Little SE, 2010, VET CLIN N AM-SMALL, V40, P1121, DOI 10.1016/j.cvsm.2010.07.004; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Majazki J, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-235; Massung RF, 1998, J CLIN MICROBIOL, V36, P1090, DOI 10.1128/JCM.36.4.1090-1095.1998; Michalik J, 2012, EMERG INFECT DIS, V18, P998, DOI 10.3201/eid1806.110997; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ogden NH, 1998, MED VET ENTOMOL, V12, P423, DOI 10.1046/j.1365-2915.1998.00133.x; Pfaffle M, 2011, EXP APPL ACAROL, V54, P151, DOI 10.1007/s10493-011-9432-x; Poitout FM, 2005, J CLIN MICROBIOL, V43, P796, DOI 10.1128/JCM.43.2.796-801.2005; Pritchard JK, 2000, GENETICS, V155, P945; Rar V, 2011, INFECT GENET EVOL, V11, P1842, DOI 10.1016/j.meegid.2011.09.019; Rikihisa Y, 2010, CURR OPIN MICROBIOL, V13, P59, DOI 10.1016/j.mib.2009.12.008; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rymaszewska A, 2008, EUR J CLIN MICROBIOL, V27, P1025, DOI 10.1007/s10096-008-0539-x; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Scharf W, 2011, J CLIN MICROBIOL, V49, P790, DOI 10.1128/JCM.02051-10; Severiano A, 2011, J CLIN MICROBIOL, V49, P3997, DOI 10.1128/JCM.00624-11; Silaghi C, 2012, TICKS TICK-BORNE DIS, V3, P49, DOI 10.1016/j.ttbdis.2011.11.005; Skuballa J, 2010, VECTOR-BORNE ZOONOT, V10, P1055, DOI 10.1089/vbz.2009.0150; SMITH JM, 1992, J MOL EVOL, V34, P126; Smrdel KS, 2009, CLIN MICROBIOL INFEC, V15, P50, DOI 10.1111/j.1469-0691.2008.02174.x; Stafford KC, 1999, J CLIN MICROBIOL, V37, P2887, DOI 10.1128/JCM.37.9.2887-2892.1999; Strle F, 2004, INT J MED MICROBIOL, V293, P27, DOI 10.1016/S1433-1128(04)80006-8; Stuen S, 2008, VET REC, V163, P338, DOI 10.1136/vr.163.11.338; Stuen S, 2002, J CLIN MICROBIOL, V40, P3192, DOI 10.1128/JCM.40.9.3192-3197.2002; Stuen S, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00031; Stuen S, 2013, TICKS TICK-BORNE DIS, V4, P197, DOI 10.1016/j.ttbdis.2012.11.014; Stuen S, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-41; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Telford SR, 1996, P NATL ACAD SCI USA, V93, P6209, DOI 10.1073/pnas.93.12.6209; Vichova B, 2013, INFECT GENET EVOL; von Loewenich FD, 2003, J CLIN MICROBIOL, V41, P5033, DOI 10.1128/JCM.41.11.5033-5040.2003; Woldehiwet Z, 2010, VET PARASITOL, V167, P108, DOI 10.1016/j.vetpar.2009.09.013; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zeman P, 2008, INT J MED MICROBIOL, V298, P203, DOI 10.1016/j.ijmm.2008.03.003; Zhang LJ, 2008, JAMA-J AM MED ASSOC, V300, P2263, DOI 10.1001/jama.2008.626; Zhang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057155	73	60	64	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93725	10.1371/journal.pone.0093725	http://dx.doi.org/10.1371/journal.pone.0093725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699849	Green Submitted, Green Published, gold			2022-12-27	WOS:000334105000097
J	Santiago, P; Grinsztejn, B; Friedman, RK; Cunha, CB; Coelho, LE; Luz, PM; de Oliveira, AV; Moreira, RI; Cardoso, SW; Veloso, VG; Suassuna, JHR				Santiago, Patricia; Grinsztejn, Beatriz; Friedman, Ruth Khalili; Cunha, Cynthia B.; Coelho, Lara Esteves; Luz, Paula Mendes; de Oliveira, Albanita Viana; Moreira, Ronaldo Ismerio; Cardoso, Sandra W.; Veloso, Valdilea G.; Rocco Suassuna, Jose H.			Screening for Decreased Glomerular Filtration Rate and Associated Risk Factors in a Cohort of HIV-Infected Patients in a Middle-Income Country	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; ANTIRETROVIRAL THERAPY; CARDIOVASCULAR MORTALITY; ESTIMATING EQUATIONS; ALL-CAUSE; PREVALENCE; PROGRESSION; POPULATION; ADULTS	With the introduction of combined active antiretroviral therapy and the improved survival of HIV-infected patients, degenerative diseases and drug toxicity have emerged as long-term concerns. We studied the prevalence of decreased glomerular filtration rate (GFR) and associated risk factors in a cohort of HIV-infected patients from a middle-income country. Our cross-sectional study included all adult patients who attended an urban outpatient clinic in 2008. GFR was estimated using the CKD-EPI equation. The prevalence ratio (PR) of decreased GFR (defined as < 60 mL/min/1.73 m(2)) was estimated using generalizing linear models assuming a Poisson distribution. We analyzed data from 1,970 patients, of which 82.9% had been exposed to ART. A total of 249 patients (12.6%) had a GFR between 60 and 89 mL/min/1.73 m(2), 3.1% had a GFR between 30 and 59, 0.3% had a GFR between 15 and 29, and 0.4% had a GFR < 15. Decreased GFR was found in only 74 patients (3.8%). In the multivariate regression model, the factors that were independently associated with a GFR below 60 mL/min/1.73 m(2) were as follows: age >= 50 years (PR=3.4; 95% CI: 1.7-6.8), diabetes (PR=2.0; 95% CI: 1.2-3.4), hypertension (PR=2.0; 95% CI: 1.3-3.2), current CD4+ cell count < 350 cells/mm3 (PR=2.1; 95% CI: 1.3-3.3), past exposure to tenofovir (PR=4.7; 95% CI: 2.3-9.4) and past exposure to indinavir (PR=1.7; 95% CI: 1.0-2.8). As in high-income countries, CKD was the predominant form of kidney involvement among HIV-infected individuals in our setting. The risk factors associated with decreased glomerular filtration were broad and included virus-related factors as well as degenerative and nephrotoxic factors. Despite the potential for nephrotoxicity associated with some antiretroviral drugs, in the short-term, advanced chronic renal disease remains very rare.	[Santiago, Patricia; Grinsztejn, Beatriz; Friedman, Ruth Khalili; Cunha, Cynthia B.; Coelho, Lara Esteves; Luz, Paula Mendes; Moreira, Ronaldo Ismerio; Cardoso, Sandra W.; Veloso, Valdilea G.] Fundaco Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, STD AIDS Clin Res Lab, Rio De Janeiro, Brazil; [Santiago, Patricia; Rocco Suassuna, Jose H.] Univ Estado Rio de Janeiro, Fac Ciencias Med, Hosp Univ Pedro Ernesto, Clin & Acad Unit Nephrol, BR-20550011 Rio De Janeiro, Brazil; [de Oliveira, Albanita Viana] Univ Estado Rio de Janeiro, Fac Ciencias Med, Dept Pathol, BR-20550011 Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Suassuna, JHR (corresponding author), Univ Estado Rio de Janeiro, Fac Ciencias Med, Hosp Univ Pedro Ernesto, Clin & Acad Unit Nephrol, BR-20550011 Rio De Janeiro, Brazil.	jsuassuna@alternex.com.br	Cardoso, Sandra W/D-7965-2015; Suassuna, José/N-5074-2014	Cardoso, Sandra W/0000-0001-5230-0003; Suassuna, José/0000-0002-4720-5391; Luz, Paula/0000-0001-9746-719X				Alves TP, 2010, CLIN J AM SOC NEPHRO, V5, P2269, DOI 10.2215/CJN.00520110; Astor BC, 2008, AM J EPIDEMIOL, V167, P1226, DOI 10.1093/aje/kwn033; Atta MG, 2006, NEPHROL DIAL TRANSPL, V21, P2809, DOI 10.1093/ndt/gfl337; Atta MG, 2008, SEMIN NEPHROL, V28, P563, DOI 10.1016/j.semnephrol.2008.08.009; Campbell LJ, 2009, HIV MED, V10, P329, DOI 10.1111/j.1468-1293.2008.00691.x; Choi AI, 2007, J AM SOC NEPHROL, V18, P2968, DOI 10.1681/ASN.2007040402; Colson AW, 2010, ACTA CLIN BELG, V65, P392, DOI 10.1179/acb.2010.65.6.004; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Crum-Cianflone N, 2010, AIDS PATIENT CARE ST, V24, P353, DOI 10.1089/apc.2009.0326; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Deti EK, 2010, HIV MED, V11, P308, DOI 10.1111/j.1468-1293.2009.00780.x; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; Earley A, 2012, ANN INTERN MED, V156, P785, DOI 10.7326/0003-4819-156-11-201203200-00391; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; Fernando SK, 2008, AM J MED SCI, V335, P89, DOI 10.1097/MAJ.0b013e31812e6b34; Flandre P, 2011, CLIN J AM SOC NEPHRO; Gardner LI, 2003, JAIDS-J ACQ IMM DEF, V32, P203, DOI 10.1097/00126334-200302010-00013; Giles PD, 2007, BMJ-BRIT MED J, V334, P1198, DOI 10.1136/bmj.39226.400694.80; Glassock RJ, 2008, CLIN J AM SOC NEPHRO, V3, P1563, DOI 10.2215/CJN.00960208; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Gupta SK, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-31; Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Holmberg SD, 2008, SCI ERRORS CONTROVER, P1; Ibrahim F, 2012, AM J KIDNEY DIS, V60, P539, DOI 10.1053/j.ajkd.2012.03.006; Inker LA, 2012, JAIDS-J ACQ IMM DEF, V61, P302, DOI 10.1097/QAI.0b013e31826a6c4f; Jaar BG, 2008, CLIN J AM SOC NEPHRO, V3, P601, DOI 10.2215/CJN.02540607; Kalyesubula R, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/562790; Lucas GM, 2008, J INFECT DIS, V197, P1548, DOI 10.1086/587994; Lucas GM, 2010, JAIDS-J ACQ IMM DEF, V55, P491, DOI 10.1097/QAI.0b013e3181e8d5a8; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Matsushita K, 2010, AM J KIDNEY DIS, V55, P648, DOI 10.1053/j.ajkd.2009.12.016; Medapalli RK, 2012, JAIDS-J ACQ IMM DEF, V60, P393, DOI 10.1097/QAI.0b013e31825b70d9; Mocroft A, 2007, AIDS, V21, P1119, DOI 10.1097/QAD.0b013e3280f774ee; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Mulenga LB, 2008, AIDS, V22, P1821, DOI 10.1097/QAD.0b013e328307a051; Myers Jeffrey D, 2009, JAAPA, V22, P20; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; Overton ET, 2009, HIV MED, V10, P343, DOI 10.1111/j.1468-1293.2009.00693.x; Phair J, 2011, CURR OPIN HIV AIDS, V6, P285, DOI 10.1097/COH.0b013e3283476bc3; Ramos AN, 2011, AIDS PATIENT CARE ST, V25, P713, DOI 10.1089/apc.2011.0044; Reid A, 2008, CLIN INFECT DIS, V46, P1271, DOI 10.1086/533468; Roe J, 2008, CLIN INFECT DIS, V47, P242, DOI 10.1086/589296; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f; Scialla JJ, 2007, AIDS, V21, P263, DOI 10.1097/QAD.0b013e3280119592; Sorli ML, 2008, J INT AIDS SOC, V11, pP130; Szczech LA, 2004, CLIN INFECT DIS, V39, P1199, DOI 10.1086/424013; US Renal Data System, 2011, USRDS 2011 ANN DAT R; Van Biesen W, 2007, EUR HEART J, V28, P478, DOI 10.1093/eurheartj/ehl455; Wever K, 2010, J ACQ IMMUN DEF SYND, V00, P1; White SL, 2010, AM J KIDNEY DIS, V55, P660, DOI 10.1053/j.ajkd.2009.12.011; WHO' UNAIDS and UNICEF Global HIV/AIDS response, WHO UNAIDS UNIEF GLO; Wyatt CM, 2007, AIDS, V21, P2101, DOI 10.1097/QAD.0b013e3282ef1bb4; Wyatt CM, 2006, AIDS, V20, P561, DOI 10.1097/01.aids.0000210610.52836.07; Yahalom G, 2013, EUROPEAN J PREVENTIV	59	21	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e93748	10.1371/journal.pone.0093748	http://dx.doi.org/10.1371/journal.pone.0093748			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699873	Green Published, gold, Green Submitted			2022-12-27	WOS:000334105000099
J	Dygalo, NN; Shemenkova, TV; Kalinina, TS; Shishkina, GT				Dygalo, Nikolay N.; Shemenkova, Tatjana V.; Kalinina, Tatjana S.; Shishkina, Galina T.			A Critical Point of Male Gonad Development: Neuroendocrine Correlates of Accelerated Testicular Growth in Rats during Early Life	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; FOLLICLE-STIMULATING-HORMONE; INHIBIN-B LEVELS; POSTNATAL-DEVELOPMENT; LUTEINIZING-HORMONE; GENE-EXPRESSION; NEONATAL-RATS; GNRH NEURONS; SIGNALING PATHWAYS; SERTOLI-CELLS	Testis growth during early life is important for future male fertility and shows acceleration during the first months of life in humans. This acceleration coincides with the peak in gonadotropic hormones in the blood, while the role of hypothalamic factors remains vague. Using neonatal rats to assess this issue, we found that day 9 of life is likely critical for testis development in rats. Before this day, testicular growth was proportional to body weight gain, but after that the testes showed accelerated growth. Hypothalamic kisspeptin and its receptor mRNA levels begin to elevate 2 days later, at day 11. A significant increase in the mRNA levels for gonadotropin-releasing hormone ( GnRH) receptors in the hypothalamus between days 5 and 7 was followed by a 3-fold decrease in GnRH mRNA levels in this brain region during the next 2 days. Starting from day 9, hypothalamic GnRH mRNA levels increased significantly and positively correlated with accelerated testicular growth. Triptorelin, an agonist of GnRH, at a dose that had no effect on testicular growth during "proportional" period, increased testis weights during the period of accelerated growth. The insensitivity of testicular growth to GnRH during "proportional" period was supported by inability of a 2.5-fold siRNA knockdown of GnRH expression in the hypothalamus of the 7-day-old animals to produce any effect on their testis weights. GnRH receptor blockade with cetrorelix was also without effect on testis weights during "proportional" period but the same doses of this GnRH antagonist significantly inhibited "accelerated" testicular growth. GnRH receptor mRNA levels in the pituitary as well as plasma LH concentrations were higher during "accelerated" period of testicular growth than during "proportional" period. In general, our data defined two distinct periods in rat testicular development that are primarily characterized by different responses to GnRH signaling.	[Dygalo, Nikolay N.; Kalinina, Tatjana S.; Shishkina, Galina T.] Russian Acad Sci, Inst Cytol & Genet, Lab Funct Neurogen, Novosibirsk 630090, Russia; [Dygalo, Nikolay N.; Shemenkova, Tatjana V.; Kalinina, Tatjana S.] Novosibirsk State Univ, Dept Physiol, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University	Dygalo, NN (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Lab Funct Neurogen, Novosibirsk 630090, Russia.	dygalo@bionet.nsc.ru	Kalinina, Tatyana/R-8412-2016	Kalinina, Tatyana/0000-0002-2575-4621; Dygalo, Nikolay/0000-0002-0638-1794	Russian Foundation for Basic Research [N 11-04-00375]; RAS [MCB 6.20]; FCP [8060]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); RAS(Russian Academy of SciencesRegione Sardegna); FCP	This work was supported by Russian Foundation for Basic Research grant N 11-04-00375, RAS Program MCB 6.20, FCP No. 8060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKLAND JF, 1991, BIOL REPROD, V45, P295, DOI 10.1095/biolreprod45.2.295; Andersson AM, 1998, J CLIN ENDOCR METAB, V83, P675, DOI 10.1210/jc.83.2.675; AUBERT ML, 1985, ENDOCRINOLOGY, V116, P1565, DOI 10.1210/endo-116-4-1565; Barakat B, 2008, REPRODUCTION, V136, P345, DOI 10.1530/REP-08-0140; Bhattacharya I, 2012, AM J PHYSIOL-ENDOC M, V303, pE886, DOI 10.1152/ajpendo.00293.2012; Buzzard JJ, 2004, ENDOCRINOLOGY, V145, P3532, DOI 10.1210/en.2003-1036; Campbell RE, 2009, P NATL ACAD SCI USA, V106, P10835, DOI 10.1073/pnas.0903463106; Castellano JM, 2006, MOL CELL ENDOCRINOL, V257-8, P75, DOI 10.1016/j.mce.2006.07.002; Chan YM, 2009, J NEUROENDOCRINOL, V21, P1015, DOI 10.1111/j.1365-2826.2009.01926.x; Chen PL, 2009, J NEUROSCI, V29, P9809, DOI 10.1523/JNEUROSCI.2509-09.2009; Ciechanowska M, 2010, REPROD BIOL, V10, P85, DOI 10.1016/S1642-431X(12)60054-0; Clarkson J, 2012, J NEUROENDOCRINOL, V24, P907, DOI 10.1111/j.1365-2826.2012.02294.x; Constantin S, 2009, ENDOCRINOLOGY, V150, P3221, DOI 10.1210/en.2008-1711; Cottrell EC, 2006, ENDOCRINOLOGY, V147, P3652, DOI 10.1210/en.2006-0296; Danneman PJ, 1997, LAB ANIM SCI, V47, P386; Dygalo NN, 2010, NEUROSCI LETT, V486, P224, DOI 10.1016/j.neulet.2010.09.058; Ehmcke J, 2006, HUM REPROD UPDATE, V12, P275, DOI 10.1093/humupd/dmk001; Glidewell-Kenney C, 2008, ENDOCRINOLOGY, V149, P4168, DOI 10.1210/en.2007-1807; Gore AC, 1999, ENDOCRINOLOGY, V140, P2280, DOI 10.1210/en.140.5.2280; Grigorova M, 2013, ANDROLOGY-US, V1, P293, DOI 10.1111/j.2047-2927.2012.00028.x; Grigorova M, 2011, J CLIN ENDOCR METAB, V96, pE1534, DOI 10.1210/jc.2011-0632; Grumbach MM, 2005, J CLIN ENDOCR METAB, V90, P3122, DOI 10.1210/jc.2004-2465; HABERT R, 1993, ACTA ENDOCRINOL-COP, V128, P268, DOI 10.1530/acta.0.1280268; Hadziselimovic F, 2005, J UROLOGY, V174, P1536, DOI 10.1097/01.ju.0000181506.97839.b0; Han SK, 2010, J NEUROENDOCRINOL, V22, P188, DOI 10.1111/j.1365-2826.2009.01950.x; KERR JB, 1988, DEVELOPMENT, V103, P535; KETELSLEGERS JM, 1978, ENDOCRINOLOGY, V103, P212, DOI 10.1210/endo-103-1-212; Kuijper EAM, 2008, HUM REPROD, V23, P792, DOI 10.1093/humrep/den021; Kuiri-Hanninen T, 2011, J CLIN ENDOCR METAB, V96, P98, DOI 10.1210/jc.2010-1359; LALAU JD, 1990, NEUROENDOCRINOLOGY, V51, P284, DOI 10.1159/000125351; LEE VWK, 1975, J REPROD FERTIL, V42, P121, DOI 10.1530/jrf.0.0420121; Lindzey J, 1998, ENDOCRINOLOGY, V139, P4092, DOI 10.1210/en.139.10.4092; MACLUSKY NJ, 1979, BRAIN RES, V178, P143, DOI 10.1016/0006-8993(79)90094-5; Main KM, 2006, J CLIN ENDOCR METAB, V91, P2732, DOI 10.1210/jc.2005-2443; Migrenne S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053257; Navarro VM, 2004, ENDOCRINOLOGY, V145, P4565, DOI 10.1210/en.2004-0413; NEMESKERI A, 1986, EXP CLIN ENDOCRINOL, V88, P275, DOI 10.1055/s-0029-1210607; Nowak FV, 1999, J NEUROENDOCRINOL, V11, P951; O'Shaughnessy PJ, 2009, MOL CELL ENDOCRINOL, V306, P2, DOI 10.1016/j.mce.2008.11.005; O'Shaughnessy PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035136; O'Shaughnessy PJ, 1998, ENDOCRINOLOGY, V139, P1141, DOI 10.1210/en.139.3.1141; PAKARINEN PA, 1992, ACTA ENDOCRINOL-COP, V127, P454, DOI 10.1530/acta.0.1270454; Petersen C, 2006, HORM RES, V66, P153, DOI 10.1159/000094142; Pinilla L, 2012, PHYSIOL REV, V92, P1235, DOI 10.1152/physrev.00037.2010; Poling MC, 2012, ENDOCRINOLOGY, V153, P782, DOI 10.1210/en.2011-1838; SALISBURY RL, 1982, NEUROENDOCRINOLOGY, V35, P265, DOI 10.1159/000123392; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Shishkina GT, 2004, NEUROSCIENCE, V129, P521, DOI 10.1016/j.neuroscience.2004.08.015; SHISHKINA GT, 1994, EXPERIENTIA, V50, P721, DOI 10.1007/BF01919370; Stukenborg JB, 2010, SEX DEV, V4, P199, DOI 10.1159/000317090; Walker DM, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102798; Walker DM, 2009, ENDOCRINOLOGY, V150, P2308, DOI 10.1210/en.2008-1396; Wu XF, 2010, REPRODUCTION, V140, P113, DOI 10.1530/REP-09-0349; Xu C, 2004, ENDOCRINOLOGY, V145, P728, DOI 10.1210/en.2003-0562; Zapatero-Caballero H, 2003, BIOL REPROD, V68, P1764, DOI 10.1095/biolreprod.102.008821; Zhang FP, 2004, ENDOCRINOLOGY, V145, P1453, DOI 10.1210/en.2003-1049; ZHENGWEI Y, 1990, BIOL REPROD, V43, P629, DOI 10.1095/biolreprod43.4.629	57	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93007	10.1371/journal.pone.0093007	http://dx.doi.org/10.1371/journal.pone.0093007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695464	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000033
J	Honjoh, T; Ji, ZG; Yokoyama, Y; Sumiyoshi, A; Shibuya, Y; Matsuzaka, Y; Kawashima, R; Mushiake, H; Ishizuka, T; Yawo, H				Honjoh, Tatsuya; Ji, Zhi-Gang; Yokoyama, Yukinobu; Sumiyoshi, Akira; Shibuya, Yuma; Matsuzaka, Yoshiya; Kawashima, Ryuta; Mushiake, Hajime; Ishizuka, Toru; Yawo, Hiromu			Optogenetic Patterning of Whisker-Barrel Cortical System in Transgenic Rat Expressing Channelrhodopsin-2	PLOS ONE			English	Article							TRIGEMINAL GANGLION NEURONS; FUNCTIONAL MRI; SOMATOSENSORY CORTEX; OBJECT LOCALIZATION; SENSORY RESPONSES; OPTICAL CONTROL; K+ CURRENTS; IN-VIVO; STATES; FMRI	The rodent whisker-barrel system has been an ideal model for studying somatosensory representations in the cortex. However, it remains a challenge to experimentally stimulate whiskers with a given pattern under spatiotemporal precision. Recently the optogenetic manipulation of neuronal activity has made possible the analysis of the neuronal network with precise spatiotemporal resolution. Here we identified the selective expression of channelrhodopsin-2 (ChR2), an algal light-driven cation channel, in the large mechanoreceptive neurons in the trigeminal ganglion (TG) as well as their peripheral nerve endings innervating the whisker follicles of a transgenic rat. The spatiotemporal pattern of whisker irradiation thus produced a barrel-cortical response with a specific spatiotemporal pattern as evidenced by electrophysiological and functional MRI (fMRI) studies. Our methods of generating an optogenetic tactile pattern (OTP) can be expected to facilitate studies on how the spatiotemporal pattern of touch is represented in the somatosensory cortex, as Hubel and Wiesel did in the visual cortex.	[Honjoh, Tatsuya; Ji, Zhi-Gang; Yokoyama, Yukinobu; Shibuya, Yuma; Ishizuka, Toru; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan; [Honjoh, Tatsuya; Ji, Zhi-Gang; Yokoyama, Yukinobu; Matsuzaka, Yoshiya; Mushiake, Hajime; Ishizuka, Toru; Yawo, Hiromu] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan; [Sumiyoshi, Akira; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Matsuzaka, Yoshiya; Mushiake, Hajime] Tohoku Univ, Grad Sch Med, Dept Physiol, Sendai, Miyagi 980, Japan; [Mushiake, Hajime; Yawo, Hiromu] Tohoku Univ, Grad Sch Med, Ctr Neurosci, Sendai, Miyagi 980, Japan	Tohoku University; Japan Science & Technology Agency (JST); Tohoku University; Tohoku University; Tohoku University	Yawo, H (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan.	yawo-hiromu@m.tohoku.ac.jp	Yawo, Hiromu/I-4871-2015; Ishizuka, Toru/L-8191-2017; Sumiyoshi, Akira/AGR-1704-2022	Yawo, Hiromu/0000-0002-4299-3288; Ishizuka, Toru/0000-0003-4405-8792; Sumiyoshi, Akira/0000-0001-9522-8064; Mushiake, Hajime/0000-0002-5130-4720	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23115501]; Japan Society for the Promotion of Science (JSPS) [25115701, 25670103]; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Research Foundation for Opto-Science and Technology	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Research Foundation for Opto-Science and Technology	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Mesoscopic Neurocircuitry" (No. 23115501) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Grant-in Aid for Scientific Research (No. 25115701) and Grant-in-Aid for challenging Exploratory Research (No. 25670103) of Japan Society for the Promotion of Science (JSPS), the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) and Research Foundation for Opto-Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2012, NEUROSCI RES, V74, P248, DOI 10.1016/j.neures.2012.08.007; Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cabanes C, 2002, J NEUROPHYSIOL, V87, P2398, DOI 10.1152/jn.2002.87.5.2398; Catacuzzeno L, 2008, J PHYSIOL-LONDON, V586, P5101, DOI 10.1113/jphysiol.2008.159384; Civillico EF, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00025; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Desai M, 2011, J NEUROPHYSIOL, V105, P1393, DOI 10.1152/jn.00828.2010; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Ebara S, 2002, J COMP NEUROL, V449, P103, DOI 10.1002/cne.10277; Erchova IA, 2002, EUR J NEUROSCI, V15, P744, DOI 10.1046/j.0953-816x.2002.01898.x; Goense J, 2012, NEURON, V76, P629, DOI 10.1016/j.neuron.2012.09.019; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Hirata A, 2008, J NEUROPHYSIOL, V100, P358, DOI 10.1152/jn.90538.2008; Honjoh T, 2013, J PHYSIOL SCI, V63, pS252; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Ichikawa H, 2004, BRAIN RES, V998, P130, DOI 10.1016/j.brainres.2003.11.019; Ikezoe K, 2012, NEUROSCI RES, V73, P312, DOI 10.1016/j.neures.2012.05.009; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Ji ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032699; Kahn I, 2011, J NEUROSCI, V31, P15086, DOI 10.1523/JNEUROSCI.0007-11.2011; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Knutsen PM, 2009, TRENDS NEUROSCI, V32, P101, DOI 10.1016/j.tins.2008.10.002; Kuki T, 2013, NEUROSCI RES, V75, P35, DOI 10.1016/j.neures.2012.10.007; Liu L, 2001, J NEUROPHYSIOL, V85, P745, DOI 10.1152/jn.2001.85.2.745; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Martin C, 2006, NEUROIMAGE, V32, P33, DOI 10.1016/j.neuroimage.2006.02.021; Nicholls J., 2001, NEURON BRAIN; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Ooi L, 2013, J NEUROSCI, V33, P6041, DOI 10.1523/JNEUROSCI.4275-12.2013; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Piao L, 2006, J NEUROSCI RES, V83, P1373, DOI 10.1002/jnr.20810; Reinohl J, 2003, NEUROSCI LETT, V338, P25, DOI 10.1016/S0304-3940(02)01360-5; Rice FL, 1997, J COMP NEUROL, V385, P149; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Sanganahalli BG, 2008, NMR BIOMED, V21, P410, DOI 10.1002/nbm.1259; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Sumiyoshi A, 2012, NEUROIMAGE, V60, P738, DOI 10.1016/j.neuroimage.2011.12.082; Tamamaki N, 2000, NEUROSCI RES, V38, P231, DOI 10.1016/S0168-0102(00)00176-0; Timofeev I, 2011, CURR TOP MED CHEM, V11, P2457, DOI 10.2174/156802611797470376; Tomita H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007679; Ushimaru M, 2012, J NEUROSCI, V32, P1730, DOI 10.1523/JNEUROSCI.4883-11.2012; Viaene AN, 2011, P NATL ACAD SCI USA, V108, P18156, DOI 10.1073/pnas.1114828108; Villiere V, 1996, J NEUROPHYSIOL, V76, P1924, DOI 10.1152/jn.1996.76.3.1924; Watson BO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003971; Xu SH, 2010, J NEUROPHYSIOL, V104, P3451, DOI 10.1152/jn.00336.2010; Yang XJ, 1996, P NATL ACAD SCI USA, V93, P475, DOI 10.1073/pnas.93.1.475; Yu X, 2010, NEUROIMAGE, V49, P1667, DOI 10.1016/j.neuroimage.2009.09.021	55	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93706	10.1371/journal.pone.0093706	http://dx.doi.org/10.1371/journal.pone.0093706			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695456	Green Submitted, gold, Green Published			2022-12-27	WOS:000334103000108
J	Berger, A; Dohnt, K; Tielen, P; Jahn, D; Becker, J; Wittmann, C				Berger, Antje; Dohnt, Katrin; Tielen, Petra; Jahn, Dieter; Becker, Judith; Wittmann, Christoph			Robustness and Plasticity of Metabolic Pathway Flux among Uropathogenic Isolates of Pseudomonas aeruginosa	PLOS ONE			English	Article							ISOCITRATE LYASE; URINARY-TRACT; CORYNEBACTERIUM-GLUTAMICUM; IN-VIVO; VIRULENCE FACTORS; BACTERIAL; ADAPTATION; INFECTION; SYSTEMS; PUTIDA	Pseudomonas aeruginosa is a human pathogen that frequently causes urinary tract and catheter-associated urinary tract infections. Here, using C-13-metabolic flux analysis, we conducted quantitative analysis of metabolic fluxes in the model strain P. aeruginosa PAO1 and 17 clinical isolates. All P. aeruginosa strains catabolized glucose through the Entner-Doudoroff pathway with fully respiratory metabolism and no overflow. Together with other NADPH supplying reactions, this high-flux pathway provided by far more NADPH than needed for anabolism: a benefit for the pathogen to counteract oxidative stress imposed by the host. P. aeruginosa recruited the pentose phosphate pathway exclusively for biosynthesis. In contrast to glycolytic metabolism, which was conserved among all isolates, the flux through pyruvate metabolism, the tricarboxylic acid cycle, and the glyoxylate shunt was highly variable, likely caused by adaptive processes in individual strains during infection. This aspect of metabolism was niche-specific with respect to the corresponding flux because strains isolated from the urinary tract clustered separately from those originating from catheter-associated infections. Interestingly, most glucose-grown strains exhibited significant flux through the glyoxylate shunt. Projection into the theoretical flux space, which was computed using elementary flux-mode analysis, indicated that P. aeruginosa metabolism is optimized for efficient growth and exhibits significant potential for increasing NADPH supply to drive oxidative stress response.	[Berger, Antje; Dohnt, Katrin; Becker, Judith; Wittmann, Christoph] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Engn, D-38106 Braunschweig, Germany; [Tielen, Petra; Jahn, Dieter] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Becker, Judith; Wittmann, Christoph] Univ Saarland, Inst Syst Biotechnol, D-66123 Saarbrucken, Germany	Braunschweig University of Technology; Braunschweig University of Technology; Saarland University	Wittmann, C (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Engn, D-38106 Braunschweig, Germany.	christoph.wittmann@uni-saarland.de		Wittmann, Christoph/0000-0002-7952-985X; Jahn, Dieter/0000-0002-4064-9205	German Federal Ministry of Eduction and Research in the initiative Medical Infection Genomics [315833D]	German Federal Ministry of Eduction and Research in the initiative Medical Infection Genomics	This work was financially supported by the German Federal Ministry of Eduction and Research (www.bmbf.de) through grant 315833D in the initiative Medical Infection Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian D, 2013, NUCLEIC ACIDS RES, V41, P1, DOI 10.1093/nar/gks1039; Bereket W, 2012, EUR REV MED PHARMACO, V16, P1039; Blank LM, 2008, FEBS J, V275, P5173, DOI 10.1111/j.1742-4658.2008.06648.x; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Chang SL, 2006, PEDIATR CLIN N AM, V53, P379, DOI 10.1016/j.pcl.2006.02.011; Chavarria M, 2013, ENVIRON MICROBIOL, V15, P1772, DOI 10.1111/1462-2920.12069; Chen PR, 2011, ANTIOXID REDOX SIGN, V14, P1107, DOI 10.1089/ars.2010.3374; Damron FH, 2012, MOL MICROBIOL, V84, P595, DOI 10.1111/j.1365-2958.2012.08049.x; Dash M, 2003, DATA KNOWL ENG, V44, P109, DOI 10.1016/S0169-023X(02)00138-6; Dohnt K, 2011, J MICROBIOL METH, V87, P302, DOI 10.1016/j.mimet.2011.09.002; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; Eschbach E, 2006, J BACTERIOL, V186, P4596; Fang FC, 2005, INFECT IMMUN, V73, P2547, DOI 10.1128/IAI.73.4.2547-2549.2005; FILISETTICOZZI TMCC, 1991, ANAL BIOCHEM, V197, P157, DOI 10.1016/0003-2697(91)90372-Z; Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Furch T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-209; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; Hamood AN, 1996, J SURG RES, V61, P425, DOI 10.1006/jsre.1996.0140; Hellerstein MK, 2008, METAB ENG, V10, P1, DOI 10.1016/j.ymben.2007.09.003; Hindre T, 2012, NAT REV MICROBIOL, V10, P352, DOI 10.1038/nrmicro2750; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; Hogardt M, 2013, CURR TOP MICROBIOL, V358, P91, DOI 10.1007/82_2011_199; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kelleher JK, 2001, METAB ENG, V3, P100, DOI 10.1006/mben.2001.0185; Kind S, 2013, METAB ENG, V15, P184, DOI 10.1016/j.ymben.2012.07.005; Kohlstedt M, 2010, APPL MICROBIOL BIOT, V88, P1065, DOI 10.1007/s00253-010-2854-2; Kondrashov FA, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-31; Kretzschmar U, 2008, ARCH MICROBIOL, V190, P151, DOI 10.1007/s00203-008-0381-7; Kromer JO, 2008, MICROBIOL-SGM, V154, P3917, DOI 10.1099/mic.0.2008/021204-0; Kucheria R, 2005, POSTGRAD MED J, V81, P83, DOI 10.1136/pgmj.2004.023036; Le Gac M, 2012, P NATL ACAD SCI USA, V109, P9487, DOI 10.1073/pnas.1207091109; Lindsey TL, 2008, MICROBIOL-SGM, V154, P1616, DOI 10.1099/mic.0.2007/014506-0; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Marx A, 1996, BIOTECHNOL BIOENG, V49, P111, DOI 10.1002/(SICI)1097-0290(19960120)49:2<111::AID-BIT1>3.0.CO;2-T; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Melzer G, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-120; Mittal Rahul, 2009, J Infect Public Health, V2, P101, DOI 10.1016/j.jiph.2009.08.003; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Oberhardt MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001116; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Poblete-Castro I, 2013, METAB ENG, V15, P113, DOI 10.1016/j.ymben.2012.10.004; Quek LE, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-25; REINSCHEID DJ, 1994, J BACTERIOL, V176, P3474, DOI 10.1128/JB.176.12.3474-3483.1994; Romano AH, 1996, RES MICROBIOL, V147, P448, DOI 10.1016/0923-2508(96)83998-2; ROSENBLOOM J, 1995, ADV EXP MED BIOL, V385, P161; Rumbaugh KP, 1999, J HOSP INFECT, V43, P211, DOI 10.1053/jhin.1999.0252; Schneider K, 2010, BIOPROC BIOSYST ENG, V33, P541, DOI 10.1007/s00449-009-0367-0; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; SMITH RA, 1957, J BIOL CHEM, V229, P305; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; STORZ G, 1990, TRENDS GENET, V6, P363, DOI 10.1016/0168-9525(90)90278-E; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tamma PD, 2012, CLIN MICROBIOL REV, V25, P450, DOI 10.1128/CMR.05041-11; Tielen P, 2011, INT J MED MICROBIOL, V301, P282, DOI 10.1016/j.ijmm.2010.10.005; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393; Wall DM, 2005, INFECT IMMUN, V73, P6736, DOI 10.1128/IAI.73.10.6736-6741.2005; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Wittmann C, 2002, APPL ENVIRON MICROB, V68, P5843, DOI 10.1128/AEM.68.12.5843-5859.2002; Wittmann C, 2002, ANAL BIOCHEM, V307, P379, DOI 10.1016/S0003-2697(02)00030-1; Wittmann C, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-6; Wittmann C, 2007, J BIOTECHNOL, V132, P375, DOI 10.1016/j.jbiotec.2007.07.495; Zamboni N, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r99	66	44	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e88368	10.1371/journal.pone.0088368	http://dx.doi.org/10.1371/journal.pone.0088368			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709961	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800005
J	Kodama, S; Yamada, T; Imai, J; Sawada, S; Takahashi, K; Tsukita, S; Kaneko, K; Uno, K; Ishigaki, Y; Oka, Y; Katagiri, H				Kodama, Shinjiro; Yamada, Tetsuya; Imai, Junta; Sawada, Shojiro; Takahashi, Kei; Tsukita, Sohei; Kaneko, Keizo; Uno, Kenji; Ishigaki, Yasushi; Oka, Yoshitomo; Katagiri, Hideki			Simultaneous Copy Number Losses within Multiple Subtelomeric Regions in Early-Onset Type2 Diabetes Mellitus	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ARRAY CGH; GENE; RISK; SUSCEPTIBILITY; MUTATION; ARCHITECTURE; EXPRESSION; DISORDERS; DISCOVERY	Genetic factors play very important roles in the onset and progression of type 2 diabetes mellitus (T2DM). However, the genetic factors correlating with T2DM onset have not as yet been fully clarified. We previously found that copy number losses in the subtelomeric region on chromosome 4p16.3 were detected in early-onset Japanese T2DM patients (onset age,35 years) at a high frequency. Herein, we additionally found two novel copy number losses within the subtelomeric regions on chromosomes 16q24.2-3 and 22q13.31-33, which have significant associations with early-onset Japanese T2DM. The associations were statistically significant by Fisher's exact tests with P values of 5.19x10(-3) and 1.8x10(-3) and odds ratios of 5.7 and 4.4 for 16q24.2-3 and 22q13.31-33, respectively. Furthermore, copy number variation (CNV) analysis of the whole genome using the CNV BeadChip system verified simultaneous copy number losses in all three subtelomeric regions in 11 of our 100 T2DM subjects, while none of 100 non-diabetic controls showed the copy number losses in all three regions. Our results suggest that the mechanism underlying induction of CNVs is involved in the pathogenesis of early-onset T2DM. Thus, copy number losses within multiple subtelomeric regions are strongly associated with early-onset T2DM and examination of simultaneous CNVs in these three regions may lead to the development of an accurate and selective procedure for detecting genetic susceptibility to T2DM.	[Kodama, Shinjiro; Yamada, Tetsuya; Imai, Junta; Sawada, Shojiro; Takahashi, Kei; Tsukita, Sohei; Kaneko, Keizo; Uno, Kenji; Ishigaki, Yasushi; Oka, Yoshitomo; Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Div Metab & Diabet, Sendai, Miyagi 980, Japan; [Katagiri, Hideki] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Tohoku University; Japan Science & Technology Agency (JST)	Katagiri, H (corresponding author), Tohoku Univ, Grad Sch Med, Div Metab & Diabet, Sendai, Miyagi 980, Japan.	katagiri@med.tohoku.ac.jp			Ministry of Health, Labor, and Welfare of Japan [H19-genome-005]; Global-COE Programs for "Network Medicine"; Grants-in-Aid for Scientific Research [24659439] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Global-COE Programs for "Network Medicine"; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research to Y. Oka (H19-genome-005) from the Ministry of Health, Labor, and Welfare of Japan, and was also supported by a grant from the Global-COE Programs for "Network Medicine" to Y. Oka and H. Katagiri from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani A, 2004, J CELL SCI, V117, P2239, DOI 10.1242/jcs.01041; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Flavell DM, 2005, DIABETES, V54, P582, DOI 10.2337/diabetes.54.2.582; Frayling TM, 2001, DIABETES, V50, pS94, DOI 10.2337/diabetes.50.2007.S94; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hayakawa T, 1998, J BIOL CHEM, V273, P20300, DOI 10.1074/jbc.273.32.20300; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; KATAGIRI H, 1992, LANCET, V340, P1316, DOI 10.1016/0140-6736(92)92494-Z; Kimura SH, 1997, GENOMICS, V44, P179, DOI 10.1006/geno.1997.4873; Kudo H, 2011, EXP DIABETES RES, DOI 10.1155/2011/498460; Lupski JR, 2009, GENOME MED, V1, DOI 10.1186/gm42; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; OKA Y, 1993, LANCET, V342, P527, DOI 10.1016/0140-6736(93)91649-7; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sakai K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076317; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Swartz DA, 1996, J BIOL CHEM, V271, P20942, DOI 10.1074/jbc.271.34.20942; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Weijnen CF, 2002, DIABETIC MED, V19, P41, DOI 10.1046/j.1464-5491.2002.00624.x; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zhang D, 2009, MOL PSYCHIATR, V14, P376, DOI 10.1038/mp.2008.144	41	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e88602	10.1371/journal.pone.0088602	http://dx.doi.org/10.1371/journal.pone.0088602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709989	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800006
J	Morato, RG; Ferraz, KMPMD; de Paula, RC; de Campos, CB				Morato, Ronaldo Goncalves; Micchi de Barros Ferraz, Katia Maria Paschoaletto; de Paula, Rogerio Cunha; de Campos, Claudia Bueno			Identification of Priority Conservation Areas and Potential Corridors for Jaguars in the Caatinga Biome, Brazil	PLOS ONE			English	Article							PANTHERA-ONCA; PUMA-CONCOLOR; HABITAT; LANDSCAPE; POPULATIONS; PREDICTION; DENSITIES; MOVEMENT	The jaguar, Panthera onca, is a top predator with the extant population found within the Brazilian Caatinga biome now known to be on the brink of extinction. Designing new conservation units and potential corridors are therefore crucial for the long-term survival of the species within the Caatinga biome. Thus, our aims were: 1) to recognize suitable areas for jaguar occurrence, 2) to delineate areas for jaguar conservation (PJCUs), 3) to design corridors among priority areas, and 4) to prioritize PJCUs. A total of 62 points records of jaguar occurrence and 10 potential predictors were analyzed in a GIS environment. A predictive distributional map was obtained using Species Distribution Modeling (SDM) as performed by the Maximum Entropy (Maxent) algorithm. Areas equal to or higher than the median suitability value of 0.595 were selected as of high suitability for jaguar occurrence and named as Priority Jaguar Conservation Units (PJCU). Ten PJCUs with sizes varying from 23.6 km(2) to 4,311.0 km(2) were identified. Afterwards, we combined the response curve, as generated by SDM, and expert opinions to create a permeability matrix and to identify least cost corridors and buffer zones between each PJCU pair. Connectivity corridors and buffer zone for jaguar movement included an area of 8.884,26 km(2) and the total corridor length is about 160.94 km. Prioritizing criteria indicated the PJCU representing c. a. 68.61% of the total PJCU area (PJCU # 1) as of high priority for conservation and connectivity with others PJCUs (PJCUs # 4, 5 and 7) desirable for the long term survival of the species. In conclusion, by using the jaguar as a focal species and combining SDM and expert opinion we were able to create a valid framework for practical conservation actions at the Caatinga biome. The same approach could be used for the conservation of other carnivores.	[Morato, Ronaldo Goncalves; de Paula, Rogerio Cunha; de Campos, Claudia Bueno] Ctr Nacl Pesquisa & Conservacao Mamiferos Carnivo, Inst Chico Mendes Conservacao Biodiversidade, Minist Meio Ambiente, Atibaia, SP, Brazil; [Morato, Ronaldo Goncalves; Micchi de Barros Ferraz, Katia Maria Paschoaletto; de Paula, Rogerio Cunha; de Campos, Claudia Bueno] Inst Conservacao Carnivoros Neotropicais, Atibaia, SP, Brazil; [Micchi de Barros Ferraz, Katia Maria Paschoaletto] Univ Sao Paulo, Escola Super Agr Luiz De Queiroz, Dept Ciencias Florestais, Piracicaba, SP, Brazil	Universidade de Sao Paulo	Ferraz, KMPMD (corresponding author), Inst Conservacao Carnivoros Neotropicais, Atibaia, SP, Brazil.	katia.ferraz@usp.br	Ferraz, Katia Maria P. M. B./D-7244-2012; DE PAULA, ROGERIO/S-2182-2017	Ferraz, Katia Maria P. M. B./0000-0002-7870-8696; Morato, Ronaldo/0000-0002-8304-9779; DE PAULA, ROGERIO/0000-0003-1943-8320	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Programa de Revitalizacao do Rio Sao Francisco/Diretoria de Recursos Hidricos e Ambiente Urbano/Ministerio de Meio Ambiente; Instituto Chico Mendes de Conservacao da Biodiversidade; Instituto Fazenda Tamandua; BOVESPA-Social	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Programa de Revitalizacao do Rio Sao Francisco/Diretoria de Recursos Hidricos e Ambiente Urbano/Ministerio de Meio Ambiente; Instituto Chico Mendes de Conservacao da Biodiversidade; Instituto Fazenda Tamandua; BOVESPA-Social	The authors thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) for financial support. The authors are grateful with Programa de Revitalizacao do Rio Sao Francisco/Diretoria de Recursos Hidricos e Ambiente Urbano/Ministerio de Meio Ambiente, Instituto Chico Mendes de Conservacao da Biodiversidade, Instituto Fazenda Tamandua and BOVESPA-Social for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVES J. J. A., 2007, CLIMEP CLIMATOLOGIA, V2, P58; Andrade-Lima D., 1981, REV BRAS BOTA NICA, V4, P149; [Anonymous], [No title captured]; [Anonymous], 2011, MON DESM BIOM BRAS S; Astete S, 2008, THESIS U BRASILIA; Astete S, 2012, THESIS U BRASILIA; Beier P, 1998, CONSERV BIOL, V7, P94; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; CARROLL C, 2006, CONNECTIVITY CONSERV, P369; CRAWSHAW PG, 1991, J ZOOL, V223, P357, DOI 10.1111/j.1469-7998.1991.tb04770.x; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cruz MAOM, 2005, BIODIVERSIDADE BIOMA, P182; Cullen Jr L, 2006, THESIS U KENT; Cullen Junior L., 2005, Natureza & Conservacao, V3, P43; De Angelo C, 2011, DIVERS DISTRIB, V17, P422, DOI 10.1111/j.1472-4642.2011.00746.x; de Paula Rogerio C., 2012, Cat News, P19; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Dickson BG, 2002, J WILDLIFE MANAGE, V66, P1235, DOI 10.2307/3802956; Doko T., 2008, ISPRS 2008, P267; Doko T, 2011, ECOL MODEL, V222, P748, DOI 10.1016/j.ecolmodel.2010.11.005; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Emperaire L., 1984, Brasil Florestal, V14, P5; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Frankel OH, 1981, CONSERVATION EVOLUTI; Galetti M, 2013, SCIENCE, V342, P930, DOI 10.1126/science.342.6161.930-a; Haag T, 2010, MOL ECOL, V19, P4906, DOI 10.1111/j.1365-294X.2010.04856.x; Hess GR, 2001, LANDSCAPE URBAN PLAN, V55, P195, DOI 10.1016/S0169-2046(01)00155-4; Hilty J. A., 2006, CORRIDOR ECOLOGY SCI; IBGE (Inst.Brasileiro de Geografia e Estatuistica), 2004, MAP BIOM BRAS 1 APR; INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA - IBGE, 2010, ATL CENS DEM; Jackson P., 1996, BIOL CONSERVATION; Jorge MLSP, 2013, BIOL CONSERV, V163, P49, DOI 10.1016/j.biocon.2013.04.018; Kautz R, 2006, BIOL CONSERV, V130, P118, DOI 10.1016/j.biocon.2005.12.007; Miller Brian, 2002, P303; MMA, 2011, DIAGN MACR EC EC BAC; Morato RG., 2013, BIODIVERSIDADE BRASI, V3, P122; Morato Ronaldo G., 2007, Cat News, V47, P23; Nascimento JL, 2011, ATLAS FAUNA BRASILEI; Noss R.F., 2006, CONNECTIVITY CONSERV, P587, DOI [10.1017/CBO9780511754821.026, DOI 10.1017/CBO9780511754821.026]; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; OLIVEIRA J. A., 2003, ECOLOGIA CONSERVACAO, P275; Paula RC, PLANO ACAO IN PRESS; Paula RC, 2011, DIAGNOSTICO MACROZON, P266; PDE, 2011, REL PLAN DES EN 2020; PEARSON RG, 2007, SPECIES DISTRIBUTION; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Prado D., 2003, ECOLOGIA CONSERVACAO, P3, DOI DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; Rodriguez-Soto C, 2011, DIVERS DISTRIB, V17, P350, DOI 10.1111/j.1472-4642.2010.00740.x; Rosques S, ORYX IN PRESS; Roura-Pascual N, 2009, BIOL INVASIONS, V11, P1017, DOI 10.1007/s10530-008-9313-3; Sampaio Everardo V. S. B., 1995, P35, DOI 10.1017/CBO9780511753398.003; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; Saterberg T, 2013, NATURE, V499, P468, DOI 10.1038/nature12277; SCHALLER GB, 1980, BIOTROPICA, V12, P161, DOI 10.2307/2387967; Scognamillo D, 2003, J ZOOL, V259, P269, DOI 10.1017/S0952836902003230; Silveira L, 2004, THESIS U BRASILIA; Silveira L, 2010, ORYX, V44, P104, DOI 10.1017/S0030605309990433; SNUC, 2000, DIARIO OFICIAL UNIAO; Sollmann R, 2013, BIOL CONSERV, V167, P242, DOI 10.1016/j.biocon.2013.08.003; Sondgerath D, 2002, LANDSCAPE ECOL, V17, P57, DOI 10.1023/A:1015237002145; Sunquist ME, 2002, WILD CATS WORLD; THIEL RP, 1985, AM MIDL NAT, V113, P404, DOI 10.2307/2425590; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Torres N.M., 2012, DIVERS DISTRIB, V2012, P1; Wilson CD, 2011, BIOL CONSERV, V144, P821, DOI 10.1016/j.biocon.2010.11.014; ZELLER K., 2007, JAGUARS NEW MILLENNI; Zeller KA, 2011, BIOL CONSERV, V144, P892, DOI 10.1016/j.biocon.2010.12.003	72	30	30	1	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e92950	10.1371/journal.pone.0092950	http://dx.doi.org/10.1371/journal.pone.0092950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709817	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800021
J	Ruocco, LA; Treno, C; Carnevale, UAG; Arra, C; Boatto, G; Nieddu, M; Pagano, C; Illiano, P; Barbato, F; Tino, A; Carboni, E; Laviola, G; Lacivita, E; Leopoldo, M; Adriani, W; Sadile, AG				Ruocco, Lucia A.; Treno, Concetta; Carnevale, Ugo A. Gironi; Arra, Claudio; Boatto, Gianpiero; Nieddu, Maria; Pagano, Cristina; Illiano, Placido; Barbato, Fabiana; Tino, Angela; Carboni, Ezio; Laviola, Giovanni; Lacivita, Enza; Leopoldo, Marcello; Adriani, Walter; Sadile, Adolfo G.			Prepuberal Stimulation of 5-HT7-R by LP-211 in a Rat Model of Hyper-Activity and Attention-Deficit: Permanent Effects on Attention, Brain Amino Acids and Synaptic Markers in the Fronto-Striatal Interface	PLOS ONE			English	Article							NAPLES HIGH-EXCITABILITY; PREFRONTAL CORTEX; ANIMAL-MODEL; D-ASPARTATE; GLUTAMATERGIC NEUROTRANSMISSION; DOPAMINE NEUROTRANSMISSION; FUNCTIONAL CONNECTIVITY; RECEPTOR; FOREBRAIN; SEROTONIN	The cross-talk at the prefronto-striatal interface involves excitatory amino acids, different receptors, transducers and modulators. We investigated long-term effects of a prepuberal, subchronic 5-HT7-R agonist (LP-211) on adult behaviour, amino acids and synaptic markers in a model for Attention-Deficit/Hyperactivity Disorder (ADHD). Naples High Excitability rats (NHE) and their Random Bred controls (NRB) were daily treated with LP-211 in the 5th and 6th postnatal week. One month after treatment, these rats were tested for indices of activity, non selective (NSA), selective spatial attention (SSA) and emotionality. The quantity of L-Glutamate (L-Glu), L-Aspartate (L-Asp) and L-Leucine (L-Leu), dopamine transporter (DAT), NMDAR1 subunit and CAMKII alpha, were assessed in prefrontal cortex (PFC), dorsal (DS) and ventral striatum (VS), for their role in synaptic transmission, neural plasticity and information processing. Prepuberal LP-211 (at lower dose) reduced horizontal activity and (at higher dose) increased SSA, only for NHE but not in NRB rats. Prepuberal LP-211 increased, in NHE rats, L-Glu in the PFC and L-Asp in the VS (at 0.250 mg/kg dose), whereas (at 0.125 mg/kg dose) it decreased L-Glu and L-Asp in the DS. The L-Glu was decreased, at 0.125 mg/kg, only in the VS of NRB rats. The DAT levels were decreased with the 0.125 mg/kg dose (in the PFC), and increased with the 0.250 mg/kg dose (in the VS), significantly for NHE rats. The basal NMDAR1 level was higher in the PFC of NHE than NRB rats; LP-211 treatment (at 0.125 mg/kg dose) decreased NMDAR1 in the VS of NRB rats. This study represents a starting point about the impact of developmental 5-HT7-R activation on neuro-physiology of attentive processes, executive functions and their neural substrates.	[Ruocco, Lucia A.; Treno, Concetta; Carnevale, Ugo A. Gironi; Sadile, Adolfo G.] Univ Naples 2, Sch Med, Dept Expt Med, Naples, Italy; [Arra, Claudio] Natl Canc Inst, Anim Facil, Naples, Italy; [Boatto, Gianpiero; Nieddu, Maria] Univ Sassari, Dept Chem & Pharm, I-07100 Sassari, Italy; [Pagano, Cristina; Illiano, Placido; Barbato, Fabiana; Tino, Angela] CNR, Ist Cibernet Eduardo Caianiello, I-80125 Naples, Italy; [Carboni, Ezio] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Laviola, Giovanni; Adriani, Walter] Ist Super Sanita, Dept Cell Biol & Neurosci, Sect Behav Neurosci, I-00161 Rome, Italy; [Leopoldo, Marcello] Univ Bari, Dept Med Chem, Bari, Italy	Universita della Campania Vanvitelli; IRCCS Fondazione Pascale; University of Sassari; Consiglio Nazionale delle Ricerche (CNR); Istituto di Cibernetica "Eduardo Caianiello" (ICIB-CNR); University of Cagliari; Istituto Superiore di Sanita (ISS); Universita degli Studi di Bari Aldo Moro	Sadile, AG (corresponding author), Univ Naples 2, Sch Med, Dept Expt Med, Naples, Italy.	agsadile@alice.it	Laviola, Giovanni/K-4392-2016; Carboni, Ezio/AAU-4585-2021; Nieddu, Maria/HDM-6360-2022; Adriani, Walter/N-9329-2017; Tino, Angela/E-8425-2014; Laviola, Giovanni/AAA-2391-2022	Laviola, Giovanni/0000-0003-0388-0835; Nieddu, Maria/0000-0001-7589-0464; Adriani, Walter/0000-0002-0067-4430; Tino, Angela/0000-0002-9673-1064; Laviola, Giovanni/0000-0003-0388-0835; Leopoldo, Marcello/0000-0001-8401-2815; Arra, Claudio/0000-0003-3162-2091; Boatto, Gianpiero/0000-0001-6271-2378; Lacivita, Enza/0000-0003-2443-1174; sadile, adolfo/0000-0003-2470-3328; Pagano, Cristina/0000-0002-9181-6595	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	Young Investigator "ADHD-sythe" Project 2009-2012 and ERA-net PrioMedChild "NeuroGenMRI" Project 2011-2015 from the Italian Ministry of Health (local unit to LAR, Principal Investigator WA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani W, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-54; Adriani Walter, 2012, Curr Top Behav Neurosci, V9, P113, DOI 10.1007/7854_2011_156; Andersen SL, 1997, N-S ARCH PHARMACOL, V356, P173, DOI 10.1007/PL00005038; Arnsten AFT, 2012, NEURON, V76, P223, DOI 10.1016/j.neuron.2012.08.038; Arnsten AFT, 2009, CNS DRUGS, V23, P33, DOI 10.2165/00023210-200923000-00005; Bauer M, 2012, CURR PHARM DESIGN, V18, P1568, DOI 10.2174/138161212799958611; Berke JD, 2009, J NEUROPHYSIOL, V101, P1575, DOI 10.1152/jn.91106.2008; Bonaventure P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020210; Broadhurst P.L., 1960, EXPERIMENTS PERSONAL, V1, P1; Canese R, 2013, PSYCHOPHARM IN PRESS; Carnevale UAG, 2007, BEHAV BRAIN RES, V183, P130, DOI 10.1016/j.bbr.2007.05.032; D'Aniello A, 2007, BRAIN RES REV, V53, P215, DOI 10.1016/j.brainresrev.2006.08.005; Davids E, 2003, BRAIN RES REV, V42, P1, DOI 10.1016/S0165-0173(02)00274-6; DiChiara G, 1996, BEHAV PHARMACOL, V7, P640; Dobbing J., 1968, APPLIED NEUROCHEMIST, P287; Eriksson TM, 2008, EUR J PHARMACOL, V596, P107, DOI 10.1016/j.ejphar.2008.08.026; Errico F, 2008, J NEUROSCI, V28, P10404, DOI 10.1523/JNEUROSCI.1618-08.2008; Esposito F, 2009, ARCH ITAL BIOL, V147, P11; Esposito F, 2008, MAGN RESON IMAGING, V26, P905, DOI 10.1016/j.mri.2008.01.045; Filipek PA, 1997, NEUROLOGY, V48, P589, DOI 10.1212/WNL.48.3.589; Fumagalli F, 2008, MOL PHARMACOL, V73, P1484, DOI 10.1124/mol.107.043786; Fumagalli F, 2010, PHARMACOL RES, V62, P523, DOI 10.1016/j.phrs.2010.07.009; Genro JP, 2010, EXPERT REV NEUROTHER, V10, P587, DOI [10.1586/ern.10.17, 10.1586/ERN.10.17]; Girault JA, 2012, ADV EXP MED BIOL, V970, P407, DOI 10.1007/978-3-7091-0932-8_18; Grace AA, 1997, TRENDS NEUROSCI, V20, P31, DOI 10.1016/S0166-2236(96)10064-3; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hedlund PB, 2010, NEUROSCI LETT, V481, P12, DOI 10.1016/j.neulet.2010.06.036; Hirano Shigeki, 2013, Brain Nerve, V65, P659; HOLM S, 1979, SCAND J STAT, V6, P65; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Illiano P., 2011, Society for Neuroscience Abstract Viewer and Itinerary Planner, V41; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kelly A M Clare, 2007, Curr Psychiatry Rep, V9, P401, DOI 10.1007/s11920-007-0052-4; Leopoldo M, 2011, PHARMACOL THERAPEUT, V129, P120, DOI 10.1016/j.pharmthera.2010.08.013; Manuel-Apolinar L, 2004, BEHAV BRAIN RES, V148, P179, DOI 10.1016/S0166-4328(03)00186-4; Marco EM, 2011, NEUROSCI BIOBEHAV R, V35, P1722, DOI 10.1016/j.neubiorev.2011.02.011; Marmiroli P, 2012, CURR MED CHEM, V19, P1269, DOI 10.2174/092986712799462711; Masana M, 2012, CURR TOP MED CHEM, V12, P2357, DOI 10.2174/156802612805289872; Mayer ML, 2011, STRUCTURE, V19, P1370, DOI 10.1016/j.str.2011.08.009; Niciu MJ, 2012, PHARMACOL BIOCHEM BE, V100, P656, DOI 10.1016/j.pbb.2011.08.008; Ochiishi T, 1998, BRAIN RES, V790, P129, DOI 10.1016/S0006-8993(98)00058-4; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Papa M, 1996, NEUROREPORT, V7, P3017, DOI 10.1097/00001756-199611250-00044; Papa M, 2000, NEUROSCI BIOBEHAV R, V24, P149, DOI 10.1016/S0149-7634(99)00052-4; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Perez-Garcia G, 2006, BEHAV BRAIN RES, V169, P83, DOI 10.1016/j.bbr.2005.12.013; Perez-Garcia G, 2009, BEHAV BRAIN RES, V202, P102, DOI 10.1016/j.bbr.2009.03.027; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ruocco LA, 2010, BEHAV BRAIN RES, V210, P99, DOI 10.1016/j.bbr.2010.02.020; Ruocco LA, 2009, BEHAV BRAIN RES, V198, P37, DOI 10.1016/j.bbr.2008.11.006; Ruocco LA, 2009, BEHAV BRAIN RES, V198, P24, DOI 10.1016/j.bbr.2008.11.029; Ruocco LA, 2011, MOL MECH NEUROSCIENC; Ruocco LA, 2014, SYNAPSE, V68, P159, DOI 10.1002/syn.21724; Ruocco LA, 2009, PSYCHIAT THEOR APPL, P85; Ruocco LA, 2009, EUR NEUROPSYCHOPHARM, V19, P693, DOI 10.1016/j.euroneuro.2009.02.005; SADILE AG, 1993, REV NEUROSCIENCE, V4, P287; SADILE AG, 1988, ADV BIOSCI, V70, P177; Sarkisyan G, 2009, BEHAV BRAIN RES, V202, P26, DOI 10.1016/j.bbr.2009.03.011; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Speranza L, 2013, NEUROPHARMACOLOGY, V67, P155, DOI 10.1016/j.neuropharm.2012.10.026; Teicher MH, 2003, NEUROSCI LETT, V339, P169, DOI 10.1016/S0304-3940(02)01475-1; TEICHER MH, 1995, DEV BRAIN RES, V89, P167, DOI 10.1016/0165-3806(95)00109-Q; Viggiano D, 2003, NEUROSCI BIOBEHAV R, V27, P623, DOI 10.1016/j.neubiorev.2003.08.006; Viggiano D, 2003, NEUROSCI BIOBEHAV R, V27, P683, DOI 10.1016/j.neubiorev.2003.08.011; Viggiano D, 2002, BEHAV GENET, V32, P315, DOI 10.1023/A:1020210221156; Waagepetersen HS, 2007, HDB NEUROCHEMISTRY M, P1, DOI 10.1007/978-0-387-30373; YOVELL Y, 1987, P NATL ACAD SCI USA, V84, P9285, DOI 10.1073/pnas.84.24.9285; YOVELL Y, 1992, P NATL ACAD SCI USA, V89, P6526, DOI 10.1073/pnas.89.14.6526	69	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e83003	10.1371/journal.pone.0083003	http://dx.doi.org/10.1371/journal.pone.0083003			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709857	Green Published, gold			2022-12-27	WOS:000334159800002
J	Song, XQ; Li, X; Gao, JS; Zhao, JP; Li, YH; Fan, XD; Lv, LX				Song, Xueqin; Li, Xue; Gao, Jinsong; Zhao, Jingping; Li, Youhui; Fan, Xiaoduo; Lv, Luxian			APOA-I: A Possible Novel Biomarker for Metabolic Side Effects in First Episode Schizophrenia	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; CEREBROSPINAL-FLUID; EXPRESSION; BRAIN; PROTEINS; RECEPTOR; WEIGHT; PLASMA	The purpose of this study was to investigate the change in plasma protein expression in first episode schizophrenia after an 8-week treatment with risperidone, and to explore potential biomarkers for metabolic side effects associated with risperidone treatment. Eighty first-episode schizophrenia patientswere enrolled in the study. Fifteen of the 80 patients were randomly selected to undergo proteomic analysis. Plasma proteins were obtained before and after the 8-week risperidone treatment, and measured using two-dimensional gel electrophoresis (2-DE), Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry(MALDI-TOF/TOF) and peptide mass fingerprinting. Proteins with the highest fold changes after risperidone treatment were then measured for all 80 patients using enzyme linked immunosorbent assay (ELISA). The relationship between changes in plasma protein levels and changes in metabolic parameters after risperidone treatment was examined. In 15 randomly selected patients, approximately 1,500 protein spots were detected in each gel by 2-DE. Of those proteins, 22 spots showed significant difference in abundance after risperidone treatment (p's < 0.05). After MALDITOF peptide mass fingerprinting, apolipoprotein A-I (APOA-I) and Guanine Nucleotide Binding Protein, Alpha Stimulating (GNAS), were found to have the highest fold changes. The content of APOA-I was significantly increased, and the content of GNAS was significantly decreased after risperidone treatment (p's < 0.05). The analysis in the entire study sample showed similar findings in changes of APOA-I and GNAS after risperidone treatment. Further analysis showed significant relationships between changesin APOA-1 and changes in triglyceride, total cholesterol, and body mass index after controlling for age, gender and family history of diabetes. Similar analysis showed a trend positive relationship between changes in GNAS and changes in BMI. Using proteomic analysis, the study suggested that APOA-I might be a novel biomarkers related to metabolic side effects in first episode schizophrenia treated with risperidone.	[Song, Xueqin; Li, Xue; Gao, Jinsong; Li, Youhui] Zhengzhou Univ, Affiliated Hosp 1, Dept Psychiat, Zhengzhou 450052, Peoples R China; [Song, Xueqin; Lv, Luxian] Xinxiang Med Univ, Henan Key Lab Biol Psychiat, Xinxiang, Peoples R China; [Song, Xueqin; Fan, Xiaoduo] Univ Massachusetts, Sch Med, UMass Mem Med Ctr, Worcester, MA USA; [Zhao, Jingping] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Lv, Luxian] Xinxiang Med Univ, Affiliated Hosp 2, Dept Psychiat, Xinxiang, Peoples R China	Zhengzhou University; Xinxiang Medical University; University of Massachusetts System; University of Massachusetts Worcester; Central South University; Xinxiang Medical University	Song, XQ (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Psychiat, Zhengzhou 450052, Peoples R China.	sxqzhll@126.com; lvluxian@126.com	zhao, jing/B-3868-2019; Fan, Xiaoduo/AAV-1268-2020	Fan, Xiaoduo/0000-0003-4299-8924	National Natural Science Foundation of China [30971058, 81071090]; Natural Science Foundation of Henan [102300413208, 112300413226]; Youth Fund of the First Affiliated Hospital of Zhengzhou University; First Affiliated Hospital of Zhengzhou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Henan; Youth Fund of the First Affiliated Hospital of Zhengzhou University; First Affiliated Hospital of Zhengzhou University	Funding for this study was provided by the National Natural Science Foundation of China (No. 30971058 to XQS, No. 81071090 to LL), the Natural Science Foundation of Henan (No. 102300413208, 112300413226 to LL), the Youth Fund of the First Affiliated Hospital of Zhengzhou University (to XL), the Youth Fund of the First Affiliated Hospital of Zhengzhou University (to XQS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JH, 2006, PROTEOMICS, V6, P538, DOI 10.1002/pmic.200500257; EUBANKS JH, 1992, GENOMICS, V14, P1010, DOI 10.1016/S0888-7543(05)80124-7; Hahn S, 2006, EUR J ENDOCRINOL, V155, P763, DOI 10.1530/eje.1.02275; Huang JTJ, 2008, MOL PSYCHIATR, V13, P1118, DOI 10.1038/sj.mp.4002108; La YJ, 2007, J NEURAL TRANSM, V114, P657, DOI 10.1007/s00702-006-0607-2; Leucht S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008016.pub2; Martins Daniel, 2007, Briefings in Functional Genomics & Proteomics, V6, P70, DOI 10.1093/bfgp/elm009; Martins-De-Souza D, 2010, WORLD J BIOL PSYCHIA, V11, P719, DOI 10.3109/15622971003758748; Mei JF, 2006, SCHIZOPHR RES, V84, P204, DOI 10.1016/j.schres.2006.02.016; MENG QH, 1995, J BIOL CHEM, V270, P8588, DOI 10.1074/jbc.270.15.8588; Meyer JM, 2002, J CLIN PSYCHIAT, V63, P425, DOI 10.4088/JCP.v63n0509; Meyer JM, 2008, SCHIZOPHR RES, V101, P273, DOI 10.1016/j.schres.2007.12.487; Murphy AJ, 2013, J PHARMACOL EXP THER, V344, P41, DOI 10.1124/jpet.112.199257; Padrao AI, 2012, PROTEOM CLIN APPL, V6, P447, DOI 10.1002/prca.201200044; Ramachandran S, 2012, PROTEOMICS, V12, P2808, DOI 10.1002/pmic.201100586; Roerig JL, 2011, CNS DRUGS, V25, P1035, DOI 10.2165/11596300-000000000-00000; Sadler NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047996; Vasconcelos SMM, 2004, BIOCHEM CELL BIOL, V82, P315, DOI 10.1139/o03-081; Wang ES, 2010, ACTA NEUROL SCAND, V122, P350, DOI 10.1111/j.1600-0404.2009.01318.x; Wang X, 2009, EUR J CANCER CARE, V18, P625, DOI 10.1111/j.1365-2354.2008.00965.x; Wright WT, 2006, ATHEROSCLEROSIS, V185, P353, DOI 10.1016/j.atherosclerosis.2005.06.043; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Yang L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002016; Yang XJ, 1997, MOL ENDOCRINOL, V11, P1053, DOI 10.1210/me.11.8.1053; Yu J, 2012, ONCOL REP, V27, P748, DOI 10.3892/or.2011.1565	25	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93902	10.1371/journal.pone.0093902	http://dx.doi.org/10.1371/journal.pone.0093902			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710015	Green Published, gold			2022-12-27	WOS:000334159800066
J	Wand, BM; Szpak, L; George, PJ; Bulsara, MK; O'Connell, NE; Moseley, GL				Wand, Benedict Martin; Szpak, Lareina; George, Pamela J.; Bulsara, Max K.; O'Connell, Neil Edward; Moseley, G. Lorimer			Moving in an Environment of Induced Sensorimotor Incongruence Does Not Influence Pain Sensitivity in Healthy Volunteers: A Randomised Within-Subject Experiment	PLOS ONE			English	Article							SENSORY-MOTOR INCONGRUENCE; LOW-BACK-PAIN; VISUAL DISTORTION; MIRROR THERAPY; PERCEPTION; DISTURBANCES; SYMPTOMS; MOVEMENT; FEEDBACK; DISEASE	Objectives: It has been proposed that in the same way that conflict between vestibular and visual inputs leads to motion sickness, conflict between motor commands and sensory information associated with these commands may contribute to some chronic pain states. Attempts to test this hypothesis by artificially inducing a state of sensorimotor incongruence and assessing self-reported pain have yielded equivocal results. To help clarify the effect sensorimotor incongruence has on pain we investigated the effect of moving in an environment of induced incongruence on pressure pain thresholds (PPT) and the pain experienced immediately on completion of PPT testing. Methods: Thirty-five healthy subjects performed synchronous and asynchronous upper-limb movements with and without mirror visual feedback in random order. We measured PPT over the elbow and the pain evoked by testing. Generalised linear mixed-models were performed for each outcome. Condition (four levels) and baseline values for each outcome were within-subject factors. Results: There was no effect of condition on PPT (p=0.887) or pressure-evoked pain (p=0.771). A sensitivity analysis using only the first PPT measure after each condition confirmed the result (p=0.867). Discussion: Inducing a state of movement related sensorimotor incongruence in the upper-limb of healthy volunteers does not influence PPT, nor the pain evoked by testing. We found no evidence that sensorimotor incongruence upregulates the nociceptive system in healthy volunteers.	[Wand, Benedict Martin; George, Pamela J.] Univ Notre Dame Australia, Sch Physiotherapy, Fremantle, WA, Australia; [Szpak, Lareina] Floreat Physiotherapy, Floreat, WA, Australia; [Bulsara, Max K.] Univ Notre Dame Australia, Inst Hlth Res, Fremantle, WA, Australia; [O'Connell, Neil Edward] Brunel Univ, Rehabil Res Ctr, Sch Hlth Sci & Social Care, Uxbridge UB8 3PH, Middx, England; [Moseley, G. Lorimer] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia	University of Notre Dame Australia; University of Notre Dame Australia; Brunel University; University of South Australia	O'Connell, NE (corresponding author), Brunel Univ, Rehabil Res Ctr, Sch Hlth Sci & Social Care, Uxbridge UB8 3PH, Middx, England.	neil.oconnell@brunel.ac.uk	Moseley, Lorimer/A-7095-2009; Wand, Benedict/C-3341-2011	Moseley, Lorimer/0000-0002-3750-4945; Wand, Benedict/0000-0002-0297-0292	National Health & Medical Research Council of Australia [ID 579010]; Floreat Physiotherapy	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Floreat Physiotherapy	GLM is supported by the National Health & Medical Research Council of Australia (ID 579010). Floreat Physiotherapy provided support in the form of a salary for author LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Bowering KJ, 2013, J PAIN, V14, P3, DOI 10.1016/j.jpain.2012.09.007; Cacchio A, 2009, NEUROREHAB NEURAL RE, V23, P792, DOI 10.1177/1545968309335977; Chan BL, 2007, NEW ENGL J MED, V357, P2206, DOI 10.1056/NEJMc071927; Chesterton LS, 2007, CLIN J PAIN, V23, P760, DOI 10.1097/AJP.0b013e318154b6ae; Daenen L, 2012, PAIN PHYSICIAN, V15, P405; Daenen L, 2012, RHEUMATOLOGY, V51, P1492, DOI 10.1093/rheumatology/kes050; Daenen L, 2010, RHEUMATOLOGY, V49, P1281, DOI 10.1093/rheumatology/keq067; Fernandez-De-Las-Penas C, 2007, J ORTHOP SPORT PHYS, V37, P325, DOI 10.2519/jospt.2007.2542; Foell J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00310; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Harris AJ, 1999, LANCET, V354, P1464, DOI 10.1016/S0140-6736(99)05003-5; Henry DE, 2011, PM&R, V3, P1116, DOI 10.1016/j.pmrj.2011.05.018; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Lewis JS, 2010, PAIN, V149, P463, DOI 10.1016/j.pain.2010.02.007; Longo MR, 2009, J NEUROSCI, V29, P12125, DOI 10.1523/JNEUROSCI.3072-09.2009; Mancini F, 2011, PSYCHOL SCI, V22, P325, DOI 10.1177/0956797611398496; McCabe CS, 2008, RHEUMATOLOGY, V47, P1612, DOI 10.1093/rheumatology/ken254; McCabe CS, 2007, RHEUMATOLOGY, V46, P1587, DOI 10.1093/rheumatology/kem204; McCabe CS, 2008, CURR PAIN HEADACHE R, V12, P103, DOI 10.1007/s11916-008-0020-7; McCabe C, 2011, J HAND THER, V24, P170, DOI 10.1016/j.jht.2010.08.003; McCabe CS, 2005, RHEUMATOLOGY, V44, P509, DOI 10.1093/rheumatology/keh529; Mohan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052400; Moseley GL, 2007, PHYS THER REV, V12, P169, DOI 10.1179/108331907X223010; Moseley GL, 2008, PAIN, V138, P7, DOI 10.1016/j.pain.2008.06.026; Moseley GL, 2012, NEUROREHAB NEURAL RE, V26, P646, DOI 10.1177/1545968311433209; Moseley GL, 2012, NEUROSCI BIOBEHAV R, V36, P34, DOI 10.1016/j.neubiorev.2011.03.013; Moseley GL, 2008, CURR BIOL, V18, pR1047, DOI 10.1016/j.cub.2008.09.031; Moseley GL, 2006, RHEUMATOLOGY, V45, P196, DOI 10.1093/rheumatology/kei119; Moseley GL, 2005, RHEUMATOLOGY, V44, P1083, DOI 10.1093/rheumatology/keh631; Ramachandran VS, 2009, BRAIN, V132, P1693, DOI 10.1093/brain/awp135; Seifert F, 2011, CURR OPIN ANESTHESIO, V24, P515, DOI 10.1097/ACO.0b013e32834a1079; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Tracey I, 2009, J PAIN, V10, P1113, DOI 10.1016/j.jpain.2009.09.001; Wand BM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-11; Wand BM, 2012, CLIN J PAIN, V28, P602, DOI 10.1097/AJP.0b013e31823d480c; Wand BM, 2011, MANUAL THER, V16, P15, DOI 10.1016/j.math.2010.06.008	38	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93701	10.1371/journal.pone.0093701	http://dx.doi.org/10.1371/journal.pone.0093701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709995	gold, Green Published, Green Accepted			2022-12-27	WOS:000334159800045
J	Kosovec, JE; Zaidi, AH; Komatsu, Y; Kasi, PM; Cothron, K; Thompson, DV; Lynch, E; Jobe, BA				Kosovec, Juliann E.; Zaidi, Ali H.; Komatsu, Yoshihiro; Kasi, Pashtoon M.; Cothron, Kyle; Thompson, Diane V.; Lynch, Edward; Jobe, Blair A.			Establishing Magnetic Resonance Imaging as an Accurate and Reliable Tool to Diagnose and Monitor Esophageal Cancer in a Rat Model	PLOS ONE			English	Article							BARRETTS-ESOPHAGUS; GENE-EXPRESSION; GASTROESOPHAGEAL-REFLUX; ANIMAL-MODELS; LIVER-CANCER; ADENOCARCINOMA; MRI; ANASTOMOSIS; CARCINOMA	Objective: To assess the reliability of magnetic resonance imaging (MRI) for detection of esophageal cancer in the Levrat model of end-to-side esophagojejunostomy. Background: The Levrat model has proven utility in terms of its ability to replicate Barrett's carcinogenesis by inducing gastroduodenoesophageal reflux (GDER). Due to lack of data on the utility of non-invasive methods for detection of esophageal cancer, treatment efficacy studies have been limited, as adenocarcinoma histology has only been validated post-mortem. It would therefore be of great value if the validity and reliability of MRI could be established in this setting. Methods: Chronic GDER reflux was induced in 19 male Sprague-Dawley rats using the modified Levrat model. At 40 weeks post-surgery, all animals underwent endoscopy, MRI scanning, and post-mortem histological analysis of the esophagus and anastomosis. With post-mortem histology serving as the gold standard, assessment of presence of esophageal cancer was made by five esophageal specialists and five radiologists on endoscopy and MRI, respectively. Results: The accuracy of MRI and endoscopic analysis to correctly identify cancer vs. no cancer was 85.3% and 50.5%, respectively. ROC curves demonstrated that MRI rating had an AUC of 0.966 (p<0.001) and endoscopy rating had an AUC of 0.534 (p = 0.804). The sensitivity and specificity of MRI for identifying cancer vs. no-cancer was 89.1% and 80% respectively, as compared to 45.5% and 57.5% for endoscopy. False positive rates of MRI and endoscopy were 20% and 42.5%, respectively. Conclusions: MRI is a more reliable diagnostic method than endoscopy in the Levrat model. The non-invasiveness of the tool and its potential to volumetrically quantify the size and number of tumors likely makes it even more useful in evaluating novel agents and their efficacy in treatment studies of esophageal cancer.	[Kosovec, Juliann E.; Zaidi, Ali H.; Komatsu, Yoshihiro; Jobe, Blair A.] Allegheny Hlth Network, Inst Treatment Esophageal & Thorac Dis, Pittsburgh, PA 15212 USA; [Kasi, Pashtoon M.] Univ Pittsburgh, Med Ctr, Int Scholars Program, Pittsburgh, PA USA; [Cothron, Kyle] Allegheny Hlth Network, Dept Radiol, Pittsburgh, PA USA; [Thompson, Diane V.] Allegheny Hlth Network, Dept Med, Pittsburgh, PA USA; [Lynch, Edward] Allegheny Hlth Network, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jobe, BA (corresponding author), Allegheny Hlth Network, Inst Treatment Esophageal & Thorac Dis, Pittsburgh, PA 15212 USA.	bjobe1@wpahs.org	Kasi, Pashtoon Murtaza/M-2569-2019	Kasi, Pashtoon Murtaza/0000-0002-5169-7085				Budde MD, 2012, CLIN EXP METASTAS, V29, P51, DOI 10.1007/s10585-011-9428-2; Buskens CJ, 2006, J SURG RES, V135, P337, DOI 10.1016/j.jss.2006.04.023; Buttar NS, 2002, GASTROENTEROLOGY, V122, P1101, DOI 10.1053/gast.2002.32371; Chen XX, 1999, CARCINOGENESIS, V20, P1801, DOI 10.1093/carcin/20.9.1801; Cheng P, 2005, WORLD J GASTROENTERO, V11, P5117; Gibson MK, 2013, ANN SURG, V258, P82, DOI 10.1097/SLA.0b013e318270500d; Greenawalt DM, 2007, INT J CANCER, V120, P1914, DOI 10.1002/ijc.22501; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; Jankowski JA, 2000, LANCET, V356, P2079, DOI 10.1016/S0140-6736(00)03411-5; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Li Y, 2007, DIS ESOPHAGUS, V20, P372, DOI 10.1111/j.1442-2050.2007.00713.x; Lu S, 2009, DIS ESOPHAGUS, V22, P323, DOI 10.1111/j.1442-2050.2008.00909.x; Macke RA, 2011, ANN NY ACAD SCI, V1232, P392, DOI 10.1111/j.1749-6632.2011.06061.x; Miwa K, 1996, INT J CANCER, V67, P269, DOI 10.1002/(SICI)1097-0215(19960717)67:2<269::AID-IJC19>3.0.CO;2-6; Oh DS, 2009, SURG ENDOSC, V23, P1346, DOI 10.1007/s00464-008-0169-5; Paulson TG, 2004, CANCER CELL, V6, P11, DOI 10.1016/j.ccr.2004.06.021; Petre C, 1996, MAGNET RESON MED, V35, P532, DOI 10.1002/mrm.1910350412; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; Schiffman SC, 2010, SURG ENDOSC, V24, P2835, DOI 10.1007/s00464-010-1059-1; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Viera AJ, 2005, FAM MED, V37, P360; Xu XJ, 2000, J SURG RES, V88, P120, DOI 10.1006/jsre.1999.5774; Yamaguchi M, 2013, J MAGN RESON IMAGING, V38, P225, DOI 10.1002/jmri.23969; Yamashita Y, 1998, J Gastrointest Surg, V2, P350, DOI 10.1016/S1091-255X(98)80074-7; Yoon Harry H, 2007, Curr Oncol Rep, V9, P184, DOI 10.1007/s11912-007-0020-5	25	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93694	10.1371/journal.pone.0093694	http://dx.doi.org/10.1371/journal.pone.0093694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705451	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500058
J	Perez-Traves, L; Lopes, CA; Querol, A; Barrio, E				Perez-Traves, Laura; Lopes, Christian A.; Querol, Amparo; Barrio, Eladio			On the Complexity of the Saccharomyces bayanus Taxon: Hybridization and Potential Hybrid Speciation	PLOS ONE			English	Article							VAR. UVARUM; MOLECULAR CHARACTERIZATION; NATURAL HYBRIDS; YEAST STRAINS; CEREVISIAE; KUDRIAVZEVII; GENOME; WINE; EVOLUTION; SEQUENCE	Although the genus Saccharomyces has been thoroughly studied, some species in the genus has not yet been accurately resolved; an example is S. bayanus, a taxon that includes genetically diverse lineages of pure and hybrid strains. This diversity makes the assignation and classification of strains belonging to this species unclear and controversial. They have been subdivided by some authors into two varieties (bayanus and uvarum), which have been raised to the species level by others. In this work, we evaluate the complexity of 46 different strains included in the S. bayanus taxon by means of PCR-RFLP analysis and by sequencing of 34 gene regions and one mitochondrial gene. Using the sequence data, and based on the S. bayanus var. bayanus reference strain NBRC 1948, a hypothetical pure S. bayanus was reconstructed for these genes that showed alleles with similarity values lower than 97% with the S. bayanus var. uvarum strain CBS 7001, and of 99-100% with the non S. cerevisiae portion in S. pastorianus Weihenstephan 34/70 and with the new species S. eubayanus. Among the S. bayanus strains under study, different levels of homozygosity, hybridization and introgression were found; however, no pure S. bayanus var. bayanus strain was identified. These S. bayanus hybrids can be classified into two types: homozygous (type I) and heterozygous hybrids (type II), indicating that they have been originated by different hybridization processes. Therefore, a putative evolutionary scenario involving two different hybridization events between a S. bayanus var. uvarum and unknown European S. eubayanus-like strains can be postulated to explain the genomic diversity observed in our S. bayanus var. bayanus strains.	[Perez-Traves, Laura; Lopes, Christian A.; Querol, Amparo; Barrio, Eladio] CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol, E-46010 Valencia, Spain; [Lopes, Christian A.] Univ Nacl Comahue, Fac Ingn, CONICET UNCo,Dept Quim,Grp Biodiversidad & Biotec, Inst Multidisciplinario Invest & Desarrollo IDEPA, Buenos Aires, Neuquen, Argentina; [Barrio, Eladio] Univ Valencia, Dept Genet, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Universidad Nacional del Comahue; University of Valencia	Barrio, E (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol, Jaime Roig 11, E-46010 Valencia, Spain.	eladio.barrio@uv.es	Barrio, Eladio/G-8969-2015; Querol, Amparo/H-3782-2012; Querol, Amparo/AAW-7469-2020	Barrio, Eladio/0000-0003-1024-954X; Querol, Amparo/0000-0002-6478-6845; Querol, Amparo/0000-0002-6478-6845	Spanish Government [AGL2009-12673-CO2, AGL2012-39937-CO2]; CSIC; Fundacion Carolina for the I3P and Formacion Permanente	Spanish Government(Spanish GovernmentEuropean Commission); CSIC; Fundacion Carolina for the I3P and Formacion Permanente	This work was supported by grants AGL2009-12673-CO2 (01 and 02) and AGL2012-39937-CO2 (01 and 02) from the Spanish Government to AQ and EB, respectively. LP-T and CAL acknowledge to CSIC and Fundacion Carolina for the I3P and Formacion Permanente fellowships respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belloch C, 2000, INT J SYST EVOL MICR, V50, P405, DOI 10.1099/00207713-50-1-405; Berger KH, 2000, TRENDS MICROBIOL, V8, P508, DOI 10.1016/S0966-842X(00)01862-X; Casaregola S, 2001, INT J SYST EVOL MICR, V51, P1607, DOI 10.1099/00207713-51-4-1607; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Dunn B, 2008, GENOME RES, V18, P1610, DOI 10.1101/gr.076075.108; FELSENSTEIN J, 1985, SYST ZOOL, V34, P152, DOI 10.2307/2413323; Gibson BR, 2013, YEAST, V30, P255, DOI 10.1002/yea.2960; Gonzalez SS, 2008, APPL ENVIRON MICROB, V74, P2314, DOI 10.1128/AEM.01867-07; Gonzalez SS, 2006, FEMS YEAST RES, V6, P1221, DOI 10.1111/j.1567-1364.2006.00126.x; Greig D, 2002, SCIENCE, V298, P1773, DOI 10.1126/science.1076374; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Nguyen HV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025821; Joubert R, 2000, YEAST, V16, P511, DOI 10.1002/(SICI)1097-0061(200004)16:6<511::AID-YEA544>3.0.CO;2-I; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kodama Y, 2006, TOP CURR GENET, V15, P145, DOI 10.1007/b106370; Kurtzman C.P., 2003, FEMS YEAST RES, V1554, P1; Libkind D, 2011, P NATL ACAD SCI USA, V108, P14539, DOI 10.1073/pnas.1105430108; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Masneuf-Pomarede I, 2007, SYST APPL MICROBIOL, V30, P75, DOI 10.1016/j.syapm.2006.02.006; Nakao Y, 2009, DNA RES, V16, P115, DOI 10.1093/dnares/dsp003; Naumov G. I., 2000, Mikrobiologiya, V69, P410; Naumov GI, 2001, INT J FOOD MICROBIOL, V65, P163, DOI 10.1016/S0168-1605(00)00515-8; Naumova ES, 2011, RES MICROBIOL, V162, P204, DOI 10.1016/j.resmic.2010.09.023; Naumova ES, 2005, YEAST, V22, P1099, DOI 10.1002/yea.1298; Nguyen HV, 1997, SYST APPL MICROBIOL, V20, P286, DOI 10.1016/S0723-2020(97)80075-6; Nguyen HV, 2000, SYST APPL MICROBIOL, V23, P71, DOI 10.1016/S0723-2020(00)80048-X; Nguyen HV, 2005, FEMS YEAST RES, V5, P471, DOI 10.1016/j.femsyr.2004.12.004; Peris D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-407; Peris D, 2012, YEAST, V29, P81, DOI 10.1002/yea.2891; Piskur J, 1998, INT J SYST BACTERIOL, V48, P1015, DOI 10.1099/00207713-48-3-1015; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pulvirenti A, 2000, FEMS MICROBIOL LETT, V192, P191, DOI 10.1016/S0378-1097(00)00431-6; QUEROL A, 1992, APPL ENVIRON MICROB, V58, P2948, DOI 10.1128/AEM.58.9.2948-2953.1992; Rainieri S, 1999, FEMS MICROBIOL LETT, V177, P177, DOI 10.1111/j.1574-6968.1999.tb13729.x; Rainieri S, 2006, APPL ENVIRON MICROB, V72, P3968, DOI 10.1128/AEM.02769-05; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 2009, CURR BIOL, V19, pR119, DOI 10.1016/j.cub.2008.12.016; Ryu SL, 1996, YEAST, V12, P757, DOI 10.1002/(SICI)1097-0061(19960630)12:8<757::AID-YEA970>3.0.CO;2-H; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Valles BS, 2007, FOOD MICROBIOL, V24, P25, DOI 10.1016/j.fm.2006.04.001; Vaughan-Martini A, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P733, DOI 10.1016/B978-0-444-52149-1.00061-6; Yamagishi H, 1999, SYST APPL MICROBIOL, V22, P341, DOI 10.1016/S0723-2020(99)80041-1	45	51	51	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93729	10.1371/journal.pone.0093729	http://dx.doi.org/10.1371/journal.pone.0093729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705561	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500061
J	Yamanaka, T; Wong, HK; Tosaki, A; Bauer, PO; Wada, K; Kurosawa, M; Shimogori, T; Hattori, N; Nukina, N				Yamanaka, Tomoyuki; Wong, Hon Kit; Tosaki, Asako; Bauer, Peter O.; Wada, Koji; Kurosawa, Masaru; Shimogori, Tomomi; Hattori, Nobutaka; Nukina, Nobuyuki			Large-Scale RNA Interference Screening in Mammalian Cells Identifies Novel Regulators of Mutant Huntingtin Aggregation	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; EXPANDED POLYGLUTAMINE; TRANSCRIPTION FACTOR; MOUSE MODELS; DISEASE; PROTEIN; DROSOPHILA; DEGRADATION; TOXICITY; DEATH	In polyglutamine (polyQ) diseases including Huntington's disease (HD), mutant proteins containing expanded polyQ stretch form aggregates in neurons. Genetic or RNAi screenings in yeast, C. elegans or Drosophila have identified multiple genes modifying polyQ aggregation, a few of which are confirmed effective in mammals. However, the overall molecular mechanism underlying polyQ protein aggregation in mammalian cells still remains obscure. We here perform RNAi screening in mouse neuro2a cells to identify mammalian modifiers for aggregation of mutant huntingtin, a causative protein of HD. By systematic cell transfection and automated cell image analysis, we screen similar to 12000 shRNA clones and identify 111 shRNAs that either suppress or enhance mutant huntingtin aggregation, without altering its gene expression. Classification of the shRNA-targets suggests that genes with various cellular functions such as gene transcription and protein phosphorylation are involved in modifying the aggregation. Subsequent analysis suggests that, in addition to the aggregation-modifiers sensitive to proteasome inhibition, some of them, such as a transcription factor Tcf20, and kinases Csnk1d and Pik3c2a, are insensitive to it. As for Tcf20, which contains polyQ stretches at N-terminus, its binding to mutant huntingtin aggregates is observed in neuro2a cells and in HD model mouse neurons. Notably, except Pik3c2a, the rest of the modifiers identified here are novel. Thus, our first large-scale RNAi screening in mammalian system identifies previously undescribed genetic players that regulate mutant huntingtin aggregation by several, possibly mammalian-specific mechanisms.	[Yamanaka, Tomoyuki; Kurosawa, Masaru; Nukina, Nobuyuki] Juntendo Univ, Grad Sch Med, Dept Neurosci Neurodegenerat Disorders, Tokyo, Japan; [Yamanaka, Tomoyuki; Wong, Hon Kit; Tosaki, Asako; Bauer, Peter O.; Wada, Koji; Kurosawa, Masaru; Nukina, Nobuyuki] RIKEN Brain Sci Inst, Lab Struct Neuropathol, Saitama, Japan; [Yamanaka, Tomoyuki; Kurosawa, Masaru; Shimogori, Tomomi; Nukina, Nobuyuki] RIKEN Brain Sci Inst, Lab Mol Mech Thalamus Dev, Saitama, Japan; [Wong, Hon Kit] Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; [Wong, Hon Kit] Harvard Univ, Sch Med, Harvard Inst Med, Boston, MA USA; [Hattori, Nobutaka] Juntendo Univ, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Yamanaka, Tomoyuki; Kurosawa, Masaru; Nukina, Nobuyuki] JST, CREST, Tokyo, Japan	Juntendo University; RIKEN; RIKEN; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Juntendo University; Japan Science & Technology Agency (JST)	Nukina, N (corresponding author), Juntendo Univ, Grad Sch Med, Dept Neurosci Neurodegenerat Disorders, Tokyo, Japan.	nnukina@juntendo.ac.jp	Shimogori, Tomomi/L-2893-2013; Bauer, Peter O./AAD-6502-2022; Hattori, Nobutaka/ACR-0069-2022; Nukina, Nobuyuki/GPP-6265-2022; Wong, Hon-Kit/G-3944-2014	Shimogori, Tomomi/0000-0002-6931-5401; Bauer, Peter O./0000-0003-2811-1354; Yamanaka, Tomoyuki/0000-0002-5378-4326; Wong, Hon-Kit/0000-0003-0049-8454	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24111553, 23700430, 22110004, 22240037, 24659436]; Life Science Foundation of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research; CREST from JST; Ministry of Health, Welfare and Labor	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Life Science Foundation of Japan(Life Science Foundation of Japan); Mochida Memorial Foundation for Medical and Pharmaceutical Research; CREST from JST(Core Research for Evolutional Science and Technology (CREST)); Ministry of Health, Welfare and Labor(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid from Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan for TY (24111553, 23700430) and NN (22110004, 22240037, 24659436); by Life Science Foundation of Japan for TY; by Mochida Memorial Foundation for Medical and Pharmaceutical Research for TY; by CREST from JST for NN; and by Grant-in-Aid for the Research on Measures for Ataxic Diseases from the Ministry of Health, Welfare and Labor for NN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Bauer PO, 2009, J BIOL CHEM, V284, P13153, DOI 10.1074/jbc.M809229200; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Damrath E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002920; Diaz-Hernandez M, 2009, FASEB J, V23, P1893, DOI 10.1096/fj.08-122275; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Doi H, 2008, J BIOL CHEM, V283, P6489, DOI 10.1074/jbc.M705306200; Domin J, 2000, J BIOL CHEM, V275, P11943, DOI 10.1074/jbc.275.16.11943; Doumanis J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007275; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Furukawa Y, 2009, J NEUROSCI, V29, P5153, DOI 10.1523/JNEUROSCI.0783-09.2009; Garcia SM, 2007, GENE DEV, V21, P3006, DOI 10.1101/gad.1575307; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Harris DP, 2011, MOL CELL BIOL, V31, P63, DOI 10.1128/MCB.00468-10; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Jabado O, 2004, CELL DEATH DIFFER, V11, P618, DOI 10.1038/sj.cdd.4401397; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Lejeune FX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-91; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Liang YD, 2009, BRAIN RES, V1286, P221, DOI 10.1016/j.brainres.2009.06.049; Liu CR, 2012, CELL, V148, P690, DOI 10.1016/j.cell.2011.12.032; Lu BX, 2013, NAT NEUROSCI, V16, P562, DOI 10.1038/nn.3367; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Meriin AB, 2001, J CELL BIOL, V153, P851, DOI 10.1083/jcb.153.4.851; Meunier FA, 2005, MOL BIOL CELL, V16, P4841, DOI 10.1091/mbc.E05-02-0171; Miller JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003042; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Murakami T, 2004, ANN NEUROL, V55, P439, DOI 10.1002/ana.20064; Nagai Y, 2003, HUM MOL GENET, V12, P1253, DOI 10.1093/hmg/ddg144; Nagai Y, 2000, J BIOL CHEM, V275, P10437, DOI 10.1074/jbc.275.14.10437; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Silva MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002438; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; van Ham TJ, 2010, CELL, V142, P601, DOI 10.1016/j.cell.2010.07.020; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vo SH, 2012, PLOS ONE, V7; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wang GH, 1999, NEUROREPORT, V10, P2435, DOI 10.1097/00001756-199908200-00001; Weiss KR, 2012, GENETICS, V190, P581, DOI 10.1534/genetics.111.133710; Wong HK, 2008, HUM MOL GENET, V17, P3223, DOI 10.1093/hmg/ddn218; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yamanaka T, 2008, EMBO J, V27, P827, DOI 10.1038/emboj.2008.23; Yamanaka T, 2006, J CELL SCI, V119, P2107, DOI 10.1242/jcs.02938; Yamanaka T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4354; Yamanaka T, 2010, METHODS MOL BIOL, V648, P215, DOI 10.1007/978-1-60761-756-3_14; Yamanaka T, 2010, HUM MOL GENET, V19, P2099, DOI 10.1093/hmg/ddq087; Yoshioka K, 2012, NAT MED, V18, P1560, DOI 10.1038/nm.2928; Zhang S, 2010, GENETICS, V184, P1165, DOI 10.1534/genetics.109.112516	68	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93891	10.1371/journal.pone.0093891	http://dx.doi.org/10.1371/journal.pone.0093891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705917	Green Published, gold, Green Submitted			2022-12-27	WOS:000334107500087
J	Casini, M; Rouyer, T; Bartolino, V; Larson, N; Grygiel, W				Casini, Michele; Rouyer, Tristan; Bartolino, Valerio; Larson, Niklas; Grygiel, Wlodzimierz			Density-Dependence in Space and Time: Opposite Synchronous Variations in Population Distribution and Body Condition in the Baltic Sea Sprat (Sprattus sprattus) over Three Decades	PLOS ONE			English	Article							HERRING CLUPEA-HARENGUS; HABITAT SELECTION; GROWTH; DYNAMICS; AUTOCORRELATION; TEMPERATURE; ECOSYSTEM; ECOLOGY; CLIMATE; COASTAL	Spatio-temporal density-dependent processes are crucial regulatory factors for natural populations. However, there is a lack of studies addressing spatial density-dependence in fish growth. A previous investigation has suggested spatio-temporal density-dependence in body condition of Baltic sprat. Here, we used different techniques, such as centre of gravity, distance, and homogeneity indices, to better characterize the spatial and temporal variations in sprat density and body condition in the Baltic Proper. Our results evidenced a negative spatio-temporal co-variation between the centres of gravity of density and maximum condition. In the 1980s-early 1990s both centres were located in the middle of the Baltic Proper. From the mid 1990s the centres progressively separated in space, as the sprat population moved towards the north-eastern Baltic Proper, and the centre of maximum condition towards the south-western areas. Moreover, at low abundances, sprat density and condition were homogeneously distributed in space, whereas at high abundances both density and condition showed pronounced geographical gradients. The ecological processes potentially explaining the observed patterns were discussed in the light of the Ideal Free Distribution theory. We provide evidence that the shift in the spatial distribution of cod, the main predator of sprat, has been the main factor triggering the overall spatial changes in sprat density, and thus condition, during the past thirty years. The spatial indices shown here, synthesizing the spatio-temporal patterns of fish distribution, can support the implementation of the EU Marine Strategy Framework Directive.	[Casini, Michele; Bartolino, Valerio; Larson, Niklas] Swedish Univ Agr Sci, Inst Marine Res, Dept Aquat Resources, Lysekil, Sweden; [Rouyer, Tristan] Univ Oslo, Dept Biol, CEES, Oslo, Norway; [Rouyer, Tristan] IFREMER, UMR EME 212, Sete, France; [Bartolino, Valerio] Univ Gothenburg, Dept Earth Sci, Gothenburg, Sweden; [Grygiel, Wlodzimierz] Natl Marine Fisheries Res Inst NMFRI, Dept Fisheries Resources, Gdynia, Poland	Swedish University of Agricultural Sciences; University of Oslo; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Gothenburg; National Marine Fisheries Research Institute	Casini, M (corresponding author), Swedish Univ Agr Sci, Inst Marine Res, Dept Aquat Resources, Lysekil, Sweden.	michele.casini@slu.se		Casini, Michele/0000-0003-4910-5236; Bartolino, Valerio/0000-0002-4506-4329; Grygiel, Wlodzimierz/0000-0002-4897-5216	Swedish PLAN FISH project; Swedish Environmental Protection Agency; Swedish Agency for Marine and Water Management; Norwegian Research Council through the ARCWARM Project [178239]	Swedish PLAN FISH project; Swedish Environmental Protection Agency; Swedish Agency for Marine and Water Management; Norwegian Research Council through the ARCWARM Project	MC was partially funded by the Swedish PLAN FISH project financed by the "Swedish Environmental Protection Agency" and the "Swedish Agency for Marine and Water Management." Funding for TR was provided by the Norwegian Research Council through the ARCWARM Project (#178239). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolino V, 2011, ECOLOGY, V92, P189, DOI 10.1890/09-1129.1; BERTNESS MD, 1985, OECOLOGIA, V67, P192, DOI 10.1007/BF00384283; Bez N, 2001, FISH RES, V50, P41, DOI 10.1016/S0165-7836(00)00241-1; Bez N, 2000, ICES J MAR SCI, V57, P383, DOI 10.1006/jmsc.2000.0644; Bjornstad ON, 1999, ECOLOGY, V80, P1278; BRANCH GM, 1975, J ANIM ECOL, V44, P263, DOI 10.2307/3862; Burgess MD, 2011, P R SOC B, V275, P1209; Cardinale M, 2002, AQUAT LIVING RESOUR, V15, P273, DOI 10.1016/S0990-7440(02)01188-9; Cardinale M, 2009, MAR ECOL PROG SER, V386, P197, DOI 10.3354/meps08076; Casini M, 2006, OIKOS, V112, P638, DOI 10.1111/j.0030-1299.2006.13860.x; Casini M, 2008, P ROY SOC B-BIOL SCI, V275, P1793, DOI 10.1098/rspb.2007.1752; Casini M, 2011, POPUL ECOL, V53, P511, DOI 10.1007/s10144-011-0269-2; EC, 2010, 2010477EU EC; European Commission (EC), 2012, SCI TECHN RES SER, DOI [10.2788/25697.69pp, DOI 10.2788/25697.69]; Fauchald P, 2006, ECOLOGY, V87, P2915, DOI 10.1890/0012-9658(2006)87[2915:DMWITM]2.0.CO;2; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Grygiel W., 2003, B SEA FISH I, V2, P1; HAILS RS, 1992, J ANIM ECOL, V61, P567, DOI 10.2307/5612; HOLT RD, 2001, DISPERSAL; Hsieh CH, 2008, CAN J FISH AQUAT SCI, V65, P947, DOI 10.1139/F08-017; Hsieh CH, 2010, AQUAT SCI, V72, P165, DOI 10.1007/s00027-009-0122-2; Husebo A, 2007, ICES J MAR SCI, V64, P1161, DOI 10.1093/icesjms/fsm081; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; ICES, 2012, 2012ACOM43 ICES CM; ICES, 2013, 2013SSGRSP11 ICES; ICES, 2012, 2012SSGESST02 ICES C; ICES, 2012, 2012ACIN10 ICES CM W; Kondratjeva N., 1993, ICES CM, VJ25, P1; Kritzer JP, 2004, FISH FISH, V5, P131, DOI 10.1111/j.1467-2979.2004.00131.x; MacKenzie BR, 2004, ECOLOGY, V85, P784, DOI 10.1890/02-0780; Mollmann C, 2005, ICES J MAR SCI, V62, P1270, DOI 10.1016/j.icesjms.2005.04.021; MORRIS DW, 1989, EVOL ECOL, V3, P80, DOI 10.1007/BF02147934; Ojaveer E, 2010, REV FISH BIOL FISHER, V20, P203, DOI 10.1007/s11160-009-9130-5; Overmars KP, 2003, ECOL MODEL, V164, P257, DOI 10.1016/S0304-3800(03)00070-X; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; RAJASILTA M, 1992, CAN J FISH AQUAT SCI, V49, P644, DOI 10.1139/f92-073; Shepherd TD, 2004, FISH FISH, V5, P141, DOI 10.1111/j.1467-2979.2004.00143.x; Uuemaa E, 2008, ECOL INDIC, V8, P783, DOI 10.1016/j.ecolind.2006.12.002; Van Leeuwen A, 2008, J SEA RES, V60, P89, DOI 10.1016/j.seares.2008.02.008; WINTERS GH, 1994, CAN J FISH AQUAT SCI, V51, P1169, DOI 10.1139/f94-116	41	22	22	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92278	10.1371/journal.pone.0092278	http://dx.doi.org/10.1371/journal.pone.0092278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699501	gold, Green Published			2022-12-27	WOS:000334105000021
J	Rubinstein, A; Gutierrez, L; Beratarrechea, A; Irazola, VE				Rubinstein, Adolfo; Gutierrez, Laura; Beratarrechea, Andrea; Irazola, Vilma E.			Increased Prevalence of Diabetes in Argentina Is Due to Easier Health Care Access Rather than to an Actual Increase in Prevalence	PLOS ONE			English	Article							RISK-FACTORS; RELIABILITY; OBESITY; DISEASE; STROKE; WOMEN	Introduction: According to the Argentine National Risk Factor Survey (ANRFS), between 2005 and 2009, self-reported Diabetes increased in Argentina from 8.4% to 9.6%, accompanied by a raise in the prevalence of obesity and low physical activity. In the same period, it also increased blood sugar checks from 69.3% to 75.7%. Since surveillance data in Argentina rely on self-reports, the estimated prevalence of diabetes may be affected by an increase in the proportion of subjects with access to preventive services. We evaluated the independent effect of a recent blood sugar check, on the increase in self-reported diagnoses of diabetes between 2005 and 2009. Materials and Methods: A secondary analysis of data from the 2005 and 2009 ANRFS was performed. Diabetes was defined as having been diagnosed Diabetes or high blood sugar by a health professional, obesity was calculated as BMI >= 30 kg/m(2), based on self-reported height and weight and physical activity was measured using the International Physical Activity Questionnaire. We used logistic regression models to explore the relationship between prevalence of self-reported diabetes and recent blood sugar check as the main predictor. Results: The prevalence of diabetes rose from 8.4% to 9.6%; obesity from 14.5% to 18% and low physical activity from 46.2% to 55%, between 2005 and 2009. Among those who recently checked their blood sugar no differences were found in the prevalence of diabetes: 13% in 2005 vs. 13.2% in 2009. Findings of the multivariable analysis showed that obesity and low physical activity were significantly associated with self reported diabetes in the adjusted model (OR = 1.80 for obesity, and OR = 1.12 for low physical activity but the strongest predictor was recent blood sugar check (OR = 4.75). Discussion: An increased prevalence of self-reported diabetes between 2005 and 2009 might indicate an improvement in the access to preventive services rather than a positive increase in the prevalence of diabetes.	[Rubinstein, Adolfo; Gutierrez, Laura; Beratarrechea, Andrea; Irazola, Vilma E.] Inst Clin Effectiveness & Hlth Policy IECS, Ctr Excellence, South Amer Ctr Cardiovasc Hlth SACECH, Buenos Aires, DF, Argentina		Rubinstein, A (corresponding author), Inst Clin Effectiveness & Hlth Policy IECS, Ctr Excellence, South Amer Ctr Cardiovasc Hlth SACECH, Buenos Aires, DF, Argentina.	arubinstein@iecs.org.ar						Agrawal S, 2012, PUBLIC HEALTH NUTR, V15, P1065, DOI 10.1017/S1368980011002813; Brancati FL, 1999, ARCH INTERN MED, V159, P957, DOI 10.1001/archinte.159.9.957; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; Danaei Goodarz, 2009, Popul Health Metr, V7, P16, DOI 10.1186/1478-7954-7-16; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Ferrante D, 2011, REV ARGENTINA SALUD, V2, P34; Ferrante D, 2011, REV ARGENT SALUD PUB, V2, P34; Ferrante Daniel, 2007, Rev. argent. cardiol., V75, P20; Fleischer NL, 2011, AM J PUBLIC HEALTH, V101, P294, DOI 10.2105/AJPH.2009.190165; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Gasparini L, 2001, CUADERNOS EC, V38, P49; Hennekens C. H., 1987, EPIDEMIOLOGY MED LIT; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Jahangir E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045053; Javier E, 1995, ARGENTINAS POOR PROF; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; Roux AVD, 2002, J EPIDEMIOL COMMUN H, V56, P588, DOI 10.1136/jech.56.8.588; Saydah SH, 2004, ANN EPIDEMIOL, V14, P507, DOI 10.1016/j.annepidem.2003.09.016; Schneider ALC, 2012, AM J EPIDEMIOL, V176, P738, DOI 10.1093/aje/kws156; SELDEN C., 2000, HLTH LIT	22	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2014	9	4							e92245	10.1371/journal.pone.0092245	http://dx.doi.org/10.1371/journal.pone.0092245			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LR	24699429	Green Published, Green Submitted, gold			2022-12-27	WOS:000334105000020
J	Doi, T; Doi, S; Nakashima, A; Ueno, T; Yokoyama, Y; Kohno, N; Masaki, T				Doi, Toshiki; Doi, Shigehiro; Nakashima, Ayumu; Ueno, Toshinori; Yokoyama, Yukio; Kohno, Nobuoki; Masaki, Takao			Mizoribine Ameliorates Renal Injury and Hypertension along with the Attenuation of Renal Caspase-1 Expression in Aldosterone-Salt-Treated Rats	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EXPERIMENTAL PERITONEAL FIBROSIS; IL-1-BETA-CONVERTING ENZYME; MYOCARDIAL-INFARCTION; PODOCYTE INJURY; DIABETIC-RATS; INFLAMMATION; MICE; EPLERENONE; BLOCKER	Aldosterone-salt treatment induces not only hypertension but also extensive inflammation that contributes to fibrosis in the rat kidney. However, the mechanism underlying aldosterone-salt-induced renal inflammation remains unclear. Pyroptosis has recently been identified as a new type of cell death that is accompanied by the activation of inflammatory cytokines. We hypothesized that aldosterone-salt treatment could induce inflammation through pyroptosis and that mizoribine, an effective immunosuppressant, would ameliorate the renal inflammation that would otherwise cause renal fibrosis. Ten days after recovery from left uninephrectomy, rats were given drinking water with 1% sodium chloride. The animals were divided into three groups (n=7 per group): (1) vehicle infusion group, (2) aldosterone infusion group, or (3) aldosterone infusion plus oral mizoribine group. Aldosterone-salt treatment increased the expression of the nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain containing 3 and caspase-1, and also increased the number of terminal deoxynucleotidyl transferase dUTP nick end labeling-positive cells. However, the oral administration of mizoribine attenuated these alterations. Furthermore, mizoribine inhibited hypertension and renal fibrosis, and also attenuated the aldosterone-induced expression of serum/glucocorticoid-regulated kinase and a epithelial sodium channel. These results suggest that caspase-1 activation plays an important role in the development of inflammation induced by aldosterone-salt treatment and that it functions as an anti-inflammatory strategy that protects against renal injury and hypertension.	[Doi, Toshiki; Doi, Shigehiro; Nakashima, Ayumu; Ueno, Toshinori; Yokoyama, Yukio; Masaki, Takao] Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan; [Kohno, Nobuoki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Internal Med, Hiroshima, Japan	Hiroshima University; Hiroshima University	Masaki, T (corresponding author), Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan.	masakit@hiroshima-u.ac.jp	Nakashima, Ayumu/N-9158-2017; Hiyama, Eiso/A-2013-2019; Doi, Shigehiro/AAQ-2655-2020; Nakashima, Ayumu/CAF-0274-2022	Nakashima, Ayumu/0000-0002-7838-1494; Hiyama, Eiso/0000-0001-9179-5037; Nakashima, Ayumu/0000-0002-7838-1494; DOI, TOSHIKI/0000-0001-8870-5790	Tsuchiya Memorial Medical Foundation Grant	Tsuchiya Memorial Medical Foundation Grant	This work was supported by the Tsuchiya Memorial Medical Foundation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Booth RE, 2002, ADV PHYSIOL EDUC, V26, P8, DOI 10.1152/advan.00051.2001; Brown NJ, 2013, NAT REV NEPHROL, V9, P459, DOI 10.1038/nrneph.2013.110; Brown NJ, 2000, KIDNEY INT, V58, P1219, DOI 10.1046/j.1523-1755.2000.00277.x; CAVAILLON JM, 1994, BIOMED PHARMACOTHER, V48, P445, DOI 10.1016/0753-3322(94)90005-1; Cheng JZ, 2010, KIDNEY INT, V78, P668, DOI 10.1038/ki.2010.214; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; de las Hera N, 2007, J HYPERTENS, V25, P629, DOI 10.1097/HJH.0b013e3280112ce5; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Elmarakby AA, 2008, AM J PHYSIOL-REG I, V294, pR76, DOI 10.1152/ajpregu.00466.2007; Elmarakby AA, 2007, HYPERTENSION, V50, P1069, DOI 10.1161/HYPERTENSIONAHA.107.098806; Epstein M, 2006, CLIN J AM SOC NEPHRO, V1, P940, DOI 10.2215/CJN.00240106; Feria I, 2003, KIDNEY INT, V63, P43, DOI 10.1046/j.1523-1755.2003.00707.x; Frantz S, 2003, J MOL CELL CARDIOL, V35, P685, DOI 10.1016/S0022-2828(03)00113-5; Furuichi K, 2003, J AM SOC NEPHROL, V14, P2503, DOI 10.1097/01.ASN.0000089563.63641.A8; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; HEPTINSTALL RH, 1967, LAB INVEST, V16, P751; Hill GS, 2008, CURR OPIN NEPHROL HY, V17, P266, DOI 10.1097/MNH.0b013e3282f88a1f; Ikeda H, 2009, KIDNEY INT, V75, P147, DOI 10.1038/ki.2008.507; Kanamori H, 2007, BIOCHEM BIOPH RES CO, V360, P772, DOI 10.1016/j.bbrc.2007.06.148; Kawasaki Y, 2009, CLIN DEV IMMUNOL, DOI 10.1155/2009/681482; Kikuchi Y, 2005, NEPHROL DIAL TRANSPL, V20, P1573, DOI 10.1093/ndt/gfh888; Kitagawa K, 2004, AM J PATHOL, V165, P237, DOI 10.1016/S0002-9440(10)63292-0; Lee SB, 2010, KIDNEY INT, V78, pS22, DOI 10.1038/ki.2010.418; Leroy V, 2009, J AM SOC NEPHROL, V20, P131, DOI 10.1681/ASN.2008020232; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Nagase M, 2006, HYPERTENSION, V47, P1084, DOI 10.1161/01.HYP.0000222003.28517.99; Nishiyama A, 2010, J PHARMACOL EXP THER, V332, P1072, DOI 10.1124/jpet.109.158113; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rodriguez-Iturbe B, 2012, CLIN EXP PHARMACOL P, V39, P96, DOI 10.1111/j.1440-1681.2011.05482.x; Sakai T, 1997, J UROLOGY, V158, P2316, DOI 10.1016/S0022-5347(01)68242-9; Schielke GP, 1998, J CEREBR BLOOD F MET, V18, P180, DOI 10.1097/00004647-199802000-00009; Schrier RW, 2010, NAT REV NEPHROL, V6, P61, DOI 10.1038/nrneph.2009.228; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shimizu M, 1998, NEPHRON, V79, P67, DOI 10.1159/000044994; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Soundararajan R, 2010, J BIOL CHEM, V285, P30363, DOI 10.1074/jbc.R110.155341; Takahashi S, 2009, NEPHRON EXP NEPHROL, V112, pE59, DOI 10.1159/000213896; Terada Y, 2012, CLIN EXP NEPHROL, V16, P81, DOI 10.1007/s10157-011-0498-x; Ueno T, 2013, KIDNEY INT, V84, P297, DOI 10.1038/ki.2013.81; White WB, 2003, HYPERTENSION, V41, P1021, DOI 10.1161/01.HYP.0000067463.13172.EA; Williams GH, 2004, AM J CARDIOL, V93, P990, DOI 10.1016/j.amjcard.2004.01.007; Zhang AH, 2007, AM J PHYSIOL-RENAL, V293, pF723, DOI 10.1152/ajprenal.00480.2006; Zhang AH, 2011, KIDNEY INT, V80, P51, DOI 10.1038/ki.2011.29	46	23	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93513	10.1371/journal.pone.0093513	http://dx.doi.org/10.1371/journal.pone.0093513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695748	Green Submitted, Green Published, gold			2022-12-27	WOS:000334103000083
J	Miao, H; Hartman, M; Bhoo-Pathy, N; Lee, SC; Taib, NA; Tan, EY; Chan, P; Moons, KGM; Wong, HS; Goh, J; Rahim, SM; Yip, CH; Verkooijen, HM				Miao, Hui; Hartman, Mikael; Bhoo-Pathy, Nirmala; Lee, Soo-Chin; Taib, Nur Aishah; Tan, Ern-Yu; Chan, Patrick; Moons, Karel G. M.; Wong, Hoong-Seam; Goh, Jeremy; Rahim, Siti Mastura; Yip, Cheng-Har; Verkooijen, Helena M.			Predicting Survival of De Novo Metastatic Breast Cancer in Asian Women: Systematic Review and Validation Study	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; LOCO-REGIONAL TREATMENT; PROGNOSTIC INDEX; BRAIN METASTASES; IMPROVES SURVIVAL; IMPACT; CARCINOMA; SURGERY; CONFIRMATION; CHEMOTHERAPY	Background: In Asia, up to 25% of breast cancer patients present with distant metastases at diagnosis. Given the heterogeneous survival probabilities of de novo metastatic breast cancer, individual outcome prediction is challenging. The aim of the study is to identify existing prognostic models for patients with de novo metastatic breast cancer and validate them in Asia. Materials and Methods: We performed a systematic review to identify prediction models for metastatic breast cancer. Models were validated in 642 women with de novo metastatic breast cancer registered between 2000 and 2010 in the Singapore Malaysia Hospital Based Breast Cancer Registry. Survival curves for low, intermediate and high-risk groups according to each prognostic score were compared by log-rank test and discrimination of the models was assessed by concordance statistic (C-statistic). Results: We identified 16 prediction models, seven of which were for patients with brain metastases only. Performance status, estrogen receptor status, metastatic site(s) and disease-free interval were the most common predictors. We were able to validate nine prediction models. The capacity of the models to discriminate between poor and good survivors varied from poor to fair with C-statistics ranging from 0.50 (95% CI, 0.48-0.53) to 0.63 (95% CI, 0.60-0.66). Conclusion: The discriminatory performance of existing prediction models for de novo metastatic breast cancer in Asia is modest. Development of an Asian-specific prediction model is needed to improve prognostication and guide decision making.	[Miao, Hui; Hartman, Mikael; Verkooijen, Helena M.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Miao, Hui; Hartman, Mikael; Goh, Jeremy; Verkooijen, Helena M.] Natl Univ Hlth Syst, Singapore, Singapore; [Hartman, Mikael] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Hartman, Mikael] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Bhoo-Pathy, Nirmala; Wong, Hoong-Seam] Kuala Lumpur Hosp, Natl Clin Res Ctr, Kuala Lumpur, Malaysia; [Bhoo-Pathy, Nirmala; Moons, Karel G. M.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Lee, Soo-Chin] Natl Univ Hlth Syst, Natl Univ Canc Inst, Dept Hematol Oncol, Singapore, Singapore; [Taib, Nur Aishah; Yip, Cheng-Har] Univ Malaya, Fac Med, Dept Surg, Kuala Lumpur, Malaysia; [Tan, Ern-Yu; Chan, Patrick] Tan Tock Seng Hosp, Dept Surg, Singapore, Singapore; [Goh, Jeremy] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Rahim, Siti Mastura] Minist Hlth Holdings, Singapore, Singapore; [Verkooijen, Helena M.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	National University of Singapore; National University of Singapore; National University of Singapore; Karolinska Institutet; Utrecht University; Utrecht University Medical Center; National University of Singapore; Universiti Malaya; Tan Tock Seng Hospital; National University of Singapore; Utrecht University; Utrecht University Medical Center	Hartman, M (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	ephbamh@nus.edu.sg	Yip, Cheng-Har/B-1909-2010; Pathy, Nirmala Bhoo/C-1228-2010; Taib, Nur Aishah Mohd/B-2370-2010; Lee, Soo Chin/S-9111-2016; Hartman, Mikael/B-4324-2011	Pathy, Nirmala Bhoo/0000-0003-0568-8863; Taib, Nur Aishah Mohd/0000-0001-8419-0478; Lee, Soo Chin/0000-0002-5835-6419; Hartman, Mikael/0000-0001-5726-9965	Lien Centre for Palliative Care Extramural Research Award [LCPC(ER)/2012/0007]; Ministry of Higher Education, Malaysia High Impact Research Grant [UM.C/HIR/MOHE/06]	Lien Centre for Palliative Care Extramural Research Award; Ministry of Higher Education, Malaysia High Impact Research Grant	This work was supported by Lien Centre for Palliative Care Extramural Research Award (LCPC(ER)/2012/0007), and Ministry of Higher Education, Malaysia High Impact Research Grant (UM.C/HIR/MOHE/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal G, 2007, WORLD J SURG, V31, P1031, DOI 10.1007/s00268-005-0585-9; Ahn HK, 2012, NEURO-ONCOLOGY, V14, P1105, DOI 10.1093/neuonc/nos137; Perez-Fidalgo JA, 2011, BREAST, V20, P548, DOI 10.1016/j.breast.2011.06.005; Andre F, 2004, J CLIN ONCOL, V22, P3302, DOI 10.1200/JCO.2004.08.095; Balic M, 2005, CYTOM PART B-CLIN CY, V68B, P25, DOI 10.1002/cyto.b.20065; Bhoo-Pathy N, 2012, EUR J CANCER, V48, P982, DOI 10.1016/j.ejca.2012.01.034; Biganzoli E, 1998, STAT MED, V17, P1169, DOI 10.1002/(SICI)1097-0258(19980530)17:10<1169::AID-SIM796>3.0.CO;2-D; Chang J, 2003, CANCER-AM CANCER SOC, V97, P545, DOI 10.1002/cncr.11083; Chia SK, 2007, CANCER, V110, P973, DOI 10.1002/cncr.22867; Chopra R, 2001, J CLIN ONCOL, V19, p106S; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485, DOI 10.1001/jama.277.18.1485; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Giordano A, 2013, CLIN CANCER RES, V19, P1596, DOI 10.1158/1078-0432.CCR-12-3137; Giordano A, 2011, BREAST CANCER RES TR, V129, P451, DOI 10.1007/s10549-011-1645-5; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; GORDON L, 1985, CANCER TREAT REP, V69, P1065; Gradishar WJ, 2013, ANN ONCOL; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; HORTOBAGYI GN, 1983, J CLIN ONCOL, V1, P776, DOI 10.1200/JCO.1983.1.12.776; Khodari W, 2013, CRIT REV ONCOL HEMAT, V87, P69, DOI 10.1016/j.critrevonc.2012.12.005; Largillier R, 2008, ANN ONCOL, V19, P2012, DOI 10.1093/annonc/mdn424; Le Scodan R, 2007, INT J RADIAT ONCOL, V69, P839, DOI 10.1016/j.ijrobp.2007.04.024; Le Scodan R, 2012, J NEURO-ONCOL, V106, P169, DOI 10.1007/s11060-011-0654-x; Li CI, 2002, CANCER EPIDEM BIOMAR, V11, P601; Lim SE, 2007, WORLD J SURG, V31, P1387, DOI 10.1007/s00268-007-9086-3; Liu MT, 2010, SUPPORT CARE CANCER, V18, P1553, DOI 10.1007/s00520-009-0778-0; Ly BH, 2010, BREAST CANCER RES TR, V119, P537, DOI 10.1007/s10549-009-0610-z; Marko NF, 2012, CANCER-AM CANCER SOC, V118, P3749, DOI 10.1002/cncr.26716; Michaelson JS, 2011, BREAST CANCER RES TR, V128, P827, DOI 10.1007/s10549-011-1366-9; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Muller V, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3243; NASH CH, 1980, CANCER, V46, P2380, DOI 10.1002/1097-0142(19801201)46:11<2380::AID-CNCR2820461113>3.0.CO;2-M; Nieder C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-105; Niwinska A, 2012, INT J RADIAT ONCOL, V82, P2065, DOI 10.1016/j.ijrobp.2010.10.077; O'Shaughnessy J, 2005, ONCOLOGIST, V10, P20, DOI 10.1634/theoncologist.10-90003-20; Pal SK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-435; Pathy NB, 2011, BRIT J SURG, V98, P1566, DOI 10.1002/bjs.7650; Pathy NB, 2011, BREAST, V20, pS75, DOI 10.1016/j.breast.2011.01.015; RABINOVICH M, 1992, ONCOLOGY, V49, P188; Rades D, 2013, STRAHLENTHER ONKOL, V189, P41, DOI 10.1007/s00066-012-0230-0; Rapiti E, 2006, J CLIN ONCOL, V24, P2743, DOI 10.1200/JCO.2005.04.2226; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; ROBERTSON JFR, 1992, BREAST CANCER RES TR, V22, P221, DOI 10.1007/BF01840835; Ruiterkamp J, 2010, BREAST CANCER RES TR, V120, P9, DOI 10.1007/s10549-009-0670-0; Ryberg M, 2001, ANN ONCOL, V12, P81, DOI 10.1023/A:1008384019411; Sant M, 2004, CANCER-AM CANCER SOC, V100, P715, DOI 10.1002/cncr.20038; Sperduto PW, 2012, INT J RADIAT ONCOL, V82, P2111, DOI 10.1016/j.ijrobp.2011.02.027; Tai P, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-60; Tan EY, 2005, ANN ACAD MED SINGAP, V34, P595; Telli ML, 2011, BREAST CANCER RES TR, V127, P471, DOI 10.1007/s10549-010-1173-8; TODD JH, 1987, BRIT J CANCER, V56, P489, DOI 10.1038/bjc.1987.230; TODD M, 1983, J CLIN ONCOL, V1, P406, DOI 10.1200/JCO.1983.1.6.406; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WILLIAMS MR, 1986, BRIT J SURG, V73, P752, DOI 10.1002/bjs.1800730925; Yamamoto N, 1998, J CLIN ONCOL, V16, P2401, DOI 10.1200/JCO.1998.16.7.2401; Yip Cheng Har, 2006, Asian Pac J Cancer Prev, V7, P369; Yip Cheng-Har, 2009, V471, P51, DOI 10.1007/978-1-59745-416-2_3	61	23	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93755	10.1371/journal.pone.0093755	http://dx.doi.org/10.1371/journal.pone.0093755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695692	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000119
J	Thiebaut, F; Grativol, C; Tanurdzic, M; Carnavale-Bottino, M; Vieira, T; Motta, MR; Rojas, C; Vincentini, R; Chabregas, SM; Hemerly, AS; Martienssen, RA; Ferreira, PCG				Thiebaut, Flavia; Grativol, Clicia; Tanurdzic, Milos; Carnavale-Bottino, Mariana; Vieira, Tauan; Motta, Mariana Romeiro; Rojas, Cristian; Vincentini, Renato; Chabregas, Sabrina Moutinho; Hemerly, Adriana Silva; Martienssen, Robert A.; Gomes Ferreira, Paulo Cavalcanti			Differential sRNA Regulation in Leaves and Roots of Sugarcane under Water Depletion	PLOS ONE			English	Article							DROUGHT-RESPONSIVE MICRORNAS; PLANT SMALL RNAS; SIRNA BIOGENESIS; DNA METHYLATION; MEDICAGO-TRUNCATULA; STRESS RESPONSES; PRI-MIRNA; RT-PCR; ARABIDOPSIS; GENOME	Plants have developed multiple regulatory mechanisms to respond and adapt to stress. Drought stress is one of the major constraints to agricultural productivity worldwide and recent reports have highlighted the importance of plant sRNA in the response and adaptation to water availability. In order to increase our understanding of the roles of sRNA in response to water depletion, cultivars of sugarcane were submitted to treatment of ceasing drip irrigation for 24 hours. Deep sequencing analysis was carried out to identify the sRNA regulated in leaves and roots of sugarcane cultivars with different drought sensitivities. The pool of sRNA selected allowed the analysis of different sRNA classes ( miRNA and siRNA). Twenty-eight and 36 families of conserved miRNA were identified in leaf and root libraries, respectively. Dynamic regulation of miRNA was observed and the expression profiles of eight miRNA were verified in leaf samples from three biological replicates by stem-loop qRT-PCR assay using the cultivars: SP90-1638-sensitive cultivar- and; SP83-2847 and SP83-5073 tolerant cultivars. Altered miRNA regulation was correlated with changes in mRNA levels of specific targets. Two leaf libraries from individual sugarcane cultivars with contrasting drought-tolerance properties were also analyzed. An enrichment of 22-nt sRNA species was observed in leaf libraries. 22-nt miRNA triggered siRNA production by cleavage of their targets in response to water depletion. A number of genes of the sRNA biogenesis pathway were down-regulated in tolerant genotypes and up-regulated in sensitive in response to water depletion treatment. Our analysis contributes to increase the knowledge on the roles of sRNA in sugarcane submitted to water depletion.	[Thiebaut, Flavia; Grativol, Clicia; Carnavale-Bottino, Mariana; Vieira, Tauan; Motta, Mariana Romeiro; Hemerly, Adriana Silva; Gomes Ferreira, Paulo Cavalcanti] Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Biol Mol Plantas, Rio De Janeiro, Brazil; [Tanurdzic, Milos] Univ Queensland, Sch Biol Sci, Brisbane St Lucia, Qld, Australia; [Rojas, Cristian] Univ Fed INTEGRACAO Latino Amer, Foz Do Iguacu, Parana, Brazil; [Vincentini, Renato] Univ Estadual Campinas, Ctr Biol Mol Engn Genet, Campinas, SP, Brazil; [Chabregas, Sabrina Moutinho] Fazenda St Antonio Lab Biol Mol, Ctr Tecnol Canavieira, Sao Paulo, Brazil; [Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Martienssen, Robert A.] Cold Spring Harbor Lab, Gordon & Betty Moore Fdn, Cold Spring Harbor, NY 11724 USA	Universidade Federal do Rio de Janeiro; University of Queensland; Universidade Federal da Integracao Latino-Americana; Universidade Estadual de Campinas; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory	Ferreira, PCG (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Biol Mol Plantas, Rio De Janeiro, Brazil.	paulof@bioqmed.ufrj.br	Thiebaut, Flavia/AAU-5318-2021; Ferreira, Paulo C G/I-2836-2015; Thiebaut, Flavia/B-3867-2018; Tanurdzic, Milos/A-5712-2012; Rojas, Cristian/X-1027-2018	Ferreira, Paulo C G/0000-0002-5510-999X; Thiebaut, Flavia/0000-0002-8833-1722; Tanurdzic, Milos/0000-0002-7564-0868; Rojas, Cristian/0000-0002-9085-6261; Grativol, Clicia/0000-0002-8873-701X; Romeiro Motta, Mariana/0000-0002-9163-0619	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia em Fixacao Biologica de Nitrogenio (INCT); Financiadora de Estudos e Projetos (FINEP); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Fixacao Biologica de Nitrogenio (INCT); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research by the group is supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia em Fixacao Biologica de Nitrogenio (INCT), Financiadora de Estudos e Projetos (FINEP), Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2010, SEMIN CELL DEV BIOL, V21, P798, DOI 10.1016/j.semcdb.2010.03.008; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bottino MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059423; Breakfield NW, 2012, GENOME RES, V22, P163, DOI 10.1101/gr.123547.111; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cantu D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-408; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Cho SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000314; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Fu J, 2012, J BOT, V2012, P1, DOI DOI 10.1155/2012/835836; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Grativol C, 2012, BBA-GENE REGUL MECH, V1819, P176, DOI 10.1016/j.bbagrm.2011.08.010; Grivet L, 2002, CURR OPIN PLANT BIOL, V5, P122, DOI 10.1016/S1369-5266(02)00234-0; Guleria Praveen, 2011, Genomics Proteomics & Bioinformatics, V9, P183, DOI 10.1016/S1672-0229(11)60022-3; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jamalkandi SA, 2009, FUNCT INTEGR GENOMIC, V9, P419, DOI 10.1007/s10142-009-0141-z; Jeong DH, 2010, METHODS MOL BIOL, V592, P203, DOI 10.1007/978-1-60327-005-2_14; Khraiwesh Basel, 2012, Biochim Biophys Acta, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kidner CA, 2005, CURR OPIN PLANT BIOL, V8, P38, DOI 10.1016/j.pbi.2004.11.008; Kong Y. Q. M., 2010, American Journal of Plant Sciences, V1, P69, DOI 10.4236/ajps.2010.12009; Krasnikova MS, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/952304; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Liu QP, 2009, FUNCT INTEGR GENOMIC, V9, P277, DOI 10.1007/s10142-009-0111-5; Lv DK, 2010, GENE, V459, P39, DOI 10.1016/j.gene.2010.03.011; Madlung A, 2004, ANN BOT-LONDON, V94, P481, DOI 10.1093/aob/mch172; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Mica E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-109; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Nobuta K, 2008, P NATL ACAD SCI USA, V105, P14958, DOI 10.1073/pnas.0808066105; OMALLEY DM, 1993, PLANT J, V4, P751, DOI 10.1046/j.1365-313X.1993.04050751.x; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Silva M, 1997, J PLANT PHYSL, V19, P193; Simon SA, 2011, CURR OPIN PLANT BIOL, V14, P148, DOI 10.1016/j.pbi.2010.11.007; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Thiebaut F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-290; Thiebaut F, 2012, PLANT CELL ENVIRON, V35, P502, DOI 10.1111/j.1365-3040.2011.02430.x; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Vargas L, 2012, PLANT SOIL, V356, P127, DOI 10.1007/s11104-012-1274-8; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Vazquez F, 2010, TRENDS PLANT SCI, V15, P337, DOI 10.1016/j.tplants.2010.04.001; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wang W., 2010, DROUGHT INDUCED SITE, P1, DOI [10.1093/jxb/erq391, DOI 10.1093/JXB/ERQ391]; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Willmann Matthew R, 2011, Arabidopsis Book, V9, pe0146, DOI 10.1199/tab.0146; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yang TW, 2007, PLANT SCI, V172, P423, DOI 10.1016/j.plantsci.2006.10.009; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	85	19	19	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93822	10.1371/journal.pone.0093822	http://dx.doi.org/10.1371/journal.pone.0093822			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695493	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000334103000126
J	Yu, HG; Wang, QY; Wang, ZW; Sahinkaya, E; Li, YL; Ma, JX; Wu, ZC				Yu, Hongguang; Wang, Qiaoying; Wang, Zhiwei; Sahinkaya, Erkan; Li, Yongli; Ma, Jinxing; Wu, Zhichao			Start-Up of an Anaerobic Dynamic Membrane Digester for Waste Activated Sludge Digestion: Temporal Variations in Microbial Communities	PLOS ONE			English	Article							METHANOGENIC ACTIVITY; BIOREACTOR; BACTERIAL; DIVERSITY; ARCHAEAL	An anaerobic dynamic membrane digester (ADMD) was developed to digest waste sludge, and pyrosequencing was used to analyze the variations of the bacterial and archaeal communities during the start-up. Results showed that bacterial community richness decreased and then increased over time, while bacterial diversity remained almost the same during the start-up. Proteobacteria and Bacteroidetes were the major phyla. At the class level, Betaproteobacteria was the most abundant at the end of start-up, followed by Sphingobacteria. In the archaeal community, richness and diversity peaked at the end of the start-up stage. Principle component and cluster analyses demonstrated that archaeal consortia experienced a distinct shift and became stable after day 38. Methanomicrobiales and Methanosarcinales were the two predominant orders. Further investigations indicated that Methanolinea and Methanosaeta were responsible for methane production in the ADMD system. Hydrogenotrophic pathways might prevail over acetoclastic means for methanogenesis during the start-up, supported by specific methanogenic activity tests.	[Yu, Hongguang; Wang, Qiaoying; Wang, Zhiwei; Ma, Jinxing; Wu, Zhichao] Tongji Univ, Sch Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China; [Sahinkaya, Erkan] Istanbul Medeniyet Univ, Dept Bioengn, Istanbul, Turkey; [Li, Yongli] Univ Rouen, CNRS INSA, Lab Polymeres Biopolymeres & Surfaces, UMR 6270, Mont St Aignan, France	Tongji University; Istanbul Medeniyet University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rouen Normandie	Wang, QY (corresponding author), Tongji Univ, Sch Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China.	qywang@tongji.edu.cn; zwwang@tongji.edu.cn	Wang, Zhiwei/F-5666-2012; Ma, Jinxing/D-9981-2013; Sahinkaya, Erkan/A-5227-2018; Wang, Qiaoying/AAN-6945-2020	Wang, Zhiwei/0000-0001-6729-2237; Ma, Jinxing/0000-0002-5087-3972; SAHINKAYA, ERKAN/0000-0002-9898-9173	Key Special Program on the S&T for the Pollution Control and Treatment of Water Bodies [2011ZX07303-001]; Science and Technology Commission of Shanghai Municipality [12230707000]	Key Special Program on the S&T for the Pollution Control and Treatment of Water Bodies; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work is partially supported by the Key Special Program on the S&T for the Pollution Control and Treatment of Water Bodies (2011ZX07303-001) and by the Science and Technology Commission of Shanghai Municipality research project (12230707000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association, 2012, HIDROL ME, V22nd; An Y, 2009, CHEM ENG J, V155, P709, DOI 10.1016/j.cej.2009.09.003; Appels L, 2008, PROG ENERG COMBUST, V34, P755, DOI 10.1016/j.pecs.2008.06.002; Ariesyady HD, 2007, WATER RES, V41, P1554, DOI 10.1016/j.watres.2006.12.036; Chouari R, 2005, ENVIRON MICROBIOL, V7, P1104, DOI 10.1111/j.1462-2920.2005.00795.x; Coates JD, 1996, J MICROBIOL METH, V26, P237, DOI 10.1016/0167-7012(96)00915-3; Connaughton S, 2006, WATER RES, V40, P1009, DOI 10.1016/j.watres.2005.12.026; Dagnew M, 2010, WATER SCI TECHNOL, V61, P1451, DOI 10.2166/wst.2010.028; DONLON BA, 1995, APPL ENVIRON MICROB, V61, P3889, DOI 10.1128/AEM.61.11.3889-3893.1995; Fan B, 2002, ENVIRON SCI TECHNOL, V36, P5245, DOI 10.1021/es025789n; Gao WJ, 2012, J MEMBRANE SCI, V421, P131, DOI 10.1016/j.memsci.2012.07.003; Garcia JL, 2000, ANAEROBE, V6, P205, DOI 10.1006/anae.2000.0345; Hatziconstantinou GJ, 1996, WATER SCI TECHNOL, V34, P417, DOI 10.1016/0273-1223(96)00545-8; Kapdan IK, 2006, ENZYME MICROB TECH, V38, P569, DOI 10.1016/j.enzmictec.2005.09.015; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Krause L, 2008, J BIOTECHNOL, V136, P91, DOI 10.1016/j.jbiotec.2008.06.003; Krober M, 2009, J BIOTECHNOL, V142, P38, DOI 10.1016/j.jbiotec.2009.02.010; Liao BQ, 2006, CRIT REV ENV SCI TEC, V36, P489, DOI 10.1080/10643380600678146; Ma JX, 2013, PROCESS BIOCHEM, V48, P510, DOI 10.1016/j.procbio.2013.02.003; Ma JX, 2013, WATER RES, V47, P859, DOI 10.1016/j.watres.2012.11.013; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Nelson MC, 2011, BIORESOURCE TECHNOL, V102, P3730, DOI 10.1016/j.biortech.2010.11.119; Padmasiri SI, 2007, WATER RES, V41, P134, DOI 10.1016/j.watres.2006.09.021; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Wang ZW, 2013, BIOTECHNOL ADV, V31, P1187, DOI 10.1016/j.biotechadv.2013.02.004; Xu ML, 2011, BIORESOURCE TECHNOL, V102, P5617, DOI 10.1016/j.biortech.2011.02.038; Yu HG, 2013, CHEM ENG J, V231, P206, DOI 10.1016/j.cej.2013.07.012; Yukselen MA, 1997, J ENVIRON SCI HEAL A, V32, P2069; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhang XY, 2010, CHEM ENG J, V165, P175, DOI 10.1016/j.cej.2010.09.013; Zheng D, 2000, MICROBIAL ECOL, V39, P246	34	53	53	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93710	10.1371/journal.pone.0093710	http://dx.doi.org/10.1371/journal.pone.0093710			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695488	Green Submitted, Green Published, gold			2022-12-27	WOS:000334103000109
J	Kim, MC; Lee, SW; Ryu, DY; Cui, FJ; Bhak, J; Kim, Y				Kim, Myung-Chul; Lee, Seung-Woo; Ryu, Doug-Young; Cui, Feng-Ji; Bhak, Jong; Kim, Yongbaek			Identification and Characterization of MicroRNAs in Normal Equine Tissues by Next Generation Sequencing	PLOS ONE			English	Article							ADIPOSE-TISSUE; EXPRESSION; HORSE; RNA; PRINCIPLES; DISORDERS; MIR-17-92; CARTILAGE; GENOMICS; PLANT	The role of microRNAs (miRNAs) as a post-transcriptional gene regulator has been elucidated in a broad range of organisms including domestic animals. Characterization of miRNAs in normal tissues is an important step to investigate the functions of miRNAs in various physiological and pathological conditions. Using Illumina Next Generation Sequencing (NGS) technology, we identified a total of 292 known and 329 novel miRNAs in normal horse tissues including skeletal muscle, colon and liver. Distinct sets of miRNAs were differentially expressed in a tissue-specific manner. The miRNA genes were distributed across all the chromosomes except chromosomes 29 and 31 in the horse reference genome. In some chromosomes, multiple miRNAs were clustered and considered to be polycistronic transcript. A base composition analysis showed that equine miRNAs had a higher frequency of A+U than G+C. Furthermore, U tended to be more frequent at the 59 end of miRNA sequences. This is the first experimental study that identifies and characterizes the global miRNA expression profile in normal horse tissues. The present study enriches the horse miRNA database and provides useful information for further research dissecting biological functions of miRNAs in horse.	[Kim, Myung-Chul; Cui, Feng-Ji; Kim, Yongbaek] Seoul Natl Univ, Coll Vet Med, Clin Pathol Lab, Seoul, South Korea; [Lee, Seung-Woo; Ryu, Doug-Young] Seoul Natl Univ, Coll Vet Med, Lab Environm Hlth, Seoul, South Korea; [Ryu, Doug-Young; Kim, Yongbaek] Seoul Natl Univ, Coll Vet Med, Res Inst Vet Sci, Seoul, South Korea; [Bhak, Jong] Theragen Bio Inst, Suwon, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, Y (corresponding author), Seoul Natl Univ, Coll Vet Med, Clin Pathol Lab, Seoul, South Korea.	yongbaek@snu.ac.kr			Bio-industry Technology Development Program of iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [1111594]; Brain Korea 21 Plus Program for Creative Veterinary Science Research, College of Veterinary Medicine, Seoul National University	Bio-industry Technology Development Program of iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; Brain Korea 21 Plus Program for Creative Veterinary Science Research, College of Veterinary Medicine, Seoul National University	This study was supported by Bio-industry Technology Development Program (Grant no. 1111594) of iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs, Republic of Korea. Myung-Chul Kim and Seung-Woo Lee were additionally supported by the Brain Korea 21 Plus Program for Creative Veterinary Science Research, College of Veterinary Medicine, Seoul National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai L, 2012, PARASITOL RES, V110, P2373, DOI 10.1007/s00436-011-2773-x; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barrey E, 2010, EQUINE VET J, V42, P561, DOI 10.1111/j.2042-3306.2010.00267.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boggs RM, 2008, MAMM GENOME, V19, P561, DOI 10.1007/s00335-008-9128-7; Boggs RM, 2007, GENE, V404, P25, DOI 10.1016/j.gene.2007.08.015; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Chowdhary BP, 2008, ANIM REPROD SCI, V107, P208, DOI 10.1016/j.anireprosci.2008.04.010; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Das PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056535; Dunn W, 2009, ARTHRITIS RHEUM-US, V60, P2333, DOI 10.1002/art.24678; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Fleischhacker SN, 2013, VET J, V197, P688, DOI 10.1016/j.tvjl.2013.03.027; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; FREESTONE JF, 1991, EQUINE VET J, V23, P86, DOI 10.1111/j.2042-3306.1991.tb02726.x; GALUPPO LD, 1995, AM J VET RES, V56, P518; Gu ZL, 2007, FEBS LETT, V581, P981, DOI 10.1016/j.febslet.2007.01.081; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ji ZB, 2012, MOL BIOL REP, V39, P9361, DOI 10.1007/s11033-012-1779-5; Jin WW, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-90; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lacourt M, 2012, OSTEOARTHR CARTILAGE, V20, P572, DOI 10.1016/j.joca.2012.02.004; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Li HL, 2012, MOL MED REP, V5, P1457, DOI 10.3892/mmr.2012.831; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Mair T., 2002, MANUAL EQUINE GASTRO; Mair TS, 2005, EQUINE VET J, V37, P296, DOI 10.2746/0425164054529409; McKenzie E, 2011, EQUINE VET J, V43, P637, DOI 10.1111/j.2042-3306.2011.00468.x; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Nicholas FW, 2003, NUCLEIC ACIDS RES, V31, P275, DOI 10.1093/nar/gkg074; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007829; Thatcher EJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-253; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; West HJ, 1996, EQUINE VET J, V28, P146, DOI 10.1111/j.2042-3306.1996.tb01607.x; Yang Hong, 2010, Yichuan, V32, P211, DOI 10.3724/SP.J.1005.2010.00211; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhou M, 2009, GENOMICS, V94, P125, DOI 10.1016/j.ygeno.2009.04.006	48	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93662	10.1371/journal.pone.0093662	http://dx.doi.org/10.1371/journal.pone.0093662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24988450	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000099
J	Wang, J; Huang, SK; Zhao, M; Yang, M; Zhong, JL; Gu, YY; Peng, H; Che, YQ; Huang, CZ				Wang, Jia; Huang, Sheng-kai; Zhao, Mei; Yang, Mei; Zhong, Jia-ling; Gu, Yu-yu; Peng, Hua; Che, Yi-qun; Huang, Chang-zhi			Identification of a Circulating MicroRNA Signature for Colorectal Cancer Detection	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; EXPRESSION PROFILE; BIOMARKERS; SERUM; TUMOR; DIAGNOSIS; METASTASIS; MARKERS; MIR-31	Prognosis of patients with colorectal cancer (CRC) is generally poor because of the lack of simple, convenient, and noninvasive tools for CRC detection at the early stage. The discovery of microRNAs (miRNAs) and their different expression profiles among different kinds of diseases has opened a new avenue for tumor diagnosis. We built a serum microRNA expression profile signature and tested its specificity and sensitivity as a biomarker in the diagnosis of CRC. We also studied its possible role in monitoring the progression of CRC. We conducted a two phase case-control test to identify serum miRNAs as biomarkers for CRC diagnosis. Using quantitative reverse transcription polymerase chain reactions, we tested ten candidate miRNAs in a training set (30 CRCs vs 30 controls). Risk score analysis was used to evaluate the diagnostic value of the serum miRNA profiling system. Other independent samples, including 83 CRCs and 59 controls, were used to validate the diagnostic model. In the training set, six serum miRNAs (miR-21, let-7g, miR-31, miR-92a, miR-181b, and miR-203) had significantly different expression levels between the CRCs and healthy controls. Risk score analysis demonstrated that the six-miRNA-based biomarker signature had high sensitivity and specificity for distinguishing the CRC samples from cancer-free controls. The areas under the receiver operating characteristic (ROC) curve of the six-miRNA signature profiles were 0.900 and 0.923 for the two sets of serum samples, respectively. However, for the same serum samples, the areas under the ROC curve used by the tumor markers carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) were only 0.649 and 0.598, respectively. The expression levels of the six serum miRNAs were also correlated with CRC progression. Thus, the identified six-miRNA signature can be used as a noninvasive biomarker for the diagnosis of CRC, with relatively high sensitivity and specificity.	[Wang, Jia; Huang, Sheng-kai; Zhao, Mei; Yang, Mei; Zhong, Jia-ling; Gu, Yu-yu; Peng, Hua; Huang, Chang-zhi] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Che, Yi-qun] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Che, YQ (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Dept Clin Lab, Beijing 100730, Peoples R China.	cyq@cicams.ac.cn; huangpumc@163.com			National Key Basic Research Program of China [2007CB914700]	National Key Basic Research Program of China(National Basic Research Program of China)	This study was supported by the National Key Basic Research Program of China (2007CB914700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Burch JA, 2007, J MED SCREEN, V14, P132, DOI 10.1258/096914107782066220; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Chen ZL, 2011, J BIOL CHEM, V286, P10725, DOI 10.1074/jbc.M110.165654; Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4; Corte H, 2012, DIGEST LIVER DIS, V44, P195, DOI 10.1016/j.dld.2011.10.010; Duffy MJ, 2007, EUR J CANCER, V43, P1348, DOI 10.1016/j.ejca.2007.03.021; Duttagupta R, 2013, WIRES RNA, V4, P129, DOI 10.1002/wrna.1149; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Garcia-Bilbao A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-43; Hewitson P, 2007, COCHRANE DATABASE SY, V1; Li JP, 2011, BIOCHEM BIOPH RES CO, V406, P70, DOI 10.1016/j.bbrc.2011.01.111; Li ZY, 2012, ONCOL LETT, V3, P346, DOI 10.3892/ol.2011.497; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Liu JQ, 2012, INT J CANCER, V131, P683, DOI 10.1002/ijc.26422; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Murakoshi Y, 2011, CANCER SCI, V102, P630, DOI 10.1111/j.1349-7006.2010.01818.x; Nilsson S., 2012, PLOS ONE, V7; Nugent M, 2011, EJSO-EUR J SURG ONC, V37, P649, DOI 10.1016/j.ejso.2011.05.005; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Shigoka M, 2010, PATHOL INT, V60, P351, DOI 10.1111/j.1440-1827.2010.02526.x; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Takeshita N, 2013, BRIT J CANCER, V108, P644, DOI 10.1038/bjc.2013.8; Valastyan S, 2010, CANCER RES, V70, P5147, DOI 10.1158/0008-5472.CAN-10-0410; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044398; Wang S, 2013, CLIN TRANSL ONCOL, V15, P849, DOI 10.1007/s12094-013-1014-4; Zhang YY, 2010, MED ONCOL, V27, P685, DOI 10.1007/s12032-009-9269-x	35	218	228	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e87451	10.1371/journal.pone.0087451	http://dx.doi.org/10.1371/journal.pone.0087451			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709885	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800003
J	Xiao, JB; Ding, Y; Huang, J; Li, QS; Liu, Y; Ni, W; Zhang, YQ; Zhu, YF; Chen, LH; Chen, B				Xiao, Jianbiao; Ding, Yi; Huang, Jing; Li, Qisheng; Liu, Ying; Ni, Wen; Zhang, Yuqin; Zhu, Yanfei; Chen, Longhua; Chen, Bin			The Association of HMGB1 Gene with the Prognosis of HCC	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; RECURRENT HEPATOCELLULAR-CARCINOMA; HIGH-MOBILITY-GROUP-BOX-1 HMGB1; INCREASED EXPRESSION; CHROMATIN PROTEIN; POOR-PROGNOSIS; GASTRIC-CANCER; UNITED-STATES; CYTOKINE; CELLS	High-mobility group box 1 protein (HMGB1) is an evolutionarily ancient and critical regulator of cell death and survival. HMGB1 is a chromatin-associated nuclear protein molecule that triggers extracellular damage. The expression of HMGB1 has been reported in many types of cancers, but the role of HMGB1 in hepato cellular carcinoma (HCC) is unknown. The aim of this study was to analyze the roles of HMGB1 in HCC progression using HCC clinical samples. We also investigated the clinical outcomes of HCC samples with a special focus on HMBG1 expression. In an immunohistochemical study conducted on 208 cases of HCC, HMGB1 had high expression in 134 cases(64.4%). The HMGB1 expression level did not correlate with any clinicopathological parameters, except alpha fetoprotein (AFP) (p = 0.041) and CLIP stage (p = 0.007). However, survival analysis showed that the group with HMBG1 overexpression had a significantly shorter overall survival time than the group with a down-regulatedexpression of HMBG1 (HR = 0.568, CI (0.398, 0.811), p = 0.002). Multivariate analysis showed that HMGB1 expression was a significant and independent prognostic parameter (HR = 0.562, CI (0.388, 0.815), p = 0.002) for HCC patients. The ability of proliferation, migration and invasion of HCC cells was suppressed with the disruption of endogenous HMGB1 using small interfering RNAs. On the other hand, the ability of proliferation, migration and invasion of HCC cells was strengthened when the expression endogenous HMGB1 was enhanced using HMGB1 DNA. HMGB1 expression may be a novel and independent predictor for the prognosis of HCC patients. The overexpression of HMGB1 in HCC could be a novel, effective, and supplementary biomarker for HCC, since it plays a vital role in the progression of HCC.	[Xiao, Jianbiao; Ding, Yi; Huang, Jing; Li, Qisheng; Liu, Ying; Ni, Wen; Zhang, Yuqin; Zhu, Yanfei; Chen, Longhua] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China; [Chen, Bin] Peoples Liberat Army, Guangzhou Mil Command, Gen Hosp, Dept Sci & Training, Guangzhou, Guangdong, Peoples R China; [Huang, Jing] Guangdong Med Coll, Affiliated Hosp, Dept Canc Ctr, Zhanjiang, Guangdong, Peoples R China	Southern Medical University - China; Southern Theater Command General Hospital; Guangdong Medical University	Chen, LH (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China.	chenlhsmu@126.com; cbgzzyy@163.com	Ding, Yi/CAG-6304-2022; Ma, Jinxing/D-9981-2013; Lang, Eric J/A-1136-2017; Wang, Zhiwei/F-5666-2012; Wise, Andrew/B-5943-2014	Cerminara, Nadia/0000-0001-8207-5871; Ding, Yi/0000-0001-5035-9255; Kotsurovskyy, Yuriy/0000-0002-1288-518X; Ma, Jinxing/0000-0002-5087-3972; Yan, Xiaolong/0000-0003-2419-9707; Lang, Eric J/0000-0002-8524-9854; Wang, Zhiwei/0000-0001-6729-2237; Wise, Andrew/0000-0001-9715-8784; Apps, Richard/0000-0002-2064-3359	National Natural Science Foundation of China [81101822]; Guangzhou science and technology [11C26090521]; Guangdong Provincal Science Foundation [10451001002005047, S2013010014185]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou science and technology; Guangdong Provincal Science Foundation	Grant support: National Natural Science Foundation of China (No. 81101822), Guangzhou science and technology key projects (No. 11C26090521), Guangdong Provincal Science Foundation (No. 10451001002005047, No. S2013010014185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 2007, ANTICANCER RES, V27, P449; Bianchi ME, 2004, TRENDS CELL BIOL, V14, P287, DOI 10.1016/j.tcb.2004.04.004; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; Brezniceanu ML, 2003, FASEB J, V17, P1295, DOI 10.1096/fj.02-0621fje; Capocaccia R, 2007, AM J GASTROENTEROL, V102, P1661, DOI 10.1111/j.1572-0241.2007.01337.x; Choi YR, 2003, CANCER RES, V63, P2188; Dong XD, 2007, J IMMUNOTHER, V30, P596, DOI 10.1097/CJI.0b013e31804efc76; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Ellerman JE, 2007, CLIN CANCER RES, V13, P2836, DOI 10.1158/1078-0432.CCR-06-1953; Kim DY, 2007, ONCOLOGY-BASEL, V72, P52, DOI 10.1159/000111707; Kostova N, 2010, MOL CELL BIOCHEM, V337, P251, DOI 10.1007/s11010-009-0305-0; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Maeda S, 2007, BIOCHEM BIOPH RES CO, V360, P394, DOI 10.1016/j.bbrc.2007.06.065; Muller S, 2004, J INTERN MED, V255, P332, DOI 10.1111/j.1365-2796.2003.01296.x; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Naghavi MH, 2003, VIROLOGY, V314, P179, DOI 10.1016/S0042-6822(03)00453-7; Ng KK, 2008, ARCH SURG-CHICAGO, V143, P68, DOI 10.1001/archsurg.2007.15; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Poser I, 2003, MOL CELL BIOL, V23, P2991, DOI 10.1128/MCB.23.8.2991-2998.2003; Rudmik LR, 2005, J SURG ONCOL, V92, P347, DOI 10.1002/jso.20393; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Ulloa L, 2003, ARTHRITIS RHEUM, V48, P876, DOI 10.1002/art.10854; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Volp K, 2006, GUT, V55, P234, DOI 10.1136/gut.2004.062729; Wu D, 2008, J PATHOL, V216, P167, DOI 10.1002/path.2391; Xu YF, 2010, J HEPATOL, V53, P872, DOI 10.1016/j.jhep.2010.05.019; Zhang HK, 2008, CANCER LETT, V261, P183, DOI 10.1016/j.canlet.2007.11.019	34	83	85	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89097	10.1371/journal.pone.0089097	http://dx.doi.org/10.1371/journal.pone.0089097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	25121125	gold, Green Published			2022-12-27	WOS:000331711900089
J	Zhang, YG; Qiu, L; Li, SJ; Xiang, YC; Chen, JY; Ren, YG				Zhang, Yiguo; Qiu, Lu; Li, Shaojun; Xiang, Yuancai; Chen, Jiayu; Ren, Yonggang			The C-Terminal Domain of Nrf1 Negatively Regulates the Full-Length CNC-bZIP Factor and Its Shorter Isoform LCR-F1/Nrf1 beta; Both Are Also Inhibited by the Small Dominant-Negative Nrf1 gamma/delta Isoforms that Down-Regulate ARE-Battery Gene Expression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF1; TNF-ALPHA PROMOTER; OXIDATIVE STRESS; PROTEASOMAL DEGRADATION; ENDOPLASMIC-RETICULUM; TARGETED DISRUPTION; EMBRYONIC LETHALITY; BINDING DOMAIN; BETA-TRCP; KEAP1	The C-terminal domain (CTD, aa 686-741) of nuclear factor-erythroid 2 p45-related factor 1 (Nrf1) shares 53% amino acid sequence identity with the equivalent Neh3 domain of Nrf2, a homologous transcription factor. The Neh3 positively regulates Nrf2, but whether the Neh3-like (Neh3L) CTD of Nrf1 has a similar role in regulating Nrf1-target gene expression is unknown. Herein, we report that CTD negatively regulates the full-length Nrf1 (i.e. 120-kDa glycoprotein and 95-kDa deglycoprotein) and its shorter isoform LCR-F1/Nrf1 beta (55-kDa). Attachment of its CTD-adjoining 112-aa to the C-terminus of Nrf2 yields the chimaeric Nrf2-C112(Nrf1) factor with a markedly decreased activity. Live-cell imaging of GFP-CTD reveals that the extra-nuclear portion of the fusion protein is allowed to associate with the endoplasmic reticulum (ER) membrane through the amphipathic Neh3L region of Nrf1 and its basic c-tail. Thus removal of either the entire CTD or the essential Neh3L portion within CTD from Nrf1, LCR-F1/Nrf1 beta and Nrf2-C112(Nrf1), results in an increase in their transcriptional ability to regulate antioxidant response element (ARE)-driven reporter genes. Further examinations unravel that two smaller isoforms, 36-kDa Nrf1 gamma and 25-kDa Nrf1 delta, act as dominant-negative inhibitors to compete against Nrf1, LCR-F1/Nrf1 beta and Nrf2. Relative to Nrf1, LCR-F1/Nrf1 beta is a weak activator, that is positively regulated by its Asn/Ser/Thr-rich (NST) domain and acidic domain 2 (AD2). Like AD1 of Nrf1, both AD2 and NST domain of LCR-F1/Nrf1 beta fused within two different chimaeric contexts to yield Gal4D:Nrf1 beta(607) and Nrf1 beta:C270(Nrf2), positively regulate their transactivation activity of cognate Gal4- and Nrf2-target reporter genes. More importantly, differential expression of endogenous ARE-battery genes is attributable to up-regulation by Nrf1 and LCR-F1/Nrf1 beta and down-regulation by Nrf1 gamma and Nrf1 delta.	[Zhang, Yiguo] Chongqing Univ, Coll Med Bioengn, Lab Cell Biochem & Gene Regulat, Chongqing 630044, Peoples R China; Chongqing Univ, Fac Life Sci, Chongqing 630044, Peoples R China	Chongqing University; Chongqing University	Zhang, YG (corresponding author), Chongqing Univ, Coll Med Bioengn, Lab Cell Biochem & Gene Regulat, Chongqing 630044, Peoples R China.	yiguozhang@cqu.edu.cn		Jia, Jianping/0000-0003-4624-0336; Zhang, Yujuan/0000-0002-3243-1644; Zhang, Yiguo/0000-0003-3910-2779; Hayes, John/0000-0002-2927-5548	National Natural Science Foundation of China [91129703, 31270879]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (key program 91129703 and project 31270879) awarded to Prof. Yiguo Zhang (University of Chongqing, China). The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Bean TL, 1997, NUCLEIC ACIDS RES, V25, P2509, DOI 10.1093/nar/25.12.2509; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P2383, DOI 10.1093/nar/22.12.2383; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen LY, 2003, MOL CELL BIOL, V23, P4673, DOI 10.1128/MCB.23.13.4673-4686.2003; Chepelev NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029167; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Farmer SC, 1997, GENE DEV, V11, P786, DOI 10.1101/gad.11.6.786; Grimberg KB, 2011, MOL CELL BIOL, V31, P897, DOI 10.1128/MCB.00799-10; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Higgins LG, 2009, TOXICOL APPL PHARM, V237, P267, DOI 10.1016/j.taap.2009.03.005; Hirotsu Y, 2012, MOL CELL BIOL, V32, P2760, DOI 10.1128/MCB.06706-11; Huang CF, 2000, J BIOL CHEM, V275, P12313, DOI 10.1074/jbc.275.16.12313; Husberg C, 2001, J BIOL CHEM, V276, P17641, DOI 10.1074/jbc.M007951200; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Johnsen O, 1996, NUCLEIC ACIDS RES, V24, P4289, DOI 10.1093/nar/24.21.4289; Johnsen O, 1998, NUCLEIC ACIDS RES, V26, P512, DOI 10.1093/nar/26.2.512; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kim J, 2010, PHYSIOL GENOMICS, V40, P100, DOI 10.1152/physiolgenomics.00105.2009; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2011, GENES CELLS, V16, P692, DOI 10.1111/j.1365-2443.2011.01522.x; Koch A, 2011, CELL CYCLE, V10, P1200, DOI 10.4161/cc.10.8.15327; Kusunoki H, 2002, NAT STRUCT BIOL, V9, P252, DOI 10.1038/nsb771; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Kwong EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048404; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Li X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002119; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; LUNA L, 1994, GENOMICS, V22, P553, DOI 10.1006/geno.1994.1428; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Nioi P, 2005, MOL CELL BIOL, V25, P10895, DOI 10.1128/MCB.25.24.10895-10906.2005; Novotny V, 1998, NUCLEIC ACIDS RES, V26, P5480, DOI 10.1093/nar/26.23.5480; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Prieschl EE, 1998, NUCLEIC ACIDS RES, V26, P2291, DOI 10.1093/nar/26.10.2291; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Rupert PB, 1998, NAT STRUCT BIOL, V5, P484, DOI 10.1038/nsb0698-484; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; SAKURAI A, 1990, MOL ENDOCRINOL, V4, P1988, DOI 10.1210/mend-4-12-1988; Schultz MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087204; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Tsuchiya Y, 2013, MOL CELL BIOL, V33, P3461, DOI 10.1128/MCB.01271-12; Tsuchiya Y, 2011, MOL CELL BIOL, V31, P4500, DOI 10.1128/MCB.05663-11; Wang HY, 2013, CANCER RES, V73, P3097, DOI 10.1158/0008-5472.CAN-12-3386; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Wu JL, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-9; Xiao H, 2013, CURR CHEM BIOL, V7, P151, DOI [DOI 10.2174/2212796811307020008, 10.2174/2212796811307020008]; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Zhang J, 2007, BIOCHEM J, V404, P459, DOI 10.1042/BJ20061611; Zhang Y, 2014, MS1305858; Zhang YG, 2001, J BIOL CHEM, V276, P11775, DOI 10.1074/jbc.M006000200; Zhang Y, 2007, BIOCHEM J, V408, P161, DOI 10.1042/BJ20070761; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhang YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093458; Zhang YG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02006; Zhang YG, 2009, BIOCHEM J, V418, P293, DOI 10.1042/BJ20081575; Zhang Y, 2009, J BIOL CHEM, V284, P3195, DOI 10.1074/jbc.M805337200; [张玉台 Zhang Yutai], 2009, [管理世界, Management World], P1; Zhong YW, 2012, J BIOL CHEM, V287, P28057, DOI 10.1074/jbc.M112.381798	71	446	470	16	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109159	10.1371/journal.pone.0109159	http://dx.doi.org/10.1371/journal.pone.0109159			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290918	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000041
J	Zhang, YJ; Wang, DM; Yang, LN; Zhou, D; Zhang, JF				Zhang, Yujuan; Wang, Dongmei; Yang, Lina; Zhou, Dan; Zhang, Jingfang			Purification and Characterization of Flavonoids from the Leaves of Zanthoxylum bungeanum and Correlation between Their Structure and Antioxidant Activity	PLOS ONE			English	Article							ALDOSE REDUCTASE; DNA-DAMAGE; EXTRACTS; ALKYLAMIDES; PROTECTION; PERICARPS; QUERCETIN; CHROMATOGRAPHY; CONSTITUENTS; INHIBITION	Nine flavonoids were isolated and characterized from the leaves of Zanthoxylum bungeanum. Their structures were elucidated by spectroscopic techniques as quercetin (1), afzelin (2), quercitrin (3), trifolin (4), quercetin-3-O-beta-D-glucoside (5), isorhamnetin 3-O-alpha-L-rhamnoside (6), hyperoside (7), vitexin (8) and rutin (9). All compounds were isolated from the leaves of Z. bungeanum for the first time. Five compounds (2, 4, 5, 6 and 8) were found for the first time in the genus Zanthoxylum. To learn the mechanisms underlying its health benefits, in vitro (DPPH, ABTS, FRAP and lipid peroxidation inhibition assays) and in vivo (protective effect on Escherichia coli under peroxide stress) antioxidant activities of the nine flavonoids were measured. Quercetin and quercetin glycosides (compounds 1, 3, 5, 7, 9) showed the highest antioxidant activity. Structure-activity relationships indicated that the -OH in 49 position on the B ring and the -OH in 7 position on the A ring possessed high antioxidant activity; B ring and/or A ring with adjacent -OH groups could greatly increase their antioxidant ability. Also, due to the different structures of various flavonoids, they will certainly exhibit different antioxidant capacity when the reactions occur in solution or in oil-in-water emulsion. These findings suggest that Z. bungeanum leaves may have health benefits when consumed. It could become a useful supplement for pharmaceutical products and functional food ingredients in both nutraceutical and food industries as a potential source of natural antioxidants.	[Zhang, Yujuan; Wang, Dongmei; Yang, Lina; Zhou, Dan; Zhang, Jingfang] Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China	Northwest A&F University - China	Wang, DM (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China.	dmwli@163.com		Jia, Jianping/0000-0003-4624-0336; Zhang, Yujuan/0000-0002-3243-1644; Zhang, Yiguo/0000-0003-3910-2779; Hayes, John/0000-0002-2927-5548	Special Fund for Forestry Scientific Research in the Public Interest of China [201304811]; Fundamental Research Funds for the Central Universities [ZD2013010]	Special Fund for Forestry Scientific Research in the Public Interest of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors are grateful to the research fund from the Special Fund for Forestry Scientific Research in the Public Interest of China (201304811) and the Fundamental Research Funds for the Central Universities (ZD2013010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne SA, 2000, FREE RADICAL BIO MED, V29, P507, DOI 10.1016/S0891-5849(00)00360-9; Azimova SS, 2013, PHYSICOCHEMCIAL PHAR; Bauer R, 2011, CURR CLIN UROL, P191, DOI 10.1007/978-1-60327-420-3_10; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bourassa P, 2013, J PHOTOCH PHOTOBIO B, V128, P43, DOI 10.1016/j.jphotobiol.2013.07.021; Chang ZQ, 1981, ACTA PHARM SINICA, V16, P394; Costantino L, 1997, EXPERT OPIN THER PAT, V7, P843, DOI 10.1517/13543776.7.8.843; de Freitas V, 2001, J AGR FOOD CHEM, V49, P940, DOI 10.1021/jf000981z; Decker EA, 2005, J AGR FOOD CHEM, V53, P4303, DOI 10.1021/jf058012x; [邓振义 Deng Zhenyi], 2005, [西北林学院学报, Journal of Northwest Forestry College], V20, P179; Dhar P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-259; Dorman H. J. D., 1995, Journal of Essential Oil Research, V7, P645; Dubeau S, 2010, FOOD CHEM, V122, P539, DOI 10.1016/j.foodchem.2010.03.005; Duke J. A., 1985, MED PLANTS CHINA, P705; Ferrali M, 1997, FEBS LETT, V416, P123, DOI 10.1016/S0014-5793(97)01182-4; GALVEZ J, 1993, J PHARM PHARMACOL, V45, P157, DOI 10.1111/j.2042-7158.1993.tb03706.x; Gouveia S, 2012, PHYTOCHEM ANALYSIS, V23, P72, DOI 10.1002/pca.1326; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; HUANG XL, 1993, PHYTOTHER RES, V7, P41, DOI 10.1002/ptr.2650070111; Ibrahim LF, 2002, MOLECULES, V7, P245; Jung HA, 2011, FOOD CHEM TOXICOL, V49, P376, DOI 10.1016/j.fct.2010.11.012; KIMUYA Y, 1981, CHEM PHARM BULL, V29, P2610; Lee KW, 2003, J AGR FOOD CHEM, V51, P6516, DOI 10.1021/jf034475w; Li H, 2012, FOOD CHEM, V135, P2942, DOI 10.1016/j.foodchem.2012.07.048; Li Y, 2001, Zhong Yao Cai, V24, P572; Ma XF, 2005, J CHROMATOGR A, V1070, P211, DOI 10.1016/j.chroma.2005.02.052; Matsuda H, 2002, CHEM PHARM BULL, V50, P788, DOI 10.1248/cpb.50.788; Melidou M, 2005, FREE RADICAL BIO MED, V39, P1591, DOI 10.1016/j.freeradbiomed.2005.08.009; Miguel G, 2004, FOOD CHEM, V86, P183, DOI 10.1016/j.foodchem.2003.08.031; MIZUTANI K, 1988, CHEM PHARM BULL, V36, P2362, DOI 10.1248/cpb.36.2362; Nassar M. I., 2010, Revista Latinoamericana de Quimica, V38, P103; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; OSHIMA R, 1982, CARBOHYD RES, V107, P169, DOI 10.1016/S0008-6215(00)80536-4; Rastelli G, 2000, BIOORGAN MED CHEM, V8, P1151, DOI 10.1016/S0968-0896(00)00052-3; Ren L, 1981, XAOXUE XUEBAO, V16, P672; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Rodriguez P, 2010, FITOTERAPIA, V81, P1220, DOI 10.1016/j.fitote.2010.08.007; Smirnova GV, 2010, WORLD J MICROB BIOT, V26, P2269, DOI 10.1007/s11274-010-0417-4; Smirnova GV, 2009, FREE RADICAL BIO MED, V46, P759, DOI 10.1016/j.freeradbiomed.2008.11.017; Tachakittirungrod S, 2007, FOOD CHEM, V103, P381, DOI 10.1016/j.foodchem.2006.07.034; Tirillini B., 1994, Journal of Essential Oil Research, V6, P249; TK Lim, 2012, ZANTHOXYLUM SIMULANS, P904; Urzhumtsev A, 1997, STRUCTURE, V5, P601, DOI 10.1016/S0969-2126(97)00216-5; Wang DM, 2013, ALLELOPATHY J, V32, P67; Wang S, 2011, J LIQ CHROMATOGR R T, V34, P2640, DOI 10.1080/10826076.2011.593219; Watjen W, 2005, J NUTR, V135, P525, DOI 10.1093/jn/135.3.525; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; XIONG QB, 1995, PHYTOCHEMISTRY, V39, P723, DOI 10.1016/0031-9422(94)00965-V; Xiong QB, 1997, PHYTOCHEMISTRY, V46, P1123, DOI 10.1016/S0031-9422(97)84398-1; Xu HR, 2010, TEXTBOOK OF PERINATAL EPIDEMIOLOGY, P111; Yang LC, 2013, J AGR FOOD CHEM, V61, P1772, DOI 10.1021/jf3042825; Yang XG, 2008, J AGR FOOD CHEM, V56, P1689, DOI 10.1021/jf0728101; YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007; Yeung H., 1985, HDB CHINESE HERBS FO, VVolume 1; Zhou X, 2005, J CHROMATOGR A, V1092, P216, DOI 10.1016/j.chroma.2005.07.064	56	446	470	16	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105725	10.1371/journal.pone.0105725	http://dx.doi.org/10.1371/journal.pone.0105725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25290918	Green Submitted, Green Published, gold			2022-12-27	WOS:000341303200055
